sampleID	AJCC_Stage_nature2012	Age_at_Initial_Pathologic_Diagnosis_nature2012	CN_Clusters_nature2012	Converted_Stage_nature2012	Days_to_Date_of_Last_Contact_nature2012	Days_to_date_of_Death_nature2012	ER_Status_nature2012	Gender_nature2012	HER2_Final_Status_nature2012	Integrated_Clusters_no_exp__nature2012	Integrated_Clusters_unsup_exp__nature2012	Integrated_Clusters_with_PAM50__nature2012	Metastasis_Coded_nature2012	Metastasis_nature2012	Node_Coded_nature2012	Node_nature2012	OS_Time_nature2012	OS_event_nature2012	PAM50Call_RNAseq	PAM50_mRNA_nature2012	PR_Status_nature2012	RPPA_Clusters_nature2012	SigClust_Intrinsic_mRNA_nature2012	SigClust_Unsupervised_mRNA_nature2012	Survival_Data_Form_nature2012	Tumor_T1_Coded_nature2012	Tumor_nature2012	Vital_Status_nature2012	_EVENT	_INTEGRATION	_OS	_OS_IND	_PANCAN_CNA_PANCAN_K8	_PANCAN_Cluster_Cluster_PANCAN	_PANCAN_DNAMethyl_BRCA	_PANCAN_DNAMethyl_PANCAN	_PANCAN_RPPA_PANCAN_K8	_PANCAN_UNC_RNAseq_PANCAN_K16	_PANCAN_miRNA_PANCAN	_PANCAN_mirna_BRCA	_PANCAN_mutation_PANCAN	_PATIENT	_RFS	_RFS_IND	_TIME_TO_EVENT	_anatomical_origin	_cohort	_primary_disease	additional_pharmaceutical_therapy	additional_radiation_therapy	additional_surgery_locoregional_procedure	additional_surgery_metastatic_procedure	age_at_initial_pathologic_diagnosis	anatomic_neoplasm_subdivision	axillary_lymph_node_stage_method_type	axillary_lymph_node_stage_other_method_descriptive_text	bcr_followup_barcode	breast_cancer_surgery_margin_status	breast_carcinoma_estrogen_receptor_status	breast_carcinoma_immunohistochemistry_er_pos_finding_scale	breast_carcinoma_immunohistochemistry_pos_cell_score	breast_carcinoma_immunohistochemistry_prgstrn_rcptr_ps_fndng_scl	breast_carcinoma_primary_surgical_procedure_name	breast_carcinoma_progesterone_receptor_status	breast_carcinoma_surgical_procedure_name	breast_neoplasm_other_surgical_procedure_descriptive_text	cytokeratin_immunohistochemistry_staining_method_mcrmtstss_ndctr	days_to_additional_surgery_locoregional_procedure	days_to_additional_surgery_metastatic_procedure	days_to_birth	days_to_collection	days_to_death	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_last_known_alive	days_to_new_tumor_event_additional_surgery_procedure	days_to_new_tumor_event_after_initial_treatment	disease_code	distant_metastasis_present_ind2	er_detection_method_text	er_level_cell_percentage_category	first_nonlymph_node_metastasis_anatomic_site	first_recurrent_non_nodal_metastatic_anatomic_site_descriptv_txt	fluorescence_in_st_hybrdztn_dgnstc_prcdr_chrmsm_17_sgnl_rslt_rng	followup_case_report_form_submission_reason	form_completion_date	gender	her2_and_centromere_17_positive_finding_other_measuremnt_scl_txt	her2_erbb_method_calculation_method_text	her2_erbb_pos_finding_cell_percent_category	her2_erbb_pos_finding_fluorescence_n_st_hybrdztn_clcltn_mthd_txt	her2_immunohistochemistry_level_result	her2_neu_and_centromere_17_copy_number_analysis_npt_ttl_nmbr_cnt	her2_neu_breast_carcinoma_copy_analysis_input_total_number	her2_neu_chromosone_17_signal_ratio_value	her2_neu_metastatic_breast_carcinoma_copy_analysis_inpt_ttl_nmbr	histological_type	histological_type_other	history_of_neoadjuvant_treatment	hr2_n_nd_cntrmr_17_cpy_nmbr_mtsttc_brst_crcnm_nlyss_npt_ttl_nmbr	icd_10	icd_o_3_histology	icd_o_3_site	immunohistochemistry_positive_cell_score	informed_consent_verified	init_pathology_dx_method_other	initial_pathologic_diagnosis_method	initial_weight	is_ffpe	lab_proc_her2_neu_immunohistochemistry_receptor_status	lab_procedure_her2_neu_in_situ_hybrid_outcome_type	lost_follow_up	lymph_node_examined_count	margin_status	menopause_status	metastatic_breast_carcinm_ps_fndng_prgstrn_rcptr_thr_msr_scl_txt	metastatic_breast_carcinom_lb_prc_hr2_n_mmnhstchmstry_rcptr_stts	metastatic_breast_carcinoma_erbb2_immunohistochemistry_levl_rslt	metastatic_breast_carcinoma_estrogen_receptor_detection_mthd_txt	metastatic_breast_carcinoma_estrogen_receptor_status	metastatic_breast_carcinoma_estrogen_receptr_lvl_cll_prcnt_ctgry	metastatic_breast_carcinoma_her2_erbb_method_calculatin_mthd_txt	metastatic_breast_carcinoma_her2_erbb_pos_findng_cll_prcnt_ctgry	metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_rat_vl	metastatic_breast_carcinoma_immunhstchmstry_r_pstv_fndng_scl_typ	metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_scr	metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_scr	metastatic_breast_carcinoma_lab_proc_hr2_n_n_st_hybrdztn_tcm_typ	metastatic_breast_carcinoma_pos_finding_hr2_rbb2_thr_msr_scl_txt	metastatic_breast_carcinoma_progestern_rcptr_lvl_cll_prcnt_ctgry	metastatic_breast_carcinoma_progesterone_receptor_dtctn_mthd_txt	metastatic_breast_carcinoma_progesterone_receptor_status	methylation_Clusters_nature2012	miRNA_Clusters_nature2012	mtsttc_brst_crcnm_flrscnc_n_st_hybrdztn_dgnstc_prc_cntrmr_17_sgn	mtsttc_brst_crcnm_hr2_rbb_ps_fndng_flrscnc_n_st_hybrdztn_clcltn	mtsttc_brst_crcnm_mmnhstchmstry_prgstrn_rcptr_pstv_fndng_scl_typ	new_neoplasm_event_occurrence_anatomic_site	new_neoplasm_event_type	new_neoplasm_occurrence_anatomic_site_text	new_tumor_event_additional_surgery_procedure	new_tumor_event_after_initial_treatment	number_of_lymphnodes_positive_by_he	number_of_lymphnodes_positive_by_ihc	oct_embedded	pathologic_M	pathologic_N	pathologic_T	pathologic_stage	pathology_report_file_name	percent_lymphocyte_infiltration_BOTTOM	percent_lymphocyte_infiltration_TOP	percent_monocyte_infiltration_BOTTOM	percent_monocyte_infiltration_TOP	percent_necrosis_BOTTOM	percent_necrosis_TOP	percent_neutrophil_infiltration_BOTTOM	percent_neutrophil_infiltration_TOP	percent_normal_cells_BOTTOM	percent_normal_cells_TOP	percent_stromal_cells_BOTTOM	percent_stromal_cells_TOP	percent_tumor_cells_BOTTOM	percent_tumor_cells_TOP	percent_tumor_nuclei_BOTTOM	percent_tumor_nuclei_TOP	person_neoplasm_cancer_status	pgr_detection_method_text	pos_finding_her2_erbb2_other_measurement_scale_text	pos_finding_metastatic_brst_crcnm_strgn_rcptr_thr_msrmnt_scl_txt	pos_finding_progesterone_receptor_other_measurement_scale_text	positive_finding_estrogen_receptor_other_measurement_scale_text	postoperative_rx_tx	primary_lymph_node_presentation_assessment	prior_dx	progesterone_receptor_level_cell_percent_category	project_code	radiation_therapy	sample_type	sample_type_id	surgical_procedure_purpose_other_text	system_version	targeted_molecular_therapy	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	tumor_tissue_site	vial_number	vital_status	year_of_initial_pathologic_diagnosis	_GENOMIC_ID_TCGA_BRCA_mutation	_GENOMIC_ID_TCGA_BRCA_PDMarrayCNV	_GENOMIC_ID_TCGA_BRCA_miRNA_HiSeq	_GENOMIC_ID_TCGA_BRCA_miRNA	_GENOMIC_ID_TCGA_BRCA_mutation_unc_gene	_GENOMIC_ID_TCGA_BRCA_RPPA	_GENOMIC_ID_TCGA_BRCA_mutation_curated_wustl_gene	_GENOMIC_ID_TCGA_BRCA_RPPA_RBN	_GENOMIC_ID_TCGA_BRCA_mutation_wustl_gene	_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_exon	_GENOMIC_ID_TCGA_BRCA_GSNP6raw	_GENOMIC_ID_TCGA_BRCA_gistic2	_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_PANCAN	_GENOMIC_ID_TCGA_BRCA_hMethyl450	_GENOMIC_ID_TCGA_BRCA_PDMRNAseq	_GENOMIC_ID_TCGA_BRCA_G4502A_07_3	_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_percentile	_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2	_GENOMIC_ID_TCGA_BRCA_gistic2thd	_GENOMIC_ID_TCGA_BRCA_PDMarray	_GENOMIC_ID_TCGA_BRCA_PDMRNAseqCNV	_GENOMIC_ID_TCGA_BRCA_hMethyl27	_GENOMIC_ID_TCGA_BRCA_GSNP6noCNV	_GENOMIC_ID_TCGA_BRCA_miRNA_GA
TCGA-3C-AAAU-01																													0	TCGA-3C-AAAU-01	3928	0										TCGA-3C-AAAU	1808	1	3928	Breast	TCGA Breast Cancer	breast invasive carcinoma					55	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-3C-AAAU-F68069		Positive					Positive	Modified Radical Mastectomy		YES			-20211	3599		0	3928			1808				50-59%					2014-11-13	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.5		YES			60	NO	Negative		NO	13	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																							Lung	Distant Metastasis			YES	4		true	MX	NX	TX	Stage X	TCGA-3C-AAAU.0CD23E1B-3FA3-4A43-AE6E-C8E7B51252F8.pdf		40		20		0		20		0		30		70		70	WITH TUMOR						YES	YES	No	50-59%		NO	Primary Tumor	01		6th		NO	YES	3C	Breast	A	LIVING	2004			TCGA-3C-AAAU-01A-11R-A41G-13	TCGA-3C-AAAU-01A-11R-A41G-13						6ef883fc-81f3-4089-95e0-86904ffc0d38	d247c6c5-a429-41ae-83d9-bf8307ab76e5	TCGA-3C-AAAU-01A-11D-A41E-01	6ef883fc-81f3-4089-95e0-86904ffc0d38	TCGA-3C-AAAU-01A-11D-A41Q-05	TCGA-3C-AAAU-01		6ef883fc-81f3-4089-95e0-86904ffc0d38	6ef883fc-81f3-4089-95e0-86904ffc0d38	TCGA-3C-AAAU-01A-11D-A41E-01		TCGA-3C-AAAU-01		d247c6c5-a429-41ae-83d9-bf8307ab76e5	
TCGA-3C-AALI-01																													0	TCGA-3C-AALI-01	4005	0										TCGA-3C-AALI	4005	0	4005	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-3C-AALI-F68057		Positive					Positive	Lumpectomy					-18538	3772		0	4005							<10%					2014-11-13	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Core needle biopsy	120	NO	Positive		NO	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1		true	M0	N1a	T2	Stage IIB	TCGA-3C-AALI.84E6A935-1A49-4BC1-9669-3DEA161CF6FC.pdf		2		0		0		0		5		35		60		60	TUMOR FREE						YES	YES	No	<10%		YES	Primary Tumor	01		6th		NO	YES	3C	Breast	A	LIVING	2003			TCGA-3C-AALI-01A-11R-A41G-13	TCGA-3C-AALI-01A-11R-A41G-13						dd8d3665-ec9d-45be-b7b9-a85dac3585e2	0fa8d96d-b739-4da6-b525-c62cdabee68c	TCGA-3C-AALI-01A-11D-A41E-01	dd8d3665-ec9d-45be-b7b9-a85dac3585e2	TCGA-3C-AALI-01A-11D-A41Q-05	TCGA-3C-AALI-01		dd8d3665-ec9d-45be-b7b9-a85dac3585e2	dd8d3665-ec9d-45be-b7b9-a85dac3585e2	TCGA-3C-AALI-01A-11D-A41E-01		TCGA-3C-AALI-01		0fa8d96d-b739-4da6-b525-c62cdabee68c	
TCGA-3C-AALJ-01																													0	TCGA-3C-AALJ-01	1302	0										TCGA-3C-AALJ	1302	0	1302	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Right			TCGA-3C-AALJ-F68060		Positive					Positive	Modified Radical Mastectomy					-22848	1026		0	1302							90-99%					2014-11-13	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.8		YES		Core needle biopsy	420	NO	Indeterminate		NO	23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1		true	M0	N1a	T2	Stage IIB	TCGA-3C-AALJ.265E5A9A-64FD-4B86-89BC-5E89F253C118.pdf		4		0		0		0		0		0		100		65	TUMOR FREE						YES	YES	No	30-39%		NO	Primary Tumor	01		7th		NO	YES	3C	Breast	A	LIVING	2011			TCGA-3C-AALJ-01A-31R-A41G-13	TCGA-3C-AALJ-01A-31R-A41G-13						c924c2a8-ab41-4499-bb30-79705cc17d45	6cb7dc53-ea35-431b-9bd9-4f13f5ec40fd	TCGA-3C-AALJ-01A-31D-A41E-01	c924c2a8-ab41-4499-bb30-79705cc17d45	TCGA-3C-AALJ-01A-31D-A41Q-05	TCGA-3C-AALJ-01		c924c2a8-ab41-4499-bb30-79705cc17d45	c924c2a8-ab41-4499-bb30-79705cc17d45	TCGA-3C-AALJ-01A-31D-A41E-01		TCGA-3C-AALJ-01		6cb7dc53-ea35-431b-9bd9-4f13f5ec40fd	
TCGA-3C-AALK-01																													0	TCGA-3C-AALK-01	1221	0										TCGA-3C-AALK	1221	0	1221	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Right	Sentinel node biopsy alone		TCGA-3C-AALK-F68063		Positive					Positive	Simple Mastectomy		YES			-19074	1022		0	1221							70-79%					2014-11-13	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1		YES		Core needle biopsy	140	NO	Positive		NO	2	Close																												NO	0	1	true	M0	N0 (i+)	T1c	Stage IA	TCGA-3C-AALK.F43B01E6-E1DB-44B1-8003-93870606346A.pdf		2		0		5		0		5		30		60		60	TUMOR FREE						YES	YES	No	80-89%		NO	Primary Tumor	01		7th		NO	YES	3C	Breast	A	LIVING	2011			TCGA-3C-AALK-01A-11R-A41G-13	TCGA-3C-AALK-01A-11R-A41G-13						1a19e068-d213-41ef-aebb-104017a883cc	52dbb525-a0ad-4dce-bb51-650f97510c6e	TCGA-3C-AALK-01A-11D-A41E-01	1a19e068-d213-41ef-aebb-104017a883cc	TCGA-3C-AALK-01A-11D-A41Q-05	TCGA-3C-AALK-01		1a19e068-d213-41ef-aebb-104017a883cc	1a19e068-d213-41ef-aebb-104017a883cc	TCGA-3C-AALK-01A-11D-A41E-01		TCGA-3C-AALK-01		52dbb525-a0ad-4dce-bb51-650f97510c6e	
TCGA-4H-AAAK-01																													0	TCGA-4H-AAAK-01	348	0										TCGA-4H-AAAK	348	0	348	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Left|Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-4H-AAAK-F67414		Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-18371	35		0	348							60-69%					2014-11-13	FEMALE			10-19%		2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Core needle biopsy	770	NO	Equivocal		NO	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	4		true	M0	N2a	T2	Stage IIIA	TCGA-4H-AAAK.8894688F-7167-48A1-BB1B-FC219B7675C2.pdf		5		0		0		0		10		20		70		70	TUMOR FREE						YES	YES	No	70-79%		NO	Primary Tumor	01		7th		YES	NO	4H	Breast	A	LIVING	2013			TCGA-4H-AAAK-01A-12R-A41G-13	TCGA-4H-AAAK-01A-12R-A41G-13						2ea9e472-a408-4ae0-975d-50a566f22b2a	1d102fff-6466-491d-9727-9f059aad616f	TCGA-4H-AAAK-01A-12D-A41E-01	2ea9e472-a408-4ae0-975d-50a566f22b2a	TCGA-4H-AAAK-01A-12D-A41Q-05	TCGA-4H-AAAK-01		2ea9e472-a408-4ae0-975d-50a566f22b2a	2ea9e472-a408-4ae0-975d-50a566f22b2a	TCGA-4H-AAAK-01A-12D-A41E-01		TCGA-4H-AAAK-01		1d102fff-6466-491d-9727-9f059aad616f	
TCGA-5L-AAT0-01																														TCGA-5L-AAT0-01												TCGA-5L-AAT0				Breast	TCGA Breast Cancer	breast invasive carcinoma																							1320																																					80	NO																																				false					TCGA-5L-AAT0.F9B6971F-23C0-465F-BFEC-778BF228A1AE.pdf		40		20		5		20		0		25		70		70													Primary Tumor	01								A					TCGA-5L-AAT0-01A-12R-A41G-13	TCGA-5L-AAT0-01A-12R-A41G-13						32e61645-eb89-49f7-9876-85b1497c7e42	615b2826-7f9f-498b-8309-d4d54d598c50	TCGA-5L-AAT0-01A-12D-A41E-01	32e61645-eb89-49f7-9876-85b1497c7e42	TCGA-5L-AAT0-01A-12D-A41Q-05	TCGA-5L-AAT0-01		32e61645-eb89-49f7-9876-85b1497c7e42	32e61645-eb89-49f7-9876-85b1497c7e42	TCGA-5L-AAT0-01A-12D-A41E-01		TCGA-5L-AAT0-01		615b2826-7f9f-498b-8309-d4d54d598c50	
TCGA-5L-AAT1-01																														TCGA-5L-AAT1-01												TCGA-5L-AAT1				Breast	TCGA Breast Cancer	breast invasive carcinoma																							1259																																					130	NO																																				false					TCGA-5L-AAT1.B5CA42BB-9514-42C6-9FB0-C8889C1DC51A.pdf		40		20		5		20		0		35		60		60													Primary Tumor	01								A					TCGA-5L-AAT1-01A-12R-A41G-13	TCGA-5L-AAT1-01A-12R-A41G-13						34dfa8c6-6445-4ef8-bc3b-b2ba600b5808	4d7ffa3e-0218-4fc4-b3da-691d56a7df1a	TCGA-5L-AAT1-01A-12D-A41E-01	34dfa8c6-6445-4ef8-bc3b-b2ba600b5808	TCGA-5L-AAT1-01A-12D-A41Q-05	TCGA-5L-AAT1-01		34dfa8c6-6445-4ef8-bc3b-b2ba600b5808	34dfa8c6-6445-4ef8-bc3b-b2ba600b5808	TCGA-5L-AAT1-01A-12D-A41E-01		TCGA-5L-AAT1-01		4d7ffa3e-0218-4fc4-b3da-691d56a7df1a	
TCGA-5T-A9QA-01																													0	TCGA-5T-A9QA-01	303	0										TCGA-5T-A9QA	303	0	303	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Left	No axillary staging		TCGA-5T-A9QA-F66889		Positive	3 Point Scale				Negative			NO			-19031	31		0	303							70-79%					2014-10-25	FEMALE			10-19%		2+					Other  specify	infiltrating ductal and mucinous	No		C50.9	8523/3	C50.9	2+	YES		Excisional Biopsy	650	NO	Equivocal	Negative	NO																														NO			true	MX	NX	T2	Stage IIA	TCGA-5T-A9QA.2DB5519B-B36D-4616-94F3-601A01185F22.pdf		5		0		0		0		20		5		75		75							YES	NO	No			YES	Primary Tumor	01		7th		YES	NO	5T	Breast	A	LIVING	2013			TCGA-5T-A9QA-01A-11R-A41G-13	TCGA-5T-A9QA-01A-11R-A41G-13						41ab76d7-fae0-490c-9545-be576b64b827	74d626f8-5b32-4cc9-b86a-2ddd8fd46651	TCGA-5T-A9QA-01A-11D-A41E-01	41ab76d7-fae0-490c-9545-be576b64b827	TCGA-5T-A9QA-01A-11D-A41Q-05	TCGA-5T-A9QA-01		41ab76d7-fae0-490c-9545-be576b64b827	41ab76d7-fae0-490c-9545-be576b64b827	TCGA-5T-A9QA-01A-11D-A41E-01		TCGA-5T-A9QA-01		74d626f8-5b32-4cc9-b86a-2ddd8fd46651	
TCGA-A1-A0SB-01	Stage I	70	1	Stage I	259		Positive	FEMALE	Negative				Negative	M0	Negative	N0	259	0	Normal		Negative				enrollment	T1	T1	LIVING	0	TCGA-A1-A0SB-01	259	0	Kirc+	C4-BRCA/Basal	cluster 5	Low purity c2		BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-A1-A0SB			259	Breast	TCGA Breast Cancer	breast invasive carcinoma					70	Left	Sentinel node biopsy alone				Positive					Negative	Lumpectomy					-25833			0	259					NO		70-79%					2011-6-30	FEMALE										Other  specify	Adenoid Cystic Carcinoma	No		C50.9	8200/3	C50.9		YES		Fine needle aspiration biopsy			Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3									0			M0	N0	T1c	Stage I																		TUMOR FREE							YES	No				Primary Tumor	01		6th		NO	YES	A1	Breast		LIVING	2008	TCGA-A1-A0SB-01A-11D-A142-09		TCGA-A1-A0SB-01A-11R-A143-13	TCGA-A1-A0SB-01A-11R-A143-13	TCGA-A1-A0SB-01A-11D-A142-09		TCGA-A1-A0SB-01A-11D-A142-09		TCGA-A1-A0SB-01A-11D-A142-09	a2405d64-34eb-4915-abf7-8530151d5cb0	d4c2fab5-8fbd-4ab5-b18c-37f9b4b576a8	TCGA-A1-A0SB-01A-11D-A141-01	a2405d64-34eb-4915-abf7-8530151d5cb0	TCGA-A1-A0SB-01A-11D-A145-05	TCGA-A1-A0SB-01		a2405d64-34eb-4915-abf7-8530151d5cb0	a2405d64-34eb-4915-abf7-8530151d5cb0	TCGA-A1-A0SB-01A-11D-A141-01		TCGA-A1-A0SB-01		d4c2fab5-8fbd-4ab5-b18c-37f9b4b576a8	
TCGA-A1-A0SD-01	Stage IIA	59	2	Stage IIA	437		Positive	FEMALE	Negative				Negative	M0	Negative	N0	437	0	LumA	Luminal A	Positive		-9	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SD-01	437	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-A1-A0SD			437	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Left	Sentinel lymph node biopsy plus axillary dissection			Negative	Positive				Lumpectomy	Positive	Lumpectomy					-21793	1697		0	437							90-99%					2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	50	NO	Negative			3	Positive																			1	6									0	0	true	M0	N0	T2	Stage IIA	TCGA-A1-A0SD.DD89D265-9E20-49C2-93BD-666BE7D5E41B.pdf	2	2	0	0	0	1	0	0	15	3	60	36	25	60	25	60								YES	No	90-99%			Primary Tumor	01		6th		NO	YES	A1	Breast	A	LIVING	2005	TCGA-A1-A0SD-01A-11D-A10Y-09	TCGA-A1-A0SD-01	TCGA-A1-A0SD-01A-11R-A114-13	TCGA-A1-A0SD-01A-11R-A114-13	TCGA-A1-A0SD-01A-11D-A10Y-09		TCGA-A1-A0SD-01A-11D-A10Y-09		TCGA-A1-A0SD-01A-11D-A10Y-09	15bad71d-3031-413b-9e8d-6426ae5dfbea	07321363-1d47-430a-a3ce-ec16f9b52d3a	TCGA-A1-A0SD-01A-11D-A111-01	15bad71d-3031-413b-9e8d-6426ae5dfbea		TCGA-A1-A0SD-01	TCGA-A1-A0SD-01A-11R-A115-07	15bad71d-3031-413b-9e8d-6426ae5dfbea	15bad71d-3031-413b-9e8d-6426ae5dfbea	TCGA-A1-A0SD-01A-11D-A111-01	TCGA-A1-A0SD-01	TCGA-A1-A0SD-01	TCGA-A1-A0SD-01A-11D-A112-05	07321363-1d47-430a-a3ce-ec16f9b52d3a	
TCGA-A1-A0SE-01	Stage I	56	2	Stage I	1320		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1320	0	LumA	Luminal A	Positive		-5	-7	enrollment	T1	T1	LIVING	0	TCGA-A1-A0SE-01	1321	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-A1-A0SE			1321	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection				Positive		3+			Positive	Modified Radical Mastectomy					-20717	1672		0	1321							80-89%			2		2010-12-6	FEMALE					1+		2	1		Mixed Histology (please specify)	invasive ductal and lobular carcinoma	No		C50.9	8522/3	C50.9	3+	YES		Core needle biopsy	90	NO	Negative	Negative		8	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	6									0		true	M0	N0 (i-)	T1c	Stage I	TCGA-A1-A0SE.CFF567FC-8867-4CA4-85AE-81A7D30095E7.pdf	2	3	0	0	0	0	0	0	7	15	13	15	80	70	80	70	TUMOR FREE								No	90-99%			Primary Tumor	01		6th		NO	YES	A1	Breast	A	LIVING	2005	TCGA-A1-A0SE-01A-11D-A099-09	TCGA-A1-A0SE-01		TCGA-A1-A0SE-01A-11R-A085-13	TCGA-A1-A0SE-01A-11D-A099-09		TCGA-A1-A0SE-01A-11D-A099-09		TCGA-A1-A0SE-01A-11D-A099-09	a998e0ce-9248-460f-aabc-2dad452a1ff9	401a4b1d-1f1d-4d3c-b330-02fb9ba433d3	TCGA-A1-A0SE-01A-11D-A087-01	a998e0ce-9248-460f-aabc-2dad452a1ff9	TCGA-A1-A0SE-01A-11D-A10P-05	TCGA-A1-A0SE-01	TCGA-A1-A0SE-01A-11R-A084-07	a998e0ce-9248-460f-aabc-2dad452a1ff9	a998e0ce-9248-460f-aabc-2dad452a1ff9	TCGA-A1-A0SE-01A-11D-A087-01	TCGA-A1-A0SE-01	TCGA-A1-A0SE-01		401a4b1d-1f1d-4d3c-b330-02fb9ba433d3	TCGA-A1-A0SE-01A-11R-A085-13
TCGA-A1-A0SF-01	Stage IIA	54	3	Stage IIA	1463		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1463	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SF-01	1463	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 6	mutation c1uster 9	TCGA-A1-A0SF			1463	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Left	Sentinel lymph node biopsy plus axillary dissection				Positive					Positive	Modified Radical Mastectomy					-19731	1648		0	1463					NO		90-99%					2011-5-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	190	NO	Negative			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	6									0		true	M0	N0	T2	Stage IIA	TCGA-A1-A0SF.1617B36B-4EFB-445E-95BC-E63B129AAAE7.pdf	3	3	0	0	1	0	0	0	2	3	27	27	70	70	70	70	TUMOR FREE							YES	No	90-99%			Primary Tumor	01		6th		NO	YES	A1	Breast	A	LIVING	2006	TCGA-A1-A0SF-01A-11D-A142-09		TCGA-A1-A0SF-01A-11R-A143-13	TCGA-A1-A0SF-01A-11R-A143-13	TCGA-A1-A0SF-01A-11D-A142-09		TCGA-A1-A0SF-01A-11D-A142-09	TCGA-A1-A0SF-01A-21-A17I-20	TCGA-A1-A0SF-01A-11D-A142-09	28089e15-5e2c-4e83-ba6c-62b3cb40e431	ea71ebc6-d742-4a38-8b9a-1e8b63f43b38	TCGA-A1-A0SF-01A-11D-A141-01	28089e15-5e2c-4e83-ba6c-62b3cb40e431	TCGA-A1-A0SF-01A-11D-A145-05	TCGA-A1-A0SF-01		28089e15-5e2c-4e83-ba6c-62b3cb40e431	28089e15-5e2c-4e83-ba6c-62b3cb40e431	TCGA-A1-A0SF-01A-11D-A141-01		TCGA-A1-A0SF-01		ea71ebc6-d742-4a38-8b9a-1e8b63f43b38	
TCGA-A1-A0SG-01	Stage IIB	61	4	Stage IIB	433		Positive	FEMALE	Negative				Negative	M0	Positive	N1	433	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SG-01	434	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 5	mutation c1uster 9	TCGA-A1-A0SG			434	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Right	Sentinel lymph node biopsy plus axillary dissection				Positive					Positive	Lumpectomy					-22380	1581		0	434							90-99%					2011-5-31	FEMALE										Other  specify	micropapillary carcinoma invasive	No		C50.9	8507/3	C50.9		YES		Core needle biopsy	120	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	5									1		true	M0	N1a	T2	Stage IIB	TCGA-A1-A0SG.89A67051-898A-4E2A-A874-E0165F274E63.pdf	1	1	0	0	0	0	0	0	1	2	19	13	80	85	80	85								YES	No	90-99%			Primary Tumor	01		6th		NO	YES	A1	Breast	A	LIVING	2006	TCGA-A1-A0SG-01A-11D-A142-09		TCGA-A1-A0SG-01A-11R-A143-13	TCGA-A1-A0SG-01A-11R-A143-13	TCGA-A1-A0SG-01A-11D-A142-09		TCGA-A1-A0SG-01A-11D-A142-09		TCGA-A1-A0SG-01A-11D-A142-09	0df6b948-367d-4951-9d98-d3bebabff63e	75937dba-a780-42c5-91db-c7ae7a4b8c41	TCGA-A1-A0SG-01A-11D-A141-01	0df6b948-367d-4951-9d98-d3bebabff63e	TCGA-A1-A0SG-01A-11D-A145-05	TCGA-A1-A0SG-01		0df6b948-367d-4951-9d98-d3bebabff63e	0df6b948-367d-4951-9d98-d3bebabff63e	TCGA-A1-A0SG-01A-11D-A141-01		TCGA-A1-A0SG-01		75937dba-a780-42c5-91db-c7ae7a4b8c41	
TCGA-A1-A0SH-01	Stage IIA	39	5	Stage IIA	1437		Negative	FEMALE	Negative	1	1	1	Negative	M0	Negative	N0	1437	0	LumA	Luminal A	Positive	Her2	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SH-01	1437	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 9	cluster 4	mutation c1uster 10	TCGA-A1-A0SH			1437	Breast	TCGA Breast Cancer	breast invasive carcinoma					39	Left Upper Inner Quadrant	Sentinel node biopsy alone				Negative					Positive	Lumpectomy					-14595	1305		0	1437										1.8		2010-12-6	FEMALE					2+		2.5	1.4		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	240	NO	Equivocal	Negative		2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	4									0		true	M0	N0 (i-)	T2	Stage IIA	TCGA-A1-A0SH.1FB1255E-D9EC-4FE9-BE96-F81271FCCFB6.pdf	2	2	0	0	0	0	0	0	3	0	22	15	75	85	75	85	TUMOR FREE								No	90-99%			Primary Tumor	01		6th		NO	YES	A1	Breast	A	LIVING	2006	TCGA-A1-A0SH-01A-11D-A099-09	TCGA-A1-A0SH-01		TCGA-A1-A0SH-01A-11R-A085-13	TCGA-A1-A0SH-01A-11D-A099-09	4760c029-9150-4384-b036-263684155c89	TCGA-A1-A0SH-01A-11D-A099-09	TCGA-A1-A0SH-01A-21-A13A-20	TCGA-A1-A0SH-01A-11D-A099-09	dce3de3e-f851-4859-a208-72e65d36ab3d	43ba3339-996b-4477-878f-4a62c471ab5f	TCGA-A1-A0SH-01A-11D-A087-01	dce3de3e-f851-4859-a208-72e65d36ab3d	TCGA-A1-A0SH-01A-11D-A10P-05	TCGA-A1-A0SH-01	TCGA-A1-A0SH-01A-11R-A084-07	dce3de3e-f851-4859-a208-72e65d36ab3d	dce3de3e-f851-4859-a208-72e65d36ab3d	TCGA-A1-A0SH-01A-11D-A087-01	TCGA-A1-A0SH-01	TCGA-A1-A0SH-01		43ba3339-996b-4477-878f-4a62c471ab5f	TCGA-A1-A0SH-01A-11R-A085-13
TCGA-A1-A0SI-01	Stage IIB	52	3	Stage IIB	634		Positive	FEMALE	Negative				Negative	M0	Positive	N1	634	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SI-01	635	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 7	mutation cluster 3	TCGA-A1-A0SI			635	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Right	Sentinel lymph node biopsy plus axillary dissection				Positive					Positive	Lumpectomy					-19250	1267		0	635					NO		50-59%					2011-6-30	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	40	NO	Negative			23	Negative																			5	7									1		true	M0	N1a	T2	Stage IIB	TCGA-A1-A0SI.4CD6BDB7-9629-41C6-8514-7661E3D33A66.pdf	3	2	0	0	1	1	0	0	2	2	27	17	70	80	70	80	TUMOR FREE							YES	No	10-19%			Primary Tumor	01		6th		NO	YES	A1	Breast	A	LIVING	2007	TCGA-A1-A0SI-01A-11D-A142-09		TCGA-A1-A0SI-01A-11R-A143-13	TCGA-A1-A0SI-01A-11R-A143-13	TCGA-A1-A0SI-01A-11D-A142-09		TCGA-A1-A0SI-01A-11D-A142-09		TCGA-A1-A0SI-01A-11D-A142-09	44d93b9f-95d6-4382-9590-f6e7bdda65c5	35d22d6b-6b95-48bc-bc2f-fe4495ff188e	TCGA-A1-A0SI-01A-11D-A141-01	44d93b9f-95d6-4382-9590-f6e7bdda65c5	TCGA-A1-A0SI-01A-11D-A145-05	TCGA-A1-A0SI-01		44d93b9f-95d6-4382-9590-f6e7bdda65c5	44d93b9f-95d6-4382-9590-f6e7bdda65c5	TCGA-A1-A0SI-01A-11D-A141-01		TCGA-A1-A0SI-01		35d22d6b-6b95-48bc-bc2f-fe4495ff188e	
TCGA-A1-A0SJ-01	Stage IIIA	39	3	Stage IIIA	426		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N1	426	0	LumA	Luminal A	Positive	ReacI	-3	-3	enrollment	T_Other	T3	LIVING	0	TCGA-A1-A0SJ-01	416	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A1-A0SJ			416	Breast	TCGA Breast Cancer	breast invasive carcinoma					39	Left	Sentinel lymph node biopsy plus axillary dissection				Positive					Positive	Modified Radical Mastectomy					-14383	1399		0	416							70-79%			4		2010-12-6	FEMALE					2+		5	1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	140	NO	Equivocal	Negative		19	Negative																			4	4									3		true	M0	N1a	T3	Stage IIIA	TCGA-A1-A0SJ.0C0EEC9F-A715-4769-B58C-99D06C3C91F3.pdf	2	2	0	0	0	1	0	0	5	1	45	28	50	70	50	70	TUMOR FREE								No	10-19%			Primary Tumor	01		6th		NO	YES	A1	Breast	A	LIVING	2006	TCGA-A1-A0SJ-01A-11D-A099-09	TCGA-A1-A0SJ-01		TCGA-A1-A0SJ-01A-11R-A085-13	TCGA-A1-A0SJ-01A-11D-A099-09	33773418-77f8-4219-9b75-04d5ba09bb97	TCGA-A1-A0SJ-01A-11D-A099-09	TCGA-A1-A0SJ-01A-21-A13A-20	TCGA-A1-A0SJ-01A-11D-A099-09	61017170-a36a-4ce9-9b8e-324755b88dd7	c9020c2b-9c08-45c6-b13d-1bcb9f9d451f	TCGA-A1-A0SJ-01A-11D-A087-01	61017170-a36a-4ce9-9b8e-324755b88dd7	TCGA-A1-A0SJ-01A-11D-A10P-05	TCGA-A1-A0SJ-01	TCGA-A1-A0SJ-01A-11R-A084-07	61017170-a36a-4ce9-9b8e-324755b88dd7	61017170-a36a-4ce9-9b8e-324755b88dd7	TCGA-A1-A0SJ-01A-11D-A087-01	TCGA-A1-A0SJ-01	TCGA-A1-A0SJ-01		c9020c2b-9c08-45c6-b13d-1bcb9f9d451f	TCGA-A1-A0SJ-01A-11R-A085-13
TCGA-A1-A0SK-01	Stage IIA	54	1	Stage IIA	594	967	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	967	1	Basal	Basal-like	Negative	Basal	-13	-6	followup	T_Other	T2	DECEASED	1	TCGA-A1-A0SK-01	967	1	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	GBM-like c6	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-A1-A0SK			967	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A1-A0SK-F15926	Negative	Negative				Other	Negative	Lumpectomy	surgical resection				-20048	1164	967	0												Scheduled Follow-up Submission	2011-9-7	FEMALE					0					Other  specify	Neuroendocrine carcinoma, large-cell type, high-grade	No		C50.9	8013/3	C50.9		YES		Excisional Biopsy	160	NO	Negative			4	Positive	Indeterminate (neither Pre or Postmenopausal)																		5	5									0		true	M0	N0 (i-)	T2	Stage IIA	TCGA-A1-A0SK.13302EC6-6511-42FE-AA8B-C875B5384FFE.pdf	1	1	0	0	2	5	0	0	0	0	8	15	90	80	90	80	WITH TUMOR								No				Primary Tumor	01		6th		NO	YES	A1	Breast	A	DECEASED	2007	TCGA-A1-A0SK-01A-12D-A099-09	TCGA-A1-A0SK-01		TCGA-A1-A0SK-01A-12R-A085-13	TCGA-A1-A0SK-01A-12D-A099-09	8d8099ba-c207-473b-8ffc-e9610494386c	TCGA-A1-A0SK-01A-12D-A099-09	TCGA-A1-A0SK-01A-21-A13A-20	TCGA-A1-A0SK-01A-12D-A099-09	a63583ca-0ef2-4417-b435-5f3a6951d0c2	c76440c7-2213-4933-b79d-d832910334ea	TCGA-A1-A0SK-01A-12D-A087-01	a63583ca-0ef2-4417-b435-5f3a6951d0c2	TCGA-A1-A0SK-01A-12D-A10P-05	TCGA-A1-A0SK-01	TCGA-A1-A0SK-01A-12R-A084-07	a63583ca-0ef2-4417-b435-5f3a6951d0c2	a63583ca-0ef2-4417-b435-5f3a6951d0c2	TCGA-A1-A0SK-01A-12D-A087-01	TCGA-A1-A0SK-01	TCGA-A1-A0SK-01		c76440c7-2213-4933-b79d-d832910334ea	TCGA-A1-A0SK-01A-12R-A085-13
TCGA-A1-A0SM-01	Stage IIA	77	2	Stage IIA	242		Positive	MALE	Positive				Negative	M0	Negative	N0	242	0	LumA	Luminal B	Negative		-1	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SM-01	242	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A1-A0SM			242	Breast	TCGA Breast Cancer	breast invasive carcinoma					77	Left	Sentinel lymph node biopsy plus axillary dissection				Positive					Negative	Modified Radical Mastectomy					-28198	1115		0	242							20-29%			2		2010-12-6	MALE					3+		21	11		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Positive	Positive		3	Negative																			4	4									0		true	M0	N0 (i-)	T2	Stage IIA	TCGA-A1-A0SM.4F047F5B-EF3A-4590-8E7A-D90A52860324.pdf	3	2	0	0	1	1	0	0	0	0	19	9	80	90	80	90	TUMOR FREE								No				Primary Tumor	01		6th		NO	YES	A1	Breast	A	LIVING	2007	TCGA-A1-A0SM-01A-11D-A099-09	TCGA-A1-A0SM-01		TCGA-A1-A0SM-01A-11R-A085-13	TCGA-A1-A0SM-01A-11D-A099-09		TCGA-A1-A0SM-01A-11D-A099-09		TCGA-A1-A0SM-01A-11D-A099-09	e637db43-508a-4a37-92e4-eea96b35b65b	17bd1937-b31e-46af-8334-49b86f7a1922	TCGA-A1-A0SM-01A-11D-A087-01	e637db43-508a-4a37-92e4-eea96b35b65b	TCGA-A1-A0SM-01A-11D-A10P-05	TCGA-A1-A0SM-01	TCGA-A1-A0SM-01A-11R-A084-07	e637db43-508a-4a37-92e4-eea96b35b65b	e637db43-508a-4a37-92e4-eea96b35b65b	TCGA-A1-A0SM-01A-11D-A087-01	TCGA-A1-A0SM-01	TCGA-A1-A0SM-01		17bd1937-b31e-46af-8334-49b86f7a1922	TCGA-A1-A0SM-01A-11R-A085-13
TCGA-A1-A0SN-01	Stage IIIA	50	5	Stage IIA	1196		Positive	FEMALE	Positive				Negative	M0	Positive	N1	1196	0	LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-A1-A0SN-01	1196	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A1-A0SN			1196	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Left	Sentinel lymph node biopsy plus axillary dissection				Positive					Positive	Lumpectomy					-18401	1091		0	1196							90-99%					2011-5-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Positive			13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4									4		true	MX	N1	T1c	Stage IIA	TCGA-A1-A0SN.D0269758-EFAE-4EBA-8CCF-4A6CF4D4B35A.pdf	3	3	0	0	0	1	0	0	2	2	18	17	80	80	80	80	TUMOR FREE							YES	No	60-69%			Primary Tumor	01		6th		NO	YES	A1	Breast	A	LIVING	2007	TCGA-A1-A0SN-01A-11D-A142-09		TCGA-A1-A0SN-01A-11R-A143-13	TCGA-A1-A0SN-01A-11R-A143-13	TCGA-A1-A0SN-01A-11D-A142-09		TCGA-A1-A0SN-01A-11D-A142-09		TCGA-A1-A0SN-01A-11D-A142-09	7fdf1ebf-149a-43d5-bae7-6e01beb647dd	2e5d28ee-b288-466f-9d14-0ed674e0c6b0	TCGA-A1-A0SN-01A-11D-A141-01	7fdf1ebf-149a-43d5-bae7-6e01beb647dd	TCGA-A1-A0SN-01A-11D-A145-05	TCGA-A1-A0SN-01		7fdf1ebf-149a-43d5-bae7-6e01beb647dd	7fdf1ebf-149a-43d5-bae7-6e01beb647dd	TCGA-A1-A0SN-01A-11D-A141-01		TCGA-A1-A0SN-01		2e5d28ee-b288-466f-9d14-0ed674e0c6b0	
TCGA-A1-A0SO-01	Stage IIB	67	1	Stage IIB	852		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	852	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SO-01	852	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-A1-A0SO			852	Breast	TCGA Breast Cancer	breast invasive carcinoma					67	Right	Sentinel lymph node biopsy plus axillary dissection				Negative					Negative	Modified Radical Mastectomy					-24826	1057		0	852										3.2		2010-12-6	FEMALE							5	1.6		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Equivocal	Negative		9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5									1		true	M0	N1	T2	Stage IIB	TCGA-A1-A0SO.6104F94F-BA8F-4435-A839-E1FEA6EFFDF3.pdf	1	1	0	0	1	2	0	0	0	0	9	8	90	90	90	90	TUMOR FREE								No				Primary Tumor	01		6th		NO	YES	A1	Breast	A	LIVING	2007	TCGA-A1-A0SO-01A-22D-A099-09	TCGA-A1-A0SO-01		TCGA-A1-A0SO-01A-22R-A085-13	TCGA-A1-A0SO-01A-22D-A099-09	3c86150e-49f3-4303-bd6e-3d4bcc4aad50		TCGA-A1-A0SO-01A-11-A13A-20	TCGA-A1-A0SO-01A-22D-A099-09	e3b4918d-43c1-4dde-9a92-f9c5cd6e63a0	e3b21b55-af53-4b23-97ef-5be59a3495d8	TCGA-A1-A0SO-01A-22D-A087-01	e3b4918d-43c1-4dde-9a92-f9c5cd6e63a0	TCGA-A1-A0SO-01A-22D-A10P-05	TCGA-A1-A0SO-01	TCGA-A1-A0SO-01A-22R-A084-07	e3b4918d-43c1-4dde-9a92-f9c5cd6e63a0	e3b4918d-43c1-4dde-9a92-f9c5cd6e63a0	TCGA-A1-A0SO-01A-22D-A087-01	TCGA-A1-A0SO-01	TCGA-A1-A0SO-01		e3b21b55-af53-4b23-97ef-5be59a3495d8	TCGA-A1-A0SO-01A-22R-A085-13
TCGA-A1-A0SP-01	Stage IIA	40		Stage IIA	583		Negative	FEMALE	Negative				Negative	M0	Negative	N0	583	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SP-01	584	0	High	C4-BRCA/Basal		BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 12		mutation cluster 5	TCGA-A1-A0SP			584	Breast	TCGA Breast Cancer	breast invasive carcinoma					40	Right	Axillary lymph node dissection alone				Negative					Negative	Lumpectomy					-14954			0	584												2010-12-6	FEMALE					0					Infiltrating Ductal Carcinoma				C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy			Negative			3	Negative																													0			M0	N0 (i-)	T2	Stage IIA																		TUMOR FREE								Yes				Primary Tumor	01		6th		NO	YES	A1	Breast		LIVING	2007	TCGA-A1-A0SP-01A-11D-A099-09	TCGA-A1-A0SP-01		TCGA-A1-A0SP-01A-11R-A085-13	TCGA-A1-A0SP-01A-11D-A099-09		TCGA-A1-A0SP-01A-11D-A099-09		TCGA-A1-A0SP-01A-11D-A099-09	f091d050-4847-4d4d-b94c-1efacecdef6b	fda83c5d-bec0-427d-8c6e-e8c06953e58a	TCGA-A1-A0SP-01A-11D-A087-01	f091d050-4847-4d4d-b94c-1efacecdef6b	TCGA-A1-A0SP-01A-11D-A10P-05	TCGA-A1-A0SP-01	TCGA-A1-A0SP-01A-11R-A084-07	f091d050-4847-4d4d-b94c-1efacecdef6b	f091d050-4847-4d4d-b94c-1efacecdef6b	TCGA-A1-A0SP-01A-11D-A087-01	TCGA-A1-A0SP-01	TCGA-A1-A0SP-01		fda83c5d-bec0-427d-8c6e-e8c06953e58a	TCGA-A1-A0SP-01A-11R-A085-13
TCGA-A1-A0SQ-01	Stage IIB	45	3	Stage IIB	553		Positive	FEMALE	Negative				Negative	M0	Positive	N1	553	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SQ-01	554	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3	cluster 2	mutation c1uster 9	TCGA-A1-A0SQ			554	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Left	Sentinel lymph node biopsy plus axillary dissection				Positive					Positive	Modified Radical Mastectomy					-16458	967		0	554					NO		90-99%					2011-6-30	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Negative			15	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	2									1		true	MX	N1	T2	Stage IIB	TCGA-A1-A0SQ.92EE56BF-AAA0-438E-9244-780DBB2D9835.pdf	1	1	0	0	0	0	0	0	0	10	10	15	90	75	90	75	TUMOR FREE							YES	No	90-99%			Primary Tumor	01		6th		NO	YES	A1	Breast	A	LIVING	2007	TCGA-A1-A0SQ-01A-21D-A142-09		TCGA-A1-A0SQ-01A-21R-A143-13	TCGA-A1-A0SQ-01A-21R-A143-13	TCGA-A1-A0SQ-01A-21D-A142-09		TCGA-A1-A0SQ-01A-21D-A142-09	TCGA-A1-A0SQ-01A-11-A17I-20	TCGA-A1-A0SQ-01A-21D-A142-09	9efdba02-2752-4c89-bb53-e8018f5aa7bf	e4c6cf2d-7eac-44e0-b338-a8dbeffc212e	TCGA-A1-A0SQ-01A-21D-A141-01	9efdba02-2752-4c89-bb53-e8018f5aa7bf	TCGA-A1-A0SQ-01A-21D-A145-05	TCGA-A1-A0SQ-01		9efdba02-2752-4c89-bb53-e8018f5aa7bf	9efdba02-2752-4c89-bb53-e8018f5aa7bf	TCGA-A1-A0SQ-01A-21D-A141-01		TCGA-A1-A0SQ-01		e4c6cf2d-7eac-44e0-b338-a8dbeffc212e	
TCGA-A2-A04N-01	Stage IA	66	4	Stage I	3188		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	3188	0	LumA	Luminal A	Positive	LumA	-5	-3	followup	T1	T1	LIVING	0	TCGA-A2-A04N-01	3188	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-A2-A04N			3188	Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Right	Other (specify)	Sentinel lymph node biopsy plus non-sentinel lymph node biopsy	TCGA-A2-A04N-F9336		Positive					Positive	Lumpectomy		YES			-24155	2850		0	3188												2011-3-18	FEMALE								1.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	130	NO		Negative		6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6									0	0	true	M0	N0 (i-)	T1c	Stage IA	TCGA-A2-A04N.45B4B99C-80E6-4AF4-8692-F7EE19D0467A.pdf	20	1	0	0	1	2	0	0	9	0	10	23	75	75	60	75	TUMOR FREE								No			YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2002	TCGA-A2-A04N-01A-11D-A10Y-09	TCGA-A2-A04N-01	TCGA-A2-A04N-01A-11R-A114-13	TCGA-A2-A04N-01A-11R-A114-13	TCGA-A2-A04N-01A-11D-A10Y-09	2ef34d44-4aa3-4b06-8029-f92c4b3a49a7	TCGA-A2-A04N-01A-11D-A10Y-09	TCGA-A2-A04N-01A-21-A13A-20	TCGA-A2-A04N-01A-11D-A10Y-09	71b60d53-513c-4da5-b095-39f913bd4f11	5ed8c239-3f5f-409e-9d46-8995ca7fa57d	TCGA-A2-A04N-01A-11D-A111-01	71b60d53-513c-4da5-b095-39f913bd4f11		TCGA-A2-A04N-01	TCGA-A2-A04N-01A-11R-A115-07	71b60d53-513c-4da5-b095-39f913bd4f11	71b60d53-513c-4da5-b095-39f913bd4f11	TCGA-A2-A04N-01A-11D-A111-01	TCGA-A2-A04N-01	TCGA-A2-A04N-01	TCGA-A2-A04N-01A-11D-A112-05	5ed8c239-3f5f-409e-9d46-8995ca7fa57d	
TCGA-A2-A04P-01	Stage IIIC	36	1	No_Conversion	547	547	Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N3	547	1	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	DECEASED	1	TCGA-A2-A04P-01	548	1	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 3	TCGA-A2-A04P			548	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	YES	YES	NO	36	Left	Axillary lymph node dissection alone		TCGA-A2-A04P-F2652	Positive	Negative				Mastectomy NOS	Negative	Lumpectomy		NO	179		-13238	2623	548	0				179				<10%	Lung|Liver				2010-8-26	FEMALE								1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	250	NO		Negative		20	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	5									18	0	true	M0	N3c	T2	Stage IIIC	TCGA-A2-A04P.0E4B0EA9-14D1-4A82-814D-51CC2B9BA2B5.pdf	12	7	0	0	1	2	0	0	0	7	9	7	90	84	75	85	WITH TUMOR								No	<10%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	DECEASED	2003	TCGA-A2-A04P-01A-31D-A128-09	TCGA-A2-A04P-01		TCGA-A2-A04P-01A-31R-A035-13	TCGA-A2-A04P-01A-31D-A128-09	15a1aee0-d9cf-4122-9290-0d4bfaee159a	TCGA-A2-A04P-01A-31D-A128-09	TCGA-A2-A04P-01A-41-A13A-20	TCGA-A2-A04P-01A-31D-A128-09	357ba9f6-716c-4ef0-8ac8-41977397dbf5	514e30c9-fe93-4d52-a31f-9e771c71d300	TCGA-A2-A04P-01A-31D-A036-01	357ba9f6-716c-4ef0-8ac8-41977397dbf5		TCGA-A2-A04P-01	TCGA-A2-A04P-01A-31R-A034-07	357ba9f6-716c-4ef0-8ac8-41977397dbf5	357ba9f6-716c-4ef0-8ac8-41977397dbf5	TCGA-A2-A04P-01A-31D-A036-01	TCGA-A2-A04P-01	TCGA-A2-A04P-01	TCGA-A2-A04P-01A-31D-A032-05	514e30c9-fe93-4d52-a31f-9e771c71d300	TCGA-A2-A04P-01A-31R-A035-13
TCGA-A2-A04Q-01	Stage IA	48	3	Stage I	1275		Negative	FEMALE	Negative	1	2	3	Negative	M0	Negative	N0	1275	0	Basal	Basal-like	Negative	ReacII	-13	-12	followup	T1	T1	LIVING	0	TCGA-A2-A04Q-01	2385	0	High	C4-BRCA/Basal	cluster 1	BRCA CIMP c7	KIRC-like c1	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A2-A04Q			2385	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Right Upper Outer Quadrant|Right	Other (specify)	SLN AND NON-SLN BX	TCGA-A2-A04Q-F9329		Negative					Negative	Simple Mastectomy		YES			-17660	2260		0	1276	2385						<10%					2011-3-21	FEMALE					2+			1.4		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	SKIN BIOPSY	Other method, specify:	230	NO	Equivocal	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4									0	0	true	M0	N0 (i-)	T1	Stage IA	TCGA-A2-A04Q.726B60CA-1B1C-440D-82FA-A4C978C4D484.pdf	2	1	0	0	1	2	0	0	23	0	6	25	70	73	80	80	TUMOR FREE								No	<10%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2004	TCGA-A2-A04Q-01A-21W-A050-09	TCGA-A2-A04Q-01		TCGA-A2-A04Q-01A-21R-A035-13	TCGA-A2-A04Q-01A-21W-A050-09	9e43165b-f93c-4a25-a1c8-7bdad54cee95	TCGA-A2-A04Q-01A-21W-A050-09	TCGA-A2-A04Q-01A-11-A13A-20	TCGA-A2-A04Q-01A-21W-A050-09	d71e12c1-d92c-4cb6-8244-d100b2ef1c43	e69d3fc4-7639-471d-9a76-41e20afd4b62	TCGA-A2-A04Q-01A-21D-A036-01	d71e12c1-d92c-4cb6-8244-d100b2ef1c43		TCGA-A2-A04Q-01	TCGA-A2-A04Q-01A-21R-A034-07	d71e12c1-d92c-4cb6-8244-d100b2ef1c43	d71e12c1-d92c-4cb6-8244-d100b2ef1c43	TCGA-A2-A04Q-01A-21D-A036-01	TCGA-A2-A04Q-01	TCGA-A2-A04Q-01	TCGA-A2-A04Q-01A-21D-A032-05	e69d3fc4-7639-471d-9a76-41e20afd4b62	TCGA-A2-A04Q-01A-21R-A035-13
TCGA-A2-A04R-01	Stage IA	36	5	Stage I	2499		Positive	FEMALE	Negative				Negative	M0	Negative	N0	2499	0	LumB	Luminal B	Positive		-10	-3	followup	T1	T1	LIVING	0	TCGA-A2-A04R-01	2499	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 10	TCGA-A2-A04R			2499	Breast	TCGA Breast Cancer	breast invasive carcinoma					36	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-A2-A04R-F9327		Positive					Positive	Lumpectomy		YES			-13483	2233		0	2499							60-69%					2010-3-21	FEMALE					2+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	160	NO	Equivocal	Negative		1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4									0	0	true	M0	N0 (i-)	T1	Stage IA	TCGA-A2-A04R.6A97C809-91BB-4E35-9E12-F5F2A58C9D35.pdf	0	0	0	0	1	1	0	0	4	0	5	19	90	80	95	90	TUMOR FREE								No	80-89%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2004	TCGA-A2-A04R-01A-41D-A117-09	TCGA-A2-A04R-01		TCGA-A2-A04R-01A-41R-A108-13	TCGA-A2-A04R-01A-41D-A117-09		TCGA-A2-A04R-01A-41D-A117-09		TCGA-A2-A04R-01A-41D-A117-09	8801f107-f5d5-4ad5-877d-a5acb12596b3	ca39b4e5-b1ee-4f4f-a78c-5aaf90044663	TCGA-A2-A04R-01A-41D-A107-01	8801f107-f5d5-4ad5-877d-a5acb12596b3	TCGA-A2-A04R-01A-41D-A10A-05	TCGA-A2-A04R-01	TCGA-A2-A04R-01A-41R-A109-07	8801f107-f5d5-4ad5-877d-a5acb12596b3	8801f107-f5d5-4ad5-877d-a5acb12596b3	TCGA-A2-A04R-01A-41D-A107-01	TCGA-A2-A04R-01	TCGA-A2-A04R-01		ca39b4e5-b1ee-4f4f-a78c-5aaf90044663	TCGA-A2-A04R-01A-41R-A108-13
TCGA-A2-A04T-01	Stage IIA	62	1	Stage IIA	2246		Negative	FEMALE	Negative				Negative	M0	Negative	N0	2246	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-A2-A04T-01	2246	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14	cluster 5		TCGA-A2-A04T			2246	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-A2-A04T-F9343		Negative					Negative	Lumpectomy		YES			-22707	1979		0	2246							<10%					2011-3-17	FEMALE					2+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Equivocal	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5									0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A04T.24D42292-B875-4FAF-8C3A-9834414C3A01.pdf	2	1	1	0	2	3	0	0	0	2	18	90	80	85	80	85	TUMOR FREE								No	<10%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2004		TCGA-A2-A04T-01		TCGA-A2-A04T-01A-21R-A035-13		2724de89-78e5-4da5-b2d9-350a986a8abb	TCGA-A2-A04T-01A-21W-A050-09	TCGA-A2-A04T-01A-31-A13A-20		79d7a589-60bd-4b4a-89c1-d557fe24c733	9f5d61da-fe30-4975-a3d5-3ba4eab06683	TCGA-A2-A04T-01A-21D-A036-01	79d7a589-60bd-4b4a-89c1-d557fe24c733		TCGA-A2-A04T-01	TCGA-A2-A04T-01A-21R-A034-07	79d7a589-60bd-4b4a-89c1-d557fe24c733	79d7a589-60bd-4b4a-89c1-d557fe24c733	TCGA-A2-A04T-01A-21D-A036-01	TCGA-A2-A04T-01	TCGA-A2-A04T-01	TCGA-A2-A04T-01A-21D-A032-05	9f5d61da-fe30-4975-a3d5-3ba4eab06683	TCGA-A2-A04T-01A-21R-A035-13
TCGA-A2-A04U-01	Stage IIA	47		Stage IIA	670		Negative	FEMALE	Negative				Negative	M0	Negative	N0	670	0	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA-A2-A04U-01	1486	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-A2-A04U			1486	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Right	Sentinel node biopsy alone		TCGA-A2-A04U-F9334		Negative					Negative	Simple Mastectomy		YES			-17474	1924		0	671	1486						<10%					2011-3-17	FEMALE					1+			2.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO	Negative	Positive		3	Negative	Peri (6-12 months since last menstrual period)																		5	5									0	1	true	M0	N0 (i+)	T2	Stage IIA	TCGA-A2-A04U.B14456B1-4992-492D-AFB5-4F975F20A277.pdf	1	1	0	0	3	1	0	0	0	2	32	32	65	65	65	65	TUMOR FREE								No	<10%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2004	TCGA-A2-A04U-01A-11D-A10Y-09	TCGA-A2-A04U-01	TCGA-A2-A04U-01A-11R-A114-13	TCGA-A2-A04U-01A-11R-A114-13	TCGA-A2-A04U-01A-11D-A10Y-09	485e1504-dfe0-43a4-83a1-f4376e8e687b	TCGA-A2-A04U-01A-11D-A10Y-09	TCGA-A2-A04U-01A-21-A13A-20	TCGA-A2-A04U-01A-11D-A10Y-09	4d12d021-3673-4e14-9fd9-033f811f87da	544dd94e-abd8-4cca-98cf-d1c2c646f23a	TCGA-A2-A04U-01A-11D-A111-01	4d12d021-3673-4e14-9fd9-033f811f87da		TCGA-A2-A04U-01	TCGA-A2-A04U-01A-11R-A115-07	4d12d021-3673-4e14-9fd9-033f811f87da	4d12d021-3673-4e14-9fd9-033f811f87da	TCGA-A2-A04U-01A-11D-A111-01	TCGA-A2-A04U-01	TCGA-A2-A04U-01	TCGA-A2-A04U-01A-11D-A112-05	544dd94e-abd8-4cca-98cf-d1c2c646f23a	
TCGA-A2-A04V-01	Stage IIA	39	2	Stage IIA	1920	1920	Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	1920	1	LumA	Luminal A	Positive	LumA/B	0	-3	enrollment	T_Other	T2	DECEASED	1	TCGA-A2-A04V-01	1920	1	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A2-A04V			1920	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO	NO	NO	39	Right Lower Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-A2-A04V-F10273		Positive					Positive	Simple Mastectomy		YES			-14250	1812	1920	0				1470				90-99%	Bone				2011-3-18	FEMALE					2+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Equivocal	Negative		2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	2									0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A04V.7D84A145-19AF-48D0-A5D9-F5724068CB26.pdf	2	0	2	0	10	0	2	0	0	0	25	10	65	90	65	90	WITH TUMOR				MODERATE	STRONG			No	10-19%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	DECEASED	2005	TCGA-A2-A04V-01A-21W-A050-09	TCGA-A2-A04V-01		TCGA-A2-A04V-01A-21R-A035-13	TCGA-A2-A04V-01A-21W-A050-09	676bd916-c1a1-4b1f-b406-0c3bae66640e	TCGA-A2-A04V-01A-21W-A050-09	TCGA-A2-A04V-01A-11-A13A-20	TCGA-A2-A04V-01A-21W-A050-09,TCGA-A2-A04V-01A-21D-A045-09	72d79574-45e1-453a-bc95-a2dca1d3e251	48d99272-3117-4309-9800-25900f7c695a	TCGA-A2-A04V-01A-21D-A036-01	72d79574-45e1-453a-bc95-a2dca1d3e251		TCGA-A2-A04V-01	TCGA-A2-A04V-01A-21R-A034-07	72d79574-45e1-453a-bc95-a2dca1d3e251	72d79574-45e1-453a-bc95-a2dca1d3e251	TCGA-A2-A04V-01A-21D-A036-01	TCGA-A2-A04V-01	TCGA-A2-A04V-01	TCGA-A2-A04V-01A-21D-A032-05	48d99272-3117-4309-9800-25900f7c695a	TCGA-A2-A04V-01A-21R-A035-13
TCGA-A2-A04W-01	Stage IIB	50	3	No_Conversion	1948		Negative	FEMALE	Positive				Negative	M0	Positive	N1	1948	0	Her2	HER2-enriched	Negative	Her2	-11	-5	followup	T_Other	T2	LIVING	0	TCGA-A2-A04W-01	1948	0	Squamous	C3-BRCA/Luminal	cluster 1	Cluster 5	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA c1uster 9	cluster 4	mutation cluster 3	TCGA-A2-A04W			1948	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A04W-F9331		Negative					Negative	Modified Radical Mastectomy		NO			-18345	1630		0	1948							<10%					2011-3-18	FEMALE								3.2		Other  specify	Apocrine	No		C50.9	8401/3	C50.9		YES		Core needle biopsy	420	NO	Positive	Positive		19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4									1		true	M0	N1mi	T2	Stage IIB	TCGA-A2-A04W.84CA9DDD-36CA-466E-A74C-C7FB03E7C9E4.pdf	1	1	0	0	1	1	0	0	39	5	0	14	60	80	55	65	TUMOR FREE								No	<10%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2005	TCGA-A2-A04W-01A-31D-A10Y-09	TCGA-A2-A04W-01	TCGA-A2-A04W-01A-31R-A114-13	TCGA-A2-A04W-01A-31R-A114-13	TCGA-A2-A04W-01A-31D-A10Y-09	469913c6-08bb-4c19-8a68-2735f5c4f981	TCGA-A2-A04W-01A-31D-A10Y-09	TCGA-A2-A04W-01A-21-A13A-20	TCGA-A2-A04W-01A-31D-A10Y-09	ddb62dc3-293b-4021-905a-83ae10aa0f8e	e22edca1-493b-4d79-a311-3d5027d1e509	TCGA-A2-A04W-01A-31D-A111-01	ddb62dc3-293b-4021-905a-83ae10aa0f8e		TCGA-A2-A04W-01	TCGA-A2-A04W-01A-31R-A115-07	ddb62dc3-293b-4021-905a-83ae10aa0f8e	ddb62dc3-293b-4021-905a-83ae10aa0f8e	TCGA-A2-A04W-01A-31D-A111-01	TCGA-A2-A04W-01	TCGA-A2-A04W-01	TCGA-A2-A04W-01A-31D-A112-05	e22edca1-493b-4d79-a311-3d5027d1e509	
TCGA-A2-A04X-01	Stage IIA	34	3	Stage IIA	1686		Positive	FEMALE	Positive				Negative	M0	Negative	N0	1686	0	Her2	HER2-enriched	Positive		-2	-5	followup	T_Other	T2	LIVING	0	TCGA-A2-A04X-01	1686	0	High	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A2-A04X			1686	Breast	TCGA Breast Cancer	breast invasive carcinoma					34	Left	Sentinel node biopsy alone		TCGA-A2-A04X-F9335		Positive					Positive	Simple Mastectomy		YES			-12642	1390		0	1686							80-89%					2011-3-18	FEMALE					3+			3.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	180	NO	Positive	Positive		3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4									0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A04X.F114D078-5F03-47F8-82AE-B8A21C2F9D31.pdf	1	2	1	1	8	3	0	0	0	0	12	12	80	85	80	85	TUMOR FREE				MODERATE	STRONG			No	50-59%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2006	TCGA-A2-A04X-01A-21W-A050-09	TCGA-A2-A04X-01		TCGA-A2-A04X-01A-21R-A035-13	TCGA-A2-A04X-01A-21W-A050-09		TCGA-A2-A04X-01A-21W-A050-09		TCGA-A2-A04X-01A-21W-A050-09	08c54c9c-195c-4754-83af-a97544d0eb12	456b1e0c-72a4-4850-b52b-8eecf5ecabd8	TCGA-A2-A04X-01A-21D-A036-01	08c54c9c-195c-4754-83af-a97544d0eb12		TCGA-A2-A04X-01	TCGA-A2-A04X-01A-21R-A034-07	08c54c9c-195c-4754-83af-a97544d0eb12	08c54c9c-195c-4754-83af-a97544d0eb12	TCGA-A2-A04X-01A-21D-A036-01	TCGA-A2-A04X-01	TCGA-A2-A04X-01	TCGA-A2-A04X-01A-21D-A032-05	456b1e0c-72a4-4850-b52b-8eecf5ecabd8	TCGA-A2-A04X-01A-21R-A035-13
TCGA-A2-A04Y-01	Stage IIB	53	5	No_Conversion	1099		Positive	FEMALE	Negative	2	3	3	Negative	M0	Positive	N1	1099	0	LumB	Luminal A	Positive	LumA	-2	-3	followup	T_Other	T2	LIVING	0	TCGA-A2-A04Y-01	1099	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 5	mutation c1uster 9	TCGA-A2-A04Y			1099	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Right Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A04Y-F9330		Positive					Positive	Simple Mastectomy		YES			-19533	756		0	1099							90-99%					2011-3-18	FEMALE					1+			1.13		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	220	NO	Negative	Negative		13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	5									1	0	true	M0	N1mi	T2	Stage IIB	TCGA-A2-A04Y.E4F7064C-9D81-49B5-9992-898155B3F11E.pdf	2	10	0	0	1	1	0	0	2	2	17	17	80	80	80	80	TUMOR FREE					Strong			No	10-19%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2008	TCGA-A2-A04Y-01A-21W-A050-09	TCGA-A2-A04Y-01		TCGA-A2-A04Y-01A-21R-A035-13	TCGA-A2-A04Y-01A-21W-A050-09	b850ebdc-d177-4c59-8c71-9cf8dd589307	TCGA-A2-A04Y-01A-21W-A050-09	TCGA-A2-A04Y-01A-11-A13A-20	TCGA-A2-A04Y-01A-21W-A050-09	7002615e-435b-4631-bb5b-e4b7532a143a	93a1aed5-c6cc-4e07-9060-fd6cead060b2	TCGA-A2-A04Y-01A-21D-A036-01	7002615e-435b-4631-bb5b-e4b7532a143a		TCGA-A2-A04Y-01	TCGA-A2-A04Y-01A-21R-A034-07	7002615e-435b-4631-bb5b-e4b7532a143a	7002615e-435b-4631-bb5b-e4b7532a143a	TCGA-A2-A04Y-01A-21D-A036-01	TCGA-A2-A04Y-01	TCGA-A2-A04Y-01	TCGA-A2-A04Y-01A-21D-A032-05	93a1aed5-c6cc-4e07-9060-fd6cead060b2	TCGA-A2-A04Y-01A-21R-A035-13
TCGA-A2-A0CK-01																													0	TCGA-A2-A0CK-01	4159	0	Iq			BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 14			TCGA-A2-A0CK	1364	1	4159	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO			60	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A0CK-F42396	Negative	Positive	3 Point Scale	3+	3 Point Scale	Modified radical mastectomy	Positive	Lumpectomy		NO			-22094			0	4159		1409	1364		NO		40-49%					2013-4-18	FEMALE								1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Excisional Biopsy			Negative	Negative	NO	20	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative			Positive	50-59%			1.2	3 Point Scale	2+	1+	Negative		10-19%		Positive					3 Point Scale	Other, specify	New Primary Tumor	LEFT BREAST	YES	YES	4			M0	N2a	T3	Stage IIIA																		TUMOR FREE						YES	YES	No	80-89%		YES	Primary Tumor	01		5th		NO	YES	A2	Breast		LIVING	2001			TCGA-A2-A0CK-01A-11R-A22I-13	TCGA-A2-A0CK-01A-11R-A22I-13			TCGA-A2-A0CK-01A-11D-A228-09	TCGA-A2-A0CK-01A-21-A24A-20		fe5e8cb8-45e2-4321-ad32-a776f79bfcac	da561a17-8bdc-4bbb-b6be-c4fe38e5b1b9	TCGA-A2-A0CK-01A-11D-A227-01	fe5e8cb8-45e2-4321-ad32-a776f79bfcac	TCGA-A2-A0CK-01A-11D-A22B-05	TCGA-A2-A0CK-01		fe5e8cb8-45e2-4321-ad32-a776f79bfcac	fe5e8cb8-45e2-4321-ad32-a776f79bfcac	TCGA-A2-A0CK-01A-11D-A227-01		TCGA-A2-A0CK-01		da561a17-8bdc-4bbb-b6be-c4fe38e5b1b9	
TCGA-A2-A0CL-01	Stage IIIA	37	3	No_Conversion	1963		Positive	FEMALE	Negative	1	1	1	Negative	M0	Positive	N2	1963	0	Normal	HER2-enriched	Positive	Basal	-2	-5	followup	T_Other	T3	LIVING	0	TCGA-A2-A0CL-01	1964	0	High	C3-BRCA/Luminal	cluster 1	Cluster 5	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A2-A0CL	1964	0	1964	Breast	TCGA Breast Cancer	breast invasive carcinoma					37	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A0CL-F14457		Positive					Positive	Modified Radical Mastectomy		NO			-13556			0	1964							20-29%				Scheduled Follow-up Submission	2011-6-9	FEMALE					1+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative	Negative		14	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4								NO	9	0		M0	N2a	T3	Stage IIIA																		TUMOR FREE								No	<10%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast		LIVING	2006	TCGA-A2-A0CL-01A-11D-A10Y-09	TCGA-A2-A0CL-01	TCGA-A2-A0CL-01A-11R-A114-13	TCGA-A2-A0CL-01A-11R-A114-13	TCGA-A2-A0CL-01A-11D-A10Y-09	f660575f-37ae-427d-acf6-767799017d6d	TCGA-A2-A0CL-01A-11D-A10Y-09	TCGA-A2-A0CL-01A-21-A13C-20	TCGA-A2-A0CL-01A-11D-A10Y-09	ee92fcd7-4be2-47c2-9725-1ec425d212cf	ffc153c8-b303-4bf6-aa6a-9db6f698a9fb	TCGA-A2-A0CL-01A-11D-A111-01	ee92fcd7-4be2-47c2-9725-1ec425d212cf		TCGA-A2-A0CL-01	TCGA-A2-A0CL-01A-11R-A115-07	ee92fcd7-4be2-47c2-9725-1ec425d212cf	ee92fcd7-4be2-47c2-9725-1ec425d212cf	TCGA-A2-A0CL-01A-11D-A111-01	TCGA-A2-A0CL-01	TCGA-A2-A0CL-01	TCGA-A2-A0CL-01A-11D-A112-05	ffc153c8-b303-4bf6-aa6a-9db6f698a9fb	
TCGA-A2-A0CM-01	Stage IIA	40	4	Stage IIA	754	754	Negative	FEMALE	Negative	1	1	2	Negative	M0	Negative	N0	754	1	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	DECEASED	1	TCGA-A2-A0CM-01	754	1	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A2-A0CM			754	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO	NO		40	Left	Sentinel node biopsy alone		TCGA-A2-A0CM-F2013		Negative		0			Negative	Simple Mastectomy		YES			-14969	2546	754	0				382				<10%	Lung|Other, specify	Mediastinal lymph nodes			2010-9-6	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Excisional Biopsy	300	NO	Negative			1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4									0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0CM.2972AB07-2C29-43B8-96DA-1386C5E248EB.pdf	20	25	10	10	5	7	10	10	0	0	15	23	80	70	80	75	WITH TUMOR								No	<10%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	DECEASED	2003	TCGA-A2-A0CM-01A-31W-A050-09	TCGA-A2-A0CM-01		TCGA-A2-A0CM-01A-31R-A035-13	TCGA-A2-A0CM-01A-31W-A050-09	bd38e599-aa6d-4349-b7de-630514cc1220	TCGA-A2-A0CM-01A-31W-A050-09	TCGA-A2-A0CM-01A-21-A13C-20	TCGA-A2-A0CM-01A-31W-A050-09	62dd11c2-2271-45e7-b753-d0f0d79fdf23	34e39e63-405b-4eae-a326-163ea06baa81	TCGA-A2-A0CM-01A-31D-A036-01	62dd11c2-2271-45e7-b753-d0f0d79fdf23		TCGA-A2-A0CM-01	TCGA-A2-A0CM-01A-31R-A034-07	62dd11c2-2271-45e7-b753-d0f0d79fdf23	62dd11c2-2271-45e7-b753-d0f0d79fdf23	TCGA-A2-A0CM-01A-31D-A036-01	TCGA-A2-A0CM-01	TCGA-A2-A0CM-01	TCGA-A2-A0CM-01A-31D-A032-05	34e39e63-405b-4eae-a326-163ea06baa81	TCGA-A2-A0CM-01A-31R-A035-13
TCGA-A2-A0CO-01																													1	TCGA-A2-A0CO-01	3492	1	Iq			BRCA non-CIMP c9			miRNA cluster 3			TCGA-A2-A0CO	3492	0	3492	Breast	TCGA Breast Cancer	breast invasive carcinoma					85	Right	Axillary lymph node dissection alone		TCGA-A2-A0CO-F42395		Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-31404	2709	3492	0	3409					NO		40-49%					2013-4-18	FEMALE								1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Core needle biopsy	260	NO	Negative	Negative	NO	11	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	true	M0	N0	T3	Stage IIB	TCGA-A2-A0CO.8C440009-E05E-4046-96AB-BAB211CB7D02.pdf	0	0	0	0	0	0	0	0	0	0	70	60	30	40	60	50	TUMOR FREE						YES	YES	No	20-29%		YES	Primary Tumor	01		7th		NO	YES	A2	Breast	A	DECEASED	2002			TCGA-A2-A0CO-01A-13R-A22I-13	TCGA-A2-A0CO-01A-13R-A22I-13			TCGA-A2-A0CO-01A-13D-A228-09			cb2d5668-d44b-49dc-8941-79615d2fb6c2	04dc714b-e905-4d74-a53a-f41ecfbbbe7c	TCGA-A2-A0CO-01A-13D-A227-01	cb2d5668-d44b-49dc-8941-79615d2fb6c2	TCGA-A2-A0CO-01A-13D-A22B-05	TCGA-A2-A0CO-01		cb2d5668-d44b-49dc-8941-79615d2fb6c2	cb2d5668-d44b-49dc-8941-79615d2fb6c2	TCGA-A2-A0CO-01A-13D-A227-01		TCGA-A2-A0CO-01		04dc714b-e905-4d74-a53a-f41ecfbbbe7c	
TCGA-A2-A0CP-01	Stage IA	60	4	Stage I	2813		Positive	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	2813	0	LumA	Luminal A	Positive	X	-5	-7	followup	T1	T1	LIVING	0	TCGA-A2-A0CP-01	2813	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A2-A0CP	2813	0	2813	Breast	TCGA Breast Cancer	breast invasive carcinoma					60	Right	Sentinel node biopsy alone		TCGA-A2-A0CP-F13741		Positive					Positive	Lumpectomy		YES			-22133	2445		0	2813							90-99%				Scheduled Follow-up Submission	2011-6-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	160	NO		Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	0	0	true	M0	N0 (i-)	T1c	Stage IA	TCGA-A2-A0CP.DAB9A2B8-FCE7-4FF4-BAC4-4D2A04D7A43B.pdf	2	1	0	0	0	0	0	0	5	3	40	22	55	75	60	80	TUMOR FREE								No	90-99%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2003	TCGA-A2-A0CP-01A-11W-A050-09	TCGA-A2-A0CP-01		TCGA-A2-A0CP-01A-11R-A035-13	TCGA-A2-A0CP-01A-11W-A050-09	901a41bd-d57b-46b6-afec-bfc93e5d2c93	TCGA-A2-A0CP-01A-11W-A050-09	TCGA-A2-A0CP-01A-21-A13B-20	TCGA-A2-A0CP-01A-11W-A050-09	5c4dae2a-4b4a-47d0-b6fb-456bdf58ca15	a7998037-e713-46a6-adc2-8c22aa0cd362	TCGA-A2-A0CP-01A-11D-A036-01	5c4dae2a-4b4a-47d0-b6fb-456bdf58ca15		TCGA-A2-A0CP-01	TCGA-A2-A0CP-01A-11R-A034-07	5c4dae2a-4b4a-47d0-b6fb-456bdf58ca15	5c4dae2a-4b4a-47d0-b6fb-456bdf58ca15	TCGA-A2-A0CP-01A-11D-A036-01	TCGA-A2-A0CP-01	TCGA-A2-A0CP-01	TCGA-A2-A0CP-01A-11D-A032-05	a7998037-e713-46a6-adc2-8c22aa0cd362	TCGA-A2-A0CP-01A-11R-A035-13
TCGA-A2-A0CQ-01	Stage IA	62	2	Stage I	2694		Positive	FEMALE	Negative	1	3	3	Negative	M0	Negative	N0	2694	0	LumA	Luminal A	Positive	LumA/B	-12	-3	followup	T1	T1	LIVING	0	TCGA-A2-A0CQ-01	2695	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A2-A0CQ	2695	0	2695	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Right	Sentinel node biopsy alone		TCGA-A2-A0CQ-F13723	Negative	Positive				Lumpectomy	Positive	Lumpectomy		YES			-22810	2310		0	2695							90-99%				Scheduled Follow-up Submission	2011-6-10	FEMALE					2+			1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Equivocal	Negative		1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO	0	0	true	M0	N0 (i-)	T1	Stage IA	TCGA-A2-A0CQ.964DFAC8-91EC-4C0E-B499-3ED5F2D70096.pdf	15	10	1	1	3	3	0	0	0	0	32	27	65	70	65	80	TUMOR FREE								No	90-99%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2003	TCGA-A2-A0CQ-01A-21W-A050-09	TCGA-A2-A0CQ-01		TCGA-A2-A0CQ-01A-21R-A035-13	TCGA-A2-A0CQ-01A-21W-A050-09	deba1bb0-c1bf-4018-8c35-1376661c7d01	TCGA-A2-A0CQ-01A-21W-A050-09	TCGA-A2-A0CQ-01A-11-A13B-20	TCGA-A2-A0CQ-01A-21W-A050-09	31ff1045-fdc1-4b02-ae0e-880f652adb31	28486246-1a3f-463d-87e4-a70d1eed0c88	TCGA-A2-A0CQ-01A-21D-A036-01	31ff1045-fdc1-4b02-ae0e-880f652adb31		TCGA-A2-A0CQ-01	TCGA-A2-A0CQ-01A-21R-A034-07	31ff1045-fdc1-4b02-ae0e-880f652adb31	31ff1045-fdc1-4b02-ae0e-880f652adb31	TCGA-A2-A0CQ-01A-21D-A036-01	TCGA-A2-A0CQ-01	TCGA-A2-A0CQ-01	TCGA-A2-A0CQ-01A-21D-A032-05	28486246-1a3f-463d-87e4-a70d1eed0c88	TCGA-A2-A0CQ-01A-21R-A035-13
TCGA-A2-A0CR-01																													0	TCGA-A2-A0CR-01	3283	0	Quiet			BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 13			TCGA-A2-A0CR	3283	0	3283	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-A2-A0CR-F42400		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-20075	2191		0	3283					NO		60-69%					2013-4-18	FEMALE								1.2		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	1+	YES		Core needle biopsy	280	NO	Negative	Negative	NO	16	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	true	M0	N0	T3	Stage IIB	TCGA-A2-A0CR.A3167E2D-3588-41D4-99AA-6DCB660D55A4.pdf	100	100	0	0	0	0	0	0	0	3	60	57	40	40	70	80	TUMOR FREE						YES	YES	No	80-89%		NO	Primary Tumor	01		7th		NO	YES	A2	Breast	A	LIVING	2004			TCGA-A2-A0CR-01A-11R-A22I-13	TCGA-A2-A0CR-01A-11R-A22I-13			TCGA-A2-A0CR-01A-11D-A228-09	TCGA-A2-A0CR-01A-22-A24A-20		00e597fa-72b4-4e92-9428-7ec686e4cc0b	e98fb773-897b-48bb-9b3d-387079e5e5db	TCGA-A2-A0CR-01A-11D-A227-01	00e597fa-72b4-4e92-9428-7ec686e4cc0b	TCGA-A2-A0CR-01A-11D-A22B-05	TCGA-A2-A0CR-01		00e597fa-72b4-4e92-9428-7ec686e4cc0b	00e597fa-72b4-4e92-9428-7ec686e4cc0b	TCGA-A2-A0CR-01A-11D-A227-01		TCGA-A2-A0CR-01		e98fb773-897b-48bb-9b3d-387079e5e5db	
TCGA-A2-A0CS-01	Stage IV	73	2	No_Conversion	2298		Positive	FEMALE	Negative	3	3	3	Positive	M1	Positive	N3	2298	0	LumA	Luminal A	Positive	LumA	-12	-3	followup	T_Other	T4	LIVING	0	TCGA-A2-A0CS-01	2298	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A2-A0CS	2298	0	2298	Breast	TCGA Breast Cancer	breast invasive carcinoma					73	Left	Axillary lymph node dissection alone		TCGA-A2-A0CS-F14456		Positive					Positive	Modified Radical Mastectomy		NO			-26817	2030		0	2298							80-89%	Other, specify	Ovary		Scheduled Follow-up Submission	2011-6-13	FEMALE					2+			1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Skin biopsy	Other method, specify:	220	NO	Equivocal	Negative		15	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative			Positive				1.09				Negative				Positive	2	4								NO	12	0	true	M1	N3a	T4b	Stage IV	TCGA-A2-A0CS.A985FB5C-9E91-40E1-864E-CEA887B3866D.pdf	0	0	0	0	0	0	0	0	0	0	0	0	100	100	50	60	TUMOR FREE								No	80-89%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2004	TCGA-A2-A0CS-01A-11D-A10Y-09	TCGA-A2-A0CS-01	TCGA-A2-A0CS-01A-11R-A114-13	TCGA-A2-A0CS-01A-11R-A114-13	TCGA-A2-A0CS-01A-11D-A10Y-09	b49a2c08-435f-4790-818a-267a2ce6499c	TCGA-A2-A0CS-01A-11D-A10Y-09	TCGA-A2-A0CS-01A-21-A13B-20	TCGA-A2-A0CS-01A-11D-A10Y-09	560ab6aa-cbfe-42ac-9446-9d3df720bc81	f00b3a1a-5336-4540-a8e6-d731947f9ee5	TCGA-A2-A0CS-01A-11D-A111-01	560ab6aa-cbfe-42ac-9446-9d3df720bc81		TCGA-A2-A0CS-01	TCGA-A2-A0CS-01A-11R-A115-07	560ab6aa-cbfe-42ac-9446-9d3df720bc81	560ab6aa-cbfe-42ac-9446-9d3df720bc81	TCGA-A2-A0CS-01A-11D-A111-01	TCGA-A2-A0CS-01	TCGA-A2-A0CS-01	TCGA-A2-A0CS-01A-11D-A112-05	f00b3a1a-5336-4540-a8e6-d731947f9ee5	
TCGA-A2-A0CT-01	Stage IIA	71	5	Stage IIA	2288		Positive	FEMALE	Negative	4	3	4	Negative	M0	Negative	N0	2288	0	LumA	Luminal B	Negative	LumA/B	-10	-3	followup	T_Other	T2	LIVING	0	TCGA-A2-A0CT-01	2289	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A2-A0CT	2289	0	2289	Breast	TCGA Breast Cancer	breast invasive carcinoma					71	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A0CT-F13730		Positive		0			Negative	Simple Mastectomy		YES			-25959	1931		0	2289							90-99%				Scheduled Follow-up Submission	2011-6-9	FEMALE					2+			1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	2								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0CT.FDF38AA6-DC65-4043-8277-71BAE47902B1.pdf	4	2	0	0	1	1	0	0	10	40	10	10	79	49	88	70	TUMOR FREE								No	<10%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2005	TCGA-A2-A0CT-01A-31W-A071-09	TCGA-A2-A0CT-01		TCGA-A2-A0CT-01A-31R-A057-13	TCGA-A2-A0CT-01A-31W-A071-09	cfc7cb7e-3c46-41d6-9b19-ee2652b2c3e9	TCGA-A2-A0CT-01A-31W-A071-09	TCGA-A2-A0CT-01A-11-A13B-20	TCGA-A2-A0CT-01A-31W-A071-09	f33b0a48-706b-4fd8-b8b3-0a9f625bd0c0	548f7871-ac2a-469a-8f4a-4bda2aaae71a	TCGA-A2-A0CT-01A-31D-A059-01	f33b0a48-706b-4fd8-b8b3-0a9f625bd0c0	TCGA-A2-A0CT-01A-31D-A10P-05	TCGA-A2-A0CT-01	TCGA-A2-A0CT-01A-31R-A056-07	f33b0a48-706b-4fd8-b8b3-0a9f625bd0c0	f33b0a48-706b-4fd8-b8b3-0a9f625bd0c0	TCGA-A2-A0CT-01A-31D-A059-01	TCGA-A2-A0CT-01	TCGA-A2-A0CT-01		548f7871-ac2a-469a-8f4a-4bda2aaae71a	TCGA-A2-A0CT-01A-31R-A057-13
TCGA-A2-A0CU-01	Stage IIA	73	5	Stage IIA	139	157	Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	157	1	LumA	Luminal A	Positive	LumA/B	0	-3	followup	T_Other	T2	DECEASED	1	TCGA-A2-A0CU-01	158	1	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A2-A0CU	158	0	158	Breast	TCGA Breast Cancer	breast invasive carcinoma					73	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A0CU-F13735		Positive					Positive	Simple Mastectomy		YES			-26823	1911	158	0								90-99%				Scheduled Follow-up Submission	2011-6-10	FEMALE					2+			1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO	Equivocal	Negative		1	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	0	1	true	M0	N0 (i+)	T2	Stage IIA	TCGA-A2-A0CU.D503E73D-8B94-46A0-A24F-93069A56DC7D.pdf	0	0	0	0	0	0	0	0	5	5	30	15	65	80	70	85	TUMOR FREE								No	<10%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	DECEASED	2005	TCGA-A2-A0CU-01A-12W-A050-09	TCGA-A2-A0CU-01		TCGA-A2-A0CU-01A-12R-A035-13	TCGA-A2-A0CU-01A-12W-A050-09	74d7ee07-2eba-4552-a888-c29010bbc5ea	TCGA-A2-A0CU-01A-12W-A050-09	TCGA-A2-A0CU-01A-21-A13B-20	TCGA-A2-A0CU-01A-12W-A050-09	84ea9827-9ad4-4e2f-be02-c88a9d4c4051	846ab0bd-1c82-48a3-a25a-8a3af1f2bfa0	TCGA-A2-A0CU-01A-12D-A036-01	84ea9827-9ad4-4e2f-be02-c88a9d4c4051		TCGA-A2-A0CU-01	TCGA-A2-A0CU-01A-12R-A034-07	84ea9827-9ad4-4e2f-be02-c88a9d4c4051	84ea9827-9ad4-4e2f-be02-c88a9d4c4051	TCGA-A2-A0CU-01A-12D-A036-01	TCGA-A2-A0CU-01	TCGA-A2-A0CU-01	TCGA-A2-A0CU-01A-12D-A032-05	846ab0bd-1c82-48a3-a25a-8a3af1f2bfa0	TCGA-A2-A0CU-01A-12R-A035-13
TCGA-A2-A0CV-01	Stage IIB	41	2	No_Conversion	1929		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N1	1929	0	LumA	Luminal A	Positive	LumA/B	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-A2-A0CV-01	1930	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 6	mutation c1uster 9	TCGA-A2-A0CV	1930	0	1930	Breast	TCGA Breast Cancer	breast invasive carcinoma					41	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A0CV-F13722		Positive					Positive	Modified Radical Mastectomy		NO			-15289	1574		0	1930							90-99%				Scheduled Follow-up Submission	2011-6-13	FEMALE					1+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	310	NO	Negative	Negative		18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6								NO	4	0	true	M0	N1a	T2	Stage IIB	TCGA-A2-A0CV.FBDDD9EE-0A5C-4CAB-9EB3-48B6431A9A84.pdf	20	10	25	30	10	10	30	20	0	0	20	30	70	60	70	60	TUMOR FREE								No	90-99%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2005	TCGA-A2-A0CV-01A-31D-A10Y-09	TCGA-A2-A0CV-01	TCGA-A2-A0CV-01A-31R-A114-13	TCGA-A2-A0CV-01A-31R-A114-13	TCGA-A2-A0CV-01A-31D-A10Y-09	b595e1e2-77fa-4ebd-b2d4-054e8b9ca3ae	TCGA-A2-A0CV-01A-31D-A10Y-09	TCGA-A2-A0CV-01A-21-A13B-20	TCGA-A2-A0CV-01A-31D-A10Y-09	a8154f60-e391-44b5-b378-c944c5e8621d	8c3a83e9-071e-429b-88c7-21d4b2748ba3	TCGA-A2-A0CV-01A-31D-A111-01	a8154f60-e391-44b5-b378-c944c5e8621d		TCGA-A2-A0CV-01	TCGA-A2-A0CV-01A-31R-A115-07	a8154f60-e391-44b5-b378-c944c5e8621d	a8154f60-e391-44b5-b378-c944c5e8621d	TCGA-A2-A0CV-01A-31D-A111-01	TCGA-A2-A0CV-01	TCGA-A2-A0CV-01	TCGA-A2-A0CV-01A-31D-A112-05	8c3a83e9-071e-429b-88c7-21d4b2748ba3	
TCGA-A2-A0CW-01	Stage IIB	67	1	No_Conversion	1947		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1947	0	LumB	Luminal B	Positive	LumA/B	-2	-5	followup	T_Other	T2	LIVING	0	TCGA-A2-A0CW-01	1948	0	Squamous	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7			mutation cluster 3	TCGA-A2-A0CW	1948	0	1948	Breast	TCGA Breast Cancer	breast invasive carcinoma					67	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A0CW-F13727		Positive					Positive	Lumpectomy		YES			-24541	1533		0	1948							90-99%				Scheduled Follow-up Submission	2011-6-13	FEMALE					2+			0.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	290	NO	Equivocal	Negative		19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1									NO	2	0	true	M0	N1a	T2	Stage IIB	TCGA-A2-A0CW.7D1C2CD8-9842-48AC-BB16-897E2A45B88D.pdf	95	95	0	0	0	0	0	0	0	10	5	0	95	90	65	55	TUMOR FREE								No	10-19%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2006	TCGA-A2-A0CW-01A-21D-A10Y-09	TCGA-A2-A0CW-01	TCGA-A2-A0CW-01A-21R-A114-13	TCGA-A2-A0CW-01A-21R-A114-13	TCGA-A2-A0CW-01A-21D-A10Y-09	6d65d556-9be9-4491-bd22-85cee7a0ee7c	TCGA-A2-A0CW-01A-21D-A10Y-09	TCGA-A2-A0CW-01A-11-A13B-20	TCGA-A2-A0CW-01A-21D-A10Y-09	1c1560f6-62bf-4185-912f-25c234ebd71f	6f1627be-b4c7-4b99-874b-f1313bc2f284	TCGA-A2-A0CW-01A-21D-A111-01	1c1560f6-62bf-4185-912f-25c234ebd71f		TCGA-A2-A0CW-01	TCGA-A2-A0CW-01A-21R-A115-07	1c1560f6-62bf-4185-912f-25c234ebd71f	1c1560f6-62bf-4185-912f-25c234ebd71f	TCGA-A2-A0CW-01A-21D-A111-01	TCGA-A2-A0CW-01	TCGA-A2-A0CW-01	TCGA-A2-A0CW-01A-21D-A112-05	6f1627be-b4c7-4b99-874b-f1313bc2f284	
TCGA-A2-A0CX-01	Stage IIA	52	3	Stage IIA	1728		Positive	FEMALE	Positive				Negative	M0	Negative	N0	1728	0	Her2	HER2-enriched	Negative	Her2	-11	-5	followup	T_Other	T2	LIVING	0	TCGA-A2-A0CX-01	1728	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7			mutation cluster 5	TCGA-A2-A0CX	1728	0	1728	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Left	Sentinel node biopsy alone		TCGA-A2-A0CX-F13721		Positive					Negative	Lumpectomy		YES			-19152	1316		0	1728											Scheduled Follow-up Submission	2011-6-10	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	560	NO	Positive			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4									NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0CX.28AFD5DD-B607-4837-819F-688C9218ED06.pdf	0	0	0	0	2	0	0	0	0	0	8	10	90	90	80	60	TUMOR FREE								No	<10%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2006	TCGA-A2-A0CX-01A-21W-A019-09	TCGA-A2-A0CX-01			TCGA-A2-A0CX-01A-21W-A019-09	1f7a4605-1972-4f36-b0e7-543ce95a3d0f	TCGA-A2-A0CX-01A-21W-A019-09	TCGA-A2-A0CX-01A-11-A13B-20	TCGA-A2-A0CX-01A-21W-A019-09	b1ecc303-eb55-436f-9629-cdac63bde297	17076dfd-f38a-4894-b39e-f732f4a0823a	TCGA-A2-A0CX-01A-21D-A011-01	b1ecc303-eb55-436f-9629-cdac63bde297		TCGA-A2-A0CX-01	TCGA-A2-A0CX-01A-21R-A00Z-07	b1ecc303-eb55-436f-9629-cdac63bde297	b1ecc303-eb55-436f-9629-cdac63bde297	TCGA-A2-A0CX-01A-21D-A011-01	TCGA-A2-A0CX-01	TCGA-A2-A0CX-01	TCGA-A2-A0CX-01A-21D-A00Y-05	17076dfd-f38a-4894-b39e-f732f4a0823a	
TCGA-A2-A0CY-01	Stage IIB	63	1	No_Conversion	1673		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1673	0		HER2-enriched	Positive	LumA/B	0	-3	followup	T_Other	T2	LIVING	0	TCGA-A2-A0CY-01	1673	0	Kirc+		cluster 5	Cluster 5	BRCA nonbasal-like c8		miRNA c1uster 10	cluster 7		TCGA-A2-A0CY	1673	0	1673	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A0CY-F13731		Positive					Positive	Simple Mastectomy		YES			-23229	1274		0	1673							90-99%				Scheduled Follow-up Submission	2011-6-9	FEMALE					1+			0.89		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	220	NO	Negative	Negative		22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	7								NO	1	0	true	M0	N1	T2	Stage IIB	TCGA-A2-A0CY.CB780DE7-E98C-4F7E-9487-8F25FE80DC21.pdf	0	0	0	0	0	0	0	0	0	0	25	40	75	60	85	80	TUMOR FREE								No	10-19%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2006				TCGA-A2-A0CY-01A-12R-A035-13		3dc93dcc-2b14-4725-b40e-23be7cdbbb9d		TCGA-A2-A0CY-01A-21-A13C-20		c7d2b685-5f11-4879-82d5-e983b5dbb07d			c7d2b685-5f11-4879-82d5-e983b5dbb07d		TCGA-A2-A0CY-01	TCGA-A2-A0CY-01A-12R-A034-07	c7d2b685-5f11-4879-82d5-e983b5dbb07d	c7d2b685-5f11-4879-82d5-e983b5dbb07d		TCGA-A2-A0CY-01		TCGA-A2-A0CY-01A-12D-A032-05		TCGA-A2-A0CY-01A-12R-A035-13
TCGA-A2-A0CZ-01	Stage IIA	46	4	Stage IIA	1615		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	1615	0	Normal	Luminal A	Positive	ReacII	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-A2-A0CZ-01	1616	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A2-A0CZ	1616	0	1616	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-A2-A0CZ-F13728		Positive					Positive	Simple Mastectomy		YES			-17026	1204		0	1616							90-99%				Scheduled Follow-up Submission	2011-6-10	FEMALE					1+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	240	NO	Negative	Negative		2	Positive	Peri (6-12 months since last menstrual period)																		1	2								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0CZ.57153075-9055-4D7E-9CD6-9167D165E860.pdf	0	0	0	0	0	0	0	0	60	55	0	0	40	45	85	90	TUMOR FREE								No	20-29%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2007	TCGA-A2-A0CZ-01A-11W-A050-09			TCGA-A2-A0CZ-01A-11R-A035-13		af5345d8-db03-4d37-b327-5a62c1fe1285	TCGA-A2-A0CZ-01A-11W-A050-09	TCGA-A2-A0CZ-01A-21-A13C-20	TCGA-A2-A0CZ-01A-11W-A050-09	229ebbe9-4dc8-434f-998c-fc0660cd2b00			229ebbe9-4dc8-434f-998c-fc0660cd2b00		TCGA-A2-A0CZ-01	TCGA-A2-A0CZ-01A-11R-A034-07	229ebbe9-4dc8-434f-998c-fc0660cd2b00	229ebbe9-4dc8-434f-998c-fc0660cd2b00		TCGA-A2-A0CZ-01		TCGA-A2-A0CZ-01A-11D-A032-05		TCGA-A2-A0CZ-01A-11R-A035-13
TCGA-A2-A0D0-01	Stage IIA	60	1	Stage IIA	643		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	643	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-A2-A0D0-01	643	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14	cluster 5	mutation cluster 5	TCGA-A2-A0D0	643	0	643	Breast	TCGA Breast Cancer	breast invasive carcinoma					60	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A0D0-F13729		Negative		0			Negative	Simple Mastectomy		NO			-22115	720		0	643							<10%				Scheduled Follow-up Submission	2011-6-9	FEMALE					0			1.17		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	500	NO	Negative	Negative		8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0D0.D8B44020-EC34-4788-B7FB-790B9C12D886.pdf	2	2	0	0	2	2	0	0	0	0	13	8	85	90	85	90	TUMOR FREE								No	<10%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2008	TCGA-A2-A0D0-01A-11W-A019-09	TCGA-A2-A0D0-01		TCGA-A2-A0D0-01A-11R-A010-13	TCGA-A2-A0D0-01A-11W-A019-09	980c774a-c662-489e-82a3-212d0a45f759	TCGA-A2-A0D0-01A-11W-A019-09	TCGA-A2-A0D0-01A-21-A13C-20	TCGA-A2-A0D0-01A-11W-A019-09	bd51f90a-ec67-4a7d-87bf-9d85acd65d51	ad8186c8-9dc3-40dd-92ea-4a952ddbad11	TCGA-A2-A0D0-01A-11D-A011-01	bd51f90a-ec67-4a7d-87bf-9d85acd65d51		TCGA-A2-A0D0-01	TCGA-A2-A0D0-01A-11R-A00Z-07	bd51f90a-ec67-4a7d-87bf-9d85acd65d51	bd51f90a-ec67-4a7d-87bf-9d85acd65d51	TCGA-A2-A0D0-01A-11D-A011-01	TCGA-A2-A0D0-01	TCGA-A2-A0D0-01	TCGA-A2-A0D0-01A-11D-A00Y-05	ad8186c8-9dc3-40dd-92ea-4a952ddbad11	TCGA-A2-A0D0-01A-11R-A010-13
TCGA-A2-A0D1-01	Stage IIA	76	1	Stage IIA	1051		Negative	FEMALE	Positive	2	2	1	Negative	M0	Negative	N0	1051	0	Her2	HER2-enriched	Negative	Basal	-2	-6	followup	T_Other	T2	LIVING	0	TCGA-A2-A0D1-01	1051	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 8	TCGA-A2-A0D1	1051	0	1051	Breast	TCGA Breast Cancer	breast invasive carcinoma					76	Left Lower Inner Quadrant	Sentinel node biopsy alone		TCGA-A2-A0D1-F13733		Negative					Negative	Lumpectomy		YES			-28084	637		0	1051							<10%				Scheduled Follow-up Submission	2011-6-9	FEMALE					3+			5.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	340	NO	Positive	Positive		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	1								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0D1.5DFA7970-3F68-4FC3-B2BA-5A42E866ECC3.pdf	1	2	0	0	0	1	0	0	0	0	10	24	90	75	90	75	TUMOR FREE				Intensity=Weak	Intensity=Weak			No	<10%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2008	TCGA-A2-A0D1-01A-11W-A050-09	TCGA-A2-A0D1-01		TCGA-A2-A0D1-01A-11R-A035-13	TCGA-A2-A0D1-01A-11W-A050-09	aa90ba5a-1a36-46e9-a3f5-21ba48c5f29a	TCGA-A2-A0D1-01A-11W-A050-09	TCGA-A2-A0D1-01A-21-A13C-20	TCGA-A2-A0D1-01A-11W-A050-09	01370d42-f75c-4532-9b9c-24ff7302b033	bca3ec5f-f504-4f47-9359-6576d0ca164a	TCGA-A2-A0D1-01A-11D-A036-01	01370d42-f75c-4532-9b9c-24ff7302b033		TCGA-A2-A0D1-01	TCGA-A2-A0D1-01A-11R-A034-07	01370d42-f75c-4532-9b9c-24ff7302b033	01370d42-f75c-4532-9b9c-24ff7302b033	TCGA-A2-A0D1-01A-11D-A036-01	TCGA-A2-A0D1-01	TCGA-A2-A0D1-01	TCGA-A2-A0D1-01A-11D-A032-05	bca3ec5f-f504-4f47-9359-6576d0ca164a	TCGA-A2-A0D1-01A-11R-A035-13
TCGA-A2-A0D2-01	Stage IIB	45	3	Stage IIA	1027		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1027	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-A2-A0D2-01	1027	0	High	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-A2-A0D2	1027	0	1027	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A0D2-F14458		Negative		0			Negative	Simple Mastectomy		YES			-16623	614		0	1027							<10%				Scheduled Follow-up Submission	2011-6-9	FEMALE					0			1.05		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	330	NO	Negative	Negative		5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	4								NO	0	4	true	M0	N0 (i+)	T2	Stage IIA	TCGA-A2-A0D2.B0DE3388-7826-40D3-ADEE-0B25FE201F4A.pdf	1	1	0	0	1	1	0	0	0	3	19	16	80	80	85	80	TUMOR FREE								No	<10%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2008	TCGA-A2-A0D2-01A-21W-A050-09	TCGA-A2-A0D2-01		TCGA-A2-A0D2-01A-21R-A035-13	TCGA-A2-A0D2-01A-21W-A050-09	74c3c43d-b3f1-4846-be03-3b65098774c7	TCGA-A2-A0D2-01A-21W-A050-09	TCGA-A2-A0D2-01A-11-A13C-20	TCGA-A2-A0D2-01A-21W-A050-09	2ad8d416-08a4-4e6f-947e-d74269d02ab1	3da4a808-275c-45fd-b9e4-81183ebeb0c9	TCGA-A2-A0D2-01A-21D-A036-01	2ad8d416-08a4-4e6f-947e-d74269d02ab1		TCGA-A2-A0D2-01	TCGA-A2-A0D2-01A-21R-A034-07	2ad8d416-08a4-4e6f-947e-d74269d02ab1	2ad8d416-08a4-4e6f-947e-d74269d02ab1	TCGA-A2-A0D2-01A-21D-A036-01	TCGA-A2-A0D2-01	TCGA-A2-A0D2-01	TCGA-A2-A0D2-01A-21D-A032-05	3da4a808-275c-45fd-b9e4-81183ebeb0c9	TCGA-A2-A0D2-01A-21R-A035-13
TCGA-A2-A0D3-01	Stage IA	42	2	Stage I	875		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	875	0	LumA	Luminal A	Positive	LumA	-5	-3	followup	T1	T1	LIVING	0	TCGA-A2-A0D3-01	875	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-A2-A0D3	875	0	875	Breast	TCGA Breast Cancer	breast invasive carcinoma					42	Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A0D3-F13715		Positive					Positive	Simple Mastectomy		YES			-15524	545		0	875							90-99%				Scheduled Follow-up Submission	2011-6-9	FEMALE					1+			1.41		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	420	NO	Negative	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6								NO	0	0	true	M0	N0 (i-)	T1c	Stage IA	TCGA-A2-A0D3.5C563F73-3793-4902-ACBB-82F432AED592.pdf	4	6	0	0	1	1	0	0	0	0	54	34	45	65	45	65	TUMOR FREE								No	90-99%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2008	TCGA-A2-A0D3-01A-11D-A10Y-09	TCGA-A2-A0D3-01	TCGA-A2-A0D3-01A-11R-A114-13	TCGA-A2-A0D3-01A-11R-A114-13	TCGA-A2-A0D3-01A-11D-A10Y-09	068b3d7e-b3b4-4fd1-89c5-2019253806b2	TCGA-A2-A0D3-01A-11D-A10Y-09	TCGA-A2-A0D3-01A-21-A13A-20	TCGA-A2-A0D3-01A-11D-A10Y-09	eefe67c9-48a1-4381-a3ef-81b51e46c6df	34a4a64c-d8a5-44c8-ae5e-3ef0258179d6	TCGA-A2-A0D3-01A-11D-A111-01	eefe67c9-48a1-4381-a3ef-81b51e46c6df		TCGA-A2-A0D3-01	TCGA-A2-A0D3-01A-11R-A115-07	eefe67c9-48a1-4381-a3ef-81b51e46c6df	eefe67c9-48a1-4381-a3ef-81b51e46c6df	TCGA-A2-A0D3-01A-11D-A111-01	TCGA-A2-A0D3-01	TCGA-A2-A0D3-01	TCGA-A2-A0D3-01A-11D-A112-05	34a4a64c-d8a5-44c8-ae5e-3ef0258179d6	
TCGA-A2-A0D4-01	Stage IIB	37	5	No_Conversion	767		Positive	FEMALE	Negative	4	3	4	Negative	M0	Positive	N1	767	0	LumB	Luminal B	Positive	LumA/B	-10	-3	followup	T_Other	T2	LIVING	0	TCGA-A2-A0D4-01	767	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 5	mutation c1uster 9	TCGA-A2-A0D4	767	0	767	Breast	TCGA Breast Cancer	breast invasive carcinoma					37	Left	Axillary lymph node dissection alone		TCGA-A2-A0D4-F13726		Positive					Positive	Lumpectomy		NO			-13805	384		0	767							90-99%				Scheduled Follow-up Submission	2011-6-10	FEMALE					1+			1.14		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	220	NO	Negative	Negative		23	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		3	5								NO	1	0	true	M0	N1a	T2	Stage IIB	TCGA-A2-A0D4.990F5885-8EDD-42A2-AEFE-9DEE3E95A0B1.pdf	1	2	0	0	1	0	0	0	0	0	14	20	85	80	85	80	TUMOR FREE				Intensity=weak	Intensity=moderate			No	10-19%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2009	TCGA-A2-A0D4-01A-11W-A019-09	TCGA-A2-A0D4-01		TCGA-A2-A0D4-01A-11R-A038-13	TCGA-A2-A0D4-01A-11W-A019-09	33556a57-3d4b-4d1d-ac6f-bf0974c4ca36	TCGA-A2-A0D4-01A-11W-A019-09	TCGA-A2-A0D4-01A-21-A13C-20	TCGA-A2-A0D4-01A-11W-A019-09	2522bd3d-f6b3-45df-b68f-577ffbf3a819	a1b53759-99b5-4470-bb22-242ab09561dd	TCGA-A2-A0D4-01A-11D-A011-01	2522bd3d-f6b3-45df-b68f-577ffbf3a819		TCGA-A2-A0D4-01	TCGA-A2-A0D4-01A-11R-A00Z-07	2522bd3d-f6b3-45df-b68f-577ffbf3a819	2522bd3d-f6b3-45df-b68f-577ffbf3a819	TCGA-A2-A0D4-01A-11D-A011-01	TCGA-A2-A0D4-01	TCGA-A2-A0D4-01	TCGA-A2-A0D4-01A-11D-A00Y-05	a1b53759-99b5-4470-bb22-242ab09561dd	TCGA-A2-A0D4-01A-11R-A038-13
TCGA-A2-A0EM-01	Stage IA	73	2	Stage I	3093		Positive	FEMALE	Negative				Negative	M0	Negative	N0	3093	0	LumA	Luminal A	Positive		-12	-3	followup	T1	T1	LIVING	0	TCGA-A2-A0EM-01	3094	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A2-A0EM	3094	0	3094	Breast	TCGA Breast Cancer	breast invasive carcinoma					73	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-A2-A0EM-F13714		Positive					Positive	Lumpectomy		YES			-26845	2696		0	3094											Scheduled Follow-up Submission	2011-6-9	FEMALE								1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	20	NO		Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	0	0	true	M0	N0 (i-)	T1	Stage IA	TCGA-A2-A0EM.454CB5E9-3778-4666-9CED-913E08CB3615.pdf	3	5	2	2	2	1	0	0	5	5	43	64	50	30	85	75	TUMOR FREE								No			YES	Primary Tumor	01		5th	YES	NO	YES	A2	Breast	A	LIVING	2002	TCGA-A2-A0EM-01A-11W-A050-09	TCGA-A2-A0EM-01		TCGA-A2-A0EM-01A-11R-A035-13	TCGA-A2-A0EM-01A-11W-A050-09		TCGA-A2-A0EM-01A-11W-A050-09		TCGA-A2-A0EM-01A-11W-A050-09	8d30a0ab-a41f-40ef-bd59-f738f4b39941	3b12a9e9-a268-4469-b63e-2a735e164803	TCGA-A2-A0EM-01A-11D-A036-01	8d30a0ab-a41f-40ef-bd59-f738f4b39941		TCGA-A2-A0EM-01	TCGA-A2-A0EM-01A-11R-A034-07	8d30a0ab-a41f-40ef-bd59-f738f4b39941	8d30a0ab-a41f-40ef-bd59-f738f4b39941	TCGA-A2-A0EM-01A-11D-A036-01	TCGA-A2-A0EM-01	TCGA-A2-A0EM-01	TCGA-A2-A0EM-01A-11D-A032-05	3b12a9e9-a268-4469-b63e-2a735e164803	TCGA-A2-A0EM-01A-11R-A035-13
TCGA-A2-A0EN-01	Stage IIA	70	2	Stage IIA	2717		Positive	FEMALE	Negative				Negative	M0	Negative	N0	2717	0	LumA	Luminal A	Positive		-5	-7	followup	T_Other	T2	LIVING	0	TCGA-A2-A0EN-01	2718	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A2-A0EN	2718	0	2718	Breast	TCGA Breast Cancer	breast invasive carcinoma					70	Right	Sentinel node biopsy alone		TCGA-A2-A0EN-F13725		Positive					Positive	Lumpectomy		YES			-25771	2348		0	2718											Scheduled Follow-up Submission	2011-6-10	FEMALE					2+			1.4		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Excisional Biopsy	110	NO	Equivocal	Negative		4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	2								NO	0	1	true	M0	N0 (i+)	T2	Stage IIA	TCGA-A2-A0EN.8169AA00-E396-4A3E-A91C-F67B1F0B8E3E.pdf	1	1	0	0	0	0	0	0	1	2	14	13	85	85	85	85	TUMOR FREE								No	50-59%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2003	TCGA-A2-A0EN-01A-13D-A099-09	TCGA-A2-A0EN-01		TCGA-A2-A0EN-01A-13R-A085-13	TCGA-A2-A0EN-01A-13D-A099-09		TCGA-A2-A0EN-01A-13D-A099-09		TCGA-A2-A0EN-01A-13D-A099-09	3ac4a6fe-9d2b-4c95-a74a-525b0328c7ed	38decb88-ca75-4a0c-bdd2-917ccdd60851	TCGA-A2-A0EN-01A-13D-A087-01	3ac4a6fe-9d2b-4c95-a74a-525b0328c7ed	TCGA-A2-A0EN-01A-13D-A10P-05	TCGA-A2-A0EN-01	TCGA-A2-A0EN-01A-13R-A084-07	3ac4a6fe-9d2b-4c95-a74a-525b0328c7ed	3ac4a6fe-9d2b-4c95-a74a-525b0328c7ed	TCGA-A2-A0EN-01A-13D-A087-01	TCGA-A2-A0EN-01	TCGA-A2-A0EN-01		38decb88-ca75-4a0c-bdd2-917ccdd60851	TCGA-A2-A0EN-01A-13R-A085-13
TCGA-A2-A0EO-01	Stage IA	54	2	Stage I	2441		Positive	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	2441	0	LumA	Luminal A	Positive	LumA	-5	-7	followup	T1	T1	LIVING	0	TCGA-A2-A0EO-01	2442	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A2-A0EO	2442	0	2442	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Left	Sentinel node biopsy alone		TCGA-A2-A0EO-F13732		Positive					Positive	Lumpectomy		YES			-19880	2331		0	2442											Scheduled Follow-up Submission	2011-6-13	FEMALE					1+			1.6		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Negative	Negative		3	Close	Peri (6-12 months since last menstrual period)																		4	2								NO	0	0	true	M0	N0 (i-)	T1	Stage IA	TCGA-A2-A0EO.61BC91AE-CD06-432D-BCBA-6FAE2209C610.pdf	15	3	1	0	1	1	0	0	20	4	20	20	59	75	65	80	TUMOR FREE								No			YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2003	TCGA-A2-A0EO-01A-11W-A050-09	TCGA-A2-A0EO-01		TCGA-A2-A0EO-01A-11R-A035-13	TCGA-A2-A0EO-01A-11W-A050-09	368ae06c-f56e-4ba9-af38-0cc01e900f70	TCGA-A2-A0EO-01A-11W-A050-09	TCGA-A2-A0EO-01A-21-A13B-20	TCGA-A2-A0EO-01A-11W-A050-09	cdeceaf0-beb6-4374-8aea-83bd35318892	8aba442b-9f10-4d63-8780-b3462cfc2945	TCGA-A2-A0EO-01A-11D-A036-01	cdeceaf0-beb6-4374-8aea-83bd35318892		TCGA-A2-A0EO-01	TCGA-A2-A0EO-01A-11R-A034-07	cdeceaf0-beb6-4374-8aea-83bd35318892	cdeceaf0-beb6-4374-8aea-83bd35318892	TCGA-A2-A0EO-01A-11D-A036-01	TCGA-A2-A0EO-01	TCGA-A2-A0EO-01	TCGA-A2-A0EO-01A-11D-A032-05	8aba442b-9f10-4d63-8780-b3462cfc2945	TCGA-A2-A0EO-01A-11R-A035-13
TCGA-A2-A0EP-01																													0	TCGA-A2-A0EP-01	3273	0					BRCA nonbasal-like c8		miRNA cluster 4			TCGA-A2-A0EP	3273	0	3273	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Right Lower Inner Quadrant	Sentinel node biopsy alone		TCGA-A2-A0EP-F42402		Positive	3 Point Scale				Negative	Simple Mastectomy		YES			-20585			0	3273							80-89%					2013-4-18	FEMALE								1.3		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy			Negative	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	1		M0	N0 (i+)	T1	Stage I																		TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		6th		NO	YES	A2	Breast		LIVING	2004			TCGA-A2-A0EP-01A-52R-A22V-13	TCGA-A2-A0EP-01A-52R-A22V-13			TCGA-A2-A0EP-01A-52D-A22X-09	TCGA-A2-A0EP-01A-61-A24A-20		b1dbf4a7-16f8-49bc-a89f-aeac729e3c3c	fd6c7c33-de06-4766-9e4f-6f40b761008e	TCGA-A2-A0EP-01A-52D-A22W-01	b1dbf4a7-16f8-49bc-a89f-aeac729e3c3c	TCGA-A2-A0EP-01A-52D-A230-05	TCGA-A2-A0EP-01		b1dbf4a7-16f8-49bc-a89f-aeac729e3c3c	b1dbf4a7-16f8-49bc-a89f-aeac729e3c3c	TCGA-A2-A0EP-01A-52D-A22W-01		TCGA-A2-A0EP-01		fd6c7c33-de06-4766-9e4f-6f40b761008e	
TCGA-A2-A0EQ-01	Stage IIA	64	4	Stage IIA	2426		Negative	FEMALE	Positive	1	1	4	Negative	M0	Negative	N0	2426	0	Her2	HER2-enriched	Negative	Basal	-2	-5	followup	T_Other	T2	LIVING	0	TCGA-A2-A0EQ-01	2426	0	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 8	TCGA-A2-A0EQ	2426	0	2426	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Left	Other (specify)	Sentinel lymph node and non-sentinel lymph node biopsy	TCGA-A2-A0EQ-F13720	Negative	Negative		0		Lumpectomy	Negative	Lumpectomy		YES			-23543	2038		0	2426							<10%				Scheduled Follow-up Submission	2011-6-13	FEMALE					3+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	600	NO	Positive	Negative		2	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0EQ.60569C8B-7209-4A3F-A177-F337085E9146.pdf	2	5	0	0	0	0	0	0	0	0	15	25	85	75	90	75	TUMOR FREE								No	<10%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2004	TCGA-A2-A0EQ-01A-11W-A050-09	TCGA-A2-A0EQ-01		TCGA-A2-A0EQ-01A-11R-A035-13	TCGA-A2-A0EQ-01A-11W-A050-09	cd49aac8-9c6e-41d7-816c-1bdcb4aaca4a	TCGA-A2-A0EQ-01A-11W-A050-09	TCGA-A2-A0EQ-01A-21-A13C-20	TCGA-A2-A0EQ-01A-11W-A050-09	a083b072-7c1e-4ed6-90cf-1e49d21df4cb	7b6fada0-555f-4234-9436-a498d03e7413	TCGA-A2-A0EQ-01A-11D-A036-01	a083b072-7c1e-4ed6-90cf-1e49d21df4cb		TCGA-A2-A0EQ-01	TCGA-A2-A0EQ-01A-11R-A034-07	a083b072-7c1e-4ed6-90cf-1e49d21df4cb	a083b072-7c1e-4ed6-90cf-1e49d21df4cb	TCGA-A2-A0EQ-01A-11D-A036-01	TCGA-A2-A0EQ-01	TCGA-A2-A0EQ-01	TCGA-A2-A0EQ-01A-11D-A032-05	7b6fada0-555f-4234-9436-a498d03e7413	TCGA-A2-A0EQ-01A-11R-A035-13
TCGA-A2-A0ER-01	Stage IB	63	5	No_Conversion	2262		Positive	FEMALE	Negative				Negative	M0	Positive	N1	2262	0	LumA	Luminal B	Positive	ReacII	-10	-3	followup	T1	T1	LIVING	0	TCGA-A2-A0ER-01	2263	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A2-A0ER	2263	0	2263	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A0ER-F13719	Negative	Positive				Lumpectomy	Positive	Lumpectomy		YES			-23021	1862		0	2263							90-99%				Scheduled Follow-up Submission	2011-6-13	FEMALE					2+			1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	300	NO	Equivocal	Negative		14	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	1	0	true	M0	N1mi	T1c	Stage IB	TCGA-A2-A0ER.A5D94D02-5423-4055-96E3-B5AA5799DC02.pdf	6	2	1	0	1	0	0	0	34	3	5	17	60	80	60	85	TUMOR FREE								No	80-89%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2005	TCGA-A2-A0ER-01A-21W-A050-09	TCGA-A2-A0ER-01		TCGA-A2-A0ER-01A-21R-A035-13	TCGA-A2-A0ER-01A-21W-A050-09	7b71576b-d077-4e99-ae77-0c061517a5f9	TCGA-A2-A0ER-01A-21W-A050-09	TCGA-A2-A0ER-01A-11-A13C-20	TCGA-A2-A0ER-01A-21W-A050-09	9c8e0865-894b-4a0b-83e4-c3e7a40e871b	49f8fe03-b923-4bb7-b042-6cb4d6f6e2b0	TCGA-A2-A0ER-01A-21D-A036-01	9c8e0865-894b-4a0b-83e4-c3e7a40e871b		TCGA-A2-A0ER-01	TCGA-A2-A0ER-01A-21R-A034-07	9c8e0865-894b-4a0b-83e4-c3e7a40e871b	9c8e0865-894b-4a0b-83e4-c3e7a40e871b	TCGA-A2-A0ER-01A-21D-A036-01	TCGA-A2-A0ER-01	TCGA-A2-A0ER-01	TCGA-A2-A0ER-01A-21D-A032-05	49f8fe03-b923-4bb7-b042-6cb4d6f6e2b0	TCGA-A2-A0ER-01A-21R-A035-13
TCGA-A2-A0ES-01	Stage IIA	52	4	Stage IIA	1127		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	1127	0	LumA	Luminal A	Positive	ReacII	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-A2-A0ES-01	1127	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-A2-A0ES	1127	0	1127	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A0ES-F13718		Positive					Positive	Simple Mastectomy		YES			-19160	756		0	1127							60-69%				Scheduled Follow-up Submission	2011-6-10	FEMALE					1+			1.32		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	460	NO	Negative	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0ES.6860A718-FAAB-44A1-A3C1-E4A9EC1ECB05.pdf	2	2	0	0	0	0	0	0	15	15	75	45	10	40	10	65	TUMOR FREE								No	10-19%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2008	TCGA-A2-A0ES-01A-11D-A10Y-09	TCGA-A2-A0ES-01	TCGA-A2-A0ES-01A-11R-A114-13	TCGA-A2-A0ES-01A-11R-A114-13	TCGA-A2-A0ES-01A-11D-A10Y-09	8d841c4a-d6b2-4d89-8d26-b415bce6c25d	TCGA-A2-A0ES-01A-11D-A10Y-09	TCGA-A2-A0ES-01A-21-A13B-20	TCGA-A2-A0ES-01A-11D-A10Y-09	698c9928-1aa8-4b48-9048-5675e5943c22	3dc8a0fe-341f-4f09-af43-1e142208caba	TCGA-A2-A0ES-01A-11D-A111-01	698c9928-1aa8-4b48-9048-5675e5943c22		TCGA-A2-A0ES-01	TCGA-A2-A0ES-01A-11R-A115-07	698c9928-1aa8-4b48-9048-5675e5943c22	698c9928-1aa8-4b48-9048-5675e5943c22	TCGA-A2-A0ES-01A-11D-A111-01	TCGA-A2-A0ES-01	TCGA-A2-A0ES-01	TCGA-A2-A0ES-01A-11D-A112-05	3dc8a0fe-341f-4f09-af43-1e142208caba	
TCGA-A2-A0ET-01	Stage IIIA	58	3	No_Conversion	1066		Positive	FEMALE	Negative				Negative	M0	Positive	N2	1066	0	LumA	Luminal A	Positive		-10	-3	followup	T_Other	T2	LIVING	0	TCGA-A2-A0ET-01	1066	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-A2-A0ET	1066	0	1066	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A0ET-F13713		Positive					Positive	Lumpectomy		NO			-21464	674		0	1066							90-99%				Scheduled Follow-up Submission	2011-6-10	FEMALE					2+			1.09		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	890	NO	Equivocal	Negative		15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	1								NO	5	0	true	M0	N2a	T2	Stage IIIA	TCGA-A2-A0ET.E9D3FFF1-5FB2-4F17-9C1D-D9775E3CC5AC.pdf	7	5	0	0	1	1	0	0	15	15	0	5	84	79	90	90	TUMOR FREE				Intensity=Strong	Intensity=Strong			No	70-79%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2008	TCGA-A2-A0ET-01A-31D-A045-09	TCGA-A2-A0ET-01		TCGA-A2-A0ET-01A-31R-A035-13	TCGA-A2-A0ET-01A-31D-A045-09		TCGA-A2-A0ET-01A-31D-A045-09		TCGA-A2-A0ET-01A-31D-A045-09	4eb0c00d-595c-47ee-bcad-818c7723656d	fec7f250-896a-40c3-a6ed-82607bf7af4d	TCGA-A2-A0ET-01A-31D-A036-01	4eb0c00d-595c-47ee-bcad-818c7723656d		TCGA-A2-A0ET-01	TCGA-A2-A0ET-01A-31R-A034-07	4eb0c00d-595c-47ee-bcad-818c7723656d	4eb0c00d-595c-47ee-bcad-818c7723656d	TCGA-A2-A0ET-01A-31D-A036-01	TCGA-A2-A0ET-01	TCGA-A2-A0ET-01	TCGA-A2-A0ET-01A-31D-A032-05	fec7f250-896a-40c3-a6ed-82607bf7af4d	TCGA-A2-A0ET-01A-31R-A035-13
TCGA-A2-A0EU-01	Stage IA	79	4	Stage I	1043		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	1043	0	LumA	Luminal A	Positive	ReacI	-10	-3	followup	T1	T1	LIVING	0	TCGA-A2-A0EU-01	1043	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A2-A0EU	1043	0	1043	Breast	TCGA Breast Cancer	breast invasive carcinoma					79	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A0EU-F13717	Negative	Positive				Lumpectomy	Positive	Lumpectomy		YES			-29144	644		0	1043							90-99%				Scheduled Follow-up Submission	2011-6-10	FEMALE					0			0.97		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	610	NO	Negative	Negative		1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	0	0	true	M0	N0 (i-)	T1c	Stage IA	TCGA-A2-A0EU.42649B9A-29D4-4D05-A78C-AC801792ADEB.pdf	15	2	0	0	1	0	0	0	5	0	54	20	40	80	70	80	TUMOR FREE				Intensity=Strong	Intensity=Strong			No	90-99%		YES	Primary Tumor	01			NO	NO	YES	A2	Breast	A	LIVING	2008	TCGA-A2-A0EU-01A-22W-A071-09	TCGA-A2-A0EU-01		TCGA-A2-A0EU-01A-22R-A057-13	TCGA-A2-A0EU-01A-22W-A071-09	616af0e6-b37f-48aa-aa61-2e5b5a72b749	TCGA-A2-A0EU-01A-22W-A071-09	TCGA-A2-A0EU-01A-11-A13B-20	TCGA-A2-A0EU-01A-22W-A071-09	70633069-e9df-4fce-84df-6849f4b2693c	d30e36ac-0c71-4210-bf07-334f2b5ba904	TCGA-A2-A0EU-01A-22D-A059-01	70633069-e9df-4fce-84df-6849f4b2693c	TCGA-A2-A0EU-01A-22D-A10P-05	TCGA-A2-A0EU-01	TCGA-A2-A0EU-01A-22R-A056-07	70633069-e9df-4fce-84df-6849f4b2693c	70633069-e9df-4fce-84df-6849f4b2693c	TCGA-A2-A0EU-01A-22D-A059-01	TCGA-A2-A0EU-01	TCGA-A2-A0EU-01		d30e36ac-0c71-4210-bf07-334f2b5ba904	TCGA-A2-A0EU-01A-22R-A057-13
TCGA-A2-A0EV-01	Stage IA	80	3	Stage I	968		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	968	0	LumA	Luminal A	Positive	ReacI	0	-4	followup	T1	T1	LIVING	0	TCGA-A2-A0EV-01	968	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A2-A0EV	968	0	968	Breast	TCGA Breast Cancer	breast invasive carcinoma					80	Left	Sentinel node biopsy alone		TCGA-A2-A0EV-F13712		Positive					Positive	Lumpectomy		YES			-29285	590		0	968							90-99%				Scheduled Follow-up Submission	2011-6-10	FEMALE			<10%		0			1.40		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	960	NO	Negative	Negative		6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4								NO	0	0	true	M0	N0 (i-)	T1c	Stage IA	TCGA-A2-A0EV.2A62DD22-EFE6-48CD-8BE6-59B08168F78A.pdf	2	5	0	0	0	0	0	0	5	0	40	30	55	70	65	75	TUMOR FREE								No	90-99%		NO	Primary Tumor	01			NO	NO	YES	A2	Breast	A	LIVING	2008	TCGA-A2-A0EV-01A-11W-A050-09	TCGA-A2-A0EV-01		TCGA-A2-A0EV-01A-11R-A035-13	TCGA-A2-A0EV-01A-11W-A050-09	19683ba7-695c-484a-95ba-39a8dd02a6a3	TCGA-A2-A0EV-01A-11W-A050-09	TCGA-A2-A0EV-01A-21-A13C-20	TCGA-A2-A0EV-01A-11W-A050-09	75cd6423-52b8-4d29-97de-1fe2583dbac1	2ee9b4c3-15a5-4766-b762-ad8a96dc08f8	TCGA-A2-A0EV-01A-11D-A036-01	75cd6423-52b8-4d29-97de-1fe2583dbac1		TCGA-A2-A0EV-01	TCGA-A2-A0EV-01A-11R-A034-07	75cd6423-52b8-4d29-97de-1fe2583dbac1	75cd6423-52b8-4d29-97de-1fe2583dbac1	TCGA-A2-A0EV-01A-11D-A036-01	TCGA-A2-A0EV-01	TCGA-A2-A0EV-01	TCGA-A2-A0EV-01A-11D-A032-05	2ee9b4c3-15a5-4766-b762-ad8a96dc08f8	TCGA-A2-A0EV-01A-11R-A035-13
TCGA-A2-A0EW-01	Stage IIIC	53	2	No_Conversion	904		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N3	904	0	LumA	Luminal A	Positive	ReacI	-5	-7	followup	T1	T1	LIVING	0	TCGA-A2-A0EW-01	905	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-A2-A0EW	905	0	905	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A0EW-F13724		Positive					Positive	Simple Mastectomy		YES			-19413	542		0	905							90-99%				Scheduled Follow-up Submission	2011-6-10	FEMALE					0			1.33		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	1710	NO	Negative	Negative			Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6								NO	26	0	true	M0	N3a	T1b	Stage IIIC	TCGA-A2-A0EW.2620E5E7-ED7D-4F04-A8AF-1499E9711E8A.pdf	2	2	0	0	0	0	0	0	10	15	25	60	65	25	65	25	TUMOR FREE								No	10-19%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2008	TCGA-A2-A0EW-01A-21D-A10Y-09	TCGA-A2-A0EW-01	TCGA-A2-A0EW-01A-21R-A114-13	TCGA-A2-A0EW-01A-21R-A114-13	TCGA-A2-A0EW-01A-21D-A10Y-09	e365a292-15b3-4e28-bf58-3ecdde392c22	TCGA-A2-A0EW-01A-21D-A10Y-09	TCGA-A2-A0EW-01A-31-A13B-20	TCGA-A2-A0EW-01A-21D-A10Y-09	5bf6cf0d-8d00-4a50-b239-4b9d8f3e51b9	581771be-7430-4032-8cec-55b339d22c49	TCGA-A2-A0EW-01A-21D-A111-01	5bf6cf0d-8d00-4a50-b239-4b9d8f3e51b9		TCGA-A2-A0EW-01	TCGA-A2-A0EW-01A-21R-A115-07	5bf6cf0d-8d00-4a50-b239-4b9d8f3e51b9	5bf6cf0d-8d00-4a50-b239-4b9d8f3e51b9	TCGA-A2-A0EW-01A-21D-A111-01	TCGA-A2-A0EW-01	TCGA-A2-A0EW-01	TCGA-A2-A0EW-01A-21D-A112-05	581771be-7430-4032-8cec-55b339d22c49	
TCGA-A2-A0EX-01	Stage IIB	46	4	Stage IIB	549		Positive	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	549	0	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T_Other	T3	LIVING	0	TCGA-A2-A0EX-01	752	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A2-A0EX	752	0	752	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO			46	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A0EX-F13742	Negative	Positive				Mastectomy NOS	Positive	Lumpectomy		YES			-16858	468		0	752							60-69%				Scheduled Follow-up Submission	2011-6-10	FEMALE					1+			1.22		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	650	NO	Negative	Negative		1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	0	1	true	M0	N0 (i+)	T3	Stage IIB	TCGA-A2-A0EX.5B82545F-2636-4A8A-88DD-1B387DE678FF.pdf	10	2	0	0	1	0	0	0	39	3	10	22	50	75	70	75	TUMOR FREE								No	90-99%		NO	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2009	TCGA-A2-A0EX-01A-21W-A050-09	TCGA-A2-A0EX-01		TCGA-A2-A0EX-01A-21R-A035-13	TCGA-A2-A0EX-01A-21W-A050-09	83a37012-5a0c-4263-a361-3aaff03b0429	TCGA-A2-A0EX-01A-21W-A050-09	TCGA-A2-A0EX-01A-11-A13C-20	TCGA-A2-A0EX-01A-21W-A050-09	6fc8b7da-3de6-4111-b685-bb03c032466a	5382306d-84ce-4839-acb5-ba11a8f8cea5	TCGA-A2-A0EX-01A-21D-A036-01	6fc8b7da-3de6-4111-b685-bb03c032466a		TCGA-A2-A0EX-01	TCGA-A2-A0EX-01A-21R-A034-07	6fc8b7da-3de6-4111-b685-bb03c032466a	6fc8b7da-3de6-4111-b685-bb03c032466a	TCGA-A2-A0EX-01A-21D-A036-01	TCGA-A2-A0EX-01	TCGA-A2-A0EX-01	TCGA-A2-A0EX-01A-21D-A032-05	5382306d-84ce-4839-acb5-ba11a8f8cea5	TCGA-A2-A0EX-01A-21R-A035-13
TCGA-A2-A0EY-01	Stage IIB	62	3	No_Conversion	735		Positive	FEMALE	Positive	1	1	4	Negative	M0	Positive	N1	735	0	LumB	Luminal B	Negative	Her2	-2	-5	followup	T_Other	T2	LIVING	0	TCGA-A2-A0EY-01	735	0	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 3	TCGA-A2-A0EY	735	0	735	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A0EY-F13716		Positive					Negative	Lumpectomy		YES			-22872	358		0	735							60-69%				Scheduled Follow-up Submission	2011-6-10	FEMALE					3+			7.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	580	NO	Positive	Positive		23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	1								NO	1	0	true	M0	N1a	T2	Stage IIB	TCGA-A2-A0EY.61462D57-DF98-4F89-BAEF-E8156A47E2DD.pdf	4	2	0	0	0	0	0	0	0	0	15	20	85	80	85	85	TUMOR FREE								No	<10%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2009	TCGA-A2-A0EY-01A-11W-A050-09	TCGA-A2-A0EY-01		TCGA-A2-A0EY-01A-11R-A035-13	TCGA-A2-A0EY-01A-11W-A050-09	b4fefb35-16bd-4db4-aa7a-805703f36514	TCGA-A2-A0EY-01A-11W-A050-09	TCGA-A2-A0EY-01A-21-A13C-20	TCGA-A2-A0EY-01A-11W-A050-09	4f1ffb0e-b2f8-42ae-86cb-bbd3405014f6	93f09df2-f3c1-43d6-9c79-4751740bfa45	TCGA-A2-A0EY-01A-11D-A036-01	4f1ffb0e-b2f8-42ae-86cb-bbd3405014f6		TCGA-A2-A0EY-01	TCGA-A2-A0EY-01A-11R-A034-07	4f1ffb0e-b2f8-42ae-86cb-bbd3405014f6	4f1ffb0e-b2f8-42ae-86cb-bbd3405014f6	TCGA-A2-A0EY-01A-11D-A036-01	TCGA-A2-A0EY-01	TCGA-A2-A0EY-01	TCGA-A2-A0EY-01A-11D-A032-05	93f09df2-f3c1-43d6-9c79-4751740bfa45	TCGA-A2-A0EY-01A-11R-A035-13
TCGA-A2-A0ST-01	Stage IIA	62	1	No_Conversion	1643		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	1643	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T1	T1	LIVING	0	TCGA-A2-A0ST-01	3017	0	Kirc+	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-A2-A0ST			3017	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A0ST-F14035		Negative					Negative	Lumpectomy		YES			-22922	2597		0	3017											Scheduled Follow-up Submission	2011-7-14	FEMALE								1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	210	NO		Negative		9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3								YES	3	0	true	M0	N1a	T1c	Stage IIA	TCGA-A2-A0ST.1E8B978E-3D1B-46E8-80EE-3A11EE571CEC.pdf	12	2	0	0	2	2	1	1	0	0	28	28	70	70	90	85	WITH TUMOR								No			YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2003	TCGA-A2-A0ST-01A-12D-A099-09	TCGA-A2-A0ST-01		TCGA-A2-A0ST-01A-12R-A085-13	TCGA-A2-A0ST-01A-12D-A099-09	d662c746-aeee-4b37-b811-a236222583b8	TCGA-A2-A0ST-01A-12D-A099-09	TCGA-A2-A0ST-01A-21-A13A-20	TCGA-A2-A0ST-01A-12D-A099-09	920e47c0-1b19-46e6-b1db-b5fd95e44df0	db464b40-f99f-4427-9d17-edd9af51b2c8	TCGA-A2-A0ST-01A-12D-A087-01	920e47c0-1b19-46e6-b1db-b5fd95e44df0	TCGA-A2-A0ST-01A-12D-A10P-05	TCGA-A2-A0ST-01	TCGA-A2-A0ST-01A-12R-A084-07	920e47c0-1b19-46e6-b1db-b5fd95e44df0	920e47c0-1b19-46e6-b1db-b5fd95e44df0	TCGA-A2-A0ST-01A-12D-A087-01	TCGA-A2-A0ST-01	TCGA-A2-A0ST-01		db464b40-f99f-4427-9d17-edd9af51b2c8	TCGA-A2-A0ST-01A-12R-A085-13
TCGA-A2-A0SU-01	Stage IIA	66	2	Stage IIA	1661		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	1661	0	LumA	Luminal A	Positive	LumA/B	0	0	followup	T_Other	T2	LIVING	0	TCGA-A2-A0SU-01	1662	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A2-A0SU	1662	0	1662	Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Left	Sentinel node biopsy alone		TCGA-A2-A0SU-F13954		Positive					Positive	Simple Mastectomy		YES			-24219	1317		0	1662							90-99%				Scheduled Follow-up Submission	2011-7-12	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	380	NO	Negative			7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	0	1	true	M0	N0 (i+)	T2	Stage IIA	TCGA-A2-A0SU.BC75790C-FBC7-4897-B228-762245C48740.pdf	1	2	0	0	0	0	0	0	2	5	20	35	78	60	88	90	TUMOR FREE								No	<10%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2006	TCGA-A2-A0SU-01A-11D-A099-09	TCGA-A2-A0SU-01		TCGA-A2-A0SU-01A-11R-A085-13	TCGA-A2-A0SU-01A-11D-A099-09	4fbcc317-6f56-4227-a6ef-304afa8880eb	TCGA-A2-A0SU-01A-11D-A099-09	TCGA-A2-A0SU-01A-21-A13C-20	TCGA-A2-A0SU-01A-11D-A099-09	05aa0960-505b-4b04-be9f-7b54940f5b27	8d301711-4802-4905-ac86-8b13a545e414	TCGA-A2-A0SU-01A-11D-A087-01	05aa0960-505b-4b04-be9f-7b54940f5b27	TCGA-A2-A0SU-01A-11D-A10P-05	TCGA-A2-A0SU-01	TCGA-A2-A0SU-01A-11R-A084-07	05aa0960-505b-4b04-be9f-7b54940f5b27	05aa0960-505b-4b04-be9f-7b54940f5b27	TCGA-A2-A0SU-01A-11D-A087-01	TCGA-A2-A0SU-01	TCGA-A2-A0SU-01		8d301711-4802-4905-ac86-8b13a545e414	TCGA-A2-A0SU-01A-11R-A085-13
TCGA-A2-A0SV-01	Stage IV	63	5	No_Conversion	825	825	Positive	FEMALE	Negative	3	3	4	Positive	M1	Positive	N2	825	1	LumB	Luminal B	Positive	Basal	-2	-3	followup	T_Other	T2	DECEASED	1	TCGA-A2-A0SV-01	825	1	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 5	TCGA-A2-A0SV			825	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO		NO	63	Right	Axillary lymph node dissection alone		TCGA-A2-A0SV-F3755		Positive					Positive	Simple Mastectomy		NO			-23126	1513	825	0								90-99%	Bone				2010-11-22	FEMALE					2+			1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	600	NO	Equivocal	Negative		9	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6									8		true	M1	N2a	T2	Stage IV	TCGA-A2-A0SV.161E2817-7DB2-46F8-BFEB-256DBBEFE633.pdf	1	2	0	0	0	6	0	1	0	1	12	13	88	80	95	90	WITH TUMOR								No	10-19%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	DECEASED	2006	TCGA-A2-A0SV-01A-11D-A099-09	TCGA-A2-A0SV-01		TCGA-A2-A0SV-01A-11R-A085-13	TCGA-A2-A0SV-01A-11D-A099-09	fc3b7efa-17e1-4f22-82f6-46b9eb25ab83	TCGA-A2-A0SV-01A-11D-A099-09	TCGA-A2-A0SV-01A-21-A13A-20	TCGA-A2-A0SV-01A-11D-A099-09	783d861d-ba0c-4b0d-9922-06ac23d3fc85	438bf0f6-af07-42dd-8121-fce6c1163e97	TCGA-A2-A0SV-01A-11D-A087-01	783d861d-ba0c-4b0d-9922-06ac23d3fc85	TCGA-A2-A0SV-01A-11D-A10P-05	TCGA-A2-A0SV-01	TCGA-A2-A0SV-01A-11R-A084-07	783d861d-ba0c-4b0d-9922-06ac23d3fc85	783d861d-ba0c-4b0d-9922-06ac23d3fc85	TCGA-A2-A0SV-01A-11D-A087-01	TCGA-A2-A0SV-01	TCGA-A2-A0SV-01		438bf0f6-af07-42dd-8121-fce6c1163e97	TCGA-A2-A0SV-01A-11R-A085-13
TCGA-A2-A0SW-01	Stage IV	82	4	No_Conversion	1364	1364	Positive	FEMALE	Negative	1	1	4	Positive	M1	Positive	N2	1364	1	LumB	Luminal B	Negative	Basal	-2	-5	followup	T_Other	T2	DECEASED	1	TCGA-A2-A0SW-01	1365	1	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 3	TCGA-A2-A0SW			1365	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO		82	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A0SW-F3701		Positive					Negative	Lumpectomy		NO			-30085		1365	0				653				40-49%	Liver				2010-11-8	FEMALE				Enumerate 60 tumor cells; ratio HER2/Centromer 17 >= 2.1 is amplified		60		1.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy				Negative		15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	3									4			M1	N2	T2	Stage IV																		WITH TUMOR								No	<10%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast		DECEASED	2006	TCGA-A2-A0SW-01A-11D-A099-09	TCGA-A2-A0SW-01		TCGA-A2-A0SW-01A-11R-A085-13	TCGA-A2-A0SW-01A-11D-A099-09	dc3609ce-4a40-4456-b26f-f366770af706	TCGA-A2-A0SW-01A-11D-A099-09	TCGA-A2-A0SW-01A-21-A13A-20	TCGA-A2-A0SW-01A-11D-A099-09	d17676ea-d64e-49d0-9737-3b852879ce52	e06babf2-ca3c-4bde-9c36-9799e305c520	TCGA-A2-A0SW-01A-11D-A087-01	d17676ea-d64e-49d0-9737-3b852879ce52	TCGA-A2-A0SW-01A-11D-A10P-05	TCGA-A2-A0SW-01	TCGA-A2-A0SW-01A-11R-A084-07	d17676ea-d64e-49d0-9737-3b852879ce52	d17676ea-d64e-49d0-9737-3b852879ce52	TCGA-A2-A0SW-01A-11D-A087-01	TCGA-A2-A0SW-01	TCGA-A2-A0SW-01		e06babf2-ca3c-4bde-9c36-9799e305c520	TCGA-A2-A0SW-01A-11R-A085-13
TCGA-A2-A0SX-01	Stage IA	48	1	Stage I	1288		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1288	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T1	T1	LIVING	0	TCGA-A2-A0SX-01	1534	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A2-A0SX	1534	0	1534	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO	YES		48	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-A2-A0SX-F14037	Negative	Negative				Lumpectomy	Negative	Lumpectomy		YES	1239		-17774	1177		0	1534			1239								Scheduled Follow-up Submission	2011-7-14	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	910	NO	Negative			1	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	4								NO	0	0	true	M0	N0 (i-)	T1c	Stage IA	TCGA-A2-A0SX.63F76DB5-8433-4EFE-9054-6C04F065DF2D.pdf	20	5	0	0	2	4	1	0	0	0	23	21	75	75	70	80	WITH TUMOR								No			YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2007	TCGA-A2-A0SX-01A-12D-A099-09	TCGA-A2-A0SX-01		TCGA-A2-A0SX-01A-12R-A085-13	TCGA-A2-A0SX-01A-12D-A099-09	13ef422e-b0f0-4c0a-bbe4-3d38bb2a2532	TCGA-A2-A0SX-01A-12D-A099-09	TCGA-A2-A0SX-01A-21-A13A-20	TCGA-A2-A0SX-01A-12D-A099-09	28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825	aa2d584e-9a6b-418e-a401-c8a17d669cb8	TCGA-A2-A0SX-01A-12D-A087-01	28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825	TCGA-A2-A0SX-01A-12D-A10P-05	TCGA-A2-A0SX-01	TCGA-A2-A0SX-01A-12R-A084-07	28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825	28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825	TCGA-A2-A0SX-01A-12D-A087-01	TCGA-A2-A0SX-01	TCGA-A2-A0SX-01		aa2d584e-9a6b-418e-a401-c8a17d669cb8	TCGA-A2-A0SX-01A-12R-A085-13
TCGA-A2-A0SY-01	Stage IIIA	62	2	No_Conversion	1347		Positive	FEMALE	Positive				Negative	M0	Positive	N1	1347	0	LumA	Luminal A	Positive		-5	-7	followup	T_Other	T3	LIVING	0	TCGA-A2-A0SY-01	1347	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-A2-A0SY	1347	0	1347	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A0SY-F13943		Positive					Positive	Modified Radical Mastectomy		YES			-22928	1083		0	1347							80-89%				Scheduled Follow-up Submission	2011-7-18	FEMALE				Enumerate 60 tumor cells; ratio HER2/Centromere 17 >= 2.1 is amplified		60		4.8		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	510	NO		Positive		14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6								NO	1	0	true	M0	N1	T3	Stage IIIA	TCGA-A2-A0SY.8E6902A6-A673-46CC-9AEB-3A71EF11099F.pdf	3	3	0	0	2	2	0	0	0	0	18	28	80	70	80	70	TUMOR FREE								No	40-49%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2007	TCGA-A2-A0SY-01A-31D-A099-09	TCGA-A2-A0SY-01		TCGA-A2-A0SY-01A-31R-A085-13	TCGA-A2-A0SY-01A-31D-A099-09		TCGA-A2-A0SY-01A-31D-A099-09		TCGA-A2-A0SY-01A-31D-A099-09	30fad3cd-09a5-4867-9d18-a940041a2b60	b322940e-f03c-46f9-9dd4-f027089d5b40	TCGA-A2-A0SY-01A-31D-A087-01	30fad3cd-09a5-4867-9d18-a940041a2b60	TCGA-A2-A0SY-01A-31D-A10P-05	TCGA-A2-A0SY-01	TCGA-A2-A0SY-01A-31R-A084-07	30fad3cd-09a5-4867-9d18-a940041a2b60	30fad3cd-09a5-4867-9d18-a940041a2b60	TCGA-A2-A0SY-01A-31D-A087-01	TCGA-A2-A0SY-01	TCGA-A2-A0SY-01		b322940e-f03c-46f9-9dd4-f027089d5b40	TCGA-A2-A0SY-01A-31R-A085-13
TCGA-A2-A0T0-01	Stage IIB	59	1	No_Conversion	533		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	533	0	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA-A2-A0T0-01	533	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 11	cluster 5	mutation cluster 12	TCGA-A2-A0T0	533	0	533	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A0T0-F13944		Negative					Negative	Lumpectomy		NO			-21575	268		0	533							<10%				Scheduled Follow-up Submission	2011-7-18	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5								NO	2		true	M0	N1	T2	Stage IIB	TCGA-A2-A0T0.6F5EBE67-0A25-4B20-A1F6-9CE6C4FF4096.pdf	20	0	10	0	5	0	10	0	0	0	15	30	80	70	80	70	TUMOR FREE								No	<10%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2009	TCGA-A2-A0T0-01A-22D-A099-09	TCGA-A2-A0T0-01		TCGA-A2-A0T0-01A-22R-A085-13	TCGA-A2-A0T0-01A-22D-A099-09	87565b35-30bd-4e31-bb26-404baf053cdc	TCGA-A2-A0T0-01A-22D-A099-09	TCGA-A2-A0T0-01A-11-A13D-20	TCGA-A2-A0T0-01A-22D-A099-09	7e073ecd-452a-4cba-9dfd-8601f3245721	07d13cdb-332c-4bd8-82f6-8655881cea74	TCGA-A2-A0T0-01A-22D-A087-01	7e073ecd-452a-4cba-9dfd-8601f3245721	TCGA-A2-A0T0-01A-22D-A10P-05	TCGA-A2-A0T0-01	TCGA-A2-A0T0-01A-22R-A084-07	7e073ecd-452a-4cba-9dfd-8601f3245721	7e073ecd-452a-4cba-9dfd-8601f3245721	TCGA-A2-A0T0-01A-22D-A087-01	TCGA-A2-A0T0-01	TCGA-A2-A0T0-01		07d13cdb-332c-4bd8-82f6-8655881cea74	TCGA-A2-A0T0-01A-22R-A085-13
TCGA-A2-A0T1-01	Stage IIIC	55	4	No_Conversion	520		Negative	FEMALE	Positive	1	1	1	Negative	M0	Positive	N3	520	0	Her2	HER2-enriched	Negative	Her2	-11	-5	followup	T_Other	T3	LIVING	0	TCGA-A2-A0T1-01	521	0	High	C3-BRCA/Luminal	cluster 5	Cluster 5	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A2-A0T1	521	0	521	Breast	TCGA Breast Cancer	breast invasive carcinoma					55	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A0T1-F13946		Negative					Negative	Lumpectomy		NO			-20227	233		0	521							<10%				Scheduled Follow-up Submission	2011-7-18	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	230	NO	Positive			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4								NO	10	0	true	M0	N3	T3	Stage IIIC	TCGA-A2-A0T1.7546B7FB-1976-4994-AFB7-6270382D44D7.pdf	30	30	10	10	5	5	10	20	0	0	15	15	80	80	80	80	TUMOR FREE								No	<10%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2009	TCGA-A2-A0T1-01A-21D-A099-09	TCGA-A2-A0T1-01		TCGA-A2-A0T1-01A-21R-A085-13	TCGA-A2-A0T1-01A-21D-A099-09	84b6d9cc-201e-421d-b7af-77156e50c627	TCGA-A2-A0T1-01A-21D-A099-09	TCGA-A2-A0T1-01A-11-A13D-20	TCGA-A2-A0T1-01A-21D-A099-09	8a19b992-4173-400d-8aec-d156525eedd6	e8889068-b216-4662-816f-b8e712b61ec7	TCGA-A2-A0T1-01A-21D-A087-01	8a19b992-4173-400d-8aec-d156525eedd6	TCGA-A2-A0T1-01A-21D-A10P-05	TCGA-A2-A0T1-01	TCGA-A2-A0T1-01A-21R-A084-07	8a19b992-4173-400d-8aec-d156525eedd6	8a19b992-4173-400d-8aec-d156525eedd6	TCGA-A2-A0T1-01A-21D-A087-01	TCGA-A2-A0T1-01	TCGA-A2-A0T1-01		e8889068-b216-4662-816f-b8e712b61ec7	TCGA-A2-A0T1-01A-21R-A085-13
TCGA-A2-A0T2-01	Stage IV	66	3	No_Conversion	240	240	Negative	FEMALE	Negative	2	2	2	Positive	M1	Positive	N3	240	1	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T3	DECEASED	1	TCGA-A2-A0T2-01	255	1	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-A2-A0T2			255	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO		NO	66	Right	Axillary lymph node dissection alone		TCGA-A2-A0T2-F3706		Negative					Negative	Modified Radical Mastectomy		NO			-24235	261	255	0				78				<10%	Liver	Abdomen			2010-11-12	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	270	NO	Negative			14	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3									10	0	true	M1	N3	T3	Stage IV	TCGA-A2-A0T2.0DCD80E1-173E-4A1B-BDD8-74C7D12C1313.pdf	40	40	10	10	0	5	30	30	0	0	15	15	85	80	85	80	WITH TUMOR								No	<10%		NO	Primary Tumor	01			NO	NO	YES	A2	Breast	A	DECEASED	2009	TCGA-A2-A0T2-01A-11W-A097-09	TCGA-A2-A0T2-01		TCGA-A2-A0T2-01A-11R-A085-13	TCGA-A2-A0T2-01A-11W-A097-09	73634c23-d25e-4268-a1bb-f8270a5d1d00	TCGA-A2-A0T2-01A-11W-A097-09	TCGA-A2-A0T2-01A-21-A13D-20	TCGA-A2-A0T2-01A-11W-A097-09	491c6c41-d1c5-4be7-bb7c-9df7275aa388	eaf1eb18-1568-459d-be40-71e5e92df673	TCGA-A2-A0T2-01A-11D-A087-01	491c6c41-d1c5-4be7-bb7c-9df7275aa388	TCGA-A2-A0T2-01A-11D-A10P-05	TCGA-A2-A0T2-01	TCGA-A2-A0T2-01A-11R-A084-07	491c6c41-d1c5-4be7-bb7c-9df7275aa388	491c6c41-d1c5-4be7-bb7c-9df7275aa388	TCGA-A2-A0T2-01A-11D-A087-01	TCGA-A2-A0T2-01	TCGA-A2-A0T2-01		eaf1eb18-1568-459d-be40-71e5e92df673	TCGA-A2-A0T2-01A-11R-A085-13
TCGA-A2-A0T3-01	Stage IA	37	3	Stage IIA	569		Positive	FEMALE	Negative	4	5	4	Negative	M0	Positive	N1	569	0	LumB	Luminal B	Positive	ReacII	0	-3	followup	T1	T1	LIVING	0	TCGA-A2-A0T3-01	569	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 7	mutation cluster 5	TCGA-A2-A0T3	569	0	569	Breast	TCGA Breast Cancer	breast invasive carcinoma					37	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A0T3-F13956	Negative	Positive	3 Point Scale	3+	3 Point Scale	Other	Positive	Lumpectomy	Margin resection	YES			-13680			0	569					NO		90-99%			2.3	Scheduled Follow-up Submission	2011-7-12	FEMALE					2+	556	3.2	1.4		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy			Equivocal	Negative		13	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		3	7								NO	2	0		M0	N1mi	T1c	Stage IB																		TUMOR FREE							YES	No	90-99%		YES	Primary Tumor	01		7th	YES	NO	YES	A2	Breast		LIVING	2009	TCGA-A2-A0T3-01A-21D-A10Y-09	TCGA-A2-A0T3-01	TCGA-A2-A0T3-01A-21R-A114-13	TCGA-A2-A0T3-01A-21R-A114-13	TCGA-A2-A0T3-01A-21D-A10Y-09	c6a1647b-f6fb-4d3d-a67e-07719db0a308	TCGA-A2-A0T3-01A-21D-A10Y-09	TCGA-A2-A0T3-01A-11-A13D-20	TCGA-A2-A0T3-01A-21D-A10Y-09	d0f11931-ddcc-4cd5-8dfc-8ef984aa8a32	e4aa08a3-8089-4ed2-a6f3-8778934936d9	TCGA-A2-A0T3-01A-21D-A111-01	d0f11931-ddcc-4cd5-8dfc-8ef984aa8a32		TCGA-A2-A0T3-01	TCGA-A2-A0T3-01A-21R-A115-07	d0f11931-ddcc-4cd5-8dfc-8ef984aa8a32	d0f11931-ddcc-4cd5-8dfc-8ef984aa8a32	TCGA-A2-A0T3-01A-21D-A111-01	TCGA-A2-A0T3-01	TCGA-A2-A0T3-01	TCGA-A2-A0T3-01A-21D-A112-05	e4aa08a3-8089-4ed2-a6f3-8778934936d9	
TCGA-A2-A0T4-01	Stage IIA	62	2	Stage IIA	624		Positive	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	624	0	LumA	Luminal B	Positive	ReacI	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-A2-A0T4-01	624	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A2-A0T4	624	0	624	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Right Upper Inner Quadrant	Other (specify)	SLN and non-SLN biopsy	TCGA-A2-A0T4-F13948		Positive		2+			Positive	Simple Mastectomy		YES			-22849	303		0	624							90-99%				Scheduled Follow-up Submission	2011-7-12	FEMALE					2+			1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	1500	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0T4.5B685F7F-917D-41BA-A7AB-D0E15D457BC5.pdf	0	0	0	0	0	0	0	0	5	0	25	30	70	70	80	80	TUMOR FREE								No	60-69%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2009	TCGA-A2-A0T4-01A-31D-A099-09	TCGA-A2-A0T4-01		TCGA-A2-A0T4-01A-31R-A085-13	TCGA-A2-A0T4-01A-31D-A099-09	a5869d20-d1ff-42f3-979d-797d1ed7a9e2	TCGA-A2-A0T4-01A-31D-A099-09	TCGA-A2-A0T4-01A-21-A13D-20	TCGA-A2-A0T4-01A-31D-A099-09	09787ddc-336f-4a53-a687-339d90457085	504fc7b4-3097-420e-b9e0-8981e934c2b6	TCGA-A2-A0T4-01A-31D-A087-01	09787ddc-336f-4a53-a687-339d90457085	TCGA-A2-A0T4-01A-31D-A10P-05	TCGA-A2-A0T4-01	TCGA-A2-A0T4-01A-31R-A084-07	09787ddc-336f-4a53-a687-339d90457085	09787ddc-336f-4a53-a687-339d90457085	TCGA-A2-A0T4-01A-31D-A087-01	TCGA-A2-A0T4-01	TCGA-A2-A0T4-01		504fc7b4-3097-420e-b9e0-8981e934c2b6	TCGA-A2-A0T4-01A-31R-A085-13
TCGA-A2-A0T5-01	Stage IIB	39	2	Stage IIA	531		Positive	FEMALE	Negative				Negative	M0	Negative	N0	531	0	LumA	Luminal A	Positive	LumA	-5	-3	followup	T_Other	T2	LIVING	0	TCGA-A2-A0T5-01	531	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6		TCGA-A2-A0T5	531	0	531	Breast	TCGA Breast Cancer	breast invasive carcinoma					39	Left	Sentinel node biopsy alone		TCGA-A2-A0T5-F13949		Positive					Positive	Simple Mastectomy		YES			-14503	263		0	531							90-99%				Scheduled Follow-up Submission	2011-7-12	FEMALE					1+			1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1740	NO	Negative	Negative		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0T5.7B1E6EEB-3B61-4CE8-B695-ED11C2EF169F.pdf	30	30	10	10	0	0	20	30	0	0	30	25	70	75	70	75	TUMOR FREE								No	90-99%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2009		TCGA-A2-A0T5-01		TCGA-A2-A0T5-01A-21R-A085-13		c7933393-6f03-4495-9e54-53e3e72d81e7	TCGA-A2-A0T5-01A-21D-A099-09	TCGA-A2-A0T5-01A-11-A13D-20		4c15b588-6017-4f0c-9b66-4f18122acc83	05cc8716-27bb-48f1-8bf7-563a728a1873	TCGA-A2-A0T5-01A-21D-A087-01	4c15b588-6017-4f0c-9b66-4f18122acc83	TCGA-A2-A0T5-01A-21D-A10P-05	TCGA-A2-A0T5-01	TCGA-A2-A0T5-01A-21R-A084-07	4c15b588-6017-4f0c-9b66-4f18122acc83	4c15b588-6017-4f0c-9b66-4f18122acc83	TCGA-A2-A0T5-01A-21D-A087-01	TCGA-A2-A0T5-01	TCGA-A2-A0T5-01		05cc8716-27bb-48f1-8bf7-563a728a1873	TCGA-A2-A0T5-01A-21R-A085-13
TCGA-A2-A0T6-01	Stage IIB	50	2	Stage IIB	575		Positive	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	575	0	LumA	Luminal A	Positive	ReacI	-5	-7	followup	T_Other	T3	LIVING	0	TCGA-A2-A0T6-01	575	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A2-A0T6	575	0	575	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Left	Sentinel node biopsy alone		TCGA-A2-A0T6-F13950		Positive		3+			Positive	Simple Mastectomy		YES			-18334			0	575							90-99%				Scheduled Follow-up Submission	2011-7-12	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy			Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	2								NO	0	0		M0	N0 (i-)	T3	Stage IIB																		TUMOR FREE								No	90-99%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast		LIVING	2009	TCGA-A2-A0T6-01A-11D-A099-09	TCGA-A2-A0T6-01		TCGA-A2-A0T6-01A-11R-A085-13	TCGA-A2-A0T6-01A-11D-A099-09	dcf310c3-9f6b-492b-b733-ece45d60089a	TCGA-A2-A0T6-01A-11D-A099-09	TCGA-A2-A0T6-01A-21-A13C-20	TCGA-A2-A0T6-01A-11D-A099-09	e3639f71-cfe7-46c7-8390-73f8043ac6b0	c6bd807e-dcb7-4f05-bba1-5caf20e43415	TCGA-A2-A0T6-01A-11D-A087-01	e3639f71-cfe7-46c7-8390-73f8043ac6b0	TCGA-A2-A0T6-01A-11D-A10P-05	TCGA-A2-A0T6-01	TCGA-A2-A0T6-01A-11R-A084-07	e3639f71-cfe7-46c7-8390-73f8043ac6b0	e3639f71-cfe7-46c7-8390-73f8043ac6b0	TCGA-A2-A0T6-01A-11D-A087-01	TCGA-A2-A0T6-01	TCGA-A2-A0T6-01		c6bd807e-dcb7-4f05-bba1-5caf20e43415	TCGA-A2-A0T6-01A-11R-A085-13
TCGA-A2-A0T7-01	Stage IIA	51	2	Stage IIA	631		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	631	0	LumA	Luminal A	Positive	ReacI	-3	0	followup	T_Other	T2	LIVING	0	TCGA-A2-A0T7-01	631	0	High	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A2-A0T7	631	0	631	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-A2-A0T7-F13953	Negative	Positive		2+		Other	Positive	Modified Radical Mastectomy	Skin excision	YES			-18756	280		0	631							90-99%				Scheduled Follow-up Submission	2011-7-12	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	990	NO	Negative			2	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4								NO	0	1	true	M0	N0 (i+)	T2	Stage IIA	TCGA-A2-A0T7.383EC600-FBF3-4F91-8FAC-41E3DDE6589E.pdf	40	30	10	10	5	5	20	20	0	0	15	15	80	80	80	80	TUMOR FREE								No	70-79%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2009	TCGA-A2-A0T7-01A-21D-A099-09	TCGA-A2-A0T7-01		TCGA-A2-A0T7-01A-21R-A085-13	TCGA-A2-A0T7-01A-21D-A099-09	7a10bda1-1af5-4641-91bd-9a5174a68ff9	TCGA-A2-A0T7-01A-21D-A099-09	TCGA-A2-A0T7-01A-11-A13A-20	TCGA-A2-A0T7-01A-21D-A099-09	b5de3654-8983-45ab-a83a-d15284740d39	1dafc3c4-349e-4af4-871c-566f44080b09	TCGA-A2-A0T7-01A-21D-A087-01	b5de3654-8983-45ab-a83a-d15284740d39	TCGA-A2-A0T7-01A-21D-A10P-05	TCGA-A2-A0T7-01	TCGA-A2-A0T7-01A-21R-A084-07	b5de3654-8983-45ab-a83a-d15284740d39	b5de3654-8983-45ab-a83a-d15284740d39	TCGA-A2-A0T7-01A-21D-A087-01	TCGA-A2-A0T7-01	TCGA-A2-A0T7-01		1dafc3c4-349e-4af4-871c-566f44080b09	TCGA-A2-A0T7-01A-21R-A085-13
TCGA-A2-A0YC-01	Stage IIB	59	2	No_Conversion	989		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N1	989	0	LumA	Luminal A	Positive	ReacII	-12	-3	followup	T_Other	T2	LIVING	0	TCGA-A2-A0YC-01	990	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A2-A0YC	756	1	990	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO	YES		59	Right Upper Inner Quadrant	Other (specify)	Sentinel lymph node biopsy x 2 and 1 non-sentinel lymph node biopsy	TCGA-A2-A0YC-F15845		Positive					Positive	Lumpectomy		YES		756	-21685	673		0	990			756				90-99%				Scheduled Follow-up Submission	2011-8-30	FEMALE				Enumerate 60 tumor cells; ratio of HER2/Centromere 17 >= 2.1 is amplified		60		1.18		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1170	NO		Negative		3	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative	2+		Positive	90-99%									90-99%		Positive	4	4					Locoregional Disease			YES	1	0	true	M0	N1mi	T2	Stage IIB	TCGA-A2-A0YC.9BAD4BD4-A54B-4115-A00E-6AA88F344FE1.pdf	0	4	0	1	0	0	0	0	0	0	10	30	90	70	75	70	WITH TUMOR								No	90-99%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2008	TCGA-A2-A0YC-01A-11D-A117-09	TCGA-A2-A0YC-01		TCGA-A2-A0YC-01A-11R-A108-13	TCGA-A2-A0YC-01A-11D-A117-09	ca761204-8a14-4297-afa7-f200bc37d53a	TCGA-A2-A0YC-01A-11D-A117-09	TCGA-A2-A0YC-01A-21-A13D-20	TCGA-A2-A0YC-01A-11D-A117-09	40c2be3f-f14a-4ab2-845a-2c1c174a4be7	bac34a30-d37a-4bd6-a196-ff72ecd07e65	TCGA-A2-A0YC-01A-11D-A107-01	40c2be3f-f14a-4ab2-845a-2c1c174a4be7	TCGA-A2-A0YC-01A-11D-A10A-05	TCGA-A2-A0YC-01	TCGA-A2-A0YC-01A-11R-A109-07	40c2be3f-f14a-4ab2-845a-2c1c174a4be7	40c2be3f-f14a-4ab2-845a-2c1c174a4be7	TCGA-A2-A0YC-01A-11D-A107-01	TCGA-A2-A0YC-01	TCGA-A2-A0YC-01		bac34a30-d37a-4bd6-a196-ff72ecd07e65	TCGA-A2-A0YC-01A-11R-A108-13
TCGA-A2-A0YD-01	Stage IIB	63	2	Stage IIB	769		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	769	0	LumA	Luminal A	Positive	LumA	-5	-7	followup	T_Other	T3	LIVING	0	TCGA-A2-A0YD-01	769	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A2-A0YD	769	0	769	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A0YD-F15770		Positive					Positive	Simple Mastectomy		YES			-23021			0	769							90-99%				Scheduled Follow-up Submission	2011-8-30	FEMALE				Enumerate 60 tumor cells; ratio of HER2/Centromere 17 >= 2.1 is amplified		60		1.04		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy				Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	0	1		M0	N0 (i+)	T3	Stage IIB																		TUMOR FREE								No	80-89%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast		LIVING	2009	TCGA-A2-A0YD-01A-11D-A10G-09	TCGA-A2-A0YD-01		TCGA-A2-A0YD-01A-11R-A108-13	TCGA-A2-A0YD-01A-11D-A10G-09	b3a0423a-0d47-45f2-aa7c-1ae650ab5dd0	TCGA-A2-A0YD-01A-11D-A10G-09	TCGA-A2-A0YD-01A-21-A13D-20	TCGA-A2-A0YD-01A-11D-A10G-09	c1190b96-b6cf-4cd5-8c4e-bc57d964a557	ed834fb2-f108-4b4c-b543-57f8dc0520c1	TCGA-A2-A0YD-01A-11D-A107-01	c1190b96-b6cf-4cd5-8c4e-bc57d964a557	TCGA-A2-A0YD-01A-11D-A10A-05	TCGA-A2-A0YD-01	TCGA-A2-A0YD-01A-11R-A109-07	c1190b96-b6cf-4cd5-8c4e-bc57d964a557	c1190b96-b6cf-4cd5-8c4e-bc57d964a557	TCGA-A2-A0YD-01A-11D-A107-01	TCGA-A2-A0YD-01	TCGA-A2-A0YD-01		ed834fb2-f108-4b4c-b543-57f8dc0520c1	TCGA-A2-A0YD-01A-11R-A108-13
TCGA-A2-A0YE-01	Stage IIB	48	3	No_Conversion	553		Negative	FEMALE	Negative				Negative	M0	Positive	N1	553	0	Basal	Basal-like	Negative	X	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-A2-A0YE-01	554	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8				TCGA-A2-A0YE	554	0	554	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A0YE-F15771		Negative					Negative	Lumpectomy		NO			-17727	238		0	554							<10%				Scheduled Follow-up Submission	2011-8-30	FEMALE		No membrane staining or incomplete membrane staining in <10% of tumor cells is negative	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	240	NO	Negative			19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5									NO	1		true	M0	N1a	T2	Stage IIB	TCGA-A2-A0YE.C58701EF-98C4-448E-978C-B39D125CC7E8.pdf	3	3	1	1	2	0	1	1	0	0	18	20	80	80	80	80	TUMOR FREE								No	<10%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2010		TCGA-A2-A0YE-01				510563aa-4a19-4dd1-82c8-ac67f8a77a55	TCGA-A2-A0YE-01A-11D-A10G-09	TCGA-A2-A0YE-01A-21-A13D-20		7f57b9e7-1b1b-4e07-beb4-b877b7651f7b	c5387233-2168-406d-aa69-9e92df136d0d	TCGA-A2-A0YE-01A-11D-A107-01	7f57b9e7-1b1b-4e07-beb4-b877b7651f7b	TCGA-A2-A0YE-01A-11D-A10A-05	TCGA-A2-A0YE-01	TCGA-A2-A0YE-01A-11R-A109-07	7f57b9e7-1b1b-4e07-beb4-b877b7651f7b	7f57b9e7-1b1b-4e07-beb4-b877b7651f7b	TCGA-A2-A0YE-01A-11D-A107-01	TCGA-A2-A0YE-01	TCGA-A2-A0YE-01		c5387233-2168-406d-aa69-9e92df136d0d	
TCGA-A2-A0YF-01	Stage IA	67	2	Stage I	469		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	469	0	LumA	Luminal A	Negative	ReacII	-12	-3	followup	T1	T1	LIVING	0	TCGA-A2-A0YF-01	1535	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-A2-A0YF	1535	0	1535	Breast	TCGA Breast Cancer	breast invasive carcinoma					67	Right	Sentinel node biopsy alone		TCGA-A2-A0YF-F59385		Positive		0			Negative	Simple Mastectomy		YES			-24660	343		0	1535							90-99%				Scheduled Follow-up Submission	2014-5-12	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4	3+	YES		Core needle biopsy	600	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	1								NO	0	1	true	M0	N0 (i+)	T1b	[Discrepancy]	TCGA-A2-A0YF.C4C7D190-F0EC-4A70-8136-534EA3419217.pdf	0	3	0	0	5	0	0	0	0	0	15	25	80	75	92	75	TUMOR FREE						YES		No	<10%		NO	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2009	TCGA-A2-A0YF-01A-21D-A10G-09	TCGA-A2-A0YF-01		TCGA-A2-A0YF-01A-21R-A108-13	TCGA-A2-A0YF-01A-21D-A10G-09	85fd3e18-e927-47b3-9e06-b73de5edd740	TCGA-A2-A0YF-01A-21D-A10G-09	TCGA-A2-A0YF-01A-11-A13D-20	TCGA-A2-A0YF-01A-21D-A10G-09	b3ac6331-6c8f-4165-add7-482aadf7fa68	fb2d1af2-81a7-4eb7-8a49-e6448c76e44e	TCGA-A2-A0YF-01A-21D-A107-01	b3ac6331-6c8f-4165-add7-482aadf7fa68	TCGA-A2-A0YF-01A-21D-A10A-05	TCGA-A2-A0YF-01	TCGA-A2-A0YF-01A-21R-A109-07	b3ac6331-6c8f-4165-add7-482aadf7fa68	b3ac6331-6c8f-4165-add7-482aadf7fa68	TCGA-A2-A0YF-01A-21D-A107-01	TCGA-A2-A0YF-01	TCGA-A2-A0YF-01		fb2d1af2-81a7-4eb7-8a49-e6448c76e44e	TCGA-A2-A0YF-01A-21R-A108-13
TCGA-A2-A0YG-01	Stage IIIC	63	5	No_Conversion	665		Positive	FEMALE	Positive	1	1	4	Negative	M0	Positive	N3	665	0	LumB	Luminal B	Positive	Her2	-2	-5	followup	T_Other	T2	LIVING	0	TCGA-A2-A0YG-01	666	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-A2-A0YG	666	0	666	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A0YG-F16753		Positive		2+			Positive	Lumpectomy		NO			-23058	329		0	666							90-99%				Scheduled Follow-up Submission	2011-9-16	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	1530	NO	Positive			18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	14		true	M0	N3a	T2	Stage IIIC	TCGA-A2-A0YG.B3D6A0F7-5E3C-4921-8399-6458E5222CC5.pdf	2	2	1	1	0	0	1	0	0	0	25	15	75	85	75	85	TUMOR FREE								No	<10%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2009	TCGA-A2-A0YG-01A-21D-A10G-09	TCGA-A2-A0YG-01		TCGA-A2-A0YG-01A-21R-A108-13	TCGA-A2-A0YG-01A-21D-A10G-09	2d2789e0-0933-496a-a29b-63c0b05cfa19	TCGA-A2-A0YG-01A-21D-A10G-09	TCGA-A2-A0YG-01A-31-A13D-20	TCGA-A2-A0YG-01A-21D-A10G-09	c539f561-93db-41f3-8d9f-71cd77a096a7	2c4bb4d1-3f75-4aa5-aec3-c402ba52579e	TCGA-A2-A0YG-01A-21D-A107-01	c539f561-93db-41f3-8d9f-71cd77a096a7	TCGA-A2-A0YG-01A-21D-A10A-05	TCGA-A2-A0YG-01	TCGA-A2-A0YG-01A-21R-A109-07	c539f561-93db-41f3-8d9f-71cd77a096a7	c539f561-93db-41f3-8d9f-71cd77a096a7	TCGA-A2-A0YG-01A-21D-A107-01	TCGA-A2-A0YG-01	TCGA-A2-A0YG-01		2c4bb4d1-3f75-4aa5-aec3-c402ba52579e	TCGA-A2-A0YG-01A-21R-A108-13
TCGA-A2-A0YH-01	Stage IIIA	53	4	No_Conversion	658		Positive	FEMALE	Negative	3	3	4	Negative	M0	Positive	N2	658	0	LumB	Luminal B	Positive	LumA/B	-2	-5	followup	T_Other	T2	LIVING	0	TCGA-A2-A0YH-01	659	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	Cluster 5	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-A2-A0YH	659	0	659	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A0YH-F16752		Positive		3+			Positive	Lumpectomy		NO			-19596	321		0	659							80-89%				Scheduled Follow-up Submission	2011-9-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	480	NO	Negative			28	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4								NO	5		true	M0	N2a	T2	Stage IIIA	TCGA-A2-A0YH.0C344CD7-6FAB-462B-9A8E-75B720F2D626.pdf	0	0	0	0	0	0	0	0	0	0	40	10	60	90	70	80	TUMOR FREE								No	70-79%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2009	TCGA-A2-A0YH-01A-11D-A10G-09	TCGA-A2-A0YH-01		TCGA-A2-A0YH-01A-11R-A108-13	TCGA-A2-A0YH-01A-11D-A10G-09	1682b578-8f05-4a4c-b98c-4ffe7ef3346e	TCGA-A2-A0YH-01A-11D-A10G-09	TCGA-A2-A0YH-01A-21-A13D-20	TCGA-A2-A0YH-01A-11D-A10G-09	5275bc42-18a3-43d1-9dee-dfb80c39ba20	2d4e7bff-a4ec-4bf0-9925-6b21b231f4b8	TCGA-A2-A0YH-01A-11D-A107-01	5275bc42-18a3-43d1-9dee-dfb80c39ba20	TCGA-A2-A0YH-01A-11D-A10A-05	TCGA-A2-A0YH-01	TCGA-A2-A0YH-01A-11R-A109-07	5275bc42-18a3-43d1-9dee-dfb80c39ba20	5275bc42-18a3-43d1-9dee-dfb80c39ba20	TCGA-A2-A0YH-01A-11D-A107-01	TCGA-A2-A0YH-01	TCGA-A2-A0YH-01		2d4e7bff-a4ec-4bf0-9925-6b21b231f4b8	TCGA-A2-A0YH-01A-11R-A108-13
TCGA-A2-A0YI-01	Stage IA	62	3	Stage I	441		Positive	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	441	0	LumA	Luminal A	Positive	ReacI	-12	-4	followup	T1	T1	LIVING	0	TCGA-A2-A0YI-01	1505	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A2-A0YI	1505	0	1505	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Right Upper Outer Quadrant	Other (specify)	Sentinel Lymph node biopsy and one non-sentinel lymph node biopsy	TCGA-A2-A0YI-F59386		Positive		2+			Positive	Lumpectomy		YES			-22961	303		0	1505							90-99%				Scheduled Follow-up Submission	2014-5-12	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8522/3	C50.9	3+	YES		Core needle biopsy	340	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	0	1	true	M0	N0 (i+)	T1c	Stage I	TCGA-A2-A0YI.CEFD12BB-1AF7-400D-8A84-49650DFDD8A5.pdf	2	15	0	0	1	1	0	0	20	20	20	10	59	69	85	70	TUMOR FREE						YES		No	60-69%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2009	TCGA-A2-A0YI-01A-31D-A10M-09	TCGA-A2-A0YI-01		TCGA-A2-A0YI-01A-31R-A10I-13	TCGA-A2-A0YI-01A-31D-A10M-09	0dca7119-3230-47a7-89e3-93c4bd405f4d	TCGA-A2-A0YI-01A-31D-A10M-09	TCGA-A2-A0YI-01A-21-A13D-20	TCGA-A2-A0YI-01A-31D-A10M-09	4de3ad78-68e4-4ab9-b1f6-eb0666140761	9758cc40-6f04-4297-b933-dd2d0a938930	TCGA-A2-A0YI-01A-31D-A10L-01	4de3ad78-68e4-4ab9-b1f6-eb0666140761	TCGA-A2-A0YI-01A-31D-A10N-05	TCGA-A2-A0YI-01	TCGA-A2-A0YI-01A-31R-A10J-07	4de3ad78-68e4-4ab9-b1f6-eb0666140761	4de3ad78-68e4-4ab9-b1f6-eb0666140761	TCGA-A2-A0YI-01A-31D-A10L-01	TCGA-A2-A0YI-01	TCGA-A2-A0YI-01		9758cc40-6f04-4297-b933-dd2d0a938930	TCGA-A2-A0YI-01A-31R-A10I-13
TCGA-A2-A0YJ-01	Stage IIIA	39	3	No_Conversion	565		Positive	FEMALE	Negative				Negative	M0	Positive	N2	565	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T3	LIVING	0	TCGA-A2-A0YJ-01	566	0	COAD-READ	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8			mutation cluster 5	TCGA-A2-A0YJ	559	1	566	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	YES		39	Left	Axillary lymph node dissection alone		TCGA-A2-A0YJ-F16756		Positive		0			Negative	Modified Radical Mastectomy		NO		559	-14448	264		0	566			559				<10%				Scheduled Follow-up Submission	2011-9-16	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Core needle biopsy	1080	NO	Negative			18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)		Negative	1+		Negative			<10%									Negative	5					Other, specify	Distant Metastasis	Left Cervical Lymph Node		YES	5		true	M0	N2a	T3	Stage IIIA	TCGA-A2-A0YJ.90F13DE2-7C8F-4FA2-B9BF-D68EEC37D514.pdf	0	0	0	0	0	5	0	0	0	0	10	20	90	75	95	95	WITH TUMOR								No	<10%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2010	TCGA-A2-A0YJ-01A-11D-A10G-09	TCGA-A2-A0YJ-01			TCGA-A2-A0YJ-01A-11D-A10G-09	d6e27bfa-0efe-457b-8628-38958d21268b	TCGA-A2-A0YJ-01A-11D-A10G-09	TCGA-A2-A0YJ-01A-21-A13D-20	TCGA-A2-A0YJ-01A-11D-A10G-09	330bf4ac-9ed5-4bd1-93d0-f89b4f52bc19	98c00874-2525-47b6-b555-ebd259cbbcd1	TCGA-A2-A0YJ-01A-11D-A107-01	330bf4ac-9ed5-4bd1-93d0-f89b4f52bc19	TCGA-A2-A0YJ-01A-11D-A10A-05	TCGA-A2-A0YJ-01	TCGA-A2-A0YJ-01A-11R-A109-07	330bf4ac-9ed5-4bd1-93d0-f89b4f52bc19	330bf4ac-9ed5-4bd1-93d0-f89b4f52bc19	TCGA-A2-A0YJ-01A-11D-A107-01	TCGA-A2-A0YJ-01	TCGA-A2-A0YJ-01		98c00874-2525-47b6-b555-ebd259cbbcd1	
TCGA-A2-A0YK-01	Stage IIA	61	5	Stage IIA	587		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	587	0	Normal	Normal-like	Negative	ReacII	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-A2-A0YK-01	588	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-A2-A0YK	588	0	588	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A0YK-F16750		Positive					Negative	Simple Mastectomy		YES			-22625	280		0	588							90-99%				Scheduled Follow-up Submission	2011-9-16	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	620	NO	Negative			3	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0YK.C3B5F075-864A-4D8B-B0CB-1B1FA28ACF4F.pdf	0	0	0	0	0	0	0	0	10	15	10	10	80	75	70	75	TUMOR FREE								No	<10%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2009	TCGA-A2-A0YK-01A-22D-A117-09	TCGA-A2-A0YK-01		TCGA-A2-A0YK-01A-22R-A108-13	TCGA-A2-A0YK-01A-22D-A117-09	07e19b85-cee6-4ea4-8588-5df93bf33053	TCGA-A2-A0YK-01A-22D-A117-09	TCGA-A2-A0YK-01A-31-A13D-20	TCGA-A2-A0YK-01A-22D-A117-09	ae614f7b-b310-4c60-bd50-9e02be984943	8536ff4e-4027-4673-96b9-43f4f61a5376	TCGA-A2-A0YK-01A-22D-A107-01	ae614f7b-b310-4c60-bd50-9e02be984943	TCGA-A2-A0YK-01A-22D-A10A-05	TCGA-A2-A0YK-01	TCGA-A2-A0YK-01A-22R-A109-07	ae614f7b-b310-4c60-bd50-9e02be984943	ae614f7b-b310-4c60-bd50-9e02be984943	TCGA-A2-A0YK-01A-22D-A107-01	TCGA-A2-A0YK-01	TCGA-A2-A0YK-01		8536ff4e-4027-4673-96b9-43f4f61a5376	TCGA-A2-A0YK-01A-22R-A108-13
TCGA-A2-A0YL-01	Stage IIIA	48	2	No_Conversion	445		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N2	445	0	LumA	Luminal A	Positive	ReacI	-5	-7	followup	T_Other	T3	LIVING	0	TCGA-A2-A0YL-01	1474	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-A2-A0YL	1474	0	1474	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A0YL-F59387		Positive		3+			Positive	Simple Mastectomy		YES			-17702	205		0	1474							70-79%				Scheduled Follow-up Submission	2014-5-12	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	730	NO	Negative		NO	29	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	6								NO	4	0	true	M0	N2a	T3	Stage IIIA	TCGA-A2-A0YL.AB083371-A2AB-4F57-8FBF-0DB2C91CEDDE.pdf	0	0	0	0	0	0	0	0	5	15	10	35	85	50	95	60	TUMOR FREE						YES		No	90-99%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2010	TCGA-A2-A0YL-01A-21D-A10G-09	TCGA-A2-A0YL-01		TCGA-A2-A0YL-01A-21R-A108-13	TCGA-A2-A0YL-01A-21D-A10G-09	2f4ab3d7-e280-4c21-9b13-e1c240627337	TCGA-A2-A0YL-01A-21D-A10G-09	TCGA-A2-A0YL-01A-11-A13D-20	TCGA-A2-A0YL-01A-21D-A10G-09	32cfb4f4-1de9-4937-8cfa-dc6c37081583	d1740289-b374-4298-a155-88bbb5f1a87d	TCGA-A2-A0YL-01A-21D-A107-01	32cfb4f4-1de9-4937-8cfa-dc6c37081583	TCGA-A2-A0YL-01A-21D-A10A-05	TCGA-A2-A0YL-01	TCGA-A2-A0YL-01A-21R-A109-07	32cfb4f4-1de9-4937-8cfa-dc6c37081583	32cfb4f4-1de9-4937-8cfa-dc6c37081583	TCGA-A2-A0YL-01A-21D-A107-01	TCGA-A2-A0YL-01	TCGA-A2-A0YL-01		d1740289-b374-4298-a155-88bbb5f1a87d	TCGA-A2-A0YL-01A-21R-A108-13
TCGA-A2-A0YM-01	Stage IIA	67	3	Stage IIA	964		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	964	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-A2-A0YM-01	965	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	OV-like c4	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 13	TCGA-A2-A0YM	965	0	965	Breast	TCGA Breast Cancer	breast invasive carcinoma					67	Left Upper Outer Quadrant	Other (specify)	Sentinel lymph node biopsy and non-sentinel lymph node biopsy	TCGA-A2-A0YM-F15767		Negative					Negative	Lumpectomy		YES			-24831	691		0	965							<10%				Scheduled Follow-up Submission	2011-8-30	FEMALE				Enumerate 60 tumor cells; ratio of HER2/Centromere >=2.1 is amplified		60		1.08		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	360	NO		Negative		5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0YM.E1D8F2CB-25F1-49E0-92D3-132DCA8FD533.pdf	0	0	0	0	0	0	0	0	0	0	70	5	30	95	85	97	TUMOR FREE								No	<10%		YES	Primary Tumor	01			NO	NO	YES	A2	Breast	A	LIVING	2008	TCGA-A2-A0YM-01A-11D-A10G-09	TCGA-A2-A0YM-01		TCGA-A2-A0YM-01A-11R-A108-13	TCGA-A2-A0YM-01A-11D-A10G-09	a55195f2-8c4d-40ab-a452-8424a0403d03	TCGA-A2-A0YM-01A-11D-A10G-09	TCGA-A2-A0YM-01A-21-A13D-20	TCGA-A2-A0YM-01A-11D-A10G-09	1e59ea3f-36fa-4860-8c28-87b4b09075ec	356ec0ad-a065-44db-8a4d-218efff4c3b4	TCGA-A2-A0YM-01A-11D-A107-01	1e59ea3f-36fa-4860-8c28-87b4b09075ec	TCGA-A2-A0YM-01A-11D-A10A-05	TCGA-A2-A0YM-01	TCGA-A2-A0YM-01A-11R-A109-07	1e59ea3f-36fa-4860-8c28-87b4b09075ec	1e59ea3f-36fa-4860-8c28-87b4b09075ec	TCGA-A2-A0YM-01A-11D-A107-01	TCGA-A2-A0YM-01	TCGA-A2-A0YM-01		356ec0ad-a065-44db-8a4d-218efff4c3b4	TCGA-A2-A0YM-01A-11R-A108-13
TCGA-A2-A0YT-01	Stage IIIB	56		No_Conversion	669	723	Positive	FEMALE	Negative				Negative	M0	Positive	N2	723	1	LumB		Negative				followup	T_Other	T4	DECEASED	1	TCGA-A2-A0YT-01	723	1	High	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6		mutation cluster 3	TCGA-A2-A0YT	723	0	723	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A0YT-F15768		Positive					Negative	Modified Radical Mastectomy		NO			-20482	884	723	0								90-99%				Scheduled Follow-up Submission	2011-8-30	FEMALE				Enumerate 60 tumor cells; Ratio of HER2/Centromere 17 >=2.1 is amplified		60		1.3		Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9		YES		Core needle biopsy	950	NO		Negative		5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	5		true	M0	N2a	T4b	Stage IIIB	TCGA-A2-A0YT.1C420F6B-8720-4CB0-9FB3-86A0EC05FBBD.pdf	0	0	0	0	0	0	0	0	0	0	0	5	100	95	85	85	TUMOR FREE								No	<10%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	DECEASED	2008	TCGA-A2-A0YT-01A-11D-A10G-09	TCGA-A2-A0YT-01		TCGA-A2-A0YT-01A-11R-A108-13	TCGA-A2-A0YT-01A-11D-A10G-09	cea5a1de-f9e8-406b-a6ac-08e3d9869c5b	TCGA-A2-A0YT-01A-11D-A10G-09	TCGA-A2-A0YT-01A-21-A13D-20	TCGA-A2-A0YT-01A-11D-A10G-09	451099b0-f348-4aec-bf9f-2982601f013c	0b6fed27-b3fc-4078-a9d3-e766d718c19b	TCGA-A2-A0YT-01A-11D-A107-01	451099b0-f348-4aec-bf9f-2982601f013c	TCGA-A2-A0YT-01A-11D-A10A-05	TCGA-A2-A0YT-01	TCGA-A2-A0YT-01A-11R-A109-07	451099b0-f348-4aec-bf9f-2982601f013c	451099b0-f348-4aec-bf9f-2982601f013c	TCGA-A2-A0YT-01A-11D-A107-01	TCGA-A2-A0YT-01	TCGA-A2-A0YT-01		0b6fed27-b3fc-4078-a9d3-e766d718c19b	TCGA-A2-A0YT-01A-11R-A108-13
TCGA-A2-A1FV-01	Stage IIB	74	4	Stage IIB	460		Positive	FEMALE	Negative				Negative	M0	Negative	N0	460	0	LumA		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-A2-A1FV-01	714	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 6	mutation c1uster 9	TCGA-A2-A1FV	714	0	714	Breast	TCGA Breast Cancer	breast invasive carcinoma					74	Left	Sentinel node biopsy alone		TCGA-A2-A1FV-F20238		Positive					Positive	Simple Mastectomy		YES			-27287	372		0	714					NO		90-99%				Scheduled Follow-up Submission	2012-1-9	FEMALE					1+			0.92		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	150	NO	Negative	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	6								NO	0	1	true	M0	N0 (i+)	T3	Stage IIB	TCGA-A2-A1FV.074223E9-5E1C-47E8-BE40-1C4442CAE9F0.pdf		0		0		0		0		0		20		80		90					Strong	Strong		YES	No	<10%		YES	Primary Tumor	01		7th	YES	YES	NO	A2	Breast	A	LIVING	2010	TCGA-A2-A1FV-01A-11D-A13L-09		TCGA-A2-A1FV-01A-11R-A13P-13	TCGA-A2-A1FV-01A-11R-A13P-13	TCGA-A2-A1FV-01A-11D-A13L-09		TCGA-A2-A1FV-01A-11D-A13L-09	TCGA-A2-A1FV-01A-21-A17I-20	TCGA-A2-A1FV-01A-11D-A13L-09	ee12f85b-64f8-4052-9477-392c4bd99257	9deea0fe-12ed-4cd6-8d76-11d857b03607	TCGA-A2-A1FV-01A-11D-A13J-01	ee12f85b-64f8-4052-9477-392c4bd99257	TCGA-A2-A1FV-01A-11D-A13K-05	TCGA-A2-A1FV-01		ee12f85b-64f8-4052-9477-392c4bd99257	ee12f85b-64f8-4052-9477-392c4bd99257	TCGA-A2-A1FV-01A-11D-A13J-01		TCGA-A2-A1FV-01		9deea0fe-12ed-4cd6-8d76-11d857b03607	
TCGA-A2-A1FW-01	Stage IIIA	62	3	Stage IIIA	221		Positive	FEMALE	Negative				Negative	M0	Positive	N2	221	0	LumB		Negative				enrollment	T_Other	T3	LIVING	0	TCGA-A2-A1FW-01	528	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-A2-A1FW	528	0	528	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A1FW-F20810		Positive					Negative	Modified Radical Mastectomy		NO			-22779	198		0	528					NO		90-99%				Scheduled Follow-up Submission	2012-1-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	640	NO	Negative			19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6								NO	5	0	true	M0	N2a	T3	Stage IIIA	TCGA-A2-A1FW.849E9FA7-3420-427B-A310-3346CFA9F0CC.pdf		0		0		0		0		10		30		60		75	TUMOR FREE							YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	A2	Breast	A	LIVING	2010	TCGA-A2-A1FW-01A-11D-A13L-09		TCGA-A2-A1FW-01A-11R-A13P-13	TCGA-A2-A1FW-01A-11R-A13P-13	TCGA-A2-A1FW-01A-11D-A13L-09		TCGA-A2-A1FW-01A-11D-A13L-09	TCGA-A2-A1FW-01A-21-A17I-20	TCGA-A2-A1FW-01A-11D-A13L-09	2f1af8cf-ded3-45b6-88cd-2c154c66ab8c	b8ee56ee-5cac-45d1-af7d-d89eb8fa3360	TCGA-A2-A1FW-01A-11D-A13J-01	2f1af8cf-ded3-45b6-88cd-2c154c66ab8c	TCGA-A2-A1FW-01A-11D-A13K-05	TCGA-A2-A1FW-01		2f1af8cf-ded3-45b6-88cd-2c154c66ab8c	2f1af8cf-ded3-45b6-88cd-2c154c66ab8c	TCGA-A2-A1FW-01A-11D-A13J-01		TCGA-A2-A1FW-01		b8ee56ee-5cac-45d1-af7d-d89eb8fa3360	
TCGA-A2-A1FX-01	Stage IIIA	61	4	Stage IIIA	935		Positive	FEMALE	Negative				Negative	M0	Positive	N2	935	0	LumB		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-A2-A1FX-01	1119	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A2-A1FX	1119	0	1119	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A1FX-F20806	Negative	Positive				Mastectomy NOS	Positive	Lumpectomy		NO			-22344	937		0	1119					NO		70-79%			160	Scheduled Follow-up Submission	2012-1-12	FEMALE						60	185	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	360	NO		Negative		24	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	6	0	true	M0	N2a	T3	Stage IIIA	TCGA-A2-A1FX.EAFC71A1-D6FC-46EA-BC47-D054C497D705.pdf		0		0		0		0		0		0		100		90	TUMOR FREE							YES	No	60-69%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2008	TCGA-A2-A1FX-01A-11D-A13L-09		TCGA-A2-A1FX-01A-11R-A13P-13	TCGA-A2-A1FX-01A-11R-A13P-13	TCGA-A2-A1FX-01A-11D-A13L-09		TCGA-A2-A1FX-01A-11D-A13L-09	TCGA-A2-A1FX-01A-21-A17I-20	TCGA-A2-A1FX-01A-11D-A13L-09	60f078d7-d594-48a2-9011-f0f926243a42	a3f4ad97-3d59-4568-84e8-674280b1f04a	TCGA-A2-A1FX-01A-11D-A13J-01	60f078d7-d594-48a2-9011-f0f926243a42	TCGA-A2-A1FX-01A-11D-A13K-05	TCGA-A2-A1FX-01		60f078d7-d594-48a2-9011-f0f926243a42	60f078d7-d594-48a2-9011-f0f926243a42	TCGA-A2-A1FX-01A-11D-A13J-01		TCGA-A2-A1FX-01		a3f4ad97-3d59-4568-84e8-674280b1f04a	
TCGA-A2-A1FZ-01	Stage IIA	63	3	Stage IIA	409		Positive	FEMALE	Negative				Negative	M0	Negative	N0	409	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A1FZ-01	683	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA c1uster 9	cluster 6	mutation cluster 4	TCGA-A2-A1FZ	683	0	683	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Right	Sentinel node biopsy alone		TCGA-A2-A1FZ-F20803		Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		YES			-23055	335		0	683					NO		90-99%				Scheduled Follow-up Submission	2012-1-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1	3+	YES		Core needle biopsy	740	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A1FZ.F93E326D-F4E0-4000-8A67-AA19C4D3637A.pdf		0		0		0		0		0		45		55		75	TUMOR FREE							YES	No	90-99%		NO	Primary Tumor	01		7th	YES	YES	NO	A2	Breast	A	LIVING	2010	TCGA-A2-A1FZ-01A-51D-A17G-09		TCGA-A2-A1FZ-01A-51R-A14C-13	TCGA-A2-A1FZ-01A-51R-A14C-13	TCGA-A2-A1FZ-01A-51D-A17G-09		TCGA-A2-A1FZ-01A-51D-A17G-09	TCGA-A2-A1FZ-01A-11-A17I-20	TCGA-A2-A1FZ-01A-51D-A17G-09	27e70f84-80c5-4f6c-9d22-83c5a6e66eb5	2324a415-fc47-477f-8842-822a48b120a6	TCGA-A2-A1FZ-01A-51D-A14F-01	27e70f84-80c5-4f6c-9d22-83c5a6e66eb5	TCGA-A2-A1FZ-01A-51D-A14H-05	TCGA-A2-A1FZ-01		27e70f84-80c5-4f6c-9d22-83c5a6e66eb5	27e70f84-80c5-4f6c-9d22-83c5a6e66eb5	TCGA-A2-A1FZ-01A-51D-A14F-01		TCGA-A2-A1FZ-01		2324a415-fc47-477f-8842-822a48b120a6	
TCGA-A2-A1G0-01	Stage IIB	49	3	Stage IIB	380		Positive	FEMALE	Negative				Negative	M0	Positive	N1	380	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A1G0-01	616	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-A2-A1G0	616	0	616	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A1G0-F20802		Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		NO			-18002	315		0	616					NO		90-99%				Scheduled Follow-up Submission	2012-1-9	FEMALE					2+			1.2		Infiltrating Ductal Carcinoma		No		C50.9	8520/3	C50.2	3+	YES		Core needle biopsy	730	NO	Equivocal	Negative		19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6								NO	2		true	M0	N1a	T2	Stage IIB	TCGA-A2-A1G0.DA82E751-09C3-466E-A63A-38368D8A2C7C.pdf		0		0		0		0		0		0		100		95	TUMOR FREE							YES	No	90-99%		YES	Primary Tumor	01		7th	YES	YES	NO	A2	Breast	A	LIVING	2010	TCGA-A2-A1G0-01A-11D-A13L-09		TCGA-A2-A1G0-01A-11R-A13P-13	TCGA-A2-A1G0-01A-11R-A13P-13	TCGA-A2-A1G0-01A-11D-A13L-09		TCGA-A2-A1G0-01A-11D-A13L-09	TCGA-A2-A1G0-01A-21-A17I-20	TCGA-A2-A1G0-01A-11D-A13L-09	753e77c2-6175-49d8-afd4-3a87d1dc2404	454e0016-63ac-4727-a1bd-0319b09d17a0	TCGA-A2-A1G0-01A-11D-A13J-01	753e77c2-6175-49d8-afd4-3a87d1dc2404	TCGA-A2-A1G0-01A-11D-A13K-05	TCGA-A2-A1G0-01		753e77c2-6175-49d8-afd4-3a87d1dc2404	753e77c2-6175-49d8-afd4-3a87d1dc2404	TCGA-A2-A1G0-01A-11D-A13J-01		TCGA-A2-A1G0-01		454e0016-63ac-4727-a1bd-0319b09d17a0	
TCGA-A2-A1G1-01	Stage IIB	85	4	Stage IIB	371		Negative	FEMALE	Positive				Negative	M0	Positive	N1	371	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A1G1-01	584	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 14	cluster 6	mutation cluster 5	TCGA-A2-A1G1	584	0	584	Breast	TCGA Breast Cancer	breast invasive carcinoma					85	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A1G1-F20808		Negative					Negative	Lumpectomy		NO			-31223	338		0	584					NO					51	Scheduled Follow-up Submission	2012-1-12	FEMALE					2+	30	816	16.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Equivocal	Positive		13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	6								NO	1	0	true	M0	N1	T2	Stage IIB	TCGA-A2-A1G1.E2E6CA22-AFE4-4B8F-90AC-32639687A590.pdf		0		0		10		0		0		20		70		70	TUMOR FREE							YES	No			YES	Primary Tumor	01		7th	NO	YES	NO	A2	Breast	A	LIVING	2010	TCGA-A2-A1G1-01A-21D-A13L-09		TCGA-A2-A1G1-01A-21R-A13P-13	TCGA-A2-A1G1-01A-21R-A13P-13	TCGA-A2-A1G1-01A-21D-A13L-09		TCGA-A2-A1G1-01A-21D-A13L-09	TCGA-A2-A1G1-01A-11-A17I-20	TCGA-A2-A1G1-01A-21D-A13L-09	122a1ed2-9757-4cac-9656-149da6d872f4	b71535be-881b-4ea5-888a-1f2afbdec4d1	TCGA-A2-A1G1-01A-21D-A13J-01	122a1ed2-9757-4cac-9656-149da6d872f4	TCGA-A2-A1G1-01A-21D-A13K-05	TCGA-A2-A1G1-01		122a1ed2-9757-4cac-9656-149da6d872f4	122a1ed2-9757-4cac-9656-149da6d872f4	TCGA-A2-A1G1-01A-21D-A13J-01		TCGA-A2-A1G1-01		b71535be-881b-4ea5-888a-1f2afbdec4d1	
TCGA-A2-A1G4-01	Stage IIIA	71	4	Stage IIIA	372		Positive	FEMALE	Negative				Negative	M0	Positive	N1	372	0	LumB		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-A2-A1G4-01	595	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-A2-A1G4	595	0	595	Breast	TCGA Breast Cancer	breast invasive carcinoma					71	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A1G4-F20805		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-25966	310		0	595					NO		90-99%				Scheduled Follow-up Submission	2012-1-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	710	NO	Negative			15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5								NO	2		true	M0	N1a	T3	Stage IIIA	TCGA-A2-A1G4.5AD3B697-F097-496C-978B-F73BDA5394A7.pdf		0		0		0		0		0		0		100		90	TUMOR FREE							YES	No	90-99%		NO	Primary Tumor	01		7th	YES	YES	NO	A2	Breast	A	LIVING	2010	TCGA-A2-A1G4-01A-11D-A13L-09		TCGA-A2-A1G4-01A-11R-A13P-13	TCGA-A2-A1G4-01A-11R-A13P-13	TCGA-A2-A1G4-01A-11D-A13L-09		TCGA-A2-A1G4-01A-11D-A13L-09	TCGA-A2-A1G4-01A-21-A17I-20	TCGA-A2-A1G4-01A-11D-A13L-09	2ce88ee9-0fc6-4d1d-82a7-be79eaee21d2	6b688e59-a222-4068-8b2b-71494fdfde17	TCGA-A2-A1G4-01A-11D-A13J-01	2ce88ee9-0fc6-4d1d-82a7-be79eaee21d2	TCGA-A2-A1G4-01A-11D-A13K-05	TCGA-A2-A1G4-01		2ce88ee9-0fc6-4d1d-82a7-be79eaee21d2	2ce88ee9-0fc6-4d1d-82a7-be79eaee21d2	TCGA-A2-A1G4-01A-11D-A13J-01		TCGA-A2-A1G4-01		6b688e59-a222-4068-8b2b-71494fdfde17	
TCGA-A2-A1G6-01	Stage IIIA	50	1	Stage IIIA	132		Negative	FEMALE	Negative				Negative	M0	Positive	N2	132	0	Normal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A1G6-01	501	0	Quiet	C5-KIRC	cluster 5	Low purity c2	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-A2-A1G6	501	0	501	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Right	Axillary lymph node dissection alone		TCGA-A2-A1G6-F20947		Negative					Negative	Modified Radical Mastectomy		NO			-18514	229		0	501					NO						Scheduled Follow-up Submission	2012-1-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	770	NO	Negative			9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	6								NO	4		true	M0	N2a	T2	Stage IIIA	TCGA-A2-A1G6.02B4C31E-38F0-4AF3-8DAD-527D5F27C11A.pdf		0		0		0		0		0		10		90		75	TUMOR FREE							YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	A2	Breast	A	LIVING	2010	TCGA-A2-A1G6-01A-11D-A13L-09		TCGA-A2-A1G6-01A-11R-A13P-13	TCGA-A2-A1G6-01A-11R-A13P-13			TCGA-A2-A1G6-01A-11D-A13L-09	TCGA-A2-A1G6-01A-21-A17I-20	TCGA-A2-A1G6-01A-11D-A13L-09	8b216b0f-1881-45de-a4ae-78dfd87764fe	e64cdbe2-a5a8-4714-b25f-e27b254e95e8	TCGA-A2-A1G6-01A-11D-A13J-01	8b216b0f-1881-45de-a4ae-78dfd87764fe	TCGA-A2-A1G6-01A-11D-A13K-05	TCGA-A2-A1G6-01		8b216b0f-1881-45de-a4ae-78dfd87764fe	8b216b0f-1881-45de-a4ae-78dfd87764fe	TCGA-A2-A1G6-01A-11D-A13J-01		TCGA-A2-A1G6-01		e64cdbe2-a5a8-4714-b25f-e27b254e95e8	
TCGA-A2-A259-01	Stage IA	70	4	Stage I	1285		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1285	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-A2-A259-01	1596	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 14		mutation c1uster 9	TCGA-A2-A259	1596	0	1596	Breast	TCGA Breast Cancer	breast invasive carcinoma					70	Left	Sentinel node biopsy alone		TCGA-A2-A259-F31034		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		YES			-25666	1238		0	1596					NO		90-99%			125	Scheduled Follow-up Submission	2012-4-23	FEMALE						60	132	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Negative	Negative		2	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1									NO	0	0	true	M0	N0 (i-)	T1c	Stage IA	TCGA-A2-A259.33569E07-D7BF-491B-A352-CEEA81556800.pdf		1		0		0		0		1		34		65		85	TUMOR FREE				Strong using Weak, Moderate and Strong	Strong using Weak, Moderate and Strong		YES	No	80-89%		NO	Primary Tumor	01		7th	YES	NO	YES	A2	Breast	A	LIVING	2007	TCGA-A2-A259-01A-11D-A16D-09		TCGA-A2-A259-01A-11R-A16E-13	TCGA-A2-A259-01A-11R-A16E-13	TCGA-A2-A259-01A-11D-A16D-09		TCGA-A2-A259-01A-11D-A16D-09	TCGA-A2-A259-01A-21-A17I-20	TCGA-A2-A259-01A-11D-A16D-09	7157ccb4-b4f6-41ba-9f9c-da862b749a57	ec4242c5-4c16-43d6-9fe3-0fc2766928a1	TCGA-A2-A259-01A-11D-A16C-01	7157ccb4-b4f6-41ba-9f9c-da862b749a57	TCGA-A2-A259-01A-11D-A16G-05	TCGA-A2-A259-01		7157ccb4-b4f6-41ba-9f9c-da862b749a57	7157ccb4-b4f6-41ba-9f9c-da862b749a57	TCGA-A2-A259-01A-11D-A16C-01		TCGA-A2-A259-01		ec4242c5-4c16-43d6-9fe3-0fc2766928a1	
TCGA-A2-A25A-01	Stage IIA	44	2	Stage IIA	2968		Positive	FEMALE	Negative				Negative	M0	Negative	N0	2968	0	Normal		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A25A-01	3276	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 5		mutation cluster 4	TCGA-A2-A25A	3276	0	3276	Breast	TCGA Breast Cancer	breast invasive carcinoma					44	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-A2-A25A-F30927		Positive					Positive	Simple Mastectomy		YES			-16084	2927		0	3276					NO		<10%				Scheduled Follow-up Submission	2012-4-19	FEMALE					2+			1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	160	NO	Equivocal	Negative		14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4									NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A25A.3971CA42-F1B0-4D85-9AD3-210B98E76A9C.pdf		1		0		0		0		2		28		70		80	TUMOR FREE							YES	Yes	<10%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2003	TCGA-A2-A25A-01A-12D-A16D-09		TCGA-A2-A25A-01A-12R-A16E-13	TCGA-A2-A25A-01A-12R-A16E-13	TCGA-A2-A25A-01A-12D-A16D-09		TCGA-A2-A25A-01A-12D-A16D-09	TCGA-A2-A25A-01A-21-A17I-20	TCGA-A2-A25A-01A-12D-A16D-09	50c720f4-dbcb-4b8b-9808-d130f5197d27	3e0fb875-1681-4fb4-a955-924eba446e9b	TCGA-A2-A25A-01A-12D-A16C-01	50c720f4-dbcb-4b8b-9808-d130f5197d27	TCGA-A2-A25A-01A-12D-A16G-05	TCGA-A2-A25A-01		50c720f4-dbcb-4b8b-9808-d130f5197d27	50c720f4-dbcb-4b8b-9808-d130f5197d27	TCGA-A2-A25A-01A-12D-A16C-01		TCGA-A2-A25A-01		3e0fb875-1681-4fb4-a955-924eba446e9b	
TCGA-A2-A25B-01	Stage IIB	39	5	Stage IIB	258		Positive	FEMALE	Negative				Negative	M0	Positive	N1	258	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A25B-01	496	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 2	cluster 5	mutation c1uster 9	TCGA-A2-A25B	496	0	496	Breast	TCGA Breast Cancer	breast invasive carcinoma					39	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A25B-F31267		Positive					Positive	Modified Radical Mastectomy		NO			-14454	183		0	496					NO		90-99%				Scheduled Follow-up Submission	2012-4-16	FEMALE					2+			0.93		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	840	NO	Equivocal	Negative		8	Close	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	5								NO	2	0	true	M0	N1	T2	Stage IIB	TCGA-A2-A25B.FCE29F34-5D13-4A21-A950-A8577C957C10.pdf		2		0		0		0		0		25		75		80	TUMOR FREE							YES	No	10-19%		YES	Primary Tumor	01		7th	YES	YES	NO	A2	Breast	A	LIVING	2010	TCGA-A2-A25B-01A-11D-A167-09		TCGA-A2-A25B-01A-11R-A168-13	TCGA-A2-A25B-01A-11R-A168-13	TCGA-A2-A25B-01A-11D-A167-09		TCGA-A2-A25B-01A-11D-A167-09	TCGA-A2-A25B-01A-21-A17I-20	TCGA-A2-A25B-01A-11D-A167-09	3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b	716578b3-e202-483b-b15c-784f5a0c60f3	TCGA-A2-A25B-01A-11D-A166-01	3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b	TCGA-A2-A25B-01A-11D-A16A-05	TCGA-A2-A25B-01		3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b	3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b	TCGA-A2-A25B-01A-11D-A166-01		TCGA-A2-A25B-01		716578b3-e202-483b-b15c-784f5a0c60f3	
TCGA-A2-A25C-01	Stage IIB	50	3	Stage IIB	285		Positive	FEMALE	Negative				Negative	M0	Positive	N1	285	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A25C-01	523	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 2	cluster 5	mutation cluster 4	TCGA-A2-A25C	523	0	523	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A25C-F31282		Positive	3 Point Scale	2+	3 Point Scale		Positive	Simple Mastectomy		NO			-18508			0	523					NO		90-99%				Scheduled Follow-up Submission	2012-4-17	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy			Negative			14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	5								NO	3	0		M0	N1a	T2	Stage IIB																		TUMOR FREE							YES	No	20-29%		YES	Primary Tumor	01		7th	YES	YES	NO	A2	Breast		LIVING	2010	TCGA-A2-A25C-01A-11D-A167-09		TCGA-A2-A25C-01A-11R-A168-13	TCGA-A2-A25C-01A-11R-A168-13	TCGA-A2-A25C-01A-11D-A167-09		TCGA-A2-A25C-01A-11D-A167-09	TCGA-A2-A25C-01A-21-A17I-20	TCGA-A2-A25C-01A-11D-A167-09	f5b16ba5-0fd1-4ca4-865f-fdff0af65901	bd2557ec-ce5b-4e98-aed0-2ca6ad51742e	TCGA-A2-A25C-01A-11D-A166-01	f5b16ba5-0fd1-4ca4-865f-fdff0af65901	TCGA-A2-A25C-01A-11D-A16A-05	TCGA-A2-A25C-01		f5b16ba5-0fd1-4ca4-865f-fdff0af65901	f5b16ba5-0fd1-4ca4-865f-fdff0af65901	TCGA-A2-A25C-01A-11D-A166-01		TCGA-A2-A25C-01		bd2557ec-ce5b-4e98-aed0-2ca6ad51742e	
TCGA-A2-A25D-01	Stage IIIC	90	4	Stage IIIC	243		Positive	FEMALE	Negative				Negative	M0	Positive	N3	243	0	LumA		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A25D-01	552	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13		mutation cluster 4	TCGA-A2-A25D	552	0	552	Breast	TCGA Breast Cancer	breast invasive carcinoma					90	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A25D-F30931		Positive					Negative	Lumpectomy		NO			-32872	224		0	552					NO		70-79%			118	Scheduled Follow-up Submission	2012-4-19	FEMALE					1+	60	145	1.22		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	430	NO	Negative	Negative		24	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4									NO	22	0	true	M0	N3a	T2	Stage IIIC	TCGA-A2-A25D.BE63B06A-E3E0-4E00-9B9F-5E7DE8852E07.pdf		1		0		4		0		0		41		55		80	TUMOR FREE					Moderate using the scale of Weak, Moderate, Strong		YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	A2	Breast	A	LIVING	2010	TCGA-A2-A25D-01A-12D-A16D-09		TCGA-A2-A25D-01A-12R-A16E-13	TCGA-A2-A25D-01A-12R-A16E-13	TCGA-A2-A25D-01A-12D-A16D-09		TCGA-A2-A25D-01A-12D-A16D-09	TCGA-A2-A25D-01A-21-A17I-20	TCGA-A2-A25D-01A-12D-A16D-09	d6b5cec3-edeb-46c5-839b-e62a1e850e0e	91bb8c75-008a-4c32-84bd-fb55524a39aa	TCGA-A2-A25D-01A-12D-A16C-01	d6b5cec3-edeb-46c5-839b-e62a1e850e0e	TCGA-A2-A25D-01A-12D-A16G-05	TCGA-A2-A25D-01		d6b5cec3-edeb-46c5-839b-e62a1e850e0e	d6b5cec3-edeb-46c5-839b-e62a1e850e0e	TCGA-A2-A25D-01A-12D-A16C-01		TCGA-A2-A25D-01		91bb8c75-008a-4c32-84bd-fb55524a39aa	
TCGA-A2-A25E-01	Stage IIIA	34	5	Stage IIIA	2511		Positive	FEMALE	Equivocal				Negative	M0	Positive	N2	2511	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A25E-01	2796	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 2	cluster 5	mutation c1uster 9	TCGA-A2-A25E	2796	0	2796	Breast	TCGA Breast Cancer	breast invasive carcinoma					34	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A25E-F31056		Positive					Positive	Modified Radical Mastectomy		NO			-12601	2441		0	2796					NO		80-89%				Scheduled Follow-up Submission	2012-4-23	FEMALE					2+			2.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	200	NO	Equivocal	Equivocal		10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	5								NO	6	0	true	M0	N2a	T2	Stage IIIA	TCGA-A2-A25E.B81555D4-78D9-4235-AABE-F852CA6F15B5.pdf		5		0		2		0		0		26		72		85	TUMOR FREE				Strong, using scale of Weak, Moderate and Strong	Moderate using scale of Weak, Moderate, Strong		YES	No	60-69%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2004	TCGA-A2-A25E-01A-11D-A167-09		TCGA-A2-A25E-01A-11R-A168-13	TCGA-A2-A25E-01A-11R-A168-13	TCGA-A2-A25E-01A-11D-A167-09		TCGA-A2-A25E-01A-11D-A167-09	TCGA-A2-A25E-01A-21-A17I-20	TCGA-A2-A25E-01A-11D-A167-09	7265c93b-7138-4bc8-bc9c-22ce1abf0ef2	d8bafd3e-45a4-4392-b06d-554c5d2eb95a	TCGA-A2-A25E-01A-11D-A166-01	7265c93b-7138-4bc8-bc9c-22ce1abf0ef2	TCGA-A2-A25E-01A-11D-A16A-05	TCGA-A2-A25E-01		7265c93b-7138-4bc8-bc9c-22ce1abf0ef2	7265c93b-7138-4bc8-bc9c-22ce1abf0ef2	TCGA-A2-A25E-01A-11D-A166-01		TCGA-A2-A25E-01		d8bafd3e-45a4-4392-b06d-554c5d2eb95a	
TCGA-A2-A25F-01	Stage IIA	66	1	Stage IIA	113		Negative	FEMALE	Negative				Negative	M0	Negative	N0	113	0	Basal		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A25F-01	322	0	Kirc+	C4-BRCA/Basal	cluster 1	Low purity c2	BRCA basal-like c6	BRCA basal-like c8			mutation c1uster 9	TCGA-A2-A25F	322	0	322	Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A25F-F31197		Negative					Positive	Lumpectomy		YES			-24319			0	322					NO						Scheduled Follow-up Submission	2012-4-23	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1									NO	0	0		M0	N0 (i-)	T2	Stage IIA																		TUMOR FREE							YES	No	<10%		YES	Primary Tumor	01		7th	YES	YES	NO	A2	Breast		LIVING	2011	TCGA-A2-A25F-01A-11D-A167-09		TCGA-A2-A25F-01A-11R-A168-13	TCGA-A2-A25F-01A-11R-A168-13	TCGA-A2-A25F-01A-11D-A167-09		TCGA-A2-A25F-01A-11D-A167-09	TCGA-A2-A25F-01A-21-A17I-20	TCGA-A2-A25F-01A-11D-A167-09	acd59617-770c-4653-891f-71ea87d67c41	c4d15095-d0bf-4fe0-a2b9-52e0119a7a26	TCGA-A2-A25F-01A-11D-A166-01	acd59617-770c-4653-891f-71ea87d67c41	TCGA-A2-A25F-01A-11D-A16A-05	TCGA-A2-A25F-01		acd59617-770c-4653-891f-71ea87d67c41	acd59617-770c-4653-891f-71ea87d67c41	TCGA-A2-A25F-01A-11D-A166-01		TCGA-A2-A25F-01		c4d15095-d0bf-4fe0-a2b9-52e0119a7a26	
TCGA-A2-A3KC-01																			LumA										0	TCGA-A2-A3KC-01	635	0	Iq	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-A2-A3KC	635	0	635	Breast	TCGA Breast Cancer	breast invasive carcinoma					55	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A3KC-F37340		Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		NO			-20401	299		0	635					NO		90-99%			1.9		2012-12-3	FEMALE					2+	20	1.8	1.0		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	780	NO	Equivocal	Negative	NO	19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	2	0	true	M0	N1a	T2	Stage IIB	TCGA-A2-A3KC.593AF241-8F84-4BA0-8878-7C1CE72A460B.pdf		0		0		0		0		0		0		100		75	TUMOR FREE						YES	YES	No	90-99%		YES	Primary Tumor	01		7th		YES	NO	A2	Breast	A	LIVING	2011			TCGA-A2-A3KC-01A-11R-A214-13	TCGA-A2-A3KC-01A-11R-A214-13			TCGA-A2-A3KC-01A-11D-A20S-09	TCGA-A2-A3KC-01A-21-A24A-20		7bbe4637-394e-42c0-af7d-6184c3f48916	add405f0-8223-4e7d-b1aa-7cdf9432a16f	TCGA-A2-A3KC-01A-11D-A20R-01	7bbe4637-394e-42c0-af7d-6184c3f48916	TCGA-A2-A3KC-01A-11D-A212-05	TCGA-A2-A3KC-01		7bbe4637-394e-42c0-af7d-6184c3f48916	7bbe4637-394e-42c0-af7d-6184c3f48916	TCGA-A2-A3KC-01A-11D-A20R-01		TCGA-A2-A3KC-01		add405f0-8223-4e7d-b1aa-7cdf9432a16f	
TCGA-A2-A3KD-01																			LumA										0	TCGA-A2-A3KD-01	1206	0	Iq	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-A2-A3KD	1206	0	1206	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A3KD-F37343	Close	Positive	3 Point Scale		3 Point Scale	Mastectomy NOS	Positive	Lumpectomy		YES			-17372	700		0	1206					NO		90-99%					2012-12-3	FEMALE					1+			1.2		Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Core needle biopsy	770	NO	Negative	Negative	NO	19	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	1	1	true	M0	N1mi	T3	Stage IIIA	TCGA-A2-A3KD.3E4717BA-E9AE-45F9-9696-F8928D9FCECC.pdf		0		0		0		0		0		0		100		90	TUMOR FREE				Strong	Strong	YES	YES	No	70-79%		YES	Primary Tumor	01		7th		YES	NO	A2	Breast	A	LIVING	2010			TCGA-A2-A3KD-01A-12R-A214-13	TCGA-A2-A3KD-01A-12R-A214-13			TCGA-A2-A3KD-01A-12D-A20S-09	TCGA-A2-A3KD-01A-21-A24A-20		8a224dc6-632b-418b-bd5e-bcefc8ad049e	b9d3e65d-b417-4611-b340-e9d8365e9fd9	TCGA-A2-A3KD-01A-12D-A20R-01	8a224dc6-632b-418b-bd5e-bcefc8ad049e	TCGA-A2-A3KD-01A-12D-A212-05	TCGA-A2-A3KD-01		8a224dc6-632b-418b-bd5e-bcefc8ad049e	8a224dc6-632b-418b-bd5e-bcefc8ad049e	TCGA-A2-A3KD-01A-12D-A20R-01		TCGA-A2-A3KD-01		b9d3e65d-b417-4611-b340-e9d8365e9fd9	
TCGA-A2-A3XS-01																													1	TCGA-A2-A3XS-01	1032	1							miRNA cluster 4			TCGA-A2-A3XS	682	1	1032	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO	NO		62	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A3XS-F34446	Negative	Negative				Mastectomy NOS	Negative	Lumpectomy		YES			-23000	3355	1032	0				682		YES						Additional New Tumor Event	2012-8-15	FEMALE								1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	40	NO		Negative		19	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																							Lung	Distant Metastasis			YES	9	0	true	M0	N2a	T1	Stage IIIA	TCGA-A2-A3XS.DD5295D4-3896-4AA5-AF75-30AEA45D1652.pdf		0		0		2		0		0		13		85		68	WITH TUMOR							YES	No			NO	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	DECEASED	2003			TCGA-A2-A3XS-01A-11R-A22V-13	TCGA-A2-A3XS-01A-11R-A22V-13			TCGA-A2-A3XS-01A-11D-A22X-09			799df122-75f1-46bf-8b5e-ca557cd38d53	b53f403a-449d-4a77-891e-562a0ce6ff75	TCGA-A2-A3XS-01A-11D-A22W-01	799df122-75f1-46bf-8b5e-ca557cd38d53	TCGA-A2-A3XS-01A-11D-A230-05	TCGA-A2-A3XS-01		799df122-75f1-46bf-8b5e-ca557cd38d53	799df122-75f1-46bf-8b5e-ca557cd38d53	TCGA-A2-A3XS-01A-11D-A22W-01		TCGA-A2-A3XS-01		b53f403a-449d-4a77-891e-562a0ce6ff75	
TCGA-A2-A3XT-01																													0	TCGA-A2-A3XT-01	2525	0					BRCA basal-like c6		miRNA cluster 4			TCGA-A2-A3XT	2525	0	2525	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Left	Other (specify)	F plus axillary lymph node dissection	TCGA-A2-A3XT-F43309		Negative					Negative	Modified Radical Mastectomy		NO			-16649			0	2525												2013-5-16	FEMALE								1.13		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy			Negative	Negative	NO	13	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	1			M0	N1a	T2	Stage IIB																		TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		6th		NO	YES	A2	Breast		LIVING	2006			TCGA-A2-A3XT-01A-11R-A22V-13	TCGA-A2-A3XT-01A-11R-A22V-13			TCGA-A2-A3XT-01A-11D-A22X-09	TCGA-A2-A3XT-01A-21-A24A-20		e0a10445-6266-4f41-a747-fb19d7182652	bbbed4e0-9f0b-4312-999a-dcd592b8e383	TCGA-A2-A3XT-01A-11D-A22W-01	e0a10445-6266-4f41-a747-fb19d7182652	TCGA-A2-A3XT-01A-11D-A230-05	TCGA-A2-A3XT-01		e0a10445-6266-4f41-a747-fb19d7182652	e0a10445-6266-4f41-a747-fb19d7182652	TCGA-A2-A3XT-01A-11D-A22W-01		TCGA-A2-A3XT-01		bbbed4e0-9f0b-4312-999a-dcd592b8e383	
TCGA-A2-A3XU-01																													1	TCGA-A2-A3XU-01	912	1					BRCA basal-like c6		miRNA cluster 4			TCGA-A2-A3XU	596	1	912	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO			35	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A3XU-F34704		Negative					Negative	Lumpectomy		NO			-13046	2089	912	0				596							1.5		2012-8-30	FEMALE						60	1.66	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	350	NO		Negative	NO	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)					Positive												Positive						Other, specify	Locoregional Recurrence	Breast	NO	YES	3	0	true	M0	N1mi	T2	Stage IIB	TCGA-A2-A3XU.5018EC57-96C6-4D63-B708-45559B4D8527.pdf		0		0		0		0		3		7		90		90	WITH TUMOR						YES	YES	No			YES	Primary Tumor	01		6th		NO	YES	A2	Breast	A	DECEASED	2006			TCGA-A2-A3XU-01A-12R-A22V-13	TCGA-A2-A3XU-01A-12R-A22V-13			TCGA-A2-A3XU-01A-12D-A22X-09	TCGA-A2-A3XU-01A-21-A24A-20		2ec1df5c-7272-44f4-922c-cdd6ba37f6b6	a57d2d29-cd47-4048-9c06-8b8cd2456f9b	TCGA-A2-A3XU-01A-12D-A22W-01	2ec1df5c-7272-44f4-922c-cdd6ba37f6b6	TCGA-A2-A3XU-01A-12D-A230-05	TCGA-A2-A3XU-01		2ec1df5c-7272-44f4-922c-cdd6ba37f6b6	2ec1df5c-7272-44f4-922c-cdd6ba37f6b6	TCGA-A2-A3XU-01A-12D-A22W-01		TCGA-A2-A3XU-01		a57d2d29-cd47-4048-9c06-8b8cd2456f9b	
TCGA-A2-A3XV-01																													0	TCGA-A2-A3XV-01	699	0					BRCA basal-like c6					TCGA-A2-A3XV	699	0	699	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Right	Sentinel node biopsy alone		TCGA-A2-A3XV-F43306		Positive	3 Point Scale				Negative	Lumpectomy		YES			-16971	344		0	699							<10%			1.7		2013-5-16	FEMALE					2+	60	4.5	2.6		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Core needle biopsy	360	NO	Equivocal	Positive	NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0	0	true	M0	N0	T2	Stage IIA	TCGA-A2-A3XV.405B9D03-6200-4DFA-A7D1-C622D3A48AEA.pdf		0		0		0		0		0		0		100		85	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th		YES	NO	A2	Breast	A	LIVING	2011			TCGA-A2-A3XV-01A-21R-A23A-13	TCGA-A2-A3XV-01A-21R-A23A-13			TCGA-A2-A3XV-01A-21D-A23C-09	TCGA-A2-A3XV-01A-41-A24A-20		fc2aa9aa-3df5-4723-9892-95edcc92bb6f	5018e45a-c0ab-462d-8c8b-9fe67b472002	TCGA-A2-A3XV-01A-21D-A238-01	fc2aa9aa-3df5-4723-9892-95edcc92bb6f	TCGA-A2-A3XV-01A-21D-A23D-05	TCGA-A2-A3XV-01		fc2aa9aa-3df5-4723-9892-95edcc92bb6f	fc2aa9aa-3df5-4723-9892-95edcc92bb6f	TCGA-A2-A3XV-01A-21D-A238-01		TCGA-A2-A3XV-01		5018e45a-c0ab-462d-8c8b-9fe67b472002	
TCGA-A2-A3XW-01																													0	TCGA-A2-A3XW-01	1505	0					BRCA nonbasal-like c8					TCGA-A2-A3XW	1505	0	1505	Breast	TCGA Breast Cancer	breast invasive carcinoma					42	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A3XW-F43308		Positive	3 Point Scale				Negative	Simple Mastectomy		YES			-15670			0	1505					NO		90-99%					2013-5-16	FEMALE			<10%					1.31		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy			Negative	Negative	NO	18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	3	0		M0	N1a	T2	Stage IIB																		TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th		YES	NO	A2	Breast		LIVING	2009			TCGA-A2-A3XW-01A-11R-A23A-13	TCGA-A2-A3XW-01A-11R-A23A-13			TCGA-A2-A3XW-01A-11D-A23C-09	TCGA-A2-A3XW-01A-21-A24A-20		f6cbfa5a-7d10-4efb-ae74-195e1a1e9774	ec923957-81ba-44b9-8e2c-15305f8829a5	TCGA-A2-A3XW-01A-11D-A238-01	f6cbfa5a-7d10-4efb-ae74-195e1a1e9774	TCGA-A2-A3XW-01A-11D-A23D-05	TCGA-A2-A3XW-01		f6cbfa5a-7d10-4efb-ae74-195e1a1e9774	f6cbfa5a-7d10-4efb-ae74-195e1a1e9774	TCGA-A2-A3XW-01A-11D-A238-01		TCGA-A2-A3XW-01		ec923957-81ba-44b9-8e2c-15305f8829a5	
TCGA-A2-A3XX-01																													1	TCGA-A2-A3XX-01	1439	1					KIRC-like c1					TCGA-A2-A3XX	1439	0	1439	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A3XX-F43310		Negative					Negative	Simple Mastectomy		YES			-17981	1143	1439	0	1168					NO							2013-5-16	FEMALE					1+			1.25		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	780	NO	Negative	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	true	M0	N0	T2	Stage IIA	TCGA-A2-A3XX.770EEADF-19CD-4AB9-A7FA-1A05EE17984C.pdf		0		0		0		0		50		0		50		88	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		7th		YES	NO	A2	Breast	A	DECEASED	2009			TCGA-A2-A3XX-01A-21R-A23A-13	TCGA-A2-A3XX-01A-21R-A23A-13			TCGA-A2-A3XX-01A-21D-A23C-09	TCGA-A2-A3XX-01A-41-A24A-20		043d5dcd-1524-402b-939c-984a1dc916a0	1a12cd14-3f98-41bd-b89f-c0fb2848f8d5	TCGA-A2-A3XX-01A-21D-A238-01	043d5dcd-1524-402b-939c-984a1dc916a0	TCGA-A2-A3XX-01A-21D-A23D-05	TCGA-A2-A3XX-01		043d5dcd-1524-402b-939c-984a1dc916a0	043d5dcd-1524-402b-939c-984a1dc916a0	TCGA-A2-A3XX-01A-21D-A238-01		TCGA-A2-A3XX-01		1a12cd14-3f98-41bd-b89f-c0fb2848f8d5	
TCGA-A2-A3XY-01																													0	TCGA-A2-A3XY-01	1064	0										TCGA-A2-A3XY	802	1	1064	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO			49	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A3XY-F43311		Negative					Negative	Modified Radical Mastectomy		NO			-18059	703		0	1064			802		NO							2013-5-16	FEMALE								1.13		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Core needle biopsy	950	NO	Negative	Negative	NO	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																							Lung	Distant Metastasis		NO	YES	3		true	M0	N1a	T2	Stage IIB	TCGA-A2-A3XY.EC1BB6E8-6897-4E70-80A6-5A4E4B9C4E1F.pdf		0		0		5		0		0		35		60		70	WITH TUMOR						YES	YES	No			YES	Primary Tumor	01		7th		YES	NO	A2	Breast	A	LIVING	2010			TCGA-A2-A3XY-01A-11R-A23A-13	TCGA-A2-A3XY-01A-11R-A23A-13			TCGA-A2-A3XY-01A-11D-A23C-09			42c88ed3-de96-487d-8b03-e1d4269d0505	43446fc2-82dd-4759-af34-b0db537143f2	TCGA-A2-A3XY-01A-11D-A238-01	42c88ed3-de96-487d-8b03-e1d4269d0505	TCGA-A2-A3XY-01A-11D-A23D-05	TCGA-A2-A3XY-01		42c88ed3-de96-487d-8b03-e1d4269d0505	42c88ed3-de96-487d-8b03-e1d4269d0505	TCGA-A2-A3XY-01A-11D-A238-01		TCGA-A2-A3XY-01		43446fc2-82dd-4759-af34-b0db537143f2	
TCGA-A2-A3XZ-01																													0	TCGA-A2-A3XZ-01	1165	0					BRCA basal-like c6					TCGA-A2-A3XZ	1165	0	1165	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A3XZ-F43307		Negative					Negative	Simple Mastectomy		YES			-16978	909		0	1165												2013-5-17	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1100	NO	Positive		NO	3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0	0	true	M0	N0	T1c	Stage I	TCGA-A2-A3XZ.A7B6FCF6-1B81-40B5-AD92-54681CBC8FE0.pdf		6		0		3		0		5		52		40		85	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		6th		NO	YES	A2	Breast	A	LIVING	2009			TCGA-A2-A3XZ-01A-42R-A23A-13	TCGA-A2-A3XZ-01A-42R-A23A-13			TCGA-A2-A3XZ-01A-42D-A23C-09	TCGA-A2-A3XZ-01A-51-A24A-20		176b2422-3599-41c5-be62-ae6e28d60b90	7a55f6a3-a438-418f-a5a8-dcea12c977d9	TCGA-A2-A3XZ-01A-42D-A238-01	176b2422-3599-41c5-be62-ae6e28d60b90	TCGA-A2-A3XZ-01A-42D-A23D-05	TCGA-A2-A3XZ-01		176b2422-3599-41c5-be62-ae6e28d60b90	176b2422-3599-41c5-be62-ae6e28d60b90	TCGA-A2-A3XZ-01A-42D-A238-01		TCGA-A2-A3XZ-01		7a55f6a3-a438-418f-a5a8-dcea12c977d9	
TCGA-A2-A3Y0-01																													0	TCGA-A2-A3Y0-01	1167	0										TCGA-A2-A3Y0	1167	0	1167	Breast	TCGA Breast Cancer	breast invasive carcinoma					57	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A3Y0-F43305		Positive	3 Point Scale				Negative	Modified Radical Mastectomy		NO			-21024	845		0	1167							90-99%					2013-5-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4	3+	YES		Core needle biopsy	850	NO	Negative		NO	39	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1	0	true	M0	N1a	T2	Stage IIB	TCGA-A2-A3Y0.0FEAEEBA-A72C-4207-AC21-6AF5B5ED1AFC.pdf		0		0		5		0		0		5		90		95	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		7th		NO	YES	A2	Breast	A	LIVING	2010			TCGA-A2-A3Y0-01A-11R-A23A-13	TCGA-A2-A3Y0-01A-11R-A23A-13			TCGA-A2-A3Y0-01A-11D-A23C-09			9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5	7eda3bc1-76cc-4eff-ad0a-7f855ec2d7f3	TCGA-A2-A3Y0-01A-11D-A238-01	9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5	TCGA-A2-A3Y0-01A-11D-A23D-05	TCGA-A2-A3Y0-01		9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5	9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5	TCGA-A2-A3Y0-01A-11D-A238-01		TCGA-A2-A3Y0-01		7eda3bc1-76cc-4eff-ad0a-7f855ec2d7f3	
TCGA-A2-A4RW-01																													0	TCGA-A2-A4RW-01	222	0										TCGA-A2-A4RW	222	0	222	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Right|Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A4RW-F59123		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-18060	567		0	222							80-89%					2014-5-1	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	1550	NO	Negative		YES	27	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	27	0	true	M0	N3a	T2	Stage IIIC	TCGA-A2-A4RW.C1D4D6BB-AF86-4208-A729-C61365941217.pdf		40		10		10		10		0		30		60		60	TUMOR FREE							YES	No	90-99%			Primary Tumor	01		7th		YES	NO	A2	Breast	A	LIVING	2011			TCGA-A2-A4RW-01A-21R-A25Z-13	TCGA-A2-A4RW-01A-21R-A25Z-13			TCGA-A2-A4RW-01A-21D-A25Q-09			f8bfd67a-1d78-44b0-9715-712dee01b008	82aeac9e-e169-41dc-8580-4165d4ea0ac9	TCGA-A2-A4RW-01A-21D-A25N-01	f8bfd67a-1d78-44b0-9715-712dee01b008	TCGA-A2-A4RW-01A-21D-A268-05	TCGA-A2-A4RW-01		f8bfd67a-1d78-44b0-9715-712dee01b008	f8bfd67a-1d78-44b0-9715-712dee01b008	TCGA-A2-A4RW-01A-21D-A25N-01		TCGA-A2-A4RW-01		82aeac9e-e169-41dc-8580-4165d4ea0ac9	
TCGA-A2-A4RX-01																													0	TCGA-A2-A4RX-01	742	0										TCGA-A2-A4RX	742	0	742	Breast	TCGA Breast Cancer	breast invasive carcinoma					67	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A4RX-F58491		Positive	3 Point Scale	2+	3 Point Scale		Positive	Simple Mastectomy		YES			-24779	210		0	742							<10%					2014-4-11	FEMALE					1+					Other  specify	Metaplastic	No		C50.9	8575/3	C50.9	1+	YES		Core needle biopsy	920	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	true	M0	N0	T2	Stage IIA	TCGA-A2-A4RX.CA88491F-5572-4B0D-8E3D-D536E3CE5069.pdf		5		0		0		0		40		0		60		65	TUMOR FREE							YES	No	<10%			Primary Tumor	01		7th		YES	NO	A2	Breast	A	LIVING	2012			TCGA-A2-A4RX-01A-11R-A25Z-13	TCGA-A2-A4RX-01A-11R-A25Z-13			TCGA-A2-A4RX-01A-11D-A25Q-09			cbef9672-38ba-4873-b232-9a656b7428ce	73cfbf43-5452-47f9-9a59-6b985e15d66c	TCGA-A2-A4RX-01A-11D-A25N-01	cbef9672-38ba-4873-b232-9a656b7428ce	TCGA-A2-A4RX-01A-11D-A268-05	TCGA-A2-A4RX-01		cbef9672-38ba-4873-b232-9a656b7428ce	cbef9672-38ba-4873-b232-9a656b7428ce	TCGA-A2-A4RX-01A-11D-A25N-01		TCGA-A2-A4RX-01		73cfbf43-5452-47f9-9a59-6b985e15d66c	
TCGA-A2-A4RY-01																													0	TCGA-A2-A4RY-01	648	0										TCGA-A2-A4RY	648	0	648	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Right	Axillary lymph node dissection alone		TCGA-A2-A4RY-F59208		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-17157	149		0	648							90-99%					2014-5-5	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Core needle biopsy	1180	NO	Negative		NO	30	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	18	0	true	M0	N3a	T3	Stage IIIC	TCGA-A2-A4RY.2D6815B5-7704-4D67-93D1-78EDD924F131.pdf		0		0		0		0		2		0		98		85	TUMOR FREE						YES	YES	No	90-99%		YES	Primary Tumor	01		7th		YES	NO	A2	Breast	A	LIVING	2012			TCGA-A2-A4RY-01A-31R-A25Z-13	TCGA-A2-A4RY-01A-31R-A25Z-13			TCGA-A2-A4RY-01A-31D-A25Q-09			51d9b960-276a-4c7b-b135-f2f8c05f3bd6	fa655127-d3c8-4a16-a5cb-b1b4853a6adb	TCGA-A2-A4RY-01A-31D-A25N-01	51d9b960-276a-4c7b-b135-f2f8c05f3bd6	TCGA-A2-A4RY-01A-31D-A268-05	TCGA-A2-A4RY-01		51d9b960-276a-4c7b-b135-f2f8c05f3bd6	51d9b960-276a-4c7b-b135-f2f8c05f3bd6	TCGA-A2-A4RY-01A-31D-A25N-01		TCGA-A2-A4RY-01		fa655127-d3c8-4a16-a5cb-b1b4853a6adb	
TCGA-A2-A4S0-01																													0	TCGA-A2-A4S0-01	706	0										TCGA-A2-A4S0	706	0	706	Breast	TCGA Breast Cancer	breast invasive carcinoma					77	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A4S0-F59120		Positive	3 Point Scale	2+	3 Point Scale		Positive	Simple Mastectomy		YES			-28416	159		0	706							90-99%					2014-5-1	FEMALE					1+					Mucinous Carcinoma		No		C50.9	8480/3	C50.9	3+	YES		Core needle biopsy	960	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	true	M0	N0	T2	Stage IIA	TCGA-A2-A4S0.0118D9AE-B923-4EEF-BBBC-82D559763FF9.pdf		40		25		0		10		0		20		80		80	TUMOR FREE						NO	YES	No	90-99%		NO	Primary Tumor	01		7th		YES	NO	A2	Breast	A	LIVING	2012			TCGA-A2-A4S0-01A-21R-A25Z-13	TCGA-A2-A4S0-01A-21R-A25Z-13			TCGA-A2-A4S0-01A-21D-A25Q-09			81e350d9-7e2f-4650-9871-54ed2d5a5ab3	e3fdbf1e-1a63-4a7d-9f84-e36e40ffd4f3	TCGA-A2-A4S0-01A-21D-A25N-01	81e350d9-7e2f-4650-9871-54ed2d5a5ab3	TCGA-A2-A4S0-01A-21D-A268-05	TCGA-A2-A4S0-01		81e350d9-7e2f-4650-9871-54ed2d5a5ab3	81e350d9-7e2f-4650-9871-54ed2d5a5ab3	TCGA-A2-A4S0-01A-21D-A25N-01		TCGA-A2-A4S0-01		e3fdbf1e-1a63-4a7d-9f84-e36e40ffd4f3	
TCGA-A2-A4S1-01																													0	TCGA-A2-A4S1-01	820	0										TCGA-A2-A4S1	820	0	820	Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A4S1-F58925		Positive	3 Point Scale				Negative	Lumpectomy		YES			-24353	282		0	820							<10%					2014-4-28	FEMALE										Other  specify	Metaplastic	No		C50.9	8575/3	C50.9	1+	YES		Core needle biopsy	350	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	true	M0	N0	T2	Stage IIA	TCGA-A2-A4S1.041580F0-700A-4A47-83A6-207ED267E844.pdf		40		20		10		20		0		20		70		70	TUMOR FREE						NO	YES	No			YES	Primary Tumor	01		7th		YES	NO	A2	Breast	A	LIVING	2012			TCGA-A2-A4S1-01A-21R-A25Z-13	TCGA-A2-A4S1-01A-21R-A25Z-13			TCGA-A2-A4S1-01A-21D-A25Q-09			3d9d61f1-ad25-45a5-b0be-8698dc4b8c68	fbe3afb5-4dcf-488b-b118-6c8adae6e740	TCGA-A2-A4S1-01A-21D-A25N-01	3d9d61f1-ad25-45a5-b0be-8698dc4b8c68	TCGA-A2-A4S1-01A-21D-A268-05	TCGA-A2-A4S1-01		3d9d61f1-ad25-45a5-b0be-8698dc4b8c68	3d9d61f1-ad25-45a5-b0be-8698dc4b8c68	TCGA-A2-A4S1-01A-21D-A25N-01		TCGA-A2-A4S1-01		fbe3afb5-4dcf-488b-b118-6c8adae6e740	
TCGA-A2-A4S2-01																													0	TCGA-A2-A4S2-01	643	0										TCGA-A2-A4S2	643	0	643	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Right	Axillary lymph node dissection alone		TCGA-A2-A4S2-F59085		Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-22936	112		0	643							90-99%					2014-4-30	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8524/3	C50.9	2+	YES		Core needle biopsy	1390	NO	Negative		NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	5	0	true	M0	N2	T3	Stage IIIA	TCGA-A2-A4S2.4A5630FF-0ADC-4E69-B22A-02F1F34F61F9.pdf		40		20		0		20		0		40		60		60	TUMOR FREE						YES	YES	No	90-99%		YES	Primary Tumor	01		7th		YES	NO	A2	Breast	A	LIVING	2012			TCGA-A2-A4S2-01A-12R-A25Z-13	TCGA-A2-A4S2-01A-12R-A25Z-13			TCGA-A2-A4S2-01A-12D-A25Q-09			2c6af71f-b876-4475-a94a-61e99075123f	8c74f209-9286-4af4-8c65-61801d2aa47e	TCGA-A2-A4S2-01A-12D-A25N-01	2c6af71f-b876-4475-a94a-61e99075123f	TCGA-A2-A4S2-01A-12D-A268-05	TCGA-A2-A4S2-01		2c6af71f-b876-4475-a94a-61e99075123f	2c6af71f-b876-4475-a94a-61e99075123f	TCGA-A2-A4S2-01A-12D-A25N-01		TCGA-A2-A4S2-01		8c74f209-9286-4af4-8c65-61801d2aa47e	
TCGA-A2-A4S3-01																													0	TCGA-A2-A4S3-01	666	0										TCGA-A2-A4S3	666	0	666	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A4S3-F59128		Positive					Positive	Modified Radical Mastectomy		NO			-21762			0	666							90-99%					2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative		NO	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	2	0		M0	N1a	T2	Stage IIB																		TUMOR FREE							YES	No	90-99%			Primary Tumor	01		7th		YES	NO	A2	Breast		LIVING	2012			TCGA-A2-A4S3-01A-21R-A25Z-13	TCGA-A2-A4S3-01A-21R-A25Z-13			TCGA-A2-A4S3-01A-21D-A25Q-09			a26b4751-91a2-420c-9ff3-7df7361939fd	c3744133-3c3e-4f65-b3cc-3ddadc486384	TCGA-A2-A4S3-01A-21D-A25N-01	a26b4751-91a2-420c-9ff3-7df7361939fd	TCGA-A2-A4S3-01A-21D-A268-05	TCGA-A2-A4S3-01		a26b4751-91a2-420c-9ff3-7df7361939fd	a26b4751-91a2-420c-9ff3-7df7361939fd	TCGA-A2-A4S3-01A-21D-A25N-01		TCGA-A2-A4S3-01		c3744133-3c3e-4f65-b3cc-3ddadc486384	
TCGA-A7-A0CD-01	Stage IA	66	3	Stage I	372		Positive	FEMALE	Negative	4	3	3	Negative	M0	Negative	N0	372	0	LumA	Luminal A	Positive	LumA	-10	-3	followup	T1	T1	LIVING	0	TCGA-A7-A0CD-01	1165	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A7-A0CD	1165	0	1165	Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Left	Sentinel node biopsy alone		TCGA-A7-A0CD-F39827		Positive					Positive	Lumpectomy		NO			-24242	157		0	1165							90-99%			4.0		2013-2-4	FEMALE				PathVysion HER-2 D Probe Kit	2+	279	4.6	1.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	420	NO	Equivocal	Negative	NO	2	Negative	Indeterminate (neither Pre or Postmenopausal)																		3	2								NO	0		false	M0	N0	T1	Stage I	TCGA-A7-A0CD.DEB67EB8-155C-4ACF-B3D4-595E4CBE2E5C.pdf	9	7	0	0	2	2	0	0	15	7	33	26	50	65	80	85	TUMOR FREE						YES		Yes	70-79%		YES	Primary Tumor	01		6th	YES	YES	NO	A7	Breast	A	LIVING	2009	TCGA-A7-A0CD-01A-11W-A019-09	TCGA-A7-A0CD-01		TCGA-A7-A0CD-01A-11R-A010-13	TCGA-A7-A0CD-01A-11W-A019-09	0466e496-e1c2-4cd0-ab1d-34babdbfc80f	TCGA-A7-A0CD-01A-11W-A019-09	TCGA-A7-A0CD-01A-21-A13A-20	TCGA-A7-A0CD-01A-11W-A019-09	1edf44b5-61ba-47cd-81ed-b586ae81cb32	a82e297d-8342-44f1-b7e8-e42872c834fa	TCGA-A7-A0CD-01A-11D-A011-01	1edf44b5-61ba-47cd-81ed-b586ae81cb32		TCGA-A7-A0CD-01	TCGA-A7-A0CD-01A-11R-A00Z-07	1edf44b5-61ba-47cd-81ed-b586ae81cb32	1edf44b5-61ba-47cd-81ed-b586ae81cb32	TCGA-A7-A0CD-01A-11D-A011-01	TCGA-A7-A0CD-01	TCGA-A7-A0CD-01	TCGA-A7-A0CD-01A-11D-A00Y-05	a82e297d-8342-44f1-b7e8-e42872c834fa	TCGA-A7-A0CD-01A-11R-A010-13
TCGA-A7-A0CE-01	Stage IIA	57	1	Stage IIA	309		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	309	0	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA-A7-A0CE-01	1074	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-A7-A0CE	1074	0	1074	Breast	TCGA Breast Cancer	breast invasive carcinoma					57	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A0CE-F39153		Negative					Negative	Lumpectomy		YES			-20863	129		0	1074							<10%			2.9		2013-1-14	FEMALE	Vysis AutoVysion System			PathVysion	2+	389	3.2	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	330	NO	Equivocal	Negative	NO	1	Negative	Indeterminate (neither Pre or Postmenopausal)																		5	5								NO	0	0	false	M0	N0 (i-)	T2	Stage IIA	TCGA-A7-A0CE.8A853D7F-979F-4112-9659-1FDE84EF5102.pdf	6	12	1	1	17	20	1	1	0	0	13	15	70	65	87	80	TUMOR FREE						YES		No	<10%		YES	Primary Tumor	01			YES	YES	NO	A7	Breast	A	LIVING	2009	TCGA-A7-A0CE-01A-11W-A019-09	TCGA-A7-A0CE-01		TCGA-A7-A0CE-01A-11R-A010-13	TCGA-A7-A0CE-01A-11W-A019-09	7a0dcaa3-a8ab-4437-b642-11872fbf6456	TCGA-A7-A0CE-01A-11W-A019-09	TCGA-A7-A0CE-01A-21-A13A-20	TCGA-A7-A0CE-01A-11W-A019-09	e8ef8b75-7c0c-4a42-9a10-3789b6afa5d2	f79ed0dc-7704-4967-b62c-0112de377fc3	TCGA-A7-A0CE-01A-11D-A011-01	e8ef8b75-7c0c-4a42-9a10-3789b6afa5d2		TCGA-A7-A0CE-01	TCGA-A7-A0CE-01A-11R-A00Z-07	e8ef8b75-7c0c-4a42-9a10-3789b6afa5d2	e8ef8b75-7c0c-4a42-9a10-3789b6afa5d2	TCGA-A7-A0CE-01A-11D-A011-01	TCGA-A7-A0CE-01	TCGA-A7-A0CE-01	TCGA-A7-A0CE-01A-11D-A00Y-05	f79ed0dc-7704-4967-b62c-0112de377fc3	TCGA-A7-A0CE-01A-11R-A010-13
TCGA-A7-A0CE-11		57			309			FEMALE									309	0							followup			LIVING	0	TCGA-A7-A0CE-11	1074	0		C4-BRCA/Basal							mutation cluster 5	TCGA-A7-A0CE	1074	0	1074	Breast	TCGA Breast Cancer	breast invasive carcinoma					57	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A0CE-F39153		Negative					Negative	Lumpectomy		YES			-20863	129		0	1074							<10%			2.9		2013-1-14	FEMALE	Vysis AutoVysion System			PathVysion	2+	389	3.2	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	290	NO	Equivocal	Negative	NO	1	Negative	Indeterminate (neither Pre or Postmenopausal)																											NO	0	0	false	M0	N0 (i-)	T2	Stage IIA		2	3	2	0			0	0	100	100			0	0			TUMOR FREE						YES		No	<10%		YES	Solid Tissue Normal	11			YES	YES	NO	A7	Breast	A	LIVING	2009				TCGA-A7-A0CE-11A-21R-A090-13						2d5351f1-e9d7-44a3-ae43-f595a0151516			2d5351f1-e9d7-44a3-ae43-f595a0151516	TCGA-A7-A0CE-11A-21D-A10Q-05		TCGA-A7-A0CE-11A-21R-A089-07	2d5351f1-e9d7-44a3-ae43-f595a0151516	2d5351f1-e9d7-44a3-ae43-f595a0151516						TCGA-A7-A0CE-11A-21R-A090-13
TCGA-A7-A0CG-01	Stage IIA	78	2	Stage IIA	230		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	230	0	LumA	Luminal A	Negative	ReacI	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-A7-A0CG-01	1043	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 7	mutation cluster 4	TCGA-A7-A0CG	1043	0	1043	Breast	TCGA Breast Cancer	breast invasive carcinoma					78	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A0CG-F39202		Positive					Negative	Lumpectomy		YES			-28596	93		0	1043							90-99%					2013-1-15	FEMALE					1+					Mixed Histology (please specify)	Mixed infiltrating lobular and grade 1 ductal carcinoma	No		C50.9	8522/3	C50.9		YES		Core needle biopsy	200	NO	Negative		NO	5	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	7								NO	0	0	false	M0	N0 (i-)	T2	Stage IIA	TCGA-A7-A0CG.2BE28F5D-2DBB-476F-9AFF-6B2103ECF0CE.pdf	12	17	0	0	2	2	0	0	10	18	18	15	70	65	80	75	TUMOR FREE						NO		No	<10%		YES	Primary Tumor	01			NO	YES	NO	A7	Breast	A	LIVING	2010	TCGA-A7-A0CG-01A-11W-A019-09	TCGA-A7-A0CG-01		TCGA-A7-A0CG-01A-11R-A038-13	TCGA-A7-A0CG-01A-11W-A019-09	0b26254d-1199-487f-8cc1-e99d2dc58737	TCGA-A7-A0CG-01A-11W-A019-09	TCGA-A7-A0CG-01A-21-A13A-20	TCGA-A7-A0CG-01A-11W-A019-09	2b0e2135-a1e4-4785-8b9f-b4cf7b36d938	5c6ed3a7-7ba7-44e2-b33f-dc104789b0eb	TCGA-A7-A0CG-01A-11D-A011-01	2b0e2135-a1e4-4785-8b9f-b4cf7b36d938		TCGA-A7-A0CG-01	TCGA-A7-A0CG-01A-12R-A056-07	2b0e2135-a1e4-4785-8b9f-b4cf7b36d938	2b0e2135-a1e4-4785-8b9f-b4cf7b36d938	TCGA-A7-A0CG-01A-11D-A011-01	TCGA-A7-A0CG-01	TCGA-A7-A0CG-01	TCGA-A7-A0CG-01A-11D-A00Y-05	5c6ed3a7-7ba7-44e2-b33f-dc104789b0eb	TCGA-A7-A0CG-01A-11R-A038-13
TCGA-A7-A0CH-01	Stage IIA	79	2	Stage IIA	232			FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	232	0	LumA	Luminal A		LumA	-12	-3	followup	T_Other	T2	LIVING	0	TCGA-A7-A0CH-01	1079	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A7-A0CH	1079	0	1079	Breast	TCGA Breast Cancer	breast invasive carcinoma					79	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-A7-A0CH-F39148								Simple Mastectomy		YES			-29104	121		0	1079												2013-1-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	360	NO			NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	0	0	false	M0	N0 (i-)	T2	Stage IIA	TCGA-A7-A0CH.F70DA7E5-2AB3-487F-8B2C-72EEE91E58E0.pdf	6	8	0	0	2	3	0	0	0	0	23	27	75	70	80	70	TUMOR FREE						YES		No			NO	Primary Tumor	01			YES	YES	NO	A7	Breast	A	LIVING	2009	TCGA-A7-A0CH-01A-21W-A019-09	TCGA-A7-A0CH-01		TCGA-A7-A0CH-01A-21R-A038-13		d44c8f0f-090f-417f-b80e-ff5da42138d0	TCGA-A7-A0CH-01A-21W-A019-09	TCGA-A7-A0CH-01A-11-A13A-20	TCGA-A7-A0CH-01A-21W-A019-09	0b225e38-d4c8-4cb5-a668-316894ab858f	05ee789e-dc0f-4f44-a238-84ec5a8207ab	TCGA-A7-A0CH-01A-21D-A011-01	0b225e38-d4c8-4cb5-a668-316894ab858f		TCGA-A7-A0CH-01	TCGA-A7-A0CH-01A-21R-A00Z-07	0b225e38-d4c8-4cb5-a668-316894ab858f	0b225e38-d4c8-4cb5-a668-316894ab858f	TCGA-A7-A0CH-01A-21D-A011-01	TCGA-A7-A0CH-01	TCGA-A7-A0CH-01	TCGA-A7-A0CH-01A-21D-A00Y-05	05ee789e-dc0f-4f44-a238-84ec5a8207ab	TCGA-A7-A0CH-01A-21R-A038-13
TCGA-A7-A0CH-11		79			232			FEMALE									232	0							followup			LIVING	0	TCGA-A7-A0CH-11	1079	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-A7-A0CH	1079	0	1079	Breast	TCGA Breast Cancer	breast invasive carcinoma					79	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-A7-A0CH-F39148								Simple Mastectomy		YES			-29104	121		0	1079												2013-1-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	390	NO			NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	M0	N0 (i-)	T2	Stage IIA		1	35	0	2	0		0	0	10	100	90		0	0	0		TUMOR FREE						YES		No			NO	Solid Tissue Normal	11			YES	YES	NO	A7	Breast	A	LIVING	2009										a4b19504-8f04-48db-b88b-d76b8b3c3881			a4b19504-8f04-48db-b88b-d76b8b3c3881	TCGA-A7-A0CH-11A-32D-A10Q-05		TCGA-A7-A0CH-11A-32R-A089-07	a4b19504-8f04-48db-b88b-d76b8b3c3881	a4b19504-8f04-48db-b88b-d76b8b3c3881						
TCGA-A7-A0CJ-01	Stage IIA	57	1	Stage IIA	409		Positive	FEMALE	Negative	4	3	4	Negative	M0	Negative	N0	409	0	LumB	Luminal B	Positive	LumA/B	-6	-3	followup	T_Other	T2	LIVING	0	TCGA-A7-A0CJ-01	931	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 3	TCGA-A7-A0CJ	931	0	931	Breast	TCGA Breast Cancer	breast invasive carcinoma					57	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A0CJ-F39740		Positive				Other	Positive	Lumpectomy	Re-excision of the inferior margin	YES			-21014	36		0	931							90-99%					2013-1-31	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	310	NO	Negative		NO	1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	2								NO	0	0	false	M0	N0 (i-)	T2	Stage IIA	TCGA-A7-A0CJ.019F390D-7479-4CDC-8C82-45A27910E782.pdf	11	9	0	0	5	5	0	0	0	0	17	17	78	78	75	80	TUMOR FREE						YES		No	70-79%		YES	Primary Tumor	01			YES	YES	NO	A7	Breast	A	LIVING	2010	TCGA-A7-A0CJ-01A-21W-A019-09	TCGA-A7-A0CJ-01		TCGA-A7-A0CJ-01A-21R-A010-13	TCGA-A7-A0CJ-01A-21W-A019-09	d9f09beb-2d34-4507-a3bf-039786bba9a9	TCGA-A7-A0CJ-01A-21W-A019-09	TCGA-A7-A0CJ-01A-11-A13A-20	TCGA-A7-A0CJ-01A-21W-A019-09	62de6863-5d60-473c-8e13-e300b0640ed7	363b439f-0335-48f6-838b-e603c24ff1e3	TCGA-A7-A0CJ-01A-21D-A011-01	62de6863-5d60-473c-8e13-e300b0640ed7		TCGA-A7-A0CJ-01	TCGA-A7-A0CJ-01A-21R-A00Z-07	62de6863-5d60-473c-8e13-e300b0640ed7	62de6863-5d60-473c-8e13-e300b0640ed7	TCGA-A7-A0CJ-01A-21D-A011-01	TCGA-A7-A0CJ-01	TCGA-A7-A0CJ-01	TCGA-A7-A0CJ-01A-21D-A00Y-05	363b439f-0335-48f6-838b-e603c24ff1e3	TCGA-A7-A0CJ-01A-21R-A010-13
TCGA-A7-A0D9-01	Stage IIA	37	4	Stage IIA	272		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	272	0	LumA	Luminal A	Negative	ReacII	-3	-3	followup	T_Other	T2	LIVING	0	TCGA-A7-A0D9-01	1139	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 4	TCGA-A7-A0D9	1139	0	1139	Breast	TCGA Breast Cancer	breast invasive carcinoma					37	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-A7-A0D9-F39771		Positive					Negative	Simple Mastectomy		YES			-13836	173		0	1139							90-99%					2013-2-1	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1760	NO	Negative		NO	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	5								NO	0	0	false	M0	N0 (i-)	T2	Stage IIA	TCGA-A7-A0D9.7D5763F7-7284-4AF5-BBFC-5D8B5CB7F495.pdf	4	1	0	0	1	0	0	0	15	5	10	35	74	60	90	65	TUMOR FREE						YES		No	<10%		NO	Primary Tumor	01			YES	YES	NO	A7	Breast	A	LIVING	2009	TCGA-A7-A0D9-01A-31W-A071-09	TCGA-A7-A0D9-01		TCGA-A7-A0D9-01A-31R-A057-13	TCGA-A7-A0D9-01A-31W-A071-09	8cbc03f3-4f0a-4a76-99cd-3a8479558cb1	TCGA-A7-A0D9-01A-31W-A071-09	TCGA-A7-A0D9-01A-21-A13C-20	TCGA-A7-A0D9-01A-31W-A071-09	755912f4-6725-4b7b-84b1-518c7529a176	3338d4d6-755c-446a-ae7f-7da3bfaf68af	TCGA-A7-A0D9-01A-31D-A059-01	755912f4-6725-4b7b-84b1-518c7529a176	TCGA-A7-A0D9-01A-31D-A10P-05	TCGA-A7-A0D9-01	TCGA-A7-A0D9-01A-31R-A056-07	755912f4-6725-4b7b-84b1-518c7529a176	755912f4-6725-4b7b-84b1-518c7529a176	TCGA-A7-A0D9-01A-31D-A059-01	TCGA-A7-A0D9-01	TCGA-A7-A0D9-01		3338d4d6-755c-446a-ae7f-7da3bfaf68af	TCGA-A7-A0D9-01A-31R-A057-13
TCGA-A7-A0D9-11		37			272			FEMALE									272	0	Normal						followup			LIVING	0	TCGA-A7-A0D9-11	1139	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-A7-A0D9	1139	0	1139	Breast	TCGA Breast Cancer	breast invasive carcinoma					37	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-A7-A0D9-F39771		Positive					Negative	Simple Mastectomy		YES			-13836	173		0	1139							90-99%					2013-2-1	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1830	NO	Negative		NO	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0	0	false	M0	N0 (i-)	T2	Stage IIA			1		5		0		0		0		100		0		0	TUMOR FREE						YES		No	<10%		NO	Solid Tissue Normal	11			YES	YES	NO	A7	Breast	A	LIVING	2009				TCGA-A7-A0D9-11A-53R-A090-13						fc5bb351-c5f7-4d8c-850c-13e69e13e04d			fc5bb351-c5f7-4d8c-850c-13e69e13e04d	TCGA-A7-A0D9-11A-53D-A10Q-05		TCGA-A7-A0D9-11A-53R-A089-07	fc5bb351-c5f7-4d8c-850c-13e69e13e04d	fc5bb351-c5f7-4d8c-850c-13e69e13e04d						TCGA-A7-A0D9-11A-53R-A090-13
TCGA-A7-A0DA-01	Stage IIA	62	1	Stage IIA	373		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	373	0	Basal	Basal-like	Negative	X	-13	0	followup	T_Other	T2	LIVING	0	TCGA-A7-A0DA-01	1085	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA c1uster 9	cluster 4	mutation cluster 13	TCGA-A7-A0DA	1085	0	1085	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A0DA-F38487		Negative					Negative	Lumpectomy					-22708	177		0	1085												2012-12-14	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	350	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4								NO	0		false	M0	N0 (i-)	T2	Stage IIA	TCGA-A7-A0DA.69AC5937-3FFD-40FB-9922-79DB3CED7510.pdf		2		0		3		0		20		47		30		75	TUMOR FREE						YES		No			YES	Primary Tumor	01			YES	YES	NO	A7	Breast	A	LIVING	2009	TCGA-A7-A0DA-01A-31D-A10Y-09	TCGA-A7-A0DA-01	TCGA-A7-A0DA-01A-31R-A114-13	TCGA-A7-A0DA-01A-31R-A114-13	TCGA-A7-A0DA-01A-31D-A10Y-09	190fcd17-0d7a-4d28-9958-492d56360678	TCGA-A7-A0DA-01A-31D-A10Y-09	TCGA-A7-A0DA-01A-11-A13C-20	TCGA-A7-A0DA-01A-31D-A10Y-09	9d04c180-7c23-490e-92cf-c018629b8b7f	91c8c373-e923-4e7f-b8b3-2417e92760c7	TCGA-A7-A0DA-01A-31D-A111-01	9d04c180-7c23-490e-92cf-c018629b8b7f		TCGA-A7-A0DA-01	TCGA-A7-A0DA-01A-31R-A115-07	9d04c180-7c23-490e-92cf-c018629b8b7f	9d04c180-7c23-490e-92cf-c018629b8b7f	TCGA-A7-A0DA-01A-31D-A111-01	TCGA-A7-A0DA-01	TCGA-A7-A0DA-01	TCGA-A7-A0DA-01A-31D-A112-05	91c8c373-e923-4e7f-b8b3-2417e92760c7	
TCGA-A7-A0DB-01	Stage IIA	56	2	Stage IIA	266		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	266	0	LumA	Luminal A	Positive	LumA	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-A7-A0DB-01	1007	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 4	mutation cluster 4	TCGA-A7-A0DB	1007	0	1007	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A0DB-F38479		Positive					Positive	Simple Mastectomy		YES			-20570	167		0	1007				FPPP			90-99%					2012-12-14	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	300	NO	Negative		NO	4	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	0	0	false	M0	N0 (i-)	T2	Stage IIA	TCGA-A7-A0DB.511CB4C5-FCEE-4EC4-98A4-4DD32ECA83C3.pdf	1	1	0	0	1	0	0	0	0	3	14	27	85	70	90	80	TUMOR FREE						YES		No	60-69%	TCGA	YES	Primary Tumor	01			YES	YES	NO	A7	Breast	A	LIVING	2009	TCGA-A7-A0DB-01A-11W-A019-09	TCGA-A7-A0DB-01	TCGA-A7-A0DB-01A-11R-A27D-13,TCGA-A7-A0DB-01C-02R-A27D-13	TCGA-A7-A0DB-01A-11R-A010-13,TCGA-A7-A0DB-01A-11R-A27D-13,TCGA-A7-A0DB-01C-02R-A27D-13	TCGA-A7-A0DB-01A-11W-A019-09	74072dd9-7503-4152-9734-65dcb4bca217	TCGA-A7-A0DB-01A-11W-A019-09,TCGA-A7-A0DB-01A-11D-A272-09	TCGA-A7-A0DB-01A-21-A13C-20	TCGA-A7-A0DB-01A-11W-A019-09	0c74bde4-0411-4cfd-9c60-d8eaf8a09629	8428a325-211e-4a7d-99df-ef5cf6e57c77	TCGA-A7-A0DB-01A-11D-A011-01	0c74bde4-0411-4cfd-9c60-d8eaf8a09629		TCGA-A7-A0DB-01	TCGA-A7-A0DB-01A-11R-A00Z-07	0c74bde4-0411-4cfd-9c60-d8eaf8a09629	0c74bde4-0411-4cfd-9c60-d8eaf8a09629	TCGA-A7-A0DB-01A-11D-A011-01	TCGA-A7-A0DB-01	TCGA-A7-A0DB-01	TCGA-A7-A0DB-01A-11D-A00Y-05	8428a325-211e-4a7d-99df-ef5cf6e57c77	TCGA-A7-A0DB-01A-11R-A010-13
TCGA-A7-A0DB-11		56			266			FEMALE									266	0	Normal						followup			LIVING	0	TCGA-A7-A0DB-11	1007	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-A7-A0DB	1007	0	1007	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A0DB-F38479		Positive					Positive	Simple Mastectomy		YES			-20570	167		0	1007				FPPP			90-99%					2012-12-14	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	400	NO	Negative		NO	4	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	M0	N0 (i-)	T2	Stage IIA		1	0	0	0	0		0	0	0	100	100		0	0	0		TUMOR FREE						YES		No	60-69%	TCGA	YES	Solid Tissue Normal	11			YES	YES	NO	A7	Breast	A	LIVING	2009				TCGA-A7-A0DB-11A-33R-A090-13						3f3bdfbb-3490-42e4-9511-9df4b8a126a3			3f3bdfbb-3490-42e4-9511-9df4b8a126a3	TCGA-A7-A0DB-11A-33D-A093-05		TCGA-A7-A0DB-11A-33R-A089-07	3f3bdfbb-3490-42e4-9511-9df4b8a126a3	3f3bdfbb-3490-42e4-9511-9df4b8a126a3						TCGA-A7-A0DB-11A-33R-A090-13
TCGA-A7-A0DC-01	Stage IA	63		Stage I	386		Positive	FEMALE	Negative				Negative	M0	Negative	N0	386	0	LumA		Negative				followup	T1	T1	LIVING	0	TCGA-A7-A0DC-01	906	0					BRCA nonbasal-like c8					TCGA-A7-A0DC	906	0	906	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A0DC-F40607		Positive					Negative	Simple Mastectomy		YES			-23294	238		0	906							90-99%					2013-2-25	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	200	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	M0	N0 (i-)	T1c	Stage IA	TCGA-A7-A0DC.43D912CD-BD3C-4E69-B28B-AB2E173C0BC2.pdf	1	1	0	0	1	0	0	0	0	0	29	15	70	85	70	85	TUMOR FREE						YES		No	<10%		YES	Primary Tumor	01			YES	YES	NO	A7	Breast	A	LIVING	2009			TCGA-A7-A0DC-01B-04R-A22P-13	TCGA-A7-A0DC-01A-11R-A010-13,TCGA-A7-A0DC-01B-04R-A22P-13		31b94bd4-e63e-4e52-b366-3bafe08524e7	TCGA-A7-A0DC-01B-04D-A22N-09	TCGA-A7-A0DC-01A-21-A13C-20		43bbd0f7-87d7-472f-ad3e-e016df3d5d89	5bfd4ac0-78fb-4ee5-ac75-7e20a268685c,e781547e-415c-4656-b656-c1df8cc22fc3		43bbd0f7-87d7-472f-ad3e-e016df3d5d89	TCGA-A7-A0DC-01B-04D-A22R-05		TCGA-A7-A0DC-01A-11R-A00Z-07	43bbd0f7-87d7-472f-ad3e-e016df3d5d89	43bbd0f7-87d7-472f-ad3e-e016df3d5d89				TCGA-A7-A0DC-01A-11D-A00Y-05	5bfd4ac0-78fb-4ee5-ac75-7e20a268685c,e781547e-415c-4656-b656-c1df8cc22fc3	TCGA-A7-A0DC-01A-11R-A010-13
TCGA-A7-A0DC-11		63			386			FEMALE									386	0	Normal						followup			LIVING	0	TCGA-A7-A0DC-11	906	0										TCGA-A7-A0DC	906	0	906	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A0DC-F40607		Positive					Negative	Simple Mastectomy		YES			-23294	238		0	906							90-99%					2013-2-25	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	470	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	M0	N0 (i-)	T1c	Stage IA			1		0		0		0		0		100		0		0	TUMOR FREE						YES		No	<10%		YES	Solid Tissue Normal	11			YES	YES	NO	A7	Breast	A	LIVING	2009				TCGA-A7-A0DC-11A-41R-A090-13						cb3f974e-6bce-4757-a350-aef8e7925086			cb3f974e-6bce-4757-a350-aef8e7925086	TCGA-A7-A0DC-11A-41D-A10Q-05		TCGA-A7-A0DC-11A-41R-A089-07	cb3f974e-6bce-4757-a350-aef8e7925086	cb3f974e-6bce-4757-a350-aef8e7925086						TCGA-A7-A0DC-11A-41R-A090-13
TCGA-A7-A13D-01	Stage IIA	46	3	Stage IIA	267		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	267	0	Basal	Basal-like	Positive	ReacII	-13	0	followup	T_Other	T2	LIVING	0	TCGA-A7-A13D-01	965	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 2	TCGA-A7-A13D	965	0	965	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A7-A13D-F39794	Negative	Negative				Lumpectomy	Positive	Lumpectomy		NO			-17070	240		0	965				FPPP			<10%			1.8		2013-2-1	FEMALE				PathVysion HER-2 D Probe Kit	2+	197	1.9	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	240	NO	Equivocal	Negative	NO	4	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5								NO	0		false	M0	N0 (i-)	T2	Stage IIA	TCGA-A7-A13D.6F3784B2-4A75-447C-9EAE-F146461C737E.pdf	0	0	0	0	20	20	0	0	10	0	40	5	30	75	50	70	TUMOR FREE						YES		No	<10%	TCGA	YES	Primary Tumor	01			YES	YES	NO	A7	Breast	A	LIVING	2010	TCGA-A7-A13D-01A-13D-A12Q-09	TCGA-A7-A13D-01	TCGA-A7-A13D-01B-04R-A27D-13,TCGA-A7-A13D-01A-13R-A12O-13,TCGA-A7-A13D-01A-13R-A27D-13	TCGA-A7-A13D-01B-04R-A27D-13,TCGA-A7-A13D-01A-13R-A12O-13,TCGA-A7-A13D-01A-13R-A27D-13	TCGA-A7-A13D-01A-13D-A12Q-09	bf4b9dc3-df06-4735-b9b6-4cc8240c93b7	TCGA-A7-A13D-01A-13D-A12Q-09,TCGA-A7-A13D-01A-13D-A272-09	TCGA-A7-A13D-01A-21-A13E-20	TCGA-A7-A13D-01A-13D-A12Q-09	3af60b03-66c3-48a1-a42b-1e05fdb529c4	498cc80a-ec3c-4d05-839a-b3ea73ebc774	TCGA-A7-A13D-01A-13D-A12N-01	3af60b03-66c3-48a1-a42b-1e05fdb529c4	TCGA-A7-A13D-01A-13D-A12R-05	TCGA-A7-A13D-01	TCGA-A7-A13D-01A-13R-A12P-07	3af60b03-66c3-48a1-a42b-1e05fdb529c4	3af60b03-66c3-48a1-a42b-1e05fdb529c4	TCGA-A7-A13D-01A-13D-A12N-01	TCGA-A7-A13D-01	TCGA-A7-A13D-01		498cc80a-ec3c-4d05-839a-b3ea73ebc774	
TCGA-A7-A13E-01	Stage IIB	62	1	No_Conversion	326		Positive	FEMALE	Negative				Negative	M0	Positive	N1	326	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	1	TCGA-A7-A13E-01	614	1	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5		TCGA-A7-A13E	556	1	614	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	YES	NO		62	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A13E-F30405		Positive					Negative	Lumpectomy		NO			-22690	220	614	0	326			556	FPPP			20-29%			3.0	Additional New Tumor Event	2012-4-9	FEMALE				PathVysion HER-2 D Probe Kit	2+	561	3.2	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	730	NO	Equivocal	Negative		12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative	1+		Negative												Negative	4	5				Other, specify	Distant Metastasis	Lung, Bone, Liver, Brain and Skin Nodules		YES	2		false	MX	N1	T2	Stage IIB	TCGA-A7-A13E.2180850C-CC8D-4376-B2EE-1ADC3F5B3EC1.pdf	0	0	0	0	0	0	0	0	0	0	5	0	95	100	95	75	WITH TUMOR								No	<10%	TCGA	NO	Primary Tumor	01			YES	YES	NO	A7	Breast	A	DECEASED	2010		TCGA-A7-A13E-01	TCGA-A7-A13E-01A-11R-A27D-13,TCGA-A7-A13E-01A-11R-A12O-13,TCGA-A7-A13E-01B-06R-A27D-13	TCGA-A7-A13E-01A-11R-A27D-13,TCGA-A7-A13E-01A-11R-A12O-13,TCGA-A7-A13E-01B-06R-A27D-13		724b7cef-9bb6-4c6b-8c78-b632f910fe85	TCGA-A7-A13E-01A-11D-A12Q-09,TCGA-A7-A13E-01A-11D-A272-09	TCGA-A7-A13E-01A-21-A13E-20		b7f491a9-eddf-43b1-9baf-862db2d50383	2518f7da-afba-4a61-9ff1-41bc919e10af	TCGA-A7-A13E-01A-11D-A12N-01	b7f491a9-eddf-43b1-9baf-862db2d50383	TCGA-A7-A13E-01A-11D-A12R-05	TCGA-A7-A13E-01	TCGA-A7-A13E-01A-11R-A12P-07	b7f491a9-eddf-43b1-9baf-862db2d50383	b7f491a9-eddf-43b1-9baf-862db2d50383	TCGA-A7-A13E-01A-11D-A12N-01	TCGA-A7-A13E-01	TCGA-A7-A13E-01		2518f7da-afba-4a61-9ff1-41bc919e10af	
TCGA-A7-A13E-11		62			326			FEMALE									326	0	Normal						followup			LIVING	1	TCGA-A7-A13E-11	614	1		C4-BRCA/Basal								TCGA-A7-A13E	556	1	614	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	YES	NO		62	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A13E-F30405		Positive					Negative	Lumpectomy		NO			-22690	220	614	0	326			556	FPPP			20-29%			3.0	Additional New Tumor Event	2012-4-9	FEMALE				PathVysion HER-2 D Probe Kit	2+	561	3.2	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	770	NO	Equivocal	Negative		12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative	1+		Negative												Negative						Other, specify	Distant Metastasis	Lung, Bone, Liver, Brain and Skin Nodules		YES	2		false	MX	N1	T2	Stage IIB			0		0		0		0		100		0		0		0	WITH TUMOR								No	<10%	TCGA	NO	Solid Tissue Normal	11			YES	YES	NO	A7	Breast	A	DECEASED	2010			TCGA-A7-A13E-11A-61R-A12O-13	TCGA-A7-A13E-11A-61R-A12O-13						80efdbaa-067b-4018-89b2-b8869bfb9163			80efdbaa-067b-4018-89b2-b8869bfb9163	TCGA-A7-A13E-11A-61D-A12R-05		TCGA-A7-A13E-11A-61R-A12P-07	80efdbaa-067b-4018-89b2-b8869bfb9163	80efdbaa-067b-4018-89b2-b8869bfb9163						
TCGA-A7-A13F-01	Stage IIIA	44	3	No_Conversion	387		Positive	FEMALE	Negative	1	3	4	Negative	M0	Positive	N1	387	0	LumB	Luminal B	Positive	LumA/B	0	-3	followup	T_Other	T3	LIVING	0	TCGA-A7-A13F-01	765	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A7-A13F	765	0	765	Breast	TCGA Breast Cancer	breast invasive carcinoma					44	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A13F-F39779		Positive					Positive	Modified Radical Mastectomy		NO			-16363			0	765										2.8	Scheduled Follow-up Submission	2013-2-1	FEMALE				PathVysion HER-2 D Probe Kit	2+	403	3.0	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Equivocal	Negative	NO	11	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4								NO	3			M0	N1a	T3	Stage IIIA																		TUMOR FREE						YES		No			YES	Primary Tumor	01			YES	YES	NO	A7	Breast		LIVING	2010	TCGA-A7-A13F-01A-11D-A12Q-09	TCGA-A7-A13F-01	TCGA-A7-A13F-01A-11R-A12O-13	TCGA-A7-A13F-01A-11R-A12O-13	TCGA-A7-A13F-01A-11D-A12Q-09	ad57bf3d-f283-4c26-95ad-86a116794296	TCGA-A7-A13F-01A-11D-A12Q-09	TCGA-A7-A13F-01A-21-A13E-20	TCGA-A7-A13F-01A-11D-A12Q-09	fc4f35dd-9924-4e5d-ba71-0d7a79752b6a	b2b8924a-2ad1-4463-9b5d-c6c5609318ef	TCGA-A7-A13F-01A-11D-A12N-01	fc4f35dd-9924-4e5d-ba71-0d7a79752b6a	TCGA-A7-A13F-01A-11D-A12R-05	TCGA-A7-A13F-01	TCGA-A7-A13F-01A-11R-A12P-07	fc4f35dd-9924-4e5d-ba71-0d7a79752b6a	fc4f35dd-9924-4e5d-ba71-0d7a79752b6a	TCGA-A7-A13F-01A-11D-A12N-01	TCGA-A7-A13F-01	TCGA-A7-A13F-01		b2b8924a-2ad1-4463-9b5d-c6c5609318ef	
TCGA-A7-A13F-11		44			387			FEMALE									387	0	Normal						followup			LIVING	0	TCGA-A7-A13F-11	765	0		C3-BRCA/Luminal							mutation c1uster 9	TCGA-A7-A13F	765	0	765	Breast	TCGA Breast Cancer	breast invasive carcinoma					44	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A13F-F39779		Positive					Positive	Modified Radical Mastectomy		NO			-16363	121		0	765										2.8	Scheduled Follow-up Submission	2013-2-1	FEMALE				PathVysion HER-2 D Probe Kit	2+	403	3.0	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	960	NO	Equivocal	Negative	NO	11	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	3		false	M0	N1a	T3	Stage IIIA			0		0		0		0		100		0		0		0	TUMOR FREE						YES		No			YES	Solid Tissue Normal	11			YES	YES	NO	A7	Breast	A	LIVING	2010			TCGA-A7-A13F-11A-42R-A12O-13	TCGA-A7-A13F-11A-42R-A12O-13						82f3157c-09cc-40d7-872e-59f82f5f31f4			82f3157c-09cc-40d7-872e-59f82f5f31f4	TCGA-A7-A13F-11A-42D-A12R-05		TCGA-A7-A13F-11A-42R-A12P-07	82f3157c-09cc-40d7-872e-59f82f5f31f4	82f3157c-09cc-40d7-872e-59f82f5f31f4						
TCGA-A7-A13G-01	Stage IIA	79	2	Stage IIA	348		Positive	FEMALE	Negative				Negative	M0	Negative	N0	348	0	LumA		Positive				followup	T_Other	T2	LIVING	0	TCGA-A7-A13G-01	718	0	Iq		cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 3	mutation cluster 4	TCGA-A7-A13G	586	1	718	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO			79	Left	Sentinel node biopsy alone		TCGA-A7-A13G-F35039		Positive					Positive	Simple Mastectomy		NO			-28969			0	718		586	586		NO		90-99%				Scheduled Follow-up Submission	2012-9-14	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	3				Other, specify	New Primary Tumor	Skin, right leg	YES	YES	0			MX	N0	T2	Stage IIA																		TUMOR FREE						YES	YES	Yes	50-59%		NO	Primary Tumor	01		7th	YES	YES	NO	A7	Breast		LIVING	2010	TCGA-A7-A13G-01A-11D-A13L-09		TCGA-A7-A13G-01A-11R-A13P-13,TCGA-A7-A13G-01B-04R-A22P-13	TCGA-A7-A13G-01A-11R-A13P-13,TCGA-A7-A13G-01B-04R-A22P-13	TCGA-A7-A13G-01A-11D-A13L-09		TCGA-A7-A13G-01A-11D-A13L-09		TCGA-A7-A13G-01A-11D-A13L-09	ac567288-88cc-4a65-937e-086655c038df	defdce72-fa52-4bbc-8f34-b3e9e1c3f12d,df947eb4-659d-46a6-95e1-fcc0d471a17c	TCGA-A7-A13G-01A-11D-A13J-01	ac567288-88cc-4a65-937e-086655c038df	TCGA-A7-A13G-01A-11D-A13K-05,TCGA-A7-A13G-01B-04D-A22R-05	TCGA-A7-A13G-01		ac567288-88cc-4a65-937e-086655c038df	ac567288-88cc-4a65-937e-086655c038df	TCGA-A7-A13G-01A-11D-A13J-01		TCGA-A7-A13G-01		defdce72-fa52-4bbc-8f34-b3e9e1c3f12d,df947eb4-659d-46a6-95e1-fcc0d471a17c	
TCGA-A7-A13G-11		79			348			FEMALE									348	0	LumA						followup			LIVING	0	TCGA-A7-A13G-11	718	0									mutation cluster 4	TCGA-A7-A13G	586	1	718	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO			79	Left	Sentinel node biopsy alone		TCGA-A7-A13G-F35039		Positive					Positive	Simple Mastectomy		NO			-28969	69		0	718		586	586		NO		90-99%				Scheduled Follow-up Submission	2012-9-14	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	880	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																							Other, specify	New Primary Tumor	Skin, right leg	YES	YES	0		false	MX	N0	T2	Stage IIA											100				0			TUMOR FREE						YES	YES	Yes	50-59%		NO	Solid Tissue Normal	11		7th	YES	YES	NO	A7	Breast	A	LIVING	2010			TCGA-A7-A13G-11A-51R-A13P-13	TCGA-A7-A13G-11A-51R-A13P-13						76f30f56-7b80-4938-b514-1e1c2d24ff66			76f30f56-7b80-4938-b514-1e1c2d24ff66	TCGA-A7-A13G-11A-51D-A13T-05			76f30f56-7b80-4938-b514-1e1c2d24ff66	76f30f56-7b80-4938-b514-1e1c2d24ff66						
TCGA-A7-A13H-01																													0	TCGA-A7-A13H-01	740	0	Iq			BRCA non-CIMP c9			miRNA cluster 4			TCGA-A7-A13H	740	0	740	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO			61	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A13H-F41651		Positive					Positive	Simple Mastectomy		YES			-22643	62		0	740		840	795		NO		80-89%			2.7		2012-10-19	FEMALE				Pathvysion HER2 D Probe Kit	2+	371	3.2	2.2		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	140	NO	Equivocal	Negative	NO	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																							Other, specify	New Primary Tumor	Skin lesion-Basal Cell Left Lower Lateral Back	YES	NO	2	2	false	MX	N1a	T2	Stage IIB	TCGA-A7-A13H.642B4B50-E227-4484-904E-E629F7F9DBC1.pdf	0	0	0	0	0	0	0	0	5	10	15	50	80	40	55	70	TUMOR FREE						YES	YES	No	30-39%		NO	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2010			TCGA-A7-A13H-01A-11R-A22I-13	TCGA-A7-A13H-01A-11R-A22I-13			TCGA-A7-A13H-01A-11D-A228-09			4f0fdfc6-6578-4d9a-92ae-6d82291a3785	812b77aa-63c6-47ef-9ad4-5938ae3661d4	TCGA-A7-A13H-01A-11D-A227-01	4f0fdfc6-6578-4d9a-92ae-6d82291a3785	TCGA-A7-A13H-01A-11D-A22B-05	TCGA-A7-A13H-01		4f0fdfc6-6578-4d9a-92ae-6d82291a3785	4f0fdfc6-6578-4d9a-92ae-6d82291a3785	TCGA-A7-A13H-01A-11D-A227-01		TCGA-A7-A13H-01		812b77aa-63c6-47ef-9ad4-5938ae3661d4	
TCGA-A7-A26E-01	Stage IIIA	71	2	Stage IIIA	421		Positive	FEMALE	Negative				Negative	M0	Positive	N1	421	0	LumA		Positive				followup	T_Other	T3	LIVING	0	TCGA-A7-A26E-01	954	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 1	TCGA-A7-A26E	954	0	954	Breast	TCGA Breast Cancer	breast invasive carcinoma					71	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A26E-F39792		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		NO			-26274	588		0	954				FPPP	NO		90-99%				Scheduled Follow-up Submission	2013-2-1	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy		YES	Negative		NO	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	7								NO	0		false	MX	N1a	T3	Stage IIIA		40	40	20	20	0	0	20	20	0	0	20	20	80	80	80	80	TUMOR FREE						YES	YES	Yes	20-29%	TCGA	YES	Primary Tumor	01		7th	YES	YES	NO	A7	Breast	B	LIVING	2010	TCGA-A7-A26E-01A-11D-A167-09		TCGA-A7-A26E-01A-11R-A168-13,TCGA-A7-A26E-01A-11R-A27D-13,TCGA-A7-A26E-01B-06R-A27D-13	TCGA-A7-A26E-01A-11R-A168-13,TCGA-A7-A26E-01A-11R-A27D-13,TCGA-A7-A26E-01B-06R-A27D-13	TCGA-A7-A26E-01A-11D-A167-09		TCGA-A7-A26E-01B-06D-A272-09,TCGA-A7-A26E-01A-11D-A167-09,TCGA-A7-A26E-01A-11D-A272-09	TCGA-A7-A26E-01A-21-A17I-20	TCGA-A7-A26E-01A-11D-A167-09	6130b450-8b88-4a9a-b462-a34ec94183c9	2b8ab526-01bc-4c93-b019-273a04d94c8c,a1eac6e1-39d3-4e29-a381-1bd7848b7bc2,ba887b57-a7ae-4bb7-b7fb-8e37f5e0cc20	TCGA-A7-A26E-01A-11D-A166-01	6130b450-8b88-4a9a-b462-a34ec94183c9	TCGA-A7-A26E-01A-11D-A16A-05,TCGA-A7-A26E-01B-06D-A27B-05,TCGA-A7-A26E-01A-11D-A27B-05	TCGA-A7-A26E-01		6130b450-8b88-4a9a-b462-a34ec94183c9	6130b450-8b88-4a9a-b462-a34ec94183c9	TCGA-A7-A26E-01A-11D-A166-01		TCGA-A7-A26E-01		2b8ab526-01bc-4c93-b019-273a04d94c8c,a1eac6e1-39d3-4e29-a381-1bd7848b7bc2,ba887b57-a7ae-4bb7-b7fb-8e37f5e0cc20	
TCGA-A7-A26F-01	Stage IA	55	3	Stage I	257		Negative	FEMALE	Negative				Negative	M0	Negative	N0	257	0	Basal		Negative				enrollment	T1	T1	LIVING	0	TCGA-A7-A26F-01	738	0	BRCA-LUAD+	C4-BRCA/Basal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 5	mutation cluster 3	TCGA-A7-A26F	738	0	738	Breast	TCGA Breast Cancer	breast invasive carcinoma					55	Left	Sentinel node biopsy alone		TCGA-A7-A26F-F38499	Negative	Negative					Negative	Lumpectomy		NO			-20210	173		0	738					NO					1.8	Scheduled Follow-up Submission	2012-12-14	FEMALE				PathVysion HER-2 D probe kit.	2+	330	1.9	1.1		Other  specify	Adenocarcinoma with squamous differentiation, metaplastic	No		C50.9	8575/3	C50.9		YES		Fine needle aspiration biopsy	190	NO	Equivocal	Negative	NO	1	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5								NO	0		false	M0	N0	T1	Stage IA	TCGA-A7-A26F.46A75AD3-BAD1-4A16-873E-0099BD10FA8C.pdf		0		0		0		0		0		20		80		80	TUMOR FREE						YES	YES	Yes			YES	Primary Tumor	01		7th	YES	YES	NO	A7	Breast	A	LIVING	2010	TCGA-A7-A26F-01A-21D-A167-09		TCGA-A7-A26F-01A-21R-A168-13,TCGA-A7-A26F-01B-04R-A22P-13	TCGA-A7-A26F-01A-21R-A168-13,TCGA-A7-A26F-01B-04R-A22P-13	TCGA-A7-A26F-01A-21D-A167-09		TCGA-A7-A26F-01A-21D-A167-09,TCGA-A7-A26F-01B-04D-A22N-09	TCGA-A7-A26F-01A-11-A17I-20	TCGA-A7-A26F-01A-21D-A167-09	2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b	2d32a4ba-d5da-4f17-915c-ac1c1bceac01,5676cfeb-171d-493a-bd7f-902315494da7	TCGA-A7-A26F-01A-21D-A166-01	2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b	TCGA-A7-A26F-01A-21D-A16A-05,TCGA-A7-A26F-01B-04D-A22R-05	TCGA-A7-A26F-01		2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b	2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b	TCGA-A7-A26F-01A-21D-A166-01		TCGA-A7-A26F-01		2d32a4ba-d5da-4f17-915c-ac1c1bceac01,5676cfeb-171d-493a-bd7f-902315494da7	
TCGA-A7-A26G-01	Stage IIA	50	3	Stage IIA	209		Negative	FEMALE	Negative				Negative	M0	Negative	N0	209	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-A7-A26G-01	722	0	COAD-READ	C4-BRCA/Basal	cluster 5	Low purity c2	KIRC-like c1	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A7-A26G	722	0	722	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A26G-F39047		Negative					Negative	Other		NO			-18362	161		0	722					NO						Scheduled Follow-up Submission	2013-1-9	FEMALE										Other  specify	Invasive ductal carcinoma with Metaplastic features (Area of sarcomatoid carcinoma)	No		C50.9	8575/3	C50.9		YES		Core needle biopsy	410	NO	Negative		NO	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	4								NO	0		false	M0	N0 (i+)	T2	Stage IIA	TCGA-A7-A26G.6BE810A6-3D30-4F75-89B7-00C866553165.pdf		100		0		0		0		0		60		40		60	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01	Total Mastectomy	7th	YES	YES	NO	A7	Breast	A	LIVING	2010	TCGA-A7-A26G-01A-21D-A167-09		TCGA-A7-A26G-01A-21R-A168-13	TCGA-A7-A26G-01A-21R-A168-13	TCGA-A7-A26G-01A-21D-A167-09		TCGA-A7-A26G-01A-21D-A167-09	TCGA-A7-A26G-01A-11-A17I-20	TCGA-A7-A26G-01A-21D-A167-09	8cf1853a-55b2-4fb9-9a65-a46243304d54	766041d3-8592-405b-8fec-225c17bcfa96	TCGA-A7-A26G-01A-21D-A166-01	8cf1853a-55b2-4fb9-9a65-a46243304d54	TCGA-A7-A26G-01A-21D-A16A-05	TCGA-A7-A26G-01		8cf1853a-55b2-4fb9-9a65-a46243304d54	8cf1853a-55b2-4fb9-9a65-a46243304d54	TCGA-A7-A26G-01A-21D-A166-01		TCGA-A7-A26G-01		766041d3-8592-405b-8fec-225c17bcfa96	
TCGA-A7-A26H-01	Stage IIA	72	3	Stage IIA	64		Positive	FEMALE	Positive				Negative	M0	Positive	N1	64	0	LumA		Negative				enrollment	T1	T1	LIVING	0	TCGA-A7-A26H-01	724	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4		mutation cluster 4	TCGA-A7-A26H	311	1	724	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO	NO		72	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A26H-F39890		Positive					Negative	Other		NO			-26423	79		0	724			311		NO		90-99%			2.2	Scheduled Follow-up Submission	2013-2-5	FEMALE				PathVysion Her-2 D	2+	20	5.8	2.6		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Equivocal	Positive	NO	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative			Positive	10-19%											Negative	4					Liver	Distant Metastasis			YES	0	1	false	M0	N1a	T1	Stage IIA	TCGA-A7-A26H.1159E2EF-6407-4D90-8ED6-7AB04CF4FB32.pdf		0		0		10		0		0		30		60		80	WITH TUMOR						YES	YES	Yes			NO	Primary Tumor	01	Bilateral Mastectomy	7th	YES	YES	NO	A7	Breast	A	LIVING	2011	TCGA-A7-A26H-01A-11D-A167-09		TCGA-A7-A26H-01A-11R-A168-13	TCGA-A7-A26H-01A-11R-A168-13	TCGA-A7-A26H-01A-11D-A167-09		TCGA-A7-A26H-01A-11D-A167-09	TCGA-A7-A26H-01A-21-A17I-20	TCGA-A7-A26H-01A-11D-A167-09	d1810175-47a5-4409-b1b8-f5ba78ed1c30	3b70861d-2c7b-4139-a282-6cfdd8aa4386	TCGA-A7-A26H-01A-11D-A166-01	d1810175-47a5-4409-b1b8-f5ba78ed1c30	TCGA-A7-A26H-01A-11D-A16A-05	TCGA-A7-A26H-01		d1810175-47a5-4409-b1b8-f5ba78ed1c30	d1810175-47a5-4409-b1b8-f5ba78ed1c30	TCGA-A7-A26H-01A-11D-A166-01		TCGA-A7-A26H-01		3b70861d-2c7b-4139-a282-6cfdd8aa4386	
TCGA-A7-A26I-01	Stage IIA	65	1	Stage IIA	122		Negative	FEMALE	Negative				Negative	M0	Negative	N0	122	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-A7-A26I-01	661	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4		mutation cluster 5	TCGA-A7-A26I	661	0	661	Breast	TCGA Breast Cancer	breast invasive carcinoma					65	Left	Axillary lymph node dissection alone		TCGA-A7-A26I-F39791	Negative	Negative				Other	Negative	Lumpectomy	Re-Excision of Superior Margin	NO			-23948	40		0	661					NO					2.0	Scheduled Follow-up Submission	2013-2-1	FEMALE				Path Vysion HER-2 D probe kit	2+	229	2.2	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	120	NO	Equivocal	Negative	NO	2	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5									NO	0		false	M0	N0	T2	Stage IIA	TCGA-A7-A26I.CCE33A95-774E-4242-B2A1-05FF002ED1D9.pdf		0		0		0		0		0		30		70		80	TUMOR FREE						YES	YES	Yes			YES	Primary Tumor	01		7th	YES	YES	NO	A7	Breast	A	LIVING	2011	TCGA-A7-A26I-01A-11D-A167-09		TCGA-A7-A26I-01B-06R-A22P-13,TCGA-A7-A26I-01A-11R-A168-13	TCGA-A7-A26I-01B-06R-A22P-13,TCGA-A7-A26I-01A-11R-A168-13	TCGA-A7-A26I-01A-11D-A167-09		TCGA-A7-A26I-01A-11D-A167-09,TCGA-A7-A26I-01B-06D-A22N-09	TCGA-A7-A26I-01A-21-A17I-20	TCGA-A7-A26I-01A-11D-A167-09	5610fa97-eac4-4306-aead-983ee6570baf	eaf26eaa-106e-46e3-9963-c6185c6ec4d7	TCGA-A7-A26I-01A-11D-A166-01	5610fa97-eac4-4306-aead-983ee6570baf	TCGA-A7-A26I-01A-11D-A16A-05	TCGA-A7-A26I-01		5610fa97-eac4-4306-aead-983ee6570baf	5610fa97-eac4-4306-aead-983ee6570baf	TCGA-A7-A26I-01A-11D-A166-01		TCGA-A7-A26I-01		eaf26eaa-106e-46e3-9963-c6185c6ec4d7	
TCGA-A7-A26J-01	Stage IIA	49	3	Stage IIA	67		Positive	FEMALE	Negative				Negative	M0	Negative	N0	67	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A7-A26J-01	627	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-A7-A26J	627	0	627	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A26J-F39793		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		NO			-17930			0	627				FPPP	NO		90-99%				Scheduled Follow-up Submission	2013-2-1	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative		NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	6								NO	0			M0	N0	T2	Stage IIA																		TUMOR FREE						YES	YES	No	70-79%	TCGA	NO	Primary Tumor	01		7th	YES	YES	NO	A7	Breast		LIVING	2011	TCGA-A7-A26J-01A-11D-A167-09		TCGA-A7-A26J-01A-11R-A27D-13,TCGA-A7-A26J-01A-11R-A168-13,TCGA-A7-A26J-01B-02R-A27D-13	TCGA-A7-A26J-01A-11R-A27D-13,TCGA-A7-A26J-01A-11R-A168-13,TCGA-A7-A26J-01B-02R-A27D-13	TCGA-A7-A26J-01A-11D-A167-09		TCGA-A7-A26J-01B-02D-A272-09,TCGA-A7-A26J-01A-11D-A272-09,TCGA-A7-A26J-01A-11D-A167-09		TCGA-A7-A26J-01A-11D-A167-09	ed40061b-ad15-4f91-94ae-ae276394f42d	be8500f8-6446-4f52-aa16-2ac597e6eb68,f373fd2d-5d41-4ade-ba39-f290ef8482ce,fa523b14-e71e-4e6f-a1f3-b445af1ff788	TCGA-A7-A26J-01A-11D-A166-01	ed40061b-ad15-4f91-94ae-ae276394f42d	TCGA-A7-A26J-01A-11D-A16A-05,TCGA-A7-A26J-01B-02D-A27B-05,TCGA-A7-A26J-01A-11D-A27B-05	TCGA-A7-A26J-01		ed40061b-ad15-4f91-94ae-ae276394f42d	ed40061b-ad15-4f91-94ae-ae276394f42d	TCGA-A7-A26J-01A-11D-A166-01		TCGA-A7-A26J-01		be8500f8-6446-4f52-aa16-2ac597e6eb68,f373fd2d-5d41-4ade-ba39-f290ef8482ce,fa523b14-e71e-4e6f-a1f3-b445af1ff788	
TCGA-A7-A2KD-01																			LumB										0	TCGA-A7-A2KD-01	679	0	Squamous	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-A7-A2KD	679	0	679	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Right	No axillary staging		TCGA-A7-A2KD-F39783		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-19563	141		0	679							90-99%				Scheduled Follow-up Submission	2013-2-1	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	260	NO	Positive		NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	8	0	false	MX	N2a	T2	Stage IIIA	TCGA-A7-A2KD.3C301346-4594-4071-A754-04F8B3BE894C.pdf		0		0		0		0		0		5		95		80	TUMOR FREE						YES	YES	Yes	90-99%		YES	Primary Tumor	01		7th	YES	YES	NO	A7	Breast	A	LIVING	2011			TCGA-A7-A2KD-01A-31R-A21U-13	TCGA-A7-A2KD-01A-31R-A21U-13			TCGA-A7-A2KD-01A-31D-A21Q-09	TCGA-A7-A2KD-01A-41-A24A-20		5e04619f-0fa5-45fa-a30b-31b062600047	647c33ff-55fa-43b7-91ef-eb63ab47a549	TCGA-A7-A2KD-01A-31D-A21P-01	5e04619f-0fa5-45fa-a30b-31b062600047	TCGA-A7-A2KD-01A-31D-A21R-05	TCGA-A7-A2KD-01		5e04619f-0fa5-45fa-a30b-31b062600047	5e04619f-0fa5-45fa-a30b-31b062600047	TCGA-A7-A2KD-01A-31D-A21P-01		TCGA-A7-A2KD-01		647c33ff-55fa-43b7-91ef-eb63ab47a549	
TCGA-A7-A3IY-01																			LumA										0	TCGA-A7-A3IY-01	345	0	Kirc+			BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4			TCGA-A7-A3IY	345	0	345	Breast	TCGA Breast Cancer	breast invasive carcinoma					71	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A7-A3IY-F33856	Negative	Positive				Lumpectomy	Positive	Lumpectomy		NO			-26042	143		0	345					NO		90-99%				Scheduled Follow-up Submission	2012-7-20	FEMALE										Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Core needle biopsy	130	NO	Negative			1	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T1c	Stage I	TCGA-A7-A3IY.63F5F3D8-6393-4DA7-BB74-7D587199D7FD.pdf		0		0		0		0		10		25		65		65	TUMOR FREE							YES	No	90-99%		YES	Primary Tumor	01		7th	YES	YES	NO	A7	Breast	A	LIVING	2011			TCGA-A7-A3IY-01A-21R-A21U-13	TCGA-A7-A3IY-01A-21R-A21U-13			TCGA-A7-A3IY-01A-21D-A21Q-09			c4149cf6-980f-4da1-b749-c24aae86f351	6b3ed6de-3485-430e-aeda-024874161978	TCGA-A7-A3IY-01A-21D-A21P-01	c4149cf6-980f-4da1-b749-c24aae86f351	TCGA-A7-A3IY-01A-21D-A21R-05	TCGA-A7-A3IY-01		c4149cf6-980f-4da1-b749-c24aae86f351	c4149cf6-980f-4da1-b749-c24aae86f351	TCGA-A7-A3IY-01A-21D-A21P-01		TCGA-A7-A3IY-01		6b3ed6de-3485-430e-aeda-024874161978	
TCGA-A7-A3IZ-01																			LumA										0	TCGA-A7-A3IZ-01	322	0	Kirc+	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14			TCGA-A7-A3IZ	322	0	322	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A3IZ-F34491	Negative	Positive				Other	Negative	Lumpectomy	Reexcision	YES			-22997			0	322					NO		90-99%			3.0		2012-8-16	FEMALE				PathVysion HER-2 D probe kit.	2+	569	3.0	1.0		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Equivocal	Negative	NO	1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO		1		M0	N0 (i+)	T2	Stage IIA																		TUMOR FREE						YES	YES	No	<10%		YES	Primary Tumor	01		7th		YES	NO	A7	Breast		LIVING	2011			TCGA-A7-A3IZ-01A-11R-A214-13	TCGA-A7-A3IZ-01A-11R-A214-13			TCGA-A7-A3IZ-01A-11D-A20S-09	TCGA-A7-A3IZ-01A-21-A24A-20		e4400dbf-b871-48ab-b571-4f883bb3c24e	a5acf8e3-4062-4ee9-a31f-5ab07d991230	TCGA-A7-A3IZ-01A-11D-A20R-01	e4400dbf-b871-48ab-b571-4f883bb3c24e	TCGA-A7-A3IZ-01A-11D-A212-05	TCGA-A7-A3IZ-01		e4400dbf-b871-48ab-b571-4f883bb3c24e	e4400dbf-b871-48ab-b571-4f883bb3c24e	TCGA-A7-A3IZ-01A-11D-A20R-01		TCGA-A7-A3IZ-01		a5acf8e3-4062-4ee9-a31f-5ab07d991230	
TCGA-A7-A3J0-01																			LumA										0	TCGA-A7-A3J0-01	313	0	BRCA-LUAD+	C3-BRCA/Luminal		Low purity c2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6			TCGA-A7-A3J0	313	0	313	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Right	Sentinel node biopsy alone		TCGA-A7-A3J0-F35965		Positive					Positive	Lumpectomy		NO			-22672	78		0	313					NO		90-99%					2012-10-12	FEMALE					1+					Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Core needle biopsy	110	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T2	Stage IIA	TCGA-A7-A3J0.A5AED5F0-A144-4615-AF78-539B8523D15F.pdf		0		0		0		0		0		5		95		92	TUMOR FREE						YES	YES	No	90-99%		YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2011			TCGA-A7-A3J0-01A-11R-A214-13	TCGA-A7-A3J0-01A-11R-A214-13			TCGA-A7-A3J0-01A-11D-A20S-09	TCGA-A7-A3J0-01A-21-A24A-20		1fbf8004-0091-4eb0-9042-d2f1a5174abe	23d1f5b1-6b5f-45f3-b30a-b6b04692ba68	TCGA-A7-A3J0-01A-11D-A20R-01	1fbf8004-0091-4eb0-9042-d2f1a5174abe	TCGA-A7-A3J0-01A-11D-A212-05	TCGA-A7-A3J0-01		1fbf8004-0091-4eb0-9042-d2f1a5174abe	1fbf8004-0091-4eb0-9042-d2f1a5174abe	TCGA-A7-A3J0-01A-11D-A20R-01		TCGA-A7-A3J0-01		23d1f5b1-6b5f-45f3-b30a-b6b04692ba68	
TCGA-A7-A3J1-01																			LumA										0	TCGA-A7-A3J1-01	343	0	Iq	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-A7-A3J1	343	0	343	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A3J1-F36693		Positive					Positive	Lumpectomy					-23209	49		0	343					NO		90-99%					2012-11-12	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	100	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	MX	N0	T1c	Stage IA	TCGA-A7-A3J1.D8EFFB62-6A23-4033-8144-24B751DECB08.pdf		0		0		0		0		0		0		100		90	TUMOR FREE						YES	YES	Yes	<10%		YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2011			TCGA-A7-A3J1-01A-11R-A214-13	TCGA-A7-A3J1-01A-11R-A214-13			TCGA-A7-A3J1-01A-11D-A20S-09	TCGA-A7-A3J1-01A-21-A24A-20		3b042185-867f-492b-a448-7c51e05f9b42	bcc81b67-ecd6-442f-abc4-dd5b916bea85	TCGA-A7-A3J1-01A-11D-A20R-01	3b042185-867f-492b-a448-7c51e05f9b42	TCGA-A7-A3J1-01A-11D-A212-05	TCGA-A7-A3J1-01		3b042185-867f-492b-a448-7c51e05f9b42	3b042185-867f-492b-a448-7c51e05f9b42	TCGA-A7-A3J1-01A-11D-A20R-01		TCGA-A7-A3J1-01		bcc81b67-ecd6-442f-abc4-dd5b916bea85	
TCGA-A7-A3RF-01																													0	TCGA-A7-A3RF-01	408	0	Quiet			BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA c1uster 10			TCGA-A7-A3RF	174	1	408	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO			79	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A7-A3RF-F40413	Negative	Positive				Other	Positive	Lumpectomy	Left breast reexcision	NO			-29184	61		0	408			174				90-99%					2013-2-19	FEMALE										Mucinous Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	190	NO	Negative		NO	2	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																							Bone	Distant Metastasis		NO	YES	0		false	M0	N0	T2	Stage IIA	TCGA-A7-A3RF.4AF67A51-97C1-4D58-9E60-03FDFFACD38A.pdf		4		2		0		1		0		25		75		75	WITH TUMOR						YES	YES	No	30-39%		YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2012			TCGA-A7-A3RF-01A-11R-A22I-13	TCGA-A7-A3RF-01A-11R-A22I-13			TCGA-A7-A3RF-01A-11D-A228-09	TCGA-A7-A3RF-01A-21-A24A-20		de0a584e-117e-4cf6-8c4a-6fb040270eda	2e06544e-c9e6-4f9b-a1d9-804c7051ddd5	TCGA-A7-A3RF-01A-11D-A227-01	de0a584e-117e-4cf6-8c4a-6fb040270eda	TCGA-A7-A3RF-01A-11D-A22B-05	TCGA-A7-A3RF-01		de0a584e-117e-4cf6-8c4a-6fb040270eda	de0a584e-117e-4cf6-8c4a-6fb040270eda	TCGA-A7-A3RF-01A-11D-A227-01		TCGA-A7-A3RF-01		2e06544e-c9e6-4f9b-a1d9-804c7051ddd5	
TCGA-A7-A425-01																													0	TCGA-A7-A425-01	447	0										TCGA-A7-A425	419	1	447	Breast	TCGA Breast Cancer	breast invasive carcinoma					70	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A425-F41648		Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		YES			-25678	198		0	447		419	419				90-99%			2.5		2013-3-25	FEMALE			30-39%	Pathvysion HER-2 D Probe Kit	3+	228	2.8	1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	400	NO	Indeterminate	Negative	NO	19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative	1+		Positive	90-99%				3 Point Scale					<10%		Negative					3 Point Scale	Other, specify	Locoregional Recurrence	Left Breast	YES	YES	12		false	MX	N3a	T3	Stage IIIC	TCGA-A7-A425.F969E3E4-0053-44E9-85BC-BEFDBD62C512.pdf		0		0		0		0		5		15		80		85	WITH TUMOR						YES	YES	No	70-79%		YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2012			TCGA-A7-A425-01A-11R-A24J-13	TCGA-A7-A425-01A-11R-A24J-13			TCGA-A7-A425-01A-11D-A243-09			0a423f86-ffa5-4c16-97ab-2d262c34fd41	d0a1e510-1f13-4153-ab54-e813217d5704	TCGA-A7-A425-01A-11D-A242-01	0a423f86-ffa5-4c16-97ab-2d262c34fd41	TCGA-A7-A425-01A-11D-A244-05	TCGA-A7-A425-01		0a423f86-ffa5-4c16-97ab-2d262c34fd41	0a423f86-ffa5-4c16-97ab-2d262c34fd41	TCGA-A7-A425-01A-11D-A242-01		TCGA-A7-A425-01		d0a1e510-1f13-4153-ab54-e813217d5704	
TCGA-A7-A426-01																													0	TCGA-A7-A426-01	364	0										TCGA-A7-A426	364	0	364	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A426-F41743		Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		YES			-18296	132		0	364							70-79%					2013-3-26	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Core needle biopsy	180	NO	Negative		NO	20	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	13		false	MX	N3a	T3	Stage IIIC	TCGA-A7-A426.B644AEB6-7D46-4D4D-BA00-D42BCDDCB164.pdf		0		0		0		0		0		70		30		80	TUMOR FREE						YES	YES	Yes	70-79%		YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2012			TCGA-A7-A426-01A-22R-A24J-13	TCGA-A7-A426-01A-22R-A24J-13			TCGA-A7-A426-01A-22D-A243-09			185d3410-2daa-4d28-ab60-a7c13ae9d4fb	e134fc8d-f999-402a-9414-864b0a1e660d	TCGA-A7-A426-01A-22D-A242-01	185d3410-2daa-4d28-ab60-a7c13ae9d4fb	TCGA-A7-A426-01A-22D-A244-05	TCGA-A7-A426-01		185d3410-2daa-4d28-ab60-a7c13ae9d4fb	185d3410-2daa-4d28-ab60-a7c13ae9d4fb	TCGA-A7-A426-01A-22D-A242-01		TCGA-A7-A426-01		e134fc8d-f999-402a-9414-864b0a1e660d	
TCGA-A7-A4SA-01																													0	TCGA-A7-A4SA-01	454	0										TCGA-A7-A4SA	454	0	454	Breast	TCGA Breast Cancer	breast invasive carcinoma					40	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A4SA-F49560		Positive	3 Point Scale				Negative	Simple Mastectomy		YES			-14906	127		0	454							80-89%					2013-10-3	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	220	NO	Negative		NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	1	0	false	M0	N1a	T2	Stage IIB	TCGA-A7-A4SA.2649764C-9566-49DB-B8E9-B4B86DBB763C.pdf		5		0		0		0		0		45		55		75	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2012			TCGA-A7-A4SA-01A-11R-A25Z-13	TCGA-A7-A4SA-01A-11R-A25Z-13			TCGA-A7-A4SA-01A-11D-A25Q-09			781945fb-6d9e-4b45-8082-57675f21dc4a	1d92f9a9-b47a-4a3d-821c-99b7538ac5a9	TCGA-A7-A4SA-01A-11D-A25N-01	781945fb-6d9e-4b45-8082-57675f21dc4a	TCGA-A7-A4SA-01A-11D-A268-05	TCGA-A7-A4SA-01		781945fb-6d9e-4b45-8082-57675f21dc4a	781945fb-6d9e-4b45-8082-57675f21dc4a	TCGA-A7-A4SA-01A-11D-A25N-01		TCGA-A7-A4SA-01		1d92f9a9-b47a-4a3d-821c-99b7538ac5a9	
TCGA-A7-A4SB-01																													0	TCGA-A7-A4SB-01	418	0										TCGA-A7-A4SB	418	0	418	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A7-A4SB-F49625	Negative	Positive	3 Point Scale		3 Point Scale	Other	Positive	Lumpectomy	Right Breast reexcision	YES			-20539	75		0	418							70-79%					2013-10-4	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	120	NO	Negative		NO	2	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	1	false	M0	N1mi	T3	Stage IIIA	TCGA-A7-A4SB.03B39A59-0068-4276-8340-7B97A1395E68.pdf		1		0		3		0		0		57		40		80	TUMOR FREE						YES	YES	No	50-59%		YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2012			TCGA-A7-A4SB-01A-21R-A25Z-13	TCGA-A7-A4SB-01A-21R-A25Z-13			TCGA-A7-A4SB-01A-21D-A25Q-09			352dc94a-fc74-4292-890c-4ed9c22dcfbc	58f16a99-4220-411d-be80-c354c3dde02f	TCGA-A7-A4SB-01A-21D-A25N-01	352dc94a-fc74-4292-890c-4ed9c22dcfbc	TCGA-A7-A4SB-01A-21D-A268-05	TCGA-A7-A4SB-01		352dc94a-fc74-4292-890c-4ed9c22dcfbc	352dc94a-fc74-4292-890c-4ed9c22dcfbc	TCGA-A7-A4SB-01A-21D-A25N-01		TCGA-A7-A4SB-01		58f16a99-4220-411d-be80-c354c3dde02f	
TCGA-A7-A4SC-01																													0	TCGA-A7-A4SC-01	446	0										TCGA-A7-A4SC	446	0	446	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Right Upper Outer Quadrant			TCGA-A7-A4SC-F49714		Positive					Negative	Simple Mastectomy		YES			-23008	110		0	446							90-99%			2.2		2013-10-8	FEMALE				PathVysion HER-2 D Probe kit	3+	303	2.4	1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	360	NO	Equivocal	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0	T3	Stage IIB	TCGA-A7-A4SC.5E14E7CA-3417-4379-8EE3-7F00D6D4A02B.pdf		1		0		2		0		2		73		23		60	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2012			TCGA-A7-A4SC-01A-12R-A25Z-13	TCGA-A7-A4SC-01A-12R-A25Z-13			TCGA-A7-A4SC-01A-12D-A25Q-09			84633979-56dd-4244-90bc-fa4652718880			84633979-56dd-4244-90bc-fa4652718880	TCGA-A7-A4SC-01A-12D-A268-05	TCGA-A7-A4SC-01		84633979-56dd-4244-90bc-fa4652718880	84633979-56dd-4244-90bc-fa4652718880						
TCGA-A7-A4SD-01																													0	TCGA-A7-A4SD-01	441	0										TCGA-A7-A4SD	441	0	441	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Right	Sentinel node biopsy alone		TCGA-A7-A4SD-F52732		Negative					Negative	Simple Mastectomy		YES			-19131			0	441										5		2013-12-5	FEMALE				PathVysion HER-2 D Probe Kit	2+	20	6.4	1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Equivocal	Negative	NO	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0		M0	N0	T2	Stage IIA																		TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		7th		YES	NO	A7	Breast		LIVING	2012			TCGA-A7-A4SD-01A-11R-A25Z-13	TCGA-A7-A4SD-01A-11R-A25Z-13			TCGA-A7-A4SD-01A-11D-A25Q-09			cb0d669b-658a-4a41-9904-f838ddb12db2	cf272587-883b-4844-a81e-46fca956cc66	TCGA-A7-A4SD-01A-11D-A25N-01	cb0d669b-658a-4a41-9904-f838ddb12db2	TCGA-A7-A4SD-01A-11D-A268-05	TCGA-A7-A4SD-01		cb0d669b-658a-4a41-9904-f838ddb12db2	cb0d669b-658a-4a41-9904-f838ddb12db2	TCGA-A7-A4SD-01A-11D-A25N-01		TCGA-A7-A4SD-01		cf272587-883b-4844-a81e-46fca956cc66	
TCGA-A7-A4SE-01																													0	TCGA-A7-A4SE-01	644	0										TCGA-A7-A4SE	644	0	644	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Left	Sentinel node biopsy alone		TCGA-A7-A4SE-F50162		Negative					Negative	Lumpectomy		YES			-20080	306		0	644												2013-10-16	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	160	NO	Negative		YES	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	M0	N0	T2	Stage IIA	TCGA-A7-A4SE.C0C49D41-AA66-435B-9312-FAD8E2DC3305.pdf		4		0		20		0		5		50		25		65	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2011			TCGA-A7-A4SE-01A-11R-A25Z-13	TCGA-A7-A4SE-01A-11R-A25Z-13			TCGA-A7-A4SE-01A-11D-A25Q-09			6bb217e7-3fd4-477f-87bf-b55e50a33e45	7b527732-597f-49af-bf0c-69b485bbe511	TCGA-A7-A4SE-01A-11D-A25N-01	6bb217e7-3fd4-477f-87bf-b55e50a33e45	TCGA-A7-A4SE-01A-11D-A268-05	TCGA-A7-A4SE-01		6bb217e7-3fd4-477f-87bf-b55e50a33e45	6bb217e7-3fd4-477f-87bf-b55e50a33e45	TCGA-A7-A4SE-01A-11D-A25N-01		TCGA-A7-A4SE-01		7b527732-597f-49af-bf0c-69b485bbe511	
TCGA-A7-A4SF-01																													0	TCGA-A7-A4SF-01	545	0										TCGA-A7-A4SF	545	0	545	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Right	Sentinel node biopsy alone		TCGA-A7-A4SF-F49721	Positive	Positive	3 Point Scale			Other	Negative	Lumpectomy	Right Breast Reexcision	YES			-19985	245		0	545							90-99%					2013-10-9	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO	Positive		NO	2	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	M0	N0	T2	Stage IIA	TCGA-A7-A4SF.C1B1FAA6-EB15-43BB-B3A3-D11511C76060.pdf		0		0		0		0		0		10		90		68	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2012			TCGA-A7-A4SF-01A-11R-A25Z-13	TCGA-A7-A4SF-01A-11R-A25Z-13			TCGA-A7-A4SF-01A-11D-A25Q-09			f8b3fd9c-ba8c-49bf-aeb7-4e7dfedbb9a8	2080f468-6807-4c8d-a9d8-99775effd6ba	TCGA-A7-A4SF-01A-11D-A25N-01	f8b3fd9c-ba8c-49bf-aeb7-4e7dfedbb9a8	TCGA-A7-A4SF-01A-11D-A268-05	TCGA-A7-A4SF-01		f8b3fd9c-ba8c-49bf-aeb7-4e7dfedbb9a8	f8b3fd9c-ba8c-49bf-aeb7-4e7dfedbb9a8	TCGA-A7-A4SF-01A-11D-A25N-01		TCGA-A7-A4SF-01		2080f468-6807-4c8d-a9d8-99775effd6ba	
TCGA-A7-A56D-01																													0	TCGA-A7-A56D-01	448	0										TCGA-A7-A56D	448	0	448	Breast	TCGA Breast Cancer	breast invasive carcinoma					84	Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A56D-F50426		Positive	3 Point Scale	1+	3 Point Scale		Positive	Lumpectomy		YES			-30783	140		0	448							90-99%					2013-10-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.3	3+	YES		Core needle biopsy	80	NO	Negative		NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	M0	N0	T2	Stage IIA	TCGA-A7-A56D.D564A7FB-4F0A-4589-AB32-A6CD8B547219.pdf		2		0		0		0		0		40		60		65	TUMOR FREE						YES	YES	No	<10%		NO	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2012			TCGA-A7-A56D-01A-11R-A27U-13	TCGA-A7-A56D-01A-11R-A27U-13			TCGA-A7-A56D-01A-11D-A27P-09			3858b3ae-a4a9-4b91-8bd3-b7e20fb531e4	71bafb6d-c0cd-499e-98cb-12bca4360593	TCGA-A7-A56D-01A-11D-A27O-01	3858b3ae-a4a9-4b91-8bd3-b7e20fb531e4		TCGA-A7-A56D-01		3858b3ae-a4a9-4b91-8bd3-b7e20fb531e4	3858b3ae-a4a9-4b91-8bd3-b7e20fb531e4	TCGA-A7-A56D-01A-11D-A27O-01		TCGA-A7-A56D-01		71bafb6d-c0cd-499e-98cb-12bca4360593	
TCGA-A7-A5ZV-01																													0	TCGA-A7-A5ZV-01	368	0										TCGA-A7-A5ZV	368	0	368	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Left	Sentinel node biopsy alone		TCGA-A7-A5ZV-F51143		Negative					Negative	Lumpectomy		NO			-22966	154		0	368										2.5		2013-11-8	FEMALE				PathVysion HER-2 D Probe Kit	2+	40	3.8	1.5		Infiltrating Carcinoma NOS		No		C50.9	8010/3	C50.9		YES		Core needle biopsy	940	NO	Equivocal	Negative	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T2	Stage IIA	TCGA-A7-A5ZV.FA5CF5A2-F44A-4303-9200-32250FAEF374.pdf		20		20		20		40		0		10		70		70	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2012			TCGA-A7-A5ZV-01A-11R-A28I-13	TCGA-A7-A5ZV-01A-11R-A28I-13			TCGA-A7-A5ZV-01A-11D-A28B-09			e121ae32-63c2-4b13-b135-d1837fc10999	37f156e4-c11a-4934-b0d2-c860222f68d6	TCGA-A7-A5ZV-01A-11D-A28A-01	e121ae32-63c2-4b13-b135-d1837fc10999	TCGA-A7-A5ZV-01A-11D-A28C-05	TCGA-A7-A5ZV-01		e121ae32-63c2-4b13-b135-d1837fc10999	e121ae32-63c2-4b13-b135-d1837fc10999	TCGA-A7-A5ZV-01A-11D-A28A-01		TCGA-A7-A5ZV-01		37f156e4-c11a-4934-b0d2-c860222f68d6	
TCGA-A7-A5ZW-01																													0	TCGA-A7-A5ZW-01	326	0										TCGA-A7-A5ZW	326	0	326	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A7-A5ZW-F51509		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		NO			-17529	77		0	326							90-99%					2013-11-19	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	60	NO	Negative		NO	1	Negative	Peri (6-12 months since last menstrual period)																											NO	1		false	M0	N1a	T1c	Stage IIA	TCGA-A7-A5ZW.A56585F9-9651-472B-BF53-C708A686EB7D.pdf		40		20		0		20		0		30		70		70	TUMOR FREE						YES	YES	No	80-89%		YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2012			TCGA-A7-A5ZW-01A-12R-A29V-13	TCGA-A7-A5ZW-01A-12R-A29V-13			TCGA-A7-A5ZW-01A-12D-A29N-09			8fc9ea4e-d3ce-40b1-81b7-fc3967503a8f	1fe5b258-cd2d-401f-b119-75f183b44711	TCGA-A7-A5ZW-01A-12D-A29M-01	8fc9ea4e-d3ce-40b1-81b7-fc3967503a8f	TCGA-A7-A5ZW-01A-12D-A29O-05	TCGA-A7-A5ZW-01		8fc9ea4e-d3ce-40b1-81b7-fc3967503a8f	8fc9ea4e-d3ce-40b1-81b7-fc3967503a8f	TCGA-A7-A5ZW-01A-12D-A29M-01		TCGA-A7-A5ZW-01		1fe5b258-cd2d-401f-b119-75f183b44711	
TCGA-A7-A5ZX-01																													0	TCGA-A7-A5ZX-01	336	0										TCGA-A7-A5ZX	336	0	336	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A5ZX-F52721		Positive	3 Point Scale		3 Point Scale		Positive	Other		YES			-17683			0	336												2013-12-6	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES		Core needle biopsy			Negative		NO	24		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	21			M0	N3a	T2	Stage IIIC																		TUMOR FREE						YES	YES	Yes			YES	Primary Tumor	01	Bilateral skin sparing Mastectomy and Bilateral breast reconstruction with tissue expanders.	7th		YES	NO	A7	Breast		LIVING	2012			TCGA-A7-A5ZX-01A-12R-A29V-13	TCGA-A7-A5ZX-01A-12R-A29V-13			TCGA-A7-A5ZX-01A-12D-A29N-09			e3c70f4d-4a23-486b-b221-3058b13a1c69	e1e56aa2-5327-450f-ab74-b1472d75e5df	TCGA-A7-A5ZX-01A-12D-A29M-01	e3c70f4d-4a23-486b-b221-3058b13a1c69	TCGA-A7-A5ZX-01A-12D-A29O-05	TCGA-A7-A5ZX-01		e3c70f4d-4a23-486b-b221-3058b13a1c69	e3c70f4d-4a23-486b-b221-3058b13a1c69	TCGA-A7-A5ZX-01A-12D-A29M-01		TCGA-A7-A5ZX-01		e1e56aa2-5327-450f-ab74-b1472d75e5df	
TCGA-A7-A6VV-01																													0	TCGA-A7-A6VV-01	313	0										TCGA-A7-A6VV	313	0	313	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A6VV-F57249		Negative					Negative	Modified Radical Mastectomy		NO			-18695	85		0	313												2014-3-6	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.8		YES		Core needle biopsy	1100	NO	Negative		NO	5	Negative	Peri (6-12 months since last menstrual period)																											NO	0		false	M0	N0	T2	Stage IIA	TCGA-A7-A6VV.C26EAF0E-202B-4F3E-9E59-3395A1BFCAB8.pdf		8		2		1		0		0		49		50		85	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2013			TCGA-A7-A6VV-01A-22R-A33A-13	TCGA-A7-A6VV-01A-22R-A33A-13						c02ec36d-9e79-4e2f-a46c-f898838766df	7406aaff-b28a-4b4c-8fa3-b4e208b8cf85	TCGA-A7-A6VV-01A-22D-A33D-01	c02ec36d-9e79-4e2f-a46c-f898838766df	TCGA-A7-A6VV-01A-22D-A33F-05	TCGA-A7-A6VV-01		c02ec36d-9e79-4e2f-a46c-f898838766df	c02ec36d-9e79-4e2f-a46c-f898838766df	TCGA-A7-A6VV-01A-22D-A33D-01		TCGA-A7-A6VV-01		7406aaff-b28a-4b4c-8fa3-b4e208b8cf85	
TCGA-A7-A6VW-01																													0	TCGA-A7-A6VW-01	285	0										TCGA-A7-A6VW	285	0	285	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Left	Sentinel node biopsy alone		TCGA-A7-A6VW-F57227		Negative					Negative	Lumpectomy		NO			-17539	71		0	285												2014-3-6	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	370	NO	Negative		NO	2	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T2	Stage IIA	TCGA-A7-A6VW.BE19CEFA-7A66-480C-BEC0-AF52F4C8A04C.pdf		5		2		18		2		0		22		60		85	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2013			TCGA-A7-A6VW-01A-21R-A33A-13	TCGA-A7-A6VW-01A-21R-A33A-13						f572c953-e1aa-4dd2-a8f8-e292ab7bd139	8a5f6839-507d-4288-91e9-22badf54b089	TCGA-A7-A6VW-01A-21D-A33D-01	f572c953-e1aa-4dd2-a8f8-e292ab7bd139	TCGA-A7-A6VW-01A-21D-A33F-05	TCGA-A7-A6VW-01		f572c953-e1aa-4dd2-a8f8-e292ab7bd139	f572c953-e1aa-4dd2-a8f8-e292ab7bd139	TCGA-A7-A6VW-01A-21D-A33D-01		TCGA-A7-A6VW-01		8a5f6839-507d-4288-91e9-22badf54b089	
TCGA-A7-A6VX-01																													0	TCGA-A7-A6VX-01	317	0										TCGA-A7-A6VX	317	0	317	Breast	TCGA Breast Cancer	breast invasive carcinoma					68	Left|Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A7-A6VX-F57518		Positive					Positive	Lumpectomy		NO			-25066	73		0	317						Immune Stain by GenPath	90-99%					2014-3-13	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T2	Stage IIA	TCGA-A7-A6VX.80EDDCAC-B87B-47E6-A48C-F166D227DA6C.pdf		5		1		0		1		20		20		60		60	TUMOR FREE	Immune stain by GenPath					YES	YES	No			YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2013			TCGA-A7-A6VX-01A-12R-A33A-13	TCGA-A7-A6VX-01A-12R-A33A-13						aed86155-1d12-4447-bdf6-3aaba9938a71	5856d23e-c230-4122-abf1-fa304bdceee9	TCGA-A7-A6VX-01A-12D-A33D-01	aed86155-1d12-4447-bdf6-3aaba9938a71	TCGA-A7-A6VX-01A-12D-A33F-05	TCGA-A7-A6VX-01		aed86155-1d12-4447-bdf6-3aaba9938a71	aed86155-1d12-4447-bdf6-3aaba9938a71	TCGA-A7-A6VX-01A-12D-A33D-01		TCGA-A7-A6VX-01		5856d23e-c230-4122-abf1-fa304bdceee9	
TCGA-A7-A6VY-01																													0	TCGA-A7-A6VY-01	266	0										TCGA-A7-A6VY	266	0	266	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Right|Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A6VY-F57257		Negative					Negative	Lumpectomy		NO			-17640	29		0	266												2014-3-6	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	70	NO	Negative		NO	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	2		false	M0	N1	T2	Stage IIB	TCGA-A7-A6VY.BB85F844-C710-41D5-8620-E246DC9D2C6A.pdf		5		0		1		0		0		44		55		90	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2013			TCGA-A7-A6VY-01A-12R-A33A-13	TCGA-A7-A6VY-01A-12R-A33A-13						2fb506f2-4b76-4c20-ae45-8939f2e14753	317d4bae-a933-41ef-ab8a-d4fbb6de5285	TCGA-A7-A6VY-01A-12D-A33D-01	2fb506f2-4b76-4c20-ae45-8939f2e14753	TCGA-A7-A6VY-01A-12D-A33F-05	TCGA-A7-A6VY-01		2fb506f2-4b76-4c20-ae45-8939f2e14753	2fb506f2-4b76-4c20-ae45-8939f2e14753	TCGA-A7-A6VY-01A-12D-A33D-01		TCGA-A7-A6VY-01		317d4bae-a933-41ef-ab8a-d4fbb6de5285	
TCGA-A8-A06N-01	Stage IIIB	66	3	Stage IIIB	0		Positive	FEMALE	Negative	1	3	4	Negative	M0	Negative	N0	0	0	LumB	Luminal B	Negative	LumA/B	-10	-3	enrollment	T_Other	T4	LIVING		TCGA-A8-A06N-01			Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A06N				Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Left					Positive					Negative	Other					-24288	241		0	0												2011-5-27	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			510	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2											false	M0	N0	T4b	Stage IIIB	TCGA-A8-A06N.2F0333BC-E9BB-4903-B3E2-8AE241DDDF84.pdf	7	1	0	0	2	7	0	0	0	0	56	40	42	53	85	90	TUMOR FREE								No				Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A06N-01A-11W-A019-09	TCGA-A8-A06N-01		TCGA-A8-A06N-01A-11R-A010-13		99692232-7d23-4ea5-847e-17064bac010d	TCGA-A8-A06N-01A-11W-A019-09	TCGA-A8-A06N-01A-21-A13B-20	TCGA-A8-A06N-01A-11W-A019-09	a14dc21a-6a46-4be8-9247-76cbc70dfe8b	0a28c663-7cc6-466c-b64d-f9d8d6d6b4c8	TCGA-A8-A06N-01A-11D-A011-01	a14dc21a-6a46-4be8-9247-76cbc70dfe8b		TCGA-A8-A06N-01	TCGA-A8-A06N-01A-12R-A056-07	a14dc21a-6a46-4be8-9247-76cbc70dfe8b	a14dc21a-6a46-4be8-9247-76cbc70dfe8b	TCGA-A8-A06N-01A-11D-A011-01	TCGA-A8-A06N-01	TCGA-A8-A06N-01	TCGA-A8-A06N-01A-11D-A00Y-05	0a28c663-7cc6-466c-b64d-f9d8d6d6b4c8	TCGA-A8-A06N-01A-11R-A010-13
TCGA-A8-A06O-01	Stage I	60	5	Stage I	396		Positive	FEMALE	Negative				Negative	M0	Negative	N0	396	0	LumB	Luminal B	Positive		-2	-3	enrollment	T1	T1	LIVING	0	TCGA-A8-A06O-01	396	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A8-A06O	396	0	396	Breast	TCGA Breast Cancer	breast invasive carcinoma					60	Left			TCGA-A8-A06O-F40806		Positive					Positive	Other					-22157	272		0	396												2013-3-1	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			100	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO			false	M0	N0	T1c	Stage I	TCGA-A8-A06O.EB9B8904-F6CC-451F-8628-50CC71F1F7C3.pdf	14	18	0	0	2	2	0	0	15	15	40	43	43	40	80	75	TUMOR FREE						YES		No			NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A06O-01A-11W-A019-09	TCGA-A8-A06O-01		TCGA-A8-A06O-01A-11R-A010-13	TCGA-A8-A06O-01A-11W-A019-09		TCGA-A8-A06O-01A-11W-A019-09		TCGA-A8-A06O-01A-11W-A019-09	7dbd8795-b264-4f68-bdea-4cfe39884864	dc99456b-c429-4e33-8ceb-26dd8d43b78a	TCGA-A8-A06O-01A-11D-A011-01	7dbd8795-b264-4f68-bdea-4cfe39884864		TCGA-A8-A06O-01	TCGA-A8-A06O-01A-11R-A00Z-07	7dbd8795-b264-4f68-bdea-4cfe39884864	7dbd8795-b264-4f68-bdea-4cfe39884864	TCGA-A8-A06O-01A-11D-A011-01	TCGA-A8-A06O-01	TCGA-A8-A06O-01	TCGA-A8-A06O-01A-11D-A00Y-05	dc99456b-c429-4e33-8ceb-26dd8d43b78a	TCGA-A8-A06O-01A-11R-A010-13
TCGA-A8-A06P-01	Stage IIIA	63	4	Stage IIIA	396		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N2	396	0	LumA	Luminal A	Positive	ReacI	-5	-3	enrollment	T1	T1	LIVING	0	TCGA-A8-A06P-01	396	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A06P			396	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Right			TCGA-A8-A06P-F40814		Positive					Positive	Other					-23011	241		0	396												2013-3-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			210	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4											false	M0	N2a	T1c	Stage IIIA	TCGA-A8-A06P.AADFAF8B-92B8-4292-96A3-912D55EB9C31.pdf	8	2	0	0	2	2	0	0	8	0	15	20	75	78	85	90	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A06P-01A-11W-A019-09	TCGA-A8-A06P-01		TCGA-A8-A06P-01A-11R-A010-13	TCGA-A8-A06P-01A-11W-A019-09	9d804a48-aeb9-4785-af7c-2b8a4763c148	TCGA-A8-A06P-01A-11W-A019-09	TCGA-A8-A06P-01A-21-A13B-20	TCGA-A8-A06P-01A-11W-A019-09	9d8f2b85-f203-47ac-8217-987640f89b26	90ef86f0-9b29-4f97-b8c8-128a5771ed75	TCGA-A8-A06P-01A-11D-A011-01	9d8f2b85-f203-47ac-8217-987640f89b26		TCGA-A8-A06P-01	TCGA-A8-A06P-01A-11R-A00Z-07	9d8f2b85-f203-47ac-8217-987640f89b26	9d8f2b85-f203-47ac-8217-987640f89b26	TCGA-A8-A06P-01A-11D-A011-01	TCGA-A8-A06P-01	TCGA-A8-A06P-01	TCGA-A8-A06P-01A-11D-A00Y-05	90ef86f0-9b29-4f97-b8c8-128a5771ed75	TCGA-A8-A06P-01A-11R-A010-13
TCGA-A8-A06Q-01	Stage IIIA	63	3	No_Conversion	31		Positive	FEMALE	Negative				Negative	M0	Positive	N2	31	0	LumB	Luminal B	Positive		-2	-3	enrollment	T_Other	T3	LIVING	0	TCGA-A8-A06Q-01	31	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 7	cluster 7	mutation cluster 3	TCGA-A8-A06Q			31	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Left Upper Outer Quadrant					Positive					Positive	Other					-23164	1184		0	31												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			50	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	7											false	M0	N2	T3	Stage IIIA	TCGA-A8-A06Q.8FE77EF7-C83A-431F-B3BA-D93B5ECC70AF.pdf	10	10	0	0	0	0	0	0	0	0	5	7	95	93	85	85	TUMOR FREE								No				Primary Tumor	01	Surgical Resection	5th		NO	YES	A8	Breast	A	LIVING	2007	TCGA-A8-A06Q-01A-11W-A050-09	TCGA-A8-A06Q-01		TCGA-A8-A06Q-01A-11R-A035-13	TCGA-A8-A06Q-01A-11W-A050-09		TCGA-A8-A06Q-01A-11W-A050-09		TCGA-A8-A06Q-01A-11W-A050-09	0e2a3a2c-173a-43b8-bd7d-0c09dfa8a2ae	ac9a0bec-1011-41da-b5b4-774fed87b5b0	TCGA-A8-A06Q-01A-11D-A036-01	0e2a3a2c-173a-43b8-bd7d-0c09dfa8a2ae		TCGA-A8-A06Q-01	TCGA-A8-A06Q-01A-11R-A034-07	0e2a3a2c-173a-43b8-bd7d-0c09dfa8a2ae	0e2a3a2c-173a-43b8-bd7d-0c09dfa8a2ae	TCGA-A8-A06Q-01A-11D-A036-01	TCGA-A8-A06Q-01	TCGA-A8-A06Q-01	TCGA-A8-A06Q-01A-11D-A032-05	ac9a0bec-1011-41da-b5b4-774fed87b5b0	TCGA-A8-A06Q-01A-11R-A035-13
TCGA-A8-A06R-01	Stage IIB	69		No_Conversion	546		Positive	FEMALE	Equivocal				Negative	M0	Positive	N1	546	0	LumB	Luminal B	Negative	ReacI	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A06R-01	547	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A06R	547	0	547	Breast	TCGA Breast Cancer	breast invasive carcinoma					69	Right Upper Outer Quadrant			TCGA-A8-A06R-F40815		Positive					Negative	Other					-25477	1184		0	547												2013-3-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			220	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO			false	M0	N1a	T2	Stage IIB	TCGA-A8-A06R.B6B7939C-63AF-4B52-B494-AA09A9C03871.pdf	5	17	0	0	8	5	0	0	0	0	22	15	70	80	85	75	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	5th		NO	YES	A8	Breast	A	LIVING	2007	TCGA-A8-A06R-01A-11D-A015-09	TCGA-A8-A06R-01		TCGA-A8-A06R-01A-11R-A010-13		7bcd06e7-a4de-4c5b-9337-4d7d3b8014b9	TCGA-A8-A06R-01A-11D-A015-09	TCGA-A8-A06R-01A-21-A13A-20	TCGA-A8-A06R-01A-11D-A015-09	e2d7656c-0d06-427c-998c-c26ba4a1def4	aa0e910d-28fb-41f0-b545-601feb989ee1	TCGA-A8-A06R-01A-11D-A011-01	e2d7656c-0d06-427c-998c-c26ba4a1def4		TCGA-A8-A06R-01	TCGA-A8-A06R-01A-11R-A00Z-07	e2d7656c-0d06-427c-998c-c26ba4a1def4	e2d7656c-0d06-427c-998c-c26ba4a1def4	TCGA-A8-A06R-01A-11D-A011-01	TCGA-A8-A06R-01	TCGA-A8-A06R-01	TCGA-A8-A06R-01A-11D-A00Y-05	aa0e910d-28fb-41f0-b545-601feb989ee1	TCGA-A8-A06R-01A-11R-A010-13
TCGA-A8-A06T-01	Stage IIIA	75	4	Stage IIIA	1249		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1249	0	LumA	Luminal A	Positive		-10	-3	enrollment	T_Other	T3	LIVING	0	TCGA-A8-A06T-01	1614	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 14	TCGA-A8-A06T			1614	Breast	TCGA Breast Cancer	breast invasive carcinoma					75	Left Upper Outer Quadrant			TCGA-A8-A06T-F40816		Positive					Positive	Other					-27393	941		0	1614												2013-3-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			110	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2											false	M0	N1a	T3	Stage IIIA	TCGA-A8-A06T.5D888D65-685F-4598-884F-AD057DE5FD1D.pdf	7	7	0	0	2	2	0	0	0	0	15	15	83	83	85	85	TUMOR FREE						YES		Yes			NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2007	TCGA-A8-A06T-01A-11W-A019-09	TCGA-A8-A06T-01		TCGA-A8-A06T-01A-11R-A010-13	TCGA-A8-A06T-01A-11W-A019-09		TCGA-A8-A06T-01A-11W-A019-09		TCGA-A8-A06T-01A-11W-A019-09	de1cdf25-62e6-41c0-b1c8-257175519041	768075b7-62ca-4f16-b1a6-7700c94a146b	TCGA-A8-A06T-01A-11D-A011-01	de1cdf25-62e6-41c0-b1c8-257175519041		TCGA-A8-A06T-01	TCGA-A8-A06T-01A-11R-A00Z-07	de1cdf25-62e6-41c0-b1c8-257175519041	de1cdf25-62e6-41c0-b1c8-257175519041	TCGA-A8-A06T-01A-11D-A011-01	TCGA-A8-A06T-01	TCGA-A8-A06T-01	TCGA-A8-A06T-01A-11D-A00Y-05	768075b7-62ca-4f16-b1a6-7700c94a146b	TCGA-A8-A06T-01A-11R-A010-13
TCGA-A8-A06U-01	Stage IIB	80		Stage IIB	882	882	Positive	FEMALE	Equivocal				Negative	M0	Positive	N1	882	1	LumA	Luminal A	Positive	LumA/B	-2	-5	enrollment	T_Other	T2	DECEASED	1	TCGA-A8-A06U-01	883	1	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A06U			883	Breast	TCGA Breast Cancer	breast invasive carcinoma					80	Right Upper Outer Quadrant			TCGA-A8-A06U-F40817		Positive					Positive	Other					-29525	759	883	0													2013-3-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			250	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4											false	M0	N1a	T2	Stage IIB	TCGA-A8-A06U.A314FB55-F20A-4485-965D-D7894D070A16.pdf	15	5	0	0	0	0	0	0	40	25	10	10	50	65	75	80	TUMOR FREE								Yes			NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	DECEASED	2008	TCGA-A8-A06U-01A-11W-A019-09	TCGA-A8-A06U-01		TCGA-A8-A06U-01A-11R-A010-13		f47ef5b8-45ae-4cd2-915a-ba5f790465bd	TCGA-A8-A06U-01A-11W-A019-09	TCGA-A8-A06U-01A-21-A13A-20	TCGA-A8-A06U-01A-11W-A019-09	89f9e509-5f4c-439b-b610-860f209332d2	714b3b2b-ad91-483d-8754-2afc96067e5e	TCGA-A8-A06U-01A-11D-A011-01	89f9e509-5f4c-439b-b610-860f209332d2		TCGA-A8-A06U-01	TCGA-A8-A06U-01A-11R-A00Z-07	89f9e509-5f4c-439b-b610-860f209332d2	89f9e509-5f4c-439b-b610-860f209332d2	TCGA-A8-A06U-01A-11D-A011-01	TCGA-A8-A06U-01	TCGA-A8-A06U-01	TCGA-A8-A06U-01A-11D-A00Y-05	714b3b2b-ad91-483d-8754-2afc96067e5e	TCGA-A8-A06U-01A-11R-A010-13
TCGA-A8-A06X-01	Stage IIB	77	1	Stage IIB	943	943	Positive	FEMALE	Positive				Negative	M0	Negative	N0	943	1	LumB	Luminal B	Negative	LumA/B	-2	-5	enrollment	T_Other	T3	DECEASED	1	TCGA-A8-A06X-01	943	1	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7			mutation c1uster 10	TCGA-A8-A06X			943	Breast	TCGA Breast Cancer	breast invasive carcinoma					77	Right Upper Outer Quadrant			TCGA-A8-A06X-F40818		Positive					Negative	Other					-28338	1276	943	0													2013-3-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			760	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3												false	M0	N0	T3	Stage IIB	TCGA-A8-A06X.738B601A-24D8-4261-B000-198648213070.pdf	14	16	0	0	0	0	0	0	60	75	10	5	30	20	78	75	TUMOR FREE								No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	DECEASED	2006	TCGA-A8-A06X-01A-21W-A019-09	TCGA-A8-A06X-01			TCGA-A8-A06X-01A-21W-A019-09	1896a8eb-415e-4b05-aad1-dec8b4a5c473	TCGA-A8-A06X-01A-21W-A019-09	TCGA-A8-A06X-01A-11-A13A-20	TCGA-A8-A06X-01A-21W-A019-09	3ea9e7f1-39af-4089-b1c0-3c62db4e3102	b8726c73-a8fe-4444-b034-a3100bd3d02b	TCGA-A8-A06X-01A-21D-A011-01	3ea9e7f1-39af-4089-b1c0-3c62db4e3102		TCGA-A8-A06X-01	TCGA-A8-A06X-01A-21R-A00Z-07	3ea9e7f1-39af-4089-b1c0-3c62db4e3102	3ea9e7f1-39af-4089-b1c0-3c62db4e3102	TCGA-A8-A06X-01A-21D-A011-01	TCGA-A8-A06X-01	TCGA-A8-A06X-01	TCGA-A8-A06X-01A-21D-A00Y-05	b8726c73-a8fe-4444-b034-a3100bd3d02b	
TCGA-A8-A06Y-01	Stage IIA	66	4	Stage IIA	791		Positive	FEMALE	Negative	1	3	3	Negative	M0	Negative	N0	791	0	LumA	Luminal A	Positive	LumA	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A06Y-01	791	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A06Y	791	1	791	Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Left Upper Outer Quadrant			TCGA-A8-A06Y-F40819		Positive					Positive	Other					-24442	667		0	791			791									2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			130	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								YES			false	M0	N0	T2	Stage IIA	TCGA-A8-A06Y.5664F531-9D45-4302-A455-63E46B5EDD26.pdf	3	5	0	0	2	0	0	0	15	25	45	50	38	25	85	75	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	TCGA-A8-A06Y-01A-21W-A019-09	TCGA-A8-A06Y-01		TCGA-A8-A06Y-01A-21R-A010-13	TCGA-A8-A06Y-01A-21W-A019-09	71251016-7304-4492-8278-a1718ecdb97a	TCGA-A8-A06Y-01A-21W-A019-09	TCGA-A8-A06Y-01A-11-A13A-20	TCGA-A8-A06Y-01A-21W-A019-09	14f20743-35f3-4e68-a2e5-e03edfe31a97	2e6c87bb-1fb1-4c26-9081-8848b022d900	TCGA-A8-A06Y-01A-21D-A011-01	14f20743-35f3-4e68-a2e5-e03edfe31a97		TCGA-A8-A06Y-01	TCGA-A8-A06Y-01A-21R-A00Z-07	14f20743-35f3-4e68-a2e5-e03edfe31a97	14f20743-35f3-4e68-a2e5-e03edfe31a97	TCGA-A8-A06Y-01A-21D-A011-01	TCGA-A8-A06Y-01	TCGA-A8-A06Y-01	TCGA-A8-A06Y-01A-21D-A00Y-05	2e6c87bb-1fb1-4c26-9081-8848b022d900	TCGA-A8-A06Y-01A-21R-A010-13
TCGA-A8-A06Z-01	Stage IIB	84	5	Stage IIB	31		Positive	FEMALE	Negative	1	3	4	Negative	M0	Negative	N0	31	0	LumB	Luminal B	Positive	Her2	-10	-3	enrollment	T_Other	T3	LIVING	0	TCGA-A8-A06Z-01	31	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 5	Cluster 5	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-A8-A06Z			31	Breast	TCGA Breast Cancer	breast invasive carcinoma					84	Right Upper Outer Quadrant					Positive					Positive	Other					-30984	1003		0	31												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			330	NO	Negative	Negative				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	1											false	M0	N0	T3	Stage IIB	TCGA-A8-A06Z.956F45E5-A8C6-4A4A-9D1F-D31912180584.pdf	2	3	0	0	4	2	0	0	10	25	16	38	70	35	90	85									No				Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2007	TCGA-A8-A06Z-01A-11W-A019-09	TCGA-A8-A06Z-01		TCGA-A8-A06Z-01A-11R-A010-13	TCGA-A8-A06Z-01A-11W-A019-09	afd9a962-46e2-4b42-bc6e-eb091d7f9b5b	TCGA-A8-A06Z-01A-11W-A019-09	TCGA-A8-A06Z-01A-21-A13A-20	TCGA-A8-A06Z-01A-11W-A019-09	42b99ee7-a1ae-4383-b343-adf468cb8b51	0cea4cc3-5997-4ab3-8528-2e13e1e0fade	TCGA-A8-A06Z-01A-11D-A011-01	42b99ee7-a1ae-4383-b343-adf468cb8b51		TCGA-A8-A06Z-01	TCGA-A8-A06Z-01A-11R-A00Z-07	42b99ee7-a1ae-4383-b343-adf468cb8b51	42b99ee7-a1ae-4383-b343-adf468cb8b51	TCGA-A8-A06Z-01A-11D-A011-01	TCGA-A8-A06Z-01	TCGA-A8-A06Z-01	TCGA-A8-A06Z-01A-11D-A00Y-05	0cea4cc3-5997-4ab3-8528-2e13e1e0fade	TCGA-A8-A06Z-01A-11R-A010-13
TCGA-A8-A075-01	Stage IIB	42	2	Stage IIB	517		Positive	FEMALE	Negative	5	2	1	Negative	M0	Positive	N1	517	0	LumB	HER2-enriched	Positive	X	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A075-01	518	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 3	TCGA-A8-A075	518	0	518	Breast	TCGA Breast Cancer	breast invasive carcinoma					42	Left Upper Outer Quadrant			TCGA-A8-A075-F40820		Positive					Positive	Other					-15369	394		0	518												2013-3-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			120	NO	Positive	Positive	NO		Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	1								NO			false	M0	N1a	T2	Stage IIB	TCGA-A8-A075.6643B290-5D7A-4649-B57D-47A5BA4E8D31.pdf	10	10	0	0	10	5	20	5	0	0	5	15	85	80	90	80	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A075-01A-11D-A099-09	TCGA-A8-A075-01		TCGA-A8-A075-01A-11R-A085-13	TCGA-A8-A075-01A-11D-A099-09	a84864ab-5eba-4a64-aa65-883deca0c967	TCGA-A8-A075-01A-11D-A099-09	TCGA-A8-A075-01A-21-A13A-20	TCGA-A8-A075-01A-11D-A099-09	1ccf908a-7620-4af8-b83f-0e287f3655c5	a213bd41-34bd-4bf5-b8af-096156c79b8d	TCGA-A8-A075-01A-11D-A087-01	1ccf908a-7620-4af8-b83f-0e287f3655c5	TCGA-A8-A075-01A-11D-A10P-05	TCGA-A8-A075-01	TCGA-A8-A075-01A-11R-A084-07	1ccf908a-7620-4af8-b83f-0e287f3655c5	1ccf908a-7620-4af8-b83f-0e287f3655c5	TCGA-A8-A075-01A-11D-A087-01	TCGA-A8-A075-01	TCGA-A8-A075-01		a213bd41-34bd-4bf5-b8af-096156c79b8d	TCGA-A8-A075-01A-11R-A085-13
TCGA-A8-A076-01	Stage IIA	66	4	Stage IIA	1641		Positive	FEMALE	Positive	1	1	1	Negative	M0	Negative	N0	1641	0	LumB	HER2-enriched	Positive	Her2	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A076-01	1642	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 6	cluster 4	mutation c1uster 9	TCGA-A8-A076	1642	0	1642	Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Left Upper Outer Quadrant			TCGA-A8-A076-F40821		Positive					Positive	Other					-24230	1518		0	1642												2013-3-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			210	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4								NO			false	M0	N0	T2	Stage IIA	TCGA-A8-A076.DD669244-34D8-4725-A52C-F3AAF59852F9.pdf	15	10	0	0	0	0	5	0	0	0	10	15	90	85	90	85	TUMOR FREE						YES		No			NO	Primary Tumor	01	Surgical Resection	5th		NO	YES	A8	Breast	A	LIVING	2006	TCGA-A8-A076-01A-21W-A019-09	TCGA-A8-A076-01		TCGA-A8-A076-01A-21R-A010-13	TCGA-A8-A076-01A-21W-A019-09	9d5a9ed1-b633-4e0d-8006-826e20c62538	TCGA-A8-A076-01A-21W-A019-09	TCGA-A8-A076-01A-11-A13A-20	TCGA-A8-A076-01A-21W-A019-09	95b5d7ca-4078-4af9-ac6b-4ed1c3cd9c60	4f7e5b63-0735-4b62-82c8-0def83906d4c	TCGA-A8-A076-01A-21D-A011-01	95b5d7ca-4078-4af9-ac6b-4ed1c3cd9c60		TCGA-A8-A076-01	TCGA-A8-A076-01A-21R-A00Z-07	95b5d7ca-4078-4af9-ac6b-4ed1c3cd9c60	95b5d7ca-4078-4af9-ac6b-4ed1c3cd9c60	TCGA-A8-A076-01A-21D-A011-01	TCGA-A8-A076-01	TCGA-A8-A076-01	TCGA-A8-A076-01A-21D-A00Y-05	4f7e5b63-0735-4b62-82c8-0def83906d4c	TCGA-A8-A076-01A-21R-A010-13
TCGA-A8-A079-01	Stage IIIB	69	5	Stage IIIC	274		Positive	FEMALE	Negative	4	3	4	Negative	M0	Positive	N3	274	0	LumB	Luminal B	Positive	LumA/B	-6	-3	enrollment	T_Other	T4	LIVING	0	TCGA-A8-A079-01	274	0	Kirc+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-A8-A079			274	Breast	TCGA Breast Cancer	breast invasive carcinoma					69	Left Upper Outer Quadrant			TCGA-A8-A079-F40822		Positive					Positive	Other					-25294	1033		0	274												2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			380	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	5											false	M0	N3	T4b	Stage IIIB	TCGA-A8-A079.81ADDBAB-C02F-4DA8-9429-76293FB42E42.pdf	1	4	0	0	8	1	0	0	2	0	26	24	64	75	65	80	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	5th		NO	YES	A8	Breast	A	LIVING	2007	TCGA-A8-A079-01A-21W-A019-09	TCGA-A8-A079-01		TCGA-A8-A079-01A-21R-A010-13	TCGA-A8-A079-01A-21W-A019-09	b22ff43f-3646-49dd-ba2e-3cc1a82eb7bd	TCGA-A8-A079-01A-21W-A019-09	TCGA-A8-A079-01A-11-A13A-20	TCGA-A8-A079-01A-21W-A019-09	6fcf4a82-7687-4a9b-bae9-9dabff66aca8	105f3c7d-547d-45d9-b722-5c9fa04ee8d0	TCGA-A8-A079-01A-21D-A011-01	6fcf4a82-7687-4a9b-bae9-9dabff66aca8		TCGA-A8-A079-01	TCGA-A8-A079-01A-21R-A00Z-07	6fcf4a82-7687-4a9b-bae9-9dabff66aca8	6fcf4a82-7687-4a9b-bae9-9dabff66aca8	TCGA-A8-A079-01A-21D-A011-01	TCGA-A8-A079-01	TCGA-A8-A079-01	TCGA-A8-A079-01A-21D-A00Y-05	105f3c7d-547d-45d9-b722-5c9fa04ee8d0	TCGA-A8-A079-01A-21R-A010-13
TCGA-A8-A07B-01	Stage IIA	69	5	Stage IIA	1004		Positive	FEMALE	Positive				Negative	M0	Negative	N0	1004	0	LumA	HER2-enriched	Positive		-1	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07B-01	1308	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 2	TCGA-A8-A07B			1308	Breast	TCGA Breast Cancer	breast invasive carcinoma					69	Left Lower Outer Quadrant			TCGA-A8-A07B-F40823		Positive					Positive	Other					-25475	880		0	1308												2013-3-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			90	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	2											false	M0	N0	T2	Stage IIA	TCGA-A8-A07B.F24A752C-1AAE-4C70-B6D4-DD0E8C89D9AA.pdf	2	2	1	1	10	5	0	0	0	0	25	55	65	40	90	75	TUMOR FREE						NO		No			NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2007	TCGA-A8-A07B-01A-11W-A019-09	TCGA-A8-A07B-01		TCGA-A8-A07B-01A-11R-A010-13	TCGA-A8-A07B-01A-11W-A019-09		TCGA-A8-A07B-01A-11W-A019-09		TCGA-A8-A07B-01A-11W-A019-09	0c9fe532-3920-4a59-b348-65b184c0eff4	46ca210a-0284-4e84-9a0b-4648b337ed02	TCGA-A8-A07B-01A-11D-A011-01	0c9fe532-3920-4a59-b348-65b184c0eff4		TCGA-A8-A07B-01	TCGA-A8-A07B-01A-11R-A00Z-07	0c9fe532-3920-4a59-b348-65b184c0eff4	0c9fe532-3920-4a59-b348-65b184c0eff4	TCGA-A8-A07B-01A-11D-A011-01	TCGA-A8-A07B-01	TCGA-A8-A07B-01	TCGA-A8-A07B-01A-11D-A00Y-05	46ca210a-0284-4e84-9a0b-4648b337ed02	TCGA-A8-A07B-01A-11R-A010-13
TCGA-A8-A07C-01	Stage IIA	57	2	Stage IIA	580		Negative	FEMALE	Negative				Negative	M0	Negative	N0	580	0	Basal	Basal-like	Negative		-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07C-01	1034	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 4	cluster 5	mutation cluster 14	TCGA-A8-A07C	1034	0	1034	Breast	TCGA Breast Cancer	breast invasive carcinoma					57	Right Upper Outer Quadrant			TCGA-A8-A07C-F40824		Negative					Negative	Other					-20820	637		0	1034												2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			80	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5								NO			false	M0	N0	T2	Stage IIA	TCGA-A8-A07C.DC5B662B-1ADD-4D6E-A6E3-3EF8B922BC71.pdf	10	15	0	0	5	5	0	0	2	0	10	10	83	85	85	80	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	TCGA-A8-A07C-01A-11D-A045-09			TCGA-A8-A07C-01A-11R-A035-13			TCGA-A8-A07C-01A-11D-A045-09		TCGA-A8-A07C-01A-11D-A045-09	19d713e8-e754-44a4-9b23-0ef70f5d6b44			19d713e8-e754-44a4-9b23-0ef70f5d6b44		TCGA-A8-A07C-01	TCGA-A8-A07C-01A-11R-A034-07	19d713e8-e754-44a4-9b23-0ef70f5d6b44	19d713e8-e754-44a4-9b23-0ef70f5d6b44		TCGA-A8-A07C-01		TCGA-A8-A07C-01A-11D-A032-05		TCGA-A8-A07C-01A-11R-A035-13
TCGA-A8-A07E-01	Stage X	81	2	Stage IIIC	608		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N3	608	0	LumA	Luminal A	Positive	ReacII	-4	-3	enrollment	T_Other	T4	LIVING	0	TCGA-A8-A07E-01	608	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-A8-A07E	608	0	608	Breast	TCGA Breast Cancer	breast invasive carcinoma					81	Left Upper Outer Quadrant			TCGA-A8-A07E-F40825		Positive					Positive	Other					-29800	545		0	608												2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			260	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	1								NO			false	MX	N3a	T4b	Stage X	TCGA-A8-A07E.E20AC0FF-43C4-49EA-9E33-764E553933B7.pdf	25	10	0	0	2	2	0	0	15	15	18	13	65	70	65	75	TUMOR FREE						YES		Yes			NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	TCGA-A8-A07E-01A-11W-A050-09	TCGA-A8-A07E-01		TCGA-A8-A07E-01A-11R-A035-13		857d3ad8-e3a8-4366-8f34-2b89be3dd24c	TCGA-A8-A07E-01A-11W-A050-09	TCGA-A8-A07E-01A-21-A13B-20	TCGA-A8-A07E-01A-11W-A050-09	3510559d-33b7-423a-88c9-d8c42270d546	16f17633-0917-4fe4-bea8-a1301a37bcc9	TCGA-A8-A07E-01A-11D-A036-01	3510559d-33b7-423a-88c9-d8c42270d546		TCGA-A8-A07E-01	TCGA-A8-A07E-01A-11R-A034-07	3510559d-33b7-423a-88c9-d8c42270d546	3510559d-33b7-423a-88c9-d8c42270d546	TCGA-A8-A07E-01A-11D-A036-01	TCGA-A8-A07E-01	TCGA-A8-A07E-01	TCGA-A8-A07E-01A-11D-A032-05	16f17633-0917-4fe4-bea8-a1301a37bcc9	TCGA-A8-A07E-01A-11R-A035-13
TCGA-A8-A07F-01	Stage IIB	65	2	Stage IIB	576		Positive	FEMALE	Negative	1	4	3	Negative	M0	Positive	N1	576	0	LumA	Luminal A	Positive	ReacI	-1	-1	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07F-01	577	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 4	mutation c1uster 9	TCGA-A8-A07F	577	0	577	Breast	TCGA Breast Cancer	breast invasive carcinoma					65	Left Upper Outer Quadrant			TCGA-A8-A07F-F40826		Positive					Positive	Other					-23742	453		0	577												2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			150	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO			false	M0	N1a	T2	Stage IIB	TCGA-A8-A07F.D1456192-83E7-4FC8-B783-90D615830156.pdf	7	7	0	0	1	2	0	0	4	0	15	23	80	75	85	85	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A07F-01A-11W-A019-09	TCGA-A8-A07F-01		TCGA-A8-A07F-01A-11R-A038-13	TCGA-A8-A07F-01A-11W-A019-09	4d97ec15-8bf1-4bc7-9bc9-4ef5c58f1fbc	TCGA-A8-A07F-01A-11W-A019-09	TCGA-A8-A07F-01A-21-A13B-20	TCGA-A8-A07F-01A-11W-A019-09	f6fd41e3-c597-4c5d-8f47-a315be0330f8	1609caae-f341-4227-ac2a-a76a6c253e95	TCGA-A8-A07F-01A-11D-A011-01	f6fd41e3-c597-4c5d-8f47-a315be0330f8		TCGA-A8-A07F-01	TCGA-A8-A07F-01A-11R-A00Z-07	f6fd41e3-c597-4c5d-8f47-a315be0330f8	f6fd41e3-c597-4c5d-8f47-a315be0330f8	TCGA-A8-A07F-01A-11D-A011-01	TCGA-A8-A07F-01	TCGA-A8-A07F-01	TCGA-A8-A07F-01A-11D-A00Y-05	1609caae-f341-4227-ac2a-a76a6c253e95	TCGA-A8-A07F-01A-11R-A038-13
TCGA-A8-A07G-01	Stage IIA	65	3	Stage IIA	576		Positive	FEMALE	Negative				Negative	M0	Positive	N1	576	0	LumA	Luminal A	Positive		-5	-7	enrollment	T1	T1	LIVING	0	TCGA-A8-A07G-01	577	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A07G	577	0	577	Breast	TCGA Breast Cancer	breast invasive carcinoma					65	Right Upper Outer Quadrant			TCGA-A8-A07G-F40827		Positive					Positive	Other					-23926			0	577												2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES					Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO				M0	N1a	T1c	Stage IIA																		TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast		LIVING	2009	TCGA-A8-A07G-01A-11W-A050-09	TCGA-A8-A07G-01		TCGA-A8-A07G-01A-11R-A035-13	TCGA-A8-A07G-01A-11W-A050-09		TCGA-A8-A07G-01A-11W-A050-09		TCGA-A8-A07G-01A-11W-A050-09	aad6a297-72fe-4483-8c81-b7bef2522437	acf17ee7-c238-4602-9ec3-855c8d334089	TCGA-A8-A07G-01A-11D-A036-01	aad6a297-72fe-4483-8c81-b7bef2522437		TCGA-A8-A07G-01	TCGA-A8-A07G-01A-11R-A034-07	aad6a297-72fe-4483-8c81-b7bef2522437	aad6a297-72fe-4483-8c81-b7bef2522437	TCGA-A8-A07G-01A-11D-A036-01	TCGA-A8-A07G-01	TCGA-A8-A07G-01	TCGA-A8-A07G-01A-11D-A032-05	acf17ee7-c238-4602-9ec3-855c8d334089	TCGA-A8-A07G-01A-11R-A035-13
TCGA-A8-A07I-01	Stage IIIA	69	3	Stage IIIA	426		Positive	FEMALE	Positive	1	1	1	Negative	M0	Positive	N2	426	0	Her2	HER2-enriched	Negative	Her2	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07I-01	426	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A8-A07I	426	0	426	Breast	TCGA Breast Cancer	breast invasive carcinoma					69	Left Upper Outer Quadrant			TCGA-A8-A07I-F40828		Positive					Negative	Other					-25263	302		0	426												2013-3-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			130	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4								NO			false	M0	N2a	T2	Stage IIIA	TCGA-A8-A07I.5DA3A8E1-7EE6-45EC-89EC-69423E2B866B.pdf	21	11	0	0	2	2	0	0	7	5	15	18	76	75	70	80	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A07I-01A-11W-A019-09	TCGA-A8-A07I-01		TCGA-A8-A07I-01A-11R-A010-13	TCGA-A8-A07I-01A-11W-A019-09	f8e3aadc-06b2-43d4-9cdb-a3c285bedaee	TCGA-A8-A07I-01A-11W-A019-09	TCGA-A8-A07I-01A-21-A13B-20	TCGA-A8-A07I-01A-11W-A019-09	670eab31-e873-4404-bbff-1b427e7b80c1	8c976a66-2f34-4441-8f79-a13136e1dbe7	TCGA-A8-A07I-01A-11D-A011-01	670eab31-e873-4404-bbff-1b427e7b80c1		TCGA-A8-A07I-01	TCGA-A8-A07I-01A-11R-A00Z-07	670eab31-e873-4404-bbff-1b427e7b80c1	670eab31-e873-4404-bbff-1b427e7b80c1	TCGA-A8-A07I-01A-11D-A011-01	TCGA-A8-A07I-01	TCGA-A8-A07I-01	TCGA-A8-A07I-01A-11D-A00Y-05	8c976a66-2f34-4441-8f79-a13136e1dbe7	TCGA-A8-A07I-01A-11R-A010-13
TCGA-A8-A07J-01	Stage IIB	35	2	Stage IIB	365		Positive	FEMALE	Negative				Negative	M0	Positive	N1	365	0	LumA	Luminal A	Positive		-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07J-01	365	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A07J	365	0	365	Breast	TCGA Breast Cancer	breast invasive carcinoma					35	Right Upper Outer Quadrant			TCGA-A8-A07J-F40829		Positive					Positive	Other					-12965	241		0	365												2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			130	NO	Negative	Negative	NO		Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4								NO			false	M0	N1a	T2	Stage IIB	TCGA-A8-A07J.2243F29C-191C-4D33-8483-09BB3AD36598.pdf	2	2	0	0	0	0	0	0	4	5	21	25	75	70	75	70	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A07J-01A-11W-A019-09	TCGA-A8-A07J-01		TCGA-A8-A07J-01A-21R-A057-13	TCGA-A8-A07J-01A-11W-A019-09		TCGA-A8-A07J-01A-11W-A019-09		TCGA-A8-A07J-01A-11W-A019-09	a5405b3a-e351-4e9e-b3fa-07c33e3318d3	8990de9b-eee2-4d3c-9711-87bdf6019586	TCGA-A8-A07J-01A-11D-A011-01	a5405b3a-e351-4e9e-b3fa-07c33e3318d3		TCGA-A8-A07J-01	TCGA-A8-A07J-01A-11R-A00Z-07	a5405b3a-e351-4e9e-b3fa-07c33e3318d3	a5405b3a-e351-4e9e-b3fa-07c33e3318d3	TCGA-A8-A07J-01A-11D-A011-01	TCGA-A8-A07J-01	TCGA-A8-A07J-01	TCGA-A8-A07J-01A-11D-A00Y-05	8990de9b-eee2-4d3c-9711-87bdf6019586	TCGA-A8-A07J-01A-21R-A057-13
TCGA-A8-A07L-01	Stage IIIA	58	4	Stage IIIA	517		Positive	FEMALE	Negative				Negative	M0	Positive	N1	517	0	LumB	Luminal B	Positive		-10	-3	enrollment	T_Other	T3	LIVING	0	TCGA-A8-A07L-01	975	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 5	mutation cluster 12	TCGA-A8-A07L	975	0	975	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Right Upper Outer Quadrant			TCGA-A8-A07L-F40830		Positive					Positive	Other					-21428	394		0	975												2013-3-2	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			80	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5								NO			false	M0	N1a	T3	Stage IIIA	TCGA-A8-A07L.5D93AE27-79A0-4809-AE7C-54814CED0851.pdf	1	2	0	0	0	1	0	0	1	1	14	18	85	80	85	80	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A07L-01A-11W-A019-09	TCGA-A8-A07L-01		TCGA-A8-A07L-01A-11R-A010-13	TCGA-A8-A07L-01A-11W-A019-09		TCGA-A8-A07L-01A-11W-A019-09		TCGA-A8-A07L-01A-11W-A019-09	76cbecbe-22ef-479a-9306-2f09e1d87757	11e4ced1-680d-482e-85fc-0a518c4f3e81	TCGA-A8-A07L-01A-11D-A011-01	76cbecbe-22ef-479a-9306-2f09e1d87757		TCGA-A8-A07L-01	TCGA-A8-A07L-01A-11R-A040-07	76cbecbe-22ef-479a-9306-2f09e1d87757	76cbecbe-22ef-479a-9306-2f09e1d87757	TCGA-A8-A07L-01A-11D-A011-01	TCGA-A8-A07L-01	TCGA-A8-A07L-01	TCGA-A8-A07L-01A-11D-A00Y-05	11e4ced1-680d-482e-85fc-0a518c4f3e81	TCGA-A8-A07L-01A-11R-A010-13
TCGA-A8-A07O-01	Stage IIA	51	1	Stage IIA	304		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	304	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07O-01	304	0	BRCA-LUAD+	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A8-A07O	304	0	304	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Right Upper Outer Quadrant			TCGA-A8-A07O-F40831		Negative					Negative	Other					-18870	180		0	304												2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			220	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4								NO			false	M0	N0	T2	Stage IIA	TCGA-A8-A07O.9ECA4450-A550-44DE-B2E5-FD1CFF02A9FE.pdf	2	4	0	0	9	5	0	0	0	0	10	10	81	85	90	90	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A07O-01A-11W-A019-09	TCGA-A8-A07O-01		TCGA-A8-A07O-01A-11R-A038-13	TCGA-A8-A07O-01A-11W-A019-09	d7dd9819-8523-4dff-8ffb-689d37a73368	TCGA-A8-A07O-01A-11W-A019-09	TCGA-A8-A07O-01A-21-A13B-20	TCGA-A8-A07O-01A-11W-A019-09	0b743ba9-a340-46a0-9276-a5ddd3ee69d6	8ed5d79e-3f1b-497f-b9da-fde3a6798c21	TCGA-A8-A07O-01A-11D-A011-01	0b743ba9-a340-46a0-9276-a5ddd3ee69d6		TCGA-A8-A07O-01	TCGA-A8-A07O-01A-11R-A00Z-07	0b743ba9-a340-46a0-9276-a5ddd3ee69d6	0b743ba9-a340-46a0-9276-a5ddd3ee69d6	TCGA-A8-A07O-01A-11D-A011-01	TCGA-A8-A07O-01	TCGA-A8-A07O-01	TCGA-A8-A07O-01A-11D-A00Y-05	8ed5d79e-3f1b-497f-b9da-fde3a6798c21	TCGA-A8-A07O-01A-11R-A038-13
TCGA-A8-A07P-01	Stage IIB	68	4	Stage IIB	334		Positive	FEMALE	Positive	4	3	3	Negative	M0	Positive	N1	334	0	LumA	Luminal A	Positive	LumA/B	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07P-01	334	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A07P			334	Breast	TCGA Breast Cancer	breast invasive carcinoma					68	Left Upper Outer Quadrant			TCGA-A8-A07P-F40832		Positive					Positive	Other					-24929	210		0	334												2013-3-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			120	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	2											false	M0	N1	T2	Stage IIB	TCGA-A8-A07P.6C7D956E-1247-4663-9ED5-D406AE6E2959.pdf	2	1	0	0	2	0	0	0	0	0	28	20	70	80	70	80	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A07P-01A-11W-A019-09	TCGA-A8-A07P-01		TCGA-A8-A07P-01A-11R-A010-13	TCGA-A8-A07P-01A-11W-A019-09	00703e0f-8964-4b44-a5f3-d1246e5358ff	TCGA-A8-A07P-01A-11W-A019-09	TCGA-A8-A07P-01A-21-A13B-20	TCGA-A8-A07P-01A-11W-A019-09	dad4f72e-cb2c-4015-af6a-53ad0ae45f12	5a7e3234-ced9-46cb-ac95-cbf4c9ef1d85	TCGA-A8-A07P-01A-11D-A011-01	dad4f72e-cb2c-4015-af6a-53ad0ae45f12		TCGA-A8-A07P-01	TCGA-A8-A07P-01A-11R-A00Z-07	dad4f72e-cb2c-4015-af6a-53ad0ae45f12	dad4f72e-cb2c-4015-af6a-53ad0ae45f12	TCGA-A8-A07P-01A-11D-A011-01	TCGA-A8-A07P-01	TCGA-A8-A07P-01	TCGA-A8-A07P-01A-11D-A00Y-05	5a7e3234-ced9-46cb-ac95-cbf4c9ef1d85	TCGA-A8-A07P-01A-11R-A010-13
TCGA-A8-A07R-01	Stage IIIC	80	3	Stage IIIC	273		Negative	FEMALE	Equivocal	2	2	2	Negative	M0	Positive	N3	273	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07R-01	273	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A8-A07R			273	Breast	TCGA Breast Cancer	breast invasive carcinoma					80	Left Upper Outer Quadrant					Negative					Negative	Other					-29251			0	273												2011-5-27	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES					Positive				Positive																			5	4												M0	N3a	T2	Stage IIIC																										No				Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast		LIVING	2009	TCGA-A8-A07R-01A-21W-A050-09	TCGA-A8-A07R-01		TCGA-A8-A07R-01A-21R-A035-13	TCGA-A8-A07R-01A-21W-A050-09	f547b351-f375-4f31-970f-40e006020b01	TCGA-A8-A07R-01A-21W-A050-09	TCGA-A8-A07R-01A-12-A13B-20	TCGA-A8-A07R-01A-21W-A050-09	ce045098-cbfb-4c73-9bbe-6a1d677ae0b0	b5e9e344-a813-442e-8bd4-504111e98c0b	TCGA-A8-A07R-01A-21D-A036-01	ce045098-cbfb-4c73-9bbe-6a1d677ae0b0		TCGA-A8-A07R-01	TCGA-A8-A07R-01A-21R-A034-07	ce045098-cbfb-4c73-9bbe-6a1d677ae0b0	ce045098-cbfb-4c73-9bbe-6a1d677ae0b0	TCGA-A8-A07R-01A-21D-A036-01	TCGA-A8-A07R-01	TCGA-A8-A07R-01	TCGA-A8-A07R-01A-21D-A032-05	b5e9e344-a813-442e-8bd4-504111e98c0b	TCGA-A8-A07R-01A-21R-A035-13
TCGA-A8-A07S-01	Stage IIA	73	2	Stage IIA	242		Positive	FEMALE	Negative				Negative	M0	Negative	N0	242	0	LumB	Luminal B	Negative	LumA	-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07S-01	243	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7		TCGA-A8-A07S	243	0	243	Breast	TCGA Breast Cancer	breast invasive carcinoma					73	Left Upper Outer Quadrant			TCGA-A8-A07S-F40833		Positive					Negative	Other					-26998	119		0	243												2013-3-2	FEMALE										Mixed Histology (please specify)	lobular/ductal	No		C50.9	8522/3	C50.4		YES			220	NO	Negative	Negative	NO		Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	7								NO			false	M0	N0	T2	Stage IIA	TCGA-A8-A07S.AC2E3DDC-3AF6-45F0-8269-E9DA68F4367A.pdf	1	2	0	0	12	6	0	0	0	0	8	19	80	75	80	75	WITH TUMOR						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009		TCGA-A8-A07S-01		TCGA-A8-A07S-01A-11R-A035-13		a86ad293-8480-4f2f-b3d2-6f59fa709d03		TCGA-A8-A07S-01A-22-A13B-20		15acd388-f958-4f43-bc38-39bab4cb830e	3d19e369-66d9-425c-b692-b82da1c5455a	TCGA-A8-A07S-01A-11D-A036-01	15acd388-f958-4f43-bc38-39bab4cb830e		TCGA-A8-A07S-01	TCGA-A8-A07S-01A-11R-A034-07	15acd388-f958-4f43-bc38-39bab4cb830e	15acd388-f958-4f43-bc38-39bab4cb830e	TCGA-A8-A07S-01A-11D-A036-01	TCGA-A8-A07S-01	TCGA-A8-A07S-01	TCGA-A8-A07S-01A-11D-A032-05	3d19e369-66d9-425c-b692-b82da1c5455a	TCGA-A8-A07S-01A-11R-A035-13
TCGA-A8-A07U-01	Stage IIIA	66	3	Stage IIIA	303		Negative	FEMALE	Negative				Negative	M0	Positive	N2	303	0	Basal	Basal-like	Positive		-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07U-01	760	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 7	cluster 4	mutation cluster 5	TCGA-A8-A07U	760	0	760	Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Right Upper Outer Quadrant			TCGA-A8-A07U-F40834		Negative					Positive	Other					-24411	210		0	760												2013-3-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			100	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4								NO			false	M0	N2a	T2	Stage IIIA	TCGA-A8-A07U.1E7788D8-B5FC-473A-8A10-79910443799A.pdf	10	10	2	2	5	15	0	0	0	0	15	10	80	75	75	80	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A07U-01A-11W-A050-09	TCGA-A8-A07U-01		TCGA-A8-A07U-01A-11R-A035-13	TCGA-A8-A07U-01A-11W-A050-09		TCGA-A8-A07U-01A-11W-A050-09		TCGA-A8-A07U-01A-11W-A050-09	77daa4a6-93c2-4455-a173-ead372d92010	b010bf66-762b-4080-9427-130a56fe2760	TCGA-A8-A07U-01A-11D-A036-01	77daa4a6-93c2-4455-a173-ead372d92010		TCGA-A8-A07U-01	TCGA-A8-A07U-01A-11R-A034-07	77daa4a6-93c2-4455-a173-ead372d92010	77daa4a6-93c2-4455-a173-ead372d92010	TCGA-A8-A07U-01A-11D-A036-01	TCGA-A8-A07U-01	TCGA-A8-A07U-01	TCGA-A8-A07U-01A-11D-A032-05	b010bf66-762b-4080-9427-130a56fe2760	TCGA-A8-A07U-01A-11R-A035-13
TCGA-A8-A07W-01	Stage IV	76	3	Stage IV	304		Positive	FEMALE	Negative	1	1	4	Positive	M1	Negative	N0	304	0	LumB	Luminal B	Positive	LumA/B	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07W-01	304	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A8-A07W			304	Breast	TCGA Breast Cancer	breast invasive carcinoma					76	Left Upper Outer Quadrant			TCGA-A8-A07W-F40835		Positive					Positive	Other					-27942	180		0	304												2013-3-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			180	NO	Negative	Negative	NO		Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4											false	M1	NX	T2	Stage IV	TCGA-A8-A07W.C39563FD-CD7F-47C6-A257-5CB70A01C67C.pdf	9	5	3	1	10	5	0	0	0	2	25	35	65	58	80	80	WITH TUMOR						YES		No			NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A07W-01A-11W-A019-09	TCGA-A8-A07W-01		TCGA-A8-A07W-01A-11R-A010-13	TCGA-A8-A07W-01A-11W-A019-09	e407dd09-754f-4167-b2cf-391893051541	TCGA-A8-A07W-01A-11W-A019-09	TCGA-A8-A07W-01A-21-A13A-20	TCGA-A8-A07W-01A-11W-A019-09	03403807-a06f-4d79-ac2d-2d494d4fabee	3e06faf7-1e08-4c15-9aee-8891de8cad5c	TCGA-A8-A07W-01A-11D-A011-01	03403807-a06f-4d79-ac2d-2d494d4fabee		TCGA-A8-A07W-01	TCGA-A8-A07W-01A-11R-A00Z-07	03403807-a06f-4d79-ac2d-2d494d4fabee	03403807-a06f-4d79-ac2d-2d494d4fabee	TCGA-A8-A07W-01A-11D-A011-01	TCGA-A8-A07W-01	TCGA-A8-A07W-01	TCGA-A8-A07W-01A-11D-A00Y-05	3e06faf7-1e08-4c15-9aee-8891de8cad5c	TCGA-A8-A07W-01A-11R-A010-13
TCGA-A8-A07Z-01	Stage IIA	85	3	Stage IIA	853		Positive	FEMALE	Negative	3	3	4	Negative	M0	Negative	N0	853	0		Luminal B	Positive	LumA	-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07Z-01	1371	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A8-A07Z	1371	0	1371	Breast	TCGA Breast Cancer	breast invasive carcinoma					85	Left			TCGA-A8-A07Z-F40836		Positive					Positive	Other					-31351	698		0	1371												2013-3-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1		YES			130	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO			false	M0	N0	T2	Stage IIA	TCGA-A8-A07Z.DD558354-3BF1-4037-881E-011E6BFC0987.pdf	5	3	0	0	0	0	0	0	10	40	20	25	70	35	90	90	TUMOR FREE						YES		No			NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	TCGA-A8-A07Z-01A-11W-A019-09	TCGA-A8-A07Z-01		TCGA-A8-A07Z-01A-11R-A010-13		a0ca1a15-ed13-4ba7-9565-604073ec88a3	TCGA-A8-A07Z-01A-11W-A019-09	TCGA-A8-A07Z-01A-21-A13A-20	TCGA-A8-A07Z-01A-11W-A019-09	a88a7f5b-09bc-43ec-ad0c-1a094d022f90	5ea9f45c-2863-4516-a5a2-057ff494b14e	TCGA-A8-A07Z-01A-11D-A011-01	a88a7f5b-09bc-43ec-ad0c-1a094d022f90		TCGA-A8-A07Z-01	TCGA-A8-A07Z-01A-11R-A00Z-07	a88a7f5b-09bc-43ec-ad0c-1a094d022f90	a88a7f5b-09bc-43ec-ad0c-1a094d022f90	TCGA-A8-A07Z-01A-11D-A011-01	TCGA-A8-A07Z-01	TCGA-A8-A07Z-01	TCGA-A8-A07Z-01A-11D-A00Y-05	5ea9f45c-2863-4516-a5a2-057ff494b14e	TCGA-A8-A07Z-01A-11R-A010-13
TCGA-A8-A081-01	Stage IIA	80	5	Stage IIA	0		Positive	FEMALE	Negative	1	1	1	Negative	M0	Negative	N0	0	0	LumB	HER2-enriched	Positive	Her2	-2	-5	enrollment	T_Other	T2	LIVING		TCGA-A8-A081-01			High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 3	TCGA-A8-A081				Breast	TCGA Breast Cancer	breast invasive carcinoma					80	Right					Positive					Positive	Other					-29555	637		0	0												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1		YES			150	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	3											false	M0	N0	T2	Stage IIA	TCGA-A8-A081.DE25BF82-5F7A-489B-BFC1-9386C44E7D62.pdf	1	2	0	0	2	5	0	1	0	5	20	20	78	70	80	75	TUMOR FREE								No				Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	TCGA-A8-A081-01A-11W-A019-09	TCGA-A8-A081-01		TCGA-A8-A081-01A-11R-A010-13	TCGA-A8-A081-01A-11W-A019-09	8392c9cd-b36d-4cb2-887b-8fa3c219d843	TCGA-A8-A081-01A-11W-A019-09	TCGA-A8-A081-01A-21-A13A-20	TCGA-A8-A081-01A-11W-A019-09	c88b614b-811e-42f9-86e3-10909ced98e7	fe041229-97be-4bac-9294-04b42df07890	TCGA-A8-A081-01A-11D-A011-01	c88b614b-811e-42f9-86e3-10909ced98e7		TCGA-A8-A081-01	TCGA-A8-A081-01A-11R-A00Z-07	c88b614b-811e-42f9-86e3-10909ced98e7	c88b614b-811e-42f9-86e3-10909ced98e7	TCGA-A8-A081-01A-11D-A011-01	TCGA-A8-A081-01	TCGA-A8-A081-01	TCGA-A8-A081-01A-11D-A00Y-05	fe041229-97be-4bac-9294-04b42df07890	TCGA-A8-A081-01A-11R-A010-13
TCGA-A8-A082-01	Stage IIB	58	4	Stage IIB	549		Positive	FEMALE	Negative	1	3	4	Negative	M0	Positive	N1	549	0	LumB	Luminal B	Positive	LumA	-9	-3	enrollment	T_Other	T2	LIVING		TCGA-A8-A082-01			Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 5	mutation c1uster 9	TCGA-A8-A082				Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Right			TCGA-A8-A082-F40837		Positive					Positive	Other					-21338	606		0	-31												2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1		YES			130	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5								NO			false	M0	N1a	T2	Stage IIB	TCGA-A8-A082.3E967C4F-B916-4A80-A9A1-A5E94F02322C.pdf	1	1	0	0	1	1	0	0	1	1	10	10	88	88	90	90	TUMOR FREE						YES		No			NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	TCGA-A8-A082-01A-11W-A019-09	TCGA-A8-A082-01		TCGA-A8-A082-01A-11R-A010-13	TCGA-A8-A082-01A-11W-A019-09	a9d13722-7419-4250-a943-ccb78a486228	TCGA-A8-A082-01A-11W-A019-09	TCGA-A8-A082-01A-21-A13A-20	TCGA-A8-A082-01A-11W-A019-09	2fd81438-46a2-42f5-910e-728faea3872a	4b289590-8f98-4153-a0e8-1d59e7d3260c	TCGA-A8-A082-01A-11D-A011-01	2fd81438-46a2-42f5-910e-728faea3872a		TCGA-A8-A082-01	TCGA-A8-A082-01A-11R-A00Z-07	2fd81438-46a2-42f5-910e-728faea3872a	2fd81438-46a2-42f5-910e-728faea3872a	TCGA-A8-A082-01A-11D-A011-01	TCGA-A8-A082-01	TCGA-A8-A082-01	TCGA-A8-A082-01A-11D-A00Y-05	4b289590-8f98-4153-a0e8-1d59e7d3260c	TCGA-A8-A082-01A-11R-A010-13
TCGA-A8-A083-01	Stage IIB	67	2	Stage IIB	0		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	0	0	LumA	Luminal A	Positive	LumA	-12	-3	enrollment	T_Other	T3	LIVING		TCGA-A8-A083-01			Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A083				Breast	TCGA Breast Cancer	breast invasive carcinoma					67	Left					Positive					Positive	Other					-24746	575		0	0												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1		YES			300	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2											false	M0	N0	T3	Stage IIB	TCGA-A8-A083.AF0A2220-DEEC-44C8-B15C-B6442D5B7517.pdf	4	1	2	0	1	1	0	0	0	2	24	27	75	70	85	70	TUMOR FREE								No				Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	TCGA-A8-A083-01A-21W-A019-09	TCGA-A8-A083-01		TCGA-A8-A083-01A-21R-A010-13		503f0e18-bc85-4950-bba1-b55d4c29760a	TCGA-A8-A083-01A-21W-A019-09	TCGA-A8-A083-01A-11-A13A-20	TCGA-A8-A083-01A-21W-A019-09	72b7ab0e-81e0-4385-8125-5146243e21ac	0d197013-8a77-4839-a2ad-bc70650613eb	TCGA-A8-A083-01A-21D-A011-01	72b7ab0e-81e0-4385-8125-5146243e21ac		TCGA-A8-A083-01	TCGA-A8-A083-01A-21R-A00Z-07	72b7ab0e-81e0-4385-8125-5146243e21ac	72b7ab0e-81e0-4385-8125-5146243e21ac	TCGA-A8-A083-01A-21D-A011-01	TCGA-A8-A083-01	TCGA-A8-A083-01	TCGA-A8-A083-01A-21D-A00Y-05	0d197013-8a77-4839-a2ad-bc70650613eb	TCGA-A8-A083-01A-21R-A010-13
TCGA-A8-A084-01	Stage IIB	81	1	No_Conversion	458		Positive	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	458	0	LumB	Luminal B	Negative	X	-1	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A084-01	458	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 3	TCGA-A8-A084			458	Breast	TCGA Breast Cancer	breast invasive carcinoma					81	Left			TCGA-A8-A084-F40838		Positive					Negative	Other					-29858	1033		0	458												2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.1		YES			270	NO	Negative	Negative	NO		Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	3											false	M0	N1a	T2	Stage IIB	TCGA-A8-A084.6A49B3F9-6B43-4D74-A28B-C83BFE61EC7B.pdf	1	1	0	1	1	1	0	0	1	0	13	6	85	93	85	70	WITH TUMOR						NO		Yes			YES	Primary Tumor	01	Surgical resection	5th		NO	YES	A8	Breast	A	LIVING	2007	TCGA-A8-A084-01A-21W-A019-09	TCGA-A8-A084-01		TCGA-A8-A084-01A-21R-A010-13		adfcebcc-edf7-4351-ba59-e1fea8580893	TCGA-A8-A084-01A-21W-A019-09	TCGA-A8-A084-01A-11-A13A-20	TCGA-A8-A084-01A-21W-A019-09	2f2fe990-f8f6-4904-b3d5-083e17a7a29d	5b2d8ac0-cdb6-486f-bbad-3555c216ab0a	TCGA-A8-A084-01A-21D-A011-01	2f2fe990-f8f6-4904-b3d5-083e17a7a29d		TCGA-A8-A084-01	TCGA-A8-A084-01A-21R-A00Z-07	2f2fe990-f8f6-4904-b3d5-083e17a7a29d	2f2fe990-f8f6-4904-b3d5-083e17a7a29d	TCGA-A8-A084-01A-21D-A011-01	TCGA-A8-A084-01	TCGA-A8-A084-01	TCGA-A8-A084-01A-21D-A00Y-05	5b2d8ac0-cdb6-486f-bbad-3555c216ab0a	TCGA-A8-A084-01A-21R-A010-13
TCGA-A8-A085-01	Stage IIB	44	5	Stage IIB	1124		Positive	MALE	Negative	1	3	4	Negative	M0	Positive	N1	1124	0	LumB	Luminal B	Positive	LumA/B	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A085-01	1124	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A085	1124	0	1124	Breast	TCGA Breast Cancer	breast invasive carcinoma					44	Left			TCGA-A8-A085-F40839		Positive					Positive	Other					-16377	788		0	1124												2013-3-2	MALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1		YES			130	NO	Negative	Negative	NO		Negative																			4	2								NO			false	M0	N1a	T2	Stage IIB	TCGA-A8-A085.64F84FF4-A477-4E1E-B4BB-E5614517229E.pdf	1	1	0	0	0	0	0	0	0	1	10	19	90	80	90	80	TUMOR FREE						YES		No			NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	TCGA-A8-A085-01A-11W-A019-09	TCGA-A8-A085-01		TCGA-A8-A085-01A-11R-A010-13	TCGA-A8-A085-01A-11W-A019-09	96e8bae5-7cde-475e-b1ba-ec2ac2efeb6e	TCGA-A8-A085-01A-11W-A019-09	TCGA-A8-A085-01A-21-A13B-20	TCGA-A8-A085-01A-11W-A019-09	4be8001c-c6a2-420c-8761-93469a6a7904	03b447b0-d92c-4d78-a496-fcf20be55ce5	TCGA-A8-A085-01A-11D-A011-01	4be8001c-c6a2-420c-8761-93469a6a7904		TCGA-A8-A085-01	TCGA-A8-A085-01A-11R-A00Z-07	4be8001c-c6a2-420c-8761-93469a6a7904	4be8001c-c6a2-420c-8761-93469a6a7904	TCGA-A8-A085-01A-11D-A011-01	TCGA-A8-A085-01	TCGA-A8-A085-01	TCGA-A8-A085-01A-11D-A00Y-05	03b447b0-d92c-4d78-a496-fcf20be55ce5	TCGA-A8-A085-01A-11R-A010-13
TCGA-A8-A086-01	Stage IIA	59	5	Stage IIA	396		Positive	FEMALE	Negative	2	3	3	Negative	M0	Positive	N1	396	0	LumA	Luminal A	Positive	LumA	-9	-3	enrollment	T1	T1	LIVING	0	TCGA-A8-A086-01	396	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 5	mutation c1uster 9	TCGA-A8-A086	396	0	396	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Right			TCGA-A8-A086-F40840		Positive					Positive	Other					-21731	272		0	396												2013-3-2	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1		YES			150	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	5								NO			false	M0	N1a	T1c	Stage IIA	TCGA-A8-A086.D4E86E20-B75E-4CDA-83F2-22C481D4B9E8.pdf	3	2	0	0	3	0	0	0	2	2	30	18	65	80	65	80	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A086-01A-11W-A019-09	TCGA-A8-A086-01		TCGA-A8-A086-01A-11R-A010-13		faed055f-e054-4c59-953f-c118dd531f04	TCGA-A8-A086-01A-11W-A019-09	TCGA-A8-A086-01A-21-A13B-20	TCGA-A8-A086-01A-11W-A019-09	7347a336-6248-47be-817b-88543164d564	064b8a58-45eb-4abe-8627-5b4a8c69e6c7	TCGA-A8-A086-01A-11D-A011-01	7347a336-6248-47be-817b-88543164d564		TCGA-A8-A086-01	TCGA-A8-A086-01A-11R-A00Z-07	7347a336-6248-47be-817b-88543164d564	7347a336-6248-47be-817b-88543164d564	TCGA-A8-A086-01A-11D-A011-01	TCGA-A8-A086-01	TCGA-A8-A086-01	TCGA-A8-A086-01A-11D-A00Y-05	064b8a58-45eb-4abe-8627-5b4a8c69e6c7	TCGA-A8-A086-01A-11R-A010-13
TCGA-A8-A08A-01	Stage I	89	2	Stage I	30		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	30	0		Luminal A	Positive	LumA	-12	-3	enrollment	T1	T1	LIVING	0	TCGA-A8-A08A-01	30	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A08A			30	Breast	TCGA Breast Cancer	breast invasive carcinoma					89	Left Upper Inner Quadrant					Positive					Positive	Other					-32750	1033		0	30												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES			160	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2											false	M0	N0	T1c	Stage I	TCGA-A8-A08A.6D2212CE-C80F-4545-A895-3F1B6E4C6DB6.pdf	2	2	1	1	3	1	0	0	0	2	15	13	82	84	85	85	TUMOR FREE								No				Primary Tumor	01	Surgical Resection	5th		NO	YES	A8	Breast	A	LIVING	2007	TCGA-A8-A08A-01A-11W-A019-09	TCGA-A8-A08A-01		TCGA-A8-A08A-01A-11R-A010-13		80af2202-8a16-4cb7-8556-5ff94a042038	TCGA-A8-A08A-01A-11W-A019-09	TCGA-A8-A08A-01A-21-A13A-20	TCGA-A8-A08A-01A-11W-A019-09	bf92b8cc-9a5c-4e96-917c-c264fe588f8d	46a7082e-19e7-4f1a-806b-31c2db120c34	TCGA-A8-A08A-01A-11D-A011-01	bf92b8cc-9a5c-4e96-917c-c264fe588f8d		TCGA-A8-A08A-01	TCGA-A8-A08A-01A-11R-A00Z-07	bf92b8cc-9a5c-4e96-917c-c264fe588f8d	bf92b8cc-9a5c-4e96-917c-c264fe588f8d	TCGA-A8-A08A-01A-11D-A011-01	TCGA-A8-A08A-01	TCGA-A8-A08A-01	TCGA-A8-A08A-01A-11D-A00Y-05	46a7082e-19e7-4f1a-806b-31c2db120c34	TCGA-A8-A08A-01A-11R-A010-13
TCGA-A8-A08B-01	Stage IIA	52	3	Stage IIA	702		Positive	FEMALE	Positive				Negative	M0	Negative	N0	702	0	Her2	HER2-enriched	Negative		-1	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08B-01	1156	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 7	mutation cluster 4	TCGA-A8-A08B	1156	0	1156	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Right Upper Inner Quadrant			TCGA-A8-A08B-F40841		Positive					Negative	Other					-19114	759		0	1156												2013-3-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES			100	NO	Positive	Positive	NO		Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	7								NO			false	M0	N0	T2	Stage IIA	TCGA-A8-A08B.2261B407-340D-4BB3-94BC-F06096FBDA80.pdf	20	20	0	0	2	5	0	0	15	20	23	18	60	57	75	75	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	TCGA-A8-A08B-01A-11W-A019-09	TCGA-A8-A08B-01		TCGA-A8-A08B-01A-11R-A010-13	TCGA-A8-A08B-01A-11W-A019-09		TCGA-A8-A08B-01A-11W-A019-09		TCGA-A8-A08B-01A-11W-A019-09	0307bd0b-b59a-4996-b89d-612e72652890	95a462db-8ab9-4a3e-8463-0927b77a9a93	TCGA-A8-A08B-01A-11D-A011-01	0307bd0b-b59a-4996-b89d-612e72652890		TCGA-A8-A08B-01	TCGA-A8-A08B-01A-11R-A00Z-07	0307bd0b-b59a-4996-b89d-612e72652890	0307bd0b-b59a-4996-b89d-612e72652890	TCGA-A8-A08B-01A-11D-A011-01	TCGA-A8-A08B-01	TCGA-A8-A08B-01	TCGA-A8-A08B-01A-11D-A00Y-05	95a462db-8ab9-4a3e-8463-0927b77a9a93	TCGA-A8-A08B-01A-11R-A010-13
TCGA-A8-A08C-01	Stage IIA	65	2	Stage IIA	607		Positive	FEMALE	Negative				Negative	M0	Negative	N0	607	0	LumA	Luminal A	Positive		-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08C-01	881	0	BRCA-LUAD+		cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7				TCGA-A8-A08C	881	0	881	Breast	TCGA Breast Cancer	breast invasive carcinoma					65	Left Upper Inner Quadrant			TCGA-A8-A08C-F40842		Positive					Positive	Other					-24017	484		0	881												2013-3-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			110	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2									NO			false	M0	N0	T2	Stage IIA	TCGA-A8-A08C.6E136F3D-A6E1-4541-AA4B-65BC5872DE06.pdf	4	3	0	0	2	2	0	0	0	0	20	20	78	78	88	90	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008		TCGA-A8-A08C-01			TCGA-A8-A08C-01A-11W-A019-09		TCGA-A8-A08C-01A-11W-A019-09		TCGA-A8-A08C-01A-11W-A019-09	7c8b9d9a-653a-4dc7-8c53-b196fbd0482a	22c2050e-587d-4dc3-8955-9578bdd050d9	TCGA-A8-A08C-01A-11D-A011-01	7c8b9d9a-653a-4dc7-8c53-b196fbd0482a		TCGA-A8-A08C-01	TCGA-A8-A08C-01A-11R-A00Z-07	7c8b9d9a-653a-4dc7-8c53-b196fbd0482a	7c8b9d9a-653a-4dc7-8c53-b196fbd0482a	TCGA-A8-A08C-01A-11D-A011-01	TCGA-A8-A08C-01	TCGA-A8-A08C-01	TCGA-A8-A08C-01A-11D-A00Y-05	22c2050e-587d-4dc3-8955-9578bdd050d9	
TCGA-A8-A08F-01	Stage IIIC	59	4	Stage IIIC	549		Positive	FEMALE	Negative				Negative	M0	Positive	N3	549	0	LumB	Luminal B	Positive		-2	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08F-01	1004	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7			mutation c1uster 9	TCGA-A8-A08F	1004	0	1004	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Right Upper Inner Quadrant			TCGA-A8-A08F-F40843		Positive					Positive	Other					-21641	637		0	1004												2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.2		YES			100	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2									NO			false	M0	N3a	T2	Stage IIIC	TCGA-A8-A08F.683AAF99-3B91-4501-B701-C3A4E8439647.pdf	3	2	0	0	1	0	0	0	1	1	18	19	80	80	80	80	TUMOR FREE						YES		Yes			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	TCGA-A8-A08F-01A-11W-A019-09	TCGA-A8-A08F-01			TCGA-A8-A08F-01A-11W-A019-09		TCGA-A8-A08F-01A-11W-A019-09		TCGA-A8-A08F-01A-11W-A019-09	523e45c2-4f98-4010-b48e-bdbda62865cf	91094862-5aee-4304-b503-12a163a52532	TCGA-A8-A08F-01A-11D-A011-01	523e45c2-4f98-4010-b48e-bdbda62865cf		TCGA-A8-A08F-01	TCGA-A8-A08F-01A-11R-A00Z-07	523e45c2-4f98-4010-b48e-bdbda62865cf	523e45c2-4f98-4010-b48e-bdbda62865cf	TCGA-A8-A08F-01A-11D-A011-01	TCGA-A8-A08F-01	TCGA-A8-A08F-01	TCGA-A8-A08F-01A-11D-A00Y-05	91094862-5aee-4304-b503-12a163a52532	
TCGA-A8-A08G-01	Stage IIA	41	3	Stage IIA	606		Positive	FEMALE	Positive	3	3	4	Negative	M0	Negative	N0	606	0	LumB	Luminal B	Positive	LumA/B	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08G-01	607	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A8-A08G	607	0	607	Breast	TCGA Breast Cancer	breast invasive carcinoma					41	Left Upper Inner Quadrant			TCGA-A8-A08G-F40844		Positive					Positive	Other					-14976	422		0	607												2013-3-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			180	NO	Positive	Positive	NO		Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	4								NO			false	M0	N0	T2	Stage IIA	TCGA-A8-A08G.6DCA5C2C-F28A-409D-9623-24AB748FB4E7.pdf	5	2	0	0	0	0	0	0	1	1	24	14	75	85	75	85	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A08G-01A-11W-A019-09	TCGA-A8-A08G-01		TCGA-A8-A08G-01A-11R-A010-13		df81dd47-6e43-495c-ad4a-e3347a9d233e	TCGA-A8-A08G-01A-11W-A019-09	TCGA-A8-A08G-01A-21-A13B-20	TCGA-A8-A08G-01A-11W-A019-09	0584b467-a0f7-45fd-9948-9a01318d34bd	d46db8e4-b4f2-4a38-b4f1-57bb62d5c989	TCGA-A8-A08G-01A-11D-A011-01	0584b467-a0f7-45fd-9948-9a01318d34bd		TCGA-A8-A08G-01	TCGA-A8-A08G-01A-11R-A00Z-07	0584b467-a0f7-45fd-9948-9a01318d34bd	0584b467-a0f7-45fd-9948-9a01318d34bd	TCGA-A8-A08G-01A-11D-A011-01	TCGA-A8-A08G-01	TCGA-A8-A08G-01	TCGA-A8-A08G-01A-11D-A00Y-05	d46db8e4-b4f2-4a38-b4f1-57bb62d5c989	TCGA-A8-A08G-01A-11R-A010-13
TCGA-A8-A08H-01	Stage IIA	66	1	Stage IIA	0		Positive	FEMALE	Positive	1	4	3	Negative	M0	Negative	N0	0	0	Normal	Basal-like	Positive	ReacI	-5	-8	enrollment	T_Other	T2	LIVING		TCGA-A8-A08H-01			Quiet	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A8-A08H				Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Left Upper Inner Quadrant					Positive					Positive	Other					-24137	1184		0	0												2011-5-27	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES			250	NO	Positive	Positive			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4											false	M0	N0	T2	Stage IIA	TCGA-A8-A08H.33188769-D86E-41AD-A74D-31A7C2DD08B7.pdf	2	3	0	0	0	1	0	0	0	0	20	19	80	80	80	80	TUMOR FREE								No				Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2007	TCGA-A8-A08H-01A-21W-A019-09	TCGA-A8-A08H-01		TCGA-A8-A08H-01A-21R-A010-13		1ff81e2a-4af2-471e-805a-073a952b5b0e	TCGA-A8-A08H-01A-21W-A019-09	TCGA-A8-A08H-01A-11-A13B-20	TCGA-A8-A08H-01A-21W-A019-09	9c5eb452-caec-4a9a-9ced-215be92c91d2	b091515b-e33a-4f0b-bc81-72dad7fb5414	TCGA-A8-A08H-01A-21D-A011-01	9c5eb452-caec-4a9a-9ced-215be92c91d2		TCGA-A8-A08H-01	TCGA-A8-A08H-01A-21R-A00Z-07	9c5eb452-caec-4a9a-9ced-215be92c91d2	9c5eb452-caec-4a9a-9ced-215be92c91d2	TCGA-A8-A08H-01A-21D-A011-01	TCGA-A8-A08H-01	TCGA-A8-A08H-01	TCGA-A8-A08H-01A-21D-A00Y-05	b091515b-e33a-4f0b-bc81-72dad7fb5414	TCGA-A8-A08H-01A-21R-A010-13
TCGA-A8-A08I-01	Stage IIA	53	4	Stage IIA	365		Positive	FEMALE	Negative				Negative	M0	Negative	N0	365	0	LumB	Luminal B	Positive		-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08I-01	365	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-A8-A08I	365	0	365	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Right Upper Inner Quadrant			TCGA-A8-A08I-F40845		Positive					Positive	Other					-19389	241		0	365												2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES			80	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	3								NO			false	M0	N0	T2	Stage IIA	TCGA-A8-A08I.F2077079-D683-4D18-94B9-84C760674AF6.pdf	1	2	0	0	0	1	0	0	0	1	15	18	85	80	85	80	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A08I-01A-11W-A019-09	TCGA-A8-A08I-01		TCGA-A8-A08I-01A-11R-A010-13			TCGA-A8-A08I-01A-11W-A019-09		TCGA-A8-A08I-01A-11W-A019-09	3e853cb1-4747-4f98-be64-d5de7fba801e	6527b4d3-3706-41e5-8106-55ed4981f593	TCGA-A8-A08I-01A-11D-A011-01	3e853cb1-4747-4f98-be64-d5de7fba801e		TCGA-A8-A08I-01	TCGA-A8-A08I-01A-11R-A00Z-07	3e853cb1-4747-4f98-be64-d5de7fba801e	3e853cb1-4747-4f98-be64-d5de7fba801e	TCGA-A8-A08I-01A-11D-A011-01	TCGA-A8-A08I-01	TCGA-A8-A08I-01	TCGA-A8-A08I-01A-11D-A00Y-05	6527b4d3-3706-41e5-8106-55ed4981f593	TCGA-A8-A08I-01A-11R-A010-13
TCGA-A8-A08J-01	Stage IV	52	5	Stage IV	1127	1127	Positive	FEMALE	Negative	1	1	1	Positive	M1	Positive	N3	1127	1	Her2	HER2-enriched	Negative	Her2	-2	-5	enrollment	T_Other	T4	DECEASED	1	TCGA-A8-A08J-01	1127	1	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 12	TCGA-A8-A08J			1127	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Right			TCGA-A8-A08J-F40846		Positive					Negative	Other					-19266	1733	1127	0													2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8541/3	C50.9		YES			630	NO	Negative	Negative	NO		Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4											false	M1	N3	T4b	Stage IV	TCGA-A8-A08J.C1D59BA7-FC3E-46EA-B095-3B6DF42892B0.pdf	4	4	0	0	2	2	0	0	0	0	20	20	78	78	90	90	WITH TUMOR								No			NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	DECEASED	2005	TCGA-A8-A08J-01A-11W-A019-09	TCGA-A8-A08J-01		TCGA-A8-A08J-01A-11R-A010-13	TCGA-A8-A08J-01A-11W-A019-09	c8144900-30dc-4081-882a-4dc863120a39	TCGA-A8-A08J-01A-11W-A019-09	TCGA-A8-A08J-01A-21-A13A-20	TCGA-A8-A08J-01A-11W-A019-09	67e019fc-65c4-4274-a0f7-5a92f0f87bba	d3063866-3dfe-4bb7-a0ae-e59b059dc816	TCGA-A8-A08J-01A-11D-A011-01	67e019fc-65c4-4274-a0f7-5a92f0f87bba		TCGA-A8-A08J-01	TCGA-A8-A08J-01A-11R-A00Z-07	67e019fc-65c4-4274-a0f7-5a92f0f87bba	67e019fc-65c4-4274-a0f7-5a92f0f87bba	TCGA-A8-A08J-01A-11D-A011-01	TCGA-A8-A08J-01	TCGA-A8-A08J-01	TCGA-A8-A08J-01A-11D-A00Y-05	d3063866-3dfe-4bb7-a0ae-e59b059dc816	TCGA-A8-A08J-01A-11R-A010-13
TCGA-A8-A08L-01	Stage IIIA	89	1	Stage IIIA	304	304	Positive	FEMALE	Negative	5	2	1	Negative	M0	Positive	N2	304	1	Her2	HER2-enriched	Negative	X	-2	-6	enrollment	T_Other	T3	DECEASED	1	TCGA-A8-A08L-01	304	1	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 1	TCGA-A8-A08L			304	Breast	TCGA Breast Cancer	breast invasive carcinoma					89	Left			TCGA-A8-A08L-F40847		Positive					Negative	Other					-32842	698	304	0													2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			200	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	1											false	M0	N2a	T3	Stage IIIA	TCGA-A8-A08L.BC0E0F93-B183-44E8-B551-EA463B2FBCE4.pdf	13	19	0	0	0	0	0	0	0	0	40	15	60	85	75	75	TUMOR FREE								No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	DECEASED	2008	TCGA-A8-A08L-01A-11W-A019-09	TCGA-A8-A08L-01		TCGA-A8-A08L-01A-11R-A010-13	TCGA-A8-A08L-01A-11W-A019-09	7a837782-6edf-48bb-83db-40548ddd2b69	TCGA-A8-A08L-01A-11W-A019-09	TCGA-A8-A08L-01A-21-A13A-20	TCGA-A8-A08L-01A-11W-A019-09	0b3c65ed-ff55-45c9-b6a3-dd3a596a0271	35d16368-1462-4c9b-952a-b81b4e08d33c	TCGA-A8-A08L-01A-11D-A011-01	0b3c65ed-ff55-45c9-b6a3-dd3a596a0271		TCGA-A8-A08L-01	TCGA-A8-A08L-01A-11R-A00Z-07	0b3c65ed-ff55-45c9-b6a3-dd3a596a0271	0b3c65ed-ff55-45c9-b6a3-dd3a596a0271	TCGA-A8-A08L-01A-11D-A011-01	TCGA-A8-A08L-01	TCGA-A8-A08L-01	TCGA-A8-A08L-01A-11D-A00Y-05	35d16368-1462-4c9b-952a-b81b4e08d33c	TCGA-A8-A08L-01A-11R-A010-13
TCGA-A8-A08O-01	Stage IV	45	2	Stage IV	942		Positive	FEMALE	Negative	3	4	3	Positive	M1	Positive	N3	942	0	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08O-01	943	0	COAD-READ	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3	cluster 6	mutation cluster 4	TCGA-A8-A08O	762	1	943	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Right			TCGA-A8-A08O-F40848		Positive					Positive	Other					-16681	819		0	943			762									2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			130	NO	Negative	Negative	NO		Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6								YES			false	M1	N3a	T2	Stage IV	TCGA-A8-A08O.2F102533-4B6B-4411-9080-3697ED3099EA.pdf	5	8	0	0	4	2	0	0	5	15	30	20	61	63	80	80	WITH TUMOR						YES		No			NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	TCGA-A8-A08O-01A-21W-A071-09	TCGA-A8-A08O-01		TCGA-A8-A08O-01A-21R-A057-13	TCGA-A8-A08O-01A-21W-A071-09	b661ea2e-2f24-44b9-b8ed-30f38223b85c	TCGA-A8-A08O-01A-21W-A071-09	TCGA-A8-A08O-01A-11-A13A-20	TCGA-A8-A08O-01A-21W-A071-09	f71db767-ac59-49c8-b6a9-50bf20767ddc	84e50324-d98b-4fa7-b6df-27714ed34a48	TCGA-A8-A08O-01A-21D-A059-01	f71db767-ac59-49c8-b6a9-50bf20767ddc	TCGA-A8-A08O-01A-21D-A10P-05	TCGA-A8-A08O-01	TCGA-A8-A08O-01A-21R-A056-07	f71db767-ac59-49c8-b6a9-50bf20767ddc	f71db767-ac59-49c8-b6a9-50bf20767ddc	TCGA-A8-A08O-01A-21D-A059-01	TCGA-A8-A08O-01	TCGA-A8-A08O-01		84e50324-d98b-4fa7-b6df-27714ed34a48	TCGA-A8-A08O-01A-21R-A057-13
TCGA-A8-A08P-01	Stage IIIA	70	3	Stage IIIA	942		Positive	FEMALE	Positive				Negative	M0	Positive	N2	942	0	LumB	Luminal B	Positive	ReacII	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08P-01	943	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7			mutation cluster 3	TCGA-A8-A08P	943	0	943	Breast	TCGA Breast Cancer	breast invasive carcinoma					70	Right			TCGA-A8-A08P-F40561		Positive					Positive	Other					-25598	819		0	943												2013-2-24	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			210	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4									NO			false	M0	N2a	T2	Stage IIIA	TCGA-A8-A08P.7DB1F816-A55F-449A-8DF9-6724B5100CA1.pdf	8	10	0	2	12	5	0	0	0	0	20	25	68	70	85	80	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	TCGA-A8-A08P-01A-11W-A019-09	TCGA-A8-A08P-01			TCGA-A8-A08P-01A-11W-A019-09	4e6516f3-1962-4f3e-99a4-e086891381c1	TCGA-A8-A08P-01A-11W-A019-09	TCGA-A8-A08P-01A-21-A13A-20	TCGA-A8-A08P-01A-11W-A019-09	f8dbf3ce-7c30-4e62-a25f-d98843794672	0a972399-22e7-41f5-af02-e2cbc04c72f3	TCGA-A8-A08P-01A-11D-A011-01	f8dbf3ce-7c30-4e62-a25f-d98843794672		TCGA-A8-A08P-01	TCGA-A8-A08P-01A-11R-A00Z-07	f8dbf3ce-7c30-4e62-a25f-d98843794672	f8dbf3ce-7c30-4e62-a25f-d98843794672	TCGA-A8-A08P-01A-11D-A011-01	TCGA-A8-A08P-01	TCGA-A8-A08P-01	TCGA-A8-A08P-01A-11D-A00Y-05	0a972399-22e7-41f5-af02-e2cbc04c72f3	
TCGA-A8-A08R-01	Stage IIB	52	4	Stage IIB	30		Negative	FEMALE	Negative				Negative	M0	Positive	N1	30	0	Basal	Basal-like	Negative		-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08R-01	30	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-A8-A08R			30	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Left					Negative					Negative	Other					-19298	728		0	30												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			90	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4											false	M0	N1a	T2	Stage IIB	TCGA-A8-A08R.FC0C1BF3-74C3-4DFC-B9B5-2FD1728E287A.pdf	10	15	0	0	3	3	0	0	0	0	12	12	85	85	70	70	TUMOR FREE								No				Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	TCGA-A8-A08R-01A-11W-A050-09	TCGA-A8-A08R-01		TCGA-A8-A08R-01A-11R-A035-13	TCGA-A8-A08R-01A-11W-A050-09		TCGA-A8-A08R-01A-11W-A050-09		TCGA-A8-A08R-01A-11W-A050-09	3a1d8959-f829-4b8a-a65f-70a51845f118	a60f9ab6-65cb-4ef0-89ae-33db4d5546c4	TCGA-A8-A08R-01A-11D-A036-01	3a1d8959-f829-4b8a-a65f-70a51845f118		TCGA-A8-A08R-01	TCGA-A8-A08R-01A-11R-A034-07	3a1d8959-f829-4b8a-a65f-70a51845f118	3a1d8959-f829-4b8a-a65f-70a51845f118	TCGA-A8-A08R-01A-11D-A036-01	TCGA-A8-A08R-01	TCGA-A8-A08R-01	TCGA-A8-A08R-01A-11D-A032-05	a60f9ab6-65cb-4ef0-89ae-33db4d5546c4	TCGA-A8-A08R-01A-11R-A035-13
TCGA-A8-A08S-01	Stage IIA	71		Stage IIA	580		Positive	FEMALE	Positive				Negative	M0	Positive	N1	580	0	LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-A8-A08S-01	1004	0	Squamous	C3-BRCA/Luminal		BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4		mutation cluster 4	TCGA-A8-A08S	1004	0	1004	Breast	TCGA Breast Cancer	breast invasive carcinoma					71	Left			TCGA-A8-A08S-F40560		Positive					Positive	Other					-25994	637		0	1004												2013-2-24	FEMALE					3+					Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9		YES			80	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO			false	M0	N1	T1c	Stage IIA	TCGA-A8-A08S.0D293DF8-374D-4681-9B2A-ACC98601AA25.pdf	3	0	1	0	1	1	0	0	0	0	39	49	60	50	80	80	TUMOR FREE						YES		Yes			YES	Primary Tumor	01	Surgical resection	6th		NO	YES	A8	Breast	A	LIVING	2008	TCGA-A8-A08S-01A-11W-A050-09	TCGA-A8-A08S-01		TCGA-A8-A08S-01A-11R-A035-13	TCGA-A8-A08S-01A-11W-A050-09		TCGA-A8-A08S-01A-11W-A050-09		TCGA-A8-A08S-01A-11W-A050-09	667c209e-9b4a-474d-8f69-102cfaffddf2	3ab709a7-87e2-44e5-bce1-ca2a0fc0286e	TCGA-A8-A08S-01A-11D-A036-01	667c209e-9b4a-474d-8f69-102cfaffddf2		TCGA-A8-A08S-01	TCGA-A8-A08S-01A-11R-A034-07	667c209e-9b4a-474d-8f69-102cfaffddf2	667c209e-9b4a-474d-8f69-102cfaffddf2	TCGA-A8-A08S-01A-11D-A036-01	TCGA-A8-A08S-01	TCGA-A8-A08S-01	TCGA-A8-A08S-01A-11D-A032-05	3ab709a7-87e2-44e5-bce1-ca2a0fc0286e	TCGA-A8-A08S-01A-11R-A035-13
TCGA-A8-A08T-01	Stage IV	64	4	Stage IV	2830		Positive	FEMALE	Negative	1	3	3	Positive	M1	Positive	N1	2830	0	LumA	Luminal A	Positive	LumA	-5	-3	enrollment	T_Other	T2	LIVING	1	TCGA-A8-A08T-01	3409	1	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A8-A08T	2557	1	3409	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Right			TCGA-A8-A08T-F40559		Positive					Positive	Other					-23560	2767	3409	0	2830			2557									2013-2-24	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			190	NO	Positive	Positive	NO		Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								YES			false	M1	N1a	T2	Stage IV	TCGA-A8-A08T.5780D50C-5BF0-4392-BC9B-894D1369866A.pdf	1	2	0	0	1	1	0	0	0	0	69	34	30	65	60	80	WITH TUMOR								No			NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	DECEASED	2002	TCGA-A8-A08T-01A-21W-A019-09	TCGA-A8-A08T-01		TCGA-A8-A08T-01A-21R-A010-13	TCGA-A8-A08T-01A-21W-A019-09	68cba786-7b1c-4e7c-863b-19a037b1d07e	TCGA-A8-A08T-01A-21W-A019-09	TCGA-A8-A08T-01A-11-A13A-20	TCGA-A8-A08T-01A-21W-A019-09	ed6ebb15-1401-49e0-be9a-e1391e84b374	dfe66ee6-0535-42b6-b6b1-b961604d8a27	TCGA-A8-A08T-01A-21D-A011-01	ed6ebb15-1401-49e0-be9a-e1391e84b374		TCGA-A8-A08T-01	TCGA-A8-A08T-01A-21R-A00Z-07	ed6ebb15-1401-49e0-be9a-e1391e84b374	ed6ebb15-1401-49e0-be9a-e1391e84b374	TCGA-A8-A08T-01A-21D-A011-01	TCGA-A8-A08T-01	TCGA-A8-A08T-01	TCGA-A8-A08T-01A-21D-A00Y-05	dfe66ee6-0535-42b6-b6b1-b961604d8a27	TCGA-A8-A08T-01A-21R-A010-13
TCGA-A8-A08X-01	Stage IIIC	43	3	Stage IIIC	1034		Negative	FEMALE	Positive	2	2	1	Negative	M0	Positive	N3	1034	0	Her2	HER2-enriched	Negative	Her2	-13	-10	enrollment	T_Other	T4	LIVING	0	TCGA-A8-A08X-01	1308	0	High	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-A8-A08X	366	1	1308	Breast	TCGA Breast Cancer	breast invasive carcinoma					43	Left			TCGA-A8-A08X-F40558		Negative					Negative	Other					-15705	941		0	1308			366									2013-2-24	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			170	NO	Positive	Positive	NO		Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	3								YES			false	M0	N3a	T4d	Stage IIIC	TCGA-A8-A08X.CA911D90-5DDA-49F1-993F-68FCA77A8558.pdf	6	7	0	0	2	1	0	0	0	1	23	33	75	65	75	65	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2007	TCGA-A8-A08X-01A-21W-A019-09	TCGA-A8-A08X-01		TCGA-A8-A08X-01A-21R-A010-13	TCGA-A8-A08X-01A-21W-A019-09	3fd8c428-08bb-4598-b3cb-0c4a33fc4eab	TCGA-A8-A08X-01A-21W-A019-09	TCGA-A8-A08X-01A-11-A13B-20	TCGA-A8-A08X-01A-21W-A019-09	354adce5-6ca4-4d6d-a519-4eabc01c6b36	04174e2d-2241-4ac5-a0b1-653b8fd41db9	TCGA-A8-A08X-01A-21D-A011-01	354adce5-6ca4-4d6d-a519-4eabc01c6b36		TCGA-A8-A08X-01	TCGA-A8-A08X-01A-21R-A00Z-07	354adce5-6ca4-4d6d-a519-4eabc01c6b36	354adce5-6ca4-4d6d-a519-4eabc01c6b36	TCGA-A8-A08X-01A-21D-A011-01	TCGA-A8-A08X-01	TCGA-A8-A08X-01	TCGA-A8-A08X-01A-21D-A00Y-05	04174e2d-2241-4ac5-a0b1-653b8fd41db9	TCGA-A8-A08X-01A-21R-A010-13
TCGA-A8-A08Z-01	Stage IIIB	76	2	Stage IIIC	1217		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N3	1217	0	LumA	Luminal A	Positive	LumA	-5	-3	enrollment	T_Other	T4	LIVING	0	TCGA-A8-A08Z-01	1217	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A08Z			1217	Breast	TCGA Breast Cancer	breast invasive carcinoma					76	Left					Positive					Positive	Other					-28003	2036		0	1217												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			350	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4											false	M0	N3a	T4b	Stage IIIB	TCGA-A8-A08Z.DA7BD84B-C00E-40A0-9AE2-33FCE7995696.pdf	5	6	0	0	1	1	0	0	2	2	22	27	75	70	75	70	TUMOR FREE								No				Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2004	TCGA-A8-A08Z-01A-21W-A019-09	TCGA-A8-A08Z-01		TCGA-A8-A08Z-01A-21R-A010-13		8f5042d5-cb01-4d32-a80e-f1e3c161ab78	TCGA-A8-A08Z-01A-21W-A019-09	TCGA-A8-A08Z-01A-11-A13B-20	TCGA-A8-A08Z-01A-21W-A019-09	1462b0a9-6467-4977-aea7-006ea3f5109e	2b58ea3d-2a6b-4acb-9db2-526ad07551bb	TCGA-A8-A08Z-01A-21D-A011-01	1462b0a9-6467-4977-aea7-006ea3f5109e		TCGA-A8-A08Z-01	TCGA-A8-A08Z-01A-21R-A00Z-07	1462b0a9-6467-4977-aea7-006ea3f5109e	1462b0a9-6467-4977-aea7-006ea3f5109e	TCGA-A8-A08Z-01A-21D-A011-01	TCGA-A8-A08Z-01	TCGA-A8-A08Z-01	TCGA-A8-A08Z-01A-21D-A00Y-05	2b58ea3d-2a6b-4acb-9db2-526ad07551bb	TCGA-A8-A08Z-01A-21R-A010-13
TCGA-A8-A090-01	Stage IIA	74	4	Stage IIA	0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	0	0	LumA	Luminal A	Positive		0	-3	enrollment	T_Other	T2	LIVING		TCGA-A8-A090-01			COAD-READ	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A090				Breast	TCGA Breast Cancer	breast invasive carcinoma					74	Right					Positive					Positive	Other					-27121	667		0	0												2011-5-27	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			110	NO	Positive	Positive			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2											false	M0	N0	T2	Stage IIA	TCGA-A8-A090.549E825B-F206-4FF9-835B-2FBE51C7B831.pdf	1	1	0	0	0	0	0	0	2	3	23	27	75	70	75	70	TUMOR FREE								No				Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	TCGA-A8-A090-01A-11W-A019-09	TCGA-A8-A090-01		TCGA-A8-A090-01A-11R-A010-13	TCGA-A8-A090-01A-11W-A019-09		TCGA-A8-A090-01A-11W-A019-09		TCGA-A8-A090-01A-11W-A019-09	752efa27-8d87-4007-9dc5-baef53b37a87	145a4a31-347b-418f-a5ad-4e77ca35e3ca	TCGA-A8-A090-01A-11D-A011-01	752efa27-8d87-4007-9dc5-baef53b37a87		TCGA-A8-A090-01	TCGA-A8-A090-01A-11R-A00Z-07	752efa27-8d87-4007-9dc5-baef53b37a87	752efa27-8d87-4007-9dc5-baef53b37a87	TCGA-A8-A090-01A-11D-A011-01	TCGA-A8-A090-01	TCGA-A8-A090-01	TCGA-A8-A090-01A-11D-A00Y-05	145a4a31-347b-418f-a5ad-4e77ca35e3ca	TCGA-A8-A090-01A-11R-A010-13
TCGA-A8-A091-01	Stage IIA	61	4	Stage IIA	580		Positive	FEMALE	Negative	1	3	3	Negative	M0	Negative	N0	580	0	LumA	Luminal A	Negative	LumA/B	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A091-01	1004	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A091	243	1	1004	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Right			TCGA-A8-A091-F40557		Positive					Negative	Other					-22554	637		0	1004			243									2013-2-23	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			180	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								YES			false	M0	N0	T2	Stage IIA	TCGA-A8-A091.FECA34F6-CEF7-4A6D-AA7E-F88542EAF6F7.pdf	1	1	0	0	1	1	0	0	36	22	8	10	55	67	80	85	TUMOR FREE						YES		Yes			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	TCGA-A8-A091-01A-11W-A019-09	TCGA-A8-A091-01		TCGA-A8-A091-01A-11R-A010-13	TCGA-A8-A091-01A-11W-A019-09	30426ea5-f884-4216-9435-4ba810f8687e	TCGA-A8-A091-01A-11W-A019-09	TCGA-A8-A091-01A-21-A13B-20	TCGA-A8-A091-01A-11W-A019-09	e43cb8f2-6541-4d55-b11c-8288dcf3b78f	7cd3f9f8-20a8-468e-aaca-9a49a32d250f	TCGA-A8-A091-01A-11D-A011-01	e43cb8f2-6541-4d55-b11c-8288dcf3b78f		TCGA-A8-A091-01	TCGA-A8-A091-01A-11R-A00Z-07	e43cb8f2-6541-4d55-b11c-8288dcf3b78f	e43cb8f2-6541-4d55-b11c-8288dcf3b78f	TCGA-A8-A091-01A-11D-A011-01	TCGA-A8-A091-01	TCGA-A8-A091-01	TCGA-A8-A091-01A-11D-A00Y-05	7cd3f9f8-20a8-468e-aaca-9a49a32d250f	TCGA-A8-A091-01A-11R-A010-13
TCGA-A8-A092-01	Stage IIIA	48	2	Stage IIIA	518		Positive	FEMALE	Negative				Negative	M0	Positive	N2	518	0	LumB	HER2-enriched	Positive		-2	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A092-01	942	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-A8-A092	942	0	942	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Left			TCGA-A8-A092-F40556		Positive					Positive	Other					-17807	575		0	942												2013-2-23	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			100	NO	Negative	Negative	NO		Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	4								NO			false	M0	N2a	T2	Stage IIIA	TCGA-A8-A092.93D66EAD-B7D3-4688-8EC9-75C4380619D9.pdf	4	2	0	0	1	1	0	0	0	0	4	9	95	90	75	80	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	TCGA-A8-A092-01A-11W-A019-09	TCGA-A8-A092-01		TCGA-A8-A092-01A-11R-A010-13	TCGA-A8-A092-01A-11W-A019-09		TCGA-A8-A092-01A-11W-A019-09		TCGA-A8-A092-01A-11W-A019-09	98b2b18a-004d-459c-8aba-499d06897910	d03b22fa-5bae-4247-a7fa-e8f77e38d8fd	TCGA-A8-A092-01A-11D-A011-01	98b2b18a-004d-459c-8aba-499d06897910		TCGA-A8-A092-01	TCGA-A8-A092-01A-11R-A00Z-07	98b2b18a-004d-459c-8aba-499d06897910	98b2b18a-004d-459c-8aba-499d06897910	TCGA-A8-A092-01A-11D-A011-01	TCGA-A8-A092-01	TCGA-A8-A092-01	TCGA-A8-A092-01A-11D-A00Y-05	d03b22fa-5bae-4247-a7fa-e8f77e38d8fd	TCGA-A8-A092-01A-11R-A010-13
TCGA-A8-A093-01	Stage IIA	61	3	Stage IIA	545		Positive	FEMALE	Negative				Negative	M0	Negative	N0	545	0	LumA	Luminal A	Positive		-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A093-01	546	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 2	mutation cluster 4	TCGA-A8-A093	546	0	546	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Right			TCGA-A8-A093-F40555		Positive					Positive	Other					-22373	422		0	546												2013-2-23	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			100	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO			false	M0	N0	T2	Stage IIA	TCGA-A8-A093.9DCF000D-D996-49A6-950A-0CD1E90CC6C7.pdf	10	1	0	0	1	1	0	0	59	0	0	0	40	99	60	90	TUMOR FREE						YES		Yes			YES	Primary Tumor	01	Surgical resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A093-01A-11W-A019-09	TCGA-A8-A093-01		TCGA-A8-A093-01A-11R-A010-13	TCGA-A8-A093-01A-11W-A019-09		TCGA-A8-A093-01A-11W-A019-09		TCGA-A8-A093-01A-11W-A019-09	54d372bf-07c8-4525-a081-ff26c28aff39	66c6efd3-406c-4b96-ac62-b570d161c825	TCGA-A8-A093-01A-11D-A011-01	54d372bf-07c8-4525-a081-ff26c28aff39		TCGA-A8-A093-01	TCGA-A8-A093-01A-11R-A00Z-07	54d372bf-07c8-4525-a081-ff26c28aff39	54d372bf-07c8-4525-a081-ff26c28aff39	TCGA-A8-A093-01A-11D-A011-01	TCGA-A8-A093-01	TCGA-A8-A093-01	TCGA-A8-A093-01A-11D-A00Y-05	66c6efd3-406c-4b96-ac62-b570d161c825	TCGA-A8-A093-01A-11R-A010-13
TCGA-A8-A094-01	Stage IIA	75	1	Stage IIA	0		Positive	FEMALE	Negative	2	2	1	Negative	M0	Negative	N0	0	0	Her2	HER2-enriched	Negative	Basal	-11	-5	enrollment	T_Other	T2	LIVING		TCGA-A8-A094-01			Squamous	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 6	TCGA-A8-A094				Breast	TCGA Breast Cancer	breast invasive carcinoma					75	Left					Positive					Negative	Other					-27729	363		0	0												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			400	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	3											false	M0	N0	T2	Stage IIA	TCGA-A8-A094.85288EC6-0BDC-4955-8B88-1DEECBF0E235.pdf	2	1	0	0	5	4	0	0	0	0	20	16	75	80	75	85	TUMOR FREE								No				Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A094-01A-11W-A019-09	TCGA-A8-A094-01		TCGA-A8-A094-01A-11R-A038-13	TCGA-A8-A094-01A-11W-A019-09	c7af042d-07e1-40fd-878d-a91d31397bb6	TCGA-A8-A094-01A-11W-A019-09	TCGA-A8-A094-01A-21-A13B-20	TCGA-A8-A094-01A-11W-A019-09	877adc79-0651-4140-bb6a-876162733bf3	deedcd96-88fd-445e-bc6c-085c79a431ab	TCGA-A8-A094-01A-11D-A011-01	877adc79-0651-4140-bb6a-876162733bf3		TCGA-A8-A094-01	TCGA-A8-A094-01A-11R-A00Z-07	877adc79-0651-4140-bb6a-876162733bf3	877adc79-0651-4140-bb6a-876162733bf3	TCGA-A8-A094-01A-11D-A011-01	TCGA-A8-A094-01	TCGA-A8-A094-01	TCGA-A8-A094-01A-11D-A00Y-05	deedcd96-88fd-445e-bc6c-085c79a431ab	TCGA-A8-A094-01A-11R-A038-13
TCGA-A8-A095-01	Stage I	45	3	Stage I	1276		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1276	0	LumB	Luminal B	Positive	ReacII	-7	-3	enrollment	T1	T1	LIVING	0	TCGA-A8-A095-01	1277	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A095	1277	0	1277	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Left			TCGA-A8-A095-F40554		Positive					Positive	Other					-16742	1153		0	1277												2013-2-23	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			160	NO	Negative	Negative	NO		Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4								NO			false	M0	N0	T1c	Stage I	TCGA-A8-A095.41A41A7F-E4DD-4D3A-B97D-B4657CA211E1.pdf	2	2	0	0	1	15	0	0	2	3	32	22	65	60	75	70	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2007	TCGA-A8-A095-01A-11W-A019-09	TCGA-A8-A095-01		TCGA-A8-A095-01A-11R-A010-13	TCGA-A8-A095-01A-11W-A019-09	61dbc912-9edf-4635-926c-e9ae57c40b67	TCGA-A8-A095-01A-11W-A019-09	TCGA-A8-A095-01A-21-A13B-20	TCGA-A8-A095-01A-11W-A019-09	c943873c-e153-42bc-a8de-e1080b252e81	8bb0471f-9d25-4c27-9a4c-ecc00090a7da	TCGA-A8-A095-01A-11D-A011-01	c943873c-e153-42bc-a8de-e1080b252e81		TCGA-A8-A095-01	TCGA-A8-A095-01A-11R-A00Z-07	c943873c-e153-42bc-a8de-e1080b252e81	c943873c-e153-42bc-a8de-e1080b252e81	TCGA-A8-A095-01A-11D-A011-01	TCGA-A8-A095-01	TCGA-A8-A095-01	TCGA-A8-A095-01A-11D-A00Y-05	8bb0471f-9d25-4c27-9a4c-ecc00090a7da	TCGA-A8-A095-01A-11R-A010-13
TCGA-A8-A096-01	Stage IIA	73	2	Stage IIA	0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	0	0	LumB	Luminal B	Positive		-12	-4	enrollment	T_Other	T2	LIVING		TCGA-A8-A096-01			Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A096				Breast	TCGA Breast Cancer	breast invasive carcinoma					73	Right					Positive					Positive	Other					-26723	394		0	0												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			110	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4											false	M0	N0	T2	Stage IIA	TCGA-A8-A096.91BFC77A-E56F-49F0-A294-A5EE9F266FB6.pdf	3	3	0	0	0	0	0	0	0	0	25	30	75	70	85	80	TUMOR FREE								No				Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A096-01A-11W-A019-09	TCGA-A8-A096-01		TCGA-A8-A096-01A-11R-A038-13			TCGA-A8-A096-01A-11W-A019-09		TCGA-A8-A096-01A-11W-A019-09	7bf79330-52fa-4111-88fe-b3ea62bcc63a	b9f519b1-a3ef-48a2-8a66-fe83096ef611	TCGA-A8-A096-01A-11D-A011-01	7bf79330-52fa-4111-88fe-b3ea62bcc63a		TCGA-A8-A096-01	TCGA-A8-A096-01A-11R-A00Z-07	7bf79330-52fa-4111-88fe-b3ea62bcc63a	7bf79330-52fa-4111-88fe-b3ea62bcc63a	TCGA-A8-A096-01A-11D-A011-01	TCGA-A8-A096-01	TCGA-A8-A096-01	TCGA-A8-A096-01A-11D-A00Y-05	b9f519b1-a3ef-48a2-8a66-fe83096ef611	TCGA-A8-A096-01A-11R-A038-13
TCGA-A8-A097-01	Stage IIB	65	5	Stage IIB	365		Positive	FEMALE	Positive				Negative	M0	Positive	N1	365	0	LumA	Luminal B	Positive		0	-2	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A097-01	365	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A8-A097	365	0	365	Breast	TCGA Breast Cancer	breast invasive carcinoma					65	Left			TCGA-A8-A097-F40553		Positive					Positive	Other					-23741	241		0	365												2013-2-23	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			100	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4								NO			false	M0	N1	T2	Stage IIB	TCGA-A8-A097.5B867CB6-F94D-435D-83E3-0ADB814B8077.pdf	2	2	0	0	0	0	0	0	3	4	27	21	70	75	75	80	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A097-01A-11W-A050-09	TCGA-A8-A097-01		TCGA-A8-A097-01A-11R-A035-13	TCGA-A8-A097-01A-11W-A050-09		TCGA-A8-A097-01A-11W-A050-09		TCGA-A8-A097-01A-11W-A050-09	1873a785-0f15-40ef-a7c9-1799ab482338	efbe880f-55bf-4c85-b30c-902c44578821	TCGA-A8-A097-01A-11D-A036-01	1873a785-0f15-40ef-a7c9-1799ab482338		TCGA-A8-A097-01	TCGA-A8-A097-01A-11R-A034-07	1873a785-0f15-40ef-a7c9-1799ab482338	1873a785-0f15-40ef-a7c9-1799ab482338	TCGA-A8-A097-01A-11D-A036-01	TCGA-A8-A097-01	TCGA-A8-A097-01	TCGA-A8-A097-01A-11D-A032-05	efbe880f-55bf-4c85-b30c-902c44578821	TCGA-A8-A097-01A-11R-A035-13
TCGA-A8-A099-01	Stage X	76	2	Stage IIIC	304		Positive	FEMALE	Positive	4	3	3	Negative	M0	Positive	N3	304	0	LumA	Luminal A	Positive	LumA/B	-12	-3	enrollment	T_Other	T4	LIVING	0	TCGA-A8-A099-01	304	0	Iq	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-A8-A099	304	0	304	Breast	TCGA Breast Cancer	breast invasive carcinoma					76	Right			TCGA-A8-A099-F40552		Positive					Positive	Other					-28063	180		0	304												2013-2-23	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			210	NO	Positive	Positive	NO			Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	1								NO			false	MX	N3a	T4b	Stage X	TCGA-A8-A099.34499A83-DFCE-4DB8-BAA0-A7590AF8BC07.pdf	2	2	0	0	3	1	0	0	0	2	17	17	80	80	85	85							YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A099-01A-11W-A019-09	TCGA-A8-A099-01		TCGA-A8-A099-01A-11R-A010-13		6e221e0d-416e-420d-a798-9afde72b03fb	TCGA-A8-A099-01A-11W-A019-09	TCGA-A8-A099-01A-21-A13B-20	TCGA-A8-A099-01A-11W-A019-09	09d1b9e5-a828-4e12-8a66-2a90c18d2f3e	e7d3f302-d068-487a-b1cf-89cf4d9f6f60	TCGA-A8-A099-01A-11D-A011-01	09d1b9e5-a828-4e12-8a66-2a90c18d2f3e		TCGA-A8-A099-01	TCGA-A8-A099-01A-11R-A00Z-07	09d1b9e5-a828-4e12-8a66-2a90c18d2f3e	09d1b9e5-a828-4e12-8a66-2a90c18d2f3e	TCGA-A8-A099-01A-11D-A011-01	TCGA-A8-A099-01	TCGA-A8-A099-01	TCGA-A8-A099-01A-11D-A00Y-05	e7d3f302-d068-487a-b1cf-89cf4d9f6f60	TCGA-A8-A099-01A-11R-A010-13
TCGA-A8-A09A-01	Stage X	40	4	Stage IIA	304		Positive	FEMALE	Negative	1	3	3	Negative	M0	Negative	N0	304	0	LumA	Luminal A	Positive	LumA	-3	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09A-01	304	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 4	mutation c1uster 10	TCGA-A8-A09A			304	Breast	TCGA Breast Cancer	breast invasive carcinoma					40	Left			TCGA-A8-A09A-F40551		Positive					Positive	Other					-14883	180		0	304												2013-2-23	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			170	NO	Negative	Negative	NO		Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4											false	M0	NX	T2	Stage X	TCGA-A8-A09A.5A6E0F10-758E-4DC1-A5C7-57D5DF9B25EF.pdf	2	1	0	0	0	0	0	0	2	3	18	17	80	80	80	85	WITH TUMOR						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A09A-01A-11W-A019-09	TCGA-A8-A09A-01		TCGA-A8-A09A-01A-11R-A038-13	TCGA-A8-A09A-01A-11W-A019-09	5e5a89f5-a778-4893-9d17-38c946016d53	TCGA-A8-A09A-01A-11W-A019-09	TCGA-A8-A09A-01A-21-A13B-20	TCGA-A8-A09A-01A-11W-A019-09	7b1992b8-781d-49cc-a600-4bee56bcf1b5	14c07825-f4cc-4d62-ad12-6a0bcc00e4b9	TCGA-A8-A09A-01A-11D-A011-01	7b1992b8-781d-49cc-a600-4bee56bcf1b5		TCGA-A8-A09A-01	TCGA-A8-A09A-01A-11R-A00Z-07	7b1992b8-781d-49cc-a600-4bee56bcf1b5	7b1992b8-781d-49cc-a600-4bee56bcf1b5	TCGA-A8-A09A-01A-11D-A011-01	TCGA-A8-A09A-01	TCGA-A8-A09A-01	TCGA-A8-A09A-01A-11D-A00Y-05	14c07825-f4cc-4d62-ad12-6a0bcc00e4b9	TCGA-A8-A09A-01A-11R-A038-13
TCGA-A8-A09B-01	Stage IIIB	58	4	Stage IIIB	365		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N1	365	0	LumA	Luminal A	Positive	LumA	0	-3	enrollment	T_Other	T4	LIVING	0	TCGA-A8-A09B-01	365	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A09B			365	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Left			TCGA-A8-A09B-F40550		Positive					Positive	Other					-21520			0	365												2013-2-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES					Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4												M0	N1a	T4b	Stage IIIB																		TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast		LIVING	2009	TCGA-A8-A09B-01A-11W-A019-09	TCGA-A8-A09B-01		TCGA-A8-A09B-01A-11R-A010-13	TCGA-A8-A09B-01A-11W-A019-09	cc046686-7a84-4a71-8b94-70b2ec82c616	TCGA-A8-A09B-01A-11W-A019-09	TCGA-A8-A09B-01A-21-A13B-20	TCGA-A8-A09B-01A-11W-A019-09	df95b9f5-437f-438d-89b4-7c556e79b616	f7d6ee92-7add-46f0-9de5-17f1bea1842d	TCGA-A8-A09B-01A-11D-A011-01	df95b9f5-437f-438d-89b4-7c556e79b616		TCGA-A8-A09B-01	TCGA-A8-A09B-01A-11R-A00Z-07	df95b9f5-437f-438d-89b4-7c556e79b616	df95b9f5-437f-438d-89b4-7c556e79b616	TCGA-A8-A09B-01A-11D-A011-01	TCGA-A8-A09B-01	TCGA-A8-A09B-01	TCGA-A8-A09B-01A-11D-A00Y-05	f7d6ee92-7add-46f0-9de5-17f1bea1842d	TCGA-A8-A09B-01A-11R-A010-13
TCGA-A8-A09C-01	Stage X	69	4	Stage IIA	31		Positive	FEMALE	Negative	3	3	4	Negative	M0	Negative	N0	31	0	LumB	Luminal B	Positive	LumA	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09C-01	31	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A8-A09C			31	Breast	TCGA Breast Cancer	breast invasive carcinoma					69	Right					Positive					Positive	Other					-25355	180		0	31												2011-5-27	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			120	NO	Negative	Negative				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2											false	MX	N0	T2	Stage X	TCGA-A8-A09C.1E002C47-CEC6-491C-9E67-B289687D5B66.pdf	1	1	0	0	1	1	0	0	5	0	14	14	80	85	90	96									Yes				Primary Tumor	01	Surgical resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A09C-01A-11W-A019-09	TCGA-A8-A09C-01		TCGA-A8-A09C-01A-11R-A010-13	TCGA-A8-A09C-01A-11W-A019-09	9012f763-2482-415b-9d86-fdabde299719	TCGA-A8-A09C-01A-11W-A019-09	TCGA-A8-A09C-01A-21-A13A-20	TCGA-A8-A09C-01A-11W-A019-09	95bcf18b-40bf-4a20-82bf-727c7bb2a8c2	967323eb-3ae6-4b35-bab3-35abf8b80299	TCGA-A8-A09C-01A-11D-A011-01	95bcf18b-40bf-4a20-82bf-727c7bb2a8c2		TCGA-A8-A09C-01	TCGA-A8-A09C-01A-11R-A00Z-07	95bcf18b-40bf-4a20-82bf-727c7bb2a8c2	95bcf18b-40bf-4a20-82bf-727c7bb2a8c2	TCGA-A8-A09C-01A-11D-A011-01	TCGA-A8-A09C-01	TCGA-A8-A09C-01	TCGA-A8-A09C-01A-11D-A00Y-05	967323eb-3ae6-4b35-bab3-35abf8b80299	TCGA-A8-A09C-01A-11R-A010-13
TCGA-A8-A09D-01	Stage IIB	47	5	No_Conversion	396		Positive	FEMALE	Negative				Negative	M0	Positive	N1	396	0	LumA	Luminal B	Positive		-3	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09D-01	1522	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-A8-A09D	1522	0	1522	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Right Lower Outer Quadrant			TCGA-A8-A09D-F40549		Positive					Positive	Other					-17440			0	1522												2013-2-23	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.5		YES					Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	1								NO				M0	N1	T2	Stage IIB																		TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	5th		NO	YES	A8	Breast		LIVING	2007	TCGA-A8-A09D-01A-11W-A019-09	TCGA-A8-A09D-01		TCGA-A8-A09D-01A-11R-A010-13	TCGA-A8-A09D-01A-11W-A019-09		TCGA-A8-A09D-01A-11W-A019-09		TCGA-A8-A09D-01A-11W-A019-09	f2563687-e055-41a8-8436-614fbad762d4	ccbe901d-210e-402f-92b3-875c51074ef3	TCGA-A8-A09D-01A-11D-A011-01	f2563687-e055-41a8-8436-614fbad762d4		TCGA-A8-A09D-01	TCGA-A8-A09D-01A-11R-A00Z-07	f2563687-e055-41a8-8436-614fbad762d4	f2563687-e055-41a8-8436-614fbad762d4	TCGA-A8-A09D-01A-11D-A011-01	TCGA-A8-A09D-01	TCGA-A8-A09D-01	TCGA-A8-A09D-01A-11D-A00Y-05	ccbe901d-210e-402f-92b3-875c51074ef3	TCGA-A8-A09D-01A-11R-A010-13
TCGA-A8-A09E-01	Stage IIIB	73		Stage IIIB	942		Positive	FEMALE	Equivocal				Negative	M0	Positive	N1	942	0			Positive				enrollment	T_Other	T4	LIVING	0	TCGA-A8-A09E-01	1492	0	High	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 14		mutation c1uster 9	TCGA-A8-A09E	1492	0	1492	Breast	TCGA Breast Cancer	breast invasive carcinoma					73	Left Lower Outer Quadrant			TCGA-A8-A09E-F40334		Positive					Positive	Other					-26724	819		0	1492												2013-2-17	FEMALE					2+					Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.5		YES			220	NO	Positive	Positive	NO		Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO			false	M0	N1a	T4b	Stage IIIB	TCGA-A8-A09E.C55B6F4B-1248-4FBF-83C2-B0A1B33DEA03.pdf	4	8	0	0	2	2	0	0	7	0	16	18	75	80	90	87	WITH TUMOR						YES		Yes			YES	Primary Tumor	01	Surgical resection	6th		NO	YES	A8	Breast	A	LIVING	2008	TCGA-A8-A09E-01A-11W-A019-09	TCGA-A8-A09E-01		TCGA-A8-A09E-01A-11R-A010-13		f0bc5acd-5e59-47c9-b2a6-8f47508a9ec6	TCGA-A8-A09E-01A-11W-A019-09	TCGA-A8-A09E-01A-21-A13A-20	TCGA-A8-A09E-01A-11W-A019-09	1bbb85e8-8f55-44e3-8bd8-58c0a46c43bd	70b9ece6-dedc-44c7-8f35-b78d9bac626e	TCGA-A8-A09E-01A-11D-A011-01	1bbb85e8-8f55-44e3-8bd8-58c0a46c43bd		TCGA-A8-A09E-01	TCGA-A8-A09E-01A-11R-A00Z-07	1bbb85e8-8f55-44e3-8bd8-58c0a46c43bd	1bbb85e8-8f55-44e3-8bd8-58c0a46c43bd	TCGA-A8-A09E-01A-11D-A011-01	TCGA-A8-A09E-01	TCGA-A8-A09E-01	TCGA-A8-A09E-01A-11D-A00Y-05	70b9ece6-dedc-44c7-8f35-b78d9bac626e	TCGA-A8-A09E-01A-11R-A010-13
TCGA-A8-A09G-01	Stage IIIC	79	2	Stage IIIC	0		Positive	FEMALE	Positive	3	2	1	Negative	M0	Positive	N3	0	0	Her2	HER2-enriched	Negative	Her2	-11	-5	enrollment	T_Other	T3	LIVING		TCGA-A8-A09G-01			Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-A8-A09G				Breast	TCGA Breast Cancer	breast invasive carcinoma					79	Right Lower Outer Quadrant					Positive					Negative	Other					-29006	759		0	0												2011-5-27	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.5		YES			270	NO	Positive	Positive			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	3											false	M0	N3a	T3	Stage IIIC	TCGA-A8-A09G.2728DB14-66D5-4E67-B9B6-63D93DBF509C.pdf	5	5	0	0	1	1	0	0	0	0	9	34	90	65	85	70	TUMOR FREE								No				Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	TCGA-A8-A09G-01A-21W-A019-09	TCGA-A8-A09G-01		TCGA-A8-A09G-01A-21R-A010-13	TCGA-A8-A09G-01A-21W-A019-09	8390a7e5-0373-43e2-adc0-8f6fbdc665d1	TCGA-A8-A09G-01A-21W-A019-09	TCGA-A8-A09G-01A-11-A13A-20	TCGA-A8-A09G-01A-21W-A019-09	31757dda-12d6-4f35-87f1-d00464f2815b	3cd925e9-93f6-4810-87c6-f3c7ecaf6e77	TCGA-A8-A09G-01A-21D-A011-01	31757dda-12d6-4f35-87f1-d00464f2815b		TCGA-A8-A09G-01	TCGA-A8-A09G-01A-21R-A00Z-07	31757dda-12d6-4f35-87f1-d00464f2815b	31757dda-12d6-4f35-87f1-d00464f2815b	TCGA-A8-A09G-01A-21D-A011-01	TCGA-A8-A09G-01	TCGA-A8-A09G-01	TCGA-A8-A09G-01A-21D-A00Y-05	3cd925e9-93f6-4810-87c6-f3c7ecaf6e77	TCGA-A8-A09G-01A-21R-A010-13
TCGA-A8-A09I-01	Stage IIA	84	5	Stage IIA	1006		Positive	FEMALE	Positive	1	1	4	Negative	M0	Negative	N0	1006	0	LumB	Luminal B	Positive	Her2	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09I-01	1371	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A8-A09I	1371	0	1371	Breast	TCGA Breast Cancer	breast invasive carcinoma					84	Right Lower Outer Quadrant			TCGA-A8-A09I-F40333		Positive					Positive	Other					-30711	698		0	1371												2013-2-17	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			430	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4								NO			false	M0	N0	T2	Stage IIA	TCGA-A8-A09I.AF12859A-D67A-488D-8BC2-ED28698F2ACA.pdf	5	1	0	0	1	1	0	0	5	0	14	14	80	85	75	90	TUMOR FREE						YES		Yes			NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	TCGA-A8-A09I-01A-22W-A050-09	TCGA-A8-A09I-01		TCGA-A8-A09I-01A-22R-A035-13	TCGA-A8-A09I-01A-22W-A050-09	93a8128c-9314-44b7-8737-0c5b08c057f4	TCGA-A8-A09I-01A-22W-A050-09	TCGA-A8-A09I-01A-11-A13A-20	TCGA-A8-A09I-01A-22W-A050-09	433b49ba-949b-4914-985a-be19b3b32502	bd4d930e-0848-48c1-8b03-c04a986f22d8	TCGA-A8-A09I-01A-22D-A036-01	433b49ba-949b-4914-985a-be19b3b32502		TCGA-A8-A09I-01	TCGA-A8-A09I-01A-22R-A034-07	433b49ba-949b-4914-985a-be19b3b32502	433b49ba-949b-4914-985a-be19b3b32502	TCGA-A8-A09I-01A-22D-A036-01	TCGA-A8-A09I-01	TCGA-A8-A09I-01	TCGA-A8-A09I-01A-22D-A032-05	bd4d930e-0848-48c1-8b03-c04a986f22d8	TCGA-A8-A09I-01A-22R-A035-13
TCGA-A8-A09K-01	Stage IIA	68		Stage IIA	911		Positive	FEMALE	Negative				Negative	M0	Positive	N1	911	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-A8-A09K-01	912	0	High	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6		mutation c1uster 9	TCGA-A8-A09K	912	0	912	Breast	TCGA Breast Cancer	breast invasive carcinoma					68	Left Lower Outer Quadrant			TCGA-A8-A09K-F40332		Positive					Positive	Other					-24960	788		0	912												2013-2-17	FEMALE					0					Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.5		YES			240	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO			false	M0	N1	T1c	Stage IIA	TCGA-A8-A09K.56C24ABB-CF1D-447F-A5A8-B762C4B01566.pdf	20	20	3	2	1	1	0	0	5	0	4	9	90	90	75	70	TUMOR FREE						NO		Yes			NO	Primary Tumor	01	Surgical resection	6th		NO	YES	A8	Breast	A	LIVING	2008	TCGA-A8-A09K-01A-11W-A019-09	TCGA-A8-A09K-01		TCGA-A8-A09K-01A-11R-A010-13	TCGA-A8-A09K-01A-11W-A019-09	795da071-d853-421e-85e3-902a7e1af1eb	TCGA-A8-A09K-01A-11W-A019-09	TCGA-A8-A09K-01A-21-A13A-20	TCGA-A8-A09K-01A-11W-A019-09	9b54f75f-80eb-441d-83ca-5ae1d00bdfa9	b412fc52-5776-4ff9-b9c4-829efabfb377	TCGA-A8-A09K-01A-11D-A011-01	9b54f75f-80eb-441d-83ca-5ae1d00bdfa9		TCGA-A8-A09K-01	TCGA-A8-A09K-01A-11R-A00Z-07	9b54f75f-80eb-441d-83ca-5ae1d00bdfa9	9b54f75f-80eb-441d-83ca-5ae1d00bdfa9	TCGA-A8-A09K-01A-11D-A011-01	TCGA-A8-A09K-01	TCGA-A8-A09K-01	TCGA-A8-A09K-01A-11D-A00Y-05	b412fc52-5776-4ff9-b9c4-829efabfb377	TCGA-A8-A09K-01A-11R-A010-13
TCGA-A8-A09M-01	Stage IIIC	75	5	Stage IIIC	457		Positive	FEMALE	Negative	1	1	4	Negative	M0	Positive	N3	457	0	LumB	Luminal B	Positive	LumA/B	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09M-01	1006	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 5	mutation c1uster 10	TCGA-A8-A09M	1006	0	1006	Breast	TCGA Breast Cancer	breast invasive carcinoma					75	Right Lower Outer Quadrant			TCGA-A8-A09M-F40331		Positive					Positive	Other					-27455	333		0	1006												2013-2-17	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.5		YES			170	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5								NO			false	M0	N3a	T2	Stage IIIC	TCGA-A8-A09M.EBBF2A70-2773-40FA-823A-E608ABFEF591.pdf	20	15	0	0	1	1	0	0	2	2	17	17	80	80	70	75	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A09M-01A-11W-A019-09	TCGA-A8-A09M-01		TCGA-A8-A09M-01A-11R-A010-13		fcc864a9-3f22-4717-a5e1-2c034b9ae7f5	TCGA-A8-A09M-01A-11W-A019-09	TCGA-A8-A09M-01A-21-A13B-20	TCGA-A8-A09M-01A-11W-A019-09	3e08280c-f748-43c7-928b-007b322917b2	9240c87f-41fc-4576-aedb-2c8010079920	TCGA-A8-A09M-01A-11D-A011-01	3e08280c-f748-43c7-928b-007b322917b2		TCGA-A8-A09M-01	TCGA-A8-A09M-01A-11R-A00Z-07	3e08280c-f748-43c7-928b-007b322917b2	3e08280c-f748-43c7-928b-007b322917b2	TCGA-A8-A09M-01A-11D-A011-01	TCGA-A8-A09M-01	TCGA-A8-A09M-01	TCGA-A8-A09M-01A-11D-A00Y-05	9240c87f-41fc-4576-aedb-2c8010079920	TCGA-A8-A09M-01A-11R-A010-13
TCGA-A8-A09N-01	Stage IIIC	57	1	Stage IIIC	31		Positive	FEMALE	Positive				Negative	M0	Positive	N3	31	0	LumB	Luminal B	Positive		0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09N-01	31	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 7	mutation cluster 5	TCGA-A8-A09N			31	Breast	TCGA Breast Cancer	breast invasive carcinoma					57	Right Lower Outer Quadrant					Positive					Positive	Other					-21002	1276		0	31												2011-5-27	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.5		YES			70	NO	Positive	Positive			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	7											false	M0	N3a	T2	Stage IIIC	TCGA-A8-A09N.F5A97F05-4B5C-4B10-BF10-5DDE7D412BCF.pdf	10	10	0	0	1	1	0	0	3	22	16	2	80	75	80	85	TUMOR FREE								No				Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2006	TCGA-A8-A09N-01A-11W-A019-09	TCGA-A8-A09N-01		TCGA-A8-A09N-01A-11R-A010-13	TCGA-A8-A09N-01A-11W-A019-09		TCGA-A8-A09N-01A-11W-A019-09		TCGA-A8-A09N-01A-11W-A019-09	653e3eb4-ebdb-42d2-9479-a1ea8a43bdc5	bdf230f7-71c7-4ee8-b1ed-b29015b40f57	TCGA-A8-A09N-01A-11D-A011-01	653e3eb4-ebdb-42d2-9479-a1ea8a43bdc5		TCGA-A8-A09N-01	TCGA-A8-A09N-01A-11R-A00Z-07	653e3eb4-ebdb-42d2-9479-a1ea8a43bdc5	653e3eb4-ebdb-42d2-9479-a1ea8a43bdc5	TCGA-A8-A09N-01A-11D-A011-01	TCGA-A8-A09N-01	TCGA-A8-A09N-01	TCGA-A8-A09N-01A-11D-A00Y-05	bdf230f7-71c7-4ee8-b1ed-b29015b40f57	TCGA-A8-A09N-01A-11R-A010-13
TCGA-A8-A09Q-01	Stage IIIB	83	2	Stage IIIB	761		Positive	FEMALE	Negative				Negative	M0	Positive	N2	761	0	LumB	Luminal B	Positive		-2	-5	enrollment	T_Other	T4	LIVING	0	TCGA-A8-A09Q-01	761	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A8-A09Q			761	Breast	TCGA Breast Cancer	breast invasive carcinoma					83	Left Lower Inner Quadrant			TCGA-A8-A09Q-F41022		Positive					Positive	Other					-30528	637		0	761												2013-3-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.3		YES			100	NO	Negative	Negative	NO		Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4											false	M0	N2a	T4b	Stage IIIB	TCGA-A8-A09Q.46C0AB7B-82FC-4D06-9F26-22AEC8BEEDA7.pdf	8	5	0	0	2	2	0	0	0	0	24	24	74	74	75	75	WITH TUMOR						YES		No			NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	TCGA-A8-A09Q-01A-11W-A019-09	TCGA-A8-A09Q-01		TCGA-A8-A09Q-01A-11R-A010-13	TCGA-A8-A09Q-01A-11W-A019-09		TCGA-A8-A09Q-01A-11W-A019-09		TCGA-A8-A09Q-01A-11W-A019-09	9560e482-cb14-4456-b9a6-d2ac12f96a4f	f2824bc4-e4fd-4416-83ce-f9ab555cd208	TCGA-A8-A09Q-01A-11D-A011-01	9560e482-cb14-4456-b9a6-d2ac12f96a4f		TCGA-A8-A09Q-01	TCGA-A8-A09Q-01A-11R-A00Z-07	9560e482-cb14-4456-b9a6-d2ac12f96a4f	9560e482-cb14-4456-b9a6-d2ac12f96a4f	TCGA-A8-A09Q-01A-11D-A011-01	TCGA-A8-A09Q-01	TCGA-A8-A09Q-01	TCGA-A8-A09Q-01A-11D-A00Y-05	f2824bc4-e4fd-4416-83ce-f9ab555cd208	TCGA-A8-A09Q-01A-11R-A010-13
TCGA-A8-A09R-01	Stage IIB	82	5	Stage IIB	273		Positive	FEMALE	Negative	1	1	4	Negative	M0	Positive	N1	273	0	LumB	Luminal B	Positive	Her2	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09R-01	273	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A8-A09R	273	0	273	Breast	TCGA Breast Cancer	breast invasive carcinoma					82	Left Lower Inner Quadrant			TCGA-A8-A09R-F40330		Positive					Positive	Other					-30196	149		0	273												2013-2-17	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.3		YES			180	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO			false	M0	N1	T2	Stage IIB	TCGA-A8-A09R.5E615F92-6FD0-48C7-AC37-78526974BCFC.pdf	10	10	1	1	3	1	0	0	3	3	34	46	60	50	80	65	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A09R-01A-11W-A019-09	TCGA-A8-A09R-01		TCGA-A8-A09R-01A-11R-A010-13		7c1073e9-1995-4dfa-a9aa-e260e8999d54	TCGA-A8-A09R-01A-11W-A019-09	TCGA-A8-A09R-01A-21-A13B-20	TCGA-A8-A09R-01A-11W-A019-09	f4fcb7e1-20b8-4b66-86a2-1be81b06785e	c7064fcd-f96a-4977-8782-9131dfdf843e	TCGA-A8-A09R-01A-11D-A011-01	f4fcb7e1-20b8-4b66-86a2-1be81b06785e		TCGA-A8-A09R-01	TCGA-A8-A09R-01A-11R-A00Z-07	f4fcb7e1-20b8-4b66-86a2-1be81b06785e	f4fcb7e1-20b8-4b66-86a2-1be81b06785e	TCGA-A8-A09R-01A-11D-A011-01	TCGA-A8-A09R-01	TCGA-A8-A09R-01	TCGA-A8-A09R-01A-11D-A00Y-05	c7064fcd-f96a-4977-8782-9131dfdf843e	TCGA-A8-A09R-01A-11R-A010-13
TCGA-A8-A09T-01	Stage X	68	4	Stage I	578		Positive	FEMALE	Negative				Negative	M0	Negative	N0	578	0	LumA	Luminal A	Positive		-12	-3	enrollment	T1	T1	LIVING	0	TCGA-A8-A09T-01	579	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A09T	579	0	579	Breast	TCGA Breast Cancer	breast invasive carcinoma					68	Left			TCGA-A8-A09T-F40329		Positive					Positive	Other					-25110	394		0	579												2013-2-17	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			100	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO			false	MX	N0	T1c	Stage X	TCGA-A8-A09T.C616E97C-8352-4FED-9E83-558318216FB6.pdf	0	1	0	0	1	0	0	0	1	5	9	10	89	85	90	85	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A09T-01A-11W-A019-09	TCGA-A8-A09T-01		TCGA-A8-A09T-01A-11R-A010-13	TCGA-A8-A09T-01A-11W-A019-09		TCGA-A8-A09T-01A-11W-A019-09		TCGA-A8-A09T-01A-11W-A019-09	c14f7362-25c3-4e1a-acd7-871bb22ea8a3	63eeed5c-ee46-43e0-8886-3ad9b50634e3	TCGA-A8-A09T-01A-11D-A011-01	c14f7362-25c3-4e1a-acd7-871bb22ea8a3		TCGA-A8-A09T-01	TCGA-A8-A09T-01A-11R-A00Z-07	c14f7362-25c3-4e1a-acd7-871bb22ea8a3	c14f7362-25c3-4e1a-acd7-871bb22ea8a3	TCGA-A8-A09T-01A-11D-A011-01	TCGA-A8-A09T-01	TCGA-A8-A09T-01	TCGA-A8-A09T-01A-11D-A00Y-05	63eeed5c-ee46-43e0-8886-3ad9b50634e3	TCGA-A8-A09T-01A-11R-A010-13
TCGA-A8-A09V-01	Stage IIA	51	2	Stage IIA	457		Positive	FEMALE	Negative				Negative	M0	Negative	N0	457	0	LumA	Luminal A	Positive		-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09V-01	457	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7			mutation c1uster 9	TCGA-A8-A09V	457	0	457	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Right Upper Inner Quadrant			TCGA-A8-A09V-F40328		Positive					Positive	Other					-18628	333		0	457												2013-2-17	FEMALE					0					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.2		YES			60	NO	Negative	Negative	NO		Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2									NO			false	M0	N0	T2	Stage IIA	TCGA-A8-A09V.E0B04FB6-9500-4786-B6D9-303165EF9090.pdf	1	1	0	0	0	0	0	0	0	0	30	25	70	75	70	75	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A09V-01A-11D-A045-09	TCGA-A8-A09V-01			TCGA-A8-A09V-01A-11D-A045-09		TCGA-A8-A09V-01A-11D-A045-09		TCGA-A8-A09V-01A-11D-A045-09	416041ff-f179-4c72-a281-f39d32c595c1	72d21cce-e233-49e4-8277-aa1b0be0a160	TCGA-A8-A09V-01A-11D-A036-01	416041ff-f179-4c72-a281-f39d32c595c1		TCGA-A8-A09V-01	TCGA-A8-A09V-01A-11R-A034-07	416041ff-f179-4c72-a281-f39d32c595c1	416041ff-f179-4c72-a281-f39d32c595c1	TCGA-A8-A09V-01A-11D-A036-01	TCGA-A8-A09V-01	TCGA-A8-A09V-01	TCGA-A8-A09V-01A-11D-A032-05	72d21cce-e233-49e4-8277-aa1b0be0a160	
TCGA-A8-A09W-01	Stage IIIB	70	2	Stage IIIC	30		Positive	FEMALE	Negative				Negative	M0	Positive	N3	30	0	LumB	Luminal B	Positive	Her2	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09W-01	30	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7			mutation c1uster 9	TCGA-A8-A09W			30	Breast	TCGA Breast Cancer	breast invasive carcinoma					70	Right Upper Inner Quadrant					Positive					Positive	Other					-25659	1033		0	30												2011-5-27	FEMALE					0					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.2		YES			180	NO	Negative	Negative				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4												false	M0	N3	T2	Stage IIIB	TCGA-A8-A09W.B73AF7B0-EED3-413C-B249-C97F27E4EA1C.pdf	1	1	0	0	2	2	0	0	0	0	23	28	75	70	75	70									No				Primary Tumor	01	Surgical Resection	5th		NO	YES	A8	Breast	A	LIVING	2007	TCGA-A8-A09W-01A-11W-A019-09	TCGA-A8-A09W-01				074231b9-2438-4e1e-9965-6ae7e02ae660	TCGA-A8-A09W-01A-11W-A019-09	TCGA-A8-A09W-01A-21-A13A-20	TCGA-A8-A09W-01A-11W-A019-09	aaec0cbc-a493-48f4-9cc7-32629880ee24	51f01aa5-6fd7-4f74-ba41-603e338b3ed1	TCGA-A8-A09W-01A-11D-A011-01	aaec0cbc-a493-48f4-9cc7-32629880ee24		TCGA-A8-A09W-01	TCGA-A8-A09W-01A-11R-A00Z-07	aaec0cbc-a493-48f4-9cc7-32629880ee24	aaec0cbc-a493-48f4-9cc7-32629880ee24	TCGA-A8-A09W-01A-11D-A011-01	TCGA-A8-A09W-01	TCGA-A8-A09W-01	TCGA-A8-A09W-01A-11D-A00Y-05	51f01aa5-6fd7-4f74-ba41-603e338b3ed1	
TCGA-A8-A09X-01	Stage IIIC	62	3	Stage IIIC	426	426	Negative	FEMALE	Negative	2	1	1	Negative	M0	Positive	N3	426	1	Her2	HER2-enriched	Negative	Her2	-11	-5	enrollment	T_Other	T2	DECEASED	1	TCGA-A8-A09X-01	426	1	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-A8-A09X			426	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Left Upper Inner Quadrant					Negative					Negative	Other					-22858	302	426	0													2011-5-27	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.2		YES			150	NO	Negative	Negative				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	3											false	M0	N3a	T2	Stage IIIC	TCGA-A8-A09X.F72703A2-2C57-459A-9015-94BD3D302491.pdf	1	1	0	0	2	1	0	0	0	0	13	14	85	85	85	85									No				Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	DECEASED	2009	TCGA-A8-A09X-01A-11W-A019-09	TCGA-A8-A09X-01		TCGA-A8-A09X-01A-11R-A010-13	TCGA-A8-A09X-01A-11W-A019-09	62752717-e2ef-42c9-b0c2-282f66bc0096	TCGA-A8-A09X-01A-11W-A019-09	TCGA-A8-A09X-01A-21-A13A-20	TCGA-A8-A09X-01A-11W-A019-09	f97f68be-6838-455c-91bf-7549543a82c3	aff06258-5ee9-4f2b-8947-f296ca0b34f3	TCGA-A8-A09X-01A-11D-A011-01	f97f68be-6838-455c-91bf-7549543a82c3		TCGA-A8-A09X-01	TCGA-A8-A09X-01A-11R-A00Z-07	f97f68be-6838-455c-91bf-7549543a82c3	f97f68be-6838-455c-91bf-7549543a82c3	TCGA-A8-A09X-01A-11D-A011-01	TCGA-A8-A09X-01	TCGA-A8-A09X-01	TCGA-A8-A09X-01A-11D-A00Y-05	aff06258-5ee9-4f2b-8947-f296ca0b34f3	TCGA-A8-A09X-01A-11R-A010-13
TCGA-A8-A09Z-01	Stage IIB	83	2	Stage IIB	0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	0	0		Luminal B	Negative	Basal	0	-5	enrollment	T_Other	T3	LIVING		TCGA-A8-A09Z-01			Iq		cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 14	cluster 2		TCGA-A8-A09Z				Breast	TCGA Breast Cancer	breast invasive carcinoma					83	Right					Positive					Negative	Other					-30590	728		0	0												2011-5-27	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			320	NO	Negative	Negative			Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2											false	M0	N0	T3	Stage IIB	TCGA-A8-A09Z.DF890966-D14E-4EDF-B6E3-E10E40BA5B5D.pdf	1	1	0	0	1	1	0	0	0	0	24	9	75	90	75	90	WITH TUMOR								No				Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008		TCGA-A8-A09Z-01		TCGA-A8-A09Z-01A-11R-A010-13		c8b43014-8e13-462a-90c5-c38032e02d7a	TCGA-A8-A09Z-01A-11W-A019-09	TCGA-A8-A09Z-01A-21-A13A-20		2c3ad15f-0d26-441e-8139-85194b3389f2	6696111b-ca51-4c58-806d-2d5faa3a9456	TCGA-A8-A09Z-01A-11D-A011-01	2c3ad15f-0d26-441e-8139-85194b3389f2		TCGA-A8-A09Z-01	TCGA-A8-A09Z-01A-11R-A00Z-07	2c3ad15f-0d26-441e-8139-85194b3389f2	2c3ad15f-0d26-441e-8139-85194b3389f2	TCGA-A8-A09Z-01A-11D-A011-01	TCGA-A8-A09Z-01	TCGA-A8-A09Z-01	TCGA-A8-A09Z-01A-11D-A00Y-05	6696111b-ca51-4c58-806d-2d5faa3a9456	TCGA-A8-A09Z-01A-11R-A010-13
TCGA-A8-A0A1-01	Stage IIA	84	2	Stage IIA	365		Positive	FEMALE	Negative				Negative	M0	Negative	N0	365	0	LumA	Luminal A	Positive		-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A0A1-01	365	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 4	mutation cluster 4	TCGA-A8-A0A1			365	Breast	TCGA Breast Cancer	breast invasive carcinoma					84	Right					Positive					Positive	Other					-30742	241		0	365												2011-5-27	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			90	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4											false	M0	N0	T2	Stage IIA	TCGA-A8-A0A1.3BC6CE69-2641-4B6D-85DF-E8FE838015D0.pdf	10	10	0	5	5	5	0	0	10	10	40	55	45	30	80	65	TUMOR FREE								No				Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A0A1-01A-11W-A019-09	TCGA-A8-A0A1-01		TCGA-A8-A0A1-01A-11R-A010-13	TCGA-A8-A0A1-01A-11W-A019-09		TCGA-A8-A0A1-01A-11W-A019-09		TCGA-A8-A0A1-01A-11W-A019-09	8522865b-457c-4199-a870-bf8353f2b0a5	ebcb8722-05fc-441d-a13a-1fb5c8f1228f	TCGA-A8-A0A1-01A-11D-A011-01	8522865b-457c-4199-a870-bf8353f2b0a5		TCGA-A8-A0A1-01	TCGA-A8-A0A1-01A-11R-A00Z-07	8522865b-457c-4199-a870-bf8353f2b0a5	8522865b-457c-4199-a870-bf8353f2b0a5	TCGA-A8-A0A1-01A-11D-A011-01	TCGA-A8-A0A1-01	TCGA-A8-A0A1-01	TCGA-A8-A0A1-01A-11D-A00Y-05	ebcb8722-05fc-441d-a13a-1fb5c8f1228f	TCGA-A8-A0A1-01A-11R-A010-13
TCGA-A8-A0A2-01	Stage IIA	66	2	Stage IIA	578		Positive	FEMALE	Negative				Negative	M0	Negative	N0	578	0	LumA	Luminal A	Positive		0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A0A2-01	579	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A0A2			579	Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Right Lower Outer Quadrant					Positive					Positive	Other					-24380	394		0	579												2011-5-27	FEMALE					0					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.5		YES			70	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	2											false	M0	N0	T2	Stage IIA	TCGA-A8-A0A2.6443B16E-E6D9-4A1D-B950-BEEC7BAEDBBE.pdf	1	2	0	0	1	1	0	0	3	0	26	19	70	80	70	80	TUMOR FREE								No				Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A0A2-01A-11W-A050-09	TCGA-A8-A0A2-01		TCGA-A8-A0A2-01A-11R-A035-13	TCGA-A8-A0A2-01A-11W-A050-09		TCGA-A8-A0A2-01A-11W-A050-09		TCGA-A8-A0A2-01A-11W-A050-09	6330ab59-db9d-4b22-a96b-1024c9b4908d	2c01b1ef-d826-4183-b79d-903d4fe5ef5e	TCGA-A8-A0A2-01A-11D-A036-01	6330ab59-db9d-4b22-a96b-1024c9b4908d		TCGA-A8-A0A2-01	TCGA-A8-A0A2-01A-11R-A034-07	6330ab59-db9d-4b22-a96b-1024c9b4908d	6330ab59-db9d-4b22-a96b-1024c9b4908d	TCGA-A8-A0A2-01A-11D-A036-01	TCGA-A8-A0A2-01	TCGA-A8-A0A2-01	TCGA-A8-A0A2-01A-11D-A032-05	2c01b1ef-d826-4183-b79d-903d4fe5ef5e	TCGA-A8-A0A2-01A-11R-A035-13
TCGA-A8-A0A4-01	Stage IIA	73	2	Stage IIA	396		Positive	FEMALE	Negative	1	3	3	Negative	M0	Negative	N0	396	0	LumA	Luminal A	Positive	ReacII	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A0A4-01	396	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-A8-A0A4	396	0	396	Breast	TCGA Breast Cancer	breast invasive carcinoma					73	Left			TCGA-A8-A0A4-F40326		Positive					Positive	Other					-26693	272		0	396												2013-2-16	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.1		YES			160	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	3								NO			false	M0	N0	T2	Stage IIA	TCGA-A8-A0A4.25F8F043-2CD0-4344-9B4A-5BBB691B5BF9.pdf	1	1	0	0	1	1	0	0	0	0	14	19	85	80	85	80	TUMOR FREE						YES		No			NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A0A4-01A-11W-A019-09	TCGA-A8-A0A4-01		TCGA-A8-A0A4-01A-11R-A010-13	TCGA-A8-A0A4-01A-11W-A019-09	9748e726-7d5e-4e3c-ad24-ab078118010c	TCGA-A8-A0A4-01A-11W-A019-09	TCGA-A8-A0A4-01A-21-A13A-20	TCGA-A8-A0A4-01A-11W-A019-09	d9d0e575-bca2-45e6-9df3-fb6fee59ccd9	a4acb159-6b4b-431f-9ae3-1352299bc461	TCGA-A8-A0A4-01A-11D-A011-01	d9d0e575-bca2-45e6-9df3-fb6fee59ccd9		TCGA-A8-A0A4-01	TCGA-A8-A0A4-01A-11R-A00Z-07	d9d0e575-bca2-45e6-9df3-fb6fee59ccd9	d9d0e575-bca2-45e6-9df3-fb6fee59ccd9	TCGA-A8-A0A4-01A-11D-A011-01	TCGA-A8-A0A4-01	TCGA-A8-A0A4-01	TCGA-A8-A0A4-01A-11D-A00Y-05	a4acb159-6b4b-431f-9ae3-1352299bc461	TCGA-A8-A0A4-01A-11R-A010-13
TCGA-A8-A0A6-01	Stage IIIC	64	2	Stage IIIC	640		Positive	FEMALE	Negative				Negative	M0	Positive	N3	640	0	LumA	Luminal A	Positive		-5	-4	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A0A6-01	640	0	BRCA-LUAD+		cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 6	cluster 1		TCGA-A8-A0A6	640	0	640	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Left Upper Outer Quadrant			TCGA-A8-A0A6-F40325		Positive					Positive	Other					-23404	394		0	640												2013-2-16	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES			90	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	1								NO			false	M0	N3a	T2	Stage IIIC	TCGA-A8-A0A6.161A2735-C3CF-466D-AE21-C6A2C987BB1E.pdf	8	2	1	0	1	2	0	0	15	3	24	20	60	75	75	75	TUMOR FREE						YES		No			YES	Primary Tumor	01	surgical resection	6th		NO	YES	A8	Breast	A	LIVING	2009		TCGA-A8-A0A6-01		TCGA-A8-A0A6-01A-12R-A057-13			TCGA-A8-A0A6-01A-12W-A071-09			6ba764ba-f6ae-4977-8b7f-4e9528009eb0	0f68f8f1-514a-41b6-bf5a-87792ef5a50f	TCGA-A8-A0A6-01A-12D-A059-01	6ba764ba-f6ae-4977-8b7f-4e9528009eb0	TCGA-A8-A0A6-01A-12D-A10P-05	TCGA-A8-A0A6-01	TCGA-A8-A0A6-01A-12R-A056-07	6ba764ba-f6ae-4977-8b7f-4e9528009eb0	6ba764ba-f6ae-4977-8b7f-4e9528009eb0	TCGA-A8-A0A6-01A-12D-A059-01	TCGA-A8-A0A6-01	TCGA-A8-A0A6-01		0f68f8f1-514a-41b6-bf5a-87792ef5a50f	TCGA-A8-A0A6-01A-12R-A057-13
TCGA-A8-A0A7-01	Stage IIB	57	3	Stage IIB	30		Negative	FEMALE	Positive	1	1	1	Negative	M0	Positive	N1	30	0	Her2	HER2-enriched	Negative	Her2	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A0A7-01	30	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A0A7			30	Breast	TCGA Breast Cancer	breast invasive carcinoma					57	Right Upper Outer Quadrant					Negative					Negative	Other					-20940			0	30												2011-5-27	FEMALE					3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES					Positive	Positive			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4												M0	N1a	T2	Stage IIB																		TUMOR FREE								No				Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast		LIVING	2009	TCGA-A8-A0A7-01A-11W-A019-09	TCGA-A8-A0A7-01		TCGA-A8-A0A7-01A-11R-A010-13	TCGA-A8-A0A7-01A-11W-A019-09	d459629a-8ef9-4556-adfb-a3105e460556	TCGA-A8-A0A7-01A-11W-A019-09	TCGA-A8-A0A7-01A-21-A13A-20	TCGA-A8-A0A7-01A-11W-A019-09	bae23acf-5981-4071-a7e1-6363ab128561	ea568589-43f0-4539-acdf-c626aeb20446	TCGA-A8-A0A7-01A-11D-A011-01	bae23acf-5981-4071-a7e1-6363ab128561		TCGA-A8-A0A7-01	TCGA-A8-A0A7-01A-11R-A040-07	bae23acf-5981-4071-a7e1-6363ab128561	bae23acf-5981-4071-a7e1-6363ab128561	TCGA-A8-A0A7-01A-11D-A011-01	TCGA-A8-A0A7-01	TCGA-A8-A0A7-01	TCGA-A8-A0A7-01A-11D-A00Y-05	ea568589-43f0-4539-acdf-c626aeb20446	TCGA-A8-A0A7-01A-11R-A010-13
TCGA-A8-A0A9-01	Stage IIA	80	3	Stage IIA	396		Positive	FEMALE	Negative				Negative	M0	Negative	N0	396	0	LumA	Luminal B	Positive		0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A0A9-01	822	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A8-A0A9	822	0	822	Breast	TCGA Breast Cancer	breast invasive carcinoma					80	Left Upper Outer Quadrant			TCGA-A8-A0A9-F40323		Positive					Positive	Other					-29370	272		0	822												2013-2-16	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			100	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	2								NO			false	M0	N0	T2	Stage IIA	TCGA-A8-A0A9.8612388B-3680-4BD8-986C-E7ABE9F92F91.pdf	1	2	0	0	0	0	0	0	0	0	15	15	85	85	85	85	TUMOR FREE						YES		No			YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A0A9-01A-11W-A019-09	TCGA-A8-A0A9-01		TCGA-A8-A0A9-01A-11R-A010-13	TCGA-A8-A0A9-01A-11W-A019-09		TCGA-A8-A0A9-01A-11W-A019-09		TCGA-A8-A0A9-01A-11W-A019-09	1766e42e-f8cf-447d-a694-3999a1fec43a	e58bcf4e-94ae-47b3-9148-43a76567841d	TCGA-A8-A0A9-01A-11D-A011-01	1766e42e-f8cf-447d-a694-3999a1fec43a		TCGA-A8-A0A9-01	TCGA-A8-A0A9-01A-11R-A00Z-07	1766e42e-f8cf-447d-a694-3999a1fec43a	1766e42e-f8cf-447d-a694-3999a1fec43a	TCGA-A8-A0A9-01A-11D-A011-01	TCGA-A8-A0A9-01	TCGA-A8-A0A9-01	TCGA-A8-A0A9-01A-11D-A00Y-05	e58bcf4e-94ae-47b3-9148-43a76567841d	TCGA-A8-A0A9-01A-11R-A010-13
TCGA-A8-A0AB-01	Stage IIA	54	2	Stage IIA	517		Positive	FEMALE	Negative				Negative	M0	Negative	N0	517	0	LumA	Luminal B	Positive		-1	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A0AB-01	518	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A0AB	518	0	518	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Left Upper Outer Quadrant			TCGA-A8-A0AB-F40322		Positive					Positive	Other					-19814	394		0	518												2013-2-16	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES			70	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO			false	M0	N0	T2	Stage IIA	TCGA-A8-A0AB.E4D30B42-383A-40BF-BB91-511A90227655.pdf	5	5	1	1	5	5	0	0	15	0	50	45	30	50	60	80	TUMOR FREE						YES		No			NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	TCGA-A8-A0AB-01A-11W-A050-09	TCGA-A8-A0AB-01		TCGA-A8-A0AB-01A-11R-A035-13	TCGA-A8-A0AB-01A-11W-A050-09		TCGA-A8-A0AB-01A-11W-A050-09		TCGA-A8-A0AB-01A-11W-A050-09	83fe3d7b-6905-49ea-bbc8-ea9c468004f6	bffa483f-5c3a-4945-be72-4b868b1c10fb	TCGA-A8-A0AB-01A-11D-A036-01	83fe3d7b-6905-49ea-bbc8-ea9c468004f6		TCGA-A8-A0AB-01	TCGA-A8-A0AB-01A-11R-A034-07	83fe3d7b-6905-49ea-bbc8-ea9c468004f6	83fe3d7b-6905-49ea-bbc8-ea9c468004f6	TCGA-A8-A0AB-01A-11D-A036-01	TCGA-A8-A0AB-01	TCGA-A8-A0AB-01	TCGA-A8-A0AB-01A-11D-A032-05	bffa483f-5c3a-4945-be72-4b868b1c10fb	TCGA-A8-A0AB-01A-11R-A035-13
TCGA-A8-A0AD-01	Stage I	83	2	Stage I	1157		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1157	0	LumA	Luminal A	Positive		-12	-3	enrollment	T1	T1	LIVING	0	TCGA-A8-A0AD-01	1157	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 3	cluster 2	mutation c1uster 9	TCGA-A8-A0AD	1157	0	1157	Breast	TCGA Breast Cancer	breast invasive carcinoma					83	Right Upper Outer Quadrant			TCGA-A8-A0AD-F40321		Positive					Positive	Other					-30407			0	1157												2013-2-16	FEMALE					1+					Mixed Histology (please specify)	lobular/ductal	No		C50.9	8522/3	C50.4		YES					Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO				M0	N0	T1c	Stage I																		TUMOR FREE						YES		No			NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast		LIVING	2007	TCGA-A8-A0AD-01A-11W-A071-09	TCGA-A8-A0AD-01		TCGA-A8-A0AD-01A-11R-A057-13	TCGA-A8-A0AD-01A-11W-A071-09		TCGA-A8-A0AD-01A-11W-A071-09		TCGA-A8-A0AD-01A-11W-A071-09	b62f3825-9634-4252-b841-4c455a007353	f9e62dfe-3037-4306-be92-dfbeae90283e	TCGA-A8-A0AD-01A-11D-A059-01	b62f3825-9634-4252-b841-4c455a007353	TCGA-A8-A0AD-01A-11D-A10P-05	TCGA-A8-A0AD-01	TCGA-A8-A0AD-01A-11R-A056-07	b62f3825-9634-4252-b841-4c455a007353	b62f3825-9634-4252-b841-4c455a007353	TCGA-A8-A0AD-01A-11D-A059-01	TCGA-A8-A0AD-01	TCGA-A8-A0AD-01		f9e62dfe-3037-4306-be92-dfbeae90283e	TCGA-A8-A0AD-01A-11R-A057-13
TCGA-AC-A23C-01		62	3	Stage IIB	29		Positive	FEMALE	Positive				Negative	M0	Positive	N1	29	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AC-A23C-01	29	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 7	mutation cluster 4	TCGA-AC-A23C			29	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Left					Positive					Positive	Modified Radical Mastectomy					-22751	198		0	29					NO		90-99%					2011-7-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	100	NO	Positive	Positive		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	7									1		false	MX	N1	T2	Stage IIB	TCGA-AC-A23C.926E93B6-EF7C-4F13-824D-13D08B7F7938.pdf		1		0		5		0		0		30		65		85								YES	No	50-59%			Primary Tumor	01		7th		NO	YES	AC	Breast	A	LIVING	2010	TCGA-AC-A23C-01A-12D-A167-09		TCGA-AC-A23C-01A-12R-A168-13	TCGA-AC-A23C-01A-12R-A168-13	TCGA-AC-A23C-01A-12D-A167-09		TCGA-AC-A23C-01A-12D-A167-09	TCGA-AC-A23C-01A-21-A17I-20	TCGA-AC-A23C-01A-12D-A167-09	052b565f-1955-4c4e-8b1f-dd48743ba944	2036be70-c64b-4ef4-82c6-822c5afae946	TCGA-AC-A23C-01A-12D-A166-01	052b565f-1955-4c4e-8b1f-dd48743ba944	TCGA-AC-A23C-01A-12D-A16A-05	TCGA-AC-A23C-01		052b565f-1955-4c4e-8b1f-dd48743ba944	052b565f-1955-4c4e-8b1f-dd48743ba944	TCGA-AC-A23C-01A-12D-A166-01		TCGA-AC-A23C-01		2036be70-c64b-4ef4-82c6-822c5afae946	
TCGA-AC-A23E-01		50	2	Stage IIB	72		Positive	FEMALE	Negative				Negative	M0	Positive	N1	72	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AC-A23E-01	72	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13		mutation cluster 4	TCGA-AC-A23E			72	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Right	Sentinel node biopsy alone				Positive					Positive	Modified Radical Mastectomy					-18500	158		0	72					NO		30-39%					2011-7-18	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO				2	Negative																			2										1		false	MX	N1	T2	Stage IIB	TCGA-AC-A23E.C976ACED-7FF8-4287-9D68-C6FD17895FC0.pdf		1		0		1		0		0		54		45		70	TUMOR FREE							YES	No	80-89%			Primary Tumor	01		7th				AC	Breast	A	LIVING	2010	TCGA-AC-A23E-01A-11D-A159-09		TCGA-AC-A23E-01A-11R-A156-13	TCGA-AC-A23E-01A-11R-A156-13	TCGA-AC-A23E-01A-11D-A159-09		TCGA-AC-A23E-01A-11D-A159-09	TCGA-AC-A23E-01A-21-A17I-20	TCGA-AC-A23E-01A-11D-A159-09	25be50e7-7705-492d-a44a-0e40180d10c8	f875e50e-fc0f-4421-8ffb-4fec24d3340c	TCGA-AC-A23E-01A-11D-A160-01	25be50e7-7705-492d-a44a-0e40180d10c8	TCGA-AC-A23E-01A-11D-A161-05	TCGA-AC-A23E-01		25be50e7-7705-492d-a44a-0e40180d10c8	25be50e7-7705-492d-a44a-0e40180d10c8	TCGA-AC-A23E-01A-11D-A160-01		TCGA-AC-A23E-01		f875e50e-fc0f-4421-8ffb-4fec24d3340c	
TCGA-AC-A23G-01																			LumA										0	TCGA-AC-A23G-01	330	0	Iq			BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4			TCGA-AC-A23G			330	Breast	TCGA Breast Cancer	breast invasive carcinoma					76	Right Upper Inner Quadrant					Positive					Positive	Other					-27934	1590		0	330					NO		90-99%					2011-7-14	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	40	NO	Positive	Positive		8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												2		false	MX	N1	T1c	Stage IIA	TCGA-AC-A23G.810663DD-1718-4FD6-B9C2-77B4C091B3F1.pdf		1		0		0		0		10		40		50		65	TUMOR FREE							YES	No	80-89%			Primary Tumor	01	Right Total Mastectomy and Sentinel Node Biopsy	6th		NO	YES	AC	Breast	A	LIVING	2006			TCGA-AC-A23G-01A-11R-A214-13	TCGA-AC-A23G-01A-11R-A214-13			TCGA-AC-A23G-01A-11D-A20S-09			3cd0b704-99b5-401b-8f52-daead9359692	02bde32b-37e9-4768-9222-aba698b4ef49	TCGA-AC-A23G-01A-11D-A20R-01	3cd0b704-99b5-401b-8f52-daead9359692	TCGA-AC-A23G-01A-11D-A212-05	TCGA-AC-A23G-01		3cd0b704-99b5-401b-8f52-daead9359692	3cd0b704-99b5-401b-8f52-daead9359692	TCGA-AC-A23G-01A-11D-A20R-01		TCGA-AC-A23G-01		02bde32b-37e9-4768-9222-aba698b4ef49	
TCGA-AC-A23H-01		90	3	Stage IIA	81		Positive	FEMALE	Positive				Negative	M0	Negative	N0	81	0	Her2		Negative				enrollment	T_Other	T2	LIVING	1	TCGA-AC-A23H-01	174	1	High		cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4			TCGA-AC-A23H	174	0	174	Breast	TCGA Breast Cancer	breast invasive carcinoma					90	Right Upper Inner Quadrant|Right Lower Inner Quadrant			TCGA-AC-A23H-F45572		Positive					Negative	Simple Mastectomy					-32873	478	174	0	81					NO		10-19%					2013-7-17	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	70	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO			false	M0	NX	T2	Stage IIA	TCGA-AC-A23H.A7C7D409-D086-4A9B-8C8F-E7E231D5891D.pdf		1		0		0		0		0		25		75		85	WITH TUMOR						NO	NO	No			NO	Primary Tumor	01		7th		NO	YES	AC	Breast	A	DECEASED	2009			TCGA-AC-A23H-01A-11R-A156-13	TCGA-AC-A23H-01A-11R-A156-13			TCGA-AC-A23H-01A-11D-A159-09			28199d71-9111-4763-a07f-66734769bb98	f8597ba1-42d8-4506-a306-3e443b82018d	TCGA-AC-A23H-01A-11D-A160-01	28199d71-9111-4763-a07f-66734769bb98	TCGA-AC-A23H-01A-11D-A161-05	TCGA-AC-A23H-01		28199d71-9111-4763-a07f-66734769bb98	28199d71-9111-4763-a07f-66734769bb98	TCGA-AC-A23H-01A-11D-A160-01		TCGA-AC-A23H-01		f8597ba1-42d8-4506-a306-3e443b82018d	
TCGA-AC-A23H-11		90			81			FEMALE									81	0	Normal						enrollment			LIVING	1	TCGA-AC-A23H-11	174	1										TCGA-AC-A23H	174	0	174	Breast	TCGA Breast Cancer	breast invasive carcinoma					90	Right Upper Inner Quadrant|Right Lower Inner Quadrant			TCGA-AC-A23H-F45572		Positive					Negative	Simple Mastectomy					-32873	478	174	0	81					NO		10-19%					2013-7-17	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	70	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO			false	M0	NX	T2	Stage IIA			2		0		0		0		22		78		0		0	WITH TUMOR						NO	NO	No			NO	Solid Tissue Normal	11		7th		NO	YES	AC	Breast	A	DECEASED	2009			TCGA-AC-A23H-11A-12R-A156-13	TCGA-AC-A23H-11A-12R-A156-13						93108690-ccc2-4ae4-89e0-042a654a0228			93108690-ccc2-4ae4-89e0-042a654a0228	TCGA-AC-A23H-11A-12D-A161-05			93108690-ccc2-4ae4-89e0-042a654a0228	93108690-ccc2-4ae4-89e0-042a654a0228						
TCGA-AC-A2B8-01			2																LumA										0	TCGA-AC-A2B8-01	45	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-AC-A2B8			45	Breast	TCGA Breast Cancer	breast invasive carcinoma					84	Right	Axillary lymph node dissection alone				Positive					Positive	Simple Mastectomy					-31003			0	45					NO		90-99%					2011-9-12	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Negative	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1										0	0		M0	N0 (i-)	T3	Stage IIB																									YES	No	90-99%			Primary Tumor	01		7th		YES	NO	AC	Breast		LIVING	2011			TCGA-AC-A2B8-01A-11R-A17A-13	TCGA-AC-A2B8-01A-11R-A17A-13			TCGA-AC-A2B8-01A-11D-A17D-09	TCGA-AC-A2B8-01A-21-A24A-20		ed74a7e1-90de-4943-9ca2-e7f94a5540e4	abfdddc2-b118-4b4e-a283-f8cbc56730b4	TCGA-AC-A2B8-01A-11D-A17C-01	ed74a7e1-90de-4943-9ca2-e7f94a5540e4	TCGA-AC-A2B8-01A-11D-A17F-05	TCGA-AC-A2B8-01		ed74a7e1-90de-4943-9ca2-e7f94a5540e4	ed74a7e1-90de-4943-9ca2-e7f94a5540e4	TCGA-AC-A2B8-01A-11D-A17C-01		TCGA-AC-A2B8-01		abfdddc2-b118-4b4e-a283-f8cbc56730b4	
TCGA-AC-A2BK-01																			Basal										0	TCGA-AC-A2BK-01	1172	0	High	C4-BRCA/Basal		BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4			TCGA-AC-A2BK			1172	Breast	TCGA Breast Cancer	breast invasive carcinoma					78	Left Upper Outer Quadrant	Axillary lymph node dissection alone				Negative					Negative	Modified Radical Mastectomy		NO			-28625	1717		0	1172					NO							2011-9-16	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	140	NO	Negative			23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												6		false	MX	N2a	T2	Stage IIIA	TCGA-AC-A2BK.3E54B0CE-8863-4728-BC95-A47C1869F52A.pdf		0		0		0		0		0		0		100		95	TUMOR FREE							YES	No				Primary Tumor	01		6th		NO	YES	AC	Breast	A	LIVING	2006			TCGA-AC-A2BK-01A-11R-A21U-13	TCGA-AC-A2BK-01A-11R-A21U-13			TCGA-AC-A2BK-01A-11D-A21Q-09	TCGA-AC-A2BK-01A-21-A24A-20		08893743-829b-4594-ab67-d5eb5e80a4f3	d35e1d61-8d2b-4a12-a245-99c4d13c7f43	TCGA-AC-A2BK-01A-11D-A21P-01	08893743-829b-4594-ab67-d5eb5e80a4f3	TCGA-AC-A2BK-01A-11D-A21R-05	TCGA-AC-A2BK-01		08893743-829b-4594-ab67-d5eb5e80a4f3	08893743-829b-4594-ab67-d5eb5e80a4f3	TCGA-AC-A2BK-01A-11D-A21P-01		TCGA-AC-A2BK-01		d35e1d61-8d2b-4a12-a245-99c4d13c7f43	
TCGA-AC-A2BM-01																			LumB										0	TCGA-AC-A2BM-01	3022	0	BRCA-LUAD+	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-AC-A2BM	3022	0	3022	Breast	TCGA Breast Cancer	breast invasive carcinoma					41	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AC-A2BM-F66202		Positive					Positive	Modified Radical Mastectomy		YES			-15212	2164		0	3022					NO		60-69%					2014-10-3	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	120	NO		Negative	NO	13	Negative																												NO	1	1	false	MX	N1a	T2	Stage IIB	TCGA-AC-A2BM.9F00B6F4-EE91-4A18-B533-127E39EF8554.pdf		0		0		5		0		0		15		80		90	TUMOR FREE						NO	YES	No	10-19%		NO	Primary Tumor	01		6th		NO	YES	AC	Breast	A	LIVING	2005			TCGA-AC-A2BM-01A-11R-A21U-13	TCGA-AC-A2BM-01A-11R-A21U-13			TCGA-AC-A2BM-01A-11D-A21Q-09	TCGA-AC-A2BM-01A-21-A24A-20		54f1981b-9d8f-48cc-9586-d2e9a8d468f5	af345a5e-3793-4751-b412-333cf037cda8	TCGA-AC-A2BM-01A-11D-A21P-01	54f1981b-9d8f-48cc-9586-d2e9a8d468f5	TCGA-AC-A2BM-01A-11D-A21R-05	TCGA-AC-A2BM-01		54f1981b-9d8f-48cc-9586-d2e9a8d468f5	54f1981b-9d8f-48cc-9586-d2e9a8d468f5	TCGA-AC-A2BM-01A-11D-A21P-01		TCGA-AC-A2BM-01		af345a5e-3793-4751-b412-333cf037cda8	
TCGA-AC-A2FB-01			3																LumA										0	TCGA-AC-A2FB-01	1234	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-AC-A2FB	1234	0	1234	Breast	TCGA Breast Cancer	breast invasive carcinoma					65	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-AC-A2FB-F45574		Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		NO			-23851			0	1234					NO		90-99%					2013-7-17	FEMALE			10-19%		3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Core needle biopsy			Positive		NO	1	Negative																			1									NO	0			MX	N0	T2	Stage IIA																		TUMOR FREE						YES	YES	No	<10%		NO	Primary Tumor	01		6th		NO	YES	AC	Breast		LIVING	2009			TCGA-AC-A2FB-01A-11R-A17A-13	TCGA-AC-A2FB-01A-11R-A17A-13			TCGA-AC-A2FB-01A-11D-A17D-09	TCGA-AC-A2FB-01A-21-A24A-20		fce0d59e-78a5-4d7b-8136-b8421f5116b0	ebef629e-e465-4ef3-84db-81ff8522b7f9	TCGA-AC-A2FB-01A-11D-A17C-01	fce0d59e-78a5-4d7b-8136-b8421f5116b0	TCGA-AC-A2FB-01A-11D-A17F-05	TCGA-AC-A2FB-01		fce0d59e-78a5-4d7b-8136-b8421f5116b0	fce0d59e-78a5-4d7b-8136-b8421f5116b0	TCGA-AC-A2FB-01A-11D-A17C-01		TCGA-AC-A2FB-01		ebef629e-e465-4ef3-84db-81ff8522b7f9	
TCGA-AC-A2FB-11																			Normal										0	TCGA-AC-A2FB-11	1234	0		C3-BRCA/Luminal								TCGA-AC-A2FB	1234	0	1234	Breast	TCGA Breast Cancer	breast invasive carcinoma					65	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-AC-A2FB-F45574		Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		NO			-23851	576		0	1234					NO		90-99%					2013-7-17	FEMALE			10-19%		3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Core needle biopsy	100	NO	Positive		NO	1	Negative																												NO	0		false	MX	N0	T2	Stage IIA			0		0		0		0		100		0		0		0	TUMOR FREE						YES	YES	No	<10%		NO	Solid Tissue Normal	11		6th		NO	YES	AC	Breast	A	LIVING	2009			TCGA-AC-A2FB-11A-13R-A17A-13	TCGA-AC-A2FB-11A-13R-A17A-13						f18b2ff7-eddb-40b5-9bbe-7ef09787ddef			f18b2ff7-eddb-40b5-9bbe-7ef09787ddef	TCGA-AC-A2FB-11A-13D-A17F-05			f18b2ff7-eddb-40b5-9bbe-7ef09787ddef	f18b2ff7-eddb-40b5-9bbe-7ef09787ddef						
TCGA-AC-A2FE-01																														TCGA-AC-A2FE-01			BRCA-LUAD+			BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 5			TCGA-AC-A2FE				Breast	TCGA Breast Cancer	breast invasive carcinoma																							2228																																					120	NO																																				false					TCGA-AC-A2FE.F694CBD6-880D-40C7-AB17-D0AD02B7F06B.pdf		0		0		0		0		40		25		35		75													Primary Tumor	01								A					TCGA-AC-A2FE-01A-11R-A19V-13	TCGA-AC-A2FE-01A-11R-A19V-13			TCGA-AC-A2FE-01A-11D-A19Y-09	TCGA-AC-A2FE-01A-21-A24A-20		22e03b77-aa0f-4348-98c1-9b0914e8af8b	dfc59958-404b-4e0e-9950-9c120f6956c0	TCGA-AC-A2FE-01A-11D-A19X-01	22e03b77-aa0f-4348-98c1-9b0914e8af8b	TCGA-AC-A2FE-01A-11D-A19Z-05	TCGA-AC-A2FE-01		22e03b77-aa0f-4348-98c1-9b0914e8af8b	22e03b77-aa0f-4348-98c1-9b0914e8af8b	TCGA-AC-A2FE-01A-11D-A19X-01		TCGA-AC-A2FE-01		dfc59958-404b-4e0e-9950-9c120f6956c0	
TCGA-AC-A2FF-01			1																LumA										0	TCGA-AC-A2FF-01	1686	0	Quiet	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-AC-A2FF			1686	Breast	TCGA Breast Cancer	breast invasive carcinoma					40	Right	Sentinel lymph node biopsy plus axillary dissection				Positive					Positive	Lumpectomy		YES						0	1686					NO		30-39%					2011-9-23	FEMALE								1.7		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy				Negative		7	Negative																			1										3	0		MX	N1	T2	Stage IIB																		TUMOR FREE							YES	No	70-79%			Primary Tumor	01		6th		NO	YES	AC	Breast		LIVING	2006			TCGA-AC-A2FF-01A-11R-A17A-13	TCGA-AC-A2FF-01A-11R-A17A-13			TCGA-AC-A2FF-01A-11D-A17D-09	TCGA-AC-A2FF-01A-21-A24A-20		f99cbdbb-ae9c-4dc2-9b69-eeaa7798c2b8	aabd1bd8-a5fc-44fd-8a1c-300fbab3032f	TCGA-AC-A2FF-01A-11D-A17C-01	f99cbdbb-ae9c-4dc2-9b69-eeaa7798c2b8	TCGA-AC-A2FF-01A-11D-A17F-05	TCGA-AC-A2FF-01		f99cbdbb-ae9c-4dc2-9b69-eeaa7798c2b8	f99cbdbb-ae9c-4dc2-9b69-eeaa7798c2b8	TCGA-AC-A2FF-01A-11D-A17C-01		TCGA-AC-A2FF-01		aabd1bd8-a5fc-44fd-8a1c-300fbab3032f	
TCGA-AC-A2FF-11																			Normal										0	TCGA-AC-A2FF-11	1686	0		C3-BRCA/Luminal								TCGA-AC-A2FF			1686	Breast	TCGA Breast Cancer	breast invasive carcinoma					40	Right	Sentinel lymph node biopsy plus axillary dissection				Positive					Positive	Lumpectomy		YES				1904		0	1686					NO		30-39%					2011-9-23	FEMALE								1.7		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	80	NO		Negative		7	Negative																													3	0	false	MX	N1	T2	Stage IIB			1		0		0		0		20		80		0		0	TUMOR FREE							YES	No	70-79%			Solid Tissue Normal	11		6th		NO	YES	AC	Breast	A	LIVING	2006										3610639e-d947-446f-8483-86be65c80ed3			3610639e-d947-446f-8483-86be65c80ed3	TCGA-AC-A2FF-11A-13D-A17F-05			3610639e-d947-446f-8483-86be65c80ed3	3610639e-d947-446f-8483-86be65c80ed3						
TCGA-AC-A2FG-01			2																LumA										0	TCGA-AC-A2FG-01	1125	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10			TCGA-AC-A2FG			1125	Breast	TCGA Breast Cancer	breast invasive carcinoma					79	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection				Positive					Negative	Modified Radical Mastectomy		YES			-29211	1517		0	1125					NO		90-99%					2011-9-21	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	120	NO		Negative		11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1										1	1	false	MX	N1a	T2	Stage IIB	TCGA-AC-A2FG.C1ABCD83-40EA-4FF7-BEB6-69679589E8E7.pdf		1		0		0		0		10		72		18		60	TUMOR FREE							YES	No				Primary Tumor	01		6th		NO	YES	AC	Breast	A	LIVING	2007			TCGA-AC-A2FG-01A-11R-A17A-13	TCGA-AC-A2FG-01A-11R-A17A-13			TCGA-AC-A2FG-01A-11D-A17D-09	TCGA-AC-A2FG-01A-21-A24A-20		c4cc228f-ab41-4779-b405-175618e5f77c	709f0022-50be-49df-839c-9e716e3e0869	TCGA-AC-A2FG-01A-11D-A17C-01	c4cc228f-ab41-4779-b405-175618e5f77c	TCGA-AC-A2FG-01A-11D-A17F-05	TCGA-AC-A2FG-01		c4cc228f-ab41-4779-b405-175618e5f77c	c4cc228f-ab41-4779-b405-175618e5f77c	TCGA-AC-A2FG-01A-11D-A17C-01		TCGA-AC-A2FG-01		709f0022-50be-49df-839c-9e716e3e0869	
TCGA-AC-A2FG-11																													0	TCGA-AC-A2FG-11	1125	0		C3-BRCA/Luminal								TCGA-AC-A2FG			1125	Breast	TCGA Breast Cancer	breast invasive carcinoma					79	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection				Positive					Negative	Modified Radical Mastectomy		YES			-29211	1517		0	1125					NO		90-99%					2011-9-21	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	120	NO		Negative		11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												1	1	false	MX	N1a	T2	Stage IIB			0		0		0		0		25		75		0		0	TUMOR FREE							YES	No				Solid Tissue Normal	11		6th		NO	YES	AC	Breast	A	LIVING	2007														TCGA-AC-A2FG-11A-22D-A17F-05										
TCGA-AC-A2FK-01																			Normal										0	TCGA-AC-A2FK-01	1180	0	Quiet			Low purity c2		BRCA nonbasal-like c7	miRNA cluster 5			TCGA-AC-A2FK			1180	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Left Upper Outer Quadrant					Positive					Positive	Simple Mastectomy					-16627	1833		0	1180					NO		90-99%					2011-9-13	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	80	NO		Negative		3	Negative																													3		false	M0	N3a	T2	Stage IIIC	TCGA-AC-A2FK.1CF3FA64-EAE6-4A18-9B51-F5980A885371.pdf		1		0		0		0		7		68		25		70	TUMOR FREE							YES	No	90-99%			Primary Tumor	01		6th		NO	YES	AC	Breast	A	LIVING	2006			TCGA-AC-A2FK-01A-12R-A17X-13	TCGA-AC-A2FK-01A-12R-A17X-13			TCGA-AC-A2FK-01A-12D-A17W-09			1fff796f-626b-4408-9fd1-4fea54e153a6	643d3847-9b4e-44c3-ae8e-965a14b19a55	TCGA-AC-A2FK-01A-12D-A17U-01	1fff796f-626b-4408-9fd1-4fea54e153a6	TCGA-AC-A2FK-01A-12D-A17Z-05	TCGA-AC-A2FK-01		1fff796f-626b-4408-9fd1-4fea54e153a6	1fff796f-626b-4408-9fd1-4fea54e153a6	TCGA-AC-A2FK-01A-12D-A17U-01		TCGA-AC-A2FK-01		643d3847-9b4e-44c3-ae8e-965a14b19a55	
TCGA-AC-A2FM-01																													1	TCGA-AC-A2FM-01	792	1	High			BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 5			TCGA-AC-A2FM			792	Breast	TCGA Breast Cancer	breast invasive carcinoma					87	Right Upper Inner Quadrant	Sentinel node biopsy alone										Modified Radical Mastectomy		YES			-31805	2606	792	0						YES			Other, specify	perinodal connective tissue			2012-2-22	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	170	NO				2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0	0	false	M0	N1mi	T2	Stage IIB	TCGA-AC-A2FM.83BA3E82-E8E4-4A70-ADEE-A1360940EECE.pdf		2		0		1		0		34		5		60		80	WITH TUMOR							YES	No				Primary Tumor	01		6th		NO	YES	AC	Breast	A	DECEASED	2004			TCGA-AC-A2FM-01A-11R-A19V-13	TCGA-AC-A2FM-01A-11R-A19V-13			TCGA-AC-A2FM-01A-11D-A19Y-09	TCGA-AC-A2FM-01A-21-A24A-20		c1280be2-b926-4632-975a-fe52bb04c65d	92864651-156a-44ab-a442-f17567476e0f	TCGA-AC-A2FM-01A-11D-A19X-01	c1280be2-b926-4632-975a-fe52bb04c65d	TCGA-AC-A2FM-01A-11D-A19Z-05	TCGA-AC-A2FM-01		c1280be2-b926-4632-975a-fe52bb04c65d	c1280be2-b926-4632-975a-fe52bb04c65d	TCGA-AC-A2FM-01A-11D-A19X-01		TCGA-AC-A2FM-01		92864651-156a-44ab-a442-f17567476e0f	
TCGA-AC-A2FM-11																													1	TCGA-AC-A2FM-11	792	1										TCGA-AC-A2FM			792	Breast	TCGA Breast Cancer	breast invasive carcinoma					87	Right Upper Inner Quadrant	Sentinel node biopsy alone										Modified Radical Mastectomy		YES			-31805	2733	792	0						YES			Other, specify	perinodal connective tissue			2012-2-22	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	220	NO				2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0	0	false	M0	N1mi	T2	Stage IIB			0		0		0		0		10		90		0		0	WITH TUMOR							YES	No				Solid Tissue Normal	11		6th		NO	YES	AC	Breast	B	DECEASED	2004			TCGA-AC-A2FM-11B-32R-A19V-13	TCGA-AC-A2FM-11B-32R-A19V-13						68ec8441-f60a-4c80-8a9f-7609a0f81430			68ec8441-f60a-4c80-8a9f-7609a0f81430	TCGA-AC-A2FM-11B-32D-A19Z-05			68ec8441-f60a-4c80-8a9f-7609a0f81430	68ec8441-f60a-4c80-8a9f-7609a0f81430						
TCGA-AC-A2FO-01																			LumA										0	TCGA-AC-A2FO-01	1542	0	Iq			BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14			TCGA-AC-A2FO			1542	Breast	TCGA Breast Cancer	breast invasive carcinoma					65	Left Upper Outer Quadrant	Other (specify)	Sentinel lymph node plus Level I and Level II lymph nodes			Positive					Negative	Simple Mastectomy		NO			-23928	2051		0	1542					NO		90-99%					2011-9-21	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	120	NO	Negative	Indeterminate		10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												2		false	MX	N1	T2	Stage IIB	TCGA-AC-A2FO.5A7EB73F-E681-46CC-B2D6-C87EEAB0AC99.pdf		10		0		1		0		30		19		50		60	TUMOR FREE							YES	No				Primary Tumor	01		6th		NO	YES	AC	Breast	A	LIVING	2005			TCGA-AC-A2FO-01A-11R-A17X-13	TCGA-AC-A2FO-01A-11R-A17X-13			TCGA-AC-A2FO-01A-11D-A17W-09			bd07aa68-708b-4bd3-88b9-78a8b9e298f5	51d21451-3c81-475b-bcd8-02e23e44cbd0	TCGA-AC-A2FO-01A-11D-A17U-01	bd07aa68-708b-4bd3-88b9-78a8b9e298f5	TCGA-AC-A2FO-01A-11D-A17Z-05	TCGA-AC-A2FO-01		bd07aa68-708b-4bd3-88b9-78a8b9e298f5	bd07aa68-708b-4bd3-88b9-78a8b9e298f5	TCGA-AC-A2FO-01A-11D-A17U-01		TCGA-AC-A2FO-01		51d21451-3c81-475b-bcd8-02e23e44cbd0	
TCGA-AC-A2QH-01																			Basal										0	TCGA-AC-A2QH-01	1005	0	Squamous			Cluster 5		GBM-like c6	miRNA cluster 13			TCGA-AC-A2QH	1005	0	1005	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-AC-A2QH-F64100		Negative					Negative	Modified Radical Mastectomy		YES			-21488	108		0	1005					NO							2014-8-26	FEMALE										Other  specify	Invasive high-grade sarcomatoid (metaplastic) carcinoma with areas of matrix-producing carcinoma.	No		C50.9	8575/3	C50.9		YES		Core needle biopsy	150	NO	Negative		NO	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0	T3	Stage IIB	TCGA-AC-A2QH.C2A0E948-2B9E-4E49-90C4-57CE4C4A95B3.pdf		0		0		0		0		0		30		70		90	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2011			TCGA-AC-A2QH-01A-11R-A18L-13,TCGA-AC-A2QH-01B-04R-A22P-13	TCGA-AC-A2QH-01A-11R-A18L-13,TCGA-AC-A2QH-01B-04R-A22P-13			TCGA-AC-A2QH-01B-04D-A22N-09,TCGA-AC-A2QH-01A-11D-A18P-09			d848ad65-9261-4854-a6bd-e76484c6a337	116845a5-2178-44ff-8cac-58b95dd85081,86c22622-a7fb-4c73-8d6a-40be9a307dbe	TCGA-AC-A2QH-01A-11D-A18N-01	d848ad65-9261-4854-a6bd-e76484c6a337	TCGA-AC-A2QH-01A-11D-A18O-05,TCGA-AC-A2QH-01B-04D-A22R-05	TCGA-AC-A2QH-01		d848ad65-9261-4854-a6bd-e76484c6a337	d848ad65-9261-4854-a6bd-e76484c6a337	TCGA-AC-A2QH-01A-11D-A18N-01		TCGA-AC-A2QH-01		116845a5-2178-44ff-8cac-58b95dd85081,86c22622-a7fb-4c73-8d6a-40be9a307dbe	
TCGA-AC-A2QI-01																													0	TCGA-AC-A2QI-01	28	0	BRCA-LUAD+			BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 3			TCGA-AC-A2QI			28	Breast	TCGA Breast Cancer	breast invasive carcinoma					76	Right	Sentinel node biopsy alone				Positive					Negative	Other					-27865			0	28					NO		90-99%					2011-10-18	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												2			MX	N1a	T3	Stage IIIA																									YES	No				Primary Tumor	01	Total Mastectomy	7th		YES	NO	AC	Breast		LIVING	2011			TCGA-AC-A2QI-01A-12R-A19V-13	TCGA-AC-A2QI-01A-12R-A19V-13			TCGA-AC-A2QI-01A-12D-A19Y-09	TCGA-AC-A2QI-01A-21-A24A-20		d620baa1-c329-46c6-a56a-dc08dfa23470	daf25698-598f-4efb-b1b5-6083d673b63f	TCGA-AC-A2QI-01A-12D-A19X-01	d620baa1-c329-46c6-a56a-dc08dfa23470	TCGA-AC-A2QI-01A-12D-A19Z-05	TCGA-AC-A2QI-01		d620baa1-c329-46c6-a56a-dc08dfa23470	d620baa1-c329-46c6-a56a-dc08dfa23470	TCGA-AC-A2QI-01A-12D-A19X-01		TCGA-AC-A2QI-01		daf25698-598f-4efb-b1b5-6083d673b63f	
TCGA-AC-A2QJ-01																													0	TCGA-AC-A2QJ-01	69	0	BRCA-LUAD+			BRCA non-CIMP c9	KIRC-like c1		miRNA cluster 5			TCGA-AC-A2QJ			69	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Other (specify)	Sentinel lymph node and axillary lymph node biopsy			Negative					Negative	Other		NO			-17569	160		0	69					NO							2011-10-18	FEMALE										Other  specify	Invasive Metaplastic Carcinoma	No		C50.9	8575/3	C50.9		YES		Core needle biopsy	150	NO	Negative			2	Negative	Peri (6-12 months since last menstrual period)																												0		false	M0	N0	T4b	Stage IIIB	TCGA-AC-A2QJ.E422C6E8-084F-42B8-84E7-4EF387F098C7.pdf		0		0		0		0		0		10		90		90	TUMOR FREE							YES	No				Primary Tumor	01	Mastectomy	7th		YES	NO	AC	Breast	A	LIVING	2011			TCGA-AC-A2QJ-01A-12R-A19V-13	TCGA-AC-A2QJ-01A-12R-A19V-13			TCGA-AC-A2QJ-01A-12D-A19Y-09	TCGA-AC-A2QJ-01A-21-A24A-20		49a0f1eb-6ece-48fc-970f-3922263fd20b	52daa11e-014a-4418-8d86-f8c405bd9cc5	TCGA-AC-A2QJ-01A-12D-A19X-01	49a0f1eb-6ece-48fc-970f-3922263fd20b	TCGA-AC-A2QJ-01A-12D-A19Z-05	TCGA-AC-A2QJ-01		49a0f1eb-6ece-48fc-970f-3922263fd20b	49a0f1eb-6ece-48fc-970f-3922263fd20b	TCGA-AC-A2QJ-01A-12D-A19X-01		TCGA-AC-A2QJ-01		52daa11e-014a-4418-8d86-f8c405bd9cc5	
TCGA-AC-A3BB-01																													0	TCGA-AC-A3BB-01	987	0	BRCA-LUAD+			BRCA non-CIMP c9			miRNA cluster 5			TCGA-AC-A3BB	987	0	987	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AC-A3BB-F58953		Positive					Positive	Modified Radical Mastectomy					-16983	106		0	987					NO		90-99%					2014-4-29	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	160	NO	Negative		NO	14	Negative																												NO	5		false	MX	N2a	T3	Stage IIIA	TCGA-AC-A3BB.4D864947-076C-4A66-940D-682E75E525A2.pdf		0		0		0		0		10		0		90		85	TUMOR FREE						YES	NO	No	90-99%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2011			TCGA-AC-A3BB-01A-21R-A19V-13	TCGA-AC-A3BB-01A-21R-A19V-13			TCGA-AC-A3BB-01A-21D-A19Y-09			5b9b0b0c-c751-4b7d-9951-a8f6a13e1afa	325333bd-a1cc-43d2-bb16-420130c6ebf9	TCGA-AC-A3BB-01A-21D-A19X-01	5b9b0b0c-c751-4b7d-9951-a8f6a13e1afa	TCGA-AC-A3BB-01A-21D-A19Z-05	TCGA-AC-A3BB-01		5b9b0b0c-c751-4b7d-9951-a8f6a13e1afa	5b9b0b0c-c751-4b7d-9951-a8f6a13e1afa	TCGA-AC-A3BB-01A-21D-A19X-01		TCGA-AC-A3BB-01		325333bd-a1cc-43d2-bb16-420130c6ebf9	
TCGA-AC-A3EH-01																														TCGA-AC-A3EH-01			BRCA-LUAD+			BRCA CIMP c7			miRNA c1uster 9			TCGA-AC-A3EH				Breast	TCGA Breast Cancer	breast invasive carcinoma																							67																																					150	NO																																				false					TCGA-AC-A3EH.3094774B-B764-4D60-BFF3-48FEF39F4BEA.pdf		1		0		0		0		0		40		60		85													Primary Tumor	01								A					TCGA-AC-A3EH-01A-22R-A22I-13	TCGA-AC-A3EH-01A-22R-A22I-13			TCGA-AC-A3EH-01A-22D-A228-09			616255fe-88b3-4567-ae8d-bd68dd8380a3	0efe66fb-f938-47f8-8f5e-25f519faa2fc	TCGA-AC-A3EH-01A-22D-A227-01	616255fe-88b3-4567-ae8d-bd68dd8380a3	TCGA-AC-A3EH-01A-22D-A22B-05	TCGA-AC-A3EH-01		616255fe-88b3-4567-ae8d-bd68dd8380a3	616255fe-88b3-4567-ae8d-bd68dd8380a3	TCGA-AC-A3EH-01A-22D-A227-01		TCGA-AC-A3EH-01		0efe66fb-f938-47f8-8f5e-25f519faa2fc	
TCGA-AC-A3HN-01																			LumA										0	TCGA-AC-A3HN-01	496	0	Iq	C3-BRCA/Luminal		BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-AC-A3HN	496	0	496	Breast	TCGA Breast Cancer	breast invasive carcinoma					87	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-AC-A3HN-F65835		Positive	3 Point Scale	1+	3 Point Scale		Positive	Simple Mastectomy		YES			-32061	97		0	496					NO		90-99%					2014-9-30	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	160	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	2	0	false	MX	N1a	T2	Stage IIB	TCGA-AC-A3HN.F0308FC8-D8B4-487F-A072-05E66D01842A.pdf		0		0		0		0		0		0		100		80	TUMOR FREE						YES	YES	No	<10%		NO	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2011			TCGA-AC-A3HN-01A-11R-A214-13	TCGA-AC-A3HN-01A-11R-A214-13			TCGA-AC-A3HN-01A-11D-A20S-09	TCGA-AC-A3HN-01A-21-A24A-20		79a14838-69d2-4c73-83a7-b57ff6ecdd79	a7973daa-ca19-42a9-bf7c-a4dfc2359ba3	TCGA-AC-A3HN-01A-11D-A20R-01	79a14838-69d2-4c73-83a7-b57ff6ecdd79	TCGA-AC-A3HN-01A-11D-A212-05	TCGA-AC-A3HN-01		79a14838-69d2-4c73-83a7-b57ff6ecdd79	79a14838-69d2-4c73-83a7-b57ff6ecdd79	TCGA-AC-A3HN-01A-11D-A20R-01		TCGA-AC-A3HN-01		a7973daa-ca19-42a9-bf7c-a4dfc2359ba3	
TCGA-AC-A3OD-01																			LumA										0	TCGA-AC-A3OD-01	451	0	High			BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14			TCGA-AC-A3OD	451	0	451	Breast	TCGA Breast Cancer	breast invasive carcinoma					68	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AC-A3OD-F45582		Positive					Positive	Modified Radical Mastectomy		YES			-25186	63		0	451					NO		90-99%					2013-7-17	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	30	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1		false	MX	N1mi	T2	Stage IIB	TCGA-AC-A3OD.9F7E2B98-29E7-465F-AE12-33D78FDFD71A.pdf		10		0		0		5		0		0		100		80	TUMOR FREE						NO	YES	No	90-99%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2011			TCGA-AC-A3OD-01B-06R-A22P-13,TCGA-AC-A3OD-01A-11R-A21U-13	TCGA-AC-A3OD-01B-06R-A22P-13,TCGA-AC-A3OD-01A-11R-A21U-13			TCGA-AC-A3OD-01B-06D-A22N-09,TCGA-AC-A3OD-01A-11D-A21Q-09			7c521ef7-4adf-46ef-ade0-088cbe02223d	1a425572-ceb5-4f65-89c4-8fb8bc4c648e,339d0eca-df55-41e8-8415-9017c03018df	TCGA-AC-A3OD-01A-11D-A21P-01	7c521ef7-4adf-46ef-ade0-088cbe02223d	TCGA-AC-A3OD-01B-06D-A22R-05,TCGA-AC-A3OD-01A-11D-A21R-05	TCGA-AC-A3OD-01		7c521ef7-4adf-46ef-ade0-088cbe02223d	7c521ef7-4adf-46ef-ade0-088cbe02223d	TCGA-AC-A3OD-01A-11D-A21P-01		TCGA-AC-A3OD-01		1a425572-ceb5-4f65-89c4-8fb8bc4c648e,339d0eca-df55-41e8-8415-9017c03018df	
TCGA-AC-A3QP-01																													0	TCGA-AC-A3QP-01	675	0					BRCA nonbasal-like c8		miRNA cluster 4			TCGA-AC-A3QP	675	0	675	Breast	TCGA Breast Cancer	breast invasive carcinoma					79	Right	Sentinel node biopsy alone		TCGA-AC-A3QP-F56161		Positive					Positive	Lumpectomy					-29113	184		0	675					NO		70-79%			2.2		2014-1-29	FEMALE					2+	30	2.6	1.2		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	150	NO	Equivocal	Negative	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1	1	true	MX	N1mi	T2	Stage IIB	TCGA-AC-A3QP.14E2FC4E-7205-4929-81B5-7FF3006F08AD.pdf		10		0		0		0		50		0		50		60	TUMOR FREE						YES	YES	No	90-99%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2011			TCGA-AC-A3QP-01A-11R-A22V-13	TCGA-AC-A3QP-01A-11R-A22V-13			TCGA-AC-A3QP-01A-11D-A22X-09	TCGA-AC-A3QP-01A-21-A24A-20		4545ed8f-a83b-4049-9504-ba673ecd6d1d	19b4b554-9f45-46e8-b92d-65ee32331cb4	TCGA-AC-A3QP-01A-11D-A22W-01	4545ed8f-a83b-4049-9504-ba673ecd6d1d	TCGA-AC-A3QP-01A-11D-A230-05	TCGA-AC-A3QP-01		4545ed8f-a83b-4049-9504-ba673ecd6d1d	4545ed8f-a83b-4049-9504-ba673ecd6d1d	TCGA-AC-A3QP-01A-11D-A22W-01		TCGA-AC-A3QP-01		19b4b554-9f45-46e8-b92d-65ee32331cb4	
TCGA-AC-A3QQ-01																														TCGA-AC-A3QQ-01			Iq			BRCA non-CIMP c9			miRNA c1uster 10			TCGA-AC-A3QQ				Breast	TCGA Breast Cancer	breast invasive carcinoma																							77																																					30	NO																																				true					TCGA-AC-A3QQ.07833A91-F827-4708-AECC-728C708F8E2D.pdf		2		0		0		0		30		0		70		85													Primary Tumor	01								A					TCGA-AC-A3QQ-01A-11R-A22I-13,TCGA-AC-A3QQ-01B-06R-A22P-13	TCGA-AC-A3QQ-01A-11R-A22I-13,TCGA-AC-A3QQ-01B-06R-A22P-13						bf9ca847-f30f-4dcf-bb91-a483be8db666	25dbaee9-17b6-4279-94ec-99b5b97e14e9	TCGA-AC-A3QQ-01A-11D-A227-01	bf9ca847-f30f-4dcf-bb91-a483be8db666	TCGA-AC-A3QQ-01A-11D-A22B-05	TCGA-AC-A3QQ-01		bf9ca847-f30f-4dcf-bb91-a483be8db666	bf9ca847-f30f-4dcf-bb91-a483be8db666	TCGA-AC-A3QQ-01A-11D-A227-01		TCGA-AC-A3QQ-01		25dbaee9-17b6-4279-94ec-99b5b97e14e9	
TCGA-AC-A3TM-01																														TCGA-AC-A3TM-01			Iq			BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 4			TCGA-AC-A3TM				Breast	TCGA Breast Cancer	breast invasive carcinoma																							136																																					160	NO																																				false					TCGA-AC-A3TM.87DB9AD3-7640-4A78-B401-D5562D03BA76.pdf		2		0		1		0		1		33		65		85													Primary Tumor	01								A					TCGA-AC-A3TM-01A-11R-A22I-13	TCGA-AC-A3TM-01A-11R-A22I-13			TCGA-AC-A3TM-01A-11D-A228-09	TCGA-AC-A3TM-01A-21-A24A-20		902592e6-c7c5-46b8-b70b-5520df79a8a3	af766e9d-ade5-4aed-bf45-52f1804d0850	TCGA-AC-A3TM-01A-11D-A227-01	902592e6-c7c5-46b8-b70b-5520df79a8a3	TCGA-AC-A3TM-01A-11D-A22B-05	TCGA-AC-A3TM-01		902592e6-c7c5-46b8-b70b-5520df79a8a3	902592e6-c7c5-46b8-b70b-5520df79a8a3	TCGA-AC-A3TM-01A-11D-A227-01		TCGA-AC-A3TM-01		af766e9d-ade5-4aed-bf45-52f1804d0850	
TCGA-AC-A3TN-01																													0	TCGA-AC-A3TN-01	456	0	Iq			BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 4			TCGA-AC-A3TN	456	0	456	Breast	TCGA Breast Cancer	breast invasive carcinoma					75	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AC-A3TN-F60190		Positive					Positive	Simple Mastectomy					-27421	78		0	456					NO		90-99%					2014-5-31	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Other method, specify:	140	NO	Positive	Indeterminate	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	MX	N0	T3	Stage IIB	TCGA-AC-A3TN.1A0D203A-BC4B-441F-97F6-D1FF7E959262.pdf		2		1		1		0		8		61		30		70	TUMOR FREE						YES	YES	No	80-89%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2012			TCGA-AC-A3TN-01A-11R-A22I-13	TCGA-AC-A3TN-01A-11R-A22I-13			TCGA-AC-A3TN-01A-11D-A228-09	TCGA-AC-A3TN-01A-21-A24A-20		032db552-7828-4ed4-a1d7-b01b7fa89e29	0016bb20-f9ab-42ad-9d22-154bc12dfc14	TCGA-AC-A3TN-01A-11D-A227-01	032db552-7828-4ed4-a1d7-b01b7fa89e29	TCGA-AC-A3TN-01A-11D-A22B-05	TCGA-AC-A3TN-01		032db552-7828-4ed4-a1d7-b01b7fa89e29	032db552-7828-4ed4-a1d7-b01b7fa89e29	TCGA-AC-A3TN-01A-11D-A227-01		TCGA-AC-A3TN-01		0016bb20-f9ab-42ad-9d22-154bc12dfc14	
TCGA-AC-A3W5-01																													0	TCGA-AC-A3W5-01	504	0	High			BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 4			TCGA-AC-A3W5	504	0	504	Breast	TCGA Breast Cancer	breast invasive carcinoma					65	Right	Sentinel node biopsy alone		TCGA-AC-A3W5-F56177		Positive					Positive	Lumpectomy		YES			-24029	120		0	504							50-59%					2014-1-29	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	130	NO		Positive	NO	3	Close																												NO	0	0	false	MX	N0	T2	Stage IIA	TCGA-AC-A3W5.CA0CD57E-DA92-463E-A004-D554825A22D6.pdf		0		0		0		0		10		0		90		75	TUMOR FREE						YES	YES	Yes	30-39%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2011			TCGA-AC-A3W5-01A-11R-A22I-13	TCGA-AC-A3W5-01A-11R-A22I-13			TCGA-AC-A3W5-01A-11D-A228-09	TCGA-AC-A3W5-01A-21-A24A-20		3e775d6c-3845-49a7-80e0-82c5c68a473c	28b8f0a3-764b-4156-aea9-dc97f06fac1f	TCGA-AC-A3W5-01A-11D-A227-01	3e775d6c-3845-49a7-80e0-82c5c68a473c	TCGA-AC-A3W5-01A-11D-A22B-05	TCGA-AC-A3W5-01		3e775d6c-3845-49a7-80e0-82c5c68a473c	3e775d6c-3845-49a7-80e0-82c5c68a473c	TCGA-AC-A3W5-01A-11D-A227-01		TCGA-AC-A3W5-01		28b8f0a3-764b-4156-aea9-dc97f06fac1f	
TCGA-AC-A3W6-01																													0	TCGA-AC-A3W6-01	602	0	Iq			BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 4			TCGA-AC-A3W6	602	0	602	Breast	TCGA Breast Cancer	breast invasive carcinoma					90	Right	Sentinel node biopsy alone		TCGA-AC-A3W6-F57046		Positive	3 Point Scale	1+	3 Point Scale		Positive	Modified Radical Mastectomy		YES			-32872	101		0	602							90-99%					2014-2-28	FEMALE					3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	1+	YES		Core needle biopsy	140	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	3	3	false	MX	N1	T3	Stage IIIA	TCGA-AC-A3W6.B52E150F-5B34-482A-84E7-1739B9AC09B7.pdf		0		0		0		0		0		5		95		80	TUMOR FREE						NO	YES	Yes	20-29%		NO	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2012			TCGA-AC-A3W6-01A-12R-A22I-13	TCGA-AC-A3W6-01A-12R-A22I-13			TCGA-AC-A3W6-01A-12D-A228-09	TCGA-AC-A3W6-01A-21-A24A-20		bfedc051-75dd-44f8-add4-40ec7eabf0b0	077a366b-98ed-4fea-a525-9405f7aa4dea	TCGA-AC-A3W6-01A-12D-A227-01	bfedc051-75dd-44f8-add4-40ec7eabf0b0	TCGA-AC-A3W6-01A-12D-A22B-05	TCGA-AC-A3W6-01		bfedc051-75dd-44f8-add4-40ec7eabf0b0	bfedc051-75dd-44f8-add4-40ec7eabf0b0	TCGA-AC-A3W6-01A-12D-A227-01		TCGA-AC-A3W6-01		077a366b-98ed-4fea-a525-9405f7aa4dea	
TCGA-AC-A3W7-01																														TCGA-AC-A3W7-01			Iq			BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 4			TCGA-AC-A3W7				Breast	TCGA Breast Cancer	breast invasive carcinoma																							65																																					210	NO																																				false					TCGA-AC-A3W7.3B77A3E1-AB8F-47B2-A5CC-A3B593A055CE.pdf		0		0		0		0		5		0		95		85													Primary Tumor	01								A					TCGA-AC-A3W7-01A-11R-A22I-13	TCGA-AC-A3W7-01A-11R-A22I-13			TCGA-AC-A3W7-01A-11D-A228-09	TCGA-AC-A3W7-01A-21-A24A-20		e5636c48-9d0d-42d5-9ac2-31ad566bd168	4925e901-5ffb-4a14-93dd-d89bd32b09af	TCGA-AC-A3W7-01A-11D-A227-01	e5636c48-9d0d-42d5-9ac2-31ad566bd168	TCGA-AC-A3W7-01A-11D-A22B-05	TCGA-AC-A3W7-01		e5636c48-9d0d-42d5-9ac2-31ad566bd168	e5636c48-9d0d-42d5-9ac2-31ad566bd168	TCGA-AC-A3W7-01A-11D-A227-01		TCGA-AC-A3W7-01		4925e901-5ffb-4a14-93dd-d89bd32b09af	
TCGA-AC-A3YI-01																													0	TCGA-AC-A3YI-01	707	0										TCGA-AC-A3YI	707	0	707	Breast	TCGA Breast Cancer	breast invasive carcinoma					74	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AC-A3YI-F61513		Positive					Positive	Lumpectomy		NO			-27143	87		0	707							90-99%					2014-6-30	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	120	NO	Positive		NO	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	12		false	MX	N3a	T1c	Stage IIIC	TCGA-AC-A3YI.52CEF542-0F5B-4660-8746-2CF4A27B214E.pdf		3		1		0		1		5		15		80		80	TUMOR FREE						YES	YES	No	20-29%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2012			TCGA-AC-A3YI-01A-21R-A23A-13	TCGA-AC-A3YI-01A-21R-A23A-13			TCGA-AC-A3YI-01A-21D-A23C-09			20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26	3207d7c9-bfaa-4b09-a86b-6bbc22280e8c	TCGA-AC-A3YI-01A-21D-A238-01	20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26	TCGA-AC-A3YI-01A-21D-A23D-05	TCGA-AC-A3YI-01		20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26	20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26	TCGA-AC-A3YI-01A-21D-A238-01		TCGA-AC-A3YI-01		3207d7c9-bfaa-4b09-a86b-6bbc22280e8c	
TCGA-AC-A3YJ-01																													0	TCGA-AC-A3YJ-01	754	0					BRCA nonbasal-like c8					TCGA-AC-A3YJ	754	0	754	Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Right	Sentinel node biopsy alone		TCGA-AC-A3YJ-F60187		Positive					Positive	Modified Radical Mastectomy		YES			-24439	114		0	754												2014-5-31	FEMALE										Other  specify	Invasive Papillary Carcinoma	No		C50.9	8050/3	C50.9		YES		Core needle biopsy	220	NO			NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0 (i-)	T2	Stage IIA	TCGA-AC-A3YJ.0F890724-8554-4B2B-B4EC-6B9B24C757D8.pdf		4		1		0		1		1		19		80		80	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2012			TCGA-AC-A3YJ-01A-11R-A22V-13	TCGA-AC-A3YJ-01A-11R-A22V-13			TCGA-AC-A3YJ-01A-11D-A22X-09	TCGA-AC-A3YJ-01A-21-A24A-20		5d5982c0-530f-4b2b-b1fb-d70c8168c793	72908a86-8eb9-4a84-af76-cea3e9eed064	TCGA-AC-A3YJ-01A-11D-A22W-01	5d5982c0-530f-4b2b-b1fb-d70c8168c793	TCGA-AC-A3YJ-01A-11D-A230-05	TCGA-AC-A3YJ-01		5d5982c0-530f-4b2b-b1fb-d70c8168c793	5d5982c0-530f-4b2b-b1fb-d70c8168c793	TCGA-AC-A3YJ-01A-11D-A22W-01		TCGA-AC-A3YJ-01		72908a86-8eb9-4a84-af76-cea3e9eed064	
TCGA-AC-A4ZE-01																														TCGA-AC-A4ZE-01												TCGA-AC-A4ZE				Breast	TCGA Breast Cancer	breast invasive carcinoma																																																												180	NO																																				false					TCGA-AC-A4ZE.6931CAAE-6DFE-4A61-84D5-4EC804C2F2C6.pdf		0		0		0		0		0		20		80		90													Primary Tumor	01								A					TCGA-AC-A4ZE-01A-11R-A41G-13	TCGA-AC-A4ZE-01A-11R-A41G-13						089da1d2-bdac-4ef2-9d59-2d144f77d5da	09a78982-3fe5-4dd0-be97-03b03a6bf683	TCGA-AC-A4ZE-01A-11D-A41E-01	089da1d2-bdac-4ef2-9d59-2d144f77d5da	TCGA-AC-A4ZE-01A-11D-A41Q-05	TCGA-AC-A4ZE-01		089da1d2-bdac-4ef2-9d59-2d144f77d5da	089da1d2-bdac-4ef2-9d59-2d144f77d5da	TCGA-AC-A4ZE-01A-11D-A41E-01		TCGA-AC-A4ZE-01		09a78982-3fe5-4dd0-be97-03b03a6bf683	
TCGA-AC-A5EH-01																														TCGA-AC-A5EH-01												TCGA-AC-A5EH				Breast	TCGA Breast Cancer	breast invasive carcinoma																																																																																																																																			Primary Tumor	01													TCGA-AC-A5EH-01A-11R-A28I-13	TCGA-AC-A5EH-01A-11R-A28I-13			TCGA-AC-A5EH-01A-11D-A28B-09			eb9b8bcb-aa3a-4e57-9479-543b53dc1cf7	cbcffc05-aa0d-493e-a5e3-47bbb833af4c	TCGA-AC-A5EH-01A-11D-A28A-01	eb9b8bcb-aa3a-4e57-9479-543b53dc1cf7	TCGA-AC-A5EH-01A-11D-A28C-05	TCGA-AC-A5EH-01		eb9b8bcb-aa3a-4e57-9479-543b53dc1cf7	eb9b8bcb-aa3a-4e57-9479-543b53dc1cf7	TCGA-AC-A5EH-01A-11D-A28A-01		TCGA-AC-A5EH-01		cbcffc05-aa0d-493e-a5e3-47bbb833af4c	
TCGA-AC-A5EI-01																														TCGA-AC-A5EI-01												TCGA-AC-A5EI				Breast	TCGA Breast Cancer	breast invasive carcinoma																							36																																					120	NO																																				false					TCGA-AC-A5EI.C0F7848A-DD0B-47B2-956F-A24D597D70BC.pdf		1		0		0		0		0		0		100		80													Primary Tumor	01								A					TCGA-AC-A5EI-01A-11R-A27U-13	TCGA-AC-A5EI-01A-11R-A27U-13			TCGA-AC-A5EI-01A-11D-A27P-09				92324d49-edbe-410b-9613-47089246d8a1	TCGA-AC-A5EI-01A-11D-A27O-01							TCGA-AC-A5EI-01A-11D-A27O-01				92324d49-edbe-410b-9613-47089246d8a1	
TCGA-AC-A5XS-01																													0	TCGA-AC-A5XS-01	47	0										TCGA-AC-A5XS	47	0	47	Breast	TCGA Breast Cancer	breast invasive carcinoma					74	Left Upper Inner Quadrant	Sentinel node biopsy alone				Positive					Positive	Simple Mastectomy		NO			-27160			0	47												2013-7-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Negative			8	Negative																												NO	0			MX	N0	T2	Stage IIA																		TUMOR FREE							YES	Yes				Primary Tumor	01		7th		YES	NO	AC	Breast		LIVING	2012			TCGA-AC-A5XS-01A-11R-A29V-13	TCGA-AC-A5XS-01A-11R-A29V-13			TCGA-AC-A5XS-01A-11D-A29N-09			b713b36d-44c7-41ed-82a5-762322472a56	afe43453-1c7a-45fc-9db5-e2ff478c5077	TCGA-AC-A5XS-01A-11D-A29M-01	b713b36d-44c7-41ed-82a5-762322472a56	TCGA-AC-A5XS-01A-11D-A29O-05	TCGA-AC-A5XS-01		b713b36d-44c7-41ed-82a5-762322472a56	b713b36d-44c7-41ed-82a5-762322472a56	TCGA-AC-A5XS-01A-11D-A29M-01		TCGA-AC-A5XS-01		afe43453-1c7a-45fc-9db5-e2ff478c5077	
TCGA-AC-A5XU-01																														TCGA-AC-A5XU-01												TCGA-AC-A5XU				Breast	TCGA Breast Cancer	breast invasive carcinoma																							44																																					150	NO																																				false					TCGA-AC-A5XU.D61D4CCC-2AB5-4268-AEB7-C8928E0AF964.pdf		0		0		0		0		0		20		80		65													Primary Tumor	01								A					TCGA-AC-A5XU-01A-11R-A28I-13	TCGA-AC-A5XU-01A-11R-A28I-13			TCGA-AC-A5XU-01A-11D-A28B-09			f48e8432-bcb7-4aa9-9c8f-6de4a96179b2	513f5d19-3ff2-436a-adeb-817f9ac828d6	TCGA-AC-A5XU-01A-11D-A28A-01	f48e8432-bcb7-4aa9-9c8f-6de4a96179b2	TCGA-AC-A5XU-01A-11D-A28C-05	TCGA-AC-A5XU-01		f48e8432-bcb7-4aa9-9c8f-6de4a96179b2	f48e8432-bcb7-4aa9-9c8f-6de4a96179b2	TCGA-AC-A5XU-01A-11D-A28A-01		TCGA-AC-A5XU-01		513f5d19-3ff2-436a-adeb-817f9ac828d6	
TCGA-AC-A62V-01																													1	TCGA-AC-A62V-01	348	1										TCGA-AC-A62V	348	0	348	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-AC-A62V-F60177		Positive					Positive	Modified Radical Mastectomy		NO			-21389	38	348	0	2							90-99%	Bone				2014-5-31	MALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Core needle biopsy	120	NO			NO	17	Negative																												NO	3		false	M1	N1a	T2	Stage IV	TCGA-AC-A62V.BBA96852-E70C-4D37-A185-611F568BE90C.pdf		40		20		10		20		0		20		70		70	WITH TUMOR						YES	YES	No	<10%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	DECEASED	2013			TCGA-AC-A62V-01A-11R-A31S-13	TCGA-AC-A62V-01A-11R-A31S-13						7a356940-c460-4714-a949-42afe6ea5d86	938700b3-a62c-4bb7-886f-7b01dc98e33b	TCGA-AC-A62V-01A-11D-A31T-01	7a356940-c460-4714-a949-42afe6ea5d86	TCGA-AC-A62V-01A-11D-A31V-05	TCGA-AC-A62V-01		7a356940-c460-4714-a949-42afe6ea5d86	7a356940-c460-4714-a949-42afe6ea5d86	TCGA-AC-A62V-01A-11D-A31T-01		TCGA-AC-A62V-01		938700b3-a62c-4bb7-886f-7b01dc98e33b	
TCGA-AC-A62X-01																													0	TCGA-AC-A62X-01	417	0										TCGA-AC-A62X	417	0	417	Breast	TCGA Breast Cancer	breast invasive carcinoma					72	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-AC-A62X-F64105		Positive					Negative	Modified Radical Mastectomy		NO			-26627			0	417							<10%					2014-8-26	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Core needle biopsy					NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0			MX	N0	T2	Stage IIA																		TUMOR FREE						NO	YES	Yes			NO	Primary Tumor	01		7th		YES	NO	AC	Breast		LIVING	2013			TCGA-AC-A62X-01A-11R-A29V-13	TCGA-AC-A62X-01A-11R-A29V-13			TCGA-AC-A62X-01A-11D-A29N-09			cdc523d2-da82-4a3d-a97e-9745c8a802d1	cdd09ef8-5842-49ac-a579-f71cd06ae41c	TCGA-AC-A62X-01A-11D-A29M-01	cdc523d2-da82-4a3d-a97e-9745c8a802d1	TCGA-AC-A62X-01A-11D-A29O-05	TCGA-AC-A62X-01		cdc523d2-da82-4a3d-a97e-9745c8a802d1	cdc523d2-da82-4a3d-a97e-9745c8a802d1	TCGA-AC-A62X-01A-11D-A29M-01		TCGA-AC-A62X-01		cdd09ef8-5842-49ac-a579-f71cd06ae41c	
TCGA-AC-A62Y-01																													0	TCGA-AC-A62Y-01	530	0										TCGA-AC-A62Y	530	0	530	Breast	TCGA Breast Cancer	breast invasive carcinoma					79	Right	Sentinel node biopsy alone		TCGA-AC-A62Y-F65833		Positive	3 Point Scale		3 Point Scale		Positive	Modified Radical Mastectomy		NO			-28876	112		0	530							90-99%					2014-9-30	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES		Core needle biopsy	50	NO	Negative		NO	1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1		false	MX	N1	T2	Stage IIB	TCGA-AC-A62Y.83BCCC3C-0384-45CD-84B4-67E2EDE822EE.pdf		40		20		0		20		0		30		70		70	TUMOR FREE						YES	YES	No	80-89%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2012			TCGA-AC-A62Y-01A-11R-A29V-13	TCGA-AC-A62Y-01A-11R-A29V-13			TCGA-AC-A62Y-01A-11D-A29N-09			02d9d59b-de6f-41c7-b529-142116debfd9	67091f0b-d37a-45b7-9b30-9254fdf898a5	TCGA-AC-A62Y-01A-11D-A29M-01	02d9d59b-de6f-41c7-b529-142116debfd9	TCGA-AC-A62Y-01A-11D-A29O-05	TCGA-AC-A62Y-01		02d9d59b-de6f-41c7-b529-142116debfd9	02d9d59b-de6f-41c7-b529-142116debfd9	TCGA-AC-A62Y-01A-11D-A29M-01		TCGA-AC-A62Y-01		67091f0b-d37a-45b7-9b30-9254fdf898a5	
TCGA-AC-A6IV-01																													0	TCGA-AC-A6IV-01	568	0										TCGA-AC-A6IV	568	0	568	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Right	Sentinel node biopsy alone		TCGA-AC-A6IV-F66023		Positive					Positive	Modified Radical Mastectomy		YES			-17521	289		0	568							90-99%					2014-10-1	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8524/3	C50.9		YES		Core needle biopsy	110	NO	Equivocal		NO	1	Negative																												NO	1	1	false	MX	N1	T2	Stage IIB	TCGA-AC-A6IV.5B978086-7443-4721-854B-877CE0FC10C0.pdf		5		0		0		0		5		0		95		60	TUMOR FREE						YES	YES	No	60-69%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2012			TCGA-AC-A6IV-01A-12R-A33A-13	TCGA-AC-A6IV-01A-12R-A33A-13						253e692f-71db-4a5a-b2f4-9e640ef831a2	52fad299-e76e-48e7-a770-c7737f5cd89c	TCGA-AC-A6IV-01A-12D-A33D-01	253e692f-71db-4a5a-b2f4-9e640ef831a2	TCGA-AC-A6IV-01A-12D-A33F-05	TCGA-AC-A6IV-01		253e692f-71db-4a5a-b2f4-9e640ef831a2	253e692f-71db-4a5a-b2f4-9e640ef831a2	TCGA-AC-A6IV-01A-12D-A33D-01		TCGA-AC-A6IV-01		52fad299-e76e-48e7-a770-c7737f5cd89c	
TCGA-AC-A6IW-01																													0	TCGA-AC-A6IW-01	413	0										TCGA-AC-A6IW	413	0	413	Breast	TCGA Breast Cancer	breast invasive carcinoma					73	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-AC-A6IW-F64106		Negative					Negative	Simple Mastectomy		YES			-26896			0	413							<10%					2014-8-26	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES		Core needle biopsy			Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0		MX	N0 (i-)	T2	Stage IIA																		TUMOR FREE						NO	YES	No	<10%		NO	Primary Tumor	01		7th		YES	NO	AC	Breast		LIVING	2013			TCGA-AC-A6IW-01A-12R-A33A-13	TCGA-AC-A6IW-01A-12R-A33A-13						fceb1551-4b16-45de-8ba0-7906aa3fe841	fd183f1b-305a-48f9-a42b-a0d2711bcadb	TCGA-AC-A6IW-01A-12D-A33D-01	fceb1551-4b16-45de-8ba0-7906aa3fe841	TCGA-AC-A6IW-01A-12D-A33F-05	TCGA-AC-A6IW-01		fceb1551-4b16-45de-8ba0-7906aa3fe841	fceb1551-4b16-45de-8ba0-7906aa3fe841	TCGA-AC-A6IW-01A-12D-A33D-01		TCGA-AC-A6IW-01		fd183f1b-305a-48f9-a42b-a0d2711bcadb	
TCGA-AC-A6IX-01																													0	TCGA-AC-A6IX-01	373	0										TCGA-AC-A6IX	373	0	373	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AC-A6IX-F66025		Positive					Positive	Modified Radical Mastectomy		NO			-17969			0	373							90-99%					2014-10-1	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.5		YES		Core needle biopsy					NO	21	Negative	Peri (6-12 months since last menstrual period)																											NO	19			MX	N3a	T2	Stage IIIC																		TUMOR FREE						YES	YES	No	<10%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast		LIVING	2013			TCGA-AC-A6IX-01A-12R-A32K-13	TCGA-AC-A6IX-01A-12R-A32K-13						ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182	a96dcbf3-d86b-4747-810d-f6d9751d273e	TCGA-AC-A6IX-01A-12D-A32H-01	ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182	TCGA-AC-A6IX-01A-12D-A32T-05	TCGA-AC-A6IX-01		ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182	ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182	TCGA-AC-A6IX-01A-12D-A32H-01		TCGA-AC-A6IX-01		a96dcbf3-d86b-4747-810d-f6d9751d273e	
TCGA-AC-A6IX-06																													0	TCGA-AC-A6IX-06	373	0										TCGA-AC-A6IX	373	0	373	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AC-A6IX-F66025		Positive					Positive	Modified Radical Mastectomy		NO			-17969	107		0	373							90-99%					2014-10-1	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.5		YES		Core needle biopsy	40	NO			NO	21	Negative	Peri (6-12 months since last menstrual period)																											NO	19		false	MX	N3a	T2	Stage IIIC	TCGA-AC-A6IX.A92859DA-41AD-4CF9-86AF-E4073E6276ED.pdf		5		0		0		0		0		0		100		75	TUMOR FREE						YES	YES	No	<10%		YES	Metastatic	06		7th		YES	NO	AC	Breast	A	LIVING	2013			TCGA-AC-A6IX-06A-11R-A32K-13	TCGA-AC-A6IX-06A-11R-A32K-13						9d5cd723-da40-47ce-a413-20057593905d	98022470-8d33-46c2-b162-78626a3eb4b7		9d5cd723-da40-47ce-a413-20057593905d	TCGA-AC-A6IX-06A-11D-A32T-05			9d5cd723-da40-47ce-a413-20057593905d	9d5cd723-da40-47ce-a413-20057593905d					98022470-8d33-46c2-b162-78626a3eb4b7	
TCGA-AC-A6NO-01																													0	TCGA-AC-A6NO-01	51	0										TCGA-AC-A6NO	51	0	51	Breast	TCGA Breast Cancer	breast invasive carcinoma					43	Right	Axillary lymph node dissection alone				Positive					Positive	Modified Radical Mastectomy		NO			-15996	605		0	51												2014-4-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES		Fine needle aspiration biopsy	150	NO	Negative			16	Negative																												NO	2		false	MX	N1a	T2	Stage IIB	TCGA-AC-A6NO.A81EB5E0-305E-4657-94AD-0922CD1D79C6.pdf		5		1		2		1		12		16		70		70	TUMOR FREE							YES	No				Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2011			TCGA-AC-A6NO-01A-12R-A33A-13	TCGA-AC-A6NO-01A-12R-A33A-13						5055b564-b80d-4003-b1c1-3fe080c99fc1	1806385b-a8a3-45e4-980f-638292039978	TCGA-AC-A6NO-01A-12D-A33D-01	5055b564-b80d-4003-b1c1-3fe080c99fc1	TCGA-AC-A6NO-01A-12D-A33F-05	TCGA-AC-A6NO-01		5055b564-b80d-4003-b1c1-3fe080c99fc1	5055b564-b80d-4003-b1c1-3fe080c99fc1	TCGA-AC-A6NO-01A-12D-A33D-01		TCGA-AC-A6NO-01		1806385b-a8a3-45e4-980f-638292039978	
TCGA-AC-A7VB-01																													0	TCGA-AC-A7VB-01	250	0										TCGA-AC-A7VB	250	0	250	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AC-A7VB-F66026		Positive					Negative	Modified Radical Mastectomy		NO			-18806	131		0	250							80-89%					2014-10-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	60	NO			NO	15	Negative																												NO	3		false	MX	N1a	T1c	Stage IIA	TCGA-AC-A7VB.53881871-C36B-4622-BFC6-4DA3635D7B26.pdf		2		1		2		1		4		4		90		90	TUMOR FREE						YES	YES	No	<10%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2013			TCGA-AC-A7VB-01A-11R-A358-13	TCGA-AC-A7VB-01A-11R-A358-13						a0059fcb-6adc-47f4-8601-b7eed9e12576	3285e0c3-243c-41ac-b930-880af2f6ab87	TCGA-AC-A7VB-01A-11D-A350-01	a0059fcb-6adc-47f4-8601-b7eed9e12576	TCGA-AC-A7VB-01A-11D-A357-05	TCGA-AC-A7VB-01		a0059fcb-6adc-47f4-8601-b7eed9e12576	a0059fcb-6adc-47f4-8601-b7eed9e12576	TCGA-AC-A7VB-01A-11D-A350-01		TCGA-AC-A7VB-01		3285e0c3-243c-41ac-b930-880af2f6ab87	
TCGA-AC-A7VC-01																													0	TCGA-AC-A7VC-01	1	0										TCGA-AC-A7VC	1	0	1	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Left	Sentinel node biopsy alone				Negative					Negative	Simple Mastectomy		YES			-20479	63		0	1												2014-3-29	FEMALE										Metaplastic Carcinoma		No		C50.9	8575/3	C50.9		YES		Tumor resection	80	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0	T3	Stage IIB	TCGA-AC-A7VC.A1681334-684E-41E0-B3FA-EFFE1E5A8B7F.pdf		5		2		10		2		20		10		60		60	TUMOR FREE							YES	No				Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2013			TCGA-AC-A7VC-01A-11R-A358-13	TCGA-AC-A7VC-01A-11R-A358-13						f88a5259-4413-4d0c-9083-600d74caffbc	1a7b4ca8-2987-4327-a79d-9a54531434e8	TCGA-AC-A7VC-01A-11D-A350-01	f88a5259-4413-4d0c-9083-600d74caffbc	TCGA-AC-A7VC-01A-11D-A357-05	TCGA-AC-A7VC-01		f88a5259-4413-4d0c-9083-600d74caffbc	f88a5259-4413-4d0c-9083-600d74caffbc	TCGA-AC-A7VC-01A-11D-A350-01		TCGA-AC-A7VC-01		1a7b4ca8-2987-4327-a79d-9a54531434e8	
TCGA-AC-A8OP-01																													0	TCGA-AC-A8OP-01	614	0										TCGA-AC-A8OP	614	0	614	Breast	TCGA Breast Cancer	breast invasive carcinoma					72	Right Lower Inner Quadrant	Sentinel node biopsy alone		TCGA-AC-A8OP-F66027		Positive					Positive	Simple Mastectomy		YES			-26550	921		0	614							90-99%					2014-10-1	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	80	NO	Indeterminate		NO	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0 (i-)	T1c	Stage IA	TCGA-AC-A8OP.F4F5C477-30BB-41EE-B188-B20DE019F30A.pdf		10		1		0		2		5		73		22		70	TUMOR FREE						YES	YES	No	10-19%		NO	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2011			TCGA-AC-A8OP-01A-11R-A36A-13	TCGA-AC-A8OP-01A-11R-A36A-13						001773a6-9cf3-48a1-8ea1-1f0da4991bc5	0a7bfa84-8239-4d2b-8320-3d8a9db2a3ef	TCGA-AC-A8OP-01A-11D-A36I-01	001773a6-9cf3-48a1-8ea1-1f0da4991bc5	TCGA-AC-A8OP-01A-11D-A36K-05	TCGA-AC-A8OP-01		001773a6-9cf3-48a1-8ea1-1f0da4991bc5	001773a6-9cf3-48a1-8ea1-1f0da4991bc5	TCGA-AC-A8OP-01A-11D-A36I-01		TCGA-AC-A8OP-01		0a7bfa84-8239-4d2b-8320-3d8a9db2a3ef	
TCGA-AC-A8OQ-01																													0	TCGA-AC-A8OQ-01	34	0										TCGA-AC-A8OQ	34	0	34	Breast	TCGA Breast Cancer	breast invasive carcinoma					72	Right Upper Outer Quadrant	Sentinel node biopsy alone				Negative					Negative	Lumpectomy		NO			-26535	742		0	34												2014-2-26	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	100	NO	Indeterminate			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1		false	MX	N1a	T2	Stage IIB	TCGA-AC-A8OQ.FFA6F9F3-71C1-4AF9-B9F7-0466550EBC90.pdf		10		2		1		1		2		52		45		82	TUMOR FREE							YES	No				Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2011			TCGA-AC-A8OQ-01A-11R-A41G-13	TCGA-AC-A8OQ-01A-11R-A41G-13						cca6f765-44ff-4540-a961-0a2be4e41f93	9e0a88d5-c42a-4094-a44d-f638243a23f9	TCGA-AC-A8OQ-01A-11D-A41E-01	cca6f765-44ff-4540-a961-0a2be4e41f93	TCGA-AC-A8OQ-01A-11D-A41Q-05	TCGA-AC-A8OQ-01		cca6f765-44ff-4540-a961-0a2be4e41f93	cca6f765-44ff-4540-a961-0a2be4e41f93	TCGA-AC-A8OQ-01A-11D-A41E-01		TCGA-AC-A8OQ-01		9e0a88d5-c42a-4094-a44d-f638243a23f9	
TCGA-AC-A8OR-01																													0	TCGA-AC-A8OR-01	40	0										TCGA-AC-A8OR	40	0	40	Breast	TCGA Breast Cancer	breast invasive carcinoma					75	Left	Sentinel node biopsy alone				Positive					Positive	Simple Mastectomy		YES			-27605	98		0	40							90-99%					2014-2-26	FEMALE			<10%							Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Core needle biopsy	120	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0 (i-)	T1c	Stage IA	TCGA-AC-A8OR.1E706FF8-F42C-4FC6-8976-BEB4213BD730.pdf		1		0		0		0		0		5		95		96	TUMOR FREE							YES	No	90-99%			Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2013			TCGA-AC-A8OR-01A-21R-A41G-13	TCGA-AC-A8OR-01A-21R-A41G-13						15c73666-b316-4108-97e9-9d0e40540a2c	963b652a-9415-435b-ab29-0fdb15de3305	TCGA-AC-A8OR-01A-21D-A41E-01	15c73666-b316-4108-97e9-9d0e40540a2c	TCGA-AC-A8OR-01A-21D-A41Q-05	TCGA-AC-A8OR-01		15c73666-b316-4108-97e9-9d0e40540a2c	15c73666-b316-4108-97e9-9d0e40540a2c	TCGA-AC-A8OR-01A-21D-A41E-01		TCGA-AC-A8OR-01		963b652a-9415-435b-ab29-0fdb15de3305	
TCGA-AC-A8OS-01																													0	TCGA-AC-A8OS-01	70	0										TCGA-AC-A8OS	70	0	70	Breast	TCGA Breast Cancer	breast invasive carcinoma					71	Right Upper Outer Quadrant	Sentinel node biopsy alone				Positive					Positive	Simple Mastectomy		YES			-26248	106		0	70							90-99%					2014-2-26	FEMALE			10-19%		1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	70	NO	Positive			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0 (i-)	T2	Stage IIA	TCGA-AC-A8OS.EEF4E8C6-6D80-4C6A-BFC6-E529692088C1.pdf		8		0		0		0		1		85		14		85	TUMOR FREE							YES	No	<10%			Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2013			TCGA-AC-A8OS-01A-12R-A41G-13	TCGA-AC-A8OS-01A-12R-A41G-13						c119a170-e1ba-4965-a9c6-5c0b41ceefba	4f6bea16-ba0c-4c4f-a7b6-188e5b9c58a5	TCGA-AC-A8OS-01A-12D-A41E-01	c119a170-e1ba-4965-a9c6-5c0b41ceefba	TCGA-AC-A8OS-01A-12D-A41Q-05	TCGA-AC-A8OS-01		c119a170-e1ba-4965-a9c6-5c0b41ceefba	c119a170-e1ba-4965-a9c6-5c0b41ceefba	TCGA-AC-A8OS-01A-12D-A41E-01		TCGA-AC-A8OS-01		4f6bea16-ba0c-4c4f-a7b6-188e5b9c58a5	
TCGA-AN-A03X-01	Stage IIA	74	4	No_Conversion	10		Positive	FEMALE	Negative				Negative	M0	Negative	N0	10	0	LumA	Luminal A	Positive		0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A03X-01	10	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-AN-A03X			10	Breast	TCGA Breast Cancer	breast invasive carcinoma					74	Left Upper Outer Quadrant	No axillary staging		TCGA-AN-A03X-F68976		Positive					Positive	Modified Radical Mastectomy		NO			-27163			0	10												2014-12-24	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Positive		YES	19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4									0	0		M0	N0	T2	Stage IIA																		TUMOR FREE				200	200	NO		No			NO	Primary Tumor	01				NO	YES	AN	Breast		LIVING	2010	TCGA-AN-A03X-01A-21W-A019-09	TCGA-AN-A03X-01		TCGA-AN-A03X-01A-21R-A010-13			TCGA-AN-A03X-01A-21W-A019-09		TCGA-AN-A03X-01A-21W-A019-09	ae97b841-ddef-4bed-81ac-0b91627c4ef3	eb8bc681-2b7a-4100-a3cc-b8b90e1f017f	TCGA-AN-A03X-01A-21D-A011-01	ae97b841-ddef-4bed-81ac-0b91627c4ef3		TCGA-AN-A03X-01	TCGA-AN-A03X-01A-21R-A00Z-07	ae97b841-ddef-4bed-81ac-0b91627c4ef3	ae97b841-ddef-4bed-81ac-0b91627c4ef3	TCGA-AN-A03X-01A-21D-A011-01	TCGA-AN-A03X-01	TCGA-AN-A03X-01	TCGA-AN-A03X-01A-21D-A00Y-05	eb8bc681-2b7a-4100-a3cc-b8b90e1f017f	TCGA-AN-A03X-01A-21R-A010-13
TCGA-AN-A03Y-01	Stage IIA	66	3	No_Conversion	10		Positive	FEMALE	Negative				Negative	M0	Negative	N0	10	0	LumB	Luminal B	Positive		-1	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A03Y-01	10	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 5	mutation cluster 4	TCGA-AN-A03Y			10	Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Left Upper Outer Quadrant	No axillary staging		TCGA-AN-A03Y-F68977		Positive					Positive	Modified Radical Mastectomy		NO			-24232	36		0	10												2014-12-24	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	160	NO	Negative		YES	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5									0	0	true	M0	N0	T2	Stage IIA	TCGA-AN-A03Y.76734A82-9137-4DA4-871E-D4EC1BC33831.pdf	1	1	1	1	2	2	0	0	1	0	15	30	83	68	90	90	TUMOR FREE				210	210	NO		No			NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A03Y-01A-21W-A019-09	TCGA-AN-A03Y-01		TCGA-AN-A03Y-01A-21R-A010-13			TCGA-AN-A03Y-01A-21W-A019-09		TCGA-AN-A03Y-01A-21W-A019-09	7509b7dc-18cc-4430-ad93-fa598fc97330	da97f597-b09e-40b2-8517-e98c3e643ce3	TCGA-AN-A03Y-01A-21D-A011-01	7509b7dc-18cc-4430-ad93-fa598fc97330		TCGA-AN-A03Y-01	TCGA-AN-A03Y-01A-21R-A00Z-07	7509b7dc-18cc-4430-ad93-fa598fc97330	7509b7dc-18cc-4430-ad93-fa598fc97330	TCGA-AN-A03Y-01A-21D-A011-01	TCGA-AN-A03Y-01	TCGA-AN-A03Y-01	TCGA-AN-A03Y-01A-21D-A00Y-05	da97f597-b09e-40b2-8517-e98c3e643ce3	TCGA-AN-A03Y-01A-21R-A010-13
TCGA-AN-A041-01	Stage IIB	29	5	Stage IIB	7		Positive	FEMALE	Equivocal	1	3	4	Negative	M0	Positive	N1	7	0	LumA	Luminal B	Negative	LumA	-2	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A041-01	7	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AN-A041			7	Breast	TCGA Breast Cancer	breast invasive carcinoma					29	Left Upper Outer Quadrant			TCGA-AN-A041-F68971		Positive					Negative						-10812			0	7					NO							2014-12-24	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Positive		YES	18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4									1			M0	N1a	T2	Stage IIB																		TUMOR FREE				0	170	NO	YES	No			NO	Primary Tumor	01		7th		NO	YES	AN	Breast		LIVING	2010	TCGA-AN-A041-01A-11W-A050-09	TCGA-AN-A041-01		TCGA-AN-A041-01A-11R-A035-13	TCGA-AN-A041-01A-11W-A050-09	a64d4ca5-a6f8-4e09-9278-c8f7e2d88e86	TCGA-AN-A041-01A-11W-A050-09	TCGA-AN-A041-01A-31-A13A-20	TCGA-AN-A041-01A-11W-A050-09	dc131436-aa38-4601-a42e-e3ad746d5be3	e9846666-467e-4ae9-b9c3-c749fb7cc6c3	TCGA-AN-A041-01A-11D-A036-01	dc131436-aa38-4601-a42e-e3ad746d5be3		TCGA-AN-A041-01	TCGA-AN-A041-01A-11R-A034-07	dc131436-aa38-4601-a42e-e3ad746d5be3	dc131436-aa38-4601-a42e-e3ad746d5be3	TCGA-AN-A041-01A-11D-A036-01	TCGA-AN-A041-01	TCGA-AN-A041-01	TCGA-AN-A041-01A-11D-A032-05	e9846666-467e-4ae9-b9c3-c749fb7cc6c3	TCGA-AN-A041-01A-11R-A035-13
TCGA-AN-A046-01	Stage IIA	68	2	No_Conversion	10		Positive	FEMALE	Negative				Negative	M0	Negative	N0	10	0	LumA	Luminal A	Positive		0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A046-01	10	0	Iq		cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 12	cluster 4		TCGA-AN-A046			10	Breast	TCGA Breast Cancer	breast invasive carcinoma					68	Right Lower Inner Quadrant	No axillary staging		TCGA-AN-A046-F68972		Positive					Positive	Modified Radical Mastectomy		NO			-25158	27		0	10												2014-12-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	150	NO	Negative		NO	19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									0	0	true	M0	N0	T2	Stage IIA	TCGA-AN-A046.1304FB17-A20A-4EBC-9CC8-1554808AC1F6.pdf	6	1	2	1	1	1	0	0	0	0	10	7	89	92	80	92	TUMOR FREE		0		108	205	NO		No			NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010		TCGA-AN-A046-01		TCGA-AN-A046-01A-21R-A035-13			TCGA-AN-A046-01A-21W-A050-09			20eb1da4-ef70-49dd-956f-18d65725ba27	c62fa764-5d48-4bbc-ad18-6e0aff57fa4f	TCGA-AN-A046-01A-21D-A036-01	20eb1da4-ef70-49dd-956f-18d65725ba27		TCGA-AN-A046-01	TCGA-AN-A046-01A-21R-A034-07	20eb1da4-ef70-49dd-956f-18d65725ba27	20eb1da4-ef70-49dd-956f-18d65725ba27	TCGA-AN-A046-01A-21D-A036-01	TCGA-AN-A046-01	TCGA-AN-A046-01	TCGA-AN-A046-01A-21D-A032-05	c62fa764-5d48-4bbc-ad18-6e0aff57fa4f	TCGA-AN-A046-01A-21R-A035-13
TCGA-AN-A049-01	Stage IIA	62	5	No_Conversion	19		Positive	FEMALE	Negative	1	3	4	Negative	M0	Negative	N0	19	0	LumA	Luminal B	Positive	ReacI	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A049-01	19	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-AN-A049			19	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Left Upper Outer Quadrant	No axillary staging		TCGA-AN-A049-F68978		Positive		2+		Modified radical mastectomy	Positive	Simple Mastectomy		NO			-22710	769		0	19						Allred (Biocare)						2014-12-24	FEMALE		Dako Hercept test			0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	330	NO	Negative		YES	9	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	3									0	0	true	M0	N0	T2	Stage IIA	TCGA-AN-A049.8C2B719A-D45A-4DF3-BA61-908A2E1F6D1D.pdf	1	4	0	2	2	2	0	0	0	0	38	18	60	80	90	85	TUMOR FREE	Allred (Biocare)			100	80			No				Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2008	TCGA-AN-A049-01A-21W-A019-09	TCGA-AN-A049-01		TCGA-AN-A049-01A-21R-A010-13	TCGA-AN-A049-01A-21W-A019-09	e292a5df-0dcf-4760-92cf-7bb2c8f69e1e	TCGA-AN-A049-01A-21W-A019-09	TCGA-AN-A049-01A-31-A13A-20	TCGA-AN-A049-01A-21W-A019-09	53a89c04-16e5-4cc3-838c-6b6d1b8ea0c0	4b29c2ad-b966-4f56-b97b-35f5d4aea434	TCGA-AN-A049-01A-21D-A011-01	53a89c04-16e5-4cc3-838c-6b6d1b8ea0c0		TCGA-AN-A049-01	TCGA-AN-A049-01A-21R-A00Z-07	53a89c04-16e5-4cc3-838c-6b6d1b8ea0c0	53a89c04-16e5-4cc3-838c-6b6d1b8ea0c0	TCGA-AN-A049-01A-21D-A011-01	TCGA-AN-A049-01	TCGA-AN-A049-01	TCGA-AN-A049-01A-21D-A00Y-05	4b29c2ad-b966-4f56-b97b-35f5d4aea434	TCGA-AN-A049-01A-21R-A010-13
TCGA-AN-A04A-01	Stage IIIA	36	5	No_Conversion	89		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N2	89	0	LumA	Luminal A	Positive	LumA/B	-5	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A04A-01	90	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AN-A04A			90	Breast	TCGA Breast Cancer	breast invasive carcinoma					36	Right Lower Inner Quadrant|Right Lower Outer Quadrant	No axillary staging				Positive		1+		Modified radical mastectomy	Positive	Simple Mastectomy		NO			-13445	743		0	90						Allred (Biocare)						2010-12-29	FEMALE		Dako Hercept test			0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Tumor resection	370	NO	Negative			7	Positive	Peri (6-12 months since last menstrual period)																		2	4									4	0	true	M0	N2	T2	Stage IIIA	TCGA-AN-A04A.6FB7A794-C3E7-4501-A844-CF65B9C3D32C.pdf	3	13	1	1	5	2	0	0	0	15	23	16	72	67	85	70	TUMOR FREE	Allred (Biocare)	0		87	112			No				Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2008	TCGA-AN-A04A-01A-21W-A050-09	TCGA-AN-A04A-01		TCGA-AN-A04A-01A-21R-A035-13	TCGA-AN-A04A-01A-21W-A050-09	08c6c9ec-04e4-4ce9-8b57-b35f8e562e32	TCGA-AN-A04A-01A-21W-A050-09	TCGA-AN-A04A-01A-11-A13A-20	TCGA-AN-A04A-01A-21W-A050-09	7e09faf6-137d-4d33-98dd-80c48af7ebab	928be25e-9343-4042-a5c0-851465def55b	TCGA-AN-A04A-01A-21D-A036-01	7e09faf6-137d-4d33-98dd-80c48af7ebab		TCGA-AN-A04A-01	TCGA-AN-A04A-01A-21R-A034-07	7e09faf6-137d-4d33-98dd-80c48af7ebab	7e09faf6-137d-4d33-98dd-80c48af7ebab	TCGA-AN-A04A-01A-21D-A036-01	TCGA-AN-A04A-01	TCGA-AN-A04A-01	TCGA-AN-A04A-01A-21D-A032-05	928be25e-9343-4042-a5c0-851465def55b	TCGA-AN-A04A-01A-21R-A035-13
TCGA-AN-A04C-01	Stage IIB	51	3	No_Conversion	54		Negative	FEMALE	Positive				Negative	M0	Positive	N1	54	0	Her2	HER2-enriched	Negative		-11	-9	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A04C-01	54	0	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 6	cluster 5	mutation cluster 3	TCGA-AN-A04C			54	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AN-A04C-F68974		Negative		0		Modified radical mastectomy	Negative	Simple Mastectomy		NO			-18851	656		0	54						Allred (Biocare)						2014-12-24	FEMALE		Dako Hecept Test			3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Tumor resection	190	NO	Positive		YES	15	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5									2	0	true	M0	N1	T2	Stage IIB	TCGA-AN-A04C.045B2852-E1FF-4376-8F39-60FC940224D0.pdf	3	4	0	15	3	1	0	0	0	0	32	19	65	80	85	80	TUMOR FREE	Allred (Biocare)			0	0			No				Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2008	TCGA-AN-A04C-01A-21W-A050-09	TCGA-AN-A04C-01		TCGA-AN-A04C-01A-21R-A035-13	TCGA-AN-A04C-01A-21W-A050-09		TCGA-AN-A04C-01A-21W-A050-09		TCGA-AN-A04C-01A-21W-A050-09	b713c549-0c1f-4c64-bffd-a3b5b693d5a6	87d149dc-fcf5-4c2b-8c3e-f866ed274cee	TCGA-AN-A04C-01A-21D-A036-01	b713c549-0c1f-4c64-bffd-a3b5b693d5a6		TCGA-AN-A04C-01	TCGA-AN-A04C-01A-21R-A034-07	b713c549-0c1f-4c64-bffd-a3b5b693d5a6	b713c549-0c1f-4c64-bffd-a3b5b693d5a6	TCGA-AN-A04C-01A-21D-A036-01	TCGA-AN-A04C-01	TCGA-AN-A04C-01	TCGA-AN-A04C-01A-21D-A032-05	87d149dc-fcf5-4c2b-8c3e-f866ed274cee	TCGA-AN-A04C-01A-21R-A035-13
TCGA-AN-A04D-01	Stage IIB	58	1	No_Conversion	52		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	52	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A04D-01	52	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-AN-A04D			52	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Left Upper Outer Quadrant	No axillary staging		TCGA-AN-A04D-F68975		Negative		0		Modified radical mastectomy	Negative	Simple Mastectomy		NO			-21426	676		0	52						Allred (Biocare)						2014-12-24	FEMALE		Dako Hercept Test			0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Tumor resection	260	NO	Negative		YES	15	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5									2	0	true	M0	N1	T2	Stage IIB	TCGA-AN-A04D.A3CB59DE-5893-4FA2-B4D5-EDA612480E76.pdf	1	1	1	0	2	30	0	0	0	0	15	7	83	63	90	95	TUMOR FREE	Allred (Biocare)			0	0			No				Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2008	TCGA-AN-A04D-01A-21W-A050-09	TCGA-AN-A04D-01		TCGA-AN-A04D-01A-21R-A035-13	TCGA-AN-A04D-01A-21W-A050-09	e48b250c-b634-4bfb-90e4-c2e1c0069400	TCGA-AN-A04D-01A-21W-A050-09	TCGA-AN-A04D-01A-31-A13A-20	TCGA-AN-A04D-01A-21W-A050-09	a09baab9-3eac-4271-9c12-2684642f8869	336a5a76-3373-47ac-85ea-c78ba65cd902	TCGA-AN-A04D-01A-21D-A036-01	a09baab9-3eac-4271-9c12-2684642f8869		TCGA-AN-A04D-01	TCGA-AN-A04D-01A-21R-A034-07	a09baab9-3eac-4271-9c12-2684642f8869	a09baab9-3eac-4271-9c12-2684642f8869	TCGA-AN-A04D-01A-21D-A036-01	TCGA-AN-A04D-01	TCGA-AN-A04D-01	TCGA-AN-A04D-01A-21D-A032-05	336a5a76-3373-47ac-85ea-c78ba65cd902	TCGA-AN-A04D-01A-21R-A035-13
TCGA-AN-A0AJ-01	Stage IIB	79	5	No_Conversion	243		Positive	FEMALE	Positive	1	1	4	Negative	M0	Negative	N0	243	0	LumB	Luminal B	Positive	LumA	-2	-5	enrollment	T_Other	T3	LIVING	0	TCGA-AN-A0AJ-01	303	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-AN-A0AJ	303	0	303	Breast	TCGA Breast Cancer	breast invasive carcinoma					79	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AN-A0AJ-F68941		Positive		2+			Positive	Modified Radical Mastectomy		NO			-29131	63		0	303						dextran coated charcoal	80-89%					2014-12-23	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8522/3	C50.9	3+	YES		Tumor resection	310	NO	Positive		NO	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4								NO	0	0	false	M0	N0	T3	Stage IIB	TCGA-AN-A0AJ.6E2365F3-0875-4949-8409-7E26BBCDE700.pdf	10	10	0	0	0	5	5	5	2	0	13	15	85	80	85	85	TUMOR FREE	dextran coated charcoal			120	230	NO		No	40-49%		NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0AJ-01A-11W-A019-09	TCGA-AN-A0AJ-01		TCGA-AN-A0AJ-01A-11R-A010-13	TCGA-AN-A0AJ-01A-11W-A019-09	69d158b2-9c07-471c-a594-36551fb6f7f3	TCGA-AN-A0AJ-01A-11W-A019-09	TCGA-AN-A0AJ-01A-21-A13B-20	TCGA-AN-A0AJ-01A-11W-A019-09	cc92e983-2367-4353-ac01-88851fd0f71e	48548c7f-466f-419b-b9c1-e600adc7c2fa	TCGA-AN-A0AJ-01A-11D-A011-01	cc92e983-2367-4353-ac01-88851fd0f71e		TCGA-AN-A0AJ-01	TCGA-AN-A0AJ-01A-11R-A00Z-07	cc92e983-2367-4353-ac01-88851fd0f71e	cc92e983-2367-4353-ac01-88851fd0f71e	TCGA-AN-A0AJ-01A-11D-A011-01	TCGA-AN-A0AJ-01	TCGA-AN-A0AJ-01	TCGA-AN-A0AJ-01A-11D-A00Y-05	48548c7f-466f-419b-b9c1-e600adc7c2fa	TCGA-AN-A0AJ-01A-11R-A010-13
TCGA-AN-A0AK-01	Stage IIA	76	1	No_Conversion	223		Positive	FEMALE	Negative				Negative	M0	Negative	N0	223	0	LumB	Luminal B	Negative	Basal	-10	-5	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0AK-01	224	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1		TCGA-AN-A0AK	224	0	224	Breast	TCGA Breast Cancer	breast invasive carcinoma					76	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AN-A0AK-F68942		Positive		0			Negative	Modified Radical Mastectomy		NO			-27977	58		0	224						dextran coated charcoal	80-89%					2014-12-23	FEMALE			70-79%		2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Tumor resection	290	NO	Positive		NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	1								NO	0	0	false	M0	N0	T2	Stage IIA	TCGA-AN-A0AK.12683FCC-4828-4D9A-9B35-E4B7295CC417.pdf	10	10	25	25	15	10	5	5	0	0	20	20	65	70	70	70	TUMOR FREE	dextran coated charcoal				230	NO		No	<10%		NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010		TCGA-AN-A0AK-01		TCGA-AN-A0AK-01A-21R-A010-13		d4158db7-366b-400e-af77-9a6db7eec59c	TCGA-AN-A0AK-01A-21W-A019-09	TCGA-AN-A0AK-01A-11-A13B-20		5cf8f64b-a9f4-4903-9e24-5d0be19e5d44	05afee4e-9acd-44f1-8a0c-ffa34d772b9c	TCGA-AN-A0AK-01A-21D-A011-01	5cf8f64b-a9f4-4903-9e24-5d0be19e5d44		TCGA-AN-A0AK-01	TCGA-AN-A0AK-01A-21R-A00Z-07	5cf8f64b-a9f4-4903-9e24-5d0be19e5d44	5cf8f64b-a9f4-4903-9e24-5d0be19e5d44	TCGA-AN-A0AK-01A-21D-A011-01	TCGA-AN-A0AK-01	TCGA-AN-A0AK-01	TCGA-AN-A0AK-01A-21D-A00Y-05	05afee4e-9acd-44f1-8a0c-ffa34d772b9c	TCGA-AN-A0AK-01A-21R-A010-13
TCGA-AN-A0AL-01	Stage IIIB	41	1	No_Conversion	197		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	197	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T4	LIVING	0	TCGA-AN-A0AL-01	198	0	Squamous	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AN-A0AL			198	Breast	TCGA Breast Cancer	breast invasive carcinoma					41	Right Lower Outer Quadrant	Axillary lymph node dissection alone				Negative		0			Negative	Modified Radical Mastectomy		NO			-15286	49		0	198						dextran coated charcoal	<10%					2010-12-21	FEMALE		dextran coated charcoal	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Tumor resection	300	NO	Negative			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	3									0	0	false	M0	N0	T4	Stage IIIB	TCGA-AN-A0AL.20F4DBD9-02FA-4FFD-AEF5-234910D31263.pdf	10	10	15	10	5	10	5	25	0	0	15	10	80	80	80	80	TUMOR FREE	dextran coated charcoal							No	<10%			Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0AL-01A-11W-A019-09	TCGA-AN-A0AL-01		TCGA-AN-A0AL-01A-11R-A010-13	TCGA-AN-A0AL-01A-11W-A019-09	b689bc66-7909-4edc-a0e1-701ffcd1a602	TCGA-AN-A0AL-01A-11W-A019-09	TCGA-AN-A0AL-01A-21-A13B-20	TCGA-AN-A0AL-01A-11W-A019-09	467314d6-f946-447f-920a-d33b60f66eb2	7076a7b9-6f06-4660-9fd9-3cbcc66bafda	TCGA-AN-A0AL-01A-11D-A011-01	467314d6-f946-447f-920a-d33b60f66eb2		TCGA-AN-A0AL-01	TCGA-AN-A0AL-01A-11R-A00Z-07	467314d6-f946-447f-920a-d33b60f66eb2	467314d6-f946-447f-920a-d33b60f66eb2	TCGA-AN-A0AL-01A-11D-A011-01	TCGA-AN-A0AL-01	TCGA-AN-A0AL-01	TCGA-AN-A0AL-01A-11D-A00Y-05	7076a7b9-6f06-4660-9fd9-3cbcc66bafda	TCGA-AN-A0AL-01A-11R-A010-13
TCGA-AN-A0AM-01	Stage IIA	56	3	No_Conversion	5		Positive	FEMALE	Negative	1	1	4	Negative	M0	Negative	N0	5	0	LumB	Luminal B	Negative	LumA/B	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0AM-01	5	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AN-A0AM			5	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Left Upper Outer Quadrant	No axillary staging		TCGA-AN-A0AM-F68945		Positive					Negative	Modified Radical Mastectomy		NO			-20713	47		0	5												2014-12-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	350	NO	Negative		YES	20	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									0	0	false	M0	N0	T2	Stage IIA	TCGA-AN-A0AM.7189A8A8-EB8B-4795-B7FE-725CCC4B7FA7.pdf	10	10	25	30	15	10	20	5	0	0	5	20	80	70	85	80	TUMOR FREE		0		0	205	NO		No			NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0AM-01A-11W-A050-09	TCGA-AN-A0AM-01		TCGA-AN-A0AM-01A-11R-A035-13	TCGA-AN-A0AM-01A-11W-A050-09	a2edc1b2-9932-44f8-9135-cf6ec465f84d	TCGA-AN-A0AM-01A-11W-A050-09	TCGA-AN-A0AM-01A-21-A13B-20	TCGA-AN-A0AM-01A-11W-A050-09	6050d8b9-2d10-4a03-ae57-979cba25bb70	e444884d-d4ee-4ffb-a429-558fd4c1dd5a	TCGA-AN-A0AM-01A-11D-A036-01	6050d8b9-2d10-4a03-ae57-979cba25bb70		TCGA-AN-A0AM-01	TCGA-AN-A0AM-01A-11R-A034-07	6050d8b9-2d10-4a03-ae57-979cba25bb70	6050d8b9-2d10-4a03-ae57-979cba25bb70	TCGA-AN-A0AM-01A-11D-A036-01	TCGA-AN-A0AM-01	TCGA-AN-A0AM-01	TCGA-AN-A0AM-01A-11D-A032-05	e444884d-d4ee-4ffb-a429-558fd4c1dd5a	TCGA-AN-A0AM-01A-11R-A035-13
TCGA-AN-A0AR-01	Stage IIA	55	1	No_Conversion	9		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	9	0		Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0AR-01	10	0	Squamous	C8-BLCA	cluster 5	Cluster 5	BRCA basal-like c6		miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AN-A0AR			10	Breast	TCGA Breast Cancer	breast invasive carcinoma					55	Right Upper Inner Quadrant	No axillary staging		TCGA-AN-A0AR-F68946		Negative		0			Negative	Modified Radical Mastectomy		NO			-20152	34		0	10												2014-12-23	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Tumor resection	150	NO	Negative		YES	17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	5									0	0	false	M0	N0	T2	Stage IIA	TCGA-AN-A0AR.0E27F140-3D60-4027-A370-68127564DE38.pdf	4	4	0	0	3	3	0	0	7	0	10	12	80	85	90	90	TUMOR FREE						NO		No			NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0AR-01A-11W-A019-09	TCGA-AN-A0AR-01		TCGA-AN-A0AR-01A-11R-A010-13		a18bbbc7-9c94-4fe9-a927-5c07be69428c	TCGA-AN-A0AR-01A-11W-A019-09	TCGA-AN-A0AR-01A-21-A13B-20	TCGA-AN-A0AR-01A-11W-A019-09	12c36b7c-f302-4cea-bb4f-5a01211e00e9	f6743da4-ebb2-4223-ba29-2b1a0859181f	TCGA-AN-A0AR-01A-11D-A011-01	12c36b7c-f302-4cea-bb4f-5a01211e00e9		TCGA-AN-A0AR-01	TCGA-AN-A0AR-01A-11R-A00Z-07	12c36b7c-f302-4cea-bb4f-5a01211e00e9	12c36b7c-f302-4cea-bb4f-5a01211e00e9	TCGA-AN-A0AR-01A-11D-A011-01	TCGA-AN-A0AR-01	TCGA-AN-A0AR-01	TCGA-AN-A0AR-01A-11D-A00Y-05	f6743da4-ebb2-4223-ba29-2b1a0859181f	TCGA-AN-A0AR-01A-11R-A010-13
TCGA-AN-A0AS-01	Stage IIIA	70	3	No_Conversion	9		Positive	FEMALE	Negative	3	3	4	Negative	M0	Positive	N2	9	0	LumA	Luminal B	Negative	Basal	-1	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0AS-01	10	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-AN-A0AS			10	Breast	TCGA Breast Cancer	breast invasive carcinoma					70	Left Upper Outer Quadrant	No axillary staging		TCGA-AN-A0AS-F68947		Positive		0			Negative	Modified Radical Mastectomy		NO			-25658	33		0	10												2014-12-23	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	290	NO	Negative		YES	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2									4	0	false	M0	N2	T2	Stage IIIA	TCGA-AN-A0AS.0D1ACC76-910E-4243-A229-5F76B5A3299A.pdf	13	5	0	1	4	2	0	0	3	0	28	28	65	70	73	88	TUMOR FREE				0	190	NO		No			NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0AS-01A-11W-A019-09	TCGA-AN-A0AS-01		TCGA-AN-A0AS-01A-11R-A010-13	TCGA-AN-A0AS-01A-11W-A019-09	52341dad-b2bf-4985-bb60-4921675983de	TCGA-AN-A0AS-01A-11W-A019-09	TCGA-AN-A0AS-01A-21-A13B-20	TCGA-AN-A0AS-01A-11W-A019-09	e866475d-4919-4bf6-920e-5390720d15bf	47150649-c6a6-48fc-a65c-bc621cbaec41	TCGA-AN-A0AS-01A-11D-A011-01	e866475d-4919-4bf6-920e-5390720d15bf		TCGA-AN-A0AS-01	TCGA-AN-A0AS-01A-11R-A00Z-07	e866475d-4919-4bf6-920e-5390720d15bf	e866475d-4919-4bf6-920e-5390720d15bf	TCGA-AN-A0AS-01A-11D-A011-01	TCGA-AN-A0AS-01	TCGA-AN-A0AS-01	TCGA-AN-A0AS-01A-11D-A00Y-05	47150649-c6a6-48fc-a65c-bc621cbaec41	TCGA-AN-A0AS-01A-11R-A010-13
TCGA-AN-A0AT-01	Stage IIA	62	1	No_Conversion	10		Negative	FEMALE	Negative				Negative	M0	Negative	N0	10	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0AT-01	10	0	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8			mutation c1uster 9	TCGA-AN-A0AT			10	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Right Upper Inner Quadrant	No axillary staging		TCGA-AN-A0AT-F68948		Negative					Negative	Modified Radical Mastectomy		NO			-22798	28		0	10												2014-12-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	170	NO	Negative		YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5										0	0	false	M0	N0	T2	Stage IIA	TCGA-AN-A0AT.3E8F2012-A457-4358-9C8B-23292374A743.pdf	18	21	0	0	30	8	0	0	1	0	12	20	57	72	75	70	TUMOR FREE		0		0	0	NO		No			NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0AT-01A-11D-A045-09	TCGA-AN-A0AT-01	TCGA-AN-A0AT-01A-11R-A035-13	TCGA-AN-A0AT-01A-11R-A035-13	TCGA-AN-A0AT-01A-11D-A045-09	d29e84ac-dc3b-4139-950c-fd197d9ca11f	TCGA-AN-A0AT-01A-11D-A045-09	TCGA-AN-A0AT-01A-21-A13C-20	TCGA-AN-A0AT-01A-11D-A045-09	edda9023-a8d9-45dc-af21-5bba663967e4	170030ae-72f3-46cc-b82a-d23c7f3ad70d	TCGA-AN-A0AT-01A-11D-A036-01	edda9023-a8d9-45dc-af21-5bba663967e4		TCGA-AN-A0AT-01	TCGA-AN-A0AT-01A-11R-A034-07	edda9023-a8d9-45dc-af21-5bba663967e4	edda9023-a8d9-45dc-af21-5bba663967e4	TCGA-AN-A0AT-01A-11D-A036-01	TCGA-AN-A0AT-01	TCGA-AN-A0AT-01	TCGA-AN-A0AT-01A-11D-A032-05	170030ae-72f3-46cc-b82a-d23c7f3ad70d	
TCGA-AN-A0FD-01	Stage IIA	71	1	No_Conversion	195		Positive	FEMALE	Positive	3	3	3	Negative	M0	Negative	N0	195	0	LumA	Luminal A	Positive	LumA/B	-8	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0FD-01	196	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AN-A0FD			196	Breast	TCGA Breast Cancer	breast invasive carcinoma					71	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AN-A0FD-F68949		Positive		1+			Positive	Modified Radical Mastectomy		NO			-26007	84		0	196						dextran coated charcoal	80-89%					2014-12-23	FEMALE		dextran coated charcoal	60-69%		2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Tumor resection	260	NO	Positive	Positive	YES	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4									0	0	false	M0	N0	T2	Stage IIA	TCGA-AN-A0FD.F124155D-6131-47F6-8320-46A41AB125D3.pdf	1	2	0	0	0	0	0	0	0	0	15	15	85	85	85	85	TUMOR FREE	dextran coated charcoal					NO		No	10-19%		NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0FD-01A-11W-A050-09	TCGA-AN-A0FD-01		TCGA-AN-A0FD-01A-11R-A035-13	TCGA-AN-A0FD-01A-11W-A050-09	aecc7da7-67e1-41cb-b17f-5be1e6c55e34	TCGA-AN-A0FD-01A-11W-A050-09	TCGA-AN-A0FD-01A-21-A13C-20	TCGA-AN-A0FD-01A-11W-A050-09	3264f809-4bbf-48e6-bbfd-77eaca9e602e	ba8ff683-777a-4d41-9261-014c89e17791	TCGA-AN-A0FD-01A-11D-A036-01	3264f809-4bbf-48e6-bbfd-77eaca9e602e		TCGA-AN-A0FD-01	TCGA-AN-A0FD-01A-11R-A034-07	3264f809-4bbf-48e6-bbfd-77eaca9e602e	3264f809-4bbf-48e6-bbfd-77eaca9e602e	TCGA-AN-A0FD-01A-11D-A036-01	TCGA-AN-A0FD-01	TCGA-AN-A0FD-01	TCGA-AN-A0FD-01A-11D-A032-05	ba8ff683-777a-4d41-9261-014c89e17791	TCGA-AN-A0FD-01A-11R-A035-13
TCGA-AN-A0FE-01																														TCGA-AN-A0FE-01												TCGA-AN-A0FE				Breast	TCGA Breast Cancer	breast invasive carcinoma																																																												330																																					false						1	1	0	0	1	0	0	0	0	0	19	10	80	90	85	90													Primary Tumor	01								A						TCGA-AN-A0FE-01A-11R-A010-13							97bf6a26-512f-493e-b7fe-53d309f1159a					TCGA-AN-A0FE-01A-11R-A00Z-07						TCGA-AN-A0FE-01A-11D-A00Y-05	97bf6a26-512f-493e-b7fe-53d309f1159a	TCGA-AN-A0FE-01A-11R-A010-13
TCGA-AN-A0FF-01	Stage IA	32	3	No_Conversion	140		Positive	FEMALE	Negative	1	3	4	Negative	M0	Negative	N0	140	0	LumB	Luminal B	Positive	LumA	0	-3	enrollment	T1	T1	LIVING	0	TCGA-AN-A0FF-01	172	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-AN-A0FF	172	0	172	Breast	TCGA Breast Cancer	breast invasive carcinoma					32	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AN-A0FF-F68943		Positive		3+			Positive	Modified Radical Mastectomy		NO			-11929	75		0	172						dextran coated charcoal	90-99%					2014-12-23	FEMALE		dextran coated charcoal	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Tumor resection	300	NO	Negative		NO	14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	1								NO	0	0	false	M0	N0	T1b	Stage IA	TCGA-AN-A0FF.9B4BA15D-A071-4213-AD2C-075A04ED48CD.pdf	1	1	0	0	0	1	0	0	0	0	15	14	85	85	90	85	TUMOR FREE	dextran coated charcoal					NO		No	90-99%		NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0FF-01A-11W-A050-09	TCGA-AN-A0FF-01		TCGA-AN-A0FF-01A-11R-A035-13	TCGA-AN-A0FF-01A-11W-A050-09	87bf53e1-aab3-44d0-a641-3464095b9a51	TCGA-AN-A0FF-01A-11W-A050-09	TCGA-AN-A0FF-01A-21-A13C-20	TCGA-AN-A0FF-01A-11W-A050-09	7a5bc56e-e787-4798-8c4d-ee792f9e3149	9add77c5-e24a-4c2f-9e79-fa09dc8697cd	TCGA-AN-A0FF-01A-11D-A036-01	7a5bc56e-e787-4798-8c4d-ee792f9e3149		TCGA-AN-A0FF-01	TCGA-AN-A0FF-01A-11R-A034-07	7a5bc56e-e787-4798-8c4d-ee792f9e3149	7a5bc56e-e787-4798-8c4d-ee792f9e3149	TCGA-AN-A0FF-01A-11D-A036-01	TCGA-AN-A0FF-01	TCGA-AN-A0FF-01	TCGA-AN-A0FF-01A-11D-A032-05	9add77c5-e24a-4c2f-9e79-fa09dc8697cd	TCGA-AN-A0FF-01A-11R-A035-13
TCGA-AN-A0FG-01																														TCGA-AN-A0FG-01												TCGA-AN-A0FG				Breast	TCGA Breast Cancer	breast invasive carcinoma																																																												400																																					false						1	1	0	0	2	3	0	0	0	0	18	17	80	80	85	80													Primary Tumor	01								A						TCGA-AN-A0FG-01A-11R-A010-13							0e82163d-bfb2-4b39-9f36-4672b12040ed					TCGA-AN-A0FG-01A-11R-A00Z-07						TCGA-AN-A0FG-01A-11D-A00Y-05	0e82163d-bfb2-4b39-9f36-4672b12040ed	TCGA-AN-A0FG-01A-11R-A010-13
TCGA-AN-A0FJ-01	Stage IV	59	1	No_Conversion	241		Positive	FEMALE	Negative	2	2	2	Negative	M0	Positive	N2	241	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0FJ-01	242	0	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AN-A0FJ			242	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AN-A0FJ-F68950		Positive		0			Negative	Modified Radical Mastectomy		NO			-21910	70		0	242						dextran coated charcoal	10-19%					2014-12-23	FEMALE		dextran coated charcoal	40-49%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Tumor resection	280	NO	Positive		YES	14	Negative	Peri (6-12 months since last menstrual period)																		5	5									8	0	false	M1	N2	T2	Stage IV	TCGA-AN-A0FJ.59163BD6-41E8-4489-81F0-036484447886.pdf	3	1	0	0	9	2	0	0	0	0	21	18	70	80	75	85	TUMOR FREE	dextran coated charcoal					NO		No	<10%		NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0FJ-01A-11W-A019-09	TCGA-AN-A0FJ-01		TCGA-AN-A0FJ-01A-11R-A010-13	TCGA-AN-A0FJ-01A-11W-A019-09	d2876882-dd7e-43af-b066-d578da1f8f3d	TCGA-AN-A0FJ-01A-11W-A019-09	TCGA-AN-A0FJ-01A-21-A13A-20	TCGA-AN-A0FJ-01A-11W-A019-09	d6b8993f-e850-47a9-842d-ef6173866780	84412819-5a7d-4d8c-a834-7170777e94e6	TCGA-AN-A0FJ-01A-11D-A011-01	d6b8993f-e850-47a9-842d-ef6173866780		TCGA-AN-A0FJ-01	TCGA-AN-A0FJ-01A-11R-A00Z-07	d6b8993f-e850-47a9-842d-ef6173866780	d6b8993f-e850-47a9-842d-ef6173866780	TCGA-AN-A0FJ-01A-11D-A011-01	TCGA-AN-A0FJ-01	TCGA-AN-A0FJ-01	TCGA-AN-A0FJ-01A-11D-A00Y-05	84412819-5a7d-4d8c-a834-7170777e94e6	TCGA-AN-A0FJ-01A-11R-A010-13
TCGA-AN-A0FK-01	Stage IIIB	88	2	No_Conversion	212		Positive	FEMALE	Negative	3	3	4	Negative	M0	Negative	N0	212	0	LumA	Luminal B	Positive	LumA	-12	-3	enrollment	T_Other	T4	LIVING	0	TCGA-AN-A0FK-01	213	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AN-A0FK			213	Breast	TCGA Breast Cancer	breast invasive carcinoma					88	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-AN-A0FK-F68951		Positive		3+			Positive	Modified Radical Mastectomy		NO			-32462	69		0	213						dextran coated charcoal	90-99%					2014-12-23	FEMALE		dextran coated charcoal	20-29%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Tumor resection	340	NO	Positive		YES	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4									0	0	false	M0	N0	T4	Stage IIIB	TCGA-AN-A0FK.5F5FF3CA-2DBB-4DE1-9190-1FE36E2B5ACB.pdf	1	1	0	0	0	0	0	0	0	0	10	20	90	80	90	85	TUMOR FREE	dextran coated charcoal			230	230	NO		No	90-99%		NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0FK-01A-11W-A050-09	TCGA-AN-A0FK-01		TCGA-AN-A0FK-01A-11R-A035-13	TCGA-AN-A0FK-01A-11W-A050-09	2030c965-6cfa-4164-b5c9-222e1d522f58	TCGA-AN-A0FK-01A-11W-A050-09	TCGA-AN-A0FK-01A-21-A13A-20	TCGA-AN-A0FK-01A-11W-A050-09	570ee0fd-7003-45ce-9c42-8f6145604186	4da6e060-d771-42fd-9d1b-2310848775d7	TCGA-AN-A0FK-01A-11D-A036-01	570ee0fd-7003-45ce-9c42-8f6145604186		TCGA-AN-A0FK-01	TCGA-AN-A0FK-01A-11R-A034-07	570ee0fd-7003-45ce-9c42-8f6145604186	570ee0fd-7003-45ce-9c42-8f6145604186	TCGA-AN-A0FK-01A-11D-A036-01	TCGA-AN-A0FK-01	TCGA-AN-A0FK-01	TCGA-AN-A0FK-01A-11D-A032-05	4da6e060-d771-42fd-9d1b-2310848775d7	TCGA-AN-A0FK-01A-11R-A035-13
TCGA-AN-A0FL-01	Stage IIA	62	1	No_Conversion	230		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	230	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0FL-01	231	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AN-A0FL			231	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-AN-A0FL-F68952		Negative		1+			Negative	Modified Radical Mastectomy		NO			-22805	69		0	231						dextran coated charcoal	<10%					2014-12-23	FEMALE		dextran coated charcoal	20-29%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Tumor resection	310	NO	Positive		YES	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5									0	0	false	M0	N0	T2	Stage IIA	TCGA-AN-A0FL.049A2CA6-951A-452F-963A-F54FE87ECA31.pdf	1	1	0	0	4	3	0	0	3	0	23	10	70	87	75	90	TUMOR FREE	dextran coated charcoal					NO		No	<10%		NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0FL-01A-11W-A050-09	TCGA-AN-A0FL-01		TCGA-AN-A0FL-01A-11R-A035-13	TCGA-AN-A0FL-01A-11W-A050-09	ef3ba9e1-e1ca-477a-8700-37e88c048655	TCGA-AN-A0FL-01A-11W-A050-09	TCGA-AN-A0FL-01A-21-A13A-20	TCGA-AN-A0FL-01A-11W-A050-09	299add94-3b97-41a6-9fd4-c572f88982d5	a5ec69cb-1eeb-4a12-bdc6-e7f3b6eaa7df	TCGA-AN-A0FL-01A-11D-A036-01	299add94-3b97-41a6-9fd4-c572f88982d5		TCGA-AN-A0FL-01	TCGA-AN-A0FL-01A-11R-A034-07	299add94-3b97-41a6-9fd4-c572f88982d5	299add94-3b97-41a6-9fd4-c572f88982d5	TCGA-AN-A0FL-01A-11D-A036-01	TCGA-AN-A0FL-01	TCGA-AN-A0FL-01	TCGA-AN-A0FL-01A-11D-A032-05	a5ec69cb-1eeb-4a12-bdc6-e7f3b6eaa7df	TCGA-AN-A0FL-01A-11R-A035-13
TCGA-AN-A0FN-01	Stage IB	61	1	No_Conversion	218		Positive	FEMALE	Negative				Negative	M0	Negative	N0	218	0	LumA	Luminal A	Positive		-5	-7	enrollment	T1	T1	LIVING	0	TCGA-AN-A0FN-01	218	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AN-A0FN			218	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-AN-A0FN-F68953		Positive		1+			Positive	Modified Radical Mastectomy		NO			-22629	57		0	218						dextran coated charcoal	90-99%					2014-12-23	FEMALE		dextran coated charcoal	20-29%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Tumor resection	110	NO	Positive		YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4									0	0	false	M0	N0	T1c	Stage IB	TCGA-AN-A0FN.6B53F577-5EB6-4AF5-9773-3654D3432BE4.pdf	1	2	0	0	0	0	0	0	1	0	24	27	75	73	75	80	TUMOR FREE	dextran coated charcoal				250	NO		No	10-19%		NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0FN-01A-11W-A050-09	TCGA-AN-A0FN-01		TCGA-AN-A0FN-01A-11R-A035-13	TCGA-AN-A0FN-01A-11W-A050-09		TCGA-AN-A0FN-01A-11W-A050-09		TCGA-AN-A0FN-01A-11W-A050-09	4aac7c40-db6b-4648-a82a-7bf397de913a	ce822227-cbde-4263-9264-71ef718916ea	TCGA-AN-A0FN-01A-11D-A036-01	4aac7c40-db6b-4648-a82a-7bf397de913a		TCGA-AN-A0FN-01	TCGA-AN-A0FN-01A-11R-A034-07	4aac7c40-db6b-4648-a82a-7bf397de913a	4aac7c40-db6b-4648-a82a-7bf397de913a	TCGA-AN-A0FN-01A-11D-A036-01	TCGA-AN-A0FN-01	TCGA-AN-A0FN-01	TCGA-AN-A0FN-01A-11D-A032-05	ce822227-cbde-4263-9264-71ef718916ea	TCGA-AN-A0FN-01A-11R-A035-13
TCGA-AN-A0FS-01	Stage IB	55	2	No_Conversion	191		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	191	0	LumA	Luminal A	Negative	ReacII	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-AN-A0FS-01	191	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-AN-A0FS			191	Breast	TCGA Breast Cancer	breast invasive carcinoma					55	Right Lower Outer Quadrant	Axillary lymph node dissection alone				Positive		0			Negative	Modified Radical Mastectomy		NO			-20352	44		0	191						dextran coated charcoal	90-99%					2010-12-20	FEMALE		dextran coated charcoal	20-29%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Tumor resection	170	NO	Positive			14	Negative	Peri (6-12 months since last menstrual period)																		2	2									0	0	false	M0	N0	T1c	Stage IB	TCGA-AN-A0FS.3CD1D537-29E4-479B-99FA-26D27E192948.pdf	0	0	0	0	0	0	0	0	60	5	5	10	35	85	60	85	TUMOR FREE	dextran coated charcoal				230			No	<10%			Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0FS-01A-11W-A050-09	TCGA-AN-A0FS-01		TCGA-AN-A0FS-01A-11R-A035-13	TCGA-AN-A0FS-01A-11W-A050-09	9cc29dc5-b324-4ee3-b94b-42a1f5927ae9	TCGA-AN-A0FS-01A-11W-A050-09	TCGA-AN-A0FS-01A-21-A13C-20	TCGA-AN-A0FS-01A-11W-A050-09	29ac13ea-a350-42e9-a3eb-024c537ead94	5ed36cde-08a1-439e-8b03-7ed3fbddbacf	TCGA-AN-A0FS-01A-11D-A036-01	29ac13ea-a350-42e9-a3eb-024c537ead94		TCGA-AN-A0FS-01	TCGA-AN-A0FS-01A-11R-A034-07	29ac13ea-a350-42e9-a3eb-024c537ead94	29ac13ea-a350-42e9-a3eb-024c537ead94	TCGA-AN-A0FS-01A-11D-A036-01	TCGA-AN-A0FS-01	TCGA-AN-A0FS-01	TCGA-AN-A0FS-01A-11D-A032-05	5ed36cde-08a1-439e-8b03-7ed3fbddbacf	TCGA-AN-A0FS-01A-11R-A035-13
TCGA-AN-A0FT-01	Stage IIB	63	3	No_Conversion	183		Positive	FEMALE	Positive	4	5	3	Negative	M0	Positive	N1	183	0	LumA	Luminal A	Positive	Her2	-2	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0FT-01	214	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 6	cluster 5	mutation cluster 5	TCGA-AN-A0FT			214	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-AN-A0FT-F68964		Positive		3+			Positive	Modified Radical Mastectomy		NO			-23300	44		0	214						dextran coated charcoal	90-99%					2014-12-24	FEMALE		dextran coated charcoal	90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	130	NO	Positive		YES	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	5									1	0	false	M0	N1	T2	Stage IIB	TCGA-AN-A0FT.338D5387-0CFB-4D91-944F-1F054C21C769.pdf	0	0	0	0	0	0	0	0	0	0	35	10	65	90	90	90	TUMOR FREE	dextran coated charcoal				230	NO		No	90-99%		NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0FT-01A-11W-A050-09	TCGA-AN-A0FT-01		TCGA-AN-A0FT-01A-11R-A035-13	TCGA-AN-A0FT-01A-11W-A050-09	3953f300-15f9-4c43-a4a2-cc7d1c056d59	TCGA-AN-A0FT-01A-11W-A050-09	TCGA-AN-A0FT-01A-21-A13C-20	TCGA-AN-A0FT-01A-11W-A050-09	ae592879-5689-4818-8ac3-23a00c5d3934	8f41eb88-b15f-4b04-934a-0a110a544fbc	TCGA-AN-A0FT-01A-11D-A036-01	ae592879-5689-4818-8ac3-23a00c5d3934		TCGA-AN-A0FT-01	TCGA-AN-A0FT-01A-11R-A034-07	ae592879-5689-4818-8ac3-23a00c5d3934	ae592879-5689-4818-8ac3-23a00c5d3934	TCGA-AN-A0FT-01A-11D-A036-01	TCGA-AN-A0FT-01	TCGA-AN-A0FT-01	TCGA-AN-A0FT-01A-11D-A032-05	8f41eb88-b15f-4b04-934a-0a110a544fbc	TCGA-AN-A0FT-01A-11R-A035-13
TCGA-AN-A0FV-01	Stage IIA	58	1	No_Conversion	10		Negative	FEMALE	Positive	1	1	1	Negative	M0	Negative	N0	10	0	Her2	HER2-enriched	Negative	Her2	-11	-5	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0FV-01	10	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 6	cluster 4	mutation cluster 5	TCGA-AN-A0FV			10	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Left Upper Outer Quadrant	No axillary staging				Negative					Negative	Modified Radical Mastectomy		NO			-21479	42		0	10												2010-12-28	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	180	NO	Positive			12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4									0	0	false	M0	N0	T2	Stage IIA	TCGA-AN-A0FV.5AEE90E0-A9A1-4944-AD6A-2675764D869D.pdf	0	0	0	0	0	0	0	0	0	0	40	50	60	50	70	70	TUMOR FREE				0	0			No				Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0FV-01A-11W-A019-09	TCGA-AN-A0FV-01		TCGA-AN-A0FV-01A-11R-A010-13	TCGA-AN-A0FV-01A-11W-A019-09	db678c4c-245c-4438-9e57-6daad3be0250	TCGA-AN-A0FV-01A-11W-A019-09	TCGA-AN-A0FV-01A-21-A13A-20	TCGA-AN-A0FV-01A-11W-A019-09	600db536-d7c5-4cfa-bb80-fcc269b96b8c	1df1f52c-ac80-480a-af35-772bd79ad3d0	TCGA-AN-A0FV-01A-11D-A011-01	600db536-d7c5-4cfa-bb80-fcc269b96b8c		TCGA-AN-A0FV-01	TCGA-AN-A0FV-01A-11R-A00Z-07	600db536-d7c5-4cfa-bb80-fcc269b96b8c	600db536-d7c5-4cfa-bb80-fcc269b96b8c	TCGA-AN-A0FV-01A-11D-A011-01	TCGA-AN-A0FV-01	TCGA-AN-A0FV-01	TCGA-AN-A0FV-01A-11D-A00Y-05	1df1f52c-ac80-480a-af35-772bd79ad3d0	TCGA-AN-A0FV-01A-11R-A010-13
TCGA-AN-A0FW-01	Stage IIIA	67	3	No_Conversion	11		Positive	FEMALE	Negative	4	3	3	Negative	M0	Positive	N2	11	0	LumA	Luminal A	Indeterminate	LumA/B	-4	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0FW-01	11	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-AN-A0FW			11	Breast	TCGA Breast Cancer	breast invasive carcinoma					67	Left Upper Outer Quadrant	No axillary staging				Positive					Indeterminate	Modified Radical Mastectomy		NO			-24692	41		0	11												2010-12-28	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	180	NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	1									2	0	false	M0	N2	T2	Stage IIIA	TCGA-AN-A0FW.03BD8920-CA01-4818-BBD7-925DDD3F6908.pdf	0	0	0	0	0	0	0	0	0	2	5	8	95	90	85	90	TUMOR FREE				10	180			No				Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0FW-01A-11W-A050-09	TCGA-AN-A0FW-01		TCGA-AN-A0FW-01A-11R-A035-13	TCGA-AN-A0FW-01A-11W-A050-09	3eec78cf-bead-4279-b0b3-60b9dea9496f	TCGA-AN-A0FW-01A-11W-A050-09	TCGA-AN-A0FW-01A-21-A13C-20	TCGA-AN-A0FW-01A-11W-A050-09	34b7764e-748a-415c-84b5-c45d0932e642	9450b2d6-de1d-4c14-8d56-21cc3363d9ab	TCGA-AN-A0FW-01A-11D-A036-01	34b7764e-748a-415c-84b5-c45d0932e642		TCGA-AN-A0FW-01	TCGA-AN-A0FW-01A-11R-A034-07	34b7764e-748a-415c-84b5-c45d0932e642	34b7764e-748a-415c-84b5-c45d0932e642	TCGA-AN-A0FW-01A-11D-A036-01	TCGA-AN-A0FW-01	TCGA-AN-A0FW-01	TCGA-AN-A0FW-01A-11D-A032-05	9450b2d6-de1d-4c14-8d56-21cc3363d9ab	TCGA-AN-A0FW-01A-11R-A035-13
TCGA-AN-A0FX-01	Stage IIA	52	1	No_Conversion	10		Negative	FEMALE	Negative	1	1	2	Negative	M0	Negative	N0	10	0	Basal	Basal-like	Negative	ReacII	-13	-11	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0FX-01	10	0	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AN-A0FX			10	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Left Upper Outer Quadrant	No axillary staging		TCGA-AN-A0FX-F68967		Negative					Negative	Modified Radical Mastectomy		NO			-19309	34		0	10												2014-12-24	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	230	NO	Positive		YES	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									0	0	false	M0	N0	T2	Stage IIA	TCGA-AN-A0FX.0CC079D3-EB90-47B5-B554-599A67C9E12A.pdf	2	0	3	0	20	5	0	0	8	15	32	5	40	75	80	70	TUMOR FREE				0	0	NO		No			NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0FX-01A-11W-A050-09	TCGA-AN-A0FX-01		TCGA-AN-A0FX-01A-11R-A035-13	TCGA-AN-A0FX-01A-11W-A050-09	14bd231c-c5f5-4e4a-a2e3-4ee4a17248af	TCGA-AN-A0FX-01A-11W-A050-09	TCGA-AN-A0FX-01A-21-A13C-20	TCGA-AN-A0FX-01A-11W-A050-09	c1dc3f35-324b-4a69-b32c-24652ccf9e3a	de299c77-a9d8-4acf-97ae-337427f27132	TCGA-AN-A0FX-01A-11D-A036-01	c1dc3f35-324b-4a69-b32c-24652ccf9e3a		TCGA-AN-A0FX-01	TCGA-AN-A0FX-01A-11R-A034-07	c1dc3f35-324b-4a69-b32c-24652ccf9e3a	c1dc3f35-324b-4a69-b32c-24652ccf9e3a	TCGA-AN-A0FX-01A-11D-A036-01	TCGA-AN-A0FX-01	TCGA-AN-A0FX-01	TCGA-AN-A0FX-01A-11D-A032-05	de299c77-a9d8-4acf-97ae-337427f27132	TCGA-AN-A0FX-01A-11R-A035-13
TCGA-AN-A0FY-01	Stage IB	55	3	No_Conversion	10		Positive	FEMALE	Negative	3	3	4	Negative	M0	Negative	N0	10	0	LumB	Luminal B	Positive	LumA	-2	-3	enrollment	T1	T1	LIVING	0	TCGA-AN-A0FY-01	10	0	High	C3-BRCA/Luminal	cluster 2	Cluster 5	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-AN-A0FY			10	Breast	TCGA Breast Cancer	breast invasive carcinoma					55	Left Upper Outer Quadrant	No axillary staging				Positive					Positive	Modified Radical Mastectomy		NO			-20347	34		0	10												2010-12-29	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	170	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	5									0	0	false	M0	N0	T1c	Stage IB	TCGA-AN-A0FY.6C520037-2A9B-41CB-8362-97FFCA2AA6E2.pdf	0	0	0	0	0	0	0	0	0	0	10	0	90	100	80	80	TUMOR FREE				110	80			No				Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0FY-01A-11W-A050-09	TCGA-AN-A0FY-01		TCGA-AN-A0FY-01A-11R-A035-13	TCGA-AN-A0FY-01A-11W-A050-09	22b79545-b004-46b6-a9dc-02285b1e2988	TCGA-AN-A0FY-01A-11W-A050-09	TCGA-AN-A0FY-01A-21-A13C-20	TCGA-AN-A0FY-01A-11W-A050-09	9f3ddcc1-a6a9-4f55-84b3-cbe06e58ff8d	52ebb933-775a-448c-82ba-42fd1da8cf2e	TCGA-AN-A0FY-01A-11D-A036-01	9f3ddcc1-a6a9-4f55-84b3-cbe06e58ff8d		TCGA-AN-A0FY-01	TCGA-AN-A0FY-01A-11R-A034-07	9f3ddcc1-a6a9-4f55-84b3-cbe06e58ff8d	9f3ddcc1-a6a9-4f55-84b3-cbe06e58ff8d	TCGA-AN-A0FY-01A-11D-A036-01	TCGA-AN-A0FY-01	TCGA-AN-A0FY-01	TCGA-AN-A0FY-01A-11D-A032-05	52ebb933-775a-448c-82ba-42fd1da8cf2e	TCGA-AN-A0FY-01A-11R-A035-13
TCGA-AN-A0FZ-01	Stage IIIA	45	3	No_Conversion	10		Positive	FEMALE	Equivocal	3	3	3	Negative	M0	Positive	N2	10	0	LumA	Luminal A	Negative	LumA/B	-3	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0FZ-01	10	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 4	mutation c1uster 9	TCGA-AN-A0FZ			10	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Left Upper Outer Quadrant	No axillary staging		TCGA-AN-A0FZ-F68969		Positive					Negative	Modified Radical Mastectomy		NO			-16533	34		0	10												2014-12-24	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	230	NO	Positive		YES	14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	4									1	0	false	M0	N2	T2	Stage IIIA	TCGA-AN-A0FZ.8CC70CDC-01EC-4E2B-84C1-F1C946602CCE.pdf	0	0	0	0	0	0	0	0	0	0	5	0	95	100	85	90	TUMOR FREE				0	120	NO		No			NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0FZ-01A-11W-A050-09	TCGA-AN-A0FZ-01		TCGA-AN-A0FZ-01A-11R-A035-13	TCGA-AN-A0FZ-01A-11W-A050-09	e91f0195-b30d-4641-b90c-5f5b2082c391	TCGA-AN-A0FZ-01A-11W-A050-09	TCGA-AN-A0FZ-01A-21-A13C-20	TCGA-AN-A0FZ-01A-11W-A050-09	1fc2800f-3427-4134-8a02-fea3ecbd2656	522b6d2e-b8b1-46d0-b0cb-3823d574e549	TCGA-AN-A0FZ-01A-11D-A036-01	1fc2800f-3427-4134-8a02-fea3ecbd2656		TCGA-AN-A0FZ-01	TCGA-AN-A0FZ-01A-11R-A034-07	1fc2800f-3427-4134-8a02-fea3ecbd2656	1fc2800f-3427-4134-8a02-fea3ecbd2656	TCGA-AN-A0FZ-01A-11D-A036-01	TCGA-AN-A0FZ-01	TCGA-AN-A0FZ-01	TCGA-AN-A0FZ-01A-11D-A032-05	522b6d2e-b8b1-46d0-b0cb-3823d574e549	TCGA-AN-A0FZ-01A-11R-A035-13
TCGA-AN-A0G0-01	Stage IIA	56		No_Conversion	16		Negative	FEMALE	Negative				Negative	M0	Negative	N0	16	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0G0-01	16	0		C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AN-A0G0			16	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Right Upper Inner Quadrant	No axillary staging		TCGA-AN-A0G0-F68970		Negative					Negative	Modified Radical Mastectomy		NO			-20504	34		0	16												2014-12-24	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	210	NO	Negative		YES	23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3									0	0	false	M0	N0	T2	Stage IIA	TCGA-AN-A0G0.08519263-5ADD-4BA3-9BC6-C737ACA7DFE4.pdf	2	1	0	0	1	2	0	0	0	0	14	10	85	88	85	90	TUMOR FREE				0	0	YES		No			YES	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0G0-01A-11W-A050-09			TCGA-AN-A0G0-01A-11R-A035-13	TCGA-AN-A0G0-01A-11W-A050-09	8675dc8b-b185-4aa8-9c1c-60505e502215	TCGA-AN-A0G0-01A-11W-A050-09	TCGA-AN-A0G0-01A-21-A13C-20	TCGA-AN-A0G0-01A-11W-A050-09	c09e8a88-5a82-4fd6-8d03-ef3ecb988003	ab6ead94-e5ae-4bfc-bbe3-8ecac5a98a54		c09e8a88-5a82-4fd6-8d03-ef3ecb988003		TCGA-AN-A0G0-01	TCGA-AN-A0G0-01A-11R-A034-07	c09e8a88-5a82-4fd6-8d03-ef3ecb988003	c09e8a88-5a82-4fd6-8d03-ef3ecb988003		TCGA-AN-A0G0-01		TCGA-AN-A0G0-01A-11D-A032-05	ab6ead94-e5ae-4bfc-bbe3-8ecac5a98a54	TCGA-AN-A0G0-01A-11R-A035-13
TCGA-AN-A0XL-01	Stage IIA	61	5	Stage IIA	10		Positive	FEMALE	Negative				Negative	M0	Negative	N0	10	0	LumA	Luminal A	Positive		-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XL-01	10	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 14	TCGA-AN-A0XL			10	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Left Upper Outer Quadrant					Positive					Positive						-22341	169		0	10					NO							2011-3-25	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	130	NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6									0		true	M0	N0	T2	Stage IIA	TCGA-AN-A0XL.A85A959B-F18C-43D3-8BBF-770DA2189462.pdf	0	1	0	0	0	1	0	0	10	49	15	20	75	30	70	88					60	130		YES	No				Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0XL-01A-11D-A10M-09	TCGA-AN-A0XL-01		TCGA-AN-A0XL-01A-11R-A10I-13			TCGA-AN-A0XL-01A-11D-A10M-09		TCGA-AN-A0XL-01A-11D-A10M-09	0cde4246-2dcb-478b-ace9-df557f71e4cd	c73ed584-52f7-4eda-ba8d-cbe2ac0867b7	TCGA-AN-A0XL-01A-11D-A10L-01	0cde4246-2dcb-478b-ace9-df557f71e4cd	TCGA-AN-A0XL-01A-11D-A10N-05	TCGA-AN-A0XL-01	TCGA-AN-A0XL-01A-11R-A10J-07	0cde4246-2dcb-478b-ace9-df557f71e4cd	0cde4246-2dcb-478b-ace9-df557f71e4cd	TCGA-AN-A0XL-01A-11D-A10L-01	TCGA-AN-A0XL-01	TCGA-AN-A0XL-01		c73ed584-52f7-4eda-ba8d-cbe2ac0867b7	TCGA-AN-A0XL-01A-11R-A10I-13
TCGA-AN-A0XN-01	Stage IIIA	68	4	Stage IIIA	10		Negative	FEMALE	Negative	1	3	3	Negative	M0	Positive	N2	10	0	LumA	Luminal A	Positive	ReacI	-5	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XN-01	10	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-AN-A0XN			10	Breast	TCGA Breast Cancer	breast invasive carcinoma					68	Right Upper Inner Quadrant					Negative					Positive						-25029	163		0	10					NO							2011-3-25	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	180	NO	Negative			15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4									1		true	M0	N2	T2	Stage IIIA	TCGA-AN-A0XN.4C9C9D24-07E1-47BE-8D34-F94693576BD2.pdf	0	0	0	0	0	0	0	0	30	0	0	0	70	100	80	80			0		170	0		YES	No				Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0XN-01A-21D-A10G-09	TCGA-AN-A0XN-01		TCGA-AN-A0XN-01A-21R-A108-13	TCGA-AN-A0XN-01A-21D-A10G-09	20ec155a-e210-4e70-8de0-236318167eff	TCGA-AN-A0XN-01A-21D-A10G-09	TCGA-AN-A0XN-01A-11-A13D-20	TCGA-AN-A0XN-01A-21D-A10G-09	5a269a43-59a4-4718-878e-1086a07b13ee	109817fb-aa2e-4ac8-8bac-a8c6f0d93551	TCGA-AN-A0XN-01A-21D-A107-01	5a269a43-59a4-4718-878e-1086a07b13ee	TCGA-AN-A0XN-01A-21D-A10A-05	TCGA-AN-A0XN-01	TCGA-AN-A0XN-01A-21R-A109-07	5a269a43-59a4-4718-878e-1086a07b13ee	5a269a43-59a4-4718-878e-1086a07b13ee	TCGA-AN-A0XN-01A-21D-A107-01	TCGA-AN-A0XN-01	TCGA-AN-A0XN-01		109817fb-aa2e-4ac8-8bac-a8c6f0d93551	TCGA-AN-A0XN-01A-21R-A108-13
TCGA-AN-A0XO-01	Stage IIIA	59	2	Stage IIIA	375		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N2	375	0	LumA	Luminal A	Negative	LumA/B	-7	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XO-01	375	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-AN-A0XO			375	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Left Upper Outer Quadrant			TCGA-AN-A0XO-F68957		Positive					Negative						-21640	163		0	375					NO							2014-12-23	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	190	NO	Negative		YES	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									2		true	M0	N2	T2	Stage IIIA	TCGA-AN-A0XO.3423E8AE-CE73-4212-BB72-2AF92FD0BC2D.pdf	0	0	0	0	0	0	0	0	0	5	5	10	95	85	90	75	TUMOR FREE				0	180	NO	YES	No			NO	Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0XO-01A-11D-A10G-09	TCGA-AN-A0XO-01		TCGA-AN-A0XO-01A-11R-A108-13	TCGA-AN-A0XO-01A-11D-A10G-09	591208e6-48b0-4a0a-b925-255e07225396	TCGA-AN-A0XO-01A-11D-A10G-09	TCGA-AN-A0XO-01A-21-A13D-20	TCGA-AN-A0XO-01A-11D-A10G-09	508f0932-673f-48b4-ac71-845ed9eb7c52	20e3c431-7416-49c3-88a0-b59801f6b05d	TCGA-AN-A0XO-01A-11D-A107-01	508f0932-673f-48b4-ac71-845ed9eb7c52	TCGA-AN-A0XO-01A-11D-A10A-05	TCGA-AN-A0XO-01	TCGA-AN-A0XO-01A-11R-A109-07	508f0932-673f-48b4-ac71-845ed9eb7c52	508f0932-673f-48b4-ac71-845ed9eb7c52	TCGA-AN-A0XO-01A-11D-A107-01	TCGA-AN-A0XO-01	TCGA-AN-A0XO-01		20e3c431-7416-49c3-88a0-b59801f6b05d	TCGA-AN-A0XO-01A-11R-A108-13
TCGA-AN-A0XP-01	Stage IIIA	69	2	Stage IIIA	9		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N2	9	0	LumA	Luminal A	Positive	LumA	-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XP-01	9	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-AN-A0XP			9	Breast	TCGA Breast Cancer	breast invasive carcinoma					69	Right Upper Inner Quadrant			TCGA-AN-A0XP-F68958		Positive					Positive						-25305	162		0	9					NO							2014-12-23	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	160	NO	Positive		YES	19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4									1		true	M0	N2	T2	Stage IIIA	TCGA-AN-A0XP.80E9B7CE-0D5D-4C01-A8E3-E6345BE145EC.pdf	0	0	0	0	0	0	0	0	0	0	30	75	70	25	90	70	TUMOR FREE				140	260	NO	YES	No			NO	Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0XP-01A-11D-A117-09	TCGA-AN-A0XP-01		TCGA-AN-A0XP-01A-11R-A108-13	TCGA-AN-A0XP-01A-11D-A117-09	a4ce1a58-da4d-4beb-9785-856f1d1a72e5	TCGA-AN-A0XP-01A-11D-A117-09	TCGA-AN-A0XP-01A-21-A13D-20	TCGA-AN-A0XP-01A-11D-A117-09	14fb9342-c11d-460d-af84-f31f7753beeb	dd464f65-b905-44a2-8e45-018d58c112c7	TCGA-AN-A0XP-01A-11D-A107-01	14fb9342-c11d-460d-af84-f31f7753beeb	TCGA-AN-A0XP-01A-11D-A10A-05	TCGA-AN-A0XP-01	TCGA-AN-A0XP-01A-11R-A109-07	14fb9342-c11d-460d-af84-f31f7753beeb	14fb9342-c11d-460d-af84-f31f7753beeb	TCGA-AN-A0XP-01A-11D-A107-01	TCGA-AN-A0XP-01	TCGA-AN-A0XP-01		dd464f65-b905-44a2-8e45-018d58c112c7	TCGA-AN-A0XP-01A-11R-A108-13
TCGA-AN-A0XR-01	Stage IIIA	55	2	Stage IIIA	10		Positive	FEMALE	Negative				Negative	M0	Positive	N2	10	0	LumB	Luminal B	Negative		-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XR-01	10	0	Iq	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-AN-A0XR			10	Breast	TCGA Breast Cancer	breast invasive carcinoma					55	Left Upper Outer Quadrant			TCGA-AN-A0XR-F56951		Positive					Negative						-20381	155		0	10					NO							2014-12-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	130	NO	Negative		YES	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4									7		true	M0	N2	T2	Stage IIIA	TCGA-AN-A0XR.1351520E-9B6A-4F06-B631-DF374396C7E6.pdf	2	2	1	1	2	0	1	0	0	0	18	15	80	85	80	85	TUMOR FREE				0	160	NO	YES	No			NO	Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0XR-01A-11D-A10G-09	TCGA-AN-A0XR-01		TCGA-AN-A0XR-01A-11R-A108-13	TCGA-AN-A0XR-01A-11D-A10G-09		TCGA-AN-A0XR-01A-11D-A10G-09		TCGA-AN-A0XR-01A-11D-A10G-09	2738d02e-ac2a-4d26-beb6-794f3e11cf88	73792381-9fcb-4a9f-b192-9eb30f94a4fa	TCGA-AN-A0XR-01A-11D-A107-01	2738d02e-ac2a-4d26-beb6-794f3e11cf88	TCGA-AN-A0XR-01A-11D-A10A-05	TCGA-AN-A0XR-01	TCGA-AN-A0XR-01A-11R-A109-07	2738d02e-ac2a-4d26-beb6-794f3e11cf88	2738d02e-ac2a-4d26-beb6-794f3e11cf88	TCGA-AN-A0XR-01A-11D-A107-01	TCGA-AN-A0XR-01	TCGA-AN-A0XR-01		73792381-9fcb-4a9f-b192-9eb30f94a4fa	TCGA-AN-A0XR-01A-11R-A108-13
TCGA-AN-A0XS-01	Stage IIIA	63	4	Stage IIIA	10		Negative	FEMALE	Negative	3	3	3	Negative	M0	Positive	N2	10	0	LumA	Luminal A	Positive	LumA	-5	-4	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XS-01	10	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 14	TCGA-AN-A0XS	10	0	10	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Left Upper Outer Quadrant			TCGA-AN-A0XS-F68959		Negative					Positive						-23358	120		0	10					NO							2014-12-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	210	NO	Negative		YES	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4								NO	1		true	M0	N2	T2	Stage IIIA	TCGA-AN-A0XS.D5C9D3FF-3799-4773-8A86-B000DBE42BD8.pdf	2	2	1	1	2	0	1	1	0	4	18	21	80	75	80	75	TUMOR FREE				160	0	NO	YES	No			NO	Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0XS-01A-22D-A10G-09	TCGA-AN-A0XS-01		TCGA-AN-A0XS-01A-22R-A108-13	TCGA-AN-A0XS-01A-22D-A10G-09	7ca812ab-5eb8-4ae0-8da0-8a53020c32ef	TCGA-AN-A0XS-01A-22D-A10G-09	TCGA-AN-A0XS-01A-11-A13D-20	TCGA-AN-A0XS-01A-22D-A10G-09	b77f4222-9000-4485-8728-8864780ebcb8	b90d3cc1-678c-414a-b57f-864f8b6951eb	TCGA-AN-A0XS-01A-22D-A107-01	b77f4222-9000-4485-8728-8864780ebcb8	TCGA-AN-A0XS-01A-22D-A10A-05	TCGA-AN-A0XS-01	TCGA-AN-A0XS-01A-22R-A109-07	b77f4222-9000-4485-8728-8864780ebcb8	b77f4222-9000-4485-8728-8864780ebcb8	TCGA-AN-A0XS-01A-22D-A107-01	TCGA-AN-A0XS-01	TCGA-AN-A0XS-01		b90d3cc1-678c-414a-b57f-864f8b6951eb	TCGA-AN-A0XS-01A-22R-A108-13
TCGA-AN-A0XT-01	Stage IIIA	54	2	Stage IIIA	10		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N2	10	0	LumA	Luminal A	Negative	LumA/B	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XT-01	10	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 5	Low purity c2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 7	mutation cluster 5	TCGA-AN-A0XT			10	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Left Upper Outer Quadrant			TCGA-AN-A0XT-F68960		Positive					Negative						-19794	114		0	10					NO							2014-12-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	160	NO	Negative		YES	17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	7									1		true	M0	N2	T2	Stage IIIA	TCGA-AN-A0XT.3C94BBAC-923E-43F0-B5DC-01207868AD05.pdf	5	2	0	0	1	1	0	0	0	0	24	14	75	85	75	85	TUMOR FREE				0	120	NO	YES	No			NO	Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0XT-01A-11D-A10G-09	TCGA-AN-A0XT-01		TCGA-AN-A0XT-01A-11R-A108-13	TCGA-AN-A0XT-01A-11D-A10G-09	95d4260a-5886-44ff-824f-6c2c76c9c1bc	TCGA-AN-A0XT-01A-11D-A10G-09	TCGA-AN-A0XT-01A-21-A13D-20	TCGA-AN-A0XT-01A-11D-A10G-09	21f22460-fac7-4dbc-8ab2-75738331cb5c	98d18655-65da-47d9-982e-de5ab600a3a0	TCGA-AN-A0XT-01A-11D-A107-01	21f22460-fac7-4dbc-8ab2-75738331cb5c	TCGA-AN-A0XT-01A-11D-A10A-05	TCGA-AN-A0XT-01	TCGA-AN-A0XT-01A-11R-A109-07	21f22460-fac7-4dbc-8ab2-75738331cb5c	21f22460-fac7-4dbc-8ab2-75738331cb5c	TCGA-AN-A0XT-01A-11D-A107-01	TCGA-AN-A0XT-01	TCGA-AN-A0XT-01		98d18655-65da-47d9-982e-de5ab600a3a0	TCGA-AN-A0XT-01A-11R-A108-13
TCGA-AN-A0XU-01	Stage IIA	54	1	Stage IIA	10		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	10	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XU-01	10	0	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AN-A0XU			10	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Left Upper Outer Quadrant			TCGA-AN-A0XU-F68961		Negative					Negative						-20052	106		0	10					NO							2014-12-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	180	NO	Negative		YES	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4									0		true	M0	N0	T2	Stage IIA	TCGA-AN-A0XU.8216B837-DCF3-4E7F-A72A-212655F394F0.pdf	3	3	1	0	4	0	1	0	0	0	16	20	80	80	80	80	TUMOR FREE				0	0	NO	YES	No			NO	Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0XU-01A-11D-A10G-09	TCGA-AN-A0XU-01		TCGA-AN-A0XU-01A-11R-A108-13	TCGA-AN-A0XU-01A-11D-A10G-09	fa8604b6-7128-4db4-bfaf-6f1000fb4017	TCGA-AN-A0XU-01A-11D-A10G-09	TCGA-AN-A0XU-01A-21-A13D-20	TCGA-AN-A0XU-01A-11D-A10G-09	74cba80b-7677-41d6-ab22-10f1a962ba2f	150ed41d-ca97-413a-ae3e-4cc3ba52d6f1	TCGA-AN-A0XU-01A-11D-A107-01	74cba80b-7677-41d6-ab22-10f1a962ba2f	TCGA-AN-A0XU-01A-11D-A10A-05	TCGA-AN-A0XU-01	TCGA-AN-A0XU-01A-11R-A109-07	74cba80b-7677-41d6-ab22-10f1a962ba2f	74cba80b-7677-41d6-ab22-10f1a962ba2f	TCGA-AN-A0XU-01A-11D-A107-01	TCGA-AN-A0XU-01	TCGA-AN-A0XU-01		150ed41d-ca97-413a-ae3e-4cc3ba52d6f1	TCGA-AN-A0XU-01A-11R-A108-13
TCGA-AN-A0XV-01	Stage IIIA	67	4	Stage IIIA	162		Positive	FEMALE	Negative				Negative	M0	Positive	N2	162	0	LumA	Luminal A	Positive		0	0	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XV-01	162	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-AN-A0XV			162	Breast	TCGA Breast Cancer	breast invasive carcinoma					67	Left Upper Outer Quadrant	Axillary lymph node dissection alone				Positive		1+	3 Point Scale		Positive			NO			-24779	121		0	162					NO	dextran coated charcoal	90-99%					2011-3-29	FEMALE			60-69%		2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	100	NO	Positive	Negative		16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2									7		true	M0	N2	T2	Stage IIIA	TCGA-AN-A0XV.5F626AB6-EEB5-4005-97C5-9E48D9FA7730.pdf	2	2	1	1	0	0	1	1	0	0	20	30	80	70	80	70		dextran coated charcoal			90 H	270 H		YES	No	30-39%			Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0XV-01A-11D-A10G-09	TCGA-AN-A0XV-01		TCGA-AN-A0XV-01A-11R-A108-13	TCGA-AN-A0XV-01A-11D-A10G-09		TCGA-AN-A0XV-01A-11D-A10G-09		TCGA-AN-A0XV-01A-11D-A10G-09	7b33b321-fe4b-4296-91bc-53bac35828e5	7754e179-0e81-431d-926e-c24be0e6b4e1	TCGA-AN-A0XV-01A-11D-A107-01	7b33b321-fe4b-4296-91bc-53bac35828e5	TCGA-AN-A0XV-01A-11D-A10A-05	TCGA-AN-A0XV-01	TCGA-AN-A0XV-01A-11R-A109-07	7b33b321-fe4b-4296-91bc-53bac35828e5	7b33b321-fe4b-4296-91bc-53bac35828e5	TCGA-AN-A0XV-01A-11D-A107-01	TCGA-AN-A0XV-01	TCGA-AN-A0XV-01		7754e179-0e81-431d-926e-c24be0e6b4e1	TCGA-AN-A0XV-01A-11R-A108-13
TCGA-AN-A0XW-01	Stage IIIA	36	5	Stage IIIA	170		Positive	FEMALE	Negative	1	1	4	Negative	M0	Positive	N2	170	0	LumA	Luminal B	Positive	Her2	-2	-4	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XW-01	170	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AN-A0XW	170	0	170	Breast	TCGA Breast Cancer	breast invasive carcinoma					36	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-AN-A0XW-F68963		Positive	3 Point Scale	3+	3 Point Scale		Positive			NO			-13208	121		0	170					NO	dextran coated charcoal	90-99%					2014-12-23	FEMALE			60-69%		2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Tumor resection	270	NO	Positive	Negative	YES	14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	4								NO	1		true	M0	N2	T2	Stage IIIA	TCGA-AN-A0XW.5CBC6417-4E3D-4E9C-AE93-A56B777EF2F4.pdf	2	2	0	0	0	0	0	0	0	0	15	20	85	80	85	80	TUMOR FREE	dextran coated charcoal			240 H	240 H	NO	YES	No	90-99%		NO	Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	TCGA-AN-A0XW-01A-11D-A10G-09	TCGA-AN-A0XW-01		TCGA-AN-A0XW-01A-11R-A108-13	TCGA-AN-A0XW-01A-11D-A10G-09	a8db4abd-7071-4135-96f6-dfcd0f003f02	TCGA-AN-A0XW-01A-11D-A10G-09	TCGA-AN-A0XW-01A-21-A13D-20	TCGA-AN-A0XW-01A-11D-A10G-09	52033f64-1e6f-4657-a4fb-7cfeffc61951	742b1f3f-a199-4dac-8d56-82db36855633	TCGA-AN-A0XW-01A-11D-A107-01	52033f64-1e6f-4657-a4fb-7cfeffc61951	TCGA-AN-A0XW-01A-11D-A10A-05	TCGA-AN-A0XW-01	TCGA-AN-A0XW-01A-11R-A109-07	52033f64-1e6f-4657-a4fb-7cfeffc61951	52033f64-1e6f-4657-a4fb-7cfeffc61951	TCGA-AN-A0XW-01A-11D-A107-01	TCGA-AN-A0XW-01	TCGA-AN-A0XW-01		742b1f3f-a199-4dac-8d56-82db36855633	TCGA-AN-A0XW-01A-11R-A108-13
TCGA-AO-A03L-01	Stage IIIA	34	5	No_Conversion	2442		Positive	FEMALE	Negative	1	3	1	Negative	M0	Positive	N2	2442	0	LumA	HER2-enriched	Positive	Basal	-2	-4	followup	T_Other	T3	LIVING	0	TCGA-AO-A03L-01	2442	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 3	TCGA-AO-A03L			2442	Breast	TCGA Breast Cancer	breast invasive carcinoma					34	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A03L-F5858		Positive		2+			Positive	Modified Radical Mastectomy		NO			-12443	2456		0	2442							70-79%			63		2010-12-7	FEMALE			10-19%	>= 2.0 Positive	2+	30	47	1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	680	NO	Positive	Negative		17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	1									4		true	M0	N2	T3	Stage IIIA	TCGA-AO-A03L.FF7212E5-9A44-4659-B3B9-3EF2DB7A9E6D.pdf	10	20	0	0	1	1	0	0	2	6	12	8	85	85	80	60	TUMOR FREE								No	10-19%		YES	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2003	TCGA-AO-A03L-01A-41W-A071-09	TCGA-AO-A03L-01		TCGA-AO-A03L-01A-41R-A057-13	TCGA-AO-A03L-01A-41W-A071-09	f54048ea-ae8d-4786-b466-a9f4604507e0	TCGA-AO-A03L-01A-41W-A071-09	TCGA-AO-A03L-01A-31-A13A-20	TCGA-AO-A03L-01A-41W-A071-09	34980e1d-956b-4d89-8bf2-dcc008dbaad7	c5f3f2c3-0c41-4b3d-91d5-767a54746db9	TCGA-AO-A03L-01A-41D-A059-01	34980e1d-956b-4d89-8bf2-dcc008dbaad7	TCGA-AO-A03L-01A-41D-A10P-05	TCGA-AO-A03L-01	TCGA-AO-A03L-01A-41R-A056-07	34980e1d-956b-4d89-8bf2-dcc008dbaad7	34980e1d-956b-4d89-8bf2-dcc008dbaad7	TCGA-AO-A03L-01A-41D-A059-01	TCGA-AO-A03L-01	TCGA-AO-A03L-01		c5f3f2c3-0c41-4b3d-91d5-767a54746db9	TCGA-AO-A03L-01A-41R-A057-13
TCGA-AO-A03M-01	Stage IA	29	1	Stage I	1455		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1455	0	LumA	Luminal A	Positive	ReacII	-2	-5	followup	T1	T1	LIVING	0	TCGA-AO-A03M-01	1866	0	High	C3-BRCA/Luminal	cluster 1	Cluster 5	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 7		TCGA-AO-A03M	1866	0	1866	Breast	TCGA Breast Cancer	breast invasive carcinoma					29	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-AO-A03M-F30186		Positive		3+			Positive	Simple Mastectomy		YES			-10616	1414		0	1866							70-79%				Scheduled Follow-up Submission	2012-4-4	FEMALE		3+ Positive	30-39%	>= 2.0 Positive	2+			1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	310	NO	Negative	Negative		2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	7								NO	0	0	true	M0	N0 (i-)	T1c	Stage I		2	4	0	2	0	2	0	1	0	2	10	26	90	70	90	70	TUMOR FREE								No	60-69%		NO	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	B	LIVING	2006		TCGA-AO-A03M-01		TCGA-AO-A03M-01B-11R-A10I-13		dbfbb734-f8c7-46df-b27b-0320a0372428	TCGA-AO-A03M-01B-11D-A10M-09	TCGA-AO-A03M-01B-21-A13E-20		f65936bc-02d6-4954-9068-0fb7c930d685	1d26df40-c4fd-4609-8f7d-a7ad6c39ea1e	TCGA-AO-A03M-01B-11D-A10L-01	f65936bc-02d6-4954-9068-0fb7c930d685	TCGA-AO-A03M-01B-11D-A10N-05	TCGA-AO-A03M-01	TCGA-AO-A03M-01B-11R-A10J-07	f65936bc-02d6-4954-9068-0fb7c930d685	f65936bc-02d6-4954-9068-0fb7c930d685	TCGA-AO-A03M-01B-11D-A10L-01	TCGA-AO-A03M-01	TCGA-AO-A03M-01		1d26df40-c4fd-4609-8f7d-a7ad6c39ea1e	TCGA-AO-A03M-01B-11R-A10I-13
TCGA-AO-A03N-01	Stage IIB	59	3	No_Conversion	1645		Positive	FEMALE	Negative	3	3	4	Negative	M0	Positive	N1	1645	0	LumB	HER2-enriched	Positive	Her2	-2	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A03N-01	2031	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 6	mutation cluster 2	TCGA-AO-A03N	1645	1	2031	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO	NO		59	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A03N-F20915		Positive		1+			Positive	Modified Radical Mastectomy		NO			-21816	1596		0	2031			1645				70-79%				Scheduled Follow-up Submission	2012-1-24	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	360	NO	Negative			19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative			Negative					4 Point Scale							Negative	2	6			4 Point Scale		Locoregional Disease			YES	2		true	M0	N1a	T2	Stage IIB		2	3	1	2	0	0	1	1	0	0	30	30	70	70	70	70	WITH TUMOR								No	<10%		NO	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	B	LIVING	2006	TCGA-AO-A03N-01B-11D-A10M-09	TCGA-AO-A03N-01		TCGA-AO-A03N-01B-11R-A10I-13		0a7af48e-5b73-42e8-acf6-a0bca1372cc4	TCGA-AO-A03N-01B-11D-A10M-09	TCGA-AO-A03N-01B-21-A13E-20	TCGA-AO-A03N-01B-11D-A10M-09	ef37a73c-e0a0-4ff6-83a3-6befcdcb51c6	b721638f-668e-4118-b704-04e85f308aa3	TCGA-AO-A03N-01B-11D-A10L-01	ef37a73c-e0a0-4ff6-83a3-6befcdcb51c6	TCGA-AO-A03N-01B-11D-A10N-05	TCGA-AO-A03N-01	TCGA-AO-A03N-01B-11R-A10J-07	ef37a73c-e0a0-4ff6-83a3-6befcdcb51c6	ef37a73c-e0a0-4ff6-83a3-6befcdcb51c6	TCGA-AO-A03N-01B-11D-A10L-01	TCGA-AO-A03N-01	TCGA-AO-A03N-01		b721638f-668e-4118-b704-04e85f308aa3	TCGA-AO-A03N-01B-11R-A10I-13
TCGA-AO-A03O-01	Stage IIA	69	3	Stage IIA	993	2483	Positive	FEMALE	Negative	1	1	4	Negative	M0	Negative	N0	2483	1	LumB	Luminal B	Positive	LumA/B	-2	-5	followup	T_Other	T2	DECEASED	1	TCGA-AO-A03O-01	2483	1	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 8	TCGA-AO-A03O			2483	Breast	TCGA Breast Cancer	breast invasive carcinoma					69	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A03O-F3141		Positive					Positive	Modified Radical Mastectomy		YES			-25362	2694	2483	0							>10% STAINING = POSITIVE				68		2010-9-19	FEMALE		3+ POSITIVE	<10%	> = 2.0	1+	29	73	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	690	NO	Negative	Negative		17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	1									0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A03O.FE9C56C4-B6D4-4054-A58C-13642370052E.pdf	7	7	3	3	5	0	1	1	0	0	25	20	70	80	85	80	TUMOR FREE				>10% STAINING = POSITIVE				No			NO	Primary Tumor	01			YES	NO	YES	AO	Breast	A	DECEASED	2002	TCGA-AO-A03O-01A-11W-A019-09	TCGA-AO-A03O-01		TCGA-AO-A03O-01A-11R-A010-13	TCGA-AO-A03O-01A-11W-A019-09	191dae29-7228-4645-9efe-8c80596a5e50	TCGA-AO-A03O-01A-11W-A019-09	TCGA-AO-A03O-01A-31-A13A-20	TCGA-AO-A03O-01A-11W-A019-09	a1460e9a-c4aa-4e07-abf4-fdb5f42f5eeb	e866c189-b2f5-4948-afcf-adfc6ff323eb	TCGA-AO-A03O-01A-11D-A011-01	a1460e9a-c4aa-4e07-abf4-fdb5f42f5eeb		TCGA-AO-A03O-01	TCGA-AO-A03O-01A-11R-A00Z-07	a1460e9a-c4aa-4e07-abf4-fdb5f42f5eeb	a1460e9a-c4aa-4e07-abf4-fdb5f42f5eeb	TCGA-AO-A03O-01A-11D-A011-01	TCGA-AO-A03O-01	TCGA-AO-A03O-01	TCGA-AO-A03O-01A-11D-A00Y-05	e866c189-b2f5-4948-afcf-adfc6ff323eb	TCGA-AO-A03O-01A-11R-A010-13
TCGA-AO-A03P-01	Stage IIA	54	3	No_Conversion	2576		Positive	FEMALE	Negative				Negative	M0	Positive	N1	2576	0	LumB	Luminal B	Positive	LumA/B	-10	-5	enrollment	T_Other	T2	LIVING	1	TCGA-AO-A03P-01	2911	1	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7			mutation c1uster 9	TCGA-AO-A03P	1922	1	2911	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO	NO		54	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A03P-F15452		Positive		2+			Positive	Lumpectomy		YES		1922	-19724	2414	2911	0	2576	2576		1922				90-99%				Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		0				4.0	Infiltrating Ductal Carcinoma		No	40	C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	370	NO	Negative			26	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Equivocal	2+		Positive	90-99%	3 Point Scale	20-29%	1.7	4 Point Scale	4+	2+	Negative		80-89%		Positive	2		2.4	RATIO >2.2	4 Point Scale	Liver	Distant Metastasis			YES	0	2	true	M0	N1	T2	Stage IIB	TCGA-AO-A03P.0BFAB667-8B40-46AE-A224-535573E268C7.pdf	3	7	1	3	2	2	0	1	0	0	33	23	65	75	90	85	WITH TUMOR								No	40-49%		YES	Primary Tumor	01		6th	NO	NO	YES	AO	Breast	A	DECEASED	2003	TCGA-AO-A03P-01A-11W-A019-09	TCGA-AO-A03P-01			TCGA-AO-A03P-01A-11W-A019-09	dafdae39-54bf-4a1a-a15b-3538e36ed42c	TCGA-AO-A03P-01A-11W-A019-09	TCGA-AO-A03P-01A-31-A13A-20	TCGA-AO-A03P-01A-11W-A019-09	9543095d-b05b-43e0-8b8d-74bd916b510b	1ec0101f-dc3b-4d2e-b182-b70350f92562	TCGA-AO-A03P-01A-11D-A011-01	9543095d-b05b-43e0-8b8d-74bd916b510b		TCGA-AO-A03P-01	TCGA-AO-A03P-01A-11R-A00Z-07	9543095d-b05b-43e0-8b8d-74bd916b510b	9543095d-b05b-43e0-8b8d-74bd916b510b	TCGA-AO-A03P-01A-11D-A011-01	TCGA-AO-A03P-01	TCGA-AO-A03P-01	TCGA-AO-A03P-01A-11D-A00Y-05	1ec0101f-dc3b-4d2e-b182-b70350f92562	
TCGA-AO-A03R-01	Stage IIB	57	4	No_Conversion	1707		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1707	0	Normal	Normal-like	Positive		0	0	followup	T_Other	T2	LIVING	0	TCGA-AO-A03R-01	2091	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 3	cluster 2	mutation cluster 5	TCGA-AO-A03R	2091	0	2091	Breast	TCGA Breast Cancer	breast invasive carcinoma					57	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A03R-F15469		Positive		2+			Positive	Modified Radical Mastectomy		NO			-20930	1608		0	2091							90-99%			70	Scheduled Follow-up Submission	2011-8-22	FEMALE			<10%	Ratio >=2.0	0	28	105	1.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	140	NO	Negative	Negative		26	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	3	0	true	M0	N1a	T2	Stage IIB	TCGA-AO-A03R.D779EEF8-C83C-4CCA-A140-9BF15DCF14AE.pdf	12	12	1	1	2	2	0	0	0	0	63	15	35	83	80	80	TUMOR FREE								No	<10%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2005	TCGA-AO-A03R-01A-21W-A050-09	TCGA-AO-A03R-01		TCGA-AO-A03R-01A-21R-A035-13	TCGA-AO-A03R-01A-21W-A050-09		TCGA-AO-A03R-01A-21W-A050-09		TCGA-AO-A03R-01A-21W-A050-09	6722de75-5d6d-4b1d-a961-856ec5bd12f1	cd00934b-6df0-467f-ae7d-ea7f4632e77c	TCGA-AO-A03R-01A-21D-A036-01	6722de75-5d6d-4b1d-a961-856ec5bd12f1		TCGA-AO-A03R-01	TCGA-AO-A03R-01A-21R-A034-07	6722de75-5d6d-4b1d-a961-856ec5bd12f1	6722de75-5d6d-4b1d-a961-856ec5bd12f1	TCGA-AO-A03R-01A-21D-A036-01	TCGA-AO-A03R-01	TCGA-AO-A03R-01	TCGA-AO-A03R-01A-21D-A032-05	cd00934b-6df0-467f-ae7d-ea7f4632e77c	TCGA-AO-A03R-01A-21R-A035-13
TCGA-AO-A03T-01	Stage IIB	42	5	No_Conversion	1187		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1187	0	Normal	Normal-like	Positive		-2	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AO-A03T-01	1456	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 12	TCGA-AO-A03T	1456	0	1456	Breast	TCGA Breast Cancer	breast invasive carcinoma					42	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A03T-F15475		Positive		2+			Positive	Modified Radical Mastectomy		NO			-15540	1031		0	1456							90-99%				Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	140	NO	Negative			12	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	4								NO	2		true	M0	N1a	T2	Stage IIB	TCGA-AO-A03T.D5EF8C37-811E-42B7-84E5-E6ED71217971.pdf	20	0	0	0	0	1	0	0	50	0	0	19	50	80	65	90	TUMOR FREE								No	60-69%		YES	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2007	TCGA-AO-A03T-01A-21W-A050-09	TCGA-AO-A03T-01		TCGA-AO-A03T-01A-21R-A035-13	TCGA-AO-A03T-01A-21W-A050-09		TCGA-AO-A03T-01A-21W-A050-09		TCGA-AO-A03T-01A-21W-A050-09	0e6447b4-6e63-4420-bfa8-5b1d711d90fc	fb504c0c-2c3c-4b5d-8836-dc9bbf30ff98	TCGA-AO-A03T-01A-21D-A036-01	0e6447b4-6e63-4420-bfa8-5b1d711d90fc		TCGA-AO-A03T-01	TCGA-AO-A03T-01A-21R-A034-07	0e6447b4-6e63-4420-bfa8-5b1d711d90fc	0e6447b4-6e63-4420-bfa8-5b1d711d90fc	TCGA-AO-A03T-01A-21D-A036-01	TCGA-AO-A03T-01	TCGA-AO-A03T-01	TCGA-AO-A03T-01A-21D-A032-05	fb504c0c-2c3c-4b5d-8836-dc9bbf30ff98	TCGA-AO-A03T-01A-21R-A035-13
TCGA-AO-A03U-01	Stage IA	31	1	Stage I	1727	1796	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1796	1	Normal	Normal-like	Negative	Basal	-5	0	followup	T1	T1	DECEASED	1	TCGA-AO-A03U-01	1793	1	Kirc+	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AO-A03U	1614	1	1793	Breast	TCGA Breast Cancer	breast invasive carcinoma			NO		31	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-AO-A03U-F20907		Negative					Negative	Simple Mastectomy		YES			-11354	3254	1793	0				1614				<10%				Scheduled Follow-up Submission	2012-1-24	FEMALE		3+ Positive	<10%		0					Other  specify	secretory	No		C50.9	8502/3	C50.9		YES		Core needle biopsy	170	NO	Negative	Negative		8	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)		Negative			Negative												Negative	5	4				Lung	New Primary Tumor			YES	0	0	true	M0	N0 (i-)	T1c	Stage I		2	2	1	1	0	0	1	1	7	2	23	28	70	70	70	70	TUMOR FREE								No	<10%		NO	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	B	DECEASED	2001	TCGA-AO-A03U-01B-21D-A10M-09	TCGA-AO-A03U-01		TCGA-AO-A03U-01B-21R-A10I-13		93635795-8741-4a0d-b538-48fb08377942	TCGA-AO-A03U-01B-21D-A10M-09	TCGA-AO-A03U-01B-11-A13E-20	TCGA-AO-A03U-01B-21D-A10M-09	bbca4523-28a7-416c-98a8-02c3350705fc	1f2b4987-b022-40f8-a9cf-4dbfd5d377f9	TCGA-AO-A03U-01B-21D-A10L-01	bbca4523-28a7-416c-98a8-02c3350705fc	TCGA-AO-A03U-01B-21D-A10N-05	TCGA-AO-A03U-01	TCGA-AO-A03U-01B-21R-A10J-07	bbca4523-28a7-416c-98a8-02c3350705fc	bbca4523-28a7-416c-98a8-02c3350705fc	TCGA-AO-A03U-01B-21D-A10L-01	TCGA-AO-A03U-01	TCGA-AO-A03U-01		1f2b4987-b022-40f8-a9cf-4dbfd5d377f9	TCGA-AO-A03U-01B-21R-A10I-13
TCGA-AO-A03V-01	Stage IA	41	1	Stage I	886		Positive	FEMALE	Negative				Negative	M0	Negative	N0	886	0	LumA	Luminal A	Positive		0	-3	followup	T1	T1	LIVING	0	TCGA-AO-A03V-01	886	0	COAD-READ	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 5	TCGA-AO-A03V			886	Breast	TCGA Breast Cancer	breast invasive carcinoma					41	Left Upper Inner Quadrant|Left	Sentinel node biopsy alone		TCGA-AO-A03V-F5865		Positive		2+			Positive	Simple Mastectomy		YES			-15284	670		0	886							90-99%					2011-1-9	FEMALE		3+ Positive	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	70	NO	Negative			2	Negative	Peri (6-12 months since last menstrual period)																		2	7									0	0	true	M0	N0 (i-)	T1c	Stage I	TCGA-AO-A03V.63E34973-F630-4295-AC1B-94F81BBEBE41.pdf	5	5	0	0	1	1	0	0	10	55	39	9	50	35	65	70	TUMOR FREE								No	80-89%		NO	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2008	TCGA-AO-A03V-01A-11D-A10Y-09	TCGA-AO-A03V-01	TCGA-AO-A03V-01A-11R-A114-13	TCGA-AO-A03V-01A-11R-A114-13	TCGA-AO-A03V-01A-11D-A10Y-09		TCGA-AO-A03V-01A-11D-A10Y-09		TCGA-AO-A03V-01A-11D-A10Y-09	35a76121-7e58-4e28-a39c-6301a4cc0e2e	6c95b250-69e7-444d-8087-731383aaff4f	TCGA-AO-A03V-01A-11D-A111-01	35a76121-7e58-4e28-a39c-6301a4cc0e2e		TCGA-AO-A03V-01	TCGA-AO-A03V-01A-11R-A115-07	35a76121-7e58-4e28-a39c-6301a4cc0e2e	35a76121-7e58-4e28-a39c-6301a4cc0e2e	TCGA-AO-A03V-01A-11D-A111-01	TCGA-AO-A03V-01	TCGA-AO-A03V-01	TCGA-AO-A03V-01A-11D-A112-05	6c95b250-69e7-444d-8087-731383aaff4f	
TCGA-AO-A0J2-01	Stage IA	41	3	Stage I	585		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	585	0	Her2	HER2-enriched	Negative	Basal	-11	-9	followup	T1	T1	LIVING	0	TCGA-AO-A0J2-01	997	0	High	C3-BRCA/Luminal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AO-A0J2	997	0	997	Breast	TCGA Breast Cancer	breast invasive carcinoma					41	Left Lower Inner Quadrant|Left	Sentinel node biopsy alone		TCGA-AO-A0J2-F15481		Negative					Negative	Simple Mastectomy		YES			-15324	668		0	997							<10%			2.4	Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	30-39%	RATIO > 2.2	2+	40	3.5	1.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	260	NO	Equivocal	Negative		5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	4								NO	0	0	true	M0	N0 (i-)	T1c	Stage IA	TCGA-AO-A0J2.DB0B1C9D-6B94-46EF-A84E-3D912E08B7FD.pdf	1	1	0	0	0	0	0	0	0	0	10	15	90	85	90	85	TUMOR FREE								No	<10%		NO	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2008	TCGA-AO-A0J2-01A-11W-A050-09	TCGA-AO-A0J2-01		TCGA-AO-A0J2-01A-11R-A035-13	TCGA-AO-A0J2-01A-11W-A050-09	c8e29a9a-2a2c-49ad-8101-2f74df959c0c	TCGA-AO-A0J2-01A-11W-A050-09	TCGA-AO-A0J2-01A-21-A13A-20	TCGA-AO-A0J2-01A-11W-A050-09	81689324-2986-49f6-bef6-f5a525ca36c2	3b7dc667-6a9b-46e3-b0db-f11980cac1fe	TCGA-AO-A0J2-01A-11D-A036-01	81689324-2986-49f6-bef6-f5a525ca36c2		TCGA-AO-A0J2-01	TCGA-AO-A0J2-01A-11R-A034-07	81689324-2986-49f6-bef6-f5a525ca36c2	81689324-2986-49f6-bef6-f5a525ca36c2	TCGA-AO-A0J2-01A-11D-A036-01	TCGA-AO-A0J2-01	TCGA-AO-A0J2-01	TCGA-AO-A0J2-01A-11D-A032-05	3b7dc667-6a9b-46e3-b0db-f11980cac1fe	TCGA-AO-A0J2-01A-11R-A035-13
TCGA-AO-A0J3-01	Stage IIB	67	5	No_Conversion	302		Positive	FEMALE	Negative	4	3	4	Negative	M0	Positive	N1	302	0	LumB	Luminal B	Positive	LumA/B	-10	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A0J3-01	651	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 1	mutation c1uster 9	TCGA-AO-A0J3	651	0	651	Breast	TCGA Breast Cancer	breast invasive carcinoma					67	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-AO-A0J3-F15477		Positive		4+			Positive	Modified Radical Mastectomy		YES			-24519	220		0	651							<10%			2.6	Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ Positive	10-19%	Ratio >=2.2	2+	40	2.4	0.9		Other  specify	neuroendocrine and ductal	No		C50.9	8523/3	C50.9	4+	YES		Core needle biopsy	1180	NO	Equivocal	Negative		36	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	1								NO	1	0	true	M0	N1b	T2	Stage IIB	TCGA-AO-A0J3.29C262B5-D49D-4125-9661-19033A8EC6A8.pdf	2	5	0	0	0	0	0	0	0	3	15	27	85	70	85	70	TUMOR FREE								No	<10%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2009	TCGA-AO-A0J3-01A-11W-A050-09	TCGA-AO-A0J3-01		TCGA-AO-A0J3-01A-11R-A035-13	TCGA-AO-A0J3-01A-11W-A050-09	67394de8-86f3-40e0-b897-52e23c163647	TCGA-AO-A0J3-01A-11W-A050-09	TCGA-AO-A0J3-01A-21-A13B-20	TCGA-AO-A0J3-01A-11W-A050-09	7455cc98-aceb-4adc-932b-4fddd979c522	40c683dc-6337-4e19-9a9d-bad8fcfaa026	TCGA-AO-A0J3-01A-11D-A036-01	7455cc98-aceb-4adc-932b-4fddd979c522		TCGA-AO-A0J3-01	TCGA-AO-A0J3-01A-11R-A034-07	7455cc98-aceb-4adc-932b-4fddd979c522	7455cc98-aceb-4adc-932b-4fddd979c522	TCGA-AO-A0J3-01A-11D-A036-01	TCGA-AO-A0J3-01	TCGA-AO-A0J3-01	TCGA-AO-A0J3-01A-11D-A032-05	40c683dc-6337-4e19-9a9d-bad8fcfaa026	TCGA-AO-A0J3-01A-11R-A035-13
TCGA-AO-A0J4-01	Stage IA	41	1	Stage I	294		Negative	FEMALE	Negative				Negative	M0	Negative	N0	294	0	Basal	Basal-like	Negative		-13	-12	followup	T1	T1	LIVING	0	TCGA-AO-A0J4-01	1587	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AO-A0J4	1587	0	1587	Breast	TCGA Breast Cancer	breast invasive carcinoma					41	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-AO-A0J4-F15478		Negative					Negative	Lumpectomy		YES			-15052	224		0	1587							<10%				Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO	Negative			4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	4								NO	0	0	true	M0	N0 (i-)	T1c	Stage IA	TCGA-AO-A0J4.846851BE-3D24-46F0-A6BE-CEB22C7D0F62.pdf	15	2	0	0	0	1	0	0	5	0	35	19	60	80	60	80	TUMOR FREE								No	<10%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2009	TCGA-AO-A0J4-01A-11W-A050-09	TCGA-AO-A0J4-01		TCGA-AO-A0J4-01A-11R-A035-13	TCGA-AO-A0J4-01A-11W-A050-09		TCGA-AO-A0J4-01A-11W-A050-09		TCGA-AO-A0J4-01A-11W-A050-09	4808bc63-000a-4a49-a25b-4b817ca5ea54	4883e039-c3b8-4777-a0fa-765f06006523	TCGA-AO-A0J4-01A-11D-A036-01	4808bc63-000a-4a49-a25b-4b817ca5ea54		TCGA-AO-A0J4-01	TCGA-AO-A0J4-01A-11R-A034-07	4808bc63-000a-4a49-a25b-4b817ca5ea54	4808bc63-000a-4a49-a25b-4b817ca5ea54	TCGA-AO-A0J4-01A-11D-A036-01	TCGA-AO-A0J4-01	TCGA-AO-A0J4-01	TCGA-AO-A0J4-01A-11D-A032-05	4883e039-c3b8-4777-a0fa-765f06006523	TCGA-AO-A0J4-01A-11R-A035-13
TCGA-AO-A0J5-01	Stage IV	48		No_Conversion	704		Positive	FEMALE	Negative				Positive	M1	Positive	N1	704	0	LumA		Negative				followup	T_Other	T4	LIVING	1	TCGA-AO-A0J5-01	792	1	BRCA-LUAD+	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4		mutation cluster 4	TCGA-AO-A0J5	792	0	792	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-AO-A0J5-F19407		Positive					Negative	Modified Radical Mastectomy		NO			-17815	554	792	0	705	735						90-99%	Lung|Bone|Liver		64	Scheduled Follow-up Submission	2011-12-12	FEMALE	>2.2 Positive	3+ Positive	10-19%		2+	25	71	1.1		Other  specify	Ductal/micropapillary	Yes		C50.9	8523/3	C50.9	4+	YES		Core needle biopsy	500	NO	Equivocal	Negative		2	Close	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	2		true	M1	N1a	T4	Stage IV	TCGA-AO-A0J5.5EFC16F4-7FC7-479E-93F7-AEDC2D350A22.pdf	1	2	0	0	0	2	0	0	1	0	14	18	85	80	85	80	WITH TUMOR								No	<10%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	DECEASED	2008	TCGA-AO-A0J5-01A-11W-A050-09	TCGA-AO-A0J5-01		TCGA-AO-A0J5-01A-11R-A035-13	TCGA-AO-A0J5-01A-11W-A050-09	42dea565-bb3c-4c5f-badc-b1615a3482e4	TCGA-AO-A0J5-01A-11W-A050-09	TCGA-AO-A0J5-01A-21-A13A-20	TCGA-AO-A0J5-01A-11W-A050-09	5d033f3f-b22f-4d10-b39b-0bae2b4db5be	7a2353f9-e0cf-4231-8c96-1799f9547328	TCGA-AO-A0J5-01A-11D-A036-01	5d033f3f-b22f-4d10-b39b-0bae2b4db5be		TCGA-AO-A0J5-01	TCGA-AO-A0J5-01A-11R-A034-07	5d033f3f-b22f-4d10-b39b-0bae2b4db5be	5d033f3f-b22f-4d10-b39b-0bae2b4db5be	TCGA-AO-A0J5-01A-11D-A036-01	TCGA-AO-A0J5-01	TCGA-AO-A0J5-01	TCGA-AO-A0J5-01A-11D-A032-05	7a2353f9-e0cf-4231-8c96-1799f9547328	TCGA-AO-A0J5-01A-11R-A035-13
TCGA-AO-A0J6-01	Stage IIA	61	1	Stage IIA	775		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	775	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-AO-A0J6-01	1140	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-AO-A0J6	1140	0	1140	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-AO-A0J6-F15479		Negative					Negative	Lumpectomy		YES			-22462	748		0	1140							<10%				Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	390	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	2								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A0J6.CE2FF4D3-B82C-4435-AE1C-3E2E6F104271.pdf	0	0	0	0	0	0	0	0	0	0	5	5	95	95	95	95	TUMOR FREE								No	<10%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2008	TCGA-AO-A0J6-01A-11W-A050-09	TCGA-AO-A0J6-01		TCGA-AO-A0J6-01A-11R-A035-13	TCGA-AO-A0J6-01A-11W-A050-09	13c00c4c-d6c9-4d3f-b63d-780757d0e5e1	TCGA-AO-A0J6-01A-11W-A050-09	TCGA-AO-A0J6-01A-21-A13A-20	TCGA-AO-A0J6-01A-11W-A050-09	1fe98b05-6803-4803-83cd-a59e794b956e	6fc05d70-1569-4bfa-bab2-5947d36fd71b	TCGA-AO-A0J6-01A-11D-A036-01	1fe98b05-6803-4803-83cd-a59e794b956e		TCGA-AO-A0J6-01	TCGA-AO-A0J6-01A-11R-A034-07	1fe98b05-6803-4803-83cd-a59e794b956e	1fe98b05-6803-4803-83cd-a59e794b956e	TCGA-AO-A0J6-01A-11D-A036-01	TCGA-AO-A0J6-01	TCGA-AO-A0J6-01	TCGA-AO-A0J6-01A-11D-A032-05	6fc05d70-1569-4bfa-bab2-5947d36fd71b	TCGA-AO-A0J6-01A-11R-A035-13
TCGA-AO-A0J7-01	Stage IIB	71	2	No_Conversion	260		Positive	FEMALE	Negative	1	3	4	Negative	M0	Positive	N1	260	0	LumB	Luminal B	Positive	LumA/B	0	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A0J7-01	618	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-AO-A0J7	618	0	618	Breast	TCGA Breast Cancer	breast invasive carcinoma					71	Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A0J7-F15480		Positive					Positive	Modified Radical Mastectomy		NO			-26281	177		0	618							90-99%					2011-8-22	FEMALE		3+ POSITIVE	<10%		1+					Other  specify	Ductal & Mucinous	No		C50.9	8523/3	C50.9	4+	YES		Core needle biopsy	300	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO	3	0	true	M0	N1	T2	Stage IIB	TCGA-AO-A0J7.4022B2EB-04C3-43F6-9D2C-1A47D80EF6EE.pdf	5	1	0	0	0	0	0	0	3	0	32	10	65	90	65	90	TUMOR FREE								No	<10%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2009	TCGA-AO-A0J7-01A-11W-A050-09	TCGA-AO-A0J7-01		TCGA-AO-A0J7-01A-11R-A035-13	TCGA-AO-A0J7-01A-11W-A050-09	dd6cd205-238d-4ba8-88db-6f0028931ca7	TCGA-AO-A0J7-01A-11W-A050-09	TCGA-AO-A0J7-01A-21-A13B-20	TCGA-AO-A0J7-01A-11W-A050-09	542bb107-1b0c-4ace-834d-9e32ed82429c	1dcce010-051a-42dc-a569-f669660fe99a	TCGA-AO-A0J7-01A-11D-A036-01	542bb107-1b0c-4ace-834d-9e32ed82429c		TCGA-AO-A0J7-01	TCGA-AO-A0J7-01A-11R-A034-07	542bb107-1b0c-4ace-834d-9e32ed82429c	542bb107-1b0c-4ace-834d-9e32ed82429c	TCGA-AO-A0J7-01A-11D-A036-01	TCGA-AO-A0J7-01	TCGA-AO-A0J7-01	TCGA-AO-A0J7-01A-11D-A032-05	1dcce010-051a-42dc-a569-f669660fe99a	TCGA-AO-A0J7-01A-11R-A035-13
TCGA-AO-A0J8-01	Stage IIA	61	2	Stage IIA	277		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	277	0	LumA	Luminal A	Positive	ReacI	-12	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A0J8-01	680	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-AO-A0J8	680	0	680	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-AO-A0J8-F15482		Positive		3+			Positive	Lumpectomy		YES			-22284	241		0	680							90-99%				Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	4+	YES		Core needle biopsy	670	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	2								NO	0	1	true	M0	N0 (i+)	T2	Stage IIA	TCGA-AO-A0J8.03C7A677-C223-47D6-869E-E6C3250B0C08.pdf	1	3	0	0	1	2	0	0	2	0	12	23	85	75	85	75	TUMOR FREE								No	70-79%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2009	TCGA-AO-A0J8-01A-21D-A045-09	TCGA-AO-A0J8-01		TCGA-AO-A0J8-01A-21R-A035-13	TCGA-AO-A0J8-01A-21D-A045-09	287094b7-2cf5-415d-81f7-5ef0196d181c	TCGA-AO-A0J8-01A-21D-A045-09	TCGA-AO-A0J8-01A-11-A13A-20	TCGA-AO-A0J8-01A-21D-A045-09	70109263-1d2b-4abe-a582-2b28e87cde67	962ff806-5a8d-44ff-ac8b-9f158d65d014	TCGA-AO-A0J8-01A-21D-A036-01	70109263-1d2b-4abe-a582-2b28e87cde67		TCGA-AO-A0J8-01	TCGA-AO-A0J8-01A-21R-A034-07	70109263-1d2b-4abe-a582-2b28e87cde67	70109263-1d2b-4abe-a582-2b28e87cde67	TCGA-AO-A0J8-01A-21D-A036-01	TCGA-AO-A0J8-01	TCGA-AO-A0J8-01	TCGA-AO-A0J8-01A-21D-A032-05	962ff806-5a8d-44ff-ac8b-9f158d65d014	TCGA-AO-A0J8-01A-21R-A035-13
TCGA-AO-A0J9-01	Stage IIIC	61	2	No_Conversion	1255		Positive	FEMALE	Negative	1	4	3	Negative	M0	Positive	N3	1255	0	LumA	Luminal A	Positive	ReacI	-2	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A0J9-01	1613	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-AO-A0J9	1066	1	1613	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO	YES		61	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A0J9-F15483	Negative	Positive		4+		Mastectomy NOS	Positive	Lumpectomy		NO		1066	-22642	1207		0	1613			1066				90-99%			127	Scheduled Follow-up Submission	2011-8-22	FEMALE				RATIO >EQUAL 2.0		33	149	1.2		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	4+	YES		Core needle biopsy	430	NO		Negative		32	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative	1+		Positive	90-99%	3+ POSITIVE	<10%		4 Point Scale	4+	1+		3 Point Scale	10-19%		Positive	4	2			4 Point Scale	Bone	Distant Metastasis			YES	15	0	true	M0	N3	T2	Stage IIIC	TCGA-AO-A0J9.1E3F3136-6D86-4470-85AA-55B11C9E24CD.pdf	1	2	0	0	0	0	0	0	0	0	15	15	85	85	85	85	WITH TUMOR								No	30-39%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2007	TCGA-AO-A0J9-01A-11W-A050-09	TCGA-AO-A0J9-01		TCGA-AO-A0J9-01A-11R-A035-13	TCGA-AO-A0J9-01A-11W-A050-09	5141cf13-4997-4411-b0d5-9d2ecb048cdb	TCGA-AO-A0J9-01A-11W-A050-09	TCGA-AO-A0J9-01A-21-A13B-20	TCGA-AO-A0J9-01A-11W-A050-09	2d4b31ad-8790-426a-965b-25b74293156c	556981d5-78ea-4e3e-ad02-4d9f71729caa	TCGA-AO-A0J9-01A-11D-A036-01	2d4b31ad-8790-426a-965b-25b74293156c		TCGA-AO-A0J9-01	TCGA-AO-A0J9-01A-11R-A034-07	2d4b31ad-8790-426a-965b-25b74293156c	2d4b31ad-8790-426a-965b-25b74293156c	TCGA-AO-A0J9-01A-11D-A036-01	TCGA-AO-A0J9-01	TCGA-AO-A0J9-01	TCGA-AO-A0J9-01A-11D-A032-05	556981d5-78ea-4e3e-ad02-4d9f71729caa	TCGA-AO-A0J9-01A-11R-A035-13
TCGA-AO-A0JA-01	Stage IIIC	36	2	No_Conversion	346		Positive	FEMALE	Negative				Negative	M0	Positive	N3	346	0	LumA	Luminal A	Positive		-4	-4	followup	T_Other	T2	LIVING	0	TCGA-AO-A0JA-01	655	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-AO-A0JA	143	1	655	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO	NO		36	Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A0JA-F15484		Positive		1+			Positive	Modified Radical Mastectomy		NO		143	-13307	258		0	655			143				90-99%				Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	100	NO	Negative			11	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)		Negative	1+		Negative	<10%	3+ POSITIVE	<10%		4 Point Scale		2+		3 Point Scale	70-79%		Positive	4	1			4 Point Scale	Bone	Distant Metastasis			YES	11		true	M0	N3	T2	Stage IIIC	TCGA-AO-A0JA.2E8A1816-E963-4063-B2F0-6289514084A5.pdf	1	2	0	0	0	0	0	0	5	3	15	17	80	80	80	80	WITH TUMOR								No	<10%		NO	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2009	TCGA-AO-A0JA-01A-11W-A071-09	TCGA-AO-A0JA-01		TCGA-AO-A0JA-01A-11R-A057-13	TCGA-AO-A0JA-01A-11W-A071-09		TCGA-AO-A0JA-01A-11W-A071-09		TCGA-AO-A0JA-01A-11W-A071-09	d38a839f-06dc-40d2-81e9-3b7822e258c7	25822371-680d-4663-98ef-ebf79e6dff4d	TCGA-AO-A0JA-01A-11D-A059-01	d38a839f-06dc-40d2-81e9-3b7822e258c7	TCGA-AO-A0JA-01A-11D-A10P-05	TCGA-AO-A0JA-01	TCGA-AO-A0JA-01A-11R-A056-07	d38a839f-06dc-40d2-81e9-3b7822e258c7	d38a839f-06dc-40d2-81e9-3b7822e258c7	TCGA-AO-A0JA-01A-11D-A059-01	TCGA-AO-A0JA-01	TCGA-AO-A0JA-01		25822371-680d-4663-98ef-ebf79e6dff4d	TCGA-AO-A0JA-01A-11R-A057-13
TCGA-AO-A0JB-01	Stage IIIA	50	1	No_Conversion	1150		Positive	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	1150	0		Normal-like	Positive	Basal	-2	-3	followup	T_Other	T3	LIVING	0	TCGA-AO-A0JB-01	1542	0	High	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-AO-A0JB	1542	0	1542	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-AO-A0JB-F15485		Positive		2+			Positive	Modified Radical Mastectomy		NO			-18561	1178		0	1542							90-99%				Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	510	NO	Negative			14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	2								NO	1	0	true	M0	N1a	T3	Stage IIIA	TCGA-AO-A0JB.6C202D3E-5670-4B63-82A2-9EE7AC385089.pdf	1	1	0	0	5	0	0	0	0	3	25	17	70	80	70	80	TUMOR FREE								No	60-69%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2007	TCGA-AO-A0JB-01A-11W-A071-09	TCGA-AO-A0JB-01		TCGA-AO-A0JB-01A-11R-A057-13		a9a1fd2e-401f-4469-87fd-a42b3680c32b	TCGA-AO-A0JB-01A-11W-A071-09	TCGA-AO-A0JB-01A-21-A13A-20	TCGA-AO-A0JB-01A-11W-A071-09	ad3c5cd7-6115-4e63-a282-f3f02907ebe5	747d51ed-f576-421b-8e92-868a35b01cdb	TCGA-AO-A0JB-01A-11D-A059-01	ad3c5cd7-6115-4e63-a282-f3f02907ebe5	TCGA-AO-A0JB-01A-11D-A10P-05	TCGA-AO-A0JB-01	TCGA-AO-A0JB-01A-11R-A056-07	ad3c5cd7-6115-4e63-a282-f3f02907ebe5	ad3c5cd7-6115-4e63-a282-f3f02907ebe5	TCGA-AO-A0JB-01A-11D-A059-01	TCGA-AO-A0JB-01	TCGA-AO-A0JB-01		747d51ed-f576-421b-8e92-868a35b01cdb	TCGA-AO-A0JB-01A-11R-A057-13
TCGA-AO-A0JC-01	Stage IIA	64	1	Stage IIA	1547		Positive	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1547	0	LumA	Luminal B	Positive	LumA	-2	-5	followup	T_Other	T2	LIVING	0	TCGA-AO-A0JC-01	1547	0	Quiet	C3-BRCA/Luminal	cluster 5	Low purity c2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-AO-A0JC	1547	0	1547	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Right Upper Outer Quadrant|Right Lower Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A0JC-F15486		Positive		3+			Positive	Modified Radical Mastectomy		YES			-23404	1522		0	1547							90-99%				Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	550	NO	Negative			12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	2								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A0JC.A1F0FEB5-6FEF-4FF7-AA1E-8EAAE551138B.pdf	1	1	0	0	0	0	0	0	0	0	10	10	90	90	90	90	TUMOR FREE								No	50-59%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2006	TCGA-AO-A0JC-01A-11W-A071-09	TCGA-AO-A0JC-01		TCGA-AO-A0JC-01A-11R-A057-13	TCGA-AO-A0JC-01A-11W-A071-09	020a471c-8f4c-40c5-b4e2-6181b5499a0a	TCGA-AO-A0JC-01A-11W-A071-09	TCGA-AO-A0JC-01A-21-A13A-20	TCGA-AO-A0JC-01A-11W-A071-09	0f578102-ede7-46ad-ae1f-3c7351edb491	6ef9047c-f0c6-4414-8025-2ea0dc914014	TCGA-AO-A0JC-01A-11D-A059-01	0f578102-ede7-46ad-ae1f-3c7351edb491	TCGA-AO-A0JC-01A-11D-A10P-05	TCGA-AO-A0JC-01	TCGA-AO-A0JC-01A-11R-A056-07	0f578102-ede7-46ad-ae1f-3c7351edb491	0f578102-ede7-46ad-ae1f-3c7351edb491	TCGA-AO-A0JC-01A-11D-A059-01	TCGA-AO-A0JC-01	TCGA-AO-A0JC-01		6ef9047c-f0c6-4414-8025-2ea0dc914014	TCGA-AO-A0JC-01A-11R-A057-13
TCGA-AO-A0JD-01	Stage IIIA	59	2	No_Conversion	1813		Positive	FEMALE	Negative	3	3	4	Negative	M0	Positive	N1	1813	0	LumB	Luminal B	Positive	Basal	-2	-2	followup	T_Other	T3	LIVING	0	TCGA-AO-A0JD-01	2190	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 5	mutation cluster 8	TCGA-AO-A0JD	2190	0	2190	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A0JD-F15487		Positive		2+			Positive	Modified Radical Mastectomy		NO			-21831	1863		0	2190							90-99%			49	Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%	RATIO > = 2.0	1+	20	68	1.4		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	230	NO	Negative	Negative		27	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	5								NO	3	0	true	M0	N1a	T3	Stage IIIA	TCGA-AO-A0JD.E8A43FF3-3D98-45EE-9567-6EED4DA38274.pdf	1	1	0	0	0	0	0	0	4	2	21	13	75	85	75	85	TUMOR FREE								No	40-49%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2005	TCGA-AO-A0JD-01A-11W-A071-09	TCGA-AO-A0JD-01		TCGA-AO-A0JD-01A-11R-A057-13	TCGA-AO-A0JD-01A-11W-A071-09	ac0bdea2-ebe1-454a-8425-960820b9a1ad	TCGA-AO-A0JD-01A-11W-A071-09	TCGA-AO-A0JD-01A-21-A13B-20	TCGA-AO-A0JD-01A-11W-A071-09	0bef9bfc-43d3-4ac9-a60f-9b65623f7e37	ce2e1bd2-6d7a-45d2-92ca-e2550974cfc8	TCGA-AO-A0JD-01A-11D-A059-01	0bef9bfc-43d3-4ac9-a60f-9b65623f7e37	TCGA-AO-A0JD-01A-11D-A10P-05	TCGA-AO-A0JD-01	TCGA-AO-A0JD-01A-11R-A056-07	0bef9bfc-43d3-4ac9-a60f-9b65623f7e37	0bef9bfc-43d3-4ac9-a60f-9b65623f7e37	TCGA-AO-A0JD-01A-11D-A059-01	TCGA-AO-A0JD-01	TCGA-AO-A0JD-01		ce2e1bd2-6d7a-45d2-92ca-e2550974cfc8	TCGA-AO-A0JD-01A-11R-A057-13
TCGA-AO-A0JE-01	Stage IIIA	53	5	No_Conversion	1965		Negative	FEMALE	Positive	1	1	1	Negative	M0	Positive	N2	1965	0	Her2	HER2-enriched	Negative	Her2	-11	-5	followup	T_Other	T2	LIVING	0	TCGA-AO-A0JE-01	2335	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 4	mutation cluster 3	TCGA-AO-A0JE	2335	0	2335	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Right Lower Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A0JE-F15488		Negative					Negative	Lumpectomy		NO			-19516	1910		0	2335							<10%			71	Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	50-59%	RATIO > = 2.0	3+	33	269	3.8		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	550	NO	Positive	Positive		29	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	8	0	true	M0	N2a	T2	Stage IIIA	TCGA-AO-A0JE.15CAD156-1E40-4C83-B3ED-484964FE407F.pdf	1	1	0	0	0	0	0	0	1	2	14	13	85	85	85	85	TUMOR FREE								No	<10%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2005	TCGA-AO-A0JE-01A-11W-A071-09	TCGA-AO-A0JE-01		TCGA-AO-A0JE-01A-11R-A057-13	TCGA-AO-A0JE-01A-11W-A071-09	d9cdfaa4-a07d-4172-9ffd-67fb62cc8d9a	TCGA-AO-A0JE-01A-11W-A071-09	TCGA-AO-A0JE-01A-21-A13B-20	TCGA-AO-A0JE-01A-11W-A071-09	d73174ef-182c-48b9-af79-dfb457d5b7be	3110bb7f-d80d-4f08-9758-d90368f07cf0	TCGA-AO-A0JE-01A-11D-A059-01	d73174ef-182c-48b9-af79-dfb457d5b7be	TCGA-AO-A0JE-01A-11D-A10P-05	TCGA-AO-A0JE-01	TCGA-AO-A0JE-01A-11R-A056-07	d73174ef-182c-48b9-af79-dfb457d5b7be	d73174ef-182c-48b9-af79-dfb457d5b7be	TCGA-AO-A0JE-01A-11D-A059-01	TCGA-AO-A0JE-01	TCGA-AO-A0JE-01		3110bb7f-d80d-4f08-9758-d90368f07cf0	TCGA-AO-A0JE-01A-11R-A057-13
TCGA-AO-A0JF-01	Stage IIA	68	2	No_Conversion	354		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N1	354	0	LumA	Luminal A	Positive	ReacI	-5	-7	followup	T1	T1	LIVING	0	TCGA-AO-A0JF-01	650	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 7	mutation cluster 4	TCGA-AO-A0JF	650	0	650	Breast	TCGA Breast Cancer	breast invasive carcinoma					68	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A0JF-F15489		Positive		2+			Positive	Lumpectomy		NO			-24923	273		0	650							90-99%				Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	410	NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	7								NO	2	0	true	M0	N1a	T1c	Stage IIA	TCGA-AO-A0JF.D58E5D64-B5B9-4487-8E46-225AE3617C14.pdf	2	1	0	0	0	0	0	0	1	1	24	14	75	85	75	85	TUMOR FREE								No	70-79%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2009	TCGA-AO-A0JF-01A-11W-A071-09	TCGA-AO-A0JF-01		TCGA-AO-A0JF-01A-11R-A057-13	TCGA-AO-A0JF-01A-11W-A071-09	c730759a-51df-45f0-94f3-c9054b9f40ff	TCGA-AO-A0JF-01A-11W-A071-09	TCGA-AO-A0JF-01A-21-A13B-20	TCGA-AO-A0JF-01A-11W-A071-09	3389d4b9-0190-4a69-a647-a6d53e3c96be	d075dd35-f392-4092-8e32-3f4fb622ccb1	TCGA-AO-A0JF-01A-11D-A059-01	3389d4b9-0190-4a69-a647-a6d53e3c96be	TCGA-AO-A0JF-01A-11D-A10P-05	TCGA-AO-A0JF-01	TCGA-AO-A0JF-01A-11R-A056-07	3389d4b9-0190-4a69-a647-a6d53e3c96be	3389d4b9-0190-4a69-a647-a6d53e3c96be	TCGA-AO-A0JF-01A-11D-A059-01	TCGA-AO-A0JF-01	TCGA-AO-A0JF-01		d075dd35-f392-4092-8e32-3f4fb622ccb1	TCGA-AO-A0JF-01A-11R-A057-13
TCGA-AO-A0JG-01	Stage IIIA	49	5	No_Conversion	449		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N2	449	0	LumA	Luminal A	Positive	LumA/B	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-AO-A0JG-01	798	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-AO-A0JG	798	0	798	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Right Lower Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-AO-A0JG-F15492		Positive		3+			Positive	Modified Radical Mastectomy		NO			-18021	395		0	798							90-99%				Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		1+					Other  specify	Ductal & Mucinous	No		C50.9	8523/3	C50.9	4+	YES		Core needle biopsy	410	NO	Negative			19	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	1								NO	4	0	true	M0	N2a	T2	Stage IIIA	TCGA-AO-A0JG.3671D46F-6D69-42DA-9830-24F67EB8B0B6.pdf	6	2	0	0	0	0	0	0	1	5	24	25	75	70	75	70	TUMOR FREE								No	10-19%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2009	TCGA-AO-A0JG-01A-31D-A099-09	TCGA-AO-A0JG-01		TCGA-AO-A0JG-01A-31R-A085-13	TCGA-AO-A0JG-01A-31D-A099-09	a9d2c3f6-0a53-4e38-8a3c-93bf0748df8f		TCGA-AO-A0JG-01A-21-A13C-20	TCGA-AO-A0JG-01A-31D-A099-09	97b5ef6f-d621-4093-ab77-d60dcf706173	fda181a5-c1fa-4e2a-8df5-57b5cd18b0e0	TCGA-AO-A0JG-01A-31D-A087-01	97b5ef6f-d621-4093-ab77-d60dcf706173	TCGA-AO-A0JG-01A-31D-A10P-05	TCGA-AO-A0JG-01	TCGA-AO-A0JG-01A-31R-A084-07	97b5ef6f-d621-4093-ab77-d60dcf706173	97b5ef6f-d621-4093-ab77-d60dcf706173	TCGA-AO-A0JG-01A-31D-A087-01	TCGA-AO-A0JG-01	TCGA-AO-A0JG-01		fda181a5-c1fa-4e2a-8df5-57b5cd18b0e0	TCGA-AO-A0JG-01A-31R-A085-13
TCGA-AO-A0JI-01	Stage IIA	56	4	No_Conversion	1172		Positive	FEMALE	Negative	4	3	4	Negative	M0	Positive	N1	1172	0	LumA	Luminal B	Negative	LumA/B	-10	-3	followup	T1	T1	LIVING	0	TCGA-AO-A0JI-01	1528	0	Kirc+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-AO-A0JI	1528	0	1528	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A0JI-F19410		Positive					Negative	Modified Radical Mastectomy		YES			-20694			0	1528							90-99%				Scheduled Follow-up Submission	2011-12-12	FEMALE		3+ Positive	<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy			Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	2								NO	0	1		M0	N1	T1c	Stage IIA																		TUMOR FREE								No	<10%		NO	Primary Tumor	01			YES	NO	YES	AO	Breast		LIVING	2007	TCGA-AO-A0JI-01A-21W-A100-09	TCGA-AO-A0JI-01		TCGA-AO-A0JI-01A-21R-A057-13	TCGA-AO-A0JI-01A-21W-A100-09	ff238c04-e4ff-43e6-8ee6-38828939ed9f	TCGA-AO-A0JI-01A-21W-A100-09	TCGA-AO-A0JI-01A-11-A13A-20	TCGA-AO-A0JI-01A-21W-A100-09	fb0cd718-5300-4447-9740-a63308f65d92	fdc086da-5ae1-4600-9039-4ea5c1fb7655	TCGA-AO-A0JI-01A-21D-A059-01	fb0cd718-5300-4447-9740-a63308f65d92	TCGA-AO-A0JI-01A-21D-A10P-05	TCGA-AO-A0JI-01	TCGA-AO-A0JI-01A-21R-A056-07	fb0cd718-5300-4447-9740-a63308f65d92	fb0cd718-5300-4447-9740-a63308f65d92	TCGA-AO-A0JI-01A-21D-A059-01	TCGA-AO-A0JI-01	TCGA-AO-A0JI-01		fdc086da-5ae1-4600-9039-4ea5c1fb7655	TCGA-AO-A0JI-01A-21R-A057-13
TCGA-AO-A0JJ-01	Stage IIB	54	2	No_Conversion	1512		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N1	1512	0	LumA	Luminal A	Positive	LumA/B	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-AO-A0JJ-01	1887	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3	cluster 7	mutation c1uster 9	TCGA-AO-A0JJ	1887	0	1887	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A0JJ-F15493		Positive		3+			Positive	Modified Radical Mastectomy		NO			-19758	1477		0	1887							90-99%				Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		0					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	4+	YES		Core needle biopsy	260	NO	Negative			44	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	7								NO	2		true	M0	N1a	T2	Stage IIB	TCGA-AO-A0JJ.EB9B6625-6674-4665-9BEE-D4DFD9366A02.pdf	0	0	0	0	0	0	0	0	0	0	20	20	80	80	75	65	TUMOR FREE								No	70-79%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2006	TCGA-AO-A0JJ-01A-11W-A071-09	TCGA-AO-A0JJ-01		TCGA-AO-A0JJ-01A-11R-A057-13	TCGA-AO-A0JJ-01A-11W-A071-09	c4fcf63c-a35e-451c-bf06-64b36bc30ba0	TCGA-AO-A0JJ-01A-11W-A071-09	TCGA-AO-A0JJ-01A-21-A13A-20	TCGA-AO-A0JJ-01A-11W-A071-09	b5eeba4f-8e46-4084-9054-961ea524cf72	8429bc9e-7bf1-44b1-8e7f-a3ee2d8c2b43	TCGA-AO-A0JJ-01A-11D-A059-01	b5eeba4f-8e46-4084-9054-961ea524cf72	TCGA-AO-A0JJ-01A-11D-A10P-05	TCGA-AO-A0JJ-01	TCGA-AO-A0JJ-01A-11R-A056-07	b5eeba4f-8e46-4084-9054-961ea524cf72	b5eeba4f-8e46-4084-9054-961ea524cf72	TCGA-AO-A0JJ-01A-11D-A059-01	TCGA-AO-A0JJ-01	TCGA-AO-A0JJ-01		8429bc9e-7bf1-44b1-8e7f-a3ee2d8c2b43	TCGA-AO-A0JJ-01A-11R-A057-13
TCGA-AO-A0JL-01	Stage IIIA	59	3	No_Conversion	1319		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N2	1319	0	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA-AO-A0JL-01	1683	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AO-A0JL	1683	0	1683	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-AO-A0JL-F15495		Negative					Negative	Modified Radical Mastectomy		NO			-21895	1332		0	1683							<10%			50	Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%	RATIO > = 2.0	1+	21	131	2.6		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	380	NO	Negative	Positive		26	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5								NO	7		true	M0	N2a	T2	Stage IIIA	TCGA-AO-A0JL.C2976F78-89AF-4461-8D22-BFEBC0504722.pdf	0	0	0	0	10	10	0	0	0	0	15	0	75	90	70	95	TUMOR FREE								No	<10%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2006	TCGA-AO-A0JL-01A-11W-A071-09	TCGA-AO-A0JL-01		TCGA-AO-A0JL-01A-11R-A057-13	TCGA-AO-A0JL-01A-11W-A071-09	8299edee-f043-4cf2-8dc5-501df636be7d	TCGA-AO-A0JL-01A-11W-A071-09	TCGA-AO-A0JL-01A-21-A13A-20	TCGA-AO-A0JL-01A-11W-A071-09	7953e62d-4871-4928-a2ba-a38c740134e1	cb51709b-1103-435b-b9da-eb362eae58fe	TCGA-AO-A0JL-01A-11D-A059-01	7953e62d-4871-4928-a2ba-a38c740134e1	TCGA-AO-A0JL-01A-11D-A10P-05	TCGA-AO-A0JL-01	TCGA-AO-A0JL-01A-11R-A056-07	7953e62d-4871-4928-a2ba-a38c740134e1	7953e62d-4871-4928-a2ba-a38c740134e1	TCGA-AO-A0JL-01A-11D-A059-01	TCGA-AO-A0JL-01	TCGA-AO-A0JL-01		cb51709b-1103-435b-b9da-eb362eae58fe	TCGA-AO-A0JL-01A-11R-A057-13
TCGA-AO-A0JM-01	Stage IIB	40	3	No_Conversion	1826		Positive	FEMALE	Positive	4	5	4	Negative	M0	Positive	N1	1826	0	LumB	Luminal B	Positive	ReacII	-2	-5	followup	T_Other	T2	LIVING	0	TCGA-AO-A0JM-01	2184	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-AO-A0JM	2184	0	2184	Breast	TCGA Breast Cancer	breast invasive carcinoma					40	Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A0JM-F15496		Positive		1+			Positive	Modified Radical Mastectomy		NO			-14653	1828		0	2184							90-99%			74		2011-8-22	FEMALE		3+ POSITIVE	70-79%		3+	30	366	5.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	710	NO	Positive	Positive		23	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		3	5								NO	2		true	M0	N1	T2	Stage IIB	TCGA-AO-A0JM.3023C34B-CF59-43EA-9241-33B738D19B05.pdf	0	0	0	0	0	0	0	0	0	0	5	10	95	90	75	95	TUMOR FREE								No	<10%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2005	TCGA-AO-A0JM-01A-21W-A071-09	TCGA-AO-A0JM-01		TCGA-AO-A0JM-01A-21R-A057-13	TCGA-AO-A0JM-01A-21W-A071-09	f53d3976-6b25-4a6d-9969-89f363a1b810	TCGA-AO-A0JM-01A-21W-A071-09	TCGA-AO-A0JM-01A-11-A13A-20	TCGA-AO-A0JM-01A-21W-A071-09	7b53ba9f-506e-4af7-9752-ae50e4445880	34401e18-8273-4fbb-bbf6-4830e1d7cc96	TCGA-AO-A0JM-01A-21D-A059-01	7b53ba9f-506e-4af7-9752-ae50e4445880	TCGA-AO-A0JM-01A-21D-A10P-05	TCGA-AO-A0JM-01	TCGA-AO-A0JM-01A-21R-A056-07	7b53ba9f-506e-4af7-9752-ae50e4445880	7b53ba9f-506e-4af7-9752-ae50e4445880	TCGA-AO-A0JM-01A-21D-A059-01	TCGA-AO-A0JM-01	TCGA-AO-A0JM-01		34401e18-8273-4fbb-bbf6-4830e1d7cc96	TCGA-AO-A0JM-01A-21R-A057-13
TCGA-AO-A124-01	Stage IIA	38	3	Stage IIA	3119		Negative	FEMALE	Negative				Negative	M0	Negative	N0	3119	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-AO-A124-01	3120	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AO-A124			3120	Breast	TCGA Breast Cancer	breast invasive carcinoma					38	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A124-F5872		Negative					Negative	Modified Radical Mastectomy		YES			-14174	3213		0	3120							<10%					2010-12-7	FEMALE		3+ Positive	<10%		0					Other  specify	mucinous & NOS	No		C50.9	8523/3	C50.9		YES		Core needle biopsy	730	NO	Negative			18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	3									0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A124.9009B4A7-3570-4AD6-878E-90CE8DA7980A.pdf	2	3	1	1	3	0	1	1	0	0	22	30	75	70	75	70	TUMOR FREE								No	<10%		NO	Primary Tumor	01		5th	YES	NO	YES	AO	Breast	A	LIVING	2002	TCGA-AO-A124-01A-11D-A10M-09	TCGA-AO-A124-01		TCGA-AO-A124-01A-11R-A10I-13	TCGA-AO-A124-01A-11D-A10M-09	184cfad8-a50d-4212-b808-dd5a0275cc32	TCGA-AO-A124-01A-11D-A10M-09	TCGA-AO-A124-01A-21-A13E-20	TCGA-AO-A124-01A-11D-A10M-09	5cd42d4a-5971-4a01-8c10-99321105a864	cea1bfb5-fe63-4515-8f2b-66696afa23b2	TCGA-AO-A124-01A-11D-A10L-01	5cd42d4a-5971-4a01-8c10-99321105a864	TCGA-AO-A124-01A-11D-A10N-05	TCGA-AO-A124-01	TCGA-AO-A124-01A-11R-A10J-07	5cd42d4a-5971-4a01-8c10-99321105a864	5cd42d4a-5971-4a01-8c10-99321105a864	TCGA-AO-A124-01A-11D-A10L-01	TCGA-AO-A124-01	TCGA-AO-A124-01		cea1bfb5-fe63-4515-8f2b-66696afa23b2	TCGA-AO-A124-01A-11R-A10I-13
TCGA-AO-A125-01	Stage IIA	72	2	Stage IIA	3018		Positive	FEMALE	Negative				Negative	M0	Negative	N0	3018	0	LumA	Luminal A	Positive		-12	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A125-01	3019	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-AO-A125			3019	Breast	TCGA Breast Cancer	breast invasive carcinoma					72	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-AO-A125-F5874		Positive		4+			Positive	Simple Mastectomy		YES			-26466	3193		0	3019							50-59%					2010-12-7	FEMALE		3+ Positive	<10%	>=2.0 Positive	0			1.0		Other  specify	Papillary Carcinoma	No		C50.9	8050/3	C50.9	3+	YES		Core needle biopsy	90	NO	Negative	Negative		5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	3									0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A125.AE348902-0573-4A57-BBD6-037FA2AF1872.pdf	1	1	0	0	0	0	0	0	0	0	4	4	96	96	96	96	TUMOR FREE								No	90-99%		NO	Primary Tumor	01		5th	YES	NO	YES	AO	Breast	A	LIVING	2002	TCGA-AO-A125-01A-11D-A10M-09	TCGA-AO-A125-01		TCGA-AO-A125-01A-11R-A10I-13			TCGA-AO-A125-01A-11D-A10M-09		TCGA-AO-A125-01A-11D-A10M-09	6c8cb6ae-99bb-4878-b6f5-9da28be98588	dbda4063-8216-488e-b84f-65847e980fe5	TCGA-AO-A125-01A-11D-A10L-01	6c8cb6ae-99bb-4878-b6f5-9da28be98588	TCGA-AO-A125-01A-11D-A10N-05	TCGA-AO-A125-01	TCGA-AO-A125-01A-11R-A10J-07	6c8cb6ae-99bb-4878-b6f5-9da28be98588	6c8cb6ae-99bb-4878-b6f5-9da28be98588	TCGA-AO-A125-01A-11D-A10L-01	TCGA-AO-A125-01	TCGA-AO-A125-01		dbda4063-8216-488e-b84f-65847e980fe5	TCGA-AO-A125-01A-11R-A10I-13
TCGA-AO-A126-01	Stage IIA	39	5	Stage IIA	2850		Positive	FEMALE	Negative	1	3	3	Negative	M0	Negative	N0	2850	0	LumA	Luminal A	Positive	Her2	0	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A126-01	3307	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 14	TCGA-AO-A126	267	1	3307	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	YES	YES	NO	39	Right Upper Inner Quadrant|Right	Sentinel node biopsy alone		TCGA-AO-A126-F19402		Positive		2+			Positive	Simple Mastectomy		YES	295	295	-14264	3033		0	3307			267				20-29%			49	Scheduled Follow-up Submission	2011-12-12	FEMALE		3+ Positive	<10%	>=2.0 Positive	0	31	62	1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	450	NO	Negative	Negative		5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)		Negative	0		Positive	20-29%		<10%	1.3	4 Point Scale			Negative		60-69%		Positive	4	6			4 Point Scale		Locoregional Disease			YES	0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A126.A4BFA94D-166F-43D4-90B5-3C547F4026A0.pdf	1	1	0	0	1	0	0	0	0	0	19	55	80	45	90	80	TUMOR FREE								No	60-69%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2002	TCGA-AO-A126-01A-11D-A10M-09	TCGA-AO-A126-01		TCGA-AO-A126-01A-11R-A10I-13		da59b9c1-ff1d-4949-ac71-087257291201	TCGA-AO-A126-01A-11D-A10M-09	TCGA-AO-A126-01A-21-A13E-20	TCGA-AO-A126-01A-11D-A10M-09	690cf196-9b2c-4886-a0e2-ce3a49cb4389	b232d272-6cc0-43ec-92e6-f854213a4b19	TCGA-AO-A126-01A-11D-A10L-01	690cf196-9b2c-4886-a0e2-ce3a49cb4389	TCGA-AO-A126-01A-11D-A10N-05	TCGA-AO-A126-01	TCGA-AO-A126-01A-11R-A10J-07	690cf196-9b2c-4886-a0e2-ce3a49cb4389	690cf196-9b2c-4886-a0e2-ce3a49cb4389	TCGA-AO-A126-01A-11D-A10L-01	TCGA-AO-A126-01	TCGA-AO-A126-01		b232d272-6cc0-43ec-92e6-f854213a4b19	TCGA-AO-A126-01A-11R-A10I-13
TCGA-AO-A128-01	Stage IIA	61	3	Stage IIA	2877		Negative	FEMALE	Negative				Negative	M0	Negative	N0	2877	0	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA-AO-A128-01	3248	0	BRCA-LUAD+	C4-BRCA/Basal	cluster 5	Cluster 5	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14	cluster 6		TCGA-AO-A128	3248	0	3248	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Right Lower Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-AO-A128-F19405		Negative					Negative	Lumpectomy		YES			-22340	2960		0	3248							<10%			49	Scheduled Follow-up Submission	2011-12-12	FEMALE		3+ Positive	<10%	>=2.0 Positive	0	30	52	1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	590	NO	Negative	Negative		15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	6								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A128.03526CFD-0C3E-4ACB-AB26-3E0B0ED0ADA2.pdf	3	5	0	0	10	1	0	0	0	0	8	6	82	93	90	93	TUMOR FREE								No	<10%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2002		TCGA-AO-A128-01		TCGA-AO-A128-01A-11R-A10I-13		b629bd13-8d7f-4bff-aa80-08dec4b64d8e	TCGA-AO-A128-01A-11D-A10M-09	TCGA-AO-A128-01A-21-A13E-20		4a93eaee-d821-4640-a441-255008aaf3b4	e704bf4e-f9a2-4ae5-a6ae-2cf62564c0ec	TCGA-AO-A128-01A-11D-A10L-01	4a93eaee-d821-4640-a441-255008aaf3b4	TCGA-AO-A128-01A-11D-A10N-05	TCGA-AO-A128-01	TCGA-AO-A128-01A-11R-A10J-07	4a93eaee-d821-4640-a441-255008aaf3b4	4a93eaee-d821-4640-a441-255008aaf3b4	TCGA-AO-A128-01A-11D-A10L-01	TCGA-AO-A128-01	TCGA-AO-A128-01		e704bf4e-f9a2-4ae5-a6ae-2cf62564c0ec	TCGA-AO-A128-01A-11R-A10I-13
TCGA-AO-A129-01	Stage IIB	29	1	No_Conversion	2923		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	2923	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-AO-A129-01	2923	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 3	mutation cluster 5	TCGA-AO-A129			2923	Breast	TCGA Breast Cancer	breast invasive carcinoma					29	Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-AO-A129-F5882		Negative					Negative	Modified Radical Mastectomy		NO			-10898	2915		0	2923							<10%			49		2010-12-8	FEMALE		3+ Positive	<10%	>=2.0 Positive	0	31	52	1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	320	NO	Negative	Negative		21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	3									2		true	M0	N1a	T2	Stage IIB	TCGA-AO-A129.DD973A0E-3CC3-4ED7-BE2C-7E5E3C55032B.pdf	0	0	0	0	15	15	0	0	0	0	0	0	85	85	70	75	TUMOR FREE								No	<10%		YES	Primary Tumor	01		5th	YES	NO	YES	AO	Breast	A	LIVING	2002	TCGA-AO-A129-01A-21D-A10M-09	TCGA-AO-A129-01		TCGA-AO-A129-01A-21R-A10I-13		480c68cf-c569-476a-86eb-cd14d5ba6b54	TCGA-AO-A129-01A-21D-A10M-09	TCGA-AO-A129-01A-11-A13E-20	TCGA-AO-A129-01A-21D-A10M-09	15b9736e-eafc-465e-9ddd-b1b498e8b701	4cd8277c-8a70-44e6-b491-cd35c63408db	TCGA-AO-A129-01A-21D-A10L-01	15b9736e-eafc-465e-9ddd-b1b498e8b701	TCGA-AO-A129-01A-21D-A10N-05	TCGA-AO-A129-01	TCGA-AO-A129-01A-21R-A10J-07	15b9736e-eafc-465e-9ddd-b1b498e8b701	15b9736e-eafc-465e-9ddd-b1b498e8b701	TCGA-AO-A129-01A-21D-A10L-01	TCGA-AO-A129-01	TCGA-AO-A129-01		4cd8277c-8a70-44e6-b491-cd35c63408db	TCGA-AO-A129-01A-21R-A10I-13
TCGA-AO-A12A-01	Stage IIA	47	2	Stage IIA	2754		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	2754	0	LumA	Luminal A	Positive	LumA	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-AO-A12A-01	2755	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-AO-A12A			2755	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A12A-F5885		Positive		4+			Positive	Modified Radical Mastectomy		YES			-17420	2793		0	2755							90-99%			58		2010-12-8	FEMALE		3+ Positive	<10%	>=2.0 Positive	1+	30	61	1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	220	NO	Negative	Negative		27	Close	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6									0	1	true	M0	N0 (i+)	T2	Stage IIA	TCGA-AO-A12A.A54E82A4-D7C2-4A5C-A69C-C66976F0282F.pdf	0	0	0	0	0	0	0	0	5	5	0	10	95	85	65	55	TUMOR FREE								No	90-99%		NO	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2003	TCGA-AO-A12A-01A-21D-A10Y-09	TCGA-AO-A12A-01	TCGA-AO-A12A-01A-21R-A114-13	TCGA-AO-A12A-01A-21R-A114-13	TCGA-AO-A12A-01A-21D-A10Y-09	e6f501dd-64cd-404e-92f3-56c0de08d987	TCGA-AO-A12A-01A-21D-A10Y-09	TCGA-AO-A12A-01A-11-A13E-20	TCGA-AO-A12A-01A-21D-A10Y-09	3f4c6d17-a971-4ba0-83ad-3addc24f1298	2cbacdf7-951b-4e62-b703-909aaae769ae	TCGA-AO-A12A-01A-21D-A111-01	3f4c6d17-a971-4ba0-83ad-3addc24f1298		TCGA-AO-A12A-01	TCGA-AO-A12A-01A-21R-A115-07	3f4c6d17-a971-4ba0-83ad-3addc24f1298	3f4c6d17-a971-4ba0-83ad-3addc24f1298	TCGA-AO-A12A-01A-21D-A111-01	TCGA-AO-A12A-01	TCGA-AO-A12A-01	TCGA-AO-A12A-01A-21D-A112-05	2cbacdf7-951b-4e62-b703-909aaae769ae	
TCGA-AO-A12B-01	Stage IIA	63	3	Stage IIA	2359		Positive	FEMALE	Negative	3	3	4	Negative	M0	Negative	N0	2359	0	LumA	Luminal B	Positive	LumA/B	-12	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A12B-01	2989	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-AO-A12B	2989	0	2989	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right	Sentinel node biopsy alone		TCGA-AO-A12B-F43473		Positive		4+			Positive	Simple Mastectomy		YES			-23150	2365		0	2989							90-99%				Scheduled Follow-up Submission	2013-5-22	FEMALE		3+ Positive	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	570	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	3								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A12B.CF071D24-7BA2-43BE-B3E7-A981DBDFCA0F.pdf	0	0	0	0	0	0	0	0	0	0	0	0	100	100	95	95	TUMOR FREE						YES		No	90-99%		NO	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2004	TCGA-AO-A12B-01A-11D-A10M-09	TCGA-AO-A12B-01	TCGA-AO-A12B-01A-11R-A10I-13	TCGA-AO-A12B-01A-11R-A10I-13		1ecefd90-2eeb-48bb-9f53-3c5ccdfa465c	TCGA-AO-A12B-01A-11D-A10M-09	TCGA-AO-A12B-01A-21-A13E-20	TCGA-AO-A12B-01A-11D-A10M-09	44225bb7-92c6-4a6d-b136-bc51666ba84a	9c9304d2-57bc-42b3-91ae-e4671165e030	TCGA-AO-A12B-01A-11D-A10L-01	44225bb7-92c6-4a6d-b136-bc51666ba84a	TCGA-AO-A12B-01A-11D-A10N-05	TCGA-AO-A12B-01	TCGA-AO-A12B-01A-11R-A10J-07	44225bb7-92c6-4a6d-b136-bc51666ba84a	44225bb7-92c6-4a6d-b136-bc51666ba84a	TCGA-AO-A12B-01A-11D-A10L-01	TCGA-AO-A12B-01	TCGA-AO-A12B-01		9c9304d2-57bc-42b3-91ae-e4671165e030	
TCGA-AO-A12C-01	Stage IIB	42	2	No_Conversion	1993		Positive	FEMALE	Positive				Negative	M0	Positive	N1	1993	0	LumA	Luminal A	Positive	ReacI	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-AO-A12C-01	1994	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6		TCGA-AO-A12C			1994	Breast	TCGA Breast Cancer	breast invasive carcinoma					42	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A12C-F5889	Negative	Positive		2+		Modified radical mastectomy	Positive	Lumpectomy		NO			-15469	2086		0	1994							90-99%			78		2010-12-8	FEMALE		3+ Positive	90-99%	>=2.0 Positive	3+	30	125	1.6		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	350	NO	Positive	Negative		31	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	6									2		true	M0	N1a	T2	Stage IIB	TCGA-AO-A12C.7E9202F6-F2DB-4CC0-A10F-3D9A82E84242.pdf	3	2	0	0	0	0	0	0	2	7	38	33	60	60	80	80	TUMOR FREE								No	40-49%		YES	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2005				TCGA-AO-A12C-01A-11R-A10I-13		6b20b15d-4ebc-4169-a36c-e9abab1dd6f0		TCGA-AO-A12C-01A-21-A13E-20		3b1da7ee-4470-4ab5-b1a7-53ac92b4e4d3			3b1da7ee-4470-4ab5-b1a7-53ac92b4e4d3	TCGA-AO-A12C-01A-11D-A10N-05	TCGA-AO-A12C-01	TCGA-AO-A12C-01A-11R-A10J-07	3b1da7ee-4470-4ab5-b1a7-53ac92b4e4d3	3b1da7ee-4470-4ab5-b1a7-53ac92b4e4d3		TCGA-AO-A12C-01				TCGA-AO-A12C-01A-11R-A10I-13
TCGA-AO-A12D-01	Stage IIA	43	3	No_Conversion	1948		Negative	FEMALE	Positive	2	2	1	Negative	M0	Positive	N1	1948	0	Her2	HER2-enriched	Negative	Her2	-11	-10	followup	T1	T1	LIVING	0	TCGA-AO-A12D-01	1948	0	High	C3-BRCA/Luminal	cluster 5	Cluster 5	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AO-A12D			1948	Breast	TCGA Breast Cancer	breast invasive carcinoma					43	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A12D-F5892		Negative					Negative	Modified Radical Mastectomy		YES			-15774	1948		0	1948							<10%			66		2010-12-8	FEMALE		3+ Positive	90-99%	>=2.0 Positive	3+	32	441	6.7		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	750	NO	Positive	Positive		16	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	3									1	0	true	M0	N1a	T1c	Stage IIA	TCGA-AO-A12D.9363D53D-BC3B-4AC0-8185-536C6DB3A6AE.pdf	4	3	0	0	1	1	0	0	0	0	19	14	80	85	85	90	TUMOR FREE								No	<10%		YES	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2005	TCGA-AO-A12D-01A-11D-A10Y-09	TCGA-AO-A12D-01	TCGA-AO-A12D-01A-11R-A114-13	TCGA-AO-A12D-01A-11R-A114-13	TCGA-AO-A12D-01A-11D-A10Y-09	1dd0fa5e-8122-4008-a89b-025ed17a3dd9	TCGA-AO-A12D-01A-11D-A10Y-09	TCGA-AO-A12D-01A-21-A13E-20	TCGA-AO-A12D-01A-11D-A10Y-09	4adf4439-3d60-44ac-a6f0-9f42cc081a93	83122683-8f67-481a-92f2-f60687a83ba3	TCGA-AO-A12D-01A-11D-A111-01	4adf4439-3d60-44ac-a6f0-9f42cc081a93		TCGA-AO-A12D-01	TCGA-AO-A12D-01A-11R-A115-07	4adf4439-3d60-44ac-a6f0-9f42cc081a93	4adf4439-3d60-44ac-a6f0-9f42cc081a93	TCGA-AO-A12D-01A-11D-A111-01	TCGA-AO-A12D-01	TCGA-AO-A12D-01	TCGA-AO-A12D-01A-11D-A112-05	83122683-8f67-481a-92f2-f60687a83ba3	
TCGA-AO-A12E-01	Stage IIB	51	3	Stage IIB	1742		Positive	FEMALE	Negative	4	3	3	Negative	M0	Negative	N0	1742	0	LumA	Luminal A	Positive	LumA/B	-5	-7	followup	T_Other	T3	LIVING	0	TCGA-AO-A12E-01	1743	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-AO-A12E			1743	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-AO-A12E-F5895		Positive		2+			Positive	Modified Radical Mastectomy		YES			-18721	1822		0	1743							80-89%					2010-12-8	FEMALE		3+ Positive	<10%		0					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Core needle biopsy	630	NO	Negative			13	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		3	1									0	1	true	M0	N0 (i+)	T3	Stage IIB	TCGA-AO-A12E.332675C9-53CB-4244-8480-82E1546DA7F2.pdf	0	0	0	0	0	0	0	0	0	5	20	40	80	55	80	70	TUMOR FREE								No	40-49%		YES	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2005	TCGA-AO-A12E-01A-11D-A10M-09	TCGA-AO-A12E-01		TCGA-AO-A12E-01A-11R-A10I-13		b6ec964a-db35-4120-aaaf-f3018a330490	TCGA-AO-A12E-01A-11D-A10M-09	TCGA-AO-A12E-01A-21-A13E-20	TCGA-AO-A12E-01A-11D-A10M-09	222c7e4d-f6ed-4db0-ba36-1670159cee1b	ecb453b9-9594-424f-9a73-be8f90737a6a	TCGA-AO-A12E-01A-11D-A10L-01	222c7e4d-f6ed-4db0-ba36-1670159cee1b	TCGA-AO-A12E-01A-11D-A10N-05	TCGA-AO-A12E-01	TCGA-AO-A12E-01A-11R-A10J-07	222c7e4d-f6ed-4db0-ba36-1670159cee1b	222c7e4d-f6ed-4db0-ba36-1670159cee1b	TCGA-AO-A12E-01A-11D-A10L-01	TCGA-AO-A12E-01	TCGA-AO-A12E-01		ecb453b9-9594-424f-9a73-be8f90737a6a	TCGA-AO-A12E-01A-11R-A10I-13
TCGA-AO-A12F-01	Stage IIA	36	1	Stage IIA	1471		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1471	0	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA-AO-A12F-01	1471	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-AO-A12F			1471	Breast	TCGA Breast Cancer	breast invasive carcinoma					36	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-AO-A12F-F5899		Negative					Negative	Simple Mastectomy		YES			-13409	1578		0	1471							<10%					2010-12-8	FEMALE		3+ Positive	<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	600	NO	Negative			17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	5									0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A12F.96B43BA2-7099-436C-8AFD-FD53E55E7F51.pdf	1	2	1	1	2	2	0	0	0	0	18	13	80	85	80	85	TUMOR FREE								No	<10%		YES	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2006	TCGA-AO-A12F-01A-11D-A10Y-09	TCGA-AO-A12F-01	TCGA-AO-A12F-01A-11R-A114-13	TCGA-AO-A12F-01A-11R-A114-13	TCGA-AO-A12F-01A-11D-A10Y-09	8f64c41b-17ee-40d2-98d6-4c483e5d5384	TCGA-AO-A12F-01A-11D-A10Y-09	TCGA-AO-A12F-01A-21-A13D-20	TCGA-AO-A12F-01A-11D-A10Y-09	05610046-ec77-4592-892a-464a81d55c45	d36528cb-bb4a-4878-abf6-1709a1a0fb7e	TCGA-AO-A12F-01A-11D-A111-01	05610046-ec77-4592-892a-464a81d55c45		TCGA-AO-A12F-01	TCGA-AO-A12F-01A-11R-A115-07	05610046-ec77-4592-892a-464a81d55c45	05610046-ec77-4592-892a-464a81d55c45	TCGA-AO-A12F-01A-11D-A111-01	TCGA-AO-A12F-01	TCGA-AO-A12F-01	TCGA-AO-A12F-01A-11D-A112-05	d36528cb-bb4a-4878-abf6-1709a1a0fb7e	
TCGA-AO-A12G-01	Stage IIA	75	2	Stage IIA	1265		Positive	FEMALE	Negative	1	3	3	Negative	M0	Negative	N0	1265	0	LumA	Luminal A	Positive	LumA/B	-1	0	followup	T_Other	T2	LIVING	0	TCGA-AO-A12G-01	1266	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 8	TCGA-AO-A12G			1266	Breast	TCGA Breast Cancer	breast invasive carcinoma					75	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-AO-A12G-F5907		Positive		2+			Positive	Simple Mastectomy		YES			-27705	1415		0	1266							90-99%			67		2010-12-8	FEMALE				>=2.0 Positive	2+	23	66	1.0		Other  specify	pleomorphic infiltrating lobular carcinoma	No		C50.9	8022/3	C50.9	4+	YES		Core needle biopsy	280	NO	Positive	Negative		4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2									0	1	true	M0	N0 (i+)	T2	Stage IIA	TCGA-AO-A12G.6CE21603-4200-40BA-94AA-15F24EE4AC7F.pdf	2	2	1	1	1	0	0	0	2	0	17	20	80	80	80	80	TUMOR FREE								No	30-39%		NO	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2006	TCGA-AO-A12G-01A-11D-A10M-09	TCGA-AO-A12G-01		TCGA-AO-A12G-01A-11R-A10I-13		e5214399-e1f0-42f1-be38-366c47e438fa	TCGA-AO-A12G-01A-11D-A10M-09	TCGA-AO-A12G-01A-21-A13D-20	TCGA-AO-A12G-01A-11D-A10M-09	348a0fd6-eb6b-4550-a26a-3896c4963b3a	4a2c3e4c-941a-4d08-9d30-386ac70cd657	TCGA-AO-A12G-01A-11D-A10L-01	348a0fd6-eb6b-4550-a26a-3896c4963b3a	TCGA-AO-A12G-01A-11D-A10N-05	TCGA-AO-A12G-01	TCGA-AO-A12G-01A-11R-A10J-07	348a0fd6-eb6b-4550-a26a-3896c4963b3a	348a0fd6-eb6b-4550-a26a-3896c4963b3a	TCGA-AO-A12G-01A-11D-A10L-01	TCGA-AO-A12G-01	TCGA-AO-A12G-01		4a2c3e4c-941a-4d08-9d30-386ac70cd657	TCGA-AO-A12G-01A-11R-A10I-13
TCGA-AO-A12H-01	Stage IIA	69	1	Stage IIA	862		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	862	0	LumA	Luminal A	Positive	LumA/B	-12	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A12H-01	863	0	Quiet	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 2	mutation cluster 4	TCGA-AO-A12H			863	Breast	TCGA Breast Cancer	breast invasive carcinoma					69	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-AO-A12H-F5910		Positive		2+			Positive	Simple Mastectomy		YES			-25515	1017		0	863							90-99%					2010-12-8	FEMALE		3+ Positive	<10%		0					Mixed Histology (please specify)	MUCINOUS & PAPILLARY	No		C50.9	8523/3	C50.9	4+	YES		Core needle biopsy	290	NO	Negative			10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	2									0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A12H.2FDFCEB5-74F7-417E-9FD1-ECC81B27803B.pdf	0	0	0	0	0	0	0	0	0	10	0	0	100	90	98	90	TUMOR FREE								No	<10%		NO	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2008	TCGA-AO-A12H-01A-11D-A10Y-09	TCGA-AO-A12H-01	TCGA-AO-A12H-01A-11R-A114-13	TCGA-AO-A12H-01A-11R-A114-13	TCGA-AO-A12H-01A-11D-A10Y-09	6988badd-172f-4880-9ad6-75f7896112bb	TCGA-AO-A12H-01A-11D-A10Y-09	TCGA-AO-A12H-01A-21-A13D-20	TCGA-AO-A12H-01A-11D-A10Y-09	71b58051-3bf8-4dfb-a431-c8aceab7c799	099a5aae-f24a-47e6-b40d-a0db5c009c27	TCGA-AO-A12H-01A-11D-A111-01	71b58051-3bf8-4dfb-a431-c8aceab7c799		TCGA-AO-A12H-01	TCGA-AO-A12H-01A-11R-A115-07	71b58051-3bf8-4dfb-a431-c8aceab7c799	71b58051-3bf8-4dfb-a431-c8aceab7c799	TCGA-AO-A12H-01A-11D-A111-01	TCGA-AO-A12H-01	TCGA-AO-A12H-01	TCGA-AO-A12H-01A-11D-A112-05	099a5aae-f24a-47e6-b40d-a0db5c009c27	
TCGA-AO-A1KO-01	Stage IIB	46	1	Stage IIB	448		Positive	FEMALE	Negative				Negative	M0	Negative	N0	448	0	Normal		Positive				followup	T_Other	T3	LIVING	0	TCGA-AO-A1KO-01	448	0	Quiet	C3-BRCA/Luminal	cluster 5	Low purity c2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 6	mutation c1uster 9	TCGA-AO-A1KO			448	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A1KO-F9898		Positive	4 Point Scale	4+	4 Point Scale		Positive	Simple Mastectomy		YES			-16817	832		0	448					NO		90-99%					2011-4-1	FEMALE			<10%		1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	4+	YES		Excisional Biopsy	580	NO	Negative			19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	6									0	1	true	M0	N0 (i+)	T3	Stage IIB	TCGA-AO-A1KO.15FB8CBD-85EF-45BE-8065-9F4E922D457E.pdf		2		1		0		1		10		20		70		70	TUMOR FREE							YES	No	90-99%		NO	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2008	TCGA-AO-A1KO-01A-31D-A188-09		TCGA-AO-A1KO-01A-31R-A13P-13	TCGA-AO-A1KO-01A-31R-A13P-13			TCGA-AO-A1KO-01A-31D-A188-09	TCGA-AO-A1KO-01A-41-A17I-20	TCGA-AO-A1KO-01A-31D-A188-09	62a37d05-a1f5-48e1-b4cd-7b24b5ca0b34	5152cac8-5c7e-419c-a4da-46a1607db2e8	TCGA-AO-A1KO-01A-31D-A13J-01	62a37d05-a1f5-48e1-b4cd-7b24b5ca0b34	TCGA-AO-A1KO-01A-31D-A13K-05	TCGA-AO-A1KO-01		62a37d05-a1f5-48e1-b4cd-7b24b5ca0b34	62a37d05-a1f5-48e1-b4cd-7b24b5ca0b34	TCGA-AO-A1KO-01A-31D-A13J-01		TCGA-AO-A1KO-01		5152cac8-5c7e-419c-a4da-46a1607db2e8	
TCGA-AO-A1KP-01	Stage IIA	77	2	Stage IIA	2513		Positive	FEMALE	Negative				Negative	M0	Positive	N1	2513	0	LumB		Positive				followup	T1	T1	LIVING	0	TCGA-AO-A1KP-01	2513	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-AO-A1KP			2513	Breast	TCGA Breast Cancer	breast invasive carcinoma					77	Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A1KP-F9887		Positive	4 Point Scale	4+	4 Point Scale		Positive	Simple Mastectomy		YES			-28247	2604		0	2513					NO		80-89%					2011-4-1	FEMALE			<10%	>=2.0 Positive	1+			1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	360	NO	Negative	Negative		9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6									0	1	true	M0	N1	T1	Stage IIA	TCGA-AO-A1KP.467172CC-6EA1-435D-BDC1-D65FBF8EA0E8.pdf		0		0		0		0		0		30		70		80	TUMOR FREE							YES	No	40-49%		NO	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2003	TCGA-AO-A1KP-01A-11D-A13L-09		TCGA-AO-A1KP-01A-11R-A13P-13	TCGA-AO-A1KP-01A-11R-A13P-13	TCGA-AO-A1KP-01A-11D-A13L-09		TCGA-AO-A1KP-01A-11D-A13L-09	TCGA-AO-A1KP-01A-21-A17I-20	TCGA-AO-A1KP-01A-11D-A13L-09	773a2357-99b8-40df-b657-f237d9735db9	a22ae2e3-fd36-4ec5-a76d-a34a3961060b	TCGA-AO-A1KP-01A-11D-A13J-01	773a2357-99b8-40df-b657-f237d9735db9	TCGA-AO-A1KP-01A-11D-A13K-05	TCGA-AO-A1KP-01		773a2357-99b8-40df-b657-f237d9735db9	773a2357-99b8-40df-b657-f237d9735db9	TCGA-AO-A1KP-01A-11D-A13J-01		TCGA-AO-A1KP-01		a22ae2e3-fd36-4ec5-a76d-a34a3961060b	
TCGA-AO-A1KQ-01	Stage IIIB	84	4	Stage IIIB	1519		Positive	MALE	Negative				Negative	M0	Positive	N1	1519	0	LumB		Positive				followup	T_Other	T4	LIVING	0	TCGA-AO-A1KQ-01	1882	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4		TCGA-AO-A1KQ	1882	0	1882	Breast	TCGA Breast Cancer	breast invasive carcinoma					84	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A1KQ-F21775		Positive	4 Point Scale	3+	4 Point Scale		Positive	Modified Radical Mastectomy		NO			-30859	1553		0	1882					NO		90-99%				Scheduled Follow-up Submission	2012-2-20	MALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	540	NO	Negative			9	Negative																			2	4								NO	2	0	true	M0	N1	T4	Stage IIIB	TCGA-AO-A1KQ.EB5199BA-6164-4CFB-AFAA-B41544B83103.pdf		0		0		0		0		0		20		80		90	TUMOR FREE							YES	No	80-89%		NO	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2006			TCGA-AO-A1KQ-01A-11R-A13P-13	TCGA-AO-A1KQ-01A-11R-A13P-13				TCGA-AO-A1KQ-01A-21-A17I-20		204a78d9-67aa-4e49-b285-bbb25c6ed142	ebc2cde9-7556-4c6d-94d4-b61e14efb0f3	TCGA-AO-A1KQ-01A-11D-A13J-01	204a78d9-67aa-4e49-b285-bbb25c6ed142	TCGA-AO-A1KQ-01A-11D-A13K-05	TCGA-AO-A1KQ-01		204a78d9-67aa-4e49-b285-bbb25c6ed142	204a78d9-67aa-4e49-b285-bbb25c6ed142	TCGA-AO-A1KQ-01A-11D-A13J-01		TCGA-AO-A1KQ-01		ebc2cde9-7556-4c6d-94d4-b61e14efb0f3	
TCGA-AO-A1KR-01		51	1		2140		Negative	FEMALE									2140	0	Basal		Negative				enrollment			LIVING	0	TCGA-AO-A1KR-01	2141	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-AO-A1KR			2141	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Right Upper Inner Quadrant	Sentinel node biopsy alone				Negative	4 Point Scale		3 Point Scale		Negative	Simple Mastectomy		YES			-18900	1932		0	2141					NO							2011-9-15	FEMALE					1+		1			Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO	Negative	Negative		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	3									0	0	true	M0	N0	T2	Stage IIA	TCGA-AO-A1KR.FF188295-E139-4AEE-8EE8-364536F2BBE8.pdf		0		0		0		0		5		20		75		90	TUMOR FREE							YES	No				Primary Tumor	01		6th		NO	YES	AO	Breast	A	LIVING	2005	TCGA-AO-A1KR-01A-12D-A142-09		TCGA-AO-A1KR-01A-12R-A143-13	TCGA-AO-A1KR-01A-12R-A143-13	TCGA-AO-A1KR-01A-12D-A142-09		TCGA-AO-A1KR-01A-12D-A142-09	TCGA-AO-A1KR-01A-21-A17I-20	TCGA-AO-A1KR-01A-12D-A142-09	6d22f538-114f-48b6-94ba-fb60151ed567	0d7cde44-ec86-415a-8667-0ea894d1c344	TCGA-AO-A1KR-01A-12D-A141-01	6d22f538-114f-48b6-94ba-fb60151ed567	TCGA-AO-A1KR-01A-12D-A145-05	TCGA-AO-A1KR-01		6d22f538-114f-48b6-94ba-fb60151ed567	6d22f538-114f-48b6-94ba-fb60151ed567	TCGA-AO-A1KR-01A-12D-A141-01		TCGA-AO-A1KR-01		0d7cde44-ec86-415a-8667-0ea894d1c344	
TCGA-AO-A1KS-01	Stage IIA	69	5	Stage IIA	16		Positive	FEMALE	Negative				Negative	M0	Negative	N0	16	0	LumB		Positive				followup	T_Other	T2	LIVING	0	TCGA-AO-A1KS-01	16	0	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-AO-A1KS			16	Breast	TCGA Breast Cancer	breast invasive carcinoma					69	Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-AO-A1KS-F9872		Positive	4 Point Scale	2+	4 Point Scale		Positive	Lumpectomy		YES			-25230	147		0	16					NO		90-99%			3.2		2011-4-1	FEMALE			10-19%	Positive >2.2	2+	40	3.2	1.0		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	4+	YES		Core needle biopsy	420	NO	Equivocal	Negative		5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5									0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A1KS.0FB93D92-81F6-4241-9094-4AABF70E6A0F.pdf		0		0		0		0		0		20		80		90	TUMOR FREE							YES	No	90-99%		YES	Primary Tumor	01		7th	YES	NO	YES	AO	Breast	A	LIVING	2010	TCGA-AO-A1KS-01A-11D-A13L-09		TCGA-AO-A1KS-01A-11R-A13P-13	TCGA-AO-A1KS-01A-11R-A13P-13	TCGA-AO-A1KS-01A-11D-A13L-09		TCGA-AO-A1KS-01A-11D-A13L-09	TCGA-AO-A1KS-01A-21-A17I-20	TCGA-AO-A1KS-01A-11D-A13L-09	9eab0553-20cc-41bb-bcdb-9ade0578da82	4f393818-bf59-495d-85cf-6ddf1571e717	TCGA-AO-A1KS-01A-11D-A13J-01	9eab0553-20cc-41bb-bcdb-9ade0578da82	TCGA-AO-A1KS-01A-11D-A13K-05	TCGA-AO-A1KS-01		9eab0553-20cc-41bb-bcdb-9ade0578da82	9eab0553-20cc-41bb-bcdb-9ade0578da82	TCGA-AO-A1KS-01A-11D-A13J-01		TCGA-AO-A1KS-01		4f393818-bf59-495d-85cf-6ddf1571e717	
TCGA-AO-A1KT-01	Stage IIA	78	2	Stage IIA	541		Positive	FEMALE	Negative				Negative	M0	Positive	N1	541	0	LumB		Positive				followup	T1	T1	LIVING	0	TCGA-AO-A1KT-01	541	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AO-A1KT			541	Breast	TCGA Breast Cancer	breast invasive carcinoma					78	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-AO-A1KT-F9905		Positive	4 Point Scale	4+	4 Point Scale		Positive	Lumpectomy		YES			-28660	617		0	541					NO		90-99%			1.7		2011-4-1	FEMALE			10-19%	>2.2 Positive	2+	40	2.4	1.4		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	200	NO	Equivocal	Negative		5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4									1	1	true	M0	N1	T1	Stage IIA	TCGA-AO-A1KT.D9432167-0F2E-4377-9DB4-EA4E59A6C9B9.pdf		0		0		0		0		0		40		60		85	TUMOR FREE							YES	No	40-49%		YES	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2009	TCGA-AO-A1KT-01A-11D-A13L-09		TCGA-AO-A1KT-01A-11R-A13P-13	TCGA-AO-A1KT-01A-11R-A13P-13	TCGA-AO-A1KT-01A-11D-A13L-09		TCGA-AO-A1KT-01A-11D-A13L-09	TCGA-AO-A1KT-01A-21-A17I-20	TCGA-AO-A1KT-01A-11D-A13L-09	82140d3a-0787-4e1e-993d-1b222c073cf8	b93dd87f-11db-4cd2-8051-32251eace393	TCGA-AO-A1KT-01A-11D-A13J-01	82140d3a-0787-4e1e-993d-1b222c073cf8	TCGA-AO-A1KT-01A-11D-A13K-05	TCGA-AO-A1KT-01		82140d3a-0787-4e1e-993d-1b222c073cf8	82140d3a-0787-4e1e-993d-1b222c073cf8	TCGA-AO-A1KT-01A-11D-A13J-01		TCGA-AO-A1KT-01		b93dd87f-11db-4cd2-8051-32251eace393	
TCGA-AQ-A04H-01	Stage IIIA	61	5	No_Conversion	439		Positive	FEMALE	Positive						Positive	N2	439	0	LumB	Luminal B	Positive		-10	-3	followup	T_Other	T2	LIVING	0	TCGA-AQ-A04H-01	754	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 5	TCGA-AQ-A04H	754	0	754	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-AQ-A04H-F35322		Positive					Positive	Modified Radical Mastectomy		NO			-22539	365		0	754							90-99%					2012-9-24	FEMALE					2+	30		3.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	100	NO	Indeterminate	Positive	NO	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	7								NO	4		false	MX	N2a	T2	Stage IIIA		2	3	1	1	1	1	0	0	0	2	54	48	45	49	85	85	TUMOR FREE				>10%	>10%	YES		No	20-29%		YES	Primary Tumor	01		6th	YES	NO	YES	AQ	Breast	B	LIVING	2009	TCGA-AQ-A04H-01B-11D-A10M-09	TCGA-AQ-A04H-01		TCGA-AQ-A04H-01B-11R-A10I-13	TCGA-AQ-A04H-01B-11D-A10M-09		TCGA-AQ-A04H-01B-11D-A10M-09		TCGA-AQ-A04H-01B-11D-A10M-09	bcd8ae7a-cd43-4781-9ce3-8c87b92dd69d	965e2ec0-0a64-4ad1-a201-97cdf65dcb39	TCGA-AQ-A04H-01B-11D-A10L-01	bcd8ae7a-cd43-4781-9ce3-8c87b92dd69d	TCGA-AQ-A04H-01B-11D-A10N-05	TCGA-AQ-A04H-01	TCGA-AQ-A04H-01B-11R-A10J-07	bcd8ae7a-cd43-4781-9ce3-8c87b92dd69d	bcd8ae7a-cd43-4781-9ce3-8c87b92dd69d	TCGA-AQ-A04H-01B-11D-A10L-01	TCGA-AQ-A04H-01	TCGA-AQ-A04H-01		965e2ec0-0a64-4ad1-a201-97cdf65dcb39	TCGA-AQ-A04H-01B-11R-A10I-13
TCGA-AQ-A04J-01	Stage IIA	45	1	Stage IIA	499		Negative	FEMALE	Negative				Negative	M0	Negative	N0	499	0	Basal	Basal-like	Negative		-13	-12	followup	T_Other	T2	LIVING	0	TCGA-AQ-A04J-01	819	0	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AQ-A04J	819	0	819	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AQ-A04J-F21740		Negative		0			Negative	Simple Mastectomy		NO			-16615	118		0	819							<10%				Scheduled Follow-up Submission	2012-2-20	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	160	NO	Negative			20	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	4								NO	0	0	false	M0	N0 (i+)	T2	Stage IIA	TCGA-AQ-A04J.71CEC5F6-16E5-46E1-A91B-B5E0F699B231.pdf	25	5	2	0	15	5	0	0	8	10	27	20	50	65	65	80	TUMOR FREE								No	<10%		NO	Primary Tumor	01			YES	NO	YES	AQ	Breast	A	LIVING	2009	TCGA-AQ-A04J-01A-02W-A050-09	TCGA-AQ-A04J-01		TCGA-AQ-A04J-01A-02R-A035-13	TCGA-AQ-A04J-01A-02W-A050-09		TCGA-AQ-A04J-01A-02W-A050-09		TCGA-AQ-A04J-01A-02W-A050-09	97168a1f-abf8-414b-af10-b63f5daa7023	57b92480-0f4d-436d-b6f0-1d01a2d6ce21	TCGA-AQ-A04J-01A-02D-A036-01	97168a1f-abf8-414b-af10-b63f5daa7023		TCGA-AQ-A04J-01	TCGA-AQ-A04J-01A-02R-A034-07	97168a1f-abf8-414b-af10-b63f5daa7023	97168a1f-abf8-414b-af10-b63f5daa7023	TCGA-AQ-A04J-01A-02D-A036-01	TCGA-AQ-A04J-01	TCGA-AQ-A04J-01	TCGA-AQ-A04J-01A-02D-A032-05	57b92480-0f4d-436d-b6f0-1d01a2d6ce21	TCGA-AQ-A04J-01A-02R-A035-13
TCGA-AQ-A04L-01	Stage IIA	48	1	Stage IIA	3344		Positive	FEMALE	Positive	2	2	2	Negative	M0	Negative	N0	3344	0	LumA	Luminal A	Negative	ReacI	-1	-5	followup	T_Other	T2	LIVING	0	TCGA-AQ-A04L-01	3957	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 13	TCGA-AQ-A04L	3957	0	3957	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Right	Sentinel node biopsy alone		TCGA-AQ-A04L-F35324		Positive					Negative	Modified Radical Mastectomy		NO			-17759	3403		0	3957							60-69%					2012-9-24	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Fine needle aspiration biopsy	160	NO	Positive		NO	2	Negative	Peri (6-12 months since last menstrual period)																		3	3								NO	0		false	MX	N0 (i-)	T2	Stage IIA		2	2	2	2	1	2	0	0	0	0	30	49	69	49	90	80	TUMOR FREE						YES		No			NO	Primary Tumor	01		5th	YES	NO	YES	AQ	Breast	B	LIVING	2001	TCGA-AQ-A04L-01B-21D-A10M-09	TCGA-AQ-A04L-01		TCGA-AQ-A04L-01B-21R-A10I-13		16b9cd57-86e9-4409-8ad3-02d5a4540f0f	TCGA-AQ-A04L-01B-21D-A10M-09	TCGA-AQ-A04L-01B-11-A13D-20	TCGA-AQ-A04L-01B-21D-A10M-09	1fa9c013-4d2c-4f3e-8e77-6437dad440c9	f77f1d25-be2a-4a1e-a262-f01482406c10	TCGA-AQ-A04L-01B-21D-A10L-01	1fa9c013-4d2c-4f3e-8e77-6437dad440c9	TCGA-AQ-A04L-01B-21D-A10N-05	TCGA-AQ-A04L-01	TCGA-AQ-A04L-01B-21R-A10J-07	1fa9c013-4d2c-4f3e-8e77-6437dad440c9	1fa9c013-4d2c-4f3e-8e77-6437dad440c9	TCGA-AQ-A04L-01B-21D-A10L-01	TCGA-AQ-A04L-01	TCGA-AQ-A04L-01		f77f1d25-be2a-4a1e-a262-f01482406c10	TCGA-AQ-A04L-01B-21R-A10I-13
TCGA-AQ-A0Y5-01	Stage IIIA	70	3	Stage IIIA		161	Positive	FEMALE	Positive				Negative	M0	Positive	N2	161	1	LumA		Positive				followup	T_Other	T2	DECEASED	1	TCGA-AQ-A0Y5-01	172	1	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-AQ-A0Y5			172	Breast	TCGA Breast Cancer	breast invasive carcinoma					70	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AQ-A0Y5-F10119		Positive					Positive	Modified Radical Mastectomy		NO			-25793	212	172	0						NO		70-79%					2011-4-7	FEMALE					2+			3.8		Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9		YES		Core needle biopsy	160	NO	Positive	Positive		17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									5		false	MX	N2a	T2	Stage IIIA	TCGA-AQ-A0Y5.5BC01981-366E-44EC-A986-087DB7904E5C.pdf	2	0	1	0	1	1	0	0	2	0	70	84	27	15	70	15	TUMOR FREE							YES	Yes	40-49%		NO	Primary Tumor	01		7th	YES	YES	NO	AQ	Breast	A	DECEASED	2010	TCGA-AQ-A0Y5-01A-11D-A14K-09		TCGA-AQ-A0Y5-01A-11R-A14L-13	TCGA-AQ-A0Y5-01A-11R-A14L-13	TCGA-AQ-A0Y5-01A-11D-A14K-09		TCGA-AQ-A0Y5-01A-11D-A14K-09		TCGA-AQ-A0Y5-01A-11D-A14K-09	9bb258a4-dd26-4c43-bd29-04b68ea3c7ca	80ffdd30-9845-4ee5-8f68-f272c0b0b1f5	TCGA-AQ-A0Y5-01A-11D-A14J-01	9bb258a4-dd26-4c43-bd29-04b68ea3c7ca	TCGA-AQ-A0Y5-01A-11D-A14N-05	TCGA-AQ-A0Y5-01		9bb258a4-dd26-4c43-bd29-04b68ea3c7ca	9bb258a4-dd26-4c43-bd29-04b68ea3c7ca	TCGA-AQ-A0Y5-01A-11D-A14J-01		TCGA-AQ-A0Y5-01		80ffdd30-9845-4ee5-8f68-f272c0b0b1f5	
TCGA-AQ-A1H2-01	Stage IIIA	84	5	Stage IIIA	197		Positive	FEMALE	Positive				Negative	M0	Positive	N2	197	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AQ-A1H2-01	475	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-AQ-A1H2	475	0	475	Breast	TCGA Breast Cancer	breast invasive carcinoma					84	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AQ-A1H2-F19896		Positive					Positive	Modified Radical Mastectomy		NO			-30958	156		0	475					NO		90-99%				Scheduled Follow-up Submission	2012-1-3	FEMALE					2+			2.7		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Core needle biopsy	210	NO	Indeterminate	Positive		19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	1								NO	13		false	MX	N2a	T2	Stage IIIA	TCGA-AQ-A1H2.1B5FA34B-E3B4-4D4B-AF0A-1C90016CC532.pdf		40		20		10		20		0		30		60		60	TUMOR FREE							YES	No	10-19%		YES	Primary Tumor	01		7th	YES	YES	NO	AQ	Breast	A	LIVING	2010	TCGA-AQ-A1H2-01A-11D-A13L-09		TCGA-AQ-A1H2-01A-11R-A13P-13	TCGA-AQ-A1H2-01A-11R-A13P-13	TCGA-AQ-A1H2-01A-11D-A13L-09		TCGA-AQ-A1H2-01A-11D-A13L-09	TCGA-AQ-A1H2-01A-21-A17I-20	TCGA-AQ-A1H2-01A-11D-A13L-09	8b954cec-cf3e-4b0d-a4e8-cfbc9575a732	fd45dc6f-bce7-4005-b1e7-be2b2b7dbbca	TCGA-AQ-A1H2-01A-11D-A13J-01	8b954cec-cf3e-4b0d-a4e8-cfbc9575a732	TCGA-AQ-A1H2-01A-11D-A13K-05	TCGA-AQ-A1H2-01		8b954cec-cf3e-4b0d-a4e8-cfbc9575a732	8b954cec-cf3e-4b0d-a4e8-cfbc9575a732	TCGA-AQ-A1H2-01A-11D-A13J-01		TCGA-AQ-A1H2-01		fd45dc6f-bce7-4005-b1e7-be2b2b7dbbca	
TCGA-AQ-A1H3-01	Stage IIIC	49	2	Stage IIIC	138		Positive	FEMALE	Negative				Negative	M0	Positive	N3	138	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AQ-A1H3-01	989	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 5	cluster 6	mutation c1uster 9	TCGA-AQ-A1H3	989	0	989	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AQ-A1H3-F50661		Positive					Positive	Modified Radical Mastectomy		NO			-18177	94		0	989					NO		90-99%				Scheduled Follow-up Submission	2013-10-28	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Core needle biopsy	300	NO	Negative		NO	23	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	6								NO	14		false	MX	N3a	T2	Stage IIIC	TCGA-AQ-A1H3.6EB1A616-E99C-4AF6-9C0A-0FDC521A79CD.pdf		0		0		0		0		0		10		90		80	TUMOR FREE						YES	YES	No	80-89%		YES	Primary Tumor	01		7th	YES	YES	NO	AQ	Breast	A	LIVING	2010	TCGA-AQ-A1H3-01A-31D-A13L-09		TCGA-AQ-A1H3-01A-31R-A13P-13	TCGA-AQ-A1H3-01A-31R-A13P-13	TCGA-AQ-A1H3-01A-31D-A13L-09		TCGA-AQ-A1H3-01A-31D-A13L-09	TCGA-AQ-A1H3-01A-41-A17I-20	TCGA-AQ-A1H3-01A-31D-A13L-09	554df3b0-e305-4dab-a268-47ad7c1dcffc	3ca91d58-5838-480a-8708-61a9a6b40447	TCGA-AQ-A1H3-01A-31D-A13J-01	554df3b0-e305-4dab-a268-47ad7c1dcffc	TCGA-AQ-A1H3-01A-31D-A13K-05	TCGA-AQ-A1H3-01		554df3b0-e305-4dab-a268-47ad7c1dcffc	554df3b0-e305-4dab-a268-47ad7c1dcffc	TCGA-AQ-A1H3-01A-31D-A13J-01		TCGA-AQ-A1H3-01		3ca91d58-5838-480a-8708-61a9a6b40447	
TCGA-AQ-A54N-01																													0	TCGA-AQ-A54N-01	78	0										TCGA-AQ-A54N	78	0	78	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Left Lower Inner Quadrant	Sentinel node biopsy alone		TCGA-AQ-A54N-F55736		Negative					Negative	Lumpectomy		YES			-18741	639		0	78												2014-1-14	FEMALE					2+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	360	NO	Equivocal	Negative	YES	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	M0	N0	T2	Stage IIA	TCGA-AQ-A54N.9BF0E34A-F78C-4BFD-AC4C-926FA1D60342.pdf		0		0		1		0		0		1		98		95	TUMOR FREE						NO	YES	Yes			NO	Primary Tumor	01		7th		YES	NO	AQ	Breast	A	LIVING	2011			TCGA-AQ-A54N-01A-11R-A25Z-13	TCGA-AQ-A54N-01A-11R-A25Z-13			TCGA-AQ-A54N-01A-11D-A25Q-09			ed3e6c57-a0ec-4441-a1a1-794f3f15e112	1ba42f73-8bc1-44c5-87ca-251e2691764d	TCGA-AQ-A54N-01A-11D-A25N-01	ed3e6c57-a0ec-4441-a1a1-794f3f15e112	TCGA-AQ-A54N-01A-11D-A268-05	TCGA-AQ-A54N-01		ed3e6c57-a0ec-4441-a1a1-794f3f15e112	ed3e6c57-a0ec-4441-a1a1-794f3f15e112	TCGA-AQ-A54N-01A-11D-A25N-01		TCGA-AQ-A54N-01		1ba42f73-8bc1-44c5-87ca-251e2691764d	
TCGA-AQ-A54O-01																													0	TCGA-AQ-A54O-01	1001	0										TCGA-AQ-A54O	1001	0	1001	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AQ-A54O-F55731		Positive					Positive	Simple Mastectomy		YES			-18694	617		0	1001							90-99%					2014-1-14	MALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.3		YES		Fine needle aspiration biopsy	360	NO	Negative		NO	14	Negative																												NO	0	0	false	M0	N0	T2	Stage IIA	TCGA-AQ-A54O.B3884493-D0D2-445C-B9BB-BC475021EBA4.pdf		0		0		0		0		0		20		80		80	TUMOR FREE						YES	YES	Yes	70-79%		NO	Primary Tumor	01		7th		YES	NO	AQ	Breast	A	LIVING	2011			TCGA-AQ-A54O-01A-11R-A25Z-13	TCGA-AQ-A54O-01A-11R-A25Z-13			TCGA-AQ-A54O-01A-11D-A25Q-09			3c1b6647-26bb-4110-aaea-f542024e8bf3	f9396883-7828-4aaf-b487-9deec4e199fb	TCGA-AQ-A54O-01A-11D-A25N-01	3c1b6647-26bb-4110-aaea-f542024e8bf3	TCGA-AQ-A54O-01A-11D-A268-05	TCGA-AQ-A54O-01		3c1b6647-26bb-4110-aaea-f542024e8bf3	3c1b6647-26bb-4110-aaea-f542024e8bf3	TCGA-AQ-A54O-01A-11D-A25N-01		TCGA-AQ-A54O-01		f9396883-7828-4aaf-b487-9deec4e199fb	
TCGA-AQ-A7U7-01																													1	TCGA-AQ-A7U7-01	584	1										TCGA-AQ-A7U7	584	0	584	Breast	TCGA Breast Cancer	breast invasive carcinoma					55	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AQ-A7U7-F68763		Positive					Positive	Other		YES			-20239	223	584	0	304							80-89%					2014-12-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy		NO	Negative		NO	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	4	0	false	M0	N2a	T2	Stage IIIA	TCGA-AQ-A7U7.2B30A85F-7A5F-46E4-BE22-28C902D5DFA3.pdf		40		20		0		20		0		40		60		60	TUMOR FREE						YES	YES	Yes	80-89%		YES	Primary Tumor	01	L Total Mastectomy	7th		YES	NO	AQ	Breast	A	DECEASED	2013			TCGA-AQ-A7U7-01A-22R-A358-13	TCGA-AQ-A7U7-01A-22R-A358-13						0f3672e4-ab71-4cb6-9d46-3ae57b58e249	8b2ac658-78b4-40dc-8151-fb5296ecc828	TCGA-AQ-A7U7-01A-22D-A350-01	0f3672e4-ab71-4cb6-9d46-3ae57b58e249	TCGA-AQ-A7U7-01A-22D-A357-05	TCGA-AQ-A7U7-01		0f3672e4-ab71-4cb6-9d46-3ae57b58e249	0f3672e4-ab71-4cb6-9d46-3ae57b58e249	TCGA-AQ-A7U7-01A-22D-A350-01		TCGA-AQ-A7U7-01		8b2ac658-78b4-40dc-8151-fb5296ecc828	
TCGA-AR-A0TP-01	Stage II	43	1	No_Conversion	2392		Positive	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	2392	0	Basal	Basal-like	Negative	Basal	-13	-11	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0TP-01	3386	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AR-A0TP	3386	0	3386	Breast	TCGA Breast Cancer	breast invasive carcinoma					43	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A0TP-F49514		Positive					Negative	Other		YES			-15812	2512		0	3386							<10%				Scheduled Follow-up Submission	2013-10-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	650	NO	Negative			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	3								NO	0	0	true	M0	N0	T2	Stage IIA	TCGA-AR-A0TP.E1A92F92-1DD2-4E33-9C16-3FD0371D1431.pdf	0	0	0	0	10	0	0	0	0	0	10	10	80	90	80	80	TUMOR FREE						YES		No			YES	Primary Tumor	01	Wide local excision		YES	NO	YES	AR	Breast	A	LIVING	2003	TCGA-AR-A0TP-01A-11D-A099-09	TCGA-AR-A0TP-01		TCGA-AR-A0TP-01A-11R-A085-13	TCGA-AR-A0TP-01A-11D-A099-09	c8173431-25a0-4853-a0ca-7df5c5cf40e8		TCGA-AR-A0TP-01A-21-A13C-20	TCGA-AR-A0TP-01A-11D-A099-09	f9739b94-ac64-40d5-bfdd-041a412976c4	17e54aa6-f5d6-437a-8345-d40805c86430	TCGA-AR-A0TP-01A-11D-A087-01	f9739b94-ac64-40d5-bfdd-041a412976c4	TCGA-AR-A0TP-01A-11D-A10P-05	TCGA-AR-A0TP-01	TCGA-AR-A0TP-01A-11R-A084-07	f9739b94-ac64-40d5-bfdd-041a412976c4	f9739b94-ac64-40d5-bfdd-041a412976c4	TCGA-AR-A0TP-01A-11D-A087-01	TCGA-AR-A0TP-01	TCGA-AR-A0TP-01		17e54aa6-f5d6-437a-8345-d40805c86430	TCGA-AR-A0TP-01A-11R-A085-13
TCGA-AR-A0TQ-01	Stage III	27	3	No_Conversion	1500		Positive	FEMALE	Positive	1	1	4	Negative	M0	Positive	N1	1500	0	LumB	Luminal B	Negative	Her2	-2	-5	enrollment	T_Other	T3	LIVING	0	TCGA-AR-A0TQ-01	2240	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-AR-A0TQ	2240	0	2240	Breast	TCGA Breast Cancer	breast invasive carcinoma					27	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AR-A0TQ-F49515		Positive					Negative	Simple Mastectomy		NO			-9873	1512		0	2240							10-19%				Scheduled Follow-up Submission	2013-10-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	750	NO	Equivocal	Positive		15	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4								NO	2		true	M0	N1	T3	Stage IIIA	TCGA-AR-A0TQ.6061FCA5-A113-4985-905D-E17020F6933E.pdf	0	0	0	0	0	0	0	0	10	0	40	20	50	80	70	70	TUMOR FREE						YES		No			YES	Primary Tumor	01			YES	NO	YES	AR	Breast	A	LIVING	2006	TCGA-AR-A0TQ-01A-11D-A099-09	TCGA-AR-A0TQ-01		TCGA-AR-A0TQ-01A-11R-A085-13	TCGA-AR-A0TQ-01A-11D-A099-09	e214f5bd-2ee3-4f27-b1e4-2895df122c9f		TCGA-AR-A0TQ-01A-21-A13C-20	TCGA-AR-A0TQ-01A-11D-A099-09	7c7b9232-aadf-476f-b9c7-2fdd67efe1e7	5d48d86f-703e-4390-a86f-c48426aa290f	TCGA-AR-A0TQ-01A-11D-A087-01	7c7b9232-aadf-476f-b9c7-2fdd67efe1e7	TCGA-AR-A0TQ-01A-11D-A10P-05	TCGA-AR-A0TQ-01	TCGA-AR-A0TQ-01A-11R-A084-07	7c7b9232-aadf-476f-b9c7-2fdd67efe1e7	7c7b9232-aadf-476f-b9c7-2fdd67efe1e7	TCGA-AR-A0TQ-01A-11D-A087-01	TCGA-AR-A0TQ-01	TCGA-AR-A0TQ-01		5d48d86f-703e-4390-a86f-c48426aa290f	TCGA-AR-A0TQ-01A-11R-A085-13
TCGA-AR-A0TR-01	Stage II	68	1	No_Conversion	21	160	Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	160	1	LumA	Luminal A	Positive	LumA/B	-12	-3	enrollment	T_Other	T2	DECEASED	1	TCGA-AR-A0TR-01	160	1	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 7	mutation cluster 4	TCGA-AR-A0TR	160	0	160	Breast	TCGA Breast Cancer	breast invasive carcinoma					68	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A0TR-F18771		Positive					Positive	Modified Radical Mastectomy		NO			-25190	1535	160	0												Scheduled Follow-up Submission	2011-12-12	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy not specified	Other method, specify:	520	NO	Equivocal	Negative		27	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	7								NO	1		true	M0	N1	T2	Stage IIB	TCGA-AR-A0TR.6535D911-D718-4794-9D5E-6E06553464FF.pdf	0	0	0	0	0	0	0	0	0	0	10	10	90	90	80	70									No			NO	Primary Tumor	01			YES	NO	YES	AR	Breast	A	DECEASED	2006	TCGA-AR-A0TR-01A-11D-A099-09	TCGA-AR-A0TR-01		TCGA-AR-A0TR-01A-11R-A085-13	TCGA-AR-A0TR-01A-11D-A099-09	64d25a8c-e5fc-42f2-8d71-7cf2afb1d9ff		TCGA-AR-A0TR-01A-21-A13C-20	TCGA-AR-A0TR-01A-11D-A099-09	b31bf328-6ead-4ee4-b8c7-4407372dc683	0d98d3ff-375a-4f82-ba8e-734a8a8fc17e	TCGA-AR-A0TR-01A-11D-A087-01	b31bf328-6ead-4ee4-b8c7-4407372dc683	TCGA-AR-A0TR-01A-11D-A10P-05	TCGA-AR-A0TR-01	TCGA-AR-A0TR-01A-11R-A084-07	b31bf328-6ead-4ee4-b8c7-4407372dc683	b31bf328-6ead-4ee4-b8c7-4407372dc683	TCGA-AR-A0TR-01A-11D-A087-01	TCGA-AR-A0TR-01	TCGA-AR-A0TR-01		0d98d3ff-375a-4f82-ba8e-734a8a8fc17e	TCGA-AR-A0TR-01A-11R-A085-13
TCGA-AR-A0TS-01	Stage II	46	4	No_Conversion	1138		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	1138	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0TS-01	2275	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA c1uster 9	cluster 5	mutation cluster 5	TCGA-AR-A0TS	2275	0	2275	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A0TS-F49516		Negative		0			Negative	Lumpectomy		YES			-17141	1549		0	2275											Scheduled Follow-up Submission	2013-10-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	250	NO	Negative			16	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	5								NO	2		true	M0	N1	T2	Stage IIB	TCGA-AR-A0TS.39A0AD32-D372-422F-94F2-173F963C7AAB.pdf	80	100	20	0	0	0	0	0	0	0	40	30	60	70	60	60	TUMOR FREE						YES		No			YES	Primary Tumor	01			YES	NO	YES	AR	Breast	A	LIVING	2006	TCGA-AR-A0TS-01A-11D-A10Y-09	TCGA-AR-A0TS-01	TCGA-AR-A0TS-01A-11R-A114-13	TCGA-AR-A0TS-01A-11R-A114-13	TCGA-AR-A0TS-01A-11D-A10Y-09	3dd4ebe5-1445-46c9-8815-f9a3dc659585	TCGA-AR-A0TS-01A-11D-A10Y-09	TCGA-AR-A0TS-01A-21-A13C-20	TCGA-AR-A0TS-01A-11D-A10Y-09	3e57b40c-7079-4f05-bf37-f560304966c1	51577886-4016-4714-8b35-c7a61a85baa2	TCGA-AR-A0TS-01A-11D-A111-01	3e57b40c-7079-4f05-bf37-f560304966c1		TCGA-AR-A0TS-01	TCGA-AR-A0TS-01A-11R-A115-07	3e57b40c-7079-4f05-bf37-f560304966c1	3e57b40c-7079-4f05-bf37-f560304966c1	TCGA-AR-A0TS-01A-11D-A111-01	TCGA-AR-A0TS-01	TCGA-AR-A0TS-01	TCGA-AR-A0TS-01A-11D-A112-05	51577886-4016-4714-8b35-c7a61a85baa2	
TCGA-AR-A0TT-01	Stage III	53	3	No_Conversion	1679		Positive	FEMALE	Negative	1	1	4	Negative	M0	Positive	N2	1679	0	LumB	Luminal B	Negative	LumA/B	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0TT-01	2636	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AR-A0TT	2636	0	2636	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A0TT-F49517		Positive		0			Negative	Other					-19679	1567		0	2636							10-19%				Scheduled Follow-up Submission	2013-10-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	310	NO	Negative			19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4								NO	5		true	M0	N2	T2	Stage IIIA	TCGA-AR-A0TT.E9231B33-E1CE-4396-9F9E-03DBF049919A.pdf	2	2	1	0	2	2	1	0	0	0	18	18	80	80	80	80	TUMOR FREE						YES		No			YES	Primary Tumor	01	Wide local excision		YES	NO	YES	AR	Breast	A	LIVING	2006	TCGA-AR-A0TT-01A-31D-A099-09	TCGA-AR-A0TT-01		TCGA-AR-A0TT-01A-31R-A085-13	TCGA-AR-A0TT-01A-31D-A099-09	5f13706f-5c4d-421f-9b16-eaeec34f283b		TCGA-AR-A0TT-01A-21-A13C-20	TCGA-AR-A0TT-01A-31D-A099-09	dc2ddb88-79d7-44b2-a770-a5f7dde21e3c	2b2697ab-f5e8-476f-b043-62ecdf1ca8b0	TCGA-AR-A0TT-01A-31D-A087-01	dc2ddb88-79d7-44b2-a770-a5f7dde21e3c	TCGA-AR-A0TT-01A-31D-A10P-05	TCGA-AR-A0TT-01	TCGA-AR-A0TT-01A-31R-A084-07	dc2ddb88-79d7-44b2-a770-a5f7dde21e3c	dc2ddb88-79d7-44b2-a770-a5f7dde21e3c	TCGA-AR-A0TT-01A-31D-A087-01	TCGA-AR-A0TT-01	TCGA-AR-A0TT-01		2b2697ab-f5e8-476f-b043-62ecdf1ca8b0	TCGA-AR-A0TT-01A-31R-A085-13
TCGA-AR-A0TU-01	Stage II	35	4	No_Conversion	360		Negative	FEMALE	Negative				Negative	M0	Negative	N0	360	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0TU-01	417	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8			mutation c1uster 9	TCGA-AR-A0TU	417	0	417	Breast	TCGA Breast Cancer	breast invasive carcinoma					35	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A0TU-F18575		Negative		0			Negative	Simple Mastectomy		YES			-13039	1633		0	417											Scheduled Follow-up Submission	2011-12-15	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	830	NO	Negative			4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5									NO	0		true	M0	N0	T2	Stage IIA	TCGA-AR-A0TU.81A39E94-059E-4307-A75A-E8C051E9D0C3.pdf	3	5	0	0	23	5	0	0	0	20	2	0	75	75	96	90									No			NO	Primary Tumor	01			YES	NO	YES	AR	Breast	A	LIVING	2006	TCGA-AR-A0TU-01A-31D-A10G-09				TCGA-AR-A0TU-01A-31D-A10G-09	3c72159d-4ac6-4f06-89f5-4e7bc6a4e134	TCGA-AR-A0TU-01A-31D-A10G-09	TCGA-AR-A0TU-01A-21-A13C-20	TCGA-AR-A0TU-01A-31D-A10G-09	2877059f-b560-413b-b8be-40d9fde8fbcf			2877059f-b560-413b-b8be-40d9fde8fbcf	TCGA-AR-A0TU-01A-31D-A10A-05	TCGA-AR-A0TU-01	TCGA-AR-A0TU-01A-31R-A109-07	2877059f-b560-413b-b8be-40d9fde8fbcf	2877059f-b560-413b-b8be-40d9fde8fbcf		TCGA-AR-A0TU-01				
TCGA-AR-A0TV-01	Stage II	66	1	No_Conversion	904		Positive	FEMALE	Negative	1	1	4	Negative	M0	Negative	N0	904	0	LumB	Luminal B	Positive	LumA/B	-10	-5	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0TV-01	1288	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 8	TCGA-AR-A0TV	1288	0	1288	Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A0TV-F18574		Positive					Positive	Simple Mastectomy		YES			-24279	1716		0	1288							90-99%				Scheduled Follow-up Submission	2011-12-12	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	550	NO	Equivocal	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO	0		true	M0	N0	T2	Stage IIA	TCGA-AR-A0TV.7594A7F8-1806-4B74-99EF-4E4C889E7BEA.pdf	2	2	0	0	2	1	0	0	0	0	13	9	85	90	85	90									No			NO	Primary Tumor	01			NO	NO	YES	AR	Breast	A	LIVING	2005	TCGA-AR-A0TV-01A-21D-A099-09	TCGA-AR-A0TV-01		TCGA-AR-A0TV-01A-21R-A085-13	TCGA-AR-A0TV-01A-21D-A099-09	457d54a9-a2c9-4747-928c-4c428e187548		TCGA-AR-A0TV-01A-11-A13D-20	TCGA-AR-A0TV-01A-21D-A099-09	3d0d24de-c3b4-4396-bfb1-2c8c2788cf0c	5f623237-b478-4bca-8647-d633e9e63d7c	TCGA-AR-A0TV-01A-21D-A087-01	3d0d24de-c3b4-4396-bfb1-2c8c2788cf0c	TCGA-AR-A0TV-01A-21D-A10P-05	TCGA-AR-A0TV-01	TCGA-AR-A0TV-01A-21R-A084-07	3d0d24de-c3b4-4396-bfb1-2c8c2788cf0c	3d0d24de-c3b4-4396-bfb1-2c8c2788cf0c	TCGA-AR-A0TV-01A-21D-A087-01	TCGA-AR-A0TV-01	TCGA-AR-A0TV-01		5f623237-b478-4bca-8647-d633e9e63d7c	TCGA-AR-A0TV-01A-21R-A085-13
TCGA-AR-A0TW-01	Stage III	50	4	No_Conversion	739		Positive	FEMALE	Negative				Negative	M0	Positive	N1	739	0	LumA	Luminal A	Positive	Basal	-2	-5	enrollment	T_Other	T3	LIVING	0	TCGA-AR-A0TW-01	3009	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7			mutation c1uster 9	TCGA-AR-A0TW	3009	0	3009	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Right Upper Outer Quadrant|Right Lower Outer Quadrant			TCGA-AR-A0TW-F49464		Positive					Positive	Modified Radical Mastectomy					-18263	1888		0	3009			739								Scheduled Follow-up Submission	2013-10-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	760	NO	Equivocal	Negative		27	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4									NO	3		true	M0	N1	T3	Stage IIIA	TCGA-AR-A0TW.F832C787-3668-475F-8F67-6342DA3777F4.pdf	2	2	0	0	1	1	0	0	0	0	9	9	90	90	90	90	TUMOR FREE						YES		No			NO	Primary Tumor	01			YES	NO	YES	AR	Breast	A	LIVING	2005	TCGA-AR-A0TW-01A-11D-A099-09	TCGA-AR-A0TW-01			TCGA-AR-A0TW-01A-11D-A099-09	d09f498e-9952-4926-b6e2-56e774b0bdcf		TCGA-AR-A0TW-01A-21-A13D-20	TCGA-AR-A0TW-01A-11D-A099-09	f8fd0762-44b8-41ff-9c1a-ff688497e312	18466ec8-1c12-4047-b792-9693e00fe15b	TCGA-AR-A0TW-01A-11D-A087-01	f8fd0762-44b8-41ff-9c1a-ff688497e312	TCGA-AR-A0TW-01A-11D-A10P-05	TCGA-AR-A0TW-01	TCGA-AR-A0TW-01A-11R-A084-07	f8fd0762-44b8-41ff-9c1a-ff688497e312	f8fd0762-44b8-41ff-9c1a-ff688497e312	TCGA-AR-A0TW-01A-11D-A087-01	TCGA-AR-A0TW-01	TCGA-AR-A0TW-01		18466ec8-1c12-4047-b792-9693e00fe15b	
TCGA-AR-A0TX-01	Stage II	64	1	No_Conversion	15		Positive	FEMALE	Positive	2	2	1	Negative	M0	Positive	N1	15	0	Her2	HER2-enriched	Positive	ReacII	-11	-5	enrollment	T1	T1	LIVING	0	TCGA-AR-A0TX-01	1972	0	High	C3-BRCA/Luminal	cluster 1	Cluster 5	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 8	TCGA-AR-A0TX	1972	0	1972	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AR-A0TX-F49468		Positive					Positive	Other		NO			-23653	1976		0	1972							<10%				Scheduled Follow-up Submission	2013-10-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	470	NO	Positive			25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	1								NO	3		true	M0	N1	T1	Stage IIA	TCGA-AR-A0TX.4FC34715-9004-4F53-B914-F0004AEA88C8.pdf	3	3	1	0	20	1	1	0	0	0	15	19	65	80	65	80	TUMOR FREE								No			YES	Primary Tumor	01	Wide local excision			NO	YES	AR	Breast	A	LIVING	2005	TCGA-AR-A0TX-01A-11D-A099-09	TCGA-AR-A0TX-01		TCGA-AR-A0TX-01A-11R-A085-13	TCGA-AR-A0TX-01A-11D-A099-09	82828084-520c-4384-aa18-0d668bfa5ed6	TCGA-AR-A0TX-01A-11D-A099-09	TCGA-AR-A0TX-01A-21-A13D-20	TCGA-AR-A0TX-01A-11D-A099-09	08d85849-cda7-4709-a934-fdc586418d7f	ffb216a3-2131-42ce-97ba-9a4fb4ad0a69	TCGA-AR-A0TX-01A-11D-A087-01	08d85849-cda7-4709-a934-fdc586418d7f	TCGA-AR-A0TX-01A-11D-A10P-05	TCGA-AR-A0TX-01	TCGA-AR-A0TX-01A-11R-A084-07	08d85849-cda7-4709-a934-fdc586418d7f	08d85849-cda7-4709-a934-fdc586418d7f	TCGA-AR-A0TX-01A-11D-A087-01	TCGA-AR-A0TX-01	TCGA-AR-A0TX-01		ffb216a3-2131-42ce-97ba-9a4fb4ad0a69	TCGA-AR-A0TX-01A-11R-A085-13
TCGA-AR-A0TY-01	Stage II	54	1	No_Conversion	544	1699	Positive	FEMALE	Negative	1	1	4	Negative	M0	Negative	N0	1699	1	LumB	Luminal B	Negative	LumA/B	-2	-5	enrollment	T_Other	T2	DECEASED	1	TCGA-AR-A0TY-01	1699	1	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 12	TCGA-AR-A0TY	544	1	1699	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A0TY-F18561		Positive		0			Negative	Simple Mastectomy		YES			-19836	2141	1699	0				544				10-19%				Scheduled Follow-up Submission	2011-12-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	410	NO	Negative			15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)			1+		Positive												Negative	4	4				Bone	Distant Metastasis			YES	0		true	M0	N0	T2	Stage IIA	TCGA-AR-A0TY.12A4A731-1ADF-4D36-88F3-16C9642484F3.pdf	3	2	0	0	0	1	0	0	10	3	90	21	0	75	0	75	WITH TUMOR								No			NO	Primary Tumor	01			YES	NO	YES	AR	Breast	A	DECEASED	2004	TCGA-AR-A0TY-01A-12W-A12T-09	TCGA-AR-A0TY-01	TCGA-AR-A0TY-01A-12R-A114-13	TCGA-AR-A0TY-01A-12R-A114-13	TCGA-AR-A0TY-01A-12W-A12T-09	8a76d3b0-5e1c-48d9-a325-71be8a93a093	TCGA-AR-A0TY-01A-12W-A12T-09	TCGA-AR-A0TY-01A-21-A13D-20	TCGA-AR-A0TY-01A-12W-A12T-09	7fe47d2c-6b7d-4fa3-8e22-14fdb2b44920	1614a21e-1cc6-430a-a5da-c2a15e4542b2	TCGA-AR-A0TY-01A-12D-A111-01	7fe47d2c-6b7d-4fa3-8e22-14fdb2b44920		TCGA-AR-A0TY-01	TCGA-AR-A0TY-01A-12R-A115-07	7fe47d2c-6b7d-4fa3-8e22-14fdb2b44920	7fe47d2c-6b7d-4fa3-8e22-14fdb2b44920	TCGA-AR-A0TY-01A-12D-A111-01	TCGA-AR-A0TY-01	TCGA-AR-A0TY-01	TCGA-AR-A0TY-01A-12D-A112-05	1614a21e-1cc6-430a-a5da-c2a15e4542b2	
TCGA-AR-A0TZ-01	Stage III	43	5	No_Conversion	1313		Positive	FEMALE	Negative	4	3	4	Negative	M0	Positive	N2	1313	0	LumA	Luminal B	Positive	ReacII	-10	-3	enrollment	T_Other	T2	LIVING	1	TCGA-AR-A0TZ-01	3262	1	Kirc+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-AR-A0TZ	1313	1	3262	Breast	TCGA Breast Cancer	breast invasive carcinoma					43	Left Upper Outer Quadrant			TCGA-AR-A0TZ-F49471		Positive					Positive	Modified Radical Mastectomy					-15720	2239	3262	0	2316			1313					Bone			Scheduled Follow-up Submission	2013-10-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	290	NO	Equivocal	Negative	NO	30	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)		Negative	1+		Positive	70-79%									<10%		Positive	3	2				Bone	Distant Metastasis			YES	6		true	M1	N2	T2	Stage IIIA	TCGA-AR-A0TZ.48F86416-8304-479E-B477-7C37A2F951A2.pdf	0	0	0	0	0	0	0	0	0	0	40	40	60	60	70	70							YES		No			YES	Primary Tumor	01			YES	NO	YES	AR	Breast	A	DECEASED	2004	TCGA-AR-A0TZ-01A-12D-A099-09	TCGA-AR-A0TZ-01		TCGA-AR-A0TZ-01A-12R-A085-13	TCGA-AR-A0TZ-01A-12D-A099-09	5afd9456-59f9-44d4-ac7c-b086ef899105		TCGA-AR-A0TZ-01A-21-A13D-20	TCGA-AR-A0TZ-01A-12D-A099-09	1d6480da-a470-4726-8bc4-57fa30799a15	0509eaa2-2671-4c59-b98b-200a6132cede	TCGA-AR-A0TZ-01A-12D-A087-01	1d6480da-a470-4726-8bc4-57fa30799a15	TCGA-AR-A0TZ-01A-12D-A10P-05	TCGA-AR-A0TZ-01	TCGA-AR-A0TZ-01A-12R-A084-07	1d6480da-a470-4726-8bc4-57fa30799a15	1d6480da-a470-4726-8bc4-57fa30799a15	TCGA-AR-A0TZ-01A-12D-A087-01	TCGA-AR-A0TZ-01	TCGA-AR-A0TZ-01		0509eaa2-2671-4c59-b98b-200a6132cede	TCGA-AR-A0TZ-01A-12R-A085-13
TCGA-AR-A0U0-01	Stage II	73	1	No_Conversion	8		Negative	FEMALE	Negative				Negative	M0	Positive	N1	8	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0U0-01	1988	0	Squamous	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA basal-like c6	BRCA basal-like c8			mutation cluster 3	TCGA-AR-A0U0	1988	0	1988	Breast	TCGA Breast Cancer	breast invasive carcinoma					73	Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A0U0-F65068		Negative		0			Negative	Simple Mastectomy		YES			-26993	2289		0	1988											Scheduled Follow-up Submission	2014-9-18	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	370	NO			NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1									NO	0	2	true	M0	N1	T2	Stage IIB	TCGA-AR-A0U0.322BB8BB-100F-4838-9771-EAEE5A3B817A.pdf	2	0	1	0	2	5	1	0	2	0	11	10	85	85	85	70	TUMOR FREE								No			YES	Primary Tumor	01				NO	YES	AR	Breast	A	LIVING	2004	TCGA-AR-A0U0-01A-11D-A10G-09	TCGA-AR-A0U0-01			TCGA-AR-A0U0-01A-11D-A10G-09	4c67c3c8-cc93-4bb4-a8c6-76232335c00f	TCGA-AR-A0U0-01A-11D-A10G-09	TCGA-AR-A0U0-01A-21-A13D-20	TCGA-AR-A0U0-01A-11D-A10G-09	dea20128-b180-4da1-9da5-0f00bea3b1ab	0c2f9cdb-8c8f-4741-b98f-0d41ac50be83	TCGA-AR-A0U0-01A-11D-A107-01	dea20128-b180-4da1-9da5-0f00bea3b1ab	TCGA-AR-A0U0-01A-11D-A10A-05	TCGA-AR-A0U0-01	TCGA-AR-A0U0-01A-11R-A109-07	dea20128-b180-4da1-9da5-0f00bea3b1ab	dea20128-b180-4da1-9da5-0f00bea3b1ab	TCGA-AR-A0U0-01A-11D-A107-01	TCGA-AR-A0U0-01	TCGA-AR-A0U0-01		0c2f9cdb-8c8f-4741-b98f-0d41ac50be83	
TCGA-AR-A0U1-01	Stage II	36	1	No_Conversion	185		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	185	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0U1-01	3101	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6		miRNA cluster 13	cluster 6	mutation cluster 5	TCGA-AR-A0U1	3101	0	3101	Breast	TCGA Breast Cancer	breast invasive carcinoma					36	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A0U1-F49477		Negative		0			Negative	Other		NO			-13467	2301		0	3101											Scheduled Follow-up Submission	2013-10-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	300	NO	Negative			31	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	6								NO	1		true	M0	N1	T2	Stage IIB	TCGA-AR-A0U1.007C609A-7874-4E39-BC4D-1EA81F4722EA.pdf	2	0	2	0	2	5	1	0	15	0	23	55	60	40	60	70	TUMOR FREE						YES		No			YES	Primary Tumor	01	wide local excision		YES	NO	YES	AR	Breast	A	LIVING	2004	TCGA-AR-A0U1-01A-11D-A10Y-09		TCGA-AR-A0U1-01A-11R-A114-13	TCGA-AR-A0U1-01A-11R-A114-13		9b542860-aebc-49d8-a1a3-3f693c8b119a	TCGA-AR-A0U1-01A-11D-A10Y-09	TCGA-AR-A0U1-01A-21-A13C-20	TCGA-AR-A0U1-01A-11D-A10Y-09	3450eaab-777a-46ab-9d13-8e0783c4a686	aee2ca13-3b6a-4459-b42a-b6a3c3496927	TCGA-AR-A0U1-01A-11D-A111-01	3450eaab-777a-46ab-9d13-8e0783c4a686			TCGA-AR-A0U1-01A-11R-A115-07	3450eaab-777a-46ab-9d13-8e0783c4a686	3450eaab-777a-46ab-9d13-8e0783c4a686	TCGA-AR-A0U1-01A-11D-A111-01			TCGA-AR-A0U1-01A-11D-A112-05	aee2ca13-3b6a-4459-b42a-b6a3c3496927	
TCGA-AR-A0U2-01	Stage III	47	5	No_Conversion	1608	2551	Positive	FEMALE	Negative				Negative	M0	Positive	N2	2551	1	LumB	Luminal B	Positive	ReacII	-10	-5	enrollment	T_Other	T2	DECEASED	1	TCGA-AR-A0U2-01	2551	1	High	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	squamous c3	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AR-A0U2	1609	1	2551	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-AR-A0U2-F18483	Negative	Positive					Positive	Modified Radical Mastectomy		NO			-17390	2395	2551	0				1609				10-19%	Bone|Liver			Scheduled Follow-up Submission	2011-12-15	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	150	NO	Negative			16	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)		Negative	2+		Positive	70-79%			2.47				Negative				Negative	2	5				Bone	Distant Metastasis	Liver		YES	4	0	true	M0	N2	T2	Stage IIIA	TCGA-AR-A0U2.51F69645-9564-4257-A86E-3A574C27034F.pdf	0	0	0	0	0	0	0	0	0	0	10	20	90	80	85	90	WITH TUMOR								No			YES	Primary Tumor	01			YES	NO	YES	AR	Breast	A	DECEASED	2004	TCGA-AR-A0U2-01A-11D-A10G-09	TCGA-AR-A0U2-01		TCGA-AR-A0U2-01A-11R-A108-13	TCGA-AR-A0U2-01A-11D-A10G-09	bb541d0b-a4ba-482a-b4ff-427185e70239	TCGA-AR-A0U2-01A-11D-A10G-09	TCGA-AR-A0U2-01A-21-A13D-20	TCGA-AR-A0U2-01A-11D-A10G-09	45f011a1-cc58-47f8-9545-66c313441650	90cc0bf8-5e04-4c34-bc2d-7d9d3b98569c	TCGA-AR-A0U2-01A-11D-A107-01	45f011a1-cc58-47f8-9545-66c313441650	TCGA-AR-A0U2-01A-11D-A10A-05	TCGA-AR-A0U2-01	TCGA-AR-A0U2-01A-11R-A109-07	45f011a1-cc58-47f8-9545-66c313441650	45f011a1-cc58-47f8-9545-66c313441650	TCGA-AR-A0U2-01A-11D-A107-01	TCGA-AR-A0U2-01	TCGA-AR-A0U2-01		90cc0bf8-5e04-4c34-bc2d-7d9d3b98569c	TCGA-AR-A0U2-01A-11R-A108-13
TCGA-AR-A0U3-01	Stage II	59	4	No_Conversion	2263		Positive	FEMALE	Negative	4	3	4	Negative	M0	Positive	N1	2263	0	LumA	Luminal B	Positive	LumA/B	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0U3-01	3468	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 7	mutation cluster 5	TCGA-AR-A0U3	3468	0	3468	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A0U3-F49481		Positive					Positive	Other		NO			-21755			0	3468							10-19%				Scheduled Follow-up Submission	2013-10-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	7								NO	1			M0	N1	T2	Stage IIB																		TUMOR FREE						YES		No			YES	Primary Tumor	01	Wide local excision		YES	NO	YES	AR	Breast		LIVING	2004	TCGA-AR-A0U3-01A-11D-A10G-09	TCGA-AR-A0U3-01		TCGA-AR-A0U3-01A-11R-A108-13	TCGA-AR-A0U3-01A-11D-A10G-09	c5be7166-dd6f-422d-b420-ee73dc2675f4	TCGA-AR-A0U3-01A-11D-A10G-09	TCGA-AR-A0U3-01A-21-A13C-20	TCGA-AR-A0U3-01A-11D-A10G-09	b36b5a17-972f-442a-84a0-469099a619ec	c64f2c9b-e2e4-4a48-94e8-7f76569c8b7b	TCGA-AR-A0U3-01A-11D-A107-01	b36b5a17-972f-442a-84a0-469099a619ec	TCGA-AR-A0U3-01A-11D-A10A-05	TCGA-AR-A0U3-01	TCGA-AR-A0U3-01A-11R-A109-07	b36b5a17-972f-442a-84a0-469099a619ec	b36b5a17-972f-442a-84a0-469099a619ec	TCGA-AR-A0U3-01A-11D-A107-01	TCGA-AR-A0U3-01	TCGA-AR-A0U3-01		c64f2c9b-e2e4-4a48-94e8-7f76569c8b7b	TCGA-AR-A0U3-01A-11R-A108-13
TCGA-AR-A0U4-01	Stage II	54	1	No_Conversion	1627		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1627	0	Basal	Basal-like	Negative	ReacII	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0U4-01	2615	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	squamous c3	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 11	TCGA-AR-A0U4	2615	0	2615	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A0U4-F49483		Negative		0			Negative	Simple Mastectomy		NO			-19729	1517		0	2615											Scheduled Follow-up Submission	2013-10-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	530	NO	Negative			10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	5								NO	0		true	M0	N0	T2	Stage IIA	TCGA-AR-A0U4.6424BA69-DA2B-4CCD-ADDF-DB1BEDA11EBF.pdf	0	0	0	0	30	10	0	0	0	0	0	5	70	85	65	90	TUMOR FREE						YES		No			NO	Primary Tumor	01			YES	NO	YES	AR	Breast	A	LIVING	2006	TCGA-AR-A0U4-01A-11D-A117-09	TCGA-AR-A0U4-01		TCGA-AR-A0U4-01A-11R-A108-13		e4120a7f-41ff-4928-a173-0cb5f7fb8674		TCGA-AR-A0U4-01A-21-A13D-20	TCGA-AR-A0U4-01A-11D-A117-09	ee7156b6-f469-402c-8f63-f4c2f6913db1	753d28b1-7ff1-4211-beaf-6966e9ce0d18	TCGA-AR-A0U4-01A-11D-A107-01	ee7156b6-f469-402c-8f63-f4c2f6913db1	TCGA-AR-A0U4-01A-11D-A10A-05	TCGA-AR-A0U4-01	TCGA-AR-A0U4-01A-11R-A109-07	ee7156b6-f469-402c-8f63-f4c2f6913db1	ee7156b6-f469-402c-8f63-f4c2f6913db1	TCGA-AR-A0U4-01A-11D-A107-01	TCGA-AR-A0U4-01	TCGA-AR-A0U4-01		753d28b1-7ff1-4211-beaf-6966e9ce0d18	TCGA-AR-A0U4-01A-11R-A108-13
TCGA-AR-A1AH-01	Stage II	51	1	Stage IIB	2298		Positive	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	2298	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A1AH-01	2298	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AR-A1AH	1136	1	2298	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Right Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-AR-A1AH-F21695		Positive					Negative	Other					-18991	2368		0	2298			1136				10-19%				Scheduled Follow-up Submission	2012-2-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	140	NO	Negative			9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5				Other, specify	New Primary Tumor	Renal		YES	1		true	M0	N1	T2	Stage IIB	TCGA-AR-A1AH.75F29A17-B6AF-43B9-BE12-3ABF850F23BA.pdf		0		0		0		0		0		0		100		95	TUMOR FREE							YES	No			NO	Primary Tumor	01	Total Mastectomy	6th	YES	NO	YES	AR	Breast	A	LIVING	2004	TCGA-AR-A1AH-01A-11D-A12B-09	TCGA-AR-A1AH-01	TCGA-AR-A1AH-01A-11R-A12C-13	TCGA-AR-A1AH-01A-11R-A12C-13	TCGA-AR-A1AH-01A-11D-A12B-09	180cde2e-13d3-462d-bba2-ae37bdee0f3f	TCGA-AR-A1AH-01A-11D-A12B-09	TCGA-AR-A1AH-01A-21-A13E-20	TCGA-AR-A1AH-01A-11D-A12B-09	ff0d7627-cec2-42e7-891b-cba5f42e3272	1d7e40a7-9af9-45db-9586-9f8a3f6a1824	TCGA-AR-A1AH-01A-11D-A12A-01	ff0d7627-cec2-42e7-891b-cba5f42e3272		TCGA-AR-A1AH-01	TCGA-AR-A1AH-01A-11R-A12D-07	ff0d7627-cec2-42e7-891b-cba5f42e3272	ff0d7627-cec2-42e7-891b-cba5f42e3272	TCGA-AR-A1AH-01A-11D-A12A-01	TCGA-AR-A1AH-01	TCGA-AR-A1AH-01	TCGA-AR-A1AH-01A-11D-A12E-05	1d7e40a7-9af9-45db-9586-9f8a3f6a1824	
TCGA-AR-A1AI-01	Stage II	47	1	Stage IIA	1881		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1881	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A1AI-01	1881	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AR-A1AI	588	1	1881	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AI-F22164		Negative					Negative	Simple Mastectomy		YES			-17229	1939		0	1881			588								Scheduled Follow-up Submission	2012-3-1	FEMALE					2+					Medullary Carcinoma		No		C50.9	8510/3	C50.4		YES		Fine needle aspiration biopsy	1050	NO	Equivocal	Negative		5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3				Other, specify	New Primary Tumor	Contralateral Breast		YES	0		true	M0	N0	T2	Stage IIA	TCGA-AR-A1AI.F5CAE962-5347-46FA-86EE-169121BED547.pdf		0		0		0		0		0		0		100		95	TUMOR FREE							YES	No			NO	Primary Tumor	01		6th	YES	NO	YES	AR	Breast	A	LIVING	2005	TCGA-AR-A1AI-01A-11D-A12Q-09	TCGA-AR-A1AI-01	TCGA-AR-A1AI-01A-11R-A12O-13	TCGA-AR-A1AI-01A-11R-A12O-13	TCGA-AR-A1AI-01A-11D-A12Q-09	d872badb-8c24-48fe-b482-6b3c262a4259	TCGA-AR-A1AI-01A-11D-A12Q-09	TCGA-AR-A1AI-01A-21-A13E-20	TCGA-AR-A1AI-01A-11D-A12Q-09	52ff562f-6a13-435a-acab-16a064633b1d	68564280-daf0-4bbb-9aa0-79493b39231b	TCGA-AR-A1AI-01A-11D-A12N-01	52ff562f-6a13-435a-acab-16a064633b1d	TCGA-AR-A1AI-01A-11D-A12R-05	TCGA-AR-A1AI-01	TCGA-AR-A1AI-01A-11R-A12P-07	52ff562f-6a13-435a-acab-16a064633b1d	52ff562f-6a13-435a-acab-16a064633b1d	TCGA-AR-A1AI-01A-11D-A12N-01	TCGA-AR-A1AI-01	TCGA-AR-A1AI-01		68564280-daf0-4bbb-9aa0-79493b39231b	
TCGA-AR-A1AJ-01	Stage I	83	3	Stage I	1604		Positive	FEMALE	Negative	1	2	2	Negative	M0	Negative	N0	1604	0	Basal	Basal-like	Negative	ReacI	-13	-12	enrollment	T1	T1	LIVING	0	TCGA-AR-A1AJ-01	1605	0	High	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AR-A1AJ	1605	0	1605	Breast	TCGA Breast Cancer	breast invasive carcinoma					83	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AJ-F21724		Positive					Negative	Other		YES			-30489	1828		0	1605							10-19%				Scheduled Follow-up Submission	2012-2-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Negative			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4								NO	0		true	M0	N0	T1	Stage I	TCGA-AR-A1AJ.0DEAC35F-8B73-4A9F-B7FA-2F501B736B0E.pdf		0		0		0		0		0		20		80		65	TUMOR FREE							YES	No			YES	Primary Tumor	01	Wide local excision	6th	NO	NO	YES	AR	Breast	A	LIVING	2005	TCGA-AR-A1AJ-01A-21D-A12Q-09	TCGA-AR-A1AJ-01	TCGA-AR-A1AJ-01A-21R-A12O-13	TCGA-AR-A1AJ-01A-21R-A12O-13	TCGA-AR-A1AJ-01A-21D-A12Q-09	26cb824a-251d-4b4c-a00c-19de6d7e2562	TCGA-AR-A1AJ-01A-21D-A12Q-09	TCGA-AR-A1AJ-01A-31-A13E-20	TCGA-AR-A1AJ-01A-21D-A12Q-09	98703904-572d-4220-b959-a1293a2e1c33	146bbf8b-4047-4e89-9463-abba54e8d992	TCGA-AR-A1AJ-01A-21D-A12N-01	98703904-572d-4220-b959-a1293a2e1c33	TCGA-AR-A1AJ-01A-21D-A12R-05	TCGA-AR-A1AJ-01	TCGA-AR-A1AJ-01A-21R-A12P-07	98703904-572d-4220-b959-a1293a2e1c33	98703904-572d-4220-b959-a1293a2e1c33	TCGA-AR-A1AJ-01A-21D-A12N-01	TCGA-AR-A1AJ-01	TCGA-AR-A1AJ-01		146bbf8b-4047-4e89-9463-abba54e8d992	
TCGA-AR-A1AK-01	Stage I	70	3	Stage I	1558		Positive	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	1558	0	LumA	Luminal A	Positive	ReacI	-5	0	enrollment	T1	T1	LIVING	0	TCGA-AR-A1AK-01	1559	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AR-A1AK	1559	0	1559	Breast	TCGA Breast Cancer	breast invasive carcinoma					70	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AK-F22154		Positive					Positive	Simple Mastectomy		YES			-25825			0	1559							10-19%				Scheduled Follow-up Submission	2012-3-1	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Negative			5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	0			M0	N0	T1	Stage I																		TUMOR FREE							YES	No	10-19%		NO	Primary Tumor	01		6th	YES	NO	YES	AR	Breast		LIVING	2006	TCGA-AR-A1AK-01A-21D-A12Q-09	TCGA-AR-A1AK-01	TCGA-AR-A1AK-01A-21R-A12O-13	TCGA-AR-A1AK-01A-21R-A12O-13	TCGA-AR-A1AK-01A-21D-A12Q-09	f0e4daf7-c2e8-40e8-826e-1cb9df14327e	TCGA-AR-A1AK-01A-21D-A12Q-09	TCGA-AR-A1AK-01A-31-A13E-20	TCGA-AR-A1AK-01A-21D-A12Q-09	a3568fd6-4b6d-4507-9c59-1788834d3a75	a972d2c7-e885-4dfe-b56c-d0468d154419	TCGA-AR-A1AK-01A-21D-A12N-01	a3568fd6-4b6d-4507-9c59-1788834d3a75	TCGA-AR-A1AK-01A-21D-A12R-05	TCGA-AR-A1AK-01	TCGA-AR-A1AK-01A-21R-A12P-07	a3568fd6-4b6d-4507-9c59-1788834d3a75	a3568fd6-4b6d-4507-9c59-1788834d3a75	TCGA-AR-A1AK-01A-21D-A12N-01	TCGA-AR-A1AK-01	TCGA-AR-A1AK-01		a972d2c7-e885-4dfe-b56c-d0468d154419	
TCGA-AR-A1AL-01	Stage III	60	2	Stage IIIA	1485		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N1	1485	0	LumA	Luminal A	Positive	ReacI	-4	0	enrollment	T_Other	T3	LIVING	0	TCGA-AR-A1AL-01	1485	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation cluster 1	TCGA-AR-A1AL	1485	0	1485	Breast	TCGA Breast Cancer	breast invasive carcinoma					60	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AL-F22156		Positive					Positive	Simple Mastectomy		YES			-22023	1528		0	1485							70-79%				Scheduled Follow-up Submission	2012-3-1	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.8		YES		Core needle biopsy	630	NO	Negative			15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6								NO	3		true	M0	N1	T3	Stage IIIA	TCGA-AR-A1AL.E3D44C6B-4497-4212-8CA1-AC9444B4CC54.pdf		0		0		0		0		5		10		85		80	TUMOR FREE							YES	No	70-79%		YES	Primary Tumor	01		6th	YES	NO	YES	AR	Breast	A	LIVING	2006	TCGA-AR-A1AL-01A-21D-A12Q-09	TCGA-AR-A1AL-01	TCGA-AR-A1AL-01A-21R-A12O-13	TCGA-AR-A1AL-01A-21R-A12O-13	TCGA-AR-A1AL-01A-21D-A12Q-09	12c1530b-8aaf-4eb5-bda4-5d3225242d79	TCGA-AR-A1AL-01A-21D-A12Q-09	TCGA-AR-A1AL-01A-31-A13E-20	TCGA-AR-A1AL-01A-21D-A12Q-09	ad602633-fdd7-4bf1-b3ac-e1c8e0a02934	9c918c56-fd45-443d-8137-00685de9f0c3	TCGA-AR-A1AL-01A-21D-A12N-01	ad602633-fdd7-4bf1-b3ac-e1c8e0a02934	TCGA-AR-A1AL-01A-21D-A12R-05	TCGA-AR-A1AL-01	TCGA-AR-A1AL-01A-21R-A12P-07	ad602633-fdd7-4bf1-b3ac-e1c8e0a02934	ad602633-fdd7-4bf1-b3ac-e1c8e0a02934	TCGA-AR-A1AL-01A-21D-A12N-01	TCGA-AR-A1AL-01	TCGA-AR-A1AL-01		9c918c56-fd45-443d-8137-00685de9f0c3	
TCGA-AR-A1AM-01																													0	TCGA-AR-A1AM-01	1903	0	Iq			BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 4			TCGA-AR-A1AM	1903	0	1903	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Right Upper Outer Quadrant			TCGA-AR-A1AM-F36898		Positive					Positive	Simple Mastectomy					-19123			0	1903												2012-11-20	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES		Core needle biopsy			Equivocal	Negative	NO	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1			M0	N1	T3	Stage IIIA																								YES	YES	No			NO	Primary Tumor	01		6th		NO	YES	AR	Breast		LIVING	2006			TCGA-AR-A1AM-01A-41R-A22I-13	TCGA-AR-A1AM-01A-41R-A22I-13			TCGA-AR-A1AM-01A-41D-A228-09	TCGA-AR-A1AM-01A-31-A24A-20		a58de230-f177-4c58-95ec-55b6edb08452	e08e1eac-89df-42a3-b202-2280c39146d5	TCGA-AR-A1AM-01A-41D-A227-01	a58de230-f177-4c58-95ec-55b6edb08452	TCGA-AR-A1AM-01A-41D-A22B-05	TCGA-AR-A1AM-01		a58de230-f177-4c58-95ec-55b6edb08452	a58de230-f177-4c58-95ec-55b6edb08452	TCGA-AR-A1AM-01A-41D-A227-01		TCGA-AR-A1AM-01		e08e1eac-89df-42a3-b202-2280c39146d5	
TCGA-AR-A1AN-01	Stage II	46	1	Stage IIA	1329		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1329	0	LumA	Luminal A	Positive		-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A1AN-01	1330	0	High	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 7	cluster 6	mutation cluster 5	TCGA-AR-A1AN	1330	0	1330	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AN-F21986		Positive					Positive	Other		YES			-16974	1463		0	1330							70-79%				Scheduled Follow-up Submission	2012-2-28	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	70	NO	Negative			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	6								NO	0		true	M0	N0	T2	Stage IIA	TCGA-AR-A1AN.DA251274-7966-4F48-A02F-393ABBDAB4E9.pdf		0		0		0		0		0		25		75		80	TUMOR FREE							YES	No	70-79%		YES	Primary Tumor	01	Wide Local Excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2006	TCGA-AR-A1AN-01A-11D-A12Q-09	TCGA-AR-A1AN-01	TCGA-AR-A1AN-01A-11R-A12O-13	TCGA-AR-A1AN-01A-11R-A12O-13	TCGA-AR-A1AN-01A-11D-A12Q-09		TCGA-AR-A1AN-01A-11D-A12Q-09		TCGA-AR-A1AN-01A-11D-A12Q-09	9046caf3-bbfe-4554-b9d2-11b333ad7704	cc0c2c46-bf0a-4a5d-b441-55037838b7d5	TCGA-AR-A1AN-01A-11D-A12N-01	9046caf3-bbfe-4554-b9d2-11b333ad7704	TCGA-AR-A1AN-01A-11D-A12R-05	TCGA-AR-A1AN-01	TCGA-AR-A1AN-01A-11R-A12P-07	9046caf3-bbfe-4554-b9d2-11b333ad7704	9046caf3-bbfe-4554-b9d2-11b333ad7704	TCGA-AR-A1AN-01A-11D-A12N-01	TCGA-AR-A1AN-01	TCGA-AR-A1AN-01		cc0c2c46-bf0a-4a5d-b441-55037838b7d5	
TCGA-AR-A1AO-01	Stage II	47	1	Stage IIA	1324		Positive	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	1324	0	Normal	Normal-like	Negative	Basal	-5	-8	enrollment	T1	T1	LIVING	0	TCGA-AR-A1AO-01	1325	0	Quiet	C3-BRCA/Luminal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AR-A1AO	1325	0	1325	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AO-F21756		Positive					Negative	Other		YES			-17332	1471		0	1325											Scheduled Follow-up Submission	2012-2-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Negative			39	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	4								NO	2		true	M0	N1	T1	Stage IIA	TCGA-AR-A1AO.37EF1828-0A53-4358-97C7-A7849EC653AF.pdf		0		0		2		0		8		10		80		80	TUMOR FREE							YES	No			YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2006	TCGA-AR-A1AO-01A-11D-A12Q-09	TCGA-AR-A1AO-01	TCGA-AR-A1AO-01A-11R-A12O-13	TCGA-AR-A1AO-01A-11R-A12O-13	TCGA-AR-A1AO-01A-11D-A12Q-09	310b6320-7ad9-4977-9c23-e80e0500e94c	TCGA-AR-A1AO-01A-11D-A12Q-09	TCGA-AR-A1AO-01A-21-A13E-20	TCGA-AR-A1AO-01A-11D-A12Q-09	56183330-0700-46d7-b45f-6d915ae587fa	e18c22cb-6ef7-44c4-8bca-a3d70a3be9ed	TCGA-AR-A1AO-01A-11D-A12N-01	56183330-0700-46d7-b45f-6d915ae587fa	TCGA-AR-A1AO-01A-11D-A12R-05	TCGA-AR-A1AO-01	TCGA-AR-A1AO-01A-11R-A12P-07	56183330-0700-46d7-b45f-6d915ae587fa	56183330-0700-46d7-b45f-6d915ae587fa	TCGA-AR-A1AO-01A-11D-A12N-01	TCGA-AR-A1AO-01	TCGA-AR-A1AO-01		e18c22cb-6ef7-44c4-8bca-a3d70a3be9ed	
TCGA-AR-A1AP-01	Stage I	80	2	Stage I	1215		Positive	FEMALE	Negative	1	3	3	Negative	M0	Negative	N0	1215	0	LumA	Luminal A	Positive	LumA/B	0	0	enrollment	T1	T1	LIVING	0	TCGA-AR-A1AP-01	1216	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AR-A1AP	1216	0	1216	Breast	TCGA Breast Cancer	breast invasive carcinoma					80	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AP-F21792	Negative	Positive				Mastectomy NOS	Positive	Other		YES			-29406	1450		0	1216							70-79%				Scheduled Follow-up Submission	2012-2-27	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	310	NO	Equivocal	Negative		1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	0		true	M0	N0	T1	Stage I	TCGA-AR-A1AP.0BFF09DE-6F36-4F68-AC13-8BC16AA0DCBE.pdf		0		0		0		0		5		0		95		90	TUMOR FREE							YES	No	<10%		NO	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2007	TCGA-AR-A1AP-01A-11D-A12Q-09	TCGA-AR-A1AP-01	TCGA-AR-A1AP-01A-11R-A12O-13	TCGA-AR-A1AP-01A-11R-A12O-13	TCGA-AR-A1AP-01A-11D-A12Q-09	07e57b56-5370-4a69-86e4-cdd0955d371b	TCGA-AR-A1AP-01A-11D-A12Q-09	TCGA-AR-A1AP-01A-21-A13E-20	TCGA-AR-A1AP-01A-11D-A12Q-09	8b0f1897-20d8-492d-9ea9-22f771bbae9d	81e9397d-c246-4d14-a6e9-f3e068e8c43f	TCGA-AR-A1AP-01A-11D-A12N-01	8b0f1897-20d8-492d-9ea9-22f771bbae9d	TCGA-AR-A1AP-01A-11D-A12R-05	TCGA-AR-A1AP-01	TCGA-AR-A1AP-01A-11R-A12P-07	8b0f1897-20d8-492d-9ea9-22f771bbae9d	8b0f1897-20d8-492d-9ea9-22f771bbae9d	TCGA-AR-A1AP-01A-11D-A12N-01	TCGA-AR-A1AP-01	TCGA-AR-A1AP-01		81e9397d-c246-4d14-a6e9-f3e068e8c43f	
TCGA-AR-A1AQ-01	Stage II	49	1	Stage IIA	1309		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1309	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A1AQ-01	1310	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AR-A1AQ	1310	0	1310	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Right Upper Inner Quadrant|Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AQ-F21801		Negative					Negative	Other		YES			-18109	1424		0	1310											Scheduled Follow-up Submission	2012-2-27	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	180	NO	Equivocal	Negative		6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3								NO	0		true	M0	N0	T2	Stage IIA	TCGA-AR-A1AQ.FC236604-AAE5-4394-9D39-270FFEFB635A.pdf		0		0		0		0		0		0		100		93	TUMOR FREE							YES	No			YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2007	TCGA-AR-A1AQ-01A-11D-A12Q-09	TCGA-AR-A1AQ-01	TCGA-AR-A1AQ-01A-11R-A12O-13	TCGA-AR-A1AQ-01A-11R-A12O-13	TCGA-AR-A1AQ-01A-11D-A12Q-09	23358473-9909-47ff-b683-d046e292d504	TCGA-AR-A1AQ-01A-11D-A12Q-09	TCGA-AR-A1AQ-01A-21-A13E-20	TCGA-AR-A1AQ-01A-11D-A12Q-09	747f56be-2fdd-4eb8-99a7-34afd923d8e1	ffbdf887-0c9a-40c0-971a-61eb2bb70e2a	TCGA-AR-A1AQ-01A-11D-A12N-01	747f56be-2fdd-4eb8-99a7-34afd923d8e1	TCGA-AR-A1AQ-01A-11D-A12R-05	TCGA-AR-A1AQ-01	TCGA-AR-A1AQ-01A-11R-A12P-07	747f56be-2fdd-4eb8-99a7-34afd923d8e1	747f56be-2fdd-4eb8-99a7-34afd923d8e1	TCGA-AR-A1AQ-01A-11D-A12N-01	TCGA-AR-A1AQ-01	TCGA-AR-A1AQ-01		ffbdf887-0c9a-40c0-971a-61eb2bb70e2a	
TCGA-AR-A1AR-01	Stage III	50	1	Stage IIIA		523	Negative	FEMALE	Negative				Negative	M0	Positive	N2	523	1	Basal	Basal-like	Negative		-13	0	enrollment	T1	T1	DECEASED	1	TCGA-AR-A1AR-01	524	1	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-AR-A1AR	268	1	524	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-AR-A1AR-F21816		Negative					Negative	Lumpectomy					-18482	1416	524	0				268								Scheduled Follow-up Submission	2012-2-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	250	NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5				Other, specify	New Primary Tumor	Breast		YES	5		true	M0	N2	T1	Stage IIIA	TCGA-AR-A1AR.747FB91B-F523-4FA0-91DD-6014EF55643D.pdf		0		0		0		0		0		20		80		90	WITH TUMOR								Yes			YES	Primary Tumor	01		6th	YES	NO	YES	AR	Breast	A	DECEASED	2007	TCGA-AR-A1AR-01A-31D-A135-09	TCGA-AR-A1AR-01	TCGA-AR-A1AR-01A-31R-A136-13	TCGA-AR-A1AR-01A-31R-A136-13	TCGA-AR-A1AR-01A-31D-A135-09		TCGA-AR-A1AR-01A-31D-A135-09		TCGA-AR-A1AR-01A-31D-A135-09	6d066a72-f59f-45a8-ab90-216000b36da4	c7976361-e689-44f1-9e5a-2a07064f2f95	TCGA-AR-A1AR-01A-31D-A134-01	6d066a72-f59f-45a8-ab90-216000b36da4	TCGA-AR-A1AR-01A-31D-A138-05	TCGA-AR-A1AR-01	TCGA-AR-A1AR-01A-31R-A137-07	6d066a72-f59f-45a8-ab90-216000b36da4	6d066a72-f59f-45a8-ab90-216000b36da4	TCGA-AR-A1AR-01A-31D-A134-01	TCGA-AR-A1AR-01	TCGA-AR-A1AR-01		c7976361-e689-44f1-9e5a-2a07064f2f95	
TCGA-AR-A1AS-01	Stage II	54	3	Stage IIB	1242		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	1242	0	LumA	Luminal A	Positive	LumA	-7	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A1AS-01	1150	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-AR-A1AS	1150	0	1150	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-AR-A1AS-F49470		Positive					Positive	Other					-20028	1331		0	1150							70-79%				Scheduled Follow-up Submission	2013-10-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	300	NO	Negative		NO	17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4								NO	1		true	M0	N1	T2	Stage IIB	TCGA-AR-A1AS.180AA688-0B63-4DD9-BA29-708E80FBC4C9.pdf		0		0		0		0		0		0		100		90	TUMOR FREE						NO	YES	No	70-79%		YES	Primary Tumor	01	Wide local excision	6th	NO	NO	YES	AR	Breast	A	LIVING	2007	TCGA-AR-A1AS-01A-11D-A12Q-09	TCGA-AR-A1AS-01	TCGA-AR-A1AS-01A-11R-A12O-13	TCGA-AR-A1AS-01A-11R-A12O-13	TCGA-AR-A1AS-01A-11D-A12Q-09	0db7dee4-ca2e-4f47-a9bc-5e55ca0df269	TCGA-AR-A1AS-01A-11D-A12Q-09	TCGA-AR-A1AS-01A-21-A13E-20	TCGA-AR-A1AS-01A-11D-A12Q-09	e7b64cc3-9b2b-4938-9896-84b640d1586f	8fcff679-66ba-4348-93ed-eb7166302c3e	TCGA-AR-A1AS-01A-11D-A12N-01	e7b64cc3-9b2b-4938-9896-84b640d1586f	TCGA-AR-A1AS-01A-11D-A12R-05	TCGA-AR-A1AS-01	TCGA-AR-A1AS-01A-11R-A12P-07	e7b64cc3-9b2b-4938-9896-84b640d1586f	e7b64cc3-9b2b-4938-9896-84b640d1586f	TCGA-AR-A1AS-01A-11D-A12N-01	TCGA-AR-A1AS-01	TCGA-AR-A1AS-01		8fcff679-66ba-4348-93ed-eb7166302c3e	
TCGA-AR-A1AT-01	Stage II	62		Stage IIA		1272	Positive	FEMALE	Positive				Negative	M0	Negative	N0	1272	1		HER2-enriched	Positive	Her2	-11	-5	enrollment	T_Other	T2	DECEASED	1	TCGA-AR-A1AT-01	1272	1			cluster 1	BRCA CIMP c7	BRCA basal-like c6		miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AR-A1AT	1272	0	1272	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AT-F22148		Positive					Positive	Other		YES			-22942	1339	1272	0								<10%				Scheduled Follow-up Submission	2012-3-1	FEMALE					3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	250	NO	Positive			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	1		true	M0	N0	T2	Stage IIA	TCGA-AR-A1AT.D52A6E4B-C80A-4947-96FE-3295E418EC67.pdf		40		20		15		20		0		15		70		70								YES	No	<10%		YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	DECEASED	2007	TCGA-AR-A1AT-01A-11D-A12Q-09		TCGA-AR-A1AT-01A-11R-A12O-13	TCGA-AR-A1AT-01A-11R-A12O-13		6605222f-3dc9-4a93-987e-a8720dc38b32	TCGA-AR-A1AT-01A-11D-A12Q-09	TCGA-AR-A1AT-01A-21-A13E-20	TCGA-AR-A1AT-01A-11D-A12Q-09	e70e1882-b4be-4ed6-9c2d-4e8c84fde633			e70e1882-b4be-4ed6-9c2d-4e8c84fde633	TCGA-AR-A1AT-01A-11D-A12R-05	TCGA-AR-A1AT-01	TCGA-AR-A1AT-01A-11R-A12P-07	e70e1882-b4be-4ed6-9c2d-4e8c84fde633	e70e1882-b4be-4ed6-9c2d-4e8c84fde633		TCGA-AR-A1AT-01				
TCGA-AR-A1AU-01	Stage III	39	4	Stage IIIA	1409		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N2	1409	0	LumA	Luminal A	Positive	ReacI	-3	-7	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A1AU-01	2318	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-AR-A1AU	2318	0	2318	Breast	TCGA Breast Cancer	breast invasive carcinoma					39	Right Upper Inner Quadrant|Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AU-F49472		Positive					Positive	Other					-14564	1317		0	2318							70-79%				Scheduled Follow-up Submission	2013-10-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	260	NO	Equivocal	Negative	NO	37	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6								NO	4		true	M0	N2	T2	Stage IIIA	TCGA-AR-A1AU.5654FC27-47D3-4C7F-A0E7-A5B6140991C2.pdf		40		20		0		20		0		20		80		80	TUMOR FREE						YES	YES	No	70-79%		YES	Primary Tumor	01	Total Mastectomy	6th	YES	NO	YES	AR	Breast	A	LIVING	2007	TCGA-AR-A1AU-01A-11D-A12Q-09	TCGA-AR-A1AU-01	TCGA-AR-A1AU-01A-11R-A12O-13	TCGA-AR-A1AU-01A-11R-A12O-13	TCGA-AR-A1AU-01A-11D-A12Q-09	48cc7955-160a-4e19-aafc-4fad203a9082	TCGA-AR-A1AU-01A-11D-A12Q-09	TCGA-AR-A1AU-01A-21-A13E-20	TCGA-AR-A1AU-01A-11D-A12Q-09	bb07b646-1dcc-4cf5-9aae-1df150e84a84	3830d91c-48eb-4f67-9db9-1a4ff4b28c92	TCGA-AR-A1AU-01A-11D-A12N-01	bb07b646-1dcc-4cf5-9aae-1df150e84a84	TCGA-AR-A1AU-01A-11D-A12R-05	TCGA-AR-A1AU-01	TCGA-AR-A1AU-01A-11R-A12P-07	bb07b646-1dcc-4cf5-9aae-1df150e84a84	bb07b646-1dcc-4cf5-9aae-1df150e84a84	TCGA-AR-A1AU-01A-11D-A12N-01	TCGA-AR-A1AU-01	TCGA-AR-A1AU-01		3830d91c-48eb-4f67-9db9-1a4ff4b28c92	
TCGA-AR-A1AV-01	Stage II	68	3	Stage IIB	1295		Positive	MALE	Negative	4	5	4	Negative	M0	Positive	N1	1295	0	LumA	Luminal B	Positive	LumA/B	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A1AV-01	1864	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-AR-A1AV	1864	0	1864	Breast	TCGA Breast Cancer	breast invasive carcinoma					68	Left	Axillary lymph node dissection alone		TCGA-AR-A1AV-F49475		Positive					Positive	Modified Radical Mastectomy					-24875	1233		0	1864							70-79%				Scheduled Follow-up Submission	2013-10-2	MALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	420	NO	Negative		NO	25	Negative																			3	7								NO	1		true	M0	N1	T2	Stage IIB	TCGA-AR-A1AV.5AD5B38F-5CC1-4A2F-96E6-F344D8FE0149.pdf		40		20		10		20		0		30		60		60	TUMOR FREE						YES	YES	No	70-79%		YES	Primary Tumor	01		6th	YES	NO	YES	AR	Breast	A	LIVING	2007	TCGA-AR-A1AV-01A-21D-A12Q-09	TCGA-AR-A1AV-01	TCGA-AR-A1AV-01A-21R-A12O-13	TCGA-AR-A1AV-01A-21R-A12O-13	TCGA-AR-A1AV-01A-21D-A12Q-09	9432773f-696b-4104-9232-c6e6a6a379c2	TCGA-AR-A1AV-01A-21D-A12Q-09	TCGA-AR-A1AV-01A-31-A13E-20	TCGA-AR-A1AV-01A-21D-A12Q-09	dddfaed8-0d0e-42ba-9add-fae3cc1e5a9a	135f0af7-da27-4a64-b7a5-16c0eaa1df7a	TCGA-AR-A1AV-01A-21D-A12N-01	dddfaed8-0d0e-42ba-9add-fae3cc1e5a9a	TCGA-AR-A1AV-01A-21D-A12R-05	TCGA-AR-A1AV-01	TCGA-AR-A1AV-01A-21R-A12P-07	dddfaed8-0d0e-42ba-9add-fae3cc1e5a9a	dddfaed8-0d0e-42ba-9add-fae3cc1e5a9a	TCGA-AR-A1AV-01A-21D-A12N-01	TCGA-AR-A1AV-01	TCGA-AR-A1AV-01		135f0af7-da27-4a64-b7a5-16c0eaa1df7a	
TCGA-AR-A1AW-01	Stage II	65	3	Stage IIA	1072		Positive	FEMALE	Negative	2	2	3	Negative	M0	Negative	N0	1072	0	LumB	Luminal A	Positive	ReacII	-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A1AW-01	1935	0	High	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 3	TCGA-AR-A1AW	1935	0	1935	Breast	TCGA Breast Cancer	breast invasive carcinoma					65	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AW-F49478		Positive					Positive	Lumpectomy		YES			-23855	1157		0	1935							70-79%				Scheduled Follow-up Submission	2013-10-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES		Incisional Biopsy	800	NO	Equivocal	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	3								NO	0		true	M0	N0	T2	Stage IIA	TCGA-AR-A1AW.BB485405-199C-48C7-96D7-8C315DEA66B4.pdf		40		20		5		20		0		25		70		70	TUMOR FREE						YES	YES	No	70-79%		YES	Primary Tumor	01		6th	YES	NO	YES	AR	Breast	A	LIVING	2007	TCGA-AR-A1AW-01A-21D-A12Q-09	TCGA-AR-A1AW-01	TCGA-AR-A1AW-01A-21R-A12O-13	TCGA-AR-A1AW-01A-21R-A12O-13	TCGA-AR-A1AW-01A-21D-A12Q-09	15e9c25c-1736-4fed-9c7f-5a2f86ee7248	TCGA-AR-A1AW-01A-21D-A12Q-09	TCGA-AR-A1AW-01A-11-A13E-20	TCGA-AR-A1AW-01A-21D-A12Q-09	cff4a5bc-ba2b-47d6-8d36-6277ae991606	4fe5e02e-c89b-445d-8b84-8db10e210c86	TCGA-AR-A1AW-01A-21D-A12N-01	cff4a5bc-ba2b-47d6-8d36-6277ae991606	TCGA-AR-A1AW-01A-21D-A12R-05	TCGA-AR-A1AW-01	TCGA-AR-A1AW-01A-21R-A12P-07	cff4a5bc-ba2b-47d6-8d36-6277ae991606	cff4a5bc-ba2b-47d6-8d36-6277ae991606	TCGA-AR-A1AW-01A-21D-A12N-01	TCGA-AR-A1AW-01	TCGA-AR-A1AW-01		4fe5e02e-c89b-445d-8b84-8db10e210c86	
TCGA-AR-A1AX-01	Stage I	64	4	Stage I	1103		Positive	FEMALE	Positive	3	1	3	Negative	M0	Negative	N0	1103	0	LumA	Luminal A	Positive	ReacII	0	-5	enrollment	T1	T1	LIVING	0	TCGA-AR-A1AX-01	1890	0	Squamous	C5-KIRC	cluster 5	Low purity c2	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-AR-A1AX	1890	0	1890	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AX-F49480		Positive					Positive	Other		YES			-23507	1140		0	1890											Scheduled Follow-up Submission	2013-10-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	340	NO	Positive		NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	6								NO	0		true	M0	N0	T1	Stage I	TCGA-AR-A1AX.4FDBA110-6E14-428C-BF82-168AE28A14E4.pdf		40		20		0		20		0		30		70		70	TUMOR FREE						YES	YES	No	70-79%		YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2007	TCGA-AR-A1AX-01A-11D-A12Q-09	TCGA-AR-A1AX-01	TCGA-AR-A1AX-01A-11R-A12O-13	TCGA-AR-A1AX-01A-11R-A12O-13	TCGA-AR-A1AX-01A-11D-A12Q-09	f30b231a-6dd9-4ae5-a0d4-34056bcbd5f8	TCGA-AR-A1AX-01A-11D-A12Q-09	TCGA-AR-A1AX-01A-21-A13E-20	TCGA-AR-A1AX-01A-11D-A12Q-09	66626142-7c5c-4ed0-8ef0-f4133423f275	e79dcb48-5228-42e7-8b67-1e51a68796e6	TCGA-AR-A1AX-01A-11D-A12N-01	66626142-7c5c-4ed0-8ef0-f4133423f275	TCGA-AR-A1AX-01A-11D-A12R-05	TCGA-AR-A1AX-01	TCGA-AR-A1AX-01A-11R-A12P-07	66626142-7c5c-4ed0-8ef0-f4133423f275	66626142-7c5c-4ed0-8ef0-f4133423f275	TCGA-AR-A1AX-01A-11D-A12N-01	TCGA-AR-A1AX-01	TCGA-AR-A1AX-01		e79dcb48-5228-42e7-8b67-1e51a68796e6	
TCGA-AR-A1AY-01	Stage I	65	1	Stage I	614		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	614	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T1	T1	LIVING	0	TCGA-AR-A1AY-01	1026	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AR-A1AY	1026	0	1026	Breast	TCGA Breast Cancer	breast invasive carcinoma					65	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AY-F49482		Negative					Negative	Other		YES			-23927	1085		0	1026											Scheduled Follow-up Submission	2013-10-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	110	NO	Negative		NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5								NO	0		true	M0	N0	T1	Stage I	TCGA-AR-A1AY.01D97550-C616-4001-85A5-5502D35FA38E.pdf		40		20		0		20		0		20		80		80	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01	Wide Local Excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2008	TCGA-AR-A1AY-01A-21D-A12Q-09	TCGA-AR-A1AY-01	TCGA-AR-A1AY-01A-21R-A12O-13	TCGA-AR-A1AY-01A-21R-A12O-13	TCGA-AR-A1AY-01A-21D-A12Q-09	1815b916-4da0-4ada-9774-7231a10c6862	TCGA-AR-A1AY-01A-21D-A12Q-09	TCGA-AR-A1AY-01A-11-A13E-20	TCGA-AR-A1AY-01A-21D-A12Q-09	49c4166c-701a-4f53-8968-99aec3347214	dab4207f-5e33-4cbb-81af-b3f005c74c16	TCGA-AR-A1AY-01A-21D-A12N-01	49c4166c-701a-4f53-8968-99aec3347214	TCGA-AR-A1AY-01A-21D-A12R-05	TCGA-AR-A1AY-01	TCGA-AR-A1AY-01A-21R-A12P-07	49c4166c-701a-4f53-8968-99aec3347214	49c4166c-701a-4f53-8968-99aec3347214	TCGA-AR-A1AY-01A-21D-A12N-01	TCGA-AR-A1AY-01	TCGA-AR-A1AY-01		dab4207f-5e33-4cbb-81af-b3f005c74c16	
TCGA-AR-A24H-01	Stage II	65	2	Stage IIA	3333		Positive	FEMALE	Negative				Negative	M0	Negative	N0	3333	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A24H-01	4776	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 13		mutation c1uster 9	TCGA-AR-A24H	4776	0	4776	Breast	TCGA Breast Cancer	breast invasive carcinoma					65	Right Lower Inner Quadrant|Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24H-F49484		Positive					Positive	Other					-24046	3641		0	4776											Scheduled Follow-up Submission	2013-10-2	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	40	NO	Negative		NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	0		true	M0	N0	T2	Stage IIA	TCGA-AR-A24H.C373F2EE-C601-4E17-8E2D-D9BC6AC0301A.pdf		1		1		2		1		0		8		90		90	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01	Excision	5th	YES	NO	YES	AR	Breast	A	LIVING	2001	TCGA-AR-A24H-01A-11D-A167-09		TCGA-AR-A24H-01A-11R-A168-13	TCGA-AR-A24H-01A-11R-A168-13	TCGA-AR-A24H-01A-11D-A167-09		TCGA-AR-A24H-01A-11D-A167-09		TCGA-AR-A24H-01A-11D-A167-09	a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c	95021181-8971-4d62-acf9-9a7bd1b960f2	TCGA-AR-A24H-01A-11D-A166-01	a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c	TCGA-AR-A24H-01A-11D-A16A-05	TCGA-AR-A24H-01		a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c	a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c	TCGA-AR-A24H-01A-11D-A166-01		TCGA-AR-A24H-01		95021181-8971-4d62-acf9-9a7bd1b960f2	
TCGA-AR-A24K-01	Stage II	46	3	Stage IIA	1548		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1548	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A24K-01	1548	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13		mutation cluster 3	TCGA-AR-A24K	1548	0	1548	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24K-F49485		Positive					Positive	Other		YES			-16961	2325		0	1548						No value Given	10-19%				Scheduled Follow-up Submission	2013-10-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Equivocal	Negative	NO	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4									NO	0		true	M0	N0	T2	Stage IIA	TCGA-AR-A24K.BC7B3577-CA6C-41AD-98E2-89D357D29D37.pdf		3		1		0		1		0		25		75		75	TUMOR FREE						YES	YES	No	10-19%		YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2004	TCGA-AR-A24K-01A-11D-A167-09		TCGA-AR-A24K-01A-11R-A168-13	TCGA-AR-A24K-01A-11R-A168-13	TCGA-AR-A24K-01A-11D-A167-09		TCGA-AR-A24K-01A-11D-A167-09	TCGA-AR-A24K-01A-21-A17I-20	TCGA-AR-A24K-01A-11D-A167-09	e3008c10-aa31-40ef-ad50-77fd8ec7a1a9	51797bbf-7ed7-49ef-b23f-d3ba37a31ae6	TCGA-AR-A24K-01A-11D-A166-01	e3008c10-aa31-40ef-ad50-77fd8ec7a1a9	TCGA-AR-A24K-01A-11D-A16A-05	TCGA-AR-A24K-01		e3008c10-aa31-40ef-ad50-77fd8ec7a1a9	e3008c10-aa31-40ef-ad50-77fd8ec7a1a9	TCGA-AR-A24K-01A-11D-A166-01		TCGA-AR-A24K-01		51797bbf-7ed7-49ef-b23f-d3ba37a31ae6	
TCGA-AR-A24L-01	Stage II	26	5	Stage IIB	2221		Positive	FEMALE	Negative				Negative	M0	Positive	N1	2221	0	LumA		Positive				enrollment	T_Other	T2	LIVING	1	TCGA-AR-A24L-01	2866	1	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AR-A24L	1414	1	2866	Breast	TCGA Breast Cancer	breast invasive carcinoma					26	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24L-F49488		Positive					Positive	Other					-9706	2275	2866	0	2221			1414				10-19%				Scheduled Follow-up Submission	2013-10-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1250	NO	Equivocal	Negative	NO	12	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	4					Locoregional Disease			YES	2		true	M0	N1	T2	Stage IIB	TCGA-AR-A24L.BF82AD23-B40E-459F-83EC-590D392664FD.pdf		3		1		0		1		0		20		80		80	WITH TUMOR						YES	YES	No	10-19%		YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	DECEASED	2005	TCGA-AR-A24L-01A-11D-A167-09		TCGA-AR-A24L-01A-11R-A168-13	TCGA-AR-A24L-01A-11R-A168-13	TCGA-AR-A24L-01A-11D-A167-09		TCGA-AR-A24L-01A-11D-A167-09	TCGA-AR-A24L-01A-21-A17I-20	TCGA-AR-A24L-01A-11D-A167-09	bfa78a45-16bf-410a-816d-bd369ded91e5	0d02b005-05e4-4287-b451-40a4424d1a54	TCGA-AR-A24L-01A-11D-A166-01	bfa78a45-16bf-410a-816d-bd369ded91e5	TCGA-AR-A24L-01A-11D-A16A-05	TCGA-AR-A24L-01		bfa78a45-16bf-410a-816d-bd369ded91e5	bfa78a45-16bf-410a-816d-bd369ded91e5	TCGA-AR-A24L-01A-11D-A166-01		TCGA-AR-A24L-01		0d02b005-05e4-4287-b451-40a4424d1a54	
TCGA-AR-A24M-01	Stage III	38	3	Stage IIIA	1990		Positive	FEMALE	Negative				Negative	M0	Positive	N2	1990	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A24M-01	2947	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-AR-A24M	2947	0	2947	Breast	TCGA Breast Cancer	breast invasive carcinoma					38	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24M-F49489		Positive					Positive	Other					-14119	2245		0	2947							10-19%				Scheduled Follow-up Submission	2013-10-2	FEMALE					1+					Mixed Histology (please specify)	Mixed invasive ductal and invasive lobular	No		C50.9	8522/3	C50.9		YES		Core needle biopsy	400	NO	Negative		NO	28	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	7								NO	4		true	M0	N2	T2	Stage IIIA	TCGA-AR-A24M.56DFBCCE-A9D9-4F08-AC7E-33998F3439B2.pdf		4		1		0		1		2		23		75		75	TUMOR FREE						YES	YES	No	10-19%		YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2005	TCGA-AR-A24M-01A-11D-A167-09		TCGA-AR-A24M-01A-11R-A168-13	TCGA-AR-A24M-01A-11R-A168-13	TCGA-AR-A24M-01A-11D-A167-09		TCGA-AR-A24M-01A-11D-A167-09	TCGA-AR-A24M-01A-21-A17I-20	TCGA-AR-A24M-01A-11D-A167-09	4977200c-765d-475f-8df4-bf8d9a3b0aa9	071b569b-3b44-4a6b-ac2c-bbda7d13c501	TCGA-AR-A24M-01A-11D-A166-01	4977200c-765d-475f-8df4-bf8d9a3b0aa9	TCGA-AR-A24M-01A-11D-A16A-05	TCGA-AR-A24M-01		4977200c-765d-475f-8df4-bf8d9a3b0aa9	4977200c-765d-475f-8df4-bf8d9a3b0aa9	TCGA-AR-A24M-01A-11D-A166-01		TCGA-AR-A24M-01		071b569b-3b44-4a6b-ac2c-bbda7d13c501	
TCGA-AR-A24N-01	Stage I	54	2	Stage I	2074		Positive	FEMALE	Negative				Negative	M0	Negative	N0	2074	0	LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-AR-A24N-01	2388	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 3	mutation c1uster 9	TCGA-AR-A24N	2388	0	2388	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24N-F49491		Positive					Positive	Simple Mastectomy		YES			-19989	2219		0	2388							10-19%				Scheduled Follow-up Submission	2013-10-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	310	NO	Equivocal	Negative	NO	4	Negative	Peri (6-12 months since last menstrual period)																		3	3								NO	0		true	M0	N0	T1	Stage I	TCGA-AR-A24N.AAF32BB7-716A-4C0E-AE7E-04F6A5BF5628.pdf		2		1		1		1		0		14		85		85	TUMOR FREE						NO	YES	No	10-19%		NO	Primary Tumor	01		6th	NO	NO	YES	AR	Breast	A	LIVING	2005	TCGA-AR-A24N-01A-11D-A167-09		TCGA-AR-A24N-01A-11R-A168-13	TCGA-AR-A24N-01A-11R-A168-13	TCGA-AR-A24N-01A-11D-A167-09		TCGA-AR-A24N-01A-11D-A167-09	TCGA-AR-A24N-01A-21-A17I-20	TCGA-AR-A24N-01A-11D-A167-09	48bf0fa5-66c2-495d-93ef-943bc7ff31ac	27715ff1-8709-46a3-84c3-41b1ae9dbbc4	TCGA-AR-A24N-01A-11D-A166-01	48bf0fa5-66c2-495d-93ef-943bc7ff31ac	TCGA-AR-A24N-01A-11D-A16A-05	TCGA-AR-A24N-01		48bf0fa5-66c2-495d-93ef-943bc7ff31ac	48bf0fa5-66c2-495d-93ef-943bc7ff31ac	TCGA-AR-A24N-01A-11D-A166-01		TCGA-AR-A24N-01		27715ff1-8709-46a3-84c3-41b1ae9dbbc4	
TCGA-AR-A24O-01	Stage III	43	2	Stage IIIA	1997		Positive	FEMALE	Negative				Negative	M0	Positive	N2	1997	0	LumA		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-AR-A24O-01	2561	0	Squamous	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-AR-A24O	2561	1	2561	Breast	TCGA Breast Cancer	breast invasive carcinoma					43	Left			TCGA-AR-A24O-F49492	Negative	Positive				Mastectomy NOS	Positive	Modified Radical Mastectomy					-15977	2213		0	2561			2561								Scheduled Follow-up Submission	2013-10-2	FEMALE										Mixed Histology (please specify)	Lobular carcinoma with ductal features	No		C50.9	8522/3	C50.9		YES		Incisional Biopsy	700	NO	Negative		NO	19	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	7								YES	7		true	M0	N2	T3	Stage IIIA	TCGA-AR-A24O.887F0E3A-DC70-4CD4-AAAF-3C613195D895.pdf		2		1		0		1		3		17		80		80	WITH TUMOR						YES	YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	AR	Breast	A	LIVING	2005	TCGA-AR-A24O-01A-11D-A167-09		TCGA-AR-A24O-01A-11R-A168-13	TCGA-AR-A24O-01A-11R-A168-13	TCGA-AR-A24O-01A-11D-A167-09		TCGA-AR-A24O-01A-11D-A167-09	TCGA-AR-A24O-01A-21-A17I-20	TCGA-AR-A24O-01A-11D-A167-09	2cd8167d-d35f-43e8-927f-cd7decebd9cf	f4558e75-6fb7-4042-8b8b-589aacc8ff47	TCGA-AR-A24O-01A-11D-A166-01	2cd8167d-d35f-43e8-927f-cd7decebd9cf	TCGA-AR-A24O-01A-11D-A16A-05	TCGA-AR-A24O-01		2cd8167d-d35f-43e8-927f-cd7decebd9cf	2cd8167d-d35f-43e8-927f-cd7decebd9cf	TCGA-AR-A24O-01A-11D-A166-01		TCGA-AR-A24O-01		f4558e75-6fb7-4042-8b8b-589aacc8ff47	
TCGA-AR-A24P-01	Stage I	47	2	Stage I	26		Positive	FEMALE	Negative				Negative	M0	Negative	N0	26	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-AR-A24P-01	84	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-AR-A24P	84	0	84	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24P-F31403		Positive					Positive	Other		YES			-17490	2161		0	84							10-19%				Scheduled Follow-up Submission	2012-5-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO	Equivocal	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO	0		true	M0	N0	T1	Stage I	TCGA-AR-A24P.0BF7CB67-49F1-42EA-8B41-988BD7E0DE61.pdf		2		1		0		1		2		18		80		80								YES	No	10-19%			Primary Tumor	01	Wide local excision	6th		NO	YES	AR	Breast	A	LIVING	2005	TCGA-AR-A24P-01A-11D-A167-09		TCGA-AR-A24P-01A-11R-A168-13	TCGA-AR-A24P-01A-11R-A168-13	TCGA-AR-A24P-01A-11D-A167-09		TCGA-AR-A24P-01A-11D-A167-09	TCGA-AR-A24P-01A-21-A17I-20	TCGA-AR-A24P-01A-11D-A167-09	49bdbb64-75a8-4a30-bde6-57f3c2a38f9b	28b9b7dd-f419-4894-a629-eee1891015e1	TCGA-AR-A24P-01A-11D-A166-01	49bdbb64-75a8-4a30-bde6-57f3c2a38f9b	TCGA-AR-A24P-01A-11D-A16A-05	TCGA-AR-A24P-01		49bdbb64-75a8-4a30-bde6-57f3c2a38f9b	49bdbb64-75a8-4a30-bde6-57f3c2a38f9b	TCGA-AR-A24P-01A-11D-A166-01		TCGA-AR-A24P-01		28b9b7dd-f419-4894-a629-eee1891015e1	
TCGA-AR-A24Q-01	Stage II	49	1	Stage IIB	2008		Positive	FEMALE	Negative				Negative	M0	Negative	N0	2008	0	Basal		Negative				enrollment	T_Other	T3	LIVING	0	TCGA-AR-A24Q-01	3088	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA c1uster 9	cluster 6	mutation cluster 2	TCGA-AR-A24Q	3088	0	3088	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24Q-F49495		Positive					Negative	Simple Mastectomy					-18084	1932		0	3088							<10%				Scheduled Follow-up Submission	2013-10-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	590	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	6								NO	0		true	M0	N0	T3	Stage IIB	TCGA-AR-A24Q.CCE8E855-2582-4214-B9B1-25F0431065CB.pdf		8		1		0		1		2		23		75		75	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	AR	Breast	A	LIVING	2006	TCGA-AR-A24Q-01A-12D-A167-09		TCGA-AR-A24Q-01A-12R-A168-13	TCGA-AR-A24Q-01A-12R-A168-13	TCGA-AR-A24Q-01A-12D-A167-09		TCGA-AR-A24Q-01A-12D-A167-09	TCGA-AR-A24Q-01A-21-A17I-20	TCGA-AR-A24Q-01A-12D-A167-09	72c34d2c-f255-492b-9249-e9e9c506ece2	f4a87897-7b1c-4783-ac66-b99a74b8eec6	TCGA-AR-A24Q-01A-12D-A166-01	72c34d2c-f255-492b-9249-e9e9c506ece2	TCGA-AR-A24Q-01A-12D-A16A-05	TCGA-AR-A24Q-01		72c34d2c-f255-492b-9249-e9e9c506ece2	72c34d2c-f255-492b-9249-e9e9c506ece2	TCGA-AR-A24Q-01A-12D-A166-01		TCGA-AR-A24Q-01		f4a87897-7b1c-4783-ac66-b99a74b8eec6	
TCGA-AR-A24R-01	Stage III	45	5	Stage IIIA	1745		Positive	FEMALE	Negative				Negative	M0	Positive	N2	1745	0	LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-AR-A24R-01	2653	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-AR-A24R	2653	0	2653	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Right Upper Inner Quadrant|Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24R-F49499		Positive					Positive	Other					-16642	1913		0	2653							10-19%				Scheduled Follow-up Submission	2013-10-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	300	NO	Negative	Negative	NO	28	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		3	5								NO	6		true	M0	N2	T1	Stage IIIA	TCGA-AR-A24R.C3259BD1-1A2A-40C4-A106-FA2EF0201811.pdf		2		1		0		1		0		10		90		90	TUMOR FREE						YES	YES	No	10-19%		YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2006	TCGA-AR-A24R-01A-11D-A167-09		TCGA-AR-A24R-01A-11R-A168-13	TCGA-AR-A24R-01A-11R-A168-13	TCGA-AR-A24R-01A-11D-A167-09		TCGA-AR-A24R-01A-11D-A167-09	TCGA-AR-A24R-01A-21-A17I-20	TCGA-AR-A24R-01A-11D-A167-09	401721b2-a1d1-46d3-b73c-ec06df30d61e	17f5d685-ed80-4953-b02e-b069e529faa6	TCGA-AR-A24R-01A-11D-A166-01	401721b2-a1d1-46d3-b73c-ec06df30d61e	TCGA-AR-A24R-01A-11D-A16A-05	TCGA-AR-A24R-01		401721b2-a1d1-46d3-b73c-ec06df30d61e	401721b2-a1d1-46d3-b73c-ec06df30d61e	TCGA-AR-A24R-01A-11D-A166-01		TCGA-AR-A24R-01		17f5d685-ed80-4953-b02e-b069e529faa6	
TCGA-AR-A24S-01	Stage I	61	1	Stage I	1888		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1888	0	LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-AR-A24S-01	2976	0	Squamous	C3-BRCA/Luminal	cluster 2	Cluster 5	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-AR-A24S	2976	0	2976	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24S-F31496		Positive					Positive	Other		YES			-22587	1812		0	2976							70-79%				Scheduled Follow-up Submission	2012-5-4	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	520	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4								NO	0		true	M0	N0	T1	Stage I	TCGA-AR-A24S.C0A8A457-8790-4745-BD5D-AFBE55254A1C.pdf		4		0		0		0		0		40		60		85								YES	No			YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2006	TCGA-AR-A24S-01A-11D-A167-09		TCGA-AR-A24S-01A-11R-A168-13	TCGA-AR-A24S-01A-11R-A168-13	TCGA-AR-A24S-01A-11D-A167-09		TCGA-AR-A24S-01A-11D-A167-09	TCGA-AR-A24S-01A-21-A17I-20	TCGA-AR-A24S-01A-11D-A167-09	3795f6d6-3a1d-4b41-8a4b-e832078e9d48	ce2bf11c-61cb-49c7-8135-906719050d28	TCGA-AR-A24S-01A-11D-A166-01	3795f6d6-3a1d-4b41-8a4b-e832078e9d48	TCGA-AR-A24S-01A-11D-A16A-05	TCGA-AR-A24S-01		3795f6d6-3a1d-4b41-8a4b-e832078e9d48	3795f6d6-3a1d-4b41-8a4b-e832078e9d48	TCGA-AR-A24S-01A-11D-A166-01		TCGA-AR-A24S-01		ce2bf11c-61cb-49c7-8135-906719050d28	
TCGA-AR-A24T-01	Stage III	46	2	Stage IIIC	1620		Positive	FEMALE	Negative				Negative	M0	Positive	N3	1620	0	LumA		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-AR-A24T-01	2312	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-AR-A24T	2312	0	2312	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24T-F49463		Positive					Positive	Simple Mastectomy					-17135	1786		0	2312							10-19%				Scheduled Follow-up Submission	2013-10-2	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	490	NO	Equivocal	Negative		17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	2								NO	15		true	M0	N3	T3	Stage IIIC	TCGA-AR-A24T.226031B3-D9C2-4343-B3F7-4E0C36B901E7.pdf		2		0		0		0		7		23		70		80	TUMOR FREE						YES	YES	No	10-19%		YES	Primary Tumor	01		6th	YES	NO	YES	AR	Breast	A	LIVING	2006	TCGA-AR-A24T-01A-11D-A167-09		TCGA-AR-A24T-01A-11R-A168-13	TCGA-AR-A24T-01A-11R-A168-13	TCGA-AR-A24T-01A-11D-A167-09		TCGA-AR-A24T-01A-11D-A167-09	TCGA-AR-A24T-01A-21-A17I-20	TCGA-AR-A24T-01A-11D-A167-09	d2e1fdf7-1ac9-49e9-a611-b15c90772bf6	101abe3f-d317-4f8b-9b20-042da3d22457	TCGA-AR-A24T-01A-11D-A166-01	d2e1fdf7-1ac9-49e9-a611-b15c90772bf6	TCGA-AR-A24T-01A-11D-A16A-05	TCGA-AR-A24T-01		d2e1fdf7-1ac9-49e9-a611-b15c90772bf6	d2e1fdf7-1ac9-49e9-a611-b15c90772bf6	TCGA-AR-A24T-01A-11D-A166-01		TCGA-AR-A24T-01		101abe3f-d317-4f8b-9b20-042da3d22457	
TCGA-AR-A24U-01	Stage II	47	4	Stage IIA	1623		Negative	FEMALE	Positive				Negative	M0	Positive	N1	1623	0	Her2		Negative				enrollment	T1	T1	LIVING	0	TCGA-AR-A24U-01	1623	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 7	mutation c1uster 9	TCGA-AR-A24U			1623	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			Negative	Negative				Mastectomy NOS	Negative	Simple Mastectomy					-17523	1763		0	1623												2011-8-26	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	320	NO	Positive			25	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	7									2		true	M0	N1	T1	Stage IIA	TCGA-AR-A24U.B481795F-C52C-4FCE-827A-07991C7A7C2E.pdf		3		0		0		0		0		75		25		85								YES	No				Primary Tumor	01		6th		NO	YES	AR	Breast	A	LIVING	2006	TCGA-AR-A24U-01A-11D-A167-09		TCGA-AR-A24U-01A-11R-A168-13	TCGA-AR-A24U-01A-11R-A168-13	TCGA-AR-A24U-01A-11D-A167-09		TCGA-AR-A24U-01A-11D-A167-09	TCGA-AR-A24U-01A-21-A17I-20	TCGA-AR-A24U-01A-11D-A167-09	296c69de-2b77-4b3a-a228-9552a8a9836e	6c84f85f-2dd5-452e-8658-a7844f7143ed	TCGA-AR-A24U-01A-11D-A166-01	296c69de-2b77-4b3a-a228-9552a8a9836e	TCGA-AR-A24U-01A-11D-A16A-05	TCGA-AR-A24U-01		296c69de-2b77-4b3a-a228-9552a8a9836e	296c69de-2b77-4b3a-a228-9552a8a9836e	TCGA-AR-A24U-01A-11D-A166-01		TCGA-AR-A24U-01		6c84f85f-2dd5-452e-8658-a7844f7143ed	
TCGA-AR-A24V-01	Stage II	52	5	Stage IIB	1648		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1648	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A24V-01	2596	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AR-A24V	2596	0	2596	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24V-F49479		Positive					Positive	Other		YES			-19027	1720		0	2596							80-89%				Scheduled Follow-up Submission	2013-10-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	400	NO	Negative			2	Negative	Peri (6-12 months since last menstrual period)																		4	4								NO	1		true	M0	N1	T2	Stage IIB	TCGA-AR-A24V.468CD293-C9F7-43C6-A40A-18FCDD22F6AA.pdf		1		0		0		0		0		35		65		85	TUMOR FREE						YES	YES	No	<10%		YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2006	TCGA-AR-A24V-01A-21D-A167-09		TCGA-AR-A24V-01A-21R-A168-13	TCGA-AR-A24V-01A-21R-A168-13	TCGA-AR-A24V-01A-21D-A167-09		TCGA-AR-A24V-01A-21D-A167-09	TCGA-AR-A24V-01A-11-A17I-20	TCGA-AR-A24V-01A-21D-A167-09	29b04717-c5f2-4d4c-b006-e5c5f0aade7a	2623f99f-9e60-476b-b522-50e7fc6fef5a	TCGA-AR-A24V-01A-21D-A166-01	29b04717-c5f2-4d4c-b006-e5c5f0aade7a	TCGA-AR-A24V-01A-21D-A16A-05	TCGA-AR-A24V-01		29b04717-c5f2-4d4c-b006-e5c5f0aade7a	29b04717-c5f2-4d4c-b006-e5c5f0aade7a	TCGA-AR-A24V-01A-21D-A166-01		TCGA-AR-A24V-01		2623f99f-9e60-476b-b522-50e7fc6fef5a	
TCGA-AR-A24W-01			3																LumA										0	TCGA-AR-A24W-01	991	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation c1uster 9	TCGA-AR-A24W	991	0	991	Breast	TCGA Breast Cancer	breast invasive carcinoma					55	Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24W-F49476		Positive					Positive	Other					-20123	1720		0	991											Scheduled Follow-up Submission	2013-10-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	110	NO	Negative			22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6								NO	3		true	M0	N1	T2	Stage IIB	TCGA-AR-A24W.0F2464F7-4108-4700-B2EC-17BC6C432D42.pdf		1		0		1		0		20		29		50		60	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01	Total Mastectomy	6th	YES	NO	YES	AR	Breast	A	LIVING	2006	TCGA-AR-A24W-01A-11D-A17G-09		TCGA-AR-A24W-01A-11R-A168-13	TCGA-AR-A24W-01A-11R-A168-13	TCGA-AR-A24W-01A-11D-A17G-09		TCGA-AR-A24W-01A-11D-A17G-09	TCGA-AR-A24W-01A-21-A17I-20	TCGA-AR-A24W-01A-11D-A17G-09	a2f3fd7f-9a5d-44aa-8810-4978abad6e12	10a3bfcd-1650-480e-a3eb-f72d6ae052fe	TCGA-AR-A24W-01A-11D-A166-01	a2f3fd7f-9a5d-44aa-8810-4978abad6e12	TCGA-AR-A24W-01A-11D-A16A-05	TCGA-AR-A24W-01		a2f3fd7f-9a5d-44aa-8810-4978abad6e12	a2f3fd7f-9a5d-44aa-8810-4978abad6e12	TCGA-AR-A24W-01A-11D-A166-01		TCGA-AR-A24W-01		10a3bfcd-1650-480e-a3eb-f72d6ae052fe	
TCGA-AR-A24X-01	Stage II	52	2	Stage IIA	1465		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1465	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A24X-01	2548	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-AR-A24X	2548	0	2548	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24X-F49505		Positive					Positive	Simple Mastectomy		YES			-19030	1717		0	2548							80-89%				Scheduled Follow-up Submission	2013-10-2	FEMALE					2+					Mixed Histology (please specify)	Mixed invasive ductal and invasive lobular	No		C50.9	8522/3	C50.9		YES		Core needle biopsy	210	NO	Equivocal	Negative		7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	2								NO	0		true	M0	N0	T2	Stage IIA	TCGA-AR-A24X.B537A19C-C7E8-42EB-BA3F-673417F3A9BA.pdf		2		0		0		0		1		34		65		85	TUMOR FREE						YES	YES	No	90-99%		NO	Primary Tumor	01		6th	YES	NO	YES	AR	Breast	A	LIVING	2006	TCGA-AR-A24X-01A-11D-A167-09		TCGA-AR-A24X-01A-11R-A168-13	TCGA-AR-A24X-01A-11R-A168-13	TCGA-AR-A24X-01A-11D-A167-09		TCGA-AR-A24X-01A-11D-A167-09	TCGA-AR-A24X-01A-21-A17I-20	TCGA-AR-A24X-01A-11D-A167-09	42a7e579-365d-4393-8b98-e4516863299e	2f68651c-31bc-4e28-af88-ae2c22c34d5c	TCGA-AR-A24X-01A-11D-A166-01	42a7e579-365d-4393-8b98-e4516863299e	TCGA-AR-A24X-01A-11D-A16A-05	TCGA-AR-A24X-01		42a7e579-365d-4393-8b98-e4516863299e	42a7e579-365d-4393-8b98-e4516863299e	TCGA-AR-A24X-01A-11D-A166-01		TCGA-AR-A24X-01		2f68651c-31bc-4e28-af88-ae2c22c34d5c	
TCGA-AR-A24Z-01	Stage II	57	3	Stage IIA	1574		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1574	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A24Z-01	2403	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6		mutation c1uster 9	TCGA-AR-A24Z	2403	0	2403	Breast	TCGA Breast Cancer	breast invasive carcinoma					57	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24Z-F49507		Positive					Positive	Other		YES			-20900	1673		0	2403											Scheduled Follow-up Submission	2013-10-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4									NO	0		true	M0	N0	T2	Stage IIA	TCGA-AR-A24Z.AD07F611-0EEA-4890-A02C-6DA3F5F57C45.pdf		2		0		5		0		0		25		70		90	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01	Total mastectomy	6th	YES	NO	YES	AR	Breast	A	LIVING	2006	TCGA-AR-A24Z-01A-11D-A167-09		TCGA-AR-A24Z-01A-11R-A168-13	TCGA-AR-A24Z-01A-11R-A168-13	TCGA-AR-A24Z-01A-11D-A167-09		TCGA-AR-A24Z-01A-11D-A167-09	TCGA-AR-A24Z-01A-21-A17I-20	TCGA-AR-A24Z-01A-11D-A167-09	8d0d1eea-9e60-4507-8cfa-1fac66edc8a4	712486dc-9fc5-4e76-85ae-34a1e35120b5	TCGA-AR-A24Z-01A-11D-A166-01	8d0d1eea-9e60-4507-8cfa-1fac66edc8a4	TCGA-AR-A24Z-01A-11D-A16A-05	TCGA-AR-A24Z-01		8d0d1eea-9e60-4507-8cfa-1fac66edc8a4	8d0d1eea-9e60-4507-8cfa-1fac66edc8a4	TCGA-AR-A24Z-01A-11D-A166-01		TCGA-AR-A24Z-01		712486dc-9fc5-4e76-85ae-34a1e35120b5	
TCGA-AR-A250-01	Stage II	58	3	Stage IIA	1707		Positive	FEMALE	Positive				Negative	M0	Negative	N0	1707	0	LumB		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A250-01	2274	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AR-A250	2274	0	2274	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A250-F49508	Negative	Positive				Mastectomy NOS	Negative	Other					-21309	1629		0	2274							70-79%					2013-10-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	300	NO	Equivocal	Positive		4	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4								NO	0		true	M0	N0	T2	Stage IIA	TCGA-AR-A250.16BE833B-E17B-4B8A-9D71-B0D83D73D9DE.pdf		1		0		2		0		0		28		70		85	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01	Wide local excision and simple mastectomy	6th	YES	NO	YES	AR	Breast	A	LIVING	2006	TCGA-AR-A250-01A-31D-A167-09		TCGA-AR-A250-01A-31R-A168-13	TCGA-AR-A250-01A-31R-A168-13	TCGA-AR-A250-01A-31D-A167-09		TCGA-AR-A250-01A-31D-A167-09	TCGA-AR-A250-01A-41-A17I-20	TCGA-AR-A250-01A-31D-A167-09	86373f83-264a-4875-8672-749ea434422f	66b51ec8-15d1-4d1e-9edf-28f2a6b037d9	TCGA-AR-A250-01A-31D-A166-01	86373f83-264a-4875-8672-749ea434422f	TCGA-AR-A250-01A-31D-A16A-05	TCGA-AR-A250-01		86373f83-264a-4875-8672-749ea434422f	86373f83-264a-4875-8672-749ea434422f	TCGA-AR-A250-01A-31D-A166-01		TCGA-AR-A250-01		66b51ec8-15d1-4d1e-9edf-28f2a6b037d9	
TCGA-AR-A251-01	Stage III	51	1	Stage IIIA	1373		Positive	FEMALE	Negative				Negative	M0	Positive	N2	1373	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A251-01	2387	0	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 7		mutation c1uster 9	TCGA-AR-A251	2387	0	2387	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A251-F49509	Negative	Positive				Mastectomy NOS	Negative	Other					-18771	1611		0	2387											Scheduled Follow-up Submission	2013-10-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	450	NO	Equivocal	Negative		7	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5									NO	4		true	M0	N2	T2	Stage IIIA	TCGA-AR-A251.F5B17108-8904-48E7-9B3D-182F0EA388B7.pdf		2		0		1		0		0		39		60		85	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2006	TCGA-AR-A251-01A-12D-A167-09		TCGA-AR-A251-01A-12R-A168-13	TCGA-AR-A251-01A-12R-A168-13	TCGA-AR-A251-01A-12D-A167-09		TCGA-AR-A251-01A-12D-A167-09	TCGA-AR-A251-01A-21-A17I-20	TCGA-AR-A251-01A-12D-A167-09	06760907-c6ec-4b72-bfd4-87811823b8ba	a36f9f16-a240-419b-b230-17e2eb03eb73	TCGA-AR-A251-01A-12D-A166-01	06760907-c6ec-4b72-bfd4-87811823b8ba	TCGA-AR-A251-01A-12D-A16A-05	TCGA-AR-A251-01		06760907-c6ec-4b72-bfd4-87811823b8ba	06760907-c6ec-4b72-bfd4-87811823b8ba	TCGA-AR-A251-01A-12D-A166-01		TCGA-AR-A251-01		a36f9f16-a240-419b-b230-17e2eb03eb73	
TCGA-AR-A252-01	Stage I	50	3	Stage I	1236		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1236	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-AR-A252-01	2226	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-AR-A252	2226	0	2226	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A252-F49510		Positive					Positive	Other		YES			-18611	1405		0	2226							70-79%				Scheduled Follow-up Submission	2013-10-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	480	NO	Negative			4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	1								NO	0		true	M0	N0	T1	Stage I	TCGA-AR-A252.8C52C92F-26CA-4E72-BE47-CA2ED1746785.pdf		3		0		0		0		3		22		75		80	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2007	TCGA-AR-A252-01A-11D-A167-09		TCGA-AR-A252-01A-11R-A168-13	TCGA-AR-A252-01A-11R-A168-13	TCGA-AR-A252-01A-11D-A167-09		TCGA-AR-A252-01A-11D-A167-09	TCGA-AR-A252-01A-21-A17I-20	TCGA-AR-A252-01A-11D-A167-09	f325c7a8-46b0-4d75-9228-db391c270c71	4100914c-192f-4cac-ac05-56f707463196	TCGA-AR-A252-01A-11D-A166-01	f325c7a8-46b0-4d75-9228-db391c270c71	TCGA-AR-A252-01A-11D-A16A-05	TCGA-AR-A252-01		f325c7a8-46b0-4d75-9228-db391c270c71	f325c7a8-46b0-4d75-9228-db391c270c71	TCGA-AR-A252-01A-11D-A166-01		TCGA-AR-A252-01		4100914c-192f-4cac-ac05-56f707463196	
TCGA-AR-A254-01	Stage III	50	3	Stage IIIA	1212		Positive	FEMALE	Positive				Negative	M0	Positive	N2	1212	0	Her2		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A254-01	2213	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4		mutation cluster 5	TCGA-AR-A254	2213	0	2213	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Left Upper Inner Quadrant|Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A254-F49511		Positive					Positive	Other					-18270	1381		0	2213											Scheduled Follow-up Submission	2013-10-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Wide local incision	Other method, specify:	990	NO	Positive			30	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4									NO	9		true	M0	N2	T2	Stage IIIA	TCGA-AR-A254.C026CFCE-1A82-446D-AC78-8CF4788FD9EB.pdf		0		0		0		0		0		5		95		70	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2007	TCGA-AR-A254-01A-21D-A167-09		TCGA-AR-A254-01A-21R-A168-13	TCGA-AR-A254-01A-21R-A168-13	TCGA-AR-A254-01A-21D-A167-09		TCGA-AR-A254-01A-21D-A167-09	TCGA-AR-A254-01A-11-A17I-20	TCGA-AR-A254-01A-21D-A167-09	5741e1ce-5d4c-40dc-aa01-e71a45341884	7385c5f6-5fb1-4d45-a17d-93636a161c7c	TCGA-AR-A254-01A-21D-A166-01	5741e1ce-5d4c-40dc-aa01-e71a45341884	TCGA-AR-A254-01A-21D-A16A-05	TCGA-AR-A254-01		5741e1ce-5d4c-40dc-aa01-e71a45341884	5741e1ce-5d4c-40dc-aa01-e71a45341884	TCGA-AR-A254-01A-21D-A166-01		TCGA-AR-A254-01		7385c5f6-5fb1-4d45-a17d-93636a161c7c	
TCGA-AR-A255-01	Stage I	62	5	Stage I	1058		Positive	FEMALE	Positive				Negative	M0	Negative	N0	1058	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-AR-A255-01	1792	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 13		mutation cluster 4	TCGA-AR-A255	1792	0	1792	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A255-F49512		Positive					Positive	Other		YES			-22809	1225		0	1792											Scheduled Follow-up Submission	2013-10-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	250	NO	Positive			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	0		true	M0	N0	T1	Stage I	TCGA-AR-A255.492DDF00-858B-4420-A43F-4FED2DF61C15.pdf		0		0		0		0		5		0		95		85	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2007	TCGA-AR-A255-01A-11D-A167-09		TCGA-AR-A255-01A-11R-A168-13	TCGA-AR-A255-01A-11R-A168-13	TCGA-AR-A255-01A-11D-A167-09		TCGA-AR-A255-01A-11D-A167-09	TCGA-AR-A255-01A-21-A17I-20	TCGA-AR-A255-01A-11D-A167-09	5f714b76-1ed1-4828-8b66-3627c5d78189	5845be86-bd10-4bf5-ade3-71674a1eecca	TCGA-AR-A255-01A-11D-A166-01	5f714b76-1ed1-4828-8b66-3627c5d78189	TCGA-AR-A255-01A-11D-A16A-05	TCGA-AR-A255-01		5f714b76-1ed1-4828-8b66-3627c5d78189	5f714b76-1ed1-4828-8b66-3627c5d78189	TCGA-AR-A255-01A-11D-A166-01		TCGA-AR-A255-01		5845be86-bd10-4bf5-ade3-71674a1eecca	
TCGA-AR-A256-01	Stage II	45	1	Stage IIA	2854	2854	Negative	FEMALE	Negative				Negative	M0	Negative	N0	2854	1	Basal		Negative				enrollment	T_Other	T2	DECEASED	1	TCGA-AR-A256-01	2854	1	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12		mutation cluster 5	TCGA-AR-A256	1640	1	2854	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A256-F31923		Negative					Negative	Other		YES			-16642	3740	2854	0				1640								Scheduled Follow-up Submission	2012-5-11	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	210	NO	Negative			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5						Locoregional Disease			YES	0		true	M0	N0	T2	Stage IIA	TCGA-AR-A256.0FDC2801-71F8-4D45-BFF1-89445E621A41.pdf		0		0		0		0		0		5		95		95								YES	No			NO	Primary Tumor	01	Mastectomy	5th	YES	NO	YES	AR	Breast	A	DECEASED	2001	TCGA-AR-A256-01A-11D-A167-09		TCGA-AR-A256-01A-11R-A168-13	TCGA-AR-A256-01A-11R-A168-13	TCGA-AR-A256-01A-11D-A167-09		TCGA-AR-A256-01A-11D-A167-09	TCGA-AR-A256-01A-21-A17I-20	TCGA-AR-A256-01A-11D-A167-09	60534f8f-970a-4308-9844-a3a41dd6c187	4b23b5e1-813b-4975-8594-627aadcd3f92	TCGA-AR-A256-01A-11D-A166-01	60534f8f-970a-4308-9844-a3a41dd6c187	TCGA-AR-A256-01A-11D-A16A-05	TCGA-AR-A256-01		60534f8f-970a-4308-9844-a3a41dd6c187	60534f8f-970a-4308-9844-a3a41dd6c187	TCGA-AR-A256-01A-11D-A166-01		TCGA-AR-A256-01		4b23b5e1-813b-4975-8594-627aadcd3f92	
TCGA-AR-A2LE-01																			LumA										0	TCGA-AR-A2LE-01	4239	0	Iq	C3-BRCA/Luminal		BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA c1uster 10			TCGA-AR-A2LE	4203	1	4239	Breast	TCGA Breast Cancer	breast invasive carcinoma					69	Right	Sentinel node biopsy alone		TCGA-AR-A2LE-F35164		Positive					Negative	Other		YES			-25499	3755		0	4239			4203		NO							2012-12-6	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	320	NO			NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																							Other, specify	New Primary Tumor	Endometrium		YES	0		true	M0	N0	T1	Stage I	TCGA-AR-A2LE.95DC80AB-C070-4613-8C11-A124AEDF9754.pdf		1		0		0		0		0		35		65		92							YES	YES	No			YES	Primary Tumor	01	Excision	5th		NO	YES	AR	Breast	A	LIVING	2001			TCGA-AR-A2LE-01A-11R-A17X-13	TCGA-AR-A2LE-01A-11R-A17X-13			TCGA-AR-A2LE-01A-11D-A17W-09	TCGA-AR-A2LE-01A-21-A24A-20		5c052fcb-a9f9-4d6a-86cd-6fa490fe9d74	8689ec70-41c0-43fb-9d1d-723c0ef60a16	TCGA-AR-A2LE-01A-11D-A17U-01	5c052fcb-a9f9-4d6a-86cd-6fa490fe9d74	TCGA-AR-A2LE-01A-11D-A17Z-05	TCGA-AR-A2LE-01		5c052fcb-a9f9-4d6a-86cd-6fa490fe9d74	5c052fcb-a9f9-4d6a-86cd-6fa490fe9d74	TCGA-AR-A2LE-01A-11D-A17U-01		TCGA-AR-A2LE-01		8689ec70-41c0-43fb-9d1d-723c0ef60a16	
TCGA-AR-A2LH-01																			Normal										1	TCGA-AR-A2LH-01	616	1	Quiet	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-AR-A2LH	434	1	616	Breast	TCGA Breast Cancer	breast invasive carcinoma					55	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A2LH-F35165		Negative					Negative	Modified Radical Mastectomy					-20288	1661	616	0				434		YES			Bone|Liver				2012-12-6	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	1100	NO	Equivocal	Negative	NO	39	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																							Bone	Distant Metastasis			YES	29		true	M0	N3	T3	Stage III	TCGA-AR-A2LH.4E3FDA72-93E1-4961-B1DE-5BFDAC7E947D.pdf		1		1		0		0		3		47		50		80							YES	YES	No			YES	Primary Tumor	01		6th		NO	YES	AR	Breast	A	DECEASED	2007			TCGA-AR-A2LH-01A-31R-A18L-13	TCGA-AR-A2LH-01A-31R-A18L-13			TCGA-AR-A2LH-01A-31D-A18P-09	TCGA-AR-A2LH-01A-41-A24A-20		6aa1a643-013f-43d4-a3e6-a4a946ac3678	b99a1cb6-1b23-4d66-8865-ab265a85b41b	TCGA-AR-A2LH-01A-31D-A18N-01	6aa1a643-013f-43d4-a3e6-a4a946ac3678	TCGA-AR-A2LH-01A-31D-A18O-05	TCGA-AR-A2LH-01		6aa1a643-013f-43d4-a3e6-a4a946ac3678	6aa1a643-013f-43d4-a3e6-a4a946ac3678	TCGA-AR-A2LH-01A-31D-A18N-01		TCGA-AR-A2LH-01		b99a1cb6-1b23-4d66-8865-ab265a85b41b	
TCGA-AR-A2LJ-01																													0	TCGA-AR-A2LJ-01	1865	0	Iq			BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 4			TCGA-AR-A2LJ	1865	0	1865	Breast	TCGA Breast Cancer	breast invasive carcinoma					40	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A2LJ-F35167		Positive					Positive	Other		YES			-14723	1382		0	1865					NO		70-79%					2012-12-7	FEMALE					3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	540	NO	Positive	Positive	NO	18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	1		true	MX	N1	T3	Stage IIIA	TCGA-AR-A2LJ.5411AC07-09E4-40C3-844F-2DFAA216D947.pdf		1		0		0		0		10		50		40		70							YES	YES	No	70-79%		YES	Primary Tumor	01	Total Mastectomy	6th		NO	YES	AR	Breast	A	LIVING	2007			TCGA-AR-A2LJ-01A-12R-A19V-13	TCGA-AR-A2LJ-01A-12R-A19V-13			TCGA-AR-A2LJ-01A-12D-A19Y-09	TCGA-AR-A2LJ-01A-21-A24B-20		52cca577-c5d1-4dff-9e3a-4007beb120db	18114439-8780-438d-a7cc-50b73533b619	TCGA-AR-A2LJ-01A-12D-A19X-01	52cca577-c5d1-4dff-9e3a-4007beb120db	TCGA-AR-A2LJ-01A-12D-A19Z-05	TCGA-AR-A2LJ-01		52cca577-c5d1-4dff-9e3a-4007beb120db	52cca577-c5d1-4dff-9e3a-4007beb120db	TCGA-AR-A2LJ-01A-12D-A19X-01		TCGA-AR-A2LJ-01		18114439-8780-438d-a7cc-50b73533b619	
TCGA-AR-A2LK-01																			LumB										1	TCGA-AR-A2LK-01	1649	1	BRCA-LUAD+	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-AR-A2LK	1304	1	1649	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Right Upper Outer Quadrant|Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A2LK-F35203	Negative	Positive				Mastectomy NOS	Positive	Other					-22800	1340	1649	0	1304			1304		NO		70-79%					2012-12-6	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	650	NO	Equivocal	Negative	NO	18	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative			Positive												Positive						Bone	Distant Metastasis			YES	5		true	M0	N2	T3	Stage III	TCGA-AR-A2LK.73FFBADB-37C0-4F17-8C95-F8DC94EF1AD3.pdf		1		0		0		0		0		55		45		75							YES	YES	No			YES	Primary Tumor	01	Wide local excision	6th		NO	YES	AR	Breast	A	DECEASED	2007			TCGA-AR-A2LK-01A-11R-A17X-13	TCGA-AR-A2LK-01A-11R-A17X-13			TCGA-AR-A2LK-01A-11D-A17W-09	TCGA-AR-A2LK-01A-21-A24A-20		047160f7-3727-4915-b02d-61557350d88b	263be494-445c-469b-8b53-d27860d73f8d	TCGA-AR-A2LK-01A-11D-A17U-01	047160f7-3727-4915-b02d-61557350d88b	TCGA-AR-A2LK-01A-11D-A17Z-05	TCGA-AR-A2LK-01		047160f7-3727-4915-b02d-61557350d88b	047160f7-3727-4915-b02d-61557350d88b	TCGA-AR-A2LK-01A-11D-A17U-01		TCGA-AR-A2LK-01		263be494-445c-469b-8b53-d27860d73f8d	
TCGA-AR-A2LL-01																			LumB										0	TCGA-AR-A2LL-01	1719	0	High	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14			TCGA-AR-A2LL	1719	0	1719	Breast	TCGA Breast Cancer	breast invasive carcinoma					70	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A2LL-F35205		Positive					Positive	Simple Mastectomy		YES			-25747	1315		0	1719					NO		70-79%					2012-12-6	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	1300	NO	Equivocal	Negative	NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		true	M0	N0	T3	Stage IIB	TCGA-AR-A2LL.B2314041-3E85-4E3F-8924-39FC285B08B2.pdf		5		0		2		0		0		43		55		75							YES	YES	Yes	70-79%		NO	Primary Tumor	01		6th		NO	YES	AR	Breast	A	LIVING	2007			TCGA-AR-A2LL-01A-11R-A17X-13	TCGA-AR-A2LL-01A-11R-A17X-13			TCGA-AR-A2LL-01A-11D-A17W-09	TCGA-AR-A2LL-01A-21-A24A-20		2c08d3bc-c5f6-4077-86b5-633ed85818ec	1e086721-663c-47b9-9753-a468d2b1df1b	TCGA-AR-A2LL-01A-11D-A17U-01	2c08d3bc-c5f6-4077-86b5-633ed85818ec	TCGA-AR-A2LL-01A-11D-A17Z-05	TCGA-AR-A2LL-01		2c08d3bc-c5f6-4077-86b5-633ed85818ec	2c08d3bc-c5f6-4077-86b5-633ed85818ec	TCGA-AR-A2LL-01A-11D-A17U-01		TCGA-AR-A2LL-01		1e086721-663c-47b9-9753-a468d2b1df1b	
TCGA-AR-A2LM-01																			LumA										0	TCGA-AR-A2LM-01	1585	0	Iq	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12			TCGA-AR-A2LM	1585	0	1585	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A2LM-F37336		Positive					Positive	Simple Mastectomy		YES			-18053	1339		0	1585					NO		70-79%					2012-12-6	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	490	NO		Negative	NO	3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	1		true	M0	N1	T1	Stage II	TCGA-AR-A2LM.F868DC95-23CA-4DFC-BAA3-FBF5BF6F45A9.pdf		1		2		0		0		8		32		60		75	TUMOR FREE						YES	YES	No	70-79%		NO	Primary Tumor	01		6th		NO	YES	AR	Breast	A	LIVING	2007			TCGA-AR-A2LM-01A-11R-A17X-13	TCGA-AR-A2LM-01A-11R-A17X-13			TCGA-AR-A2LM-01A-11D-A17W-09	TCGA-AR-A2LM-01A-21-A24A-20		461cbf67-a11d-4411-95b5-cf83ecf05d02	27925a3c-9258-4c9e-9674-34c744a31eb3	TCGA-AR-A2LM-01A-11D-A17U-01	461cbf67-a11d-4411-95b5-cf83ecf05d02	TCGA-AR-A2LM-01A-11D-A17Z-05	TCGA-AR-A2LM-01		461cbf67-a11d-4411-95b5-cf83ecf05d02	461cbf67-a11d-4411-95b5-cf83ecf05d02	TCGA-AR-A2LM-01A-11D-A17U-01		TCGA-AR-A2LM-01		27925a3c-9258-4c9e-9674-34c744a31eb3	
TCGA-AR-A2LN-01																			LumA										0	TCGA-AR-A2LN-01	997	0	BRCA-LUAD+	C3-BRCA/Luminal		BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-AR-A2LN	997	0	997	Breast	TCGA Breast Cancer	breast invasive carcinoma					65	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A2LN-F37537		Positive					Positive	Other					-23992	513		0	997					NO		70-79%					2012-12-6	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	1460	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		true	M0	N0	T2	Stage IIA	TCGA-AR-A2LN.128D4F7D-017D-459F-9664-AF509AE4555E.pdf		1		0		0		0		1		59		40		75							YES	YES	No	70-79%		NO	Primary Tumor	01	Mastectomy	7th		NO	YES	AR	Breast	A	LIVING	2010			TCGA-AR-A2LN-01A-21R-A18L-13	TCGA-AR-A2LN-01A-21R-A18L-13			TCGA-AR-A2LN-01A-21D-A18P-09	TCGA-AR-A2LN-01A-31-A24A-20		8a23348d-3371-431e-a6c8-b031cde82279	e0e62b44-bcb1-4776-843d-a9493b115324	TCGA-AR-A2LN-01A-21D-A18N-01	8a23348d-3371-431e-a6c8-b031cde82279	TCGA-AR-A2LN-01A-21D-A18O-05	TCGA-AR-A2LN-01		8a23348d-3371-431e-a6c8-b031cde82279	8a23348d-3371-431e-a6c8-b031cde82279	TCGA-AR-A2LN-01A-21D-A18N-01		TCGA-AR-A2LN-01		e0e62b44-bcb1-4776-843d-a9493b115324	
TCGA-AR-A2LO-01																			LumA										0	TCGA-AR-A2LO-01	935	0	BRCA-LUAD+	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-AR-A2LO	935	0	935	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A2LO-F37193		Positive					Positive	Simple Mastectomy					-17080	486		0	935					NO		70-79%					2012-12-7	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	1650	NO	Equivocal	Negative	NO	16	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	1		true	M0	N1	T2	Stage IIB	TCGA-AR-A2LO.E5B6771D-450A-49AD-AEBC-7FC056BFCDBE.pdf		3		1		0		1		0		50		50		85							YES	YES	No			YES	Primary Tumor	01		7th		NO	YES	AR	Breast	A	LIVING	2010			TCGA-AR-A2LO-01A-31R-A18L-13	TCGA-AR-A2LO-01A-31R-A18L-13			TCGA-AR-A2LO-01A-31D-A18P-09	TCGA-AR-A2LO-01A-41-A24A-20		3e71718b-3ab9-4b0d-a92b-52c46e6f1670	491e98e5-27e9-4e1e-809b-09a3715fc609	TCGA-AR-A2LO-01A-31D-A19G-01	3e71718b-3ab9-4b0d-a92b-52c46e6f1670	TCGA-AR-A2LO-01A-31D-A18O-05	TCGA-AR-A2LO-01		3e71718b-3ab9-4b0d-a92b-52c46e6f1670	3e71718b-3ab9-4b0d-a92b-52c46e6f1670	TCGA-AR-A2LO-01A-31D-A19G-01		TCGA-AR-A2LO-01		491e98e5-27e9-4e1e-809b-09a3715fc609	
TCGA-AR-A2LQ-01																			Normal										0	TCGA-AR-A2LQ-01	895	0	Quiet	C3-BRCA/Luminal		BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-AR-A2LQ	895	0	895	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Right Upper Inner Quadrant|Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A2LQ-F37558		Positive					Positive	Simple Mastectomy					-21865	449		0	895					NO		70-79%					2012-12-6	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	1270	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		true	M0	N0	T3	Stage IIB	TCGA-AR-A2LQ.C3537961-4636-4BD1-BC89-892580B36E43.pdf		2		0		0		0		10		50		40		60							YES	YES	No	<10%		YES	Primary Tumor	01		7th		NO	YES	AR	Breast	A	LIVING	2010			TCGA-AR-A2LQ-01A-22R-A18L-13	TCGA-AR-A2LQ-01A-22R-A18L-13			TCGA-AR-A2LQ-01A-22D-A18P-09	TCGA-AR-A2LQ-01A-11-A24A-20		7a72bd47-7504-4a59-ae95-096c32f70965	895c4a2a-2c43-4e3a-ab26-694f80b7ca70	TCGA-AR-A2LQ-01A-22D-A18N-01	7a72bd47-7504-4a59-ae95-096c32f70965	TCGA-AR-A2LQ-01A-22D-A18O-05	TCGA-AR-A2LQ-01		7a72bd47-7504-4a59-ae95-096c32f70965	7a72bd47-7504-4a59-ae95-096c32f70965	TCGA-AR-A2LQ-01A-22D-A18N-01		TCGA-AR-A2LQ-01		895c4a2a-2c43-4e3a-ab26-694f80b7ca70	
TCGA-AR-A2LR-01																			Basal										0	TCGA-AR-A2LR-01	620	0	High	C4-BRCA/Basal		BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 5			TCGA-AR-A2LR			620	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Right	Sentinel lymph node biopsy plus axillary dissection				Negative					Negative	Simple Mastectomy					-18214	447		0	620					NO							2012-2-14	FEMALE										Other  specify	Metaplastic carcinoma	No		C50.9	8575/3	C50.9		YES		Core needle biopsy	800	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N0	T1	Stage I	TCGA-AR-A2LR.C310F4EC-D8B1-45C4-8D55-705A9EE35902.pdf		3		0		0		0		0		70		30		60								YES	Yes				Primary Tumor	01		7th		NO	YES	AR	Breast	A	LIVING	2010			TCGA-AR-A2LR-01A-12R-A18L-13	TCGA-AR-A2LR-01A-12R-A18L-13			TCGA-AR-A2LR-01A-12D-A18P-09	TCGA-AR-A2LR-01A-21-A24A-20		9f693816-6957-413c-a100-54f7bc0eddf9	9ba65dff-5f6c-4d9e-8e58-8350a7c1dcbe	TCGA-AR-A2LR-01A-12D-A18N-01	9f693816-6957-413c-a100-54f7bc0eddf9	TCGA-AR-A2LR-01A-12D-A18O-05	TCGA-AR-A2LR-01		9f693816-6957-413c-a100-54f7bc0eddf9	9f693816-6957-413c-a100-54f7bc0eddf9	TCGA-AR-A2LR-01A-12D-A18N-01		TCGA-AR-A2LR-01		9ba65dff-5f6c-4d9e-8e58-8350a7c1dcbe	
TCGA-AR-A5QM-01																													0	TCGA-AR-A5QM-01	1665	0										TCGA-AR-A5QM	968	1	1665	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A5QM-F43848		Positive					Positive	Other					-22780	1541		0	1665			968									2013-6-10	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	350	NO	Equivocal		NO	9		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																							Other, specify	New Primary Tumor	Malignant melanoma		YES	0		true	M0	N0	T2	Stage IIA	TCGA-AR-A5QM.4C3E3E5B-E24E-447B-A688-68D6EBE15A9F.pdf		40		20		10		20		0		20		70		70	TUMOR FREE						YES	YES	Yes			YES	Primary Tumor	01	Wide Excision	6th		NO	YES	AR	Breast	A	LIVING	2008			TCGA-AR-A5QM-01A-11R-A27U-13	TCGA-AR-A5QM-01A-11R-A27U-13			TCGA-AR-A5QM-01A-11D-A27P-09			6bbb74ed-93be-4cbe-a854-4ea6aaec0615	2bb73e92-de96-408c-a239-ed6999006c6f	TCGA-AR-A5QM-01A-11D-A27O-01	6bbb74ed-93be-4cbe-a854-4ea6aaec0615		TCGA-AR-A5QM-01		6bbb74ed-93be-4cbe-a854-4ea6aaec0615	6bbb74ed-93be-4cbe-a854-4ea6aaec0615	TCGA-AR-A5QM-01A-11D-A27O-01		TCGA-AR-A5QM-01		2bb73e92-de96-408c-a239-ed6999006c6f	
TCGA-AR-A5QN-01																													0	TCGA-AR-A5QN-01	488	0										TCGA-AR-A5QN	488	0	488	Breast	TCGA Breast Cancer	breast invasive carcinoma					68	Left	Axillary lymph node dissection alone		TCGA-AR-A5QN-F43862		Positive					Positive	Modified Radical Mastectomy					-25089	328		0	488												2013-6-10	FEMALE					3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	510	NO	Positive		NO	19		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	10		true	M0	N3	T2	Stage IIIC	TCGA-AR-A5QN.A9015F6A-F6BB-4AC8-B681-099232A6DFAC.pdf		40		20		5		20		0		35		60		60	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th		NO	YES	AR	Breast	A	LIVING	2012			TCGA-AR-A5QN-01A-12R-A28I-13	TCGA-AR-A5QN-01A-12R-A28I-13			TCGA-AR-A5QN-01A-12D-A28B-09			76353751-a05c-432e-a35b-12f2bf62a494	c5bb2a65-d71d-4a5b-bc29-afc97e38b8c1	TCGA-AR-A5QN-01A-12D-A28A-01	76353751-a05c-432e-a35b-12f2bf62a494	TCGA-AR-A5QN-01A-12D-A28C-05	TCGA-AR-A5QN-01		76353751-a05c-432e-a35b-12f2bf62a494	76353751-a05c-432e-a35b-12f2bf62a494	TCGA-AR-A5QN-01A-12D-A28A-01		TCGA-AR-A5QN-01		c5bb2a65-d71d-4a5b-bc29-afc97e38b8c1	
TCGA-AR-A5QP-01																													0	TCGA-AR-A5QP-01	622	0										TCGA-AR-A5QP	622	0	622	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A5QP-F43875		Positive					Positive	Lumpectomy					-19805	498		0	622												2013-6-10	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			230	NO	Equivocal		NO	40		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1		true	M0	N1	T2	Stage IIB	TCGA-AR-A5QP.F2409024-D848-4B02-A371-92BEA1105EC4.pdf		40		20		0		20		0		20		80		80	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th		NO	YES	AR	Breast	A	LIVING	2011			TCGA-AR-A5QP-01A-11R-A28I-13	TCGA-AR-A5QP-01A-11R-A28I-13			TCGA-AR-A5QP-01A-11D-A28B-09			b2d0c724-40ae-44ca-90eb-ce86a9546c05	62f32fa7-690a-4896-980a-831208a3c6ae	TCGA-AR-A5QP-01A-11D-A28A-01	b2d0c724-40ae-44ca-90eb-ce86a9546c05	TCGA-AR-A5QP-01A-11D-A28C-05	TCGA-AR-A5QP-01		b2d0c724-40ae-44ca-90eb-ce86a9546c05	b2d0c724-40ae-44ca-90eb-ce86a9546c05	TCGA-AR-A5QP-01A-11D-A28A-01		TCGA-AR-A5QP-01		62f32fa7-690a-4896-980a-831208a3c6ae	
TCGA-AR-A5QQ-01																													1	TCGA-AR-A5QQ-01	322	1										TCGA-AR-A5QQ	301	1	322	Breast	TCGA Breast Cancer	breast invasive carcinoma					68	Right	Axillary lymph node dissection alone		TCGA-AR-A5QQ-F42734		Negative					Negative	Modified Radical Mastectomy					-24841	576	322	0				301									2013-6-10	FEMALE					1+					Other  specify	Squamous (metaplastic) carcinoma	No		C50.9	8575/3	C50.1		YES		Core needle biopsy	800	NO	Negative		NO	24		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																							Lung	Distant Metastasis	Liver, bone, chest wall, adrenal glands		YES	1		true	M0	N1	T3	Stage IIIA	TCGA-AR-A5QQ.511282C5-02AC-4105-8B52-5BBEC8B45D22.pdf		40		20		5		20		0		5		90		90	WITH TUMOR						YES	YES	No			YES	Primary Tumor	01		7th		NO	YES	AR	Breast	A	DECEASED	2011			TCGA-AR-A5QQ-01A-11R-A28I-13	TCGA-AR-A5QQ-01A-11R-A28I-13			TCGA-AR-A5QQ-01A-11D-A28B-09			16f90247-c9a5-40d5-a3a1-08bba2d1d266	d871dcd8-1cb2-4c05-8ecf-4e30837267ff	TCGA-AR-A5QQ-01A-11D-A28A-01	16f90247-c9a5-40d5-a3a1-08bba2d1d266	TCGA-AR-A5QQ-01A-11D-A28C-05	TCGA-AR-A5QQ-01		16f90247-c9a5-40d5-a3a1-08bba2d1d266	16f90247-c9a5-40d5-a3a1-08bba2d1d266	TCGA-AR-A5QQ-01A-11D-A28A-01		TCGA-AR-A5QQ-01		d871dcd8-1cb2-4c05-8ecf-4e30837267ff	
TCGA-B6-A0I1-01																			Basal										1	TCGA-B6-A0I1-01	2361	1	High			BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 4			TCGA-B6-A0I1			2361	Breast	TCGA Breast Cancer	breast invasive carcinoma					73	Left Upper Outer Quadrant	Axillary lymph node dissection alone				Negative					Negative	Modified Radical Mastectomy		NO			-26902	4248	2361	0							image cytometry						2012-1-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	100	NO				7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N0	T2	Stage IIA	TCGA-B6-A0I1.1E498731-FE74-493E-A330-477643800305.pdf	1	0	0	0	15	30	0	0	0	0	25	5	60	65	65	65	TUMOR FREE	image cytometry						YES	No				Primary Tumor	01		5th		NO	YES	B6	Breast	A	DECEASED	1998			TCGA-B6-A0I1-01A-11R-A21U-13	TCGA-B6-A0I1-01A-11R-A21U-13			TCGA-B6-A0I1-01A-11D-A21Q-09			785856fc-d042-4b7f-a137-95b17c59b876	42f8da15-4b82-4660-8f91-7bf874fbe35c	TCGA-B6-A0I1-01A-11D-A21P-01	785856fc-d042-4b7f-a137-95b17c59b876	TCGA-B6-A0I1-01A-11D-A21R-05	TCGA-B6-A0I1-01		785856fc-d042-4b7f-a137-95b17c59b876	785856fc-d042-4b7f-a137-95b17c59b876	TCGA-B6-A0I1-01A-11D-A21P-01		TCGA-B6-A0I1-01		42f8da15-4b82-4660-8f91-7bf874fbe35c	
TCGA-B6-A0I2-01	Stage IA	45	3	Stage I	4360			FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	4360	0	Basal	Basal-like		ReacII	-13	-12	followup	T1	T1	LIVING	0	TCGA-B6-A0I2-01	4361	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-B6-A0I2	4361	0	4361	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-B6-A0I2-F12630								Other		NO			-16702	5305		0	4361											Scheduled Follow-up Submission	2011-6-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	200	NO				8	Negative	Indeterminate (neither Pre or Postmenopausal)																		5	3								NO	0		true	M0	N0 (i-)	T1c	Stage IA	TCGA-B6-A0I2.CA834E5F-30DC-46CF-AF33-AD11226FC09E.pdf	1	1	0	0	0	0	0	0	0	0	15	10	85	90	85	90	TUMOR FREE								No			YES	Primary Tumor	01	Excisional biopsy		YES	NO	YES	B6	Breast	A	LIVING	1995	TCGA-B6-A0I2-01A-11W-A050-09	TCGA-B6-A0I2-01		TCGA-B6-A0I2-01A-11R-A035-13	TCGA-B6-A0I2-01A-11W-A050-09	3c520911-0d5d-4a69-bef5-f2666b99544c	TCGA-B6-A0I2-01A-11W-A050-09	TCGA-B6-A0I2-01A-21-A13C-20	TCGA-B6-A0I2-01A-11W-A050-09	7175b3eb-5198-4d7f-b205-91ae8df344b4	aa5e3733-d47a-4371-99ab-34d98aec9bf6	TCGA-B6-A0I2-01A-11D-A036-01	7175b3eb-5198-4d7f-b205-91ae8df344b4		TCGA-B6-A0I2-01	TCGA-B6-A0I2-01A-11R-A034-07	7175b3eb-5198-4d7f-b205-91ae8df344b4	7175b3eb-5198-4d7f-b205-91ae8df344b4	TCGA-B6-A0I2-01A-11D-A036-01	TCGA-B6-A0I2-01	TCGA-B6-A0I2-01	TCGA-B6-A0I2-01A-11D-A032-05	aa5e3733-d47a-4371-99ab-34d98aec9bf6	TCGA-B6-A0I2-01A-11R-A035-13
TCGA-B6-A0I5-01	Stage IIB	49	2	No_Conversion	4549		Positive	FEMALE	Negative				Negative	M0	Positive	N1	4549	0	LumA	Luminal A	Positive		-5	-3	followup	T_Other	T2	LIVING	0	TCGA-B6-A0I5-01	4550	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 12	cluster 6	mutation cluster 4	TCGA-B6-A0I5	4550	0	4550	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Right Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-B6-A0I5-F12603		Positive					Positive	Other		NO			-18038	7820		0	4550											Scheduled Follow-up Submission	2011-6-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	biopsy, NOS	Other method, specify:	50	NO				13	Negative	Indeterminate (neither Pre or Postmenopausal)																		1	6								NO	5		true	M0	N1b	T2	Stage IIB	TCGA-B6-A0I5.FA43414D-3757-43CC-8949-77F82DF4FA4D.pdf	1	1	0	0	0	0	0	0	3	0	17	15	80	85	80	85	TUMOR FREE								No			NO	Primary Tumor	01	biopsy		YES	NO	YES	B6	Breast	A	LIVING	1988	TCGA-B6-A0I5-01A-11W-A100-09	TCGA-B6-A0I5-01		TCGA-B6-A0I5-01A-11R-A035-13	TCGA-B6-A0I5-01A-11W-A100-09		TCGA-B6-A0I5-01A-11W-A100-09		TCGA-B6-A0I5-01A-11W-A100-09	2448118f-9664-4b9e-b67f-c019cf5b8d35	2ecbf2ad-e0d5-4197-a4a1-90014bdcc615	TCGA-B6-A0I5-01A-11D-A036-01	2448118f-9664-4b9e-b67f-c019cf5b8d35		TCGA-B6-A0I5-01	TCGA-B6-A0I5-01A-11R-A034-07	2448118f-9664-4b9e-b67f-c019cf5b8d35	2448118f-9664-4b9e-b67f-c019cf5b8d35	TCGA-B6-A0I5-01A-11D-A036-01	TCGA-B6-A0I5-01	TCGA-B6-A0I5-01	TCGA-B6-A0I5-01A-11D-A032-05	2ecbf2ad-e0d5-4197-a4a1-90014bdcc615	TCGA-B6-A0I5-01A-11R-A035-13
TCGA-B6-A0I6-01	Stage IIA	49		No_Conversion	991	997	Negative	FEMALE					Negative	M0	Positive	N1	997	1	Basal	Basal-like	Negative	Basal	-13	0	followup	T1	T1	DECEASED	1	TCGA-B6-A0I6-01	997	1		C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-B6-A0I6	859	1	997	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO		49	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-B6-A0I6-F12605		Negative					Negative	Modified Radical Mastectomy		NO			-18014	7362	997	0				859								Scheduled Follow-up Submission	2011-6-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	200	NO				32	Negative	Indeterminate (neither Pre or Postmenopausal)																		5	4				Bone	Distant Metastasis	Skin		YES	6		true	M0	N1	T1c	Stage IIA	TCGA-B6-A0I6.2D3D759B-D06A-4FC6-855A-5E9F83ADBED9.pdf	2	2	0	0	0	0	0	0	0	2	15	18	85	80	85	80	WITH TUMOR								No			NO	Primary Tumor	01			YES	NO	YES	B6	Breast	A	DECEASED	1990	TCGA-B6-A0I6-01A-11D-A128-09			TCGA-B6-A0I6-01A-11R-A035-13	TCGA-B6-A0I6-01A-11D-A128-09	4b55651d-88f5-411e-9986-702e8173a3d9	TCGA-B6-A0I6-01A-11D-A128-09	TCGA-B6-A0I6-01A-21-A13B-20	TCGA-B6-A0I6-01A-11D-A128-09	09c248f8-cdd7-4c13-9085-26c56544bcf7	ba92130c-fd4f-492f-b4c8-8420a9d017f9		09c248f8-cdd7-4c13-9085-26c56544bcf7		TCGA-B6-A0I6-01	TCGA-B6-A0I6-01A-11R-A034-07	09c248f8-cdd7-4c13-9085-26c56544bcf7	09c248f8-cdd7-4c13-9085-26c56544bcf7		TCGA-B6-A0I6-01		TCGA-B6-A0I6-01A-11D-A032-05	ba92130c-fd4f-492f-b4c8-8420a9d017f9	TCGA-B6-A0I6-01A-11R-A035-13
TCGA-B6-A0I8-01		46		No_Conversion	749	749		FEMALE					Negative	M0	Negative	N0	749	1	LumA	Luminal A		Her2	0	-3	followup	T1	T1	DECEASED	1	TCGA-B6-A0I8-01	749	1		C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-B6-A0I8	746	1	749	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	YES	YES		46	Right Upper Inner Quadrant|Right	No axillary staging		TCGA-B6-A0I8-F12607								Other		NO		746	-17073	6372	749	0				746								Scheduled Follow-up Submission	2011-6-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES	Biopsy, NOS	Other method, specify:	190	NO					Negative	Indeterminate (neither Pre or Postmenopausal)																		2	4				Other, specify	Locoregional Disease	Pectoral muscle		YES			true	M0	NX	T1	Stage X	TCGA-B6-A0I8.E958CD3C-EE14-4CE1-B55C-7830E320F6AE.pdf	1	1	0	0	0	0	0	0	0	1	10	9	90	90	90	90	WITH TUMOR								Yes			NO	Primary Tumor	01	Excisional biopsy		YES	NO	YES	B6	Breast	A	DECEASED	1992	TCGA-B6-A0I8-01A-11W-A050-09			TCGA-B6-A0I8-01A-11R-A035-13	TCGA-B6-A0I8-01A-11W-A050-09	b8370b84-548e-42c1-8cf5-435502ae0050	TCGA-B6-A0I8-01A-11W-A050-09	TCGA-B6-A0I8-01A-21-A13B-20	TCGA-B6-A0I8-01A-11W-A050-09	c71ca9f7-248f-460c-b5d3-afb2c648fef2	20605d45-0b1d-4c98-a2fe-8ad7e9f81b22		c71ca9f7-248f-460c-b5d3-afb2c648fef2		TCGA-B6-A0I8-01	TCGA-B6-A0I8-01A-11R-A034-07	c71ca9f7-248f-460c-b5d3-afb2c648fef2	c71ca9f7-248f-460c-b5d3-afb2c648fef2		TCGA-B6-A0I8-01		TCGA-B6-A0I8-01A-11D-A032-05	20605d45-0b1d-4c98-a2fe-8ad7e9f81b22	TCGA-B6-A0I8-01A-11R-A035-13
TCGA-B6-A0I9-01	Stage IV	62	5	No_Conversion	369	369	Indeterminate	FEMALE	Positive	1	1	1	Positive	M1	Negative	N0	369	1	Her2	HER2-enriched	Positive	Her2	-2	-5	followup	T_Other	T3	DECEASED	1	TCGA-B6-A0I9-01	369	1	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-B6-A0I9	369	0	369	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Left Lower Outer Quadrant|Left	No axillary staging		TCGA-B6-A0I9-F12609		Indeterminate					Positive	Other		NO			-22791	6694	369	0							IHC		Bone			Scheduled Follow-up Submission	2011-6-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	180	NO					Negative	Indeterminate (neither Pre or Postmenopausal)																		4	4								NO			true	M1	NX	T3	Stage IV	TCGA-B6-A0I9.291884D2-FDFD-4C98-BA19-1A0824ABB68F.pdf	1	1	0	0	0	2	0	0	0	0	20	8	80	90	80	90	WITH TUMOR	IHC							No			YES	Primary Tumor	01	Excisional biopsy		YES	NO	YES	B6	Breast	A	DECEASED	1992	TCGA-B6-A0I9-01A-11W-A050-09	TCGA-B6-A0I9-01		TCGA-B6-A0I9-01A-11R-A035-13	TCGA-B6-A0I9-01A-11W-A050-09	be91388f-7261-4e1a-94a0-29215be9bb4d	TCGA-B6-A0I9-01A-11W-A050-09	TCGA-B6-A0I9-01A-21-A13B-20	TCGA-B6-A0I9-01A-11W-A050-09	1a99c4ba-6948-4054-96cd-62164ff4a6f0	947bb0f4-c580-43da-967d-1026abbd4e32	TCGA-B6-A0I9-01A-11D-A036-01	1a99c4ba-6948-4054-96cd-62164ff4a6f0		TCGA-B6-A0I9-01	TCGA-B6-A0I9-01A-11R-A034-07	1a99c4ba-6948-4054-96cd-62164ff4a6f0	1a99c4ba-6948-4054-96cd-62164ff4a6f0	TCGA-B6-A0I9-01A-11D-A036-01	TCGA-B6-A0I9-01	TCGA-B6-A0I9-01	TCGA-B6-A0I9-01A-11D-A032-05	947bb0f4-c580-43da-967d-1026abbd4e32	TCGA-B6-A0I9-01A-11R-A035-13
TCGA-B6-A0IA-01	Stage IIA	51	4	Stage IIA	6718		Positive	FEMALE	Negative				Negative	M0	Negative	N0	6718	0	LumA	Luminal A	Positive		-12	-3	followup	T_Other	T2	LIVING	0	TCGA-B6-A0IA-01	6719	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 12	cluster 4	mutation c1uster 9	TCGA-B6-A0IA	6719	0	6719	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Right	Axillary lymph node dissection alone		TCGA-B6-A0IA-F12610		Positive					Positive	Other		NO			-18748	6664		0	6719						IHC					Scheduled Follow-up Submission	2011-6-1	FEMALE										Other  specify	Ductal/Cribiform	No		C50.9	8523/3	C50.9		YES	Biopsy, NOS	Other method, specify:	70	NO				15	Negative	Indeterminate (neither Pre or Postmenopausal)																		2	4								NO	0		true	M0	N0 (i-)	T2	Stage IIA	TCGA-B6-A0IA.55F3F917-E441-4C10-A3E3-0645A4E8374E.pdf	1	1	0	0	0	1	0	0	0	0	15	14	85	85	85	85	TUMOR FREE	IHC							No			NO	Primary Tumor	01	Excisional biopsy		YES	NO	YES	B6	Breast	A	LIVING	1992	TCGA-B6-A0IA-01A-11W-A050-09	TCGA-B6-A0IA-01		TCGA-B6-A0IA-01A-11R-A035-13	TCGA-B6-A0IA-01A-11W-A050-09		TCGA-B6-A0IA-01A-11W-A050-09		TCGA-B6-A0IA-01A-11W-A050-09	80cfaf9d-f0aa-4a35-918a-2eaad05b3a5a	8b4314b3-0f2a-4451-87ff-ad498c7a1ab9	TCGA-B6-A0IA-01A-11D-A036-01	80cfaf9d-f0aa-4a35-918a-2eaad05b3a5a		TCGA-B6-A0IA-01	TCGA-B6-A0IA-01A-11R-A034-07	80cfaf9d-f0aa-4a35-918a-2eaad05b3a5a	80cfaf9d-f0aa-4a35-918a-2eaad05b3a5a	TCGA-B6-A0IA-01A-11D-A036-01	TCGA-B6-A0IA-01	TCGA-B6-A0IA-01	TCGA-B6-A0IA-01A-11D-A032-05	8b4314b3-0f2a-4451-87ff-ad498c7a1ab9	TCGA-B6-A0IA-01A-11R-A035-13
TCGA-B6-A0IB-01	Stage IV	64	4	No_Conversion	3941	3941	Positive	FEMALE	Negative	1	3	4	Positive	M1	Positive	N3	3941	1	LumB	Luminal B	Positive	LumA/B	0	-3	followup	T_Other	T3	DECEASED	1	TCGA-B6-A0IB-01	3941	1	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-B6-A0IB	2717	1	3941	Breast	TCGA Breast Cancer	breast invasive carcinoma			NO		64	Right Upper Inner Quadrant|Right	Axillary lymph node dissection alone		TCGA-B6-A0IB-F12612	Positive	Positive					Positive	Modified Radical Mastectomy		NO			-23646	6660	3941	0				2717			IHC		Other, specify	Skin		Scheduled Follow-up Submission	2011-6-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	150	NO				15	Negative	Indeterminate (neither Pre or Postmenopausal)	fmol/mg			image cytometry	Positive											image cytometry	Positive	4	1				Other, specify	Distant Metastasis	lung, bone, liver		YES	8		true	M1	N3	T3	Stage IV	TCGA-B6-A0IB.CFC4801B-04BD-4FFC-911A-7B88E2FA4B49.pdf	1	2	0	0	0	0	0	0	0	0	15	15	85	85	85	85	WITH TUMOR	IHC		fmol/mg					No			NO	Primary Tumor	01			YES	NO	YES	B6	Breast	A	DECEASED	1992	TCGA-B6-A0IB-01A-11W-A050-09	TCGA-B6-A0IB-01		TCGA-B6-A0IB-01A-11R-A035-13	TCGA-B6-A0IB-01A-11W-A050-09	5e4f32df-eccb-4283-b97e-41addb397f4b	TCGA-B6-A0IB-01A-11W-A050-09	TCGA-B6-A0IB-01A-21-A13B-20	TCGA-B6-A0IB-01A-11W-A050-09	9857acef-08eb-43d6-b086-4b513e23753a	b7d03467-5de2-47e1-9f1b-2ab9e2a968f4	TCGA-B6-A0IB-01A-11D-A036-01	9857acef-08eb-43d6-b086-4b513e23753a		TCGA-B6-A0IB-01	TCGA-B6-A0IB-01A-11R-A034-07	9857acef-08eb-43d6-b086-4b513e23753a	9857acef-08eb-43d6-b086-4b513e23753a	TCGA-B6-A0IB-01A-11D-A036-01	TCGA-B6-A0IB-01	TCGA-B6-A0IB-01	TCGA-B6-A0IB-01A-11D-A032-05	b7d03467-5de2-47e1-9f1b-2ab9e2a968f4	TCGA-B6-A0IB-01A-11R-A035-13
TCGA-B6-A0IC-01		90	2	No_Conversion	1542	1542	Positive	FEMALE	Negative						Negative	N0	1542	1	LumA	Luminal B	Positive		-12	-3	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0IC-01	1542	1	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-B6-A0IC	1542	0	1542	Breast	TCGA Breast Cancer	breast invasive carcinoma					90	Right	No axillary staging		TCGA-B6-A0IC-F12613		Positive					Positive	Other		NO			-32872	6475	1542	0							IHC					Scheduled Follow-up Submission	2011-6-1	FEMALE										Other  specify	Invasive Papillary	No		C50.9	8503/3	C50.9		YES		Fine needle aspiration biopsy	100	NO					Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO			true	MX	NX	T2	Stage X	TCGA-B6-A0IC.8AABC46F-03C7-4FBF-AC20-2C862E303A8B.pdf	1	0	0	0	0	0	0	0	0	0	15	5	85	95	85	95	TUMOR FREE	IHC							No			NO	Primary Tumor	01	Excisional biopsy		NO	NO	YES	B6	Breast	A	DECEASED	1992	TCGA-B6-A0IC-01A-11W-A050-09	TCGA-B6-A0IC-01		TCGA-B6-A0IC-01A-11R-A035-13	TCGA-B6-A0IC-01A-11W-A050-09		TCGA-B6-A0IC-01A-11W-A050-09		TCGA-B6-A0IC-01A-11W-A050-09	718599d7-723a-4121-ac07-51120cde9af1	3f92a9cb-5bd0-44b4-bc75-efe4b8c29b92	TCGA-B6-A0IC-01A-11D-A036-01	718599d7-723a-4121-ac07-51120cde9af1		TCGA-B6-A0IC-01	TCGA-B6-A0IC-01A-11R-A034-07	718599d7-723a-4121-ac07-51120cde9af1	718599d7-723a-4121-ac07-51120cde9af1	TCGA-B6-A0IC-01A-11D-A036-01	TCGA-B6-A0IC-01	TCGA-B6-A0IC-01	TCGA-B6-A0IC-01A-11D-A032-05	3f92a9cb-5bd0-44b4-bc75-efe4b8c29b92	TCGA-B6-A0IC-01A-11R-A035-13
TCGA-B6-A0IE-01		38	3	No_Conversion	1998	1998	Negative	FEMALE	Negative				Negative	M0	Positive	N1	1998	1	LumA	Normal-like	Negative		-2	-3	followup		TX	DECEASED	1	TCGA-B6-A0IE-01	1999	1	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-B6-A0IE	840	1	1999	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	YES	NO		38	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-B6-A0IE-F12614	Negative	Negative				Modified radical mastectomy	Negative	Other		NO			-13976	5563	1999	0				840			Image Analysis					Scheduled Follow-up Submission	2011-6-1	FEMALE										Mixed Histology (please specify)	Lobular/Ductal	No		C50.9	8520/3	C50.9		YES	Biopsy, NOS	Other method, specify:	90	NO				24	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4				Bone	Distant Metastasis			YES	6		true	M0	N1b	TX	Stage Tis	TCGA-B6-A0IE.DFCA9C6E-710E-4645-9CFC-A908AAD583F3.pdf	2	1	0	0	2	2	0	0	0	0	28	18	70	80	70	80	WITH TUMOR	Image Analysis							No			YES	Primary Tumor	01	Excisional biopsy		YES	NO	YES	B6	Breast	A	DECEASED	1995	TCGA-B6-A0IE-01A-11W-A050-09	TCGA-B6-A0IE-01		TCGA-B6-A0IE-01A-11R-A035-13	TCGA-B6-A0IE-01A-11W-A050-09		TCGA-B6-A0IE-01A-11W-A050-09		TCGA-B6-A0IE-01A-11W-A050-09	f40b4aa3-b474-4c2e-a197-0347e46d3309	0716b4fb-1209-4a73-b14f-245d7277c7f3	TCGA-B6-A0IE-01A-11D-A036-01	f40b4aa3-b474-4c2e-a197-0347e46d3309		TCGA-B6-A0IE-01	TCGA-B6-A0IE-01A-11R-A034-07	f40b4aa3-b474-4c2e-a197-0347e46d3309	f40b4aa3-b474-4c2e-a197-0347e46d3309	TCGA-B6-A0IE-01A-11D-A036-01	TCGA-B6-A0IE-01	TCGA-B6-A0IE-01	TCGA-B6-A0IE-01A-11D-A032-05	0716b4fb-1209-4a73-b14f-245d7277c7f3	TCGA-B6-A0IE-01A-11R-A035-13
TCGA-B6-A0IG-01	Stage IIB	50		No_Conversion	4456	4456	Positive	FEMALE					Negative	M0	Positive	N1	4456	1	LumA	Luminal A	Positive	Her2	-2	0	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0IG-01	4456	1	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 6	cluster 7	mutation cluster 12	TCGA-B6-A0IG			4456	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Left	Axillary lymph node dissection alone		TCGA-B6-A0IG-F12616		Positive					Positive	Modified Radical Mastectomy		NO			-18433	5836	4456	0							Image Analysis					Scheduled Follow-up Submission	2011-6-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES	Biopsy, NOS	Other method, specify:	200	NO				16	Negative	Indeterminate (neither Pre or Postmenopausal)																		4	7									4		true	M0	N1b	T2	Stage IIB	TCGA-B6-A0IG.4379DEE0-F7CB-4A73-8828-21EA0AA830F5.pdf	1	2	0	0	1	0	0	0	2	5	17	25	80	70	80	70	WITH TUMOR	Image Analysis							No			YES	Primary Tumor	01			YES	NO	YES	B6	Breast	A	DECEASED	1994	TCGA-B6-A0IG-01A-11W-A050-09	TCGA-B6-A0IG-01		TCGA-B6-A0IG-01A-11R-A035-13		439c88c2-8efe-4981-96b8-015a9360ec6a	TCGA-B6-A0IG-01A-11W-A050-09	TCGA-B6-A0IG-01A-21-A13B-20	TCGA-B6-A0IG-01A-11W-A050-09	463d3f12-16bb-456a-8fb1-f200c7996406	9c3fcdbc-c563-416e-8cd4-b95d15b9bee9	TCGA-B6-A0IG-01A-11D-A036-01	463d3f12-16bb-456a-8fb1-f200c7996406		TCGA-B6-A0IG-01	TCGA-B6-A0IG-01A-11R-A034-07	463d3f12-16bb-456a-8fb1-f200c7996406	463d3f12-16bb-456a-8fb1-f200c7996406	TCGA-B6-A0IG-01A-11D-A036-01	TCGA-B6-A0IG-01	TCGA-B6-A0IG-01	TCGA-B6-A0IG-01A-11D-A032-05	9c3fcdbc-c563-416e-8cd4-b95d15b9bee9	TCGA-B6-A0IG-01A-11R-A035-13
TCGA-B6-A0IH-01	Stage IIIA	81	2	Stage IIIA		3418	Positive	FEMALE	Negative				Negative	M0	Positive	N1	3418	1	LumA	Luminal A	Positive		-5	-7	followup	T_Other	T3	DECEASED	1	TCGA-B6-A0IH-01	3418	1	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-B6-A0IH			3418	Breast	TCGA Breast Cancer	breast invasive carcinoma					81	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-B6-A0IH-F12617	Negative	Positive				Modified radical mastectomy	Positive	Other		NO			-29907	5388	3418	0							Image Analysis					Scheduled Follow-up Submission	2011-6-2	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES		Excisional Biopsy	110	NO				27	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6									25		true	M0	N1b	T3	Stage IIIA	TCGA-B6-A0IH.12C64846-1CB3-42E4-B307-54C7AD12F530.pdf	2	2	0	0	0	0	0	0	6	0	69	25	25	75	25	75		Image Analysis						YES	No			YES	Primary Tumor	01	Excisional biopsy	6th	YES	NO	YES	B6	Breast	A	DECEASED	1995	TCGA-B6-A0IH-01A-11D-A10Y-09	TCGA-B6-A0IH-01	TCGA-B6-A0IH-01A-11R-A114-13	TCGA-B6-A0IH-01A-11R-A114-13	TCGA-B6-A0IH-01A-11D-A10Y-09		TCGA-B6-A0IH-01A-11D-A10Y-09		TCGA-B6-A0IH-01A-11D-A10Y-09	76fabc98-ad85-4315-8653-4028e24cd2ff	79e2c7cc-5875-41c6-9586-301a4aea7597	TCGA-B6-A0IH-01A-11D-A111-01	76fabc98-ad85-4315-8653-4028e24cd2ff		TCGA-B6-A0IH-01	TCGA-B6-A0IH-01A-11R-A115-07	76fabc98-ad85-4315-8653-4028e24cd2ff	76fabc98-ad85-4315-8653-4028e24cd2ff	TCGA-B6-A0IH-01A-11D-A111-01	TCGA-B6-A0IH-01	TCGA-B6-A0IH-01	TCGA-B6-A0IH-01A-11D-A112-05	79e2c7cc-5875-41c6-9586-301a4aea7597	
TCGA-B6-A0IJ-01	Stage IIB	42	3	Stage IIB	5383		Positive	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	5383	0	Basal	Basal-like	Positive	Basal	-13	-12	followup	T_Other	T3	LIVING	0	TCGA-B6-A0IJ-01	5383	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	squamous c3	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-B6-A0IJ	5383	0	5383	Breast	TCGA Breast Cancer	breast invasive carcinoma					42	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-B6-A0IJ-F12619		Positive					Positive	Modified Radical Mastectomy		NO			-15625	5350		0	5383						Image Analysis					Scheduled Follow-up Submission	2011-6-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Excisional Biopsy	170	NO				27	Negative	Indeterminate (neither Pre or Postmenopausal)																		5	5								NO	0		true	M0	N0 (i-)	T3	Stage IIB	TCGA-B6-A0IJ.F3BAF04C-35EE-450F-BFA8-E9DFE9F984FD.pdf	1	0	0	0	1	2	0	0	0	0	4	3	95	95	95	95	TUMOR FREE	Image Analysis							No			NO	Primary Tumor	01			YES	NO	YES	B6	Breast	A	LIVING	1995	TCGA-B6-A0IJ-01A-11W-A050-09	TCGA-B6-A0IJ-01		TCGA-B6-A0IJ-01A-11R-A035-13	TCGA-B6-A0IJ-01A-11W-A050-09	25933fc4-60a0-4223-af5f-c8eed92f0f02	TCGA-B6-A0IJ-01A-11W-A050-09	TCGA-B6-A0IJ-01A-21-A13B-20	TCGA-B6-A0IJ-01A-11W-A050-09	f77e9ef0-0a62-426b-98d9-6813edeb63a5	6c71c171-be2a-4eac-bae9-841c1192ab61	TCGA-B6-A0IJ-01A-11D-A036-01	f77e9ef0-0a62-426b-98d9-6813edeb63a5		TCGA-B6-A0IJ-01	TCGA-B6-A0IJ-01A-11R-A034-07	f77e9ef0-0a62-426b-98d9-6813edeb63a5	f77e9ef0-0a62-426b-98d9-6813edeb63a5	TCGA-B6-A0IJ-01A-11D-A036-01	TCGA-B6-A0IJ-01	TCGA-B6-A0IJ-01	TCGA-B6-A0IJ-01A-11D-A032-05	6c71c171-be2a-4eac-bae9-841c1192ab61	TCGA-B6-A0IJ-01A-11R-A035-13
TCGA-B6-A0IK-01	Stage IIIB	63	5	No_Conversion	571	571	Negative	FEMALE	Negative	1	1	1	Negative	M0	Positive	N1	571	1	Her2	HER2-enriched	Negative	ReacII	-11	-5	followup	T_Other	T4	DECEASED	1	TCGA-B6-A0IK-01	571	1	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-B6-A0IK	489	1	571	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	YES	YES		63	Left			TCGA-B6-A0IK-F12621	Negative	Negative				Modified radical mastectomy	Negative	Lumpectomy		NO		489	-23150	5724	571	0				489			Image Analysis					Scheduled Follow-up Submission	2011-6-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	140	NO				14	Positive	Indeterminate (neither Pre or Postmenopausal)																		4	4				Brain	Distant Metastasis			YES	1		true	M0	N1	T4	Stage IIIB	TCGA-B6-A0IK.3A38A97C-2CBB-4802-9528-A4BBD62AEA4A.pdf	3	2	0	0	1	2	0	0	4	0	30	23	65	75	65	75	WITH TUMOR	Image Analysis							No			NO	Primary Tumor	01			YES	NO	YES	B6	Breast	A	DECEASED	1994	TCGA-B6-A0IK-01A-12W-A071-09	TCGA-B6-A0IK-01		TCGA-B6-A0IK-01A-12R-A057-13	TCGA-B6-A0IK-01A-12W-A071-09	3d6a2ce9-3d70-4bec-80f1-bd5035ae2b3d	TCGA-B6-A0IK-01A-12W-A071-09	TCGA-B6-A0IK-01A-21-A13B-20	TCGA-B6-A0IK-01A-12W-A071-09	8fb338fe-ffa8-45c2-857b-f713d1935330	e0a41bf9-0af4-4a94-9b08-724a938ae4ae	TCGA-B6-A0IK-01A-12D-A059-01	8fb338fe-ffa8-45c2-857b-f713d1935330	TCGA-B6-A0IK-01A-12D-A10P-05	TCGA-B6-A0IK-01	TCGA-B6-A0IK-01A-12R-A056-07	8fb338fe-ffa8-45c2-857b-f713d1935330	8fb338fe-ffa8-45c2-857b-f713d1935330	TCGA-B6-A0IK-01A-12D-A059-01	TCGA-B6-A0IK-01	TCGA-B6-A0IK-01		e0a41bf9-0af4-4a94-9b08-724a938ae4ae	TCGA-B6-A0IK-01A-12R-A057-13
TCGA-B6-A0IM-01	Stage IIB	75	4	Stage IIB	3836		Positive	FEMALE	Negative				Negative	M0	Negative	N0	3836	0	LumA	Luminal B	Positive		-10	-3	followup	T_Other	T3	LIVING	0	TCGA-B6-A0IM-01	3836	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-B6-A0IM	3836	0	3836	Breast	TCGA Breast Cancer	breast invasive carcinoma					75	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-B6-A0IM-F12623	Negative	Positive				Modified radical mastectomy	Positive	Lumpectomy		NO			-27557	4754		0	3836						Image Analysis					Scheduled Follow-up Submission	2011-6-2	FEMALE										Other  specify	Ductal/cribiform	No		C50.9	8523/3	C50.4		YES		Fine needle aspiration biopsy	110	NO				9	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	0		true	M0	N0 (i-)	T3	Stage IIB	TCGA-B6-A0IM.4A86A028-C56D-455E-A5CD-47D8A34B5734.pdf	1	1	0	0	0	0	0	0	0	2	20	18	80	80	80	80	TUMOR FREE	Image Analysis							No			NO	Primary Tumor	01			YES	NO	YES	B6	Breast	A	LIVING	1997	TCGA-B6-A0IM-01A-11W-A050-09	TCGA-B6-A0IM-01		TCGA-B6-A0IM-01A-11R-A035-13	TCGA-B6-A0IM-01A-11W-A050-09		TCGA-B6-A0IM-01A-11W-A050-09		TCGA-B6-A0IM-01A-11W-A050-09	53f4d557-cad7-4367-9546-c10752cc6189	a12ef456-3010-4ec9-a428-0259be208606	TCGA-B6-A0IM-01A-11D-A036-01	53f4d557-cad7-4367-9546-c10752cc6189		TCGA-B6-A0IM-01	TCGA-B6-A0IM-01A-11R-A034-07	53f4d557-cad7-4367-9546-c10752cc6189	53f4d557-cad7-4367-9546-c10752cc6189	TCGA-B6-A0IM-01A-11D-A036-01	TCGA-B6-A0IM-01	TCGA-B6-A0IM-01	TCGA-B6-A0IM-01A-11D-A032-05	a12ef456-3010-4ec9-a428-0259be208606	TCGA-B6-A0IM-01A-11R-A035-13
TCGA-B6-A0IN-01		45	3	No_Conversion	2573	2573	Positive	FEMALE							Negative	N0	2573	1	LumB	Luminal A	Negative		-2	-3	followup	T1	T1	DECEASED	1	TCGA-B6-A0IN-01	2573	1	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-B6-A0IN	1412	1	2573	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES		NO		45	Right Upper Outer Quadrant|Right	No axillary staging		TCGA-B6-A0IN-F12625	Negative	Positive				Modified radical mastectomy	Negative	Other		NO			-16705	5073	2573	0				1412			Image Analysis					Scheduled Follow-up Submission	2011-6-2	FEMALE										Other  specify	Ductal with mucinous features	No		C50.9	8523/3	C50.9		YES		Fine needle aspiration biopsy	20	NO					Positive	Indeterminate (neither Pre or Postmenopausal)																		4	1				Other, specify	Distant Metastasis	bone, brain		YES			true	MX	NX	T1c	Stage X	TCGA-B6-A0IN.267F1EFD-AB89-4124-B803-00CC0E8E9CD2.pdf		1		0		0		0		0		10		90		90	WITH TUMOR	Image Analysis							No			NO	Primary Tumor	01	Excisional biopsy		YES	NO	YES	B6	Breast	A	DECEASED	1996	TCGA-B6-A0IN-01A-11W-A050-09	TCGA-B6-A0IN-01		TCGA-B6-A0IN-01A-11R-A035-13	TCGA-B6-A0IN-01A-11W-A050-09		TCGA-B6-A0IN-01A-11W-A050-09		TCGA-B6-A0IN-01A-11W-A050-09	4eaae575-d631-4e2e-8e70-4b4e0a429d74	83dfa7a2-901f-40ed-ab73-fa8f0a938566	TCGA-B6-A0IN-01A-11D-A036-01	4eaae575-d631-4e2e-8e70-4b4e0a429d74		TCGA-B6-A0IN-01	TCGA-B6-A0IN-01A-11R-A034-07	4eaae575-d631-4e2e-8e70-4b4e0a429d74	4eaae575-d631-4e2e-8e70-4b4e0a429d74	TCGA-B6-A0IN-01A-11D-A036-01	TCGA-B6-A0IN-01	TCGA-B6-A0IN-01	TCGA-B6-A0IN-01A-11D-A032-05	83dfa7a2-901f-40ed-ab73-fa8f0a938566	TCGA-B6-A0IN-01A-11R-A035-13
TCGA-B6-A0IO-01	Stage IIA	66	3	Stage IIA	3350		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	3350	0	LumA	Luminal A	Indeterminate	X	0	-3	followup	T_Other	T2	LIVING	0	TCGA-B6-A0IO-01	3350	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-B6-A0IO	3350	0	3350	Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Left	Axillary lymph node dissection alone		TCGA-B6-A0IO-F12626		Positive					Indeterminate	Modified Radical Mastectomy		NO			-24322			0	3350						Image Analysis					Scheduled Follow-up Submission	2011-6-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Core needle biopsy						17	Negative	Indeterminate (neither Pre or Postmenopausal)																		2	1								NO	0			M0	N0 (i-)	T2	Stage IIA																		TUMOR FREE	Image Analysis							No			NO	Primary Tumor	01			YES	NO	YES	B6	Breast		LIVING	2001	TCGA-B6-A0IO-01A-11W-A050-09	TCGA-B6-A0IO-01		TCGA-B6-A0IO-01A-11R-A035-13		f7075f2f-6892-4338-b042-1c48529275bd	TCGA-B6-A0IO-01A-11W-A050-09	TCGA-B6-A0IO-01A-21-A13B-20	TCGA-B6-A0IO-01A-11W-A050-09	e7a1527b-dbaf-48ae-a322-e54efd36985d	e9f6dacc-c812-45f5-8ec1-d70866537325	TCGA-B6-A0IO-01A-11D-A036-01	e7a1527b-dbaf-48ae-a322-e54efd36985d		TCGA-B6-A0IO-01	TCGA-B6-A0IO-01A-11R-A034-07	e7a1527b-dbaf-48ae-a322-e54efd36985d	e7a1527b-dbaf-48ae-a322-e54efd36985d	TCGA-B6-A0IO-01A-11D-A036-01	TCGA-B6-A0IO-01	TCGA-B6-A0IO-01	TCGA-B6-A0IO-01A-11D-A032-05	e9f6dacc-c812-45f5-8ec1-d70866537325	TCGA-B6-A0IO-01A-11R-A035-13
TCGA-B6-A0IP-01	Stage IA	74	2	Stage I	3374		Positive	FEMALE	Negative				Negative	M0	Negative	N0	3374	0	LumA	Luminal A	Positive		-5	0	followup	T1	T1	LIVING	0	TCGA-B6-A0IP-01	3374	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-B6-A0IP	3374	0	3374	Breast	TCGA Breast Cancer	breast invasive carcinoma					74	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-B6-A0IP-F12628		Positive					Positive	Modified Radical Mastectomy		NO			-27047	4565		0	3374						IMAGE ALYSIS					Scheduled Follow-up Submission	2011-6-2	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	80	NO				16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO	0		true	M0	N0 (i-)	T1c	Stage IA	TCGA-B6-A0IP.6C91D49C-9738-4A4F-A480-E71CD8EE5268.pdf	1	1	0	0	2	0	0	0	0	0	23	15	75	85	75	85	TUMOR FREE	IMAGE ALYSIS						YES	No			NO	Primary Tumor	01			NO	NO	YES	B6	Breast	A	LIVING	1997	TCGA-B6-A0IP-01A-11D-A045-09	TCGA-B6-A0IP-01		TCGA-B6-A0IP-01A-11R-A035-13			TCGA-B6-A0IP-01A-11D-A045-09		TCGA-B6-A0IP-01A-11D-A045-09	9384eb09-5787-49e8-b07e-bd9f71997771	12dff233-d164-4560-8045-1712fd973416	TCGA-B6-A0IP-01A-11D-A036-01	9384eb09-5787-49e8-b07e-bd9f71997771		TCGA-B6-A0IP-01	TCGA-B6-A0IP-01A-11R-A034-07	9384eb09-5787-49e8-b07e-bd9f71997771	9384eb09-5787-49e8-b07e-bd9f71997771	TCGA-B6-A0IP-01A-11D-A036-01	TCGA-B6-A0IP-01	TCGA-B6-A0IP-01	TCGA-B6-A0IP-01A-11D-A032-05	12dff233-d164-4560-8045-1712fd973416	TCGA-B6-A0IP-01A-11R-A035-13
TCGA-B6-A0IQ-01	Stage IIIA	40	1	No_Conversion	4284		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	4284	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T3	LIVING	0	TCGA-B6-A0IQ-01	4285	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 5	mutation cluster 5	TCGA-B6-A0IQ	4285	0	4285	Breast	TCGA Breast Cancer	breast invasive carcinoma					40	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-B6-A0IQ-F12629		Negative					Negative	Modified Radical Mastectomy		NO			-14669	5238		0	4285						Image Analysis					Scheduled Follow-up Submission	2011-6-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	210	NO				26	Negative	Indeterminate (neither Pre or Postmenopausal)																		5	5								NO	1		true	M0	N1b	T3	Stage IIIA	TCGA-B6-A0IQ.0ED7357E-662C-4D65-82ED-29739919068F.pdf	1	2	0	0	0	0	0	0	0	0	15	20	85	80	85	80	TUMOR FREE	Image Analysis							No			YES	Primary Tumor	01			YES	NO	YES	B6	Breast	A	LIVING	1996	TCGA-B6-A0IQ-01A-11W-A050-09	TCGA-B6-A0IQ-01		TCGA-B6-A0IQ-01A-11R-A035-13		940d8074-3223-49f6-8d86-d50e9ae69c9b	TCGA-B6-A0IQ-01A-11W-A050-09	TCGA-B6-A0IQ-01A-21-A13B-20	TCGA-B6-A0IQ-01A-11W-A050-09	2e9c893c-1d72-49a7-8755-1ede20b26fcf	758e3752-e267-4bb3-be83-a88b6eb7e9fc	TCGA-B6-A0IQ-01A-11D-A036-01	2e9c893c-1d72-49a7-8755-1ede20b26fcf		TCGA-B6-A0IQ-01	TCGA-B6-A0IQ-01A-11R-A034-07	2e9c893c-1d72-49a7-8755-1ede20b26fcf	2e9c893c-1d72-49a7-8755-1ede20b26fcf	TCGA-B6-A0IQ-01A-11D-A036-01	TCGA-B6-A0IQ-01	TCGA-B6-A0IQ-01	TCGA-B6-A0IQ-01A-11D-A032-05	758e3752-e267-4bb3-be83-a88b6eb7e9fc	TCGA-B6-A0IQ-01A-11R-A035-13
TCGA-B6-A0RE-01		61	1	No_Conversion	6434		Negative	FEMALE	Negative				Negative	M0	Negative	N0	6434	0	Basal	Basal-like	Negative		-13	-12	followup		TX	LIVING	0	TCGA-B6-A0RE-01	6435	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-B6-A0RE	6435	0	6435	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-B6-A0RE-F13792		Negative					Negative	Modified Radical Mastectomy		NO			-22449	7492		0	6435											Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Other method, specify:	90	NO				14	Negative	Indeterminate (neither Pre or Postmenopausal)																		5	4								NO	0		true	M0	N0 (i-)	TX	Stage X	TCGA-B6-A0RE.5607C6CE-21D5-495E-9174-85F1E2E0CB9D.pdf	0	0	0	0	0	0	0	0	0	0	20	20	80	80	80	80	TUMOR FREE								No			YES	Primary Tumor	01			NO	NO	YES	B6	Breast	A	LIVING	1989	TCGA-B6-A0RE-01A-11W-A071-09	TCGA-B6-A0RE-01		TCGA-B6-A0RE-01A-11R-A057-13	TCGA-B6-A0RE-01A-11W-A071-09		TCGA-B6-A0RE-01A-11W-A071-09		TCGA-B6-A0RE-01A-11W-A071-09	ad46ed65-3cc2-4956-9d90-3e1edca24417	268d0a2b-cd03-425f-8775-4202f6a2e339	TCGA-B6-A0RE-01A-11D-A059-01	ad46ed65-3cc2-4956-9d90-3e1edca24417	TCGA-B6-A0RE-01A-11D-A10P-05	TCGA-B6-A0RE-01	TCGA-B6-A0RE-01A-11R-A056-07	ad46ed65-3cc2-4956-9d90-3e1edca24417	ad46ed65-3cc2-4956-9d90-3e1edca24417	TCGA-B6-A0RE-01A-11D-A059-01	TCGA-B6-A0RE-01	TCGA-B6-A0RE-01		268d0a2b-cd03-425f-8775-4202f6a2e339	TCGA-B6-A0RE-01A-11R-A057-13
TCGA-B6-A0RG-01	Stage IIB	26	2	Stage IIB	2082		Negative	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	2082	0	LumA	Luminal A	Negative	ReacII	0	-3	followup	T_Other	T3	LIVING	0	TCGA-B6-A0RG-01	2082	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3	cluster 4	mutation cluster 4	TCGA-B6-A0RG	2082	0	2082	Breast	TCGA Breast Cancer	breast invasive carcinoma					26	Left	Axillary lymph node dissection alone		TCGA-B6-A0RG-F13793		Negative					Negative	Lumpectomy		NO			-9840	6869		0	2082						IHC					Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES	Biopsy, NOS	Other method, specify:	160	NO				19	Negative	Indeterminate (neither Pre or Postmenopausal)																		2	4								NO	0		true	M0	N0 (i-)	T3	Stage IIB	TCGA-B6-A0RG.0429FA9A-AD19-424C-94ED-1A902119E559.pdf	0	0	0	0	0	10	0	0	0	0	20	50	80	40	90	80	TUMOR FREE	IHC							No			NO	Primary Tumor	01			YES	NO	YES	B6	Breast	A	LIVING	1991	TCGA-B6-A0RG-01A-11W-A071-09	TCGA-B6-A0RG-01		TCGA-B6-A0RG-01A-11R-A057-13	TCGA-B6-A0RG-01A-11W-A071-09	5da7a020-3d19-499b-9941-2028de5c5a3e	TCGA-B6-A0RG-01A-11W-A071-09	TCGA-B6-A0RG-01A-21-A13C-20	TCGA-B6-A0RG-01A-11W-A071-09	006e88ce-ad31-45bf-8da5-802f0e387b3a	64c61d5d-6be8-48e4-a111-3eb9a72f9efc	TCGA-B6-A0RG-01A-11D-A059-01	006e88ce-ad31-45bf-8da5-802f0e387b3a	TCGA-B6-A0RG-01A-11D-A10P-05	TCGA-B6-A0RG-01	TCGA-B6-A0RG-01A-11R-A056-07	006e88ce-ad31-45bf-8da5-802f0e387b3a	006e88ce-ad31-45bf-8da5-802f0e387b3a	TCGA-B6-A0RG-01A-11D-A059-01	TCGA-B6-A0RG-01	TCGA-B6-A0RG-01		64c61d5d-6be8-48e4-a111-3eb9a72f9efc	TCGA-B6-A0RG-01A-11R-A057-13
TCGA-B6-A0RH-01	Stage IIA	51	2	Stage IIA	5748		Positive	FEMALE	Positive	3	3	3	Negative	M0	Negative	N0	5748	0	Her2	HER2-enriched	Positive	ReacII	-1	-5	followup	T_Other	T2	LIVING	0	TCGA-B6-A0RH-01	5749	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 3	TCGA-B6-A0RH	2165	1	5749	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	YES	YES		51	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-B6-A0RH-F13794	Negative	Positive					Positive	Modified Radical Mastectomy		NO		2268	-18759	6821		0	5749			2165			Immunohistochemistry					Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	130	NO				23	Positive	Indeterminate (neither Pre or Postmenopausal)																		2	6				Other, specify	Locoregional Disease	Chest Wall		YES	0		true	M0	N0 (i-)	T2	Stage IIA	TCGA-B6-A0RH.3801F39A-6F4B-40C0-9625-9E0818266819.pdf	0	0	0	0	0	0	0	0	0	0	60	70	40	30	60	40	TUMOR FREE	Immunohistochemistry						YES	No			NO	Primary Tumor	01		6th	YES	NO	YES	B6	Breast	A	LIVING	1991	TCGA-B6-A0RH-01A-21D-A10Y-09	TCGA-B6-A0RH-01	TCGA-B6-A0RH-01A-21R-A114-13	TCGA-B6-A0RH-01A-21R-A114-13	TCGA-B6-A0RH-01A-21D-A10Y-09	90975b3f-f130-4032-804a-88f06b0d3147	TCGA-B6-A0RH-01A-21D-A10Y-09	TCGA-B6-A0RH-01A-11-A13C-20	TCGA-B6-A0RH-01A-21D-A10Y-09	d40f62c9-c134-4477-98d7-11d343b5e867	5994c06d-ee9b-4ead-b3d1-2e1f286f7d6d	TCGA-B6-A0RH-01A-21D-A111-01	d40f62c9-c134-4477-98d7-11d343b5e867		TCGA-B6-A0RH-01	TCGA-B6-A0RH-01A-21R-A115-07	d40f62c9-c134-4477-98d7-11d343b5e867	d40f62c9-c134-4477-98d7-11d343b5e867	TCGA-B6-A0RH-01A-21D-A111-01	TCGA-B6-A0RH-01	TCGA-B6-A0RH-01	TCGA-B6-A0RH-01A-21D-A112-05	5994c06d-ee9b-4ead-b3d1-2e1f286f7d6d	
TCGA-B6-A0RI-01	Stage IIIB	44	2	No_Conversion	7125		Positive	FEMALE	Negative				Negative	M0	Positive	N1	7125	0	LumA	Luminal A	Positive		-7	-3	followup	T_Other	T4	LIVING	0	TCGA-B6-A0RI-01	7126	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-B6-A0RI	1100	1	7126	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	YES	YES		44	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-B6-A0RI-F13795		Positive					Positive	Modified Radical Mastectomy		NO		1100	-16138	6755		0	7126			1100			IHC					Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES	Biopsy, NOS	Other method, specify:	50	NO				15	Negative	Indeterminate (neither Pre or Postmenopausal)	105 fmol/mg			image cytometry	Positive					Other Reporting Scale						image cytometry	Positive	2	4			Other Reporting Scale	Other, specify	Locoregional Disease	Chest Wall		YES	6		true	M0	N1b	T4b	Stage IIIB	TCGA-B6-A0RI.F2B21F52-74F4-44C5-9991-60EBCC4E43A6.pdf	0	0	0	0	0	0	0	0	0	0	20	30	80	70	90	60	WITH TUMOR	IHC		133 fmol/mg					No			YES	Primary Tumor	01			YES	NO	YES	B6	Breast	A	LIVING	1992	TCGA-B6-A0RI-01A-11W-A071-09	TCGA-B6-A0RI-01		TCGA-B6-A0RI-01A-11R-A057-13	TCGA-B6-A0RI-01A-11W-A071-09		TCGA-B6-A0RI-01A-11W-A071-09		TCGA-B6-A0RI-01A-11W-A071-09	6f5986b6-28b9-4213-97a9-899190ea36dd	83cdf265-ec7f-40cf-ae0c-b1f28c791d7f	TCGA-B6-A0RI-01A-11D-A059-01	6f5986b6-28b9-4213-97a9-899190ea36dd	TCGA-B6-A0RI-01A-11D-A10P-05	TCGA-B6-A0RI-01	TCGA-B6-A0RI-01A-11R-A056-07	6f5986b6-28b9-4213-97a9-899190ea36dd	6f5986b6-28b9-4213-97a9-899190ea36dd	TCGA-B6-A0RI-01A-11D-A059-01	TCGA-B6-A0RI-01	TCGA-B6-A0RI-01		83cdf265-ec7f-40cf-ae0c-b1f28c791d7f	TCGA-B6-A0RI-01A-11R-A057-13
TCGA-B6-A0RL-01	Stage IIA	60	2	Stage IIA	2469	2469	Positive	FEMALE	Negative	4	3	4	Negative	M0	Negative	N0	2469	1	LumB	Luminal B	Positive	LumA/B	-10	-3	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0RL-01	2469	1	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation c1uster 10	TCGA-B6-A0RL	2469	0	2469	Breast	TCGA Breast Cancer	breast invasive carcinoma					60	Left	Axillary lymph node dissection alone		TCGA-B6-A0RL-F13796		Positive					Positive	Modified Radical Mastectomy		NO			-22238	6336	2469	0							Image Analysis					Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	170	NO				16	Negative																			3	5								NO	0		true	M0	N0 (i-)	T2	Stage IIA	TCGA-B6-A0RL.6C50D456-A828-4514-92D2-01A5900B74F1.pdf	2	2	0	0	1	1	0	0	0	0	24	19	75	80	75	80	TUMOR FREE	Image Analysis							No			NO	Primary Tumor	01			YES	NO	YES	B6	Breast	A	DECEASED	1993	TCGA-B6-A0RL-01A-11D-A099-09	TCGA-B6-A0RL-01		TCGA-B6-A0RL-01A-11R-A085-13	TCGA-B6-A0RL-01A-11D-A099-09	0ca6a866-1fd5-4144-80a9-01cc7f7caa9c		TCGA-B6-A0RL-01A-21-A13C-20	TCGA-B6-A0RL-01A-11D-A099-09	0e704d8f-c0c0-4165-83c4-a1fa93014894	6217eb8d-0841-471a-aaba-b21023267625	TCGA-B6-A0RL-01A-11D-A087-01	0e704d8f-c0c0-4165-83c4-a1fa93014894	TCGA-B6-A0RL-01A-11D-A10P-05	TCGA-B6-A0RL-01	TCGA-B6-A0RL-01A-11R-A084-07	0e704d8f-c0c0-4165-83c4-a1fa93014894	0e704d8f-c0c0-4165-83c4-a1fa93014894	TCGA-B6-A0RL-01A-11D-A087-01	TCGA-B6-A0RL-01	TCGA-B6-A0RL-01		6217eb8d-0841-471a-aaba-b21023267625	TCGA-B6-A0RL-01A-11R-A085-13
TCGA-B6-A0RM-01		57	4	No_Conversion	2373	2373	Positive	FEMALE	Negative	3	3	3			Negative	N0	2373	1	LumA	Luminal A	Positive	LumA	-10	-3	followup		TX	DECEASED	1	TCGA-B6-A0RM-01	2373	1	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-B6-A0RM	2373	0	2373	Breast	TCGA Breast Cancer	breast invasive carcinoma					57	Left	No axillary staging		TCGA-B6-A0RM-F13797		Positive					Positive	Modified Radical Mastectomy		NO			-21047	6279	2373	0							Image Analysis					Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	160	NO				0	Positive	Indeterminate (neither Pre or Postmenopausal)																		2	2								NO			true	MX	NX	TX	Stage X	TCGA-B6-A0RM.EC8093CD-66E7-4466-99AD-B2A6B93526FD.pdf	1	1	0	0	0	0	0	0	0	0	25	18	75	82	85	85	TUMOR FREE	Image Analysis							No			NO	Primary Tumor	01			NO	NO	YES	B6	Breast	A	DECEASED	1993	TCGA-B6-A0RM-01A-11D-A099-09	TCGA-B6-A0RM-01		TCGA-B6-A0RM-01A-11R-A085-13	TCGA-B6-A0RM-01A-11D-A099-09	10cf7b61-7523-4c17-a786-618537217cff		TCGA-B6-A0RM-01A-21-A13C-20	TCGA-B6-A0RM-01A-11D-A099-09	17fdb26d-d808-4b0d-a794-6b664dae8b2b	4a733db9-a92f-457b-b0ef-25a0722e9d44	TCGA-B6-A0RM-01A-11D-A087-01	17fdb26d-d808-4b0d-a794-6b664dae8b2b	TCGA-B6-A0RM-01A-11D-A10P-05	TCGA-B6-A0RM-01	TCGA-B6-A0RM-01A-11R-A084-07	17fdb26d-d808-4b0d-a794-6b664dae8b2b	17fdb26d-d808-4b0d-a794-6b664dae8b2b	TCGA-B6-A0RM-01A-11D-A087-01	TCGA-B6-A0RM-01	TCGA-B6-A0RM-01		4a733db9-a92f-457b-b0ef-25a0722e9d44	TCGA-B6-A0RM-01A-11R-A085-13
TCGA-B6-A0RN-01	Stage IA	60	2	Stage I	5261		Negative	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	5261	0	LumA	Luminal A	Negative	ReacI	-5	-3	followup	T1	T1	LIVING	0	TCGA-B6-A0RN-01	5261	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-B6-A0RN	5261	0	5261	Breast	TCGA Breast Cancer	breast invasive carcinoma					60	Right Upper Inner Quadrant|Right	Axillary lymph node dissection alone		TCGA-B6-A0RN-F13798		Negative					Negative	Modified Radical Mastectomy		NO			-22077	6286		0	5261						Image Analysis					Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	130	NO				19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO	0		true	M0	N0 (i-)	T1c	Stage IA	TCGA-B6-A0RN.5F08632D-BC1D-4414-80C1-75F67F3A07AF.pdf	2	2	0	0	0	0	0	0	0	0	20	28	80	72	85	85	TUMOR FREE	Image Analysis							No			YES	Primary Tumor	01			YES	NO	YES	B6	Breast	A	LIVING	1993	TCGA-B6-A0RN-01A-12D-A099-09	TCGA-B6-A0RN-01		TCGA-B6-A0RN-01A-12R-A085-13	TCGA-B6-A0RN-01A-12D-A099-09	734fdc04-4666-4ae2-898f-d375c47eb33b	TCGA-B6-A0RN-01A-12D-A099-09	TCGA-B6-A0RN-01A-21-A13C-20	TCGA-B6-A0RN-01A-12D-A099-09	c417152a-d278-4aeb-951e-a7b6ae5654c1	ff2a4301-de9c-46b1-9b37-4c5c20935883	TCGA-B6-A0RN-01A-12D-A087-01	c417152a-d278-4aeb-951e-a7b6ae5654c1	TCGA-B6-A0RN-01A-12D-A10P-05	TCGA-B6-A0RN-01	TCGA-B6-A0RN-01A-12R-A084-07	c417152a-d278-4aeb-951e-a7b6ae5654c1	c417152a-d278-4aeb-951e-a7b6ae5654c1	TCGA-B6-A0RN-01A-12D-A087-01	TCGA-B6-A0RN-01	TCGA-B6-A0RN-01		ff2a4301-de9c-46b1-9b37-4c5c20935883	TCGA-B6-A0RN-01A-12R-A085-13
TCGA-B6-A0RO-01	Stage IIIB	71	3	No_Conversion	4928		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	4928	0	LumA	Luminal A	Positive	ReacI	0	-3	followup	T_Other	T4	LIVING	0	TCGA-B6-A0RO-01	4929	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-B6-A0RO	4929	0	4929	Breast	TCGA Breast Cancer	breast invasive carcinoma					71	Right	Axillary lymph node dissection alone		TCGA-B6-A0RO-F13799		Positive					Positive	Modified Radical Mastectomy		NO			-26269	6035		0	4929						Image Analysis					Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	140	NO				17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	1								NO	2		true	M0	N1a	T4	Stage IIIB	TCGA-B6-A0RO.EFA0354A-641D-4EC2-A1BE-4ACC7CE421DF.pdf	1	2	0	0	3	2	0	0	0	0	27	48	70	50	80	80	TUMOR FREE	Image Analysis							No			NO	Primary Tumor	01			YES	NO	YES	B6	Breast	A	LIVING	1993	TCGA-B6-A0RO-01A-22D-A099-09	TCGA-B6-A0RO-01		TCGA-B6-A0RO-01A-22R-A085-13	TCGA-B6-A0RO-01A-22D-A099-09	02857059-5b3e-4a7a-a0e0-93ee7f90cfff	TCGA-B6-A0RO-01A-22D-A099-09	TCGA-B6-A0RO-01A-11-A13C-20	TCGA-B6-A0RO-01A-22D-A099-09	d99fef01-1eb5-4300-8031-d5a157fd5b28	c42276ca-218e-44c7-9ac3-b8fd17937399	TCGA-B6-A0RO-01A-22D-A087-01	d99fef01-1eb5-4300-8031-d5a157fd5b28	TCGA-B6-A0RO-01A-22D-A10P-05	TCGA-B6-A0RO-01	TCGA-B6-A0RO-01A-22R-A084-07	d99fef01-1eb5-4300-8031-d5a157fd5b28	d99fef01-1eb5-4300-8031-d5a157fd5b28	TCGA-B6-A0RO-01A-22D-A087-01	TCGA-B6-A0RO-01	TCGA-B6-A0RO-01		c42276ca-218e-44c7-9ac3-b8fd17937399	TCGA-B6-A0RO-01A-22R-A085-13
TCGA-B6-A0RP-01	Stage IIIB	73	4	No_Conversion	3126	3126	Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	3126	1	LumA	Luminal A	Positive	LumA	-12	-4	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0RP-01	3126	1	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-B6-A0RP	2787	1	3126	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO	NO		73	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-B6-A0RP-F13786	Negative	Positive				Modified radical mastectomy	Positive	Lumpectomy		NO			-26941		3126	0				2787			Image Analysis					Scheduled Follow-up Submission	2011-7-12	FEMALE										Mixed Histology (please specify)	ductal/lobular	No		C50.9	8522/3	C50.4		YES	Biopsy, NOS	Other method, specify:						15	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4				Bone	Distant Metastasis			YES	2			M0	N1b	T2	Stage IIIB																		WITH TUMOR	Image Analysis							No			NO	Primary Tumor	01			YES	NO	YES	B6	Breast		DECEASED	1994	TCGA-B6-A0RP-01A-21D-A099-09	TCGA-B6-A0RP-01		TCGA-B6-A0RP-01A-21R-A085-13	TCGA-B6-A0RP-01A-21D-A099-09	ac2921f3-13fa-457b-b436-1da8977a163c	TCGA-B6-A0RP-01A-21D-A099-09	TCGA-B6-A0RP-01A-11-A13C-20	TCGA-B6-A0RP-01A-21D-A099-09	a77173cb-3e81-4957-a76f-18824d5e06dd	b4881758-2563-45d9-8ad6-1121335492a8	TCGA-B6-A0RP-01A-21D-A087-01	a77173cb-3e81-4957-a76f-18824d5e06dd	TCGA-B6-A0RP-01A-21D-A10P-05	TCGA-B6-A0RP-01	TCGA-B6-A0RP-01A-21R-A084-07	a77173cb-3e81-4957-a76f-18824d5e06dd	a77173cb-3e81-4957-a76f-18824d5e06dd	TCGA-B6-A0RP-01A-21D-A087-01	TCGA-B6-A0RP-01	TCGA-B6-A0RP-01		b4881758-2563-45d9-8ad6-1121335492a8	TCGA-B6-A0RP-01A-21R-A085-13
TCGA-B6-A0RQ-01	Stage IIB	68	1	Stage IIB		4273	Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	4273	1	Normal	Luminal A	Positive	ReacI	-5	-7	followup	T_Other	T3	DECEASED	1	TCGA-B6-A0RQ-01	4273	1	Quiet	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-B6-A0RQ	4273	0	4273	Breast	TCGA Breast Cancer	breast invasive carcinoma					68	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-B6-A0RQ-F13787	Negative	Positive				Modified radical mastectomy	Positive	Other		NO			-25004	5896	4273	0							Image Analysis					Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.2		YES		Excisional Biopsy	160	NO				14	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6								NO	0		true	M0	N0 (i-)	T3	Stage IIB	TCGA-B6-A0RQ.46B892B9-82C8-4305-BCB9-805F6F5FC90A.pdf	1	2	0	0	0	0	0	0	6	10	64	45	30	45	40	60	TUMOR FREE	Image Analysis						YES	No			NO	Primary Tumor	01	excisional biopsy	6th	YES	NO	YES	B6	Breast	A	DECEASED	1994	TCGA-B6-A0RQ-01A-11D-A10Y-09	TCGA-B6-A0RQ-01	TCGA-B6-A0RQ-01A-11R-A114-13	TCGA-B6-A0RQ-01A-11R-A114-13	TCGA-B6-A0RQ-01A-11D-A10Y-09	23aabbc3-fe66-44d8-8640-5c153f409754	TCGA-B6-A0RQ-01A-11D-A10Y-09	TCGA-B6-A0RQ-01A-21-A13C-20	TCGA-B6-A0RQ-01A-11D-A10Y-09	184fe3c4-58bb-45c5-a9a5-9a8a56985f9f	76bd56f0-661c-4165-8818-b564fe6d8b56	TCGA-B6-A0RQ-01A-11D-A111-01	184fe3c4-58bb-45c5-a9a5-9a8a56985f9f		TCGA-B6-A0RQ-01	TCGA-B6-A0RQ-01A-11R-A115-07	184fe3c4-58bb-45c5-a9a5-9a8a56985f9f	184fe3c4-58bb-45c5-a9a5-9a8a56985f9f	TCGA-B6-A0RQ-01A-11D-A111-01	TCGA-B6-A0RQ-01	TCGA-B6-A0RQ-01	TCGA-B6-A0RQ-01A-11D-A112-05	76bd56f0-661c-4165-8818-b564fe6d8b56	
TCGA-B6-A0RS-01	Stage IIA	38	1	Stage IIA	3062	3062	Negative	FEMALE	Negative				Negative	M0	Negative	N0	3062	1	Her2	HER2-enriched	Negative		0	0	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0RS-01	3063	1	High	C3-BRCA/Luminal	cluster 5	Cluster 5		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-B6-A0RS	2041	1	3063	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO	YES		38	Left Lower Inner Quadrant|Left	Axillary lymph node dissection alone		TCGA-B6-A0RS-F13788		Negative					Negative	Modified Radical Mastectomy		NO		2041	-14134		3063	0				2041								Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:						15	Negative	Indeterminate (neither Pre or Postmenopausal)					Negative												Negative	5	4				Other, specify	New Primary Tumor	Breast		YES	0			M0	N0 (i-)	T2	Stage IIA																		WITH TUMOR								No			NO	Primary Tumor	01			YES	NO	YES	B6	Breast		DECEASED	1988	TCGA-B6-A0RS-01A-11D-A099-09	TCGA-B6-A0RS-01		TCGA-B6-A0RS-01A-11R-A085-13	TCGA-B6-A0RS-01A-11D-A099-09				TCGA-B6-A0RS-01A-11D-A099-09	be1f09ae-deec-45d7-8504-fea3f6e7feb4	e191f444-0987-42d9-baed-ceb74591810f	TCGA-B6-A0RS-01A-11D-A087-01	be1f09ae-deec-45d7-8504-fea3f6e7feb4	TCGA-B6-A0RS-01A-11D-A10P-05	TCGA-B6-A0RS-01	TCGA-B6-A0RS-01A-11R-A084-07	be1f09ae-deec-45d7-8504-fea3f6e7feb4	be1f09ae-deec-45d7-8504-fea3f6e7feb4	TCGA-B6-A0RS-01A-11D-A087-01	TCGA-B6-A0RS-01	TCGA-B6-A0RS-01		e191f444-0987-42d9-baed-ceb74591810f	TCGA-B6-A0RS-01A-11R-A085-13
TCGA-B6-A0RT-01	Stage IIIA	39	1	No_Conversion	2721		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	2721	0	Basal	Basal-like	Negative	ReacII	-13	-12	followup	T_Other	T3	LIVING	0	TCGA-B6-A0RT-01	2721	0	BRCA-LUAD+	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-B6-A0RT	2721	0	2721	Breast	TCGA Breast Cancer	breast invasive carcinoma					39	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-B6-A0RT-F13789		Negative					Negative			NO			-14374	5047		0	2721						Image Analysis					Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Excisional Biopsy	230	NO				23	Close	Indeterminate (neither Pre or Postmenopausal)																		5	3								NO	1		true	M0	N1	T3	Stage IIIA	TCGA-B6-A0RT.64D53A4B-4735-4AD2-A413-520797F5F9CB.pdf	4	0	0	0	1	0	0	0	0	0	14	60	85	40	85	60	TUMOR FREE	Image Analysis							No			YES	Primary Tumor	01			YES	NO	YES	B6	Breast	A	LIVING	1996	TCGA-B6-A0RT-01A-21D-A099-09	TCGA-B6-A0RT-01		TCGA-B6-A0RT-01A-21R-A085-13	TCGA-B6-A0RT-01A-21D-A099-09	f4b94eba-e9e8-4f06-812e-7f68eefa407b	TCGA-B6-A0RT-01A-21D-A099-09	TCGA-B6-A0RT-01A-11-A13C-20	TCGA-B6-A0RT-01A-21D-A099-09	2b721e04-5452-4b34-b3df-c6cdd04e87b1	ee1a99fc-1434-4d2f-a989-02edc2d64dba	TCGA-B6-A0RT-01A-21D-A087-01	2b721e04-5452-4b34-b3df-c6cdd04e87b1	TCGA-B6-A0RT-01A-21D-A10P-05	TCGA-B6-A0RT-01	TCGA-B6-A0RT-01A-21R-A084-07	2b721e04-5452-4b34-b3df-c6cdd04e87b1	2b721e04-5452-4b34-b3df-c6cdd04e87b1	TCGA-B6-A0RT-01A-21D-A087-01	TCGA-B6-A0RT-01	TCGA-B6-A0RT-01		ee1a99fc-1434-4d2f-a989-02edc2d64dba	TCGA-B6-A0RT-01A-21R-A085-13
TCGA-B6-A0RU-01	Stage IA	49	1	Stage I	3991		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	3991	0	Basal	Basal-like	Negative	Basal	-13	-11	followup	T1	T1	LIVING	0	TCGA-B6-A0RU-01	3991	0	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 13	cluster 6	mutation cluster 5	TCGA-B6-A0RU	3991	0	3991	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Right	Axillary lymph node dissection alone		TCGA-B6-A0RU-F13790		Negative					Negative	Other		NO			-17996	4214		0	3991						Image Analysis					Scheduled Follow-up Submission	2011-7-12	FEMALE										Other  specify	Ductal/Metaplastic	No		C50.9	8523/3	C50.9		YES		Core needle biopsy	170	NO				15	Negative	Indeterminate (neither Pre or Postmenopausal)																		5	6								NO	0		true	M0	N0 (i-)	T1c	Stage IA	TCGA-B6-A0RU.39C689CA-F7BA-4554-BEC8-11F9C8142D9C.pdf	0	0	0	0	0	0	0	0	0	50	5	0	95	50	85	60	TUMOR FREE	Image Analysis							No			YES	Primary Tumor	01	Excisional biopsy		YES	NO	YES	B6	Breast	A	LIVING	1998	TCGA-B6-A0RU-01A-11D-A099-09	TCGA-B6-A0RU-01		TCGA-B6-A0RU-01A-11R-A085-13	TCGA-B6-A0RU-01A-11D-A099-09	608bb166-ceaa-49d5-ae7d-d4060e8c6dc2	TCGA-B6-A0RU-01A-11D-A099-09	TCGA-B6-A0RU-01A-21-A13C-20	TCGA-B6-A0RU-01A-11D-A099-09	7abad802-817a-4d95-b022-f21cc4b1d9bc	39df545d-dade-4342-8ac3-312fd5664692	TCGA-B6-A0RU-01A-11D-A087-01	7abad802-817a-4d95-b022-f21cc4b1d9bc	TCGA-B6-A0RU-01A-11D-A10P-05	TCGA-B6-A0RU-01	TCGA-B6-A0RU-01A-11R-A084-07	7abad802-817a-4d95-b022-f21cc4b1d9bc	7abad802-817a-4d95-b022-f21cc4b1d9bc	TCGA-B6-A0RU-01A-11D-A087-01	TCGA-B6-A0RU-01	TCGA-B6-A0RU-01		39df545d-dade-4342-8ac3-312fd5664692	TCGA-B6-A0RU-01A-11R-A085-13
TCGA-B6-A0RV-01	Stage IIIA	42	4	No_Conversion	4788		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N2	4788	0	LumA	Luminal A	Positive	ReacII	-5	0	followup	T_Other	T3	LIVING	0	TCGA-B6-A0RV-01	4788	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-B6-A0RV	4788	0	4788	Breast	TCGA Breast Cancer	breast invasive carcinoma					42	Right	Axillary lymph node dissection alone		TCGA-B6-A0RV-F13791		Positive					Positive	Modified Radical Mastectomy		NO			-15507	5165		0	4788						Image Analysis					Scheduled Follow-up Submission	2011-7-12	FEMALE										Mixed Histology (please specify)	Lobular/Ductal	No		C50.9	8522/3	C50.9		YES		Incisional Biopsy	480	NO				10	Negative	Indeterminate (neither Pre or Postmenopausal)																		1	6								NO	5		true	M0	N2	T3	Stage IIIA	TCGA-B6-A0RV.FF5D000A-4600-4C42-8802-4BCD29F61CA6.pdf	0	0	0	0	0	0	0	0	5	5	25	10	70	85	75	70	TUMOR FREE	Image Analysis							No			YES	Primary Tumor	01			YES	NO	YES	B6	Breast	A	LIVING	1996	TCGA-B6-A0RV-01A-11D-A099-09	TCGA-B6-A0RV-01		TCGA-B6-A0RV-01A-11R-A085-13	TCGA-B6-A0RV-01A-11D-A099-09	f132d6af-68eb-4b00-8a2d-84322ac5758b	TCGA-B6-A0RV-01A-11D-A099-09	TCGA-B6-A0RV-01A-21-A13C-20	TCGA-B6-A0RV-01A-11D-A099-09	25068ef3-d87f-45e2-a15f-152b87e9dedb	671267f1-3fef-4709-8df2-97b8cb9cf052	TCGA-B6-A0RV-01A-11D-A087-01	25068ef3-d87f-45e2-a15f-152b87e9dedb	TCGA-B6-A0RV-01A-11D-A10P-05	TCGA-B6-A0RV-01	TCGA-B6-A0RV-01A-11R-A084-07	25068ef3-d87f-45e2-a15f-152b87e9dedb	25068ef3-d87f-45e2-a15f-152b87e9dedb	TCGA-B6-A0RV-01A-11D-A087-01	TCGA-B6-A0RV-01	TCGA-B6-A0RV-01		671267f1-3fef-4709-8df2-97b8cb9cf052	TCGA-B6-A0RV-01A-11R-A085-13
TCGA-B6-A0WS-01		58	4	Stage I		2965	Positive	FEMALE	Negative				Negative	M0	Negative	N0	2965	1	LumA	Luminal A	Positive		0	-4	followup	T1	T1	DECEASED	1	TCGA-B6-A0WS-01	2965	1	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation c1uster 9	TCGA-B6-A0WS	2965	0	2965	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Left Upper Outer Quadrant|Left	No axillary staging		TCGA-B6-A0WS-F15707	Negative	Positive					Positive	Lumpectomy		NO			-21230	5113	2965	0							Image Analysis					Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	110	NO					Positive	Indeterminate (neither Pre or Postmenopausal)																		1	7								NO			true	MX	NX	T1c	Stage X	TCGA-B6-A0WS.36AE47A6-B881-4C1D-8436-EB65783243CF.pdf	40	4	10	1	10	0	40	1	0	0	60	20	30	80	30	80	TUMOR FREE	Image Analysis						NO	No			NO	Primary Tumor	01		6th	NO	NO	YES	B6	Breast	A	DECEASED	1996	TCGA-B6-A0WS-01A-11D-A10Y-09	TCGA-B6-A0WS-01	TCGA-B6-A0WS-01A-11R-A114-13	TCGA-B6-A0WS-01A-11R-A114-13	TCGA-B6-A0WS-01A-11D-A10Y-09		TCGA-B6-A0WS-01A-11D-A10Y-09		TCGA-B6-A0WS-01A-11D-A10Y-09	44bd10a8-c4c0-466c-8cd8-31a5da70ba0b	e217bf80-4072-44c6-9675-d1a1c3029977	TCGA-B6-A0WS-01A-11D-A111-01	44bd10a8-c4c0-466c-8cd8-31a5da70ba0b		TCGA-B6-A0WS-01	TCGA-B6-A0WS-01A-11R-A115-07	44bd10a8-c4c0-466c-8cd8-31a5da70ba0b	44bd10a8-c4c0-466c-8cd8-31a5da70ba0b	TCGA-B6-A0WS-01A-11D-A111-01	TCGA-B6-A0WS-01	TCGA-B6-A0WS-01	TCGA-B6-A0WS-01A-11D-A112-05	e217bf80-4072-44c6-9675-d1a1c3029977	
TCGA-B6-A0WT-01	Stage IIB	61	3	No_Conversion	5739		Positive	FEMALE	Negative				Negative	M0	Positive	N1	5739	0	LumA	Luminal A	Positive		-2	-4	followup	T_Other	T2	LIVING	0	TCGA-B6-A0WT-01	5739	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-B6-A0WT	3862	1	5739	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO	YES		61	Left Lower Inner Quadrant|Left	Axillary lymph node dissection alone		TCGA-B6-A0WT-F15728		Positive					Positive	Modified Radical Mastectomy		NO		3862	-22362	5606		0	5739			3862			Image Analysis					Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	90	NO				15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	fmol/mg	Equivocal	2+	image cytometry	Positive					Other Reporting Scale			Negative			image cytometry	Positive	2	4			Other Reporting Scale	Other, specify	New Primary Tumor	right breast cancer contralateral		YES	1		true	M0	N1	T2	Stage IIB	TCGA-B6-A0WT.BACD800B-F320-472C-ACFF-175E9F525E9F.pdf	3	2	1	1	0	0	1	1	0	0	40	20	60	80	60	80	TUMOR FREE	Image Analysis		fmol/mg					No			NO	Primary Tumor	01			YES	NO	YES	B6	Breast	A	LIVING	1995	TCGA-B6-A0WT-01A-11D-A10G-09	TCGA-B6-A0WT-01		TCGA-B6-A0WT-01A-11R-A108-13	TCGA-B6-A0WT-01A-11D-A10G-09		TCGA-B6-A0WT-01A-11D-A10G-09		TCGA-B6-A0WT-01A-11D-A10G-09	0507f62d-e776-4efb-bd51-dba9d74090bd	5b9509ca-fb9c-4e51-b7d4-9c04f5cc141f	TCGA-B6-A0WT-01A-11D-A107-01	0507f62d-e776-4efb-bd51-dba9d74090bd	TCGA-B6-A0WT-01A-11D-A10A-05	TCGA-B6-A0WT-01	TCGA-B6-A0WT-01A-11R-A109-07	0507f62d-e776-4efb-bd51-dba9d74090bd	0507f62d-e776-4efb-bd51-dba9d74090bd	TCGA-B6-A0WT-01A-11D-A107-01	TCGA-B6-A0WT-01	TCGA-B6-A0WT-01		5b9509ca-fb9c-4e51-b7d4-9c04f5cc141f	TCGA-B6-A0WT-01A-11R-A108-13
TCGA-B6-A0WV-01	Stage IIB	67	5	No_Conversion	2422	2422	Positive	FEMALE	Negative				Negative	M0	Positive	N1	2422	1	LumB	Luminal B	Positive		0	-3	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0WV-01	2422	1	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-B6-A0WV	2422	0	2422	Breast	TCGA Breast Cancer	breast invasive carcinoma					67	Right	Axillary lymph node dissection alone		TCGA-B6-A0WV-F15732		Positive					Positive	Lumpectomy		NO			-24798	5536	2422	0							Image Analysis					Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	30	NO				7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	4		true	M0	N1b	T2	Stage IIB	TCGA-B6-A0WV.506BFD3B-240B-440E-B7A0-E596FC0B7F72.pdf	3	2	1	1	0	0	1	1	0	0	25	20	75	80	75	80	TUMOR FREE	Image Analysis							No			NO	Primary Tumor	01			YES	NO	YES	B6	Breast	A	DECEASED	1995	TCGA-B6-A0WV-01A-11D-A10G-09	TCGA-B6-A0WV-01		TCGA-B6-A0WV-01A-11R-A108-13	TCGA-B6-A0WV-01A-11D-A10G-09		TCGA-B6-A0WV-01A-11D-A10G-09		TCGA-B6-A0WV-01A-11D-A10G-09	87bdfb78-8690-4569-ba85-592cd2390c24	b4ebf80f-787e-4a3f-b0a1-63ad56d36aa2	TCGA-B6-A0WV-01A-11D-A107-01	87bdfb78-8690-4569-ba85-592cd2390c24	TCGA-B6-A0WV-01A-11D-A10A-05	TCGA-B6-A0WV-01	TCGA-B6-A0WV-01A-11R-A109-07	87bdfb78-8690-4569-ba85-592cd2390c24	87bdfb78-8690-4569-ba85-592cd2390c24	TCGA-B6-A0WV-01A-11D-A107-01	TCGA-B6-A0WV-01	TCGA-B6-A0WV-01		b4ebf80f-787e-4a3f-b0a1-63ad56d36aa2	TCGA-B6-A0WV-01A-11R-A108-13
TCGA-B6-A0WW-01		58	4	No_Conversion	546	557	Positive	FEMALE	Negative						Positive	N1	557	1	LumB	Luminal B	Positive		0	-3	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0WW-01	558	1	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-B6-A0WW	447	1	558	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO	NO		58	Right Upper Inner Quadrant|Right	Axillary lymph node dissection alone		TCGA-B6-A0WW-F15734		Positive					Positive	Simple Mastectomy		NO			-21479	4664	558	0	547			447			Image Analysis					Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES		Incisional Biopsy	30	NO				18	Negative	Indeterminate (neither Pre or Postmenopausal)																		4	2				Liver	Distant Metastasis			YES	5		true	MX	N1b	T2	Stage X	TCGA-B6-A0WW.F05F5886-DC5D-4685-B2BF-57A68A0BB7B9.pdf	3	2	1	0	0	0	2	0	2	2	18	23	80	75	80	75	WITH TUMOR	Image Analysis							No			YES	Primary Tumor	01			NO	NO	YES	B6	Breast	A	DECEASED	1997	TCGA-B6-A0WW-01A-11D-A10G-09	TCGA-B6-A0WW-01		TCGA-B6-A0WW-01A-11R-A108-13	TCGA-B6-A0WW-01A-11D-A10G-09		TCGA-B6-A0WW-01A-11D-A10G-09		TCGA-B6-A0WW-01A-11D-A10G-09	3bdcdadf-67da-4a50-b311-81196c0c8362	5494421e-ace6-4315-8337-edbd09f2e30e	TCGA-B6-A0WW-01A-11D-A107-01	3bdcdadf-67da-4a50-b311-81196c0c8362	TCGA-B6-A0WW-01A-11D-A10A-05	TCGA-B6-A0WW-01	TCGA-B6-A0WW-01A-11R-A109-07	3bdcdadf-67da-4a50-b311-81196c0c8362	3bdcdadf-67da-4a50-b311-81196c0c8362	TCGA-B6-A0WW-01A-11D-A107-01	TCGA-B6-A0WW-01	TCGA-B6-A0WW-01		5494421e-ace6-4315-8337-edbd09f2e30e	TCGA-B6-A0WW-01A-11R-A108-13
TCGA-B6-A0WX-01	Stage IIIA	40	1	No_Conversion	653	653	Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	653	1	Basal	Basal-like	Negative	X	-13	0	followup	T_Other	T3	DECEASED	1	TCGA-B6-A0WX-01	653	1	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-B6-A0WX	577	1	653	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO		40	Left	Axillary lymph node dissection alone		TCGA-B6-A0WX-F15729		Negative					Negative			NO			-14770	4490	653	0				577			Image Analysis					Scheduled Follow-up Submission	2011-8-29	FEMALE										Other  specify	Plemomorphic/lobular	No		C50.9	8520/3	C50.9		YES		Excisional Biopsy	300	NO				21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	4				Bone	Distant Metastasis			YES	9		true	M0	N1b	T3	Stage IIIA	TCGA-B6-A0WX.EE5BB205-D59B-4FEF-8D8F-D5720EDEB075.pdf	3	5	1	1	0	0	2	1	0	0	25	25	75	75	75	75	WITH TUMOR	Image Analysis							No			NO	Primary Tumor	01			YES	NO	YES	B6	Breast	A	DECEASED	1998	TCGA-B6-A0WX-01A-11D-A10G-09	TCGA-B6-A0WX-01		TCGA-B6-A0WX-01A-11R-A108-13	TCGA-B6-A0WX-01A-11D-A10G-09	f484ca3b-7c40-42fe-b5aa-a73453b45b0b	TCGA-B6-A0WX-01A-11D-A10G-09	TCGA-B6-A0WX-01A-21-A13D-20	TCGA-B6-A0WX-01A-11D-A10G-09	8dc04505-fae5-4185-b3f8-53882fbbb4fd	b0c0bc65-5f9b-4f23-a1c9-e3f86c0ef65c	TCGA-B6-A0WX-01A-11D-A107-01	8dc04505-fae5-4185-b3f8-53882fbbb4fd	TCGA-B6-A0WX-01A-11D-A10A-05	TCGA-B6-A0WX-01	TCGA-B6-A0WX-01A-11R-A109-07	8dc04505-fae5-4185-b3f8-53882fbbb4fd	8dc04505-fae5-4185-b3f8-53882fbbb4fd	TCGA-B6-A0WX-01A-11D-A107-01	TCGA-B6-A0WX-01	TCGA-B6-A0WX-01		b0c0bc65-5f9b-4f23-a1c9-e3f86c0ef65c	TCGA-B6-A0WX-01A-11R-A108-13
TCGA-B6-A0WY-01	Stage IIIA	40	4	No_Conversion	3410	3460	Positive	FEMALE	Negative				Negative	M0	Positive	N1	3460	1	LumA	Luminal A	Negative		-5	-3	followup	T_Other	T3	DECEASED	1	TCGA-B6-A0WY-01	3461	1	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-B6-A0WY	2011	1	3461	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	YES	NO		40	Left Lower Inner Quadrant|Left	Axillary lymph node dissection alone		TCGA-B6-A0WY-F15730		Positive					Negative	Lumpectomy		NO			-14778	5294	3461	0				2011			Image Analysis					Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	30	NO				21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)													Negative					1	4				Bone	Distant Metastasis			YES	3		true	M0	N1b	T3	Stage IIIA	TCGA-B6-A0WY.C0E92852-4146-468C-9713-2DE9C3316B9F.pdf	2	2	0	1	1	0	0	1	20	0	9	30	70	70	70	70	WITH TUMOR	Image Analysis							No			YES	Primary Tumor	01			YES	NO	YES	B6	Breast	A	DECEASED	1996	TCGA-B6-A0WY-01A-11D-A10G-09	TCGA-B6-A0WY-01		TCGA-B6-A0WY-01A-11R-A108-13	TCGA-B6-A0WY-01A-11D-A10G-09		TCGA-B6-A0WY-01A-11D-A10G-09		TCGA-B6-A0WY-01A-11D-A10G-09	90a60ebe-ce7e-4b64-af2a-1676f46e6601	2e1d7b07-9e79-47b6-98c2-d5966f1760d2	TCGA-B6-A0WY-01A-11D-A107-01	90a60ebe-ce7e-4b64-af2a-1676f46e6601	TCGA-B6-A0WY-01A-11D-A10A-05	TCGA-B6-A0WY-01	TCGA-B6-A0WY-01A-11R-A109-07	90a60ebe-ce7e-4b64-af2a-1676f46e6601	90a60ebe-ce7e-4b64-af2a-1676f46e6601	TCGA-B6-A0WY-01A-11D-A107-01	TCGA-B6-A0WY-01	TCGA-B6-A0WY-01		2e1d7b07-9e79-47b6-98c2-d5966f1760d2	TCGA-B6-A0WY-01A-11R-A108-13
TCGA-B6-A0WZ-01	Stage IIB	50	2	No_Conversion	3941		Positive	FEMALE	Negative				Negative	M0	Positive	N1	3941	0	LumA	Luminal A	Positive		-12	-3	followup	T_Other	T2	LIVING	0	TCGA-B6-A0WZ-01	3941	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 12	cluster 4	mutation cluster 4	TCGA-B6-A0WZ	3941	0	3941	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Right Upper Inner Quadrant|Right	Axillary lymph node dissection alone		TCGA-B6-A0WZ-F15735		Positive					Positive	Simple Mastectomy		NO			-18584			0	3941						Image Analysis					Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Fine needle aspiration biopsy						21	Negative	Indeterminate (neither Pre or Postmenopausal)																		4	4								NO	11			M0	N1b	T2	Stage IIB																		TUMOR FREE	Image Analysis							No			YES	Primary Tumor	01			YES	NO	YES	B6	Breast		LIVING	1996	TCGA-B6-A0WZ-01A-11D-A10G-09	TCGA-B6-A0WZ-01		TCGA-B6-A0WZ-01A-11R-A108-13	TCGA-B6-A0WZ-01A-11D-A10G-09		TCGA-B6-A0WZ-01A-11D-A10G-09		TCGA-B6-A0WZ-01A-11D-A10G-09	dc4a013a-c52a-40ef-8aeb-e1163519cdb8	f9bccbe0-28c1-4d60-b656-432527eaf911	TCGA-B6-A0WZ-01A-11D-A107-01	dc4a013a-c52a-40ef-8aeb-e1163519cdb8	TCGA-B6-A0WZ-01A-11D-A10A-05	TCGA-B6-A0WZ-01	TCGA-B6-A0WZ-01A-11R-A109-07	dc4a013a-c52a-40ef-8aeb-e1163519cdb8	dc4a013a-c52a-40ef-8aeb-e1163519cdb8	TCGA-B6-A0WZ-01A-11D-A107-01	TCGA-B6-A0WZ-01	TCGA-B6-A0WZ-01		f9bccbe0-28c1-4d60-b656-432527eaf911	TCGA-B6-A0WZ-01A-11R-A108-13
TCGA-B6-A0X0-01	Stage IA	54	2	Stage I		3945	Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	3945	1	LumA	Luminal A	Positive	LumA	-5	-3	followup	T1	T1	DECEASED	1	TCGA-B6-A0X0-01	3945	1	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 12	TCGA-B6-A0X0	3945	0	3945	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-B6-A0X0-F15710	Negative	Positive					Positive			NO			-19802	5243	3945	0							Image Analysis					Scheduled Follow-up Submission	2011-8-29	FEMALE										Other  specify	Cribiform	No			8201/3	C50.9		YES		Excisional Biopsy	150	NO				31	Negative	Indeterminate (neither Pre or Postmenopausal)																		2	7								NO	0		true	M0	N0 (i-)	T1c	Stage IA	TCGA-B6-A0X0.84A8BA4A-35F0-46C4-BDB0-64C033AFD1A8.pdf	60	60	30	30	0	0	0	0	10	0	30	40	60	60	60	60		Image Analysis						YES	No			NO	Primary Tumor	01		6th	YES	NO	YES	B6	Breast	A	DECEASED	1996	TCGA-B6-A0X0-01A-21D-A10Y-09	TCGA-B6-A0X0-01	TCGA-B6-A0X0-01A-21R-A114-13	TCGA-B6-A0X0-01A-21R-A114-13	TCGA-B6-A0X0-01A-21D-A10Y-09	1831ec43-6958-4950-8b0f-dd822fc81f17	TCGA-B6-A0X0-01A-21D-A10Y-09	TCGA-B6-A0X0-01A-11-A13D-20	TCGA-B6-A0X0-01A-21D-A10Y-09	222a566c-2bad-4b47-97dc-ca1f60a9a981	c9d3c5ea-400a-47dd-82e1-7b2d3d0f9fa6	TCGA-B6-A0X0-01A-21D-A111-01	222a566c-2bad-4b47-97dc-ca1f60a9a981		TCGA-B6-A0X0-01	TCGA-B6-A0X0-01A-21R-A115-07	222a566c-2bad-4b47-97dc-ca1f60a9a981	222a566c-2bad-4b47-97dc-ca1f60a9a981	TCGA-B6-A0X0-01A-21D-A111-01	TCGA-B6-A0X0-01	TCGA-B6-A0X0-01	TCGA-B6-A0X0-01A-21D-A112-05	c9d3c5ea-400a-47dd-82e1-7b2d3d0f9fa6	
TCGA-B6-A0X1-01	Stage IV	48	3	No_Conversion	5671		Negative	FEMALE					Positive	M1	Positive	N2	5671	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-B6-A0X1-01	5672	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8			mutation cluster 5	TCGA-B6-A0X1	485	1	5672	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	YES	NO		48	Left	Axillary lymph node dissection alone		TCGA-B6-A0X1-F15717		Negative					Negative	Modified Radical Mastectomy		NO			-17629	6030		0	5672			485			Image Analysis					Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	240	NO				21	Negative	Indeterminate (neither Pre or Postmenopausal)																		5					Brain	Distant Metastasis	lung		YES	16		true	M1	N2	T2	Stage IV	TCGA-B6-A0X1.D792031E-2CCE-4341-B3B3-C7D1D84F8F6B.pdf	10	10	0	0	20	0	0	0	0	5	0	5	80	90	80	80	TUMOR FREE	Image Analysis							No			NO	Primary Tumor	01			YES	NO	YES	B6	Breast	A	LIVING	1994	TCGA-B6-A0X1-01A-11D-A10G-09	TCGA-B6-A0X1-01			TCGA-B6-A0X1-01A-11D-A10G-09	03c36239-f261-44e4-829b-01e679a414ad	TCGA-B6-A0X1-01A-11D-A10G-09	TCGA-B6-A0X1-01A-21-A13D-20	TCGA-B6-A0X1-01A-11D-A10G-09	897b769d-f66a-4baf-b5fa-fe92ed49a8b4	66665c22-d495-4ae1-a6fe-378d96c05c1a	TCGA-B6-A0X1-01A-11D-A107-01	897b769d-f66a-4baf-b5fa-fe92ed49a8b4	TCGA-B6-A0X1-01A-11D-A10A-05	TCGA-B6-A0X1-01	TCGA-B6-A0X1-01A-11R-A109-07	897b769d-f66a-4baf-b5fa-fe92ed49a8b4	897b769d-f66a-4baf-b5fa-fe92ed49a8b4	TCGA-B6-A0X1-01A-11D-A107-01	TCGA-B6-A0X1-01	TCGA-B6-A0X1-01		66665c22-d495-4ae1-a6fe-378d96c05c1a	
TCGA-B6-A0X4-01	Stage IIB	62	3	No_Conversion	776	859	Positive	FEMALE	Negative				Negative	M0	Positive	N1	859	1	LumA	Luminal A	Positive		-12	-3	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0X4-01	860	1	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-B6-A0X4	716	1	860	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	YES	NO		62	Left	Axillary lymph node dissection alone		TCGA-B6-A0X4-F15723		Positive					Positive	Modified Radical Mastectomy		NO			-22688	5323	860	0				716			Image Analysis					Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	110	NO				21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	1				Bone	Distant Metastasis			YES	2		true	M0	N1b	T2	Stage IIB	TCGA-B6-A0X4.CA935E8D-ED8A-4485-BDC6-02C07CCE2EA5.pdf	0	5	0	5	0	0	0	0	0	0	15	20	85	80	90	80	WITH TUMOR	Image Analysis							No			NO	Primary Tumor	01			YES	NO	YES	B6	Breast	A	DECEASED	1996	TCGA-B6-A0X4-01A-11D-A10G-09	TCGA-B6-A0X4-01		TCGA-B6-A0X4-01A-11R-A108-13	TCGA-B6-A0X4-01A-11D-A10G-09		TCGA-B6-A0X4-01A-11D-A10G-09		TCGA-B6-A0X4-01A-11D-A10G-09	3d3d2beb-8c6f-45d0-bde3-12a68dbd5317	90a0edb3-d939-4c43-bbc5-0ed30023e35b	TCGA-B6-A0X4-01A-11D-A107-01	3d3d2beb-8c6f-45d0-bde3-12a68dbd5317	TCGA-B6-A0X4-01A-11D-A10A-05	TCGA-B6-A0X4-01	TCGA-B6-A0X4-01A-11R-A109-07	3d3d2beb-8c6f-45d0-bde3-12a68dbd5317	3d3d2beb-8c6f-45d0-bde3-12a68dbd5317	TCGA-B6-A0X4-01A-11D-A107-01	TCGA-B6-A0X4-01	TCGA-B6-A0X4-01		90a0edb3-d939-4c43-bbc5-0ed30023e35b	TCGA-B6-A0X4-01A-11R-A108-13
TCGA-B6-A0X5-01	Stage IIB	61	4	No_Conversion	2097	2097	Positive	FEMALE	Negative				Negative	M0	Positive	N1	2097	1	LumB	Luminal B	Positive		0	-3	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0X5-01	2097	1	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-B6-A0X5	1343	1	2097	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO		61	Left	Axillary lymph node dissection alone		TCGA-B6-A0X5-F15726		Positive					Positive	Modified Radical Mastectomy		NO			-22380		2097	0				1343			Image Analysis					Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES								14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	1				Bone	Distant Metastasis	Liver and Pleura		YES	3			M0	N1b	T2	Stage IIB																		WITH TUMOR	Image Analysis							No			NO	Primary Tumor	01			YES	NO	YES	B6	Breast		DECEASED	1995	TCGA-B6-A0X5-01A-21D-A10G-09	TCGA-B6-A0X5-01		TCGA-B6-A0X5-01A-21R-A108-13	TCGA-B6-A0X5-01A-21D-A10G-09		TCGA-B6-A0X5-01A-21D-A10G-09		TCGA-B6-A0X5-01A-21D-A10G-09	d4d04af8-9c60-4d14-90a2-c2b211e20092	b8269119-af11-4653-bab9-fb56da542fab	TCGA-B6-A0X5-01A-21D-A107-01	d4d04af8-9c60-4d14-90a2-c2b211e20092	TCGA-B6-A0X5-01A-21D-A10A-05	TCGA-B6-A0X5-01	TCGA-B6-A0X5-01A-21R-A109-07	d4d04af8-9c60-4d14-90a2-c2b211e20092	d4d04af8-9c60-4d14-90a2-c2b211e20092	TCGA-B6-A0X5-01A-21D-A107-01	TCGA-B6-A0X5-01	TCGA-B6-A0X5-01		b8269119-af11-4653-bab9-fb56da542fab	TCGA-B6-A0X5-01A-21R-A108-13
TCGA-B6-A0X7-01		62	2	No_Conversion	1791	1791	Positive	FEMALE	Negative						Negative	N0	1791	1	LumA	Luminal A	Positive		-5	-3	enrollment	T1	T1	DECEASED	1	TCGA-B6-A0X7-01	1791	1	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-B6-A0X7	1114	1	1791	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	YES		62	Right	No axillary staging		TCGA-B6-A0X7-F15714		Positive					Positive	Simple Mastectomy		NO		1114	-22713	6012	1791	0				1114			Image Analysis					Scheduled Follow-up Submission	2011-8-29	FEMALE										Mixed Histology (please specify)	Ductal/Lobular	No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	40	NO				0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	3				Other, specify	New Primary Tumor	colon		YES			true	MX	NX	T1c	Stage X	TCGA-B6-A0X7.0FB6BB0F-C3F9-43E6-8BDE-90D1DBA298CA.pdf	0	2	0	0	0	0	0	0	0	2	0	18	100	80	70	80	TUMOR FREE	Image Analysis							No			YES	Primary Tumor	01			YES	NO	YES	B6	Breast	A	DECEASED	1994	TCGA-B6-A0X7-01A-11D-A10M-09	TCGA-B6-A0X7-01		TCGA-B6-A0X7-01A-11R-A10I-13			TCGA-B6-A0X7-01A-11D-A10M-09		TCGA-B6-A0X7-01A-11D-A10M-09	b5ec5184-90d6-4b74-b08c-e39af59bc807	8e7476bd-4f16-472b-9368-23096042b16c	TCGA-B6-A0X7-01A-11D-A10L-01	b5ec5184-90d6-4b74-b08c-e39af59bc807	TCGA-B6-A0X7-01A-11D-A10N-05	TCGA-B6-A0X7-01	TCGA-B6-A0X7-01A-11R-A10J-07	b5ec5184-90d6-4b74-b08c-e39af59bc807	b5ec5184-90d6-4b74-b08c-e39af59bc807	TCGA-B6-A0X7-01A-11D-A10L-01	TCGA-B6-A0X7-01	TCGA-B6-A0X7-01		8e7476bd-4f16-472b-9368-23096042b16c	TCGA-B6-A0X7-01A-11R-A10I-13
TCGA-B6-A1KC-01	Stage IIA	67	4	Stage IIB	1326		Positive	FEMALE					Negative	M0	Positive	N1	1326	0	LumB		Negative				followup	T_Other	T2	LIVING	0	TCGA-B6-A1KC-01	1326	0	BRCA-LUAD+		cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA c1uster 9	cluster 5	mutation c1uster 9	TCGA-B6-A1KC	1326	0	1326	Breast	TCGA Breast Cancer	breast invasive carcinoma					67	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-B6-A1KC-F15740		Positive					Negative	Lumpectomy		NO			-24791	2781		0	1326					NO	image cytometry					Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	50	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	5								NO	1		true	M0	N1	T2	Stage IIA			0		0		0		0		0		0		100		95	TUMOR FREE	image cytometry				49 fmol/mg protein		YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	B6	Breast	B	LIVING	2003	TCGA-B6-A1KC-01B-11D-A159-09		TCGA-B6-A1KC-01B-11R-A156-13,TCGA-B6-A1KC-01A-11R-A13P-13	TCGA-B6-A1KC-01B-11R-A156-13,TCGA-B6-A1KC-01A-11R-A13P-13	TCGA-B6-A1KC-01B-11D-A159-09		TCGA-B6-A1KC-01B-11D-A159-09		TCGA-B6-A1KC-01B-11D-A159-09	fe5e5b08-d5c0-4165-ae92-bec6a1d98e60	63c1bf52-78e7-48aa-ba7c-acf89b20b1e0,89a93ef7-73a7-451f-9c83-251b827f02c6	TCGA-B6-A1KC-01B-11D-A160-01	fe5e5b08-d5c0-4165-ae92-bec6a1d98e60	TCGA-B6-A1KC-01A-11D-A13K-05,TCGA-B6-A1KC-01B-11D-A161-05	TCGA-B6-A1KC-01		fe5e5b08-d5c0-4165-ae92-bec6a1d98e60	fe5e5b08-d5c0-4165-ae92-bec6a1d98e60	TCGA-B6-A1KC-01B-11D-A160-01		TCGA-B6-A1KC-01		63c1bf52-78e7-48aa-ba7c-acf89b20b1e0,89a93ef7-73a7-451f-9c83-251b827f02c6	
TCGA-B6-A1KF-01	Stage IIB	68	1	Stage IIB	3088		Negative	FEMALE	Positive				Negative	M0	Positive	N1	3088	0	Basal		Negative				followup	T_Other	T2	LIVING	0	TCGA-B6-A1KF-01	3088	0	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-B6-A1KF	3088	0	3088	Breast	TCGA Breast Cancer	breast invasive carcinoma					68	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-B6-A1KF-F15739		Negative					Negative	Lumpectomy		NO			-24891	4536		0	3088					NO						Scheduled Follow-up Submission	2011-8-29	FEMALE			60-69%		2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	20	NO	Equivocal			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5								NO	2		true	M0	N1	T2	Stage IIB	TCGA-B6-A1KF.40EE8416-9DD8-457D-94AC-A871B5C62873.pdf		0		0		0		0		0		0		100		90	TUMOR FREE							YES	No			YES	Primary Tumor	01		5th	YES	NO	YES	B6	Breast	A	LIVING	1998	TCGA-B6-A1KF-01A-11D-A13L-09		TCGA-B6-A1KF-01A-11R-A13P-13	TCGA-B6-A1KF-01A-11R-A13P-13	TCGA-B6-A1KF-01A-11D-A13L-09		TCGA-B6-A1KF-01A-11D-A13L-09		TCGA-B6-A1KF-01A-11D-A13L-09	e7d1fcd1-eb2a-4b6d-b5bd-6a0a6e4bec66	2b07b60b-de7c-4b22-a292-8a30c10dab05	TCGA-B6-A1KF-01A-11D-A13J-01	e7d1fcd1-eb2a-4b6d-b5bd-6a0a6e4bec66	TCGA-B6-A1KF-01A-11D-A13K-05	TCGA-B6-A1KF-01		e7d1fcd1-eb2a-4b6d-b5bd-6a0a6e4bec66	e7d1fcd1-eb2a-4b6d-b5bd-6a0a6e4bec66	TCGA-B6-A1KF-01A-11D-A13J-01		TCGA-B6-A1KF-01		2b07b60b-de7c-4b22-a292-8a30c10dab05	
TCGA-B6-A1KI-01	Stage I	63	2	Stage I	2236		Positive	FEMALE	Negative				Negative	M0	Negative	N0	2236	0	LumA		Positive				followup	T1	T1	LIVING	0	TCGA-B6-A1KI-01	2236	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-B6-A1KI	2236	0	2236	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-B6-A1KI-F15737		Positive					Positive	Lumpectomy		NO			-23031	2634		0	2236					NO	image cytometry				3.1	Scheduled Follow-up Submission	2011-8-29	FEMALE			90-99%		2+	60	3.8	1.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	40	NO	Equivocal	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	2								NO	0		true	M0	N0	T1c	Stage I	TCGA-B6-A1KI.C2711492-0BDD-487E-9C9B-CEF20BBE57C3.pdf		2		1		2		1		0		18		80		80	TUMOR FREE	image cytometry			70 fmol/mg	288 fmol/mg		YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	B6	Breast	A	LIVING	2003	TCGA-B6-A1KI-01A-11D-A14K-09		TCGA-B6-A1KI-01A-11R-A14L-13	TCGA-B6-A1KI-01A-11R-A14L-13			TCGA-B6-A1KI-01A-11D-A14K-09		TCGA-B6-A1KI-01A-11D-A14K-09	7d34b1bc-ac5a-4365-8dae-75b3f2ea5055	82bfe88a-541f-4187-be75-b05bec1ce60c	TCGA-B6-A1KI-01A-11D-A14J-01	7d34b1bc-ac5a-4365-8dae-75b3f2ea5055	TCGA-B6-A1KI-01A-11D-A14N-05	TCGA-B6-A1KI-01		7d34b1bc-ac5a-4365-8dae-75b3f2ea5055	7d34b1bc-ac5a-4365-8dae-75b3f2ea5055	TCGA-B6-A1KI-01A-11D-A14J-01		TCGA-B6-A1KI-01		82bfe88a-541f-4187-be75-b05bec1ce60c	
TCGA-B6-A1KN-01	Stage IIIB	57	5	Stage IIIC	4233		Negative	FEMALE	Positive				Negative	M0	Positive	N1	4233	0	LumB		Negative				followup	T_Other	T4	LIVING	0	TCGA-B6-A1KN-01	4233	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 5	TCGA-B6-A1KN	4233	0	4233	Breast	TCGA Breast Cancer	breast invasive carcinoma					57	Right Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-B6-A1KN-F15738		Negative					Negative	Modified Radical Mastectomy		NO			-21183	4537		0	4233					NO						Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	80	NO				30	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	6								NO	24		true	M0	N1	T4b	Stage IIIB	TCGA-B6-A1KN.72996825-1FFA-4C51-8DB0-DA74BCB595EB.pdf		0		0		0		0		10		40		50		65	TUMOR FREE							YES	No			YES	Primary Tumor	01		5th	YES	NO	YES	B6	Breast	A	LIVING	1998	TCGA-B6-A1KN-01A-11D-A13L-09		TCGA-B6-A1KN-01A-11R-A13P-13	TCGA-B6-A1KN-01A-11R-A13P-13	TCGA-B6-A1KN-01A-11D-A13L-09		TCGA-B6-A1KN-01A-11D-A13L-09		TCGA-B6-A1KN-01A-11D-A13L-09	71b773fb-1efb-4d0f-9499-110ba937ade6	c5a9ae9d-9331-48b7-a5c9-a37102897313	TCGA-B6-A1KN-01A-11D-A13J-01	71b773fb-1efb-4d0f-9499-110ba937ade6	TCGA-B6-A1KN-01A-11D-A13K-05	TCGA-B6-A1KN-01		71b773fb-1efb-4d0f-9499-110ba937ade6	71b773fb-1efb-4d0f-9499-110ba937ade6	TCGA-B6-A1KN-01A-11D-A13J-01		TCGA-B6-A1KN-01		c5a9ae9d-9331-48b7-a5c9-a37102897313	
TCGA-B6-A2IU-01																			LumA										0	TCGA-B6-A2IU-01	5176	0	BRCA-LUAD+	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-B6-A2IU	4224	1	5176	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	YES			62	Right	Axillary lymph node dissection alone		TCGA-B6-A2IU-F38907		Positive					Positive	Modified Radical Mastectomy		NO			-22905	4665		0	5176			4224			image cytometry						2013-1-3	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	140	NO			NO	28	Negative	Indeterminate (neither Pre or Postmenopausal)																							Other, specify	New Primary Tumor	Lung	NO	YES	0		true	M0	N0	T2	Stage IIA	TCGA-B6-A2IU.EE769039-220E-4158-8999-09F17AFB4C46.pdf		0		0		0		0		0		40		60		70	WITH TUMOR	image cytometry					YES	YES	No			YES	Primary Tumor	01		5th		NO	YES	B6	Breast	A	LIVING	1998			TCGA-B6-A2IU-01A-32R-A18L-13	TCGA-B6-A2IU-01A-32R-A18L-13			TCGA-B6-A2IU-01A-32D-A19T-09	TCGA-B6-A2IU-01A-21-A24A-20		71a6367e-a876-4f1e-b80c-0e2d7d02e7cd	568de015-d66d-4731-83ce-8f8439ffa6b2	TCGA-B6-A2IU-01A-32D-A18N-01	71a6367e-a876-4f1e-b80c-0e2d7d02e7cd	TCGA-B6-A2IU-01A-32D-A18O-05	TCGA-B6-A2IU-01		71a6367e-a876-4f1e-b80c-0e2d7d02e7cd	71a6367e-a876-4f1e-b80c-0e2d7d02e7cd	TCGA-B6-A2IU-01A-32D-A18N-01		TCGA-B6-A2IU-01		568de015-d66d-4731-83ce-8f8439ffa6b2	
TCGA-B6-A3ZX-01																														TCGA-B6-A3ZX-01												TCGA-B6-A3ZX				Breast	TCGA Breast Cancer	breast invasive carcinoma																							1954																																					5	NO																																				true					TCGA-B6-A3ZX.B3CFFF02-89AA-43AE-B19B-BEE6817AA997.pdf		0		0		0		0		0		0		100		75													Primary Tumor	01								A					TCGA-B6-A3ZX-01A-11R-A23A-13	TCGA-B6-A3ZX-01A-11R-A23A-13			TCGA-B6-A3ZX-01A-11D-A23C-09			e89806d3-1cd5-4bc0-8e8a-edf823d8f110	4104df00-1af0-40be-867d-ba794e075ae7	TCGA-B6-A3ZX-01A-11D-A238-01	e89806d3-1cd5-4bc0-8e8a-edf823d8f110	TCGA-B6-A3ZX-01A-11D-A23D-05	TCGA-B6-A3ZX-01		e89806d3-1cd5-4bc0-8e8a-edf823d8f110	e89806d3-1cd5-4bc0-8e8a-edf823d8f110	TCGA-B6-A3ZX-01A-11D-A238-01		TCGA-B6-A3ZX-01		4104df00-1af0-40be-867d-ba794e075ae7	
TCGA-B6-A400-01																														TCGA-B6-A400-01												TCGA-B6-A400				Breast	TCGA Breast Cancer	breast invasive carcinoma																							1610																																					20	NO																																				true					TCGA-B6-A400.AF83CCA2-3AA4-4933-B6AD-9C11DF501DDD.pdf		0		0		0		0		0		10		90		75													Primary Tumor	01								A					TCGA-B6-A400-01A-11R-A23A-13	TCGA-B6-A400-01A-11R-A23A-13			TCGA-B6-A400-01A-11D-A23C-09			6b70d210-9cbd-44bc-a770-a075fd0d4672	42d878a6-160a-40a3-a72b-f5e9a4270b2d	TCGA-B6-A400-01A-11D-A238-01	6b70d210-9cbd-44bc-a770-a075fd0d4672	TCGA-B6-A400-01A-11D-A23D-05	TCGA-B6-A400-01		6b70d210-9cbd-44bc-a770-a075fd0d4672	6b70d210-9cbd-44bc-a770-a075fd0d4672	TCGA-B6-A400-01A-11D-A238-01		TCGA-B6-A400-01		42d878a6-160a-40a3-a72b-f5e9a4270b2d	
TCGA-B6-A401-01																													0	TCGA-B6-A401-01	2596	0										TCGA-B6-A401	2596	0	2596	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-B6-A401-F59658		Positive	4 Point Scale	3+	4 Point Scale		Positive	Lumpectomy		NO			-17438	1935		0	2596							80-89%					2014-6-3	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	30	NO	Negative		NO	4	Negative																												NO	1		true	M0	N1a	T1c	Stage IIA	TCGA-B6-A401.D76CF03A-54CD-4769-87AA-466473F41FC7.pdf		0		0		0		0		8		2		90		85	TUMOR FREE						NO	YES	No	90-99%		NO	Primary Tumor	01		6th		NO	YES	B6	Breast	A	LIVING	2007			TCGA-B6-A401-01A-11R-A23A-13	TCGA-B6-A401-01A-11R-A23A-13			TCGA-B6-A401-01A-11D-A23C-09			2a591fdd-c9e5-4c6e-90f8-8f993450a8d7	2221013e-55d1-4eeb-99db-c150f39432bb	TCGA-B6-A401-01A-11D-A238-01	2a591fdd-c9e5-4c6e-90f8-8f993450a8d7	TCGA-B6-A401-01A-11D-A23D-05	TCGA-B6-A401-01		2a591fdd-c9e5-4c6e-90f8-8f993450a8d7	2a591fdd-c9e5-4c6e-90f8-8f993450a8d7	TCGA-B6-A401-01A-11D-A238-01		TCGA-B6-A401-01		2221013e-55d1-4eeb-99db-c150f39432bb	
TCGA-B6-A402-01																													0	TCGA-B6-A402-01	1651	0										TCGA-B6-A402			1651	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Right Lower Outer Quadrant	Sentinel node biopsy alone				Negative	4 Point Scale	1+	4 Point Scale		Negative	Lumpectomy		YES			-17314	1563		0	1651							<10%					2012-9-20	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Core needle biopsy	10	NO	Negative			3	Negative																												YES	0	0	true	M0	N0 (i-)	T1c	Stage I	TCGA-B6-A402.9BC704DE-0914-49F1-80F9-36CFE52B8484.pdf		0		0		0		0		0		0		100		90	WITH TUMOR						YES	YES	No	<10%		YES	Primary Tumor	01		6th		NO	YES	B6	Breast	A	LIVING	2008			TCGA-B6-A402-01A-11R-A23A-13	TCGA-B6-A402-01A-11R-A23A-13			TCGA-B6-A402-01A-11D-A23C-09			976a1b88-ed7a-493a-8ac9-3d504edfbc76	1adbdc80-ec5b-4c24-8198-6e6166be39c1	TCGA-B6-A402-01A-11D-A238-01	976a1b88-ed7a-493a-8ac9-3d504edfbc76	TCGA-B6-A402-01A-11D-A23D-05	TCGA-B6-A402-01		976a1b88-ed7a-493a-8ac9-3d504edfbc76	976a1b88-ed7a-493a-8ac9-3d504edfbc76	TCGA-B6-A402-01A-11D-A238-01		TCGA-B6-A402-01		1adbdc80-ec5b-4c24-8198-6e6166be39c1	
TCGA-B6-A408-01																													0	TCGA-B6-A408-01	2072	0										TCGA-B6-A408	2072	0	2072	Breast	TCGA Breast Cancer	breast invasive carcinoma					55	Left	Axillary lymph node dissection alone		TCGA-B6-A408-F59666		Positive	4 Point Scale	3+	4 Point Scale		Positive	Simple Mastectomy		NO			-20102	1500		0	2072							90-99%			2.6		2014-6-3	FEMALE			20-29%		2+	60	2.9	1.2		Mixed Histology (please specify)	ductal and lobular	No		C50.9	8522/3	C50.9	3+	YES		Tumor resection	50	NO	Equivocal	Negative	NO	23	Negative																												NO	10		true	M0	N3a	T2	Stage IIIC	TCGA-B6-A408.F5A14797-6676-4331-9424-D8B820008924.pdf		4		2		1		2		1		23		75		75	TUMOR FREE						YES	YES	No	60-69%		YES	Primary Tumor	01		6th		NO	YES	B6	Breast	A	LIVING	2008			TCGA-B6-A408-01A-12R-A24J-13	TCGA-B6-A408-01A-12R-A24J-13			TCGA-B6-A408-01A-12D-A243-09			bbb7f769-ac55-4e7f-b0bf-acc36294bb05	2d33342b-a41f-4bb1-9226-1b5058209488	TCGA-B6-A408-01A-12D-A242-01	bbb7f769-ac55-4e7f-b0bf-acc36294bb05	TCGA-B6-A408-01A-12D-A244-05	TCGA-B6-A408-01		bbb7f769-ac55-4e7f-b0bf-acc36294bb05	bbb7f769-ac55-4e7f-b0bf-acc36294bb05	TCGA-B6-A408-01A-12D-A242-01		TCGA-B6-A408-01		2d33342b-a41f-4bb1-9226-1b5058209488	
TCGA-B6-A409-01																														TCGA-B6-A409-01												TCGA-B6-A409				Breast	TCGA Breast Cancer	breast invasive carcinoma																							1480																																					20	NO																																				true					TCGA-B6-A409.CC77BA51-CE5A-4839-A27A-DD8F389A2733.pdf		3		1		0		1		0		25		75		75													Primary Tumor	01								A					TCGA-B6-A409-01A-11R-A24J-13	TCGA-B6-A409-01A-11R-A24J-13			TCGA-B6-A409-01A-11D-A243-09			4d9bb08c-d954-4e14-aff2-3bec55cdf1c1	97bcb0a5-f1c7-4277-bce3-763473b3ff4f	TCGA-B6-A409-01A-11D-A242-01	4d9bb08c-d954-4e14-aff2-3bec55cdf1c1	TCGA-B6-A409-01A-11D-A244-05	TCGA-B6-A409-01		4d9bb08c-d954-4e14-aff2-3bec55cdf1c1	4d9bb08c-d954-4e14-aff2-3bec55cdf1c1	TCGA-B6-A409-01A-11D-A242-01		TCGA-B6-A409-01		97bcb0a5-f1c7-4277-bce3-763473b3ff4f	
TCGA-B6-A40B-01																													0	TCGA-B6-A40B-01	3152	0										TCGA-B6-A40B	3152	0	3152	Breast	TCGA Breast Cancer	breast invasive carcinoma					76	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-B6-A40B-F59661		Positive	4 Point Scale	3+	4 Point Scale		Positive	Lumpectomy		YES			-27811	2467		0	3152							90-99%					2014-6-3	FEMALE			<10%		1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	10	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	true	M0	N0 (i-)	T1b	Stage I	TCGA-B6-A40B.CB2E56BC-16AC-4BFE-AB6C-2FC7E48943BB.pdf		4		2		0		2		0		25		75		75	TUMOR FREE						NO	YES	No	90-99%		NO	Primary Tumor	01		6th		NO	YES	B6	Breast	A	LIVING	2005			TCGA-B6-A40B-01A-11R-A23A-13	TCGA-B6-A40B-01A-11R-A23A-13			TCGA-B6-A40B-01A-11D-A23C-09			40c7e862-e1f6-4425-af9d-c9d07161a2ed	2da6a5d4-1759-4d0b-b023-cf9e2dabb8a7	TCGA-B6-A40B-01A-11D-A238-01	40c7e862-e1f6-4425-af9d-c9d07161a2ed	TCGA-B6-A40B-01A-11D-A23D-05	TCGA-B6-A40B-01		40c7e862-e1f6-4425-af9d-c9d07161a2ed	40c7e862-e1f6-4425-af9d-c9d07161a2ed	TCGA-B6-A40B-01A-11D-A238-01		TCGA-B6-A40B-01		2da6a5d4-1759-4d0b-b023-cf9e2dabb8a7	
TCGA-B6-A40C-01																													0	TCGA-B6-A40C-01	2164	0										TCGA-B6-A40C	2164	0	2164	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-B6-A40C-F59660		Positive	4 Point Scale	3+	4 Point Scale		Positive	Simple Mastectomy		YES			-18852	2677		0	2164							50-59%					2014-6-3	FEMALE			<10%		1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	20	NO	Negative		NO	3	Negative																												NO	0	0	true	M0	N0 (i-)	T3	Stage IIB	TCGA-B6-A40C.87B150CC-1C5D-42D5-9951-9157A81316D5.pdf		4		1		0		2		0		20		80		80	TUMOR FREE						YES	YES	No	90-99%		YES	Primary Tumor	01		6th		NO	YES	B6	Breast	A	LIVING	2005			TCGA-B6-A40C-01A-11R-A23A-13	TCGA-B6-A40C-01A-11R-A23A-13			TCGA-B6-A40C-01A-11D-A23C-09			e04bddbb-224b-4c6c-a8c8-88fd42a52ac5	7fc82e40-6a59-4650-8eb3-6924a7572e83	TCGA-B6-A40C-01A-11D-A238-01	e04bddbb-224b-4c6c-a8c8-88fd42a52ac5	TCGA-B6-A40C-01A-11D-A23D-05	TCGA-B6-A40C-01		e04bddbb-224b-4c6c-a8c8-88fd42a52ac5	e04bddbb-224b-4c6c-a8c8-88fd42a52ac5	TCGA-B6-A40C-01A-11D-A238-01		TCGA-B6-A40C-01		7fc82e40-6a59-4650-8eb3-6924a7572e83	
TCGA-BH-A0AU-01	Stage IIA	45	1	Stage IIA	746		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	746	0	LumB	Luminal B	Positive	ReacI	-3	-3	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0AU-01	746	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-BH-A0AU			746	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Left Upper Inner Quadrant					Positive					Positive	Other					-16688	583		0	746					NO							2011-7-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Positive	Negative		2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6									0		true	M0	N0	T2	Stage IIA	TCGA-BH-A0AU.4C942A1D-53B2-43A6-9B96-5155CCDEEC34.pdf	18	15	0	0	1	1	0	0	25	25	5	5	69	69	75	80	TUMOR FREE							YES	No				Primary Tumor	01	left segmental mastectomy with sentinel node dissection	6th		NO	YES	BH	Breast	A	LIVING	2008	TCGA-BH-A0AU-01A-11D-A12Q-09	TCGA-BH-A0AU-01	TCGA-BH-A0AU-01A-11R-A12O-13	TCGA-BH-A0AU-01A-11R-A12O-13	TCGA-BH-A0AU-01A-11D-A12Q-09	6b8a5434-3207-46f0-836b-542e427d22d5	TCGA-BH-A0AU-01A-11D-A12Q-09	TCGA-BH-A0AU-01A-21-A13C-20	TCGA-BH-A0AU-01A-11D-A12Q-09	d448433c-3c4b-4371-b749-f96af8da2237	9687f34c-0460-4fef-b5ba-d7ec23013f4d	TCGA-BH-A0AU-01A-11D-A12N-01	d448433c-3c4b-4371-b749-f96af8da2237	TCGA-BH-A0AU-01A-11D-A12R-05	TCGA-BH-A0AU-01	TCGA-BH-A0AU-01A-11R-A12P-07	d448433c-3c4b-4371-b749-f96af8da2237	d448433c-3c4b-4371-b749-f96af8da2237	TCGA-BH-A0AU-01A-11D-A12N-01	TCGA-BH-A0AU-01	TCGA-BH-A0AU-01		9687f34c-0460-4fef-b5ba-d7ec23013f4d	
TCGA-BH-A0AU-11		45			746			FEMALE									746	0	Normal						enrollment			LIVING	0	TCGA-BH-A0AU-11	746	0		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0AU			746	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Left Upper Inner Quadrant					Positive					Positive	Other					-16688	583		0	746					NO							2011-7-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Positive	Negative		2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												0		true	M0	N0	T2	Stage IIA		3	1	0	0			0	0	100	100			0	0			TUMOR FREE							YES	No				Solid Tissue Normal	11	left segmental mastectomy with sentinel node dissection	6th		NO	YES	BH	Breast	A	LIVING	2008			TCGA-BH-A0AU-11A-11R-A12O-13	TCGA-BH-A0AU-11A-11R-A12O-13						eb7e6bfc-79ad-4674-9d58-2cbad8c65658			eb7e6bfc-79ad-4674-9d58-2cbad8c65658	TCGA-BH-A0AU-11A-11D-A12R-05		TCGA-BH-A0AU-11A-11R-A12P-07	eb7e6bfc-79ad-4674-9d58-2cbad8c65658	eb7e6bfc-79ad-4674-9d58-2cbad8c65658						
TCGA-BH-A0AV-01	Stage I	52	1	Stage I	1180		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1180	0	Basal	Basal-like	Negative	ReacII	-13	0	enrollment	T1	T1	LIVING	0	TCGA-BH-A0AV-01	1820	0	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A0AV	1820	0	1820	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Left Upper Inner Quadrant			TCGA-BH-A0AV-F59174		Negative					Negative	Other					-19314	761		0	1820					NO							2014-5-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	250	NO		Negative	NO	2	Negative																			5	4								NO	0		true	M0	N0	T1c	Stage I	TCGA-BH-A0AV.6DFA6F0F-09BC-4246-87B9-247207B74A39.pdf	5	15	1	2	5	10	0	1	8	0	27	40	60	50	70	60	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01	Segmental mastectomy with left axillary lymph node dissection	6th		NO	YES	BH	Breast	A	LIVING	2008	TCGA-BH-A0AV-01A-31D-A10Y-09	TCGA-BH-A0AV-01	TCGA-BH-A0AV-01A-31R-A114-13	TCGA-BH-A0AV-01A-31R-A114-13	TCGA-BH-A0AV-01A-31D-A10Y-09	9a298279-0097-4dfc-bfb0-b119b92d1fd7	TCGA-BH-A0AV-01A-31D-A10Y-09	TCGA-BH-A0AV-01A-21-A13C-20	TCGA-BH-A0AV-01A-31D-A10Y-09	afe0fbfe-18e0-4b80-a44c-7abe3c7e5c93	fe110a00-ddf8-468a-966e-4823df9cbe40	TCGA-BH-A0AV-01A-31D-A111-01	afe0fbfe-18e0-4b80-a44c-7abe3c7e5c93		TCGA-BH-A0AV-01	TCGA-BH-A0AV-01A-31R-A115-07	afe0fbfe-18e0-4b80-a44c-7abe3c7e5c93	afe0fbfe-18e0-4b80-a44c-7abe3c7e5c93	TCGA-BH-A0AV-01A-31D-A111-01	TCGA-BH-A0AV-01	TCGA-BH-A0AV-01	TCGA-BH-A0AV-01A-31D-A112-05	fe110a00-ddf8-468a-966e-4823df9cbe40	
TCGA-BH-A0AW-01	Stage IIA	56	3	No_Conversion	622		Positive	FEMALE	Positive				Negative	M0	Positive	N1	622	0	Her2	HER2-enriched	Negative		-11	-5	followup	T1	T1	LIVING	0	TCGA-BH-A0AW-01	622	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-BH-A0AW	622	0	622	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-BH-A0AW-F15445		Positive					Negative	Lumpectomy		NO			-20468	545		0	622						ER Positive H-Score 95					Scheduled Follow-up Submission	2010-11-3	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	50	NO	Positive			12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	5								NO	2	0	true	M0	N1a	T1c	Stage IIA	TCGA-BH-A0AW.D1B30DA1-FF63-4FC7-AB8B-818331EE6D72.pdf	10	20	0	0	1	1	0	0	9	9	5	10	85	80	80	75	TUMOR FREE	PR Negative H-Score 0			H-Score	H-Score			No			YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2008	TCGA-BH-A0AW-01A-11W-A071-09	TCGA-BH-A0AW-01		TCGA-BH-A0AW-01A-11R-A057-13	TCGA-BH-A0AW-01A-11W-A071-09		TCGA-BH-A0AW-01A-11W-A071-09		TCGA-BH-A0AW-01A-11W-A071-09	8b615995-6210-4dd5-bf58-cf8a109d7648	34c5238e-d4ee-424c-976c-0f9bbfb1e0bc	TCGA-BH-A0AW-01A-11D-A059-01	8b615995-6210-4dd5-bf58-cf8a109d7648	TCGA-BH-A0AW-01A-11D-A10P-05	TCGA-BH-A0AW-01	TCGA-BH-A0AW-01A-11R-A056-07	8b615995-6210-4dd5-bf58-cf8a109d7648	8b615995-6210-4dd5-bf58-cf8a109d7648	TCGA-BH-A0AW-01A-11D-A059-01	TCGA-BH-A0AW-01	TCGA-BH-A0AW-01		34c5238e-d4ee-424c-976c-0f9bbfb1e0bc	TCGA-BH-A0AW-01A-11R-A057-13
TCGA-BH-A0AY-01	Stage IIA	62	3	Stage IIA	777		Positive	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	777	0	LumA	Luminal B	Positive	ReacI	-1	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0AY-01	777	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-BH-A0AY	777	0	777	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Left Lower Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-BH-A0AY-F15456		Positive					Positive	Simple Mastectomy		NO			-22703	587		0	777											Scheduled Follow-up Submission	2010-11-3	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	0		true	M0	N0 (i-)	T2	Stage IIA	TCGA-BH-A0AY.06905BD3-4D17-4625-8631-46CA81D1B47B.pdf	15	15	0	0	1	1	0	0	0	0	10	10	89	89	70	70	TUMOR FREE								No			NO	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2008	TCGA-BH-A0AY-01A-21W-A019-09	TCGA-BH-A0AY-01		TCGA-BH-A0AY-01A-21R-A010-13	TCGA-BH-A0AY-01A-21W-A019-09	71b12add-c266-433f-b842-86be8893fb06	TCGA-BH-A0AY-01A-21W-A019-09	TCGA-BH-A0AY-01A-11-A13B-20	TCGA-BH-A0AY-01A-21W-A019-09	80817359-b0f0-4bea-ada4-b48bea37f5d2	4fd27ab7-1bec-4d0c-a8e2-9ab804d0a5eb	TCGA-BH-A0AY-01A-21D-A011-01	80817359-b0f0-4bea-ada4-b48bea37f5d2		TCGA-BH-A0AY-01	TCGA-BH-A0AY-01A-21R-A00Z-07	80817359-b0f0-4bea-ada4-b48bea37f5d2	80817359-b0f0-4bea-ada4-b48bea37f5d2	TCGA-BH-A0AY-01A-21D-A011-01	TCGA-BH-A0AY-01	TCGA-BH-A0AY-01	TCGA-BH-A0AY-01A-21D-A00Y-05	4fd27ab7-1bec-4d0c-a8e2-9ab804d0a5eb	TCGA-BH-A0AY-01A-21R-A010-13
TCGA-BH-A0AY-11		62			777			FEMALE									777	0	Normal						followup			LIVING	0	TCGA-BH-A0AY-11	777	0		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0AY	777	0	777	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Left Lower Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-BH-A0AY-F15456		Positive					Positive	Simple Mastectomy		NO			-22703	587		0	777											Scheduled Follow-up Submission	2010-11-3	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	360	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		true	M0	N0 (i-)	T2	Stage IIA		1	5	0	0			0	0	100	100			0	0			TUMOR FREE								No			NO	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2008				TCGA-BH-A0AY-11A-23R-A090-13						d9c8ecc3-0e92-49e9-99e4-9976785c73a6			d9c8ecc3-0e92-49e9-99e4-9976785c73a6	TCGA-BH-A0AY-11A-23D-A10Q-05		TCGA-BH-A0AY-11A-23R-A089-07	d9c8ecc3-0e92-49e9-99e4-9976785c73a6	d9c8ecc3-0e92-49e9-99e4-9976785c73a6						TCGA-BH-A0AY-11A-23R-A090-13
TCGA-BH-A0AZ-01	Stage IIIA	47	2	Stage IIIA	867		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N1	867	0	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T_Other	T3	LIVING	0	TCGA-BH-A0AZ-01	867	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-BH-A0AZ			867	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Right					Positive					Positive	Other					-17465	575		0	867					NO							2011-7-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	490	NO	Negative			13	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	4									1		true	cM0 (i+)	N1a	T3	Stage IIIA	TCGA-BH-A0AZ.6721193F-FE9D-4573-BF2A-ABAECF57DFD9.pdf	2	1	0	0	1	1	0	0	5	5	24	14	70	80	70	70	TUMOR FREE							YES	No				Primary Tumor	01	total mastectomy with sentinel lymph node biopsy with tissue reconstruction	6th		NO	YES	BH	Breast	A	LIVING	2008	TCGA-BH-A0AZ-01A-21D-A12Q-09	TCGA-BH-A0AZ-01	TCGA-BH-A0AZ-01A-21R-A12O-13	TCGA-BH-A0AZ-01A-21R-A12O-13	TCGA-BH-A0AZ-01A-21D-A12Q-09	e7b4dae9-ba72-4281-a84c-9207120cfd65	TCGA-BH-A0AZ-01A-21D-A12Q-09	TCGA-BH-A0AZ-01A-11-A13A-20	TCGA-BH-A0AZ-01A-21D-A12Q-09	cb9d4717-15a8-4499-ae3b-e047e5c2926a	55a8c247-5d96-4f48-9fd6-a18f75e9dc32	TCGA-BH-A0AZ-01A-21D-A12N-01	cb9d4717-15a8-4499-ae3b-e047e5c2926a	TCGA-BH-A0AZ-01A-21D-A12R-05	TCGA-BH-A0AZ-01	TCGA-BH-A0AZ-01A-21R-A12P-07	cb9d4717-15a8-4499-ae3b-e047e5c2926a	cb9d4717-15a8-4499-ae3b-e047e5c2926a	TCGA-BH-A0AZ-01A-21D-A12N-01	TCGA-BH-A0AZ-01	TCGA-BH-A0AZ-01		55a8c247-5d96-4f48-9fd6-a18f75e9dc32	
TCGA-BH-A0AZ-11		47			867			FEMALE									867	0	Normal						enrollment			LIVING	0	TCGA-BH-A0AZ-11	867	0		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0AZ			867	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Right					Positive					Positive	Other					-17465	575		0	867					NO							2011-7-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Negative			13	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												1		true	cM0 (i+)	N1a	T3	Stage IIIA		3	5	2	2			0	0	100	100			0	0			TUMOR FREE							YES	No				Solid Tissue Normal	11	total mastectomy with sentinel lymph node biopsy with tissue reconstruction	6th		NO	YES	BH	Breast	A	LIVING	2008			TCGA-BH-A0AZ-11A-22R-A12O-13	TCGA-BH-A0AZ-11A-22R-A12O-13						ec31d946-74b0-4984-b3d8-cb1bf58e4d20			ec31d946-74b0-4984-b3d8-cb1bf58e4d20	TCGA-BH-A0AZ-11A-22D-A12R-05			ec31d946-74b0-4984-b3d8-cb1bf58e4d20	ec31d946-74b0-4984-b3d8-cb1bf58e4d20						
TCGA-BH-A0B0-01	Stage I	56	2	Stage I	1427		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	1427	0	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0B0-01	1428	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 9	cluster 6	mutation cluster 3	TCGA-BH-A0B0			1428	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Left Upper Outer Quadrant					Positive					Positive	Other					-20776	1223		0	1428					NO							2011-7-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	320	NO	Negative			2	Negative	Peri (6-12 months since last menstrual period)																		1	6									0		true	M0	N0	T1c	Stage I	TCGA-BH-A0B0.EB09D890-879C-4874-AE3F-47E41C2C66FE.pdf	2	8	0	0	1	1	0	0	24	20	5	5	70	74	70	75	TUMOR FREE							YES	No				Primary Tumor	01	left segmental mastectomy with axillary sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2006	TCGA-BH-A0B0-01A-21D-A10Y-09	TCGA-BH-A0B0-01	TCGA-BH-A0B0-01A-21R-A114-13	TCGA-BH-A0B0-01A-21R-A114-13	TCGA-BH-A0B0-01A-21D-A10Y-09	3e408dd6-0e42-4310-909b-95a91fe6cd3c	TCGA-BH-A0B0-01A-21D-A10Y-09	TCGA-BH-A0B0-01A-11-A13C-20	TCGA-BH-A0B0-01A-21D-A10Y-09	059c8834-efd5-447c-97c6-49fd68c09c0d	a41f4ff0-3452-497b-a05f-952d79da82ba	TCGA-BH-A0B0-01A-21D-A111-01	059c8834-efd5-447c-97c6-49fd68c09c0d		TCGA-BH-A0B0-01	TCGA-BH-A0B0-01A-21R-A115-07	059c8834-efd5-447c-97c6-49fd68c09c0d	059c8834-efd5-447c-97c6-49fd68c09c0d	TCGA-BH-A0B0-01A-21D-A111-01	TCGA-BH-A0B0-01	TCGA-BH-A0B0-01	TCGA-BH-A0B0-01A-21D-A112-05	a41f4ff0-3452-497b-a05f-952d79da82ba	
TCGA-BH-A0B1-01	Stage IIB	66		No_Conversion	1148		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1148	0	LumA	Luminal A	Positive	LumA/B	-3	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0B1-01	1148	0					BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-BH-A0B1	1148	0	1148	Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0B1-F15429		Positive		3+			Positive	Modified Radical Mastectomy		NO			-24315	1071		0	1148							90-99%				Scheduled Follow-up Submission	2010-11-3	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	740	NO	Negative			15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																			6								NO	1	0	true	M0	N1a	T2	Stage IIB	TCGA-BH-A0B1.BAEB6705-FCDC-4B40-B1CB-D926B8287F92.pdf	0	0	0	0	1	1	0	0	89	72	0	2	10	25	80	80	TUMOR FREE								No	40-49%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2007	TCGA-BH-A0B1-01A-12W-A071-09			TCGA-BH-A0B1-01A-12R-A057-13	TCGA-BH-A0B1-01A-12W-A071-09	cb0ffa62-bbfe-481a-9eda-099f9381319e	TCGA-BH-A0B1-01A-12W-A071-09	TCGA-BH-A0B1-01A-21-A13C-20	TCGA-BH-A0B1-01A-12W-A071-09	0042b857-502f-4d8e-baac-845c1a9bb64b	4e237dc0-b785-4eb0-9948-a946b41dab8f		0042b857-502f-4d8e-baac-845c1a9bb64b		TCGA-BH-A0B1-01	TCGA-BH-A0B1-01A-12R-A056-07	0042b857-502f-4d8e-baac-845c1a9bb64b	0042b857-502f-4d8e-baac-845c1a9bb64b		TCGA-BH-A0B1-01			4e237dc0-b785-4eb0-9948-a946b41dab8f	TCGA-BH-A0B1-01A-12R-A057-13
TCGA-BH-A0B2-01	Stage I	43		Stage I	1242		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1242	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-BH-A0B2-01	1242	0					BRCA nonbasal-like c8					TCGA-BH-A0B2			1242	Breast	TCGA Breast Cancer	breast invasive carcinoma					43	Right Upper Outer Quadrant					Positive					Positive	Other					-15917	1031		0	1242					NO							2011-7-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	220		Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												0		true	M0	N0	T1a	Stage I		20	9	0	0	1	1	0	0	30	20	9	9	60	70	60	80	TUMOR FREE							YES	Yes				Primary Tumor	01	segmental mastectomy with sentinel node dissection	6th		NO	YES	BH	Breast	A	LIVING	2007				TCGA-BH-A0B2-01A-11R-A10I-13		2cdcaddf-2dd3-492b-a08f-71adc1065fec		TCGA-BH-A0B2-01A-21-A13C-20		a27c5907-1ad2-4414-a9c9-448f1b484946	ae2856f4-dafc-45b6-96af-6c6615cf9475	TCGA-BH-A0B2-01A-11D-A10L-01	a27c5907-1ad2-4414-a9c9-448f1b484946	TCGA-BH-A0B2-01A-11D-A10N-05		TCGA-BH-A0B2-01A-11R-A10J-07	a27c5907-1ad2-4414-a9c9-448f1b484946	a27c5907-1ad2-4414-a9c9-448f1b484946	TCGA-BH-A0B2-01A-11D-A10L-01				ae2856f4-dafc-45b6-96af-6c6615cf9475	TCGA-BH-A0B2-01A-11R-A10I-13
TCGA-BH-A0B2-11		43			1242			FEMALE									1242	0	Normal						enrollment			LIVING	0	TCGA-BH-A0B2-11	1242	0										TCGA-BH-A0B2			1242	Breast	TCGA Breast Cancer	breast invasive carcinoma					43	Right Upper Outer Quadrant					Positive					Positive	Other					-15917	1031		0	1242					NO							2011-7-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130		Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												0		true	M0	N0	T1a	Stage I		8	8	0	0	0	0	0	0	100	95	0	0	0	0	0	0	TUMOR FREE							YES	Yes				Solid Tissue Normal	11	segmental mastectomy with sentinel node dissection	6th		NO	YES	BH	Breast	A	LIVING	2007										83b0bb89-66a7-4c70-87e1-78a0cc7de9e6			83b0bb89-66a7-4c70-87e1-78a0cc7de9e6	TCGA-BH-A0B2-11A-11D-A10N-05		TCGA-BH-A0B2-11A-11R-A10J-07	83b0bb89-66a7-4c70-87e1-78a0cc7de9e6	83b0bb89-66a7-4c70-87e1-78a0cc7de9e6						
TCGA-BH-A0B3-01	Stage IIB	53	1	No_Conversion	1203		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	1203	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-BH-A0B3-01	1203	0	High	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A0B3	1203	0	1203	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0B3-F15418		Negative		0			Negative	Lumpectomy		NO			-19479	1030		0	1203											Scheduled Follow-up Submission	2010-11-3	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	280	NO	Negative			29	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4								NO	2		true	M0	N1a	T2	Stage IIB	TCGA-BH-A0B3.A6E2735B-AAD3-48D7-8289-306257CB5B6F.pdf	15	10	2	5	2	8	0	0	0	0	15	17	83	75	70	70	TUMOR FREE								No			YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2007	TCGA-BH-A0B3-01A-11W-A071-09	TCGA-BH-A0B3-01		TCGA-BH-A0B3-01A-11R-A057-13		971d0c2f-844b-45a2-a541-05189e0278d4	TCGA-BH-A0B3-01A-11W-A071-09	TCGA-BH-A0B3-01A-21-A13A-20	TCGA-BH-A0B3-01A-11W-A071-09	6d2744ba-4817-482b-ad46-2e4e0897ad88	c3288d38-aff7-4cf9-8b44-e3eb22e261ca	TCGA-BH-A0B3-01A-11D-A059-01	6d2744ba-4817-482b-ad46-2e4e0897ad88	TCGA-BH-A0B3-01A-11D-A10P-05	TCGA-BH-A0B3-01	TCGA-BH-A0B3-01A-11R-A056-07	6d2744ba-4817-482b-ad46-2e4e0897ad88	6d2744ba-4817-482b-ad46-2e4e0897ad88	TCGA-BH-A0B3-01A-11D-A059-01	TCGA-BH-A0B3-01	TCGA-BH-A0B3-01		c3288d38-aff7-4cf9-8b44-e3eb22e261ca	TCGA-BH-A0B3-01A-11R-A057-13
TCGA-BH-A0B3-11		53			1203			FEMALE									1203	0	Normal						followup			LIVING	0	TCGA-BH-A0B3-11	1203	0		C4-BRCA/Basal							mutation cluster 5	TCGA-BH-A0B3	1203	0	1203	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0B3-F15418		Negative		0			Negative	Lumpectomy		NO			-19479	1030		0	1203											Scheduled Follow-up Submission	2010-11-3	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	160	NO	Negative			29	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	2		true	M0	N1a	T2	Stage IIB			0		0		0		0		100		0		0		0	TUMOR FREE								No			YES	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	B	LIVING	2007				TCGA-BH-A0B3-11B-21R-A090-13						bc387ac9-46c2-49b5-9dbb-2d2b5ea2d437			bc387ac9-46c2-49b5-9dbb-2d2b5ea2d437	TCGA-BH-A0B3-11B-21D-A10Q-05		TCGA-BH-A0B3-11B-21R-A089-07	bc387ac9-46c2-49b5-9dbb-2d2b5ea2d437	bc387ac9-46c2-49b5-9dbb-2d2b5ea2d437						TCGA-BH-A0B3-11B-21R-A090-13
TCGA-BH-A0B4-01	Stage IIIA	65	5	No_Conversion	1191		Positive	MALE	Positive	1	3	3	Negative	M0	Positive	N2	1191	0	LumA	Luminal A	Positive	ReacII	-3	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0B4-01	1191	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-BH-A0B4	1191	0	1191	Breast	TCGA Breast Cancer	breast invasive carcinoma					65	Left	Axillary lymph node dissection alone		TCGA-BH-A0B4-F15435		Positive		3+			Positive	Modified Radical Mastectomy		NO			-23980	995		0	1191							80-89%			2.0	Scheduled Follow-up Submission	2010-11-4	MALE					2+	40	5.65	2.83		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	340	NO	Equivocal	Positive		10	Negative																			4	6								NO	6		true	M0	N2	T2	Stage IIIA	TCGA-BH-A0B4.00C75246-4343-490D-9782-E6C0068C77B2.pdf	2	8	0	0	1	1	0	0	20	0	5	10	74	89	90	85	TUMOR FREE								No	50-59%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2007	TCGA-BH-A0B4-01A-11W-A019-09	TCGA-BH-A0B4-01		TCGA-BH-A0B4-01A-11R-A010-13		8406b2cf-e6f8-40ac-b0e9-f63535cc3574	TCGA-BH-A0B4-01A-11W-A019-09	TCGA-BH-A0B4-01A-21-A13C-20	TCGA-BH-A0B4-01A-11W-A019-09	8af4a557-aebf-44ac-8ed5-b8b7b10ed24e	bce6d618-4fdf-49fe-b3fe-87709bd79d75	TCGA-BH-A0B4-01A-11D-A011-01	8af4a557-aebf-44ac-8ed5-b8b7b10ed24e		TCGA-BH-A0B4-01	TCGA-BH-A0B4-01A-11R-A00Z-07	8af4a557-aebf-44ac-8ed5-b8b7b10ed24e	8af4a557-aebf-44ac-8ed5-b8b7b10ed24e	TCGA-BH-A0B4-01A-11D-A011-01	TCGA-BH-A0B4-01	TCGA-BH-A0B4-01	TCGA-BH-A0B4-01A-11D-A00Y-05	bce6d618-4fdf-49fe-b3fe-87709bd79d75	TCGA-BH-A0B4-01A-11R-A010-13
TCGA-BH-A0B5-01	Stage IIIA	40	2	Stage IIIA	1471		Positive	FEMALE	Negative	1	3	4	Negative	M0	Positive	N2	1471	0	LumA	Luminal B	Positive	ReacII	-7	-3	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0B5-01	1471	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 1	TCGA-BH-A0B5			1471	Breast	TCGA Breast Cancer	breast invasive carcinoma					40	Left					Positive					Positive	Modified Radical Mastectomy					-14920	1008		0	1471					NO							2011-8-2	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	700	NO	Negative			24	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	7									5		true	M0	N2a	T2	Stage IIIA	TCGA-BH-A0B5.F44C515D-5A58-4382-A147-4429A78D434F.pdf	1	2	0	1	1	1	0	0	29	7	40	7	30	85	45	70	TUMOR FREE							YES	No				Primary Tumor	01	Sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007	TCGA-BH-A0B5-01A-11D-A12Q-09	TCGA-BH-A0B5-01	TCGA-BH-A0B5-01A-11R-A12O-13	TCGA-BH-A0B5-01A-11R-A12O-13	TCGA-BH-A0B5-01A-11D-A12Q-09	e6f7c6af-6c88-4305-a8f4-d8ea46f8b302	TCGA-BH-A0B5-01A-11D-A12Q-09	TCGA-BH-A0B5-01A-21-A13C-20	TCGA-BH-A0B5-01A-11D-A12Q-09	4b964043-f6dd-4f19-ab4c-439ee68ce2b0	78ff5370-519b-4bb9-ae5a-67f862038ff8	TCGA-BH-A0B5-01A-11D-A12N-01	4b964043-f6dd-4f19-ab4c-439ee68ce2b0	TCGA-BH-A0B5-01A-11D-A12R-05	TCGA-BH-A0B5-01	TCGA-BH-A0B5-01A-11R-A12P-07	4b964043-f6dd-4f19-ab4c-439ee68ce2b0	4b964043-f6dd-4f19-ab4c-439ee68ce2b0	TCGA-BH-A0B5-01A-11D-A12N-01	TCGA-BH-A0B5-01	TCGA-BH-A0B5-01		78ff5370-519b-4bb9-ae5a-67f862038ff8	
TCGA-BH-A0B5-11		40			1471			FEMALE									1471	0	LumA						enrollment			LIVING	0	TCGA-BH-A0B5-11	1471	0		C3-BRCA/Luminal							mutation cluster 1	TCGA-BH-A0B5			1471	Breast	TCGA Breast Cancer	breast invasive carcinoma					40	Left					Positive					Positive	Modified Radical Mastectomy					-14920	1008		0	1471					NO							2011-8-2	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	600	NO	Negative			24	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												5		true	M0	N2a	T2	Stage IIIA			0		0		0		0		100		0		0		0	TUMOR FREE							YES	No				Solid Tissue Normal	11	Sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007			TCGA-BH-A0B5-11A-23R-A12O-13	TCGA-BH-A0B5-11A-23R-A12O-13						35429f42-252a-4a9d-8e99-125f26019418			35429f42-252a-4a9d-8e99-125f26019418			TCGA-BH-A0B5-11A-23R-A12P-07	35429f42-252a-4a9d-8e99-125f26019418	35429f42-252a-4a9d-8e99-125f26019418						
TCGA-BH-A0B6-01																													0	TCGA-BH-A0B6-01	1732	0	Squamous			BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 3			TCGA-BH-A0B6			1732	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Left Upper Outer Quadrant					Positive					Positive	Other					-17346			0	1732					NO							2011-8-4	FEMALE										Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy			Positive			4	Negative																													0			M0	N0	T1c	Stage I																		TUMOR FREE							YES	Yes				Primary Tumor	01	segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast		LIVING	2006			TCGA-BH-A0B6-01A-11R-A19V-13	TCGA-BH-A0B6-01A-11R-A19V-13			TCGA-BH-A0B6-01A-11D-A19Y-09	TCGA-BH-A0B6-01A-21-A24A-20		b455387f-a8b4-43b8-b898-89628723d7da	aee8a3d7-7392-4e87-8315-b4fb849705fe	TCGA-BH-A0B6-01A-11D-A19X-01	b455387f-a8b4-43b8-b898-89628723d7da	TCGA-BH-A0B6-01A-11D-A19Z-05	TCGA-BH-A0B6-01		b455387f-a8b4-43b8-b898-89628723d7da	b455387f-a8b4-43b8-b898-89628723d7da	TCGA-BH-A0B6-01A-11D-A19X-01		TCGA-BH-A0B6-01		aee8a3d7-7392-4e87-8315-b4fb849705fe	
TCGA-BH-A0B7-01	Stage IIB	42	3	Stage IIB	1733		Positive	FEMALE	Positive	2	2	1	Negative	M0	Positive	N1	1733	0	Her2	HER2-enriched	Positive	Her2	-11	-8	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0B7-01	1733	0	High	C3-BRCA/Luminal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-BH-A0B7			1733	Breast	TCGA Breast Cancer	breast invasive carcinoma					42	Right					Positive					Positive	Other					-15593	1391		0	1733					NO							2011-8-4	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	320	NO	Positive			17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	3									1		true	M0	N1a	T2	Stage IIB	TCGA-BH-A0B7.B5E5A3B8-108E-47D3-99DA-EC7A64B5FA9C.pdf	30	30	0	0	3	1	0	0	20	15	11	10	66	74	55	60								YES	No				Primary Tumor	01	right total mastectomy with sentinel lymph node dissection right reconstruction with TRAMP	6th		NO	YES	BH	Breast	A	LIVING	2006	TCGA-BH-A0B7-01A-12D-A10Y-09	TCGA-BH-A0B7-01	TCGA-BH-A0B7-01A-12R-A114-13	TCGA-BH-A0B7-01A-12R-A114-13	TCGA-BH-A0B7-01A-12D-A10Y-09	c759e411-0873-4535-8b6d-ed41dd2e6fba	TCGA-BH-A0B7-01A-12D-A10Y-09	TCGA-BH-A0B7-01A-21-A13B-20	TCGA-BH-A0B7-01A-12D-A10Y-09	2af2adfe-bd7b-4eb1-9971-182b11075159	08da84c6-2240-4884-be29-4f7c683f9e4e	TCGA-BH-A0B7-01A-12D-A111-01	2af2adfe-bd7b-4eb1-9971-182b11075159		TCGA-BH-A0B7-01	TCGA-BH-A0B7-01A-12R-A115-07	2af2adfe-bd7b-4eb1-9971-182b11075159	2af2adfe-bd7b-4eb1-9971-182b11075159	TCGA-BH-A0B7-01A-12D-A111-01	TCGA-BH-A0B7-01	TCGA-BH-A0B7-01	TCGA-BH-A0B7-01A-12D-A112-05	08da84c6-2240-4884-be29-4f7c683f9e4e	
TCGA-BH-A0B7-11		42			1733			FEMALE									1733	0	Normal						enrollment			LIVING	0	TCGA-BH-A0B7-11	1733	0		C3-BRCA/Luminal							mutation cluster 5	TCGA-BH-A0B7			1733	Breast	TCGA Breast Cancer	breast invasive carcinoma					42	Right					Positive					Positive	Other					-15593	1391		0	1733					NO							2011-8-4	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	930	NO	Positive			17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												1		true	M0	N1a	T2	Stage IIB			0		0		0		0		100		0		0		0								YES	No				Solid Tissue Normal	11	right total mastectomy with sentinel lymph node dissection right reconstruction with TRAMP	6th		NO	YES	BH	Breast	A	LIVING	2006			TCGA-BH-A0B7-11A-34R-A114-13	TCGA-BH-A0B7-11A-34R-A114-13						30cee921-7fb5-4543-aeb6-ab3eaf669f84			30cee921-7fb5-4543-aeb6-ab3eaf669f84			TCGA-BH-A0B7-11A-34R-A115-07	30cee921-7fb5-4543-aeb6-ab3eaf669f84	30cee921-7fb5-4543-aeb6-ab3eaf669f84				TCGA-BH-A0B7-11A-34D-A112-05		
TCGA-BH-A0B8-01	Stage IB	64		Stage I	1569		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1569	0	LumA	Luminal A	Positive		-10	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0B8-01	1569	0			cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 6	cluster 7	mutation c1uster 9	TCGA-BH-A0B8	1569	0	1569	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Right Upper Inner Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0B8-F15442		Positive		3+			Positive	Lumpectomy		NO			-23380	1401		0	1569							90-99%				Scheduled Follow-up Submission	2010-11-3	FEMALE					2+			1.29		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	150	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	7								NO	0		true	M0	N0 (i-)	T1b	Stage I	TCGA-BH-A0B8.11E1BCE2-F246-4930-A97C-A14B34BCF840.pdf	1	2	0	0	1	1	0	0	15	30	14	9	70	60	85	85	TUMOR FREE								No	30-39%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2006	TCGA-BH-A0B8-01A-21W-A071-09			TCGA-BH-A0B8-01A-21R-A057-13			TCGA-BH-A0B8-01A-21W-A071-09		TCGA-BH-A0B8-01A-21W-A071-09	de7eef02-1a8d-4a6a-9d87-e2b1430066e3	79cc92c6-95f1-4a56-b064-d26a3d38b254		de7eef02-1a8d-4a6a-9d87-e2b1430066e3	TCGA-BH-A0B8-01A-21D-A10P-05	TCGA-BH-A0B8-01	TCGA-BH-A0B8-01A-21R-A056-07	de7eef02-1a8d-4a6a-9d87-e2b1430066e3	de7eef02-1a8d-4a6a-9d87-e2b1430066e3		TCGA-BH-A0B8-01			79cc92c6-95f1-4a56-b064-d26a3d38b254	TCGA-BH-A0B8-01A-21R-A057-13
TCGA-BH-A0B8-11		64			1569			FEMALE									1569	0	Normal						followup			LIVING	0	TCGA-BH-A0B8-11	1569	0									mutation c1uster 9	TCGA-BH-A0B8	1569	0	1569	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Right Upper Inner Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0B8-F15442		Positive		3+			Positive	Lumpectomy		NO			-23380	1401		0	1569							90-99%				Scheduled Follow-up Submission	2010-11-3	FEMALE					2+			1.29		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	400	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		true	M0	N0 (i-)	T1b	Stage I			2		5				0		0				0			TUMOR FREE								No	30-39%		YES	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2006										61e357f3-e4e1-49b8-9e37-7e0ef5a29e23			61e357f3-e4e1-49b8-9e37-7e0ef5a29e23	TCGA-BH-A0B8-11A-41D-A093-05		TCGA-BH-A0B8-11A-41R-A089-07	61e357f3-e4e1-49b8-9e37-7e0ef5a29e23	61e357f3-e4e1-49b8-9e37-7e0ef5a29e23						
TCGA-BH-A0B9-01	Stage IA	44	1	Stage I	1572		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1572	0		Basal-like	Negative	Basal	-13	-12	followup	T1	T1	LIVING	0	TCGA-BH-A0B9-01	1572	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6		miRNA cluster 14	cluster 5	mutation cluster 5	TCGA-BH-A0B9	1572	0	1572	Breast	TCGA Breast Cancer	breast invasive carcinoma					44	Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0B9-F15438		Negative		0			Negative	Lumpectomy		NO			-16310	1391		0	1572											Scheduled Follow-up Submission	2010-11-4	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	190	NO	Negative			1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	5								NO	0		true	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0B9.EB00527B-1E37-420E-85E4-10063DB4BC1C.pdf	11	11	0	0	5	5	1	0	5	5	5	5	85	85	85	85	TUMOR FREE								No			YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2006	TCGA-BH-A0B9-01A-11W-A071-09	TCGA-BH-A0B9-01		TCGA-BH-A0B9-01A-11R-A057-13		99bf951a-a4c0-424e-bdf5-4308ec20f38d	TCGA-BH-A0B9-01A-11W-A071-09	TCGA-BH-A0B9-01A-21-A13C-20	TCGA-BH-A0B9-01A-11W-A071-09	d5c39754-79c3-432c-b496-34a394662e17	7fd0974b-7ac4-4bdd-904d-234af0722313	TCGA-BH-A0B9-01A-11D-A059-01	d5c39754-79c3-432c-b496-34a394662e17	TCGA-BH-A0B9-01A-11D-A10P-05	TCGA-BH-A0B9-01	TCGA-BH-A0B9-01A-11R-A056-07	d5c39754-79c3-432c-b496-34a394662e17	d5c39754-79c3-432c-b496-34a394662e17	TCGA-BH-A0B9-01A-11D-A059-01	TCGA-BH-A0B9-01	TCGA-BH-A0B9-01		7fd0974b-7ac4-4bdd-904d-234af0722313	TCGA-BH-A0B9-01A-11R-A057-13
TCGA-BH-A0BA-01	Stage IIIC	51	3	No_Conversion	1132		Positive	FEMALE	Negative	1	4	3	Negative	M0	Positive	N3	1132	0	LumA	Luminal A	Positive	ReacI	-5	0	followup	T_Other	T3	LIVING	0	TCGA-BH-A0BA-01	1132	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-BH-A0BA	1132	0	1132	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BA-F15461		Positive		1+			Positive	Modified Radical Mastectomy		NO			-18839	1266		0	1132							80-89%				Scheduled Follow-up Submission	2010-11-4	FEMALE					1+					Mixed Histology (please specify)	Infiltrating ductal & lobular	No		C50.9	8522/3	C50.9	3+	YES		Core needle biopsy	360	NO	Negative			27	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	6								NO	27		true	M0	N3a	T3	Stage IIIC	TCGA-BH-A0BA.142F03FE-5B60-416D-8DCD-EC34DB5495DB.pdf	10	0	0	0	1	1	0	0	64	5	5	5	30	89	80	94	TUMOR FREE								No	40-49%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2006	TCGA-BH-A0BA-01A-11W-A071-09	TCGA-BH-A0BA-01		TCGA-BH-A0BA-01A-11R-A057-13	TCGA-BH-A0BA-01A-11W-A071-09	348679c1-9edf-44d0-96e2-83602db6c2e7	TCGA-BH-A0BA-01A-11W-A071-09	TCGA-BH-A0BA-01A-21-A13C-20	TCGA-BH-A0BA-01A-11W-A071-09	651d6ca6-8e1c-4c5a-b7f4-1af98b415561	c4a07ce3-f12a-4e73-b791-6dfa05f4b435	TCGA-BH-A0BA-01A-11D-A059-01	651d6ca6-8e1c-4c5a-b7f4-1af98b415561	TCGA-BH-A0BA-01A-11D-A10P-05	TCGA-BH-A0BA-01	TCGA-BH-A0BA-01A-11R-A056-07	651d6ca6-8e1c-4c5a-b7f4-1af98b415561	651d6ca6-8e1c-4c5a-b7f4-1af98b415561	TCGA-BH-A0BA-01A-11D-A059-01	TCGA-BH-A0BA-01	TCGA-BH-A0BA-01		c4a07ce3-f12a-4e73-b791-6dfa05f4b435	TCGA-BH-A0BA-01A-11R-A057-13
TCGA-BH-A0BA-11		51			1132			FEMALE									1132	0	Normal						followup			LIVING	0	TCGA-BH-A0BA-11	1132	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0BA	1132	0	1132	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BA-F15461		Positive		1+			Positive	Modified Radical Mastectomy		NO			-18839	1266		0	1132							80-89%				Scheduled Follow-up Submission	2010-11-4	FEMALE					1+					Mixed Histology (please specify)	Infiltrating ductal & lobular	No		C50.9	8522/3	C50.9	3+	YES		Core needle biopsy	220	NO	Negative			27	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	27		true	M0	N3a	T3	Stage IIIC		1	1	1	1			0	0	100	100			0	0			TUMOR FREE								No	40-49%		YES	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2006										3bfd1811-bd2a-439d-8dde-237abcf855af			3bfd1811-bd2a-439d-8dde-237abcf855af	TCGA-BH-A0BA-11A-22D-A10Q-05		TCGA-BH-A0BA-11A-22R-A089-07	3bfd1811-bd2a-439d-8dde-237abcf855af	3bfd1811-bd2a-439d-8dde-237abcf855af						
TCGA-BH-A0BC-01	Stage IIIC	60	2	No_Conversion	974		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N3	974	0	LumA	Luminal A	Positive	ReacI	-4	-4	followup	T_Other	T2	LIVING	0	TCGA-BH-A0BC-01	974	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-BH-A0BC			974	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	60	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BC-F4487		Positive		1+			Positive	Lumpectomy		NO			-21949	1098		0	974							90-99%					2010-11-4	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	160	NO	Negative			18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4									12		true	M0	N3	T2	Stage IIIC	TCGA-BH-A0BC.9714A9F8-B507-43E6-9D56-1852F5D1F675.pdf	10	12	0	0	1	1	0	0	5	5	24	20	70	74	80	80	TUMOR FREE								No	30-39%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2007	TCGA-BH-A0BC-01A-22D-A099-09	TCGA-BH-A0BC-01		TCGA-BH-A0BC-01A-22R-A085-13	TCGA-BH-A0BC-01A-22D-A099-09	6b66ea4c-8556-4fc6-8014-f99e59727021	TCGA-BH-A0BC-01A-22D-A099-09	TCGA-BH-A0BC-01A-11-A13B-20	TCGA-BH-A0BC-01A-22D-A099-09	9fc55d1c-ecb6-4406-bf25-34f59a0dcfec	0ac2333e-89ba-4790-8104-87de2772833c	TCGA-BH-A0BC-01A-22D-A087-01	9fc55d1c-ecb6-4406-bf25-34f59a0dcfec	TCGA-BH-A0BC-01A-22D-A10P-05	TCGA-BH-A0BC-01	TCGA-BH-A0BC-01A-22R-A084-07	9fc55d1c-ecb6-4406-bf25-34f59a0dcfec	9fc55d1c-ecb6-4406-bf25-34f59a0dcfec	TCGA-BH-A0BC-01A-22D-A087-01	TCGA-BH-A0BC-01	TCGA-BH-A0BC-01		0ac2333e-89ba-4790-8104-87de2772833c	TCGA-BH-A0BC-01A-22R-A085-13
TCGA-BH-A0BC-11		60			974			FEMALE									974	0	Normal						followup			LIVING	0	TCGA-BH-A0BC-11	974	0		C3-BRCA/Luminal							mutation cluster 3	TCGA-BH-A0BC			974	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	60	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BC-F4487		Positive		1+			Positive	Lumpectomy		NO			-21949	1098		0	974							90-99%					2010-11-4	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	200	NO	Negative			18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												12		true	M0	N3	T2	Stage IIIC			0		0		0		0		100		0		0		0	TUMOR FREE								No	30-39%		YES	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2007				TCGA-BH-A0BC-11A-22R-A090-13						32336250-dc07-4e96-9a6c-3c7094fd5342			32336250-dc07-4e96-9a6c-3c7094fd5342	TCGA-BH-A0BC-11A-22D-A093-05		TCGA-BH-A0BC-11A-22R-A089-07	32336250-dc07-4e96-9a6c-3c7094fd5342	32336250-dc07-4e96-9a6c-3c7094fd5342						TCGA-BH-A0BC-11A-22R-A090-13
TCGA-BH-A0BD-01	Stage IIA	47	4	No_Conversion	554		Positive	FEMALE	Negative				Negative	M0	Positive	N1	554	0	LumB	Luminal B	Positive		0	0	followup	T1	T1	LIVING	0	TCGA-BH-A0BD-01	554	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-BH-A0BD	554	0	554	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BD-F15423		Positive					Positive	Lumpectomy		NO			-17275	364		0	554						H-Score-190					Scheduled Follow-up Submission	2010-11-4	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	90	NO	Negative			9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4								NO	2		true	M0	N1a	T1c	Stage IIA	TCGA-BH-A0BD.CE70DD1E-BCA4-4F89-AA5B-D90FE18A36FF.pdf	7	5	0	0	1	1	0	0	5	12	19	12	75	75	85	85	TUMOR FREE	H-Score-230			H-Score	H-Score			No			YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2009	TCGA-BH-A0BD-01A-11W-A050-09	TCGA-BH-A0BD-01		TCGA-BH-A0BD-01A-11R-A035-13	TCGA-BH-A0BD-01A-11W-A050-09		TCGA-BH-A0BD-01A-11W-A050-09		TCGA-BH-A0BD-01A-11W-A050-09	bf23a402-18ab-47b7-8bca-a9b01eeaf605	14d1ebac-ab78-4daf-b4bf-158610be3948	TCGA-BH-A0BD-01A-11D-A036-01	bf23a402-18ab-47b7-8bca-a9b01eeaf605		TCGA-BH-A0BD-01	TCGA-BH-A0BD-01A-11R-A034-07	bf23a402-18ab-47b7-8bca-a9b01eeaf605	bf23a402-18ab-47b7-8bca-a9b01eeaf605	TCGA-BH-A0BD-01A-11D-A036-01	TCGA-BH-A0BD-01	TCGA-BH-A0BD-01	TCGA-BH-A0BD-01A-11D-A032-05	14d1ebac-ab78-4daf-b4bf-158610be3948	TCGA-BH-A0BD-01A-11R-A035-13
TCGA-BH-A0BF-01	Stage IIB	56	2	Stage IIB	781		Positive	FEMALE	Negative	3	1	4	Negative	M0	Positive	N1	781	0	LumB	Luminal B	Positive	Basal	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0BF-01	782	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-BH-A0BF			782	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Right Upper Outer Quadrant					Positive					Positive	Other					-20691	413		0	782					NO							2011-8-5	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	260	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4									1		true	M0	N1mi	T2	Stage IIB	TCGA-BH-A0BF.0D76394C-40B4-4E74-8A80-FAE00E21FD10.pdf	40	35	0	0	1	1	0	0	12	5	12	5	75	89	50	60	TUMOR FREE							YES	No				Primary Tumor	01	Total mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2009	TCGA-BH-A0BF-01A-21D-A12Q-09	TCGA-BH-A0BF-01	TCGA-BH-A0BF-01A-21R-A12O-13	TCGA-BH-A0BF-01A-21R-A12O-13	TCGA-BH-A0BF-01A-21D-A12Q-09	3d84a5c4-09f1-44f6-9ae6-dcb6a3c19b81	TCGA-BH-A0BF-01A-21D-A12Q-09	TCGA-BH-A0BF-01A-11-A13C-20	TCGA-BH-A0BF-01A-21D-A12Q-09	3491d44a-675b-4510-8699-2ee83f960d02	ce3c088b-0131-49df-a2e7-f42a2712849c	TCGA-BH-A0BF-01A-21D-A12N-01	3491d44a-675b-4510-8699-2ee83f960d02	TCGA-BH-A0BF-01A-21D-A12R-05	TCGA-BH-A0BF-01	TCGA-BH-A0BF-01A-21R-A12P-07	3491d44a-675b-4510-8699-2ee83f960d02	3491d44a-675b-4510-8699-2ee83f960d02	TCGA-BH-A0BF-01A-21D-A12N-01	TCGA-BH-A0BF-01	TCGA-BH-A0BF-01		ce3c088b-0131-49df-a2e7-f42a2712849c	
TCGA-BH-A0BF-11		56			781			FEMALE									781	0							enrollment			LIVING	0	TCGA-BH-A0BF-11	782	0		C3-BRCA/Luminal							mutation cluster 3	TCGA-BH-A0BF			782	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Right Upper Outer Quadrant					Positive					Positive	Other					-20691	413		0	782					NO							2011-8-5	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												1		true	M0	N1mi	T2	Stage IIB			0		0		0		0		100		0		0		0	TUMOR FREE							YES	No				Solid Tissue Normal	11	Total mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2009														TCGA-BH-A0BF-11A-31D-A12R-05										
TCGA-BH-A0BG-01	Stage I	73	1	Stage I	756		Negative	FEMALE	Negative				Negative	M0	Negative	N0	756	0	Basal	Basal-like	Negative		-13	-12	enrollment	T1	T1	LIVING	0	TCGA-BH-A0BG-01	756	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA c1uster 9	cluster 4	mutation cluster 5	TCGA-BH-A0BG			756	Breast	TCGA Breast Cancer	breast invasive carcinoma					73	Left Lower Outer Quadrant					Negative					Negative	Other					-26988	798		0	756					NO							2011-8-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	50	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4									0		true	M0	N0	T1	Stage I	TCGA-BH-A0BG.CB0C2E8E-2D5D-492C-9C7E-0ECD0458425A.pdf	40	35	0	0	1	0	0	0	0	20	9	10	90	70	55	60	TUMOR FREE							YES	No				Primary Tumor	01	Segmental mastectomy with sentinel axillary lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2008	TCGA-BH-A0BG-01A-11D-A10Y-09	TCGA-BH-A0BG-01	TCGA-BH-A0BG-01A-11R-A114-13	TCGA-BH-A0BG-01A-11R-A114-13	TCGA-BH-A0BG-01A-11D-A10Y-09		TCGA-BH-A0BG-01A-11D-A10Y-09		TCGA-BH-A0BG-01A-11D-A10Y-09	70b29dd6-1688-4510-94dd-5fcb26a1a908	e0ad6225-f660-4276-9609-f8fc0889a61c	TCGA-BH-A0BG-01A-11D-A111-01	70b29dd6-1688-4510-94dd-5fcb26a1a908		TCGA-BH-A0BG-01	TCGA-BH-A0BG-01A-11R-A115-07	70b29dd6-1688-4510-94dd-5fcb26a1a908	70b29dd6-1688-4510-94dd-5fcb26a1a908	TCGA-BH-A0BG-01A-11D-A111-01	TCGA-BH-A0BG-01	TCGA-BH-A0BG-01	TCGA-BH-A0BG-01A-11D-A112-05	e0ad6225-f660-4276-9609-f8fc0889a61c	
TCGA-BH-A0BJ-01	Stage IIB	41	3	No_Conversion	660		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N1	660	0	LumA	Luminal A	Positive	ReacI	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-BH-A0BJ-01	660	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 7	mutation c1uster 9	TCGA-BH-A0BJ			660	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	41	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BJ-F4480		Positive		3+			Positive	Lumpectomy		NO			-15027	595		0	660						H-Score 300	90-99%					2010-11-15	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	110	NO	Negative			18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	7									2		true	M0	N1a	T2	Stage IIB	TCGA-BH-A0BJ.A3CDF051-4162-47EC-BE8A-1519A5564518.pdf	26	10	0	0	1	1	0	0	10	5	14	14	75	80	65	75	TUMOR FREE	H-Score 260			H-Score	H Score			No	70-79%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2008	TCGA-BH-A0BJ-01A-11W-A071-09	TCGA-BH-A0BJ-01		TCGA-BH-A0BJ-01A-11R-A057-13		188575e2-83fd-4463-8bd3-aed928b5acf0	TCGA-BH-A0BJ-01A-11W-A071-09	TCGA-BH-A0BJ-01A-21-A13A-20	TCGA-BH-A0BJ-01A-11W-A071-09	224cbe13-ebf8-41eb-ab1c-1d6792a66774	e66a0d0b-c237-41dc-8411-beeee54998ec	TCGA-BH-A0BJ-01A-11D-A059-01	224cbe13-ebf8-41eb-ab1c-1d6792a66774	TCGA-BH-A0BJ-01A-11D-A10P-05	TCGA-BH-A0BJ-01	TCGA-BH-A0BJ-01A-11R-A056-07	224cbe13-ebf8-41eb-ab1c-1d6792a66774	224cbe13-ebf8-41eb-ab1c-1d6792a66774	TCGA-BH-A0BJ-01A-11D-A059-01	TCGA-BH-A0BJ-01	TCGA-BH-A0BJ-01		e66a0d0b-c237-41dc-8411-beeee54998ec	TCGA-BH-A0BJ-01A-11R-A057-13
TCGA-BH-A0BJ-11		41			660			FEMALE									660	0	Normal						followup			LIVING	0	TCGA-BH-A0BJ-11	660	0		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0BJ			660	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	41	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BJ-F4480		Positive		3+			Positive	Lumpectomy		NO			-15027	595		0	660						H-Score 300	90-99%					2010-11-15	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	200	NO	Negative			18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												2		true	M0	N1a	T2	Stage IIB		5	5	1	1			0	0	100	100			0	0			TUMOR FREE	H-Score 260			H-Score	H Score			No	70-79%		YES	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2008				TCGA-BH-A0BJ-11A-23R-A090-13						4317b197-dc43-44f2-8854-557832570098			4317b197-dc43-44f2-8854-557832570098	TCGA-BH-A0BJ-11A-23D-A10Q-05		TCGA-BH-A0BJ-11A-23R-A089-07	4317b197-dc43-44f2-8854-557832570098	4317b197-dc43-44f2-8854-557832570098						TCGA-BH-A0BJ-11A-23R-A090-13
TCGA-BH-A0BL-01	Stage I	35	3	Stage I	1339		Negative	FEMALE	Negative				Negative	M0	Negative	N0	1339	0	Basal	Basal-like	Negative		-13	-12	enrollment	T1	T1	LIVING	0	TCGA-BH-A0BL-01	1340	0	BRCA-LUAD+	C4-BRCA/Basal	cluster 5	Low purity c2		BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A0BL			1340	Breast	TCGA Breast Cancer	breast invasive carcinoma					35	Right Upper Outer Quadrant					Negative					Negative	Other					-12841	1135		0	1340					NO							2011-8-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	60	NO	Negative			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	4									0		true	M0	N0	T1c	Stage I	TCGA-BH-A0BL.DD647293-3CEA-4845-A0B3-D7000CBAB4C0.pdf	50	25	0	0	1	6	0	0	4	2	55	10	40	82	40	65	TUMOR FREE							YES	No				Primary Tumor	01	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007	TCGA-BH-A0BL-01A-11D-A10Y-09	TCGA-BH-A0BL-01	TCGA-BH-A0BL-01A-11R-A114-13	TCGA-BH-A0BL-01A-11R-A114-13	TCGA-BH-A0BL-01A-11D-A10Y-09		TCGA-BH-A0BL-01A-11D-A10Y-09		TCGA-BH-A0BL-01A-11D-A10Y-09	39ca8590-3733-4b61-9a46-4ec5e6e0501e	970819ce-f25d-4f05-98d7-7b3a22b92558	TCGA-BH-A0BL-01A-11D-A111-01	39ca8590-3733-4b61-9a46-4ec5e6e0501e		TCGA-BH-A0BL-01	TCGA-BH-A0BL-01A-11R-A115-07	39ca8590-3733-4b61-9a46-4ec5e6e0501e	39ca8590-3733-4b61-9a46-4ec5e6e0501e	TCGA-BH-A0BL-01A-11D-A111-01	TCGA-BH-A0BL-01	TCGA-BH-A0BL-01	TCGA-BH-A0BL-01A-11D-A112-05	970819ce-f25d-4f05-98d7-7b3a22b92558	
TCGA-BH-A0BL-11		35			1339			FEMALE									1339	0							enrollment			LIVING	0	TCGA-BH-A0BL-11	1340	0		C4-BRCA/Basal							mutation cluster 5	TCGA-BH-A0BL			1340	Breast	TCGA Breast Cancer	breast invasive carcinoma					35	Right Upper Outer Quadrant					Negative					Negative	Other					-12841	1135		0	1340					NO							2011-8-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	50	NO	Negative			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												0		true	M0	N0	T1c	Stage I			0		0		0		0		100		0		0		0	TUMOR FREE							YES	No				Solid Tissue Normal	11	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007																						TCGA-BH-A0BL-11A-12D-A112-05		
TCGA-BH-A0BM-01	Stage IIB	54	2	No_Conversion	1117		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N1	1117	0	LumA	Luminal A	Negative	ReacI	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0BM-01	1876	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3	cluster 6	mutation cluster 4	TCGA-BH-A0BM	1876	0	1876	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BM-F34064		Positive		0			Negative	Lumpectomy		NO			-20049	1080		0	1876											Scheduled Follow-up Submission	2012-7-29	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	100	NO	Negative			24	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6								NO	3		true	M0	N1a	T2	Stage IIB	TCGA-BH-A0BM.7F75F15A-2476-4FFD-97B3-313F06568E21.pdf	10	5	0	0	1	1	0	0	5	5	5	5	89	89	80	88	TUMOR FREE								No			NO	Primary Tumor	01		6th	YES	NO	YES	BH	Breast	A	LIVING	2007	TCGA-BH-A0BM-01A-11W-A071-09	TCGA-BH-A0BM-01		TCGA-BH-A0BM-01A-11R-A057-13	TCGA-BH-A0BM-01A-11W-A071-09	f8cccdf6-fdf0-43a1-86f9-4897d845db8c	TCGA-BH-A0BM-01A-11W-A071-09	TCGA-BH-A0BM-01A-21-A13B-20	TCGA-BH-A0BM-01A-11W-A071-09	986550fb-92db-4e9f-b79a-6c3023dd63a3	4570b87f-8116-48bf-86d3-b993536c88db	TCGA-BH-A0BM-01A-11D-A059-01	986550fb-92db-4e9f-b79a-6c3023dd63a3	TCGA-BH-A0BM-01A-11D-A10P-05	TCGA-BH-A0BM-01	TCGA-BH-A0BM-01A-11R-A056-07	986550fb-92db-4e9f-b79a-6c3023dd63a3	986550fb-92db-4e9f-b79a-6c3023dd63a3	TCGA-BH-A0BM-01A-11D-A059-01	TCGA-BH-A0BM-01	TCGA-BH-A0BM-01		4570b87f-8116-48bf-86d3-b993536c88db	TCGA-BH-A0BM-01A-11R-A057-13
TCGA-BH-A0BM-11		54			1117			FEMALE									1117	0	Normal						enrollment			LIVING	0	TCGA-BH-A0BM-11	1876	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0BM	1876	0	1876	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BM-F34064		Positive		0			Negative	Lumpectomy		NO			-20049	1080		0	1876											Scheduled Follow-up Submission	2012-7-29	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	100	NO	Negative			24	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	3		true	M0	N1a	T2	Stage IIB			1		0				0	70	95			0	0			TUMOR FREE								No			NO	Solid Tissue Normal	11		6th	YES	NO	YES	BH	Breast	A	LIVING	2007										fe538d53-c7ce-455f-afe6-cb4fc3a63dbd			fe538d53-c7ce-455f-afe6-cb4fc3a63dbd	TCGA-BH-A0BM-11A-12D-A093-05		TCGA-BH-A0BM-11A-12R-A089-07	fe538d53-c7ce-455f-afe6-cb4fc3a63dbd	fe538d53-c7ce-455f-afe6-cb4fc3a63dbd						
TCGA-BH-A0BO-01	Stage I	54	1	Stage I	1085		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	1085	0	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0BO-01	1085	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-BH-A0BO			1085	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Left Upper Inner Quadrant					Positive					Positive	Other					-19767	1162		0	1085					NO							2011-8-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	290	NO	Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	6									0		true	M0	N0	T1b	Stage I	TCGA-BH-A0BO.DDAB2FC2-D9F0-4D8F-A7FE-6C0B823E6823.pdf	10	60	0	20	1	5	0	3	34	50	35	45	30	0	65	0	TUMOR FREE							YES	No				Primary Tumor	01	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007	TCGA-BH-A0BO-01A-23D-A12B-09	TCGA-BH-A0BO-01	TCGA-BH-A0BO-01A-23R-A12C-13	TCGA-BH-A0BO-01A-23R-A12C-13	TCGA-BH-A0BO-01A-23D-A12B-09	6f30f209-57e0-4430-8132-4c36bcc0862c	TCGA-BH-A0BO-01A-23D-A12B-09	TCGA-BH-A0BO-01A-11-A13B-20	TCGA-BH-A0BO-01A-23D-A12B-09	682a9c8d-8174-4435-9ec8-cb2d58bbe6d5	54a230c7-e233-4b8b-81d9-7287b8f5d5e0	TCGA-BH-A0BO-01A-23D-A12A-01	682a9c8d-8174-4435-9ec8-cb2d58bbe6d5		TCGA-BH-A0BO-01	TCGA-BH-A0BO-01A-23R-A12D-07	682a9c8d-8174-4435-9ec8-cb2d58bbe6d5	682a9c8d-8174-4435-9ec8-cb2d58bbe6d5	TCGA-BH-A0BO-01A-23D-A12A-01	TCGA-BH-A0BO-01	TCGA-BH-A0BO-01	TCGA-BH-A0BO-01A-23D-A12E-05	54a230c7-e233-4b8b-81d9-7287b8f5d5e0	
TCGA-BH-A0BO-11		54			1085			FEMALE									1085	0							enrollment			LIVING	0	TCGA-BH-A0BO-11	1085	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0BO			1085	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Left Upper Inner Quadrant					Positive					Positive	Other					-19767	1162		0	1085					NO							2011-8-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	60	NO	Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												0		true	M0	N0	T1b	Stage I			1		0		0		0		100		0		0		0	TUMOR FREE							YES	No				Solid Tissue Normal	11	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007																						TCGA-BH-A0BO-11A-11D-A12E-05		
TCGA-BH-A0BP-01	Stage I	76	2	Stage I	1481		Positive	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	1481	0	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0BP-01	1481	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A0BP			1481	Breast	TCGA Breast Cancer	breast invasive carcinoma					76	Left Upper Outer Quadrant					Positive					Positive	Other					-27917	1217		0	1481					NO							2011-8-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	150	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									0		true	M0	N0	T1c	Stage I	TCGA-BH-A0BP.2444E1FE-E0AB-4AA0-9081-967426B90EE6.pdf	5	10	0	0	1	1	0	0	64	54	5	5	30	40	55	65	TUMOR FREE							YES	No				Primary Tumor	01	Segmental mastectomy	6th		NO	YES	BH	Breast	A	LIVING	2006	TCGA-BH-A0BP-01A-11D-A10Y-09	TCGA-BH-A0BP-01	TCGA-BH-A0BP-01A-11R-A114-13	TCGA-BH-A0BP-01A-11R-A114-13	TCGA-BH-A0BP-01A-11D-A10Y-09	4ab91e5f-6fff-4de9-a249-9013a79f6a10	TCGA-BH-A0BP-01A-11D-A10Y-09	TCGA-BH-A0BP-01A-21-A13C-20	TCGA-BH-A0BP-01A-11D-A10Y-09	acbae442-ba6c-4d28-b3bc-58bb4dd93ece	33bfefcb-2e9c-4f68-a9e7-3a3ecf8d7e59	TCGA-BH-A0BP-01A-11D-A111-01	acbae442-ba6c-4d28-b3bc-58bb4dd93ece		TCGA-BH-A0BP-01	TCGA-BH-A0BP-01A-11R-A115-07	acbae442-ba6c-4d28-b3bc-58bb4dd93ece	acbae442-ba6c-4d28-b3bc-58bb4dd93ece	TCGA-BH-A0BP-01A-11D-A111-01	TCGA-BH-A0BP-01	TCGA-BH-A0BP-01	TCGA-BH-A0BP-01A-11D-A112-05	33bfefcb-2e9c-4f68-a9e7-3a3ecf8d7e59	
TCGA-BH-A0BQ-01	Stage I	39	2	Stage I	826		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	826	0	LumA	Luminal A	Positive	Her2	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0BQ-01	827	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-BH-A0BQ			827	Breast	TCGA Breast Cancer	breast invasive carcinoma					39	Left					Positive					Positive	Other					-14494	1197		0	827					NO							2011-8-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Positive			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	6									0		true	M0	N0	T1c	Stage I	TCGA-BH-A0BQ.24245506-25BA-411D-8A43-52DB8F6B6037.pdf	15	30	0	0	3	4	0	0	10	31	20	35	67	30	60	40	TUMOR FREE							YES	No				Primary Tumor	01	Total mastectomy with retromammary lymph node excision	6th		NO	YES	BH	Breast	A	LIVING	2007	TCGA-BH-A0BQ-01A-21D-A10Y-09	TCGA-BH-A0BQ-01	TCGA-BH-A0BQ-01A-21R-A114-13	TCGA-BH-A0BQ-01A-21R-A114-13	TCGA-BH-A0BQ-01A-21D-A10Y-09	f74f1027-b835-4e74-976c-8a884db74123	TCGA-BH-A0BQ-01A-21D-A10Y-09	TCGA-BH-A0BQ-01A-11-A13C-20	TCGA-BH-A0BQ-01A-21D-A10Y-09	2ada4fe0-57f2-4a54-9580-4e0ae45a2f65	cf180187-bd5a-468e-8560-da1e48441b52	TCGA-BH-A0BQ-01A-21D-A111-01	2ada4fe0-57f2-4a54-9580-4e0ae45a2f65		TCGA-BH-A0BQ-01	TCGA-BH-A0BQ-01A-21R-A115-07	2ada4fe0-57f2-4a54-9580-4e0ae45a2f65	2ada4fe0-57f2-4a54-9580-4e0ae45a2f65	TCGA-BH-A0BQ-01A-21D-A111-01	TCGA-BH-A0BQ-01	TCGA-BH-A0BQ-01	TCGA-BH-A0BQ-01A-21D-A112-05	cf180187-bd5a-468e-8560-da1e48441b52	
TCGA-BH-A0BQ-11		39			826			FEMALE									826	0	Normal						enrollment			LIVING	0	TCGA-BH-A0BQ-11	827	0		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0BQ			827	Breast	TCGA Breast Cancer	breast invasive carcinoma					39	Left					Positive					Positive	Other					-14494	1197		0	827					NO							2011-8-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	340	NO	Positive			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												0		true	M0	N0	T1c	Stage I			0		0		0		0		100		0		0		0	TUMOR FREE							YES	No				Solid Tissue Normal	11	Total mastectomy with retromammary lymph node excision	6th		NO	YES	BH	Breast	A	LIVING	2007			TCGA-BH-A0BQ-11A-33R-A114-13	TCGA-BH-A0BQ-11A-33R-A114-13						4096c8a6-5ead-4410-8da1-a20b0f37cce8			4096c8a6-5ead-4410-8da1-a20b0f37cce8			TCGA-BH-A0BQ-11A-33R-A115-07	4096c8a6-5ead-4410-8da1-a20b0f37cce8	4096c8a6-5ead-4410-8da1-a20b0f37cce8				TCGA-BH-A0BQ-11A-33D-A112-05		
TCGA-BH-A0BR-01	Stage I	59	1	Stage I	1632		Positive	FEMALE	Negative	1	3	3	Negative	M0	Negative	N0	1632	0	LumA	Luminal A	Positive	ReacI	-4	-3	enrollment	T1	T1	LIVING	0	TCGA-BH-A0BR-01	1633	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 4	mutation cluster 3	TCGA-BH-A0BR			1633	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Left Lower Inner Quadrant					Positive					Positive	Other					-21622	1170		0	1633					NO							2011-8-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	160	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									0		true	M0	N0	T1c	Stage I	TCGA-BH-A0BR.6122CE59-23C0-4205-91B5-B71E39C6EAB8.pdf	4	4	0	0	1	1	0	0	0	0	19	19	80	80	60	60	TUMOR FREE							YES	No				Primary Tumor	01	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007	TCGA-BH-A0BR-01A-21W-A12T-09	TCGA-BH-A0BR-01	TCGA-BH-A0BR-01A-21R-A114-13	TCGA-BH-A0BR-01A-21R-A114-13	TCGA-BH-A0BR-01A-21W-A12T-09	94b57709-97e9-4421-a146-e82570a42258	TCGA-BH-A0BR-01A-21W-A12T-09	TCGA-BH-A0BR-01A-11-A13C-20	TCGA-BH-A0BR-01A-21W-A12T-09	0ef20000-2c8e-47bb-86e5-ffa2814099a7	b8ff6277-3c53-4912-ae50-8e82a94f7244	TCGA-BH-A0BR-01A-21D-A111-01	0ef20000-2c8e-47bb-86e5-ffa2814099a7		TCGA-BH-A0BR-01	TCGA-BH-A0BR-01A-21R-A115-07	0ef20000-2c8e-47bb-86e5-ffa2814099a7	0ef20000-2c8e-47bb-86e5-ffa2814099a7	TCGA-BH-A0BR-01A-21D-A111-01	TCGA-BH-A0BR-01	TCGA-BH-A0BR-01	TCGA-BH-A0BR-01A-21D-A112-05	b8ff6277-3c53-4912-ae50-8e82a94f7244	
TCGA-BH-A0BS-01	Stage IIIA	55	2	Stage IIIA	1640		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	1640	0	LumA	Luminal A	Positive	LumA/B	0	-2	enrollment	T_Other	T3	LIVING	0	TCGA-BH-A0BS-01	1641	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-BH-A0BS			1641	Breast	TCGA Breast Cancer	breast invasive carcinoma					55	Left					Positive					Positive	Simple Mastectomy					-20374	1164		0	1641					NO							2011-8-18	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	180	NO		Negative		11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	7									0		true	M0	N1c	T3	Stage IIIA	TCGA-BH-A0BS.A231BC51-EFA3-4FEB-A83F-C793FFF8E607.pdf	1	2	0	2	1	1	0	0	20	34	4	5	75	60	90	75	TUMOR FREE							YES	No				Primary Tumor	01	with left axilla sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007	TCGA-BH-A0BS-01A-11D-A12Q-09	TCGA-BH-A0BS-01	TCGA-BH-A0BS-01A-11R-A12O-13	TCGA-BH-A0BS-01A-11R-A12O-13	TCGA-BH-A0BS-01A-11D-A12Q-09	bc9af2fb-d022-40cc-9fca-685bd206e71b	TCGA-BH-A0BS-01A-11D-A12Q-09	TCGA-BH-A0BS-01A-21-A13A-20	TCGA-BH-A0BS-01A-11D-A12Q-09	354c08e2-61d3-4cfa-9d26-76d74dcfe44f	59d70e3c-da53-46e9-9f46-177223c25d95	TCGA-BH-A0BS-01A-11D-A12N-01	354c08e2-61d3-4cfa-9d26-76d74dcfe44f	TCGA-BH-A0BS-01A-11D-A12R-05	TCGA-BH-A0BS-01	TCGA-BH-A0BS-01A-11R-A12P-07	354c08e2-61d3-4cfa-9d26-76d74dcfe44f	354c08e2-61d3-4cfa-9d26-76d74dcfe44f	TCGA-BH-A0BS-01A-11D-A12N-01	TCGA-BH-A0BS-01	TCGA-BH-A0BS-01		59d70e3c-da53-46e9-9f46-177223c25d95	
TCGA-BH-A0BS-11		55			1640			FEMALE									1640	0	Normal						enrollment			LIVING	0	TCGA-BH-A0BS-11	1641	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0BS			1641	Breast	TCGA Breast Cancer	breast invasive carcinoma					55	Left					Positive					Positive	Simple Mastectomy					-20374	1164		0	1641					NO							2011-8-18	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO		Negative		11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N1c	T3	Stage IIIA		2	1	0	0			0	0	100	100			0	0			TUMOR FREE							YES	No				Solid Tissue Normal	11	with left axilla sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007			TCGA-BH-A0BS-11A-11R-A12O-13	TCGA-BH-A0BS-11A-11R-A12O-13						10d54893-647f-40a9-8aa7-602e04d55faf			10d54893-647f-40a9-8aa7-602e04d55faf	TCGA-BH-A0BS-11A-11D-A12R-05		TCGA-BH-A0BS-11A-11R-A12P-07	10d54893-647f-40a9-8aa7-602e04d55faf	10d54893-647f-40a9-8aa7-602e04d55faf						
TCGA-BH-A0BT-01	Stage IIA	56	4	Stage IIA	1386		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	1386	0	LumA	Luminal A	Positive	ReacII	-12	-3	enrollment	T1	T1	LIVING	0	TCGA-BH-A0BT-01	1386	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 6	mutation cluster 3	TCGA-BH-A0BT			1386	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Right Upper Inner Quadrant					Positive					Positive	Other					-20625	1167		0	1386					NO							2011-8-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	140	NO	Negative				Negative																			2	6											true	M0	N1mi	T1c	Stage IIA	TCGA-BH-A0BT.18E4043D-34BF-4CD1-9E2D-F906C7C7B019.pdf	5	2	0	0	1	1	0	0	3	0	17	20	79	79	80	70									No				Primary Tumor	01	segmental mastectomy with sentinel lymph node excision and biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007	TCGA-BH-A0BT-01A-11D-A12Q-09	TCGA-BH-A0BT-01	TCGA-BH-A0BT-01A-11R-A12O-13	TCGA-BH-A0BT-01A-11R-A12O-13	TCGA-BH-A0BT-01A-11D-A12Q-09	99e5ad3c-e46a-4d06-9feb-33f1b3819e6f	TCGA-BH-A0BT-01A-11D-A12Q-09	TCGA-BH-A0BT-01A-21-A13C-20	TCGA-BH-A0BT-01A-11D-A12Q-09	fe8764cf-04ee-480d-96ce-09d0d388f4f6	6ca5a3d2-bc1c-4d8b-932b-0d156d1dbaa3	TCGA-BH-A0BT-01A-11D-A12N-01	fe8764cf-04ee-480d-96ce-09d0d388f4f6	TCGA-BH-A0BT-01A-11D-A12R-05	TCGA-BH-A0BT-01	TCGA-BH-A0BT-01A-11R-A12P-07	fe8764cf-04ee-480d-96ce-09d0d388f4f6	fe8764cf-04ee-480d-96ce-09d0d388f4f6	TCGA-BH-A0BT-01A-11D-A12N-01	TCGA-BH-A0BT-01	TCGA-BH-A0BT-01		6ca5a3d2-bc1c-4d8b-932b-0d156d1dbaa3	
TCGA-BH-A0BT-11		56			1386			FEMALE									1386	0	Normal						enrollment			LIVING	0	TCGA-BH-A0BT-11	1386	0		C3-BRCA/Luminal							mutation cluster 3	TCGA-BH-A0BT			1386	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Right Upper Inner Quadrant					Positive					Positive	Other					-20625	1167		0	1386					NO							2011-8-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO	Negative				Negative																															true	M0	N1mi	T1c	Stage IIA		2	2	1	1			0	0	100	100			0	0											No				Solid Tissue Normal	11	segmental mastectomy with sentinel lymph node excision and biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007			TCGA-BH-A0BT-11A-21R-A12O-13	TCGA-BH-A0BT-11A-21R-A12O-13						8e31c471-6f4b-4d2d-8594-5c2c91f6e5ef			8e31c471-6f4b-4d2d-8594-5c2c91f6e5ef	TCGA-BH-A0BT-11A-21D-A12R-05			8e31c471-6f4b-4d2d-8594-5c2c91f6e5ef	8e31c471-6f4b-4d2d-8594-5c2c91f6e5ef						
TCGA-BH-A0BV-01	Stage IIB	78	5	No_Conversion	1519		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N1	1519	0	LumA	Luminal A	Positive	LumA/B	0	-4	followup	T_Other	T2	LIVING	0	TCGA-BH-A0BV-01	1519	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 7	mutation cluster 4	TCGA-BH-A0BV			1519	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	78	Right Upper Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BV-F4513		Positive		2+			Positive	Modified Radical Mastectomy		NO			-28699	1328		0	1519							90-99%					2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	450	NO	Negative			25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	7									2		true	M0	N1a	T2	Stage IIB	TCGA-BH-A0BV.7C877EE0-B4BC-4B17-94AB-81B67C7B6DB3.pdf	15	15	0	0	1	1	0	0	14	2	15	8	70	89	75	70	TUMOR FREE								No	50-59%		NO	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2006	TCGA-BH-A0BV-01A-11W-A019-09	TCGA-BH-A0BV-01		TCGA-BH-A0BV-01A-11R-A010-13	TCGA-BH-A0BV-01A-11W-A019-09	7815a57a-e2d9-42ae-93f3-6ddcf1f33ab2	TCGA-BH-A0BV-01A-11W-A019-09	TCGA-BH-A0BV-01A-21-A13B-20	TCGA-BH-A0BV-01A-11W-A019-09	6dc89d5b-7613-4a0f-bbdc-ba13f51d12cc	800c72cb-4f3b-4ba0-bc8c-a1c62b0e943f	TCGA-BH-A0BV-01A-11D-A011-01	6dc89d5b-7613-4a0f-bbdc-ba13f51d12cc		TCGA-BH-A0BV-01	TCGA-BH-A0BV-01A-11R-A00Z-07	6dc89d5b-7613-4a0f-bbdc-ba13f51d12cc	6dc89d5b-7613-4a0f-bbdc-ba13f51d12cc	TCGA-BH-A0BV-01A-11D-A011-01	TCGA-BH-A0BV-01	TCGA-BH-A0BV-01	TCGA-BH-A0BV-01A-11D-A00Y-05	800c72cb-4f3b-4ba0-bc8c-a1c62b0e943f	TCGA-BH-A0BV-01A-11R-A010-13
TCGA-BH-A0BV-11		78			1519			FEMALE									1519	0	Normal						followup			LIVING	0	TCGA-BH-A0BV-11	1519	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0BV			1519	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	78	Right Upper Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BV-F4513		Positive		2+			Positive	Modified Radical Mastectomy		NO			-28699	1328		0	1519							90-99%					2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	200	NO	Negative			25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												2		true	M0	N1a	T2	Stage IIB			5		0				0		35				0			TUMOR FREE								No	50-59%		NO	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2006				TCGA-BH-A0BV-11A-31R-A090-13						452bf9da-c065-4d95-8272-adce3684a9e9			452bf9da-c065-4d95-8272-adce3684a9e9	TCGA-BH-A0BV-11A-31D-A10Q-05		TCGA-BH-A0BV-11A-31R-A089-07	452bf9da-c065-4d95-8272-adce3684a9e9	452bf9da-c065-4d95-8272-adce3684a9e9						TCGA-BH-A0BV-11A-31R-A090-13
TCGA-BH-A0BW-01	Stage I	71	1	Stage I	355		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	355	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T1	T1	LIVING	0	TCGA-BH-A0BW-01	355	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-BH-A0BW			355	Breast	TCGA Breast Cancer	breast invasive carcinoma					71	Left Lower Outer Quadrant					Negative					Negative	Other					-25974	1344		0	355					NO							2011-8-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO		Negative		8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3									0		true	M0	N0	T1c	Stage I	TCGA-BH-A0BW.14CE78F3-8FB4-476D-A09C-AE87F7919D77.pdf	30	25	1	2	4	10	0	1	10	10	20	10	66	70	60	60	TUMOR FREE							YES	No				Primary Tumor	01	Segmental mastectomy	6th		NO	YES	BH	Breast	A	LIVING	2006	TCGA-BH-A0BW-01A-11D-A10Y-09	TCGA-BH-A0BW-01	TCGA-BH-A0BW-01A-11R-A114-13	TCGA-BH-A0BW-01A-11R-A114-13	TCGA-BH-A0BW-01A-11D-A10Y-09	a5fc2a17-0d67-4a6f-ae45-373d3cc91129	TCGA-BH-A0BW-01A-11D-A10Y-09	TCGA-BH-A0BW-01A-21-A13B-20	TCGA-BH-A0BW-01A-11D-A10Y-09	7e84df9f-1da5-4add-a5e8-a9d9d8af409c	75a4c81e-50fb-4ea4-b973-9e6e666f0e19	TCGA-BH-A0BW-01A-11D-A111-01	7e84df9f-1da5-4add-a5e8-a9d9d8af409c		TCGA-BH-A0BW-01	TCGA-BH-A0BW-01A-11R-A115-07	7e84df9f-1da5-4add-a5e8-a9d9d8af409c	7e84df9f-1da5-4add-a5e8-a9d9d8af409c	TCGA-BH-A0BW-01A-11D-A111-01	TCGA-BH-A0BW-01	TCGA-BH-A0BW-01	TCGA-BH-A0BW-01A-11D-A112-05	75a4c81e-50fb-4ea4-b973-9e6e666f0e19	
TCGA-BH-A0BW-11		71			355			FEMALE									355	0	Normal						enrollment			LIVING	0	TCGA-BH-A0BW-11	355	0		C4-BRCA/Basal							mutation c1uster 9	TCGA-BH-A0BW			355	Breast	TCGA Breast Cancer	breast invasive carcinoma					71	Left Lower Outer Quadrant					Negative					Negative	Other					-25974	1344		0	355					NO							2011-8-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	240	NO		Negative		8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N0	T1c	Stage I			0		0		0		0		100		0		0		0	TUMOR FREE							YES	No				Solid Tissue Normal	11	Segmental mastectomy	6th		NO	YES	BH	Breast	A	LIVING	2006			TCGA-BH-A0BW-11A-12R-A114-13	TCGA-BH-A0BW-11A-12R-A114-13						ca5076dc-0fb2-444f-b34f-305c8479cba3			ca5076dc-0fb2-444f-b34f-305c8479cba3			TCGA-BH-A0BW-11A-12R-A115-07	ca5076dc-0fb2-444f-b34f-305c8479cba3	ca5076dc-0fb2-444f-b34f-305c8479cba3				TCGA-BH-A0BW-11A-12D-A112-05		
TCGA-BH-A0BZ-01	Stage IIIA	59	4	Stage IIIA	1492		Positive	FEMALE	Negative	1	1	4	Negative	M0	Positive	N1	1492	0	LumB	Luminal B	Positive	X	-2	-5	enrollment	T_Other	T3	LIVING	0	TCGA-BH-A0BZ-01	1492	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 10	TCGA-BH-A0BZ			1492	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Left					Positive					Positive	Other					-21856	1084		0	1492					NO							2011-8-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	830	NO	Negative			23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6									1		true	M0	N1a	T3	Stage IIIA	TCGA-BH-A0BZ.1B56E5A6-35B8-4C60-8BC5-68716C946799.pdf	23	18	0	0	2	2	0	0	0	0	49	38	50	60	55	65	TUMOR FREE							YES	No				Primary Tumor	01	modified radical mastectomy with axillary dissection	6th		NO	YES	BH	Breast	A	LIVING	2007	TCGA-BH-A0BZ-01A-31D-A12Q-09	TCGA-BH-A0BZ-01	TCGA-BH-A0BZ-01A-31R-A12O-13	TCGA-BH-A0BZ-01A-31R-A12O-13	TCGA-BH-A0BZ-01A-31D-A12Q-09	d2de5993-e58f-4d41-812b-2a355dd855ea	TCGA-BH-A0BZ-01A-31D-A12Q-09	TCGA-BH-A0BZ-01A-21-A13B-20	TCGA-BH-A0BZ-01A-31D-A12Q-09	317ffb84-f4a8-435b-907b-b05587d6515e	6eee21c1-5bc4-4eb7-bf40-151fc831d5b9	TCGA-BH-A0BZ-01A-31D-A12N-01	317ffb84-f4a8-435b-907b-b05587d6515e	TCGA-BH-A0BZ-01A-31D-A12R-05	TCGA-BH-A0BZ-01	TCGA-BH-A0BZ-01A-31R-A12P-07	317ffb84-f4a8-435b-907b-b05587d6515e	317ffb84-f4a8-435b-907b-b05587d6515e	TCGA-BH-A0BZ-01A-31D-A12N-01	TCGA-BH-A0BZ-01	TCGA-BH-A0BZ-01		6eee21c1-5bc4-4eb7-bf40-151fc831d5b9	
TCGA-BH-A0BZ-11		59			1492			FEMALE									1492	0	Normal						enrollment			LIVING	0	TCGA-BH-A0BZ-11	1492	0		C3-BRCA/Luminal							mutation c1uster 10	TCGA-BH-A0BZ			1492	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Left					Positive					Positive	Other					-21856	1084		0	1492					NO							2011-8-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	620	NO	Negative			23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												1		true	M0	N1a	T3	Stage IIIA			0		0		0		0		0		0		0		0	TUMOR FREE							YES	No				Solid Tissue Normal	11	modified radical mastectomy with axillary dissection	6th		NO	YES	BH	Breast	A	LIVING	2007			TCGA-BH-A0BZ-11A-61R-A12O-13	TCGA-BH-A0BZ-11A-61R-A12O-13						561e0da7-0e2c-430c-8a54-c9a3535a1679			561e0da7-0e2c-430c-8a54-c9a3535a1679	TCGA-BH-A0BZ-11A-61D-A12R-05		TCGA-BH-A0BZ-11A-61R-A12P-07	561e0da7-0e2c-430c-8a54-c9a3535a1679	561e0da7-0e2c-430c-8a54-c9a3535a1679						
TCGA-BH-A0C0-01	Stage IIA	62	3	No_Conversion	1270		Positive	FEMALE	Positive	1	1	4	Negative	M0	Positive	N1	1270	0	LumB	Luminal B	Positive	Basal	-2	-5	followup	T1	T1	LIVING	0	TCGA-BH-A0C0-01	1270	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A0C0			1270	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	62	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-BH-A0C0-F4518		Positive					Positive	Lumpectomy		NO			-23006			0	1270							90-99%			2.65		2010-11-16	FEMALE					2+	40	12.45	4.7		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy			Equivocal	Positive		35	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									1			M0	N1a	T1c	Stage IIA																		TUMOR FREE								No	60-69%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast		LIVING	2007	TCGA-BH-A0C0-01A-21W-A071-09	TCGA-BH-A0C0-01		TCGA-BH-A0C0-01A-21R-A057-13	TCGA-BH-A0C0-01A-21W-A071-09	a4009327-f700-4c89-88fa-a560641ab193	TCGA-BH-A0C0-01A-21W-A071-09	TCGA-BH-A0C0-01A-11-A13B-20	TCGA-BH-A0C0-01A-21W-A071-09	f8ac9655-03ed-4e14-a4d3-88f63ef6bf7c	be4a4bb4-c86e-4dce-9c49-9f71eba44d32	TCGA-BH-A0C0-01A-21D-A059-01	f8ac9655-03ed-4e14-a4d3-88f63ef6bf7c	TCGA-BH-A0C0-01A-21D-A10P-05	TCGA-BH-A0C0-01	TCGA-BH-A0C0-01A-21R-A056-07	f8ac9655-03ed-4e14-a4d3-88f63ef6bf7c	f8ac9655-03ed-4e14-a4d3-88f63ef6bf7c	TCGA-BH-A0C0-01A-21D-A059-01	TCGA-BH-A0C0-01	TCGA-BH-A0C0-01		be4a4bb4-c86e-4dce-9c49-9f71eba44d32	TCGA-BH-A0C0-01A-21R-A057-13
TCGA-BH-A0C0-11		62			1270			FEMALE									1270	0	Normal						followup			LIVING	0	TCGA-BH-A0C0-11	1270	0		C3-BRCA/Luminal							mutation cluster 5	TCGA-BH-A0C0			1270	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	62	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-BH-A0C0-F4518		Positive					Positive	Lumpectomy		NO			-23006	1094		0	1270							90-99%			2.65		2010-11-16	FEMALE					2+	40	12.45	4.7		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	330	NO	Equivocal	Positive		35	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												1		true	M0	N1a	T1c	Stage IIA		30	5	1	1			0	0	100	100			0	0			TUMOR FREE								No	60-69%		YES	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2007				TCGA-BH-A0C0-11A-21R-A090-13						86c4b2fd-d034-469d-adfa-712055f30dc3			86c4b2fd-d034-469d-adfa-712055f30dc3	TCGA-BH-A0C0-11A-21D-A10Q-05		TCGA-BH-A0C0-11A-21R-A089-07	86c4b2fd-d034-469d-adfa-712055f30dc3	86c4b2fd-d034-469d-adfa-712055f30dc3						TCGA-BH-A0C0-11A-21R-A090-13
TCGA-BH-A0C1-01	Stage IIIA	61	2	Stage IIIA	1338		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N2	1338	0	LumA	Luminal A	Positive	ReacII	-1	-1	enrollment	T_Other	T3	LIVING	0	TCGA-BH-A0C1-01	1339	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-BH-A0C1			1339	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Right					Positive					Positive	Modified Radical Mastectomy					-22377	1073		0	1339					YES							2011-8-11	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	250	NO	Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5									8		true	M0	N2a	T3	Stage IIIA		0	0	0	0	0	0	0	0	5	5	30	25	65	70	80	80	TUMOR FREE							YES	No				Primary Tumor	01	sentinel lymph node biopsy	6th		NO	YES	BH	Breast	B	LIVING	2007	TCGA-BH-A0C1-01B-11D-A12B-09	TCGA-BH-A0C1-01	TCGA-BH-A0C1-01B-11R-A12C-13	TCGA-BH-A0C1-01B-11R-A12C-13	TCGA-BH-A0C1-01B-11D-A12B-09	dc364a19-d15e-4c8e-8d9b-cbd70b27d532	TCGA-BH-A0C1-01B-11D-A12B-09	TCGA-BH-A0C1-01B-21-A13D-20	TCGA-BH-A0C1-01B-11D-A12B-09	73b732bb-f387-4618-a2a3-8c7db1c75fd8	d2046f6d-cec0-4e39-a437-8be0a260cfa4	TCGA-BH-A0C1-01B-11D-A12A-01	73b732bb-f387-4618-a2a3-8c7db1c75fd8		TCGA-BH-A0C1-01	TCGA-BH-A0C1-01B-11R-A12D-07	73b732bb-f387-4618-a2a3-8c7db1c75fd8	73b732bb-f387-4618-a2a3-8c7db1c75fd8	TCGA-BH-A0C1-01B-11D-A12A-01	TCGA-BH-A0C1-01	TCGA-BH-A0C1-01	TCGA-BH-A0C1-01B-11D-A12E-05	d2046f6d-cec0-4e39-a437-8be0a260cfa4	
TCGA-BH-A0C3-01	Stage I	47	3	Stage I	1464		Positive	FEMALE	Negative	3	3	4	Negative	M0	Negative	N0	1464	0	LumB	Luminal B	Negative	Her2	-4	0	enrollment	T1	T1	LIVING	0	TCGA-BH-A0C3-01	1464	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 5	TCGA-BH-A0C3			1464	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Left					Positive					Negative	Other					-17221	1335		0	1464					NO							2011-8-11	FEMALE										Mixed Histology (please specify)	with ductal and lobular phenotypes	No		C50.9	8522/3	C50.9		YES		Core needle biopsy	160	NO	Negative			4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6									0		true	M0	N0	T1c	Stage I	TCGA-BH-A0C3.3A54CF6E-AFDB-4609-A827-77D75BB376A7.pdf	20	20	1	1	2	2	0	0	50	30	33	33	15	35	30	60	TUMOR FREE							YES	No				Primary Tumor	01	Segmental mastectomy with sentinel node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2006	TCGA-BH-A0C3-01A-21D-A12Q-09	TCGA-BH-A0C3-01	TCGA-BH-A0C3-01A-21R-A12O-13	TCGA-BH-A0C3-01A-21R-A12O-13	TCGA-BH-A0C3-01A-21D-A12Q-09	42fa3207-2c4f-4499-99b8-fe5275232eed	TCGA-BH-A0C3-01A-21D-A12Q-09	TCGA-BH-A0C3-01A-11-A13C-20	TCGA-BH-A0C3-01A-21D-A12Q-09	52a863fe-b210-456b-9c2d-545277362b65	40aac58d-9d3d-4cc3-ab4b-c02b28b8fc5f	TCGA-BH-A0C3-01A-21D-A12N-01	52a863fe-b210-456b-9c2d-545277362b65	TCGA-BH-A0C3-01A-21D-A12R-05	TCGA-BH-A0C3-01	TCGA-BH-A0C3-01A-21R-A12P-07	52a863fe-b210-456b-9c2d-545277362b65	52a863fe-b210-456b-9c2d-545277362b65	TCGA-BH-A0C3-01A-21D-A12N-01	TCGA-BH-A0C3-01	TCGA-BH-A0C3-01		40aac58d-9d3d-4cc3-ab4b-c02b28b8fc5f	
TCGA-BH-A0C3-11		47			1464			FEMALE									1464	0	Normal						enrollment			LIVING	0	TCGA-BH-A0C3-11	1464	0		C3-BRCA/Luminal							mutation cluster 5	TCGA-BH-A0C3			1464	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Left					Positive					Negative	Other					-17221	1335		0	1464					NO							2011-8-11	FEMALE										Mixed Histology (please specify)	with ductal and lobular phenotypes	No		C50.9	8522/3	C50.9		YES		Core needle biopsy	200	NO	Negative			4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												0		true	M0	N0	T1c	Stage I			2		1		0		0		20		80		0		0	TUMOR FREE							YES	No				Solid Tissue Normal	11	Segmental mastectomy with sentinel node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2006			TCGA-BH-A0C3-11A-23R-A12O-13	TCGA-BH-A0C3-11A-23R-A12O-13						65923c68-2c86-4b4d-abe2-5320c08bb68f			65923c68-2c86-4b4d-abe2-5320c08bb68f	TCGA-BH-A0C3-11A-23D-A12R-05		TCGA-BH-A0C3-11A-23R-A12P-07	65923c68-2c86-4b4d-abe2-5320c08bb68f	65923c68-2c86-4b4d-abe2-5320c08bb68f						
TCGA-BH-A0C7-01	Stage IIB	48	5	Stage IIB	1305		Positive	FEMALE	Positive	1	3	4	Negative	M0	Positive	N1	1305	0	LumB	Luminal B	Negative	LumA/B	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0C7-01	1305	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-BH-A0C7			1305	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Left					Positive					Negative	Other					-17871	1520		0	1305					NO							2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	140	NO		Positive		18	Negative	Peri (6-12 months since last menstrual period)																		4	4									1		true	M0	N1mi	T2	Stage IIB		0	0	0	0	0	0	0	0	0	2	5	3	95	95	45	60	TUMOR FREE							YES	No				Primary Tumor	01	Simple mastectomy with left lymph node sentinel biopsy	6th		NO	YES	BH	Breast	B	LIVING	2006	TCGA-BH-A0C7-01B-11D-A10Y-09	TCGA-BH-A0C7-01	TCGA-BH-A0C7-01B-11R-A114-13	TCGA-BH-A0C7-01B-11R-A114-13	TCGA-BH-A0C7-01B-11D-A10Y-09	0846b423-a60b-4c54-9224-b9d129fb3278	TCGA-BH-A0C7-01B-11D-A10Y-09	TCGA-BH-A0C7-01B-21-A13D-20	TCGA-BH-A0C7-01B-11D-A10Y-09	e58a6cf4-a4ff-4179-9671-a5661f380a8d	84f33e36-25f6-47a9-9fe9-85f8d4247ef2	TCGA-BH-A0C7-01B-11D-A111-01	e58a6cf4-a4ff-4179-9671-a5661f380a8d		TCGA-BH-A0C7-01	TCGA-BH-A0C7-01B-11R-A115-07	e58a6cf4-a4ff-4179-9671-a5661f380a8d	e58a6cf4-a4ff-4179-9671-a5661f380a8d	TCGA-BH-A0C7-01B-11D-A111-01	TCGA-BH-A0C7-01	TCGA-BH-A0C7-01	TCGA-BH-A0C7-01B-11D-A112-05	84f33e36-25f6-47a9-9fe9-85f8d4247ef2	
TCGA-BH-A0DD-01	Stage IIB	58	3	Stage IIB	1393		Positive	MALE	Positive	1	3	4	Negative	M0	Positive	N1	1393	0	LumB	Luminal B	Positive	LumA/B	-6	-3	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0DD-01	1394	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-BH-A0DD			1394	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Right					Positive					Positive	Modified Radical Mastectomy					-21386	1248		0	1394					NO							2011-8-18	MALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	430	NO	Positive	Positive		22	Negative																			4	4									0		true	M0	N1a	T2	Stage IIB	TCGA-BH-A0DD.35FFF2A4-7956-47AC-B6B8-1AA6775E332B.pdf	15	15	0	0	8	10	0	0	20	10	22	25	50	55	60	65	TUMOR FREE							YES	No				Primary Tumor	01	With sentinel lymph node biopsy (right) with simple mastectomy of left breast	6th		NO	YES	BH	Breast	A	LIVING	2006	TCGA-BH-A0DD-01A-31D-A12Q-09	TCGA-BH-A0DD-01	TCGA-BH-A0DD-01A-31R-A12O-13	TCGA-BH-A0DD-01A-31R-A12O-13	TCGA-BH-A0DD-01A-31D-A12Q-09	7ac181c9-6dba-4e27-a5fc-09cf02f735cf	TCGA-BH-A0DD-01A-31D-A12Q-09	TCGA-BH-A0DD-01A-21-A13B-20	TCGA-BH-A0DD-01A-31D-A12Q-09	e15ff180-38d3-4614-88ee-3645afaab54b	72f2a477-f43f-4ffe-a233-e09a3b66da3b	TCGA-BH-A0DD-01A-31D-A12N-01	e15ff180-38d3-4614-88ee-3645afaab54b	TCGA-BH-A0DD-01A-31D-A12R-05	TCGA-BH-A0DD-01	TCGA-BH-A0DD-01A-31R-A12P-07	e15ff180-38d3-4614-88ee-3645afaab54b	e15ff180-38d3-4614-88ee-3645afaab54b	TCGA-BH-A0DD-01A-31D-A12N-01	TCGA-BH-A0DD-01	TCGA-BH-A0DD-01		72f2a477-f43f-4ffe-a233-e09a3b66da3b	
TCGA-BH-A0DD-11		58			1393			MALE									1393	0	LumA						enrollment			LIVING	0	TCGA-BH-A0DD-11	1394	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0DD			1394	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Right					Positive					Positive	Modified Radical Mastectomy					-21386	1248		0	1394					NO							2011-8-18	MALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	460	NO	Positive	Positive		22	Negative																													0		true	M0	N1a	T2	Stage IIB		1	0	0	0			0	0	100	100			0	0			TUMOR FREE							YES	No				Solid Tissue Normal	11	With sentinel lymph node biopsy (right) with simple mastectomy of left breast	6th		NO	YES	BH	Breast	A	LIVING	2006			TCGA-BH-A0DD-11A-23R-A12O-13	TCGA-BH-A0DD-11A-23R-A12O-13						c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5			c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5			TCGA-BH-A0DD-11A-23R-A12P-07	c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5	c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5						
TCGA-BH-A0DE-01	Stage IIA	62	5	Stage IIA	948		Positive	FEMALE	Negative				Negative	M0	Negative	N0	948	0	LumA	Luminal A	Positive		-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0DE-01	948	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-BH-A0DE			948	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Left Upper Outer Quadrant					Positive					Positive	Other					-22656	1130		0	948					NO							2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	140	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6									0		true	M0	N0	T2	Stage IIA	TCGA-BH-A0DE.E8EA922D-A851-4D36-B70D-372DE9352548.pdf	3	5	0	0	1	2	0	0	7	10	52	53	40	35	70	50	TUMOR FREE							YES	No				Primary Tumor	01	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007	TCGA-BH-A0DE-01A-11D-A10Y-09	TCGA-BH-A0DE-01	TCGA-BH-A0DE-01A-11R-A114-13	TCGA-BH-A0DE-01A-11R-A114-13	TCGA-BH-A0DE-01A-11D-A10Y-09		TCGA-BH-A0DE-01A-11D-A10Y-09		TCGA-BH-A0DE-01A-11D-A10Y-09	b9a1f505-713e-4044-b76e-57134a4802f1	358c7629-e5dc-4191-aece-4a0e0eb0d5da	TCGA-BH-A0DE-01A-11D-A111-01	b9a1f505-713e-4044-b76e-57134a4802f1		TCGA-BH-A0DE-01	TCGA-BH-A0DE-01A-11R-A115-07	b9a1f505-713e-4044-b76e-57134a4802f1	b9a1f505-713e-4044-b76e-57134a4802f1	TCGA-BH-A0DE-01A-11D-A111-01	TCGA-BH-A0DE-01	TCGA-BH-A0DE-01	TCGA-BH-A0DE-01A-11D-A112-05	358c7629-e5dc-4191-aece-4a0e0eb0d5da	
TCGA-BH-A0DE-11		62			948			FEMALE									948	0							enrollment			LIVING	0	TCGA-BH-A0DE-11	948	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0DE			948	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Left Upper Outer Quadrant					Positive					Positive	Other					-22656	1130		0	948					NO							2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	150	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N0	T2	Stage IIA			1		0		0		0		10		90		0		0	TUMOR FREE							YES	No				Solid Tissue Normal	11	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007																						TCGA-BH-A0DE-11A-23D-A112-05		
TCGA-BH-A0DG-01	Stage IIA	30	3	Stage IIA	713		Positive	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	713	0	LumA	Luminal A	Negative	ReacI	-4	-4	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0DG-01	713	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-BH-A0DG			713	Breast	TCGA Breast Cancer	breast invasive carcinoma					30	Right Upper Outer Quadrant					Positive					Negative	Other					-11204	972		0	713					NO							2011-8-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1360	NO	Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4									0		true	M0	N0	T2	Stage IIA	TCGA-BH-A0DG.46B16DD0-68E6-4A7A-919B-758219D1E85C.pdf	6	20	0	0	2	1	0	0	7	5	13	20	78	74	85	70								YES	No				Primary Tumor	01	Total mastectomy	6th		NO	YES	BH	Breast	A	LIVING	2007	TCGA-BH-A0DG-01A-21D-A12Q-09	TCGA-BH-A0DG-01	TCGA-BH-A0DG-01A-21R-A12O-13	TCGA-BH-A0DG-01A-21R-A12O-13	TCGA-BH-A0DG-01A-21D-A12Q-09	c74c7143-1584-4072-872f-405fd8e3bf0c	TCGA-BH-A0DG-01A-21D-A12Q-09	TCGA-BH-A0DG-01A-11-A13B-20	TCGA-BH-A0DG-01A-21D-A12Q-09	a6b72c40-c921-4159-abad-b64e20619241	715f5846-1e11-4c15-ac61-927baf0b92d4	TCGA-BH-A0DG-01A-21D-A12N-01	a6b72c40-c921-4159-abad-b64e20619241	TCGA-BH-A0DG-01A-21D-A12R-05	TCGA-BH-A0DG-01	TCGA-BH-A0DG-01A-21R-A12P-07	a6b72c40-c921-4159-abad-b64e20619241	a6b72c40-c921-4159-abad-b64e20619241	TCGA-BH-A0DG-01A-21D-A12N-01	TCGA-BH-A0DG-01	TCGA-BH-A0DG-01		715f5846-1e11-4c15-ac61-927baf0b92d4	
TCGA-BH-A0DG-11		30			713			FEMALE									713	0	Normal						enrollment			LIVING	0	TCGA-BH-A0DG-11	713	0		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0DG			713	Breast	TCGA Breast Cancer	breast invasive carcinoma					30	Right Upper Outer Quadrant					Positive					Negative	Other					-11204	972		0	713					NO							2011-8-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	470	NO	Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												0		true	M0	N0	T2	Stage IIA			5		0				0		100				0										YES	No				Solid Tissue Normal	11	Total mastectomy	6th		NO	YES	BH	Breast	A	LIVING	2007			TCGA-BH-A0DG-11A-43R-A12O-13	TCGA-BH-A0DG-11A-43R-A12O-13						61c8278b-4c06-4563-b1ac-97cceec76ca4			61c8278b-4c06-4563-b1ac-97cceec76ca4	TCGA-BH-A0DG-11A-43D-A12R-05			61c8278b-4c06-4563-b1ac-97cceec76ca4	61c8278b-4c06-4563-b1ac-97cceec76ca4						
TCGA-BH-A0DH-01	Stage IIB	63	2	No_Conversion	1156		Positive	FEMALE	Negative	5	3	3	Negative	M0	Positive	N1	1156	0	LumA	Luminal A	Positive	X	0	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0DH-01	1156	0	Kirc+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-BH-A0DH			1156	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	63	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-BH-A0DH-F4529	Negative	Positive		3+		Mastectomy NOS	Positive	Lumpectomy		NO			-23366	968		0	1156							90-99%					2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	260	NO	Negative			28	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	1									3		true	M0	N1a	T2	Stage IIB	TCGA-BH-A0DH.79B22278-2BA1-4904-BCA6-2B1368C77475.pdf	3	3	0	0	2	2	0	0	0	0	28	38	70	60	85	85	TUMOR FREE								No	40-49%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2007	TCGA-BH-A0DH-01A-11D-A099-09	TCGA-BH-A0DH-01		TCGA-BH-A0DH-01A-11R-A085-13	TCGA-BH-A0DH-01A-11D-A099-09	ce59142d-05cc-4392-92d4-806c8136465b	TCGA-BH-A0DH-01A-11D-A099-09	TCGA-BH-A0DH-01A-21-A13B-20	TCGA-BH-A0DH-01A-11D-A099-09	c643222a-e138-4b3c-a96d-02be24ccb0d0	3d2d8785-65ba-4b5e-a5b8-8ceed713b8f6	TCGA-BH-A0DH-01A-11D-A087-01	c643222a-e138-4b3c-a96d-02be24ccb0d0	TCGA-BH-A0DH-01A-11D-A10P-05	TCGA-BH-A0DH-01	TCGA-BH-A0DH-01A-11R-A084-07	c643222a-e138-4b3c-a96d-02be24ccb0d0	c643222a-e138-4b3c-a96d-02be24ccb0d0	TCGA-BH-A0DH-01A-11D-A087-01	TCGA-BH-A0DH-01	TCGA-BH-A0DH-01		3d2d8785-65ba-4b5e-a5b8-8ceed713b8f6	TCGA-BH-A0DH-01A-11R-A085-13
TCGA-BH-A0DH-11		63			1156			FEMALE									1156	0	Normal						followup			LIVING	0	TCGA-BH-A0DH-11	1156	0		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0DH			1156	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	63	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-BH-A0DH-F4529	Negative	Positive		3+		Mastectomy NOS	Positive	Lumpectomy		NO			-23366	968		0	1156							90-99%					2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	280	NO	Negative			28	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												3		true	M0	N1a	T2	Stage IIB			0		0		0		0		100		0		0		0	TUMOR FREE								No	40-49%		YES	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2007										4a8c96d9-b08d-4812-93ec-c8c9db8139aa			4a8c96d9-b08d-4812-93ec-c8c9db8139aa	TCGA-BH-A0DH-11A-31D-A10Q-05		TCGA-BH-A0DH-11A-31R-A089-07	4a8c96d9-b08d-4812-93ec-c8c9db8139aa	4a8c96d9-b08d-4812-93ec-c8c9db8139aa						
TCGA-BH-A0DI-01	Stage IIB	63	5	Stage IIB	673		Positive	FEMALE	Negative	1	4	3	Negative	M0	Positive	N1	673	0	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0DI-01	673	0	Squamous	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-BH-A0DI			673	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Right					Positive					Positive	Other					-23327	267		0	673					NO							2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Negative			28	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4									3		true	M0	N1a	T2	Stage IIB	TCGA-BH-A0DI.5B7CE4A4-E1D5-4D0B-B9B4-71B94E32D782.pdf	10	20	0	0	2	0	0	0	8	15	25	50	65	35	55	60	TUMOR FREE							YES	No				Primary Tumor	01	Modified radical mastectomy with sentinel lymph node biopsy and with total mastectomy of left breast	6th		NO	YES	BH	Breast	A	LIVING	2009	TCGA-BH-A0DI-01A-21D-A12Q-09	TCGA-BH-A0DI-01	TCGA-BH-A0DI-01A-21R-A12O-13	TCGA-BH-A0DI-01A-21R-A12O-13	TCGA-BH-A0DI-01A-21D-A12Q-09	12b20a6c-5b0f-4014-85f5-b411c0ad5651	TCGA-BH-A0DI-01A-21D-A12Q-09	TCGA-BH-A0DI-01A-11-A13B-20	TCGA-BH-A0DI-01A-21D-A12Q-09	91285ac6-c627-4101-b551-28f37b947276	dd174335-cc95-4d3d-a25b-9abaaaa432a2	TCGA-BH-A0DI-01A-21D-A12N-01	91285ac6-c627-4101-b551-28f37b947276	TCGA-BH-A0DI-01A-21D-A12R-05	TCGA-BH-A0DI-01	TCGA-BH-A0DI-01A-21R-A12P-07	91285ac6-c627-4101-b551-28f37b947276	91285ac6-c627-4101-b551-28f37b947276	TCGA-BH-A0DI-01A-21D-A12N-01	TCGA-BH-A0DI-01	TCGA-BH-A0DI-01		dd174335-cc95-4d3d-a25b-9abaaaa432a2	
TCGA-BH-A0DI-11		63			673			FEMALE									673	0							enrollment			LIVING	0	TCGA-BH-A0DI-11	673	0		C3-BRCA/Luminal							mutation cluster 3	TCGA-BH-A0DI			673	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Right					Positive					Positive	Other					-23327	267		0	673					NO							2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	640	NO	Negative			28	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												3		true	M0	N1a	T2	Stage IIB		0	0	0	0			0	0	100	100			0	0			TUMOR FREE							YES	No				Solid Tissue Normal	11	Modified radical mastectomy with sentinel lymph node biopsy and with total mastectomy of left breast	6th		NO	YES	BH	Breast	A	LIVING	2009														TCGA-BH-A0DI-11A-32D-A12R-05										
TCGA-BH-A0DK-01	Stage IIA	49	2	Stage IIA	423		Positive	FEMALE	Negative	4	3	3	Negative	M0	Negative	N0	423	0	LumA	Luminal A	Positive	LumA/B	-4	-4	followup	T_Other	T2	LIVING	0	TCGA-BH-A0DK-01	423	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-BH-A0DK			423	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	49	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-BH-A0DK-F4532		Positive					Positive	Simple Mastectomy		NO			-18237	254		0	423						H-SCORE 260						2010-11-16	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	240	NO	Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		3	2									0		true	M0	N0 (i-)	T2	Stage IIA	TCGA-BH-A0DK.1E3F22FC-3D82-4911-9C97-8CB87A3D131C.pdf	15	15	0	0	2	2	0	0	5	8	20	20	73	70	70	70	TUMOR FREE	H-SCORE 120			H-SCORE	H-SCORE			No			NO	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2009	TCGA-BH-A0DK-01A-21W-A071-09	TCGA-BH-A0DK-01		TCGA-BH-A0DK-01A-21R-A057-13	TCGA-BH-A0DK-01A-21W-A071-09	1ae8085b-99e9-4a9c-94a7-bcf4f903b95a	TCGA-BH-A0DK-01A-21W-A071-09	TCGA-BH-A0DK-01A-11-A13B-20	TCGA-BH-A0DK-01A-21W-A071-09	fef221ff-634b-4188-92cf-5723b9a3c04d	b18d3669-3d80-4c66-b979-0d7e8541b509	TCGA-BH-A0DK-01A-21D-A059-01	fef221ff-634b-4188-92cf-5723b9a3c04d	TCGA-BH-A0DK-01A-21D-A10P-05	TCGA-BH-A0DK-01	TCGA-BH-A0DK-01A-21R-A056-07	fef221ff-634b-4188-92cf-5723b9a3c04d	fef221ff-634b-4188-92cf-5723b9a3c04d	TCGA-BH-A0DK-01A-21D-A059-01	TCGA-BH-A0DK-01	TCGA-BH-A0DK-01		b18d3669-3d80-4c66-b979-0d7e8541b509	TCGA-BH-A0DK-01A-21R-A057-13
TCGA-BH-A0DK-11		49			423			FEMALE									423	0	LumA						followup			LIVING	0	TCGA-BH-A0DK-11	423	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0DK			423	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	49	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-BH-A0DK-F4532		Positive					Positive	Simple Mastectomy		NO			-18237	254		0	423						H-SCORE 260						2010-11-16	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	550	NO	Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												0		true	M0	N0 (i-)	T2	Stage IIA		1	2	0	1			0	0		97			100	100			TUMOR FREE	H-SCORE 120			H-SCORE	H-SCORE			No			NO	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2009				TCGA-BH-A0DK-11A-13R-A090-13						4c1d73ba-31f8-4652-a83d-cc367dde9f43			4c1d73ba-31f8-4652-a83d-cc367dde9f43	TCGA-BH-A0DK-11A-13D-A10Q-05		TCGA-BH-A0DK-11A-13R-A089-07	4c1d73ba-31f8-4652-a83d-cc367dde9f43	4c1d73ba-31f8-4652-a83d-cc367dde9f43						TCGA-BH-A0DK-11A-13R-A090-13
TCGA-BH-A0DL-01	Stage IIA	64	3	Stage IIA	1467		Positive	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1467	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0DL-01	1467	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	squamous c3	BRCA basal-like c8	miRNA cluster 11	cluster 4	mutation cluster 3	TCGA-BH-A0DL			1467	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Left					Positive					Negative	Other					-23628	1074		0	1467					NO							2011-8-11	FEMALE										Other  specify	Infiltrating ductal carcinoma with metaplastic carcinoma and focal apocrine features	No		C50.9	8575/3	C50.9		YES		Core needle biopsy	350	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4									0		true	M0	N0	T2	Stage IIA	TCGA-BH-A0DL.C96287D0-A60B-4BAA-ABA0-8AD4F48662DB.pdf	27	24	0	0	2	2	1	0	0	0	20	28	78	70	65	65	TUMOR FREE							YES	No				Primary Tumor	01	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007	TCGA-BH-A0DL-01A-11D-A10Y-09	TCGA-BH-A0DL-01	TCGA-BH-A0DL-01A-11R-A114-13	TCGA-BH-A0DL-01A-11R-A114-13	TCGA-BH-A0DL-01A-11D-A10Y-09	301ec456-dd25-42ff-9779-a4f7f86ff509	TCGA-BH-A0DL-01A-11D-A10Y-09	TCGA-BH-A0DL-01A-21-A13B-20	TCGA-BH-A0DL-01A-11D-A10Y-09	1013446f-5beb-485d-809a-efe81a2138dd	298c4e12-a695-48f1-830a-ae66a78e3ee4	TCGA-BH-A0DL-01A-11D-A111-01	1013446f-5beb-485d-809a-efe81a2138dd		TCGA-BH-A0DL-01	TCGA-BH-A0DL-01A-11R-A115-07	1013446f-5beb-485d-809a-efe81a2138dd	1013446f-5beb-485d-809a-efe81a2138dd	TCGA-BH-A0DL-01A-11D-A111-01	TCGA-BH-A0DL-01	TCGA-BH-A0DL-01	TCGA-BH-A0DL-01A-11D-A112-05	298c4e12-a695-48f1-830a-ae66a78e3ee4	
TCGA-BH-A0DL-11		64			1467			FEMALE									1467	0	Normal						enrollment			LIVING	0	TCGA-BH-A0DL-11	1467	0		C4-BRCA/Basal							mutation cluster 3	TCGA-BH-A0DL			1467	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Left					Positive					Negative	Other					-23628	1074		0	1467					NO							2011-8-11	FEMALE										Other  specify	Infiltrating ductal carcinoma with metaplastic carcinoma and focal apocrine features	No		C50.9	8575/3	C50.9		YES		Core needle biopsy	100	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N0	T2	Stage IIA			0		0		0		0		100		0		0		0	TUMOR FREE							YES	No				Solid Tissue Normal	11	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007			TCGA-BH-A0DL-11A-13R-A114-13	TCGA-BH-A0DL-11A-13R-A114-13						f6745ef4-b601-4d5f-bb7a-0bf7e1f1671d			f6745ef4-b601-4d5f-bb7a-0bf7e1f1671d			TCGA-BH-A0DL-11A-13R-A115-07	f6745ef4-b601-4d5f-bb7a-0bf7e1f1671d	f6745ef4-b601-4d5f-bb7a-0bf7e1f1671d				TCGA-BH-A0DL-11A-13D-A112-05		
TCGA-BH-A0DO-01	Stage I	78	2	Stage I	525		Positive	FEMALE	Negative				Negative	M0	Negative	N0	525	0	LumA	Luminal A	Positive		-5	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0DO-01	525	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-BH-A0DO			525	Breast	TCGA Breast Cancer	breast invasive carcinoma					78	Left Upper Inner Quadrant					Positive					Positive	Simple Mastectomy					-28529	454		0	525					NO							2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	80	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6									0		true	M0	N0	T1c	Stage I		0	0	0	0	0	0	0	0	10	30	30	5	60	65	50	65	TUMOR FREE							YES	Yes				Primary Tumor	01	with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	B	LIVING	2009	TCGA-BH-A0DO-01B-11D-A12B-09	TCGA-BH-A0DO-01	TCGA-BH-A0DO-01B-11R-A12C-13	TCGA-BH-A0DO-01B-11R-A12C-13	TCGA-BH-A0DO-01B-11D-A12B-09		TCGA-BH-A0DO-01B-11D-A12B-09		TCGA-BH-A0DO-01B-11D-A12B-09	46892fa4-f179-4991-99da-629d8cf936f6	579b5e2f-f3c6-48b6-8769-4950ac5c6abb	TCGA-BH-A0DO-01B-11D-A12A-01	46892fa4-f179-4991-99da-629d8cf936f6		TCGA-BH-A0DO-01	TCGA-BH-A0DO-01B-11R-A12D-07	46892fa4-f179-4991-99da-629d8cf936f6	46892fa4-f179-4991-99da-629d8cf936f6	TCGA-BH-A0DO-01B-11D-A12A-01	TCGA-BH-A0DO-01	TCGA-BH-A0DO-01	TCGA-BH-A0DO-01B-11D-A12E-05	579b5e2f-f3c6-48b6-8769-4950ac5c6abb	
TCGA-BH-A0DO-11		78			525			FEMALE									525	0	Normal						enrollment			LIVING	0	TCGA-BH-A0DO-11	525	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0DO			525	Breast	TCGA Breast Cancer	breast invasive carcinoma					78	Left Upper Inner Quadrant					Positive					Positive	Simple Mastectomy					-28529	287		0	525					NO							2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N0	T1c	Stage I		8	0	0	0		0	0	0	100	100		0	0	0		0	TUMOR FREE							YES	Yes				Solid Tissue Normal	11	with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2009			TCGA-BH-A0DO-11A-22R-A12C-13	TCGA-BH-A0DO-11A-22R-A12C-13						eb9e415f-0545-4e97-ad35-b56b0f3db79b			eb9e415f-0545-4e97-ad35-b56b0f3db79b			TCGA-BH-A0DO-11A-22R-A12D-07	eb9e415f-0545-4e97-ad35-b56b0f3db79b	eb9e415f-0545-4e97-ad35-b56b0f3db79b				TCGA-BH-A0DO-11A-22D-A12E-05		
TCGA-BH-A0DP-01	Stage IIB	60	2	Stage IIB	476		Positive	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	476	0	LumA	Luminal A	Positive	ReacI	-5	-7	followup	T_Other	T3	LIVING	0	TCGA-BH-A0DP-01	476	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 3	cluster 2	mutation cluster 4	TCGA-BH-A0DP			476	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	60	Right	Sentinel node biopsy alone		TCGA-BH-A0DP-F4538		Positive		3+			Positive	Simple Mastectomy		NO			-22199	293		0	476						H-SCORE 280	80-89%					2010-11-16	FEMALE			<10%		0					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	510	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2									0		true	M0	N0 (i-)	T3	Stage IIB	TCGA-BH-A0DP.F04188AB-51CE-4AA1-B72C-399BE7863235.pdf	12	13	0	0	2	2	0	0	5	7	18	15	75	76	70	70	TUMOR FREE	H-SCORE 280			H-SCORE	H-SCORE			No	80-89%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2009	TCGA-BH-A0DP-01A-21W-A071-09	TCGA-BH-A0DP-01		TCGA-BH-A0DP-01A-21R-A057-13	TCGA-BH-A0DP-01A-21W-A071-09	2816036d-ed53-4c0d-b7fa-5a72f37da510	TCGA-BH-A0DP-01A-21W-A071-09	TCGA-BH-A0DP-01A-11-A13B-20	TCGA-BH-A0DP-01A-21W-A071-09	72967b75-a711-425a-819d-dd673c5edc44	da040b34-361d-4d3c-9ea1-e9964b67f19b	TCGA-BH-A0DP-01A-21D-A059-01	72967b75-a711-425a-819d-dd673c5edc44	TCGA-BH-A0DP-01A-21D-A10P-05	TCGA-BH-A0DP-01	TCGA-BH-A0DP-01A-21R-A056-07	72967b75-a711-425a-819d-dd673c5edc44	72967b75-a711-425a-819d-dd673c5edc44	TCGA-BH-A0DP-01A-21D-A059-01	TCGA-BH-A0DP-01	TCGA-BH-A0DP-01		da040b34-361d-4d3c-9ea1-e9964b67f19b	TCGA-BH-A0DP-01A-21R-A057-13
TCGA-BH-A0DP-11		60			476			FEMALE									476	0	Normal						followup			LIVING	0	TCGA-BH-A0DP-11	476	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0DP			476	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	60	Right	Sentinel node biopsy alone		TCGA-BH-A0DP-F4538		Positive		3+			Positive	Simple Mastectomy		NO			-22199	293		0	476						H-SCORE 280	80-89%					2010-11-16	FEMALE			<10%		0					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	290	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N0 (i-)	T3	Stage IIB		2	10	0	0			0	0	96	71			0	0			TUMOR FREE	H-SCORE 280			H-SCORE	H-SCORE			No	80-89%		YES	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2009				TCGA-BH-A0DP-11A-12R-A090-13						6ff2976a-2570-409b-afde-b7d2e7f2e4ea			6ff2976a-2570-409b-afde-b7d2e7f2e4ea	TCGA-BH-A0DP-11A-12D-A10Q-05		TCGA-BH-A0DP-11A-12R-A089-07	6ff2976a-2570-409b-afde-b7d2e7f2e4ea	6ff2976a-2570-409b-afde-b7d2e7f2e4ea						TCGA-BH-A0DP-11A-12R-A090-13
TCGA-BH-A0DQ-01	Stage IIB	42	5	No_Conversion	98		Positive	FEMALE	Negative				Negative	M0	Positive	N1	98	0	LumA	Luminal A	Positive		-5	0	followup	T_Other	T2	LIVING	0	TCGA-BH-A0DQ-01	98	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-BH-A0DQ			98	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	42	Right Upper Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0DQ-F4560		Positive		1+			Positive	Lumpectomy		NO			-15533	190		0	98						H-SCORE 136	60-69%					2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Core needle biopsy	110	NO	Negative			25	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6									1		true	M0	N1	T2	Stage IIB	TCGA-BH-A0DQ.D644B589-A6ED-4DCC-97D4-751E22AE3A7D.pdf	3	5	0	0	1	2	0	0	0	8	25	20	74	70	75	75	TUMOR FREE	H-SCORE 140			H-SCORE	H-SCORE			No	70-79%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2009	TCGA-BH-A0DQ-01A-11D-A099-09	TCGA-BH-A0DQ-01		TCGA-BH-A0DQ-01A-11R-A085-13	TCGA-BH-A0DQ-01A-11D-A099-09		TCGA-BH-A0DQ-01A-11D-A099-09		TCGA-BH-A0DQ-01A-11D-A099-09	6022db68-1e06-4974-b657-cd65aed560c4	01bc5261-bf91-4f7b-a6b4-0e727c5e31d2	TCGA-BH-A0DQ-01A-11D-A087-01	6022db68-1e06-4974-b657-cd65aed560c4	TCGA-BH-A0DQ-01A-11D-A10P-05	TCGA-BH-A0DQ-01	TCGA-BH-A0DQ-01A-11R-A084-07	6022db68-1e06-4974-b657-cd65aed560c4	6022db68-1e06-4974-b657-cd65aed560c4	TCGA-BH-A0DQ-01A-11D-A087-01	TCGA-BH-A0DQ-01	TCGA-BH-A0DQ-01		01bc5261-bf91-4f7b-a6b4-0e727c5e31d2	TCGA-BH-A0DQ-01A-11R-A085-13
TCGA-BH-A0DQ-11		42			98			FEMALE									98	0	LumA						followup			LIVING	0	TCGA-BH-A0DQ-11	98	0		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0DQ			98	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	42	Right Upper Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0DQ-F4560		Positive		1+			Positive	Lumpectomy		NO			-15533	190		0	98						H-SCORE 136	60-69%					2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Core needle biopsy	100	NO	Negative			25	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												1		true	M0	N1	T2	Stage IIB		20	20	0	0			0	0	100	97			0	0			TUMOR FREE	H-SCORE 140			H-SCORE	H-SCORE			No	70-79%		YES	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2009				TCGA-BH-A0DQ-11A-12R-A090-13						2b11e565-01a8-4054-a200-03e06765bd5e			2b11e565-01a8-4054-a200-03e06765bd5e	TCGA-BH-A0DQ-11A-12D-A10Q-05		TCGA-BH-A0DQ-11A-12R-A089-07	2b11e565-01a8-4054-a200-03e06765bd5e	2b11e565-01a8-4054-a200-03e06765bd5e						TCGA-BH-A0DQ-11A-12R-A090-13
TCGA-BH-A0DS-01	Stage IIIA	71	3	No_Conversion	77		Positive	FEMALE	Negative	4	5	3	Negative	M0	Positive	N2	77	0	LumA	Luminal A	Positive	LumA	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-BH-A0DS-01	78	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 6	mutation c1uster 9	TCGA-BH-A0DS			78	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	71	Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0DS-F4573		Positive		2+			Positive	Lumpectomy		NO			-25944	79		0	78						H-SCORE 190	70-79%					2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	200	NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	6									8		true	M0	N2a	T2	Stage IIIA	TCGA-BH-A0DS.E4CBDC29-63E2-4CF0-B02F-16CA9C69F26E.pdf	3	1	0	0	0	0	0	0	0	0	75	80	25	20	75	80	TUMOR FREE	H-SCORE 162			H-SCORE	H-SCORE			No	70-79%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2010	TCGA-BH-A0DS-01A-11W-A071-09	TCGA-BH-A0DS-01		TCGA-BH-A0DS-01A-11R-A057-13	TCGA-BH-A0DS-01A-11W-A071-09	ad643947-edbf-4a15-a959-76ffd5589907	TCGA-BH-A0DS-01A-11W-A071-09	TCGA-BH-A0DS-01A-21-A13B-20	TCGA-BH-A0DS-01A-11W-A071-09	00ee8acd-0841-4c85-a99a-8966a6828dd7	67942518-8522-4ba3-8458-cddcc98421c3	TCGA-BH-A0DS-01A-11D-A059-01	00ee8acd-0841-4c85-a99a-8966a6828dd7	TCGA-BH-A0DS-01A-11D-A10P-05	TCGA-BH-A0DS-01	TCGA-BH-A0DS-01A-11R-A056-07	00ee8acd-0841-4c85-a99a-8966a6828dd7	00ee8acd-0841-4c85-a99a-8966a6828dd7	TCGA-BH-A0DS-01A-11D-A059-01	TCGA-BH-A0DS-01	TCGA-BH-A0DS-01		67942518-8522-4ba3-8458-cddcc98421c3	TCGA-BH-A0DS-01A-11R-A057-13
TCGA-BH-A0DT-01	Stage IIA	41	2	Stage IIA	1170		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N1	1170	0	LumA	Luminal A	Positive	LumA	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0DT-01	1170	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-BH-A0DT			1170	Breast	TCGA Breast Cancer	breast invasive carcinoma					41	Right					Positive					Positive	Other					-15078			0	1170					NO							2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative			18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	6									1			M0	N1a	T1c	Stage IIA																		TUMOR FREE							YES	No				Primary Tumor	01	Total mastectomy with sentinel lymoh node biopsy	6th		NO	YES	BH	Breast		LIVING	2007	TCGA-BH-A0DT-01A-21D-A12B-09	TCGA-BH-A0DT-01	TCGA-BH-A0DT-01A-21R-A12C-13	TCGA-BH-A0DT-01A-21R-A12C-13	TCGA-BH-A0DT-01A-21D-A12B-09	b170d872-08a7-4c4a-9e3f-e6525d8d5a88	TCGA-BH-A0DT-01A-21D-A12B-09	TCGA-BH-A0DT-01A-11-A13B-20	TCGA-BH-A0DT-01A-21D-A12B-09	e88bcf68-e904-4511-92f6-01cbd0da62de	cc9ee06d-27bf-4038-bbcd-c95693b96321	TCGA-BH-A0DT-01A-21D-A12A-01	e88bcf68-e904-4511-92f6-01cbd0da62de		TCGA-BH-A0DT-01	TCGA-BH-A0DT-01A-21R-A12D-07	e88bcf68-e904-4511-92f6-01cbd0da62de	e88bcf68-e904-4511-92f6-01cbd0da62de	TCGA-BH-A0DT-01A-21D-A12A-01	TCGA-BH-A0DT-01	TCGA-BH-A0DT-01	TCGA-BH-A0DT-01A-21D-A12E-05	cc9ee06d-27bf-4038-bbcd-c95693b96321	
TCGA-BH-A0DT-11		41			1170			FEMALE									1170	0	Normal						enrollment			LIVING	0	TCGA-BH-A0DT-11	1170	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0DT			1170	Breast	TCGA Breast Cancer	breast invasive carcinoma					41	Right					Positive					Positive	Other					-15078	1044		0	1170					NO							2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	250	NO	Negative			18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												1		true	M0	N1a	T1c	Stage IIA			0		0		0		0		100		0		0		0	TUMOR FREE							YES	No				Solid Tissue Normal	11	Total mastectomy with sentinel lymoh node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007			TCGA-BH-A0DT-11A-12R-A12C-13	TCGA-BH-A0DT-11A-12R-A12C-13						75ba5803-449e-4770-8105-b675af8e6907			75ba5803-449e-4770-8105-b675af8e6907			TCGA-BH-A0DT-11A-12R-A12D-07	75ba5803-449e-4770-8105-b675af8e6907	75ba5803-449e-4770-8105-b675af8e6907				TCGA-BH-A0DT-11A-12D-A12E-05		
TCGA-BH-A0DV-01	Stage IIIA	54	3	Stage IIIA	1374		Positive	FEMALE	Negative				Negative	M0	Positive	N2	1374	0	LumA		Positive	ReacII			enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0DV-01	2064	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3	cluster 6	mutation cluster 4	TCGA-BH-A0DV	2064	0	2064	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left			TCGA-BH-A0DV-F63672		Positive					Positive	Modified Radical Mastectomy					-19781	975		0	2064					NO							2014-8-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	370	NO	Negative		NO	9	Negative	Peri (6-12 months since last menstrual period)																		1	6								NO	9		true	M0	N2a	T2	Stage IIIA	TCGA-BH-A0DV.3A0E1EF6-B234-46EC-BD15-95B5FAB06D45.pdf	7	4	0	0	2	2	0	0	8	12	45	45	45	41	70	70	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		6th		NO	YES	BH	Breast	A	LIVING	2007	TCGA-BH-A0DV-01A-21D-A12Q-09		TCGA-BH-A0DV-01A-21R-A12O-13	TCGA-BH-A0DV-01A-21R-A12O-13	TCGA-BH-A0DV-01A-21D-A12Q-09	2ddc51b1-8ac4-4b9e-85d3-23c698917d5f	TCGA-BH-A0DV-01A-21D-A12Q-09	TCGA-BH-A0DV-01A-11-A13B-20	TCGA-BH-A0DV-01A-21D-A12Q-09	0d029d04-13cd-4870-a9e3-9d2e65c9b0b7	5b44486e-95e0-4505-9c39-bbd1515f155b	TCGA-BH-A0DV-01A-21D-A12N-01	0d029d04-13cd-4870-a9e3-9d2e65c9b0b7	TCGA-BH-A0DV-01A-21D-A12R-05	TCGA-BH-A0DV-01		0d029d04-13cd-4870-a9e3-9d2e65c9b0b7	0d029d04-13cd-4870-a9e3-9d2e65c9b0b7	TCGA-BH-A0DV-01A-21D-A12N-01		TCGA-BH-A0DV-01		5b44486e-95e0-4505-9c39-bbd1515f155b	
TCGA-BH-A0DV-11		54			1374			FEMALE									1374	0	Normal						enrollment			LIVING	0	TCGA-BH-A0DV-11	2064	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0DV	2064	0	2064	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left			TCGA-BH-A0DV-F63672		Positive					Positive	Modified Radical Mastectomy					-19781	975		0	2064					NO							2014-8-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Negative		NO	9	Negative	Peri (6-12 months since last menstrual period)																											NO	9		true	M0	N2a	T2	Stage IIIA		1	1	2	0			0	0	100	100			0	0			TUMOR FREE						YES	YES	No			YES	Solid Tissue Normal	11		6th		NO	YES	BH	Breast	A	LIVING	2007			TCGA-BH-A0DV-11A-22R-A12O-13	TCGA-BH-A0DV-11A-22R-A12O-13						09f570eb-a751-41db-9511-300be228f24e			09f570eb-a751-41db-9511-300be228f24e	TCGA-BH-A0DV-11A-22D-A12R-05		TCGA-BH-A0DV-11A-22R-A12P-07	09f570eb-a751-41db-9511-300be228f24e	09f570eb-a751-41db-9511-300be228f24e						
TCGA-BH-A0DX-01	Stage I	62	1	Stage I	1442		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1442	0	LumA	Luminal A	Positive		-4	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0DX-01	1442	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA c1uster 9	cluster 6	mutation cluster 4	TCGA-BH-A0DX			1442	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Left Upper Inner Quadrant					Positive					Positive	Other					-22833			0	1442					NO							2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6									0			M0	N0	T1b	Stage I																		TUMOR FREE							YES	No				Primary Tumor	01	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast		LIVING	2007	TCGA-BH-A0DX-01A-11D-A10Y-09	TCGA-BH-A0DX-01	TCGA-BH-A0DX-01A-11R-A114-13	TCGA-BH-A0DX-01A-11R-A114-13	TCGA-BH-A0DX-01A-11D-A10Y-09		TCGA-BH-A0DX-01A-11D-A10Y-09		TCGA-BH-A0DX-01A-11D-A10Y-09	c791026a-9fda-47b4-86fd-9b5933325326	bb1546a4-5d30-48af-ae20-5955db13fadf	TCGA-BH-A0DX-01A-11D-A111-01	c791026a-9fda-47b4-86fd-9b5933325326		TCGA-BH-A0DX-01	TCGA-BH-A0DX-01A-11R-A115-07	c791026a-9fda-47b4-86fd-9b5933325326	c791026a-9fda-47b4-86fd-9b5933325326	TCGA-BH-A0DX-01A-11D-A111-01	TCGA-BH-A0DX-01	TCGA-BH-A0DX-01	TCGA-BH-A0DX-01A-11D-A112-05	bb1546a4-5d30-48af-ae20-5955db13fadf	
TCGA-BH-A0DZ-01	Stage IIB	43	5	No_Conversion	495		Positive	FEMALE	Positive				Negative	M0	Positive	N1	495	0	LumA	HER2-enriched	Positive		-2	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0DZ-01	495	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-BH-A0DZ			495	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	43	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0DZ-F4588		Positive		2+			Positive	Simple Mastectomy		NO			-15980	308		0	495						H-SCORE 140	50-59%					2010-11-16	FEMALE			30-39%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	170	NO	Positive			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4									1		true	M0	N1a	T2	Stage IIB	TCGA-BH-A0DZ.16DE55CE-076E-43D3-84BD-332A79B95EFD.pdf	4	1	1	0	1	1	0	0	17	29	5	0	77	70	85	92	TUMOR FREE	H-SCORE 15			H-SCORE	H-SCORE			No	<10%		NO	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2009	TCGA-BH-A0DZ-01A-11W-A019-09	TCGA-BH-A0DZ-01		TCGA-BH-A0DZ-01A-11R-A010-13	TCGA-BH-A0DZ-01A-11W-A019-09		TCGA-BH-A0DZ-01A-11W-A019-09		TCGA-BH-A0DZ-01A-11W-A019-09	4543cecd-6333-473b-b5ce-96d33ab47706	b17d5670-c08a-4863-9ceb-3af0ee4df007	TCGA-BH-A0DZ-01A-11D-A011-01	4543cecd-6333-473b-b5ce-96d33ab47706		TCGA-BH-A0DZ-01	TCGA-BH-A0DZ-01A-11R-A00Z-07	4543cecd-6333-473b-b5ce-96d33ab47706	4543cecd-6333-473b-b5ce-96d33ab47706	TCGA-BH-A0DZ-01A-11D-A011-01	TCGA-BH-A0DZ-01	TCGA-BH-A0DZ-01	TCGA-BH-A0DZ-01A-11D-A00Y-05	b17d5670-c08a-4863-9ceb-3af0ee4df007	TCGA-BH-A0DZ-01A-11R-A010-13
TCGA-BH-A0DZ-11		43			495			FEMALE									495	0							followup			LIVING	0	TCGA-BH-A0DZ-11	495	0		C3-BRCA/Luminal							mutation cluster 2	TCGA-BH-A0DZ			495	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	43	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0DZ-F4588		Positive		2+			Positive	Simple Mastectomy		NO			-15980	308		0	495						H-SCORE 140	50-59%					2010-11-16	FEMALE			30-39%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	120	NO	Positive			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												1		true	M0	N1a	T2	Stage IIB		0	5	0	0			0	0	100	100			0	0			TUMOR FREE	H-SCORE 15			H-SCORE	H-SCORE			No	<10%		NO	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2009				TCGA-BH-A0DZ-11A-22R-A090-13						f59f9272-412f-4884-9874-a6ff59ab1740			f59f9272-412f-4884-9874-a6ff59ab1740	TCGA-BH-A0DZ-11A-22D-A10Q-05		TCGA-BH-A0DZ-11A-22R-A089-07	f59f9272-412f-4884-9874-a6ff59ab1740	f59f9272-412f-4884-9874-a6ff59ab1740						TCGA-BH-A0DZ-11A-22R-A090-13
TCGA-BH-A0E0-01	Stage IIIC	38	1	No_Conversion	133		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N3	133	0	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T3	LIVING	0	TCGA-BH-A0E0-01	134	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 11	cluster 5	mutation cluster 5	TCGA-BH-A0E0			134	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	38	Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-BH-A0E0-F4603		Negative		0			Negative	Modified Radical Mastectomy		NO			-14175	136		0	134						H-SCORE 0						2010-10-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	620	NO	Negative			21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	5									10		true	M0	N3a	T3	Stage IIIC	TCGA-BH-A0E0.975989FE-8785-42C1-8551-53661B7B16A1.pdf	3	5	1	1	1	2	0	0	0	0	0	0	99	98	90	85	TUMOR FREE	H-SCORE 0			H-SCORE	H-SCORE			No			YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2009	TCGA-BH-A0E0-01A-11W-A071-09	TCGA-BH-A0E0-01		TCGA-BH-A0E0-01A-11R-A057-13	TCGA-BH-A0E0-01A-11W-A071-09	9ccd25d1-e45d-469d-942d-0b514d4cb5a0	TCGA-BH-A0E0-01A-11W-A071-09	TCGA-BH-A0E0-01A-21-A13B-20	TCGA-BH-A0E0-01A-11W-A071-09	fac9101c-a974-4415-9eac-d2d433d02b13	d0d4963f-0739-4d50-a631-119847fc08d7	TCGA-BH-A0E0-01A-11D-A059-01	fac9101c-a974-4415-9eac-d2d433d02b13	TCGA-BH-A0E0-01A-11D-A10P-05	TCGA-BH-A0E0-01	TCGA-BH-A0E0-01A-11R-A056-07	fac9101c-a974-4415-9eac-d2d433d02b13	fac9101c-a974-4415-9eac-d2d433d02b13	TCGA-BH-A0E0-01A-11D-A059-01	TCGA-BH-A0E0-01	TCGA-BH-A0E0-01		d0d4963f-0739-4d50-a631-119847fc08d7	TCGA-BH-A0E0-01A-11R-A057-13
TCGA-BH-A0E0-11		38			133			FEMALE									133	0	Normal						followup			LIVING	0	TCGA-BH-A0E0-11	134	0		C4-BRCA/Basal							mutation cluster 5	TCGA-BH-A0E0			134	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	38	Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-BH-A0E0-F4603		Negative		0			Negative	Modified Radical Mastectomy		NO			-14175	136		0	134						H-SCORE 0						2010-10-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	140	NO	Negative			21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												10		true	M0	N3a	T3	Stage IIIC		1	1	0	0			0	0	100	100			0	0			TUMOR FREE	H-SCORE 0			H-SCORE	H-SCORE			No			YES	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2009										5cc82d2c-f960-40c3-9b37-59e087563dc1			5cc82d2c-f960-40c3-9b37-59e087563dc1	TCGA-BH-A0E0-11A-13D-A10Q-05		TCGA-BH-A0E0-11A-13R-A089-07	5cc82d2c-f960-40c3-9b37-59e087563dc1	5cc82d2c-f960-40c3-9b37-59e087563dc1						
TCGA-BH-A0E1-01	Stage IIB	52	2	No_Conversion	477		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	477	0	LumA	Luminal A	Positive	ReacII	-12	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0E1-01	477	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 3	cluster 6	mutation c1uster 10	TCGA-BH-A0E1			477	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	52	Left Upper Inner Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0E1-F4631		Positive		3+			Positive	Simple Mastectomy		NO			-19192	301		0	477						H-SCORE 180	70-79%			1.67		2010-11-16	FEMALE					2+	40	2.81	1.69		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	990	NO	Equivocal	Negative		17	Negative	Peri (6-12 months since last menstrual period)																		2	6									2		true	M0	N1	T2	Stage IIB	TCGA-BH-A0E1.891F4C63-8207-4CB8-AB59-A970CC6F1A1A.pdf	5	1	1	0	1	1	0	0	5	40	14	4	80	55	85	80	TUMOR FREE	H-SCORE 245			H-SCORE	H-SCORE			No	50-59%		NO	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2009	TCGA-BH-A0E1-01A-11W-A071-09	TCGA-BH-A0E1-01		TCGA-BH-A0E1-01A-11R-A057-13	TCGA-BH-A0E1-01A-11W-A071-09	e4fbf61f-e3f8-4722-b3fc-b5479c75ddae	TCGA-BH-A0E1-01A-11W-A071-09	TCGA-BH-A0E1-01A-21-A13B-20	TCGA-BH-A0E1-01A-11W-A071-09	9bf836ee-036e-40f2-88fb-cf903a40d9f5	a2a1f3e8-7484-4105-92b6-6a7d0b2d9ace	TCGA-BH-A0E1-01A-11D-A059-01	9bf836ee-036e-40f2-88fb-cf903a40d9f5	TCGA-BH-A0E1-01A-11D-A10P-05	TCGA-BH-A0E1-01	TCGA-BH-A0E1-01A-11R-A056-07	9bf836ee-036e-40f2-88fb-cf903a40d9f5	9bf836ee-036e-40f2-88fb-cf903a40d9f5	TCGA-BH-A0E1-01A-11D-A059-01	TCGA-BH-A0E1-01	TCGA-BH-A0E1-01		a2a1f3e8-7484-4105-92b6-6a7d0b2d9ace	TCGA-BH-A0E1-01A-11R-A057-13
TCGA-BH-A0E1-11		52			477			FEMALE									477	0	Normal						followup			LIVING	0	TCGA-BH-A0E1-11	477	0		C3-BRCA/Luminal							mutation c1uster 10	TCGA-BH-A0E1			477	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	52	Left Upper Inner Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0E1-F4631		Positive		3+			Positive	Simple Mastectomy		NO			-19192	301		0	477						H-SCORE 180	70-79%			1.67		2010-11-16	FEMALE					2+	40	2.81	1.69		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	500	NO	Equivocal	Negative		17	Negative	Peri (6-12 months since last menstrual period)																												2		true	M0	N1	T2	Stage IIB		8	6	0	0			0	0	100	100			0	0			TUMOR FREE	H-SCORE 245			H-SCORE	H-SCORE			No	50-59%		NO	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2009				TCGA-BH-A0E1-11A-13R-A090-13						b6302c6b-2bab-40b1-b835-7f285719fff5			b6302c6b-2bab-40b1-b835-7f285719fff5	TCGA-BH-A0E1-11A-13D-A10Q-05		TCGA-BH-A0E1-11A-13R-A089-07	b6302c6b-2bab-40b1-b835-7f285719fff5	b6302c6b-2bab-40b1-b835-7f285719fff5						TCGA-BH-A0E1-11A-13R-A090-13
TCGA-BH-A0E2-01	Stage IIIA	49	2	No_Conversion	435		Positive	FEMALE	Negative				Negative	M0	Positive	N2	435	0	LumA	Luminal A	Positive	LumA/B	-8	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0E2-01	435	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7			mutation c1uster 9	TCGA-BH-A0E2			435	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	49	Right Upper Inner Quadrant|Right	Axillary lymph node dissection alone		TCGA-BH-A0E2-F4639		Positive		1+			Positive	Modified Radical Mastectomy		NO			-18152	210		0	435						H-SCORE 300	90-99%					2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	160	NO	Negative			26	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4										4		true	M0	N2a	T2	Stage IIIA	TCGA-BH-A0E2.29EDE507-90BA-4ABE-B3EF-559EBA4CCD56.pdf	2	2	2	0	2	1	0	0	0	0	8	4	90	95	85	90	TUMOR FREE	H-SCORE 1			H-SCORE	H-SCORE			No	<10%		NO	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2009	TCGA-BH-A0E2-01A-11W-A071-09	TCGA-BH-A0E2-01	TCGA-BH-A0E2-01A-11R-A057-13	TCGA-BH-A0E2-01A-11R-A057-13	TCGA-BH-A0E2-01A-11W-A071-09	98a8d468-efe1-41ff-a02a-615e09da0330	TCGA-BH-A0E2-01A-11W-A071-09	TCGA-BH-A0E2-01A-21-A13A-20	TCGA-BH-A0E2-01A-11W-A071-09	b605d803-523b-46e6-b656-7d9888d306cc	258d006c-a41d-49db-9bb4-e7e9a72eede1	TCGA-BH-A0E2-01A-11D-A059-01	b605d803-523b-46e6-b656-7d9888d306cc	TCGA-BH-A0E2-01A-11D-A10P-05	TCGA-BH-A0E2-01	TCGA-BH-A0E2-01A-11R-A056-07	b605d803-523b-46e6-b656-7d9888d306cc	b605d803-523b-46e6-b656-7d9888d306cc	TCGA-BH-A0E2-01A-11D-A059-01	TCGA-BH-A0E2-01	TCGA-BH-A0E2-01		258d006c-a41d-49db-9bb4-e7e9a72eede1	
TCGA-BH-A0E6-01	Stage IA	69	1	Stage I	292		Negative	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	292	0	Basal	Basal-like	Negative	ReacI	-13	0	followup	T1	T1	LIVING	0	TCGA-BH-A0E6-01	293	0	High	C4-BRCA/Basal	cluster 1	BRCA basal-like c8	OV-like c4	BRCA basal-like c8	miRNA cluster 12	cluster 4	mutation cluster 2	TCGA-BH-A0E6			293	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	69	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-BH-A0E6-F4650		Negative		0			Negative	Lumpectomy		NO			-25408	134		0	293						H-SCORE 0				2.38		2010-11-16	FEMALE					2+	40	2.83	1.19		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	80	NO	Equivocal	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4									0		true	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0E6.739E1733-3540-4E82-AC91-F511105DABD5.pdf	4	4	2	2	1	1	0	0	0	0	4	4	95	95	85	80	TUMOR FREE	H-SCORE 0			H-SCORE	H-SCORE			No			YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2009	TCGA-BH-A0E6-01A-11W-A050-09	TCGA-BH-A0E6-01		TCGA-BH-A0E6-01A-11R-A035-13		1b1bb0d9-e8c0-4efa-bab4-73225525bd9c	TCGA-BH-A0E6-01A-11W-A050-09	TCGA-BH-A0E6-01A-21-A13C-20	TCGA-BH-A0E6-01A-11W-A050-09	6bf094a5-1f62-406c-9b3a-e686bb4a074e	245f6917-4912-4707-9289-d4bc54345b81	TCGA-BH-A0E6-01A-11D-A036-01	6bf094a5-1f62-406c-9b3a-e686bb4a074e		TCGA-BH-A0E6-01	TCGA-BH-A0E6-01A-11R-A034-07	6bf094a5-1f62-406c-9b3a-e686bb4a074e	6bf094a5-1f62-406c-9b3a-e686bb4a074e	TCGA-BH-A0E6-01A-11D-A036-01	TCGA-BH-A0E6-01	TCGA-BH-A0E6-01	TCGA-BH-A0E6-01A-11D-A032-05	245f6917-4912-4707-9289-d4bc54345b81	TCGA-BH-A0E6-01A-11R-A035-13
TCGA-BH-A0E7-01	Stage IIB	79	4	No_Conversion	1362		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	1362	0	LumA	Luminal A	Positive	LumA	-12	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0E7-01	1363	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-BH-A0E7			1363	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	79	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-BH-A0E7-F4656		Positive		3+			Positive	Lumpectomy		NO			-29115	1259		0	1363							50-59%					2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Excisional Biopsy	140	NO	Negative			17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2									1		true	M0	N1a	T2	Stage IIB	TCGA-BH-A0E7.CE32A294-10FC-4DBA-A779-FAEEBE677D38.pdf	0	0	0	0	1	1	0	0	0	0	24	19	75	80	90	90	TUMOR FREE								No	60-69%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2006	TCGA-BH-A0E7-01A-11W-A050-09	TCGA-BH-A0E7-01		TCGA-BH-A0E7-01A-11R-A035-13	TCGA-BH-A0E7-01A-11W-A050-09	7c513473-0b7a-4cc6-9748-d0eaa83b6744	TCGA-BH-A0E7-01A-11W-A050-09	TCGA-BH-A0E7-01A-21-A13C-20	TCGA-BH-A0E7-01A-11W-A050-09	3850a348-8e53-497d-8e06-680672b19557	36334043-4a27-4b60-945a-bef7a9adacbc	TCGA-BH-A0E7-01A-11D-A036-01	3850a348-8e53-497d-8e06-680672b19557		TCGA-BH-A0E7-01	TCGA-BH-A0E7-01A-11R-A034-07	3850a348-8e53-497d-8e06-680672b19557	3850a348-8e53-497d-8e06-680672b19557	TCGA-BH-A0E7-01A-11D-A036-01	TCGA-BH-A0E7-01	TCGA-BH-A0E7-01	TCGA-BH-A0E7-01A-11D-A032-05	36334043-4a27-4b60-945a-bef7a9adacbc	TCGA-BH-A0E7-01A-11R-A035-13
TCGA-BH-A0E9-01	Stage IIB	53	3	Stage IIB	1405		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N1	1405	0	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0E9-01	1405	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3	cluster 6	mutation c1uster 9	TCGA-BH-A0E9			1405	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Right					Positive					Positive	Modified Radical Mastectomy					-19415	1357		0	1405					NO							2011-8-11	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	480	NO	Negative			12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6									3		true	M0	N1a	T2	Stage IIB		1	1	0	0	0	1	0	0	3	79	17	20	80	0	80	0	TUMOR FREE							YES	No				Primary Tumor	01	Sentinel lymph node biopsy	6th		NO	YES	BH	Breast	B	LIVING	2006	TCGA-BH-A0E9-01B-11D-A10Y-09	TCGA-BH-A0E9-01	TCGA-BH-A0E9-01B-11R-A114-13	TCGA-BH-A0E9-01B-11R-A114-13	TCGA-BH-A0E9-01B-11D-A10Y-09	8eb64683-4ff3-4cc6-84ff-902fbb7a2bb1	TCGA-BH-A0E9-01B-11D-A10Y-09	TCGA-BH-A0E9-01B-21-A13A-20	TCGA-BH-A0E9-01B-11D-A10Y-09	bfc39e77-7a26-4699-a4a3-217d4ea9425b	dc318c7f-d583-49ae-978d-f298cef23098	TCGA-BH-A0E9-01B-11D-A111-01	bfc39e77-7a26-4699-a4a3-217d4ea9425b		TCGA-BH-A0E9-01	TCGA-BH-A0E9-01B-11R-A115-07	bfc39e77-7a26-4699-a4a3-217d4ea9425b	bfc39e77-7a26-4699-a4a3-217d4ea9425b	TCGA-BH-A0E9-01B-11D-A111-01	TCGA-BH-A0E9-01	TCGA-BH-A0E9-01	TCGA-BH-A0E9-01B-11D-A112-05	dc318c7f-d583-49ae-978d-f298cef23098	
TCGA-BH-A0EA-01	Stage IIA	72	2	Stage IIA	831	993	Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N1	993	1	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T1	T1	DECEASED	1	TCGA-BH-A0EA-01	993	1	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 9	cluster 6	mutation cluster 4	TCGA-BH-A0EA			993	Breast	TCGA Breast Cancer	breast invasive carcinoma					72	Left					Positive					Positive	Other					-26548	567	993	0						NO							2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	220	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6									2		true	M0	N1a	T1c	Stage IIA	TCGA-BH-A0EA.28231C7B-64EE-49AC-B7AB-9BADDDDCC17C.pdf	5	10	2	10	2	5	0	25	40	0	43	15	15	80	8	85	TUMOR FREE							YES	Yes				Primary Tumor	01	Total mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	DECEASED	2008	TCGA-BH-A0EA-01A-11D-A10Y-09	TCGA-BH-A0EA-01	TCGA-BH-A0EA-01A-11R-A114-13	TCGA-BH-A0EA-01A-11R-A114-13	TCGA-BH-A0EA-01A-11D-A10Y-09	8629bf5a-cdaf-4f6a-90bb-27dd4a7565c5	TCGA-BH-A0EA-01A-11D-A10Y-09	TCGA-BH-A0EA-01A-21-A13C-20	TCGA-BH-A0EA-01A-11D-A10Y-09	ca71ca96-cbb7-4eab-9487-251dda34e107	97c64d6a-7dce-4d0f-9cb3-b3e4eb4719c5	TCGA-BH-A0EA-01A-11D-A111-01	ca71ca96-cbb7-4eab-9487-251dda34e107		TCGA-BH-A0EA-01	TCGA-BH-A0EA-01A-11R-A115-07	ca71ca96-cbb7-4eab-9487-251dda34e107	ca71ca96-cbb7-4eab-9487-251dda34e107	TCGA-BH-A0EA-01A-11D-A111-01	TCGA-BH-A0EA-01	TCGA-BH-A0EA-01	TCGA-BH-A0EA-01A-11D-A112-05	97c64d6a-7dce-4d0f-9cb3-b3e4eb4719c5	
TCGA-BH-A0EB-01	Stage IA	69	2	Stage I	745		Positive	FEMALE	Negative				Negative	M0	Negative	N0	745	0	LumA	Luminal A	Positive	LumA	-12	-4	followup	T1	T1	LIVING	0	TCGA-BH-A0EB-01	745	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7			mutation cluster 4	TCGA-BH-A0EB			745	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	69	Right Lower Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0EB-F4662		Positive		3+			Positive	Lumpectomy		NO			-25259	552		0	745						H-SCORE 300	90-99%			2.13		2010-11-16	FEMALE					2+	40	2.65	1.25		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	200	NO	Equivocal	Negative		4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1										0		true	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0EB.C6B0D463-9389-4BAE-93CA-3EE4717D20EC.pdf	10	10	10	10	2	2	15	15	1	1	12	12	85	85	85	85	TUMOR FREE	H-SCORE 210			H-SCORE	H-SCORE			No	40-49%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2008	TCGA-BH-A0EB-01A-11W-A050-09	TCGA-BH-A0EB-01			TCGA-BH-A0EB-01A-11W-A050-09	ac9f49b6-6bc1-42c6-9722-0cee04e91fdd	TCGA-BH-A0EB-01A-11W-A050-09	TCGA-BH-A0EB-01A-21-A13C-20	TCGA-BH-A0EB-01A-11W-A050-09	efb01993-cfe4-4f01-b628-ee34fceb4a5e	907f10f6-a879-43a8-9136-e943b896144d	TCGA-BH-A0EB-01A-11D-A036-01	efb01993-cfe4-4f01-b628-ee34fceb4a5e		TCGA-BH-A0EB-01	TCGA-BH-A0EB-01A-11R-A034-07	efb01993-cfe4-4f01-b628-ee34fceb4a5e	efb01993-cfe4-4f01-b628-ee34fceb4a5e	TCGA-BH-A0EB-01A-11D-A036-01	TCGA-BH-A0EB-01	TCGA-BH-A0EB-01	TCGA-BH-A0EB-01A-11D-A032-05	907f10f6-a879-43a8-9136-e943b896144d	
TCGA-BH-A0EE-01	Stage IIB	68	5	Stage IIB	943		Negative	FEMALE	Positive	2	3	1	Negative	M0	Negative	N0	943	0	Her2	HER2-enriched	Negative	Basal	-11	-9	followup	T_Other	T3	LIVING	0	TCGA-BH-A0EE-01	943	0	High	C3-BRCA/Luminal	cluster 1	Cluster 6	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-BH-A0EE			943	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	68	Right Upper Inner Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0EE-F4674		Negative		0			Negative	Simple Mastectomy		NO			-24850	946		0	943												2010-11-16	FEMALE			30-39%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	890	NO	Positive			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	7									0		true	M0	N0 (i-)	T3	Stage IIB	TCGA-BH-A0EE.B8664381-386A-44A2-AC3B-D69A4980A8EA.pdf	10	10	30	30	10	10	20	20	0	0	20	20	70	70	70	70	TUMOR FREE								No			NO	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2007	TCGA-BH-A0EE-01A-11W-A050-09	TCGA-BH-A0EE-01		TCGA-BH-A0EE-01A-11R-A035-13	TCGA-BH-A0EE-01A-11W-A050-09	b92e55c0-b921-4817-9984-3f58c13f93b5	TCGA-BH-A0EE-01A-11W-A050-09	TCGA-BH-A0EE-01A-21-A13C-20	TCGA-BH-A0EE-01A-11W-A050-09	24c0ef45-670d-4595-b623-87f81aeb92a7	de7f658d-2508-4621-afcd-c64ba3e554d2	TCGA-BH-A0EE-01A-11D-A036-01	24c0ef45-670d-4595-b623-87f81aeb92a7		TCGA-BH-A0EE-01	TCGA-BH-A0EE-01A-11R-A034-07	24c0ef45-670d-4595-b623-87f81aeb92a7	24c0ef45-670d-4595-b623-87f81aeb92a7	TCGA-BH-A0EE-01A-11D-A036-01	TCGA-BH-A0EE-01	TCGA-BH-A0EE-01	TCGA-BH-A0EE-01A-11D-A032-05	de7f658d-2508-4621-afcd-c64ba3e554d2	TCGA-BH-A0EE-01A-11R-A035-13
TCGA-BH-A0EI-01	Stage IIA	51	5	Stage IIA	743		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N1	743	0	LumA	Luminal A	Positive	LumA	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0EI-01	743	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-BH-A0EI			743	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Right					Positive					Positive	Other					-18741	541		0	743					NO							2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	240	NO	Negative			2	Negative	Peri (6-12 months since last menstrual period)																		4	4									4		true	M0	N1a	T1c	Stage IIA	TCGA-BH-A0EI.DFB21194-30C7-430E-A53C-C38345209B1F.pdf	25	20	2	1	2	2	0	0	0	10	63	53	35	35	60	60	TUMOR FREE							YES	No				Primary Tumor	01	segmental mastectomy with right sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2008	TCGA-BH-A0EI-01A-11D-A10Y-09	TCGA-BH-A0EI-01	TCGA-BH-A0EI-01A-11R-A114-13	TCGA-BH-A0EI-01A-11R-A114-13	TCGA-BH-A0EI-01A-11D-A10Y-09	d2fe1d76-437a-4eec-b376-d17426760c2a	TCGA-BH-A0EI-01A-11D-A10Y-09	TCGA-BH-A0EI-01A-21-A13B-20	TCGA-BH-A0EI-01A-11D-A10Y-09	c6929312-e22d-4d4e-830d-6f735184d9b2	690c778d-bca2-48c6-b084-3445f58cf216	TCGA-BH-A0EI-01A-11D-A111-01	c6929312-e22d-4d4e-830d-6f735184d9b2		TCGA-BH-A0EI-01	TCGA-BH-A0EI-01A-11R-A115-07	c6929312-e22d-4d4e-830d-6f735184d9b2	c6929312-e22d-4d4e-830d-6f735184d9b2	TCGA-BH-A0EI-01A-11D-A111-01	TCGA-BH-A0EI-01	TCGA-BH-A0EI-01	TCGA-BH-A0EI-01A-11D-A112-05	690c778d-bca2-48c6-b084-3445f58cf216	
TCGA-BH-A0GY-01	Stage IIA	67	3	No_Conversion	923		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	923	0	LumA	Luminal A	Positive	ReacI	-3	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0GY-01	923	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 5	mutation cluster 3	TCGA-BH-A0GY			923	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	67	Left Lower Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0GY-F4695		Positive		3+			Positive	Lumpectomy		NO			-24493	745		0	923						H-Score 150	40-49%					2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	200	NO	Negative			26	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	5									3		true	M0	N1	T2	Stage IIA	TCGA-BH-A0GY.A997FF30-F112-48BE-8FF1-15F8266A5E62.pdf	0	0	0	0	0	0	0	0	1	0	9	30	90	70	75	65	TUMOR FREE	H-Score 290			H-Score	H-Score			No	90-99%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2008	TCGA-BH-A0GY-01A-11W-A071-09	TCGA-BH-A0GY-01		TCGA-BH-A0GY-01A-11R-A057-13	TCGA-BH-A0GY-01A-11W-A071-09	9a0ff086-5678-4a7d-953e-cd6be5d03183	TCGA-BH-A0GY-01A-11W-A071-09	TCGA-BH-A0GY-01A-21-A13C-20	TCGA-BH-A0GY-01A-11W-A071-09	91d63f86-9c62-47cb-8b4a-e3bd981ab8b2	02275f5e-a3bf-4759-b481-d5ef710dff56	TCGA-BH-A0GY-01A-11D-A059-01	91d63f86-9c62-47cb-8b4a-e3bd981ab8b2	TCGA-BH-A0GY-01A-11D-A10P-05	TCGA-BH-A0GY-01	TCGA-BH-A0GY-01A-11R-A056-07	91d63f86-9c62-47cb-8b4a-e3bd981ab8b2	91d63f86-9c62-47cb-8b4a-e3bd981ab8b2	TCGA-BH-A0GY-01A-11D-A059-01	TCGA-BH-A0GY-01	TCGA-BH-A0GY-01		02275f5e-a3bf-4759-b481-d5ef710dff56	TCGA-BH-A0GY-01A-11R-A057-13
TCGA-BH-A0GZ-01	Stage IIA	62	3	No_Conversion	328		Positive	FEMALE	Negative				Negative	M0	Positive	N1	328	0	LumA	Luminal A	Positive		0	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0GZ-01	328	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-BH-A0GZ			328	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	62	Left Upper Inner Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0GZ-F4697	Negative	Positive		3+			Positive	Lumpectomy		NO			-22714	206		0	328						H-SCORE 300	90-99%			2.08		2010-11-16	FEMALE					2+	40	2.2	1.05		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	60	NO	Equivocal	Negative		14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2									1		true	M0	N1a	T1c	Stage IIA	TCGA-BH-A0GZ.C956B4B1-99E6-4823-886A-FA8FCD1E3E4D.pdf	0	0	0	0	0	0	0	0	0	0	5	5	95	95	85	80	TUMOR FREE	H-SCORE 280			H-SCORE	H-SCORE			No	80-89%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2009	TCGA-BH-A0GZ-01A-11W-A071-09	TCGA-BH-A0GZ-01		TCGA-BH-A0GZ-01A-11R-A057-13	TCGA-BH-A0GZ-01A-11W-A071-09		TCGA-BH-A0GZ-01A-11W-A071-09		TCGA-BH-A0GZ-01A-11W-A071-09	8ffcb765-094c-4623-b172-ea8400965f00	833793a9-9708-4363-ac40-ce7960a5e13d	TCGA-BH-A0GZ-01A-11D-A059-01	8ffcb765-094c-4623-b172-ea8400965f00	TCGA-BH-A0GZ-01A-11D-A10P-05	TCGA-BH-A0GZ-01	TCGA-BH-A0GZ-01A-11R-A056-07	8ffcb765-094c-4623-b172-ea8400965f00	8ffcb765-094c-4623-b172-ea8400965f00	TCGA-BH-A0GZ-01A-11D-A059-01	TCGA-BH-A0GZ-01	TCGA-BH-A0GZ-01		833793a9-9708-4363-ac40-ce7960a5e13d	TCGA-BH-A0GZ-01A-11R-A057-13
TCGA-BH-A0H0-01	Stage IA	69	2	Stage I	461		Positive	FEMALE	Negative				Negative	M0	Negative	N0	461	0	LumB	Luminal B	Positive		-10	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0H0-01	461	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 3	cluster 2	mutation c1uster 9	TCGA-BH-A0H0			461	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	69	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0H0-F4704		Positive		2+			Positive	Lumpectomy		NO			-25223	344		0	461						H-SCORE 190	50-59%					2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	70	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2									0		true	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0H0.94CF5704-1BE7-4CCC-870E-FB8527AC47E8.pdf		0		0		0		0		0		15		85		90	TUMOR FREE	H-SCORE 7			H-SCORE	H-SCORE			No	<10%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2009	TCGA-BH-A0H0-01A-11W-A071-09	TCGA-BH-A0H0-01		TCGA-BH-A0H0-01A-11R-A057-13	TCGA-BH-A0H0-01A-11W-A071-09		TCGA-BH-A0H0-01A-11W-A071-09		TCGA-BH-A0H0-01A-11W-A071-09	38e26122-c473-41c1-afb0-cd3b9096e9f4	e41ffe8d-8ad8-4ca1-9110-52c105f6f7ca	TCGA-BH-A0H0-01A-11D-A059-01	38e26122-c473-41c1-afb0-cd3b9096e9f4	TCGA-BH-A0H0-01A-11D-A10P-05	TCGA-BH-A0H0-01	TCGA-BH-A0H0-01A-11R-A056-07	38e26122-c473-41c1-afb0-cd3b9096e9f4	38e26122-c473-41c1-afb0-cd3b9096e9f4	TCGA-BH-A0H0-01A-11D-A059-01	TCGA-BH-A0H0-01	TCGA-BH-A0H0-01		e41ffe8d-8ad8-4ca1-9110-52c105f6f7ca	TCGA-BH-A0H0-01A-11R-A057-13
TCGA-BH-A0H3-01	Stage I	46	2	Stage I	1149		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1149	0	LumA	Luminal A	Positive		-2	-4	enrollment	T1	T1	LIVING	0	TCGA-BH-A0H3-01	1149	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 3	cluster 6	mutation cluster 4	TCGA-BH-A0H3			1149	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Left Upper Outer Quadrant					Positive					Positive	Other					-17152	773		0	1149					NO							2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	80	NO		Negative		2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6									0		true	M0	N0	T1c	Stage I	TCGA-BH-A0H3.6D3F79A6-C55C-497F-9CCD-1C6D3ACE7492.pdf	20	0	0	0	1	0	0	0	40	5	20	20	39	75	40	80	TUMOR FREE							YES	No				Primary Tumor	01	Left segmental mastectomy with axillary lymph node dissection	6th		NO	YES	BH	Breast	A	LIVING	2008	TCGA-BH-A0H3-01A-11D-A12Q-09	TCGA-BH-A0H3-01	TCGA-BH-A0H3-01A-11R-A12O-13	TCGA-BH-A0H3-01A-11R-A12O-13	TCGA-BH-A0H3-01A-11D-A12Q-09		TCGA-BH-A0H3-01A-11D-A12Q-09		TCGA-BH-A0H3-01A-11D-A12Q-09	4baa8edc-9ab0-4cd6-b316-dfe1ff7c1f4d	836dd390-a9e4-416f-b0e1-a9fdb37155ab	TCGA-BH-A0H3-01A-11D-A12N-01	4baa8edc-9ab0-4cd6-b316-dfe1ff7c1f4d	TCGA-BH-A0H3-01A-11D-A12R-05	TCGA-BH-A0H3-01	TCGA-BH-A0H3-01A-11R-A12P-07	4baa8edc-9ab0-4cd6-b316-dfe1ff7c1f4d	4baa8edc-9ab0-4cd6-b316-dfe1ff7c1f4d	TCGA-BH-A0H3-01A-11D-A12N-01	TCGA-BH-A0H3-01	TCGA-BH-A0H3-01		836dd390-a9e4-416f-b0e1-a9fdb37155ab	
TCGA-BH-A0H5-01	Stage I	45	1	Stage I	1080		Positive	FEMALE	Negative	2	2	1	Negative	M0	Negative	N0	1080	0	LumA	Luminal A	Positive	Basal	-2	-5	enrollment	T1	T1	LIVING	0	TCGA-BH-A0H5-01	1080	0	Quiet	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-BH-A0H5			1080	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Right Upper Outer Quadrant					Positive					Positive	Other					-16719	815		0	1080					NO							2011-8-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	410	NO		Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	3									0		true	M0	N0 (i-)	T1c	Stage I	TCGA-BH-A0H5.C350A3BE-1709-427D-8E1D-E0BBA480A56D.pdf	20	50	0	0	2	2	0	0	15	13	18	20	30	65	60	35	TUMOR FREE							YES	No				Primary Tumor	01	Right total mastectomy with lymph node left axillary lymph node excision	6th		NO	YES	BH	Breast	A	LIVING	2008	TCGA-BH-A0H5-01A-21D-A10Y-09	TCGA-BH-A0H5-01	TCGA-BH-A0H5-01A-21R-A114-13	TCGA-BH-A0H5-01A-21R-A114-13	TCGA-BH-A0H5-01A-21D-A10Y-09	3fd5b19e-218a-400d-85e7-23fb60737f41	TCGA-BH-A0H5-01A-21D-A10Y-09	TCGA-BH-A0H5-01A-11-A13C-20	TCGA-BH-A0H5-01A-21D-A10Y-09	e5378cd0-4045-4afe-8157-7187b3d294ef	faaa02ff-b4f1-4f4d-be66-1254bd2c7403	TCGA-BH-A0H5-01A-21D-A111-01	e5378cd0-4045-4afe-8157-7187b3d294ef		TCGA-BH-A0H5-01	TCGA-BH-A0H5-01A-21R-A115-07	e5378cd0-4045-4afe-8157-7187b3d294ef	e5378cd0-4045-4afe-8157-7187b3d294ef	TCGA-BH-A0H5-01A-21D-A111-01	TCGA-BH-A0H5-01	TCGA-BH-A0H5-01	TCGA-BH-A0H5-01A-21D-A112-05	faaa02ff-b4f1-4f4d-be66-1254bd2c7403	
TCGA-BH-A0H5-11		45			1080			FEMALE									1080	0	Normal						enrollment			LIVING	0	TCGA-BH-A0H5-11	1080	0		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0H5			1080	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Right Upper Outer Quadrant					Positive					Positive	Other					-16719	815		0	1080					NO							2011-8-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	620	NO		Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N0 (i-)	T1c	Stage I			0		0				0		100				0			TUMOR FREE							YES	No				Solid Tissue Normal	11	Right total mastectomy with lymph node left axillary lymph node excision	6th		NO	YES	BH	Breast	A	LIVING	2008			TCGA-BH-A0H5-11A-62R-A114-13	TCGA-BH-A0H5-11A-62R-A114-13						fe1a74fd-c9b4-405b-86a7-61bcb75f825d			fe1a74fd-c9b4-405b-86a7-61bcb75f825d			TCGA-BH-A0H5-11A-62R-A115-07	fe1a74fd-c9b4-405b-86a7-61bcb75f825d	fe1a74fd-c9b4-405b-86a7-61bcb75f825d				TCGA-BH-A0H5-11A-62D-A112-05		
TCGA-BH-A0H6-01	Stage IA	82	4	No_Conversion	747		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	747	0	LumA	Luminal A	Positive	ReacI	-5	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0H6-01	747	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-BH-A0H6			747	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	82	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	No axillary staging		TCGA-BH-A0H6-F4711		Positive		3+			Positive	Lumpectomy		NO			-30125	583		0	747						H-SCORE 230	50-59%					2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	330	NO	Negative			0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2									0	0	true	M0	NX	T1b	Stage I	TCGA-BH-A0H6.93292768-8C20-4551-8CA8-44AE0FFB487E.pdf	6	7	0	0	0	0	0	0	80	5	5	35	15	60	80	75	TUMOR FREE	H-SCORE 250			H-SCORE	H-SCORE			No	60-69%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2008	TCGA-BH-A0H6-01A-21W-A071-09	TCGA-BH-A0H6-01		TCGA-BH-A0H6-01A-21R-A057-13	TCGA-BH-A0H6-01A-21W-A071-09	cc4de94d-e4e4-4e21-823c-005b9a846f19	TCGA-BH-A0H6-01A-21W-A071-09	TCGA-BH-A0H6-01A-31-A13C-20	TCGA-BH-A0H6-01A-21W-A071-09	f7e26041-2b2f-45ea-8da9-5a0d5bf25781	7cb2d031-fc42-48ac-b6f0-88fe60245c2e	TCGA-BH-A0H6-01A-21D-A059-01	f7e26041-2b2f-45ea-8da9-5a0d5bf25781	TCGA-BH-A0H6-01A-21D-A10P-05	TCGA-BH-A0H6-01	TCGA-BH-A0H6-01A-21R-A056-07	f7e26041-2b2f-45ea-8da9-5a0d5bf25781	f7e26041-2b2f-45ea-8da9-5a0d5bf25781	TCGA-BH-A0H6-01A-21D-A059-01	TCGA-BH-A0H6-01	TCGA-BH-A0H6-01		7cb2d031-fc42-48ac-b6f0-88fe60245c2e	TCGA-BH-A0H6-01A-21R-A057-13
TCGA-BH-A0H7-01	Stage IIIA	65	3	No_Conversion	701		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N2	701	0	LumA	Luminal A	Positive	ReacII	-3	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0H7-01	702	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 6	cluster 4	mutation cluster 5	TCGA-BH-A0H7			702	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	65	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-BH-A0H7-F4737		Positive		2+			Positive	Modified Radical Mastectomy		NO			-23972	542		0	702						H-SCORE 255	70-79%					2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	440	NO	Negative			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									6		true	M0	N2a	T1c	Stage IIIA	TCGA-BH-A0H7.CC7D1177-1638-4A80-A3AA-266ADC260EC9.pdf	36	4	0	0	1	0	0	0	64	5	10	60	25	35	60	85	TUMOR FREE	H-SCORE 150			H-SCORE	H-SCORE			No	30-39%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2008	TCGA-BH-A0H7-01A-13W-A071-09	TCGA-BH-A0H7-01		TCGA-BH-A0H7-01A-13R-A057-13	TCGA-BH-A0H7-01A-13W-A071-09	571ca6b7-118d-4261-a194-c0856e62b1d9	TCGA-BH-A0H7-01A-13W-A071-09	TCGA-BH-A0H7-01A-21-A13C-20	TCGA-BH-A0H7-01A-13W-A071-09	5969d3bb-19fb-4bda-9483-db4791257b95	be2892ed-6564-4c99-ad83-025414acbe76	TCGA-BH-A0H7-01A-13D-A059-01	5969d3bb-19fb-4bda-9483-db4791257b95	TCGA-BH-A0H7-01A-13D-A10P-05	TCGA-BH-A0H7-01	TCGA-BH-A0H7-01A-13R-A056-07	5969d3bb-19fb-4bda-9483-db4791257b95	5969d3bb-19fb-4bda-9483-db4791257b95	TCGA-BH-A0H7-01A-13D-A059-01	TCGA-BH-A0H7-01	TCGA-BH-A0H7-01		be2892ed-6564-4c99-ad83-025414acbe76	TCGA-BH-A0H7-01A-13R-A057-13
TCGA-BH-A0H7-11		65			701			FEMALE									701	0	Normal						followup			LIVING	0	TCGA-BH-A0H7-11	702	0		C3-BRCA/Luminal							mutation cluster 5	TCGA-BH-A0H7			702	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	65	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-BH-A0H7-F4737		Positive		2+			Positive	Modified Radical Mastectomy		NO			-23972	542		0	702						H-SCORE 255	70-79%					2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	380	NO	Negative			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												6		true	M0	N2a	T1c	Stage IIIA		2	2	0	0			0	0	100	100			0	0			TUMOR FREE	H-SCORE 150			H-SCORE	H-SCORE			No	30-39%		YES	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2008				TCGA-BH-A0H7-11A-13R-A090-13						6136a15e-6c8f-44bc-85c2-c7cbf675cab0			6136a15e-6c8f-44bc-85c2-c7cbf675cab0	TCGA-BH-A0H7-11A-13D-A10Q-05		TCGA-BH-A0H7-11A-13R-A089-07	6136a15e-6c8f-44bc-85c2-c7cbf675cab0	6136a15e-6c8f-44bc-85c2-c7cbf675cab0						TCGA-BH-A0H7-11A-13R-A090-13
TCGA-BH-A0H9-01	Stage IIA	69	1	Stage IIA	1247		Positive	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1247	0	LumA	Luminal A	Positive	LumA/B	-3	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0H9-01	1247	0	Iq	C3-BRCA/Luminal	cluster 5	Low purity c2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 14	TCGA-BH-A0H9			1247	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	69	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0H9-F4703		Positive		1+			Positive	Lumpectomy		NO			-25289	1088		0	1247							90-99%			2.98		2010-11-16	FEMALE					2+	40	3.43	1.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	120	NO	Equivocal	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	6									0		true	M0	N0 (i-)	T2	Stage IIA	TCGA-BH-A0H9.584E15EE-1C80-4507-8AD3-558DF06DBDF3.pdf	12	18	0	0	2	2	0	0	15	12	43	46	40	40	75	65	TUMOR FREE								No	30-39%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2007	TCGA-BH-A0H9-01A-11W-A071-09	TCGA-BH-A0H9-01		TCGA-BH-A0H9-01A-11R-A057-13	TCGA-BH-A0H9-01A-11W-A071-09	84ff2baf-9961-4324-91b6-e2e9a86128aa	TCGA-BH-A0H9-01A-11W-A071-09	TCGA-BH-A0H9-01A-21-A13C-20	TCGA-BH-A0H9-01A-11W-A071-09	827431d3-e25a-45b6-9b0f-5732501e2a5b	2db50b93-b544-42c8-9c6b-39bcfe870324	TCGA-BH-A0H9-01A-11D-A059-01	827431d3-e25a-45b6-9b0f-5732501e2a5b	TCGA-BH-A0H9-01A-11D-A10P-05	TCGA-BH-A0H9-01	TCGA-BH-A0H9-01A-11R-A056-07	827431d3-e25a-45b6-9b0f-5732501e2a5b	827431d3-e25a-45b6-9b0f-5732501e2a5b	TCGA-BH-A0H9-01A-11D-A059-01	TCGA-BH-A0H9-01	TCGA-BH-A0H9-01		2db50b93-b544-42c8-9c6b-39bcfe870324	TCGA-BH-A0H9-01A-11R-A057-13
TCGA-BH-A0H9-11		69			1247			FEMALE									1247	0							followup			LIVING	0	TCGA-BH-A0H9-11	1247	0		C3-BRCA/Luminal							mutation cluster 14	TCGA-BH-A0H9			1247	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	69	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0H9-F4703		Positive		1+			Positive	Lumpectomy		NO			-25289	1088		0	1247							90-99%			2.98		2010-11-16	FEMALE					2+	40	3.43	1.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	220	NO	Equivocal	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N0 (i-)	T2	Stage IIA		0	0	0	0			0	0	100	100			0	0			TUMOR FREE								No	30-39%		YES	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2007														TCGA-BH-A0H9-11A-22D-A093-05		TCGA-BH-A0H9-11A-22R-A089-07								
TCGA-BH-A0HA-01	Stage I	31	1	Stage I	856		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	856	0	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0HA-01	1611	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-BH-A0HA	1611	0	1611	Breast	TCGA Breast Cancer	breast invasive carcinoma					31	Right			TCGA-BH-A0HA-F43320		Positive					Positive	Other					-11379	675		0	1611					NO						Scheduled Follow-up Submission	2013-5-17	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	230	NO		Negative	NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6								NO	0		true	M0	N0 (i-)	T1c	Stage I	TCGA-BH-A0HA.E6C20D27-63E5-4FFF-96BF-E8BD71296925.pdf	12	5	0	0	2	5	0	0	5	10	48	25	45	60	75	70	TUMOR FREE						NO	YES	No			NO	Primary Tumor	01	bilateral total mastectomies with right sentinel node biopsy	6th	NO	NO	YES	BH	Breast	A	LIVING	2008	TCGA-BH-A0HA-01A-11D-A12Q-09	TCGA-BH-A0HA-01	TCGA-BH-A0HA-01A-11R-A12O-13	TCGA-BH-A0HA-01A-11R-A12O-13	TCGA-BH-A0HA-01A-11D-A12Q-09	f1a9fcd6-b351-4300-ab8c-e488c8d76cee	TCGA-BH-A0HA-01A-11D-A12Q-09	TCGA-BH-A0HA-01A-21-A13C-20	TCGA-BH-A0HA-01A-11D-A12Q-09	cffc0fe5-533f-46f8-a54a-2e09c392767d	9c593bef-cf0b-42a4-9cb1-02d9d13b16dd	TCGA-BH-A0HA-01A-11D-A12N-01	cffc0fe5-533f-46f8-a54a-2e09c392767d	TCGA-BH-A0HA-01A-11D-A12R-05	TCGA-BH-A0HA-01	TCGA-BH-A0HA-01A-11R-A12P-07	cffc0fe5-533f-46f8-a54a-2e09c392767d	cffc0fe5-533f-46f8-a54a-2e09c392767d	TCGA-BH-A0HA-01A-11D-A12N-01	TCGA-BH-A0HA-01	TCGA-BH-A0HA-01		9c593bef-cf0b-42a4-9cb1-02d9d13b16dd	
TCGA-BH-A0HA-11		31			856			FEMALE									856	0	Normal						enrollment			LIVING	0	TCGA-BH-A0HA-11	1611	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0HA	1611	0	1611	Breast	TCGA Breast Cancer	breast invasive carcinoma					31	Right			TCGA-BH-A0HA-F43320		Positive					Positive	Other					-11379	675		0	1611					NO						Scheduled Follow-up Submission	2013-5-17	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	340	NO		Negative	NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0		true	M0	N0 (i-)	T1c	Stage I			0		0		0		0		100		0		0		0	TUMOR FREE						NO	YES	No			NO	Solid Tissue Normal	11	bilateral total mastectomies with right sentinel node biopsy	6th	NO	NO	YES	BH	Breast	A	LIVING	2008			TCGA-BH-A0HA-11A-31R-A12O-13	TCGA-BH-A0HA-11A-31R-A12O-13						a521a6fa-da2b-48ef-94e8-3307030427b6			a521a6fa-da2b-48ef-94e8-3307030427b6	TCGA-BH-A0HA-11A-31D-A12R-05		TCGA-BH-A0HA-11A-31R-A12P-07	a521a6fa-da2b-48ef-94e8-3307030427b6	a521a6fa-da2b-48ef-94e8-3307030427b6						
TCGA-BH-A0HB-01	Stage IA	55	5	Stage I	806		Positive	FEMALE	Negative				Negative	M0	Negative	N0	806	0	LumA	Luminal A	Positive		-8	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0HB-01	806	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 14	TCGA-BH-A0HB			806	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	55	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0HB-F4718		Positive		1+			Positive	Lumpectomy		NO			-20448	739		0	806						H-Score 300	90-99%			2.13		2010-11-16	FEMALE					2+	40	2.58	1.21		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	70	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4									0		true	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0HB.C7476B2B-0040-4013-8D30-06935E3FB897.pdf	15	20	0	1	2	1	0	0	30	5	38	24	30	70	70	70	TUMOR FREE	H-Score 70			H-Score	H-Score			No	30-39%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2008	TCGA-BH-A0HB-01A-11W-A071-09	TCGA-BH-A0HB-01		TCGA-BH-A0HB-01A-11R-A057-13	TCGA-BH-A0HB-01A-11W-A071-09		TCGA-BH-A0HB-01A-11W-A071-09		TCGA-BH-A0HB-01A-11W-A071-09	67b214bc-ac5f-4993-9907-fe0e0398d4ed	f413a46e-2b09-429d-8463-286cbcdad0b6	TCGA-BH-A0HB-01A-11D-A059-01	67b214bc-ac5f-4993-9907-fe0e0398d4ed	TCGA-BH-A0HB-01A-11D-A10P-05	TCGA-BH-A0HB-01	TCGA-BH-A0HB-01A-11R-A056-07	67b214bc-ac5f-4993-9907-fe0e0398d4ed	67b214bc-ac5f-4993-9907-fe0e0398d4ed	TCGA-BH-A0HB-01A-11D-A059-01	TCGA-BH-A0HB-01	TCGA-BH-A0HB-01		f413a46e-2b09-429d-8463-286cbcdad0b6	TCGA-BH-A0HB-01A-11R-A057-13
TCGA-BH-A0HF-01	Stage IA	77		Stage I	727		Positive	FEMALE	Negative				Negative	M0	Negative	N0	727	0	LumA	Luminal A	Positive		-5	-7	followup	T1	T1	LIVING	0	TCGA-BH-A0HF-01	727	0			cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4		TCGA-BH-A0HF			727	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	77	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0HF-F4734		Positive		1+			Positive	Lumpectomy		NO			-28233	549		0	727	696					H-Score 295	90-99%					2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	40	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4									0		true	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0HF.71291A56-C2DB-4EB9-8223-DD7563CBBDC9.pdf	5	5	0	0	2	2	0	0	0	5	55	55	43	38	75	65	TUMOR FREE	H-Score 15			H-Score	H-Score			No	<10%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2008				TCGA-BH-A0HF-01A-11R-A057-13			TCGA-BH-A0HF-01A-11W-A071-09			5b92fd62-9fec-4b18-b7c3-50c88fa0d464	598d5706-eedb-4d5a-9048-4ac324573025		5b92fd62-9fec-4b18-b7c3-50c88fa0d464	TCGA-BH-A0HF-01A-11D-A10P-05	TCGA-BH-A0HF-01	TCGA-BH-A0HF-01A-11R-A056-07	5b92fd62-9fec-4b18-b7c3-50c88fa0d464	5b92fd62-9fec-4b18-b7c3-50c88fa0d464		TCGA-BH-A0HF-01			598d5706-eedb-4d5a-9048-4ac324573025	TCGA-BH-A0HF-01A-11R-A057-13
TCGA-BH-A0HI-01	Stage IA	78	2	Stage I	619		Positive	FEMALE	Negative				Negative	M0	Negative	N0	619	0	LumA	Luminal A	Positive		-12	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0HI-01	620	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-BH-A0HI			620	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	78	Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0HI-F4756		Positive		1+			Positive	Lumpectomy		YES			-28644	554		0	620						H-Score 240	50-59%					2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	20	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	7									0	0	true	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0HI.EE9E0908-05D2-4F26-B3C2-2B40A48FEA6D.pdf		0		0		0		0		0		15		85		80	TUMOR FREE	H-Score 160			H-Score	H-Score			No	40-49%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2008	TCGA-BH-A0HI-01A-11D-A099-09	TCGA-BH-A0HI-01		TCGA-BH-A0HI-01A-11R-A085-13	TCGA-BH-A0HI-01A-11D-A099-09		TCGA-BH-A0HI-01A-11D-A099-09		TCGA-BH-A0HI-01A-11D-A099-09	682942cb-589f-4348-abc2-3c7cc76fb34d	fab48d98-dc30-4a19-8108-48476a6362ee	TCGA-BH-A0HI-01A-11D-A087-01	682942cb-589f-4348-abc2-3c7cc76fb34d	TCGA-BH-A0HI-01A-11D-A10P-05	TCGA-BH-A0HI-01	TCGA-BH-A0HI-01A-11R-A084-07	682942cb-589f-4348-abc2-3c7cc76fb34d	682942cb-589f-4348-abc2-3c7cc76fb34d	TCGA-BH-A0HI-01A-11D-A087-01	TCGA-BH-A0HI-01	TCGA-BH-A0HI-01		fab48d98-dc30-4a19-8108-48476a6362ee	TCGA-BH-A0HI-01A-11R-A085-13
TCGA-BH-A0HK-01	Stage IIB	81	2	No_Conversion	178		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	178	0	LumA	Luminal A	Negative	LumA/B	0	0	followup	T_Other	T2	LIVING	0	TCGA-BH-A0HK-01	178	0	Iq	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation c1uster 9	TCGA-BH-A0HK			178	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	81	Right Upper Inner Quadrant|Right	Axillary lymph node dissection alone		TCGA-BH-A0HK-F4758		Positive		0			Negative	Modified Radical Mastectomy		NO			-29751	35		0	178						H-SCORE 260	70-79%					2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8522/3	C50.9	3+	YES		Core needle biopsy	700	NO	Negative			17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	7									2		true	M0	N1	T2	Stage IIB	TCGA-BH-A0HK.575F2EFD-2D8B-4140-9FCB-D8CB9EC14D09.pdf	0	0	0	0	0	0	0	0	0	0	0	0	100	100	90	95	TUMOR FREE	H-SCORE 0			H-SCORE	H-SCORE			No	<10%		NO	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2010	TCGA-BH-A0HK-01A-11W-A071-09	TCGA-BH-A0HK-01		TCGA-BH-A0HK-01A-11R-A057-13	TCGA-BH-A0HK-01A-11W-A071-09	c6d75d78-0a3e-4221-840e-b2c6099b8e72	TCGA-BH-A0HK-01A-11W-A071-09	TCGA-BH-A0HK-01A-21-A13C-20	TCGA-BH-A0HK-01A-11W-A071-09	85845e8c-e9d7-43c4-8dfc-d7fb0cf85ac5	6a9b5a0c-ce6c-4445-8316-0b25795d23d1	TCGA-BH-A0HK-01A-11D-A059-01	85845e8c-e9d7-43c4-8dfc-d7fb0cf85ac5	TCGA-BH-A0HK-01A-11D-A10P-05	TCGA-BH-A0HK-01	TCGA-BH-A0HK-01A-11R-A056-07	85845e8c-e9d7-43c4-8dfc-d7fb0cf85ac5	85845e8c-e9d7-43c4-8dfc-d7fb0cf85ac5	TCGA-BH-A0HK-01A-11D-A059-01	TCGA-BH-A0HK-01	TCGA-BH-A0HK-01		6a9b5a0c-ce6c-4445-8316-0b25795d23d1	TCGA-BH-A0HK-01A-11R-A057-13
TCGA-BH-A0HK-11		81			178			FEMALE									178	0	Normal						followup			LIVING	0	TCGA-BH-A0HK-11	178	0		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0HK			178	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	81	Right Upper Inner Quadrant|Right	Axillary lymph node dissection alone		TCGA-BH-A0HK-F4758		Positive		0			Negative	Modified Radical Mastectomy		NO			-29751	35		0	178						H-SCORE 260	70-79%					2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8522/3	C50.9	3+	YES		Core needle biopsy	240	NO	Negative			17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												2		true	M0	N1	T2	Stage IIB		1	1	2	3			1	5	100	100			0	0			TUMOR FREE	H-SCORE 0			H-SCORE	H-SCORE			No	<10%		NO	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2010				TCGA-BH-A0HK-11A-11R-A090-13						01163f75-8956-40a6-97a5-3c0478d904f8			01163f75-8956-40a6-97a5-3c0478d904f8	TCGA-BH-A0HK-11A-11D-A10Q-05		TCGA-BH-A0HK-11A-11R-A089-07	01163f75-8956-40a6-97a5-3c0478d904f8	01163f75-8956-40a6-97a5-3c0478d904f8						TCGA-BH-A0HK-11A-11R-A090-13
TCGA-BH-A0HL-01	Stage IIB	56		No_Conversion	72		Positive	FEMALE	Negative				Negative	M0	Positive	N1	72	0		Basal-like	Positive	LumA/B	-13	0	followup	T_Other	T2	LIVING	0	TCGA-BH-A0HL-01	72	0			cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 11	cluster 4	mutation c1uster 9	TCGA-BH-A0HL			72	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	56	Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0HL-F4792		Positive		3+			Positive	Modified Radical Mastectomy		NO			-20804	352		0	72						H-SCORE 295	90-99%			2.25		2010-11-16	FEMALE					2+	40	2.23	0.99		Infiltrating Ductal Carcinoma		No		C50.9	8503/3	C50.9	3+	YES		Core needle biopsy	250	NO	Equivocal	Negative		17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4									2		true	M0	N1a	T2	Stage IIB	TCGA-BH-A0HL.79DAEAE5-A177-40E0-9BFC-54DC9F544764.pdf	0	0	0	0	0	0	0	0	0	0	10	35	90	65	98	95	TUMOR FREE	H-SCORE 200			H-SCORE	H-SCORE			No	40-49%		NO	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2009	TCGA-BH-A0HL-01A-11W-A050-09		TCGA-BH-A0HL-01A-11R-A10V-13	TCGA-BH-A0HL-01A-11R-A10V-13		2167df75-1057-4cb6-acea-3e737541d1ee	TCGA-BH-A0HL-01A-11W-A050-09	TCGA-BH-A0HL-01A-21-A13C-20	TCGA-BH-A0HL-01A-11W-A050-09	1ee60bda-48df-4288-90cb-480fbfbc5d50	53e67b89-52ff-4af2-a20f-378da3c2b9f4		1ee60bda-48df-4288-90cb-480fbfbc5d50		TCGA-BH-A0HL-01		1ee60bda-48df-4288-90cb-480fbfbc5d50	1ee60bda-48df-4288-90cb-480fbfbc5d50				TCGA-BH-A0HL-01A-11D-A032-05	53e67b89-52ff-4af2-a20f-378da3c2b9f4	
TCGA-BH-A0HN-01	Stage IA	67		Stage I	516		Positive	FEMALE	Negative				Negative	M0	Negative	N0	516	0		Basal-like	Positive	ReacI	-13	0	followup	T1	T1	LIVING	0	TCGA-BH-A0HN-01	516	0			cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 11	cluster 6	mutation cluster 14	TCGA-BH-A0HN			516	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	67	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-BH-A0HN-F4811	Negative	Positive		3+		Mastectomy NOS	Positive	Lumpectomy		NO			-24731	359		0	516						H-SCORE 300	90-99%			1.78		2010-11-16	FEMALE					2+	40	2.0	1.13		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	130	NO	Equivocal	Negative		2	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6									0		true	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0HN.CA7E5555-5898-411A-8A5B-9BA2239A2B30.pdf	0	0	0	0	0	0	0	0	0	0	5	5	95	95	95	95	TUMOR FREE	H-SCORE 290			H-SCORE	H-SCORE			No	90-99%		NO	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2009	TCGA-BH-A0HN-01A-11D-A099-09		TCGA-BH-A0HN-01A-11R-A10V-13	TCGA-BH-A0HN-01A-11R-A10V-13		b81e2777-d661-4576-b8dc-e95b03351e27	TCGA-BH-A0HN-01A-11D-A099-09	TCGA-BH-A0HN-01A-21-A13C-20	TCGA-BH-A0HN-01A-11D-A099-09	6f0cf450-76f1-489d-9890-5093816c0680	4e118657-b2e3-491b-ba2d-e8d16e04be75		6f0cf450-76f1-489d-9890-5093816c0680	TCGA-BH-A0HN-01A-11D-A10P-05	TCGA-BH-A0HN-01		6f0cf450-76f1-489d-9890-5093816c0680	6f0cf450-76f1-489d-9890-5093816c0680					4e118657-b2e3-491b-ba2d-e8d16e04be75	
TCGA-BH-A0HO-01	Stage IIA	48	2	No_Conversion	76		Positive	FEMALE	Negative				Negative	M0	Positive	N1	76	0	LumA	Luminal A	Positive		-12	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0HO-01	76	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 6	cluster 2	mutation c1uster 9	TCGA-BH-A0HO			76	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	48	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0HO-F4771		Positive		3+			Positive	Lumpectomy		YES			-17710	224		0	76						H-Score 200	90-99%					2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	110	NO	Negative			18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	2									1	1	true	M0	N1a	T1c	Stage IIA	TCGA-BH-A0HO.C9AD69EB-506A-4442-B1C2-C8F09B519CB2.pdf	1	1	0	0	0	0	0	0	0	0	10	5	90	95	90	95	TUMOR FREE	H-Score 290			H-Score	H-Score			No	90-99%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2009	TCGA-BH-A0HO-01A-11W-A050-09	TCGA-BH-A0HO-01		TCGA-BH-A0HO-01A-11R-A035-13	TCGA-BH-A0HO-01A-11W-A050-09		TCGA-BH-A0HO-01A-11W-A050-09		TCGA-BH-A0HO-01A-11W-A050-09	92f53e8e-abd5-4597-a6be-678be549315d	b4d2c0c0-92c9-407d-af6f-1f951e1096ae	TCGA-BH-A0HO-01A-11D-A036-01	92f53e8e-abd5-4597-a6be-678be549315d		TCGA-BH-A0HO-01	TCGA-BH-A0HO-01A-11R-A034-07	92f53e8e-abd5-4597-a6be-678be549315d	92f53e8e-abd5-4597-a6be-678be549315d	TCGA-BH-A0HO-01A-11D-A036-01	TCGA-BH-A0HO-01	TCGA-BH-A0HO-01	TCGA-BH-A0HO-01A-11D-A032-05	b4d2c0c0-92c9-407d-af6f-1f951e1096ae	TCGA-BH-A0HO-01A-11R-A035-13
TCGA-BH-A0HP-01	Stage IIIA	65	2	No_Conversion	414		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N2	414	0	LumA	Luminal A	Negative	ReacI	-5	-7	followup	T_Other	T3	LIVING	0	TCGA-BH-A0HP-01	414	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-BH-A0HP			414	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	65	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-BH-A0HP-F4784		Positive		0			Negative	Modified Radical Mastectomy		NO			-23883	346		0	414						H-Score 280	80-89%					2010-11-16	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	720	NO	Negative			17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)					Positive												Negative	1	6									8		true	M0	N2a	T3	Stage IIIA	TCGA-BH-A0HP.F13CE7B3-F275-4EEE-90A3-11B8B92FA431.pdf	3	4	0	0	1	1	0	0	2	3	17	21	80	75	80	75	TUMOR FREE	H-Score 0			H-Score	H-Score			No			NO	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2009	TCGA-BH-A0HP-01A-12D-A099-09	TCGA-BH-A0HP-01		TCGA-BH-A0HP-01A-12R-A085-13	TCGA-BH-A0HP-01A-12D-A099-09	189540a2-042e-4bac-99f0-b7b0feda0a23	TCGA-BH-A0HP-01A-12D-A099-09	TCGA-BH-A0HP-01A-21-A13C-20	TCGA-BH-A0HP-01A-12D-A099-09	f0c59856-0421-46e3-a2f9-e17f0f267930	f3f959ab-bf38-45eb-9422-ed83acae1244	TCGA-BH-A0HP-01A-12D-A087-01	f0c59856-0421-46e3-a2f9-e17f0f267930	TCGA-BH-A0HP-01A-12D-A10P-05	TCGA-BH-A0HP-01	TCGA-BH-A0HP-01A-12R-A084-07	f0c59856-0421-46e3-a2f9-e17f0f267930	f0c59856-0421-46e3-a2f9-e17f0f267930	TCGA-BH-A0HP-01A-12D-A087-01	TCGA-BH-A0HP-01	TCGA-BH-A0HP-01		f3f959ab-bf38-45eb-9422-ed83acae1244	TCGA-BH-A0HP-01A-12R-A085-13
TCGA-BH-A0HQ-01	Stage IIA	56		Stage IIA	1121		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1121	0	LumA	Luminal A	Positive		-5	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0HQ-01	1121	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-BH-A0HQ			1121	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	56	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-BH-A0HQ-F4795		Positive		3+			Positive	Lumpectomy		YES			-20719	962		0	1121							90-99%					2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	110	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2									0		true	M0	N0 (i+)	T2	Stage IIA	TCGA-BH-A0HQ.A76A272F-675E-4E56-8761-96B71419A012.pdf	1	1	0	0	0	0	0	0	3	0	12	10	85	90	85	90	TUMOR FREE								No	90-99%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2007	TCGA-BH-A0HQ-01A-11W-A050-09	TCGA-BH-A0HQ-01		TCGA-BH-A0HQ-01A-11R-A035-13	TCGA-BH-A0HQ-01A-11W-A050-09		TCGA-BH-A0HQ-01A-11W-A050-09		TCGA-BH-A0HQ-01A-11W-A050-09	856452d1-5480-4921-bf5b-4c6f625a99c0	e84b732c-f8a5-4f4c-933e-ea539fff5d48	TCGA-BH-A0HQ-01A-11D-A036-01	856452d1-5480-4921-bf5b-4c6f625a99c0		TCGA-BH-A0HQ-01	TCGA-BH-A0HQ-01A-11R-A034-07	856452d1-5480-4921-bf5b-4c6f625a99c0	856452d1-5480-4921-bf5b-4c6f625a99c0	TCGA-BH-A0HQ-01A-11D-A036-01	TCGA-BH-A0HQ-01	TCGA-BH-A0HQ-01	TCGA-BH-A0HQ-01A-11D-A032-05	e84b732c-f8a5-4f4c-933e-ea539fff5d48	TCGA-BH-A0HQ-01A-11R-A035-13
TCGA-BH-A0HU-01	Stage IA	52	2	Stage I	392		Positive	FEMALE	Negative	3	1	4	Negative	M0	Negative	N0	392	0	LumB	Luminal B	Positive	Her2	-2	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0HU-01	392	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 4	mutation cluster 4	TCGA-BH-A0HU			392	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	52	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0HU-F4813		Positive		2+			Positive	Lumpectomy		NO			-19216	394		0	392						H-Score 140	40-49%					2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	140	NO	Negative			1	Negative	Peri (6-12 months since last menstrual period)																		2	4									0		true	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0HU.1F35A542-2795-4B1F-A846-7097B442C2D9.pdf	2	1	0	0	3	2	0	0	0	0	17	18	80	80	80	80	TUMOR FREE	H-Score 140			H-Score	H-Score			No	40-49%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2009	TCGA-BH-A0HU-01A-11W-A050-09	TCGA-BH-A0HU-01		TCGA-BH-A0HU-01A-11R-A035-13	TCGA-BH-A0HU-01A-11W-A050-09	1b5d1cb8-6b38-485a-aff3-24213e459637	TCGA-BH-A0HU-01A-11W-A050-09	TCGA-BH-A0HU-01A-21-A13A-20	TCGA-BH-A0HU-01A-11W-A050-09	c3c6bd09-e8ea-45f3-bdd6-e592bfc2b94f	f5222559-bf86-457c-af8d-b14e676ae34c	TCGA-BH-A0HU-01A-11D-A036-01	c3c6bd09-e8ea-45f3-bdd6-e592bfc2b94f		TCGA-BH-A0HU-01	TCGA-BH-A0HU-01A-11R-A034-07	c3c6bd09-e8ea-45f3-bdd6-e592bfc2b94f	c3c6bd09-e8ea-45f3-bdd6-e592bfc2b94f	TCGA-BH-A0HU-01A-11D-A036-01	TCGA-BH-A0HU-01	TCGA-BH-A0HU-01	TCGA-BH-A0HU-01A-11D-A032-05	f5222559-bf86-457c-af8d-b14e676ae34c	TCGA-BH-A0HU-01A-11R-A035-13
TCGA-BH-A0HW-01	Stage IA	62	4	Stage I	1560		Positive	FEMALE	Negative	3	3	4	Negative	M0	Negative	N0	1560	0	LumB	Luminal B	Negative	LumA/B	-10	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0HW-01	1561	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-BH-A0HW			1561	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	62	Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-BH-A0HW-F4827		Positive		0			Negative	Lumpectomy		NO			-22962	1591		0	1561							90-99%					2010-11-16	FEMALE					2+			1.6		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	200	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2									0		true	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0HW.8AC7EF1D-53EB-466B-9C45-A6A7E9DB9CCD.pdf	1	1	0	0	0	3	0	0	0	0	10	7	90	90	90	90	TUMOR FREE								No	<10%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2006	TCGA-BH-A0HW-01A-11W-A050-09	TCGA-BH-A0HW-01		TCGA-BH-A0HW-01A-11R-A035-13	TCGA-BH-A0HW-01A-11W-A050-09	fe1d6a4b-4950-48e6-92fd-7ddc10953a83	TCGA-BH-A0HW-01A-11W-A050-09	TCGA-BH-A0HW-01A-21-A13B-20	TCGA-BH-A0HW-01A-11W-A050-09	0172d30c-287c-4f3e-b70c-5760c6dccb7c	6fa29a88-190a-4394-b84b-8eb6d12f5339	TCGA-BH-A0HW-01A-11D-A036-01	0172d30c-287c-4f3e-b70c-5760c6dccb7c		TCGA-BH-A0HW-01	TCGA-BH-A0HW-01A-11R-A034-07	0172d30c-287c-4f3e-b70c-5760c6dccb7c	0172d30c-287c-4f3e-b70c-5760c6dccb7c	TCGA-BH-A0HW-01A-11D-A036-01	TCGA-BH-A0HW-01	TCGA-BH-A0HW-01	TCGA-BH-A0HW-01A-11D-A032-05	6fa29a88-190a-4394-b84b-8eb6d12f5339	TCGA-BH-A0HW-01A-11R-A035-13
TCGA-BH-A0HX-01	Stage IIB	54	4	No_Conversion	829		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N1	829	0	LumA	Luminal A	Positive	LumA/B	-10	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0HX-01	829	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A0HX			829	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	54	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0HX-F4838		Positive		3+			Positive	Simple Mastectomy		YES			-19900	672		0	829						H-Score 270	80-89%					2010-11-16	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	190	NO	Negative			24	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									2	2	true	M0	N1a	T2	Stage IIB	TCGA-BH-A0HX.8C4FEB77-99B6-4C73-9751-508953A874DC.pdf	4	4	0	0	0	0	0	0	0	0	30	30	70	70	70	70	TUMOR FREE	H-Score 190			H-Score	H-Score			No	50-59%		NO	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2008	TCGA-BH-A0HX-01A-21W-A071-09	TCGA-BH-A0HX-01		TCGA-BH-A0HX-01A-21R-A057-13	TCGA-BH-A0HX-01A-21W-A071-09	a58fd02f-a169-42ee-ab9b-761d00d11179	TCGA-BH-A0HX-01A-21W-A071-09	TCGA-BH-A0HX-01A-11-A13B-20	TCGA-BH-A0HX-01A-21W-A071-09	8bbaef6c-31c4-47a4-8e7b-7e6242d02666	c07a21d6-9aad-41c8-b3fc-ff846239c1fc	TCGA-BH-A0HX-01A-21D-A059-01	8bbaef6c-31c4-47a4-8e7b-7e6242d02666	TCGA-BH-A0HX-01A-21D-A10P-05	TCGA-BH-A0HX-01	TCGA-BH-A0HX-01A-21R-A056-07	8bbaef6c-31c4-47a4-8e7b-7e6242d02666	8bbaef6c-31c4-47a4-8e7b-7e6242d02666	TCGA-BH-A0HX-01A-21D-A059-01	TCGA-BH-A0HX-01	TCGA-BH-A0HX-01		c07a21d6-9aad-41c8-b3fc-ff846239c1fc	TCGA-BH-A0HX-01A-21R-A057-13
TCGA-BH-A0HY-01	Stage I	60		Stage I	867		Positive	FEMALE					Negative	M0	Negative	N0	867	0	LumB	HER2-enriched	Negative	ReacII	-1	-5	enrollment	T1	T1	LIVING	0	TCGA-BH-A0HY-01	1545	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A0HY	1545	0	1545	Breast	TCGA Breast Cancer	breast invasive carcinoma					60	Left			TCGA-BH-A0HY-F43316		Positive					Negative	Other					-22179	470		0	1545					NO						Scheduled Follow-up Submission	2013-5-16	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	150	NO	Positive		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4								NO	0		true	M0	N0	T1c	Stage I	TCGA-BH-A0HY.E57B4989-102F-44FD-8FB2-0627143FA904.pdf	1	3	0	0	0	2	0	0	0	0	10	18	90	80	90	80	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01	Total mastectomy with left sentinel lymph node biospy	6th	YES	NO	YES	BH	Breast	A	LIVING	2009	TCGA-BH-A0HY-01A-11W-A071-09	TCGA-BH-A0HY-01		TCGA-BH-A0HY-01A-11R-A057-13	TCGA-BH-A0HY-01A-11W-A071-09	b5cba62d-f66e-40c7-88c8-0040d3d38607	TCGA-BH-A0HY-01A-11W-A071-09	TCGA-BH-A0HY-01A-21-A13B-20	TCGA-BH-A0HY-01A-11W-A071-09	e074391d-348f-4f95-aad0-7f51c56b9696	4c85d947-2682-480c-bd54-947fa45c14f6	TCGA-BH-A0HY-01A-11D-A059-01	e074391d-348f-4f95-aad0-7f51c56b9696	TCGA-BH-A0HY-01A-11D-A10P-05	TCGA-BH-A0HY-01	TCGA-BH-A0HY-01A-11R-A056-07	e074391d-348f-4f95-aad0-7f51c56b9696	e074391d-348f-4f95-aad0-7f51c56b9696	TCGA-BH-A0HY-01A-11D-A059-01	TCGA-BH-A0HY-01	TCGA-BH-A0HY-01		4c85d947-2682-480c-bd54-947fa45c14f6	TCGA-BH-A0HY-01A-11R-A057-13
TCGA-BH-A0RX-01	Stage IIA	59	4	Stage IIA	170		Negative	FEMALE	Negative	3	2	2	Negative	M0	Negative	N0	170	0	Basal	Basal-like	Negative	ReacII	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-BH-A0RX-01	170	0	High	C4-BRCA/Basal	cluster 5	Low purity c2	KIRC-like c1	BRCA basal-like c8	miRNA cluster 7	cluster 4	mutation cluster 5	TCGA-BH-A0RX			170	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO	NO	59	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-BH-A0RX-F4875		Negative		0			Negative	Lumpectomy		NO			-21857	63		0	170						H-Score 0	<10%					2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	170	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4									0		true	M0	N0 (i-)	T2	Stage IIA	TCGA-BH-A0RX.57359A9F-7E5A-4599-918C-A95DCF0D9479.pdf	3	2	0	0	4	15	2	0	2	0	24	15	70	70	70	70	TUMOR FREE	H-Score 0			H-Score	H-Score			No	<10%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2010	TCGA-BH-A0RX-01A-21D-A099-09	TCGA-BH-A0RX-01		TCGA-BH-A0RX-01A-21R-A085-13	TCGA-BH-A0RX-01A-21D-A099-09	c8d587b3-a3d1-4375-bb94-7208c050421a	TCGA-BH-A0RX-01A-21D-A099-09	TCGA-BH-A0RX-01A-11-A13C-20	TCGA-BH-A0RX-01A-21D-A099-09	5c911cb7-4e7b-4ffd-bd2b-4498ee7b0e88	c73d082f-32bf-4c0f-ac42-1419b5d367be	TCGA-BH-A0RX-01A-21D-A087-01	5c911cb7-4e7b-4ffd-bd2b-4498ee7b0e88	TCGA-BH-A0RX-01A-21D-A10P-05	TCGA-BH-A0RX-01	TCGA-BH-A0RX-01A-21R-A084-07	5c911cb7-4e7b-4ffd-bd2b-4498ee7b0e88	5c911cb7-4e7b-4ffd-bd2b-4498ee7b0e88	TCGA-BH-A0RX-01A-21D-A087-01	TCGA-BH-A0RX-01	TCGA-BH-A0RX-01		c73d082f-32bf-4c0f-ac42-1419b5d367be	TCGA-BH-A0RX-01A-21R-A085-13
TCGA-BH-A0W3-01	Stage IIA	58	2	No_Conversion	180		Positive	FEMALE	Negative				Negative	M0	Positive	N1	180	0	LumB	Luminal B	Positive		-12	-3	enrollment	T1	T1	LIVING	0	TCGA-BH-A0W3-01	728	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 4	TCGA-BH-A0W3	728	0	728	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Left Upper Inner Quadrant			TCGA-BH-A0W3-F34065		Positive					Positive	Other					-21369	85		0	728											Scheduled Follow-up Submission	2012-7-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Equivocal	Negative		4		Indeterminate (neither Pre or Postmenopausal)																		2	5								NO	1	1	true	M0	N1a	T1c	Stage IIA	TCGA-BH-A0W3.801A4E2F-E26E-424F-BF42-CD0D9CD62BCE.pdf	0	0	0	0	0	0	0	0	0	0	30	30	70	70	85	80	TUMOR FREE								No			YES	Primary Tumor	01	Segmental mastectomy	7th	NO	NO	YES	BH	Breast	A	LIVING	2010	TCGA-BH-A0W3-01A-11D-A10G-09	TCGA-BH-A0W3-01		TCGA-BH-A0W3-01A-11R-A108-13	TCGA-BH-A0W3-01A-11D-A10G-09		TCGA-BH-A0W3-01A-11D-A10G-09		TCGA-BH-A0W3-01A-11D-A10G-09	0def3ef8-7608-483c-b899-4d459f6d2e2d	6b6c28fb-84ba-407c-9317-3fad63e9e35d	TCGA-BH-A0W3-01A-11D-A107-01	0def3ef8-7608-483c-b899-4d459f6d2e2d	TCGA-BH-A0W3-01A-11D-A10A-05	TCGA-BH-A0W3-01	TCGA-BH-A0W3-01A-11R-A109-07	0def3ef8-7608-483c-b899-4d459f6d2e2d	0def3ef8-7608-483c-b899-4d459f6d2e2d	TCGA-BH-A0W3-01A-11D-A107-01	TCGA-BH-A0W3-01	TCGA-BH-A0W3-01		6b6c28fb-84ba-407c-9317-3fad63e9e35d	TCGA-BH-A0W3-01A-11R-A108-13
TCGA-BH-A0W4-01	Stage IIA	46	2	Stage IIA	175		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	175	0	LumA	Luminal A	Positive	LumA	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0W4-01	759	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-BH-A0W4	759	0	759	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Left Upper Outer Quadrant			TCGA-BH-A0W4-F34069		Positive					Positive	Other					-16911	119		0	759											Scheduled Follow-up Submission	2012-7-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO	Negative			3																				2	4								NO			true	M0	N0 (i-)	T2	Stage IIA	TCGA-BH-A0W4.0C158269-A420-4E71-9E59-8775FB26084B.pdf	2	2	1	1	0	0	1	1	0	0	25	25	75	75	75	75	TUMOR FREE								No			NO	Primary Tumor	01	Total mastectomy	7th	NO	NO	YES	BH	Breast	A	LIVING	2010	TCGA-BH-A0W4-01A-11D-A10G-09	TCGA-BH-A0W4-01		TCGA-BH-A0W4-01A-11R-A108-13	TCGA-BH-A0W4-01A-11D-A10G-09	6a26c8ad-e0f9-44a9-9039-983f6771a989	TCGA-BH-A0W4-01A-11D-A10G-09	TCGA-BH-A0W4-01A-21-A13D-20	TCGA-BH-A0W4-01A-11D-A10G-09	750469b2-05c7-4647-b101-cdd94246d254	5256eab2-28f3-467a-a26d-9da6d612ed5b	TCGA-BH-A0W4-01A-11D-A107-01	750469b2-05c7-4647-b101-cdd94246d254	TCGA-BH-A0W4-01A-11D-A10A-05	TCGA-BH-A0W4-01	TCGA-BH-A0W4-01A-11R-A109-07	750469b2-05c7-4647-b101-cdd94246d254	750469b2-05c7-4647-b101-cdd94246d254	TCGA-BH-A0W4-01A-11D-A107-01	TCGA-BH-A0W4-01	TCGA-BH-A0W4-01		5256eab2-28f3-467a-a26d-9da6d612ed5b	TCGA-BH-A0W4-01A-11R-A108-13
TCGA-BH-A0W5-01	Stage IIA	77	4	No_Conversion	543		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N1	543	0	LumA	Luminal A	Positive	LumA	-5	-4	enrollment	T1	T1	LIVING	0	TCGA-BH-A0W5-01	1288	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 4	mutation cluster 4	TCGA-BH-A0W5	1288	0	1288	Breast	TCGA Breast Cancer	breast invasive carcinoma					77	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0W5-F34070		Positive					Positive	Other					-28304	906		0	1288											Scheduled Follow-up Submission	2012-7-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	80	NO	Equivocal	Equivocal		11	Negative																			1	4								NO	1	1	true	M0	N1a	T1c	Stage IIA	TCGA-BH-A0W5.60F59595-928B-43BB-978F-9E5B48539EFA.pdf	100	100	0	0	0	0	0	0	15	5	25	15	60	80	80	70	TUMOR FREE								No			YES	Primary Tumor	01	segmental mastectomy	6th	YES	NO	YES	BH	Breast	A	LIVING	2008	TCGA-BH-A0W5-01A-11D-A10G-09	TCGA-BH-A0W5-01		TCGA-BH-A0W5-01A-11R-A108-13	TCGA-BH-A0W5-01A-11D-A10G-09	ef0f5ff2-5b71-45fa-9036-b5dfc63510aa	TCGA-BH-A0W5-01A-11D-A10G-09	TCGA-BH-A0W5-01A-21-A13D-20	TCGA-BH-A0W5-01A-11D-A10G-09	91e55e6f-b884-4112-8d3f-a9f8974dd63b	c2056ecb-78f2-4bc7-8954-030007e428dc	TCGA-BH-A0W5-01A-11D-A107-01	91e55e6f-b884-4112-8d3f-a9f8974dd63b	TCGA-BH-A0W5-01A-11D-A10A-05	TCGA-BH-A0W5-01	TCGA-BH-A0W5-01A-11R-A109-07	91e55e6f-b884-4112-8d3f-a9f8974dd63b	91e55e6f-b884-4112-8d3f-a9f8974dd63b	TCGA-BH-A0W5-01A-11D-A107-01	TCGA-BH-A0W5-01	TCGA-BH-A0W5-01		c2056ecb-78f2-4bc7-8954-030007e428dc	TCGA-BH-A0W5-01A-11R-A108-13
TCGA-BH-A0W7-01	Stage IA	49	4	Stage I	558		Positive	FEMALE	Negative				Negative	M0	Negative	N0	558	0	LumA	Luminal A	Positive		-4	-4	enrollment	T1	T1	LIVING	0	TCGA-BH-A0W7-01	1363	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-BH-A0W7	1363	0	1363	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-BH-A0W7-F34073		Positive					Positive	Other					-17996			0	1363											Scheduled Follow-up Submission	2012-7-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative			2	Negative																			1	4								NO	0	0		M0	N0 (i-)	T1c	Stage I																		TUMOR FREE								No			YES	Primary Tumor	01	segmental mastectomy	6th	YES	NO	YES	BH	Breast		LIVING	2008	TCGA-BH-A0W7-01A-11D-A10Y-09	TCGA-BH-A0W7-01	TCGA-BH-A0W7-01A-11R-A114-13	TCGA-BH-A0W7-01A-11R-A114-13	TCGA-BH-A0W7-01A-11D-A10Y-09		TCGA-BH-A0W7-01A-11D-A10Y-09		TCGA-BH-A0W7-01A-11D-A10Y-09	afaeb45f-d795-4fe0-b4ee-5b90816e6427	a9266ff7-8563-45b1-914f-0855ecb4cddd	TCGA-BH-A0W7-01A-11D-A111-01	afaeb45f-d795-4fe0-b4ee-5b90816e6427		TCGA-BH-A0W7-01	TCGA-BH-A0W7-01A-11R-A115-07	afaeb45f-d795-4fe0-b4ee-5b90816e6427	afaeb45f-d795-4fe0-b4ee-5b90816e6427	TCGA-BH-A0W7-01A-11D-A111-01	TCGA-BH-A0W7-01	TCGA-BH-A0W7-01	TCGA-BH-A0W7-01A-11D-A112-05	a9266ff7-8563-45b1-914f-0855ecb4cddd	
TCGA-BH-A0WA-01	Stage IA	82	1	Stage I	372		Negative	FEMALE	Negative				Negative	M0	Negative	N0	372	0	Basal	Basal-like	Negative		-13	-12	enrollment	T1	T1	LIVING	0	TCGA-BH-A0WA-01	701	0	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-BH-A0WA	701	0	701	Breast	TCGA Breast Cancer	breast invasive carcinoma					82	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-BH-A0WA-F34068		Negative					Negative	Other					-30025	724		0	701											Scheduled Follow-up Submission	2012-7-29	FEMALE												No		C50.9	8575/3	C50.9		YES		Fine needle aspiration biopsy	80	NO	Negative			3	Negative																			5	5								NO	0		true	M0	N0 (i-)	T1c	Stage I	TCGA-BH-A0WA.87E28DAE-5012-4A16-BE27-A9F0F3F30F5B.pdf	0	0	0	0	5	8	0	0	0	0	20	17	75	75	90	90	TUMOR FREE								No			NO	Primary Tumor	01	segmental mastectomy	6th	NO	NO	YES	BH	Breast	A	LIVING	2008	TCGA-BH-A0WA-01A-11D-A10G-09	TCGA-BH-A0WA-01		TCGA-BH-A0WA-01A-11R-A108-13	TCGA-BH-A0WA-01A-11D-A10G-09		TCGA-BH-A0WA-01A-11D-A10G-09		TCGA-BH-A0WA-01A-11D-A10G-09,TCGA-BH-A0WA-01A-11D-A128-09	519e1ea1-6658-4978-9f3d-313d7cc1e0c1	35001085-6428-46a2-a1c7-a45970cac84f	TCGA-BH-A0WA-01A-11D-A107-01	519e1ea1-6658-4978-9f3d-313d7cc1e0c1	TCGA-BH-A0WA-01A-11D-A10A-05	TCGA-BH-A0WA-01	TCGA-BH-A0WA-01A-11R-A109-07	519e1ea1-6658-4978-9f3d-313d7cc1e0c1	519e1ea1-6658-4978-9f3d-313d7cc1e0c1	TCGA-BH-A0WA-01A-11D-A107-01	TCGA-BH-A0WA-01	TCGA-BH-A0WA-01		35001085-6428-46a2-a1c7-a45970cac84f	TCGA-BH-A0WA-01A-11R-A108-13
TCGA-BH-A18F-01	Stage IIA	50	2	Stage IIA	268		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	268	0	LumA	Luminal B	Positive	ReacI	-4	-7	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A18F-01	268	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 6	mutation cluster 4	TCGA-BH-A18F			268	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Right Lower Outer Quadrant	Sentinel node biopsy alone				Positive	3 Point Scale	3+	3 Point Scale		Positive	Other					-18594	114		0	268							70-79%					2011-6-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	200	NO	Negative			1	Negative	Peri (6-12 months since last menstrual period)																		1	6									0		true	M0	N0	T2	Stage IIA	TCGA-BH-A18F.771497E1-473E-421A-A149-CFA58E95B728.pdf		3		0		1		0		3		41		55		70	TUMOR FREE							YES	No	40-49%			Primary Tumor	01	needle localized segmental mastectomy	7th		NO	YES	BH	Breast	A	LIVING	2010	TCGA-BH-A18F-01A-11D-A12B-09	TCGA-BH-A18F-01	TCGA-BH-A18F-01A-11R-A12C-13	TCGA-BH-A18F-01A-11R-A12C-13	TCGA-BH-A18F-01A-11D-A12B-09	90367af6-b44b-46f1-9482-c1ddc1bc42e6	TCGA-BH-A18F-01A-11D-A12B-09	TCGA-BH-A18F-01A-21-A13F-20	TCGA-BH-A18F-01A-11D-A12B-09	eed6d177-6cec-493a-b811-1779bebae72a	df0ea333-0f5a-4da4-9242-f74a28e6a9ac	TCGA-BH-A18F-01A-11D-A12A-01	eed6d177-6cec-493a-b811-1779bebae72a		TCGA-BH-A18F-01	TCGA-BH-A18F-01A-11R-A12D-07	eed6d177-6cec-493a-b811-1779bebae72a	eed6d177-6cec-493a-b811-1779bebae72a	TCGA-BH-A18F-01A-11D-A12A-01	TCGA-BH-A18F-01	TCGA-BH-A18F-01	TCGA-BH-A18F-01A-11D-A12E-05	df0ea333-0f5a-4da4-9242-f74a28e6a9ac	
TCGA-BH-A18F-11		50			268			FEMALE									268	0							enrollment			LIVING	0	TCGA-BH-A18F-11	268	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A18F			268	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Right Lower Outer Quadrant	Sentinel node biopsy alone				Positive	3 Point Scale	3+	3 Point Scale		Positive	Other					-18594	114		0	268							70-79%					2011-6-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	190	NO	Negative			1	Negative	Peri (6-12 months since last menstrual period)																												0		true	M0	N0	T2	Stage IIA			1		0		0		0		5		95		0		0	TUMOR FREE							YES	No	40-49%			Solid Tissue Normal	11	needle localized segmental mastectomy	7th		NO	YES	BH	Breast	A	LIVING	2010																						TCGA-BH-A18F-11A-22D-A12E-05		
TCGA-BH-A18G-01	Stage X	81	3	No_Conversion	61		Negative	FEMALE	Negative				Negative	M0	Negative	N0	61	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T1	T1	LIVING	0	TCGA-BH-A18G-01	61	0	Iq	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4		TCGA-BH-A18G			61	Breast	TCGA Breast Cancer	breast invasive carcinoma					81	Right	Sentinel lymph node biopsy plus axillary dissection				Negative					Negative	Other					-29820	78		0	61												2011-6-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.5	8500/3	C50.5		YES		Core needle biopsy	100	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									0		true	M0	N0	T1c	Stage IA	TCGA-BH-A18G.7C92F144-4A84-4D9E-8A35-C059FD082150.pdf		0		0		0		0		0		5		95		90								YES	No				Primary Tumor	01	right segmental mastectomy			NO	YES	BH	Breast	A	LIVING	2010		TCGA-BH-A18G-01	TCGA-BH-A18G-01A-11R-A12C-13	TCGA-BH-A18G-01A-11R-A12C-13		7deb8368-b91a-4e0e-bd5c-5b6c93f12d8a	TCGA-BH-A18G-01A-11D-A12B-09	TCGA-BH-A18G-01A-21-A13F-20		a8a7a335-8e21-4f24-b48b-8764caa21329	ee9101bf-b45d-41d3-bc63-16d9ca91e714	TCGA-BH-A18G-01A-11D-A12A-01	a8a7a335-8e21-4f24-b48b-8764caa21329		TCGA-BH-A18G-01	TCGA-BH-A18G-01A-11R-A12D-07	a8a7a335-8e21-4f24-b48b-8764caa21329	a8a7a335-8e21-4f24-b48b-8764caa21329	TCGA-BH-A18G-01A-11D-A12A-01	TCGA-BH-A18G-01	TCGA-BH-A18G-01	TCGA-BH-A18G-01A-11D-A12E-05	ee9101bf-b45d-41d3-bc63-16d9ca91e714	
TCGA-BH-A18H-01	Stage IB	63	3	Stage I	0		Positive	FEMALE	Negative	3	1	3	Negative	M0	Negative	N0	0	0	LumA	Luminal A	Positive	LumA/B	-2	-5	enrollment	T1	T1	LIVING		TCGA-BH-A18H-01			High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 3	TCGA-BH-A18H				Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection				Positive					Positive	Other		YES			-23065	16		0	0												2011-6-6	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	80	NO	Positive	Equivocal		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6									0		true	M0	N0	T1b	Stage IA	TCGA-BH-A18H.DF536409-601F-489B-9F8A-A2B372BF9999.pdf		10		0		10		0		5		35		50		60								YES	No				Primary Tumor	01	segmental mastectomy	7th		NO	YES	BH	Breast	A	LIVING	2010	TCGA-BH-A18H-01A-11D-A12B-09	TCGA-BH-A18H-01	TCGA-BH-A18H-01A-11R-A12C-13	TCGA-BH-A18H-01A-11R-A12C-13	TCGA-BH-A18H-01A-11D-A12B-09	d378a15a-1276-482a-b924-87df01d062f2	TCGA-BH-A18H-01A-11D-A12B-09	TCGA-BH-A18H-01A-21-A13F-20	TCGA-BH-A18H-01A-11D-A12B-09	7bc7f99c-28d4-4b54-b9bd-53d5de00cab7	cdcbf3a0-b1eb-4a63-b669-f7a6438c6902	TCGA-BH-A18H-01A-11D-A12A-01	7bc7f99c-28d4-4b54-b9bd-53d5de00cab7		TCGA-BH-A18H-01	TCGA-BH-A18H-01A-11R-A12D-07	7bc7f99c-28d4-4b54-b9bd-53d5de00cab7	7bc7f99c-28d4-4b54-b9bd-53d5de00cab7	TCGA-BH-A18H-01A-11D-A12A-01	TCGA-BH-A18H-01	TCGA-BH-A18H-01	TCGA-BH-A18H-01A-11D-A12E-05	cdcbf3a0-b1eb-4a63-b669-f7a6438c6902	
TCGA-BH-A18I-01	Stage IIA	53	4	Stage IIA	220		Positive	FEMALE	Negative				Negative	M0	Positive	N1	220	0	LumA	Luminal A	Positive		-5	-4	enrollment	T1	T1	LIVING	0	TCGA-BH-A18I-01	220	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-BH-A18I			220	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Left Upper Outer Quadrant	Sentinel node biopsy alone			Negative	Positive				Modified radical mastectomy	Positive	Other					-19489	80		0	220												2011-6-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.2	8500/3	C50.2		YES		Core needle biopsy	100	NO	Positive			3	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4									1	1	true	cM0 (i+)	N1a	T1c	Stage IIA	TCGA-BH-A18I.01E8D241-C303-47FA-B484-B800D580B34C.pdf		0		0		0		0		0		10		90		80	TUMOR FREE				H score	H score		YES	No				Primary Tumor	01	segmental mastectomy	7th		NO	YES	BH	Breast	A	LIVING	2010	TCGA-BH-A18I-01A-11D-A12B-09	TCGA-BH-A18I-01	TCGA-BH-A18I-01A-11R-A12C-13	TCGA-BH-A18I-01A-11R-A12C-13	TCGA-BH-A18I-01A-11D-A12B-09		TCGA-BH-A18I-01A-11D-A12B-09		TCGA-BH-A18I-01A-11D-A12B-09	844b3442-a740-4cb4-a1fb-b481c552cc88	aa8b87f4-9e6b-4da1-9942-1b2c86f3fcc0	TCGA-BH-A18I-01A-11D-A12A-01	844b3442-a740-4cb4-a1fb-b481c552cc88		TCGA-BH-A18I-01	TCGA-BH-A18I-01A-11R-A12D-07	844b3442-a740-4cb4-a1fb-b481c552cc88	844b3442-a740-4cb4-a1fb-b481c552cc88	TCGA-BH-A18I-01A-11D-A12A-01	TCGA-BH-A18I-01	TCGA-BH-A18I-01	TCGA-BH-A18I-01A-11D-A12E-05	aa8b87f4-9e6b-4da1-9942-1b2c86f3fcc0	
TCGA-BH-A18J-01	Stage IV	56	2	No_Conversion	611	611	Positive	FEMALE	Negative	3	3	4	Positive	M1	Positive	N2	611	1	LumA	Luminal B	Positive	ReacII	-1	-3	enrollment	T_Other	T4	DECEASED	1	TCGA-BH-A18J-01	612	1	Squamous	C3-BRCA/Luminal	cluster 1	Cluster 5	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-BH-A18J			612	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Right					Positive					Positive	Modified Radical Mastectomy					-20678	3948	612	0						YES		40-49%	Bone				2011-6-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			640	NO	Negative				Negative			Negative			Positive								Negative				Positive	1	4											true	M1	N2	T4b	Stage IV	TCGA-BH-A18J.589BC4DD-0079-4106-A2E6-9A48E9BD7DE2.pdf		0		0		0		0		0		60		40		70	WITH TUMOR								No	30-39%			Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	2000	TCGA-BH-A18J-01A-11D-A12B-09	TCGA-BH-A18J-01	TCGA-BH-A18J-01A-11R-A12C-13	TCGA-BH-A18J-01A-11R-A12C-13	TCGA-BH-A18J-01A-11D-A12B-09	dd4097f7-8330-42c3-aa6f-dd289837f65e	TCGA-BH-A18J-01A-11D-A12B-09	TCGA-BH-A18J-01A-21-A13E-20	TCGA-BH-A18J-01A-11D-A12B-09	56d889ba-6484-4940-ae85-1373ce4255b9	eedb1e37-42d4-42d9-987f-e52dee3150e2	TCGA-BH-A18J-01A-11D-A12A-01	56d889ba-6484-4940-ae85-1373ce4255b9		TCGA-BH-A18J-01	TCGA-BH-A18J-01A-11R-A12D-07	56d889ba-6484-4940-ae85-1373ce4255b9	56d889ba-6484-4940-ae85-1373ce4255b9	TCGA-BH-A18J-01A-11D-A12A-01	TCGA-BH-A18J-01	TCGA-BH-A18J-01	TCGA-BH-A18J-01A-11D-A12E-05	eedb1e37-42d4-42d9-987f-e52dee3150e2	
TCGA-BH-A18J-11		56			611	611		FEMALE									611	1	Normal						enrollment			DECEASED	1	TCGA-BH-A18J-11	612	1		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A18J			612	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Right					Positive					Positive	Modified Radical Mastectomy					-20678	3948	612	0						YES		40-49%	Bone				2011-6-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			230	NO	Negative				Negative			Negative			Positive								Negative				Positive													true	M1	N2	T4b	Stage IV			0		0		0		0		100		0		0		0	WITH TUMOR								No	30-39%			Solid Tissue Normal	11		5th		NO	YES	BH	Breast	A	DECEASED	2000			TCGA-BH-A18J-11A-31R-A12C-13	TCGA-BH-A18J-11A-31R-A12C-13						9fa440b0-6e8d-4c48-a425-50abc2682f6e			9fa440b0-6e8d-4c48-a425-50abc2682f6e			TCGA-BH-A18J-11A-31R-A12D-07	9fa440b0-6e8d-4c48-a425-50abc2682f6e	9fa440b0-6e8d-4c48-a425-50abc2682f6e				TCGA-BH-A18J-11A-31D-A12E-05		
TCGA-BH-A18K-01	Stage I	46	2	Stage I	2547	2762	Positive	FEMALE	Negative				Negative	M0	Negative	N0	2762	1	LumA	Basal-like	Positive		-13	-12	enrollment	T1	T1	DECEASED	1	TCGA-BH-A18K-01	2763	1	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 2	cluster 5	mutation cluster 4	TCGA-BH-A18K			2763	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection				Positive					Positive	Other					-16824	4011	2763	0						NO							2011-6-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	100	NO	Negative			11	Negative																			2	5									0		true	M0	N0	T1	Stage I	TCGA-BH-A18K.EEB515A4-4AF3-475B-B6C0-A6134C96480A.pdf		0		0		0		0		10		10		80		80	WITH TUMOR							YES	No				Primary Tumor	01	segmental mastectomy with axillary dissection	5th		NO	YES	BH	Breast	A	DECEASED	1999	TCGA-BH-A18K-01A-11D-A12B-09	TCGA-BH-A18K-01	TCGA-BH-A18K-01A-11R-A12C-13	TCGA-BH-A18K-01A-11R-A12C-13	TCGA-BH-A18K-01A-11D-A12B-09		TCGA-BH-A18K-01A-11D-A12B-09		TCGA-BH-A18K-01A-11D-A12B-09	78e00469-0dd6-490e-93f1-068b9a386839	c6914b68-40d4-4f98-ae22-92a713b29df3	TCGA-BH-A18K-01A-11D-A12A-01	78e00469-0dd6-490e-93f1-068b9a386839		TCGA-BH-A18K-01	TCGA-BH-A18K-01A-11R-A12D-07	78e00469-0dd6-490e-93f1-068b9a386839	78e00469-0dd6-490e-93f1-068b9a386839	TCGA-BH-A18K-01A-11D-A12A-01	TCGA-BH-A18K-01	TCGA-BH-A18K-01	TCGA-BH-A18K-01A-11D-A12E-05	c6914b68-40d4-4f98-ae22-92a713b29df3	
TCGA-BH-A18K-11		46			2547	2762		FEMALE									2762	1	Normal						enrollment			DECEASED	1	TCGA-BH-A18K-11	2763	1		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A18K			2763	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection				Positive					Positive	Other					-16824	4011	2763	0						NO							2011-6-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO	Negative			11	Negative																													0		true	M0	N0	T1	Stage I			0		0		0		0		100		0		0		0	WITH TUMOR							YES	No				Solid Tissue Normal	11	segmental mastectomy with axillary dissection	5th		NO	YES	BH	Breast	A	DECEASED	1999			TCGA-BH-A18K-11A-13R-A12C-13	TCGA-BH-A18K-11A-13R-A12C-13						dc55c016-0e33-46b0-ac5e-f854c667a378			dc55c016-0e33-46b0-ac5e-f854c667a378			TCGA-BH-A18K-11A-13R-A12D-07	dc55c016-0e33-46b0-ac5e-f854c667a378	dc55c016-0e33-46b0-ac5e-f854c667a378				TCGA-BH-A18K-11A-13D-A12E-05		
TCGA-BH-A18L-01	Stage IIB	50	5	Stage IIIA	372	811	Positive	FEMALE		1	1	4	Negative	M0	Positive	N1	811	1	LumB	Luminal B	Positive	ReacII	-10	-5	enrollment	T_Other	T3	DECEASED	1	TCGA-BH-A18L-01	811	1	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-BH-A18L			811	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Left Upper Outer Quadrant	Sentinel node biopsy alone				Positive					Positive	Other					-18519		811	0						NO							2011-6-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative			3	Negative																			4	1									1	1		M0	N1mi	T3	Stage IIIA																									YES	No				Primary Tumor	01	total mastectomy and sentinel node biopsy	6th		NO	YES	BH	Breast		DECEASED	2003	TCGA-BH-A18L-01A-32D-A12B-09	TCGA-BH-A18L-01	TCGA-BH-A18L-01A-32R-A12C-13	TCGA-BH-A18L-01A-32R-A12C-13	TCGA-BH-A18L-01A-32D-A12B-09	ede8d4b2-4cfd-4f4f-a11f-3269c0ba7661	TCGA-BH-A18L-01A-32D-A12B-09	TCGA-BH-A18L-01A-21-A13F-20	TCGA-BH-A18L-01A-32D-A12B-09	c3604281-d909-4819-a90e-a1081b1e9d7f	d814b694-f289-4784-bf97-2d21aef93e18	TCGA-BH-A18L-01A-32D-A12A-01	c3604281-d909-4819-a90e-a1081b1e9d7f		TCGA-BH-A18L-01	TCGA-BH-A18L-01A-32R-A12D-07	c3604281-d909-4819-a90e-a1081b1e9d7f	c3604281-d909-4819-a90e-a1081b1e9d7f	TCGA-BH-A18L-01A-32D-A12A-01	TCGA-BH-A18L-01	TCGA-BH-A18L-01	TCGA-BH-A18L-01A-32D-A12E-05	d814b694-f289-4784-bf97-2d21aef93e18	
TCGA-BH-A18L-11		50			372	811		FEMALE									811	1	Normal						enrollment			DECEASED	1	TCGA-BH-A18L-11	811	1		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A18L			811	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Left Upper Outer Quadrant	Sentinel node biopsy alone				Positive					Positive	Other					-18519	2669	811	0						NO							2011-6-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	530	NO	Negative			3	Negative																													1	1	true	M0	N1mi	T3	Stage IIIA			0		0		0		0		5		95		0		0								YES	No				Solid Tissue Normal	11	total mastectomy and sentinel node biopsy	6th		NO	YES	BH	Breast	A	DECEASED	2003			TCGA-BH-A18L-11A-42R-A12C-13	TCGA-BH-A18L-11A-42R-A12C-13						0b937a20-66d4-4d05-bf50-4828cead9c92			0b937a20-66d4-4d05-bf50-4828cead9c92			TCGA-BH-A18L-11A-42R-A12D-07	0b937a20-66d4-4d05-bf50-4828cead9c92	0b937a20-66d4-4d05-bf50-4828cead9c92				TCGA-BH-A18L-11A-42D-A12E-05		
TCGA-BH-A18M-01	Stage IIB	39	2	Stage IIIA	2207	2207	Positive	FEMALE	Positive	3	4	3	Negative	M0	Positive	N1	2207	1	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T_Other	T3	DECEASED	1	TCGA-BH-A18M-01	2207	1	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-BH-A18M			2207	Breast	TCGA Breast Cancer	breast invasive carcinoma					39	Left Upper Inner Quadrant					Positive					Positive	Modified Radical Mastectomy					-14532	3629	2207	0						NO							2011-6-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.3	8500/3	C50.3		YES		Core needle biopsy	360	NO	Positive	Positive		6	Negative																			1	6									4	4	true	M0	N1	T3	Stage IIIA	TCGA-BH-A18M.4F67B7BE-68C1-40E1-8276-2D26B46C744D.pdf		1		0		1		0		5		29		65		85								YES	No				Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	2001	TCGA-BH-A18M-01A-11D-A12B-09	TCGA-BH-A18M-01	TCGA-BH-A18M-01A-11R-A12C-13	TCGA-BH-A18M-01A-11R-A12C-13	TCGA-BH-A18M-01A-11D-A12B-09	1d42bf05-8579-448e-bb82-e07aa1c93c97	TCGA-BH-A18M-01A-11D-A12B-09	TCGA-BH-A18M-01A-21-A13E-20	TCGA-BH-A18M-01A-11D-A12B-09	4dfbdec6-1911-412c-9873-f6782ab8ff66	c642e766-98e7-4ea8-907a-8390e7425df2	TCGA-BH-A18M-01A-11D-A12A-01	4dfbdec6-1911-412c-9873-f6782ab8ff66		TCGA-BH-A18M-01	TCGA-BH-A18M-01A-11R-A12D-07	4dfbdec6-1911-412c-9873-f6782ab8ff66	4dfbdec6-1911-412c-9873-f6782ab8ff66	TCGA-BH-A18M-01A-11D-A12A-01	TCGA-BH-A18M-01	TCGA-BH-A18M-01	TCGA-BH-A18M-01A-11D-A12E-05	c642e766-98e7-4ea8-907a-8390e7425df2	
TCGA-BH-A18M-11		39			2207	2207		FEMALE									2207	1	Normal						enrollment			DECEASED	1	TCGA-BH-A18M-11	2207	1		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A18M			2207	Breast	TCGA Breast Cancer	breast invasive carcinoma					39	Left Upper Inner Quadrant					Positive					Positive	Modified Radical Mastectomy					-14532	3629	2207	0						NO							2011-6-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.3	8500/3	C50.3		YES		Core needle biopsy	310	NO	Positive	Positive		6	Negative																													4	4	true	M0	N1	T3	Stage IIIA			1		0		0		0		15		85		0		0								YES	No				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	A	DECEASED	2001			TCGA-BH-A18M-11A-33R-A12C-13	TCGA-BH-A18M-11A-33R-A12C-13						2147e537-16f0-4bc3-a87f-572f8dcb9191			2147e537-16f0-4bc3-a87f-572f8dcb9191			TCGA-BH-A18M-11A-33R-A12D-07	2147e537-16f0-4bc3-a87f-572f8dcb9191	2147e537-16f0-4bc3-a87f-572f8dcb9191				TCGA-BH-A18M-11A-33D-A12E-05		
TCGA-BH-A18N-01	Stage IIA	88	3	No_Conversion	1148	1148	Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	1148	1	LumA	Luminal A	Positive	LumA	-12	-3	enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A18N-01	1148	1	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation c1uster 9	TCGA-BH-A18N			1148	Breast	TCGA Breast Cancer	breast invasive carcinoma					88	Left	Axillary lymph node dissection alone		TCGA-BH-A18N-F59153		Positive					Positive	Modified Radical Mastectomy					-32404	3374	1148	0						NO							2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	350	NO	Negative		NO	26	Negative																			2	6									2	2	true	M0	N1b	T2	Stage IIA	TCGA-BH-A18N.60E8A9CF-3E2D-4E36-947D-448BA27C6561.pdf		2		0		0		0		2		23		75		90							NO	YES	No			NO	Primary Tumor	01				NO	YES	BH	Breast	A	DECEASED	2001	TCGA-BH-A18N-01A-11D-A12B-09	TCGA-BH-A18N-01	TCGA-BH-A18N-01A-11R-A12C-13	TCGA-BH-A18N-01A-11R-A12C-13		f3320803-e927-4d94-aafa-5bc8cef352f9	TCGA-BH-A18N-01A-11D-A12B-09	TCGA-BH-A18N-01A-21-A13E-20	TCGA-BH-A18N-01A-11D-A12B-09	a8884443-832f-45bb-96a0-dead699cc7e3	40ef83f0-cb32-4191-a440-3fcc76d1148f	TCGA-BH-A18N-01A-11D-A12A-01	a8884443-832f-45bb-96a0-dead699cc7e3		TCGA-BH-A18N-01	TCGA-BH-A18N-01A-11R-A12D-07	a8884443-832f-45bb-96a0-dead699cc7e3	a8884443-832f-45bb-96a0-dead699cc7e3	TCGA-BH-A18N-01A-11D-A12A-01	TCGA-BH-A18N-01	TCGA-BH-A18N-01	TCGA-BH-A18N-01A-11D-A12E-05	40ef83f0-cb32-4191-a440-3fcc76d1148f	
TCGA-BH-A18N-11		88			1148	1148		FEMALE									1148	1	Normal						enrollment			DECEASED	1	TCGA-BH-A18N-11	1148	1		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A18N			1148	Breast	TCGA Breast Cancer	breast invasive carcinoma					88	Left	Axillary lymph node dissection alone		TCGA-BH-A18N-F59153		Positive					Positive	Modified Radical Mastectomy					-32404	3374	1148	0						NO							2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	590	NO	Negative		NO	26	Negative																													2	2	true	M0	N1b	T2	Stage IIA											100				0									NO	YES	No			NO	Solid Tissue Normal	11				NO	YES	BH	Breast	A	DECEASED	2001			TCGA-BH-A18N-11A-43R-A12C-13	TCGA-BH-A18N-11A-43R-A12C-13						d40f0f2c-4acf-4ea6-b344-1eca23f50fa6			d40f0f2c-4acf-4ea6-b344-1eca23f50fa6			TCGA-BH-A18N-11A-43R-A12D-07	d40f0f2c-4acf-4ea6-b344-1eca23f50fa6	d40f0f2c-4acf-4ea6-b344-1eca23f50fa6				TCGA-BH-A18N-11A-43D-A12E-05		
TCGA-BH-A18P-01	Stage I	60	2	Stage I	921	921	Positive	FEMALE	Negative	1	3	1	Negative	M0	Negative	N0	921	1	Her2	HER2-enriched	Negative	X	-1	-1	enrollment	T1	T1	DECEASED	1	TCGA-BH-A18P-01	921	1	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 4	TCGA-BH-A18P			921	Breast	TCGA Breast Cancer	breast invasive carcinoma					60	Left Lower Inner Quadrant	Sentinel node biopsy alone				Positive					Negative	Simple Mastectomy					-22222	2639	921	0								<10%					2011-6-22	FEMALE			10-19%		2+					Infiltrating Ductal Carcinoma		No		C50.3	8500/3	C50.3	1+	YES		Fine needle aspiration biopsy	230	NO	Positive	Positive		2	Negative																			4	5									0		true	M0	N0	T1	Stage I	TCGA-BH-A18P.D24BB508-6E9A-4CF7-93C6-975E79F6E86D.pdf		0		0		0		0		5		15		80		70	WITH TUMOR							YES	No				Primary Tumor	01		6th		NO	YES	BH	Breast	A	DECEASED	2003	TCGA-BH-A18P-01A-11D-A12B-09	TCGA-BH-A18P-01	TCGA-BH-A18P-01A-11R-A12C-13	TCGA-BH-A18P-01A-11R-A12C-13		dc104da8-075e-46cb-b43b-d1c5bda730d3	TCGA-BH-A18P-01A-11D-A12B-09	TCGA-BH-A18P-01A-21-A13F-20	TCGA-BH-A18P-01A-11D-A12B-09	3b48796b-8591-4d7a-a502-5c4293647156	f73ccb89-b952-40ab-ad9f-f817102cd1ca	TCGA-BH-A18P-01A-11D-A12A-01	3b48796b-8591-4d7a-a502-5c4293647156		TCGA-BH-A18P-01	TCGA-BH-A18P-01A-11R-A12D-07	3b48796b-8591-4d7a-a502-5c4293647156	3b48796b-8591-4d7a-a502-5c4293647156	TCGA-BH-A18P-01A-11D-A12A-01	TCGA-BH-A18P-01	TCGA-BH-A18P-01	TCGA-BH-A18P-01A-11D-A12E-05	f73ccb89-b952-40ab-ad9f-f817102cd1ca	
TCGA-BH-A18P-11		60			921	921		FEMALE									921	1	Normal						enrollment			DECEASED	1	TCGA-BH-A18P-11	921	1		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A18P			921	Breast	TCGA Breast Cancer	breast invasive carcinoma					60	Left Lower Inner Quadrant	Sentinel node biopsy alone				Positive					Negative	Simple Mastectomy					-22222	2639	921	0								<10%					2011-6-22	FEMALE			10-19%		2+					Infiltrating Ductal Carcinoma		No		C50.3	8500/3	C50.3	1+	YES		Fine needle aspiration biopsy	520	NO	Positive	Positive		2	Negative																													0		true	M0	N0	T1	Stage I			70		10		10		10		90		0		0		0	WITH TUMOR							YES	No				Solid Tissue Normal	11		6th		NO	YES	BH	Breast	A	DECEASED	2003			TCGA-BH-A18P-11A-43R-A12C-13	TCGA-BH-A18P-11A-43R-A12C-13						08236177-a046-4cfe-a11c-a24292a1f777			08236177-a046-4cfe-a11c-a24292a1f777			TCGA-BH-A18P-11A-43R-A12D-07	08236177-a046-4cfe-a11c-a24292a1f777	08236177-a046-4cfe-a11c-a24292a1f777				TCGA-BH-A18P-11A-43D-A12E-05		
TCGA-BH-A18Q-01	Stage IIB	56	1	No_Conversion	1692	1692	Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	1692	1	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A18Q-01	1692	1	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 5	mutation cluster 13	TCGA-BH-A18Q			1692	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Left	Axillary lymph node dissection alone				Negative					Negative	Modified Radical Mastectomy					-20675	3417	1692	0													2011-6-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.8	8500/3	C50.8		YES		Core needle biopsy	130	NO	Positive	Negative		25	Negative																			5	5									2	2	true	M0	N1b	T2	Stage IIB	TCGA-BH-A18Q.BB4C7377-F10C-48D2-A8AA-6D5B43FEB108.pdf		0		0		0		0		5		15		80		90								YES	No				Primary Tumor	01				NO	YES	BH	Breast	A	DECEASED	2001	TCGA-BH-A18Q-01A-12D-A12B-09	TCGA-BH-A18Q-01	TCGA-BH-A18Q-01A-12R-A12C-13	TCGA-BH-A18Q-01A-12R-A12C-13		44798c24-89d7-4d25-a4bc-3d2fab66b4e8	TCGA-BH-A18Q-01A-12D-A12B-09	TCGA-BH-A18Q-01A-21-A13E-20	TCGA-BH-A18Q-01A-12D-A12B-09	2c75afc3-11b5-444d-b6e0-61d76b299f40	94a07da0-f029-444a-86d7-d9bc24e7e76d	TCGA-BH-A18Q-01A-12D-A12A-01	2c75afc3-11b5-444d-b6e0-61d76b299f40		TCGA-BH-A18Q-01	TCGA-BH-A18Q-01A-12R-A12D-07	2c75afc3-11b5-444d-b6e0-61d76b299f40	2c75afc3-11b5-444d-b6e0-61d76b299f40	TCGA-BH-A18Q-01A-12D-A12A-01	TCGA-BH-A18Q-01	TCGA-BH-A18Q-01	TCGA-BH-A18Q-01A-12D-A12E-05	94a07da0-f029-444a-86d7-d9bc24e7e76d	
TCGA-BH-A18Q-11		56			1692	1692		FEMALE									1692	1	Normal						enrollment			DECEASED	1	TCGA-BH-A18Q-11	1692	1		C4-BRCA/Basal							mutation cluster 13	TCGA-BH-A18Q			1692	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Left	Axillary lymph node dissection alone				Negative					Negative	Modified Radical Mastectomy					-20675	3417	1692	0													2011-6-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.8	8500/3	C50.8		YES		Core needle biopsy	510	NO	Positive	Negative		25	Negative																													2	2	true	M0	N1b	T2	Stage IIB											100				0										YES	No				Solid Tissue Normal	11				NO	YES	BH	Breast	A	DECEASED	2001			TCGA-BH-A18Q-11A-34R-A12C-13	TCGA-BH-A18Q-11A-34R-A12C-13						120bc298-f016-4c80-aa5f-a9006444942c			120bc298-f016-4c80-aa5f-a9006444942c			TCGA-BH-A18Q-11A-34R-A12D-07	120bc298-f016-4c80-aa5f-a9006444942c	120bc298-f016-4c80-aa5f-a9006444942c				TCGA-BH-A18Q-11A-34D-A12E-05		
TCGA-BH-A18R-01	Stage IB	50	3	No_Conversion	1099	1141	Indeterminate	FEMALE	Positive	1	1	1	Negative	M0	Positive	N1	1141	1	Her2	HER2-enriched	Negative	Her2	-2	0	enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A18R-01	1142	1	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-BH-A18R			1142	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Right Upper Outer Quadrant					Indeterminate					Negative	Modified Radical Mastectomy					-18524	3571	1142	0						NO		20-29%					2011-7-3	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	250	NO	Positive	Positive		15	Negative																			4	4									10		true	M0	N1	T2b	Stage IIA	TCGA-BH-A18R.46DE21ED-1E08-4095-9B68-88D10AC74673.pdf		2		1		1		1		2		12		85		85	TUMOR FREE							YES	No				Primary Tumor	01				NO	YES	BH	Breast	A	DECEASED	2001	TCGA-BH-A18R-01A-11D-A12B-09	TCGA-BH-A18R-01	TCGA-BH-A18R-01A-11R-A12C-13	TCGA-BH-A18R-01A-11R-A12C-13	TCGA-BH-A18R-01A-11D-A12B-09	ae2a3335-136b-4a32-b247-5b160862fb22	TCGA-BH-A18R-01A-11D-A12B-09	TCGA-BH-A18R-01A-21-A13E-20	TCGA-BH-A18R-01A-11D-A12B-09	b05828bc-eb75-4220-9972-6c6d62fa5303	01428281-1653-4839-b5cf-167bc62eb147	TCGA-BH-A18R-01A-11D-A12A-01	b05828bc-eb75-4220-9972-6c6d62fa5303		TCGA-BH-A18R-01	TCGA-BH-A18R-01A-11R-A12D-07	b05828bc-eb75-4220-9972-6c6d62fa5303	b05828bc-eb75-4220-9972-6c6d62fa5303	TCGA-BH-A18R-01A-11D-A12A-01	TCGA-BH-A18R-01	TCGA-BH-A18R-01	TCGA-BH-A18R-01A-11D-A12E-05	01428281-1653-4839-b5cf-167bc62eb147	
TCGA-BH-A18R-11		50			1099	1141		FEMALE									1141	1	Normal						enrollment			DECEASED	1	TCGA-BH-A18R-11	1142	1		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A18R			1142	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Right Upper Outer Quadrant					Indeterminate					Negative	Modified Radical Mastectomy					-18524	3571	1142	0						NO		20-29%					2011-7-3	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	350	NO	Positive	Positive		15	Negative																													10		true	M0	N1	T2b	Stage IIA			2		0		0		0		10		90		0		0	TUMOR FREE							YES	No				Solid Tissue Normal	11				NO	YES	BH	Breast	A	DECEASED	2001			TCGA-BH-A18R-11A-42R-A12C-13	TCGA-BH-A18R-11A-42R-A12C-13						5462aaff-d060-4ba7-9ab5-0e6977accb91			5462aaff-d060-4ba7-9ab5-0e6977accb91			TCGA-BH-A18R-11A-42R-A12D-07	5462aaff-d060-4ba7-9ab5-0e6977accb91	5462aaff-d060-4ba7-9ab5-0e6977accb91				TCGA-BH-A18R-11A-42D-A12E-05		
TCGA-BH-A18S-01	Stage I	79	5	Stage I	2009	2009	Positive	FEMALE		3	3	3	Negative	M0	Negative	N0	2009	1	LumA	Luminal A	Positive	LumA/B	-12	-3	enrollment	T1	T1	DECEASED	1	TCGA-BH-A18S-01	2009	1	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 12	TCGA-BH-A18S			2009	Breast	TCGA Breast Cancer	breast invasive carcinoma					79	Right Lower Inner Quadrant	Sentinel node biopsy alone				Positive					Positive	Other					-28974	2695	2009	0													2011-7-2	FEMALE										Mucinous Carcinoma		No		C50.3	8523/3	C50.3		YES		Core needle biopsy	320	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	7									0		true	M0	N0	T1c	Stage I	TCGA-BH-A18S.E89670CB-575A-4B67-AF79-1C730B9B86D4.pdf		1		1		0		0		0		15		85		85	TUMOR FREE							YES	No				Primary Tumor	01	total mastectomy	6th		NO	YES	BH	Breast	A	DECEASED	2003	TCGA-BH-A18S-01A-11D-A12B-09	TCGA-BH-A18S-01	TCGA-BH-A18S-01A-11R-A12C-13	TCGA-BH-A18S-01A-11R-A12C-13	TCGA-BH-A18S-01A-11D-A12B-09	cd625353-3b48-44c0-9695-074db13850d9	TCGA-BH-A18S-01A-11D-A12B-09	TCGA-BH-A18S-01A-21-A13E-20	TCGA-BH-A18S-01A-11D-A12B-09	cf00b389-d06b-4dd5-9b18-737b06ab9bed	037b8a48-b345-4971-9226-dc9199a29d82	TCGA-BH-A18S-01A-11D-A12A-01	cf00b389-d06b-4dd5-9b18-737b06ab9bed		TCGA-BH-A18S-01	TCGA-BH-A18S-01A-11R-A12D-07	cf00b389-d06b-4dd5-9b18-737b06ab9bed	cf00b389-d06b-4dd5-9b18-737b06ab9bed	TCGA-BH-A18S-01A-11D-A12A-01	TCGA-BH-A18S-01	TCGA-BH-A18S-01	TCGA-BH-A18S-01A-11D-A12E-05	037b8a48-b345-4971-9226-dc9199a29d82	
TCGA-BH-A18S-11		79			2009	2009		FEMALE									2009	1	Normal						enrollment			DECEASED	1	TCGA-BH-A18S-11	2009	1		C3-BRCA/Luminal							mutation cluster 12	TCGA-BH-A18S			2009	Breast	TCGA Breast Cancer	breast invasive carcinoma					79	Right Lower Inner Quadrant	Sentinel node biopsy alone				Positive					Positive	Other					-28974	2695	2009	0													2011-7-2	FEMALE										Mucinous Carcinoma		No		C50.3	8523/3	C50.3		YES		Core needle biopsy	400	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N0	T1c	Stage I			1		0		0		0		0		100		0		0	TUMOR FREE							YES	No				Solid Tissue Normal	11	total mastectomy	6th		NO	YES	BH	Breast	A	DECEASED	2003			TCGA-BH-A18S-11A-43R-A12C-13	TCGA-BH-A18S-11A-43R-A12C-13						fa7bcdff-10e1-44f1-86ed-90fab26bc61f			fa7bcdff-10e1-44f1-86ed-90fab26bc61f			TCGA-BH-A18S-11A-43R-A12D-07	fa7bcdff-10e1-44f1-86ed-90fab26bc61f	fa7bcdff-10e1-44f1-86ed-90fab26bc61f				TCGA-BH-A18S-11A-43D-A12E-05		
TCGA-BH-A18T-01	Stage IIA	70	1	Stage IIA	224	224	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	224	1	Basal	Luminal A	Negative	ReacII	0	-3	enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A18T-01	224	1	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-BH-A18T			224	Breast	TCGA Breast Cancer	breast invasive carcinoma					70	Right Upper Outer Quadrant	Sentinel node biopsy alone				Negative					Negative	Other					-25674	2737	224	0													2011-7-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	210	NO	Positive	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	2											true	M0	N0	T2	Stage IIA	TCGA-BH-A18T.B8FF655E-47AB-4BB0-B119-1402A335126A.pdf		0		0		5		0		0		10		85		95	WITH TUMOR								No				Primary Tumor	01	segmental mastectomy	6th		NO	YES	BH	Breast	A	DECEASED	2003	TCGA-BH-A18T-01A-11D-A12B-09	TCGA-BH-A18T-01	TCGA-BH-A18T-01A-11R-A12C-13	TCGA-BH-A18T-01A-11R-A12C-13	TCGA-BH-A18T-01A-11D-A12B-09	169f872a-65f6-40ae-8cd9-948822cc3a20	TCGA-BH-A18T-01A-11D-A12B-09	TCGA-BH-A18T-01A-21-A13E-20	TCGA-BH-A18T-01A-11D-A12B-09	733890d7-6557-454e-8697-fe9c619874e3	2e404295-1b50-43a0-b4cc-5d7712e4d3f5	TCGA-BH-A18T-01A-11D-A12A-01	733890d7-6557-454e-8697-fe9c619874e3		TCGA-BH-A18T-01	TCGA-BH-A18T-01A-11R-A12D-07	733890d7-6557-454e-8697-fe9c619874e3	733890d7-6557-454e-8697-fe9c619874e3	TCGA-BH-A18T-01A-11D-A12A-01	TCGA-BH-A18T-01	TCGA-BH-A18T-01	TCGA-BH-A18T-01A-11D-A12E-05	2e404295-1b50-43a0-b4cc-5d7712e4d3f5	
TCGA-BH-A18U-01	Stage IIIA	72	3	Stage IIIA	1317	1563	Positive	FEMALE	Positive	4	5	4	Negative	M0	Positive	N2	1563	1	LumB	Luminal B	Positive	ReacI	-2	-5	enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A18U-01	1563	1	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 13	TCGA-BH-A18U			1563	Breast	TCGA Breast Cancer	breast invasive carcinoma					72	Left	Sentinel lymph node biopsy plus axillary dissection				Positive					Positive	Other					-26426	2697	1563	0													2011-7-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.4	8500/3	C50.4		YES		Core needle biopsy	530	NO	Positive			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	5									9		true	M0	N2a	T2	Stage IIIA	TCGA-BH-A18U.2616F70D-3E15-45BA-8907-65694595F726.pdf		4		1		0		1		0		25		75		75	TUMOR FREE							YES	No				Primary Tumor	01	total mastectomy	6th		NO	YES	BH	Breast	A	DECEASED	2003	TCGA-BH-A18U-01A-21D-A12B-09	TCGA-BH-A18U-01	TCGA-BH-A18U-01A-21R-A12C-13	TCGA-BH-A18U-01A-21R-A12C-13	TCGA-BH-A18U-01A-21D-A12B-09	12e8835a-7f82-4402-929a-bdce63fee8ed	TCGA-BH-A18U-01A-21D-A12B-09	TCGA-BH-A18U-01A-31-A13E-20	TCGA-BH-A18U-01A-21D-A12B-09	f6e76192-c4ed-485f-bb51-1b752bd7f544	cf285aaa-51f0-4eba-a92a-ae9ca8fd2198	TCGA-BH-A18U-01A-21D-A12A-01	f6e76192-c4ed-485f-bb51-1b752bd7f544		TCGA-BH-A18U-01	TCGA-BH-A18U-01A-21R-A12D-07	f6e76192-c4ed-485f-bb51-1b752bd7f544	f6e76192-c4ed-485f-bb51-1b752bd7f544	TCGA-BH-A18U-01A-21D-A12A-01	TCGA-BH-A18U-01	TCGA-BH-A18U-01	TCGA-BH-A18U-01A-21D-A12E-05	cf285aaa-51f0-4eba-a92a-ae9ca8fd2198	
TCGA-BH-A18U-11		72			1317	1563		FEMALE									1563	1	Normal						enrollment			DECEASED	1	TCGA-BH-A18U-11	1563	1		C3-BRCA/Luminal							mutation cluster 13	TCGA-BH-A18U			1563	Breast	TCGA Breast Cancer	breast invasive carcinoma					72	Left	Sentinel lymph node biopsy plus axillary dissection				Positive					Positive	Other					-26426	2697	1563	0													2011-7-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.4	8500/3	C50.4		YES		Core needle biopsy	230	NO	Positive			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												9		true	M0	N2a	T2	Stage IIIA			1		1		0		0		5		95		0		0	TUMOR FREE							YES	No				Solid Tissue Normal	11	total mastectomy	6th		NO	YES	BH	Breast	A	DECEASED	2003			TCGA-BH-A18U-11A-23R-A12C-13	TCGA-BH-A18U-11A-23R-A12C-13						02222fea-f3da-4328-8188-8ef24d1f55e4			02222fea-f3da-4328-8188-8ef24d1f55e4			TCGA-BH-A18U-11A-23R-A12D-07	02222fea-f3da-4328-8188-8ef24d1f55e4	02222fea-f3da-4328-8188-8ef24d1f55e4				TCGA-BH-A18U-11A-23D-A12E-05		
TCGA-BH-A18V-01	Stage IIB	48	1	No_Conversion	1555	1555	Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	1555	1	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A18V-01	1556	1	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 11	cluster 5	mutation cluster 2	TCGA-BH-A18V			1556	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Right	Axillary lymph node dissection alone				Negative					Negative	Other					-17682	3621	1556	0						YES			Other, specify	axilaary node negative but intrammary node positive			2011-7-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.4	8500/3	C50.4		YES		Core needle biopsy	300	NO	Negative			25	Negative			Negative			Negative												Negative	5	5									0		true	M0	N1b	T2	Stage IIB	TCGA-BH-A18V.3C1C2CED-A1CF-48FC-BCB2-658D74E1982B.pdf		3		1		3		1		0		22		75		75								YES	No				Primary Tumor	01	Modified radical mastectomy with left breast biopsy	5th		NO	YES	BH	Breast	A	DECEASED	2001	TCGA-BH-A18V-01A-11D-A12B-09	TCGA-BH-A18V-01	TCGA-BH-A18V-01A-11R-A12C-13	TCGA-BH-A18V-01A-11R-A12C-13	TCGA-BH-A18V-01A-11D-A12B-09	7bf9da92-5872-4f29-ba4d-f247ec7984f0	TCGA-BH-A18V-01A-11D-A12B-09		TCGA-BH-A18V-01A-11D-A12B-09	429b50eb-316f-459c-bc3a-0aca6e6dba46	12aa84c3-f49b-408a-a863-97f2254e442e	TCGA-BH-A18V-01A-11D-A12A-01	429b50eb-316f-459c-bc3a-0aca6e6dba46		TCGA-BH-A18V-01	TCGA-BH-A18V-01A-11R-A12D-07	429b50eb-316f-459c-bc3a-0aca6e6dba46	429b50eb-316f-459c-bc3a-0aca6e6dba46	TCGA-BH-A18V-01A-11D-A12A-01	TCGA-BH-A18V-01	TCGA-BH-A18V-01	TCGA-BH-A18V-01A-11D-A12E-05	12aa84c3-f49b-408a-a863-97f2254e442e	
TCGA-BH-A18V-06		48			1555	1555		FEMALE									1555	1	Basal						enrollment			DECEASED	1	TCGA-BH-A18V-06	1556	1		C4-BRCA/Basal		BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 11		mutation cluster 2	TCGA-BH-A18V			1556	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Right	Axillary lymph node dissection alone				Negative					Negative	Other					-17682	3943	1556	0						YES			Other, specify	axilaary node negative but intrammary node positive			2011-7-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.4	8500/3	C50.4		YES		Core needle biopsy	1390	NO	Negative			25	Negative			Negative			Negative												Negative											0		true	M0	N1b	T2	Stage IIB	TCGA-BH-A18V.066F2FDC-3AE5-45F8-B827-620E24677A1E.pdf		0		0		0		0		5		0		95		95								YES	No				Metastatic	06	Modified radical mastectomy with left breast biopsy	5th		NO	YES	BH	Breast	A	DECEASED	2001			TCGA-BH-A18V-06A-11R-A214-13	TCGA-BH-A18V-06A-11R-A214-13			TCGA-BH-A18V-06A-11D-A20S-09	TCGA-BH-A18V-06A-21-A24B-20		ded1efed-b3b9-4d1a-b4c9-b595543fc461	3aa8422d-7f10-4aba-b6c6-80975f4850c5		ded1efed-b3b9-4d1a-b4c9-b595543fc461	TCGA-BH-A18V-06A-11D-A212-05			ded1efed-b3b9-4d1a-b4c9-b595543fc461	ded1efed-b3b9-4d1a-b4c9-b595543fc461					3aa8422d-7f10-4aba-b6c6-80975f4850c5	
TCGA-BH-A18V-11		48			1555	1555		FEMALE									1555	1	Normal						enrollment			DECEASED	1	TCGA-BH-A18V-11	1556	1		C4-BRCA/Basal							mutation cluster 2	TCGA-BH-A18V			1556	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Right	Axillary lymph node dissection alone				Negative					Negative	Other					-17682	3621	1556	0						YES			Other, specify	axilaary node negative but intrammary node positive			2011-7-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.4	8500/3	C50.4		YES		Core needle biopsy	450	NO	Negative			25	Negative			Negative			Negative												Negative											0		true	M0	N1b	T2	Stage IIB			0		0		0		0		100		0		0		0								YES	No				Solid Tissue Normal	11	Modified radical mastectomy with left breast biopsy	5th		NO	YES	BH	Breast	A	DECEASED	2001										288c81eb-4c43-406b-a5e5-fee452a95afb			288c81eb-4c43-406b-a5e5-fee452a95afb			TCGA-BH-A18V-11A-52R-A12D-07	288c81eb-4c43-406b-a5e5-fee452a95afb	288c81eb-4c43-406b-a5e5-fee452a95afb				TCGA-BH-A18V-11A-52D-A12E-05		
TCGA-BH-A1EN-01	Stage IIA	78	3	Stage IIA		2052	Negative	FEMALE	Positive				Negative	M0	Negative	N0	2052	1	Her2		Negative				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1EN-01	2053	1	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-BH-A1EN			2053	Breast	TCGA Breast Cancer	breast invasive carcinoma					78	Right					Negative					Negative	Other					-28724		2053	0						NO							2011-9-3	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8490/3	C50.9		YES		Excisional Biopsy			Positive				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	3												M0	NX	T2	Stage IIA																		TUMOR FREE								No				Primary Tumor	01	right segmental mastectomy	5th		NO	YES	BH	Breast		DECEASED	1999	TCGA-BH-A1EN-01A-11D-A17G-09		TCGA-BH-A1EN-01A-11R-A13P-13	TCGA-BH-A1EN-01A-11R-A13P-13	TCGA-BH-A1EN-01A-11D-A17G-09		TCGA-BH-A1EN-01A-11D-A17G-09	TCGA-BH-A1EN-01A-21-A17I-20	TCGA-BH-A1EN-01A-11D-A17G-09	a6db80e4-b161-412d-932a-fe2898a1722f	d47439d3-9c7a-4dea-838d-e9955842055b	TCGA-BH-A1EN-01A-11D-A13J-01	a6db80e4-b161-412d-932a-fe2898a1722f	TCGA-BH-A1EN-01A-11D-A13K-05	TCGA-BH-A1EN-01		a6db80e4-b161-412d-932a-fe2898a1722f	a6db80e4-b161-412d-932a-fe2898a1722f	TCGA-BH-A1EN-01A-11D-A13J-01		TCGA-BH-A1EN-01		d47439d3-9c7a-4dea-838d-e9955842055b	
TCGA-BH-A1EN-11		78				2052		FEMALE									2052	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1EN-11	2053	1		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1EN			2053	Breast	TCGA Breast Cancer	breast invasive carcinoma					78	Right					Negative					Negative	Other					-28724	4343	2053	0						NO							2011-9-3	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8490/3	C50.9		YES		Excisional Biopsy	230	NO	Positive				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														true	M0	NX	T2	Stage IIA			0		0		0		0		100		0		0		0	TUMOR FREE								No				Solid Tissue Normal	11	right segmental mastectomy	5th		NO	YES	BH	Breast	A	DECEASED	1999			TCGA-BH-A1EN-11A-23R-A13P-13	TCGA-BH-A1EN-11A-23R-A13P-13						c03683bd-2fe1-4ab2-9a16-796553be5467			c03683bd-2fe1-4ab2-9a16-796553be5467	TCGA-BH-A1EN-11A-23D-A13T-05			c03683bd-2fe1-4ab2-9a16-796553be5467	c03683bd-2fe1-4ab2-9a16-796553be5467						
TCGA-BH-A1EO-01	Stage IIA	68	3	Stage IIA		2798	Positive	FEMALE	Negative				Negative	M0	Positive	N1	2798	1	LumA	Luminal A	Positive		-5	-3	enrollment	T1	T1	DECEASED	1	TCGA-BH-A1EO-01	2798	1	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation c1uster 9	TCGA-BH-A1EO			2798	Breast	TCGA Breast Cancer	breast invasive carcinoma					68	Right					Positive					Positive	Other					-25136	4330	2798	0						NO							2011-9-6	FEMALE										Other  specify	infiltrating carcinoma with ductal and lobular features	No		C50.9	8522/3	C50.9		YES		Excisional Biopsy	100	NO	Negative			15		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6									1		true	M0	N1	T1c	Stage IIA	TCGA-BH-A1EO.A2B755DD-00C4-4349-8E11-C1196EBC91D3.pdf		0		0		0		0		0		0		100		90	TUMOR FREE							YES	No				Primary Tumor	01	right segmental mastectomy witrh axillary node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1999	TCGA-BH-A1EO-01A-11D-A135-09	TCGA-BH-A1EO-01	TCGA-BH-A1EO-01A-11R-A136-13	TCGA-BH-A1EO-01A-11R-A136-13	TCGA-BH-A1EO-01A-11D-A135-09		TCGA-BH-A1EO-01A-11D-A135-09	TCGA-BH-A1EO-01A-21-A17I-20	TCGA-BH-A1EO-01A-11D-A135-09	e6f1450a-6731-4593-82c3-28f839ebf148	7bed3841-5a16-43fc-8b2b-4e0aa0b89f1e	TCGA-BH-A1EO-01A-11D-A134-01	e6f1450a-6731-4593-82c3-28f839ebf148	TCGA-BH-A1EO-01A-11D-A138-05	TCGA-BH-A1EO-01	TCGA-BH-A1EO-01A-11R-A137-07	e6f1450a-6731-4593-82c3-28f839ebf148	e6f1450a-6731-4593-82c3-28f839ebf148	TCGA-BH-A1EO-01A-11D-A134-01	TCGA-BH-A1EO-01	TCGA-BH-A1EO-01		7bed3841-5a16-43fc-8b2b-4e0aa0b89f1e	
TCGA-BH-A1EO-11		68				2798		FEMALE									2798	1	LumA						enrollment			DECEASED	1	TCGA-BH-A1EO-11	2798	1		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1EO			2798	Breast	TCGA Breast Cancer	breast invasive carcinoma					68	Right					Positive					Positive	Other					-25136	4330	2798	0						NO							2011-9-6	FEMALE										Other  specify	infiltrating carcinoma with ductal and lobular features	No		C50.9	8522/3	C50.9		YES		Excisional Biopsy	250	NO	Negative			15		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												1		true	M0	N1	T1c	Stage IIA			0		0		0		0		100		0		0		0	TUMOR FREE							YES	No				Solid Tissue Normal	11	right segmental mastectomy witrh axillary node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1999			TCGA-BH-A1EO-11A-31R-A136-13	TCGA-BH-A1EO-11A-31R-A136-13						71cc9cf0-2992-4ac6-8642-6fdb66958fca			71cc9cf0-2992-4ac6-8642-6fdb66958fca	TCGA-BH-A1EO-11A-31D-A138-05		TCGA-BH-A1EO-11A-31R-A137-07	71cc9cf0-2992-4ac6-8642-6fdb66958fca	71cc9cf0-2992-4ac6-8642-6fdb66958fca						
TCGA-BH-A1ES-01	Stage IIB	35	5	Stage IIB		3462	Positive	FEMALE	Negative				Negative	M0	Positive	N1	3462	1	LumA	Luminal A	Positive		-9	-3	enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1ES-01	3462	1	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-BH-A1ES			3462	Breast	TCGA Breast Cancer	breast invasive carcinoma					35	Right Upper Inner Quadrant					Positive					Positive	Other					-13138		3462	0						NO							2011-9-6	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Negative			4		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	5									1			M0	N1a	T2	Stage IIB																		WITH TUMOR							YES	No				Primary Tumor	01	total mastectomy with rigth axillary lymph node and sentinel lymph node dissection	5th		NO	YES	BH	Breast		DECEASED	1999	TCGA-BH-A1ES-01A-11D-A135-09	TCGA-BH-A1ES-01	TCGA-BH-A1ES-01A-11R-A136-13	TCGA-BH-A1ES-01A-11R-A136-13			TCGA-BH-A1ES-01A-11D-A135-09		TCGA-BH-A1ES-01A-11D-A135-09	cbb45082-6d4e-4457-b023-52f9372ae053	c222b951-0d4d-42e1-8cf2-7011b4ba3b7d	TCGA-BH-A1ES-01A-11D-A134-01	cbb45082-6d4e-4457-b023-52f9372ae053	TCGA-BH-A1ES-01A-11D-A138-05	TCGA-BH-A1ES-01	TCGA-BH-A1ES-01A-11R-A137-07	cbb45082-6d4e-4457-b023-52f9372ae053	cbb45082-6d4e-4457-b023-52f9372ae053	TCGA-BH-A1ES-01A-11D-A134-01	TCGA-BH-A1ES-01	TCGA-BH-A1ES-01		c222b951-0d4d-42e1-8cf2-7011b4ba3b7d	
TCGA-BH-A1ES-06		35				3462		FEMALE									3462	1							enrollment			DECEASED	1	TCGA-BH-A1ES-06	3462	1		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1ES			3462	Breast	TCGA Breast Cancer	breast invasive carcinoma					35	Right Upper Inner Quadrant					Positive					Positive	Other					-13138	4787	3462	0						NO							2011-9-6	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	400	NO	Negative			4		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												1		true	M0	N1a	T2	Stage IIB	TCGA-BH-A1ES.7222C51A-3A1E-454B-A0E4-B8A0BBA042E4.pdf		2		4		10		0		0		15		75		90	WITH TUMOR							YES	No				Metastatic	06	total mastectomy with rigth axillary lymph node and sentinel lymph node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1999			TCGA-BH-A1ES-06A-12R-A24J-13	TCGA-BH-A1ES-06A-12R-A24J-13			TCGA-BH-A1ES-06A-12D-A243-09	TCGA-BH-A1ES-06A-21-A24B-20		fc895598-73b9-4269-a250-52e4475c6be7	b6ada2ae-66de-49d0-9b83-685520858aaf		fc895598-73b9-4269-a250-52e4475c6be7	TCGA-BH-A1ES-06A-12D-A244-05			fc895598-73b9-4269-a250-52e4475c6be7	fc895598-73b9-4269-a250-52e4475c6be7					b6ada2ae-66de-49d0-9b83-685520858aaf	
TCGA-BH-A1ES-11		35				3462		FEMALE									3462	1							enrollment			DECEASED	1	TCGA-BH-A1ES-11	3462	1		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1ES			3462	Breast	TCGA Breast Cancer	breast invasive carcinoma					35	Right Upper Inner Quadrant					Positive					Positive	Other					-13138	4242	3462	0						NO							2011-9-6	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	340	NO	Negative			4		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												1		true	M0	N1a	T2	Stage IIB			0		0		0		0		100		0		0		0	WITH TUMOR							YES	No				Solid Tissue Normal	11	total mastectomy with rigth axillary lymph node and sentinel lymph node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1999														TCGA-BH-A1ES-11A-33D-A138-05										
TCGA-BH-A1ET-01	Stage IIA	55	2	Stage I		2520	Positive	FEMALE	Negative				Negative	M0	Negative	N0	2520	1	LumA	Luminal A	Positive		-12	-7	enrollment	T1	T1	DECEASED	1	TCGA-BH-A1ET-01	2520	1	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-BH-A1ET			2520	Breast	TCGA Breast Cancer	breast invasive carcinoma					55	Left					Positive					Positive	Other					-20425		2520	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy			Negative			19																				2	6									1			M0	N0	T1	Stage I																		TUMOR FREE							YES	No				Primary Tumor	01	Left segmental mastectomy with left axillary lymph node dissection	5th		NO	YES	BH	Breast		DECEASED	1999	TCGA-BH-A1ET-01A-11D-A135-09	TCGA-BH-A1ET-01	TCGA-BH-A1ET-01A-11R-A136-13	TCGA-BH-A1ET-01A-11R-A136-13	TCGA-BH-A1ET-01A-11D-A135-09		TCGA-BH-A1ET-01A-11D-A135-09	TCGA-BH-A1ET-01A-21-A17I-20	TCGA-BH-A1ET-01A-11D-A135-09	b0388c2e-0793-4084-bcc3-454c2ec88931	ff6c8bdf-a663-45fe-b48f-dcca255eb1d1	TCGA-BH-A1ET-01A-11D-A134-01	b0388c2e-0793-4084-bcc3-454c2ec88931	TCGA-BH-A1ET-01A-11D-A138-05	TCGA-BH-A1ET-01	TCGA-BH-A1ET-01A-11R-A137-07	b0388c2e-0793-4084-bcc3-454c2ec88931	b0388c2e-0793-4084-bcc3-454c2ec88931	TCGA-BH-A1ET-01A-11D-A134-01	TCGA-BH-A1ET-01	TCGA-BH-A1ET-01		ff6c8bdf-a663-45fe-b48f-dcca255eb1d1	
TCGA-BH-A1ET-11		55				2520		FEMALE									2520	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1ET-11	2520	1		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A1ET			2520	Breast	TCGA Breast Cancer	breast invasive carcinoma					55	Left					Positive					Positive	Other					-20425	4137	2520	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	380	NO	Negative			19																														1		false	M0	N0	T1	Stage I			0		0		0		0		100		0		0		0	TUMOR FREE							YES	No				Solid Tissue Normal	11	Left segmental mastectomy with left axillary lymph node dissection	5th		NO	YES	BH	Breast	B	DECEASED	1999			TCGA-BH-A1ET-11B-23R-A136-13	TCGA-BH-A1ET-11B-23R-A136-13						ef7f2a68-bbfc-4458-9c3e-18c5d81ef7be			ef7f2a68-bbfc-4458-9c3e-18c5d81ef7be	TCGA-BH-A1ET-11B-23D-A138-05		TCGA-BH-A1ET-11B-23R-A137-07	ef7f2a68-bbfc-4458-9c3e-18c5d81ef7be	ef7f2a68-bbfc-4458-9c3e-18c5d81ef7be						
TCGA-BH-A1EU-01	Stage I	83	1	Stage I		1286	Positive	FEMALE	Negative				Negative	M0	Negative	N0	1286	1	LumA	Luminal A	Positive		-5	-7	enrollment	T1	T1	DECEASED	1	TCGA-BH-A1EU-01	1286	1	Squamous	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-BH-A1EU			1286	Breast	TCGA Breast Cancer	breast invasive carcinoma					83	Right					Positive					Positive						-30339	4106	1286	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	410	NO	Negative					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6											true	M0	N0	T1	Stage I	TCGA-BH-A1EU.FF6BC87F-029E-4565-A35A-6FB968F8EABA.pdf		0		0		0		0		5		10		85		65	TUMOR FREE							NO	No				Primary Tumor	01	Right segmental mastectomy	5th		NO	YES	BH	Breast	A	DECEASED	1999	TCGA-BH-A1EU-01A-11D-A135-09	TCGA-BH-A1EU-01	TCGA-BH-A1EU-01A-11R-A136-13	TCGA-BH-A1EU-01A-11R-A136-13	TCGA-BH-A1EU-01A-11D-A135-09		TCGA-BH-A1EU-01A-11D-A135-09	TCGA-BH-A1EU-01A-21-A17I-20	TCGA-BH-A1EU-01A-11D-A135-09	bfeed1cc-e0f8-493f-a950-829ecb3acccc	784df7f1-e71f-4daa-bfda-0b1b1a69e0b6	TCGA-BH-A1EU-01A-11D-A134-01	bfeed1cc-e0f8-493f-a950-829ecb3acccc	TCGA-BH-A1EU-01A-11D-A138-05	TCGA-BH-A1EU-01	TCGA-BH-A1EU-01A-11R-A137-07	bfeed1cc-e0f8-493f-a950-829ecb3acccc	bfeed1cc-e0f8-493f-a950-829ecb3acccc	TCGA-BH-A1EU-01A-11D-A134-01	TCGA-BH-A1EU-01	TCGA-BH-A1EU-01		784df7f1-e71f-4daa-bfda-0b1b1a69e0b6	
TCGA-BH-A1EU-11		83				1286		FEMALE									1286	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1EU-11	1286	1		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A1EU			1286	Breast	TCGA Breast Cancer	breast invasive carcinoma					83	Right					Positive					Positive						-30339	4106	1286	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	240	NO	Negative					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														true	M0	N0	T1	Stage I			0		0		0		0		100		0		0		0	TUMOR FREE							NO	No				Solid Tissue Normal	11	Right segmental mastectomy	5th		NO	YES	BH	Breast	A	DECEASED	1999			TCGA-BH-A1EU-11A-23R-A136-13	TCGA-BH-A1EU-11A-23R-A136-13						9e12314d-d1f0-44be-93f7-e50a56f86b46			9e12314d-d1f0-44be-93f7-e50a56f86b46	TCGA-BH-A1EU-11A-23D-A138-05		TCGA-BH-A1EU-11A-23R-A137-07	9e12314d-d1f0-44be-93f7-e50a56f86b46	9e12314d-d1f0-44be-93f7-e50a56f86b46						
TCGA-BH-A1EV-01		45	2			365	Positive	FEMALE									365	1	Her2	HER2-enriched	Positive		-1	-5	enrollment			DECEASED	1	TCGA-BH-A1EV-01	365	1	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 7	mutation cluster 5	TCGA-BH-A1EV	365	0	365	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Left			TCGA-BH-A1EV-F59154		Positive					Positive	Modified Radical Mastectomy					-16504	4103	365	0													2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	600	NO	Positive		NO	10																				2	7								NO	3		true	M0	N1b	T3	Stage IIIA	TCGA-BH-A1EV.16DEA43F-4A61-44E3-854F-6B6575B45628.pdf		0		0		5		0		0		5		90		80	WITH TUMOR						NO	YES	No			YES	Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	1999	TCGA-BH-A1EV-01A-11D-A135-09	TCGA-BH-A1EV-01	TCGA-BH-A1EV-01A-11R-A136-13	TCGA-BH-A1EV-01A-11R-A136-13	TCGA-BH-A1EV-01A-11D-A135-09		TCGA-BH-A1EV-01A-11D-A135-09	TCGA-BH-A1EV-01A-21-A17I-20	TCGA-BH-A1EV-01A-11D-A135-09	4dac7a33-db46-4815-8c6c-fb326959c741	76537c73-9c3f-44db-bc92-10957f72d425	TCGA-BH-A1EV-01A-11D-A134-01	4dac7a33-db46-4815-8c6c-fb326959c741	TCGA-BH-A1EV-01A-11D-A138-05	TCGA-BH-A1EV-01	TCGA-BH-A1EV-01A-11R-A137-07	4dac7a33-db46-4815-8c6c-fb326959c741	4dac7a33-db46-4815-8c6c-fb326959c741	TCGA-BH-A1EV-01A-11D-A134-01	TCGA-BH-A1EV-01	TCGA-BH-A1EV-01		76537c73-9c3f-44db-bc92-10957f72d425	
TCGA-BH-A1EV-11		45				365		FEMALE									365	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1EV-11	365	1		C3-BRCA/Luminal							mutation cluster 5	TCGA-BH-A1EV	365	0	365	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Left			TCGA-BH-A1EV-F59154		Positive					Positive	Modified Radical Mastectomy					-16504	4103	365	0													2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	580	NO	Positive		NO	10																													NO	3		true	M0	N1b	T3	Stage IIIA			0		0		0		0		100		0		0		0	WITH TUMOR						NO	YES	No			YES	Solid Tissue Normal	11		5th		NO	YES	BH	Breast	A	DECEASED	1999			TCGA-BH-A1EV-11A-24R-A136-13	TCGA-BH-A1EV-11A-24R-A136-13						7b234c36-729b-422d-8e2a-ebd42af74bce			7b234c36-729b-422d-8e2a-ebd42af74bce	TCGA-BH-A1EV-11A-24D-A138-05			7b234c36-729b-422d-8e2a-ebd42af74bce	7b234c36-729b-422d-8e2a-ebd42af74bce						
TCGA-BH-A1EW-01	Stage IIA	38	3	No_Conversion		1694	Negative	FEMALE	Negative				Negative	M0	Positive	N1	1694	1	LumA	Luminal B	Negative		-3	-3	enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1EW-01	1694	1	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-BH-A1EW			1694	Breast	TCGA Breast Cancer	breast invasive carcinoma					38	Left Upper Outer Quadrant					Negative					Negative	Other					-14090	4230	1694	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	550	NO	Negative			16		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	6									1		true	M0	N1b	T2	Stage IIA	TCGA-BH-A1EW.56EFCA58-2328-4C5C-9618-981447E76B12.pdf		0		0		0		0		0		5		95		80	WITH TUMOR							YES	No				Primary Tumor	01	Left segmental mastectomy with level 1 and level 2 axillary dissection	5th		NO	YES	BH	Breast	A	DECEASED	1999	TCGA-BH-A1EW-01A-11D-A135-09	TCGA-BH-A1EW-01	TCGA-BH-A1EW-01A-11R-A136-13	TCGA-BH-A1EW-01A-11R-A136-13	TCGA-BH-A1EW-01A-11D-A135-09		TCGA-BH-A1EW-01A-11D-A135-09	TCGA-BH-A1EW-01A-21-A17I-20	TCGA-BH-A1EW-01A-11D-A135-09	59783c67-6446-44c1-b9b3-505470f54c82	aff7ebf5-e7ff-4932-972f-758e23aedf4b	TCGA-BH-A1EW-01A-11D-A134-01	59783c67-6446-44c1-b9b3-505470f54c82	TCGA-BH-A1EW-01A-11D-A138-05	TCGA-BH-A1EW-01	TCGA-BH-A1EW-01A-11R-A137-07	59783c67-6446-44c1-b9b3-505470f54c82	59783c67-6446-44c1-b9b3-505470f54c82	TCGA-BH-A1EW-01A-11D-A134-01	TCGA-BH-A1EW-01	TCGA-BH-A1EW-01		aff7ebf5-e7ff-4932-972f-758e23aedf4b	
TCGA-BH-A1EW-11		38				1694		FEMALE									1694	1	LumA						enrollment			DECEASED	1	TCGA-BH-A1EW-11	1694	1		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1EW			1694	Breast	TCGA Breast Cancer	breast invasive carcinoma					38	Left Upper Outer Quadrant					Negative					Negative	Other					-14090	4230	1694	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1030	NO	Negative			16		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												1		false	M0	N1b	T2	Stage IIA			0		0		0		0		100		0		0		0	WITH TUMOR							YES	No				Solid Tissue Normal	11	Left segmental mastectomy with level 1 and level 2 axillary dissection	5th		NO	YES	BH	Breast	B	DECEASED	1999			TCGA-BH-A1EW-11B-33R-A136-13	TCGA-BH-A1EW-11B-33R-A136-13						cf1027dc-9ba9-4e3c-80d9-4bb13021cc31			cf1027dc-9ba9-4e3c-80d9-4bb13021cc31	TCGA-BH-A1EW-11B-33D-A138-05		TCGA-BH-A1EW-11B-33R-A137-07	cf1027dc-9ba9-4e3c-80d9-4bb13021cc31	cf1027dc-9ba9-4e3c-80d9-4bb13021cc31						
TCGA-BH-A1EX-01	Stage IIB	67	3	Stage IIB		1508	Positive	FEMALE	Negative				Negative	M0	Positive	N1	1508	1	LumA		Positive				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1EX-01	1508	1	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-BH-A1EX			1508	Breast	TCGA Breast Cancer	breast invasive carcinoma					67	Right Lower Inner Quadrant					Positive					Positive	Other					-24544	3752	1508	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Positive	Negative		24		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5									2		true	M0	N1b	T2	Stage IIB	TCGA-BH-A1EX.FA86A743-EA67-4554-ABA2-BB8C1DBDB0B1.pdf		0		0		0		0		0		15		85		60	WITH TUMOR							YES	No				Primary Tumor	01	Right segmental mastectomy with sentinel lymph node and axillary lymph node biopsy	5th		NO	YES	BH	Breast	A	DECEASED	2000	TCGA-BH-A1EX-01A-11D-A13L-09		TCGA-BH-A1EX-01A-11R-A13P-13	TCGA-BH-A1EX-01A-11R-A13P-13	TCGA-BH-A1EX-01A-11D-A13L-09		TCGA-BH-A1EX-01A-11D-A13L-09	TCGA-BH-A1EX-01A-21-A17I-20	TCGA-BH-A1EX-01A-11D-A13L-09	b5c8962b-15d5-45ba-9a5a-a75dfacbaad9	936d1d83-4360-4be3-8de2-8ed7414c01dc	TCGA-BH-A1EX-01A-11D-A13J-01	b5c8962b-15d5-45ba-9a5a-a75dfacbaad9	TCGA-BH-A1EX-01A-11D-A13K-05	TCGA-BH-A1EX-01		b5c8962b-15d5-45ba-9a5a-a75dfacbaad9	b5c8962b-15d5-45ba-9a5a-a75dfacbaad9	TCGA-BH-A1EX-01A-11D-A13J-01		TCGA-BH-A1EX-01		936d1d83-4360-4be3-8de2-8ed7414c01dc	
TCGA-BH-A1EY-01	Stage IIA	79	2	Stage IIA		538	Positive	FEMALE	Negative				Negative	M0	Negative	N0	538	1	LumA		Positive				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1EY-01	538	1	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 3	TCGA-BH-A1EY	396	1	538	Breast	TCGA Breast Cancer	breast invasive carcinoma					79	Left Upper Outer Quadrant			TCGA-BH-A1EY-F59173		Positive					Positive	Modified Radical Mastectomy					-28940	3840	538	0				396									2014-5-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	290	NO	Negative		NO	12		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	1				Lung	Distant Metastasis	Liver		YES	0		true	M0	N0	T2	Stage IIA	TCGA-BH-A1EY.2ED10396-96FF-4705-93AE-82FB9A80EC28.pdf		0		0		0		0		0		10		90		90	WITH TUMOR						NO	YES	No			NO	Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	2000	TCGA-BH-A1EY-01A-11D-A13L-09		TCGA-BH-A1EY-01A-11R-A13P-13	TCGA-BH-A1EY-01A-11R-A13P-13	TCGA-BH-A1EY-01A-11D-A13L-09		TCGA-BH-A1EY-01A-11D-A13L-09	TCGA-BH-A1EY-01A-21-A17I-20	TCGA-BH-A1EY-01A-11D-A13L-09	4a6f7935-86f8-4c08-9d0e-9fe77878f2ce	de9cbffc-addc-4ac0-bf95-0e1fd3ae7a00	TCGA-BH-A1EY-01A-11D-A13J-01	4a6f7935-86f8-4c08-9d0e-9fe77878f2ce	TCGA-BH-A1EY-01A-11D-A13K-05	TCGA-BH-A1EY-01		4a6f7935-86f8-4c08-9d0e-9fe77878f2ce	4a6f7935-86f8-4c08-9d0e-9fe77878f2ce	TCGA-BH-A1EY-01A-11D-A13J-01		TCGA-BH-A1EY-01		de9cbffc-addc-4ac0-bf95-0e1fd3ae7a00	
TCGA-BH-A1EY-11		79				538		FEMALE									538	1							enrollment			DECEASED	1	TCGA-BH-A1EY-11	538	1		C3-BRCA/Luminal							mutation cluster 3	TCGA-BH-A1EY	396	1	538	Breast	TCGA Breast Cancer	breast invasive carcinoma					79	Left Upper Outer Quadrant			TCGA-BH-A1EY-F59173		Positive					Positive	Modified Radical Mastectomy					-28940	3840	538	0				396									2014-5-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	450	NO	Negative		NO	12		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																							Lung	Distant Metastasis	Liver		YES	0		false	M0	N0	T2	Stage IIA			0		0		0		0		100		0		0		0	WITH TUMOR						NO	YES	No			NO	Solid Tissue Normal	11		5th		NO	YES	BH	Breast	B	DECEASED	2000														TCGA-BH-A1EY-11B-21D-A13T-05										
TCGA-BH-A1F0-01	Stage IIA	80	1	Stage IIA		785	Negative	FEMALE	Negative				Negative	M0	Positive	N1	785	1	Basal	Basal-like	Indeterminate		-13	-12	enrollment	T1	T1	DECEASED	1	TCGA-BH-A1F0-01	785	1	High	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA c1uster 9	cluster 6	mutation cluster 5	TCGA-BH-A1F0			785	Breast	TCGA Breast Cancer	breast invasive carcinoma					80	Left					Negative					Indeterminate	Modified Radical Mastectomy					-29335	3879	785	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Fine needle aspiration biopsy	180	NO	Negative			9		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	6									1		true	M0	N1c	T1a	Stage IIA	TCGA-BH-A1F0.E2EE2397-0F8A-4A71-9B3C-0007F7D00500.pdf		0		0		2		0		0		5		93		85	WITH TUMOR							YES	No				Primary Tumor	01	with left lymphatic mapping and left axillary biopsy	5th		NO	YES	BH	Breast	A	DECEASED	2000	TCGA-BH-A1F0-01A-11D-A135-09	TCGA-BH-A1F0-01	TCGA-BH-A1F0-01A-11R-A136-13	TCGA-BH-A1F0-01A-11R-A136-13	TCGA-BH-A1F0-01A-11D-A135-09		TCGA-BH-A1F0-01A-11D-A135-09	TCGA-BH-A1F0-01A-21-A17I-20	TCGA-BH-A1F0-01A-11D-A135-09	d31b476c-c047-4e5f-a0cb-eff1065f0121	898c61fd-25f3-480d-864b-0902639e7ca8	TCGA-BH-A1F0-01A-11D-A134-01	d31b476c-c047-4e5f-a0cb-eff1065f0121	TCGA-BH-A1F0-01A-11D-A138-05	TCGA-BH-A1F0-01	TCGA-BH-A1F0-01A-11R-A137-07	d31b476c-c047-4e5f-a0cb-eff1065f0121	d31b476c-c047-4e5f-a0cb-eff1065f0121	TCGA-BH-A1F0-01A-11D-A134-01	TCGA-BH-A1F0-01	TCGA-BH-A1F0-01		898c61fd-25f3-480d-864b-0902639e7ca8	
TCGA-BH-A1F0-11		80				785		FEMALE									785	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1F0-11	785	1		C4-BRCA/Basal							mutation cluster 5	TCGA-BH-A1F0			785	Breast	TCGA Breast Cancer	breast invasive carcinoma					80	Left					Negative					Indeterminate	Modified Radical Mastectomy					-29335	3879	785	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Fine needle aspiration biopsy	180	NO	Negative			9		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												1		false	M0	N1c	T1a	Stage IIA			0		0		0		0		100		0		0		0	WITH TUMOR							YES	No				Solid Tissue Normal	11	with left lymphatic mapping and left axillary biopsy	5th		NO	YES	BH	Breast	B	DECEASED	2000			TCGA-BH-A1F0-11B-23R-A136-13	TCGA-BH-A1F0-11B-23R-A136-13						889f6f61-9b3a-406c-9af8-ddee74a8a19e			889f6f61-9b3a-406c-9af8-ddee74a8a19e	TCGA-BH-A1F0-11B-23D-A138-05		TCGA-BH-A1F0-11B-23R-A137-07	889f6f61-9b3a-406c-9af8-ddee74a8a19e	889f6f61-9b3a-406c-9af8-ddee74a8a19e						
TCGA-BH-A1F2-01	Stage IIIB	53	5	Stage		959	Positive	FEMALE	Positive				Negative	M0	Positive	N1	959	1	LumB		Positive				enrollment	T_Other	T4	DECEASED	1	TCGA-BH-A1F2-01	959	1	High	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA c1uster 9	cluster 6	mutation cluster 14	TCGA-BH-A1F2			959	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Left					Positive					Positive	Modified Radical Mastectomy					-19701	4147	959	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8541/3	C50.9		YES		Core needle biopsy	230	NO	Positive			19																				2	6									6		true	M0	N1b	T4b	Stage IIIB	TCGA-BH-A1F2.FA781D93-C180-4453-BF95-B2D01B6CDB5C.pdf		0		0		0		0		30		30		40		60	TUMOR FREE							YES	No				Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	1999	TCGA-BH-A1F2-01A-31D-A13L-09		TCGA-BH-A1F2-01A-31R-A13P-13	TCGA-BH-A1F2-01A-31R-A13P-13	TCGA-BH-A1F2-01A-31D-A13L-09		TCGA-BH-A1F2-01A-31D-A13L-09	TCGA-BH-A1F2-01A-21-A17I-20	TCGA-BH-A1F2-01A-31D-A13L-09	dbba4276-4b85-4309-8f98-951313c3a3dc	684a637d-c0a0-471a-86d0-1e19aff9f17e	TCGA-BH-A1F2-01A-31D-A13J-01	dbba4276-4b85-4309-8f98-951313c3a3dc	TCGA-BH-A1F2-01A-31D-A13K-05	TCGA-BH-A1F2-01		dbba4276-4b85-4309-8f98-951313c3a3dc	dbba4276-4b85-4309-8f98-951313c3a3dc	TCGA-BH-A1F2-01A-31D-A13J-01		TCGA-BH-A1F2-01		684a637d-c0a0-471a-86d0-1e19aff9f17e	
TCGA-BH-A1F2-11		53				959		FEMALE									959	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1F2-11	959	1		C3-BRCA/Luminal							mutation cluster 14	TCGA-BH-A1F2			959	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Left					Positive					Positive	Modified Radical Mastectomy					-19701	4147	959	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8541/3	C50.9		YES		Core needle biopsy	270	NO	Positive			19																														6		true	M0	N1b	T4b	Stage IIIB			5		0		0		0		80		20		0		0	TUMOR FREE							YES	No				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	A	DECEASED	1999			TCGA-BH-A1F2-11A-32R-A13P-13	TCGA-BH-A1F2-11A-32R-A13P-13						85e9922a-0ede-4fea-8338-ead05addef79			85e9922a-0ede-4fea-8338-ead05addef79	TCGA-BH-A1F2-11A-32D-A13T-05			85e9922a-0ede-4fea-8338-ead05addef79	85e9922a-0ede-4fea-8338-ead05addef79						
TCGA-BH-A1F5-01		62				2712	Positive	FEMALE									2712	1	LumA		Positive				enrollment			DECEASED	1	TCGA-BH-A1F5-01	2712	1	Kirc+	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14		mutation c1uster 9	TCGA-BH-A1F5			2712	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Right					Positive					Positive						-22842	3091	2712	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative			4																														1		true	M0	N1a	T1c	Stage IIA	TCGA-BH-A1F5.F70DE761-F081-4F4C-AD22-9A166CF78CA8.pdf		0		0		0		0		0		50		50		85	TUMOR FREE							YES	Yes				Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	2002	TCGA-BH-A1F5-01A-12D-A13L-09		TCGA-BH-A1F5-01A-12R-A13P-13	TCGA-BH-A1F5-01A-12R-A13P-13	TCGA-BH-A1F5-01A-12D-A13L-09		TCGA-BH-A1F5-01A-12D-A13L-09	TCGA-BH-A1F5-01A-21-A17I-20	TCGA-BH-A1F5-01A-12D-A13L-09	07c52f68-8ece-4702-8573-9b21f32df787	7fedf65f-1c06-4ad9-b979-a88a75c9288c	TCGA-BH-A1F5-01A-12D-A13J-01	07c52f68-8ece-4702-8573-9b21f32df787	TCGA-BH-A1F5-01A-12D-A13K-05	TCGA-BH-A1F5-01		07c52f68-8ece-4702-8573-9b21f32df787	07c52f68-8ece-4702-8573-9b21f32df787	TCGA-BH-A1F5-01A-12D-A13J-01		TCGA-BH-A1F5-01		7fedf65f-1c06-4ad9-b979-a88a75c9288c	
TCGA-BH-A1F5-11		62				2712		FEMALE									2712	1							enrollment			DECEASED	1	TCGA-BH-A1F5-11	2712	1		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1F5			2712	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Right					Positive					Positive						-22842	3091	2712	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	420	NO	Negative			4																														1		true	M0	N1a	T1c	Stage IIA			0		0		0		0		100		0		0		0	TUMOR FREE							YES	Yes				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	A	DECEASED	2002														TCGA-BH-A1F5-11A-43D-A13T-05										
TCGA-BH-A1F6-01		51				2965	Negative	FEMALE									2965	1	Basal		Negative				enrollment			DECEASED	1	TCGA-BH-A1F6-01	2965	1	High	C4-BRCA/Basal		BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12		mutation cluster 5	TCGA-BH-A1F6			2965	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Left					Negative					Negative	Modified Radical Mastectomy					-18691	5230	2965	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	360	NO	Negative			6																														6		true	MX	N2a	T4d		TCGA-BH-A1F6.7E9B0BE7-121E-423F-AA37-445BA922FC13.pdf		2		0		0		0		10		35		55		80								YES	No				Primary Tumor	01	with axillary lymph nodes dissection			NO	YES	BH	Breast	A	DECEASED	1996	TCGA-BH-A1F6-01A-11D-A13L-09		TCGA-BH-A1F6-01A-11R-A13P-13	TCGA-BH-A1F6-01A-11R-A13P-13	TCGA-BH-A1F6-01A-11D-A13L-09		TCGA-BH-A1F6-01A-11D-A13L-09	TCGA-BH-A1F6-01A-21-A17I-20	TCGA-BH-A1F6-01A-11D-A13L-09	5f5a884c-ffbd-401a-8689-baded1bdbe50	9221bace-db00-4adc-ac61-aa064672c1ad	TCGA-BH-A1F6-01A-11D-A13J-01	5f5a884c-ffbd-401a-8689-baded1bdbe50	TCGA-BH-A1F6-01A-11D-A13K-05	TCGA-BH-A1F6-01		5f5a884c-ffbd-401a-8689-baded1bdbe50	5f5a884c-ffbd-401a-8689-baded1bdbe50	TCGA-BH-A1F6-01A-11D-A13J-01		TCGA-BH-A1F6-01		9221bace-db00-4adc-ac61-aa064672c1ad	
TCGA-BH-A1F6-11		51				2965		FEMALE									2965	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1F6-11	2965	1		C4-BRCA/Basal							mutation cluster 5	TCGA-BH-A1F6			2965	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Left					Negative					Negative	Modified Radical Mastectomy					-18691	5230	2965	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1210	NO	Negative			6																														6		false	MX	N2a	T4d				0		0				0		100				0										YES	No				Solid Tissue Normal	11	with axillary lymph nodes dissection			NO	YES	BH	Breast	B	DECEASED	1996			TCGA-BH-A1F6-11B-94R-A13P-13	TCGA-BH-A1F6-11B-94R-A13P-13						a248476b-7c40-42c6-905b-b9c3ba6b2aed			a248476b-7c40-42c6-905b-b9c3ba6b2aed	TCGA-BH-A1F6-11B-94D-A13T-05			a248476b-7c40-42c6-905b-b9c3ba6b2aed	a248476b-7c40-42c6-905b-b9c3ba6b2aed						
TCGA-BH-A1F8-01	Stage IIIB	90	1	Stage IIIC		749	Positive	FEMALE	Negative				Negative	M0	Positive	N2	749	1	LumB		Positive				enrollment	T_Other	T4	DECEASED	1	TCGA-BH-A1F8-01	749	1	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 9	cluster 4	mutation cluster 4	TCGA-BH-A1F8			749	Breast	TCGA Breast Cancer	breast invasive carcinoma					90	Left					Positive					Positive	Modified Radical Mastectomy					-32871		749	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Positive			13		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									12			M0	N2	T4b	Stage IIIB																		WITH TUMOR							YES	No				Primary Tumor	01	with axillary node dissection	5th		NO	YES	BH	Breast		DECEASED	1999	TCGA-BH-A1F8-01A-11D-A13L-09		TCGA-BH-A1F8-01A-11R-A13P-13	TCGA-BH-A1F8-01A-11R-A13P-13	TCGA-BH-A1F8-01A-11D-A13L-09		TCGA-BH-A1F8-01A-11D-A13L-09	TCGA-BH-A1F8-01A-21-A17I-20	TCGA-BH-A1F8-01A-11D-A13L-09	ca39657a-073d-4b89-a3da-900f7c9f1012	e1551e9a-dffe-4810-9836-3567199c4092	TCGA-BH-A1F8-01A-11D-A13J-01	ca39657a-073d-4b89-a3da-900f7c9f1012	TCGA-BH-A1F8-01A-11D-A13K-05	TCGA-BH-A1F8-01		ca39657a-073d-4b89-a3da-900f7c9f1012	ca39657a-073d-4b89-a3da-900f7c9f1012	TCGA-BH-A1F8-01A-11D-A13J-01		TCGA-BH-A1F8-01		e1551e9a-dffe-4810-9836-3567199c4092	
TCGA-BH-A1F8-11		90				749		FEMALE									749	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1F8-11	749	1		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A1F8			749	Breast	TCGA Breast Cancer	breast invasive carcinoma					90	Left					Positive					Positive	Modified Radical Mastectomy					-32871	4301	749	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	750	NO	Positive			13		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												12		false	M0	N2	T4b	Stage IIIB		0		0		0		0		2		98		0		0		WITH TUMOR							YES	No				Solid Tissue Normal	11	with axillary node dissection	5th		NO	YES	BH	Breast	B	DECEASED	1999			TCGA-BH-A1F8-11B-21R-A13P-13	TCGA-BH-A1F8-11B-21R-A13P-13						c6cc7496-98d2-4181-8517-fbd875fd5623			c6cc7496-98d2-4181-8517-fbd875fd5623	TCGA-BH-A1F8-11B-21D-A13T-05			c6cc7496-98d2-4181-8517-fbd875fd5623	c6cc7496-98d2-4181-8517-fbd875fd5623						
TCGA-BH-A1FB-01	Stage IIB	60	4	Stage IIB		3669	Positive	FEMALE	Negative				Negative	M0	Positive	N1	3669	1	LumA		Positive				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1FB-01	3669	1	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6		TCGA-BH-A1FB			3669	Breast	TCGA Breast Cancer	breast invasive carcinoma					60	Right					Positive					Positive						-21933	3871	3669	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Negative			15		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6									0		true	M0	N1b	T2	Stage IIB	TCGA-BH-A1FB.C5D116FF-3193-48A0-B69C-D98831D9976A.pdf		4		1		0		1		4		26		70		70	WITH TUMOR							YES	No				Primary Tumor	01	segmental mastectomy with sentinel lymph node dissection	5th		NO	YES	BH	Breast	A	DECEASED	2000			TCGA-BH-A1FB-01A-11R-A13P-13	TCGA-BH-A1FB-01A-11R-A13P-13				TCGA-BH-A1FB-01A-21-A17I-20		5b262ec0-72f2-4c54-820e-a39afad67212	ed5f14b2-ffc0-4eb6-bbb0-576c2c102128	TCGA-BH-A1FB-01A-11D-A13J-01	5b262ec0-72f2-4c54-820e-a39afad67212	TCGA-BH-A1FB-01A-11D-A13K-05	TCGA-BH-A1FB-01		5b262ec0-72f2-4c54-820e-a39afad67212	5b262ec0-72f2-4c54-820e-a39afad67212	TCGA-BH-A1FB-01A-11D-A13J-01		TCGA-BH-A1FB-01		ed5f14b2-ffc0-4eb6-bbb0-576c2c102128	
TCGA-BH-A1FB-11		60				3669		FEMALE									3669	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1FB-11	3669	1		C3-BRCA/Luminal								TCGA-BH-A1FB			3669	Breast	TCGA Breast Cancer	breast invasive carcinoma					60	Right					Positive					Positive						-21933	3871	3669	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	320	NO	Negative			15		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N1b	T2	Stage IIB			2		1		0		0		15		85		0		0	WITH TUMOR							YES	No				Solid Tissue Normal	11	segmental mastectomy with sentinel lymph node dissection	5th		NO	YES	BH	Breast	A	DECEASED	2000			TCGA-BH-A1FB-11A-33R-A13P-13	TCGA-BH-A1FB-11A-33R-A13P-13						71899388-d223-4774-a1ce-3be260240b2c			71899388-d223-4774-a1ce-3be260240b2c	TCGA-BH-A1FB-11A-33D-A13T-05			71899388-d223-4774-a1ce-3be260240b2c	71899388-d223-4774-a1ce-3be260240b2c						
TCGA-BH-A1FC-01	Stage IIA	78	4	Stage IIA		3471	Negative	FEMALE	Negative				Negative	M0	Positive	N1	3471	1	Basal		Negative				enrollment	T1	T1	DECEASED	1	TCGA-BH-A1FC-01	3472	1	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-BH-A1FC			3472	Breast	TCGA Breast Cancer	breast invasive carcinoma					78	Right Upper Outer Quadrant					Negative					Negative	Other					-28706	4456	3472	0													2011-9-8	FEMALE										Medullary Carcinoma		No		C50.9	8510/3	C50.9		YES		Fine needle aspiration biopsy	90	NO	Negative			23		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	3									1		true	M0	N1b	T1c	Stage IIA	TCGA-BH-A1FC.7B1B31D2-0CC5-4EE6-8AF3-16DF726BE13F.pdf		8		1		0		0		0		10		90		90	TUMOR FREE							YES	No				Primary Tumor	01	localized segmental mastectomy with axillary node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1998	TCGA-BH-A1FC-01A-11D-A13L-09		TCGA-BH-A1FC-01A-11R-A13P-13	TCGA-BH-A1FC-01A-11R-A13P-13	TCGA-BH-A1FC-01A-11D-A13L-09		TCGA-BH-A1FC-01A-11D-A13L-09	TCGA-BH-A1FC-01A-21-A17I-20	TCGA-BH-A1FC-01A-11D-A13L-09	42e2160c-07b5-4be6-a989-1e3474926d2a	2b2b809a-ad8d-42c1-baf9-39886ab3d8b1	TCGA-BH-A1FC-01A-11D-A13J-01	42e2160c-07b5-4be6-a989-1e3474926d2a	TCGA-BH-A1FC-01A-11D-A13K-05	TCGA-BH-A1FC-01		42e2160c-07b5-4be6-a989-1e3474926d2a	42e2160c-07b5-4be6-a989-1e3474926d2a	TCGA-BH-A1FC-01A-11D-A13J-01		TCGA-BH-A1FC-01		2b2b809a-ad8d-42c1-baf9-39886ab3d8b1	
TCGA-BH-A1FC-11		78				3471		FEMALE									3471	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1FC-11	3472	1		C4-BRCA/Basal							mutation cluster 5	TCGA-BH-A1FC			3472	Breast	TCGA Breast Cancer	breast invasive carcinoma					78	Right Upper Outer Quadrant					Negative					Negative	Other					-28706	4456	3472	0													2011-9-8	FEMALE										Medullary Carcinoma		No		C50.9	8510/3	C50.9		YES		Fine needle aspiration biopsy	260	NO	Negative			23		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												1		true	M0	N1b	T1c	Stage IIA			1		1		0		0		3		97		0		0	TUMOR FREE							YES	No				Solid Tissue Normal	11	localized segmental mastectomy with axillary node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1998			TCGA-BH-A1FC-11A-32R-A13P-13	TCGA-BH-A1FC-11A-32R-A13P-13						58e94be5-2da2-4a96-944a-060f20216572			58e94be5-2da2-4a96-944a-060f20216572	TCGA-BH-A1FC-11A-32D-A13T-05			58e94be5-2da2-4a96-944a-060f20216572	58e94be5-2da2-4a96-944a-060f20216572						
TCGA-BH-A1FD-01	Stage I	68	4	Stage I		1008	Positive	FEMALE	Negative				Negative	M0	Negative	N0	1008	1	LumB		Positive				enrollment	T1	T1	DECEASED	1	TCGA-BH-A1FD-01	1009	1	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7			mutation cluster 3	TCGA-BH-A1FD			1009	Breast	TCGA Breast Cancer	breast invasive carcinoma					68	Left					Positive					Positive						-24940	4420	1009	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative			19		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3										0		true	M0	N0	T1c	Stage I	TCGA-BH-A1FD.9F838476-4DF1-44D6-989F-33A1D490424B.pdf		2		1		2		1		0		13		85		85	WITH TUMOR							YES	No				Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	1998	TCGA-BH-A1FD-01A-11W-A14Q-09				TCGA-BH-A1FD-01A-11W-A14Q-09		TCGA-BH-A1FD-01A-11W-A14Q-09	TCGA-BH-A1FD-01A-21-A17I-20	TCGA-BH-A1FD-01A-11W-A14Q-09	744ed141-8809-4bc9-90e6-74098383914e	e8763755-1460-48c9-b60a-5a5b9ed61da5	TCGA-BH-A1FD-01A-11D-A13J-01	744ed141-8809-4bc9-90e6-74098383914e	TCGA-BH-A1FD-01A-11D-A13K-05	TCGA-BH-A1FD-01		744ed141-8809-4bc9-90e6-74098383914e	744ed141-8809-4bc9-90e6-74098383914e	TCGA-BH-A1FD-01A-11D-A13J-01		TCGA-BH-A1FD-01		e8763755-1460-48c9-b60a-5a5b9ed61da5	
TCGA-BH-A1FD-11		68				1008		FEMALE									1008	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1FD-11	1009	1		C3-BRCA/Luminal							mutation cluster 3	TCGA-BH-A1FD			1009	Breast	TCGA Breast Cancer	breast invasive carcinoma					68	Left					Positive					Positive						-24940	4420	1009	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	440	NO	Negative			19		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		false	M0	N0	T1c	Stage I			1		1		0		0		0		100		0		0	WITH TUMOR							YES	No				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	B	DECEASED	1998			TCGA-BH-A1FD-11B-21R-A13P-13	TCGA-BH-A1FD-11B-21R-A13P-13						e0ed3e93-0ead-4fc0-a82d-79807c7d5162			e0ed3e93-0ead-4fc0-a82d-79807c7d5162	TCGA-BH-A1FD-11B-21D-A13T-05			e0ed3e93-0ead-4fc0-a82d-79807c7d5162	e0ed3e93-0ead-4fc0-a82d-79807c7d5162						
TCGA-BH-A1FE-01	Stage IIB	31	2	Stage IIB		2273	Positive	FEMALE	Negative				Negative	M0	Positive	N1	2273	1	LumA		Positive				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1FE-01	2273	1	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 3	TCGA-BH-A1FE			2273	Breast	TCGA Breast Cancer	breast invasive carcinoma					31	Left					Positive					Positive	Modified Radical Mastectomy					-11650	4456	2273	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO				12																				4	6									1		true	M0	N1	T2	Stage IIB	TCGA-BH-A1FE.098BAFB4-94D0-4FC8-B938-D8A410BD8FC1.pdf		4		1		1		1		5		24		70		70	WITH TUMOR							YES	No				Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	1998	TCGA-BH-A1FE-01A-11D-A13L-09		TCGA-BH-A1FE-01A-11R-A13P-13	TCGA-BH-A1FE-01A-11R-A13P-13	TCGA-BH-A1FE-01A-11D-A13L-09		TCGA-BH-A1FE-01A-11D-A13L-09		TCGA-BH-A1FE-01A-11D-A13L-09	2cb3a793-6e37-42fd-a544-65aa2d939d50	1427907e-73c9-42c0-ab7b-64cd9b64d874	TCGA-BH-A1FE-01A-11D-A13J-01	2cb3a793-6e37-42fd-a544-65aa2d939d50	TCGA-BH-A1FE-01A-11D-A13K-05	TCGA-BH-A1FE-01		2cb3a793-6e37-42fd-a544-65aa2d939d50	2cb3a793-6e37-42fd-a544-65aa2d939d50	TCGA-BH-A1FE-01A-11D-A13J-01		TCGA-BH-A1FE-01		1427907e-73c9-42c0-ab7b-64cd9b64d874	
TCGA-BH-A1FE-06		31				2273		FEMALE									2273	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1FE-06	2273	1		C3-BRCA/Luminal		Low purity c2		GBM-like c6	miRNA cluster 5		mutation cluster 3	TCGA-BH-A1FE			2273	Breast	TCGA Breast Cancer	breast invasive carcinoma					31	Left					Positive					Positive	Modified Radical Mastectomy					-11650	4742	2273	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	900	NO				12																														1		true	M0	N1	T2	Stage IIB	TCGA-BH-A1FE.3F499CDC-18A3-44A7-B796-71716F2A2BD2.pdf		0		0		0		0		25		0		75		90	WITH TUMOR							YES	No				Metastatic	06		5th		NO	YES	BH	Breast	A	DECEASED	1998			TCGA-BH-A1FE-06A-11R-A214-13	TCGA-BH-A1FE-06A-11R-A214-13				TCGA-BH-A1FE-06A-21-A24B-20	TCGA-BH-A1FE-06A-11D-A20S-09	aad871a8-1a52-4e96-8b13-444d08289236	9817a432-9c60-42d5-928e-531e3fd480dd		aad871a8-1a52-4e96-8b13-444d08289236	TCGA-BH-A1FE-06A-11D-A212-05			aad871a8-1a52-4e96-8b13-444d08289236	aad871a8-1a52-4e96-8b13-444d08289236					9817a432-9c60-42d5-928e-531e3fd480dd	
TCGA-BH-A1FE-11		31				2273		FEMALE									2273	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1FE-11	2273	1		C3-BRCA/Luminal							mutation cluster 3	TCGA-BH-A1FE			2273	Breast	TCGA Breast Cancer	breast invasive carcinoma					31	Left					Positive					Positive	Modified Radical Mastectomy					-11650	4456	2273	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	520	NO				12																														1		true	M0	N1	T2	Stage IIB			1		1		0		0		20		80		0		0	WITH TUMOR							YES	No				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	B	DECEASED	1998			TCGA-BH-A1FE-11B-14R-A13P-13	TCGA-BH-A1FE-11B-14R-A13P-13						64f3f52d-a484-49c6-9048-6eadedd2c2c5			64f3f52d-a484-49c6-9048-6eadedd2c2c5	TCGA-BH-A1FE-11B-14D-A13T-05			64f3f52d-a484-49c6-9048-6eadedd2c2c5	64f3f52d-a484-49c6-9048-6eadedd2c2c5						
TCGA-BH-A1FG-01	Stage I	88	4	Stage I		3738	Positive	FEMALE					Negative	M0	Negative	N0	3738	1	LumA		Positive				enrollment	T1	T1	DECEASED	1	TCGA-BH-A1FG-01	3738	1	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-BH-A1FG			3738	Breast	TCGA Breast Cancer	breast invasive carcinoma					88	Left					Positive					Positive	Other					-32295	4460	3738	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	120	NO	Negative					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2											true	M0	NX	T1c	Stage I	TCGA-BH-A1FG.49927626-EB84-4A79-8073-67818722123A.pdf		40		20		0		20		0		40		60		60									No				Primary Tumor	01	segmental mastectomy	5th		NO	YES	BH	Breast	A	DECEASED	1998	TCGA-BH-A1FG-01A-11D-A13L-09		TCGA-BH-A1FG-01A-11R-A13P-13	TCGA-BH-A1FG-01A-11R-A13P-13	TCGA-BH-A1FG-01A-11D-A13L-09		TCGA-BH-A1FG-01A-11D-A13L-09	TCGA-BH-A1FG-01A-21-A17I-20	TCGA-BH-A1FG-01A-11D-A13L-09	39fe5d50-f454-4f7b-b07b-1a59b5c828f9	16ab0981-23d8-4602-ac15-898caa502ff4	TCGA-BH-A1FG-01A-11D-A13J-01	39fe5d50-f454-4f7b-b07b-1a59b5c828f9	TCGA-BH-A1FG-01A-11D-A13K-05	TCGA-BH-A1FG-01		39fe5d50-f454-4f7b-b07b-1a59b5c828f9	39fe5d50-f454-4f7b-b07b-1a59b5c828f9	TCGA-BH-A1FG-01A-11D-A13J-01		TCGA-BH-A1FG-01		16ab0981-23d8-4602-ac15-898caa502ff4	
TCGA-BH-A1FG-11		88				3738		FEMALE									3738	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1FG-11	3738	1		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1FG			3738	Breast	TCGA Breast Cancer	breast invasive carcinoma					88	Left					Positive					Positive	Other					-32295	4460	3738	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	70	NO	Negative					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														false	M0	NX	T1c	Stage I			60		0		0		30		40		60		0		0									No				Solid Tissue Normal	11	segmental mastectomy	5th		NO	YES	BH	Breast	B	DECEASED	1998			TCGA-BH-A1FG-11B-12R-A13P-13	TCGA-BH-A1FG-11B-12R-A13P-13						ea037776-3759-425c-a7f4-35e8a5571025			ea037776-3759-425c-a7f4-35e8a5571025	TCGA-BH-A1FG-11B-12D-A13T-05			ea037776-3759-425c-a7f4-35e8a5571025	ea037776-3759-425c-a7f4-35e8a5571025						
TCGA-BH-A1FH-01	Stage IV	47	4	No_Conversion		1123	Positive	FEMALE	Negative				Positive	M1	Positive	N1	1123	1	LumA		Negative				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1FH-01	1123	1	Kirc+	C3-BRCA/Luminal	cluster 1	Low purity c2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation c1uster 9	TCGA-BH-A1FH			1123	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Left Upper Outer Quadrant					Positive					Negative	Modified Radical Mastectomy					-17172	4670	1123	0						YES			Bone				2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	430	NO				13																				1	6									8		true	M1	N1b	T2	Stage IV	TCGA-BH-A1FH.501C3E1B-573B-4A5A-A0ED-3CD15432E6FF.pdf		0		0		0		0		5		10		85		60	WITH TUMOR							YES	No				Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	1998	TCGA-BH-A1FH-01A-12D-A13L-09		TCGA-BH-A1FH-01A-12R-A13P-13	TCGA-BH-A1FH-01A-12R-A13P-13	TCGA-BH-A1FH-01A-12D-A13L-09		TCGA-BH-A1FH-01A-12D-A13L-09	TCGA-BH-A1FH-01A-21-A17I-20	TCGA-BH-A1FH-01A-12D-A13L-09	693a3c69-75bd-435d-874e-f3b90b7ed180	8dedb075-afa7-4699-b486-178cdaba1e9e	TCGA-BH-A1FH-01A-12D-A13J-01	693a3c69-75bd-435d-874e-f3b90b7ed180	TCGA-BH-A1FH-01A-12D-A13K-05	TCGA-BH-A1FH-01		693a3c69-75bd-435d-874e-f3b90b7ed180	693a3c69-75bd-435d-874e-f3b90b7ed180	TCGA-BH-A1FH-01A-12D-A13J-01		TCGA-BH-A1FH-01		8dedb075-afa7-4699-b486-178cdaba1e9e	
TCGA-BH-A1FH-11		47				1123		FEMALE									1123	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1FH-11	1123	1		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1FH			1123	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Left Upper Outer Quadrant					Positive					Negative	Modified Radical Mastectomy					-17172	4670	1123	0						YES			Bone				2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO				13																														8		false	M1	N1b	T2	Stage IV			0		0		0		0		100		0		0		0	WITH TUMOR							YES	No				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	B	DECEASED	1998			TCGA-BH-A1FH-11B-42R-A13P-13	TCGA-BH-A1FH-11B-42R-A13P-13						1b831e2d-c265-4eac-aee0-248493a14218			1b831e2d-c265-4eac-aee0-248493a14218	TCGA-BH-A1FH-11B-42D-A13T-05			1b831e2d-c265-4eac-aee0-248493a14218	1b831e2d-c265-4eac-aee0-248493a14218						
TCGA-BH-A1FJ-01	Stage IIIA	66	3	Stage IIIA		1927	Negative	FEMALE	Negative				Negative	M0	Positive	N1	1927	1	LumB		Positive				enrollment	T_Other	T3	DECEASED	1	TCGA-BH-A1FJ-01	1927	1	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 2	mutation c1uster 9	TCGA-BH-A1FJ			1927	Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Right Upper Outer Quadrant					Negative					Positive	Modified Radical Mastectomy					-24262	4574	1927	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO				35																				4	2									6		true	M0	N1b	T3	Stage IIIA	TCGA-BH-A1FJ.8169BE67-03C8-4F4D-9A60-200705B795AE.pdf		0		0		0		0		0		60		40		80								YES	No				Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	1998	TCGA-BH-A1FJ-01A-11D-A13L-09		TCGA-BH-A1FJ-01A-11R-A13P-13	TCGA-BH-A1FJ-01A-11R-A13P-13	TCGA-BH-A1FJ-01A-11D-A13L-09		TCGA-BH-A1FJ-01A-11D-A13L-09	TCGA-BH-A1FJ-01A-21-A17I-20	TCGA-BH-A1FJ-01A-11D-A13L-09	28bc840d-296e-436e-93b8-9c28c0eaf47a	98f36ce5-e678-4356-a0e9-f2daf679f1f1	TCGA-BH-A1FJ-01A-11D-A13J-01	28bc840d-296e-436e-93b8-9c28c0eaf47a	TCGA-BH-A1FJ-01A-11D-A13K-05	TCGA-BH-A1FJ-01		28bc840d-296e-436e-93b8-9c28c0eaf47a	28bc840d-296e-436e-93b8-9c28c0eaf47a	TCGA-BH-A1FJ-01A-11D-A13J-01		TCGA-BH-A1FJ-01		98f36ce5-e678-4356-a0e9-f2daf679f1f1	
TCGA-BH-A1FJ-11		66				1927		FEMALE									1927	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1FJ-11	1927	1		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1FJ			1927	Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Right Upper Outer Quadrant					Negative					Positive	Modified Radical Mastectomy					-24262	4574	1927	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	380	NO				35																														6		false	M0	N1b	T3	Stage IIIA			0		0		0		0		100		0		0		0								YES	No				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	B	DECEASED	1998			TCGA-BH-A1FJ-11B-42R-A13P-13	TCGA-BH-A1FJ-11B-42R-A13P-13						3078c384-b624-4f5a-ae36-fc896212e616			3078c384-b624-4f5a-ae36-fc896212e616	TCGA-BH-A1FJ-11B-42D-A13T-05			3078c384-b624-4f5a-ae36-fc896212e616	3078c384-b624-4f5a-ae36-fc896212e616						
TCGA-BH-A1FL-01	Stage IIB	69	2	Stage IIIA		1673	Positive	FEMALE	Negative				Negative	M0	Positive	N1	1673	1	LumA		Positive				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1FL-01	1673	1	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 6	mutation c1uster 9	TCGA-BH-A1FL			1673	Breast	TCGA Breast Cancer	breast invasive carcinoma					69	Left Upper Outer Quadrant					Positive					Positive	Other					-25558	4572	1673	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8522/3	C50.9		YES		Fine needle aspiration biopsy	100	NO				22																				4	6									4		true	M0	N1b	T2	Stage IIB	TCGA-BH-A1FL.032B81C5-F936-448E-A352-C186DF160B7C.pdf		0		0		0		0		0		10		90		90	WITH TUMOR							YES	No				Primary Tumor	01	needle directed right breast biopsy with left segmental mastectomy with axillary lymph node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1998	TCGA-BH-A1FL-01A-11D-A13L-09		TCGA-BH-A1FL-01A-11R-A13P-13	TCGA-BH-A1FL-01A-11R-A13P-13	TCGA-BH-A1FL-01A-11D-A13L-09		TCGA-BH-A1FL-01A-11D-A13L-09	TCGA-BH-A1FL-01A-21-A17I-20	TCGA-BH-A1FL-01A-11D-A13L-09	0858a026-142c-4428-b05d-fdc22080afd3	f4aa579c-fa0c-4313-a4a1-ca88a367d71f	TCGA-BH-A1FL-01A-11D-A13J-01	0858a026-142c-4428-b05d-fdc22080afd3	TCGA-BH-A1FL-01A-11D-A13K-05	TCGA-BH-A1FL-01		0858a026-142c-4428-b05d-fdc22080afd3	0858a026-142c-4428-b05d-fdc22080afd3	TCGA-BH-A1FL-01A-11D-A13J-01		TCGA-BH-A1FL-01		f4aa579c-fa0c-4313-a4a1-ca88a367d71f	
TCGA-BH-A1FM-01	Stage IIIA	44	1	Stage IIIA		1388	Positive	FEMALE	Negative				Negative	M0	Positive	N2	1388	1	LumB		Negative				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1FM-01	1388	1	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-BH-A1FM			1388	Breast	TCGA Breast Cancer	breast invasive carcinoma					44	Right Upper Outer Quadrant					Positive					Negative	Modified Radical Mastectomy					-16289	4753	1388	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	260	NO				10																				3	4									8		true	M0	N2	T2	Stage IIIA	TCGA-BH-A1FM.DA6A0EC9-6E20-4E4A-9B7F-A32EFF7627AD.pdf		1		0		2		0		0		18		80		90								YES	No				Primary Tumor	01	with axillary node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1998	TCGA-BH-A1FM-01A-11D-A13L-09		TCGA-BH-A1FM-01A-11R-A13P-13	TCGA-BH-A1FM-01A-11R-A13P-13	TCGA-BH-A1FM-01A-11D-A13L-09		TCGA-BH-A1FM-01A-11D-A13L-09	TCGA-BH-A1FM-01A-21-A17I-20	TCGA-BH-A1FM-01A-11D-A13L-09	99157b66-ae2a-4ba2-8b28-5653803063a9	c1636423-5fa8-4d4c-bba1-b9dd369e3830	TCGA-BH-A1FM-01A-11D-A13J-01	99157b66-ae2a-4ba2-8b28-5653803063a9	TCGA-BH-A1FM-01A-11D-A13K-05	TCGA-BH-A1FM-01		99157b66-ae2a-4ba2-8b28-5653803063a9	99157b66-ae2a-4ba2-8b28-5653803063a9	TCGA-BH-A1FM-01A-11D-A13J-01		TCGA-BH-A1FM-01		c1636423-5fa8-4d4c-bba1-b9dd369e3830	
TCGA-BH-A1FM-11		44				1388		FEMALE									1388	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1FM-11	1388	1		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1FM			1388	Breast	TCGA Breast Cancer	breast invasive carcinoma					44	Right Upper Outer Quadrant					Positive					Negative	Modified Radical Mastectomy					-16289	4753	1388	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO				10																														8		false	M0	N2	T2	Stage IIIA			0		0		0		0		100		0		0		0								YES	No				Solid Tissue Normal	11	with axillary node dissection	5th		NO	YES	BH	Breast	B	DECEASED	1998			TCGA-BH-A1FM-11B-23R-A13P-13	TCGA-BH-A1FM-11B-23R-A13P-13						39ec3623-c15f-4af6-b2df-5413eec21bec			39ec3623-c15f-4af6-b2df-5413eec21bec	TCGA-BH-A1FM-11B-23D-A13T-05			39ec3623-c15f-4af6-b2df-5413eec21bec	39ec3623-c15f-4af6-b2df-5413eec21bec						
TCGA-BH-A1FN-01	Stage IIA	34	1	Stage IIA		2192	Positive	FEMALE	Negative				Negative	M0	Negative	N0	2192	1	LumB		Positive				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1FN-01	2192	1	High	C3-BRCA/Luminal	cluster 5	Cluster 5	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A1FN			2192	Breast	TCGA Breast Cancer	breast invasive carcinoma					34	Right Upper Outer Quadrant					Positive					Positive	Other					-12525		2192	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy						29																				5	4									0			M0	N0	T2	Stage IIA																		WITH TUMOR							YES	No				Primary Tumor	01	segmental mastectomy with axillary lymph node dissection	5th		NO	YES	BH	Breast		DECEASED	1997	TCGA-BH-A1FN-01A-11D-A13L-09		TCGA-BH-A1FN-01A-11R-A13P-13	TCGA-BH-A1FN-01A-11R-A13P-13	TCGA-BH-A1FN-01A-11D-A13L-09		TCGA-BH-A1FN-01A-11D-A13L-09	TCGA-BH-A1FN-01A-21-A17I-20	TCGA-BH-A1FN-01A-11D-A13L-09	c870e04b-c3b7-495c-8465-7ef2a00fadc7	ce3297a5-e5d6-4abb-a771-4a5d8c4da516	TCGA-BH-A1FN-01A-11D-A13J-01	c870e04b-c3b7-495c-8465-7ef2a00fadc7	TCGA-BH-A1FN-01A-11D-A13K-05	TCGA-BH-A1FN-01		c870e04b-c3b7-495c-8465-7ef2a00fadc7	c870e04b-c3b7-495c-8465-7ef2a00fadc7	TCGA-BH-A1FN-01A-11D-A13J-01		TCGA-BH-A1FN-01		ce3297a5-e5d6-4abb-a771-4a5d8c4da516	
TCGA-BH-A1FN-11		34				2192		FEMALE									2192	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1FN-11	2192	1		C3-BRCA/Luminal							mutation cluster 5	TCGA-BH-A1FN			2192	Breast	TCGA Breast Cancer	breast invasive carcinoma					34	Right Upper Outer Quadrant					Positive					Positive	Other					-12525	4838	2192	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy		NO				29																														0		true	M0	N0	T2	Stage IIA			0		0		0		0		100		0		0		0	WITH TUMOR							YES	No				Solid Tissue Normal	11	segmental mastectomy with axillary lymph node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1997			TCGA-BH-A1FN-11A-34R-A13P-13	TCGA-BH-A1FN-11A-34R-A13P-13						48353101-484c-4d47-ae60-239d710ec00a			48353101-484c-4d47-ae60-239d710ec00a	TCGA-BH-A1FN-11A-34D-A13T-05			48353101-484c-4d47-ae60-239d710ec00a	48353101-484c-4d47-ae60-239d710ec00a						
TCGA-BH-A1FR-01	Stage IIIB	73	1	No_Conversion		4398	Positive	FEMALE	Negative				Negative	M0	Positive	N1	4398	1	LumA		Positive				enrollment	T_Other	T4	DECEASED	1	TCGA-BH-A1FR-01	4398	1	Quiet	C3-BRCA/Luminal	cluster 2	KIRC-like c17	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-BH-A1FR			4398	Breast	TCGA Breast Cancer	breast invasive carcinoma					73	Right Upper Inner Quadrant					Positive					Positive	Other					-26684	4876	4398	0													2011-9-8	FEMALE										Other  specify	infiltrating ductal carcinoma with apocrine and clear cell along with microcalcifications	No		C50.9	8523/3	C50.9		YES		Core needle biopsy	110	NO				10																				2	1									4		true	M0	N1a	T4b	Stage IIIB	TCGA-BH-A1FR.B6E6765F-14BC-4D3D-9266-EF8065354070.pdf		1		1		0		0		1		14		85		85	WITH TUMOR							YES	No				Primary Tumor	01	segmental mastectomy with excision of mass on chest wall and axillary node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1997	TCGA-BH-A1FR-01A-11D-A13L-09		TCGA-BH-A1FR-01A-11R-A13P-13	TCGA-BH-A1FR-01A-11R-A13P-13	TCGA-BH-A1FR-01A-11D-A13L-09		TCGA-BH-A1FR-01A-11D-A13L-09	TCGA-BH-A1FR-01A-21-A17I-20	TCGA-BH-A1FR-01A-11D-A13L-09	56d5aac4-62b4-43e4-b0e4-f40b19a5893f	8e5ce7fa-08f9-4610-bb85-dd59c335ebbd	TCGA-BH-A1FR-01A-11D-A13J-01	56d5aac4-62b4-43e4-b0e4-f40b19a5893f	TCGA-BH-A1FR-01A-11D-A13K-05	TCGA-BH-A1FR-01		56d5aac4-62b4-43e4-b0e4-f40b19a5893f	56d5aac4-62b4-43e4-b0e4-f40b19a5893f	TCGA-BH-A1FR-01A-11D-A13J-01		TCGA-BH-A1FR-01		8e5ce7fa-08f9-4610-bb85-dd59c335ebbd	
TCGA-BH-A1FR-11		73				4398		FEMALE									4398	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1FR-11	4398	1		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1FR			4398	Breast	TCGA Breast Cancer	breast invasive carcinoma					73	Right Upper Inner Quadrant					Positive					Positive	Other					-26684	4876	4398	0													2011-9-8	FEMALE										Other  specify	infiltrating ductal carcinoma with apocrine and clear cell along with microcalcifications	No		C50.9	8523/3	C50.9		YES		Core needle biopsy	310	NO				10																														4		false	M0	N1a	T4b	Stage IIIB			5		3		0		1		3		97		0		0	WITH TUMOR							YES	No				Solid Tissue Normal	11	segmental mastectomy with excision of mass on chest wall and axillary node dissection	5th		NO	YES	BH	Breast	B	DECEASED	1997			TCGA-BH-A1FR-11B-42R-A13P-13	TCGA-BH-A1FR-11B-42R-A13P-13						c2db17b1-c288-4f73-8e22-22929d846678			c2db17b1-c288-4f73-8e22-22929d846678	TCGA-BH-A1FR-11B-42D-A13T-05			c2db17b1-c288-4f73-8e22-22929d846678	c2db17b1-c288-4f73-8e22-22929d846678						
TCGA-BH-A1FU-01	Stage IA	44	4	Stage I		2192	Negative	FEMALE	Positive				Negative	M0	Negative	N0	2192	1	Normal		Negative				enrollment	T1	T1	DECEASED	1	TCGA-BH-A1FU-01	2192	1	Kirc+	C3-BRCA/Luminal	cluster 1	Cluster 5		BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 5	TCGA-BH-A1FU			2192	Breast	TCGA Breast Cancer	breast invasive carcinoma					44	Right Upper Outer Quadrant					Negative					Negative	Modified Radical Mastectomy					-16174	5041	2192	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	110	NO				5																				1	6									0		true	M0	N0	T1c	Stage IA	TCGA-BH-A1FU.58B02C83-2AF7-4978-A3F7-A8B9E0D914A1.pdf		2		1		2		1		3		35		60		60	WITH TUMOR							YES	No				Primary Tumor	01	with axillary node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1997	TCGA-BH-A1FU-01A-11D-A14G-09		TCGA-BH-A1FU-01A-11R-A14C-13	TCGA-BH-A1FU-01A-11R-A14C-13	TCGA-BH-A1FU-01A-11D-A14G-09		TCGA-BH-A1FU-01A-11D-A14G-09		TCGA-BH-A1FU-01A-11D-A14G-09	05a4f4ff-cdfd-4332-8146-066657a4c3cc	7a83fa45-d75d-40c9-a35a-2f6b5e1e70ee	TCGA-BH-A1FU-01A-11D-A14F-01	05a4f4ff-cdfd-4332-8146-066657a4c3cc	TCGA-BH-A1FU-01A-11D-A14H-05	TCGA-BH-A1FU-01		05a4f4ff-cdfd-4332-8146-066657a4c3cc	05a4f4ff-cdfd-4332-8146-066657a4c3cc	TCGA-BH-A1FU-01A-11D-A14F-01		TCGA-BH-A1FU-01		7a83fa45-d75d-40c9-a35a-2f6b5e1e70ee	
TCGA-BH-A1FU-11		44				2192		FEMALE									2192	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1FU-11	2192	1		C3-BRCA/Luminal							mutation cluster 5	TCGA-BH-A1FU			2192	Breast	TCGA Breast Cancer	breast invasive carcinoma					44	Right Upper Outer Quadrant					Negative					Negative	Modified Radical Mastectomy					-16174	5041	2192	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	190	NO				5																														0		true	M0	N0	T1c	Stage IA			1		1		0		0		2		98		0		0	WITH TUMOR							YES	No				Solid Tissue Normal	11	with axillary node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1997			TCGA-BH-A1FU-11A-23R-A14C-13	TCGA-BH-A1FU-11A-23R-A14C-13						df661ba2-098b-49e0-884c-27cf2ecd87f2			df661ba2-098b-49e0-884c-27cf2ecd87f2				df661ba2-098b-49e0-884c-27cf2ecd87f2	df661ba2-098b-49e0-884c-27cf2ecd87f2						
TCGA-BH-A201-01		64	5		209		Positive	FEMALE									209	0	LumA		Positive				enrollment			LIVING	0	TCGA-BH-A201-01	856	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 9	cluster 6	mutation c1uster 9	TCGA-BH-A201	856	0	856	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Left			TCGA-BH-A201-F64222		Positive					Positive	Other					-23423			0	856												2014-8-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative		NO	2		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6								NO	0			M0	N0	T1	Stage IA																		TUMOR FREE						NO	YES	No			YES	Primary Tumor	01	segmental mastectomy with sentinel lymph node biopsy and wire localization	7th		NO	YES	BH	Breast		LIVING	2011	TCGA-BH-A201-01A-11D-A14K-09		TCGA-BH-A201-01A-11R-A14L-13	TCGA-BH-A201-01A-11R-A14L-13	TCGA-BH-A201-01A-11D-A14K-09		TCGA-BH-A201-01A-11D-A14K-09	TCGA-BH-A201-01A-21-A17I-20	TCGA-BH-A201-01A-11D-A14K-09	a7050752-eefd-4576-a304-c79dc6fa30e7	f4e002a0-1f2f-4ffd-bff9-8020c931d51b	TCGA-BH-A201-01A-11D-A14J-01	a7050752-eefd-4576-a304-c79dc6fa30e7	TCGA-BH-A201-01A-11D-A14N-05	TCGA-BH-A201-01		a7050752-eefd-4576-a304-c79dc6fa30e7	a7050752-eefd-4576-a304-c79dc6fa30e7	TCGA-BH-A201-01A-11D-A14J-01		TCGA-BH-A201-01		f4e002a0-1f2f-4ffd-bff9-8020c931d51b	
TCGA-BH-A202-01		60	2		22		Positive	FEMALE									22	0	LumB		Positive				enrollment			LIVING	0	TCGA-BH-A202-01	795	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 3	TCGA-BH-A202	795	0	795	Breast	TCGA Breast Cancer	breast invasive carcinoma					60	Left			TCGA-BH-A202-F64226		Positive					Positive	Other					-22052	62		0	795												2014-8-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Positive		NO	4		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6								NO	0		true	M0	N0	T2	Stage II	TCGA-BH-A202.57323AE5-3EFE-4492-8522-D9A6DB3F1BE0.pdf		0		0		10		0		0		40		50		70	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01	segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2011	TCGA-BH-A202-01A-11D-A14K-09		TCGA-BH-A202-01A-11R-A14L-13	TCGA-BH-A202-01A-11R-A14L-13	TCGA-BH-A202-01A-11D-A14K-09		TCGA-BH-A202-01A-11D-A14K-09	TCGA-BH-A202-01A-21-A17K-20	TCGA-BH-A202-01A-11D-A14K-09	d3169d74-dd69-4c6b-8232-6e15ac2920b9	6a4af154-27d5-4a5d-9d88-1f4db2dc70d8	TCGA-BH-A202-01A-11D-A14J-01	d3169d74-dd69-4c6b-8232-6e15ac2920b9	TCGA-BH-A202-01A-11D-A14N-05	TCGA-BH-A202-01		d3169d74-dd69-4c6b-8232-6e15ac2920b9	d3169d74-dd69-4c6b-8232-6e15ac2920b9	TCGA-BH-A202-01A-11D-A14J-01		TCGA-BH-A202-01		6a4af154-27d5-4a5d-9d88-1f4db2dc70d8	
TCGA-BH-A203-01		78	3			1174		FEMALE									1174	1	Her2						enrollment			DECEASED	1	TCGA-BH-A203-01	1174	1	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4		mutation cluster 4	TCGA-BH-A203			1174	Breast	TCGA Breast Cancer	breast invasive carcinoma					78	Right											Other					-28609		1174	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES								39		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3										35			M0	N1b	T2	Stage IIB																		WITH TUMOR							YES	No				Primary Tumor	01	segmental mastectomy with axillary dissection	5th		NO	YES	BH	Breast		DECEASED	1996	TCGA-BH-A203-01A-12D-A167-09		TCGA-BH-A203-01A-12R-A168-13	TCGA-BH-A203-01A-12R-A168-13	TCGA-BH-A203-01A-12D-A167-09		TCGA-BH-A203-01A-12D-A167-09	TCGA-BH-A203-01A-21-A17K-20	TCGA-BH-A203-01A-12D-A167-09	ff6fb75e-aefc-44e3-accd-c4f690a51cca	ee9ecf8c-e528-40b6-a196-eb1f2689a397	TCGA-BH-A203-01A-12D-A166-01	ff6fb75e-aefc-44e3-accd-c4f690a51cca	TCGA-BH-A203-01A-12D-A16A-05	TCGA-BH-A203-01		ff6fb75e-aefc-44e3-accd-c4f690a51cca	ff6fb75e-aefc-44e3-accd-c4f690a51cca	TCGA-BH-A203-01A-12D-A166-01		TCGA-BH-A203-01		ee9ecf8c-e528-40b6-a196-eb1f2689a397	
TCGA-BH-A203-11		78				1174		FEMALE									1174	1	Normal						enrollment			DECEASED	1	TCGA-BH-A203-11	1174	1		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A203			1174	Breast	TCGA Breast Cancer	breast invasive carcinoma					78	Right											Other					-28609	5418	1174	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			480	NO				39		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												35		false	M0	N1b	T2	Stage IIB			0		0		0		0		100		0		0		0	WITH TUMOR							YES	No				Solid Tissue Normal	11	segmental mastectomy with axillary dissection	5th		NO	YES	BH	Breast	A	DECEASED	1996			TCGA-BH-A203-11A-42R-A168-13	TCGA-BH-A203-11A-42R-A168-13						6e5015d8-55e8-448a-9663-7b8625f170ae			6e5015d8-55e8-448a-9663-7b8625f170ae	TCGA-BH-A203-11A-42D-A16A-05			6e5015d8-55e8-448a-9663-7b8625f170ae	6e5015d8-55e8-448a-9663-7b8625f170ae						
TCGA-BH-A204-01		80	4			2534		FEMALE									2534	1	LumB						enrollment			DECEASED	1	TCGA-BH-A204-01	2534	1	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6		mutation cluster 14	TCGA-BH-A204			2534	Breast	TCGA Breast Cancer	breast invasive carcinoma					80	Left											Modified Radical Mastectomy					-29529	5538	2534	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	420	NO				16		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3										2		true	M0	N1b	T2	Stage IIB	TCGA-BH-A204.531B1E8E-9936-42E0-B49B-39C61DD4E943.pdf		0		0		0		0		5		15		80		85								YES	No				Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	1996	TCGA-BH-A204-01A-11D-A159-09		TCGA-BH-A204-01A-11R-A156-13	TCGA-BH-A204-01A-11R-A156-13	TCGA-BH-A204-01A-11D-A159-09		TCGA-BH-A204-01A-11D-A159-09	TCGA-BH-A204-01A-21-A17K-20	TCGA-BH-A204-01A-11D-A159-09	19c3c4c7-d34c-47d5-b09f-c5671f49b858	88bb74ad-b634-48d4-a342-83850d37069a	TCGA-BH-A204-01A-11D-A160-01	19c3c4c7-d34c-47d5-b09f-c5671f49b858	TCGA-BH-A204-01A-11D-A161-05	TCGA-BH-A204-01		19c3c4c7-d34c-47d5-b09f-c5671f49b858	19c3c4c7-d34c-47d5-b09f-c5671f49b858	TCGA-BH-A204-01A-11D-A160-01		TCGA-BH-A204-01		88bb74ad-b634-48d4-a342-83850d37069a	
TCGA-BH-A204-11		80				2534		FEMALE									2534	1	Normal						enrollment			DECEASED	1	TCGA-BH-A204-11	2534	1		C3-BRCA/Luminal							mutation cluster 14	TCGA-BH-A204			2534	Breast	TCGA Breast Cancer	breast invasive carcinoma					80	Left											Modified Radical Mastectomy					-29529	5538	2534	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	450	NO				16		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												2		false	M0	N1b	T2	Stage IIB			0		0		0		0		100		0		0		0								YES	No				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	A	DECEASED	1996			TCGA-BH-A204-11A-53R-A156-13	TCGA-BH-A204-11A-53R-A156-13						6b52803e-274b-4a1b-910f-2d307932bbb2			6b52803e-274b-4a1b-910f-2d307932bbb2	TCGA-BH-A204-11A-53D-A161-05			6b52803e-274b-4a1b-910f-2d307932bbb2	6b52803e-274b-4a1b-910f-2d307932bbb2						
TCGA-BH-A208-01		48	3			1759		FEMALE									1759	1	Normal						enrollment			DECEASED	1	TCGA-BH-A208-01	1759	1	High	C3-BRCA/Luminal	cluster 5	OV-like c1	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 11		mutation cluster 8	TCGA-BH-A208			1759	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Left											Other					-17715	5893	1759	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	620	NO				15																				5										3		true	M0	N1b	T2	Stage IIB	TCGA-BH-A208.4F943D12-E769-45F3-86BE-75193786DD4E.pdf		0		0		0		0		0		0		100		60	TUMOR FREE							YES	No				Primary Tumor	01	left mastectomy with reconstruction tissue expand with axillary nodes dissection	5th		NO	YES	BH	Breast	A	DECEASED	1995	TCGA-BH-A208-01A-11D-A159-09		TCGA-BH-A208-01A-11R-A156-13	TCGA-BH-A208-01A-11R-A156-13	TCGA-BH-A208-01A-11D-A159-09		TCGA-BH-A208-01A-11D-A159-09	TCGA-BH-A208-01A-21-A17K-20	TCGA-BH-A208-01A-11D-A159-09	7a276d04-8f45-4c07-9c24-8b1f50a1202d	c2ab364e-16f8-47de-a506-35ec95fcd29d	TCGA-BH-A208-01A-11D-A160-01	7a276d04-8f45-4c07-9c24-8b1f50a1202d	TCGA-BH-A208-01A-11D-A161-05	TCGA-BH-A208-01		7a276d04-8f45-4c07-9c24-8b1f50a1202d	7a276d04-8f45-4c07-9c24-8b1f50a1202d	TCGA-BH-A208-01A-11D-A160-01		TCGA-BH-A208-01		c2ab364e-16f8-47de-a506-35ec95fcd29d	
TCGA-BH-A208-11		48				1759		FEMALE									1759	1	Normal						enrollment			DECEASED	1	TCGA-BH-A208-11	1759	1		C3-BRCA/Luminal							mutation cluster 8	TCGA-BH-A208			1759	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Left											Other					-17715	5893	1759	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	920	NO				15																														3		false	M0	N1b	T2	Stage IIB			0		0		0		0		100		0		0		0	TUMOR FREE							YES	No				Solid Tissue Normal	11	left mastectomy with reconstruction tissue expand with axillary nodes dissection	5th		NO	YES	BH	Breast	A	DECEASED	1995			TCGA-BH-A208-11A-51R-A156-13	TCGA-BH-A208-11A-51R-A156-13						a0ac3d9f-7700-4319-929a-fb51d85c9d49			a0ac3d9f-7700-4319-929a-fb51d85c9d49	TCGA-BH-A208-11A-51D-A161-05			a0ac3d9f-7700-4319-929a-fb51d85c9d49	a0ac3d9f-7700-4319-929a-fb51d85c9d49						
TCGA-BH-A209-01		77	4			3959	Positive	FEMALE									3959	1	LumB		Positive				enrollment			DECEASED	1	TCGA-BH-A209-01	3959	1	High	C3-BRCA/Luminal	cluster 3	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7		mutation cluster 14	TCGA-BH-A209			3959	Breast	TCGA Breast Cancer	breast invasive carcinoma					77	Left Upper Outer Quadrant					Positive					Positive	Other					-28403	5392	3959	0													2011-9-8	FEMALE										Medullary Carcinoma		No		C50.9	8510/3	C50.9		YES		Fine needle aspiration biopsy	390	NO				12		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3										0		true	M0	N0	T1c	Stage I	TCGA-BH-A209.E28150CE-E9B6-4C3F-B867-F9A75E2648DC.pdf		0		0		0		0		0		20		80		60	TUMOR FREE							YES	No				Primary Tumor	01	segmental with axillary lymph node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1996	TCGA-BH-A209-01A-11D-A17G-09		TCGA-BH-A209-01A-11R-A156-13	TCGA-BH-A209-01A-11R-A156-13	TCGA-BH-A209-01A-11D-A17G-09		TCGA-BH-A209-01A-11D-A17G-09	TCGA-BH-A209-01A-21-A17K-20	TCGA-BH-A209-01A-11D-A17G-09	9073fc5c-a281-4ed2-a66e-5235a5a55098	7e96d825-cf43-4caa-b6be-9a972e9295f3	TCGA-BH-A209-01A-11D-A160-01	9073fc5c-a281-4ed2-a66e-5235a5a55098	TCGA-BH-A209-01A-11D-A161-05	TCGA-BH-A209-01		9073fc5c-a281-4ed2-a66e-5235a5a55098	9073fc5c-a281-4ed2-a66e-5235a5a55098	TCGA-BH-A209-01A-11D-A160-01		TCGA-BH-A209-01		7e96d825-cf43-4caa-b6be-9a972e9295f3	
TCGA-BH-A209-11		77				3959		FEMALE									3959	1	Normal						enrollment			DECEASED	1	TCGA-BH-A209-11	3959	1		C3-BRCA/Luminal							mutation cluster 14	TCGA-BH-A209			3959	Breast	TCGA Breast Cancer	breast invasive carcinoma					77	Left Upper Outer Quadrant					Positive					Positive	Other					-28403	5392	3959	0													2011-9-8	FEMALE										Medullary Carcinoma		No		C50.9	8510/3	C50.9		YES		Fine needle aspiration biopsy	400	NO				12		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		false	M0	N0	T1c	Stage I			0		0		0		0		100		0		0		0	TUMOR FREE							YES	No				Solid Tissue Normal	11	segmental with axillary lymph node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1996			TCGA-BH-A209-11A-42R-A156-13	TCGA-BH-A209-11A-42R-A156-13						7a4e994d-ed10-45e7-9107-51dc02068963			7a4e994d-ed10-45e7-9107-51dc02068963	TCGA-BH-A209-11A-42D-A161-05			7a4e994d-ed10-45e7-9107-51dc02068963	7a4e994d-ed10-45e7-9107-51dc02068963						
TCGA-BH-A28O-01																													0	TCGA-BH-A28O-01	324	0	Quiet			Low purity c2			miRNA cluster 4			TCGA-BH-A28O			324	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Right Lower Outer Quadrant	Sentinel node biopsy alone				Positive					Positive			NO			-18501	163		0	324					NO							2012-7-2	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	80	NO	Negative			14	Negative																													14		true	M0	N3	T3a	Stage IIIC	TCGA-BH-A28O.12A869FC-7578-4506-BB23-7C25597834EA.pdf		0		0		0		0		15		45		40		70	TUMOR FREE							YES	No				Primary Tumor	01		7th		YES	NO	BH	Breast	A	LIVING	2010			TCGA-BH-A28O-01A-11R-A22I-13	TCGA-BH-A28O-01A-11R-A22I-13			TCGA-BH-A28O-01A-11D-A228-09			7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b	1ffca953-dced-4469-959f-307bb3670a56	TCGA-BH-A28O-01A-11D-A227-01	7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b	TCGA-BH-A28O-01A-11D-A22B-05	TCGA-BH-A28O-01		7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b	7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b	TCGA-BH-A28O-01A-11D-A227-01		TCGA-BH-A28O-01		1ffca953-dced-4469-959f-307bb3670a56	
TCGA-BH-A28Q-01		46	2		196		Positive	FEMALE									196	0	LumA		Positive				enrollment			LIVING	0	TCGA-BH-A28Q-01	196	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3		mutation c1uster 9	TCGA-BH-A28Q			196	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Right					Positive					Positive	Modified Radical Mastectomy					-16882	223		0	196												2011-9-29	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	400	NO	Negative	Indeterminate		18		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4										2		true	M0	N1a	T2	Stage IIB	TCGA-BH-A28Q.9D040C65-C225-4D41-BA4C-6BB21EC1CD32.pdf		40		20		0		20		0		20		80		80	TUMOR FREE							YES	No				Primary Tumor	01	with axillary node dissection and prophylactic left simple mastectomy	7th		NO	YES	BH	Breast	A	LIVING	2010	TCGA-BH-A28Q-01A-11D-A16D-09		TCGA-BH-A28Q-01A-11R-A16E-13	TCGA-BH-A28Q-01A-11R-A16E-13	TCGA-BH-A28Q-01A-11D-A16D-09		TCGA-BH-A28Q-01A-11D-A16D-09	TCGA-BH-A28Q-01A-21-A17K-20	TCGA-BH-A28Q-01A-11D-A16D-09	5427eb83-38f3-4258-b241-25efae8fa70a	f40a7b59-1b58-45d6-940b-3b33b6ca261a	TCGA-BH-A28Q-01A-11D-A16C-01	5427eb83-38f3-4258-b241-25efae8fa70a	TCGA-BH-A28Q-01A-11D-A16G-05	TCGA-BH-A28Q-01		5427eb83-38f3-4258-b241-25efae8fa70a	5427eb83-38f3-4258-b241-25efae8fa70a	TCGA-BH-A28Q-01A-11D-A16C-01		TCGA-BH-A28Q-01		f40a7b59-1b58-45d6-940b-3b33b6ca261a	
TCGA-BH-A2L8-01																			LumA										0	TCGA-BH-A2L8-01	612	0	Kirc+	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-BH-A2L8	612	0	612	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-BH-A2L8-F39616		Positive					Positive	Other		NO			-16658			0	612					NO		70-79%					2013-1-28	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Negative	Negative	NO	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0	0		M0	N0 (i-)	T2	Stage IIA																		TUMOR FREE				Oncotype Dx test	Oncotype Dx test	YES	YES	No	80-89%		NO	Primary Tumor	01	TOTAL MASTECTOMY	7th		YES	NO	BH	Breast		LIVING	2011			TCGA-BH-A2L8-01A-11R-A18L-13	TCGA-BH-A2L8-01A-11R-A18L-13			TCGA-BH-A2L8-01A-11D-A18P-09	TCGA-BH-A2L8-01A-21-A24A-20		c55bb0b8-3417-4142-97f8-c43f1ec56496	cf4b7782-45d9-4dfc-b36d-af59befa7c03	TCGA-BH-A2L8-01A-11D-A18N-01	c55bb0b8-3417-4142-97f8-c43f1ec56496	TCGA-BH-A2L8-01A-11D-A18O-05	TCGA-BH-A2L8-01		c55bb0b8-3417-4142-97f8-c43f1ec56496	c55bb0b8-3417-4142-97f8-c43f1ec56496	TCGA-BH-A2L8-01A-11D-A18N-01		TCGA-BH-A2L8-01		cf4b7782-45d9-4dfc-b36d-af59befa7c03	
TCGA-BH-A42T-01																													1	TCGA-BH-A42T-01	320	1										TCGA-BH-A42T	320	0	320	Breast	TCGA Breast Cancer	breast invasive carcinoma					75	Left	Sentinel node biopsy alone		TCGA-BH-A42T-F61922		Positive					Positive	Simple Mastectomy					-27731	80	320	0	30												2014-7-10	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	130	NO	Positive	Equivocal	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO		1	true	M0	N0 (i+)	T2	Stage IIA	TCGA-BH-A42T.3FFD87C3-1E75-4A8E-AA26-BF7995E42245.pdf		2		0		3		0		0		25		72		90	TUMOR FREE						NO	YES	No			NO	Primary Tumor	01		7th		YES	NO	BH	Breast	A	DECEASED	2012			TCGA-BH-A42T-01A-11R-A24J-13	TCGA-BH-A42T-01A-11R-A24J-13			TCGA-BH-A42T-01A-11D-A243-09			59b2f0cb-4789-4642-9aa6-605a1ebb0e32	a91f1e9c-3bb5-4b46-b62c-ae39f70f183f	TCGA-BH-A42T-01A-11D-A242-01	59b2f0cb-4789-4642-9aa6-605a1ebb0e32	TCGA-BH-A42T-01A-11D-A244-05	TCGA-BH-A42T-01		59b2f0cb-4789-4642-9aa6-605a1ebb0e32	59b2f0cb-4789-4642-9aa6-605a1ebb0e32	TCGA-BH-A42T-01A-11D-A242-01		TCGA-BH-A42T-01		a91f1e9c-3bb5-4b46-b62c-ae39f70f183f	
TCGA-BH-A42U-01																													0	TCGA-BH-A42U-01	3324	0										TCGA-BH-A42U	3324	0	3324	Breast	TCGA Breast Cancer	breast invasive carcinoma					80	Right					Negative					Negative	Simple Mastectomy					-29330			0	3324												2012-10-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO				MX	N0	T1a	Stage IA																								NO	YES	No			NO	Primary Tumor	01		7th		YES	NO	BH	Breast		LIVING	2004			TCGA-BH-A42U-01A-12R-A24J-13	TCGA-BH-A42U-01A-12R-A24J-13			TCGA-BH-A42U-01A-12D-A243-09			b3ce7ee4-fc5e-445c-b1ca-5f324b33678a	ede65d88-d290-4017-b9d7-9be40d87e6b0	TCGA-BH-A42U-01A-12D-A242-01	b3ce7ee4-fc5e-445c-b1ca-5f324b33678a	TCGA-BH-A42U-01A-12D-A244-05	TCGA-BH-A42U-01		b3ce7ee4-fc5e-445c-b1ca-5f324b33678a	b3ce7ee4-fc5e-445c-b1ca-5f324b33678a	TCGA-BH-A42U-01A-12D-A242-01		TCGA-BH-A42U-01		ede65d88-d290-4017-b9d7-9be40d87e6b0	
TCGA-BH-A42V-01																													0	TCGA-BH-A42V-01	272	0										TCGA-BH-A42V			272	Breast	TCGA Breast Cancer	breast invasive carcinoma					41	Left Lower Outer Quadrant	Sentinel node biopsy alone			Negative	Positive				Other	Positive	Modified Radical Mastectomy	Reexcision of segmental mastectomy				-15158	197		0	272												2013-1-17	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	60	NO	Negative			3	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											YES	1		true	M0	N1mi	T1c	Stage IB	TCGA-BH-A42V.5BB5CEFD-CC07-4451-A774-25FB146067C7.pdf		3		0		0		0		0		45		55		85	TUMOR FREE						NO	YES	No			NO	Primary Tumor	01		7th		YES	NO	BH	Breast	A	LIVING	2012			TCGA-BH-A42V-01A-11R-A24J-13	TCGA-BH-A42V-01A-11R-A24J-13			TCGA-BH-A42V-01A-11D-A243-09			2fa59be9-ecde-49b2-b109-7000d5180847	6803e7ad-1c44-43ac-999a-05ec8bc5138e	TCGA-BH-A42V-01A-11D-A242-01	2fa59be9-ecde-49b2-b109-7000d5180847	TCGA-BH-A42V-01A-11D-A244-05	TCGA-BH-A42V-01		2fa59be9-ecde-49b2-b109-7000d5180847	2fa59be9-ecde-49b2-b109-7000d5180847	TCGA-BH-A42V-01A-11D-A242-01		TCGA-BH-A42V-01		6803e7ad-1c44-43ac-999a-05ec8bc5138e	
TCGA-BH-A5IZ-01																													0	TCGA-BH-A5IZ-01	567	0										TCGA-BH-A5IZ	567	0	567	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Left			TCGA-BH-A5IZ-F63663		Positive					Negative	Lumpectomy					-18927	140		0	567												2014-8-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Core needle biopsy	70	NO	Negative	Negative	NO	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1		true	cM0 (i+)	N1a	T2	Stage IIB	TCGA-BH-A5IZ.52B5D974-2653-44CA-937D-5467EE39938B.pdf		3		0		0		0		0		0		100		75	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th		YES	NO	BH	Breast	A	LIVING	2012			TCGA-BH-A5IZ-01A-11R-A27U-13	TCGA-BH-A5IZ-01A-11R-A27U-13			TCGA-BH-A5IZ-01A-11D-A27P-09			39033a17-79c9-4723-9fa7-fa82f67f5344	368b8969-b847-4f91-8054-231f26eb565d	TCGA-BH-A5IZ-01A-11D-A27O-01	39033a17-79c9-4723-9fa7-fa82f67f5344		TCGA-BH-A5IZ-01		39033a17-79c9-4723-9fa7-fa82f67f5344	39033a17-79c9-4723-9fa7-fa82f67f5344	TCGA-BH-A5IZ-01A-11D-A27O-01		TCGA-BH-A5IZ-01		368b8969-b847-4f91-8054-231f26eb565d	
TCGA-BH-A5J0-01																													0	TCGA-BH-A5J0-01	715	0										TCGA-BH-A5J0	715	0	715	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Left			TCGA-BH-A5J0-F63664		Positive					Positive	Simple Mastectomy					-23072	184		0	715												2014-8-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Core needle biopsy	70	NO	Negative		NO	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		true	M0	N0	T1c	Stage IA	TCGA-BH-A5J0.80DA141E-2752-4464-8D23-06DC7E9B05FE.pdf		2		0		0		0		0		25		75		75	TUMOR FREE						NO	YES	No			NO	Primary Tumor	01		7th		YES	NO	BH	Breast	A	LIVING	2012			TCGA-BH-A5J0-01A-11R-A27U-13	TCGA-BH-A5J0-01A-11R-A27U-13			TCGA-BH-A5J0-01A-11D-A27P-09			a5f14d53-fe35-494e-b6b1-bc5c8484e4a9	57be94f9-39e9-4dbd-982c-78fc7cb9bdda	TCGA-BH-A5J0-01A-11D-A27O-01	a5f14d53-fe35-494e-b6b1-bc5c8484e4a9		TCGA-BH-A5J0-01		a5f14d53-fe35-494e-b6b1-bc5c8484e4a9	a5f14d53-fe35-494e-b6b1-bc5c8484e4a9	TCGA-BH-A5J0-01A-11D-A27O-01		TCGA-BH-A5J0-01		57be94f9-39e9-4dbd-982c-78fc7cb9bdda	
TCGA-BH-A6R8-01																													0	TCGA-BH-A6R8-01	293	0										TCGA-BH-A6R8	293	0	293	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Left			TCGA-BH-A6R8-F63677		Positive					Positive	Lumpectomy					-16829	260		0	293												2014-8-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Core needle biopsy	170	NO		Negative	NO	4	Negative																												NO	0		true	M0	N0	T2	Stage IIA	TCGA-BH-A6R8.BF07FF13-D7EE-40E1-9729-8F9CCBD1534F.pdf		5		1		0		1		10		5		85		85	TUMOR FREE						NO	YES	No			YES	Primary Tumor	01		7th		YES	NO	BH	Breast	A	LIVING	2012			TCGA-BH-A6R8-01A-21R-A33A-13	TCGA-BH-A6R8-01A-21R-A33A-13						2bea5d05-bcad-4a2e-8954-462b589a8aa4	7304a16f-da9e-4769-90e7-8bf1439fbfb1	TCGA-BH-A6R8-01A-21D-A33D-01	2bea5d05-bcad-4a2e-8954-462b589a8aa4	TCGA-BH-A6R8-01A-21D-A33F-05	TCGA-BH-A6R8-01		2bea5d05-bcad-4a2e-8954-462b589a8aa4	2bea5d05-bcad-4a2e-8954-462b589a8aa4	TCGA-BH-A6R8-01A-21D-A33D-01		TCGA-BH-A6R8-01		7304a16f-da9e-4769-90e7-8bf1439fbfb1	
TCGA-BH-A6R9-01																													0	TCGA-BH-A6R9-01	160	0										TCGA-BH-A6R9	160	0	160	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Left			TCGA-BH-A6R9-F63678		Negative					Positive	Modified Radical Mastectomy					-22325	237		0	160												2014-8-15	FEMALE										Metaplastic Carcinoma		No		C50.9	8575/3	C50.1		YES		Core needle biopsy	220	NO	Negative		NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO			true	M0	N0	T2	Stage IIA	TCGA-BH-A6R9.1DB8FAFB-FC4A-4401-8316-30FB5352335D.pdf		5		2		5		2		10		5		80		80	TUMOR FREE						NO		No			NO	Primary Tumor	01		7th		YES	NO	BH	Breast	A	LIVING	2012			TCGA-BH-A6R9-01A-21R-A32K-13	TCGA-BH-A6R9-01A-21R-A32K-13						7c73dae6-4478-4cbc-aee1-0b18e730f7a2	11010d89-eaee-41ba-b77b-cf1ac4f893a8	TCGA-BH-A6R9-01A-21D-A32H-01	7c73dae6-4478-4cbc-aee1-0b18e730f7a2	TCGA-BH-A6R9-01A-21D-A32T-05	TCGA-BH-A6R9-01		7c73dae6-4478-4cbc-aee1-0b18e730f7a2	7c73dae6-4478-4cbc-aee1-0b18e730f7a2	TCGA-BH-A6R9-01A-21D-A32H-01		TCGA-BH-A6R9-01		11010d89-eaee-41ba-b77b-cf1ac4f893a8	
TCGA-BH-A8FY-01																													1	TCGA-BH-A8FY-01	295	1										TCGA-BH-A8FY	295	0	295	Breast	TCGA Breast Cancer	breast invasive carcinoma					87	Left|Left Upper Outer Quadrant|Left Lower Outer Quadrant					Positive					Positive	Simple Mastectomy					-31932	477	295	0													2014-3-25	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			200	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		true	M0	N0 (i+)	T1c	Stage IA	TCGA-BH-A8FY.BC78EC6E-73C6-4234-9369-9A5586CD1A69.pdf		40		20		0		20		0		10		90		90	TUMOR FREE						NO	YES	Yes			NO	Primary Tumor	01		7th		YES	NO	BH	Breast	A	DECEASED	2012			TCGA-BH-A8FY-01A-11R-A36A-13	TCGA-BH-A8FY-01A-11R-A36A-13						f037b9d3-819b-429d-8e2d-fa8b27008e70	4ef71edc-9943-4036-a5e7-64d996970137	TCGA-BH-A8FY-01A-11D-A36I-01	f037b9d3-819b-429d-8e2d-fa8b27008e70	TCGA-BH-A8FY-01A-11D-A36K-05	TCGA-BH-A8FY-01		f037b9d3-819b-429d-8e2d-fa8b27008e70	f037b9d3-819b-429d-8e2d-fa8b27008e70	TCGA-BH-A8FY-01A-11D-A36I-01		TCGA-BH-A8FY-01		4ef71edc-9943-4036-a5e7-64d996970137	
TCGA-BH-A8FZ-01																													0	TCGA-BH-A8FZ-01	574	0										TCGA-BH-A8FZ	574	0	574	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Left			TCGA-BH-A8FZ-F63679		Positive					Positive	Simple Mastectomy					-21343	468		0	574												2014-8-27	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES		Core needle biopsy	190	NO	Equivocal		NO	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		true	M0	N0	T1b	Stage IA	TCGA-BH-A8FZ.A2B05D26-AC8E-4439-B32C-B48537D20836.pdf		40		20		0		20		5		25		70		70	TUMOR FREE						NO	YES	No			YES	Primary Tumor	01		7th		YES	NO	BH	Breast	A	LIVING	2012			TCGA-BH-A8FZ-01A-11R-A358-13	TCGA-BH-A8FZ-01A-11R-A358-13						2281c64c-9394-44f6-a4e7-87c7cce08c13	4a98eb15-a60d-4e8b-8aab-31ca9286549a	TCGA-BH-A8FZ-01A-11D-A350-01	2281c64c-9394-44f6-a4e7-87c7cce08c13	TCGA-BH-A8FZ-01A-11D-A357-05	TCGA-BH-A8FZ-01		2281c64c-9394-44f6-a4e7-87c7cce08c13	2281c64c-9394-44f6-a4e7-87c7cce08c13	TCGA-BH-A8FZ-01A-11D-A350-01		TCGA-BH-A8FZ-01		4a98eb15-a60d-4e8b-8aab-31ca9286549a	
TCGA-BH-A8G0-01																													0	TCGA-BH-A8G0-01	662	0										TCGA-BH-A8G0	662	0	662	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Left			TCGA-BH-A8G0-F64200		Positive					Positive	Simple Mastectomy					-19975	436		0	662												2014-8-27	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	110	NO	Negative		NO	3	Negative	Peri (6-12 months since last menstrual period)																											NO	3		true	M0	N1a	T2	Stage IIB	TCGA-BH-A8G0.22134EA5-5ED5-47B8-9A33-01E59E58B54C.pdf		40		20		0		20		10		30		60		60	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		7th		YES	NO	BH	Breast	A	LIVING	2012			TCGA-BH-A8G0-01A-11R-A358-13	TCGA-BH-A8G0-01A-11R-A358-13						8e9f7a7a-3115-4687-9fce-a97e4c3c9cde	4cd7d2c1-0d36-493c-8b3b-7c4148899fdc	TCGA-BH-A8G0-01A-11D-A350-01	8e9f7a7a-3115-4687-9fce-a97e4c3c9cde	TCGA-BH-A8G0-01A-11D-A357-05	TCGA-BH-A8G0-01		8e9f7a7a-3115-4687-9fce-a97e4c3c9cde	8e9f7a7a-3115-4687-9fce-a97e4c3c9cde	TCGA-BH-A8G0-01A-11D-A350-01		TCGA-BH-A8G0-01		4cd7d2c1-0d36-493c-8b3b-7c4148899fdc	
TCGA-BH-AB28-01																													0	TCGA-BH-AB28-01	185	0										TCGA-BH-AB28	185	0	185	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Left					Positive					Positive	Modified Radical Mastectomy					-19570	105		0	185												2014-6-30	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	440	NO	Negative	Indeterminate		20	Negative																												NO	3		true	M0	N1a	T3	Stage IIIA	TCGA-BH-AB28.3A87B5EE-D1AE-4D28-8F7A-3898AD4E0796.pdf		5		0		0		0		5		20		75		75	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		7th		YES	NO	BH	Breast	A	LIVING	2013			TCGA-BH-AB28-01A-31R-A41G-13	TCGA-BH-AB28-01A-31R-A41G-13						3cf4fddd-7fb5-4bb6-bca8-412019df4e2d	0edc855f-8b77-4822-980f-61d2547a588a	TCGA-BH-AB28-01A-31D-A41E-01	3cf4fddd-7fb5-4bb6-bca8-412019df4e2d	TCGA-BH-AB28-01A-31D-A41Q-05	TCGA-BH-AB28-01		3cf4fddd-7fb5-4bb6-bca8-412019df4e2d	3cf4fddd-7fb5-4bb6-bca8-412019df4e2d	TCGA-BH-AB28-01A-31D-A41E-01		TCGA-BH-AB28-01		0edc855f-8b77-4822-980f-61d2547a588a	
TCGA-C8-A12K-01	Stage IIB	80	1	No_Conversion	0			FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	0	0	Basal	Basal-like		Basal	-13	-12	enrollment	T_Other	T2	LIVING		TCGA-C8-A12K-01			High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 3	mutation cluster 8	TCGA-C8-A12K				Breast	TCGA Breast Cancer	breast invasive carcinoma					80	Right Upper Inner Quadrant	Other (specify)	Pateys surgery									Other		NO			-29463	57		0	0												2011-4-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	970	NO				7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3									1		true	M0	N1	T2	Stage IIB	TCGA-C8-A12K.149E102C-FE01-4FC0-8410-CD9743CAFA15.pdf	0	0	0	0	30	0	0	0	0	0	5	5	65	95	70	85	TUMOR FREE								No				Primary Tumor	01	Pateys surgery	6th		YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A12K-01A-21D-A10Y-09	TCGA-C8-A12K-01	TCGA-C8-A12K-01A-21R-A114-13	TCGA-C8-A12K-01A-21R-A114-13	TCGA-C8-A12K-01A-21D-A10Y-09	5daae9b4-734a-479f-a414-50e0629a8598	TCGA-C8-A12K-01A-21D-A10Y-09	TCGA-C8-A12K-01A-11-A13D-20	TCGA-C8-A12K-01A-21D-A10Y-09	0ef00203-8a0a-4d04-aa1e-c1164958d8ec	cab482fe-e5e3-438a-8ece-322111d17c4b	TCGA-C8-A12K-01A-21D-A111-01	0ef00203-8a0a-4d04-aa1e-c1164958d8ec		TCGA-C8-A12K-01	TCGA-C8-A12K-01A-21R-A115-07	0ef00203-8a0a-4d04-aa1e-c1164958d8ec	0ef00203-8a0a-4d04-aa1e-c1164958d8ec	TCGA-C8-A12K-01A-21D-A111-01	TCGA-C8-A12K-01	TCGA-C8-A12K-01	TCGA-C8-A12K-01A-21D-A112-05	cab482fe-e5e3-438a-8ece-322111d17c4b	
TCGA-C8-A12L-01	Stage IIA	67	1	Stage IIA	0		Negative	FEMALE	Positive	1	1	1	Negative	M0	Negative	N0	0	0	Her2	HER2-enriched	Negative	Her2	-11	-9	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12L-01	363	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-C8-A12L	363	0	363	Breast	TCGA Breast Cancer	breast invasive carcinoma					67	Right	Axillary lymph node dissection alone		TCGA-C8-A12L-F20258		Negative					Negative	Other					-24710	62		0	363											Scheduled Follow-up Submission	2012-1-9	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Suregery	Other method, specify:	460	NO	Equivocal			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO			true	M0	N0 (i-)	T2	Stage IIA	TCGA-C8-A12L.150DD5CB-1CA0-4110-95A7-6476B5B6FC24.pdf	0	0	0	0	30	5	0	0	0	0	5	10	65	85	85	80	TUMOR FREE								No			NO	Primary Tumor	01	Pateys Surgery	6th	NO	YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A12L-01A-11D-A10Y-09	TCGA-C8-A12L-01	TCGA-C8-A12L-01A-11R-A114-13	TCGA-C8-A12L-01A-11R-A114-13	TCGA-C8-A12L-01A-11D-A10Y-09	f9312b49-d0bf-45d8-b6b1-96b3752475e7	TCGA-C8-A12L-01A-11D-A10Y-09	TCGA-C8-A12L-01A-21-A13D-20	TCGA-C8-A12L-01A-11D-A10Y-09	0a5a7511-4e7b-4fe4-b323-c354acffab57	3cd311fc-51df-4b20-9c27-fabb68bc3e2c	TCGA-C8-A12L-01A-11D-A111-01	0a5a7511-4e7b-4fe4-b323-c354acffab57		TCGA-C8-A12L-01	TCGA-C8-A12L-01A-11R-A115-07	0a5a7511-4e7b-4fe4-b323-c354acffab57	0a5a7511-4e7b-4fe4-b323-c354acffab57	TCGA-C8-A12L-01A-11D-A111-01	TCGA-C8-A12L-01	TCGA-C8-A12L-01	TCGA-C8-A12L-01A-11D-A112-05	3cd311fc-51df-4b20-9c27-fabb68bc3e2c	
TCGA-C8-A12M-01	Stage IIA	70	5	Stage IIA	0		Positive	FEMALE		4	1	4	Negative	M0	Negative	N0	0	0	LumB	Luminal B	Negative	LumA/B	-10	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12M-01	358	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-C8-A12M	358	0	358	Breast	TCGA Breast Cancer	breast invasive carcinoma					70	Left	Axillary lymph node dissection alone		TCGA-C8-A12M-F19093		Positive					Negative	Other					-25811	57		0	358											Scheduled Follow-up Submission	2011-12-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	510	NO	Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4								NO			true	M0	N0 (i-)	T2	Stage IIA	TCGA-C8-A12M.76F67AA2-4E17-48F5-810B-E4F4338902DC.pdf	0	0	0	0	0	0	0	0	0	0	0	10	100	90	95	92	TUMOR FREE					Allred Score 8			No			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A12M-01A-11D-A135-09	TCGA-C8-A12M-01	TCGA-C8-A12M-01A-11R-A114-13	TCGA-C8-A12M-01A-11R-A114-13	TCGA-C8-A12M-01A-11D-A135-09	abdef80c-32bb-4620-95d2-16d985cd20f0	TCGA-C8-A12M-01A-11D-A135-09	TCGA-C8-A12M-01A-21-A13D-20	TCGA-C8-A12M-01A-11D-A135-09	8f007e7a-6260-4ecc-baff-f68665b760cb	29a000d7-43d4-4f30-b63b-35836f20384a	TCGA-C8-A12M-01A-11D-A111-01	8f007e7a-6260-4ecc-baff-f68665b760cb		TCGA-C8-A12M-01	TCGA-C8-A12M-01A-11R-A115-07	8f007e7a-6260-4ecc-baff-f68665b760cb	8f007e7a-6260-4ecc-baff-f68665b760cb	TCGA-C8-A12M-01A-11D-A111-01	TCGA-C8-A12M-01	TCGA-C8-A12M-01	TCGA-C8-A12M-01A-11D-A112-05	29a000d7-43d4-4f30-b63b-35836f20384a	
TCGA-C8-A12N-01	Stage IIA	58	4	Stage IIA	0		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	0	0	LumA	Luminal A	Positive	ReacI	-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12N-01	358	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-C8-A12N	358	0	358	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Right	Axillary lymph node dissection alone		TCGA-C8-A12N-F20264		Positive					Positive	Other					-21428	57		0	358											Scheduled Follow-up Submission	2012-1-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	290	NO	Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6								NO			true	M0	N0 (i-)	T2	Stage IIA	TCGA-C8-A12N.A845013D-BF15-42FB-8BFE-FCE206E943FE.pdf	0	0	0	0	0	0	0	0	5	0	0	10	95	90	80	80	TUMOR FREE				Allread Score 8	Allred Score 8			No			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A12N-01A-11D-A10Y-09	TCGA-C8-A12N-01	TCGA-C8-A12N-01A-11R-A114-13	TCGA-C8-A12N-01A-11R-A114-13	TCGA-C8-A12N-01A-11D-A10Y-09	8e2ac007-601d-45c4-a94c-3cefb96b8f99	TCGA-C8-A12N-01A-11D-A10Y-09	TCGA-C8-A12N-01A-21-A13D-20	TCGA-C8-A12N-01A-11D-A10Y-09	9eb3306d-6c84-4bc1-be42-4bd00ef46cbb	48becee8-1c71-4320-b0e8-72e345797daf	TCGA-C8-A12N-01A-11D-A111-01	9eb3306d-6c84-4bc1-be42-4bd00ef46cbb		TCGA-C8-A12N-01	TCGA-C8-A12N-01A-11R-A115-07	9eb3306d-6c84-4bc1-be42-4bd00ef46cbb	9eb3306d-6c84-4bc1-be42-4bd00ef46cbb	TCGA-C8-A12N-01A-11D-A111-01	TCGA-C8-A12N-01	TCGA-C8-A12N-01	TCGA-C8-A12N-01A-11D-A112-05	48becee8-1c71-4320-b0e8-72e345797daf	
TCGA-C8-A12O-01	Stage IIA	50		Stage IIA	0		Positive	FEMALE					Negative	M0	Negative	N0	0	0	LumA	Luminal A	Positive	Her2	-2	0	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12O-01	385	0		C3-BRCA/Luminal	cluster 1	Cluster 5	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 13	TCGA-C8-A12O	385	0	385	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Left	Axillary lymph node dissection alone		TCGA-C8-A12O-F20261		Positive					Positive	Other					-18506	57		0	385											Scheduled Follow-up Submission	2012-1-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	650	NO	Negative			10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4								NO			true	M0	N0 (i-)	T2	Stage IIA	TCGA-C8-A12O.273152AA-7B4C-4AE5-9231-1A3160058C74.pdf	0	0	0	0	0	0	0	0	0	5	5	25	95	70	85	75	TUMOR FREE				Allred Score 7	Allred Score 7			No			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A12O-01A-11D-A10Y-09	TCGA-C8-A12O-01	TCGA-C8-A12O-01A-11R-A114-13	TCGA-C8-A12O-01A-11R-A114-13	TCGA-C8-A12O-01A-11D-A10Y-09	834cc759-8dcd-4d51-9570-aef1622b90e1	TCGA-C8-A12O-01A-11D-A10Y-09	TCGA-C8-A12O-01A-21-A13D-20	TCGA-C8-A12O-01A-11D-A10Y-09	5efabaa8-f296-4c9c-9632-559ef7f6dd44	0c86eab9-cfc8-4a03-823b-4331c43d2038	TCGA-C8-A12O-01A-11D-A111-01	5efabaa8-f296-4c9c-9632-559ef7f6dd44		TCGA-C8-A12O-01	TCGA-C8-A12O-01A-11R-A115-07	5efabaa8-f296-4c9c-9632-559ef7f6dd44	5efabaa8-f296-4c9c-9632-559ef7f6dd44	TCGA-C8-A12O-01A-11D-A111-01	TCGA-C8-A12O-01	TCGA-C8-A12O-01	TCGA-C8-A12O-01A-11D-A112-05	0c86eab9-cfc8-4a03-823b-4331c43d2038	
TCGA-C8-A12P-01	Stage IIB	55	3	No_Conversion	0		Negative	FEMALE	Positive	1	1	1	Negative	M0	Positive	N1	0	0	Her2	HER2-enriched	Negative	Her2	-11	-10	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12P-01	358	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-C8-A12P	358	0	358	Breast	TCGA Breast Cancer	breast invasive carcinoma					55	Left			TCGA-C8-A12P-F20267		Negative					Negative	Other					-20332	57		0	358											Scheduled Follow-up Submission	2012-1-9	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	380	NO	Positive			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO			true	M0	N1	T2	Stage IIB	TCGA-C8-A12P.F04324BB-F0B1-4948-9189-7833646029F1.pdf	2	1	2	1	2	0	1	0	0	0	28	15	70	85	70	85	TUMOR FREE								No			NO	Primary Tumor	01	Pateys Surgery	6th	NO	YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A12P-01A-11D-A10Y-09	TCGA-C8-A12P-01	TCGA-C8-A12P-01A-11R-A114-13	TCGA-C8-A12P-01A-11R-A114-13	TCGA-C8-A12P-01A-11D-A10Y-09	a3b71b2e-5bb6-4585-95e7-6a2ddbf99659	TCGA-C8-A12P-01A-11D-A10Y-09	TCGA-C8-A12P-01A-21-A13D-20	TCGA-C8-A12P-01A-11D-A10Y-09	9e30b9ee-391d-40d9-8eba-de47656f3629	cf2aac8b-1f32-4f0c-91f6-4b80c38d4419	TCGA-C8-A12P-01A-11D-A111-01	9e30b9ee-391d-40d9-8eba-de47656f3629		TCGA-C8-A12P-01	TCGA-C8-A12P-01A-11R-A115-07	9e30b9ee-391d-40d9-8eba-de47656f3629	9e30b9ee-391d-40d9-8eba-de47656f3629	TCGA-C8-A12P-01A-11D-A111-01	TCGA-C8-A12P-01	TCGA-C8-A12P-01	TCGA-C8-A12P-01A-11D-A112-05	cf2aac8b-1f32-4f0c-91f6-4b80c38d4419	
TCGA-C8-A12Q-01	Stage IIIA	78	5	No_Conversion	0		Negative	FEMALE	Positive	1	1	1	Negative	M0	Positive	N2	0	0	Her2	HER2-enriched	Negative	Her2	-11	-5	enrollment	T1	T1	LIVING	1	TCGA-C8-A12Q-01	385	1	High	C3-BRCA/Luminal	cluster 2	Cluster 5	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-C8-A12Q			385	Breast	TCGA Breast Cancer	breast invasive carcinoma			NO		78	Left	Axillary lymph node dissection alone		TCGA-C8-A12Q-F20253		Negative					Negative	Other					-28733	57	385	0	2											Scheduled Follow-up Submission	2012-1-9	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	810	NO	Positive			7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4				Liver	Distant Metastasis			YES			true	M0	N2	T1	Stage IIIA	TCGA-C8-A12Q.90AF32F0-5684-4D5B-B619-2B12DA3823C6.pdf	2	2	1	1	2	2	1	1	2	0	21	23	75	75	75	75	WITH TUMOR								No			NO	Primary Tumor	01	Pateys Surgery		NO	YES	NO	C8	Breast	A	DECEASED	2010	TCGA-C8-A12Q-01A-11D-A10Y-09	TCGA-C8-A12Q-01	TCGA-C8-A12Q-01A-11R-A114-13	TCGA-C8-A12Q-01A-11R-A114-13	TCGA-C8-A12Q-01A-11D-A10Y-09	588f723a-3e25-4cdc-91f6-36d00bb179e5	TCGA-C8-A12Q-01A-11D-A10Y-09	TCGA-C8-A12Q-01A-21-A13D-20	TCGA-C8-A12Q-01A-11D-A10Y-09	e042ea6d-3204-41a7-9811-25f4ac0c3558	586f3601-cf46-45d6-9efd-a80482519e58	TCGA-C8-A12Q-01A-11D-A111-01	e042ea6d-3204-41a7-9811-25f4ac0c3558		TCGA-C8-A12Q-01	TCGA-C8-A12Q-01A-11R-A115-07	e042ea6d-3204-41a7-9811-25f4ac0c3558	e042ea6d-3204-41a7-9811-25f4ac0c3558	TCGA-C8-A12Q-01A-11D-A111-01	TCGA-C8-A12Q-01	TCGA-C8-A12Q-01	TCGA-C8-A12Q-01A-11D-A112-05	586f3601-cf46-45d6-9efd-a80482519e58	
TCGA-C8-A12T-01	Stage IIA	43	4	Stage IIA	0		Positive	FEMALE	Positive	1	1	1	Negative	M0	Negative	N0	0	0	Her2	HER2-enriched	Positive	ReacII	-2	-1	enrollment	T_Other	T2	LIVING		TCGA-C8-A12T-01			Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-C8-A12T				Breast	TCGA Breast Cancer	breast invasive carcinoma					43	Left	Axillary lymph node dissection alone				Positive					Positive	Other		NO				51		0	0					NO							2011-4-11	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	540	NO	Positive			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4									0		true	M0	N0	T2	Stage IIA	TCGA-C8-A12T.4D751232-CD64-468E-AEBF-46F94FB6281F.pdf	1	1	1	1	2	0	1	1	0	0	13	10	85	90	85	90	TUMOR FREE				Allred Score 8	Allred Score 6		YES	No				Primary Tumor	01	Pateys Surgery	6th		YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A12T-01A-11D-A10Y-09	TCGA-C8-A12T-01	TCGA-C8-A12T-01A-11R-A114-13	TCGA-C8-A12T-01A-11R-A114-13	TCGA-C8-A12T-01A-11D-A10Y-09	08bd259e-9a37-4dd1-b97c-c67f288f833e	TCGA-C8-A12T-01A-11D-A10Y-09	TCGA-C8-A12T-01A-21-A13D-20	TCGA-C8-A12T-01A-11D-A10Y-09	c13962b2-674a-4edc-a7c8-c077ab86d198	f4b9a452-bbf8-4130-850b-1c9b503ef0e5	TCGA-C8-A12T-01A-11D-A111-01	c13962b2-674a-4edc-a7c8-c077ab86d198		TCGA-C8-A12T-01	TCGA-C8-A12T-01A-11R-A115-07	c13962b2-674a-4edc-a7c8-c077ab86d198	c13962b2-674a-4edc-a7c8-c077ab86d198	TCGA-C8-A12T-01A-11D-A111-01	TCGA-C8-A12T-01	TCGA-C8-A12T-01	TCGA-C8-A12T-01A-11D-A112-05	f4b9a452-bbf8-4130-850b-1c9b503ef0e5	
TCGA-C8-A12U-01	Stage IB	46	5	Stage IIB	0		Positive	FEMALE	Negative	1	1	4	Negative	M0	Positive	N1	0	0	LumB	Luminal B	Positive	Basal	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12U-01	385	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 5	mutation cluster 4	TCGA-C8-A12U	385	0	385	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Right	Axillary lymph node dissection alone		TCGA-C8-A12U-F20249		Positive					Positive	Other					-17045	57		0	385					NO						Scheduled Follow-up Submission	2012-1-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	580	NO	Negative			7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	5								NO			true	M0	N1	T2	Stage IIB	TCGA-C8-A12U.B6428344-2D68-404B-AD9F-CA6E0B0552B2.pdf	2	1	1	1	2	0	1	1	2	0	26	15	70	85	70	85	TUMOR FREE				Allred Score 3	Allred Score 5		YES	No			NO	Primary Tumor	01	Pateys Surgery	6th	NO	YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A12U-01A-11D-A10Y-09	TCGA-C8-A12U-01	TCGA-C8-A12U-01A-11R-A114-13	TCGA-C8-A12U-01A-11R-A114-13	TCGA-C8-A12U-01A-11D-A10Y-09	671835d4-23bb-4945-a62a-26d5f9094325	TCGA-C8-A12U-01A-11D-A10Y-09	TCGA-C8-A12U-01A-21-A13D-20	TCGA-C8-A12U-01A-11D-A10Y-09	803bb42f-e0f2-44b6-aebb-8f956646ecc7	ad305034-cc87-4557-9031-a50710646810	TCGA-C8-A12U-01A-11D-A111-01	803bb42f-e0f2-44b6-aebb-8f956646ecc7		TCGA-C8-A12U-01	TCGA-C8-A12U-01A-11R-A115-07	803bb42f-e0f2-44b6-aebb-8f956646ecc7	803bb42f-e0f2-44b6-aebb-8f956646ecc7	TCGA-C8-A12U-01A-11D-A111-01	TCGA-C8-A12U-01	TCGA-C8-A12U-01	TCGA-C8-A12U-01A-11D-A112-05	ad305034-cc87-4557-9031-a50710646810	
TCGA-C8-A12V-01	Stage IIA	55	1	Stage IIA	0		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	0	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12V-01	385	0	BRCA-LUAD+	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-C8-A12V	385	0	385	Breast	TCGA Breast Cancer	breast invasive carcinoma					55	Right	Axillary lymph node dissection alone		TCGA-C8-A12V-F19095		Negative					Negative	Other					-20346	57		0	385					NO						Scheduled Follow-up Submission	2011-12-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	540	NO	Negative			5		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3								NO	0		true	M0	N0	T2	Stage IIA	TCGA-C8-A12V.8ED8A37B-C885-4333-AC5D-EA73A5A81173.pdf	1	1	1	1	1	0	1	0	0	0	24	15	75	85	75	85	TUMOR FREE							YES	No			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A12V-01A-11D-A10Y-09	TCGA-C8-A12V-01	TCGA-C8-A12V-01A-11R-A114-13	TCGA-C8-A12V-01A-11R-A114-13	TCGA-C8-A12V-01A-11D-A10Y-09	46c61ec3-e651-474c-8ce2-0cbced7cbca5	TCGA-C8-A12V-01A-11D-A10Y-09	TCGA-C8-A12V-01A-21-A13D-20	TCGA-C8-A12V-01A-11D-A10Y-09	b12c9095-55c7-4add-9e22-3d65eeef2040	84a2d172-c9f4-4ce9-8ee8-6ec6b5d4a747	TCGA-C8-A12V-01A-11D-A111-01	b12c9095-55c7-4add-9e22-3d65eeef2040		TCGA-C8-A12V-01	TCGA-C8-A12V-01A-11R-A115-07	b12c9095-55c7-4add-9e22-3d65eeef2040	b12c9095-55c7-4add-9e22-3d65eeef2040	TCGA-C8-A12V-01A-11D-A111-01	TCGA-C8-A12V-01	TCGA-C8-A12V-01	TCGA-C8-A12V-01A-11D-A112-05	84a2d172-c9f4-4ce9-8ee8-6ec6b5d4a747	
TCGA-C8-A12W-01	Stage IIIB	49	3	Stage IIIB	0		Positive	FEMALE	Negative	1	1	4	Negative	M0	Positive	N1	0	0	LumB	Luminal B	Positive	ReacII	-2	-5	enrollment	T_Other	T4	LIVING	0	TCGA-C8-A12W-01	385	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-C8-A12W	385	0	385	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Left	Axillary lymph node dissection alone		TCGA-C8-A12W-F20244		Positive					Positive	Other					-18140	57		0	385											Scheduled Follow-up Submission	2012-1-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	890	NO	Negative			7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4								NO			true	M0	N1	T4	Stage IIIB	TCGA-C8-A12W.8A64D890-ABEF-4AF2-8915-D17DA89B8FC5.pdf	2	2	1	1	2	2	1	1	0	0	18	18	80	80	80	80	TUMOR FREE				Allred Score 6	Allred Score 7		YES	No			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A12W-01A-11D-A10Y-09	TCGA-C8-A12W-01	TCGA-C8-A12W-01A-11R-A114-13	TCGA-C8-A12W-01A-11R-A114-13	TCGA-C8-A12W-01A-11D-A10Y-09	ee4be56e-b6c6-421f-ae10-fd129c8028df	TCGA-C8-A12W-01A-11D-A10Y-09	TCGA-C8-A12W-01A-21-A13D-20	TCGA-C8-A12W-01A-11D-A10Y-09	24e6e8f5-3caa-46f0-8915-7bd09f0736f9	b24caa7b-337e-43d0-9908-2815f24dd7b5	TCGA-C8-A12W-01A-11D-A111-01	24e6e8f5-3caa-46f0-8915-7bd09f0736f9		TCGA-C8-A12W-01	TCGA-C8-A12W-01A-11R-A115-07	24e6e8f5-3caa-46f0-8915-7bd09f0736f9	24e6e8f5-3caa-46f0-8915-7bd09f0736f9	TCGA-C8-A12W-01A-11D-A111-01	TCGA-C8-A12W-01	TCGA-C8-A12W-01	TCGA-C8-A12W-01A-11D-A112-05	b24caa7b-337e-43d0-9908-2815f24dd7b5	
TCGA-C8-A12X-01	Stage IIB	62	4	Stage IIB	0		Positive	FEMALE	Negative	4	3	4	Negative	M0	Positive	N1	0	0	LumA	Luminal B	Positive	LumA/B	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12X-01	385	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-C8-A12X	385	0	385	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Left	Axillary lymph node dissection alone		TCGA-C8-A12X-F19102		Positive					Positive	Other					-22889	57		0	385					NO						Scheduled Follow-up Submission	2011-12-2	FEMALE					1+					Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES	Pateys Surgery	Other method, specify:	410	NO	Negative			6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	1								NO			true	M0	N1	T2	Stage IIB	TCGA-C8-A12X.B3FCE052-931C-4798-A188-F04A2178A5F6.pdf	1	1	1	1	0	0	1	0	0	2	30	18	70	80	70	80	TUMOR FREE				Allred Score 7	Allred Score 8		YES	No			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A12X-01A-11D-A10Y-09	TCGA-C8-A12X-01	TCGA-C8-A12X-01A-11R-A114-13	TCGA-C8-A12X-01A-11R-A114-13	TCGA-C8-A12X-01A-11D-A10Y-09	b91a61e2-4b2e-4a9c-b79d-07570ae50cc3	TCGA-C8-A12X-01A-11D-A10Y-09	TCGA-C8-A12X-01A-21-A13D-20	TCGA-C8-A12X-01A-11D-A10Y-09	2efa4fd0-1c0b-49c8-a11f-606d8618ec97	a32074a1-de53-4200-a933-540029a37372	TCGA-C8-A12X-01A-11D-A111-01	2efa4fd0-1c0b-49c8-a11f-606d8618ec97		TCGA-C8-A12X-01	TCGA-C8-A12X-01A-11R-A115-07	2efa4fd0-1c0b-49c8-a11f-606d8618ec97	2efa4fd0-1c0b-49c8-a11f-606d8618ec97	TCGA-C8-A12X-01A-11D-A111-01	TCGA-C8-A12X-01	TCGA-C8-A12X-01	TCGA-C8-A12X-01A-11D-A112-05	a32074a1-de53-4200-a933-540029a37372	
TCGA-C8-A12Y-01	Stage IIB	44	2	Stage IIB	0			FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	0	0	LumA	Luminal A		LumA	0	-3	enrollment	T_Other	T2	LIVING		TCGA-C8-A12Y-01			Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-C8-A12Y				Breast	TCGA Breast Cancer	breast invasive carcinoma					44	Left	Axillary lymph node dissection alone										Other						57		0	0					NO							2011-4-13	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	380	NO				9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6											true	M0	N1	T2	Stage IIB	TCGA-C8-A12Y.28E368DA-56B9-4BB1-99C3-7FF2CEC964CF.pdf	1	1	1	1	2	0	1	1	0	0	28	20	70	80	70	80	TUMOR FREE							YES	No				Primary Tumor	01	Pateys Surgery	6th		YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A12Y-01A-11D-A12B-09	TCGA-C8-A12Y-01	TCGA-C8-A12Y-01A-11R-A12C-13	TCGA-C8-A12Y-01A-11R-A12C-13	TCGA-C8-A12Y-01A-11D-A12B-09	1e9b9f3a-3fb5-4404-94e5-d22d4702391e	TCGA-C8-A12Y-01A-11D-A12B-09	TCGA-C8-A12Y-01A-21-A13D-20	TCGA-C8-A12Y-01A-11D-A12B-09	ef42155a-112e-48fe-b52a-a99ebcd5f7f5	635288ea-41cf-4d68-9295-19044e6c8fda	TCGA-C8-A12Y-01A-11D-A12A-01	ef42155a-112e-48fe-b52a-a99ebcd5f7f5		TCGA-C8-A12Y-01	TCGA-C8-A12Y-01A-11R-A12D-07	ef42155a-112e-48fe-b52a-a99ebcd5f7f5	ef42155a-112e-48fe-b52a-a99ebcd5f7f5	TCGA-C8-A12Y-01A-11D-A12A-01	TCGA-C8-A12Y-01	TCGA-C8-A12Y-01	TCGA-C8-A12Y-01A-11D-A12E-05	635288ea-41cf-4d68-9295-19044e6c8fda	
TCGA-C8-A12Z-01	Stage II	45	2	Stage IIB	0		Negative	FEMALE	Positive	1	1	1	Negative	M0	Positive	N1	0	0	Her2	HER2-enriched	Negative	Her2	-11	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12Z-01	12	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-C8-A12Z			12	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Right	Axillary lymph node dissection alone			Negative	Negative					Negative	Other					-16508	69		0	12					NO							2011-4-13	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	490	NO	Positive			2	Negative	Peri (6-12 months since last menstrual period)																		4	4									2		true	M0	N1	T2	Stage IIB	TCGA-C8-A12Z.89B312D1-9FDD-4756-9C15-5442B428F75A.pdf	40	40	20	20	10	20	20	20	0	0	30	40	60	40	60	40	TUMOR FREE							YES	No				Primary Tumor	01	Pateys Surgery	6th		YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A12Z-01A-11D-A10Y-09	TCGA-C8-A12Z-01	TCGA-C8-A12Z-01A-11R-A114-13	TCGA-C8-A12Z-01A-11R-A114-13	TCGA-C8-A12Z-01A-11D-A10Y-09	76306f2d-c820-4442-966f-b79872d69025	TCGA-C8-A12Z-01A-11D-A10Y-09	TCGA-C8-A12Z-01A-21-A13D-20	TCGA-C8-A12Z-01A-11D-A10Y-09	4018d26c-0ce0-4c5a-9ce4-200bb4273349	6d730c4d-2c62-4214-aa35-f40126e65560	TCGA-C8-A12Z-01A-11D-A111-01	4018d26c-0ce0-4c5a-9ce4-200bb4273349		TCGA-C8-A12Z-01	TCGA-C8-A12Z-01A-11R-A115-07	4018d26c-0ce0-4c5a-9ce4-200bb4273349	4018d26c-0ce0-4c5a-9ce4-200bb4273349	TCGA-C8-A12Z-01A-11D-A111-01	TCGA-C8-A12Z-01	TCGA-C8-A12Z-01	TCGA-C8-A12Z-01A-11D-A112-05	6d730c4d-2c62-4214-aa35-f40126e65560	
TCGA-C8-A130-01	Stage IIIA	52	1	Stage IIIA	0		Positive	FEMALE	Equivocal	1	1	1	Negative	M0	Positive	N2	0	0	LumB	HER2-enriched	Positive	Her2	-2	0	enrollment	T_Other	T3	LIVING	0	TCGA-C8-A130-01	96	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-C8-A130	96	0	96	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Left	Axillary lymph node dissection alone		TCGA-C8-A130-F19091		Positive					Positive	Other					-19117	89		0	96					NO						Scheduled Follow-up Submission	2011-12-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	550	NO	Equivocal			8	Negative	Peri (6-12 months since last menstrual period)																		2	4								NO			true	M0	N2	T3	Stage IIIA	TCGA-C8-A130.3E24D3A0-9741-4635-89DB-EED4BA3F6AAA.pdf		0		0		0		0		0		15		85		85	TUMOR FREE				Allred Score 7	Allred Score 7		YES	No			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A130-01A-31D-A10Y-09	TCGA-C8-A130-01	TCGA-C8-A130-01A-31R-A114-13	TCGA-C8-A130-01A-31R-A114-13	TCGA-C8-A130-01A-31D-A10Y-09	62caa696-e8a5-46f6-b4c1-1baf5ae62bd4	TCGA-C8-A130-01A-31D-A10Y-09	TCGA-C8-A130-01A-21-A13D-20	TCGA-C8-A130-01A-31D-A10Y-09	697dfcbf-0c6b-4cae-b851-d46dd6be42c9	b3b38912-25f6-45ca-9ee5-a5a4a299b5ce	TCGA-C8-A130-01A-31D-A111-01	697dfcbf-0c6b-4cae-b851-d46dd6be42c9		TCGA-C8-A130-01	TCGA-C8-A130-01A-31R-A115-07	697dfcbf-0c6b-4cae-b851-d46dd6be42c9	697dfcbf-0c6b-4cae-b851-d46dd6be42c9	TCGA-C8-A130-01A-31D-A111-01	TCGA-C8-A130-01	TCGA-C8-A130-01	TCGA-C8-A130-01A-31D-A112-05	b3b38912-25f6-45ca-9ee5-a5a4a299b5ce	
TCGA-C8-A131-01	Stage III	82	1	Stage IIIA	0		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N2	0	0	Basal	Basal-like	Negative	ReacII	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A131-01	68	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	OV-like c4	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 2	TCGA-C8-A131	68	0	68	Breast	TCGA Breast Cancer	breast invasive carcinoma					82	Left	Axillary lymph node dissection alone		TCGA-C8-A131-F19083		Negative					Negative	Other					-29966	163		0	68					NO						Scheduled Follow-up Submission	2010-12-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	460	NO	Negative			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	5								NO	4		true	M0	N2	T2	Stage IIIA	TCGA-C8-A131.65C73797-1A8F-474D-94F6-45A2878B2C45.pdf	40	40	20	20	20	20	20	30	0	0	20	20	60	60	60	60	TUMOR FREE							YES	No			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A131-01A-11D-A10Y-09	TCGA-C8-A131-01	TCGA-C8-A131-01A-11R-A114-13	TCGA-C8-A131-01A-11R-A114-13	TCGA-C8-A131-01A-11D-A10Y-09	4a1fa1ef-67ab-4ea7-a650-5276030b04ee	TCGA-C8-A131-01A-11D-A10Y-09	TCGA-C8-A131-01A-21-A13D-20	TCGA-C8-A131-01A-11D-A10Y-09	5162ef6d-6978-4ff7-b385-a59325cefe17	8451e6fa-790e-4ea7-9068-520299fad8a1	TCGA-C8-A131-01A-11D-A111-01	5162ef6d-6978-4ff7-b385-a59325cefe17		TCGA-C8-A131-01	TCGA-C8-A131-01A-11R-A115-07	5162ef6d-6978-4ff7-b385-a59325cefe17	5162ef6d-6978-4ff7-b385-a59325cefe17	TCGA-C8-A131-01A-11D-A111-01	TCGA-C8-A131-01	TCGA-C8-A131-01	TCGA-C8-A131-01A-11D-A112-05	8451e6fa-790e-4ea7-9068-520299fad8a1	
TCGA-C8-A132-01	Stage II	56	5	Stage IIB	0		Positive	FEMALE	Positive	2	3	3	Negative	M0	Positive	N1	0	0	LumA	Luminal A	Positive	Her2	-2	-4	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A132-01	57	0	Squamous	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA c1uster 9	cluster 5	mutation c1uster 9	TCGA-C8-A132	57	0	57	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Left	Axillary lymph node dissection alone		TCGA-C8-A132-F19090		Positive					Positive	Other					-20471	162		0	57					NO						Scheduled Follow-up Submission	2011-12-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	420	NO				4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	5								NO	1		true	M0	N1	T2	Stage IIB	TCGA-C8-A132.175224E6-3A06-4799-B695-704C254A847C.pdf		0		0		2		0		2		11		85		60	TUMOR FREE				Allred Score 7	Allred Score 8		YES	No			NO	Primary Tumor	01	Modified Radical Masectomy	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A132-01A-31D-A10Y-09	TCGA-C8-A132-01	TCGA-C8-A132-01A-31R-A114-13	TCGA-C8-A132-01A-31R-A114-13	TCGA-C8-A132-01A-31D-A10Y-09	4b907222-06fc-47d4-b425-b116df8162aa	TCGA-C8-A132-01A-31D-A10Y-09	TCGA-C8-A132-01A-41-A13D-20	TCGA-C8-A132-01A-31D-A10Y-09	143e8620-56cc-4b65-a2aa-d793543f6854	f52bfd4d-965c-4f12-9e71-7842ed116268	TCGA-C8-A132-01A-31D-A111-01	143e8620-56cc-4b65-a2aa-d793543f6854		TCGA-C8-A132-01	TCGA-C8-A132-01A-31R-A115-07	143e8620-56cc-4b65-a2aa-d793543f6854	143e8620-56cc-4b65-a2aa-d793543f6854	TCGA-C8-A132-01A-31D-A111-01	TCGA-C8-A132-01	TCGA-C8-A132-01	TCGA-C8-A132-01A-31D-A112-05	f52bfd4d-965c-4f12-9e71-7842ed116268	
TCGA-C8-A133-01	Stage IIIA	65	1	Stage IIIA	0		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	0	0	LumA	Luminal A	Positive	LumA/B	-12	-3	enrollment	T_Other	T3	LIVING		TCGA-C8-A133-01			Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-C8-A133				Breast	TCGA Breast Cancer	breast invasive carcinoma					65	Right	Axillary lymph node dissection alone				Positive					Positive	Other					-23922	119		0	0												2011-4-15	FEMALE										Other  specify	ductal/mucinous	No		C50.9	8523/3	C50.9		YES	Modified Radical Masectomy	Other method, specify:	480	NO				26	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	1											true	M0	N1	T3	Stage IIIA	TCGA-C8-A133.C47488B4-0E7E-46FB-91C6-0BEA58695974.pdf		0		0		0		0		0		0		100		98	TUMOR FREE				Allred Score 8	Allred Score 8		YES	No				Primary Tumor	01	Modified Radical Masectomy	6th		YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A133-01A-32D-A12B-09	TCGA-C8-A133-01	TCGA-C8-A133-01A-32R-A12C-13	TCGA-C8-A133-01A-32R-A12C-13	TCGA-C8-A133-01A-32D-A12B-09	a4236581-7665-4520-84c9-16fb6fa8fd22	TCGA-C8-A133-01A-32D-A12B-09	TCGA-C8-A133-01A-21-A13D-20	TCGA-C8-A133-01A-32D-A12B-09	3028d15d-698a-4a23-8a09-a79221e28a62	de88f4c3-0824-4ce2-8d1c-c6155db0f967	TCGA-C8-A133-01A-32D-A12A-01	3028d15d-698a-4a23-8a09-a79221e28a62		TCGA-C8-A133-01	TCGA-C8-A133-01A-32R-A12D-07	3028d15d-698a-4a23-8a09-a79221e28a62	3028d15d-698a-4a23-8a09-a79221e28a62	TCGA-C8-A133-01A-32D-A12A-01	TCGA-C8-A133-01	TCGA-C8-A133-01	TCGA-C8-A133-01A-32D-A12E-05	de88f4c3-0824-4ce2-8d1c-c6155db0f967	
TCGA-C8-A134-01	Stage IIA	52	1	No_Conversion	0		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	0	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A134-01	34	0	BRCA-LUAD+	C8-BLCA	cluster 4	Cluster 6	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 5	cluster 6	mutation cluster 5	TCGA-C8-A134	34	0	34	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Left	Axillary lymph node dissection alone		TCGA-C8-A134-F19084		Negative					Negative	Other					-19010			0	34											Scheduled Follow-up Submission	2011-12-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Equivocal			7	Negative	Peri (6-12 months since last menstrual period)																		4	6								NO				M0	N0	T2	Stage IIA																		TUMOR FREE								No			NO	Primary Tumor	01	Modified Radical Masectomy	6th	YES	YES	NO	C8	Breast		LIVING	2010	TCGA-C8-A134-01A-11D-A10Y-09	TCGA-C8-A134-01	TCGA-C8-A134-01A-11R-A114-13	TCGA-C8-A134-01A-11R-A114-13	TCGA-C8-A134-01A-11D-A10Y-09	ec21c134-e0b1-44e4-be21-ff70c20ee979	TCGA-C8-A134-01A-11D-A10Y-09	TCGA-C8-A134-01A-21-A13D-20	TCGA-C8-A134-01A-11D-A10Y-09	d96863aa-33a8-43bf-a9b5-589de1e9cf44	aad64468-8c93-47ce-bc77-829f4fb8b2d6	TCGA-C8-A134-01A-11D-A111-01	d96863aa-33a8-43bf-a9b5-589de1e9cf44		TCGA-C8-A134-01	TCGA-C8-A134-01A-11R-A115-07	d96863aa-33a8-43bf-a9b5-589de1e9cf44	d96863aa-33a8-43bf-a9b5-589de1e9cf44	TCGA-C8-A134-01A-11D-A111-01	TCGA-C8-A134-01	TCGA-C8-A134-01	TCGA-C8-A134-01A-11D-A112-05	aad64468-8c93-47ce-bc77-829f4fb8b2d6	
TCGA-C8-A135-01	Stage II	64	1	Stage IIB	0		Negative	FEMALE	Positive	2	2	1	Negative	M0	Positive	N1	0	0	Her2	HER2-enriched	Negative	Her2	-11	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A135-01	32	0	High	C3-BRCA/Luminal	cluster 1	Cluster 5	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 7	mutation cluster 3	TCGA-C8-A135	32	0	32	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Left	Axillary lymph node dissection alone		TCGA-C8-A135-F19081		Negative					Negative	Modified Radical Mastectomy					-23667	162		0	32					NO						Scheduled Follow-up Submission	2011-12-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	760	NO	Positive			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	7								NO	1		true	M0	N1	T2	Stage IIB	TCGA-C8-A135.7045ECC9-72B3-4AD3-A6C6-4F8C6914EAA1.pdf	30	50	20	15	10	0	30	20	0	0	20	20	70	80	70	80	TUMOR FREE							YES	No			NO	Primary Tumor	01		6th	NO	YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A135-01A-11D-A10Y-09	TCGA-C8-A135-01	TCGA-C8-A135-01A-11R-A114-13	TCGA-C8-A135-01A-11R-A114-13	TCGA-C8-A135-01A-11D-A10Y-09	bded0f4f-068a-4577-a130-66b59f0bce47	TCGA-C8-A135-01A-11D-A10Y-09	TCGA-C8-A135-01A-21-A13D-20	TCGA-C8-A135-01A-11D-A10Y-09	306818e8-2e51-4dee-b27c-53ee9cea8d03	dc5b229b-a3c1-4e91-a28a-809ce6035c0c	TCGA-C8-A135-01A-11D-A111-01	306818e8-2e51-4dee-b27c-53ee9cea8d03		TCGA-C8-A135-01	TCGA-C8-A135-01A-11R-A115-07	306818e8-2e51-4dee-b27c-53ee9cea8d03	306818e8-2e51-4dee-b27c-53ee9cea8d03	TCGA-C8-A135-01A-11D-A111-01	TCGA-C8-A135-01	TCGA-C8-A135-01	TCGA-C8-A135-01A-11D-A112-05	dc5b229b-a3c1-4e91-a28a-809ce6035c0c	
TCGA-C8-A137-01	Stage II	34	5	Stage IIB	3		Negative	FEMALE	Positive				Negative	M0	Positive	N1	3	0	Her2	HER2-enriched	Negative	Her2	-11	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A137-01	125	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7			mutation c1uster 9	TCGA-C8-A137	125	0	125	Breast	TCGA Breast Cancer	breast invasive carcinoma					34	Left	Axillary lymph node dissection alone		TCGA-C8-A137-F19076		Negative					Negative	Modified Radical Mastectomy					-12729	102		0	125					NO						Scheduled Follow-up Submission	2011-12-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	610	NO	Positive			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4									NO			true	M0	N1	T2	Stage IIB	TCGA-C8-A137.140F8918-739F-498A-9A17-B307E40E6060.pdf	1	2	1	1	0	1	0	1	0	1	25	18	75	80	75	80	TUMOR FREE							YES	No			NO	Primary Tumor	01		6th	YES	YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A137-01A-11D-A10Y-09	TCGA-C8-A137-01	TCGA-C8-A137-01A-11R-A114-13	TCGA-C8-A137-01A-11R-A114-13	TCGA-C8-A137-01A-11D-A10Y-09	b7d481d8-71b8-473b-802b-0457592d7054	TCGA-C8-A137-01A-11D-A10Y-09	TCGA-C8-A137-01A-21-A13D-20	TCGA-C8-A137-01A-11D-A10Y-09	2c829af4-a6a7-48b1-9e48-a88be0564752	21cd18a4-1c4a-4df0-953c-2f20ab4318f1	TCGA-C8-A137-01A-11D-A111-01	2c829af4-a6a7-48b1-9e48-a88be0564752		TCGA-C8-A137-01	TCGA-C8-A137-01A-11R-A115-07	2c829af4-a6a7-48b1-9e48-a88be0564752	2c829af4-a6a7-48b1-9e48-a88be0564752	TCGA-C8-A137-01A-11D-A111-01	TCGA-C8-A137-01	TCGA-C8-A137-01	TCGA-C8-A137-01A-11D-A112-05	21cd18a4-1c4a-4df0-953c-2f20ab4318f1	
TCGA-C8-A138-01	Stage III	54	2	Stage IIIA	7		Positive	FEMALE	Positive	3	2	1	Negative	M0	Positive	N2	7	0	Her2	HER2-enriched	Negative	Basal	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A138-01	124	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 5	TCGA-C8-A138	124	0	124	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Left	Axillary lymph node dissection alone		TCGA-C8-A138-F19085		Positive					Negative	Modified Radical Mastectomy					-20053	93		0	124					NO						Scheduled Follow-up Submission	2011-12-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	230	NO	Equivocal			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	1								NO			true	M0	N2	T2	Stage IIIA	TCGA-C8-A138.3584F6CE-F9ED-441C-8714-BDF67C141CD6.pdf	2	2	2	4	0	0	0	1	0	0	25	30	75	70	75	70	TUMOR FREE					Allred Score 5		YES	No			NO	Primary Tumor	01		6th	NO	YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A138-01A-11D-A10Y-09	TCGA-C8-A138-01	TCGA-C8-A138-01A-11R-A114-13	TCGA-C8-A138-01A-11R-A114-13	TCGA-C8-A138-01A-11D-A10Y-09	5fa600b0-7ba1-45bf-be7d-8d60925dce68	TCGA-C8-A138-01A-11D-A10Y-09	TCGA-C8-A138-01A-21-A13D-20	TCGA-C8-A138-01A-11D-A10Y-09	f543c792-d997-420a-8bf1-c45456b62a8b	d8e8db6d-4f38-4ef6-a77a-d3ea769cc78f	TCGA-C8-A138-01A-11D-A111-01	f543c792-d997-420a-8bf1-c45456b62a8b		TCGA-C8-A138-01	TCGA-C8-A138-01A-11R-A115-07	f543c792-d997-420a-8bf1-c45456b62a8b	f543c792-d997-420a-8bf1-c45456b62a8b	TCGA-C8-A138-01A-11D-A111-01	TCGA-C8-A138-01	TCGA-C8-A138-01	TCGA-C8-A138-01A-11D-A112-05	d8e8db6d-4f38-4ef6-a77a-d3ea769cc78f	
TCGA-C8-A1HE-01	Stage IIA	59	2	Stage IIA	0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	0	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A1HE-01	375	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-C8-A1HE	375	0	375	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Right	Axillary lymph node dissection alone		TCGA-C8-A1HE-F20269		Positive					Positive	Other		NO				109		0	375					NO						Scheduled Follow-up Submission	2012-1-9	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.8		YES	Pateys Surgery	Other method, specify:	280	NO	Equivocal			5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO			true	M0	N0	T2	Stage IIA	TCGA-C8-A1HE.DDB31719-1D2F-4502-B80E-544B684DC16F.pdf		2		0		1		0		4		10		85		95	TUMOR FREE				Allred Score 4	Allred Score 7		YES	No			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A1HE-01A-11D-A188-09		TCGA-C8-A1HE-01A-11R-A13P-13	TCGA-C8-A1HE-01A-11R-A13P-13	TCGA-C8-A1HE-01A-11D-A188-09		TCGA-C8-A1HE-01A-11D-A188-09	TCGA-C8-A1HE-01A-21-A17J-20	TCGA-C8-A1HE-01A-11D-A188-09	b5f56bfb-6fc1-448f-8c2b-4753084aaa00	2f506a7d-668f-4b51-87b5-74b260663de6	TCGA-C8-A1HE-01A-11D-A13J-01	b5f56bfb-6fc1-448f-8c2b-4753084aaa00	TCGA-C8-A1HE-01A-11D-A13K-05	TCGA-C8-A1HE-01		b5f56bfb-6fc1-448f-8c2b-4753084aaa00	b5f56bfb-6fc1-448f-8c2b-4753084aaa00	TCGA-C8-A1HE-01A-11D-A13J-01		TCGA-C8-A1HE-01		2f506a7d-668f-4b51-87b5-74b260663de6	
TCGA-C8-A1HF-01	Stage IIA	48	2	Stage IIA	0		Negative	FEMALE	Positive				Negative	M0	Negative	N0	0	0	Her2	HER2-enriched	Positive		-11	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A1HF-01	332	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 3	TCGA-C8-A1HF	332	0	332	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Left	Axillary lymph node dissection alone		TCGA-C8-A1HF-F19092		Negative					Positive	Other		NO				109		0	332					NO						Scheduled Follow-up Submission	2011-12-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.8		YES	Pateys Surgery	Other method, specify:	460	NO	Positive			12	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6								NO			true	M0	N0	T2	Stage IIA	TCGA-C8-A1HF.40B07BB9-2CDB-463A-8773-771017E73DBC.pdf		1		0		1		0		0		0		99		95	TUMOR FREE				Allred Score 3			YES	No			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A1HF-01A-11D-A135-09	TCGA-C8-A1HF-01	TCGA-C8-A1HF-01A-11R-A136-13	TCGA-C8-A1HF-01A-11R-A136-13	TCGA-C8-A1HF-01A-11D-A135-09		TCGA-C8-A1HF-01A-11D-A135-09	TCGA-C8-A1HF-01A-21-A17J-20	TCGA-C8-A1HF-01A-11D-A135-09	62b06301-531d-4fc1-bb00-ede8e507e8f4	d5447c87-4ee0-4566-a933-997ad63e6009	TCGA-C8-A1HF-01A-11D-A134-01	62b06301-531d-4fc1-bb00-ede8e507e8f4	TCGA-C8-A1HF-01A-11D-A138-05	TCGA-C8-A1HF-01	TCGA-C8-A1HF-01A-11R-A137-07	62b06301-531d-4fc1-bb00-ede8e507e8f4	62b06301-531d-4fc1-bb00-ede8e507e8f4	TCGA-C8-A1HF-01A-11D-A134-01	TCGA-C8-A1HF-01	TCGA-C8-A1HF-01		d5447c87-4ee0-4566-a933-997ad63e6009	
TCGA-C8-A1HG-01	Stage IIA	50	4	Stage IIA	0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	0	0	LumB	Luminal B	Positive		-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A1HG-01	345	0	High	C3-BRCA/Luminal	cluster 5	Cluster 5	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 8	TCGA-C8-A1HG	345	0	345	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Right	Axillary lymph node dissection alone		TCGA-C8-A1HG-F19096		Positive					Positive	Other		NO				122		0	345					NO						Scheduled Follow-up Submission	2011-12-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.8		YES	Pateys Surgery	Other method, specify:	300	NO	Negative				Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	3								NO			true	M0	N0	T2	Stage IIA	TCGA-C8-A1HG.0813A175-83ED-4F6E-AD7D-FB4135CFF34C.pdf		2		0		1		0		0		4		95		90	TUMOR FREE				Allred Score 7	Allred Score 8		NO	No			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A1HG-01A-11D-A135-09	TCGA-C8-A1HG-01	TCGA-C8-A1HG-01A-11R-A136-13	TCGA-C8-A1HG-01A-11R-A136-13	TCGA-C8-A1HG-01A-11D-A135-09		TCGA-C8-A1HG-01A-11D-A135-09	TCGA-C8-A1HG-01A-21-A17J-20	TCGA-C8-A1HG-01A-11D-A135-09	094076d0-97e4-460d-b48c-7ee2371db99d	1580dd65-d698-4a80-8345-ad50e16709d1	TCGA-C8-A1HG-01A-11D-A134-01	094076d0-97e4-460d-b48c-7ee2371db99d	TCGA-C8-A1HG-01A-11D-A138-05	TCGA-C8-A1HG-01	TCGA-C8-A1HG-01A-11R-A137-07	094076d0-97e4-460d-b48c-7ee2371db99d	094076d0-97e4-460d-b48c-7ee2371db99d	TCGA-C8-A1HG-01A-11D-A134-01	TCGA-C8-A1HG-01	TCGA-C8-A1HG-01		1580dd65-d698-4a80-8345-ad50e16709d1	
TCGA-C8-A1HI-01	Stage IIIA	40	2	Stage IIIA	2		Positive	FEMALE	Negative				Negative	M0	Positive	N2	2	0	LumA	Luminal A	Positive		-5	0	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A1HI-01	343	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-C8-A1HI	343	0	343	Breast	TCGA Breast Cancer	breast invasive carcinoma					40	Right	Axillary lymph node dissection alone		TCGA-C8-A1HI-F19099		Positive					Positive	Other						120		0	343					NO						Scheduled Follow-up Submission	2011-12-2	FEMALE					1+					Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.1		YES	Pateys Surgery	Other method, specify:	490	NO	Negative			6	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6								NO			true	M0	N2	T2	Stage IIIA	TCGA-C8-A1HI.04EF4A48-80E1-4567-BB61-2B542F715266.pdf		1		0		1		0		0		9		90		80	TUMOR FREE				Allred Score 6	Allred Score 8		YES	No			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A1HI-01A-11D-A135-09	TCGA-C8-A1HI-01	TCGA-C8-A1HI-01A-11R-A136-13	TCGA-C8-A1HI-01A-11R-A136-13	TCGA-C8-A1HI-01A-11D-A135-09		TCGA-C8-A1HI-01A-11D-A135-09	TCGA-C8-A1HI-01A-21-A17J-20	TCGA-C8-A1HI-01A-11D-A135-09	994c96ec-ea0a-4741-8fef-53cdbfe28cfa	d8c894f8-3423-401d-9656-65dfd0383fd7	TCGA-C8-A1HI-01A-11D-A134-01	994c96ec-ea0a-4741-8fef-53cdbfe28cfa	TCGA-C8-A1HI-01A-11D-A138-05	TCGA-C8-A1HI-01	TCGA-C8-A1HI-01A-11R-A137-07	994c96ec-ea0a-4741-8fef-53cdbfe28cfa	994c96ec-ea0a-4741-8fef-53cdbfe28cfa	TCGA-C8-A1HI-01A-11D-A134-01	TCGA-C8-A1HI-01	TCGA-C8-A1HI-01		d8c894f8-3423-401d-9656-65dfd0383fd7	
TCGA-C8-A1HJ-01	Stage II	53	1	Stage IIA	5		Negative	FEMALE	Negative				Negative	M0	Negative	N0	5	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A1HJ-01	5	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	squamous c3	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 13	TCGA-C8-A1HJ			5	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Right	Axillary lymph node dissection alone				Negative					Negative	Other					-19629	121		0	5					NO							2011-6-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	1070	NO	Negative			10	Negative	Peri (6-12 months since last menstrual period)																		5	5											true	M0	N0	T2	Stage IIA	TCGA-C8-A1HJ.11F98715-1482-4D7D-9102-E362634806A7.pdf		0		0		5		0		0		0		95		95	TUMOR FREE							YES	No				Primary Tumor	01	Pateys Surgery	6th		YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A1HJ-01A-11D-A13L-09		TCGA-C8-A1HJ-01A-11R-A13P-13	TCGA-C8-A1HJ-01A-11R-A13P-13	TCGA-C8-A1HJ-01A-11D-A13L-09		TCGA-C8-A1HJ-01A-11D-A13L-09	TCGA-C8-A1HJ-01A-21-A17J-20	TCGA-C8-A1HJ-01A-11D-A13L-09	c0dd6c33-008d-44e8-b20c-8089bc3e29a3	6275c0ff-efae-4d00-b3ae-123cbb90b4e2	TCGA-C8-A1HJ-01A-11D-A13J-01	c0dd6c33-008d-44e8-b20c-8089bc3e29a3	TCGA-C8-A1HJ-01A-11D-A13K-05	TCGA-C8-A1HJ-01		c0dd6c33-008d-44e8-b20c-8089bc3e29a3	c0dd6c33-008d-44e8-b20c-8089bc3e29a3	TCGA-C8-A1HJ-01A-11D-A13J-01		TCGA-C8-A1HJ-01		6275c0ff-efae-4d00-b3ae-123cbb90b4e2	
TCGA-C8-A1HK-01	Stage IIB	53	5	Stage IIB	7		Negative	FEMALE	Positive				Negative	M0	Positive	N1	7	0	Her2		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A1HK-01	366	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 5	TCGA-C8-A1HK	366	0	366	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Right	Axillary lymph node dissection alone		TCGA-C8-A1HK-F19100		Negative					Negative	Other						116		0	366					NO						Scheduled Follow-up Submission	2011-12-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES	Pateys Surgery	Other method, specify:	460	NO	Positive			8	Negative	Peri (6-12 months since last menstrual period)																		4	1								NO			true	M0	N1	T2	Stage IIB	TCGA-C8-A1HK.4D1B4A09-FB4E-45EC-895B-2941D18AED18.pdf		0		0		0		0		0		25		75		75	TUMOR FREE							YES	No			NO	Primary Tumor	01	Pateys Surgery	6th	NO	YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A1HK-01A-21D-A13L-09		TCGA-C8-A1HK-01A-21R-A13P-13	TCGA-C8-A1HK-01A-21R-A13P-13	TCGA-C8-A1HK-01A-21D-A13L-09		TCGA-C8-A1HK-01A-21D-A13L-09	TCGA-C8-A1HK-01A-11-A17J-20	TCGA-C8-A1HK-01A-21D-A13L-09	83d9c730-9a1e-42b6-a1dd-6a57d0e24f2c	74864fc6-1cd0-46b0-9a71-65f73444f7ee	TCGA-C8-A1HK-01A-21D-A13J-01	83d9c730-9a1e-42b6-a1dd-6a57d0e24f2c	TCGA-C8-A1HK-01A-21D-A13K-05	TCGA-C8-A1HK-01		83d9c730-9a1e-42b6-a1dd-6a57d0e24f2c	83d9c730-9a1e-42b6-a1dd-6a57d0e24f2c	TCGA-C8-A1HK-01A-21D-A13J-01		TCGA-C8-A1HK-01		74864fc6-1cd0-46b0-9a71-65f73444f7ee	
TCGA-C8-A1HL-01	Stage IIIA	38	5	Stage IIIA	2		Positive	FEMALE	Positive				Negative	M0	Positive	N1	2	0	LumB	Luminal B	Negative		-2	-3	enrollment	T_Other	T3	LIVING	0	TCGA-C8-A1HL-01	317	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 4	mutation c1uster 9	TCGA-C8-A1HL	317	0	317	Breast	TCGA Breast Cancer	breast invasive carcinoma					38	Left	Axillary lymph node dissection alone		TCGA-C8-A1HL-F20266		Positive					Negative	Other						94		0	317					NO						Scheduled Follow-up Submission	2012-1-9	FEMALE					2+					Other  specify	Infiltrating Mucinous-papillary ductal carcinoma	No		C50.9	8480/3	C50.4		YES	Pateys Surgery	Other method, specify:	980	NO	Equivocal			9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	4								NO			true	M0	N1	T3	Stage IIIA	TCGA-C8-A1HL.ACA6B606-681C-427F-8923-77BAA7390795.pdf		0		0		0		0		0		0		100		95	TUMOR FREE					Allred Score 8		YES	Yes			NO	Primary Tumor	01	Pateys Surgery	6th	NO	YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A1HL-01A-11D-A135-09	TCGA-C8-A1HL-01	TCGA-C8-A1HL-01A-11R-A136-13	TCGA-C8-A1HL-01A-11R-A136-13	TCGA-C8-A1HL-01A-11D-A135-09		TCGA-C8-A1HL-01A-11D-A135-09	TCGA-C8-A1HL-01A-21-A17J-20	TCGA-C8-A1HL-01A-11D-A135-09	9d80ba46-b65f-4338-99bc-370f8eaefe4e	5b7b0e6b-b247-4478-8dd3-a9b749e32efe	TCGA-C8-A1HL-01A-11D-A134-01	9d80ba46-b65f-4338-99bc-370f8eaefe4e	TCGA-C8-A1HL-01A-11D-A138-05	TCGA-C8-A1HL-01	TCGA-C8-A1HL-01A-11R-A137-07	9d80ba46-b65f-4338-99bc-370f8eaefe4e	9d80ba46-b65f-4338-99bc-370f8eaefe4e	TCGA-C8-A1HL-01A-11D-A134-01	TCGA-C8-A1HL-01	TCGA-C8-A1HL-01		5b7b0e6b-b247-4478-8dd3-a9b749e32efe	
TCGA-C8-A1HM-01	Stage II	74	3	Stage IIA	6		Positive	FEMALE	Negative				Negative	M0	Negative	N0	6	0	LumB	Luminal B	Positive		-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A1HM-01	70	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 13	TCGA-C8-A1HM	70	0	70	Breast	TCGA Breast Cancer	breast invasive carcinoma					74	Left	Axillary lymph node dissection alone		TCGA-C8-A1HM-F19078		Positive					Positive	Modified Radical Mastectomy					-27063			0	70					NO						Scheduled Follow-up Submission	2011-12-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO				M0	N0	T2	Stage IIA																		TUMOR FREE				Allred Score 5	Allred Score 8		NO	No			NO	Primary Tumor	01		6th	YES	YES	NO	C8	Breast		LIVING	2010	TCGA-C8-A1HM-01A-12D-A135-09	TCGA-C8-A1HM-01	TCGA-C8-A1HM-01A-12R-A136-13	TCGA-C8-A1HM-01A-12R-A136-13	TCGA-C8-A1HM-01A-12D-A135-09		TCGA-C8-A1HM-01A-12D-A135-09	TCGA-C8-A1HM-01A-21-A17J-20	TCGA-C8-A1HM-01A-12D-A135-09	eb908a6f-d6f2-40ef-90da-97438cd2281e	b3696964-30e2-4342-914d-d7c2f5c88322	TCGA-C8-A1HM-01A-12D-A134-01	eb908a6f-d6f2-40ef-90da-97438cd2281e	TCGA-C8-A1HM-01A-12D-A138-05	TCGA-C8-A1HM-01	TCGA-C8-A1HM-01A-12R-A137-07	eb908a6f-d6f2-40ef-90da-97438cd2281e	eb908a6f-d6f2-40ef-90da-97438cd2281e	TCGA-C8-A1HM-01A-12D-A134-01	TCGA-C8-A1HM-01	TCGA-C8-A1HM-01		b3696964-30e2-4342-914d-d7c2f5c88322	
TCGA-C8-A1HN-01	Stage II	56		Stage IIA	2		Positive	FEMALE	Equivocal				Negative	M0	Negative	N0	2	0	LumB	Luminal B	Positive		-10	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A1HN-01	99	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation c1uster 9	TCGA-C8-A1HN	99	0	99	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Left	Axillary lymph node dissection alone		TCGA-C8-A1HN-F19089		Positive					Positive	Modified Radical Mastectomy					-20712	88		0	99					NO						Scheduled Follow-up Submission	2011-12-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Equivocal				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	7								NO			true	M0	N0	T2	Stage IIA	TCGA-C8-A1HN.4C7445ED-B346-4DD7-8AFA-2E95E65364BF.pdf		0		0		0		0		0		0		100		90	TUMOR FREE				Allred Score 3	Allred Score 8		NO	No			NO	Primary Tumor	01		6th	YES	YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A1HN-01A-11D-A135-09	TCGA-C8-A1HN-01	TCGA-C8-A1HN-01A-11R-A136-13	TCGA-C8-A1HN-01A-11R-A136-13	TCGA-C8-A1HN-01A-11D-A135-09		TCGA-C8-A1HN-01A-11D-A135-09	TCGA-C8-A1HN-01A-21-A17J-20	TCGA-C8-A1HN-01A-11D-A135-09	4795628e-50d8-41e0-b3c6-00fe4600dc5d	65261a78-78b6-4276-be43-f7e7ef91829d	TCGA-C8-A1HN-01A-11D-A134-01	4795628e-50d8-41e0-b3c6-00fe4600dc5d	TCGA-C8-A1HN-01A-11D-A138-05	TCGA-C8-A1HN-01	TCGA-C8-A1HN-01A-11R-A137-07	4795628e-50d8-41e0-b3c6-00fe4600dc5d	4795628e-50d8-41e0-b3c6-00fe4600dc5d	TCGA-C8-A1HN-01A-11D-A134-01	TCGA-C8-A1HN-01	TCGA-C8-A1HN-01		65261a78-78b6-4276-be43-f7e7ef91829d	
TCGA-C8-A1HO-01	Stage III	34	5	Stage IIIC	0		Positive	FEMALE	Negative				Negative	M0	Positive	N3	0	0	LumA		Positive				enrollment	T_Other	T3	LIVING		TCGA-C8-A1HO-01			Kirc+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-C8-A1HO				Breast	TCGA Breast Cancer	breast invasive carcinoma					34	Left Upper Inner Quadrant					Positive					Positive	Modified Radical Mastectomy					-12715	52		0	0												2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES		Tumor resection	380	NO	Negative				Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		3	5											true	M0	N3	T3	Stage IIIC	TCGA-C8-A1HO.24B1FA5C-7D84-4CE5-B094-2358ECE73C10.pdf		0		0		0		0		0		25		75		70	TUMOR FREE				Allred Score 5	Allred Score 7		NO	No				Primary Tumor	01		6th		YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A1HO-01A-11D-A13L-09		TCGA-C8-A1HO-01A-11R-A13P-13	TCGA-C8-A1HO-01A-11R-A13P-13	TCGA-C8-A1HO-01A-11D-A13L-09		TCGA-C8-A1HO-01A-11D-A13L-09	TCGA-C8-A1HO-01A-21-A17J-20	TCGA-C8-A1HO-01A-11D-A13L-09	1d8ecbae-6996-4d9d-bff8-ac761a8309ea	8cd0933f-c93e-4265-a6c4-6892f407ced9	TCGA-C8-A1HO-01A-11D-A13J-01	1d8ecbae-6996-4d9d-bff8-ac761a8309ea	TCGA-C8-A1HO-01A-11D-A13K-05	TCGA-C8-A1HO-01		1d8ecbae-6996-4d9d-bff8-ac761a8309ea	1d8ecbae-6996-4d9d-bff8-ac761a8309ea	TCGA-C8-A1HO-01A-11D-A13J-01		TCGA-C8-A1HO-01		8cd0933f-c93e-4265-a6c4-6892f407ced9	
TCGA-C8-A26V-01	Stage III	47	1	Stage IIIA	9		Positive	FEMALE	Negative				Negative	M0	Positive	N2	9	0	LumB		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-C8-A26V-01	9	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12		mutation cluster 8	TCGA-C8-A26V			9	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Right					Positive					Positive	Modified Radical Mastectomy					-17468	143		0	9												2011-7-21	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Modified Radical Masectomy	Other method, specify:	310	NO	Negative				Negative	Peri (6-12 months since last menstrual period)																		4												true	M0	N2	T3	Stage IIIA	TCGA-C8-A26V.929AB6C9-58B0-4E37-A2B4-9FC1F9099437.pdf		1		0		2		0		0		10		88		95	TUMOR FREE				Allred Score 8	Allred Score 8		NO	No				Primary Tumor	01		6th		YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A26V-01A-11D-A16D-09		TCGA-C8-A26V-01A-11R-A16E-13	TCGA-C8-A26V-01A-11R-A16E-13	TCGA-C8-A26V-01A-11D-A16D-09		TCGA-C8-A26V-01A-11D-A16D-09	TCGA-C8-A26V-01A-21-A17K-20	TCGA-C8-A26V-01A-11D-A16D-09	67a58c72-fa64-4c63-b568-bec834626edf	cdb4d8c0-f68c-4b40-a1b4-7b3b8324d9e1	TCGA-C8-A26V-01A-11D-A16C-01	67a58c72-fa64-4c63-b568-bec834626edf	TCGA-C8-A26V-01A-11D-A16G-05	TCGA-C8-A26V-01		67a58c72-fa64-4c63-b568-bec834626edf	67a58c72-fa64-4c63-b568-bec834626edf	TCGA-C8-A26V-01A-11D-A16C-01		TCGA-C8-A26V-01		cdb4d8c0-f68c-4b40-a1b4-7b3b8324d9e1	
TCGA-C8-A26W-01	Stage II	58	1	Stage IIB	7		Positive	FEMALE	Positive				Negative	M0	Positive	N1	7	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A26W-01	7	0	Squamous	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12		mutation cluster 8	TCGA-C8-A26W			7	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Left Upper Outer Quadrant					Positive					Positive	Modified Radical Mastectomy					-21391	142		0	7												2011-7-21	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	300	NO	Equivocal				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1												true	M0	N1	T2	Stage IIB	TCGA-C8-A26W.0F1DC8BC-5987-4C50-9A34-79FFC1D2BA30.pdf		1		0		1		0		0		34		65		80	TUMOR FREE				Allred Score 8	Allred Score 8		NO	No				Primary Tumor	01		6th		YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A26W-01A-11D-A16D-09		TCGA-C8-A26W-01A-11R-A16E-13	TCGA-C8-A26W-01A-11R-A16E-13	TCGA-C8-A26W-01A-11D-A16D-09		TCGA-C8-A26W-01A-11D-A16D-09	TCGA-C8-A26W-01A-21-A17K-20	TCGA-C8-A26W-01A-11D-A16D-09	bd304a35-2d0c-4b11-bd62-3db480c1e730	6311b4c7-cb03-4c2a-a3d0-039d362c4d4d	TCGA-C8-A26W-01A-11D-A16C-01	bd304a35-2d0c-4b11-bd62-3db480c1e730	TCGA-C8-A26W-01A-11D-A16G-05	TCGA-C8-A26W-01		bd304a35-2d0c-4b11-bd62-3db480c1e730	bd304a35-2d0c-4b11-bd62-3db480c1e730	TCGA-C8-A26W-01A-11D-A16C-01		TCGA-C8-A26W-01		6311b4c7-cb03-4c2a-a3d0-039d362c4d4d	
TCGA-C8-A26X-01	Stage II	58	4	Stage IIA	11		Negative	FEMALE	Negative				Negative	M0	Positive	N1	11	0	Her2		Negative				enrollment	T1	T1	LIVING	0	TCGA-C8-A26X-01	11	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7		mutation cluster 3	TCGA-C8-A26X			11	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Right Upper Outer Quadrant					Negative					Negative	Modified Radical Mastectomy					-21463	136		0	11												2011-7-21	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	190	NO	Negative				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4												true	M0	N1	T1	Stage IIA	TCGA-C8-A26X.8C845114-BBC6-45F2-9135-7E8298E24422.pdf		0		0		0		0		0		20		80		90	TUMOR FREE							NO	No				Primary Tumor	01		6th		YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A26X-01A-31D-A16D-09		TCGA-C8-A26X-01A-31R-A16E-13	TCGA-C8-A26X-01A-31R-A16E-13	TCGA-C8-A26X-01A-31D-A16D-09		TCGA-C8-A26X-01A-31D-A16D-09	TCGA-C8-A26X-01A-41-A17K-20	TCGA-C8-A26X-01A-31D-A16D-09	5213da80-35ac-4172-b2e8-de686e73a498	95c7e7dd-400b-4864-8593-40f348078b3a	TCGA-C8-A26X-01A-31D-A16C-01	5213da80-35ac-4172-b2e8-de686e73a498	TCGA-C8-A26X-01A-31D-A16G-05	TCGA-C8-A26X-01		5213da80-35ac-4172-b2e8-de686e73a498	5213da80-35ac-4172-b2e8-de686e73a498	TCGA-C8-A26X-01A-31D-A16C-01		TCGA-C8-A26X-01		95c7e7dd-400b-4864-8593-40f348078b3a	
TCGA-C8-A26Y-01	Stage II	90	2	Stage IIA	13		Negative	FEMALE	Negative				Negative	M0	Negative	N0	13	0	Her2		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A26Y-01	13	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-C8-A26Y			13	Breast	TCGA Breast Cancer	breast invasive carcinoma					90	Left Upper Outer Quadrant					Negative					Negative	Modified Radical Mastectomy					-32872			0	13												2011-7-21	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Negative				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4													M0	N0	T2	Stage IIA																		TUMOR FREE							NO	No				Primary Tumor	01		6th		YES	NO	C8	Breast		LIVING	2010			TCGA-C8-A26Y-01A-11R-A16E-13	TCGA-C8-A26Y-01A-11R-A16E-13			TCGA-C8-A26Y-01A-11D-A16D-09	TCGA-C8-A26Y-01A-21-A17K-20		afad9647-befe-4493-8386-475d0097c716	cb3f1e06-cab8-4345-bf54-4d99ea20fbb6	TCGA-C8-A26Y-01A-11D-A16C-01	afad9647-befe-4493-8386-475d0097c716	TCGA-C8-A26Y-01A-11D-A16G-05	TCGA-C8-A26Y-01		afad9647-befe-4493-8386-475d0097c716	afad9647-befe-4493-8386-475d0097c716	TCGA-C8-A26Y-01A-11D-A16C-01		TCGA-C8-A26Y-01		cb3f1e06-cab8-4345-bf54-4d99ea20fbb6	
TCGA-C8-A26Z-01	Stage IIA	59	3	Stage IIA	4		Positive	FEMALE	Negative				Negative	M0	Negative	N0	4	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A26Z-01	252	0	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14		mutation c1uster 9	TCGA-C8-A26Z	252	0	252	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Right Upper Inner Quadrant			TCGA-C8-A26Z-F20279		Positive					Positive	Other						125		0	252					NO						Scheduled Follow-up Submission	2012-1-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	470	NO	Negative				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4									NO			true	M0	N0	T2	Stage IIA	TCGA-C8-A26Z.5E21E07E-BD5F-4AC7-985A-178416D756E2.pdf		1		0		1		0		0		54		45		80	TUMOR FREE				Allred Score 4	Allred Score 8		NO	No			NO	Primary Tumor	01	Pateys Surgery	6th	NO	YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A26Z-01A-11D-A16D-09		TCGA-C8-A26Z-01A-11R-A16E-13	TCGA-C8-A26Z-01A-11R-A16E-13	TCGA-C8-A26Z-01A-11D-A16D-09		TCGA-C8-A26Z-01A-11D-A16D-09	TCGA-C8-A26Z-01A-21-A17K-20	TCGA-C8-A26Z-01A-11D-A16D-09	8213eb8c-db23-4f92-b3d3-07b45eeec76a	22d25b42-1b1e-4758-a192-6e3702414cc8	TCGA-C8-A26Z-01A-11D-A16C-01	8213eb8c-db23-4f92-b3d3-07b45eeec76a	TCGA-C8-A26Z-01A-11D-A16G-05	TCGA-C8-A26Z-01		8213eb8c-db23-4f92-b3d3-07b45eeec76a	8213eb8c-db23-4f92-b3d3-07b45eeec76a	TCGA-C8-A26Z-01A-11D-A16C-01		TCGA-C8-A26Z-01		22d25b42-1b1e-4758-a192-6e3702414cc8	
TCGA-C8-A273-01	Stage IIB	29	3	Stage IIB	6		Positive	FEMALE	Negative				Negative	M0	Positive	N1	6	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A273-01	294	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4		mutation c1uster 9	TCGA-C8-A273	294	0	294	Breast	TCGA Breast Cancer	breast invasive carcinoma					29	Right Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-C8-A273-F20280		Positive					Positive	Other								0	294											Scheduled Follow-up Submission	2012-1-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:			Negative			7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4									NO	2			M0	N1	T2	Stage IIB																		TUMOR FREE				Allred Score 5	Allred Score 8		YES	No			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast		LIVING	2010	TCGA-C8-A273-01A-11D-A16D-09		TCGA-C8-A273-01A-11R-A16E-13	TCGA-C8-A273-01A-11R-A16E-13	TCGA-C8-A273-01A-11D-A16D-09		TCGA-C8-A273-01A-11D-A16D-09	TCGA-C8-A273-01A-21-A17K-20	TCGA-C8-A273-01A-11D-A16D-09	c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa	fb139187-1f6a-4354-8e25-279dc4960116	TCGA-C8-A273-01A-11D-A16C-01	c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa	TCGA-C8-A273-01A-11D-A16G-05	TCGA-C8-A273-01		c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa	c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa	TCGA-C8-A273-01A-11D-A16C-01		TCGA-C8-A273-01		fb139187-1f6a-4354-8e25-279dc4960116	
TCGA-C8-A274-01	Stage IIA	63	2	Stage IIA	1		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A274-01	290	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13		mutation cluster 1	TCGA-C8-A274	290	0	290	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Right			TCGA-C8-A274-F20275		Positive					Positive	Other					-23337			0	290											Scheduled Follow-up Submission	2012-1-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:			Negative				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO				M0	N0	T2	Stage IIA																		TUMOR FREE				Allred Score 7	Allred Score 8		NO	No			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast		LIVING	2010	TCGA-C8-A274-01A-11D-A16D-09		TCGA-C8-A274-01A-11R-A16E-13	TCGA-C8-A274-01A-11R-A16E-13	TCGA-C8-A274-01A-11D-A16D-09		TCGA-C8-A274-01A-11D-A16D-09	TCGA-C8-A274-01A-21-A17K-20	TCGA-C8-A274-01A-11D-A16D-09	f9521be2-aaaf-414c-a906-3ba53a060614	a6343496-02a8-41be-ba50-25df086b21f7	TCGA-C8-A274-01A-11D-A16C-01	f9521be2-aaaf-414c-a906-3ba53a060614	TCGA-C8-A274-01A-11D-A16G-05	TCGA-C8-A274-01		f9521be2-aaaf-414c-a906-3ba53a060614	f9521be2-aaaf-414c-a906-3ba53a060614	TCGA-C8-A274-01A-11D-A16C-01		TCGA-C8-A274-01		a6343496-02a8-41be-ba50-25df086b21f7	
TCGA-C8-A275-01	Stage IIA	56	3	Stage IIA	1			FEMALE	Positive				Negative	M0	Positive	N1	1	0	Her2						enrollment	T1	T1	LIVING	0	TCGA-C8-A275-01	1	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4		mutation cluster 5	TCGA-C8-A275			1	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Left Upper Outer Quadrant											Other					-20774	169		0	1												2011-7-21	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	300	NO					Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4												true	M0	N1	T1	Stage IIA	TCGA-C8-A275.BDE9E2A9-09E9-49BC-AFBE-BD32916972DC.pdf		5		0		18		0		0		27		55		75	TUMOR FREE							NO	No				Primary Tumor	01	Pateys Surgery	6th		YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A275-01A-21D-A16D-09		TCGA-C8-A275-01A-21R-A16E-13	TCGA-C8-A275-01A-21R-A16E-13	TCGA-C8-A275-01A-21D-A16D-09		TCGA-C8-A275-01A-21D-A16D-09	TCGA-C8-A275-01A-11-A17K-20	TCGA-C8-A275-01A-21D-A16D-09	59c6ed76-762c-4caa-98c1-0886b6d9651c	c65dfc5d-a66d-4a43-ae04-4bd8edd88962	TCGA-C8-A275-01A-21D-A16C-01	59c6ed76-762c-4caa-98c1-0886b6d9651c	TCGA-C8-A275-01A-21D-A16G-05	TCGA-C8-A275-01		59c6ed76-762c-4caa-98c1-0886b6d9651c	59c6ed76-762c-4caa-98c1-0886b6d9651c	TCGA-C8-A275-01A-21D-A16C-01		TCGA-C8-A275-01		c65dfc5d-a66d-4a43-ae04-4bd8edd88962	
TCGA-C8-A278-01	Stage IIIA	61	4	Stage IIIA	1		Negative	FEMALE	Positive				Negative	M0	Positive	N2	1	0	Her2		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A278-01	289	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7		mutation cluster 3	TCGA-C8-A278	289	0	289	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Left			TCGA-C8-A278-F20278		Negative					Negative	Other					-22606	163		0	289											Scheduled Follow-up Submission	2012-1-9	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	630	NO	Positive				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4									NO			true	M0	N2	T2	Stage IIIA	TCGA-C8-A278.4F3E197A-9731-427C-A2AB-2D506A1C717B.pdf		40		10		5		30		0		35		60		60	TUMOR FREE							NO	No			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A278-01A-11D-A167-09		TCGA-C8-A278-01A-11R-A168-13	TCGA-C8-A278-01A-11R-A168-13	TCGA-C8-A278-01A-11D-A167-09		TCGA-C8-A278-01A-11D-A167-09	TCGA-C8-A278-01A-21-A17K-20	TCGA-C8-A278-01A-11D-A167-09	8cdae811-9f3f-4c8b-9fe5-e542d30d40f2	666a8f56-7f29-4dba-8bdf-f2fccbe78bbd	TCGA-C8-A278-01A-11D-A166-01	8cdae811-9f3f-4c8b-9fe5-e542d30d40f2	TCGA-C8-A278-01A-11D-A16A-05	TCGA-C8-A278-01		8cdae811-9f3f-4c8b-9fe5-e542d30d40f2	8cdae811-9f3f-4c8b-9fe5-e542d30d40f2	TCGA-C8-A278-01A-11D-A166-01		TCGA-C8-A278-01		666a8f56-7f29-4dba-8bdf-f2fccbe78bbd	
TCGA-C8-A27A-01	Stage IIB	48	4	Stage IIB	371		Positive	FEMALE	Negative				Negative	M0	Positive	N1	371	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A27A-01	371	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-C8-A27A			371	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Right Upper Outer Quadrant					Positive					Positive	Modified Radical Mastectomy					-17779	435		0	371												2011-7-21	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	230	NO	Negative				Negative	Peri (6-12 months since last menstrual period)																		3	5											true	M0	N1	T2	Stage IIB	TCGA-C8-A27A.4CC1413A-5D03-4BE4-91E5-80B578CE7DFA.pdf		40		10		10		30		0		20		70		70	TUMOR FREE					Allred Score 7		NO	No				Primary Tumor	01		6th		YES	NO	C8	Breast	A	LIVING	2010	TCGA-C8-A27A-01A-11D-A167-09		TCGA-C8-A27A-01A-11R-A168-13	TCGA-C8-A27A-01A-11R-A168-13	TCGA-C8-A27A-01A-11D-A167-09		TCGA-C8-A27A-01A-11D-A167-09	TCGA-C8-A27A-01A-21-A17K-20	TCGA-C8-A27A-01A-11D-A167-09	520a6569-bf3a-495f-9460-7f65e4f59687	2fb480d8-ea3c-40a7-aff7-c98eb38f0059	TCGA-C8-A27A-01A-11D-A166-01	520a6569-bf3a-495f-9460-7f65e4f59687	TCGA-C8-A27A-01A-11D-A16A-05	TCGA-C8-A27A-01		520a6569-bf3a-495f-9460-7f65e4f59687	520a6569-bf3a-495f-9460-7f65e4f59687	TCGA-C8-A27A-01A-11D-A166-01		TCGA-C8-A27A-01		2fb480d8-ea3c-40a7-aff7-c98eb38f0059	
TCGA-C8-A27B-01	Stage IIB	48	1	Stage IIB	30		Negative	FEMALE	Negative				Negative	M0	Negative	N0	30	0	Basal		Negative				enrollment	T_Other	T3	LIVING	0	TCGA-C8-A27B-01	30	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	squamous c3	BRCA basal-like c8	miRNA cluster 4	cluster 5	mutation cluster 13	TCGA-C8-A27B			30	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Left					Negative					Negative	Modified Radical Mastectomy					-17763	93		0	30												2011-7-21	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	240	NO	Negative				Negative	Peri (6-12 months since last menstrual period)																		5	5											true	M0	N0	T3	Stage IIB	TCGA-C8-A27B.CD43BA31-A5C6-4C0C-AA07-3171332776CC.pdf		30		10		5		50		0		5		90		90	TUMOR FREE							NO	No				Primary Tumor	01		6th		YES	NO	C8	Breast	A	LIVING	2011	TCGA-C8-A27B-01A-11D-A167-09		TCGA-C8-A27B-01A-11R-A168-13	TCGA-C8-A27B-01A-11R-A168-13	TCGA-C8-A27B-01A-11D-A167-09		TCGA-C8-A27B-01A-11D-A167-09	TCGA-C8-A27B-01A-21-A17K-20	TCGA-C8-A27B-01A-11D-A167-09	fb03a31f-6611-4343-816d-37a332147eac	2d4cf2b5-75ed-40f3-b2e7-a32bde10b1f2	TCGA-C8-A27B-01A-11D-A166-01	fb03a31f-6611-4343-816d-37a332147eac	TCGA-C8-A27B-01A-11D-A16A-05	TCGA-C8-A27B-01		fb03a31f-6611-4343-816d-37a332147eac	fb03a31f-6611-4343-816d-37a332147eac	TCGA-C8-A27B-01A-11D-A166-01		TCGA-C8-A27B-01		2d4cf2b5-75ed-40f3-b2e7-a32bde10b1f2	
TCGA-C8-A3M7-01																			LumA										0	TCGA-C8-A3M7-01	1	0	Iq	C3-BRCA/Luminal		BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-C8-A3M7			1	Breast	TCGA Breast Cancer	breast invasive carcinoma					60	Left Upper Inner Quadrant	Axillary lymph node dissection alone				Negative					Negative	Modified Radical Mastectomy		NO			-22096			0	1					NO							2012-3-6	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection			Negative			6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0			M0	N0	T4b	Stage IIIB																		TUMOR FREE							YES	No				Primary Tumor	01		7th		YES	NO	C8	Breast		LIVING	2010			TCGA-C8-A3M7-01A-12R-A21U-13	TCGA-C8-A3M7-01A-12R-A21U-13			TCGA-C8-A3M7-01A-12D-A21Q-09	TCGA-C8-A3M7-01A-21-A24A-20		b55b6630-7cf5-4bca-b76f-e135271018e4	fa8586a0-46be-45b5-9dd0-54f20b4c673c	TCGA-C8-A3M7-01A-12D-A21P-01	b55b6630-7cf5-4bca-b76f-e135271018e4	TCGA-C8-A3M7-01A-12D-A21R-05	TCGA-C8-A3M7-01		b55b6630-7cf5-4bca-b76f-e135271018e4	b55b6630-7cf5-4bca-b76f-e135271018e4	TCGA-C8-A3M7-01A-12D-A21P-01		TCGA-C8-A3M7-01		fa8586a0-46be-45b5-9dd0-54f20b4c673c	
TCGA-C8-A3M8-01																			LumB										0	TCGA-C8-A3M8-01	7	0	High	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-C8-A3M8			7	Breast	TCGA Breast Cancer	breast invasive carcinoma					68	Right Upper Outer Quadrant	Axillary lymph node dissection alone				Positive					Positive	Modified Radical Mastectomy		NO			-24877	264		0	7					NO							2012-3-6	FEMALE					3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	280	NO	Positive				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														true	M0	N0	T1c	Stage IA	TCGA-C8-A3M8.25CD89AC-052F-4B9F-AE1C-B0824A7A5145.pdf		2		1		0		1		0		20		80		80	TUMOR FREE		Dako		Allred	Allred		YES	No				Primary Tumor	01		7th		YES	NO	C8	Breast	A	LIVING	2011			TCGA-C8-A3M8-01A-11R-A214-13	TCGA-C8-A3M8-01A-11R-A214-13			TCGA-C8-A3M8-01A-11D-A20S-09	TCGA-C8-A3M8-01A-21-A24A-20		a04ad65d-6d83-4e84-8bd8-3cab2a195642	315dad75-6b4f-456f-be6e-77b9d066beb4	TCGA-C8-A3M8-01A-11D-A20R-01	a04ad65d-6d83-4e84-8bd8-3cab2a195642	TCGA-C8-A3M8-01A-11D-A212-05	TCGA-C8-A3M8-01		a04ad65d-6d83-4e84-8bd8-3cab2a195642	a04ad65d-6d83-4e84-8bd8-3cab2a195642	TCGA-C8-A3M8-01A-11D-A20R-01		TCGA-C8-A3M8-01		315dad75-6b4f-456f-be6e-77b9d066beb4	
TCGA-C8-A8HP-01																													0	TCGA-C8-A8HP-01	396	0										TCGA-C8-A8HP	396	0	396	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-C8-A8HP-F69610		Negative					Negative	Modified Radical Mastectomy					-21613	231		0	396												2015-1-15	FEMALE										Metaplastic Carcinoma		No		C50.9	8575/3	C50.4		YES		Core needle biopsy	240	NO	Positive		NO	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	6		true	M0	N2	T2	Stage IIIA	TCGA-C8-A8HP.581088D6-9F9C-4572-B61D-BAF0F6C79B2F.pdf		40		20		10		20		0		20		70		70	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		7th		YES	NO	C8	Breast	A	LIVING	2013			TCGA-C8-A8HP-01A-11R-A36A-13	TCGA-C8-A8HP-01A-11R-A36A-13						02cf1db9-55c0-4ece-b230-966b30cd0b94	03fd168b-3ada-472c-89a9-33dae1531fc3	TCGA-C8-A8HP-01A-11D-A36I-01	02cf1db9-55c0-4ece-b230-966b30cd0b94	TCGA-C8-A8HP-01A-11D-A36K-05	TCGA-C8-A8HP-01		02cf1db9-55c0-4ece-b230-966b30cd0b94	02cf1db9-55c0-4ece-b230-966b30cd0b94	TCGA-C8-A8HP-01A-11D-A36I-01		TCGA-C8-A8HP-01		03fd168b-3ada-472c-89a9-33dae1531fc3	
TCGA-C8-A8HQ-01																													0	TCGA-C8-A8HQ-01	380	0										TCGA-C8-A8HQ	380	0	380	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Left	Axillary lymph node dissection alone		TCGA-C8-A8HQ-F69879		Positive					Positive	Modified Radical Mastectomy		NO			-19432	185		0	380												2015-1-22	FEMALE										Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Core needle biopsy	300	NO	Negative		NO	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	3	4	true	M0	N1	T2	Stage IIB	TCGA-C8-A8HQ.37FA6CD0-E789-44EA-AD78-C195CBB1EDE3.pdf		40		20		20		20		0		20		60		60	TUMOR FREE						NO	YES	No			NO	Primary Tumor	01		7th		YES	NO	C8	Breast	A	LIVING	2013			TCGA-C8-A8HQ-01A-11R-A36A-13	TCGA-C8-A8HQ-01A-11R-A36A-13						7f8c9d62-0803-44d6-9375-b4e71612a0b1	a90a8770-3fdd-4afd-8f39-8c3b410ae8f1	TCGA-C8-A8HQ-01A-11D-A36I-01	7f8c9d62-0803-44d6-9375-b4e71612a0b1	TCGA-C8-A8HQ-01A-11D-A36K-05	TCGA-C8-A8HQ-01		7f8c9d62-0803-44d6-9375-b4e71612a0b1	7f8c9d62-0803-44d6-9375-b4e71612a0b1	TCGA-C8-A8HQ-01A-11D-A36I-01		TCGA-C8-A8HQ-01		a90a8770-3fdd-4afd-8f39-8c3b410ae8f1	
TCGA-C8-A8HR-01																													0	TCGA-C8-A8HR-01	408	0										TCGA-C8-A8HR	408	0	408	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Right	Axillary lymph node dissection alone		TCGA-C8-A8HR-F69796								Modified Radical Mastectomy		NO			-17921	162		0	408												2015-1-20	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	420	NO			NO	8	Negative	Peri (6-12 months since last menstrual period)																											NO	5		true	M0	N2	T3	Stage IIIA	TCGA-C8-A8HR.CA1E5192-ABB0-45E6-8547-2BA2B035238C.pdf		40		20		10		20		0		10		80		80	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		7th		YES	NO	C8	Breast	A	LIVING	2013			TCGA-C8-A8HR-01A-11R-A36A-13	TCGA-C8-A8HR-01A-11R-A36A-13						d817dcee-1322-4949-a6e9-138447e6fc56	77c63c3d-458d-4e59-bb39-3394cda8ba21	TCGA-C8-A8HR-01A-11D-A36I-01	d817dcee-1322-4949-a6e9-138447e6fc56	TCGA-C8-A8HR-01A-11D-A36K-05	TCGA-C8-A8HR-01		d817dcee-1322-4949-a6e9-138447e6fc56	d817dcee-1322-4949-a6e9-138447e6fc56	TCGA-C8-A8HR-01A-11D-A36I-01		TCGA-C8-A8HR-01		77c63c3d-458d-4e59-bb39-3394cda8ba21	
TCGA-C8-A9FZ-01																													0	TCGA-C8-A9FZ-01	592	0										TCGA-C8-A9FZ	592	0	592	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Left	Axillary lymph node dissection alone		TCGA-C8-A9FZ-F69966								Modified Radical Mastectomy		NO			-18038	191		0	592												2015-1-23	FEMALE										Mixed Histology (please specify)	Infiltrating Tubulo-Lobular Carcinoma	No		C50.9	8524/3	C50.1		YES		Core needle biopsy	280	NO	Negative		NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	3		true	M0	N1	T2	Stage IIB	TCGA-C8-A9FZ.23B3BAED-E281-4A1D-AB78-51D8D62466FF.pdf		0		0		0		0		0		10		90		95	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th		YES	NO	C8	Breast	A	LIVING	2013			TCGA-C8-A9FZ-01A-11R-A41G-13	TCGA-C8-A9FZ-01A-11R-A41G-13							158677fe-9918-45b1-b1b4-62288491d4a1	TCGA-C8-A9FZ-01A-11D-A41E-01		TCGA-C8-A9FZ-01A-11D-A41Q-05					TCGA-C8-A9FZ-01A-11D-A41E-01				158677fe-9918-45b1-b1b4-62288491d4a1	
TCGA-D8-A13Y-01	Stage IA	52	5	No_Conversion	362		Positive	FEMALE	Negative	3	2	4	Negative	M0	Negative	N0	362	0	LumB	Luminal B	Positive	Basal	-2	-6	followup	T1	T1	LIVING	0	TCGA-D8-A13Y-01	362	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	GBM-like c6	miRNA cluster 6	cluster 1	mutation cluster 2	TCGA-D8-A13Y	362	0	362	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A13Y-F13806		Positive					Positive	Modified Radical Mastectomy		NO			-19028	184		0	362						manual counting	70-79%				Scheduled Follow-up Submission	2011-6-20	FEMALE		Hecep Test TM DAKO			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	430	NO	Negative			6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	1								NO	0		false	M0	N0	T1c	Stage IA	TCGA-D8-A13Y.0CF5DE3C-272C-4127-8047-4359D1278181.pdf	0	1	0	0	2	5	0	0	0	0	10	45	88	50	95	80	TUMOR FREE	manual counting			10-75%	10-75%			No	70-79%		NO	Primary Tumor	01			YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A13Y-01A-11D-A10Y-09	TCGA-D8-A13Y-01	TCGA-D8-A13Y-01A-11R-A114-13	TCGA-D8-A13Y-01A-11R-A114-13	TCGA-D8-A13Y-01A-11D-A10Y-09	664694fa-7bea-4f87-b6ff-4df52540d15b	TCGA-D8-A13Y-01A-11D-A10Y-09	TCGA-D8-A13Y-01A-21-A13D-20	TCGA-D8-A13Y-01A-11D-A10Y-09	9a92e20a-2a43-4917-981d-c93179770050	7d1b722a-15e9-4ba8-846c-94fb949345ed	TCGA-D8-A13Y-01A-11D-A111-01	9a92e20a-2a43-4917-981d-c93179770050		TCGA-D8-A13Y-01	TCGA-D8-A13Y-01A-11R-A115-07	9a92e20a-2a43-4917-981d-c93179770050	9a92e20a-2a43-4917-981d-c93179770050	TCGA-D8-A13Y-01A-11D-A111-01	TCGA-D8-A13Y-01	TCGA-D8-A13Y-01	TCGA-D8-A13Y-01A-11D-A112-05	7d1b722a-15e9-4ba8-846c-94fb949345ed	
TCGA-D8-A13Z-01	Stage X	51	1	Stage IIIA	210		Negative	FEMALE	Negative	2	2	1	Negative	M0	Positive	N2	210	0	Her2	HER2-enriched	Negative	Basal	-13	-10	enrollment	T_Other	T2	LIVING	0	TCGA-D8-A13Z-01	635	0	High	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-D8-A13Z	635	0	635	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A13Z-F20731		Negative					Negative	Modified Radical Mastectomy					-18942	214		0	635											Scheduled Follow-up Submission	2012-1-14	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	470	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	9		false	M0	N2a	T2		TCGA-D8-A13Z.8EFA6C19-2FA1-4F23-AF7B-15681E8E930A.pdf	3	3	0	0	35	20	0	0	0	2	15	43	50	35	80	70	TUMOR FREE		Hercep Test  TM Dako					YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A13Z-01A-11D-A10Y-09	TCGA-D8-A13Z-01	TCGA-D8-A13Z-01A-11R-A114-13	TCGA-D8-A13Z-01A-11R-A114-13	TCGA-D8-A13Z-01A-11D-A10Y-09	ecffe473-31aa-41e3-a964-ca96147a8023	TCGA-D8-A13Z-01A-11D-A10Y-09	TCGA-D8-A13Z-01A-21-A13D-20	TCGA-D8-A13Z-01A-11D-A10Y-09	624ac458-8ff1-441c-a8c5-aaf4a08a4b84	a0230b81-eee6-4c5f-b6de-cb9215dbda5b	TCGA-D8-A13Z-01A-11D-A111-01	624ac458-8ff1-441c-a8c5-aaf4a08a4b84		TCGA-D8-A13Z-01	TCGA-D8-A13Z-01A-11R-A115-07	624ac458-8ff1-441c-a8c5-aaf4a08a4b84	624ac458-8ff1-441c-a8c5-aaf4a08a4b84	TCGA-D8-A13Z-01A-11D-A111-01	TCGA-D8-A13Z-01	TCGA-D8-A13Z-01	TCGA-D8-A13Z-01A-11D-A112-05	a0230b81-eee6-4c5f-b6de-cb9215dbda5b	
TCGA-D8-A140-01	Stage IIB	62		Stage IIB	403		Positive	FEMALE	Positive				Negative	M0	Positive	N1	403	0	LumA	Luminal B	Positive	LumA/B	-10	-5	followup	T_Other	T2	LIVING	0	TCGA-D8-A140-01	403	0		C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-D8-A140	403	0	403	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-D8-A140-F13808		Positive					Positive	Modified Radical Mastectomy		NO			-22900	204		0	403						manual counting					Scheduled Follow-up Submission	2011-6-20	FEMALE		Hercep Test TM DAKO			3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	400	NO	Positive			15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	6								NO	1		false	M0	N1a	T2	Stage IIB	TCGA-D8-A140.D78476E6-799F-4DED-A219-CBFE2DE3C77B.pdf	3	4	0	0	1	1	1	0	0	0	54	14	45	85	70	95	TUMOR FREE	manual counting			<10%	>75%		YES	No	<10%		NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A140-01A-11D-A10Y-09	TCGA-D8-A140-01	TCGA-D8-A140-01A-11R-A114-13	TCGA-D8-A140-01A-11R-A114-13	TCGA-D8-A140-01A-11D-A10Y-09	ce3b8c9f-acd7-4ba7-8042-3a3de6225cde	TCGA-D8-A140-01A-11D-A10Y-09	TCGA-D8-A140-01A-21-A13D-20	TCGA-D8-A140-01A-11D-A10Y-09	116f1b9d-8c0c-4b29-b9b2-06ea186f4480	3551b6ac-c340-4640-9bbf-fe1181e1c773	TCGA-D8-A140-01A-11D-A111-01	116f1b9d-8c0c-4b29-b9b2-06ea186f4480		TCGA-D8-A140-01	TCGA-D8-A140-01A-11R-A115-07	116f1b9d-8c0c-4b29-b9b2-06ea186f4480	116f1b9d-8c0c-4b29-b9b2-06ea186f4480	TCGA-D8-A140-01A-11D-A111-01	TCGA-D8-A140-01	TCGA-D8-A140-01	TCGA-D8-A140-01A-11D-A112-05	3551b6ac-c340-4640-9bbf-fe1181e1c773	
TCGA-D8-A141-01	Stage X	40	2	Stage IIA	113		Positive	FEMALE	Negative				Negative	M0	Positive	N1	113	0	LumA	Luminal A	Positive		-5	-4	enrollment	T1	T1	LIVING	0	TCGA-D8-A141-01	626	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-D8-A141	626	0	626	Breast	TCGA Breast Cancer	breast invasive carcinoma					40	Right	Axillary lymph node dissection alone		TCGA-D8-A141-F20734		Positive					Positive	Modified Radical Mastectomy					-14626			0	626						manual counting					Scheduled Follow-up Submission	2012-1-14	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy			Negative			15	Negative	Indeterminate (neither Pre or Postmenopausal)																		1	4								NO	1			M0	N1	T1c																			TUMOR FREE	manual counting	Hercep Test  TM Dako		>75%	>75%		YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast		LIVING	2010	TCGA-D8-A141-01A-11D-A10Y-09	TCGA-D8-A141-01	TCGA-D8-A141-01A-11R-A114-13	TCGA-D8-A141-01A-11R-A114-13	TCGA-D8-A141-01A-11D-A10Y-09		TCGA-D8-A141-01A-11D-A10Y-09		TCGA-D8-A141-01A-11D-A10Y-09	cb6c668a-ff24-4ebe-99f7-0c24fcf17c32	b96324a1-55fb-4b3a-b813-0305e6bd31c2	TCGA-D8-A141-01A-11D-A111-01	cb6c668a-ff24-4ebe-99f7-0c24fcf17c32		TCGA-D8-A141-01	TCGA-D8-A141-01A-11R-A115-07	cb6c668a-ff24-4ebe-99f7-0c24fcf17c32	cb6c668a-ff24-4ebe-99f7-0c24fcf17c32	TCGA-D8-A141-01A-11D-A111-01	TCGA-D8-A141-01	TCGA-D8-A141-01	TCGA-D8-A141-01A-11D-A112-05	b96324a1-55fb-4b3a-b813-0305e6bd31c2	
TCGA-D8-A142-01	Stage IIB	74	1	Stage IIB	425		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	425	0	Basal	Basal-like	Negative	X	-13	0	followup	T_Other	T3	LIVING	0	TCGA-D8-A142-01	425	0	High	C4-BRCA/Basal	cluster 5	Cluster 5	BRCA basal-like c6	BRCA basal-like c8	miRNA c1uster 9	cluster 3	mutation cluster 5	TCGA-D8-A142	425	0	425	Breast	TCGA Breast Cancer	breast invasive carcinoma					74	Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-D8-A142-F13813		Negative					Negative	Modified Radical Mastectomy		NO			-27313	212		0	425											Scheduled Follow-up Submission	2011-6-20	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	490	NO	Equivocal	Negative		14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3								NO	0		false	M0	N0	T3	Stage IIB	TCGA-D8-A142.7D2C880F-6897-44A0-9470-5A5B5429A9C0.pdf	60	60	10	10	5	5	20	20	0	0	25	35	70	60	70	60	TUMOR FREE		FISH					YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A142-01A-11D-A10Y-09	TCGA-D8-A142-01	TCGA-D8-A142-01A-11R-A114-13	TCGA-D8-A142-01A-11R-A114-13	TCGA-D8-A142-01A-11D-A10Y-09	d434b104-6d07-417e-9a84-c729c071cf14	TCGA-D8-A142-01A-11D-A10Y-09	TCGA-D8-A142-01A-21-A13D-20	TCGA-D8-A142-01A-11D-A10Y-09	9f440cd6-d55f-4cb6-a433-637ef1f9d38f	336577b1-b012-4346-936b-0502d0f8a597	TCGA-D8-A142-01A-11D-A111-01	9f440cd6-d55f-4cb6-a433-637ef1f9d38f		TCGA-D8-A142-01	TCGA-D8-A142-01A-11R-A115-07	9f440cd6-d55f-4cb6-a433-637ef1f9d38f	9f440cd6-d55f-4cb6-a433-637ef1f9d38f	TCGA-D8-A142-01A-11D-A111-01	TCGA-D8-A142-01	TCGA-D8-A142-01	TCGA-D8-A142-01A-11D-A112-05	336577b1-b012-4346-936b-0502d0f8a597	
TCGA-D8-A143-01	Stage IIA	51	3	Stage IIA	431		Negative	FEMALE	Negative				Negative	M0	Negative	N0	431	0	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA-D8-A143-01	431	0	High	C3-BRCA/Luminal	cluster 5	BRCA CIMP c7	squamous c3	BRCA nonbasal-like c7			mutation cluster 3	TCGA-D8-A143	431	0	431	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-D8-A143-F13817		Negative					Negative	Modified Radical Mastectomy		NO			-18984	211		0	431											Scheduled Follow-up Submission	2011-7-4	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5									NO	0		false	M0	N0	T2	Stage IIA	TCGA-D8-A143.F8C2F3EF-FA73-4FF8-9A4E-7F557E68D560.pdf	70	70	10	10	5	5	10	10	0	0	25	45	70	50	80	80	TUMOR FREE							YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A143-01A-11D-A10Y-09	TCGA-D8-A143-01	TCGA-D8-A143-01A-11R-A114-13	TCGA-D8-A143-01A-11R-A114-13	TCGA-D8-A143-01A-11D-A10Y-09	e9cd47fb-4a8f-44c9-af6a-f931387d14a7	TCGA-D8-A143-01A-11D-A10Y-09	TCGA-D8-A143-01A-21-A13D-20	TCGA-D8-A143-01A-11D-A10Y-09	4bf5f56d-448a-426a-8edc-f1bdbf6a8d55	e49bd6ce-bbab-4c77-a49d-6a85bf2e1f14	TCGA-D8-A143-01A-11D-A111-01	4bf5f56d-448a-426a-8edc-f1bdbf6a8d55		TCGA-D8-A143-01	TCGA-D8-A143-01A-11R-A115-07	4bf5f56d-448a-426a-8edc-f1bdbf6a8d55	4bf5f56d-448a-426a-8edc-f1bdbf6a8d55	TCGA-D8-A143-01A-11D-A111-01	TCGA-D8-A143-01	TCGA-D8-A143-01	TCGA-D8-A143-01A-11D-A112-05	e49bd6ce-bbab-4c77-a49d-6a85bf2e1f14	
TCGA-D8-A145-01	Stage IIA	80	1	Stage IIA	410		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N1	410	0	LumA	Luminal A	Positive	ReacI	-5	-7	followup	T1	T1	LIVING	0	TCGA-D8-A145-01	410	0	COAD-READ	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-D8-A145	410	0	410	Breast	TCGA Breast Cancer	breast invasive carcinoma					80	Right Upper Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-D8-A145-F13811		Positive					Positive	Simple Mastectomy		NO			-29280	191		0	410						manual counting					Scheduled Follow-up Submission	2011-7-4	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO	Equivocal	Negative		7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6								NO	1		false	M0	N1a	T1c	Stage IIA	TCGA-D8-A145.1D26CB97-536A-4D10-A593-73C3A846BB13.pdf	0	0	0	0	0	0	0	0	0	10	15	30	85	60	75	75	TUMOR FREE	manual counting				>75%		YES	No	<10%		NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A145-01A-11D-A10Y-09	TCGA-D8-A145-01	TCGA-D8-A145-01A-11R-A114-13	TCGA-D8-A145-01A-11R-A114-13	TCGA-D8-A145-01A-11D-A10Y-09	c734c71e-bd11-4c7c-862a-1d578d1951b1	TCGA-D8-A145-01A-11D-A10Y-09	TCGA-D8-A145-01A-21-A13D-20	TCGA-D8-A145-01A-11D-A10Y-09	6223244a-ed38-46b5-8e65-cc8e4926c809	6afb99b2-188d-4de2-9d42-821be341609d	TCGA-D8-A145-01A-11D-A111-01	6223244a-ed38-46b5-8e65-cc8e4926c809		TCGA-D8-A145-01	TCGA-D8-A145-01A-11R-A115-07	6223244a-ed38-46b5-8e65-cc8e4926c809	6223244a-ed38-46b5-8e65-cc8e4926c809	TCGA-D8-A145-01A-11D-A111-01	TCGA-D8-A145-01	TCGA-D8-A145-01	TCGA-D8-A145-01A-11D-A112-05	6afb99b2-188d-4de2-9d42-821be341609d	
TCGA-D8-A146-01	Stage IIA	57		Stage IIA	344		Positive	FEMALE	Negative				Negative	M0	Negative	N0	344	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A146-01	643	0	Iq	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4		mutation cluster 4	TCGA-D8-A146	643	0	643	Breast	TCGA Breast Cancer	breast invasive carcinoma					57	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-D8-A146-F20750		Positive					Positive	Modified Radical Mastectomy		NO			-20861	221		0	643					NO	manual counting					Scheduled Follow-up Submission	2012-1-15	FEMALE		DAKO Hercep Test TM			1+					Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	230	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	MX	N0	T2	Stage IIA	TCGA-D8-A146.79749F5D-329A-400D-8511-C4CF479C1FCC.pdf		1		0		2		0		8		55		35		80	TUMOR FREE	manual counting			>75%	>75%		YES	Yes			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A146-01A-31D-A10Y-09	TCGA-D8-A146-01	TCGA-D8-A146-01A-31R-A114-13	TCGA-D8-A146-01A-31R-A114-13	TCGA-D8-A146-01A-31D-A10Y-09	9953ddb6-cba3-4fd0-9917-42071efaabdb	TCGA-D8-A146-01A-31D-A10Y-09	TCGA-D8-A146-01A-21-A13D-20	TCGA-D8-A146-01A-31D-A10Y-09	69f535c7-8f70-4efc-98bc-7f99924d7db1	136bb2dd-32dc-434d-978c-310c93fa1dd8	TCGA-D8-A146-01A-31D-A111-01	69f535c7-8f70-4efc-98bc-7f99924d7db1		TCGA-D8-A146-01	TCGA-D8-A146-01A-31R-A115-07	69f535c7-8f70-4efc-98bc-7f99924d7db1	69f535c7-8f70-4efc-98bc-7f99924d7db1	TCGA-D8-A146-01A-31D-A111-01	TCGA-D8-A146-01	TCGA-D8-A146-01	TCGA-D8-A146-01A-31D-A112-05	136bb2dd-32dc-434d-978c-310c93fa1dd8	
TCGA-D8-A147-01	Stage X	45	1	Stage IIA	2		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	2	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-D8-A147-01	584	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 5	mutation cluster 13	TCGA-D8-A147	584	0	584	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-D8-A147-F20737		Negative					Negative	Lumpectomy					-16736	163		0	584											Scheduled Follow-up Submission	2012-1-14	FEMALE		Hercep Test  TM Dako								Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	130	NO	Negative			1	Negative	Indeterminate (neither Pre or Postmenopausal)																		5	5								NO	0		false	M0	N0	T2		TCGA-D8-A147.380639A2-E89C-4495-8168-82120617129F.pdf	0	0	0	0	0	0	0	0	0	0	10	0	90	100	70	85	TUMOR FREE							YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A147-01A-11D-A10Y-09	TCGA-D8-A147-01	TCGA-D8-A147-01A-11R-A114-13	TCGA-D8-A147-01A-11R-A114-13	TCGA-D8-A147-01A-11D-A10Y-09	a8d9009e-ecf1-420f-a3b7-faab805210de	TCGA-D8-A147-01A-11D-A10Y-09	TCGA-D8-A147-01A-21-A13D-20	TCGA-D8-A147-01A-11D-A10Y-09	4d28bcbc-dbdd-46f8-9329-49f359480a97	92830f47-3f32-4b74-bef4-4536963be38f	TCGA-D8-A147-01A-11D-A111-01	4d28bcbc-dbdd-46f8-9329-49f359480a97		TCGA-D8-A147-01	TCGA-D8-A147-01A-11R-A115-07	4d28bcbc-dbdd-46f8-9329-49f359480a97	4d28bcbc-dbdd-46f8-9329-49f359480a97	TCGA-D8-A147-01A-11D-A111-01	TCGA-D8-A147-01	TCGA-D8-A147-01	TCGA-D8-A147-01A-11D-A112-05	92830f47-3f32-4b74-bef4-4536963be38f	
TCGA-D8-A1J8-01	Stage IIB	77	2	Stage IIB	256		Positive	FEMALE	Negative				Negative	M0	Positive	N1	256	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1J8-01	431	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4		TCGA-D8-A1J8	431	0	431	Breast	TCGA Breast Cancer	breast invasive carcinoma					77	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1J8-F14040		Positive					Positive	Modified Radical Mastectomy					-28444	272		0	431							70-79%				Scheduled Follow-up Submission	2011-7-18	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	260	NO	Negative			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4								NO	3		false	M0	N1a	T2	Stage IIB	TCGA-D8-A1J8.E8E799F8-158D-4AEC-8F86-D40F132C071C.pdf		0		0		0		0		0		0		100		90	TUMOR FREE							NO	No	70-79%		NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010			TCGA-D8-A1J8-01A-11R-A13P-13	TCGA-D8-A1J8-01A-11R-A13P-13			TCGA-D8-A1J8-01A-11D-A13L-09	TCGA-D8-A1J8-01A-21-A17J-20		ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef	809e26fd-e8ab-4ad2-aaac-25fbfe767682	TCGA-D8-A1J8-01A-11D-A13J-01	ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef	TCGA-D8-A1J8-01A-11D-A13K-05	TCGA-D8-A1J8-01		ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef	ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef	TCGA-D8-A1J8-01A-11D-A13J-01		TCGA-D8-A1J8-01		809e26fd-e8ab-4ad2-aaac-25fbfe767682	
TCGA-D8-A1J9-01	Stage IA	48	2	Stage I	248		Positive	FEMALE	Positive				Negative	M0	Negative	N0	248	0	LumB		Negative				enrollment	T1	T1	LIVING	0	TCGA-D8-A1J9-01	532	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 8	TCGA-D8-A1J9	532	0	532	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1J9-F20944		Positive					Negative	Modified Radical Mastectomy					-17879	211		0	532						manual counting					Scheduled Follow-up Submission	2012-1-19	FEMALE		Hecep Test TM DAKO			3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	230	NO	Positive			6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	1								NO	0		false	M0	N0	T1c	Stage IA	TCGA-D8-A1J9.D80E9389-AAD8-4EEB-9DE0-5DE57B5E5F6B.pdf		0		0		0		0		0		0		100		92	TUMOR FREE	manual counting			0%	10-75%		NO	No			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1J9-01A-11D-A13L-09		TCGA-D8-A1J9-01A-11R-A13P-13	TCGA-D8-A1J9-01A-11R-A13P-13	TCGA-D8-A1J9-01A-11D-A13L-09		TCGA-D8-A1J9-01A-11D-A13L-09	TCGA-D8-A1J9-01A-21-A17J-20	TCGA-D8-A1J9-01A-11D-A13L-09	ff7159e7-e9f2-4cc8-ab89-f4167d19672c	6570866d-4604-4a9d-a672-516cb1168f6c	TCGA-D8-A1J9-01A-11D-A13J-01	ff7159e7-e9f2-4cc8-ab89-f4167d19672c	TCGA-D8-A1J9-01A-11D-A13K-05	TCGA-D8-A1J9-01		ff7159e7-e9f2-4cc8-ab89-f4167d19672c	ff7159e7-e9f2-4cc8-ab89-f4167d19672c	TCGA-D8-A1J9-01A-11D-A13J-01		TCGA-D8-A1J9-01		6570866d-4604-4a9d-a672-516cb1168f6c	
TCGA-D8-A1JA-01	Stage X	60	1	Stage IIIB	18		Negative	FEMALE	Positive				Negative	M0	Negative	N0	18	0	Her2		Negative				enrollment	T_Other	T4	LIVING	0	TCGA-D8-A1JA-01	502	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5		TCGA-D8-A1JA	431	1	502	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	YES	NO		60	Left Upper Outer Quadrant	No axillary staging		TCGA-D8-A1JA-F20941		Negative					Negative	Modified Radical Mastectomy		NO			-21918	194		0	502			431			manual counting	<10%				Scheduled Follow-up Submission	2012-1-19	FEMALE		Hecep Test TM DAKO			3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	310	NO	Positive				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5					Locoregional Disease			YES			false	M0	NX	T4b		TCGA-D8-A1JA.51A2B7B5-0CDD-427D-BC82-5498810B2641.pdf		0		0		10		0		0		0		90		95	WITH TUMOR	manual counting			0%			NO	No			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010			TCGA-D8-A1JA-01A-11R-A13P-13	TCGA-D8-A1JA-01A-11R-A13P-13			TCGA-D8-A1JA-01A-11D-A13L-09	TCGA-D8-A1JA-01A-21-A17J-20		ae81378c-ada3-43cb-9855-941467fd856c	05cd681e-6864-4296-88d3-f3848bdaaf58	TCGA-D8-A1JA-01A-11D-A13J-01	ae81378c-ada3-43cb-9855-941467fd856c	TCGA-D8-A1JA-01A-11D-A13K-05	TCGA-D8-A1JA-01		ae81378c-ada3-43cb-9855-941467fd856c	ae81378c-ada3-43cb-9855-941467fd856c	TCGA-D8-A1JA-01A-11D-A13J-01		TCGA-D8-A1JA-01		05cd681e-6864-4296-88d3-f3848bdaaf58	
TCGA-D8-A1JB-01	Stage IIB	54	3	Stage IIB	0		Positive	FEMALE	Positive				Negative	M0	Positive	N1	0	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1JB-01	569	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-D8-A1JB	569	0	569	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JB-F20852		Positive					Positive	Modified Radical Mastectomy		NO			-19822	232		0	569						manual counting					Scheduled Follow-up Submission	2012-1-19	FEMALE		Hecep Test TM DAKO		Path Vysion HER2 D Probe Kit	2+		not amplified			Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	350	NO	Equivocal	Positive		8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6								NO	1		false	M0	N1a	T2	Stage IIB	TCGA-D8-A1JB.27376503-A55C-4905-A885-632440EFCED2.pdf		0		0		0		0		10		5		85		60	TUMOR FREE	manual counting			10-75%	>75%		YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1JB-01A-11D-A13L-09		TCGA-D8-A1JB-01A-11R-A13P-13	TCGA-D8-A1JB-01A-11R-A13P-13	TCGA-D8-A1JB-01A-11D-A13L-09		TCGA-D8-A1JB-01A-11D-A13L-09	TCGA-D8-A1JB-01A-21-A17J-20	TCGA-D8-A1JB-01A-11D-A13L-09	45fe02d2-5d68-43c4-9cea-7da6e16a55a2	ba751e6e-5336-423f-81a4-5ec3109ae4e7	TCGA-D8-A1JB-01A-11D-A13J-01	45fe02d2-5d68-43c4-9cea-7da6e16a55a2	TCGA-D8-A1JB-01A-11D-A13K-05	TCGA-D8-A1JB-01		45fe02d2-5d68-43c4-9cea-7da6e16a55a2	45fe02d2-5d68-43c4-9cea-7da6e16a55a2	TCGA-D8-A1JB-01A-11D-A13J-01		TCGA-D8-A1JB-01		ba751e6e-5336-423f-81a4-5ec3109ae4e7	
TCGA-D8-A1JC-01	Stage IIIA	59	5	Stage IIIA	178		Positive	FEMALE	Negative				Negative	M0	Positive	N2	178	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1JC-01	480	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-D8-A1JC	480	0	480	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JC-F20847		Positive					Positive	Modified Radical Mastectomy		NO			-21898			0	480											Scheduled Follow-up Submission	2012-1-19	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:			Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4								NO	4			M0	N2a	T2	Stage IIIA																		TUMOR FREE				>75%	>75%		YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast		LIVING	2010	TCGA-D8-A1JC-01A-11D-A13L-09		TCGA-D8-A1JC-01A-11R-A13P-13	TCGA-D8-A1JC-01A-11R-A13P-13	TCGA-D8-A1JC-01A-11D-A13L-09		TCGA-D8-A1JC-01A-11D-A13L-09	TCGA-D8-A1JC-01A-21-A17J-20	TCGA-D8-A1JC-01A-11D-A13L-09	d69c60ae-d21b-4e6e-89c5-ef0750a31c71	d7bb6fff-6305-4980-ab29-0bb9757b7687	TCGA-D8-A1JC-01A-11D-A13J-01	d69c60ae-d21b-4e6e-89c5-ef0750a31c71	TCGA-D8-A1JC-01A-11D-A13K-05	TCGA-D8-A1JC-01		d69c60ae-d21b-4e6e-89c5-ef0750a31c71	d69c60ae-d21b-4e6e-89c5-ef0750a31c71	TCGA-D8-A1JC-01A-11D-A13J-01		TCGA-D8-A1JC-01		d7bb6fff-6305-4980-ab29-0bb9757b7687	
TCGA-D8-A1JD-01	Stage IIB	41	5	Stage IIB	273		Positive	FEMALE	Negative				Negative	M0	Positive	N1	273	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1JD-01	552	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-D8-A1JD	552	0	552	Breast	TCGA Breast Cancer	breast invasive carcinoma					41	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JD-F20844		Positive					Positive	Modified Radical Mastectomy					-15166	230		0	552						manual counting					Scheduled Follow-up Submission	2012-1-19	FEMALE		Hecep Test TM DAKO			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	400	NO	Negative			14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	4								NO	3	0	false	M0	N1a	T2	Stage IIB	TCGA-D8-A1JD.332880ED-FE4E-4EE4-9E96-0A61BFCCA27E.pdf		0		0		0		0		0		5		95		70	TUMOR FREE	manual counting			10-75%	>75%		NO	No			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1JD-01A-11D-A13L-09		TCGA-D8-A1JD-01A-11R-A13P-13	TCGA-D8-A1JD-01A-11R-A13P-13	TCGA-D8-A1JD-01A-11D-A13L-09		TCGA-D8-A1JD-01A-11D-A13L-09	TCGA-D8-A1JD-01A-21-A17J-20	TCGA-D8-A1JD-01A-11D-A13L-09	f2ee7101-b51e-4f75-95fa-555b5b79af74	907cd6bb-05fd-4557-b21d-d8d8d16fb8a3	TCGA-D8-A1JD-01A-11D-A13J-01	f2ee7101-b51e-4f75-95fa-555b5b79af74	TCGA-D8-A1JD-01A-11D-A13K-05	TCGA-D8-A1JD-01		f2ee7101-b51e-4f75-95fa-555b5b79af74	f2ee7101-b51e-4f75-95fa-555b5b79af74	TCGA-D8-A1JD-01A-11D-A13J-01		TCGA-D8-A1JD-01		907cd6bb-05fd-4557-b21d-d8d8d16fb8a3	
TCGA-D8-A1JE-01	Stage IIA	62	2	Stage IIA	57		Positive	FEMALE	Negative				Negative	M0	Positive	N1	57	0	LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A1JE-01	575	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-D8-A1JE	575	0	575	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JE-F20759		Positive					Positive	Modified Radical Mastectomy		NO			-22683			0	575						manual counting					Scheduled Follow-up Submission	2012-1-8	FEMALE		Hecep Test TM DAKO			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy			Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4								NO	3			M0	N1a	T1c	Stage IIA																		TUMOR FREE	manual counting			10-75%	>75%		YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast		LIVING	2010	TCGA-D8-A1JE-01A-11D-A13L-09		TCGA-D8-A1JE-01A-11R-A13P-13	TCGA-D8-A1JE-01A-11R-A13P-13	TCGA-D8-A1JE-01A-11D-A13L-09		TCGA-D8-A1JE-01A-11D-A13L-09	TCGA-D8-A1JE-01A-21-A17J-20	TCGA-D8-A1JE-01A-11D-A13L-09	c7139402-146f-4c49-bcd0-f2a6a378911e	ff8bc49a-9c34-45ab-864b-0e052fd6e594	TCGA-D8-A1JE-01A-11D-A13J-01	c7139402-146f-4c49-bcd0-f2a6a378911e	TCGA-D8-A1JE-01A-11D-A13K-05	TCGA-D8-A1JE-01		c7139402-146f-4c49-bcd0-f2a6a378911e	c7139402-146f-4c49-bcd0-f2a6a378911e	TCGA-D8-A1JE-01A-11D-A13J-01		TCGA-D8-A1JE-01		ff8bc49a-9c34-45ab-864b-0e052fd6e594	
TCGA-D8-A1JF-01	Stage IIIA	79	3	Stage IIIA	96		Negative	FEMALE	Negative				Negative	M0	Positive	N2	96	0	Her2		Negative				enrollment	T1	T1	LIVING	0	TCGA-D8-A1JF-01	366	0	COAD-READ	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 8	TCGA-D8-A1JF	366	0	366	Breast	TCGA Breast Cancer	breast invasive carcinoma					79	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JF-F14058		Negative					Negative	Modified Radical Mastectomy		NO			-29199			0	366											Scheduled Follow-up Submission	2011-7-18	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:			Negative			25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	3								NO	8			M0	N2a	T1c	Stage IIIA																		TUMOR FREE							YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast		LIVING	2010	TCGA-D8-A1JF-01A-11D-A13L-09		TCGA-D8-A1JF-01A-11R-A13P-13	TCGA-D8-A1JF-01A-11R-A13P-13	TCGA-D8-A1JF-01A-11D-A13L-09		TCGA-D8-A1JF-01A-11D-A13L-09	TCGA-D8-A1JF-01A-21-A17J-20	TCGA-D8-A1JF-01A-11D-A13L-09	a74b20ca-06f9-47ec-8888-cb01e0ba3257	b93cb7b4-ce63-4f54-864e-f271f86c0781	TCGA-D8-A1JF-01A-11D-A13J-01	a74b20ca-06f9-47ec-8888-cb01e0ba3257	TCGA-D8-A1JF-01A-11D-A13K-05	TCGA-D8-A1JF-01		a74b20ca-06f9-47ec-8888-cb01e0ba3257	a74b20ca-06f9-47ec-8888-cb01e0ba3257	TCGA-D8-A1JF-01A-11D-A13J-01		TCGA-D8-A1JF-01		b93cb7b4-ce63-4f54-864e-f271f86c0781	
TCGA-D8-A1JG-01	Stage IIA	62	1	Stage IIA	187		Negative	FEMALE	Negative				Negative	M0	Negative	N0	187	0	Her2		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1JG-01	366	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-D8-A1JG			366	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-D8-A1JG-F14060		Negative					Negative	Lumpectomy		NO			-22878	215		0	366											Scheduled Follow-up Submission	2011-7-18	FEMALE					2+		not amplified			Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	250	NO	Equivocal	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	3									0		false	M0	N0	T2	Stage IIA			0		0		5		0		0		5		90		90	TUMOR FREE							YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	B	LIVING	2010	TCGA-D8-A1JG-01B-11D-A13L-09		TCGA-D8-A1JG-01B-11R-A13P-13	TCGA-D8-A1JG-01B-11R-A13P-13	TCGA-D8-A1JG-01B-11D-A13L-09		TCGA-D8-A1JG-01B-11D-A13L-09	TCGA-D8-A1JG-01B-21-A17J-20	TCGA-D8-A1JG-01B-11D-A13L-09	ee8b563d-11bb-4d84-ac53-e2acc8d0275d	0dd5d01d-8c6d-48ff-9cc0-fdc8d853b87c	TCGA-D8-A1JG-01B-11D-A13J-01	ee8b563d-11bb-4d84-ac53-e2acc8d0275d	TCGA-D8-A1JG-01B-11D-A13K-05	TCGA-D8-A1JG-01		ee8b563d-11bb-4d84-ac53-e2acc8d0275d	ee8b563d-11bb-4d84-ac53-e2acc8d0275d	TCGA-D8-A1JG-01B-11D-A13J-01		TCGA-D8-A1JG-01		0dd5d01d-8c6d-48ff-9cc0-fdc8d853b87c	
TCGA-D8-A1JH-01	Stage IA	56	1	Stage I	426		Positive	FEMALE	Negative				Negative	M0	Negative	N0	426	0	LumA		Positive				followup	T1	T1	LIVING	0	TCGA-D8-A1JH-01	426	0	Quiet	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-D8-A1JH	426	0	426	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JH-F14055		Positive					Positive	Modified Radical Mastectomy					-20497	263		0	426						manual counting					Scheduled Follow-up Submission	2011-7-18	FEMALE		Hecep Test TM DAKO			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	140	NO	Negative			9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6								NO			false	M0	N0	T1c	Stage IA	TCGA-D8-A1JH.49C79E09-2F69-4089-BFB1-53197DA09A46.pdf		5		1		0		1		2		38		60		60	TUMOR FREE	manual counting			>75%	>75%		YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1JH-01A-11D-A188-09		TCGA-D8-A1JH-01A-11R-A13P-13	TCGA-D8-A1JH-01A-11R-A13P-13	TCGA-D8-A1JH-01A-11D-A188-09		TCGA-D8-A1JH-01A-11D-A188-09	TCGA-D8-A1JH-01A-21-A17J-20	TCGA-D8-A1JH-01A-11D-A188-09	00a3c8f4-bd75-4aa8-abb7-21005b1a5ad8	fb59b402-77cf-4eac-aaf8-4ebaf715acbb	TCGA-D8-A1JH-01A-11D-A13J-01	00a3c8f4-bd75-4aa8-abb7-21005b1a5ad8	TCGA-D8-A1JH-01A-11D-A13K-05	TCGA-D8-A1JH-01		00a3c8f4-bd75-4aa8-abb7-21005b1a5ad8	00a3c8f4-bd75-4aa8-abb7-21005b1a5ad8	TCGA-D8-A1JH-01A-11D-A13J-01		TCGA-D8-A1JH-01		fb59b402-77cf-4eac-aaf8-4ebaf715acbb	
TCGA-D8-A1JI-01	Stage IIA	54	2	Stage IIA	21		Positive	FEMALE	Negative				Negative	M0	Positive	N1	21	0	LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A1JI-01	577	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-D8-A1JI	577	0	577	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JI-F20757		Positive					Positive	Modified Radical Mastectomy		NO			-20072	226		0	577						manual counting					Scheduled Follow-up Submission	2012-1-19	FEMALE		DAKOHercepTest TM								Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	190	NO	Negative			22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	1								NO	2		false	MX	N1a	T1c	Stage IIA	TCGA-D8-A1JI.EF2DC6FB-F026-4025-B148-DF07194914AB.pdf		1		1		0		0		0		5		95		95	TUMOR FREE	manual counting			>75%	>75%		YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1JI-01A-11D-A13L-09		TCGA-D8-A1JI-01A-11R-A13P-13	TCGA-D8-A1JI-01A-11R-A13P-13	TCGA-D8-A1JI-01A-11D-A13L-09		TCGA-D8-A1JI-01A-11D-A13L-09	TCGA-D8-A1JI-01A-21-A17J-20	TCGA-D8-A1JI-01A-11D-A13L-09	27706c21-96cb-48e9-88ec-1c52769bfe45	06007408-83ae-42dd-b7ea-bd017e97669f	TCGA-D8-A1JI-01A-11D-A13J-01	27706c21-96cb-48e9-88ec-1c52769bfe45	TCGA-D8-A1JI-01A-11D-A13K-05	TCGA-D8-A1JI-01		27706c21-96cb-48e9-88ec-1c52769bfe45	27706c21-96cb-48e9-88ec-1c52769bfe45	TCGA-D8-A1JI-01A-11D-A13J-01		TCGA-D8-A1JI-01		06007408-83ae-42dd-b7ea-bd017e97669f	
TCGA-D8-A1JJ-01	Stage IIA	54	1	Stage IIA	274		Positive	FEMALE	Negative				Negative	M0	Negative	N0	274	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1JJ-01	611	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 4	mutation cluster 3	TCGA-D8-A1JJ	611	0	611	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-D8-A1JJ-F20754		Positive					Positive	Other					-19966	260		0	611						manual counting					Scheduled Follow-up Submission	2012-1-19	FEMALE		DAKOHercepTest TM			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	240	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	0		false	M0	N0	T2	Stage IIA	TCGA-D8-A1JJ.3F1DA529-4967-462D-8966-E634D66EB3E1.pdf		0		0		0		0		0		60		40		60	TUMOR FREE	manual counting	10-75%		10-75%	>75%		YES	No			YES	Primary Tumor	01	breast conserving therapy	7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1JJ-01A-31D-A14K-09		TCGA-D8-A1JJ-01A-31R-A14L-13	TCGA-D8-A1JJ-01A-31R-A14L-13	TCGA-D8-A1JJ-01A-31D-A14K-09		TCGA-D8-A1JJ-01A-31D-A14K-09	TCGA-D8-A1JJ-01A-11-A17J-20	TCGA-D8-A1JJ-01A-31D-A14K-09	091cb252-dd08-4e9c-939c-749f595713f6	d52157a2-cf02-470c-b912-78697cb75086	TCGA-D8-A1JJ-01A-31D-A14J-01	091cb252-dd08-4e9c-939c-749f595713f6	TCGA-D8-A1JJ-01A-31D-A14N-05	TCGA-D8-A1JJ-01		091cb252-dd08-4e9c-939c-749f595713f6	091cb252-dd08-4e9c-939c-749f595713f6	TCGA-D8-A1JJ-01A-31D-A14J-01		TCGA-D8-A1JJ-01		d52157a2-cf02-470c-b912-78697cb75086	
TCGA-D8-A1JK-01	Stage IIA	90	1	Stage IIA	109		Negative	FEMALE	Negative				Negative	M0	Negative	N0	109	0	Basal		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1JK-01	612	0	High	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 4	mutation cluster 3	TCGA-D8-A1JK	612	0	612	Breast	TCGA Breast Cancer	breast invasive carcinoma					90	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JK-F20751		Negative					Positive	Modified Radical Mastectomy					-32872	261		0	612						manual counting					Scheduled Follow-up Submission	2012-1-19	FEMALE		DAKOHercepTest TM			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	270	NO	Negative			13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	0		false	M0	N0	T2	Stage IIA	TCGA-D8-A1JK.1841FEE0-EC36-4EC4-8B5E-6D340C80735B.pdf		3		1		0		1		0		15		85		85	TUMOR FREE	manual counting				0%		YES	No	<10%		NO	Primary Tumor	01		7th	NO	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1JK-01A-11D-A13L-09		TCGA-D8-A1JK-01A-11R-A13P-13	TCGA-D8-A1JK-01A-11R-A13P-13	TCGA-D8-A1JK-01A-11D-A13L-09		TCGA-D8-A1JK-01A-11D-A13L-09	TCGA-D8-A1JK-01A-21-A17J-20	TCGA-D8-A1JK-01A-11D-A13L-09	f7dd2e6b-a87e-467b-890a-3c422ae3dea7	7013da0d-5e90-4f8d-a489-8077b55309b0	TCGA-D8-A1JK-01A-11D-A13J-01	f7dd2e6b-a87e-467b-890a-3c422ae3dea7	TCGA-D8-A1JK-01A-11D-A13K-05	TCGA-D8-A1JK-01		f7dd2e6b-a87e-467b-890a-3c422ae3dea7	f7dd2e6b-a87e-467b-890a-3c422ae3dea7	TCGA-D8-A1JK-01A-11D-A13J-01		TCGA-D8-A1JK-01		7013da0d-5e90-4f8d-a489-8077b55309b0	
TCGA-D8-A1JL-01	Stage IIA	72	3	Stage IIA	265		Negative	FEMALE	Negative				Negative	M0	Negative	N0	265	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1JL-01	611	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-D8-A1JL	611	0	611	Breast	TCGA Breast Cancer	breast invasive carcinoma					72	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JL-F20747		Negative					Negative	Modified Radical Mastectomy					-26484	264		0	611						manual counting					Scheduled Follow-up Submission	2012-1-15	FEMALE		DAKOHercepTest TM			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	430	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	2								NO	0		false	M0	N0	T2	Stage IIA	TCGA-D8-A1JL.156DF753-DB3A-4934-9618-1E18CE46C845.pdf		2		1		2		1		0		13		85		85	TUMOR FREE	manual counting			0%	0%		YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1JL-01A-11D-A13L-09		TCGA-D8-A1JL-01A-11R-A13P-13	TCGA-D8-A1JL-01A-11R-A13P-13	TCGA-D8-A1JL-01A-11D-A13L-09		TCGA-D8-A1JL-01A-11D-A13L-09	TCGA-D8-A1JL-01A-21-A17J-20	TCGA-D8-A1JL-01A-11D-A13L-09	b4673313-fa18-43e8-a01b-5cdb3cf5425e	8f111081-c896-403e-b965-65d3e3a9ba62	TCGA-D8-A1JL-01A-11D-A13J-01	b4673313-fa18-43e8-a01b-5cdb3cf5425e	TCGA-D8-A1JL-01A-11D-A13K-05	TCGA-D8-A1JL-01		b4673313-fa18-43e8-a01b-5cdb3cf5425e	b4673313-fa18-43e8-a01b-5cdb3cf5425e	TCGA-D8-A1JL-01A-11D-A13J-01		TCGA-D8-A1JL-01		8f111081-c896-403e-b965-65d3e3a9ba62	
TCGA-D8-A1JM-01	Stage IIB	59	1	Stage IIB	238		Positive	FEMALE	Negative				Negative	M0	Positive	N1	238	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1JM-01	590	0	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8			mutation c1uster 9	TCGA-D8-A1JM	590	0	590	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JM-F20742		Positive					Negative	Modified Radical Mastectomy					-21602			0	590						manual counting	<10%				Scheduled Follow-up Submission	2012-1-15	FEMALE		DAKOHercepTest TM			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy			Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4									NO	3			M0	N1a	T2	Stage IIB																		TUMOR FREE	manual counting			0%			YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast		LIVING	2010	TCGA-D8-A1JM-01A-11D-A13L-09				TCGA-D8-A1JM-01A-11D-A13L-09		TCGA-D8-A1JM-01A-11D-A13L-09	TCGA-D8-A1JM-01A-21-A17J-20	TCGA-D8-A1JM-01A-11D-A13L-09	ab3e7f05-9fb2-4c19-a6a9-3ffe1e4c1525	d2f50599-788e-4f91-9b11-ec882d5b7736	TCGA-D8-A1JM-01A-11D-A13J-01	ab3e7f05-9fb2-4c19-a6a9-3ffe1e4c1525	TCGA-D8-A1JM-01A-11D-A13K-05	TCGA-D8-A1JM-01		ab3e7f05-9fb2-4c19-a6a9-3ffe1e4c1525	ab3e7f05-9fb2-4c19-a6a9-3ffe1e4c1525	TCGA-D8-A1JM-01A-11D-A13J-01		TCGA-D8-A1JM-01		d2f50599-788e-4f91-9b11-ec882d5b7736	
TCGA-D8-A1JN-01	Stage IIIC	80	2	Stage IIIC	217		Positive	FEMALE	Negative				Negative	M0	Positive	N3	217	0	LumA		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-D8-A1JN-01	620	0	Iq	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-D8-A1JN	620	0	620	Breast	TCGA Breast Cancer	breast invasive carcinoma					80	Left	Axillary lymph node dissection alone		TCGA-D8-A1JN-F20745		Positive					Positive	Modified Radical Mastectomy					-29331	273		0	620						manual counting					Scheduled Follow-up Submission	2012-1-15	FEMALE	HER2 amplification - negative	DAKOHercepTest TM		PathVision HER2 D Probe Kit						Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Incisional Biopsy	180	NO	Indeterminate	Negative		13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	3								NO	11		false	MX	N3a	T3	Stage IIIC	TCGA-D8-A1JN.021DF0B3-A535-4AD4-9545-1B9A7BC3E1E6.pdf		3		1		0		0		0		20		80		80	TUMOR FREE	manual counting				>75%		YES	No	<10%		NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1JN-01A-11D-A13L-09		TCGA-D8-A1JN-01A-11R-A13P-13	TCGA-D8-A1JN-01A-11R-A13P-13	TCGA-D8-A1JN-01A-11D-A13L-09		TCGA-D8-A1JN-01A-11D-A13L-09	TCGA-D8-A1JN-01A-21-A17J-20	TCGA-D8-A1JN-01A-11D-A13L-09	874de789-c1c4-4fd3-b45c-e885f62aaeab	501e2d9b-703f-4ca0-95f6-bcf0267d1a32	TCGA-D8-A1JN-01A-11D-A13J-01	874de789-c1c4-4fd3-b45c-e885f62aaeab	TCGA-D8-A1JN-01A-11D-A13K-05	TCGA-D8-A1JN-01		874de789-c1c4-4fd3-b45c-e885f62aaeab	874de789-c1c4-4fd3-b45c-e885f62aaeab	TCGA-D8-A1JN-01A-11D-A13J-01		TCGA-D8-A1JN-01		501e2d9b-703f-4ca0-95f6-bcf0267d1a32	
TCGA-D8-A1JP-01	Stage IA	73	1	Stage I	167		Positive	FEMALE	Negative				Negative	M0	Negative	N0	167	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A1JP-01	639	0	High	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-D8-A1JP	639	0	639	Breast	TCGA Breast Cancer	breast invasive carcinoma					73	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-D8-A1JP-F20740	Negative	Positive				Mastectomy NOS	Positive	Lumpectomy					-26862	292		0	639						manual counting					Scheduled Follow-up Submission	2012-1-15	FEMALE		DAKOHercepTest TM			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	430	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	6								NO			false	M0	N0	T1c	Stage IA	TCGA-D8-A1JP.1B61F1C1-8B19-4D9C-B6B9-87EEE350A472.pdf		3		1		0		1		1		24		75		75	TUMOR FREE	manual counting				>75%		YES	No	<10%		NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1JP-01A-11D-A13L-09		TCGA-D8-A1JP-01A-11R-A13P-13	TCGA-D8-A1JP-01A-11R-A13P-13	TCGA-D8-A1JP-01A-11D-A13L-09		TCGA-D8-A1JP-01A-11D-A13L-09	TCGA-D8-A1JP-01A-21-A17J-20	TCGA-D8-A1JP-01A-11D-A13L-09	f7461164-08b5-4a5c-ae74-cb4332f5ff7a	1dd196c1-6198-4edf-b8a1-66fed90a68b3	TCGA-D8-A1JP-01A-11D-A13J-01	f7461164-08b5-4a5c-ae74-cb4332f5ff7a	TCGA-D8-A1JP-01A-11D-A13K-05	TCGA-D8-A1JP-01		f7461164-08b5-4a5c-ae74-cb4332f5ff7a	f7461164-08b5-4a5c-ae74-cb4332f5ff7a	TCGA-D8-A1JP-01A-11D-A13J-01		TCGA-D8-A1JP-01		1dd196c1-6198-4edf-b8a1-66fed90a68b3	
TCGA-D8-A1JS-01	Stage IA	77	2	Stage I	371		Positive	FEMALE	Negative				Negative	M0	Negative	N0	371	0	LumA		Positive				followup	T1	T1	LIVING	0	TCGA-D8-A1JS-01	371	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-D8-A1JS	371	0	371	Breast	TCGA Breast Cancer	breast invasive carcinoma					77	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JS-F14051		Positive					Positive	Lumpectomy		NO			-28178			0	371						manual counting					Scheduled Follow-up Submission	2011-7-18	FEMALE		Hecep Test TM DAKO			1+					Other  specify	papillary	No		C50.9	8503/3	C50.9		YES	intraoperative examination	Other method, specify:			Negative			13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	3								NO	0			M0	N0	T1c	Stage IA																		TUMOR FREE	manual counting			>75%	>75%		YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast		LIVING	2010	TCGA-D8-A1JS-01A-11D-A13L-09		TCGA-D8-A1JS-01A-11R-A13P-13	TCGA-D8-A1JS-01A-11R-A13P-13	TCGA-D8-A1JS-01A-11D-A13L-09		TCGA-D8-A1JS-01A-11D-A13L-09	TCGA-D8-A1JS-01A-21-A17J-20	TCGA-D8-A1JS-01A-11D-A13L-09	b347056d-3ae3-43c7-9e3b-f48cee1bfbb2	dce7b4c5-15a6-4201-8bbf-8cec0c229720	TCGA-D8-A1JS-01A-11D-A13J-01	b347056d-3ae3-43c7-9e3b-f48cee1bfbb2	TCGA-D8-A1JS-01A-11D-A13K-05	TCGA-D8-A1JS-01		b347056d-3ae3-43c7-9e3b-f48cee1bfbb2	b347056d-3ae3-43c7-9e3b-f48cee1bfbb2	TCGA-D8-A1JS-01A-11D-A13J-01		TCGA-D8-A1JS-01		dce7b4c5-15a6-4201-8bbf-8cec0c229720	
TCGA-D8-A1JT-01	Stage IIA	70	4	Stage IIA	405		Positive	FEMALE	Negative				Negative	M0	Negative	N0	405	0	LumB		Positive				followup	T_Other	T2	LIVING	0	TCGA-D8-A1JT-01	405	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-D8-A1JT	405	0	405	Breast	TCGA Breast Cancer	breast invasive carcinoma					70	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JT-F14048		Positive					Positive	Modified Radical Mastectomy		NO			-25677	250		0	405							70-79%				Scheduled Follow-up Submission	2011-7-18	FEMALE					2+		not amplified			Other  specify	ductal and papillary	No		C50.9	8523/3	C50.9		YES		Fine needle aspiration biopsy	250	NO	Equivocal	Negative		15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	0		false	M0	N0	T2	Stage IIA	TCGA-D8-A1JT.72AF26A2-FAD0-42FD-A63C-6E8E2597B84E.pdf		0		0		10		0		0		20		70		80	TUMOR FREE							YES	No	70-79%		NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1JT-01A-31D-A13L-09		TCGA-D8-A1JT-01A-31R-A13P-13	TCGA-D8-A1JT-01A-31R-A13P-13	TCGA-D8-A1JT-01A-31D-A13L-09		TCGA-D8-A1JT-01A-31D-A13L-09	TCGA-D8-A1JT-01A-41-A17J-20	TCGA-D8-A1JT-01A-31D-A13L-09	33600bf2-ec43-49d2-93dd-4985feb500aa	3de70cd5-875b-483a-9051-fe3e78038172	TCGA-D8-A1JT-01A-31D-A13J-01	33600bf2-ec43-49d2-93dd-4985feb500aa	TCGA-D8-A1JT-01A-31D-A13K-05	TCGA-D8-A1JT-01		33600bf2-ec43-49d2-93dd-4985feb500aa	33600bf2-ec43-49d2-93dd-4985feb500aa	TCGA-D8-A1JT-01A-31D-A13J-01		TCGA-D8-A1JT-01		3de70cd5-875b-483a-9051-fe3e78038172	
TCGA-D8-A1JU-01	Stage IA	51	2	Stage I	447		Positive	FEMALE	Negative				Negative	M0	Negative	N0	447	0	LumA		Positive				followup	T1	T1	LIVING	0	TCGA-D8-A1JU-01	447	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-D8-A1JU	447	0	447	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-D8-A1JU-F14045		Positive					Positive	Simple Mastectomy					-18733	295		0	447						manual counting					Scheduled Follow-up Submission	2011-7-18	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	450	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	6								NO	0		false	M0	N0	T1c	Stage IA	TCGA-D8-A1JU.B5074D1A-C617-414F-B349-6096F59E122D.pdf		1		1		0		1		1		19		80		80	TUMOR FREE	manual counting			>75%	>75%		YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1JU-01A-11D-A13L-09		TCGA-D8-A1JU-01A-11R-A13P-13	TCGA-D8-A1JU-01A-11R-A13P-13	TCGA-D8-A1JU-01A-11D-A13L-09		TCGA-D8-A1JU-01A-11D-A13L-09	TCGA-D8-A1JU-01A-21-A17J-20	TCGA-D8-A1JU-01A-11D-A13L-09	8e10b30e-5789-4ad4-a70b-c7a86927ac6b	5cfd5649-03c6-4919-b469-522684b6ceef	TCGA-D8-A1JU-01A-11D-A13J-01	8e10b30e-5789-4ad4-a70b-c7a86927ac6b	TCGA-D8-A1JU-01A-11D-A13K-05	TCGA-D8-A1JU-01		8e10b30e-5789-4ad4-a70b-c7a86927ac6b	8e10b30e-5789-4ad4-a70b-c7a86927ac6b	TCGA-D8-A1JU-01A-11D-A13J-01		TCGA-D8-A1JU-01		5cfd5649-03c6-4919-b469-522684b6ceef	
TCGA-D8-A1X5-01	Stage IIIC	81	5	Stage IIIC	171		Positive	FEMALE	Positive				Negative	M0	Positive	N3	171	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1X5-01	565	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	squamous c3	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-D8-A1X5	565	0	565	Breast	TCGA Breast Cancer	breast invasive carcinoma					81	Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1X5-F29934		Positive					Positive	Modified Radical Mastectomy					-29734	197		0	565					NO	manual counting					Scheduled Follow-up Submission	2012-3-30	FEMALE		Hercep Test  TM Dako			3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	240	NO	Positive			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	5								NO	14		false	MX	N3a	T2	Stage IIIC	TCGA-D8-A1X5.449F70F0-DFE1-40F9-879D-43283CFAF525.pdf		0		0		0		0		0		0		100		93	TUMOR FREE	manual counting			10-75%	>75%		YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1X5-01A-11D-A14G-09		TCGA-D8-A1X5-01A-11R-A14C-13	TCGA-D8-A1X5-01A-11R-A14C-13	TCGA-D8-A1X5-01A-11D-A14G-09		TCGA-D8-A1X5-01A-11D-A14G-09	TCGA-D8-A1X5-01A-21-A17K-20	TCGA-D8-A1X5-01A-11D-A14G-09	95a12af8-5704-4745-b0a0-960f67af8cec	778e70fe-3515-4314-8035-c97e1970bf69	TCGA-D8-A1X5-01A-11D-A14F-01	95a12af8-5704-4745-b0a0-960f67af8cec	TCGA-D8-A1X5-01A-11D-A14H-05	TCGA-D8-A1X5-01		95a12af8-5704-4745-b0a0-960f67af8cec	95a12af8-5704-4745-b0a0-960f67af8cec	TCGA-D8-A1X5-01A-11D-A14F-01		TCGA-D8-A1X5-01		778e70fe-3515-4314-8035-c97e1970bf69	
TCGA-D8-A1X6-01	Stage IIIA	80	4	Stage IIIA	236		Positive	FEMALE	Negative				Negative	M0	Positive	N2	236	0	LumB		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-D8-A1X6-01	541	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 2	cluster 5	mutation c1uster 9	TCGA-D8-A1X6	541	0	541	Breast	TCGA Breast Cancer	breast invasive carcinoma					80	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1X6-F29980		Positive					Positive	Modified Radical Mastectomy					-29256			0	541					NO	manual counting					Scheduled Follow-up Submission	2012-3-31	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy			Negative			7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5								NO	5			MX	N2a	T3	Stage IIIA																		TUMOR FREE	manual counting			>75%	>75%		YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast		LIVING	2010	TCGA-D8-A1X6-01A-11D-A14K-09		TCGA-D8-A1X6-01A-11R-A14L-13	TCGA-D8-A1X6-01A-11R-A14L-13	TCGA-D8-A1X6-01A-11D-A14K-09		TCGA-D8-A1X6-01A-11D-A14K-09	TCGA-D8-A1X6-01A-21-A17K-20	TCGA-D8-A1X6-01A-11D-A14K-09	ac361cbe-2302-4115-8c0f-40845c0ccec9	ed8ece0b-e4c8-4789-be92-e5ef0f0e6af2	TCGA-D8-A1X6-01A-11D-A14J-01	ac361cbe-2302-4115-8c0f-40845c0ccec9	TCGA-D8-A1X6-01A-11D-A14N-05	TCGA-D8-A1X6-01		ac361cbe-2302-4115-8c0f-40845c0ccec9	ac361cbe-2302-4115-8c0f-40845c0ccec9	TCGA-D8-A1X6-01A-11D-A14J-01		TCGA-D8-A1X6-01		ed8ece0b-e4c8-4789-be92-e5ef0f0e6af2	
TCGA-D8-A1X7-01	Stage IIA	40	3	Stage IIA	85		Positive	FEMALE	Negative				Negative	M0	Negative	N0	85	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1X7-01	509	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-D8-A1X7	509	0	509	Breast	TCGA Breast Cancer	breast invasive carcinoma					40	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1X7-F29985		Positive					Positive	Simple Mastectomy					-14858	141		0	509					NO	manual counting					Scheduled Follow-up Submission	2012-3-31	FEMALE										Other  specify	Ductal partially papillary	No		C50.9	8503/3	C50.9		YES		Fine needle aspiration biopsy	170	NO	Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	6								NO	0		false	MX	N0	T2	Stage IIA	TCGA-D8-A1X7.D3EA3547-7E53-442E-A957-B2DD7EBAFBB9.pdf		0		0		0		0		5		35		60		65	TUMOR FREE	manual counting			>75%	>75%		YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1X7-01A-11D-A14K-09		TCGA-D8-A1X7-01A-11R-A14L-13	TCGA-D8-A1X7-01A-11R-A14L-13	TCGA-D8-A1X7-01A-11D-A14K-09		TCGA-D8-A1X7-01A-11D-A14K-09	TCGA-D8-A1X7-01A-21-A17K-20	TCGA-D8-A1X7-01A-11D-A14K-09	6b2497ef-abe8-4f6f-9225-1d700f55ad1c	2f0ceb78-d089-4bda-8cd7-a9998b3ef37c	TCGA-D8-A1X7-01A-11D-A14J-01	6b2497ef-abe8-4f6f-9225-1d700f55ad1c	TCGA-D8-A1X7-01A-11D-A14N-05	TCGA-D8-A1X7-01		6b2497ef-abe8-4f6f-9225-1d700f55ad1c	6b2497ef-abe8-4f6f-9225-1d700f55ad1c	TCGA-D8-A1X7-01A-11D-A14J-01		TCGA-D8-A1X7-01		2f0ceb78-d089-4bda-8cd7-a9998b3ef37c	
TCGA-D8-A1X8-01	Stage IIA	62	2	Stage IIIA	272		Positive	FEMALE	Negative				Negative	M0	Positive	N2	272	0	LumA		Indeterminate				enrollment	T1	T1	LIVING	0	TCGA-D8-A1X8-01	783	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-D8-A1X8	783	0	783	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1X8-F29428		Positive		2+	4 Point Scale		Indeterminate	Modified Radical Mastectomy		NO			-22995			0	783					NO	% IHC					Scheduled Follow-up Submission	2012-10-19	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy			Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	1								NO	9	0		M0	N2a	T1c	Stage IIIA																		TUMOR FREE	%IHC			>75%	>75%		YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast		LIVING	2010	TCGA-D8-A1X8-01A-11D-A14K-09		TCGA-D8-A1X8-01A-11R-A14L-13	TCGA-D8-A1X8-01A-11R-A14L-13	TCGA-D8-A1X8-01A-11D-A14K-09		TCGA-D8-A1X8-01A-11D-A14K-09	TCGA-D8-A1X8-01A-21-A17K-20	TCGA-D8-A1X8-01A-11D-A14K-09	cbc8608e-ffe1-41d5-93c5-66dd665c9bf0	f65fbe35-608e-406e-bc17-881ce2cb6c23	TCGA-D8-A1X8-01A-11D-A14J-01	cbc8608e-ffe1-41d5-93c5-66dd665c9bf0	TCGA-D8-A1X8-01A-11D-A14N-05	TCGA-D8-A1X8-01		cbc8608e-ffe1-41d5-93c5-66dd665c9bf0	cbc8608e-ffe1-41d5-93c5-66dd665c9bf0	TCGA-D8-A1X8-01A-11D-A14J-01		TCGA-D8-A1X8-01		f65fbe35-608e-406e-bc17-881ce2cb6c23	
TCGA-D8-A1X9-01	Stage IIA	66	5	Stage IIB	380		Positive	FEMALE	Negative				Negative	M0	Positive	N1	380	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1X9-01	727	0	Kirc+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4		mutation cluster 14	TCGA-D8-A1X9	727	0	727	Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1X9-F29431		Positive					Positive	Modified Radical Mastectomy		NO			-24417	399		0	727					NO	% IHC					Scheduled Follow-up Submission	2012-3-19	FEMALE							not amplified			Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO	Indeterminate	Negative		23		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	3	0	false	M0	N1a	T2	Stage IIB	TCGA-D8-A1X9.E69CF3E3-4799-4892-87E9-4291B14A1B9C.pdf		0		0		5		0		0		0		95		90	TUMOR FREE	%IHC			>75%	>75%		YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1X9-01A-12D-A159-09		TCGA-D8-A1X9-01A-12R-A156-13	TCGA-D8-A1X9-01A-12R-A156-13	TCGA-D8-A1X9-01A-12D-A159-09		TCGA-D8-A1X9-01A-12D-A159-09	TCGA-D8-A1X9-01A-21-A17K-20	TCGA-D8-A1X9-01A-12D-A159-09	2b3d596a-68ca-4c60-bb16-8c0cbd8fb190	87fe6581-eab6-4755-8837-75771304741f	TCGA-D8-A1X9-01A-12D-A160-01	2b3d596a-68ca-4c60-bb16-8c0cbd8fb190	TCGA-D8-A1X9-01A-12D-A161-05	TCGA-D8-A1X9-01		2b3d596a-68ca-4c60-bb16-8c0cbd8fb190	2b3d596a-68ca-4c60-bb16-8c0cbd8fb190	TCGA-D8-A1X9-01A-12D-A160-01		TCGA-D8-A1X9-01		87fe6581-eab6-4755-8837-75771304741f	
TCGA-D8-A1XA-01	Stage IA	64	1	Stage I	274		Positive	FEMALE	Negative				Negative	M0	Negative	N0	274	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A1XA-01	839	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-D8-A1XA	839	0	839	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-D8-A1XA-F29434		Positive					Positive	Lumpectomy		NO			-23387	218		0	839					NO	% IHC					Scheduled Follow-up Submission	2012-12-3	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	140	NO	Equivocal			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO	0	0	false	M0	N0	T1c	Stage IA	TCGA-D8-A1XA.9320030D-5E19-4BEE-99DA-366B6762DED1.pdf		0		0		0		0		0		0		100		95	TUMOR FREE	%IHC			>75%	>75%		YES	No			YES	Primary Tumor	01		7th	NO	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1XA-01A-11D-A14G-09		TCGA-D8-A1XA-01A-11R-A14C-13	TCGA-D8-A1XA-01A-11R-A14C-13	TCGA-D8-A1XA-01A-11D-A14G-09		TCGA-D8-A1XA-01A-11D-A14G-09	TCGA-D8-A1XA-01A-21-A17K-20	TCGA-D8-A1XA-01A-11D-A14G-09	79d0e02e-b518-4dce-8c20-00073d04e399	a6a18a90-cdd5-4a5f-a8a2-6480bc1742c2	TCGA-D8-A1XA-01A-11D-A14F-01	79d0e02e-b518-4dce-8c20-00073d04e399	TCGA-D8-A1XA-01A-11D-A14H-05	TCGA-D8-A1XA-01		79d0e02e-b518-4dce-8c20-00073d04e399	79d0e02e-b518-4dce-8c20-00073d04e399	TCGA-D8-A1XA-01A-11D-A14F-01		TCGA-D8-A1XA-01		a6a18a90-cdd5-4a5f-a8a2-6480bc1742c2	
TCGA-D8-A1XB-01	Stage IIB	62	4	Stage IIB	201		Positive	FEMALE	Negative				Negative	M0	Positive	N1	201	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XB-01	552	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-D8-A1XB	552	0	552	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XB-F29436		Positive					Positive	Modified Radical Mastectomy		NO			-22976	251		0	552					NO	% IHC					Scheduled Follow-up Submission	2012-3-19	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	1	0	false	M0	N1a	T2	Stage IIB	TCGA-D8-A1XB.B7367E27-2A40-4E8F-8975-D5665E6506D9.pdf		0		0		0		0		0		0		100		70	TUMOR FREE	%IHC			>75%	>75%		YES	No			YES	Primary Tumor	01		7th	NO	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1XB-01A-11D-A14G-09		TCGA-D8-A1XB-01A-11R-A14C-13	TCGA-D8-A1XB-01A-11R-A14C-13	TCGA-D8-A1XB-01A-11D-A14G-09		TCGA-D8-A1XB-01A-11D-A14G-09	TCGA-D8-A1XB-01A-21-A17K-20	TCGA-D8-A1XB-01A-11D-A14G-09	8a2adff0-2527-43fa-ad17-a3081e22f846	0eae4d42-893c-48ff-b1a3-52ae7d1220ce	TCGA-D8-A1XB-01A-11D-A14F-01	8a2adff0-2527-43fa-ad17-a3081e22f846	TCGA-D8-A1XB-01A-11D-A14H-05	TCGA-D8-A1XB-01		8a2adff0-2527-43fa-ad17-a3081e22f846	8a2adff0-2527-43fa-ad17-a3081e22f846	TCGA-D8-A1XB-01A-11D-A14F-01		TCGA-D8-A1XB-01		0eae4d42-893c-48ff-b1a3-52ae7d1220ce	
TCGA-D8-A1XC-01	Stage IIIB	85	3	Stage IIIB	81		Positive	FEMALE	Negative				Negative	M0	Positive	N1	81	0	LumA		Positive				enrollment	T_Other	T4	LIVING	1	TCGA-D8-A1XC-01	377	1	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation c1uster 9	TCGA-D8-A1XC	446	1	377	Breast	TCGA Breast Cancer	breast invasive carcinoma			NO		85	Right Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XC-F29439		Positive					Positive	Modified Radical Mastectomy		NO			-31220	215	377	0	81			446		NO	% IHC					Scheduled Follow-up Submission	2012-3-26	FEMALE					1+					Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES	intraoperative examination	Other method, specify:	260	NO	Negative			20	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	7				Bone	Distant Metastasis			YES	1	0	false	M0	N1a	T4b	Stage IIIB	TCGA-D8-A1XC.E5D2E429-C41C-47E2-96CB-F3B6F412499B.pdf		0		0		0		0		0		0		100		98	WITH TUMOR	%IHC			>75%	>75%		YES	No			NO	Primary Tumor	01		7th	NO	YES	NO	D8	Breast	A	DECEASED	2010	TCGA-D8-A1XC-01A-11D-A14G-09		TCGA-D8-A1XC-01A-11R-A14C-13	TCGA-D8-A1XC-01A-11R-A14C-13	TCGA-D8-A1XC-01A-11D-A14G-09		TCGA-D8-A1XC-01A-11D-A14G-09	TCGA-D8-A1XC-01A-21-A17K-20	TCGA-D8-A1XC-01A-11D-A14G-09	4328ae51-6063-4296-b266-a70bc5dda94f	21024980-32e1-4b97-8f04-3d2dc520b86d	TCGA-D8-A1XC-01A-11D-A14F-01	4328ae51-6063-4296-b266-a70bc5dda94f	TCGA-D8-A1XC-01A-11D-A14H-05	TCGA-D8-A1XC-01		4328ae51-6063-4296-b266-a70bc5dda94f	4328ae51-6063-4296-b266-a70bc5dda94f	TCGA-D8-A1XC-01A-11D-A14F-01		TCGA-D8-A1XC-01		21024980-32e1-4b97-8f04-3d2dc520b86d	
TCGA-D8-A1XD-01	Stage IIIA	36	4	Stage IIIA	155		Positive	FEMALE	Negative				Negative	M0	Positive	N2	155	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A1XD-01	522	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 2	cluster 5		TCGA-D8-A1XD	522	0	522	Breast	TCGA Breast Cancer	breast invasive carcinoma					36	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XD-F29440		Positive					Positive	Modified Radical Mastectomy		NO			-13510	188		0	522					NO	% IHC					Scheduled Follow-up Submission	2012-3-19	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Negative			18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	5								NO	6		false	M0	N2a	T1c	Stage IIIA	TCGA-D8-A1XD.D5614445-4EBF-4050-8FC6-D34D5CAADD82.pdf		0		0		0		0		0		30		70		75	TUMOR FREE	%IHC			>75%	>75%		YES	No			YES	Primary Tumor	01		7th	NO	YES	NO	D8	Breast	A	LIVING	2010			TCGA-D8-A1XD-01A-11R-A14C-13	TCGA-D8-A1XD-01A-11R-A14C-13				TCGA-D8-A1XD-01A-21-A17K-20		af520d74-dc8a-4d36-bd2c-80bc23e6d029	39b1e20d-51f1-4c8b-9689-a0e054354aa3	TCGA-D8-A1XD-01A-11D-A14F-01	af520d74-dc8a-4d36-bd2c-80bc23e6d029	TCGA-D8-A1XD-01A-11D-A14H-05	TCGA-D8-A1XD-01		af520d74-dc8a-4d36-bd2c-80bc23e6d029	af520d74-dc8a-4d36-bd2c-80bc23e6d029	TCGA-D8-A1XD-01A-11D-A14F-01		TCGA-D8-A1XD-01		39b1e20d-51f1-4c8b-9689-a0e054354aa3	
TCGA-D8-A1XF-01	Stage IIA	45	3	Stage IIA	197		Positive	FEMALE	Negative				Negative	M0	Negative	N0	197	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XF-01	463	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-D8-A1XF	463	0	463	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XF-F29442		Positive					Positive	Modified Radical Mastectomy		NO			-16787	170		0	463					NO	% IHC					Scheduled Follow-up Submission	2012-3-19	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	180	NO	Negative			8		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		3	5								NO	0	0	false	M0	N0	T2	Stage IIA	TCGA-D8-A1XF.FCBB54EB-6FBF-4DC4-B4D5-DB533687FA58.pdf		0		0		0		0		0		0		100		85	TUMOR FREE	%IHC			>75%	>75%		YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1XF-01A-11D-A14G-09		TCGA-D8-A1XF-01A-11R-A14C-13	TCGA-D8-A1XF-01A-11R-A14C-13	TCGA-D8-A1XF-01A-11D-A14G-09		TCGA-D8-A1XF-01A-11D-A14G-09	TCGA-D8-A1XF-01A-21-A17K-20	TCGA-D8-A1XF-01A-11D-A14G-09	80562b20-3e3e-4f77-8ca2-958f8636d720	2084c32d-ed1a-43a7-adbb-ff2338363e11	TCGA-D8-A1XF-01A-11D-A14F-01	80562b20-3e3e-4f77-8ca2-958f8636d720	TCGA-D8-A1XF-01A-11D-A14H-05	TCGA-D8-A1XF-01		80562b20-3e3e-4f77-8ca2-958f8636d720	80562b20-3e3e-4f77-8ca2-958f8636d720	TCGA-D8-A1XF-01A-11D-A14F-01		TCGA-D8-A1XF-01		2084c32d-ed1a-43a7-adbb-ff2338363e11	
TCGA-D8-A1XG-01	Stage IIIB	86	3	Stage IIIB	196		Positive	FEMALE	Negative				Negative	M0	Positive	N1	196	0	LumA		Negative				enrollment	T_Other	T4	LIVING	0	TCGA-D8-A1XG-01	448	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-D8-A1XG	448	0	448	Breast	TCGA Breast Cancer	breast invasive carcinoma					86	Right Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XG-F29444		Positive					Negative	Modified Radical Mastectomy		YES			-31748	169		0	448					NO	% IHC					Scheduled Follow-up Submission	2012-3-26	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	590	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	1								NO	2	0	false	M0	N1a	T4b	Stage IIIB	TCGA-D8-A1XG.AA869507-1B46-4812-8EC5-A4E01C588E6E.pdf		0		0		0		0		0		10		90		85	TUMOR FREE					10-75%		YES	No			NO	Primary Tumor	01		7th	NO	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1XG-01A-11D-A14G-09		TCGA-D8-A1XG-01A-11R-A14C-13	TCGA-D8-A1XG-01A-11R-A14C-13	TCGA-D8-A1XG-01A-11D-A14G-09		TCGA-D8-A1XG-01A-11D-A14G-09	TCGA-D8-A1XG-01A-21-A17K-20	TCGA-D8-A1XG-01A-11D-A14G-09	56bc2076-bafe-47aa-8255-9f03d438cb00	f2ca4584-cab5-49ef-b6b2-f2311785e403	TCGA-D8-A1XG-01A-11D-A14F-01	56bc2076-bafe-47aa-8255-9f03d438cb00	TCGA-D8-A1XG-01A-11D-A14H-05	TCGA-D8-A1XG-01		56bc2076-bafe-47aa-8255-9f03d438cb00	56bc2076-bafe-47aa-8255-9f03d438cb00	TCGA-D8-A1XG-01A-11D-A14F-01		TCGA-D8-A1XG-01		f2ca4584-cab5-49ef-b6b2-f2311785e403	
TCGA-D8-A1XJ-01	Stage IIIA	76	1	Stage IIIA	352		Positive	FEMALE	Positive				Negative	M0	Positive	N1	352	0	Her2		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-D8-A1XJ-01	664	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 6	cluster 7	mutation cluster 5	TCGA-D8-A1XJ	664	0	664	Breast	TCGA Breast Cancer	breast invasive carcinoma					76	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XJ-F29989		Positive					Positive	Modified Radical Mastectomy					-27967	295		0	664					NO	manual counting					Scheduled Follow-up Submission	2012-3-31	FEMALE		Hercep Test  TM Dako			3+					Other  specify	Ductal/Mucinous	No		C50.9	8523/3	C50.9		YES		Fine needle aspiration biopsy	440	NO	Positive			43	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	7								NO	2		false	MX	N1a	T3	Stage IIIA	TCGA-D8-A1XJ.EEA126DE-A667-4373-9DC5-96B55E4ABF07.pdf		2		0		8		0		0		18		74		90	TUMOR FREE	manual counting			10-75%	>75%		YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1XJ-01A-11D-A14K-09		TCGA-D8-A1XJ-01A-11R-A14L-13	TCGA-D8-A1XJ-01A-11R-A14L-13	TCGA-D8-A1XJ-01A-11D-A14K-09		TCGA-D8-A1XJ-01A-11D-A14K-09	TCGA-D8-A1XJ-01A-21-A17K-20	TCGA-D8-A1XJ-01A-11D-A14K-09	ef91ee42-e50f-44f7-967a-48698e920d12	42e694ab-fa1a-4613-8066-745b28a6ea9a	TCGA-D8-A1XJ-01A-11D-A14J-01	ef91ee42-e50f-44f7-967a-48698e920d12	TCGA-D8-A1XJ-01A-11D-A14N-05	TCGA-D8-A1XJ-01		ef91ee42-e50f-44f7-967a-48698e920d12	ef91ee42-e50f-44f7-967a-48698e920d12	TCGA-D8-A1XJ-01A-11D-A14J-01		TCGA-D8-A1XJ-01		42e694ab-fa1a-4613-8066-745b28a6ea9a	
TCGA-D8-A1XK-01	Stage IB	55	1	Stage IIB	326		Negative	FEMALE	Negative				Negative	M0	Positive	N1	326	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XK-01	441	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	squamous c3	BRCA basal-like c8	miRNA cluster 14	cluster 5		TCGA-D8-A1XK	441	0	441	Breast	TCGA Breast Cancer	breast invasive carcinoma					55	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XK-F30074		Negative					Negative	Modified Radical Mastectomy					-20092	275		0	441					NO						Scheduled Follow-up Submission	2012-2-4	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	260	NO	Negative			18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5								NO	3		false	MX	N1a	T2	Stage IIB	TCGA-D8-A1XK.B3DB4F9E-C91B-4913-93E8-F18FF22CBA7C.pdf		1		0		20		0		0		20		60		90	TUMOR FREE							YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010			TCGA-D8-A1XK-01A-21R-A14L-13	TCGA-D8-A1XK-01A-21R-A14L-13			TCGA-D8-A1XK-01A-21D-A14K-09	TCGA-D8-A1XK-01A-11-A17K-20		e4edbc10-8939-4bbf-befa-ee44229e4394	97f9770c-3539-4578-84f4-bb63a7463900	TCGA-D8-A1XK-01A-21D-A14J-01	e4edbc10-8939-4bbf-befa-ee44229e4394	TCGA-D8-A1XK-01A-21D-A14N-05	TCGA-D8-A1XK-01		e4edbc10-8939-4bbf-befa-ee44229e4394	e4edbc10-8939-4bbf-befa-ee44229e4394	TCGA-D8-A1XK-01A-21D-A14J-01		TCGA-D8-A1XK-01		97f9770c-3539-4578-84f4-bb63a7463900	
TCGA-D8-A1XL-01	Stage IIB	34	1	Stage IIB	319		Positive	FEMALE	Negative				Negative	M0	Positive	N1	319	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XL-01	606	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 3	TCGA-D8-A1XL	606	0	606	Breast	TCGA Breast Cancer	breast invasive carcinoma					34	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XL-F29990		Positive					Positive	Lumpectomy					-12668	282		0	606					NO	manual counting					Scheduled Follow-up Submission	2012-3-31	FEMALE		HercepTest TM Dako			2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	260	NO	Equivocal	Negative		13	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	7								NO	2		false	MX	N1a	T2	Stage IIB	TCGA-D8-A1XL.762963FB-3D8C-4616-8C8C-0CD3E45FD243.pdf		2		0		7		0		0		43		50		75	TUMOR FREE	manual counting			>75%	>75%		YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1XL-01A-11D-A14K-09		TCGA-D8-A1XL-01A-11R-A14L-13	TCGA-D8-A1XL-01A-11R-A14L-13	TCGA-D8-A1XL-01A-11D-A14K-09		TCGA-D8-A1XL-01A-11D-A14K-09	TCGA-D8-A1XL-01A-21-A17K-20	TCGA-D8-A1XL-01A-11D-A14K-09	26f5aec2-a2d8-4151-b975-33d7518e36d0	c50f9ab3-c448-4289-b6b1-36ddcbd9efb9	TCGA-D8-A1XL-01A-11D-A14J-01	26f5aec2-a2d8-4151-b975-33d7518e36d0	TCGA-D8-A1XL-01A-11D-A14N-05	TCGA-D8-A1XL-01		26f5aec2-a2d8-4151-b975-33d7518e36d0	26f5aec2-a2d8-4151-b975-33d7518e36d0	TCGA-D8-A1XL-01A-11D-A14J-01		TCGA-D8-A1XL-01		c50f9ab3-c448-4289-b6b1-36ddcbd9efb9	
TCGA-D8-A1XM-01	Stage IA	57	3	Stage I	218		Positive	FEMALE	Negative				Negative	M0	Negative	N0	218	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A1XM-01	538	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-D8-A1XM	538	0	538	Breast	TCGA Breast Cancer	breast invasive carcinoma					57	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-D8-A1XM-F29445		Positive					Positive	Lumpectomy		NO			-21056	189		0	538					NO	% IHC					Scheduled Follow-up Submission	2012-3-19	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	200	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	0	0	false	M0	N0	T1c	Stage IA	TCGA-D8-A1XM.7E48315C-3717-40DB-8773-71D070AFC47B.pdf		5		0		2		0		0		48		50		65	TUMOR FREE	%IHC			>75%	>75%		YES	No			YES	Primary Tumor	01		7th	NO	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1XM-01A-21D-A14K-09		TCGA-D8-A1XM-01A-21R-A14L-13	TCGA-D8-A1XM-01A-21R-A14L-13	TCGA-D8-A1XM-01A-21D-A14K-09		TCGA-D8-A1XM-01A-21D-A14K-09	TCGA-D8-A1XM-01A-11-A17K-20	TCGA-D8-A1XM-01A-21D-A14K-09	3049e9ab-8e65-4264-865a-b7a14e27aae1	9f9702c2-7a67-48fd-aacf-93531102e1f7	TCGA-D8-A1XM-01A-21D-A14J-01	3049e9ab-8e65-4264-865a-b7a14e27aae1	TCGA-D8-A1XM-01A-21D-A14N-05	TCGA-D8-A1XM-01		3049e9ab-8e65-4264-865a-b7a14e27aae1	3049e9ab-8e65-4264-865a-b7a14e27aae1	TCGA-D8-A1XM-01A-21D-A14J-01		TCGA-D8-A1XM-01		9f9702c2-7a67-48fd-aacf-93531102e1f7	
TCGA-D8-A1XO-01	Stage IIB	56	2	Stage IIB	242		Positive	FEMALE	Negative				Negative	M0	Positive	N1	242	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XO-01	473	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 7	mutation cluster 4	TCGA-D8-A1XO	473	0	473	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XO-F29447		Positive					Positive	Modified Radical Mastectomy		NO			-20606	193		0	473					NO	% IHC					Scheduled Follow-up Submission	2012-3-19	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	360	NO	Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	7								NO	1	0	false	M0	N1a	T2	Stage IIB	TCGA-D8-A1XO.9AAB53EC-89A0-4878-BB9D-D96BC56B54C4.pdf		1		0		0		0		0		25		75		80	TUMOR FREE	%IHC			>75%	>75%		YES	No			YES	Primary Tumor	01		7th	NO	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1XO-01A-11D-A14K-09		TCGA-D8-A1XO-01A-11R-A14L-13	TCGA-D8-A1XO-01A-11R-A14L-13	TCGA-D8-A1XO-01A-11D-A14K-09		TCGA-D8-A1XO-01A-11D-A14K-09	TCGA-D8-A1XO-01A-21-A17K-20	TCGA-D8-A1XO-01A-11D-A14K-09	eddd285e-a946-4e4e-a21d-6e84ed397594	0323e53c-a64f-426b-9f8e-f76b6bdf6118	TCGA-D8-A1XO-01A-11D-A14J-01	eddd285e-a946-4e4e-a21d-6e84ed397594	TCGA-D8-A1XO-01A-11D-A14N-05	TCGA-D8-A1XO-01		eddd285e-a946-4e4e-a21d-6e84ed397594	eddd285e-a946-4e4e-a21d-6e84ed397594	TCGA-D8-A1XO-01A-11D-A14J-01		TCGA-D8-A1XO-01		0323e53c-a64f-426b-9f8e-f76b6bdf6118	
TCGA-D8-A1XQ-01	Stage IIA	69	1	Stage IIA	177		Negative	FEMALE	Negative				Negative	M0	Negative	N0	177	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XQ-01	499	0	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3		TCGA-D8-A1XQ	499	0	499	Breast	TCGA Breast Cancer	breast invasive carcinoma					69	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XQ-F29449		Negative					Negative	Modified Radical Mastectomy		NO			-25345	158		0	499					NO	% IHC					Scheduled Follow-up Submission	2012-3-26	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	100	NO	Negative			7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3								NO	0	0	false	M0	N0	T2	Stage IIA	TCGA-D8-A1XQ.33B6269D-1D59-4184-A786-2BEB73F6D3A8.pdf		3		0		7		0		0		23		70		90	TUMOR FREE					0%		YES	No	<10%		NO	Primary Tumor	01		7th	NO	YES	NO	D8	Breast	A	LIVING	2010			TCGA-D8-A1XQ-01A-11R-A14L-13	TCGA-D8-A1XQ-01A-11R-A14L-13			TCGA-D8-A1XQ-01A-11D-A14K-09	TCGA-D8-A1XQ-01A-21-A17K-20		0c7fc003-950b-4138-8390-036c072b640e	fd2ba09e-a9f8-4cda-810c-ac29afd0e6b2	TCGA-D8-A1XQ-01A-11D-A14J-01	0c7fc003-950b-4138-8390-036c072b640e	TCGA-D8-A1XQ-01A-11D-A14N-05	TCGA-D8-A1XQ-01		0c7fc003-950b-4138-8390-036c072b640e	0c7fc003-950b-4138-8390-036c072b640e	TCGA-D8-A1XQ-01A-11D-A14J-01		TCGA-D8-A1XQ-01		fd2ba09e-a9f8-4cda-810c-ac29afd0e6b2	
TCGA-D8-A1XR-01	Stage IIB	56	2	Stage IIB	168		Positive	FEMALE	Negative				Negative	M0	Positive	N1	168	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XR-01	482	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-D8-A1XR	482	0	482	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XR-F29451		Positive					Positive	Modified Radical Mastectomy		NO			-20488	162		0	482					NO	% IHC					Scheduled Follow-up Submission	2012-3-6	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO	Negative			7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	3								NO	2	0	false	M0	N1a	T2	Stage IIB	TCGA-D8-A1XR.D9A0E659-99BC-4704-AC85-E63098BA731D.pdf		0		0		0		0		0		50		50		70	TUMOR FREE	%IHC			>75%	>75%		YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1XR-01A-11D-A14K-09		TCGA-D8-A1XR-01A-11R-A14L-13	TCGA-D8-A1XR-01A-11R-A14L-13	TCGA-D8-A1XR-01A-11D-A14K-09		TCGA-D8-A1XR-01A-11D-A14K-09	TCGA-D8-A1XR-01A-21-A17K-20	TCGA-D8-A1XR-01A-11D-A14K-09	9c55164e-fb87-46b5-87ce-cc277ba378f5	c668fd1c-a18a-4f11-89bb-5e5384da30d6	TCGA-D8-A1XR-01A-11D-A14J-01	9c55164e-fb87-46b5-87ce-cc277ba378f5	TCGA-D8-A1XR-01A-11D-A14N-05	TCGA-D8-A1XR-01		9c55164e-fb87-46b5-87ce-cc277ba378f5	9c55164e-fb87-46b5-87ce-cc277ba378f5	TCGA-D8-A1XR-01A-11D-A14J-01		TCGA-D8-A1XR-01		c668fd1c-a18a-4f11-89bb-5e5384da30d6	
TCGA-D8-A1XS-01	Stage IIIC	48	3	Stage IIIC	18		Positive	MALE	Positive				Negative	M0	Positive	N3	18	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XS-01	496	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-D8-A1XS	496	0	496	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XS-F12133		Positive					Positive	Modified Radical Mastectomy		NO			-17708	164		0	496					NO	% IHC					Scheduled Follow-up Submission	2012-3-19	MALE					3+					Other  specify	Ductal/Micropapillary	No		C50.9	8507/3	C50.9		YES		Core needle biopsy	340	NO	Positive			28	Negative																			2	4								NO	25	0	false	M0	N3a	T2	Stage IIIC	TCGA-D8-A1XS.6C97C157-05A0-45CE-91E9-3DC8946EFEDE.pdf		0		0		0		0		2		38		60		70	TUMOR FREE	%IHC			>75%	>75%		YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1XS-01A-11D-A14K-09		TCGA-D8-A1XS-01A-11R-A14L-13	TCGA-D8-A1XS-01A-11R-A14L-13	TCGA-D8-A1XS-01A-11D-A14K-09		TCGA-D8-A1XS-01A-11D-A14K-09	TCGA-D8-A1XS-01A-21-A17K-20	TCGA-D8-A1XS-01A-11D-A14K-09	11b43261-66e4-4c28-8d24-6e38b4295f34	58be3d70-17bf-423e-86af-fd13b6b792a2	TCGA-D8-A1XS-01A-11D-A14J-01	11b43261-66e4-4c28-8d24-6e38b4295f34	TCGA-D8-A1XS-01A-11D-A14N-05	TCGA-D8-A1XS-01		11b43261-66e4-4c28-8d24-6e38b4295f34	11b43261-66e4-4c28-8d24-6e38b4295f34	TCGA-D8-A1XS-01A-11D-A14J-01		TCGA-D8-A1XS-01		58be3d70-17bf-423e-86af-fd13b6b792a2	
TCGA-D8-A1XT-01	Stage IIA	61	1	Stage IIA	193		Negative	FEMALE	Positive				Negative	M0	Positive	N1	193	0	Her2		Negative				enrollment	T1	T1	LIVING	0	TCGA-D8-A1XT-01	193	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-D8-A1XT			193	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Right Upper Outer Quadrant	Axillary lymph node dissection alone				Negative					Negative	Modified Radical Mastectomy		NO			-22448	144		0	193					NO	% IHC						2011-5-16	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	230	NO	Positive			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									3	0	false	M0	N1a	T1c	Stage IIA	TCGA-D8-A1XT.99050E48-8DFE-4405-B8D8-7649CE2C9CFF.pdf		0		0		0		0		0		15		85		95	TUMOR FREE	%IHC			0%	0%		YES	No				Primary Tumor	01		7th		YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1XT-01A-11D-A14K-09		TCGA-D8-A1XT-01A-11R-A14L-13	TCGA-D8-A1XT-01A-11R-A14L-13	TCGA-D8-A1XT-01A-11D-A14K-09		TCGA-D8-A1XT-01A-11D-A14K-09	TCGA-D8-A1XT-01A-21-A17K-20	TCGA-D8-A1XT-01A-11D-A14K-09	47901dff-8acf-4afa-9e42-851d98777085	43781f58-a738-48c1-a251-d4dc5f3fe062	TCGA-D8-A1XT-01A-11D-A14J-01	47901dff-8acf-4afa-9e42-851d98777085	TCGA-D8-A1XT-01A-11D-A14N-05	TCGA-D8-A1XT-01		47901dff-8acf-4afa-9e42-851d98777085	47901dff-8acf-4afa-9e42-851d98777085	TCGA-D8-A1XT-01A-11D-A14J-01		TCGA-D8-A1XT-01		43781f58-a738-48c1-a251-d4dc5f3fe062	
TCGA-D8-A1XU-01	Stage IA	56		Stage I	149		Positive	FEMALE	Negative				Negative	M0	Negative	N0	149	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A1XU-01	395	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-D8-A1XU	395	0	395	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-D8-A1XU-F29456	Negative	Positive					Positive	Modified Radical Mastectomy		NO			-20715	102		0	395					NO	% IHC					Scheduled Follow-up Submission	2012-3-26	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	6								NO	0	0	false	M0	N0	T1c	Stage IA	TCGA-D8-A1XU.845F8FCF-CF3C-4CEF-B673-A57DE626939C.pdf		0		0		0		0		0		30		70		80	TUMOR FREE	%IHC			10-75%	>75%		YES	No			NO	Primary Tumor	01		7th	NO	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1XU-01A-11D-A14K-09		TCGA-D8-A1XU-01A-11R-A14L-13	TCGA-D8-A1XU-01A-11R-A14L-13	TCGA-D8-A1XU-01A-11D-A14K-09		TCGA-D8-A1XU-01A-11D-A14K-09	TCGA-D8-A1XU-01A-21-A17K-20	TCGA-D8-A1XU-01A-11D-A14K-09	0718af55-25eb-45b7-9e76-5d663a00dca5	062f01fb-85b6-4c22-bb39-1ebaeca09d82	TCGA-D8-A1XU-01A-11D-A14J-01	0718af55-25eb-45b7-9e76-5d663a00dca5	TCGA-D8-A1XU-01A-11D-A14N-05	TCGA-D8-A1XU-01		0718af55-25eb-45b7-9e76-5d663a00dca5	0718af55-25eb-45b7-9e76-5d663a00dca5	TCGA-D8-A1XU-01A-11D-A14J-01		TCGA-D8-A1XU-01		062f01fb-85b6-4c22-bb39-1ebaeca09d82	
TCGA-D8-A1XV-01	Stage IIA	84	3	Stage IIA	146		Positive	FEMALE	Negative				Negative	M0	Negative	N0	146	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XV-01	461	0	Iq	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 7	mutation c1uster 9	TCGA-D8-A1XV	461	0	461	Breast	TCGA Breast Cancer	breast invasive carcinoma					84	Right Lower Inner Quadrant	Sentinel node biopsy alone		TCGA-D8-A1XV-F29457		Positive					Positive	Modified Radical Mastectomy		NO			-30830	103		0	461					NO	% IHC					Scheduled Follow-up Submission	2012-3-19	FEMALE					2+		not amplified			Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Fine needle aspiration biopsy	420	NO	Equivocal	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	7								NO	0	0	false	M0	N0	T2	Stage IIA	TCGA-D8-A1XV.D3AC6B8A-CC8F-475C-BD2E-A869BD07D94C.pdf		0		0		0		0		0		40		60		80	TUMOR FREE	%IHC			>75%	>75%		YES	No			NO	Primary Tumor	01		7th	NO	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1XV-01A-11D-A14K-09		TCGA-D8-A1XV-01A-11R-A14L-13	TCGA-D8-A1XV-01A-11R-A14L-13	TCGA-D8-A1XV-01A-11D-A14K-09		TCGA-D8-A1XV-01A-11D-A14K-09	TCGA-D8-A1XV-01A-21-A17K-20	TCGA-D8-A1XV-01A-11D-A14K-09	5a0e92d3-7eb2-4ab2-8ee7-f2f180c6a6e6	1fa10a5d-7fc9-4a26-9251-bade7c2cbf13	TCGA-D8-A1XV-01A-11D-A14J-01	5a0e92d3-7eb2-4ab2-8ee7-f2f180c6a6e6	TCGA-D8-A1XV-01A-11D-A14N-05	TCGA-D8-A1XV-01		5a0e92d3-7eb2-4ab2-8ee7-f2f180c6a6e6	5a0e92d3-7eb2-4ab2-8ee7-f2f180c6a6e6	TCGA-D8-A1XV-01A-11D-A14J-01		TCGA-D8-A1XV-01		1fa10a5d-7fc9-4a26-9251-bade7c2cbf13	
TCGA-D8-A1XW-01	Stage IIA	53	3	Stage IIA	117		Negative	FEMALE	Negative				Negative	M0	Negative	N0	117	0	Normal		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XW-01	385	0	High	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-D8-A1XW	385	0	385	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-D8-A1XW-F29459		Negative					Positive	Modified Radical Mastectomy		NO			-19478	76		0	385					NO	% IHC					Scheduled Follow-up Submission	2012-3-19	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	310	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3								NO	0	0	false	M0	N0	T2	Stage IIA	TCGA-D8-A1XW.BD71F606-58BC-46B9-8A03-CB25D5BECA96.pdf		0		0		0		0		0		0		100		90	TUMOR FREE					0%		YES	No	<10%		NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2011	TCGA-D8-A1XW-01A-11D-A14K-09		TCGA-D8-A1XW-01A-11R-A14L-13	TCGA-D8-A1XW-01A-11R-A14L-13	TCGA-D8-A1XW-01A-11D-A14K-09		TCGA-D8-A1XW-01A-11D-A14K-09	TCGA-D8-A1XW-01A-21-A17K-20	TCGA-D8-A1XW-01A-11D-A14K-09	8e24b2f8-459c-4861-9d31-d171e8d1a08b	64573c1d-c2ff-4490-b7b6-b4b587b47ccb	TCGA-D8-A1XW-01A-11D-A14J-01	8e24b2f8-459c-4861-9d31-d171e8d1a08b	TCGA-D8-A1XW-01A-11D-A14N-05	TCGA-D8-A1XW-01		8e24b2f8-459c-4861-9d31-d171e8d1a08b	8e24b2f8-459c-4861-9d31-d171e8d1a08b	TCGA-D8-A1XW-01A-11D-A14J-01		TCGA-D8-A1XW-01		64573c1d-c2ff-4490-b7b6-b4b587b47ccb	
TCGA-D8-A1XY-01	Stage IIA	74		Stage IIA	81		Positive	FEMALE	Positive				Negative	M0	Negative	N0	81	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XY-01	503	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-D8-A1XY	503	0	503	Breast	TCGA Breast Cancer	breast invasive carcinoma					74	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XY-F29994		Positive					Positive	Simple Mastectomy					-27106	135		0	503					NO	manual counting					Scheduled Follow-up Submission	2012-3-31	FEMALE		HerceptTest TM Dako			3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	190	NO	Positive			3		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4								NO	0		false	MX	N0	T2	Stage IIA	TCGA-D8-A1XY.9D1EDFE8-FA4E-4F6C-99E9-1FEB12175D6C.pdf		0		0		0		0		0		0		100		60	TUMOR FREE	manual counting			>75%	>75%		YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1XY-01A-11D-A14K-09		TCGA-D8-A1XY-01A-11R-A14L-13	TCGA-D8-A1XY-01A-11R-A14L-13	TCGA-D8-A1XY-01A-11D-A14K-09		TCGA-D8-A1XY-01A-11D-A14K-09	TCGA-D8-A1XY-01A-21-A17K-20	TCGA-D8-A1XY-01A-11D-A14K-09	5b233291-8984-4925-8be4-3911f541a15f	05936306-3484-48d1-9305-f4596aed82f3	TCGA-D8-A1XY-01A-11D-A14J-01	5b233291-8984-4925-8be4-3911f541a15f	TCGA-D8-A1XY-01A-11D-A14N-05	TCGA-D8-A1XY-01		5b233291-8984-4925-8be4-3911f541a15f	5b233291-8984-4925-8be4-3911f541a15f	TCGA-D8-A1XY-01A-11D-A14J-01		TCGA-D8-A1XY-01		05936306-3484-48d1-9305-f4596aed82f3	
TCGA-D8-A1XZ-01	Stage IIIA	81	1	Stage IIIA	120		Positive	FEMALE	Negative				Negative	M0	Positive	N2	120	0	LumB		Negative				enrollment	T1	T1	LIVING	0	TCGA-D8-A1XZ-01	466	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 5	mutation cluster 13	TCGA-D8-A1XZ	466	0	466	Breast	TCGA Breast Cancer	breast invasive carcinoma					81	Right Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XZ-F30077		Positive					Negative	Modified Radical Mastectomy					-29916	98		0	466					NO	manual counting					Scheduled Follow-up Submission	2012-4-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	130	NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5								NO	6		false	MX	N2a	T1c	Stage IIIA	TCGA-D8-A1XZ.1D6EE39C-DE75-4595-943A-CF53873F96BF.pdf		0		0		0		0		0		5		95		85	TUMOR FREE					>75%		YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1XZ-01A-11D-A14K-09		TCGA-D8-A1XZ-01A-11R-A14L-13	TCGA-D8-A1XZ-01A-11R-A14L-13	TCGA-D8-A1XZ-01A-11D-A14K-09		TCGA-D8-A1XZ-01A-11D-A14K-09	TCGA-D8-A1XZ-01A-21-A17K-20	TCGA-D8-A1XZ-01A-11D-A14K-09	8b592b3b-47b5-45fa-98eb-01bf75096605	6eb5b047-3e90-4a41-8082-46a74c008a90	TCGA-D8-A1XZ-01A-11D-A14J-01	8b592b3b-47b5-45fa-98eb-01bf75096605	TCGA-D8-A1XZ-01A-11D-A14N-05	TCGA-D8-A1XZ-01		8b592b3b-47b5-45fa-98eb-01bf75096605	8b592b3b-47b5-45fa-98eb-01bf75096605	TCGA-D8-A1XZ-01A-11D-A14J-01		TCGA-D8-A1XZ-01		6eb5b047-3e90-4a41-8082-46a74c008a90	
TCGA-D8-A1Y0-01	Stage IIIA	65	5	Stage IIIA	166		Positive	FEMALE	Negative				Negative	M0	Positive	N2	166	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A1Y0-01	472	0	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation c1uster 9	TCGA-D8-A1Y0	472	0	472	Breast	TCGA Breast Cancer	breast invasive carcinoma					65	Left	Axillary lymph node dissection alone		TCGA-D8-A1Y0-F30080		Positive					Positive	Modified Radical Mastectomy					-24083	104		0	472					NO	manual counting					Scheduled Follow-up Submission	2012-4-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	190	NO	Negative			15		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	7								NO	9		false	MX	N2a	T1c	Stage IIIA	TCGA-D8-A1Y0.53ED4388-8CD2-4925-81A9-9C4792C83566.pdf		2		1		0		1		1		14		85		85	TUMOR FREE	manual counting			>75%	>75%		YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A1Y0-01A-11D-A14K-09		TCGA-D8-A1Y0-01A-11R-A14L-13	TCGA-D8-A1Y0-01A-11R-A14L-13	TCGA-D8-A1Y0-01A-11D-A14K-09		TCGA-D8-A1Y0-01A-11D-A14K-09	TCGA-D8-A1Y0-01A-21-A17K-20	TCGA-D8-A1Y0-01A-11D-A14K-09	8dd30d68-86d0-456f-814c-ae59a5c0a071	8d743d31-2f7b-4281-ae5b-424e9adc15fe	TCGA-D8-A1Y0-01A-11D-A14J-01	8dd30d68-86d0-456f-814c-ae59a5c0a071	TCGA-D8-A1Y0-01A-11D-A14N-05	TCGA-D8-A1Y0-01		8dd30d68-86d0-456f-814c-ae59a5c0a071	8dd30d68-86d0-456f-814c-ae59a5c0a071	TCGA-D8-A1Y0-01A-11D-A14J-01		TCGA-D8-A1Y0-01		8d743d31-2f7b-4281-ae5b-424e9adc15fe	
TCGA-D8-A1Y1-01	Stage IIIA	80	2	Stage IIIA	115		Positive	FEMALE	Negative				Negative	M0	Positive	N1	115	0	LumB		Positive				enrollment	T_Other	T3	LIVING	1	TCGA-D8-A1Y1-01	302	1	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 1	TCGA-D8-A1Y1	302	0	302	Breast	TCGA Breast Cancer	breast invasive carcinoma					80	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1Y1-F30084		Positive					Positive	Modified Radical Mastectomy					-29474	93	302	0	116					NO	manual counting					Scheduled Follow-up Submission	2012-4-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	200	NO	Negative			22		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	7								NO	1		false	MX	N1a	T3	Stage IIIA	TCGA-D8-A1Y1.1B198706-8844-452A-8F5B-8880A239717C.pdf		0		0		0		0		0		0		100		90	WITH TUMOR	manual counting			>75%	10-75%		YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	DECEASED	2010	TCGA-D8-A1Y1-01A-21D-A14K-09		TCGA-D8-A1Y1-01A-21R-A14L-13	TCGA-D8-A1Y1-01A-21R-A14L-13	TCGA-D8-A1Y1-01A-21D-A14K-09		TCGA-D8-A1Y1-01A-21D-A14K-09	TCGA-D8-A1Y1-01A-11-A17K-20	TCGA-D8-A1Y1-01A-21D-A14K-09	2d49cea0-0d08-4203-afa0-a1252cbf739a	a20f3655-2ba9-4af6-b683-490b69c54070	TCGA-D8-A1Y1-01A-21D-A14J-01	2d49cea0-0d08-4203-afa0-a1252cbf739a	TCGA-D8-A1Y1-01A-21D-A14N-05	TCGA-D8-A1Y1-01		2d49cea0-0d08-4203-afa0-a1252cbf739a	2d49cea0-0d08-4203-afa0-a1252cbf739a	TCGA-D8-A1Y1-01A-21D-A14J-01		TCGA-D8-A1Y1-01		a20f3655-2ba9-4af6-b683-490b69c54070	
TCGA-D8-A1Y2-01	Stage IIA	71	4	Stage IIA	72		Positive	FEMALE	Negative				Negative	M0	Negative	N0	72	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1Y2-01	433	0	Squamous	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 9		mutation cluster 4	TCGA-D8-A1Y2	433	0	433	Breast	TCGA Breast Cancer	breast invasive carcinoma					71	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1Y2-F30086		Positive					Positive	Modified Radical Mastectomy					-26021	65		0	433					NO	manual counting					Scheduled Follow-up Submission	2012-4-2	FEMALE		Venten			2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	470	NO	Indeterminate	Negative		7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1									NO	0		false	MX	N0	T2	Stage IIA	TCGA-D8-A1Y2.4ACD42D6-9520-4DC6-BB40-9187A4D49981.pdf		0		0		0		0		0		0		100		70	TUMOR FREE	manual counting				>75%		YES	No	<10%		NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2011	TCGA-D8-A1Y2-01A-11D-A159-09		TCGA-D8-A1Y2-01A-11R-A156-13	TCGA-D8-A1Y2-01A-11R-A156-13	TCGA-D8-A1Y2-01A-11D-A159-09		TCGA-D8-A1Y2-01A-11D-A159-09	TCGA-D8-A1Y2-01A-21-A17K-20	TCGA-D8-A1Y2-01A-11D-A159-09	4d184421-3a3d-499a-bdb5-230f45e6d16f	cbe5aea9-00bc-40c4-9e9d-bbf285a2b8df	TCGA-D8-A1Y2-01A-11D-A160-01	4d184421-3a3d-499a-bdb5-230f45e6d16f	TCGA-D8-A1Y2-01A-11D-A161-05	TCGA-D8-A1Y2-01		4d184421-3a3d-499a-bdb5-230f45e6d16f	4d184421-3a3d-499a-bdb5-230f45e6d16f	TCGA-D8-A1Y2-01A-11D-A160-01		TCGA-D8-A1Y2-01		cbe5aea9-00bc-40c4-9e9d-bbf285a2b8df	
TCGA-D8-A1Y3-01	Stage IIIA	61	4	Stage IIIA	124		Positive	FEMALE	Negative				Negative	M0	Positive	N2	124	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1Y3-01	430	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10		mutation cluster 5	TCGA-D8-A1Y3	430	0	430	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1Y3-F30088		Positive					Positive	Modified Radical Mastectomy					-22317	62		0	430					NO	manual counting					Scheduled Follow-up Submission	2012-4-2	FEMALE		Venten			2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	300	NO	Indeterminate	Negative		8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	5		false	MX	N2a	T2	Stage IIIA	TCGA-D8-A1Y3.E8D4229D-5049-4991-BDE0-AFC2CBC1827E.pdf		0		0		0		0		0		0		100		90	TUMOR FREE	manual counting			>75%	>75%		YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2011	TCGA-D8-A1Y3-01A-11D-A159-09		TCGA-D8-A1Y3-01A-11R-A156-13	TCGA-D8-A1Y3-01A-11R-A156-13	TCGA-D8-A1Y3-01A-11D-A159-09		TCGA-D8-A1Y3-01A-11D-A159-09	TCGA-D8-A1Y3-01A-21-A17K-20	TCGA-D8-A1Y3-01A-11D-A159-09	e65be669-85f6-4a00-8c0f-3ee7d0fb8bf9	0da7828c-fa60-464e-bf84-43de16003663	TCGA-D8-A1Y3-01A-11D-A160-01	e65be669-85f6-4a00-8c0f-3ee7d0fb8bf9	TCGA-D8-A1Y3-01A-11D-A161-05	TCGA-D8-A1Y3-01		e65be669-85f6-4a00-8c0f-3ee7d0fb8bf9	e65be669-85f6-4a00-8c0f-3ee7d0fb8bf9	TCGA-D8-A1Y3-01A-11D-A160-01		TCGA-D8-A1Y3-01		0da7828c-fa60-464e-bf84-43de16003663	
TCGA-D8-A27E-01	Stage IA	66		Stage I	182		Positive	FEMALE	Negative				Negative	M0	Negative	N0	182	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A27E-01	530	0	Quiet	C3-BRCA/Luminal	cluster 5	Low purity c2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14		mutation c1uster 9	TCGA-D8-A27E	530	0	530	Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-D8-A27E-F30112		Positive					Positive	Other		NO			-24315	204		0	530					NO	manual counting					Scheduled Follow-up Submission	2012-4-2	FEMALE		Hercep Test  TM Dako			1+					Other  specify	infiltrating ductal and mucinous	No		C50.9	8523/3	C50.9		YES		Fine needle aspiration biopsy	110	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5									NO	0		false	M0	N0	T1c	Stage IA	TCGA-D8-A27E.36F6CB19-17FE-47FA-BFCA-3846578C028B.pdf		0		0		0		0		0		10		90		85	TUMOR FREE					>75%		YES	No	<10%		YES	Primary Tumor	01	quadrantectomy	7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A27E-01A-11D-A16D-09		TCGA-D8-A27E-01A-11R-A16E-13	TCGA-D8-A27E-01A-11R-A16E-13	TCGA-D8-A27E-01A-11D-A16D-09		TCGA-D8-A27E-01A-11D-A16D-09	TCGA-D8-A27E-01A-21-A17K-20	TCGA-D8-A27E-01A-11D-A16D-09	5e32f7e7-6022-4ce2-aa79-4c6671493406	62b607cb-63e1-4619-993e-94a5d696b1a7	TCGA-D8-A27E-01A-11D-A16C-01	5e32f7e7-6022-4ce2-aa79-4c6671493406	TCGA-D8-A27E-01A-11D-A16G-05	TCGA-D8-A27E-01		5e32f7e7-6022-4ce2-aa79-4c6671493406	5e32f7e7-6022-4ce2-aa79-4c6671493406	TCGA-D8-A27E-01A-11D-A16C-01		TCGA-D8-A27E-01		62b607cb-63e1-4619-993e-94a5d696b1a7	
TCGA-D8-A27F-01	Stage IIA	40	1	Stage IIA	227		Negative	FEMALE	Negative				Negative	M0	Negative	N0	227	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A27F-01	488	0	BRCA-LUAD+	C1-LUAD-enriched	cluster 5	BRCA basal-like c8	squamous c3	BRCA basal-like c8	miRNA cluster 12		mutation cluster 12	TCGA-D8-A27F	488	0	488	Breast	TCGA Breast Cancer	breast invasive carcinoma					40	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A27F-F29515		Negative					Negative	Modified Radical Mastectomy		NO			-14731	166		0	488					NO						Scheduled Follow-up Submission	2012-3-21	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	320	NO	Negative			11	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5									NO	0	0	false	M0	N0	T2	Stage IIA	TCGA-D8-A27F.976C6F9E-DDCB-42F4-BD2C-A4D715396B47.pdf		0		0		15		0		0		30		55		70	TUMOR FREE							YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A27F-01A-11D-A16D-09		TCGA-D8-A27F-01A-11R-A16E-13	TCGA-D8-A27F-01A-11R-A16E-13	TCGA-D8-A27F-01A-11D-A16D-09		TCGA-D8-A27F-01A-11D-A16D-09	TCGA-D8-A27F-01A-21-A17K-20	TCGA-D8-A27F-01A-11D-A16D-09	0a69935d-9552-4792-9b2e-1a630114691e	96972bfb-01a7-4731-aca8-43dc346feb10	TCGA-D8-A27F-01A-11D-A16C-01	0a69935d-9552-4792-9b2e-1a630114691e	TCGA-D8-A27F-01A-11D-A16G-05	TCGA-D8-A27F-01		0a69935d-9552-4792-9b2e-1a630114691e	0a69935d-9552-4792-9b2e-1a630114691e	TCGA-D8-A27F-01A-11D-A16C-01		TCGA-D8-A27F-01		96972bfb-01a7-4731-aca8-43dc346feb10	
TCGA-D8-A27G-01	Stage IIA	75	2	Stage IIA	209		Positive	FEMALE	Negative				Negative	M0	Negative	N0	209	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A27G-01	409	0	Iq	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-D8-A27G	409	0	409	Breast	TCGA Breast Cancer	breast invasive carcinoma					75	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A27G-F29519		Positive					Positive	Modified Radical Mastectomy		NO			-27521	156		0	409					NO	manual counting					Scheduled Follow-up Submission	2012-3-21	FEMALE					2+		not amplified			Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	170	NO	Equivocal	Negative		31	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	0	0	false	M0	N0	T2	Stage IIA	TCGA-D8-A27G.F8B8EEB1-0603-4181-9BD3-209143024EF8.pdf		0		0		0		0		0		50		50		85	TUMOR FREE	manual counting			>75%	>75%		YES	No			NO	Primary Tumor	01		7th	NO	YES	NO	D8	Breast	A	LIVING	2010			TCGA-D8-A27G-01A-11R-A16E-13	TCGA-D8-A27G-01A-11R-A16E-13			TCGA-D8-A27G-01A-11D-A16D-09	TCGA-D8-A27G-01A-21-A17K-20		2ba9072c-39b9-438d-9a2c-0726dc3dc659	38f3fe40-a4aa-4f30-94a1-91e54c11c99b	TCGA-D8-A27G-01A-11D-A16C-01	2ba9072c-39b9-438d-9a2c-0726dc3dc659	TCGA-D8-A27G-01A-11D-A16G-05	TCGA-D8-A27G-01		2ba9072c-39b9-438d-9a2c-0726dc3dc659	2ba9072c-39b9-438d-9a2c-0726dc3dc659	TCGA-D8-A27G-01A-11D-A16C-01		TCGA-D8-A27G-01		38f3fe40-a4aa-4f30-94a1-91e54c11c99b	
TCGA-D8-A27H-01	Stage IIA	72	1	Stage IIA	140		Negative	FEMALE	Negative				Negative	M0	Negative	N0	140	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A27H-01	397	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 3		mutation cluster 2	TCGA-D8-A27H	397	0	397	Breast	TCGA Breast Cancer	breast invasive carcinoma					72	Right Upper Outer Quadrant	No axillary staging		TCGA-D8-A27H-F29536		Negative					Negative	Modified Radical Mastectomy		NO			-26588	84		0	397					NO						Scheduled Follow-up Submission	2012-3-22	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8520/3	C50.9		YES	intraoperative examination	Other method, specify:	170	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5									NO			false	M0	N0	T2	Stage IIA	TCGA-D8-A27H.52D7E980-806C-499D-9DB9-40E1D651D9EB.pdf		0		0		0		0		1		0		99		94	TUMOR FREE							YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2011	TCGA-D8-A27H-01A-11D-A16D-09		TCGA-D8-A27H-01A-11R-A16E-13	TCGA-D8-A27H-01A-11R-A16E-13	TCGA-D8-A27H-01A-11D-A16D-09		TCGA-D8-A27H-01A-11D-A16D-09	TCGA-D8-A27H-01A-21-A17K-20	TCGA-D8-A27H-01A-11D-A16D-09	123725b8-4f66-4b97-9726-e0c70300d38e	e6674bdf-bebe-4c44-a6c1-36ce0ee121f7	TCGA-D8-A27H-01A-11D-A16C-01	123725b8-4f66-4b97-9726-e0c70300d38e	TCGA-D8-A27H-01A-11D-A16G-05	TCGA-D8-A27H-01		123725b8-4f66-4b97-9726-e0c70300d38e	123725b8-4f66-4b97-9726-e0c70300d38e	TCGA-D8-A27H-01A-11D-A16C-01		TCGA-D8-A27H-01		e6674bdf-bebe-4c44-a6c1-36ce0ee121f7	
TCGA-D8-A27I-01	Stage IIIA	58	3	Stage IIIA	185		Positive	FEMALE	Negative				Negative	M0	Positive	N2	185	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A27I-01	439	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 5		mutation c1uster 9	TCGA-D8-A27I	439	0	439	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A27I-F29521		Positive					Positive	Modified Radical Mastectomy		NO			-21327	132		0	439					NO	manual counting					Scheduled Follow-up Submission	2012-3-21	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8523/3	C50.9		YES		Core needle biopsy	900	NO	Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1									NO	4	0	false	M0	N2a	T1c	Stage IIIA	TCGA-D8-A27I.FAB622C2-3E45-4E72-AA36-9530BB830993.pdf		0		0		0		0		5		5		90		85	TUMOR FREE	manual counting			>75%	>75%		YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	TCGA-D8-A27I-01A-11D-A16D-09		TCGA-D8-A27I-01A-11R-A16E-13	TCGA-D8-A27I-01A-11R-A16E-13	TCGA-D8-A27I-01A-11D-A16D-09		TCGA-D8-A27I-01A-11D-A16D-09	TCGA-D8-A27I-01A-21-A17L-20	TCGA-D8-A27I-01A-11D-A16D-09	6e144eb1-f9c3-4cb1-9e69-28c63ca7e4d1	764e1076-1148-442b-ade8-a9463b88e89e	TCGA-D8-A27I-01A-11D-A16C-01	6e144eb1-f9c3-4cb1-9e69-28c63ca7e4d1	TCGA-D8-A27I-01A-11D-A16G-05	TCGA-D8-A27I-01		6e144eb1-f9c3-4cb1-9e69-28c63ca7e4d1	6e144eb1-f9c3-4cb1-9e69-28c63ca7e4d1	TCGA-D8-A27I-01A-11D-A16C-01		TCGA-D8-A27I-01		764e1076-1148-442b-ade8-a9463b88e89e	
TCGA-D8-A27K-01	Stage IIB	47	2	Stage IIB	118		Positive	FEMALE	Negative				Negative	M0	Positive	N1	118	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A27K-01	287	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3		mutation cluster 4	TCGA-D8-A27K	287	0	287	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-D8-A27K-F29588		Positive					Positive	Modified Radical Mastectomy		NO			-17426			0	287					NO	manual counting					Scheduled Follow-up Submission	2012-3-26	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy			Negative			17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1									NO	2			M0	N1a	T2	Stage IIB																		TUMOR FREE	manual counting			>75%	>75%		YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast		LIVING	2011	TCGA-D8-A27K-01A-11D-A16D-09		TCGA-D8-A27K-01A-11R-A16E-13	TCGA-D8-A27K-01A-11R-A16E-13	TCGA-D8-A27K-01A-11D-A16D-09		TCGA-D8-A27K-01A-11D-A16D-09	TCGA-D8-A27K-01A-21-A17L-20	TCGA-D8-A27K-01A-11D-A16D-09	c0ecd31a-9cce-45d2-9d04-89c465f9b55d	a602eac1-ebad-4c44-90de-62ae59208059	TCGA-D8-A27K-01A-11D-A16C-01	c0ecd31a-9cce-45d2-9d04-89c465f9b55d	TCGA-D8-A27K-01A-11D-A16G-05	TCGA-D8-A27K-01		c0ecd31a-9cce-45d2-9d04-89c465f9b55d	c0ecd31a-9cce-45d2-9d04-89c465f9b55d	TCGA-D8-A27K-01A-11D-A16C-01		TCGA-D8-A27K-01		a602eac1-ebad-4c44-90de-62ae59208059	
TCGA-D8-A27L-01	Stage IIB	49	4	Stage IIIA	125		Positive	FEMALE	Negative				Negative	M0	Positive	N2	125	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A27L-01	499	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 5		mutation cluster 14	TCGA-D8-A27L	499	0	499	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-D8-A27L-F29590		Positive					Positive	Modified Radical Mastectomy		NO			-18025	84		0	499					NO	manual counting					Scheduled Follow-up Submission	2012-6-26	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	220	NO	Negative			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1									NO	2		false	M0	N2a	T1c	Stage IIIA	TCGA-D8-A27L.1281F503-C256-4DFF-A3BD-BD5E51CE4249.pdf		0		0		0		0		0		15		85		60	TUMOR FREE	manual counting			>75%	>75%		YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2011	TCGA-D8-A27L-01A-11D-A16D-09		TCGA-D8-A27L-01A-11R-A16E-13	TCGA-D8-A27L-01A-11R-A16E-13	TCGA-D8-A27L-01A-11D-A16D-09		TCGA-D8-A27L-01A-11D-A16D-09	TCGA-D8-A27L-01A-21-A17L-20	TCGA-D8-A27L-01A-11D-A16D-09	de27ab29-90b0-4d13-8102-1c2bebc4c29a	2c270f48-b696-471a-9804-3d7427b0ba73	TCGA-D8-A27L-01A-11D-A16C-01	de27ab29-90b0-4d13-8102-1c2bebc4c29a	TCGA-D8-A27L-01A-11D-A16G-05	TCGA-D8-A27L-01		de27ab29-90b0-4d13-8102-1c2bebc4c29a	de27ab29-90b0-4d13-8102-1c2bebc4c29a	TCGA-D8-A27L-01A-11D-A16C-01		TCGA-D8-A27L-01		2c270f48-b696-471a-9804-3d7427b0ba73	
TCGA-D8-A27M-01	Stage IIA	59	1	Stage I	144		Negative	FEMALE	Negative				Negative	M0	Negative	N0	144	0	Basal		Negative				enrollment	T1	T1	LIVING	0	TCGA-D8-A27M-01	410	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 5		mutation cluster 5	TCGA-D8-A27M	410	0	410	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-D8-A27M-F29592		Negative					Negative	Modified Radical Mastectomy		NO			-21910	83		0	410					NO						Scheduled Follow-up Submission	2012-3-26	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	140	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5									NO			false	M0	N0	T1c	Stage IA	TCGA-D8-A27M.85045216-10EC-473C-96A9-268E71D2B566.pdf		0		0		0		0		0		5		95		70	TUMOR FREE							YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2011	TCGA-D8-A27M-01A-11D-A16D-09		TCGA-D8-A27M-01A-11R-A16E-13	TCGA-D8-A27M-01A-11R-A16E-13	TCGA-D8-A27M-01A-11D-A16D-09		TCGA-D8-A27M-01A-11D-A16D-09	TCGA-D8-A27M-01A-21-A17L-20	TCGA-D8-A27M-01A-11D-A16D-09	20486352-7d5f-4065-ab10-7a3f792ec1e1	e44bc46c-7def-4fec-8865-38842dd349d1	TCGA-D8-A27M-01A-11D-A16C-01	20486352-7d5f-4065-ab10-7a3f792ec1e1	TCGA-D8-A27M-01A-11D-A16G-05	TCGA-D8-A27M-01		20486352-7d5f-4065-ab10-7a3f792ec1e1	20486352-7d5f-4065-ab10-7a3f792ec1e1	TCGA-D8-A27M-01A-11D-A16C-01		TCGA-D8-A27M-01		e44bc46c-7def-4fec-8865-38842dd349d1	
TCGA-D8-A27N-01	Stage IIIA	36	5	Stage IIIA	145		Positive	FEMALE	Positive				Negative	M0	Positive	N2	145	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A27N-01	146	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4		mutation cluster 5	TCGA-D8-A27N			146	Breast	TCGA Breast Cancer	breast invasive carcinoma					36	Right Upper Outer Quadrant	Axillary lymph node dissection alone				Positive					Positive	Modified Radical Mastectomy		NO			-13243	75		0	146					NO	manual counting						2011-7-18	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO	Positive			19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4										4	0	false	M0	N2a	T2	Stage IIIA	TCGA-D8-A27N.69007BC0-E1DF-4E68-BA6A-352F6A12F233.pdf		0		0		0		0		0		20		80		85	TUMOR FREE	manual counting			10-75%	>75%		YES	No				Primary Tumor	01		7th		YES	NO	D8	Breast	A	LIVING	2011	TCGA-D8-A27N-01A-11D-A16D-09		TCGA-D8-A27N-01A-11R-A16E-13	TCGA-D8-A27N-01A-11R-A16E-13	TCGA-D8-A27N-01A-11D-A16D-09		TCGA-D8-A27N-01A-11D-A16D-09	TCGA-D8-A27N-01A-21-A17L-20	TCGA-D8-A27N-01A-11D-A16D-09	50808f98-d10b-4190-aff7-428f56abb0f9	17105ff5-33f1-4bfc-b21c-477135667919	TCGA-D8-A27N-01A-11D-A16C-01	50808f98-d10b-4190-aff7-428f56abb0f9	TCGA-D8-A27N-01A-11D-A16G-05	TCGA-D8-A27N-01		50808f98-d10b-4190-aff7-428f56abb0f9	50808f98-d10b-4190-aff7-428f56abb0f9	TCGA-D8-A27N-01A-11D-A16C-01		TCGA-D8-A27N-01		17105ff5-33f1-4bfc-b21c-477135667919	
TCGA-D8-A27P-01	Stage IIA	64	2	Stage I	22		Positive	FEMALE	Negative				Negative	M0	Negative	N0	22	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A27P-01	23	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3		mutation cluster 4	TCGA-D8-A27P			23	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Right Upper Inner Quadrant	Sentinel node biopsy alone				Positive					Positive	Modified Radical Mastectomy		NO			-23576	37		0	23					NO	manual counting						2011-7-18	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	100	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2										0		false	M0	N0	T1c	Stage IA	TCGA-D8-A27P.ACC0A0E7-218F-4112-AC74-9F5D5A512DD3.pdf		0		0		0		0		20		30		50		60	TUMOR FREE	manual counting			>75%	>75%		YES	No				Primary Tumor	01		7th		YES	NO	D8	Breast	A	LIVING	2011	TCGA-D8-A27P-01A-11D-A16D-09		TCGA-D8-A27P-01A-11R-A16E-13	TCGA-D8-A27P-01A-11R-A16E-13	TCGA-D8-A27P-01A-11D-A16D-09		TCGA-D8-A27P-01A-11D-A16D-09	TCGA-D8-A27P-01A-21-A17L-20	TCGA-D8-A27P-01A-11D-A16D-09	189c7b41-4d4e-422e-85a2-1f575b5c8b5c	2b37e86a-a7a9-445f-afec-7393f19360ff	TCGA-D8-A27P-01A-11D-A16C-01	189c7b41-4d4e-422e-85a2-1f575b5c8b5c	TCGA-D8-A27P-01A-11D-A16G-05	TCGA-D8-A27P-01		189c7b41-4d4e-422e-85a2-1f575b5c8b5c	189c7b41-4d4e-422e-85a2-1f575b5c8b5c	TCGA-D8-A27P-01A-11D-A16C-01		TCGA-D8-A27P-01		2b37e86a-a7a9-445f-afec-7393f19360ff	
TCGA-D8-A27R-01	Stage IIIC	41	5	Stage IIIC	90		Positive	FEMALE	Negative				Negative	M0	Positive	N3	90	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A27R-01	307	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 5		mutation c1uster 9	TCGA-D8-A27R	307	0	307	Breast	TCGA Breast Cancer	breast invasive carcinoma					41	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A27R-F29700		Positive					Positive	Modified Radical Mastectomy		NO			-15122	50		0	307					NO	manual counting				polisomy	Scheduled Follow-up Submission	2012-3-28	FEMALE					2+		not amplified			Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	440	NO	Equivocal	Negative		11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1									NO	11		false	M0	N3a	T2	Stage IIIC	TCGA-D8-A27R.5E997487-9A03-4723-B1E6-FA0B557D8FDF.pdf		0		0		0		0		0		30		70		80	TUMOR FREE	manual counting			>75%	>75%		YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2011	TCGA-D8-A27R-01A-11D-A16D-09		TCGA-D8-A27R-01A-11R-A16E-13	TCGA-D8-A27R-01A-11R-A16E-13	TCGA-D8-A27R-01A-11D-A16D-09		TCGA-D8-A27R-01A-11D-A16D-09	TCGA-D8-A27R-01A-21-A17L-20	TCGA-D8-A27R-01A-11D-A16D-09	70546486-80a3-452c-8722-1bd7b14d5ac4	da7c504e-b884-40e3-8c4b-6c7936a68a5c	TCGA-D8-A27R-01A-11D-A16C-01	70546486-80a3-452c-8722-1bd7b14d5ac4	TCGA-D8-A27R-01A-11D-A16G-05	TCGA-D8-A27R-01		70546486-80a3-452c-8722-1bd7b14d5ac4	70546486-80a3-452c-8722-1bd7b14d5ac4	TCGA-D8-A27R-01A-11D-A16C-01		TCGA-D8-A27R-01		da7c504e-b884-40e3-8c4b-6c7936a68a5c	
TCGA-D8-A27T-01	Stage IIIC	53	2	Stage IIIC	135		Positive	FEMALE	Negative				Negative	M0	Positive	N3	135	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A27T-01	398	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12		mutation cluster 4	TCGA-D8-A27T	398	0	398	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Right Upper Outer Quadrant|Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-D8-A27T-F30096		Positive					Positive	Simple Mastectomy		NO			-19591	68		0	398					NO	manual counting					Scheduled Follow-up Submission	2012-4-2	FEMALE		Venten			1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	170	NO	Negative			12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4									NO	12		false	M0	N3a	T2	Stage IIIC	TCGA-D8-A27T.15237FF6-A56E-4E05-B81D-B87E91B59917.pdf		0		0		0		0		0		60		40		60	TUMOR FREE	manual counting			>75%	>75%		YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2011	TCGA-D8-A27T-01A-11D-A16D-09		TCGA-D8-A27T-01A-11R-A16E-13	TCGA-D8-A27T-01A-11R-A16E-13	TCGA-D8-A27T-01A-11D-A16D-09		TCGA-D8-A27T-01A-11D-A16D-09	TCGA-D8-A27T-01A-21-A17L-20	TCGA-D8-A27T-01A-11D-A16D-09	090d6483-72df-4a55-84ef-5e196d1982cf	e7e113cc-1203-4bd9-9411-1f8dfacb7968	TCGA-D8-A27T-01A-11D-A16C-01	090d6483-72df-4a55-84ef-5e196d1982cf	TCGA-D8-A27T-01A-11D-A16G-05	TCGA-D8-A27T-01		090d6483-72df-4a55-84ef-5e196d1982cf	090d6483-72df-4a55-84ef-5e196d1982cf	TCGA-D8-A27T-01A-11D-A16C-01		TCGA-D8-A27T-01		e7e113cc-1203-4bd9-9411-1f8dfacb7968	
TCGA-D8-A27V-01	Stage IIA	62	2	Stage IIA	73		Positive	FEMALE	Negative				Negative	M0	Negative	N0	73	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A27V-01	381	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10			TCGA-D8-A27V	381	0	381	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Right Upper Outer Quadrant|Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-D8-A27V-F30105		Positive					Positive	Simple Mastectomy		NO			-22958	51		0	381					NO	manual counting					Scheduled Follow-up Submission	2012-3-29	FEMALE		Venten			1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	230	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4									NO	0		false	M0	N0	T2	Stage IIA	TCGA-D8-A27V.E5011BD1-E1DE-4A47-BF3C-66BA1E0B84DC.pdf		0		0		0		0		5		25		70		70	TUMOR FREE					>75%		YES	No	<10%		NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2011			TCGA-D8-A27V-01A-12R-A17A-13	TCGA-D8-A27V-01A-12R-A17A-13			TCGA-D8-A27V-01A-12D-A17D-09	TCGA-D8-A27V-01A-21-A24A-20		a4c963fd-c8a6-4dcb-8b6e-159591e61d49	12f03a32-be3d-40c0-b380-b104d972a3f1	TCGA-D8-A27V-01A-12D-A17C-01	a4c963fd-c8a6-4dcb-8b6e-159591e61d49	TCGA-D8-A27V-01A-12D-A17F-05	TCGA-D8-A27V-01		a4c963fd-c8a6-4dcb-8b6e-159591e61d49	a4c963fd-c8a6-4dcb-8b6e-159591e61d49	TCGA-D8-A27V-01A-12D-A17C-01		TCGA-D8-A27V-01		12f03a32-be3d-40c0-b380-b104d972a3f1	
TCGA-D8-A27W-01	Stage IIIB	55	3	Stage IIIB	15		Positive	FEMALE	Positive				Negative	M0	Negative	N0	15	0	LumB		Positive				enrollment	T_Other	T4	LIVING	0	TCGA-D8-A27W-01	373	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 5		mutation c1uster 9	TCGA-D8-A27W	373	0	373	Breast	TCGA Breast Cancer	breast invasive carcinoma					55	Right	Axillary lymph node dissection alone		TCGA-D8-A27W-F30107		Positive					Positive	Modified Radical Mastectomy		NO			-20173	43		0	373					NO	manual counting					Scheduled Follow-up Submission	2012-4-2	FEMALE		Venten		Path Vysion HER2 D Probe Kit	2+					Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Fine needle aspiration biopsy	390	NO	Equivocal	Positive		12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4									NO	0		false	M0	N0	T4b	Stage IIIB	TCGA-D8-A27W.292571E3-D500-4337-B435-834B504F3109.pdf		0		0		0		0		0		60		40		70	TUMOR FREE	manual counting			>75%	>75%		YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2011	TCGA-D8-A27W-01A-11D-A16D-09		TCGA-D8-A27W-01A-11R-A16E-13	TCGA-D8-A27W-01A-11R-A16E-13	TCGA-D8-A27W-01A-11D-A16D-09		TCGA-D8-A27W-01A-11D-A16D-09	TCGA-D8-A27W-01A-21-A17L-20	TCGA-D8-A27W-01A-11D-A16D-09	65843fe1-4da2-4165-8926-a0d6f878a7f8	4a98e514-5c43-4d64-a7e6-8a8d59b89f25	TCGA-D8-A27W-01A-11D-A16C-01	65843fe1-4da2-4165-8926-a0d6f878a7f8	TCGA-D8-A27W-01A-11D-A16G-05	TCGA-D8-A27W-01		65843fe1-4da2-4165-8926-a0d6f878a7f8	65843fe1-4da2-4165-8926-a0d6f878a7f8	TCGA-D8-A27W-01A-11D-A16C-01		TCGA-D8-A27W-01		4a98e514-5c43-4d64-a7e6-8a8d59b89f25	
TCGA-D8-A3Z5-01																													0	TCGA-D8-A3Z5-01	1015	0										TCGA-D8-A3Z5	1015	0	1015	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Right	Other (specify)	mastectomy with TLND	TCGA-D8-A3Z5-F57869		Positive					Positive	Simple Mastectomy		NO			-19846			0	1015					NO							2014-3-28	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Negative		NO	21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	19			M0	N3a	T2	Stage IIIC																		TUMOR FREE						NO	YES	No			NO	Primary Tumor	01		7th		YES	NO	D8	Breast		LIVING	2011			TCGA-D8-A3Z5-01A-41R-A24J-13	TCGA-D8-A3Z5-01A-41R-A24J-13			TCGA-D8-A3Z5-01A-41D-A243-09			f47007db-f16a-4721-aac4-c7fb6e9ca868	b43507b1-4ade-4f26-abee-1391e9433a57	TCGA-D8-A3Z5-01A-41D-A242-01	f47007db-f16a-4721-aac4-c7fb6e9ca868	TCGA-D8-A3Z5-01A-41D-A244-05	TCGA-D8-A3Z5-01		f47007db-f16a-4721-aac4-c7fb6e9ca868	f47007db-f16a-4721-aac4-c7fb6e9ca868	TCGA-D8-A3Z5-01A-41D-A242-01		TCGA-D8-A3Z5-01		b43507b1-4ade-4f26-abee-1391e9433a57	
TCGA-D8-A3Z6-01																													0	TCGA-D8-A3Z6-01	563	0										TCGA-D8-A3Z6	563	0	563	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Left	Other (specify)	mastectomy with TLND	TCGA-D8-A3Z6-F51367		Positive					Positive	Modified Radical Mastectomy		NO			-20629	160		0	563					NO							2013-11-18	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	60	NO	Negative		NO	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	19		false	M0	N3a	T3	Stage IIIC	TCGA-D8-A3Z6.A8F63D86-37DF-472E-AF29-FB734EAB7E5C.pdf		2		1		0		0		0		0		100		75	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th		YES	NO	D8	Breast	A	LIVING	2011			TCGA-D8-A3Z6-01A-11R-A23A-13	TCGA-D8-A3Z6-01A-11R-A23A-13			TCGA-D8-A3Z6-01A-11D-A23C-09			0593faf5-8fcc-4aba-a926-c06c70cef7a8	b5370ac3-c55f-464c-bb98-6baa05d8b6b8	TCGA-D8-A3Z6-01A-11D-A238-01	0593faf5-8fcc-4aba-a926-c06c70cef7a8	TCGA-D8-A3Z6-01A-11D-A23D-05	TCGA-D8-A3Z6-01		0593faf5-8fcc-4aba-a926-c06c70cef7a8	0593faf5-8fcc-4aba-a926-c06c70cef7a8	TCGA-D8-A3Z6-01A-11D-A238-01		TCGA-D8-A3Z6-01		b5370ac3-c55f-464c-bb98-6baa05d8b6b8	
TCGA-D8-A4Z1-01																													0	TCGA-D8-A4Z1-01	659	0										TCGA-D8-A4Z1	659	0	659	Breast	TCGA Breast Cancer	breast invasive carcinoma					68	Right|Right Upper Inner Quadrant	No axillary staging		TCGA-D8-A4Z1-F58485		Positive					Positive	Simple Mastectomy		NO			-25097			0	659							70-79%					2014-4-11	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0			M0	N0	T1c	Stage IA																		TUMOR FREE						YES	YES	No	10-19%		NO	Primary Tumor	01		7th		YES	NO	D8	Breast		LIVING	2012			TCGA-D8-A4Z1-01A-21R-A25Z-13	TCGA-D8-A4Z1-01A-21R-A25Z-13			TCGA-D8-A4Z1-01A-21D-A25Q-09			e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72	f552a80d-3e4c-4c0b-b827-806305e48a35	TCGA-D8-A4Z1-01A-21D-A25N-01	e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72	TCGA-D8-A4Z1-01A-21D-A268-05	TCGA-D8-A4Z1-01		e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72	e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72	TCGA-D8-A4Z1-01A-21D-A25N-01		TCGA-D8-A4Z1-01		f552a80d-3e4c-4c0b-b827-806305e48a35	
TCGA-D8-A73U-01																													0	TCGA-D8-A73U-01	492	0										TCGA-D8-A73U	492	0	492	Breast	TCGA Breast Cancer	breast invasive carcinoma					88	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-D8-A73U-F57871		Positive					Positive	Simple Mastectomy		NO			-32208	285		0	492							70-79%					2014-3-28	FEMALE			<10%		1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	90	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO			false	M0	N0	T2	Stage IIA	TCGA-D8-A73U.7BA4658F-3343-4176-BDCD-620A1001A032.pdf		1		0		0		0		0		0		100		65	WITH TUMOR						YES	NO	No	70-79%		NO	Primary Tumor	01		7th		YES	NO	D8	Breast	A	LIVING	2012			TCGA-D8-A73U-01A-11R-A33A-13	TCGA-D8-A73U-01A-11R-A33A-13						57728a07-cb68-45d9-ac86-eba57e674e1d	a527543f-fdc1-44a9-a00e-bfb45cbb15b8	TCGA-D8-A73U-01A-11D-A33D-01	57728a07-cb68-45d9-ac86-eba57e674e1d	TCGA-D8-A73U-01A-11D-A33F-05	TCGA-D8-A73U-01		57728a07-cb68-45d9-ac86-eba57e674e1d	57728a07-cb68-45d9-ac86-eba57e674e1d	TCGA-D8-A73U-01A-11D-A33D-01		TCGA-D8-A73U-01		a527543f-fdc1-44a9-a00e-bfb45cbb15b8	
TCGA-D8-A73W-01																													0	TCGA-D8-A73W-01	244	0										TCGA-D8-A73W	244	0	244	Breast	TCGA Breast Cancer	breast invasive carcinoma					79	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A73W-F57875		Positive					Negative	Simple Mastectomy		NO			-29125	191		0	244							70-79%	Lung|Bone				2014-3-28	FEMALE					1+					Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Tumor resection	230	NO	Negative		NO	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1		false	MX	N1a	T3	Stage IIIA	TCGA-D8-A73W.359DB5F2-BD23-42E1-B316-9D908DBACD78.pdf		2		0		0		0		0		0		100		80							YES	YES	No			YES	Primary Tumor	01		7th		YES	NO	D8	Breast	A	LIVING	2013			TCGA-D8-A73W-01A-22R-A358-13	TCGA-D8-A73W-01A-22R-A358-13						ae442e30-9756-46a8-825b-3e5b7ad394d5	5974f930-a7aa-432e-a3a5-281350781fd0	TCGA-D8-A73W-01A-22D-A350-01	ae442e30-9756-46a8-825b-3e5b7ad394d5	TCGA-D8-A73W-01A-22D-A357-05	TCGA-D8-A73W-01		ae442e30-9756-46a8-825b-3e5b7ad394d5	ae442e30-9756-46a8-825b-3e5b7ad394d5	TCGA-D8-A73W-01A-22D-A350-01		TCGA-D8-A73W-01		5974f930-a7aa-432e-a3a5-281350781fd0	
TCGA-D8-A73X-01																													0	TCGA-D8-A73X-01	368	0										TCGA-D8-A73X	368	0	368	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-D8-A73X-F57879		Positive					Positive	Simple Mastectomy		NO			-19607			0	368							70-79%					2014-3-28	FEMALE					1+					Other  specify	tubular carcinoma	No			8211/3	C50.1		YES		Core needle biopsy			Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO				M0	N0	T2	Stage IIA																		TUMOR FREE						YES	NO	No	70-79%		YES	Primary Tumor	01		7th		YES	NO	D8	Breast		LIVING	2013			TCGA-D8-A73X-01A-11R-A32K-13	TCGA-D8-A73X-01A-11R-A32K-13						a982e795-5256-439a-ae7b-9c250eefea53	e831ad69-0f96-4d82-a435-6b754e44122f	TCGA-D8-A73X-01A-11D-A32H-01	a982e795-5256-439a-ae7b-9c250eefea53	TCGA-D8-A73X-01A-11D-A32T-05	TCGA-D8-A73X-01		a982e795-5256-439a-ae7b-9c250eefea53	a982e795-5256-439a-ae7b-9c250eefea53	TCGA-D8-A73X-01A-11D-A32H-01		TCGA-D8-A73X-01		e831ad69-0f96-4d82-a435-6b754e44122f	
TCGA-E2-A105-01	Stage IIA	79	5	Stage IIA	1163		Positive	FEMALE	Equivocal				Negative	M0	Negative	N0	1163	0	LumA	Luminal A	Positive		-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A105-01	1308	0	Kirc+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-E2-A105	1308	0	1308	Breast	TCGA Breast Cancer	breast invasive carcinoma					79	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-E2-A105-F17431		Positive					Positive	Lumpectomy		NO			-28855	1171		0	1308						Allred score 3 + 2 = 5					Scheduled Follow-up Submission	2011-9-9	FEMALE			70-79%		2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Equivocal			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	1								NO	0		false	M0	N0 (i-)	T2	Stage IIA	TCGA-E2-A105.252A2D12-EC16-459E-8486-7814FF39E6C2.pdf	1	1	0	0	3	4	0	0	0	5	15	30	82	61	88	88	TUMOR FREE	Allred score 3 + 2 = 5			Allred score 5	Allred score 5			No			YES	Primary Tumor	01			YES	NO	YES	E2	Breast	A	LIVING	2007	TCGA-E2-A105-01A-11D-A10M-09	TCGA-E2-A105-01		TCGA-E2-A105-01A-11R-A10I-13			TCGA-E2-A105-01A-11D-A10M-09		TCGA-E2-A105-01A-11D-A10M-09	b9bb3fb2-5692-4e7b-9353-45db1d58843f	1a387c5a-10d0-4a4b-9e5d-23184f15d70c	TCGA-E2-A105-01A-11D-A10L-01	b9bb3fb2-5692-4e7b-9353-45db1d58843f	TCGA-E2-A105-01A-11D-A10N-05	TCGA-E2-A105-01	TCGA-E2-A105-01A-11R-A10J-07	b9bb3fb2-5692-4e7b-9353-45db1d58843f	b9bb3fb2-5692-4e7b-9353-45db1d58843f	TCGA-E2-A105-01A-11D-A10L-01	TCGA-E2-A105-01	TCGA-E2-A105-01		1a387c5a-10d0-4a4b-9e5d-23184f15d70c	TCGA-E2-A105-01A-11R-A10I-13
TCGA-E2-A106-01	Stage IB	34	4	No_Conversion	1807		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1807	0	LumA	Luminal A	Positive		0	-3	followup	T1	T1	LIVING	0	TCGA-E2-A106-01	1807	0	Kirc+		cluster 4	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4		TCGA-E2-A106	1807	0	1807	Breast	TCGA Breast Cancer	breast invasive carcinoma					34	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A106-F17181	Negative	Positive				Other	Positive	Simple Mastectomy	inner-upper margin re-excision	NO			-12528			0	1807							90-99%				Scheduled Follow-up Submission	2011-9-28	FEMALE			10-19%		2+			1.05		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Equivocal	Negative		16	Close	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4								NO	1			M0	N1mi	T1c	Stage IB																		TUMOR FREE								No	80-89%		NO	Primary Tumor	01			YES	NO	YES	E2	Breast		LIVING	2006				TCGA-E2-A106-01A-11R-A10I-13						cbd64838-97a7-47a9-a4dc-aa9e0d0ab3d2			cbd64838-97a7-47a9-a4dc-aa9e0d0ab3d2	TCGA-E2-A106-01A-11D-A10N-05	TCGA-E2-A106-01	TCGA-E2-A106-01A-11R-A10J-07	cbd64838-97a7-47a9-a4dc-aa9e0d0ab3d2	cbd64838-97a7-47a9-a4dc-aa9e0d0ab3d2		TCGA-E2-A106-01				TCGA-E2-A106-01A-11R-A10I-13
TCGA-E2-A107-01	Stage IIIA	54	2	No_Conversion	1046		Positive	FEMALE	Negative	1	3	4	Negative	M0	Positive	N2	1046	0		Luminal B	Negative	LumA/B	0	-3	followup	T_Other	T3	LIVING	0	TCGA-E2-A107-01	1047	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E2-A107	1047	0	1047	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A107-F17173		Positive					Negative	Simple Mastectomy		NO			-20065	715		0	1047						Allred score 5+3=8					Scheduled Follow-up Submission	2011-9-28	FEMALE					2+			1.2		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	170	NO	Equivocal	Negative		27	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	4		false	M0	N2a	T3	Stage IIIA	TCGA-E2-A107.BA87D188-A3B3-4A6F-B3AF-1FEB25B9E357.pdf	1	0	0	0	0	0	0	0	3	0	27	15	70	85	80	90	TUMOR FREE	Allred score 0+0=0			Allred score 0	Allred score 8			No			YES	Primary Tumor	01			YES	NO	YES	E2	Breast	A	LIVING	2008	TCGA-E2-A107-01A-11D-A10M-09	TCGA-E2-A107-01		TCGA-E2-A107-01A-11R-A10I-13		ea9612ed-23f6-44e6-92f4-7cc7d3cef266	TCGA-E2-A107-01A-11D-A10M-09	TCGA-E2-A107-01A-21-A13D-20	TCGA-E2-A107-01A-11D-A10M-09	254c611f-7808-4745-9155-f2d578b29df2	66b6796c-a14a-4bef-ac6b-aee438e04563	TCGA-E2-A107-01A-11D-A10L-01	254c611f-7808-4745-9155-f2d578b29df2	TCGA-E2-A107-01A-11D-A10N-05	TCGA-E2-A107-01	TCGA-E2-A107-01A-11R-A10J-07	254c611f-7808-4745-9155-f2d578b29df2	254c611f-7808-4745-9155-f2d578b29df2	TCGA-E2-A107-01A-11D-A10L-01	TCGA-E2-A107-01	TCGA-E2-A107-01		66b6796c-a14a-4bef-ac6b-aee438e04563	TCGA-E2-A107-01A-11R-A10I-13
TCGA-E2-A108-01	Stage IIIA	64	4	No_Conversion	837		Positive	FEMALE	Negative	1	4	3	Negative	M0	Positive	N2	837	0	Normal	Normal-like	Positive	ReacI	-5	-8	followup	T_Other	T2	LIVING	0	TCGA-E2-A108-01	837	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-E2-A108	837	0	837	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Right Upper Outer Quadrant			TCGA-E2-A108-F17423		Positive					Positive	Lumpectomy					-23530	596		0	837						Allred score 7 (outside facility)					Scheduled Follow-up Submission	2011-9-28	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Negative			27	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	4		false	M0	N2a	T2	Stage IIIA	TCGA-E2-A108.DDBEE56C-F8E8-4A7D-8CF6-E0D63EE53FC4.pdf	4	4	0	0	0	1	0	0	5	5	70	74	25	20	80	80	WITH TUMOR	Allred score 7 per outside facility report			Allred score 7 per outside facility report	Allred score 7 (per outside facility)			No			YES	Primary Tumor	01			YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A108-01A-13D-A10M-09	TCGA-E2-A108-01		TCGA-E2-A108-01A-13R-A10I-13		0e4168e1-0fd3-4a3b-b878-d4c88ced0311	TCGA-E2-A108-01A-13D-A10M-09	TCGA-E2-A108-01A-21-A13D-20	TCGA-E2-A108-01A-13D-A10M-09	48188b57-1f05-43dc-b8d4-a422c4f443a9	6c84b94a-ae86-4265-9620-0d66bb6cfacc	TCGA-E2-A108-01A-13D-A10L-01	48188b57-1f05-43dc-b8d4-a422c4f443a9	TCGA-E2-A108-01A-13D-A10N-05	TCGA-E2-A108-01	TCGA-E2-A108-01A-13R-A10J-07	48188b57-1f05-43dc-b8d4-a422c4f443a9	48188b57-1f05-43dc-b8d4-a422c4f443a9	TCGA-E2-A108-01A-13D-A10L-01	TCGA-E2-A108-01	TCGA-E2-A108-01		6c84b94a-ae86-4265-9620-0d66bb6cfacc	TCGA-E2-A108-01A-13R-A10I-13
TCGA-E2-A109-01	Stage IIA	64	5	Stage IIA	1417		Positive	FEMALE	Negative	4	1	4	Negative	M0	Negative	N0	1417	0	LumB	Luminal B	Negative	LumA/B	-10	-5	followup	T_Other	T2	LIVING	0	TCGA-E2-A109-01	1417	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 6	mutation cluster 5	TCGA-E2-A109	1417	0	1417	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A109-F17418		Positive					Negative	Simple Mastectomy		NO			-23521	1155		0	1417						Allred score 5+3=8					Scheduled Follow-up Submission	2011-9-9	FEMALE			50-59%		2+			1.46		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Core needle biopsy	190	NO	Equivocal	Negative		6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	6								NO	0		false	M0	N0 (i-)	T2	Stage IIA	TCGA-E2-A109.089E0FB9-6B45-4E3E-843E-EC98D39863F6.pdf	4	0	0	0	1	2	0	0	2	0	9	10	88	88	90	90	TUMOR FREE	Allred score 0+0=0			Allred score 0	Allred score 8			No			NO	Primary Tumor	01			YES	NO	YES	E2	Breast	A	LIVING	2007	TCGA-E2-A109-01A-11D-A10M-09	TCGA-E2-A109-01		TCGA-E2-A109-01A-11R-A10I-13		a2cbc0c2-b14e-460f-bc12-5aa350950e00	TCGA-E2-A109-01A-11D-A10M-09	TCGA-E2-A109-01A-21-A13D-20	TCGA-E2-A109-01A-11D-A10M-09	d6aae541-9dec-4055-bfd6-51ebbdcbf7a2	818dbfb5-8c4a-44d1-a44d-6cb138dadca6	TCGA-E2-A109-01A-11D-A10L-01	d6aae541-9dec-4055-bfd6-51ebbdcbf7a2	TCGA-E2-A109-01A-11D-A10N-05	TCGA-E2-A109-01	TCGA-E2-A109-01A-11R-A10J-07	d6aae541-9dec-4055-bfd6-51ebbdcbf7a2	d6aae541-9dec-4055-bfd6-51ebbdcbf7a2	TCGA-E2-A109-01A-11D-A10L-01	TCGA-E2-A109-01	TCGA-E2-A109-01		818dbfb5-8c4a-44d1-a44d-6cb138dadca6	TCGA-E2-A109-01A-11R-A10I-13
TCGA-E2-A10A-01	Stage IIB	41	2	Stage IIB	1229		Positive	FEMALE	Negative	3	3	4	Negative	M0	Negative	N0	1229	0	LumA	Luminal B	Positive	LumA/B	0	-3	followup	T_Other	T3	LIVING	0	TCGA-E2-A10A-01	1229	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-E2-A10A	75	1	1229	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	YES	NO		41	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A10A-F17422		Positive					Positive	Simple Mastectomy		NO			-15085	1096		0	1229			75			Allred score 4+3=7					Scheduled Follow-up Submission	2011-9-13	FEMALE			40-49%		2+			1.21		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Core needle biopsy	370	NO	Positive	Negative		3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	1				Bone	Distant Metastasis			YES	0	0	false	M0	N0 (i-)	T3	Stage IIB	TCGA-E2-A10A.AA1BACC4-0B3D-4E2E-865E-24B570DA4E74.pdf	60	60	10	10	0	0	10	10	0	0	15	15	85	85	85	85	WITH TUMOR	Allred score 5+3=8			Allred score 8	Allred score 7			No			YES	Primary Tumor	01			YES	NO	YES	E2	Breast	A	LIVING	2007	TCGA-E2-A10A-01A-21D-A10Y-09	TCGA-E2-A10A-01	TCGA-E2-A10A-01A-21R-A114-13	TCGA-E2-A10A-01A-21R-A114-13	TCGA-E2-A10A-01A-21D-A10Y-09	18a5dc5d-47d6-495a-a3d5-e19cd79678f4	TCGA-E2-A10A-01A-21D-A10Y-09	TCGA-E2-A10A-01A-11-A13D-20	TCGA-E2-A10A-01A-21D-A10Y-09	104213ad-3ec6-4a24-9760-72333b6c2c22	d01c9656-e545-4261-aceb-135ef42825ce	TCGA-E2-A10A-01A-21D-A111-01	104213ad-3ec6-4a24-9760-72333b6c2c22		TCGA-E2-A10A-01	TCGA-E2-A10A-01A-21R-A115-07	104213ad-3ec6-4a24-9760-72333b6c2c22	104213ad-3ec6-4a24-9760-72333b6c2c22	TCGA-E2-A10A-01A-21D-A111-01	TCGA-E2-A10A-01	TCGA-E2-A10A-01	TCGA-E2-A10A-01A-21D-A112-05	d01c9656-e545-4261-aceb-135ef42825ce	
TCGA-E2-A10B-01	Stage IIB	67	3	No_Conversion	1141		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N1	1141	0	LumA	Luminal A	Positive	LumA	-12	-3	followup	T_Other	T2	LIVING	0	TCGA-E2-A10B-01	1141	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E2-A10B	195	1	1141	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	YES	YES		67	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A10B-F17370		Positive					Positive	Lumpectomy		NO		195	-24577	1065		0	1141			195			Allred score 5+3= 8					Scheduled Follow-up Submission	2011-9-19	FEMALE			10-19%		2+			1.11		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Equivocal	Negative		28	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)					Negative												Negative	4	4				Lung	New Primary Tumor			YES	2	0	false	M0	N1a	T2	Stage IIB	TCGA-E2-A10B.5DAC95DD-5DA6-475B-AC14-5C79FC2F30A6.pdf	4	60	1	10	1	10	1	10	4	0	25	20	70	70	70	70	TUMOR FREE	Allred score 5+3= 8			Allred score 8	Allred score 8			No			YES	Primary Tumor	01			YES	NO	YES	E2	Breast	A	LIVING	2007	TCGA-E2-A10B-01A-11D-A10M-09	TCGA-E2-A10B-01		TCGA-E2-A10B-01A-11R-A10I-13		f0d6030f-5893-4ff7-8072-b4ecafb7a860	TCGA-E2-A10B-01A-11D-A10M-09	TCGA-E2-A10B-01A-21-A13D-20	TCGA-E2-A10B-01A-11D-A10M-09	3b72a173-8ce4-444e-aeeb-39be3f3eb558	b451d230-d158-40cb-91a9-bf25a4da50e6	TCGA-E2-A10B-01A-11D-A10L-01	3b72a173-8ce4-444e-aeeb-39be3f3eb558	TCGA-E2-A10B-01A-11D-A10N-05	TCGA-E2-A10B-01	TCGA-E2-A10B-01A-11R-A10J-07	3b72a173-8ce4-444e-aeeb-39be3f3eb558	3b72a173-8ce4-444e-aeeb-39be3f3eb558	TCGA-E2-A10B-01A-11D-A10L-01	TCGA-E2-A10B-01	TCGA-E2-A10B-01		b451d230-d158-40cb-91a9-bf25a4da50e6	TCGA-E2-A10B-01A-11R-A10I-13
TCGA-E2-A10C-01	Stage IIB	54	3	No_Conversion	1219		Positive	FEMALE	Negative	1	1	4	Negative	M0	Positive	N1	1219	0	LumB	Luminal B	Positive	ReacI	-2	-5	followup	T_Other	T2	LIVING	0	TCGA-E2-A10C-01	1220	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 3	TCGA-E2-A10C	1220	0	1220	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A10C-F17357		Positive					Positive	Lumpectomy		NO			-19849	995		0	1220						Allred score 5+3=8					Scheduled Follow-up Submission	2011-9-26	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	150	NO	Negative			13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	7								NO	1		false	M0	N1a	T2	Stage IIB	TCGA-E2-A10C.E8A61AAC-BFF5-4341-B051-EDD87515ECDC.pdf	0	0	0	0	0	0	0	0	0	0	10	5	90	95	85	75	TUMOR FREE	Allred score 3+3=6			Allred score 6	Allred score 8			No			YES	Primary Tumor	01			YES	NO	YES	E2	Breast	A	LIVING	2008	TCGA-E2-A10C-01A-21D-A10M-09	TCGA-E2-A10C-01		TCGA-E2-A10C-01A-21R-A10I-13	TCGA-E2-A10C-01A-21D-A10M-09	a000b0bf-7241-4898-8bc9-1d130065cc5d	TCGA-E2-A10C-01A-21D-A10M-09	TCGA-E2-A10C-01A-11-A13D-20	TCGA-E2-A10C-01A-21D-A10M-09	1f7762ae-94bf-4ab4-a6d6-7fe57b1e1e99	47ba6d6f-734a-4e33-af3e-eef3783cc26b	TCGA-E2-A10C-01A-21D-A10L-01	1f7762ae-94bf-4ab4-a6d6-7fe57b1e1e99	TCGA-E2-A10C-01A-21D-A10N-05	TCGA-E2-A10C-01	TCGA-E2-A10C-01A-21R-A10J-07	1f7762ae-94bf-4ab4-a6d6-7fe57b1e1e99	1f7762ae-94bf-4ab4-a6d6-7fe57b1e1e99	TCGA-E2-A10C-01A-21D-A10L-01	TCGA-E2-A10C-01	TCGA-E2-A10C-01		47ba6d6f-734a-4e33-af3e-eef3783cc26b	TCGA-E2-A10C-01A-21R-A10I-13
TCGA-E2-A10E-01	Stage IIA	64	2	No_Conversion	865		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N1	865	0	LumA	Luminal A	Positive	LumA/B	-12	-3	followup	T1	T1	LIVING	0	TCGA-E2-A10E-01	865	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A10E	865	0	865	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A10E-F17248		Positive					Positive	Simple Mastectomy		NO			-23684	869		0	865						Allred score 5+3=8					Scheduled Follow-up Submission	2011-9-26	FEMALE			40-49%		2+			1.07		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1		YES		Core needle biopsy	240	NO	Equivocal	Negative		21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	2		false	M0	N1a	T1c	Stage IIA	TCGA-E2-A10E.CFB8EE09-41D3-4A39-A4AE-4CDEC84BB9BC.pdf	0	0	0	0	0	0	0	0	25	5	15	15	60	80	70	85	TUMOR FREE	Allred score 3+2=5			Allred score 5	Allred score 8			No			YES	Primary Tumor	01			YES	NO	YES	E2	Breast	A	LIVING	2008	TCGA-E2-A10E-01A-21D-A10M-09	TCGA-E2-A10E-01		TCGA-E2-A10E-01A-21R-A10I-13		3511ab99-23f6-45bb-b2f9-28e547200841	TCGA-E2-A10E-01A-21D-A10M-09	TCGA-E2-A10E-01A-11-A13D-20	TCGA-E2-A10E-01A-21D-A10M-09	0e932148-a592-42e2-b1df-4fd599db21e9	828071d6-b83c-4040-8012-8a25ef18261a	TCGA-E2-A10E-01A-21D-A10L-01	0e932148-a592-42e2-b1df-4fd599db21e9	TCGA-E2-A10E-01A-21D-A10N-05	TCGA-E2-A10E-01	TCGA-E2-A10E-01A-21R-A10J-07	0e932148-a592-42e2-b1df-4fd599db21e9	0e932148-a592-42e2-b1df-4fd599db21e9	TCGA-E2-A10E-01A-21D-A10L-01	TCGA-E2-A10E-01	TCGA-E2-A10E-01		828071d6-b83c-4040-8012-8a25ef18261a	TCGA-E2-A10E-01A-21R-A10I-13
TCGA-E2-A10F-01	Stage IIA	47	2	Stage IIA	878		Positive	FEMALE	Negative				Negative	M0	Negative	N0	878	0	LumA	Luminal A	Positive		-5	-4	followup	T_Other	T2	LIVING	0	TCGA-E2-A10F-01	878	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E2-A10F	878	0	878	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A10F-F17187		Positive					Positive	Lumpectomy		NO			-17257	801		0	878						Allred score 5+3=8					Scheduled Follow-up Submission	2011-9-27	FEMALE			20-29%		2+			1.05		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES		Core needle biopsy	110	NO	Equivocal	Negative		2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4								NO	0		false	M0	N0 (i-)	T2	Stage IIA	TCGA-E2-A10F.71C82089-E070-4C7B-B15B-0492DECCB3BF.pdf	0	0	0	0	0	0	0	0	0	0	0	60	100	40	80	60	TUMOR FREE	Allred score 5+3=8			Allred score 8	Allred score 8			No			YES	Primary Tumor	01			YES	NO	YES	E2	Breast	A	LIVING	2008	TCGA-E2-A10F-01A-11D-A10M-09	TCGA-E2-A10F-01		TCGA-E2-A10F-01A-11R-A10I-13			TCGA-E2-A10F-01A-11D-A10M-09		TCGA-E2-A10F-01A-11D-A10M-09	05918561-a713-464b-9b5c-4f7c9258a827	49d20029-a697-4499-8ef4-e87c04dfa2dc	TCGA-E2-A10F-01A-11D-A10L-01	05918561-a713-464b-9b5c-4f7c9258a827	TCGA-E2-A10F-01A-11D-A10N-05	TCGA-E2-A10F-01	TCGA-E2-A10F-01A-11R-A10J-07	05918561-a713-464b-9b5c-4f7c9258a827	05918561-a713-464b-9b5c-4f7c9258a827	TCGA-E2-A10F-01A-11D-A10L-01	TCGA-E2-A10F-01	TCGA-E2-A10F-01		49d20029-a697-4499-8ef4-e87c04dfa2dc	TCGA-E2-A10F-01A-11R-A10I-13
TCGA-E2-A14N-01	Stage IIB	37	4	Stage IIB	1350		Negative	FEMALE	Negative				Negative	M0	Positive	N1	1350	0	Basal	Basal-like	Negative		-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14N-01	1434	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 5	cluster 6	mutation cluster 5	TCGA-E2-A14N	1434	0	1434	Breast	TCGA Breast Cancer	breast invasive carcinoma					37	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A14N-F19154		Negative					Negative	Simple Mastectomy		NO			-13743	1240		0	1434					NO	Allred score 0+0 = 0					Scheduled Follow-up Submission	2011-11-17	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES		Tumor resection	440	NO	Negative			38	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	6								NO	1		false	M0	N1	T2	Stage IIB	TCGA-E2-A14N.C972EC08-E1AE-4FCB-B8A1-15000306CDE7.pdf		0		0		0		0		0		0		100		90	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2007	TCGA-E2-A14N-01A-31D-A135-09	TCGA-E2-A14N-01	TCGA-E2-A14N-01A-31R-A136-13	TCGA-E2-A14N-01A-31R-A136-13	TCGA-E2-A14N-01A-31D-A135-09		TCGA-E2-A14N-01A-31D-A135-09	TCGA-E2-A14N-01A-21-A17I-20	TCGA-E2-A14N-01A-31D-A135-09	6e45dd01-225d-4871-9a3a-f591808ad234	ec2186e9-17fc-49c1-a3f2-81f51faf1fc7	TCGA-E2-A14N-01A-31D-A134-01	6e45dd01-225d-4871-9a3a-f591808ad234	TCGA-E2-A14N-01A-31D-A138-05	TCGA-E2-A14N-01	TCGA-E2-A14N-01A-31R-A137-07	6e45dd01-225d-4871-9a3a-f591808ad234	6e45dd01-225d-4871-9a3a-f591808ad234	TCGA-E2-A14N-01A-31D-A134-01	TCGA-E2-A14N-01	TCGA-E2-A14N-01		ec2186e9-17fc-49c1-a3f2-81f51faf1fc7	
TCGA-E2-A14O-01	Stage IIIA	76	2	Stage IIIA	1172		Positive	FEMALE	Negative	1	3	4	Negative	M0	Positive	N1	1172	0	LumB	Luminal B	Positive	LumA/B	0	-3	enrollment	T_Other	T3	LIVING	0	TCGA-E2-A14O-01	1359	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A14O	1359	0	1359	Breast	TCGA Breast Cancer	breast invasive carcinoma					76	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A14O-F18521		Positive					Positive	Modified Radical Mastectomy		NO			-27837	1064		0	1359					NO	Allred score 5+3 = 8					Scheduled Follow-up Submission	2011-10-19	FEMALE			50-59%		2+			1.65		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	210	NO	Equivocal	Negative		18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	2		false	M0	N1a	T3	Stage IIIA	TCGA-E2-A14O.42E9A561-B052-412E-B0FD-563DC097C3C5.pdf		2		0		1		0		0		69		30		80	TUMOR FREE	Allred score 5+2 = 7			Allred score = 7	Allred score = 8		YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	TCGA-E2-A14O-01A-31D-A10Y-09	TCGA-E2-A14O-01	TCGA-E2-A14O-01A-31R-A114-13	TCGA-E2-A14O-01A-31R-A114-13	TCGA-E2-A14O-01A-31D-A10Y-09	1b57149c-21de-43c8-8f92-f6adbd5623c3	TCGA-E2-A14O-01A-31D-A10Y-09	TCGA-E2-A14O-01A-21-A13E-20	TCGA-E2-A14O-01A-31D-A10Y-09	2791089c-f659-41e8-8e18-57fc6a079e6b	2def89d4-9863-4170-880b-4fec28a1465b	TCGA-E2-A14O-01A-31D-A111-01	2791089c-f659-41e8-8e18-57fc6a079e6b		TCGA-E2-A14O-01	TCGA-E2-A14O-01A-31R-A115-07	2791089c-f659-41e8-8e18-57fc6a079e6b	2791089c-f659-41e8-8e18-57fc6a079e6b	TCGA-E2-A14O-01A-31D-A111-01	TCGA-E2-A14O-01	TCGA-E2-A14O-01	TCGA-E2-A14O-01A-31D-A112-05	2def89d4-9863-4170-880b-4fec28a1465b	
TCGA-E2-A14P-01	Stage IIIC	79	3	Stage IIIC	487		Negative	FEMALE	Positive	1	1	1	Negative	M0	Positive	N3	487	0	Her2	HER2-enriched	Negative	Her2	-11	-5	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14P-01	1246	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-E2-A14P	1246	0	1246	Breast	TCGA Breast Cancer	breast invasive carcinoma					79	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A14P-F18846		Negative					Negative	Lumpectomy		NO			-28923	965		0	1246					NO	Allred score 0+0 = 0					Scheduled Follow-up Submission	2011-10-20	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	290	NO	Positive			24	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	10		false	M0	N3	T2	Stage IIIC	TCGA-E2-A14P.FD8CDFD9-6DCF-4CE1-9BB1-A7FF568EE53C.pdf		10		0		5		0		2		23		70		80	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES	No			YES	Primary Tumor	01		6th	NO	NO	YES	E2	Breast	A	LIVING	2008	TCGA-E2-A14P-01A-31D-A12B-09	TCGA-E2-A14P-01	TCGA-E2-A14P-01A-31R-A12C-13	TCGA-E2-A14P-01A-31R-A12C-13	TCGA-E2-A14P-01A-31D-A12B-09	3a9dace0-ee3c-42bc-8c9a-30998aae35f0	TCGA-E2-A14P-01A-31D-A12B-09	TCGA-E2-A14P-01A-21-A13E-20	TCGA-E2-A14P-01A-31D-A12B-09	a4cb04f5-91b3-40ba-8005-b1df46d6b555	32d3f1cd-077f-43bf-843e-1fe9f0ec0cba	TCGA-E2-A14P-01A-31D-A12A-01	a4cb04f5-91b3-40ba-8005-b1df46d6b555		TCGA-E2-A14P-01	TCGA-E2-A14P-01A-31R-A12D-07	a4cb04f5-91b3-40ba-8005-b1df46d6b555	a4cb04f5-91b3-40ba-8005-b1df46d6b555	TCGA-E2-A14P-01A-31D-A12A-01	TCGA-E2-A14P-01	TCGA-E2-A14P-01	TCGA-E2-A14P-01A-31D-A12E-05	32d3f1cd-077f-43bf-843e-1fe9f0ec0cba	
TCGA-E2-A14Q-01	Stage IIA	50	2	Stage IIB	974		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N1	974	0	LumA	Luminal A	Positive	LumA	0	-7	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14Q-01	1163	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-E2-A14Q	1163	0	1163	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A14Q-F18800		Positive					Positive	Lumpectomy		NO			-18507	960		0	1163					NO	Allred score 5+3 = 8					Scheduled Follow-up Submission	2011-10-20	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	110	NO	Negative			7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	2								NO	1		false	M0	N1mi	T2	Stage IIA	TCGA-E2-A14Q.42A1A073-69B4-4A66-A998-BE4366E0C89C.pdf		0		0		0		0		10		20		70		85	TUMOR FREE	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		YES	No			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	TCGA-E2-A14Q-01A-11D-A12B-09	TCGA-E2-A14Q-01	TCGA-E2-A14Q-01A-11R-A12C-13	TCGA-E2-A14Q-01A-11R-A12C-13	TCGA-E2-A14Q-01A-11D-A12B-09	9ebd7a3c-5f75-479b-a6a3-b4f00221955f	TCGA-E2-A14Q-01A-11D-A12B-09	TCGA-E2-A14Q-01A-21-A13E-20	TCGA-E2-A14Q-01A-11D-A12B-09	48d70a9a-b6ae-4ed6-80da-999a919f8da9	d897dae1-1649-463c-aba4-e93fae68c5e8	TCGA-E2-A14Q-01A-11D-A12A-01	48d70a9a-b6ae-4ed6-80da-999a919f8da9		TCGA-E2-A14Q-01	TCGA-E2-A14Q-01A-11R-A12D-07	48d70a9a-b6ae-4ed6-80da-999a919f8da9	48d70a9a-b6ae-4ed6-80da-999a919f8da9	TCGA-E2-A14Q-01A-11D-A12A-01	TCGA-E2-A14Q-01	TCGA-E2-A14Q-01	TCGA-E2-A14Q-01A-11D-A12E-05	d897dae1-1649-463c-aba4-e93fae68c5e8	
TCGA-E2-A14R-01	Stage IIA	62	1	Stage IIA	845		Negative	FEMALE	Negative				Negative	M0	Negative	N0	845	0	Basal	Basal-like	Negative		-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14R-01	1174	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-E2-A14R	971	1	1174	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	YES	YES		62	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A14R-F18838		Negative					Negative	Lumpectomy		NO		971	-22686	910		0	1174			971		NO	Allred score 0+0 = 0					Scheduled Follow-up Submission	2011-10-24	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1		YES		Tumor resection	190	NO	Negative			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5				Other, specify	New Primary Tumor	Endometrial		YES	0		false	M0	N0	T2	Stage IIA	TCGA-E2-A14R.0B6DCA80-3108-4D25-B095-3EC704598B23.pdf		0		0		0		0		0		50		50		80	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	TCGA-E2-A14R-01A-11D-A10Y-09	TCGA-E2-A14R-01	TCGA-E2-A14R-01A-11R-A114-13	TCGA-E2-A14R-01A-11R-A114-13	TCGA-E2-A14R-01A-11D-A10Y-09		TCGA-E2-A14R-01A-11D-A10Y-09		TCGA-E2-A14R-01A-11D-A10Y-09	76a625e9-22b3-42b8-8813-27c133d0b248	fbf955e5-ed36-4f3a-b8e0-fb63dbb7543d	TCGA-E2-A14R-01A-11D-A111-01	76a625e9-22b3-42b8-8813-27c133d0b248		TCGA-E2-A14R-01	TCGA-E2-A14R-01A-11R-A115-07	76a625e9-22b3-42b8-8813-27c133d0b248	76a625e9-22b3-42b8-8813-27c133d0b248	TCGA-E2-A14R-01A-11D-A111-01	TCGA-E2-A14R-01	TCGA-E2-A14R-01	TCGA-E2-A14R-01A-11D-A112-05	fbf955e5-ed36-4f3a-b8e0-fb63dbb7543d	
TCGA-E2-A14S-01	Stage I	65	4	Stage I	834		Positive	FEMALE	Negative	1	3	4	Negative	M0	Negative	N0	834	0	LumB	Luminal B	Positive	LumA/B	-10	-3	enrollment	T1	T1	LIVING	0	TCGA-E2-A14S-01	1009	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-E2-A14S	1009	0	1009	Breast	TCGA Breast Cancer	breast invasive carcinoma					65	Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A14S-F18831		Positive					Positive	Lumpectomy		NO			-23878	827		0	1009					NO	Allred score 5+3 = 8					Scheduled Follow-up Submission	2011-11-3	FEMALE					2+			1.04		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	120	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO	0		false	M0	N0	T1c	Stage I	TCGA-E2-A14S.810B3936-DFF0-420C-BD6C-8D4990B8F536.pdf		0		0		0		0		0		5		95		90	TUMOR FREE	Allred score 4+3 = 7			Allred score = 7	Allred score = 8		YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	TCGA-E2-A14S-01A-11D-A12B-09	TCGA-E2-A14S-01	TCGA-E2-A14S-01A-11R-A12C-13	TCGA-E2-A14S-01A-11R-A12C-13	TCGA-E2-A14S-01A-11D-A12B-09	010a31fc-4218-4110-b2d0-4791ca77d417	TCGA-E2-A14S-01A-11D-A12B-09	TCGA-E2-A14S-01A-21-A13E-20	TCGA-E2-A14S-01A-11D-A12B-09	5aaf8edc-5d66-4099-824b-f4e06827ad12	48a87c28-38ea-4e10-b545-b3b55caf3225	TCGA-E2-A14S-01A-11D-A12A-01	5aaf8edc-5d66-4099-824b-f4e06827ad12		TCGA-E2-A14S-01	TCGA-E2-A14S-01A-11R-A12D-07	5aaf8edc-5d66-4099-824b-f4e06827ad12	5aaf8edc-5d66-4099-824b-f4e06827ad12	TCGA-E2-A14S-01A-11D-A12A-01	TCGA-E2-A14S-01	TCGA-E2-A14S-01	TCGA-E2-A14S-01A-11D-A12E-05	48a87c28-38ea-4e10-b545-b3b55caf3225	
TCGA-E2-A14T-01	Stage IIA	52		Stage IIA	890		Positive	FEMALE	Negative				Negative	M0	Negative	N0	890	0	LumA	Luminal A	Positive	LumA/B	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14T-01	1013	0		C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-E2-A14T	1013	0	1013	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-E2-A14T-F18814		Positive					Positive	Simple Mastectomy		NO			-19237	792		0	1013					NO	Allred score 5+3 = 8					Scheduled Follow-up Submission	2011-11-3	FEMALE					1+			1.29		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES		Tumor resection	210	NO	Negative	Negative		7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	1								NO	0		false	M0	N0	T2	Stage IIA	TCGA-E2-A14T.6C8B56C1-330B-4116-8B60-7A81A1983277.pdf		0		0		0		0		0		20		80		80	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 8		YES	No			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	TCGA-E2-A14T-01A-11D-A10Y-09	TCGA-E2-A14T-01	TCGA-E2-A14T-01A-11R-A114-13	TCGA-E2-A14T-01A-11R-A114-13	TCGA-E2-A14T-01A-11D-A10Y-09	356382a7-c34b-4e96-aaf2-9901ccc6d72c	TCGA-E2-A14T-01A-11D-A10Y-09	TCGA-E2-A14T-01A-21-A13E-20	TCGA-E2-A14T-01A-11D-A10Y-09	7aa46530-2311-41ed-a452-9ca06f38c0c1	e0629d66-17b1-4abb-beff-7b459b373089	TCGA-E2-A14T-01A-11D-A111-01	7aa46530-2311-41ed-a452-9ca06f38c0c1		TCGA-E2-A14T-01	TCGA-E2-A14T-01A-11R-A115-07	7aa46530-2311-41ed-a452-9ca06f38c0c1	7aa46530-2311-41ed-a452-9ca06f38c0c1	TCGA-E2-A14T-01A-11D-A111-01	TCGA-E2-A14T-01	TCGA-E2-A14T-01	TCGA-E2-A14T-01A-11D-A112-05	e0629d66-17b1-4abb-beff-7b459b373089	
TCGA-E2-A14U-01																													0	TCGA-E2-A14U-01	1318	0	Quiet			BRCA non-CIMP c9			miRNA cluster 5			TCGA-E2-A14U	1318	0	1318	Breast	TCGA Breast Cancer	breast invasive carcinoma					74	Right Upper Outer Quadrant	Other (specify)	Sentinel lymph node dissection	TCGA-E2-A14U-F33622		Positive					Positive	Lumpectomy		NO			-27389	796		0	1318					NO	Allred score 5+3 = 8					Scheduled Follow-up Submission	2012-7-11	FEMALE			40-49%		2+			1.04		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES		Tumor resection	70	NO	Equivocal	Negative		8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T1c	Stage I	TCGA-E2-A14U.7E0F430B-B96B-49B1-B4C1-88C1F3A855A7.pdf		0		0		0		0		20		40		40		60	TUMOR FREE	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		YES	No			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008			TCGA-E2-A14U-01A-11R-A22I-13	TCGA-E2-A14U-01A-11R-A22I-13			TCGA-E2-A14U-01A-11D-A228-09			20d25e27-b509-45eb-a734-9b8d6a40c632	a20a0a7b-90ff-4427-91f6-72ebf8c7b61e	TCGA-E2-A14U-01A-11D-A227-01	20d25e27-b509-45eb-a734-9b8d6a40c632	TCGA-E2-A14U-01A-11D-A22B-05	TCGA-E2-A14U-01		20d25e27-b509-45eb-a734-9b8d6a40c632	20d25e27-b509-45eb-a734-9b8d6a40c632	TCGA-E2-A14U-01A-11D-A227-01		TCGA-E2-A14U-01		a20a0a7b-90ff-4427-91f6-72ebf8c7b61e	
TCGA-E2-A14V-01	Stage IIB	53	5	Stage IIB	748		Positive	FEMALE	Positive	1	1	1	Negative	M0	Positive	N1	748	0	Her2	HER2-enriched	Positive	Her2	-1	-5	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14V-01	1042	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E2-A14V	1042	0	1042	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A14V-F18870		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		NO			-19643	722		0	1042					NO						Scheduled Follow-up Submission	2011-11-4	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.3		YES		Tumor resection	160	NO	Positive			24	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	3		false	M0	N1	T2	Stage IIB	TCGA-E2-A14V.DC8FD7C7-A908-4B90-860F-04984244167C.pdf		0		0		0		0		0		25		75		60	TUMOR FREE							YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	TCGA-E2-A14V-01A-11D-A12B-09	TCGA-E2-A14V-01	TCGA-E2-A14V-01A-11R-A12C-13	TCGA-E2-A14V-01A-11R-A12C-13	TCGA-E2-A14V-01A-11D-A12B-09	40a19899-83c4-44c1-8e91-c4b4339d7ea8	TCGA-E2-A14V-01A-11D-A12B-09	TCGA-E2-A14V-01A-21-A13E-20	TCGA-E2-A14V-01A-11D-A12B-09	d6f0abd0-ff39-4c30-a8ee-e74e6f3621bf	83803fb6-49a3-46a2-a927-657c4733337a	TCGA-E2-A14V-01A-11D-A12A-01	d6f0abd0-ff39-4c30-a8ee-e74e6f3621bf		TCGA-E2-A14V-01	TCGA-E2-A14V-01A-11R-A12D-07	d6f0abd0-ff39-4c30-a8ee-e74e6f3621bf	d6f0abd0-ff39-4c30-a8ee-e74e6f3621bf	TCGA-E2-A14V-01A-11D-A12A-01	TCGA-E2-A14V-01	TCGA-E2-A14V-01	TCGA-E2-A14V-01A-11D-A12E-05	83803fb6-49a3-46a2-a927-657c4733337a	
TCGA-E2-A14W-01	Stage IIA	78	5	Stage IIA	833		Positive	FEMALE	Positive	3	3	4	Negative	M0	Negative	N0	833	0	LumB	Luminal B	Positive	Her2	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14W-01	974	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 7	mutation cluster 12	TCGA-E2-A14W	974	0	974	Breast	TCGA Breast Cancer	breast invasive carcinoma					78	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A14W-F18803		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		NO			-28664	716		0	974					NO						Scheduled Follow-up Submission	2011-11-4	MALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1		YES		Tumor resection	150	NO		Positive		5	Negative																			2	7								NO	0		false	M0	N0	T2	Stage IIA	TCGA-E2-A14W.9ECD3DA1-25A4-4325-9B3B-6D7C12283C37.pdf		0		0		0		0		0		30		70		80	TUMOR FREE							YES	No			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	TCGA-E2-A14W-01A-11D-A12B-09	TCGA-E2-A14W-01	TCGA-E2-A14W-01A-11R-A12C-13	TCGA-E2-A14W-01A-11R-A12C-13	TCGA-E2-A14W-01A-11D-A12B-09	de3f269f-cfa8-4ff2-bd60-14ffe2a45d83	TCGA-E2-A14W-01A-11D-A12B-09	TCGA-E2-A14W-01A-21-A13E-20	TCGA-E2-A14W-01A-11D-A12B-09	f898f44d-a728-41cf-b1ac-20b1995a86b9	77d07305-dbcf-4795-9f23-e69fc65b04b1	TCGA-E2-A14W-01A-11D-A12A-01	f898f44d-a728-41cf-b1ac-20b1995a86b9		TCGA-E2-A14W-01	TCGA-E2-A14W-01A-11R-A12D-07	f898f44d-a728-41cf-b1ac-20b1995a86b9	f898f44d-a728-41cf-b1ac-20b1995a86b9	TCGA-E2-A14W-01A-11D-A12A-01	TCGA-E2-A14W-01	TCGA-E2-A14W-01	TCGA-E2-A14W-01A-11D-A12E-05	77d07305-dbcf-4795-9f23-e69fc65b04b1	
TCGA-E2-A14X-01	Stage IIIA	55	4	Stage IIIA	692		Negative	FEMALE	Negative	3	2	2	Negative	M0	Positive	N2	692	0	Basal	Basal-like	Negative	ReacII	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14X-01	972	0	BRCA-LUAD+	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-E2-A14X	972	0	972	Breast	TCGA Breast Cancer	breast invasive carcinoma					55	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A14X-F18857		Negative					Negative	Lumpectomy		NO			-20105	652		0	972					NO	Allred score 0+0 = 0					Scheduled Follow-up Submission	2011-11-4	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	130	NO	Negative			21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3								NO	5		false	M0	N2	T2	Stage IIIA	TCGA-E2-A14X.734305A3-5EC4-4DE4-B263-91A49082F146.pdf		0		0		1		0		5		19		75		75	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A14X-01A-11D-A10Y-09	TCGA-E2-A14X-01	TCGA-E2-A14X-01A-11R-A114-13	TCGA-E2-A14X-01A-11R-A114-13	TCGA-E2-A14X-01A-11D-A10Y-09	29a42295-97db-4c28-885f-801d655b5b0f	TCGA-E2-A14X-01A-11D-A10Y-09	TCGA-E2-A14X-01A-21-A13E-20	TCGA-E2-A14X-01A-11D-A10Y-09	d9f827bb-2498-49b0-aa85-71cb554eb926	83255030-c4f5-48ed-829b-3b06dd57adbb	TCGA-E2-A14X-01A-11D-A111-01	d9f827bb-2498-49b0-aa85-71cb554eb926		TCGA-E2-A14X-01	TCGA-E2-A14X-01A-11R-A115-07	d9f827bb-2498-49b0-aa85-71cb554eb926	d9f827bb-2498-49b0-aa85-71cb554eb926	TCGA-E2-A14X-01A-11D-A111-01	TCGA-E2-A14X-01	TCGA-E2-A14X-01	TCGA-E2-A14X-01A-11D-A112-05	83255030-c4f5-48ed-829b-3b06dd57adbb	
TCGA-E2-A14Y-01	Stage IIA	35	2	Stage IIA	688		Positive	FEMALE	Positive	3	3	3	Negative	M0	Negative	N0	688	0	Basal	Basal-like	Positive	ReacII	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14Y-01	870	0	Iq	C4-BRCA/Basal	cluster 2	BRCA non-CIMP c9	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 11	cluster 5	mutation cluster 3	TCGA-E2-A14Y	870	0	870	Breast	TCGA Breast Cancer	breast invasive carcinoma					35	Right	Sentinel node biopsy alone		TCGA-E2-A14Y-F18497		Positive					Positive	Simple Mastectomy		NO			-13004	597		0	870					NO						Scheduled Follow-up Submission	2011-11-7	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	190	NO	Equivocal	Positive		5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	5								NO	0		false	M0	N0	T2	Stage IIA	TCGA-E2-A14Y.957AC7B0-D613-4F97-BBBC-930EB95EE2E4.pdf		0		0		5		0		0		25		70		80	TUMOR FREE							YES	No			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A14Y-01A-21D-A12B-09	TCGA-E2-A14Y-01	TCGA-E2-A14Y-01A-21R-A12C-13	TCGA-E2-A14Y-01A-21R-A12C-13	TCGA-E2-A14Y-01A-21D-A12B-09	173f9cd2-092c-479a-b9f2-f58ebd0ffa69	TCGA-E2-A14Y-01A-21D-A12B-09	TCGA-E2-A14Y-01A-11-A13E-20	TCGA-E2-A14Y-01A-21D-A12B-09	3ea70053-af2a-4fec-9416-d18b6156f516	4f21ba10-b578-4a5a-a941-399c4cc65329	TCGA-E2-A14Y-01A-21D-A12A-01	3ea70053-af2a-4fec-9416-d18b6156f516		TCGA-E2-A14Y-01	TCGA-E2-A14Y-01A-21R-A12D-07	3ea70053-af2a-4fec-9416-d18b6156f516	3ea70053-af2a-4fec-9416-d18b6156f516	TCGA-E2-A14Y-01A-21D-A12A-01	TCGA-E2-A14Y-01	TCGA-E2-A14Y-01	TCGA-E2-A14Y-01A-21D-A12E-05	4f21ba10-b578-4a5a-a941-399c4cc65329	
TCGA-E2-A14Y-11		35			688			FEMALE									688	0							enrollment			LIVING	0	TCGA-E2-A14Y-11	870	0		C4-BRCA/Basal							mutation cluster 3	TCGA-E2-A14Y	870	0	870	Breast	TCGA Breast Cancer	breast invasive carcinoma					35	Right	Sentinel node biopsy alone		TCGA-E2-A14Y-F18497		Positive					Positive	Simple Mastectomy		NO			-13004	597		0	870					NO						Scheduled Follow-up Submission	2011-11-7	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	290	NO	Equivocal	Positive		5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0		false	M0	N0	T2	Stage IIA			0		0		0		0		10		90		0		0	TUMOR FREE							YES	No			NO	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast	A	LIVING	2009																						TCGA-E2-A14Y-11A-33D-A12E-05		
TCGA-E2-A14Z-01	Stage I	64	1	Stage I	518		Positive	FEMALE	Negative	3	2	3	Negative	M0	Negative	N0	518	0	LumA	Luminal A	Positive	LumA	0	-2	enrollment	T1	T1	LIVING	1	TCGA-E2-A14Z-01	563	1	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 5	TCGA-E2-A14Z	188	1	563	Breast	TCGA Breast Cancer	breast invasive carcinoma			NO		64	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A14Z-F18790		Positive					Positive	Lumpectomy		NO			-23682	519	563	0	518			188		NO	Allred score 5+3 = 8					Scheduled Follow-up Submission	2011-11-4	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	120	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6				Bone	Distant Metastasis			YES	0		false	M0	N0	T1c	Stage I	TCGA-E2-A14Z.750D4149-BD70-4D7C-B915-9694BD1EC760.pdf		0		0		0		0		0		20		80		70	WITH TUMOR	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	DECEASED	2009	TCGA-E2-A14Z-01A-11D-A10Y-09	TCGA-E2-A14Z-01	TCGA-E2-A14Z-01A-11R-A114-13	TCGA-E2-A14Z-01A-11R-A114-13	TCGA-E2-A14Z-01A-11D-A10Y-09	5a68a63e-17ae-4bd8-ab5d-0451e8ae8cc1	TCGA-E2-A14Z-01A-11D-A10Y-09	TCGA-E2-A14Z-01A-21-A13E-20	TCGA-E2-A14Z-01A-11D-A10Y-09	bcf768ee-138c-42a4-a3bf-b8d509c644d9	04dac9e1-f867-481c-aa21-5c17336af1fd	TCGA-E2-A14Z-01A-11D-A111-01	bcf768ee-138c-42a4-a3bf-b8d509c644d9		TCGA-E2-A14Z-01	TCGA-E2-A14Z-01A-11R-A115-07	bcf768ee-138c-42a4-a3bf-b8d509c644d9	bcf768ee-138c-42a4-a3bf-b8d509c644d9	TCGA-E2-A14Z-01A-11D-A111-01	TCGA-E2-A14Z-01	TCGA-E2-A14Z-01	TCGA-E2-A14Z-01A-11D-A112-05	04dac9e1-f867-481c-aa21-5c17336af1fd	
TCGA-E2-A150-01	Stage IIA	48	1	Stage IIA	591		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	591	0	Basal	Basal-like	Negative	X	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A150-01	773	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	squamous c3	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-E2-A150	773	0	773	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A150-F18515		Negative					Negative	Lumpectomy		NO			-17580	506		0	773					NO	Allred score 0+0 = 0					Scheduled Follow-up Submission	2011-10-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	180	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3								NO	0		false	M0	N0	T2	Stage IIA	TCGA-E2-A150.5173DB84-EE23-4973-A244-4BB1D79325C9.pdf		1		0		2		0		0		13		85		90	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A150-01A-11D-A12B-09	TCGA-E2-A150-01	TCGA-E2-A150-01A-11R-A12C-13	TCGA-E2-A150-01A-11R-A12C-13	TCGA-E2-A150-01A-11D-A12B-09	c44ec1a9-cea5-46a0-b2c5-1686127fd1eb	TCGA-E2-A150-01A-11D-A12B-09	TCGA-E2-A150-01A-21-A13E-20	TCGA-E2-A150-01A-11D-A12B-09	46262a6c-8a11-4bb9-8851-8b6e44c95288	752855b4-0b2c-4e89-b11f-f4e52d40c45f	TCGA-E2-A150-01A-11D-A12A-01	46262a6c-8a11-4bb9-8851-8b6e44c95288		TCGA-E2-A150-01	TCGA-E2-A150-01A-11R-A12D-07	46262a6c-8a11-4bb9-8851-8b6e44c95288	46262a6c-8a11-4bb9-8851-8b6e44c95288	TCGA-E2-A150-01A-11D-A12A-01	TCGA-E2-A150-01	TCGA-E2-A150-01	TCGA-E2-A150-01A-11D-A12E-05	752855b4-0b2c-4e89-b11f-f4e52d40c45f	
TCGA-E2-A152-01	Stage I	56	1	Stage I	588		Positive	FEMALE	Positive	2	2	1	Negative	M0	Negative	N0	588	0	Her2	HER2-enriched	Negative	Her2	-1	-5	enrollment	T1	T1	LIVING	0	TCGA-E2-A152-01	825	0	High	C3-BRCA/Luminal	cluster 1	Cluster 5	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 8	TCGA-E2-A152	83	1	825	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO	NO		56	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-E2-A152-F19122		Positive					Negative	Lumpectomy		NO			-20705	484		0	825			83		NO						Scheduled Follow-up Submission	2011-11-17	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	140	NO	Positive			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	5				Bone	Distant Metastasis			YES	0		false	M0	N0	T1c	Stage I	TCGA-E2-A152.46EE72F9-2F59-413F-8278-7A073760F095.pdf		2		0		2		0		2		41		55		90	WITH TUMOR							YES	No			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A152-01A-11D-A12B-09	TCGA-E2-A152-01	TCGA-E2-A152-01A-11R-A12C-13	TCGA-E2-A152-01A-11R-A12C-13	TCGA-E2-A152-01A-11D-A12B-09	f726d427-03ec-4234-b1e1-fec426bb46ac	TCGA-E2-A152-01A-11D-A12B-09	TCGA-E2-A152-01A-21-A13E-20	TCGA-E2-A152-01A-11D-A12B-09	be8c1926-064b-4a2f-9345-e34f0dc78bff	01a1e8a0-51e3-400b-81dc-581a93199892	TCGA-E2-A152-01A-11D-A12A-01	be8c1926-064b-4a2f-9345-e34f0dc78bff		TCGA-E2-A152-01	TCGA-E2-A152-01A-11R-A12D-07	be8c1926-064b-4a2f-9345-e34f0dc78bff	be8c1926-064b-4a2f-9345-e34f0dc78bff	TCGA-E2-A152-01A-11D-A12A-01	TCGA-E2-A152-01	TCGA-E2-A152-01	TCGA-E2-A152-01A-11D-A12E-05	01a1e8a0-51e3-400b-81dc-581a93199892	
TCGA-E2-A153-01	Stage IIB	51	2	Stage IIA	586		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	586	0	LumA	Luminal A	Positive	LumA	-12	-3	enrollment	T1	T1	LIVING	0	TCGA-E2-A153-01	707	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E2-A153	707	0	707	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A153-F18945		Positive					Positive	Modified Radical Mastectomy		NO			-18875	475		0	707					NO						Scheduled Follow-up Submission	2011-11-8	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1		YES		Tumor resection	270	NO	Negative			15	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4								NO	3		false	M0	N1a	T1c	Stage IIB	TCGA-E2-A153.06D417E8-68C2-408C-8ABC-B3042566C976.pdf		2		4		0		1		0		40		60		60	TUMOR FREE							YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A153-01A-12D-A12B-09	TCGA-E2-A153-01	TCGA-E2-A153-01A-12R-A12C-13	TCGA-E2-A153-01A-12R-A12C-13	TCGA-E2-A153-01A-12D-A12B-09	e93fc765-47be-401c-bbbb-8b3e16ae7c65	TCGA-E2-A153-01A-12D-A12B-09	TCGA-E2-A153-01A-21-A13E-20	TCGA-E2-A153-01A-12D-A12B-09	be4b0243-555a-4e4b-94fb-af6ba60058d0	4fe0a5b3-cc20-4dc4-8d8a-6417866e392b	TCGA-E2-A153-01A-12D-A12A-01	be4b0243-555a-4e4b-94fb-af6ba60058d0		TCGA-E2-A153-01	TCGA-E2-A153-01A-12R-A12D-07	be4b0243-555a-4e4b-94fb-af6ba60058d0	be4b0243-555a-4e4b-94fb-af6ba60058d0	TCGA-E2-A153-01A-12D-A12A-01	TCGA-E2-A153-01	TCGA-E2-A153-01	TCGA-E2-A153-01A-12D-A12E-05	4fe0a5b3-cc20-4dc4-8d8a-6417866e392b	
TCGA-E2-A153-11		51			586			FEMALE									586	0	Normal						enrollment			LIVING	0	TCGA-E2-A153-11	707	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-E2-A153	707	0	707	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A153-F18945		Positive					Positive	Modified Radical Mastectomy		NO			-18875	475		0	707					NO						Scheduled Follow-up Submission	2011-11-8	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1		YES		Tumor resection	250	NO	Negative			15	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	3		false	M0	N1a	T1c	Stage IIB			3		2		0		1		15		85		0		0	TUMOR FREE							YES	No			YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast	A	LIVING	2009			TCGA-E2-A153-11A-31R-A12C-13	TCGA-E2-A153-11A-31R-A12C-13						b5ab3b76-36f6-45a7-acad-77288da0d13c			b5ab3b76-36f6-45a7-acad-77288da0d13c			TCGA-E2-A153-11A-31R-A12D-07	b5ab3b76-36f6-45a7-acad-77288da0d13c	b5ab3b76-36f6-45a7-acad-77288da0d13c				TCGA-E2-A153-11A-31D-A12E-05		
TCGA-E2-A154-01	Stage I	68	2	Stage I	325		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	325	0	LumA	Luminal A	Positive	LumA	-12	-3	enrollment	T1	T1	LIVING	0	TCGA-E2-A154-01	591	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-E2-A154	591	0	591	Breast	TCGA Breast Cancer	breast invasive carcinoma					68	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A154-F18940		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		NO			-24999	461		0	591					NO		90-99%				Scheduled Follow-up Submission	2011-11-8	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	400	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6								NO	0		false	M0	N0	T1c	Stage I	TCGA-E2-A154.8F8DCA87-B27A-429C-952A-186F8D4502AE.pdf		0		0		2		0		1		42		55		85	TUMOR FREE							YES	No	90-99%		YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A154-01A-11D-A10Y-09	TCGA-E2-A154-01	TCGA-E2-A154-01A-11R-A114-13	TCGA-E2-A154-01A-11R-A114-13	TCGA-E2-A154-01A-11D-A10Y-09	9f67c05d-d95e-4932-bace-78ee0cfbf304	TCGA-E2-A154-01A-11D-A10Y-09	TCGA-E2-A154-01A-21-A13E-20	TCGA-E2-A154-01A-11D-A10Y-09	81589acc-5dae-4cad-9f97-88b81fa53f92	38971878-2e49-4de3-be7c-e1ce5f1317b6	TCGA-E2-A154-01A-11D-A111-01	81589acc-5dae-4cad-9f97-88b81fa53f92		TCGA-E2-A154-01	TCGA-E2-A154-01A-11R-A115-07	81589acc-5dae-4cad-9f97-88b81fa53f92	81589acc-5dae-4cad-9f97-88b81fa53f92	TCGA-E2-A154-01A-11D-A111-01	TCGA-E2-A154-01	TCGA-E2-A154-01	TCGA-E2-A154-01A-11D-A112-05	38971878-2e49-4de3-be7c-e1ce5f1317b6	
TCGA-E2-A155-01	Stage IIB	58	1	Stage IIB	553		Positive	FEMALE	Negative	4	3	4	Negative	M0	Positive	N1	553	0	LumB	Luminal B	Negative	LumA/B	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A155-01	640	0	Kirc+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-E2-A155	640	0	640	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Left Upper Inner Quadrant|Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-E2-A155-F18942		Positive					Negative	Modified Radical Mastectomy		NO			-21348	457		0	640					NO						Scheduled Follow-up Submission	2011-11-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES		Tumor resection	280	NO	Negative			15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	5								NO	2		false	M0	N1a	T2	Stage IIB	TCGA-E2-A155.C3E398CE-1918-4107-948C-6579B1DA1F77.pdf		1		0		0		0		0		5		95		95	TUMOR FREE							YES	No			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A155-01A-11D-A12B-09	TCGA-E2-A155-01	TCGA-E2-A155-01A-11R-A12C-13	TCGA-E2-A155-01A-11R-A12C-13	TCGA-E2-A155-01A-11D-A12B-09	89f9e8d3-6526-4680-a393-c6b3b997599d	TCGA-E2-A155-01A-11D-A12B-09	TCGA-E2-A155-01A-21-A13E-20	TCGA-E2-A155-01A-11D-A12B-09	6a345a9e-8173-4c9e-972d-df0b154c97b0	e5ab2046-c8a8-4636-865c-c92d6b3da823	TCGA-E2-A155-01A-11D-A12A-01	6a345a9e-8173-4c9e-972d-df0b154c97b0		TCGA-E2-A155-01	TCGA-E2-A155-01A-11R-A12D-07	6a345a9e-8173-4c9e-972d-df0b154c97b0	6a345a9e-8173-4c9e-972d-df0b154c97b0	TCGA-E2-A155-01A-11D-A12A-01	TCGA-E2-A155-01	TCGA-E2-A155-01	TCGA-E2-A155-01A-11D-A12E-05	e5ab2046-c8a8-4636-865c-c92d6b3da823	
TCGA-E2-A156-01	Stage I	61	2	Stage I	481		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	481	0	LumA	Luminal A	Positive	LumA	-12	-3	enrollment	T1	T1	LIVING	0	TCGA-E2-A156-01	726	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-E2-A156	726	0	726	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Left	Sentinel node biopsy alone		TCGA-E2-A156-F18786		Positive					Positive	Lumpectomy		NO			-22422			0	726					NO						Scheduled Follow-up Submission	2011-11-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	0			M0	N0	T1c	Stage I																		TUMOR FREE							YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast		LIVING	2009	TCGA-E2-A156-01A-11D-A12B-09	TCGA-E2-A156-01	TCGA-E2-A156-01A-11R-A12C-13	TCGA-E2-A156-01A-11R-A12C-13	TCGA-E2-A156-01A-11D-A12B-09	eafe692c-6651-466b-a92c-1ed965eba047	TCGA-E2-A156-01A-11D-A12B-09	TCGA-E2-A156-01A-21-A13E-20	TCGA-E2-A156-01A-11D-A12B-09	b6ed3dfa-4d81-4e5c-9c1a-166894f92752	f0443dd8-df97-44bb-bc63-5667adfe093c	TCGA-E2-A156-01A-11D-A12A-01	b6ed3dfa-4d81-4e5c-9c1a-166894f92752		TCGA-E2-A156-01	TCGA-E2-A156-01A-11R-A12D-07	b6ed3dfa-4d81-4e5c-9c1a-166894f92752	b6ed3dfa-4d81-4e5c-9c1a-166894f92752	TCGA-E2-A156-01A-11D-A12A-01	TCGA-E2-A156-01	TCGA-E2-A156-01	TCGA-E2-A156-01A-11D-A12E-05	f0443dd8-df97-44bb-bc63-5667adfe093c	
TCGA-E2-A158-01	Stage IIA	43	1	Stage IIA	450		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	450	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T1	T1	LIVING	0	TCGA-E2-A158-01	450	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-E2-A158	450	0	450	Breast	TCGA Breast Cancer	breast invasive carcinoma					43	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A158-F18956		Negative					Negative	Simple Mastectomy		NO			-15903	436		0	450					NO	Allred score 0+0 = 0					Scheduled Follow-up Submission	2011-11-8	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	200	NO	Negative			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	5								NO	1		false	M0	N1mi	T1c	Stage IIA	TCGA-E2-A158.1CEBF20D-767A-4A19-AA41-B9EAFCF05176.pdf		2		1		3		1		0		17		80		80	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES	No			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A158-01A-11D-A12B-09	TCGA-E2-A158-01	TCGA-E2-A158-01A-11R-A12C-13	TCGA-E2-A158-01A-11R-A12C-13	TCGA-E2-A158-01A-11D-A12B-09	cc34e050-b748-413b-a5ec-064c216e98c3	TCGA-E2-A158-01A-11D-A12B-09	TCGA-E2-A158-01A-21-A13E-20	TCGA-E2-A158-01A-11D-A12B-09	43326f71-c61c-410b-af4b-c71a054e27c9	c75325af-6b3b-40b9-88a2-79754c120cae	TCGA-E2-A158-01A-11D-A12A-01	43326f71-c61c-410b-af4b-c71a054e27c9		TCGA-E2-A158-01	TCGA-E2-A158-01A-11R-A12D-07	43326f71-c61c-410b-af4b-c71a054e27c9	43326f71-c61c-410b-af4b-c71a054e27c9	TCGA-E2-A158-01A-11D-A12A-01	TCGA-E2-A158-01	TCGA-E2-A158-01	TCGA-E2-A158-01A-11D-A12E-05	c75325af-6b3b-40b9-88a2-79754c120cae	
TCGA-E2-A158-11		43			450			FEMALE									450	0	Normal						enrollment			LIVING	0	TCGA-E2-A158-11	450	0		C4-BRCA/Basal							mutation cluster 5	TCGA-E2-A158	450	0	450	Breast	TCGA Breast Cancer	breast invasive carcinoma					43	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A158-F18956		Negative					Negative	Simple Mastectomy		NO			-15903	436		0	450					NO	Allred score 0+0 = 0					Scheduled Follow-up Submission	2011-11-8	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	170	NO	Negative			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	1		false	M0	N1mi	T1c	Stage IIA			1		1		0		1		0		100		0		0	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES	No			NO	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast	A	LIVING	2009			TCGA-E2-A158-11A-22R-A12C-13	TCGA-E2-A158-11A-22R-A12C-13						5ba99650-56d2-4951-aa24-3d2fea3d1921			5ba99650-56d2-4951-aa24-3d2fea3d1921			TCGA-E2-A158-11A-22R-A12D-07	5ba99650-56d2-4951-aa24-3d2fea3d1921	5ba99650-56d2-4951-aa24-3d2fea3d1921				TCGA-E2-A158-11A-22D-A12E-05		
TCGA-E2-A159-01	Stage IIA	50	1	Stage IIA	515		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	515	0	Basal	Basal-like	Negative	Basal	-13	-10	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A159-01	762	0	High	C4-BRCA/Basal	cluster 5	Cluster 5	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-E2-A159	762	0	762	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A159-F19115		Negative					Negative	Lumpectomy		NO			-18621	434		0	762					NO	Allred score 0+0 = 0					Scheduled Follow-up Submission	2011-11-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.5		YES		Tumor resection	240	NO		Negative		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	3								NO	0		false	M0	N0	T2	Stage IIA	TCGA-E2-A159.7CA117DA-5D1C-4F8B-8330-5C58FE05DE36.pdf		3		2		0		1		0		20		80		80	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A159-01A-11D-A10Y-09	TCGA-E2-A159-01	TCGA-E2-A159-01A-11R-A114-13	TCGA-E2-A159-01A-11R-A114-13	TCGA-E2-A159-01A-11D-A10Y-09	c9662a04-c4e9-42c3-989f-cade253340dc	TCGA-E2-A159-01A-11D-A10Y-09	TCGA-E2-A159-01A-21-A13E-20	TCGA-E2-A159-01A-11D-A10Y-09	95c7abfa-a417-4d81-96c2-a952a081d997	c14c922b-4900-455a-8bf9-36021ff843aa	TCGA-E2-A159-01A-11D-A111-01	95c7abfa-a417-4d81-96c2-a952a081d997		TCGA-E2-A159-01	TCGA-E2-A159-01A-11R-A115-07	95c7abfa-a417-4d81-96c2-a952a081d997	95c7abfa-a417-4d81-96c2-a952a081d997	TCGA-E2-A159-01A-11D-A111-01	TCGA-E2-A159-01	TCGA-E2-A159-01	TCGA-E2-A159-01A-11D-A112-05	c14c922b-4900-455a-8bf9-36021ff843aa	
TCGA-E2-A15A-01	Stage IIIC	45	4	Stage IIIC	502		Positive	FEMALE	Negative	1	1	4	Negative	M0	Positive	N3	502	0	LumB	Luminal B	Positive	Her2	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15A-01	710	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A15A	710	0	710	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A15A-F18926		Positive					Positive	Simple Mastectomy		NO			-16750	426		0	710					NO						Scheduled Follow-up Submission	2011-11-10	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	330	NO	Negative			19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4								NO	13		false	M0	N3a	T2	Stage IIIC			3		0		1		0		1		23		75		90	TUMOR FREE							YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A15A-01A-11D-A12B-09	TCGA-E2-A15A-01	TCGA-E2-A15A-01A-11R-A12C-13	TCGA-E2-A15A-01A-11R-A12C-13	TCGA-E2-A15A-01A-11D-A12B-09	eee0fe49-2254-4347-b328-49a69bea7619	TCGA-E2-A15A-01A-11D-A12B-09		TCGA-E2-A15A-01A-11D-A12B-09	a4754430-f713-4aeb-998c-0f470a5549d1	42063455-e17c-42aa-a825-71b32c84437f	TCGA-E2-A15A-01A-11D-A12A-01	a4754430-f713-4aeb-998c-0f470a5549d1		TCGA-E2-A15A-01	TCGA-E2-A15A-01A-11R-A12D-07	a4754430-f713-4aeb-998c-0f470a5549d1	a4754430-f713-4aeb-998c-0f470a5549d1	TCGA-E2-A15A-01A-11D-A12A-01	TCGA-E2-A15A-01	TCGA-E2-A15A-01	TCGA-E2-A15A-01A-11D-A12E-05	42063455-e17c-42aa-a825-71b32c84437f	
TCGA-E2-A15A-06		45			502			FEMALE									502	0	LumB						enrollment			LIVING	0	TCGA-E2-A15A-06	710	0		C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A15A	710	0	710	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A15A-F18926		Positive					Positive	Simple Mastectomy		NO			-16750	426		0	710					NO						Scheduled Follow-up Submission	2011-11-10	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	120	NO	Negative			19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	13		false	M0	N3a	T2	Stage IIIC	TCGA-E2-A15A.3687AF42-4BB3-46E2-8091-E0C5C84F15E6.pdf		15		0		0		0		15		25		60		70	TUMOR FREE							YES	No			YES	Metastatic	06		6th	YES	NO	YES	E2	Breast	A	LIVING	2009			TCGA-E2-A15A-06A-11R-A12C-13	TCGA-E2-A15A-06A-11R-A12C-13			TCGA-E2-A15A-06A-11D-A12B-09	TCGA-E2-A15A-06A-21-A24B-20	TCGA-E2-A15A-06A-11D-A12B-09	e55bc0c9-ee0f-4efb-8024-3baed3c24080	8444c824-a5d8-4d12-a94e-10875f0bbc4e		e55bc0c9-ee0f-4efb-8024-3baed3c24080			TCGA-E2-A15A-06A-11R-A12D-07	e55bc0c9-ee0f-4efb-8024-3baed3c24080	e55bc0c9-ee0f-4efb-8024-3baed3c24080				TCGA-E2-A15A-06A-11D-A12E-05	8444c824-a5d8-4d12-a94e-10875f0bbc4e	
TCGA-E2-A15C-01	Stage I	61	4	Stage I	496		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	496	0	LumA	Luminal A	Positive	ReacI	-5	-4	enrollment	T1	T1	LIVING	0	TCGA-E2-A15C-01	694	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-E2-A15C	694	0	694	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15C-F18935		Positive					Positive	Lumpectomy		NO			-22583	393		0	694					NO						Scheduled Follow-up Submission	2011-11-9	FEMALE			20-29%		2+			1.02		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	200	NO	Equivocal	Negative		4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	0		false	M0	N0	T1c	Stage I	TCGA-E2-A15C.04FF2CF1-737B-4FD2-8A1D-F9B5488DE510.pdf		0		0		0		0		0		0		100		80	TUMOR FREE							YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A15C-01A-31D-A12B-09	TCGA-E2-A15C-01	TCGA-E2-A15C-01A-31R-A12C-13	TCGA-E2-A15C-01A-31R-A12C-13	TCGA-E2-A15C-01A-31D-A12B-09	b003e078-2c0b-42bc-ad2e-adb171765c57	TCGA-E2-A15C-01A-31D-A12B-09	TCGA-E2-A15C-01A-21-A13E-20	TCGA-E2-A15C-01A-31D-A12B-09	1a77082d-f130-436b-9028-23c8dd9dc565	42eb6aaf-02b1-4f22-b5d2-7c871ca4d516	TCGA-E2-A15C-01A-31D-A12A-01	1a77082d-f130-436b-9028-23c8dd9dc565		TCGA-E2-A15C-01	TCGA-E2-A15C-01A-31R-A12D-07	1a77082d-f130-436b-9028-23c8dd9dc565	1a77082d-f130-436b-9028-23c8dd9dc565	TCGA-E2-A15C-01A-31D-A12A-01	TCGA-E2-A15C-01	TCGA-E2-A15C-01	TCGA-E2-A15C-01A-31D-A12E-05	42eb6aaf-02b1-4f22-b5d2-7c871ca4d516	
TCGA-E2-A15D-01	Stage IIA	47		Stage IIA	315		Positive	FEMALE	Negative				Negative	M0	Negative	N0	315	0	LumA	Luminal A	Positive	LumA	-5	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15D-01	526	0		C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A15D	526	0	526	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Right	Sentinel node biopsy alone		TCGA-E2-A15D-F18783		Positive					Positive	Lumpectomy		NO			-17224	393		0	526					NO						Scheduled Follow-up Submission	2011-11-9	FEMALE					2+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	330	NO	Equivocal	Negative		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4								NO	0		false	M0	N0	T2	Stage IIA	TCGA-E2-A15D.1FE4EB4C-FEF8-486A-B39D-6F9F023FDAC4.pdf		2		0		0		0		5		60		35		70	TUMOR FREE				Allred score = 8	Allred score = 8		YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A15D-01A-11D-A10Y-09	TCGA-E2-A15D-01	TCGA-E2-A15D-01A-11R-A114-13	TCGA-E2-A15D-01A-11R-A114-13	TCGA-E2-A15D-01A-11D-A10Y-09	0a257700-c228-4e46-9b2d-af39db001515	TCGA-E2-A15D-01A-11D-A10Y-09	TCGA-E2-A15D-01A-21-A13E-20	TCGA-E2-A15D-01A-11D-A10Y-09	b58514d7-7785-497d-ba94-165ee0a1b941	7266b08c-75d0-4307-9852-73fc482f5644	TCGA-E2-A15D-01A-11D-A111-01	b58514d7-7785-497d-ba94-165ee0a1b941		TCGA-E2-A15D-01	TCGA-E2-A15D-01A-11R-A115-07	b58514d7-7785-497d-ba94-165ee0a1b941	b58514d7-7785-497d-ba94-165ee0a1b941	TCGA-E2-A15D-01A-11D-A111-01	TCGA-E2-A15D-01	TCGA-E2-A15D-01	TCGA-E2-A15D-01A-11D-A112-05	7266b08c-75d0-4307-9852-73fc482f5644	
TCGA-E2-A15E-01	Stage IIA	40	4	Stage IIA	517		Positive	FEMALE	Positive	3	4	3	Negative	M0	Positive	N1	517	0	LumA	Luminal A	Positive	Her2	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-E2-A15E-01	630	0	Squamous	C3-BRCA/Luminal	cluster 2	Low purity c2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 3	TCGA-E2-A15E	630	0	630	Breast	TCGA Breast Cancer	breast invasive carcinoma					40	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A15E-F18919		Positive					Positive	Lumpectomy		NO			-14894	387		0	630					NO	Allred score 5+3 = 8					Scheduled Follow-up Submission	2011-11-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.3		YES		Tumor resection	520	NO		Positive		9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6								NO	1		false	M0	N1a	T1c	Stage IIA			2		0		1		0		30		44		25		60	TUMOR FREE	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A15E-01A-11D-A12B-09	TCGA-E2-A15E-01	TCGA-E2-A15E-01A-11R-A12C-13	TCGA-E2-A15E-01A-11R-A12C-13	TCGA-E2-A15E-01A-11D-A12B-09	d0c1fe33-e7c4-4705-9a97-1520151d4ffb	TCGA-E2-A15E-01A-11D-A12B-09	TCGA-E2-A15E-01A-21-A13E-20	TCGA-E2-A15E-01A-11D-A12B-09	42ba8e87-8d37-4cbd-82f0-bca0cbe5dcd3	1c91adc5-4b1d-49e0-b2d3-eb6191a80f8f	TCGA-E2-A15E-01A-11D-A12A-01	42ba8e87-8d37-4cbd-82f0-bca0cbe5dcd3		TCGA-E2-A15E-01	TCGA-E2-A15E-01A-11R-A12D-07	42ba8e87-8d37-4cbd-82f0-bca0cbe5dcd3	42ba8e87-8d37-4cbd-82f0-bca0cbe5dcd3	TCGA-E2-A15E-01A-11D-A12A-01	TCGA-E2-A15E-01	TCGA-E2-A15E-01	TCGA-E2-A15E-01A-11D-A12E-05	1c91adc5-4b1d-49e0-b2d3-eb6191a80f8f	
TCGA-E2-A15E-06		40			517			FEMALE									517	0	LumA						enrollment			LIVING	0	TCGA-E2-A15E-06	630	0		C3-BRCA/Luminal	cluster 2	Low purity c2		BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 3	TCGA-E2-A15E	630	0	630	Breast	TCGA Breast Cancer	breast invasive carcinoma					40	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A15E-F18919		Positive					Positive	Lumpectomy		NO			-14894	387		0	630					NO	Allred score 5+3 = 8					Scheduled Follow-up Submission	2011-11-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.3		YES		Tumor resection	60	NO		Positive		9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	1		false	M0	N1a	T1c	Stage IIA	TCGA-E2-A15E.57341F00-74F5-4015-B6D4-7BDED33F35A7.pdf		10		0		0		0		10		5		85		90	TUMOR FREE	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		YES	No			YES	Metastatic	06		6th	YES	NO	YES	E2	Breast	A	LIVING	2009			TCGA-E2-A15E-06A-11R-A12C-13	TCGA-E2-A15E-06A-11R-A12C-13			TCGA-E2-A15E-06A-11D-A12B-09		TCGA-E2-A15E-06A-11D-A12B-09	8131b824-c3db-4c83-99b9-aa0c60747c5d	6c2fdfa7-33a8-462e-9d27-8ed7079938d7		8131b824-c3db-4c83-99b9-aa0c60747c5d			TCGA-E2-A15E-06A-11R-A12D-07	8131b824-c3db-4c83-99b9-aa0c60747c5d	8131b824-c3db-4c83-99b9-aa0c60747c5d				TCGA-E2-A15E-06A-11D-A12E-05	6c2fdfa7-33a8-462e-9d27-8ed7079938d7	
TCGA-E2-A15F-01	Stage I	64		Stage IIA	468		Positive	FEMALE	Negative				Negative	M0	Negative	N0	468	0		Luminal A	Positive	ReacI	-3	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15F-01	658	0			cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A15F	658	0	658	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15F-F18906		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		NO			-23660	360		0	658					NO		90-99%				Scheduled Follow-up Submission	2011-11-10	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4	3+	YES		Tumor resection	190	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4								NO	0		false	M0	N0	T1c	Stage I	TCGA-E2-A15F.19360B66-C514-4EE1-ACD7-08873828133E.pdf		2		1		1		1		2		27		70		70	TUMOR FREE							YES	No	90-99%		YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A15F-01A-11D-A10Y-09	TCGA-E2-A15F-01	TCGA-E2-A15F-01A-11R-A114-13	TCGA-E2-A15F-01A-11R-A114-13		3d2f1976-cf0a-4cab-817a-92301b6d9275	TCGA-E2-A15F-01A-11D-A10Y-09	TCGA-E2-A15F-01A-21-A13E-20	TCGA-E2-A15F-01A-11D-A10Y-09	2e41bc6a-bece-4b6d-a646-be9b98707bba	4df297a3-8822-4df2-b0ef-77279e053b32	TCGA-E2-A15F-01A-11D-A111-01	2e41bc6a-bece-4b6d-a646-be9b98707bba		TCGA-E2-A15F-01	TCGA-E2-A15F-01A-11R-A115-07	2e41bc6a-bece-4b6d-a646-be9b98707bba	2e41bc6a-bece-4b6d-a646-be9b98707bba	TCGA-E2-A15F-01A-11D-A111-01	TCGA-E2-A15F-01	TCGA-E2-A15F-01	TCGA-E2-A15F-01A-11D-A112-05	4df297a3-8822-4df2-b0ef-77279e053b32	
TCGA-E2-A15G-01	Stage IIA	76	2	Stage IIA	315		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	315	0	LumA	Luminal A	Positive	LumA	-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15G-01	554	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 1	mutation cluster 4	TCGA-E2-A15G	554	0	554	Breast	TCGA Breast Cancer	breast invasive carcinoma					76	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15G-F18901		Positive					Positive	Lumpectomy		NO			-28013	358		0	554					NO						Scheduled Follow-up Submission	2011-11-14	FEMALE					1+					Mixed Histology (please specify)	Invasive ductal and lobular carcinoma	No		C50.9	8522/3	C50.4		YES		Tumor resection	110	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	1								NO	0		false	M0	N0	T2	Stage IIA	TCGA-E2-A15G.DD9FDF3B-29CA-4D11-8615-E2EEB5D601D1.pdf		2		1		0		1		0		20		80		80	TUMOR FREE				Allred score = 8	Allred score = 8		YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A15G-01A-11D-A12B-09	TCGA-E2-A15G-01	TCGA-E2-A15G-01A-11R-A12C-13	TCGA-E2-A15G-01A-11R-A12C-13	TCGA-E2-A15G-01A-11D-A12B-09	1af0a946-026d-4dbb-b52d-db12449e4c31	TCGA-E2-A15G-01A-11D-A12B-09	TCGA-E2-A15G-01A-21-A13E-20	TCGA-E2-A15G-01A-11D-A12B-09	a88e6892-93fe-451f-9b7e-f6fe260ba9af	d0f71973-7cb2-4541-a0df-6e608af68899	TCGA-E2-A15G-01A-11D-A12A-01	a88e6892-93fe-451f-9b7e-f6fe260ba9af		TCGA-E2-A15G-01	TCGA-E2-A15G-01A-11R-A12D-07	a88e6892-93fe-451f-9b7e-f6fe260ba9af	a88e6892-93fe-451f-9b7e-f6fe260ba9af	TCGA-E2-A15G-01A-11D-A12A-01	TCGA-E2-A15G-01	TCGA-E2-A15G-01	TCGA-E2-A15G-01A-11D-A12E-05	d0f71973-7cb2-4541-a0df-6e608af68899	
TCGA-E2-A15H-01	Stage IIA	38	2	Stage IIA	42		Positive	FEMALE	Positive	3	1	3	Negative	M0	Positive	N1	42	0	LumA	Luminal A	Positive	Her2	0	0	enrollment	T1	T1	LIVING	0	TCGA-E2-A15H-01	393	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A15H	393	0	393	Breast	TCGA Breast Cancer	breast invasive carcinoma					38	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15H-F18916		Positive					Positive	Lumpectomy		NO			-13985	357		0	393					NO						Scheduled Follow-up Submission	2011-11-14	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	90	NO	Equivocal	Positive		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	4								NO	1		false	M0	N1mi	T1c	Stage IIA	TCGA-E2-A15H.E4D1A7DC-62B1-44D8-A747-5A19842C6F69.pdf		2		1		2		1		1		22		75		75	TUMOR FREE				Allred score = 8	Allred Score = 7		YES	No			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A15H-01A-11D-A12B-09	TCGA-E2-A15H-01	TCGA-E2-A15H-01A-11R-A12C-13	TCGA-E2-A15H-01A-11R-A12C-13	TCGA-E2-A15H-01A-11D-A12B-09	f381f799-7861-47be-b54f-26a1e5236887	TCGA-E2-A15H-01A-11D-A12B-09	TCGA-E2-A15H-01A-21-A13E-20	TCGA-E2-A15H-01A-11D-A12B-09	75b2227e-0279-4dfb-a1a1-e64c53b48d7a	b23312bc-ad6f-4e38-83e3-c7459ceaf7bc	TCGA-E2-A15H-01A-11D-A12A-01	75b2227e-0279-4dfb-a1a1-e64c53b48d7a		TCGA-E2-A15H-01	TCGA-E2-A15H-01A-11R-A12D-07	75b2227e-0279-4dfb-a1a1-e64c53b48d7a	75b2227e-0279-4dfb-a1a1-e64c53b48d7a	TCGA-E2-A15H-01A-11D-A12A-01	TCGA-E2-A15H-01	TCGA-E2-A15H-01	TCGA-E2-A15H-01A-11D-A12E-05	b23312bc-ad6f-4e38-83e3-c7459ceaf7bc	
TCGA-E2-A15I-01	Stage IIA	44	2	Stage IIA	411		Positive	FEMALE	Negative				Negative	M0	Negative	N0	411	0	LumA	Luminal A	Positive		-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15I-01	530	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-E2-A15I	530	0	530	Breast	TCGA Breast Cancer	breast invasive carcinoma					44	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15I-F18888		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		NO			-16163	344		0	530					NO		90-99%				Scheduled Follow-up Submission	2011-11-14	FEMALE					2+			1.04		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	100	NO	Equivocal	Negative		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	7								NO	0		false	M0	N0	T2	Stage IIA	TCGA-E2-A15I.FE41053B-16F4-46B0-B243-571F4D5A1665.pdf		2		1		0		1		1		19		80		80	TUMOR FREE							YES	No	90-99%		NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A15I-01A-21D-A135-09	TCGA-E2-A15I-01	TCGA-E2-A15I-01A-21R-A136-13	TCGA-E2-A15I-01A-21R-A136-13	TCGA-E2-A15I-01A-21D-A135-09		TCGA-E2-A15I-01A-21D-A135-09	TCGA-E2-A15I-01A-11-A17I-20	TCGA-E2-A15I-01A-21D-A135-09	4f3a68ee-00c8-44bd-b9d6-f3fa6dc4084c	db6a187b-083a-4f71-9d8b-f08b5f208d7e	TCGA-E2-A15I-01A-21D-A134-01	4f3a68ee-00c8-44bd-b9d6-f3fa6dc4084c	TCGA-E2-A15I-01A-21D-A138-05	TCGA-E2-A15I-01	TCGA-E2-A15I-01A-21R-A137-07	4f3a68ee-00c8-44bd-b9d6-f3fa6dc4084c	4f3a68ee-00c8-44bd-b9d6-f3fa6dc4084c	TCGA-E2-A15I-01A-21D-A134-01	TCGA-E2-A15I-01	TCGA-E2-A15I-01		db6a187b-083a-4f71-9d8b-f08b5f208d7e	
TCGA-E2-A15I-11		44			411			FEMALE									411	0	Normal						enrollment			LIVING	0	TCGA-E2-A15I-11	530	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-E2-A15I	530	0	530	Breast	TCGA Breast Cancer	breast invasive carcinoma					44	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15I-F18888		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		NO			-16163	344		0	530					NO		90-99%				Scheduled Follow-up Submission	2011-11-14	FEMALE					2+			1.04		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	230	NO	Equivocal	Negative		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0		false	M0	N0	T2	Stage IIA			2		0		0		0		5		95		0		0	TUMOR FREE							YES	No	90-99%		NO	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast	A	LIVING	2009			TCGA-E2-A15I-11A-32R-A136-13	TCGA-E2-A15I-11A-32R-A136-13						f9df2254-ab08-4ab2-9b86-ed40e6c8a4b9			f9df2254-ab08-4ab2-9b86-ed40e6c8a4b9	TCGA-E2-A15I-11A-32D-A138-05		TCGA-E2-A15I-11A-32R-A137-07	f9df2254-ab08-4ab2-9b86-ed40e6c8a4b9	f9df2254-ab08-4ab2-9b86-ed40e6c8a4b9						
TCGA-E2-A15J-01	Stage I	51	2	Stage I	463		Positive	FEMALE	Negative	1	3	3	Negative	M0	Negative	N0	463	0	LumA	Luminal A	Positive	LumA/B	-12	-3	enrollment	T1	T1	LIVING	0	TCGA-E2-A15J-01	590	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A15J	590	0	590	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15J-F18892		Positive					Positive	Simple Mastectomy		NO			-18771	344		0	590					NO						Scheduled Follow-up Submission	2011-11-15	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	210	NO	Equivocal	Negative		12	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4								NO	0		false	M0	N0	T1c	Stage I	TCGA-E2-A15J.352BF6A2-974B-440E-BB0B-DCD79874DAC3.pdf		2		1		2		1		0		18		80		80	TUMOR FREE				Allred score = 8	Allred score = 7		YES	No			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A15J-01A-11D-A12Q-09	TCGA-E2-A15J-01	TCGA-E2-A15J-01A-11R-A12O-13	TCGA-E2-A15J-01A-11R-A12O-13	TCGA-E2-A15J-01A-11D-A12Q-09	ffe06b3a-f290-463c-bb0e-994c0679f8be	TCGA-E2-A15J-01A-11D-A12Q-09	TCGA-E2-A15J-01A-21-A13E-20	TCGA-E2-A15J-01A-11D-A12Q-09	376c13fa-ba3e-4f2e-a8bc-87fb70541239	61104111-09d5-417b-9ca6-d53fb28bafec	TCGA-E2-A15J-01A-11D-A12N-01	376c13fa-ba3e-4f2e-a8bc-87fb70541239	TCGA-E2-A15J-01A-11D-A12R-05	TCGA-E2-A15J-01	TCGA-E2-A15J-01A-11R-A12P-07	376c13fa-ba3e-4f2e-a8bc-87fb70541239	376c13fa-ba3e-4f2e-a8bc-87fb70541239	TCGA-E2-A15J-01A-11D-A12N-01	TCGA-E2-A15J-01	TCGA-E2-A15J-01		61104111-09d5-417b-9ca6-d53fb28bafec	
TCGA-E2-A15K-01	Stage IIA	58	2	Stage IIB	34		Positive	FEMALE	Negative	3	3	4	Negative	M0	Positive	N1	34	0	LumB	Luminal B	Positive	LumA	-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15K-01	275	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E2-A15K	275	0	275	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A15K-F18869		Positive					Positive	Lumpectomy		NO			-21514	309		0	275					NO	Allred score 5+3 = 8					Scheduled Follow-up Submission	2011-11-15	FEMALE			10-19%		2+			0.9		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	170	NO	Equivocal	Negative		17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4								NO	2		false	M0	N1a	T2	Stage IIA			2		0		0		0		0		10		90		90	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 8		YES	No			YES	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	TCGA-E2-A15K-01A-11D-A12Q-09	TCGA-E2-A15K-01	TCGA-E2-A15K-01A-11R-A12O-13	TCGA-E2-A15K-01A-11R-A12O-13	TCGA-E2-A15K-01A-11D-A12Q-09	1afef343-eb28-46d1-ba40-2475188b33c5	TCGA-E2-A15K-01A-11D-A12Q-09		TCGA-E2-A15K-01A-11D-A12Q-09	141e15ac-1537-4182-9db5-ba2115cd93d6	b41bd6ce-5113-4a6f-86d8-17c45406b1ac	TCGA-E2-A15K-01A-11D-A12N-01	141e15ac-1537-4182-9db5-ba2115cd93d6	TCGA-E2-A15K-01A-11D-A12R-05	TCGA-E2-A15K-01	TCGA-E2-A15K-01A-11R-A12P-07	141e15ac-1537-4182-9db5-ba2115cd93d6	141e15ac-1537-4182-9db5-ba2115cd93d6	TCGA-E2-A15K-01A-11D-A12N-01	TCGA-E2-A15K-01	TCGA-E2-A15K-01		b41bd6ce-5113-4a6f-86d8-17c45406b1ac	
TCGA-E2-A15K-06		58			34			FEMALE									34	0	LumB						enrollment			LIVING	0	TCGA-E2-A15K-06	275	0		C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-E2-A15K	275	0	275	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A15K-F18869		Positive					Positive	Lumpectomy		NO			-21514	309		0	275					NO	Allred score 5+3 = 8					Scheduled Follow-up Submission	2011-11-15	FEMALE			10-19%		2+			0.9		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	280	NO	Equivocal	Negative		17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	2		false	M0	N1a	T2	Stage IIA	TCGA-E2-A15K.72FE0659-6B7E-4129-B61D-C376C59C428F.pdf		1		0		0		0		0		5		95		95	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 8		YES	No			YES	Metastatic	06		7th	YES	NO	YES	E2	Breast	A	LIVING	2010			TCGA-E2-A15K-06A-11R-A12O-13	TCGA-E2-A15K-06A-11R-A12O-13			TCGA-E2-A15K-06A-11D-A12Q-09	TCGA-E2-A15K-06A-21-A24B-20	TCGA-E2-A15K-06A-11D-A12Q-09	69f0bc59-c026-40e2-a3b6-88fcde091a82	7513e337-00ae-48cc-8be4-a62fa39602b9		69f0bc59-c026-40e2-a3b6-88fcde091a82	TCGA-E2-A15K-06A-11D-A12R-05		TCGA-E2-A15K-06A-11R-A12P-07	69f0bc59-c026-40e2-a3b6-88fcde091a82	69f0bc59-c026-40e2-a3b6-88fcde091a82					7513e337-00ae-48cc-8be4-a62fa39602b9	
TCGA-E2-A15K-11		58			34			FEMALE									34	0							enrollment			LIVING	0	TCGA-E2-A15K-11	275	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-E2-A15K	275	0	275	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A15K-F18869		Positive					Positive	Lumpectomy		NO			-21514	309		0	275					NO	Allred score 5+3 = 8					Scheduled Follow-up Submission	2011-11-15	FEMALE			10-19%		2+			0.9		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	120	NO	Equivocal	Negative		17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	2		false	M0	N1a	T2	Stage IIA			2		0		0		0		2		98		0		0	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 8		YES	No			YES	Solid Tissue Normal	11		7th	YES	NO	YES	E2	Breast	A	LIVING	2010			TCGA-E2-A15K-11A-13R-A12O-13	TCGA-E2-A15K-11A-13R-A12O-13						49a33b4d-4b1e-4b30-b0ba-a7c7d594db41			49a33b4d-4b1e-4b30-b0ba-a7c7d594db41	TCGA-E2-A15K-11A-13D-A12R-05			49a33b4d-4b1e-4b30-b0ba-a7c7d594db41	49a33b4d-4b1e-4b30-b0ba-a7c7d594db41						
TCGA-E2-A15L-01	Stage IIA	65	2	Stage IIA	331		Positive	FEMALE	Negative				Negative	M0	Negative	N0	331	0	LumA	Luminal B	Positive	ReacI	-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15L-01	626	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7			mutation cluster 4	TCGA-E2-A15L	626	0	626	Breast	TCGA Breast Cancer	breast invasive carcinoma					65	Right	Sentinel node biopsy alone		TCGA-E2-A15L-F18885		Positive					Positive	Simple Mastectomy		NO			-23845	289		0	626					NO	Allred score 5+3 = 8					Scheduled Follow-up Submission	2011-11-15	FEMALE			30-39%		2+			0.9		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	240	NO	Equivocal	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2									NO	0		false	M0	N0	T2	Stage IIA	TCGA-E2-A15L.C04B3267-9833-44D6-8C3D-45D7F829C38C.pdf		2		1		0		0		0		20		80		80	TUMOR FREE	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		YES	No			NO	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	TCGA-E2-A15L-01A-11D-A12B-09	TCGA-E2-A15L-01	TCGA-E2-A15L-01A-11R-A12C-13	TCGA-E2-A15L-01A-11R-A12C-13	TCGA-E2-A15L-01A-11D-A12B-09	bf925eb7-7a5b-44b2-9ace-627782f168c3	TCGA-E2-A15L-01A-11D-A12B-09	TCGA-E2-A15L-01A-21-A13E-20	TCGA-E2-A15L-01A-11D-A12B-09	68a4bd03-2b97-4387-926f-c9d25fac8d29	e96765f9-45a3-446f-924a-45202dd4b7db	TCGA-E2-A15L-01A-11D-A12A-01	68a4bd03-2b97-4387-926f-c9d25fac8d29		TCGA-E2-A15L-01	TCGA-E2-A15L-01A-11R-A12D-07	68a4bd03-2b97-4387-926f-c9d25fac8d29	68a4bd03-2b97-4387-926f-c9d25fac8d29	TCGA-E2-A15L-01A-11D-A12A-01	TCGA-E2-A15L-01	TCGA-E2-A15L-01	TCGA-E2-A15L-01A-11D-A12E-05	e96765f9-45a3-446f-924a-45202dd4b7db	
TCGA-E2-A15L-11		65			331			FEMALE									331	0							enrollment			LIVING	0	TCGA-E2-A15L-11	626	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-E2-A15L	626	0	626	Breast	TCGA Breast Cancer	breast invasive carcinoma					65	Right	Sentinel node biopsy alone		TCGA-E2-A15L-F18885		Positive					Positive	Simple Mastectomy		NO			-23845	289		0	626					NO	Allred score 5+3 = 8					Scheduled Follow-up Submission	2011-11-15	FEMALE			30-39%		2+			0.9		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	210	NO	Equivocal	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T2	Stage IIA			1		0		0		0		0		100		0		0	TUMOR FREE	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		YES	No			NO	Solid Tissue Normal	11		7th	YES	NO	YES	E2	Breast	A	LIVING	2010																						TCGA-E2-A15L-11A-31D-A12E-05		
TCGA-E2-A15M-01	Stage IIA	66	3	Stage IIA	234		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	234	0	LumA	Luminal B	Positive	ReacI	-4	-4	enrollment	T_Other	T2	LIVING	1	TCGA-E2-A15M-01	336	1	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 5	TCGA-E2-A15M	336	0	336	Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15M-F18852		Positive					Positive	Lumpectomy		NO			-24266	287	336	0	235					NO						Scheduled Follow-up Submission	2011-11-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.5		YES		Tumor resection	270	NO	Negative			5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6								NO	0		false	M0	N0	T2	Stage IIA	TCGA-E2-A15M.51601F8B-BA50-42C4-B0C9-B3581F80CD2C.pdf		6		0		1		0		0		34		65		80	TUMOR FREE				Allred score = 8	Allred score = 8		YES	No			YES	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	DECEASED	2010	TCGA-E2-A15M-01A-11D-A12B-09	TCGA-E2-A15M-01	TCGA-E2-A15M-01A-11R-A12C-13	TCGA-E2-A15M-01A-11R-A12C-13	TCGA-E2-A15M-01A-11D-A12B-09	52e4ab39-3d51-4623-a65a-09a99017e96b	TCGA-E2-A15M-01A-11D-A12B-09	TCGA-E2-A15M-01A-21-A13E-20	TCGA-E2-A15M-01A-11D-A12B-09	e596b149-e807-4d29-b0fa-685f07efb9d6	597cc060-51ba-447d-b17e-a454e38cf00b	TCGA-E2-A15M-01A-11D-A12A-01	e596b149-e807-4d29-b0fa-685f07efb9d6		TCGA-E2-A15M-01	TCGA-E2-A15M-01A-11R-A12D-07	e596b149-e807-4d29-b0fa-685f07efb9d6	e596b149-e807-4d29-b0fa-685f07efb9d6	TCGA-E2-A15M-01A-11D-A12A-01	TCGA-E2-A15M-01	TCGA-E2-A15M-01	TCGA-E2-A15M-01A-11D-A12E-05	597cc060-51ba-447d-b17e-a454e38cf00b	
TCGA-E2-A15M-11		66			234			FEMALE									234	0	Normal						enrollment			LIVING	1	TCGA-E2-A15M-11	336	1		C3-BRCA/Luminal							mutation cluster 5	TCGA-E2-A15M	336	0	336	Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15M-F18852		Positive					Positive	Lumpectomy		NO			-24266	287	336	0	235					NO						Scheduled Follow-up Submission	2011-11-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.5		YES		Tumor resection	160	NO	Negative			5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T2	Stage IIA			0		0		0		0		0		100		0		0	TUMOR FREE				Allred score = 8	Allred score = 8		YES	No			YES	Solid Tissue Normal	11		7th	YES	NO	YES	E2	Breast	A	DECEASED	2010			TCGA-E2-A15M-11A-22R-A12C-13	TCGA-E2-A15M-11A-22R-A12C-13						f75e5efb-056f-40bf-afed-33d971478ca4			f75e5efb-056f-40bf-afed-33d971478ca4			TCGA-E2-A15M-11A-22R-A12D-07	f75e5efb-056f-40bf-afed-33d971478ca4	f75e5efb-056f-40bf-afed-33d971478ca4				TCGA-E2-A15M-11A-22D-A12E-05		
TCGA-E2-A15O-01	Stage I	89	4	Stage IIA	395		Positive	FEMALE	Negative	1	3	3	Negative	M0	Negative	N0	395	0	LumA	Luminal A	Positive	LumA	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15O-01	396	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-E2-A15O	396	0	396	Breast	TCGA Breast Cancer	breast invasive carcinoma					89	Left Upper Inner Quadrant	No axillary staging		TCGA-E2-A15O-F19165		Positive					Positive	Lumpectomy		NO			-32583	273		0	396					NO	Allred score 5+2 = 7					Scheduled Follow-up Submission	2011-11-16	FEMALE			10-19%		2+			0.9		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	110	NO	Equivocal	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO			false	M0	NX	T1c	Stage I	TCGA-E2-A15O.AA4B6E2D-7503-4E51-BEA4-632CC994770A.pdf		0		0		0		0		5		5		90		95	TUMOR FREE	Allred score 4+3 = 7			Allred score = 7	Allred score = 7		NO	Yes			NO	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	TCGA-E2-A15O-01A-11D-A10Y-09	TCGA-E2-A15O-01	TCGA-E2-A15O-01A-11R-A114-13	TCGA-E2-A15O-01A-11R-A114-13	TCGA-E2-A15O-01A-11D-A10Y-09	538d33c5-6bc8-4cda-950b-93c16e500d48	TCGA-E2-A15O-01A-11D-A10Y-09	TCGA-E2-A15O-01A-21-A13E-20	TCGA-E2-A15O-01A-11D-A10Y-09	4a28ecf3-c70e-42d0-918b-866d11804c13	61a71ac8-5aad-4b2d-b931-57d347210540	TCGA-E2-A15O-01A-11D-A111-01	4a28ecf3-c70e-42d0-918b-866d11804c13		TCGA-E2-A15O-01	TCGA-E2-A15O-01A-11R-A115-07	4a28ecf3-c70e-42d0-918b-866d11804c13	4a28ecf3-c70e-42d0-918b-866d11804c13	TCGA-E2-A15O-01A-11D-A111-01	TCGA-E2-A15O-01	TCGA-E2-A15O-01	TCGA-E2-A15O-01A-11D-A112-05	61a71ac8-5aad-4b2d-b931-57d347210540	
TCGA-E2-A15P-01	Stage IA	61	2	Stage I	315		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	315	0	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-E2-A15P-01	595	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-E2-A15P	595	0	595	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15P-F19144		Positive					Positive	Lumpectomy		NO			-22524	269		0	595					NO	Allred score 5+3 = 8					Scheduled Follow-up Submission	2011-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	110	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	0		false	M0	N0	T1c	Stage IA	TCGA-E2-A15P.8C7442C0-540C-4023-BBFA-8482935259A7.pdf		0		0		0		0		10		10		80		70	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 8		YES	No			YES	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	TCGA-E2-A15P-01A-11D-A10Y-09	TCGA-E2-A15P-01	TCGA-E2-A15P-01A-11R-A114-13	TCGA-E2-A15P-01A-11R-A114-13	TCGA-E2-A15P-01A-11D-A10Y-09	776d3800-9f60-4eb4-930c-8bb036607730	TCGA-E2-A15P-01A-11D-A10Y-09	TCGA-E2-A15P-01A-21-A13E-20	TCGA-E2-A15P-01A-11D-A10Y-09	61c279ee-777a-4c05-bc38-e1a9183faaff	2bdfaad7-f202-4d89-a8f6-a55789594e2a	TCGA-E2-A15P-01A-11D-A111-01	61c279ee-777a-4c05-bc38-e1a9183faaff		TCGA-E2-A15P-01	TCGA-E2-A15P-01A-11R-A115-07	61c279ee-777a-4c05-bc38-e1a9183faaff	61c279ee-777a-4c05-bc38-e1a9183faaff	TCGA-E2-A15P-01A-11D-A111-01	TCGA-E2-A15P-01	TCGA-E2-A15P-01	TCGA-E2-A15P-01A-11D-A112-05	2bdfaad7-f202-4d89-a8f6-a55789594e2a	
TCGA-E2-A15R-01	Stage IIIA	64	4	Stage IIA	330		Positive	FEMALE	Negative	4	3	3	Negative	M0	Positive	N1	330	0	LumA	Luminal A	Positive	LumA/B	-10	-3	enrollment	T1	T1	LIVING	0	TCGA-E2-A15R-01	519	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-E2-A15R	519	0	519	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15R-F19170		Positive					Positive	Lumpectomy		NO			-23570	247		0	519					NO	Allred score 5+3 = 8				1.9	Scheduled Follow-up Submission	2011-11-16	FEMALE					2+		2.4	1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	140	NO	Equivocal	Negative		4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	5								NO	3		false	M0	N1a	T1c	Stage IIA	TCGA-E2-A15R.0F708C6E-0262-46EE-8ED2-67E791D5C379.pdf		0		0		0		0		0		5		95		95	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 8		YES	No			YES	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	TCGA-E2-A15R-01A-11D-A10Y-09	TCGA-E2-A15R-01	TCGA-E2-A15R-01A-11R-A114-13	TCGA-E2-A15R-01A-11R-A114-13	TCGA-E2-A15R-01A-11D-A10Y-09	7bec7525-d926-443f-a521-09334b963a89	TCGA-E2-A15R-01A-11D-A10Y-09	TCGA-E2-A15R-01A-21-A13E-20	TCGA-E2-A15R-01A-11D-A10Y-09	8f90121d-5f9a-4702-a2ae-2a9b34a99171	37d17072-0bcc-41ed-a80e-87a27ea956d4	TCGA-E2-A15R-01A-11D-A111-01	8f90121d-5f9a-4702-a2ae-2a9b34a99171		TCGA-E2-A15R-01	TCGA-E2-A15R-01A-11R-A115-07	8f90121d-5f9a-4702-a2ae-2a9b34a99171	8f90121d-5f9a-4702-a2ae-2a9b34a99171	TCGA-E2-A15R-01A-11D-A111-01	TCGA-E2-A15R-01	TCGA-E2-A15R-01	TCGA-E2-A15R-01A-11D-A112-05	37d17072-0bcc-41ed-a80e-87a27ea956d4	
TCGA-E2-A15S-01	Stage IIB	34		Stage IIB	274		Positive	FEMALE	Negative				Negative	M0	Positive	N1	274	0	LumB	Luminal B	Negative	LumA/B	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15S-01	428	0		C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 2	cluster 6	mutation c1uster 9	TCGA-E2-A15S	428	0	428	Breast	TCGA Breast Cancer	breast invasive carcinoma					34	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A15S-F19135		Positive					Negative	Simple Mastectomy		NO			-12671	247		0	428					NO						Scheduled Follow-up Submission	2011-11-16	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	560	NO	Equivocal	Negative		17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6								NO	1		false	M0	N1	T2	Stage IIB	TCGA-E2-A15S.AF740239-D3E2-4C74-844E-0F5AD1A905ED.pdf		0		0		5		0		0		15		80		90	TUMOR FREE				Allred score = 2	Allred score = 7		YES	No			YES	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	TCGA-E2-A15S-01A-11D-A10Y-09	TCGA-E2-A15S-01	TCGA-E2-A15S-01A-11R-A114-13	TCGA-E2-A15S-01A-11R-A114-13	TCGA-E2-A15S-01A-11D-A10Y-09	19e14655-2099-4ebc-91eb-d95db082bbc7	TCGA-E2-A15S-01A-11D-A10Y-09	TCGA-E2-A15S-01A-21-A13E-20	TCGA-E2-A15S-01A-11D-A10Y-09	754fd66b-f39a-4308-a57c-05de251f9014	888a41e1-bc82-44a2-b2c1-05b7590ab22a	TCGA-E2-A15S-01A-11D-A111-01	754fd66b-f39a-4308-a57c-05de251f9014		TCGA-E2-A15S-01	TCGA-E2-A15S-01A-11R-A115-07	754fd66b-f39a-4308-a57c-05de251f9014	754fd66b-f39a-4308-a57c-05de251f9014	TCGA-E2-A15S-01A-11D-A111-01	TCGA-E2-A15S-01	TCGA-E2-A15S-01	TCGA-E2-A15S-01A-11D-A112-05	888a41e1-bc82-44a2-b2c1-05b7590ab22a	
TCGA-E2-A15T-01	Stage IIA	65		Stage IIA	267		Positive	FEMALE	Negative				Negative	M0	Negative	N0	267	0		Luminal B	Positive	LumA/B	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15T-01	456	0			cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-E2-A15T	456	0	456	Breast	TCGA Breast Cancer	breast invasive carcinoma					65	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15T-F19142		Positive					Positive	Simple Mastectomy		NO			-24054	162		0	456					NO	Allred score 5+3 = 8					Scheduled Follow-up Submission	2011-11-16	FEMALE					2+			1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	360	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO	0		false	M0	N0	T2	Stage IIA	TCGA-E2-A15T.8FEBDA40-59FF-4E76-A9B1-F46BAB7C3E4A.pdf		0		0		0		0		0		30		70		70	TUMOR FREE	Allred score 2+3 = 5			Allred score = 5	Allred score = 8		YES	No			NO	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	TCGA-E2-A15T-01A-11D-A10Y-09	TCGA-E2-A15T-01	TCGA-E2-A15T-01A-11R-A114-13	TCGA-E2-A15T-01A-11R-A114-13		e8fe1a3f-ec8a-49a8-a932-01341de67004	TCGA-E2-A15T-01A-11D-A10Y-09	TCGA-E2-A15T-01A-21-A13E-20	TCGA-E2-A15T-01A-11D-A10Y-09	5db1c37a-2329-4bd3-baf2-89d26a8959fa	93d6d838-9563-4daa-ab69-5ba0073c9d1d	TCGA-E2-A15T-01A-11D-A111-01	5db1c37a-2329-4bd3-baf2-89d26a8959fa		TCGA-E2-A15T-01	TCGA-E2-A15T-01A-11R-A115-07	5db1c37a-2329-4bd3-baf2-89d26a8959fa	5db1c37a-2329-4bd3-baf2-89d26a8959fa	TCGA-E2-A15T-01A-11D-A111-01	TCGA-E2-A15T-01	TCGA-E2-A15T-01	TCGA-E2-A15T-01A-11D-A112-05	93d6d838-9563-4daa-ab69-5ba0073c9d1d	
TCGA-E2-A1AZ-01	Stage IIB	63	4	Stage IIB	1964		Negative	FEMALE	Negative				Negative	M0	Positive	N1	1964	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1AZ-01	2329	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8			mutation c1uster 9	TCGA-E2-A1AZ	2329	0	2329	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-E2-A1AZ-F19462		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		NO			-23230	2527		0	2329					NO						Scheduled Follow-up Submission	2011-12-6	FEMALE								0.42		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	250	NO	Indeterminate	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5									NO	1		true	M0	N1a	T2	Stage IIB	TCGA-E2-A1AZ.4E233F7D-035A-44A0-A5B6-6248357EB7B2.pdf		0		0		0		0		0		0		100		80	TUMOR FREE							YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2004	TCGA-E2-A1AZ-01A-11D-A12Q-09	TCGA-E2-A1AZ-01	TCGA-E2-A1AZ-01A-11R-A12O-13	TCGA-E2-A1AZ-01A-11R-A12O-13	TCGA-E2-A1AZ-01A-11D-A12Q-09	187a4af6-1941-419e-a58d-d3fb18510b65	TCGA-E2-A1AZ-01A-11D-A12Q-09	TCGA-E2-A1AZ-01A-21-A13E-20	TCGA-E2-A1AZ-01A-11D-A12Q-09	fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c	9ca918d1-dde6-4812-b6b8-05a6fb2332c3	TCGA-E2-A1AZ-01A-11D-A12N-01	fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c	TCGA-E2-A1AZ-01A-11D-A12R-05	TCGA-E2-A1AZ-01	TCGA-E2-A1AZ-01A-11R-A12P-07	fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c	fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c	TCGA-E2-A1AZ-01A-11D-A12N-01	TCGA-E2-A1AZ-01	TCGA-E2-A1AZ-01		9ca918d1-dde6-4812-b6b8-05a6fb2332c3	
TCGA-E2-A1B0-01	Stage IIIA	50	3	Stage IIIA	1271		Negative	FEMALE	Positive	1	2	2	Negative	M0	Positive	N2	1271	0	Her2	HER2-enriched	Negative	ReacI	-13	-10	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1B0-01	1631	0	High	C3-BRCA/Luminal	cluster 5	Cluster 5	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-E2-A1B0	1631	0	1631	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A1B0-F19460		Negative					Negative	Modified Radical Mastectomy		NO			-18346	1315		0	1631					NO	Allred score 0+0 = 0					Scheduled Follow-up Submission	2011-12-7	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.5		YES		Tumor resection	110	NO	Positive			28	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4								NO	6		true	M0	N2	T2	Stage IIIA	TCGA-E2-A1B0.9C3987A7-D474-4717-8DCE-4AF1AE03ED84.pdf		0		0		10		0		0		20		70		65	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2007	TCGA-E2-A1B0-01A-11D-A12Q-09	TCGA-E2-A1B0-01	TCGA-E2-A1B0-01A-11R-A12O-13	TCGA-E2-A1B0-01A-11R-A12O-13	TCGA-E2-A1B0-01A-11D-A12Q-09	2eae7190-37af-4257-9a9e-29a8c937a513	TCGA-E2-A1B0-01A-11D-A12Q-09	TCGA-E2-A1B0-01A-21-A13E-20	TCGA-E2-A1B0-01A-11D-A12Q-09	8bb3543b-5c83-41c6-b81c-b20935c38d72	fd63fcef-ebac-4386-beb6-29d42bdae2d9	TCGA-E2-A1B0-01A-11D-A12N-01	8bb3543b-5c83-41c6-b81c-b20935c38d72	TCGA-E2-A1B0-01A-11D-A12R-05	TCGA-E2-A1B0-01	TCGA-E2-A1B0-01A-11R-A12P-07	8bb3543b-5c83-41c6-b81c-b20935c38d72	8bb3543b-5c83-41c6-b81c-b20935c38d72	TCGA-E2-A1B0-01A-11D-A12N-01	TCGA-E2-A1B0-01	TCGA-E2-A1B0-01		fd63fcef-ebac-4386-beb6-29d42bdae2d9	
TCGA-E2-A1B1-01	Stage IIB	45	3	Stage IIB	1361		Positive	FEMALE	Positive	1	2	3	Negative	M0	Positive	N1	1361	0	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1B1-01	1613	0	Kirc+	C5-KIRC	cluster 5	Low purity c2	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A1B1	1613	0	1613	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A1B1-F19416		Positive					Positive	Lumpectomy		NO			-16603	1268		0	1613					NO	Allred score 3+2 = 5					Scheduled Follow-up Submission	2011-12-9	FEMALE			70-79%		2+			15.12		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	300	NO	Equivocal	Positive		6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4								NO	1		true	M0	N1	T2	Stage IIB	TCGA-E2-A1B1.431AE1CB-9605-45E3-B6C3-5253B24655D6.pdf		0		0		0		0		5		35		60		70	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 5		YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2007	TCGA-E2-A1B1-01A-21D-A12Q-09	TCGA-E2-A1B1-01	TCGA-E2-A1B1-01A-21R-A12O-13	TCGA-E2-A1B1-01A-21R-A12O-13	TCGA-E2-A1B1-01A-21D-A12Q-09	c476545a-0d56-4d49-9180-bb707d02a1c9	TCGA-E2-A1B1-01A-21D-A12Q-09	TCGA-E2-A1B1-01A-11-A13E-20	TCGA-E2-A1B1-01A-21D-A12Q-09	2aa34033-a6f5-45a8-833b-b433352e58ba	f4171ca1-a9b6-4e8a-8e80-a259329ac696	TCGA-E2-A1B1-01A-21D-A12N-01	2aa34033-a6f5-45a8-833b-b433352e58ba	TCGA-E2-A1B1-01A-21D-A12R-05	TCGA-E2-A1B1-01	TCGA-E2-A1B1-01A-21R-A12P-07	2aa34033-a6f5-45a8-833b-b433352e58ba	2aa34033-a6f5-45a8-833b-b433352e58ba	TCGA-E2-A1B1-01A-21D-A12N-01	TCGA-E2-A1B1-01	TCGA-E2-A1B1-01		f4171ca1-a9b6-4e8a-8e80-a259329ac696	
TCGA-E2-A1B4-01	Stage IIIA	74	2	Stage IIIA	911		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N2	911	0	LumA	Luminal A	Positive	LumA/B	-12	-3	enrollment	T1	T1	LIVING	1	TCGA-E2-A1B4-01	1004	1	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3	cluster 6	mutation cluster 4	TCGA-E2-A1B4	1004	0	1004	Breast	TCGA Breast Cancer	breast invasive carcinoma					74	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-E2-A1B4-F19443		Positive					Positive	Lumpectomy		NO			-27241	798	1004	0	911					NO	Allred score 5+3 = 8					Scheduled Follow-up Submission	2011-12-8	FEMALE			10-19%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES		Tumor resection	110	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6								NO	3		true	M0	N2a	T1c	Stage IIIA	TCGA-E2-A1B4.2F35A09A-7EB3-484C-9738-664C8914C116.pdf		0		0		0		0		0		5		95		65	TUMOR FREE	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	DECEASED	2008	TCGA-E2-A1B4-01A-11D-A12Q-09	TCGA-E2-A1B4-01	TCGA-E2-A1B4-01A-11R-A12O-13	TCGA-E2-A1B4-01A-11R-A12O-13	TCGA-E2-A1B4-01A-11D-A12Q-09	4b198843-12fe-41e0-af18-0638dd948c6a	TCGA-E2-A1B4-01A-11D-A12Q-09	TCGA-E2-A1B4-01A-21-A13E-20	TCGA-E2-A1B4-01A-11D-A12Q-09	2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6	f64a244c-40c8-4689-bd55-3263bb01f9fa	TCGA-E2-A1B4-01A-11D-A12N-01	2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6	TCGA-E2-A1B4-01A-11D-A12R-05	TCGA-E2-A1B4-01	TCGA-E2-A1B4-01A-11R-A12P-07	2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6	2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6	TCGA-E2-A1B4-01A-11D-A12N-01	TCGA-E2-A1B4-01	TCGA-E2-A1B4-01		f64a244c-40c8-4689-bd55-3263bb01f9fa	
TCGA-E2-A1B5-01	Stage IIA	46	3	Stage IIA	774		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	774	0	LumA	Basal-like	Positive	ReacI	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1B5-01	984	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-E2-A1B5	984	0	984	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Left	Sentinel node biopsy alone		TCGA-E2-A1B5-F19393		Positive					Positive	Lumpectomy		NO			-17039	783		0	984					NO	Allred score 5+3 = 8					Scheduled Follow-up Submission	2011-12-8	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	260	NO	Negative			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	6								NO	0		true	M0	N0	T2	Stage IIA	TCGA-E2-A1B5.EDD254CA-0EC6-42F8-B213-C2D386AB11F4.pdf		0		0		0		0		0		20		80		80	TUMOR FREE	Allred score 2+3 = 5			Allred score = 5	Allred score = 8		YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	TCGA-E2-A1B5-01A-21D-A12Q-09	TCGA-E2-A1B5-01	TCGA-E2-A1B5-01A-21R-A12O-13	TCGA-E2-A1B5-01A-21R-A12O-13	TCGA-E2-A1B5-01A-21D-A12Q-09	96c90192-0896-42a2-bc87-ae6bf8bb5c9f	TCGA-E2-A1B5-01A-21D-A12Q-09	TCGA-E2-A1B5-01A-31-A13E-20	TCGA-E2-A1B5-01A-21D-A12Q-09	a2c80f8e-f08d-4574-90a0-f0651c0a9b1b	4fd5a826-8410-4572-9403-960947308df7	TCGA-E2-A1B5-01A-21D-A12N-01	a2c80f8e-f08d-4574-90a0-f0651c0a9b1b	TCGA-E2-A1B5-01A-21D-A12R-05	TCGA-E2-A1B5-01	TCGA-E2-A1B5-01A-21R-A12P-07	a2c80f8e-f08d-4574-90a0-f0651c0a9b1b	a2c80f8e-f08d-4574-90a0-f0651c0a9b1b	TCGA-E2-A1B5-01A-21D-A12N-01	TCGA-E2-A1B5-01	TCGA-E2-A1B5-01		4fd5a826-8410-4572-9403-960947308df7	
TCGA-E2-A1B5-11		46			774			FEMALE									774	0							enrollment			LIVING	0	TCGA-E2-A1B5-11	984	0		C3-BRCA/Luminal							mutation c1uster 9	TCGA-E2-A1B5	984	0	984	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Left	Sentinel node biopsy alone		TCGA-E2-A1B5-F19393		Positive					Positive	Lumpectomy		NO			-17039	783		0	984					NO	Allred score 5+3 = 8					Scheduled Follow-up Submission	2011-12-8	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	260	NO	Negative			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0		true	M0	N0	T2	Stage IIA			0		0		0		0		90		10		0		0	TUMOR FREE	Allred score 2+3 = 5			Allred score = 5	Allred score = 8		YES	No			YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast	A	LIVING	2008														TCGA-E2-A1B5-11A-23D-A12R-05										
TCGA-E2-A1B6-01	Stage IIA	44	1	Stage IIA	338		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	338	0		Luminal A	Negative	Basal	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1B6-01	867	0	Quiet	C13-AML	cluster 5	Low purity c2	BRCA basal-like c6		miRNA cluster 15	cluster 6	mutation cluster 5	TCGA-E2-A1B6	867	0	867	Breast	TCGA Breast Cancer	breast invasive carcinoma					44	Left	Sentinel node biopsy alone		TCGA-E2-A1B6-F19389		Negative					Negative	Simple Mastectomy		NO			-16370	729		0	867					NO	Allred score 0+0 = 0					Scheduled Follow-up Submission	2011-12-8	FEMALE			10-19%		2+			1.03		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	290	NO	Equivocal	Negative		5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	6								NO	0		true	M0	N0	T2	Stage IIA	TCGA-E2-A1B6.539FF792-534D-401D-87A6-B3B7C2BC2EFC.pdf		40		20		0		20		10		30		60		60	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES	No			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	TCGA-E2-A1B6-01A-31D-A12Q-09	TCGA-E2-A1B6-01	TCGA-E2-A1B6-01A-31R-A12O-13	TCGA-E2-A1B6-01A-31R-A12O-13		dc503863-7967-469b-b966-69dcea2dfb86	TCGA-E2-A1B6-01A-31D-A12Q-09	TCGA-E2-A1B6-01A-21-A13E-20	TCGA-E2-A1B6-01A-31D-A12Q-09	eb398b00-8669-4c22-8285-03cdf76436f3	29e8a47e-a20b-40c2-98dc-885a21dbf7a3	TCGA-E2-A1B6-01A-31D-A12N-01	eb398b00-8669-4c22-8285-03cdf76436f3	TCGA-E2-A1B6-01A-31D-A12R-05	TCGA-E2-A1B6-01	TCGA-E2-A1B6-01A-31R-A12P-07	eb398b00-8669-4c22-8285-03cdf76436f3	eb398b00-8669-4c22-8285-03cdf76436f3	TCGA-E2-A1B6-01A-31D-A12N-01	TCGA-E2-A1B6-01	TCGA-E2-A1B6-01		29e8a47e-a20b-40c2-98dc-885a21dbf7a3	
TCGA-E2-A1BC-01	Stage IA	63	2	Stage I	297		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	297	0	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-E2-A1BC-01	501	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-E2-A1BC	501	0	501	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Right	Sentinel node biopsy alone		TCGA-E2-A1BC-F19427		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		NO			-23168	275		0	501					NO						Scheduled Follow-up Submission	2011-12-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8524/3	C50.4		YES		Tumor resection	100	NO	Negative			4	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6								NO	0		true	M0	N0	T1c	Stage IA	TCGA-E2-A1BC.817D4725-01FE-4148-A8FC-3431F28D5CD8.pdf		0		0		0		0		0		0		100		85	TUMOR FREE							YES	Yes			NO	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	TCGA-E2-A1BC-01A-11D-A14G-09	TCGA-E2-A1BC-01	TCGA-E2-A1BC-01A-11R-A12O-13	TCGA-E2-A1BC-01A-11R-A12O-13		8d3961ff-444a-4808-a697-c21898446648	TCGA-E2-A1BC-01A-11D-A14G-09	TCGA-E2-A1BC-01A-21-A13E-20	TCGA-E2-A1BC-01A-11D-A14G-09	a2cf164c-5b26-43eb-9de9-d1d457a5de06	1085f98f-9f84-4d1e-9c07-f6b43cc571b7	TCGA-E2-A1BC-01A-11D-A12N-01	a2cf164c-5b26-43eb-9de9-d1d457a5de06	TCGA-E2-A1BC-01A-11D-A12R-05	TCGA-E2-A1BC-01	TCGA-E2-A1BC-01A-11R-A12P-07	a2cf164c-5b26-43eb-9de9-d1d457a5de06	a2cf164c-5b26-43eb-9de9-d1d457a5de06	TCGA-E2-A1BC-01A-11D-A12N-01	TCGA-E2-A1BC-01	TCGA-E2-A1BC-01		1085f98f-9f84-4d1e-9c07-f6b43cc571b7	
TCGA-E2-A1BC-11		63			297			FEMALE									297	0							enrollment			LIVING	0	TCGA-E2-A1BC-11	501	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-E2-A1BC	501	0	501	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Right	Sentinel node biopsy alone		TCGA-E2-A1BC-F19427		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		NO			-23168	275		0	501					NO						Scheduled Follow-up Submission	2011-12-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8524/3	C50.4		YES		Tumor resection	260	NO	Negative			4	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		true	M0	N0	T1c	Stage IA			0		0		0		0		100		0		0		0	TUMOR FREE							YES	Yes			NO	Solid Tissue Normal	11		7th	YES	NO	YES	E2	Breast	A	LIVING	2010			TCGA-E2-A1BC-11A-32R-A12O-13	TCGA-E2-A1BC-11A-32R-A12O-13						afe373b9-f1c1-412d-9506-091749d47534			afe373b9-f1c1-412d-9506-091749d47534	TCGA-E2-A1BC-11A-32D-A12R-05		TCGA-E2-A1BC-11A-32R-A12P-07	afe373b9-f1c1-412d-9506-091749d47534	afe373b9-f1c1-412d-9506-091749d47534						
TCGA-E2-A1BD-01	Stage IIA	53	2	Stage IIA	317		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	317	0	LumA	Luminal A	Positive	LumA	-7	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1BD-01	520	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-E2-A1BD	520	0	520	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A1BD-F19439		Positive					Positive	Lumpectomy		NO			-19627	260		0	520					NO	Allred score 5+3 = 8					Scheduled Follow-up Submission	2011-12-9	FEMALE			10-19%		2+			1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	100	NO	Equivocal	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6								NO	0		true	M0	N0	T2	Stage IIA	TCGA-E2-A1BD.DF746E32-AD2F-49CB-9AA6-4F8494C16B20.pdf		0		0		0		0		0		15		85		90	TUMOR FREE	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		YES	No			YES	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	TCGA-E2-A1BD-01A-11D-A12Q-09	TCGA-E2-A1BD-01	TCGA-E2-A1BD-01A-11R-A12O-13	TCGA-E2-A1BD-01A-11R-A12O-13		139a9795-35ff-4c82-9530-fb103ea5ca8c	TCGA-E2-A1BD-01A-11D-A12Q-09	TCGA-E2-A1BD-01A-21-A13E-20	TCGA-E2-A1BD-01A-11D-A12Q-09	fa1917b0-c3e1-412d-b063-e74b5cafb8dc	58138777-4be6-498c-9b6c-4dab28541ec7	TCGA-E2-A1BD-01A-11D-A12N-01	fa1917b0-c3e1-412d-b063-e74b5cafb8dc	TCGA-E2-A1BD-01A-11D-A12R-05	TCGA-E2-A1BD-01	TCGA-E2-A1BD-01A-11R-A12P-07	fa1917b0-c3e1-412d-b063-e74b5cafb8dc	fa1917b0-c3e1-412d-b063-e74b5cafb8dc	TCGA-E2-A1BD-01A-11D-A12N-01	TCGA-E2-A1BD-01	TCGA-E2-A1BD-01		58138777-4be6-498c-9b6c-4dab28541ec7	
TCGA-E2-A1IE-01	Stage IIB	61	5	Stage IIB	983		Positive	FEMALE	Negative				Negative	M0	Positive	N1	983	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1IE-01	1165	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 12	cluster 6	mutation c1uster 9	TCGA-E2-A1IE	1165	0	1165	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Right	Sentinel node biopsy alone		TCGA-E2-A1IE-F19964		Positive					Positive	Lumpectomy		NO			-22510			0	1165					NO	allred score 5 + 3 = 8					Scheduled Follow-up Submission	2011-12-21	FEMALE			20-29%		2+			1.05		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Equivocal	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	6								NO	1			M0	N1	T2	Stage IIB																		TUMOR FREE	allred score 3 + 3 = 6			allred score = 6	allred score = 8		YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast		LIVING	2008	TCGA-E2-A1IE-01A-11D-A188-09		TCGA-E2-A1IE-01A-11R-A13P-13	TCGA-E2-A1IE-01A-11R-A13P-13	TCGA-E2-A1IE-01A-11D-A188-09		TCGA-E2-A1IE-01A-11D-A188-09		TCGA-E2-A1IE-01A-11D-A188-09	ec6f69db-ff0b-491c-8b70-d53d0e7ad65f	e3703f32-e1f2-4f3a-9861-6e25fdbd8144	TCGA-E2-A1IE-01A-11D-A13J-01	ec6f69db-ff0b-491c-8b70-d53d0e7ad65f	TCGA-E2-A1IE-01A-11D-A13K-05	TCGA-E2-A1IE-01		ec6f69db-ff0b-491c-8b70-d53d0e7ad65f	ec6f69db-ff0b-491c-8b70-d53d0e7ad65f	TCGA-E2-A1IE-01A-11D-A13J-01		TCGA-E2-A1IE-01		e3703f32-e1f2-4f3a-9861-6e25fdbd8144	
TCGA-E2-A1IF-01	Stage I	74	2	Stage I	956		Positive	FEMALE	Negative				Negative	M0	Negative	N0	956	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1IF-01	1138	0	Iq	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA c1uster 9	cluster 6	mutation cluster 1	TCGA-E2-A1IF	1138	0	1138	Breast	TCGA Breast Cancer	breast invasive carcinoma					74	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A1IF-F19962		Positive					Positive	Lumpectomy		NO			-27341	932		0	1138					NO	allred score 5+3=8					Scheduled Follow-up Submission	2011-12-21	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	70	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	6								NO	0		false	M0	N0	T1c	Stage I	TCGA-E2-A1IF.9E2EF2C8-A60D-443D-99B6-205B7053175A.pdf		0		0		0		0		0		20		80		80	TUMOR FREE	allred score 4+2=6			allred score = 6	allred scrore = 8		YES	No			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	TCGA-E2-A1IF-01A-11D-A142-09		TCGA-E2-A1IF-01A-11R-A143-13	TCGA-E2-A1IF-01A-11R-A143-13	TCGA-E2-A1IF-01A-11D-A142-09		TCGA-E2-A1IF-01A-11D-A142-09		TCGA-E2-A1IF-01A-11D-A142-09	34a8b02b-01a2-4f2d-8e8e-c3358d43665a	98d263ad-3cc6-4846-916c-17de953a89a0	TCGA-E2-A1IF-01A-11D-A141-01	34a8b02b-01a2-4f2d-8e8e-c3358d43665a	TCGA-E2-A1IF-01A-11D-A145-05	TCGA-E2-A1IF-01		34a8b02b-01a2-4f2d-8e8e-c3358d43665a	34a8b02b-01a2-4f2d-8e8e-c3358d43665a	TCGA-E2-A1IF-01A-11D-A141-01		TCGA-E2-A1IF-01		98d263ad-3cc6-4846-916c-17de953a89a0	
TCGA-E2-A1IF-11		74			956			FEMALE									956	0							enrollment			LIVING	0	TCGA-E2-A1IF-11	1138	0		C3-BRCA/Luminal							mutation cluster 1	TCGA-E2-A1IF	1138	0	1138	Breast	TCGA Breast Cancer	breast invasive carcinoma					74	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A1IF-F19962		Positive					Positive	Lumpectomy		NO			-27341	932		0	1138					NO	allred score 5+3=8					Scheduled Follow-up Submission	2011-12-21	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	140	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T1c	Stage I			0		0		0		0		100		0		0		0	TUMOR FREE	allred score 4+2=6			allred score = 6	allred scrore = 8		YES	No			NO	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast	A	LIVING	2008														TCGA-E2-A1IF-11A-22D-A145-05										
TCGA-E2-A1IG-01	Stage IIB	45	5	Stage IIB	755		Positive	FEMALE					Negative	M0	Positive	N1	755	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1IG-01	997	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 4	mutation c1uster 9	TCGA-E2-A1IG	997	0	997	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-E2-A1IG-F19932		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		NO			-16757			0	997					NO						Scheduled Follow-up Submission	2011-12-21	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection			Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4								NO	1			M0	N1mi	T2	Stage IIB																		TUMOR FREE							YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast		LIVING	2009	TCGA-E2-A1IG-01A-11D-A142-09		TCGA-E2-A1IG-01A-11R-A143-13	TCGA-E2-A1IG-01A-11R-A143-13	TCGA-E2-A1IG-01A-11D-A142-09		TCGA-E2-A1IG-01A-11D-A142-09	TCGA-E2-A1IG-01A-21-A17J-20	TCGA-E2-A1IG-01A-11D-A142-09	d0705a73-e6d0-4282-82b1-76d44bda242f	e3df00a4-ca76-4515-b652-ba5903b82f99	TCGA-E2-A1IG-01A-11D-A141-01	d0705a73-e6d0-4282-82b1-76d44bda242f	TCGA-E2-A1IG-01A-11D-A145-05	TCGA-E2-A1IG-01		d0705a73-e6d0-4282-82b1-76d44bda242f	d0705a73-e6d0-4282-82b1-76d44bda242f	TCGA-E2-A1IG-01A-11D-A141-01		TCGA-E2-A1IG-01		e3df00a4-ca76-4515-b652-ba5903b82f99	
TCGA-E2-A1IG-11		45			755			FEMALE									755	0	Normal						enrollment			LIVING	0	TCGA-E2-A1IG-11	997	0		C3-BRCA/Luminal							mutation c1uster 9	TCGA-E2-A1IG	997	0	997	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-E2-A1IG-F19932		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		NO			-16757	679		0	997					NO						Scheduled Follow-up Submission	2011-12-21	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	210	NO	Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	1		false	M0	N1mi	T2	Stage IIB			0		0		0		0		100		0		0		0	TUMOR FREE							YES	No			YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast	A	LIVING	2009			TCGA-E2-A1IG-11A-22R-A143-13	TCGA-E2-A1IG-11A-22R-A143-13						1e55cf08-da43-471d-813c-9d37c7abc730			1e55cf08-da43-471d-813c-9d37c7abc730				1e55cf08-da43-471d-813c-9d37c7abc730	1e55cf08-da43-471d-813c-9d37c7abc730						
TCGA-E2-A1IH-01	Stage I	80	2	Stage I	658		Positive	FEMALE	Negative				Negative	M0	Negative	N0	658	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1IH-01	1026	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 10	TCGA-E2-A1IH	1026	0	1026	Breast	TCGA Breast Cancer	breast invasive carcinoma					80	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-E2-A1IH-F19960		Positive					Positive	Lumpectomy		NO			-29444	883		0	1026					NO	allred score 5+3=8					Scheduled Follow-up Submission	2011-12-21	FEMALE			20-29%		2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.2		YES		Tumor resection	80	NO	Equivocal			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6								NO	0		false	M0	N0	T1c	Stage I	TCGA-E2-A1IH.12DAEBF2-CDBF-4D90-9C74-2A2AEF1E8433.pdf		0		0		0		0		0		0		100		75	TUMOR FREE	allred score 5+3+8			allred score = 8	allred score = 8		YES	No			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	TCGA-E2-A1IH-01A-11D-A188-09		TCGA-E2-A1IH-01A-11R-A13P-13	TCGA-E2-A1IH-01A-11R-A13P-13	TCGA-E2-A1IH-01A-11D-A188-09		TCGA-E2-A1IH-01A-11D-A188-09		TCGA-E2-A1IH-01A-11D-A188-09	2d06908f-3332-4b77-b88c-145dc5c4828f	ebd32da6-da68-4130-bd91-b15c230f5cdb	TCGA-E2-A1IH-01A-11D-A13J-01	2d06908f-3332-4b77-b88c-145dc5c4828f	TCGA-E2-A1IH-01A-11D-A13K-05	TCGA-E2-A1IH-01		2d06908f-3332-4b77-b88c-145dc5c4828f	2d06908f-3332-4b77-b88c-145dc5c4828f	TCGA-E2-A1IH-01A-11D-A13J-01		TCGA-E2-A1IH-01		ebd32da6-da68-4130-bd91-b15c230f5cdb	
TCGA-E2-A1II-01	Stage I	51	2	Stage I	850		Negative	FEMALE	Negative				Negative	M0	Negative	N0	850	0	Basal		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1II-01	1025	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-E2-A1II	1025	0	1025	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Left	Sentinel node biopsy alone		TCGA-E2-A1II-F19954		Negative					Positive	Lumpectomy		NO			-18788			0	1025					NO	allred score 0 + 0 = 0					Scheduled Follow-up Submission	2011-12-21	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Negative			5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5								NO	0			M0	N0	T1c	Stage I																		TUMOR FREE	allred score 2+2 = 4			allred score = 4	allred score = 0		YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast		LIVING	2008	TCGA-E2-A1II-01A-11D-A142-09		TCGA-E2-A1II-01A-11R-A143-13	TCGA-E2-A1II-01A-11R-A143-13	TCGA-E2-A1II-01A-11D-A142-09		TCGA-E2-A1II-01A-11D-A142-09		TCGA-E2-A1II-01A-11D-A142-09	f7a5cfcb-623c-4858-ba32-e6ca63c75d2a	bb949708-34dc-48db-94db-c438ce611f57	TCGA-E2-A1II-01A-11D-A141-01	f7a5cfcb-623c-4858-ba32-e6ca63c75d2a	TCGA-E2-A1II-01A-11D-A145-05	TCGA-E2-A1II-01		f7a5cfcb-623c-4858-ba32-e6ca63c75d2a	f7a5cfcb-623c-4858-ba32-e6ca63c75d2a	TCGA-E2-A1II-01A-11D-A141-01		TCGA-E2-A1II-01		bb949708-34dc-48db-94db-c438ce611f57	
TCGA-E2-A1II-11		51			850			FEMALE									850	0							enrollment			LIVING	0	TCGA-E2-A1II-11	1025	0		C4-BRCA/Basal							mutation cluster 5	TCGA-E2-A1II	1025	0	1025	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Left	Sentinel node biopsy alone		TCGA-E2-A1II-F19954		Negative					Positive	Lumpectomy		NO			-18788	854		0	1025					NO	allred score 0 + 0 = 0					Scheduled Follow-up Submission	2011-12-21	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	170	NO	Negative			5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T1c	Stage I			0		0		0		0		100		0		0		0	TUMOR FREE	allred score 2+2 = 4			allred score = 4	allred score = 0		YES	No			YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast	A	LIVING	2008														TCGA-E2-A1II-11A-21D-A145-05										
TCGA-E2-A1IJ-01	Stage I	57	3	Stage I	725		Positive	FEMALE	Negative				Negative	M0	Negative	N0	725	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1IJ-01	865	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A1IJ	865	0	865	Breast	TCGA Breast Cancer	breast invasive carcinoma					57	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A1IJ-F19950		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		NO			-20956	707		0	865					NO		90-99%				Scheduled Follow-up Submission	2011-12-21	FEMALE					2+			1.2		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	70	NO	Equivocal	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	0		false	M0	N0	T1c	Stage I	TCGA-E2-A1IJ.35F7D0D1-BA21-4135-B444-6B10EAF66F25.pdf		0		0		0		0		0		10		90		65	TUMOR FREE							YES	No	90-99%		YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A1IJ-01A-11D-A142-09		TCGA-E2-A1IJ-01A-11R-A143-13	TCGA-E2-A1IJ-01A-11R-A143-13	TCGA-E2-A1IJ-01A-11D-A142-09		TCGA-E2-A1IJ-01A-11D-A142-09		TCGA-E2-A1IJ-01A-11D-A142-09	14404fa2-adc4-4ecd-b4ee-5f4a75b54ff2	ccbdba80-fcd1-44ca-9265-4f0c5818dd60	TCGA-E2-A1IJ-01A-11D-A141-01	14404fa2-adc4-4ecd-b4ee-5f4a75b54ff2	TCGA-E2-A1IJ-01A-11D-A145-05	TCGA-E2-A1IJ-01		14404fa2-adc4-4ecd-b4ee-5f4a75b54ff2	14404fa2-adc4-4ecd-b4ee-5f4a75b54ff2	TCGA-E2-A1IJ-01A-11D-A141-01		TCGA-E2-A1IJ-01		ccbdba80-fcd1-44ca-9265-4f0c5818dd60	
TCGA-E2-A1IK-01	Stage IIA	71	1	Stage IIA	518		Positive	FEMALE	Negative				Negative	M0	Positive	N1	518	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1IK-01	689	0	Quiet	C5-KIRC	cluster 1	Low purity c2		BRCA nonbasal-like c7	miRNA cluster 6	cluster 7	mutation c1uster 9	TCGA-E2-A1IK	689	0	689	Breast	TCGA Breast Cancer	breast invasive carcinoma					71	Left	Sentinel node biopsy alone		TCGA-E2-A1IK-F19976		Positive					Positive	Lumpectomy		NO			-26052	423		0	689					NO						Scheduled Follow-up Submission	2012-1-3	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	70	NO	Negative			6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	7								NO	1		false	M0	N1mi	T1c	Stage IIA	TCGA-E2-A1IK.FE54D4DC-C35E-44D2-B8B5-0B631AE0F89D.pdf		0		0		0		0		0		20		80		80	TUMOR FREE							YES	No			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A1IK-01A-11D-A17G-09		TCGA-E2-A1IK-01A-11R-A143-13	TCGA-E2-A1IK-01A-11R-A143-13	TCGA-E2-A1IK-01A-11D-A17G-09		TCGA-E2-A1IK-01A-11D-A17G-09		TCGA-E2-A1IK-01A-11D-A17G-09	96a11934-f6cd-4892-a808-672433f84429	41e6ce80-5607-4d63-aba4-fdf657eb0227	TCGA-E2-A1IK-01A-11D-A141-01	96a11934-f6cd-4892-a808-672433f84429	TCGA-E2-A1IK-01A-11D-A145-05	TCGA-E2-A1IK-01		96a11934-f6cd-4892-a808-672433f84429	96a11934-f6cd-4892-a808-672433f84429	TCGA-E2-A1IK-01A-11D-A141-01		TCGA-E2-A1IK-01		41e6ce80-5607-4d63-aba4-fdf657eb0227	
TCGA-E2-A1IL-01	Stage IIA	78	2	Stage IIA	14		Positive	FEMALE	Negative				Negative	M0	Positive	N1	14	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1IL-01	118	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-E2-A1IL	118	0	118	Breast	TCGA Breast Cancer	breast invasive carcinoma					78	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A1IL-F20276		Positive					Positive	Lumpectomy		NO			-28495	417		0	118					NO	allred score 5+3=8					Scheduled Follow-up Submission	2012-1-3	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES		Tumor resection	120	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6								NO	1		false	M0	N1a	T1c	Stage IIA	TCGA-E2-A1IL.E0CCE6AD-38A6-446C-ACF7-358C1DFC59F8.pdf		1		0		1		0		0		4		95		65	TUMOR FREE	allred score 4 + 3 = 7			allred score = 7	allred score = 8		YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A1IL-01A-11D-A14G-09		TCGA-E2-A1IL-01A-11R-A14C-13	TCGA-E2-A1IL-01A-11R-A14C-13	TCGA-E2-A1IL-01A-11D-A14G-09		TCGA-E2-A1IL-01A-11D-A14G-09	TCGA-E2-A1IL-01A-21-A17J-20	TCGA-E2-A1IL-01A-11D-A14G-09	5610cbc9-1031-4b6a-9bba-a6b3ed7ced4d	efbd26b2-9623-45f3-a4c6-aea7266bb688	TCGA-E2-A1IL-01A-11D-A14F-01	5610cbc9-1031-4b6a-9bba-a6b3ed7ced4d	TCGA-E2-A1IL-01A-11D-A14H-05	TCGA-E2-A1IL-01		5610cbc9-1031-4b6a-9bba-a6b3ed7ced4d	5610cbc9-1031-4b6a-9bba-a6b3ed7ced4d	TCGA-E2-A1IL-01A-11D-A14F-01		TCGA-E2-A1IL-01		efbd26b2-9623-45f3-a4c6-aea7266bb688	
TCGA-E2-A1IN-01	Stage I	60	4	Stage I	392		Positive	FEMALE	Negative				Negative	M0	Negative	N0	392	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1IN-01	675	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 3	TCGA-E2-A1IN	675	0	675	Breast	TCGA Breast Cancer	breast invasive carcinoma					60	Right	Sentinel node biopsy alone		TCGA-E2-A1IN-F20323		Positive					Positive	Lumpectomy		NO			-22199	368		0	675					NO	allred score 5+3=8					Scheduled Follow-up Submission	2012-1-4	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	20	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	0		false	M0	N0	T1c	Stage I	TCGA-E2-A1IN.CC0B1145-B242-45BD-A946-B14BA5A9E923.pdf		1		0		1		0		0		4		95		85	TUMOR FREE	allred score 5+3+8			allred score = 8	allred score = 8		YES	No			YES	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	TCGA-E2-A1IN-01A-11D-A13L-09		TCGA-E2-A1IN-01A-11R-A13P-13	TCGA-E2-A1IN-01A-11R-A13P-13	TCGA-E2-A1IN-01A-11D-A13L-09		TCGA-E2-A1IN-01A-11D-A13L-09		TCGA-E2-A1IN-01A-11D-A13L-09	dde1d3ab-ad71-4526-bc98-058b6049edcf	08e895e6-2f45-436c-9b33-9768b66dc33b	TCGA-E2-A1IN-01A-11D-A13J-01	dde1d3ab-ad71-4526-bc98-058b6049edcf	TCGA-E2-A1IN-01A-11D-A13K-05	TCGA-E2-A1IN-01		dde1d3ab-ad71-4526-bc98-058b6049edcf	dde1d3ab-ad71-4526-bc98-058b6049edcf	TCGA-E2-A1IN-01A-11D-A13J-01		TCGA-E2-A1IN-01		08e895e6-2f45-436c-9b33-9768b66dc33b	
TCGA-E2-A1IO-01	Stage I	37	1	Stage I	448		Positive	FEMALE	Negative				Negative	M0	Negative	N0	448	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1IO-01	638	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-E2-A1IO	638	0	638	Breast	TCGA Breast Cancer	breast invasive carcinoma					37	Right	Sentinel node biopsy alone		TCGA-E2-A1IO-F20318		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		NO			-13720	367		0	638					NO						Scheduled Follow-up Submission	2012-1-4	FEMALE			30-39%		2+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	70	NO	Equivocal	Negative		1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4								NO	0		false	M0	N0	T1c	Stage I	TCGA-E2-A1IO.A9D36308-DAEF-48B9-A4EC-6B9B24EE3DC2.pdf		15		0		1		0		0		4		95		70	TUMOR FREE							YES	No			YES	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	TCGA-E2-A1IO-01A-11D-A142-09		TCGA-E2-A1IO-01A-11R-A143-13	TCGA-E2-A1IO-01A-11R-A143-13	TCGA-E2-A1IO-01A-11D-A142-09		TCGA-E2-A1IO-01A-11D-A142-09		TCGA-E2-A1IO-01A-11D-A142-09	72611671-51cc-4662-b992-6701eb1df987	1123e3e5-8125-432d-9246-195e8114be97	TCGA-E2-A1IO-01A-11D-A141-01	72611671-51cc-4662-b992-6701eb1df987	TCGA-E2-A1IO-01A-11D-A145-05	TCGA-E2-A1IO-01		72611671-51cc-4662-b992-6701eb1df987	72611671-51cc-4662-b992-6701eb1df987	TCGA-E2-A1IO-01A-11D-A141-01		TCGA-E2-A1IO-01		1123e3e5-8125-432d-9246-195e8114be97	
TCGA-E2-A1IO-11		37			448			FEMALE									448	0							enrollment			LIVING	0	TCGA-E2-A1IO-11	638	0		C3-BRCA/Luminal							mutation cluster 3	TCGA-E2-A1IO	638	0	638	Breast	TCGA Breast Cancer	breast invasive carcinoma					37	Right	Sentinel node biopsy alone		TCGA-E2-A1IO-F20318		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		NO			-13720	367		0	638					NO						Scheduled Follow-up Submission	2012-1-4	FEMALE			30-39%		2+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	140	NO	Equivocal	Negative		1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0		false	M0	N0	T1c	Stage I			0		0		0		0		100		0		0		0	TUMOR FREE							YES	No			YES	Solid Tissue Normal	11		7th	YES	NO	YES	E2	Breast	A	LIVING	2010														TCGA-E2-A1IO-11A-21D-A145-05										
TCGA-E2-A1IP-01	Stage IIB	42		Stage IIB	427		Positive	FEMALE	Negative				Negative	M0	Positive	N1	427	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1IP-01	659	0										TCGA-E2-A1IP	659	0	659	Breast	TCGA Breast Cancer	breast invasive carcinoma					42	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A1IP-F20291		Positive					Negative	Lumpectomy		NO			-15400	359		0	659					NO	Allred score 2+1= 3					Scheduled Follow-up Submission	2012-1-4	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	80		Negative	Not Performed		3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	1		false	M0	N1mi	T2	Stage IIB			12		0		1		0		0		0		99		80	TUMOR FREE	allred score 0+0=0			allred score = 0	Allred score = 3		YES	No			YES	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010			TCGA-E2-A1IP-01A-11R-A14C-13	TCGA-E2-A1IP-01A-11R-A14C-13						dfd81aa5-5be4-4cf3-877f-0f52e01beb60	2d0dc4e5-c1ad-4f80-b428-0b164d2803fd		dfd81aa5-5be4-4cf3-877f-0f52e01beb60	TCGA-E2-A1IP-01A-11D-A14H-05			dfd81aa5-5be4-4cf3-877f-0f52e01beb60	dfd81aa5-5be4-4cf3-877f-0f52e01beb60					2d0dc4e5-c1ad-4f80-b428-0b164d2803fd	
TCGA-E2-A1IU-01	Stage IA	60	2	Stage I	127		Positive	FEMALE	Negative				Negative	M0	Negative	N0	127	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1IU-01	337	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 2	mutation cluster 4	TCGA-E2-A1IU	337	0	337	Breast	TCGA Breast Cancer	breast invasive carcinoma					60	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A1IU-F19974		Positive					Positive	Simple Mastectomy		NO			-22279	136		0	337					NO						Scheduled Follow-up Submission	2012-1-4	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	270	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	2								NO	0		false	M0	N0 (mol+)	T1c	Stage IA	TCGA-E2-A1IU.ACE20EC5-2822-4F50-949E-E194C59F0FCD.pdf		30		20		10		30		0		30		60		60	TUMOR FREE							YES	No			NO	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	TCGA-E2-A1IU-01A-11D-A14G-09		TCGA-E2-A1IU-01A-11R-A14C-13	TCGA-E2-A1IU-01A-11R-A14C-13	TCGA-E2-A1IU-01A-11D-A14G-09		TCGA-E2-A1IU-01A-11D-A14G-09	TCGA-E2-A1IU-01A-21-A17J-20	TCGA-E2-A1IU-01A-11D-A14G-09	53c8bbbd-16cd-4790-a99b-f45b0f958157	34a6f1be-b1db-4659-b620-6e21e0f73b2b	TCGA-E2-A1IU-01A-11D-A14F-01	53c8bbbd-16cd-4790-a99b-f45b0f958157	TCGA-E2-A1IU-01A-11D-A14H-05	TCGA-E2-A1IU-01		53c8bbbd-16cd-4790-a99b-f45b0f958157	53c8bbbd-16cd-4790-a99b-f45b0f958157	TCGA-E2-A1IU-01A-11D-A14F-01		TCGA-E2-A1IU-01		34a6f1be-b1db-4659-b620-6e21e0f73b2b	
TCGA-E2-A1L6-01	Stage IIA	44	2	Stage IIA	1312		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1312	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1L6-01	1648	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 7	mutation cluster 4	TCGA-E2-A1L6	1648	0	1648	Breast	TCGA Breast Cancer	breast invasive carcinoma					44	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A1L6-F20570		Positive					Positive	Simple Mastectomy		NO			-16403	1325		0	1648					NO	allred score 5 + 3 = 8					Scheduled Follow-up Submission	2012-1-10	FEMALE			40-49%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.5		YES		Tumor resection	110	NO	Negative			6	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	7								NO	1		false	M0	N1mi	T1c	Stage IIA	TCGA-E2-A1L6.F23523C7-B6E9-4205-BD36-D76E9EE9C453.pdf		0		0		0		0		15		50		35		65	TUMOR FREE	allred score 5 + 3 = 8			allred score =  8	allred score = 8		YES	No			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2007	TCGA-E2-A1L6-01A-11D-A13L-09		TCGA-E2-A1L6-01A-11R-A13P-13	TCGA-E2-A1L6-01A-11R-A13P-13	TCGA-E2-A1L6-01A-11D-A13L-09		TCGA-E2-A1L6-01A-11D-A13L-09	TCGA-E2-A1L6-01A-21-A17J-20	TCGA-E2-A1L6-01A-11D-A13L-09	4142c779-86ab-44f5-9371-539bbaa363d2	bed7e88d-b9ca-480b-b4c5-43c3403c7990	TCGA-E2-A1L6-01A-11D-A13J-01	4142c779-86ab-44f5-9371-539bbaa363d2	TCGA-E2-A1L6-01A-11D-A13K-05	TCGA-E2-A1L6-01		4142c779-86ab-44f5-9371-539bbaa363d2	4142c779-86ab-44f5-9371-539bbaa363d2	TCGA-E2-A1L6-01A-11D-A13J-01		TCGA-E2-A1L6-01		bed7e88d-b9ca-480b-b4c5-43c3403c7990	
TCGA-E2-A1L7-01	Stage IIIA	40	1	Stage IIIA	633		Negative	FEMALE	Negative				Negative	M0	Positive	N2	633	0	LumB		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1L7-01	834	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 2	cluster 5	mutation cluster 5	TCGA-E2-A1L7	834	0	834	Breast	TCGA Breast Cancer	breast invasive carcinoma					40	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A1L7-F20588		Negative					Negative	Modified Radical Mastectomy		NO			-14854	548		0	834					NO	Allred score 1+1 = 2					Scheduled Follow-up Submission	2012-1-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	150	NO	Negative			20	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	5								NO	7		false	M0	N2	T2	Stage IIIA	TCGA-E2-A1L7.E78526AB-D72D-4407-B7E1-2255BB5B2F68.pdf		0		0		0		0		0		25		75		60	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 2		YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A1L7-01A-11D-A142-09		TCGA-E2-A1L7-01A-11R-A143-13	TCGA-E2-A1L7-01A-11R-A143-13	TCGA-E2-A1L7-01A-11D-A142-09		TCGA-E2-A1L7-01A-11D-A142-09	TCGA-E2-A1L7-01A-21-A17J-20	TCGA-E2-A1L7-01A-11D-A142-09	ec38c31b-def8-41cc-8656-57ce98f3faa7	11491d25-c862-49e4-8e23-ebbed8e1d87b	TCGA-E2-A1L7-01A-11D-A141-01	ec38c31b-def8-41cc-8656-57ce98f3faa7	TCGA-E2-A1L7-01A-11D-A145-05	TCGA-E2-A1L7-01		ec38c31b-def8-41cc-8656-57ce98f3faa7	ec38c31b-def8-41cc-8656-57ce98f3faa7	TCGA-E2-A1L7-01A-11D-A141-01		TCGA-E2-A1L7-01		11491d25-c862-49e4-8e23-ebbed8e1d87b	
TCGA-E2-A1L7-11		40			633			FEMALE									633	0	Normal						enrollment			LIVING	0	TCGA-E2-A1L7-11	834	0		C3-BRCA/Luminal							mutation cluster 5	TCGA-E2-A1L7	834	0	834	Breast	TCGA Breast Cancer	breast invasive carcinoma					40	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A1L7-F20588		Negative					Negative	Modified Radical Mastectomy		NO			-14854	548		0	834					NO	Allred score 1+1 = 2					Scheduled Follow-up Submission	2012-1-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	280	NO	Negative			20	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	7		false	M0	N2	T2	Stage IIIA			0		0		0		0		100		0		0		0	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 2		YES	No			YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast	A	LIVING	2009			TCGA-E2-A1L7-11A-33R-A143-13	TCGA-E2-A1L7-11A-33R-A143-13						53e9749e-5554-443b-b41e-5efade6fce7a			53e9749e-5554-443b-b41e-5efade6fce7a	TCGA-E2-A1L7-11A-33D-A145-05			53e9749e-5554-443b-b41e-5efade6fce7a	53e9749e-5554-443b-b41e-5efade6fce7a						
TCGA-E2-A1L8-01	Stage IIA	52	2	Stage IIB	1015		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1015	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1L8-01	1205	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 9	cluster 6	mutation cluster 4	TCGA-E2-A1L8	1205	0	1205	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A1L8-F20578		Positive					Positive	Simple Mastectomy		NO			-19187	912		0	1205					NO	allred score 5 + 3 = 8					Scheduled Follow-up Submission	2012-1-11	FEMALE			40-49%		2+			1.10		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES		Tumor resection	180	NO	Equivocal	Negative		13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6								NO	2		false	M0	N1a	T2	Stage IIA	TCGA-E2-A1L8.9AA68C63-2C14-430A-85C0-5A92F7FCCD36.pdf		0		0		0		0		0		40		60		85	TUMOR FREE	allred score 4 + 3 = 7			allred score = 7	allred score = 8		YES	Yes			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	TCGA-E2-A1L8-01A-11D-A13L-09		TCGA-E2-A1L8-01A-11R-A13P-13	TCGA-E2-A1L8-01A-11R-A13P-13	TCGA-E2-A1L8-01A-11D-A13L-09		TCGA-E2-A1L8-01A-11D-A13L-09	TCGA-E2-A1L8-01A-21-A17J-20	TCGA-E2-A1L8-01A-11D-A13L-09	68c8e567-1ac0-40f1-a3a7-a79d77a4ae12	a18c840d-01e1-4827-a756-46e677b5def8	TCGA-E2-A1L8-01A-11D-A13J-01	68c8e567-1ac0-40f1-a3a7-a79d77a4ae12	TCGA-E2-A1L8-01A-11D-A13K-05	TCGA-E2-A1L8-01		68c8e567-1ac0-40f1-a3a7-a79d77a4ae12	68c8e567-1ac0-40f1-a3a7-a79d77a4ae12	TCGA-E2-A1L8-01A-11D-A13J-01		TCGA-E2-A1L8-01		a18c840d-01e1-4827-a756-46e677b5def8	
TCGA-E2-A1L9-01	Stage IIB	40	3	Stage IIA	388		Positive	FEMALE	Negative				Negative	M0	Positive	N1	388	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1L9-01	598	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-E2-A1L9	598	0	598	Breast	TCGA Breast Cancer	breast invasive carcinoma					40	Right	Sentinel node biopsy alone		TCGA-E2-A1L9-F20597		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		NO			-14868	465		0	598					NO		80-89%				Scheduled Follow-up Submission	2012-1-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	40	NO	Negative			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	6								NO	1		false	M0	N1mi	T1c	Stage IIA	TCGA-E2-A1L9.97B6C43B-4C7D-49FC-BA49-00D2DF41827D.pdf		0		0		0		0		0		0		100		80	TUMOR FREE				allred score = 7	allred score = 7		YES	No	80-89%		YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A1L9-01A-11D-A13L-09		TCGA-E2-A1L9-01A-11R-A13P-13	TCGA-E2-A1L9-01A-11R-A13P-13	TCGA-E2-A1L9-01A-11D-A13L-09		TCGA-E2-A1L9-01A-11D-A13L-09		TCGA-E2-A1L9-01A-11D-A13L-09	05329e4e-6623-4044-9abf-46f3ed4ccfd8	e466e6b6-de5c-402e-9123-66a98b6579cb	TCGA-E2-A1L9-01A-11D-A13J-01	05329e4e-6623-4044-9abf-46f3ed4ccfd8	TCGA-E2-A1L9-01A-11D-A13K-05	TCGA-E2-A1L9-01		05329e4e-6623-4044-9abf-46f3ed4ccfd8	05329e4e-6623-4044-9abf-46f3ed4ccfd8	TCGA-E2-A1L9-01A-11D-A13J-01		TCGA-E2-A1L9-01		e466e6b6-de5c-402e-9123-66a98b6579cb	
TCGA-E2-A1LA-01	Stage IIA	59	5	Stage IIA	463		Positive	FEMALE	Negative				Negative	M0	Positive	N1	463	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1LA-01	748	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 12	TCGA-E2-A1LA	748	0	748	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A1LA-F20586		Positive					Positive	Simple Mastectomy		NO			-21773	581		0	748					NO	allred score 5 + 3 = 8					Scheduled Follow-up Submission	2012-1-12	FEMALE					2+			1.15		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES		Tumor resection	40	NO	Equivocal	Negative		35	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	1		false	M0	N1a	T1c	Stage IIA	TCGA-E2-A1LA.8F401B38-8D91-4F75-ADE5-52521EAA7DFE.pdf		0		0		0		0		0		0		100		90	TUMOR FREE	allred score 5 +3 = 8			allred score = 8	allred score = 8		YES	No			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	TCGA-E2-A1LA-01A-11D-A142-09		TCGA-E2-A1LA-01A-11R-A143-13	TCGA-E2-A1LA-01A-11R-A143-13	TCGA-E2-A1LA-01A-11D-A142-09		TCGA-E2-A1LA-01A-11D-A142-09		TCGA-E2-A1LA-01A-11D-A142-09	9a56eb8b-99fa-4671-99dc-29776dca4cd6	0c31423d-3359-4d38-889a-8156d35472f3	TCGA-E2-A1LA-01A-11D-A141-01	9a56eb8b-99fa-4671-99dc-29776dca4cd6	TCGA-E2-A1LA-01A-11D-A145-05	TCGA-E2-A1LA-01		9a56eb8b-99fa-4671-99dc-29776dca4cd6	9a56eb8b-99fa-4671-99dc-29776dca4cd6	TCGA-E2-A1LA-01A-11D-A141-01		TCGA-E2-A1LA-01		0c31423d-3359-4d38-889a-8156d35472f3	
TCGA-E2-A1LB-01	Stage IIB	41	1	Stage IIB	972		Negative	FEMALE	Positive				Negative	M0	Positive	N1	972	0	Her2		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1LB-01	1231	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-E2-A1LB	1231	0	1231	Breast	TCGA Breast Cancer	breast invasive carcinoma					41	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A1LB-F20650		Negative					Negative	Lumpectomy		NO			-15283			0	1231					NO	Allred score 0+0 = 0					Scheduled Follow-up Submission	2012-1-17	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection			Positive			25	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	3								NO	2			M0	N1	T2	Stage IIB																		TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast		LIVING	2008	TCGA-E2-A1LB-01A-11D-A142-09		TCGA-E2-A1LB-01A-11R-A143-13	TCGA-E2-A1LB-01A-11R-A143-13	TCGA-E2-A1LB-01A-11D-A142-09		TCGA-E2-A1LB-01A-11D-A142-09	TCGA-E2-A1LB-01A-21-A17J-20	TCGA-E2-A1LB-01A-11D-A142-09	acf1ec71-46a5-4e7b-84b1-55203bca29d8	b690db1d-6560-4c02-a3b9-3abc43d39c03	TCGA-E2-A1LB-01A-11D-A141-01	acf1ec71-46a5-4e7b-84b1-55203bca29d8	TCGA-E2-A1LB-01A-11D-A145-05	TCGA-E2-A1LB-01		acf1ec71-46a5-4e7b-84b1-55203bca29d8	acf1ec71-46a5-4e7b-84b1-55203bca29d8	TCGA-E2-A1LB-01A-11D-A141-01		TCGA-E2-A1LB-01		b690db1d-6560-4c02-a3b9-3abc43d39c03	
TCGA-E2-A1LB-11		41			972			FEMALE									972	0	Normal						enrollment			LIVING	0	TCGA-E2-A1LB-11	1231	0		C3-BRCA/Luminal							mutation c1uster 9	TCGA-E2-A1LB	1231	0	1231	Breast	TCGA Breast Cancer	breast invasive carcinoma					41	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A1LB-F20650		Negative					Negative	Lumpectomy		NO			-15283	909		0	1231					NO	Allred score 0+0 = 0					Scheduled Follow-up Submission	2012-1-17	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	150	NO	Positive			25	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	2		false	M0	N1	T2	Stage IIB			0		0		0		0		100		0		0		0	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES	No			YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast	A	LIVING	2008			TCGA-E2-A1LB-11A-22R-A143-13	TCGA-E2-A1LB-11A-22R-A143-13						b34ad5ac-c581-4747-88db-e2d52fa7e463			b34ad5ac-c581-4747-88db-e2d52fa7e463	TCGA-E2-A1LB-11A-22D-A145-05			b34ad5ac-c581-4747-88db-e2d52fa7e463	b34ad5ac-c581-4747-88db-e2d52fa7e463						
TCGA-E2-A1LE-01																													1	TCGA-E2-A1LE-01	879	1	Squamous			BRCA CIMP c7	BRCA basal-like c6		miRNA cluster 7			TCGA-E2-A1LE	361	1	879	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO	NO		71	Right Upper Inner Quadrant|Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A1LE-F20657		Negative					Negative	Simple Mastectomy		NO			-26239	986	879	0				361		NO	Allred score 0+0 = 0					Scheduled Follow-up Submission	2012-1-18	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES		Tumor resection	600	NO	Positive			28	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																							Lung	Distant Metastasis			YES	27		false	M0	N3a	T2	Stage IIIC	TCGA-E2-A1LE.42E3E8C1-D18A-4457-B2F0-FE49F4C027D7.pdf		0		0		0		0		0		30		70		80	WITH TUMOR	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	DECEASED	2008			TCGA-E2-A1LE-01A-12R-A19V-13	TCGA-E2-A1LE-01A-12R-A19V-13			TCGA-E2-A1LE-01A-12D-A19Y-09	TCGA-E2-A1LE-01A-21-A24A-20		776c18b3-4e53-41d6-8838-70a6029c07dd	0f1195ba-3464-497c-9c2f-9555f7af44b7	TCGA-E2-A1LE-01A-12D-A19X-01	776c18b3-4e53-41d6-8838-70a6029c07dd	TCGA-E2-A1LE-01A-12D-A19Z-05	TCGA-E2-A1LE-01		776c18b3-4e53-41d6-8838-70a6029c07dd	776c18b3-4e53-41d6-8838-70a6029c07dd	TCGA-E2-A1LE-01A-12D-A19X-01		TCGA-E2-A1LE-01		0f1195ba-3464-497c-9c2f-9555f7af44b7	
TCGA-E2-A1LG-01	Stage IIA	50	2	Stage IIA	350		Negative	FEMALE	Negative				Negative	M0	Negative	N0	350	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1LG-01	574	0	Squamous	C4-BRCA/Basal	cluster 5	Low purity c2	KIRC-like c1	BRCA basal-like c8	miRNA cluster 11	cluster 5	mutation cluster 5	TCGA-E2-A1LG	574	0	574	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A1LG-F20667		Negative					Negative	Modified Radical Mastectomy		NO			-18492	252		0	574					NO	Allred score 0+0 = 0					Scheduled Follow-up Submission	2012-1-17	FEMALE			60-69%		2+			1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES		Tumor resection	310	NO	Equivocal	Negative		19	Negative	Peri (6-12 months since last menstrual period)																		5	5								NO	0		false	M0	N0	T2	Stage IIA	TCGA-E2-A1LG.08A790DE-B01D-4140-BB1C-B4844291D71E.pdf		0		0		0		0		0		10		90		95	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES	Yes			NO	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	TCGA-E2-A1LG-01A-21D-A14K-09		TCGA-E2-A1LG-01A-21R-A14L-13	TCGA-E2-A1LG-01A-21R-A14L-13	TCGA-E2-A1LG-01A-21D-A14K-09		TCGA-E2-A1LG-01A-21D-A14K-09	TCGA-E2-A1LG-01A-41-A17J-20	TCGA-E2-A1LG-01A-21D-A14K-09	94d92cd8-21cf-495d-b4fe-8f8c6067fe9e	b2cc4c34-e90b-4377-b50b-222e507cffcc	TCGA-E2-A1LG-01A-21D-A14J-01	94d92cd8-21cf-495d-b4fe-8f8c6067fe9e	TCGA-E2-A1LG-01A-21D-A14N-05	TCGA-E2-A1LG-01		94d92cd8-21cf-495d-b4fe-8f8c6067fe9e	94d92cd8-21cf-495d-b4fe-8f8c6067fe9e	TCGA-E2-A1LG-01A-21D-A14J-01		TCGA-E2-A1LG-01		b2cc4c34-e90b-4377-b50b-222e507cffcc	
TCGA-E2-A1LH-01	Stage I	59	3	Stage I	2875		Negative	FEMALE	Negative				Negative	M0	Negative	N0	2875	0	Basal		Negative				enrollment	T1	T1	LIVING	0	TCGA-E2-A1LH-01	3247	0	High	C4-BRCA/Basal	cluster 5	Low purity c2		BRCA basal-like c8			mutation cluster 2	TCGA-E2-A1LH	3247	0	3247	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Right	Sentinel node biopsy alone		TCGA-E2-A1LH-F20649		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		NO			-21628	2998		0	3247					NO						Scheduled Follow-up Submission	2012-1-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	130	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5									NO	0		false	M0	N0	T1c	Stage I	TCGA-E2-A1LH.DAB174BB-862D-49BE-9BA4-9C11C4489305.pdf		100		0		0		0		0		30		70		80	TUMOR FREE		ACIS					YES	No			YES	Primary Tumor	01		5th	YES	NO	YES	E2	Breast	A	LIVING	2002	TCGA-E2-A1LH-01A-11D-A14G-09		TCGA-E2-A1LH-01A-11R-A14C-13	TCGA-E2-A1LH-01A-11R-A14C-13	TCGA-E2-A1LH-01A-11D-A14G-09		TCGA-E2-A1LH-01A-11D-A14G-09		TCGA-E2-A1LH-01A-11D-A14G-09	66f3892f-f4ec-412c-9c56-a9e9b56a15ee	8bab6eb6-da3c-49d9-b786-d078f8ebda09	TCGA-E2-A1LH-01A-11D-A14F-01	66f3892f-f4ec-412c-9c56-a9e9b56a15ee	TCGA-E2-A1LH-01A-11D-A14H-05	TCGA-E2-A1LH-01		66f3892f-f4ec-412c-9c56-a9e9b56a15ee	66f3892f-f4ec-412c-9c56-a9e9b56a15ee	TCGA-E2-A1LH-01A-11D-A14F-01		TCGA-E2-A1LH-01		8bab6eb6-da3c-49d9-b786-d078f8ebda09	
TCGA-E2-A1LH-11		59			2875			FEMALE									2875	0	Normal						enrollment			LIVING	0	TCGA-E2-A1LH-11	3247	0		C4-BRCA/Basal							mutation cluster 2	TCGA-E2-A1LH	3247	0	3247	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Right	Sentinel node biopsy alone		TCGA-E2-A1LH-F20649		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		NO			-21628	2998		0	3247					NO						Scheduled Follow-up Submission	2012-1-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	60	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T1c	Stage I			0		0		0		0		20		80		0		0	TUMOR FREE		ACIS					YES	No			YES	Solid Tissue Normal	11		5th	YES	NO	YES	E2	Breast	A	LIVING	2002			TCGA-E2-A1LH-11A-22R-A14C-13	TCGA-E2-A1LH-11A-22R-A14C-13						c0c2059a-2931-4834-84a7-bfacf137c182			c0c2059a-2931-4834-84a7-bfacf137c182				c0c2059a-2931-4834-84a7-bfacf137c182	c0c2059a-2931-4834-84a7-bfacf137c182						
TCGA-E2-A1LI-01	Stage IIB	57	3	Stage IIB	2750		Negative	FEMALE	Negative				Negative	M0	Positive	N1	2750	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1LI-01	3121	0	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 7		mutation c1uster 9	TCGA-E2-A1LI	3121	0	3121	Breast	TCGA Breast Cancer	breast invasive carcinoma					57	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A1LI-F20623		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		NO			-21064	2815		0	3121					NO						Scheduled Follow-up Submission	2012-1-12	FEMALE								1.21		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	80	NO	Equivocal	Negative		2	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4									NO	0		false	M0	N1	T2	Stage IIB	TCGA-E2-A1LI.B3A319BE-2230-43E2-91E5-A3B3C76B85BA.pdf		0		0		0		0		0		30		70		85	TUMOR FREE		ACIS					YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2003	TCGA-E2-A1LI-01A-12D-A159-09		TCGA-E2-A1LI-01A-12R-A156-13	TCGA-E2-A1LI-01A-12R-A156-13	TCGA-E2-A1LI-01A-12D-A159-09		TCGA-E2-A1LI-01A-12D-A159-09		TCGA-E2-A1LI-01A-12D-A159-09	fa643dcc-4f4c-44d0-9f4d-199de04f8d2b	178e0166-9a9b-4495-896e-4a08f661c49a	TCGA-E2-A1LI-01A-12D-A160-01	fa643dcc-4f4c-44d0-9f4d-199de04f8d2b	TCGA-E2-A1LI-01A-12D-A161-05	TCGA-E2-A1LI-01		fa643dcc-4f4c-44d0-9f4d-199de04f8d2b	fa643dcc-4f4c-44d0-9f4d-199de04f8d2b	TCGA-E2-A1LI-01A-12D-A160-01		TCGA-E2-A1LI-01		178e0166-9a9b-4495-896e-4a08f661c49a	
TCGA-E2-A1LI-11		57			2750			FEMALE									2750	0							enrollment			LIVING	0	TCGA-E2-A1LI-11	3121	0		C4-BRCA/Basal							mutation c1uster 9	TCGA-E2-A1LI	3121	0	3121	Breast	TCGA Breast Cancer	breast invasive carcinoma					57	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A1LI-F20623		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		NO			-21064	2815		0	3121					NO						Scheduled Follow-up Submission	2012-1-12	FEMALE								1.21		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	190	NO	Equivocal	Negative		2	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N1	T2	Stage IIB			0		0		0		0		10		90		0		0	TUMOR FREE		ACIS					YES	No			YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast	A	LIVING	2003														TCGA-E2-A1LI-11A-23D-A161-05										
TCGA-E2-A1LK-01	Stage IIIC	84	4	Stage IIIA		266	Negative	FEMALE	Negative				Negative	M0	Positive	N1	266	1	Basal		Negative				enrollment	T_Other	T3	DECEASED	1	TCGA-E2-A1LK-01	266	1	Squamous	C4-BRCA/Basal	cluster 3	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 11	cluster 5	mutation cluster 5	TCGA-E2-A1LK	155	1	266	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	YES		84	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A1LK-F20620		Negative					Negative	Modified Radical Mastectomy		NO		200	-30757	1051	266	0				155		NO	Allred score 0+0 = 0					Scheduled Follow-up Submission	2012-1-12	FEMALE			80-89%		2+			1.41		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	70	NO	Equivocal	Negative		15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Allred Score = 0	Equivocal	2+	Allred score 0+0 = 0	Negative			30-39%	0.95				Negative			Allred score 0+0 = 0	Negative	3	5				Other, specify	Locoregional Disease	Left axilla		YES	11		false	M0	N3a	T4b	Stage IIIC	TCGA-E2-A1LK.6CC4E6EF-6664-448E-933E-FFA9117C7ABF.pdf		0		0		0		0		0		30		70		90	WITH TUMOR	Allred score 0+0 = 0		Allred score = 0	Allred score = 0	Allred score = 0		YES	No			NO	Primary Tumor	01		6th	NO	NO	YES	E2	Breast	A	DECEASED	2008	TCGA-E2-A1LK-01A-21D-A14G-09		TCGA-E2-A1LK-01A-21R-A14C-13	TCGA-E2-A1LK-01A-21R-A14C-13	TCGA-E2-A1LK-01A-21D-A14G-09		TCGA-E2-A1LK-01A-21D-A14G-09	TCGA-E2-A1LK-01A-11-A17K-20	TCGA-E2-A1LK-01A-21D-A14G-09	d6301614-9ba7-4632-bdca-ac1b11e8e811	0efeb3b3-219b-452f-bc62-148b1b2d909b	TCGA-E2-A1LK-01A-21D-A14F-01	d6301614-9ba7-4632-bdca-ac1b11e8e811	TCGA-E2-A1LK-01A-21D-A14H-05	TCGA-E2-A1LK-01		d6301614-9ba7-4632-bdca-ac1b11e8e811	d6301614-9ba7-4632-bdca-ac1b11e8e811	TCGA-E2-A1LK-01A-21D-A14F-01		TCGA-E2-A1LK-01		0efeb3b3-219b-452f-bc62-148b1b2d909b	
TCGA-E2-A1LL-01	Stage IIIA	73	1	Stage IIIA	1014		Negative	FEMALE	Negative				Negative	M0	Positive	N2	1014	0	Basal		Negative				enrollment	T_Other	T3	LIVING	0	TCGA-E2-A1LL-01	1309	0	Squamous	C2-Squamous-like	cluster 1	BRCA CIMP c7	KIRC-like c1	squamous-like c4	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E2-A1LL	1303	1	1309	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	NO		73	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A1LL-F20616		Negative					Negative	Simple Mastectomy		NO			-27028	988		0	1309			1303		NO	Allred score 0+0 = 0					Scheduled Follow-up Submission	2012-1-17	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	290	NO	Negative			44	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4				Liver	Distant Metastasis			YES	5		false	MX	N2a	T3	Stage IIIA	TCGA-E2-A1LL.3327975F-94BE-460E-9900-E063340927BE.pdf		3		1		0		1		0		25		75		75	WITH TUMOR	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	TCGA-E2-A1LL-01A-11D-A142-09		TCGA-E2-A1LL-01A-11R-A143-13	TCGA-E2-A1LL-01A-11R-A143-13	TCGA-E2-A1LL-01A-11D-A142-09		TCGA-E2-A1LL-01A-11D-A142-09	TCGA-E2-A1LL-01A-21-A17J-20	TCGA-E2-A1LL-01A-11D-A142-09	526c9170-0f25-4374-9287-1fc40acb6555	d64ae769-0555-42d9-ab57-abbb6f292d82	TCGA-E2-A1LL-01A-11D-A141-01	526c9170-0f25-4374-9287-1fc40acb6555	TCGA-E2-A1LL-01A-11D-A145-05	TCGA-E2-A1LL-01		526c9170-0f25-4374-9287-1fc40acb6555	526c9170-0f25-4374-9287-1fc40acb6555	TCGA-E2-A1LL-01A-11D-A141-01		TCGA-E2-A1LL-01		d64ae769-0555-42d9-ab57-abbb6f292d82	
TCGA-E2-A1LS-01	Stage IA	46		Stage I	239		Negative	FEMALE	Negative				Negative	M0	Negative	N0	239	0	Basal		Negative				enrollment	T1	T1	LIVING	0	TCGA-E2-A1LS-01	470	0		C4-BRCA/Basal	cluster 3	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14		mutation cluster 5	TCGA-E2-A1LS	470	0	470	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A1LS-F20603		Negative					Negative	Simple Mastectomy		NO			-16887	176		0	470					NO	Allred score 0+0 = 0					Scheduled Follow-up Submission	2012-1-17	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.5		YES		Tumor resection	100	NO	Negative			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		3									NO	0		false	M0	N0	T1c	Stage IA	TCGA-E2-A1LS.A514658A-FB29-4AA0-9451-2A960B3720C1.pdf		2		2		0		1		0		20		80		80	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES	No			NO	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	TCGA-E2-A1LS-01A-12D-A159-09		TCGA-E2-A1LS-01A-12R-A156-13	TCGA-E2-A1LS-01A-12R-A156-13	TCGA-E2-A1LS-01A-12D-A159-09		TCGA-E2-A1LS-01A-12D-A159-09	TCGA-E2-A1LS-01A-21-A17J-20	TCGA-E2-A1LS-01A-12D-A159-09	81239059-614b-46b7-a21e-224ec62e2939			81239059-614b-46b7-a21e-224ec62e2939	TCGA-E2-A1LS-01A-12D-A161-05	TCGA-E2-A1LS-01		81239059-614b-46b7-a21e-224ec62e2939	81239059-614b-46b7-a21e-224ec62e2939						
TCGA-E2-A1LS-11		46			239			FEMALE									239	0	Normal						enrollment			LIVING	0	TCGA-E2-A1LS-11	470	0		C4-BRCA/Basal							mutation cluster 5	TCGA-E2-A1LS	470	0	470	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A1LS-F20603		Negative					Negative	Simple Mastectomy		NO			-16887	176		0	470					NO	Allred score 0+0 = 0					Scheduled Follow-up Submission	2012-1-17	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.5		YES		Tumor resection	280	NO	Negative			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0		false	M0	N0	T1c	Stage IA			2		0		0		0		0		100		0		0	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES	No			NO	Solid Tissue Normal	11		7th	YES	NO	YES	E2	Breast	A	LIVING	2010			TCGA-E2-A1LS-11A-32R-A156-13	TCGA-E2-A1LS-11A-32R-A156-13						a2c2973d-0af5-4065-a5b0-1dd73abdc581			a2c2973d-0af5-4065-a5b0-1dd73abdc581	TCGA-E2-A1LS-11A-32D-A161-05			a2c2973d-0af5-4065-a5b0-1dd73abdc581	a2c2973d-0af5-4065-a5b0-1dd73abdc581						
TCGA-E2-A2P5-01																													0	TCGA-E2-A2P5-01	515	0	High			BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 5			TCGA-E2-A2P5	515	0	515	Breast	TCGA Breast Cancer	breast invasive carcinoma					78	Left	Axillary lymph node dissection alone		TCGA-E2-A2P5-F33516		Positive					Positive	Modified Radical Mastectomy		NO			-28621	219		0	515					NO	Allred score = 8					Scheduled Follow-up Submission	2012-6-29	FEMALE								1.0		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	260	NO		Negative		25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	21		true	M0	N3	T2	Stage IIIC	TCGA-E2-A2P5.85E91C9F-9F61-4A25-B4D9-1BCBC7108F5E.pdf		2		0		0		0		0		40		60		85	TUMOR FREE	Allred score = 8			Allred score = 8	Allred score = 8		YES	Yes			YES	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2011			TCGA-E2-A2P5-01A-11R-A19V-13	TCGA-E2-A2P5-01A-11R-A19V-13			TCGA-E2-A2P5-01A-11D-A19Y-09	TCGA-E2-A2P5-01A-21-A24A-20		90d04601-4a15-44fc-bf1b-e0859310e644	5a5c03bd-ebac-4ee3-b6dd-d5d488bb5611	TCGA-E2-A2P5-01A-11D-A19X-01	90d04601-4a15-44fc-bf1b-e0859310e644	TCGA-E2-A2P5-01A-11D-A19Z-05	TCGA-E2-A2P5-01		90d04601-4a15-44fc-bf1b-e0859310e644	90d04601-4a15-44fc-bf1b-e0859310e644	TCGA-E2-A2P5-01A-11D-A19X-01		TCGA-E2-A2P5-01		5a5c03bd-ebac-4ee3-b6dd-d5d488bb5611	
TCGA-E2-A2P6-01																													0	TCGA-E2-A2P6-01	168	0	Iq			BRCA CIMP c7			miRNA cluster 14			TCGA-E2-A2P6	168	0	168	Breast	TCGA Breast Cancer	breast invasive carcinoma					77	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A2P6-F33514	Negative	Positive				Modified radical mastectomy	Positive	Lumpectomy		NO			-28411	174		0	168					NO	Allread score 5+3 = 8					Scheduled Follow-up Submission	2012-6-29	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	80	NO		Negative		5	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1		true	M0	N1	T2	Stage IIB	TCGA-E2-A2P6.E6A21CE6-841D-4D9B-A563-80B9BAF6E682.pdf		2		0		1		0		0		34		65		88	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 8		YES	No			NO	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2011			TCGA-E2-A2P6-01A-11R-A19V-13	TCGA-E2-A2P6-01A-11R-A19V-13			TCGA-E2-A2P6-01A-11D-A19Y-09			bc94874b-f73a-44c8-bc6f-9ec50972c9b2	7d50bbff-dd79-407c-8701-a42c332c404f	TCGA-E2-A2P6-01A-11D-A19X-01	bc94874b-f73a-44c8-bc6f-9ec50972c9b2	TCGA-E2-A2P6-01A-11D-A19Z-05	TCGA-E2-A2P6-01		bc94874b-f73a-44c8-bc6f-9ec50972c9b2	bc94874b-f73a-44c8-bc6f-9ec50972c9b2	TCGA-E2-A2P6-01A-11D-A19X-01		TCGA-E2-A2P6-01		7d50bbff-dd79-407c-8701-a42c332c404f	
TCGA-E2-A3DX-01																			LumA										0	TCGA-E2-A3DX-01	478	0	Quiet	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-E2-A3DX	478	0	478	Breast	TCGA Breast Cancer	breast invasive carcinoma					43	Right	Axillary lymph node dissection alone		TCGA-E2-A3DX-F35822		Positive					Positive	Modified Radical Mastectomy		NO			-15969	142		0	478					NO							2012-10-9	FEMALE								7.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	180	NO		Positive	NO	36	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	25		false	M0	N3	T2	Stage IIIC	TCGA-E2-A3DX.3B7CA8ED-58E2-4609-BE41-46525D3732E7.pdf		10		0		0		0		5		65		30		60	TUMOR FREE				Allred score = 8	Allred score = 7	YES	YES	No			YES	Primary Tumor	01		7th		NO	YES	E2	Breast	A	LIVING	2011			TCGA-E2-A3DX-01A-21R-A214-13	TCGA-E2-A3DX-01A-21R-A214-13			TCGA-E2-A3DX-01A-21D-A20S-09	TCGA-E2-A3DX-01A-11-A24A-20		2424c058-78c6-41dd-86e9-efcd61b72add	cba10c3b-fd66-4fe2-8a2e-1f7066481c51	TCGA-E2-A3DX-01A-21D-A20R-01	2424c058-78c6-41dd-86e9-efcd61b72add	TCGA-E2-A3DX-01A-21D-A212-05	TCGA-E2-A3DX-01		2424c058-78c6-41dd-86e9-efcd61b72add	2424c058-78c6-41dd-86e9-efcd61b72add	TCGA-E2-A3DX-01A-21D-A20R-01		TCGA-E2-A3DX-01		cba10c3b-fd66-4fe2-8a2e-1f7066481c51	
TCGA-E2-A56Z-01																													0	TCGA-E2-A56Z-01	252	0										TCGA-E2-A56Z	252	0	252	Breast	TCGA Breast Cancer	breast invasive carcinoma					69	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A56Z-F67584		Positive					Positive	Lumpectomy		NO			-25282	254		0	252						Allred 8 = 5+3	10-19%			2.2		2014-11-6	FEMALE			10-19%		2+	200	3.2	1.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	150	NO	Equivocal	Negative	NO	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1		true	M0	N1a	T2	Stage IIB	TCGA-E2-A56Z.83AAF7BF-131D-4044-AD3B-670B838A23D6.pdf		0		0		0		0		0		5		95		90	TUMOR FREE	Allred 5 = 2+3			Allred Score	Allred Score	YES	YES	No	<10%		YES	Primary Tumor	01		7th		NO	YES	E2	Breast	A	LIVING	2012			TCGA-E2-A56Z-01A-12R-A29V-13	TCGA-E2-A56Z-01A-12R-A29V-13			TCGA-E2-A56Z-01A-12D-A29N-09			96af7552-6f51-4abe-8394-b9e966a70228	f6d13af1-9daf-4ede-92d7-986820f4e3cd	TCGA-E2-A56Z-01A-12D-A29M-01	96af7552-6f51-4abe-8394-b9e966a70228	TCGA-E2-A56Z-01A-12D-A29O-05	TCGA-E2-A56Z-01		96af7552-6f51-4abe-8394-b9e966a70228	96af7552-6f51-4abe-8394-b9e966a70228	TCGA-E2-A56Z-01A-12D-A29M-01		TCGA-E2-A56Z-01		f6d13af1-9daf-4ede-92d7-986820f4e3cd	
TCGA-E2-A570-01																													0	TCGA-E2-A570-01	931	0										TCGA-E2-A570	931	0	931	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Right Lower Inner Quadrant	Sentinel node biopsy alone		TCGA-E2-A570-F61335		Positive					Positive	Simple Mastectomy		NO			-17456	416		0	931						Allred 7 = 5+2				2.0		2014-6-27	FEMALE			10-19%		2+	200	2.2	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	80	NO	Equivocal	Negative	NO	7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	1		true	M0	N1mi	T1c	Stage IB	TCGA-E2-A570.803922CD-3D37-47DC-8BDC-EF8F4779685A.pdf		5		2		5		0		0		60		35		70	TUMOR FREE	Allred 8 = 5+3			Allred Score	Allred Score	YES	YES	No			NO	Primary Tumor	01		7th		NO	YES	E2	Breast	A	LIVING	2011			TCGA-E2-A570-01A-11R-A29V-13	TCGA-E2-A570-01A-11R-A29V-13			TCGA-E2-A570-01A-11D-A29N-09			635a7c2c-7731-48c1-948d-4d7ecf05c472	b3068552-cd69-4e1f-942d-346a779fefcb	TCGA-E2-A570-01A-11D-A29M-01	635a7c2c-7731-48c1-948d-4d7ecf05c472	TCGA-E2-A570-01A-11D-A29O-05	TCGA-E2-A570-01		635a7c2c-7731-48c1-948d-4d7ecf05c472	635a7c2c-7731-48c1-948d-4d7ecf05c472	TCGA-E2-A570-01A-11D-A29M-01		TCGA-E2-A570-01		b3068552-cd69-4e1f-942d-346a779fefcb	
TCGA-E2-A572-01																													0	TCGA-E2-A572-01	1208	0										TCGA-E2-A572	1208	0	1208	Breast	TCGA Breast Cancer	breast invasive carcinoma					72	Left	Axillary lymph node dissection alone		TCGA-E2-A572-F65007		Positive	3 Point Scale	1+	3 Point Scale		Positive	Modified Radical Mastectomy		YES			-26399	560		0	1208												2014-9-17	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	140	NO	Equivocal	Negative	NO	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	8	true	M0	N2	T2	Stage IIIA	TCGA-E2-A572.5CED2FBF-42DB-4D17-95C0-DEAE27BBFD02.pdf		3		0		2		0		0		78		20		80	TUMOR FREE						YES	YES	Yes			YES	Primary Tumor	01		7th		NO	YES	E2	Breast	A	LIVING	2011			TCGA-E2-A572-01A-13R-A31S-13	TCGA-E2-A572-01A-13R-A31S-13						43a88718-f528-4d0b-88e6-f2ade6854c53	bdeb88bb-5ce8-4221-988e-1386605e693f		43a88718-f528-4d0b-88e6-f2ade6854c53	TCGA-E2-A572-01A-13D-A31V-05	TCGA-E2-A572-01		43a88718-f528-4d0b-88e6-f2ade6854c53	43a88718-f528-4d0b-88e6-f2ade6854c53					bdeb88bb-5ce8-4221-988e-1386605e693f	
TCGA-E2-A573-01																													0	TCGA-E2-A573-01	1062	0										TCGA-E2-A573	1062	0	1062	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A573-F61338		Negative					Negative	Other		NO			-17689	595		0	1062						Allred 0 = 0+0				1.8		2014-6-27	FEMALE			10-19%		2+	200	2.3	1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	70	NO	Equivocal	Negative	NO	4	Negative	Peri (6-12 months since last menstrual period)																											NO	0		true	M0	N0	T1c	Stage IA	TCGA-E2-A573.14EB270E-0AAB-4C12-8D71-ED79076C2E93.pdf		22		2		12		2		0		30		58		70	TUMOR FREE	Allred 0 = 0+0			Allred Score	Allred Score	YES	YES	No			YES	Primary Tumor	01	Partial Mastectomy	7th		NO	YES	E2	Breast	A	LIVING	2011			TCGA-E2-A573-01A-11R-A29V-13	TCGA-E2-A573-01A-11R-A29V-13			TCGA-E2-A573-01A-11D-A29N-09			be17bc7b-550a-461b-9f7b-2a5845cc12b2	150d0521-0135-44b1-b5c5-635050b30973	TCGA-E2-A573-01A-11D-A29M-01	be17bc7b-550a-461b-9f7b-2a5845cc12b2	TCGA-E2-A573-01A-11D-A29O-05	TCGA-E2-A573-01		be17bc7b-550a-461b-9f7b-2a5845cc12b2	be17bc7b-550a-461b-9f7b-2a5845cc12b2	TCGA-E2-A573-01A-11D-A29M-01		TCGA-E2-A573-01		150d0521-0135-44b1-b5c5-635050b30973	
TCGA-E2-A574-01																													0	TCGA-E2-A574-01	808	0										TCGA-E2-A574	808	0	808	Breast	TCGA Breast Cancer	breast invasive carcinoma					44	Left	Sentinel node biopsy alone		TCGA-E2-A574-F67581		Negative					Negative	Lumpectomy		NO			-16195	429		0	808						Allred 0 = 0+0				2.8		2014-11-6	FEMALE			10-19%		2+	200	2.8	1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO	Equivocal	Negative	NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0		true	M0	N0	T2	Stage IIA	TCGA-E2-A574.F3FAB505-03FF-4FAA-ABB6-96AD20F47871.pdf		1		0		0		0		0		0		100		70	TUMOR FREE	Allred 0 = 0+0			Allred Score	Allred Score	YES	YES	No			YES	Primary Tumor	01		7th		NO	YES	E2	Breast	A	LIVING	2011			TCGA-E2-A574-01A-11R-A29V-13	TCGA-E2-A574-01A-11R-A29V-13			TCGA-E2-A574-01A-11D-A29N-09			fec9b75b-9a91-4979-9056-ecdd852429d8	2df2ecf5-359b-4a32-a24f-e93f64828f7e	TCGA-E2-A574-01A-11D-A29M-01	fec9b75b-9a91-4979-9056-ecdd852429d8	TCGA-E2-A574-01A-11D-A29O-05	TCGA-E2-A574-01		fec9b75b-9a91-4979-9056-ecdd852429d8	fec9b75b-9a91-4979-9056-ecdd852429d8	TCGA-E2-A574-01A-11D-A29M-01		TCGA-E2-A574-01		2df2ecf5-359b-4a32-a24f-e93f64828f7e	
TCGA-E2-A576-01																													0	TCGA-E2-A576-01	1043	0										TCGA-E2-A576	1043	0	1043	Breast	TCGA Breast Cancer	breast invasive carcinoma					69	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A576-F67575		Positive					Positive	Lumpectomy		YES			-25350	343		0	1043												2014-11-6	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	80	NO	Equivocal	Negative	NO	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	true	MX	N0	T1c	Stage IA	TCGA-E2-A576.967CCAA8-5BC6-4744-BD9A-3DFEF9EF4F27.pdf		1		0		0		0		0		0		100		70	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th		NO	YES	E2	Breast	A	LIVING	2011			TCGA-E2-A576-01A-11R-A31S-13	TCGA-E2-A576-01A-11R-A31S-13						1323e58e-5e3f-459a-99ff-e7a6748d3d77	67328c5c-3165-45cc-b5ca-09eabe931a2c	TCGA-E2-A576-01A-11D-A31T-01	1323e58e-5e3f-459a-99ff-e7a6748d3d77	TCGA-E2-A576-01A-11D-A31V-05	TCGA-E2-A576-01		1323e58e-5e3f-459a-99ff-e7a6748d3d77	1323e58e-5e3f-459a-99ff-e7a6748d3d77	TCGA-E2-A576-01A-11D-A31T-01		TCGA-E2-A576-01		67328c5c-3165-45cc-b5ca-09eabe931a2c	
TCGA-E2-A9RU-01																													0	TCGA-E2-A9RU-01	391	0										TCGA-E2-A9RU	391	0	391	Breast	TCGA Breast Cancer	breast invasive carcinoma					90	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A9RU-F67578		Positive					Negative	Lumpectomy		YES			-32873	188		0	391							70-79%					2014-11-6	FEMALE					2+			1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	220	NO	Equivocal	Negative	NO	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	12		true	MX	N3a	T2	Stage IIIC	TCGA-E2-A9RU.E28607CD-0847-46F4-8E69-2D1DC80DE56F.pdf		5		2		5		0		10		20		65		65	TUMOR FREE					Allred Score 6	YES	YES	No			YES	Primary Tumor	01		7th		NO	YES	E2	Breast	A	LIVING	2013			TCGA-E2-A9RU-01A-11R-A41G-13	TCGA-E2-A9RU-01A-11R-A41G-13						12037b1a-ef64-4ea7-99c8-703132eb2d1e	7f4d75ed-36ef-4cca-a38b-3f4b3f65fb75	TCGA-E2-A9RU-01A-11D-A41E-01	12037b1a-ef64-4ea7-99c8-703132eb2d1e	TCGA-E2-A9RU-01A-11D-A41Q-05	TCGA-E2-A9RU-01		12037b1a-ef64-4ea7-99c8-703132eb2d1e	12037b1a-ef64-4ea7-99c8-703132eb2d1e	TCGA-E2-A9RU-01A-11D-A41E-01		TCGA-E2-A9RU-01		7f4d75ed-36ef-4cca-a38b-3f4b3f65fb75	
TCGA-E9-A1N3-01	Stage IIIA	70	1	Stage IIIA	0			FEMALE	Negative				Negative	M0	Positive	N2	0	0	LumA						enrollment	T1	T1	LIVING		TCGA-E9-A1N3-01			Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7		mutation c1uster 9	TCGA-E9-A1N3				Breast	TCGA Breast Cancer	breast invasive carcinoma					70	Right Upper Inner Quadrant	Axillary lymph node dissection alone										Modified Radical Mastectomy		NO			-25714	65		0	0					NO							2011-5-26	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	230	NO				7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4										7		true	M0	N2	T1c	Stage IIIA	TCGA-E9-A1N3.4F50E811-0743-440B-9094-6BA0F40BD734.pdf		0		0		0		0		0		0		100		90								YES	No				Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2010	TCGA-E9-A1N3-01A-12D-A159-09		TCGA-E9-A1N3-01A-12R-A156-13	TCGA-E9-A1N3-01A-12R-A156-13	TCGA-E9-A1N3-01A-12D-A159-09		TCGA-E9-A1N3-01A-12D-A159-09	TCGA-E9-A1N3-01A-21-A17J-20	TCGA-E9-A1N3-01A-12D-A159-09	aaddb80d-7710-4aab-8efc-e84da79f9c68	80b0ec2b-db01-42de-a4c5-c699754d5053	TCGA-E9-A1N3-01A-12D-A160-01	aaddb80d-7710-4aab-8efc-e84da79f9c68	TCGA-E9-A1N3-01A-12D-A161-05	TCGA-E9-A1N3-01		aaddb80d-7710-4aab-8efc-e84da79f9c68	aaddb80d-7710-4aab-8efc-e84da79f9c68	TCGA-E9-A1N3-01A-12D-A160-01		TCGA-E9-A1N3-01		80b0ec2b-db01-42de-a4c5-c699754d5053	
TCGA-E9-A1N4-01	Stage IIIA	41	2	Stage IIIA	0		Positive	FEMALE	Negative				Negative	M0	Positive	N2	0	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1N4-01	1000	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation c1uster 9	TCGA-E9-A1N4	1000	0	1000	Breast	TCGA Breast Cancer	breast invasive carcinoma					41	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N4-F39767		Positive					Positive			NO			-15055	65		0	1000					NO						Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8520/3	C50.9		YES		Tumor resection	310	NO	Positive		NO	7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	7								NO	4	0	true	M0	N2	T2	Stage IIIA	TCGA-E9-A1N4.64B91C7E-E6D8-4952-B49F-0F5D57332994.pdf		2		0		0		0		2		33		65		80	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2010	TCGA-E9-A1N4-01A-11D-A14K-09		TCGA-E9-A1N4-01A-11R-A14L-13	TCGA-E9-A1N4-01A-11R-A14L-13	TCGA-E9-A1N4-01A-11D-A14K-09		TCGA-E9-A1N4-01A-11D-A14K-09	TCGA-E9-A1N4-01A-21-A17K-20	TCGA-E9-A1N4-01A-11D-A14K-09	55b3f26e-8f8f-48b8-8c3a-4e648ac7e05a	0ad8db08-453f-4b99-9bff-4c463648a8f6	TCGA-E9-A1N4-01A-11D-A14J-01	55b3f26e-8f8f-48b8-8c3a-4e648ac7e05a	TCGA-E9-A1N4-01A-11D-A14N-05	TCGA-E9-A1N4-01		55b3f26e-8f8f-48b8-8c3a-4e648ac7e05a	55b3f26e-8f8f-48b8-8c3a-4e648ac7e05a	TCGA-E9-A1N4-01A-11D-A14J-01		TCGA-E9-A1N4-01		0ad8db08-453f-4b99-9bff-4c463648a8f6	
TCGA-E9-A1N4-11		41			0			FEMALE									0	0	Normal						enrollment			LIVING	0	TCGA-E9-A1N4-11	1000	0		C3-BRCA/Luminal							mutation c1uster 9	TCGA-E9-A1N4	1000	0	1000	Breast	TCGA Breast Cancer	breast invasive carcinoma					41	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N4-F39767		Positive					Positive			NO			-15055	65		0	1000					NO						Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8520/3	C50.9		YES		Tumor resection	340	NO	Positive		NO	7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	4	0	true	M0	N2	T2	Stage IIIA			0		0		0		0		3		97		0		0	TUMOR FREE						YES	YES	No			YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2010			TCGA-E9-A1N4-11A-33R-A14L-13	TCGA-E9-A1N4-11A-33R-A14L-13						922b7051-1447-4e8d-9343-c5521ee45346			922b7051-1447-4e8d-9343-c5521ee45346	TCGA-E9-A1N4-11A-33D-A14N-05			922b7051-1447-4e8d-9343-c5521ee45346	922b7051-1447-4e8d-9343-c5521ee45346						
TCGA-E9-A1N5-01	Stage IIB	45	5	Stage IIB	0		Positive	FEMALE	Negative				Negative	M0	Positive	N1	0	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1N5-01	1120	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 3	TCGA-E9-A1N5	1120	0	1120	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N5-F39765		Positive					Positive			NO			-16736	63		0	1120					NO						Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	190	NO	Positive		NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO	2	0	true	M0	N1	T2	Stage IIB	TCGA-E9-A1N5.224A51C8-8EEB-424C-AD88-44C4321050EA.pdf		0		0		0		0		0		0		100		80	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2010	TCGA-E9-A1N5-01A-11D-A14G-09		TCGA-E9-A1N5-01A-11R-A14C-13	TCGA-E9-A1N5-01A-11R-A14C-13	TCGA-E9-A1N5-01A-11D-A14G-09		TCGA-E9-A1N5-01A-11D-A14G-09	TCGA-E9-A1N5-01A-21-A17J-20	TCGA-E9-A1N5-01A-11D-A14G-09	1adf0e70-b1fb-4862-8a01-6454b09636f4	2dedc4aa-78bc-48c6-b280-c0b56e56beca	TCGA-E9-A1N5-01A-11D-A14F-01	1adf0e70-b1fb-4862-8a01-6454b09636f4	TCGA-E9-A1N5-01A-11D-A14H-05	TCGA-E9-A1N5-01		1adf0e70-b1fb-4862-8a01-6454b09636f4	1adf0e70-b1fb-4862-8a01-6454b09636f4	TCGA-E9-A1N5-01A-11D-A14F-01		TCGA-E9-A1N5-01		2dedc4aa-78bc-48c6-b280-c0b56e56beca	
TCGA-E9-A1N5-11		45			0			FEMALE									0	0	Normal						enrollment			LIVING	0	TCGA-E9-A1N5-11	1120	0		C3-BRCA/Luminal							mutation cluster 3	TCGA-E9-A1N5	1120	0	1120	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N5-F39765		Positive					Positive			NO			-16736	63		0	1120					NO						Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection		NO	Positive		NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	2	0	true	M0	N1	T2	Stage IIB			0		0		0		0		100		0		0		0	TUMOR FREE						YES	YES	No			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2010			TCGA-E9-A1N5-11A-41R-A14C-13	TCGA-E9-A1N5-11A-41R-A14C-13						8e7ab480-e75d-49a4-98a6-fcdd2ccefaa7			8e7ab480-e75d-49a4-98a6-fcdd2ccefaa7	TCGA-E9-A1N5-11A-41D-A14H-05			8e7ab480-e75d-49a4-98a6-fcdd2ccefaa7	8e7ab480-e75d-49a4-98a6-fcdd2ccefaa7						
TCGA-E9-A1N6-01	Stage IIB	52	5	Stage IIB	0		Positive	FEMALE	Positive				Negative	M0	Positive	N1	0	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1N6-01	410	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 9	cluster 4		TCGA-E9-A1N6	410	0	410	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N6-F29152		Positive					Positive			NO			-19327	63		0	410					NO						Scheduled Follow-up Submission	2012-3-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	220	NO	Positive			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	2	0	true	M0	N1	T2	Stage IIB	TCGA-E9-A1N6.910A4342-BBC1-47AE-9316-695B0CD0375D.pdf		0		0		0		0		0		0		100		80	TUMOR FREE							YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2010			TCGA-E9-A1N6-01A-11R-A143-13	TCGA-E9-A1N6-01A-11R-A143-13				TCGA-E9-A1N6-01A-21-A17K-20		05b5084f-5e4f-43a3-9819-456a4f24ad82	e52f1f1f-dfed-49b5-a7f2-f81e0af3c810	TCGA-E9-A1N6-01A-11D-A141-01	05b5084f-5e4f-43a3-9819-456a4f24ad82	TCGA-E9-A1N6-01A-11D-A145-05	TCGA-E9-A1N6-01		05b5084f-5e4f-43a3-9819-456a4f24ad82	05b5084f-5e4f-43a3-9819-456a4f24ad82	TCGA-E9-A1N6-01A-11D-A141-01		TCGA-E9-A1N6-01		e52f1f1f-dfed-49b5-a7f2-f81e0af3c810	
TCGA-E9-A1N6-11		52			0			FEMALE									0	0	Normal						enrollment			LIVING	0	TCGA-E9-A1N6-11	410	0		C3-BRCA/Luminal								TCGA-E9-A1N6	410	0	410	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N6-F29152		Positive					Positive			NO			-19327	63		0	410					NO						Scheduled Follow-up Submission	2012-3-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	670	NO	Positive			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	2	0	true	M0	N1	T2	Stage IIB			0		0		0		0		100		0		0		0	TUMOR FREE							YES	No			YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2010			TCGA-E9-A1N6-11A-32R-A143-13	TCGA-E9-A1N6-11A-32R-A143-13						0f263a65-a664-4e23-bd9c-91e955f3bf21			0f263a65-a664-4e23-bd9c-91e955f3bf21	TCGA-E9-A1N6-11A-32D-A145-05			0f263a65-a664-4e23-bd9c-91e955f3bf21	0f263a65-a664-4e23-bd9c-91e955f3bf21						
TCGA-E9-A1N8-01	Stage IIA	48	1	Stage IIA	0		Negative	FEMALE	Negative				Negative	M0	Negative	N0	0	0	Basal						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1N8-01	365	0	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-E9-A1N8	365	0	365	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N8-F29134		Negative								NO			-17652	66		0	365					NO						Scheduled Follow-up Submission	2012-3-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	680	NO	Negative			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5								NO	0	0	true	M0	N0	T2	Stage IIA	TCGA-E9-A1N8.4F15F8D6-9F34-4A61-A006-E5E7A2E68207.pdf		2		1		2		1		0		18		80		80	TUMOR FREE							YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2010	TCGA-E9-A1N8-01A-11D-A142-09		TCGA-E9-A1N8-01A-11R-A143-13	TCGA-E9-A1N8-01A-11R-A143-13	TCGA-E9-A1N8-01A-11D-A142-09		TCGA-E9-A1N8-01A-11D-A142-09	TCGA-E9-A1N8-01A-21-A17K-20	TCGA-E9-A1N8-01A-11D-A142-09	7d6b6a17-5f1e-4586-9316-195c0e96925c	0179d350-8a90-4269-8eee-a0b971d23cb8	TCGA-E9-A1N8-01A-11D-A141-01	7d6b6a17-5f1e-4586-9316-195c0e96925c	TCGA-E9-A1N8-01A-11D-A145-05	TCGA-E9-A1N8-01		7d6b6a17-5f1e-4586-9316-195c0e96925c	7d6b6a17-5f1e-4586-9316-195c0e96925c	TCGA-E9-A1N8-01A-11D-A141-01		TCGA-E9-A1N8-01		0179d350-8a90-4269-8eee-a0b971d23cb8	
TCGA-E9-A1N8-11		48			0			FEMALE									0	0							enrollment			LIVING	0	TCGA-E9-A1N8-11	365	0		C4-BRCA/Basal							mutation cluster 5	TCGA-E9-A1N8	365	0	365	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N8-F29134		Negative								NO			-17652	66		0	365					NO						Scheduled Follow-up Submission	2012-3-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	510	NO	Negative			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	true	M0	N0	T2	Stage IIA			1		0		0		0		0		100		0		0	TUMOR FREE							YES	No			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2010														TCGA-E9-A1N8-11A-42D-A145-05										
TCGA-E9-A1N9-01	Stage IIA	58	4	Stage IIA	0		Negative	FEMALE	Negative				Negative	M0	Negative	N0	0	0	Basal		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1N9-01	399	0	High	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-E9-A1N9	399	0	399	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N9-F29157		Negative					Positive			YES			-21228	44		0	399					NO						Scheduled Follow-up Submission	2012-3-9	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	230	NO	Positive			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	5								NO	0	0	true	M0	N0	T2	Stage IIA	TCGA-E9-A1N9.39D6D1DE-2CAE-470F-836B-926242F46E67.pdf		2		1		0		1		0		20		80		80	TUMOR FREE							YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A1N9-01A-11D-A14G-09		TCGA-E9-A1N9-01A-11R-A14C-13	TCGA-E9-A1N9-01A-11R-A14C-13	TCGA-E9-A1N9-01A-11D-A14G-09		TCGA-E9-A1N9-01A-11D-A14G-09	TCGA-E9-A1N9-01A-21-A17K-20	TCGA-E9-A1N9-01A-11D-A14G-09	cdada0b1-f90d-40bc-9257-6377987b7baa	5ae97b02-7893-4ef8-83aa-585b87983f37	TCGA-E9-A1N9-01A-11D-A14F-01	cdada0b1-f90d-40bc-9257-6377987b7baa	TCGA-E9-A1N9-01A-11D-A14H-05	TCGA-E9-A1N9-01		cdada0b1-f90d-40bc-9257-6377987b7baa	cdada0b1-f90d-40bc-9257-6377987b7baa	TCGA-E9-A1N9-01A-11D-A14F-01		TCGA-E9-A1N9-01		5ae97b02-7893-4ef8-83aa-585b87983f37	
TCGA-E9-A1N9-11		58			0			FEMALE									0	0	Normal						enrollment			LIVING	0	TCGA-E9-A1N9-11	399	0		C3-BRCA/Luminal							mutation cluster 5	TCGA-E9-A1N9	399	0	399	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N9-F29157		Negative					Positive			YES			-21228	44		0	399					NO						Scheduled Follow-up Submission	2012-3-9	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	1190	NO	Positive			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	true	M0	N0	T2	Stage IIA											100				0			TUMOR FREE							YES	No			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011			TCGA-E9-A1N9-11A-71R-A14C-13	TCGA-E9-A1N9-11A-71R-A14C-13						f6e8424b-338c-4f9a-bdc7-f7d8de0c5634			f6e8424b-338c-4f9a-bdc7-f7d8de0c5634				f6e8424b-338c-4f9a-bdc7-f7d8de0c5634	f6e8424b-338c-4f9a-bdc7-f7d8de0c5634						
TCGA-E9-A1NA-01	Stage IIA	58	5	Stage IIA	0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	0	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1NA-01	1112	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E9-A1NA	1112	0	1112	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1-F39782		Positive					Positive			YES			-21397	42		0	1112					NO						Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	110	NO	Positive		NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4								NO	0	0	true	M0	N0	T2	Stage IIA	TCGA-E9-A1.595BB256-2F3D-493A-AA90-022BE0CC995F.pdf		2		1		0		1		0		15		85		85	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A1NA-01A-11D-A142-09		TCGA-E9-A1NA-01A-11R-A143-13	TCGA-E9-A1NA-01A-11R-A143-13	TCGA-E9-A1NA-01A-11D-A142-09		TCGA-E9-A1NA-01A-11D-A142-09	TCGA-E9-A1NA-01A-21-A17K-20	TCGA-E9-A1NA-01A-11D-A142-09	7edc6614-6c8b-43ec-87dd-7720961bd174	06885aa5-33ae-4eab-ae31-f5f9c9b16480	TCGA-E9-A1NA-01A-11D-A141-01	7edc6614-6c8b-43ec-87dd-7720961bd174	TCGA-E9-A1NA-01A-11D-A145-05	TCGA-E9-A1NA-01		7edc6614-6c8b-43ec-87dd-7720961bd174	7edc6614-6c8b-43ec-87dd-7720961bd174	TCGA-E9-A1NA-01A-11D-A141-01		TCGA-E9-A1NA-01		06885aa5-33ae-4eab-ae31-f5f9c9b16480	
TCGA-E9-A1NA-11		58			0			FEMALE									0	0	Normal						enrollment			LIVING	0	TCGA-E9-A1NA-11	1112	0		C3-BRCA/Luminal							mutation c1uster 9	TCGA-E9-A1NA	1112	0	1112	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1-F39782		Positive					Positive			YES			-21397	42		0	1112					NO						Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	330	NO	Positive		NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	true	M0	N0	T2	Stage IIA			2		0		0		0		10		90		0		0	TUMOR FREE						YES	YES	No			YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011			TCGA-E9-A1NA-11A-33R-A143-13	TCGA-E9-A1NA-11A-33R-A143-13						7b9569bc-f513-4b64-9a7c-7bb53b9be79b			7b9569bc-f513-4b64-9a7c-7bb53b9be79b	TCGA-E9-A1NA-11A-33D-A145-05			7b9569bc-f513-4b64-9a7c-7bb53b9be79b	7b9569bc-f513-4b64-9a7c-7bb53b9be79b						
TCGA-E9-A1NC-01	Stage IIB	61	1	Stage IIB	0		Negative	FEMALE	Negative				Negative	M0	Positive	N1	0	0			Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1NC-01	1203	0	Squamous		cluster 5	Low purity c2			miRNA cluster 13		mutation c1uster 9	TCGA-E9-A1NC	1203	0	1203	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Right Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1NC-F40639		Negative					Positive			YES			-22355	38		0	1203					NO						Scheduled Follow-up Submission	2013-2-26	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	200	NO	Positive		NO	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5									NO	1	0	true	M0	N1	T2	Stage IIB	TCGA-E9-A1NC.AA1B707B-4DE8-4E0D-87CA-601760F4A6CF.pdf		10		1		0		1		0		30		70		70	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A1NC-01A-12W-A16L-09		TCGA-E9-A1NC-01A-12R-A156-13	TCGA-E9-A1NC-01A-12R-A156-13			TCGA-E9-A1NC-01A-12W-A16L-09		TCGA-E9-A1NC-01A-12W-A16L-09	50f23d00-f6fd-4b3d-aed2-0705f7ae6a17	7145e63d-79f8-4a72-8571-9065d51c8f8e	TCGA-E9-A1NC-01A-12D-A160-01	50f23d00-f6fd-4b3d-aed2-0705f7ae6a17	TCGA-E9-A1NC-01A-12D-A161-05	TCGA-E9-A1NC-01		50f23d00-f6fd-4b3d-aed2-0705f7ae6a17	50f23d00-f6fd-4b3d-aed2-0705f7ae6a17	TCGA-E9-A1NC-01A-12D-A160-01		TCGA-E9-A1NC-01		7145e63d-79f8-4a72-8571-9065d51c8f8e	
TCGA-E9-A1ND-01	Stage IIB	75	1	Stage IIB	0		Negative	FEMALE	Negative				Negative	M0	Positive	N1	0	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1ND-01	383	0	Squamous	C4-BRCA/Basal	cluster 5	Cluster 5	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 11	cluster 5	mutation cluster 2	TCGA-E9-A1ND	383	0	383	Breast	TCGA Breast Cancer	breast invasive carcinoma					75	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1ND-F29163		Negative					Negative			YES			-27400	37		0	383					NO						Scheduled Follow-up Submission	2012-3-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	420	NO	Positive			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5								NO	1	0	true	M0	N1	T2	Stage IIB	TCGA-E9-A1ND.AC26EE69-27D8-4523-917A-68573F5F614E.pdf		0		0		0		0		0		10		90		90	TUMOR FREE							YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A1ND-01A-11D-A142-09		TCGA-E9-A1ND-01A-11R-A143-13	TCGA-E9-A1ND-01A-11R-A143-13	TCGA-E9-A1ND-01A-11D-A142-09		TCGA-E9-A1ND-01A-11D-A142-09	TCGA-E9-A1ND-01A-21-A17J-20	TCGA-E9-A1ND-01A-11D-A142-09	526da11e-9125-4fcd-98d7-02994c9783d1	20428d6b-edda-4596-af5d-2ae057ba9bbd	TCGA-E9-A1ND-01A-11D-A141-01	526da11e-9125-4fcd-98d7-02994c9783d1	TCGA-E9-A1ND-01A-11D-A145-05	TCGA-E9-A1ND-01		526da11e-9125-4fcd-98d7-02994c9783d1	526da11e-9125-4fcd-98d7-02994c9783d1	TCGA-E9-A1ND-01A-11D-A141-01		TCGA-E9-A1ND-01		20428d6b-edda-4596-af5d-2ae057ba9bbd	
TCGA-E9-A1ND-11		75			0			FEMALE									0	0	Normal						enrollment			LIVING	0	TCGA-E9-A1ND-11	383	0		C4-BRCA/Basal							mutation cluster 2	TCGA-E9-A1ND	383	0	383	Breast	TCGA Breast Cancer	breast invasive carcinoma					75	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1ND-F29163		Negative					Negative			YES			-27400	37		0	383					NO						Scheduled Follow-up Submission	2012-3-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	1070	NO	Positive			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1	0	true	M0	N1	T2	Stage IIB			0		0		0		0		10		90		0		0	TUMOR FREE							YES	No			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011			TCGA-E9-A1ND-11A-43R-A143-13	TCGA-E9-A1ND-11A-43R-A143-13						ef84a69f-37bc-46fa-98ac-b3976212e11d			ef84a69f-37bc-46fa-98ac-b3976212e11d	TCGA-E9-A1ND-11A-43D-A145-05			ef84a69f-37bc-46fa-98ac-b3976212e11d	ef84a69f-37bc-46fa-98ac-b3976212e11d						
TCGA-E9-A1NE-01	Stage IIB	28	1	Stage IIB	0		Positive	FEMALE	Negative				Negative	M0	Positive	N1	0	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1NE-01	1088	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-E9-A1NE	1088	0	1088	Breast	TCGA Breast Cancer	breast invasive carcinoma					28	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1NE-F39781		Positive					Positive			YES			-10564	31		0	1088					NO						Scheduled Follow-up Submission	2013-2-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8522/3	C50.9		YES		Tumor resection	280	NO	Negative		NO	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	6								NO	1	0	true	M0	N1	T2	Stage IIB	TCGA-E9-A1NE.CF6E29A2-FAE6-45BB-B625-33877887A89E.pdf		4		0		3		0		8		19		70		85	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A1NE-01A-21D-A14K-09		TCGA-E9-A1NE-01A-21R-A14L-13	TCGA-E9-A1NE-01A-21R-A14L-13	TCGA-E9-A1NE-01A-21D-A14K-09		TCGA-E9-A1NE-01A-21D-A14K-09	TCGA-E9-A1NE-01A-11-A17K-20	TCGA-E9-A1NE-01A-21D-A14K-09	92691eb7-5df9-4da9-8bd0-c4f4de528bdc	f7aa01e5-56c8-4c23-94f5-c028f5b8057c	TCGA-E9-A1NE-01A-21D-A14J-01	92691eb7-5df9-4da9-8bd0-c4f4de528bdc	TCGA-E9-A1NE-01A-21D-A14N-05	TCGA-E9-A1NE-01		92691eb7-5df9-4da9-8bd0-c4f4de528bdc	92691eb7-5df9-4da9-8bd0-c4f4de528bdc	TCGA-E9-A1NE-01A-21D-A14J-01		TCGA-E9-A1NE-01		f7aa01e5-56c8-4c23-94f5-c028f5b8057c	
TCGA-E9-A1NE-11		28			0			FEMALE									0	0							enrollment			LIVING	0	TCGA-E9-A1NE-11	1088	0		C3-BRCA/Luminal							mutation c1uster 9	TCGA-E9-A1NE	1088	0	1088	Breast	TCGA Breast Cancer	breast invasive carcinoma					28	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1NE-F39781		Positive					Positive			YES			-10564	31		0	1088					NO						Scheduled Follow-up Submission	2013-2-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8522/3	C50.9		YES		Tumor resection	830	NO	Negative		NO	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	1	0	true	M0	N1	T2	Stage IIB			0		0		0		0		3		97		0		0	TUMOR FREE						YES	YES	No			YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011														TCGA-E9-A1NE-11A-43D-A14N-05										
TCGA-E9-A1NF-01	Stage IIA	60	5	Stage IIA	0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	0	0	LumB		Positive				enrollment	T_Other	T2	LIVING	1	TCGA-E9-A1NF-01	1072	1	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 13	TCGA-E9-A1NF	1072	0	1072	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES		NO		60	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1NF-F39778		Positive					Positive			YES			-21981	31	1072	0	610			90		NO						Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	240	NO	Negative		NO	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4				Lung	Distant Metastasis			NO	0	0	true	M0	N0	T2	Stage IIA	TCGA-E9-A1NF.740CF6E1-C742-47DC-8057-9D73AF4D6171.pdf		0		0		0		0		0		30		70		80	WITH TUMOR						YES	YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	DECEASED	2011	TCGA-E9-A1NF-01A-11D-A14G-09		TCGA-E9-A1NF-01A-11R-A14C-13	TCGA-E9-A1NF-01A-11R-A14C-13	TCGA-E9-A1NF-01A-11D-A14G-09		TCGA-E9-A1NF-01A-11D-A14G-09	TCGA-E9-A1NF-01A-21-A17K-20	TCGA-E9-A1NF-01A-11D-A14G-09	69e0026c-c87c-4987-8e46-f94d21f6bfb6	2c3d8b4c-f188-43e2-8b4b-246ad2e392a2	TCGA-E9-A1NF-01A-11D-A14F-01	69e0026c-c87c-4987-8e46-f94d21f6bfb6	TCGA-E9-A1NF-01A-11D-A14H-05	TCGA-E9-A1NF-01		69e0026c-c87c-4987-8e46-f94d21f6bfb6	69e0026c-c87c-4987-8e46-f94d21f6bfb6	TCGA-E9-A1NF-01A-11D-A14F-01		TCGA-E9-A1NF-01		2c3d8b4c-f188-43e2-8b4b-246ad2e392a2	
TCGA-E9-A1NF-11		60			0			FEMALE									0	0	LumA						enrollment			LIVING	1	TCGA-E9-A1NF-11	1072	1		C3-BRCA/Luminal							mutation cluster 13	TCGA-E9-A1NF	1072	0	1072	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES		NO		60	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1NF-F39778		Positive					Positive			YES			-21981	31	1072	0	610			90		NO						Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	1520	NO	Negative		NO	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																							Lung	Distant Metastasis			NO	0	0	true	M0	N0	T2	Stage IIA											100				0			WITH TUMOR						YES	YES	No			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	DECEASED	2011			TCGA-E9-A1NF-11A-73R-A14C-13	TCGA-E9-A1NF-11A-73R-A14C-13						39f6a4d4-650f-4caf-a778-4a24af4f11ba			39f6a4d4-650f-4caf-a778-4a24af4f11ba	TCGA-E9-A1NF-11A-73D-A14H-05			39f6a4d4-650f-4caf-a778-4a24af4f11ba	39f6a4d4-650f-4caf-a778-4a24af4f11ba						
TCGA-E9-A1NG-01	Stage IIA	62	1	Stage IIA	0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	0	0	LumA		Positive				enrollment	T_Other	T2	LIVING	1	TCGA-E9-A1NG-01	786	1	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 1	TCGA-E9-A1NG	786	0	786	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1NG-F39774		Positive					Positive			YES			-22896	30	786	0	656					NO						Scheduled Follow-up Submission	2013-2-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	380	NO	Negative		NO	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4								NO	0	0	true	M0	N0	T2	Stage IIA	TCGA-E9-A1NG.73953A70-DAC0-443A-AC04-28BDA8D5F673.pdf		0		0		0		0		0		60		40		60	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	DECEASED	2011	TCGA-E9-A1NG-01A-21D-A14K-09		TCGA-E9-A1NG-01A-21R-A14L-13	TCGA-E9-A1NG-01A-21R-A14L-13	TCGA-E9-A1NG-01A-21D-A14K-09		TCGA-E9-A1NG-01A-21D-A14K-09	TCGA-E9-A1NG-01A-11-A17K-20	TCGA-E9-A1NG-01A-21D-A14K-09	91918c5e-3c5c-4674-9a7f-1e93d9cf9949	e4df045b-7b42-4c67-8671-cab204450719	TCGA-E9-A1NG-01A-21D-A14J-01	91918c5e-3c5c-4674-9a7f-1e93d9cf9949	TCGA-E9-A1NG-01A-21D-A14N-05	TCGA-E9-A1NG-01		91918c5e-3c5c-4674-9a7f-1e93d9cf9949	91918c5e-3c5c-4674-9a7f-1e93d9cf9949	TCGA-E9-A1NG-01A-21D-A14J-01		TCGA-E9-A1NG-01		e4df045b-7b42-4c67-8671-cab204450719	
TCGA-E9-A1NG-11		62			0			FEMALE									0	0	Normal						enrollment			LIVING	1	TCGA-E9-A1NG-11	786	1		C3-BRCA/Luminal							mutation cluster 1	TCGA-E9-A1NG	786	0	786	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1NG-F39774		Positive					Positive			YES			-22896	30	786	0	656					NO						Scheduled Follow-up Submission	2013-2-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	740	NO	Negative		NO	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	true	M0	N0	T2	Stage IIA											100				0			TUMOR FREE						YES	YES	No			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	DECEASED	2011			TCGA-E9-A1NG-11A-52R-A14L-13	TCGA-E9-A1NG-11A-52R-A14L-13						a4172e12-2a82-436e-8cb9-a532dc0e9ec4			a4172e12-2a82-436e-8cb9-a532dc0e9ec4	TCGA-E9-A1NG-11A-52D-A14N-05			a4172e12-2a82-436e-8cb9-a532dc0e9ec4	a4172e12-2a82-436e-8cb9-a532dc0e9ec4						
TCGA-E9-A1NH-01	Stage IIB	71	2	Stage IIB	0		Positive	FEMALE	Negative				Negative	M0	Positive	N1	0	0	LumA		Positive				enrollment	T_Other	T2	LIVING		TCGA-E9-A1NH-01			BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 4	mutation cluster 4	TCGA-E9-A1NH				Breast	TCGA Breast Cancer	breast invasive carcinoma					71	Left Upper Inner Quadrant	Axillary lymph node dissection alone				Positive					Positive	Modified Radical Mastectomy		YES			-26221	30		0	0					NO							2011-6-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	140	NO	Negative			5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									3	0	true	M0	N1	T2	Stage IIB	TCGA-E9-A1NH.A6248687-C0C0-4DEF-9D92-196CBDB5CBDE.pdf		0		0		0		0		0		20		80		90								YES	No				Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A1NH-01A-11D-A14G-09		TCGA-E9-A1NH-01A-11R-A14C-13	TCGA-E9-A1NH-01A-11R-A14C-13	TCGA-E9-A1NH-01A-11D-A14G-09		TCGA-E9-A1NH-01A-11D-A14G-09	TCGA-E9-A1NH-01A-21-A17K-20	TCGA-E9-A1NH-01A-11D-A14G-09	0eb9c5a5-1e4e-4808-882e-858b4d0ed396	a01c0857-1760-45dc-b426-082a9b59fe90	TCGA-E9-A1NH-01A-11D-A14F-01	0eb9c5a5-1e4e-4808-882e-858b4d0ed396	TCGA-E9-A1NH-01A-11D-A14H-05	TCGA-E9-A1NH-01		0eb9c5a5-1e4e-4808-882e-858b4d0ed396	0eb9c5a5-1e4e-4808-882e-858b4d0ed396	TCGA-E9-A1NH-01A-11D-A14F-01		TCGA-E9-A1NH-01		a01c0857-1760-45dc-b426-082a9b59fe90	
TCGA-E9-A1NI-01	Stage IIA	51	2	Stage IIA	0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	0	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1NI-01	300	0	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E9-A1NI	300	0	300	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1NI-F29213		Positive					Positive			YES			-18985	21		0	300					NO						Scheduled Follow-up Submission	2012-3-12	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	280	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	0	0	true	M0	N0	T2	Stage IIA	TCGA-E9-A1NI.3F4F5A98-F6EA-46D5-95E8-6797D419328A.pdf		0		0		0		0		0		30		70		80	TUMOR FREE							YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A1NI-01A-11W-A16H-09		TCGA-E9-A1NI-01A-11R-A14C-13	TCGA-E9-A1NI-01A-11R-A14C-13			TCGA-E9-A1NI-01A-11W-A16H-09	TCGA-E9-A1NI-01A-21-A17K-20	TCGA-E9-A1NI-01A-11W-A16H-09	07ac0536-240f-46be-9909-a8af1a22e2b8	f532e691-9f2f-4535-b6ab-00ff42e14176	TCGA-E9-A1NI-01A-11D-A14F-01	07ac0536-240f-46be-9909-a8af1a22e2b8	TCGA-E9-A1NI-01A-11D-A14H-05	TCGA-E9-A1NI-01		07ac0536-240f-46be-9909-a8af1a22e2b8	07ac0536-240f-46be-9909-a8af1a22e2b8	TCGA-E9-A1NI-01A-11D-A14F-01		TCGA-E9-A1NI-01		f532e691-9f2f-4535-b6ab-00ff42e14176	
TCGA-E9-A1QZ-01	Stage IIA	61	3	Stage IIA	0			FEMALE	Negative				Negative	M0	Negative	N0	0	0	LumA						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1QZ-01	362	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13		mutation c1uster 9	TCGA-E9-A1QZ	362	0	362	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1QZ-F29720													-22397	58		0	362					NO						Scheduled Follow-up Submission	2012-3-28	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	590	NO				19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1									NO	0		true	M0	N0	T2	Stage IIA	TCGA-E9-A1QZ.864BB34A-1008-480C-A3B5-A2C616E95C49.pdf		0		0		0		0		0		80		20		80	TUMOR FREE							YES	No			NO	Primary Tumor	01		7th	NO	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A1QZ-01A-21D-A167-09		TCGA-E9-A1QZ-01A-21R-A168-13	TCGA-E9-A1QZ-01A-21R-A168-13	TCGA-E9-A1QZ-01A-21D-A167-09		TCGA-E9-A1QZ-01A-21D-A167-09	TCGA-E9-A1QZ-01A-41-A17J-20	TCGA-E9-A1QZ-01A-21D-A167-09	64897f59-3a93-4ac3-82d5-66e9f4dc7ac6	6ff0d34a-027a-46be-a93f-ba6ed2686157	TCGA-E9-A1QZ-01A-21D-A166-01	64897f59-3a93-4ac3-82d5-66e9f4dc7ac6	TCGA-E9-A1QZ-01A-21D-A16A-05	TCGA-E9-A1QZ-01		64897f59-3a93-4ac3-82d5-66e9f4dc7ac6	64897f59-3a93-4ac3-82d5-66e9f4dc7ac6	TCGA-E9-A1QZ-01A-21D-A166-01		TCGA-E9-A1QZ-01		6ff0d34a-027a-46be-a93f-ba6ed2686157	
TCGA-E9-A1R0-01	Stage IIA	58	2	Stage IIA	0			FEMALE	Negative				Negative	M0	Positive	N1	0	0	LumA						enrollment	T1	T1	LIVING	0	TCGA-E9-A1R0-01	860	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 5		mutation cluster 4	TCGA-E9-A1R0	860	0	860	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1R0-F41214													-21394	44		0	860					NO						Scheduled Follow-up Submission	2013-3-13	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	400	NO			NO	12		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4									NO	1		true	M0	N1	T1c	Stage IIA	TCGA-E9-A1R0.DD0ADC20-2059-435E-9EB4-351C87D7CBEB.pdf		0		0		0		0		0		5		95		65	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A1R0-01A-22D-A16D-09		TCGA-E9-A1R0-01A-22R-A16E-13	TCGA-E9-A1R0-01A-22R-A16E-13	TCGA-E9-A1R0-01A-22D-A16D-09		TCGA-E9-A1R0-01A-22D-A16D-09	TCGA-E9-A1R0-01A-11-A17J-20	TCGA-E9-A1R0-01A-22D-A16D-09	4c6443ed-bc36-4c94-85dd-9bf7aab6a5b3	ef16eca9-6bfa-4db1-860a-adccb484d2b3	TCGA-E9-A1R0-01A-22D-A16C-01	4c6443ed-bc36-4c94-85dd-9bf7aab6a5b3	TCGA-E9-A1R0-01A-22D-A16G-05	TCGA-E9-A1R0-01		4c6443ed-bc36-4c94-85dd-9bf7aab6a5b3	4c6443ed-bc36-4c94-85dd-9bf7aab6a5b3	TCGA-E9-A1R0-01A-22D-A16C-01		TCGA-E9-A1R0-01		ef16eca9-6bfa-4db1-860a-adccb484d2b3	
TCGA-E9-A1R2-01	Stage IIIC	51	5	Stage IIIC	19		Positive	FEMALE	Negative				Negative	M0	Positive	N3	19	0	LumA		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1R2-01	19	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 7	mutation c1uster 9	TCGA-E9-A1R2			19	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Left Upper Outer Quadrant	Axillary lymph node dissection alone				Positive					Negative	Lumpectomy		NO			-18936	64		0	19					NO		90-99%			74		2011-7-28	FEMALE			90-99%				114			Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	160	NO	Equivocal	Negative		19	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	7									17		true	MX	N3	T2	Stage IIIC	TCGA-E9-A1R2.5B9C0E4A-3958-4ECF-B8B2-E758E04E7722.pdf		0		0		0		0		0		0		100		80					Two-tier	Two-tier		YES	No				Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A1R2-01A-11D-A14G-09		TCGA-E9-A1R2-01A-11R-A14C-13	TCGA-E9-A1R2-01A-11R-A14C-13	TCGA-E9-A1R2-01A-11D-A14G-09		TCGA-E9-A1R2-01A-11D-A14G-09	TCGA-E9-A1R2-01A-21-A17J-20	TCGA-E9-A1R2-01A-11D-A14G-09	e24bfd9d-87b2-44a7-bddc-7b7f60461252	2e6cebd3-ce33-4553-a190-ac2dd9bcf91a	TCGA-E9-A1R2-01A-11D-A14F-01	e24bfd9d-87b2-44a7-bddc-7b7f60461252	TCGA-E9-A1R2-01A-11D-A14H-05	TCGA-E9-A1R2-01		e24bfd9d-87b2-44a7-bddc-7b7f60461252	e24bfd9d-87b2-44a7-bddc-7b7f60461252	TCGA-E9-A1R2-01A-11D-A14F-01		TCGA-E9-A1R2-01		2e6cebd3-ce33-4553-a190-ac2dd9bcf91a	
TCGA-E9-A1R3-01	Stage IIIC	70	2	Stage IIIC	64			FEMALE	Negative				Negative	M0	Positive	N3	64	0	LumA						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1R3-01	78	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E9-A1R3	78	0	78	Breast	TCGA Breast Cancer	breast invasive carcinoma					70	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1R3-F48697								Modified Radical Mastectomy		NO			-25693	80		0	78					NO						Scheduled Follow-up Submission	2013-9-19	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	420	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	10		true	M0	N3	T2	Stage IIIC	TCGA-E9-A1R3.BE186852-8596-4CDB-B5C4-AA5838C15B5F.pdf		0		0		0		0		0		0		100		82	TUMOR FREE							YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2010	TCGA-E9-A1R3-01A-31D-A14K-09		TCGA-E9-A1R3-01A-31R-A14L-13	TCGA-E9-A1R3-01A-31R-A14L-13	TCGA-E9-A1R3-01A-31D-A14K-09		TCGA-E9-A1R3-01A-31D-A14K-09	TCGA-E9-A1R3-01A-41-A17J-20	TCGA-E9-A1R3-01A-31D-A14K-09	678ba111-3b01-49b7-83d9-165ef0288a34	b48037f7-5060-4cd6-b8b1-07d77bd8c858	TCGA-E9-A1R3-01A-31D-A14J-01	678ba111-3b01-49b7-83d9-165ef0288a34	TCGA-E9-A1R3-01A-31D-A14N-05	TCGA-E9-A1R3-01		678ba111-3b01-49b7-83d9-165ef0288a34	678ba111-3b01-49b7-83d9-165ef0288a34	TCGA-E9-A1R3-01A-31D-A14J-01		TCGA-E9-A1R3-01		b48037f7-5060-4cd6-b8b1-07d77bd8c858	
TCGA-E9-A1R4-01	Stage IA	66	1	Stage I	29			FEMALE	Negative				Negative	M0	Negative	N0	29	0	LumB						enrollment	T1	T1	LIVING	0	TCGA-E9-A1R4-01	186	0	Squamous	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 4	mutation cluster 4	TCGA-E9-A1R4	186	0	186	Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1R4-F30535										NO			-24181	45		0	186					NO						Scheduled Follow-up Submission	2012-4-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Lumpectomy	Other method, specify:	430	NO				10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	0		true	M0	N0	T1c	Stage IA	TCGA-E9-A1R4.AA095896-8217-4BEE-97EC-BC79F5C395BA.pdf		0		0		0		0		5		30		65		90	TUMOR FREE							YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A1R4-01A-21D-A14G-09		TCGA-E9-A1R4-01A-21R-A14C-13	TCGA-E9-A1R4-01A-21R-A14C-13	TCGA-E9-A1R4-01A-21D-A14G-09		TCGA-E9-A1R4-01A-21D-A14G-09	TCGA-E9-A1R4-01A-11-A17J-20	TCGA-E9-A1R4-01A-21D-A14G-09	11353ea3-2ff0-4658-b528-6aa922dbb665	fcd41d63-c0f1-4f8e-ad1f-ea398203a3a4	TCGA-E9-A1R4-01A-21D-A14F-01	11353ea3-2ff0-4658-b528-6aa922dbb665	TCGA-E9-A1R4-01A-21D-A14H-05	TCGA-E9-A1R4-01		11353ea3-2ff0-4658-b528-6aa922dbb665	11353ea3-2ff0-4658-b528-6aa922dbb665	TCGA-E9-A1R4-01A-21D-A14F-01		TCGA-E9-A1R4-01		fcd41d63-c0f1-4f8e-ad1f-ea398203a3a4	
TCGA-E9-A1R5-01	Stage IA	63	2	Stage I	42			FEMALE	Negative				Negative	M0	Negative	N0	42	0	LumA						enrollment	T1	T1	LIVING	0	TCGA-E9-A1R5-01	92	0	Iq	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E9-A1R5	92	0	92	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1R5-F48700								Lumpectomy		NO			-23116	58		0	92					NO						Scheduled Follow-up Submission	2013-9-19	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	370	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4								NO	0		true	M0	N0	T1c	Stage IA	TCGA-E9-A1R5.141B770B-22DD-4C87-AFF7-04D85FC9C74A.pdf		7		0		0		0		0		30		70		80	TUMOR FREE							YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A1R5-01A-11D-A14K-09		TCGA-E9-A1R5-01A-11R-A14L-13	TCGA-E9-A1R5-01A-11R-A14L-13	TCGA-E9-A1R5-01A-11D-A14K-09		TCGA-E9-A1R5-01A-11D-A14K-09	TCGA-E9-A1R5-01A-21-A17J-20	TCGA-E9-A1R5-01A-11D-A14K-09	7b06a333-ba77-41dd-bfd1-4824fe43d06f	07e28d9a-a162-4def-b3db-1ad0ce9827f3	TCGA-E9-A1R5-01A-11D-A14J-01	7b06a333-ba77-41dd-bfd1-4824fe43d06f	TCGA-E9-A1R5-01A-11D-A14N-05	TCGA-E9-A1R5-01		7b06a333-ba77-41dd-bfd1-4824fe43d06f	7b06a333-ba77-41dd-bfd1-4824fe43d06f	TCGA-E9-A1R5-01A-11D-A14J-01		TCGA-E9-A1R5-01		07e28d9a-a162-4def-b3db-1ad0ce9827f3	
TCGA-E9-A1R6-01	Stage IIA	63	4	Stage IIA	84			FEMALE	Negative				Negative	M0	Negative	N0	84	0	LumA						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1R6-01	84	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-E9-A1R6			84	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Right Upper Outer Quadrant	Axillary lymph node dissection alone										Lumpectomy		NO			-23347	100		0	84					NO							2011-7-28	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	730	NO				10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	2									0		true	M0	N0	T2	Stage IIA	TCGA-E9-A1R6.8A865E33-082A-454F-A6DF-89E994206E65.pdf		0		0		0		0		0		0		100		85	TUMOR FREE							YES	No				Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2010	TCGA-E9-A1R6-01A-11D-A14G-09		TCGA-E9-A1R6-01A-11R-A14C-13	TCGA-E9-A1R6-01A-11R-A14C-13	TCGA-E9-A1R6-01A-11D-A14G-09		TCGA-E9-A1R6-01A-11D-A14G-09	TCGA-E9-A1R6-01A-21-A17J-20	TCGA-E9-A1R6-01A-11D-A14G-09	2b022043-a976-40a7-929e-664b9549c411	c6e7c59d-708f-497e-b6e6-ed91ba294943	TCGA-E9-A1R6-01A-11D-A14F-01	2b022043-a976-40a7-929e-664b9549c411	TCGA-E9-A1R6-01A-11D-A14H-05	TCGA-E9-A1R6-01		2b022043-a976-40a7-929e-664b9549c411	2b022043-a976-40a7-929e-664b9549c411	TCGA-E9-A1R6-01A-11D-A14F-01		TCGA-E9-A1R6-01		c6e7c59d-708f-497e-b6e6-ed91ba294943	
TCGA-E9-A1R7-01	Stage IIA	64	5	Stage IIA	34			FEMALE	Negative				Negative	M0	Negative	N0	34	0	LumB						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1R7-01	645	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-E9-A1R7	645	0	645	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1R7-F30602								Lumpectomy		NO			-23397	51		0	645					NO						Scheduled Follow-up Submission	2014-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	400	NO				10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	1								NO	0		true	M0	N0	T2	Stage IIA	TCGA-E9-A1R7.FA19C3C4-E13B-464B-84CC-3AF7E83D5B9C.pdf		0		0		0		0		0		0		100		80	TUMOR FREE							YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A1R7-01A-11D-A14K-09		TCGA-E9-A1R7-01A-11R-A14L-13	TCGA-E9-A1R7-01A-11R-A14L-13	TCGA-E9-A1R7-01A-11D-A14K-09		TCGA-E9-A1R7-01A-11D-A14K-09	TCGA-E9-A1R7-01A-21-A17J-20	TCGA-E9-A1R7-01A-11D-A14K-09	5ac273e2-3a3f-48a6-8782-956587bab667	23c38a57-6a93-4845-8c80-53d2fb835d37	TCGA-E9-A1R7-01A-11D-A14J-01	5ac273e2-3a3f-48a6-8782-956587bab667	TCGA-E9-A1R7-01A-11D-A14N-05	TCGA-E9-A1R7-01		5ac273e2-3a3f-48a6-8782-956587bab667	5ac273e2-3a3f-48a6-8782-956587bab667	TCGA-E9-A1R7-01A-11D-A14J-01		TCGA-E9-A1R7-01		23c38a57-6a93-4845-8c80-53d2fb835d37	
TCGA-E9-A1R7-11		64			34			FEMALE									34	0	Normal						enrollment			LIVING	0	TCGA-E9-A1R7-11	645	0		C3-BRCA/Luminal							mutation c1uster 9	TCGA-E9-A1R7	645	0	645	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1R7-F30602								Lumpectomy		NO			-23397	51		0	645					NO						Scheduled Follow-up Submission	2014-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	440	NO				10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T2	Stage IIA			0		0		0		0		100		0		0		0	TUMOR FREE							YES	No			YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011			TCGA-E9-A1R7-11A-42R-A14L-13	TCGA-E9-A1R7-11A-42R-A14L-13						1457ae2c-4b9b-448a-b455-432a7121beb4			1457ae2c-4b9b-448a-b455-432a7121beb4	TCGA-E9-A1R7-11A-42D-A14N-05			1457ae2c-4b9b-448a-b455-432a7121beb4	1457ae2c-4b9b-448a-b455-432a7121beb4						
TCGA-E9-A1RA-01	Stage IA	48	3	Stage I	29			FEMALE	Negative				Negative	M0	Negative	N0	29	0							enrollment	T1	T1	LIVING	0	TCGA-E9-A1RA-01	976	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-E9-A1RA	976	0	976	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RA-F39519										NO			-17699	45		0	976					NO						Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Lumpectomy	Other method, specify:	200	NO			NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	6								NO	0		true	M0	N0	T1c	Stage IA	TCGA-E9-A1RA.26140CA5-AF22-47DD-BE48-C3C7DE07E5DB.pdf		0		0		0		0		0		15		85		75	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A1RA-01A-11D-A14G-09		TCGA-E9-A1RA-01A-11R-A14C-13	TCGA-E9-A1RA-01A-11R-A14C-13			TCGA-E9-A1RA-01A-11D-A14G-09	TCGA-E9-A1RA-01A-21-A17J-20	TCGA-E9-A1RA-01A-11D-A14G-09	da9bcd8c-7f5b-41f4-bff8-7129a88caf22	29f0d297-d89f-41a2-8d31-51f9194996f0	TCGA-E9-A1RA-01A-11D-A14F-01	da9bcd8c-7f5b-41f4-bff8-7129a88caf22	TCGA-E9-A1RA-01A-11D-A14H-05	TCGA-E9-A1RA-01		da9bcd8c-7f5b-41f4-bff8-7129a88caf22	da9bcd8c-7f5b-41f4-bff8-7129a88caf22	TCGA-E9-A1RA-01A-11D-A14F-01		TCGA-E9-A1RA-01		29f0d297-d89f-41a2-8d31-51f9194996f0	
TCGA-E9-A1RB-01	Stage IIA	40	4	Stage IIA	21			FEMALE	Negative				Negative	M0	Negative	N0	21	0	LumB						enrollment	T_Other	T2	LIVING	1	TCGA-E9-A1RB-01	976	1	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4		mutation cluster 5	TCGA-E9-A1RB	976	0	976	Breast	TCGA Breast Cancer	breast invasive carcinoma					40	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RB-F39530								Modified Radical Mastectomy		NO			-14755	39	976	0	633					NO						Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	490	NO			NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1									NO	0	0	true	M0	N0	T2	Stage IIA	TCGA-E9-A1RB.3BE8EA29-3C5F-4339-9CE7-98994B545848.pdf		0		0		0		0		0		25		75		90	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	DECEASED	2011	TCGA-E9-A1RB-01A-11D-A17G-09		TCGA-E9-A1RB-01A-11R-A156-13	TCGA-E9-A1RB-01A-11R-A156-13	TCGA-E9-A1RB-01A-11D-A17G-09		TCGA-E9-A1RB-01A-11D-A17G-09	TCGA-E9-A1RB-01A-21-A17J-20	TCGA-E9-A1RB-01A-11D-A17G-09	7e2a8676-10a4-4abf-b153-2255e06bcb40	458805a0-64c5-4e9a-958e-537047e41a86	TCGA-E9-A1RB-01A-11D-A160-01	7e2a8676-10a4-4abf-b153-2255e06bcb40	TCGA-E9-A1RB-01A-11D-A161-05	TCGA-E9-A1RB-01		7e2a8676-10a4-4abf-b153-2255e06bcb40	7e2a8676-10a4-4abf-b153-2255e06bcb40	TCGA-E9-A1RB-01A-11D-A160-01		TCGA-E9-A1RB-01		458805a0-64c5-4e9a-958e-537047e41a86	
TCGA-E9-A1RB-11		40			21			FEMALE									21	0	Normal						enrollment			LIVING	1	TCGA-E9-A1RB-11	976	1		C3-BRCA/Luminal							mutation cluster 5	TCGA-E9-A1RB	976	0	976	Breast	TCGA Breast Cancer	breast invasive carcinoma					40	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RB-F39530								Modified Radical Mastectomy		NO			-14755	39	976	0	633					NO						Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	640	NO			NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0	0	false	M0	N0	T2	Stage IIA			0		0		0		0		100		0		0		0	TUMOR FREE						YES	YES	No			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	DECEASED	2011			TCGA-E9-A1RB-11A-33R-A156-13	TCGA-E9-A1RB-11A-33R-A156-13						b8499b28-1746-4ffd-a183-a765e6d290e3			b8499b28-1746-4ffd-a183-a765e6d290e3	TCGA-E9-A1RB-11A-33D-A161-05			b8499b28-1746-4ffd-a183-a765e6d290e3	b8499b28-1746-4ffd-a183-a765e6d290e3						
TCGA-E9-A1RC-01	Stage IIIC	56	3	Stage IIIC	1228			FEMALE	Negative				Negative	M0	Positive	N3	1228	0	LumA						enrollment	T_Other	T4	LIVING	0	TCGA-E9-A1RC-01	1224	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14		mutation cluster 4	TCGA-E9-A1RC	1224	0	1224	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RC-F48701								Modified Radical Mastectomy		NO			-20795	1246		0	1224					NO						Scheduled Follow-up Submission	2013-9-19	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	620	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	10	0	true	M0	N3	T4b	Stage IIIC	TCGA-E9-A1RC.D10A419F-B161-4998-97DE-45DF70F4E212.pdf		0		0		0		0		0		30		70		80	TUMOR FREE							YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2007	TCGA-E9-A1RC-01A-11D-A159-09		TCGA-E9-A1RC-01A-11R-A156-13	TCGA-E9-A1RC-01A-11R-A156-13	TCGA-E9-A1RC-01A-11D-A159-09		TCGA-E9-A1RC-01A-11D-A159-09	TCGA-E9-A1RC-01A-21-A17J-20	TCGA-E9-A1RC-01A-11D-A159-09	00168e86-d23a-48ae-8c60-36d970051907	8805f2a1-b210-4663-b5c6-f2f9baca280a	TCGA-E9-A1RC-01A-11D-A160-01	00168e86-d23a-48ae-8c60-36d970051907	TCGA-E9-A1RC-01A-11D-A161-05	TCGA-E9-A1RC-01		00168e86-d23a-48ae-8c60-36d970051907	00168e86-d23a-48ae-8c60-36d970051907	TCGA-E9-A1RC-01A-11D-A160-01		TCGA-E9-A1RC-01		8805f2a1-b210-4663-b5c6-f2f9baca280a	
TCGA-E9-A1RC-11		56			1228			FEMALE									1228	0	LumA						enrollment			LIVING	0	TCGA-E9-A1RC-11	1224	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-E9-A1RC	1224	0	1224	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RC-F48701								Modified Radical Mastectomy		NO			-20795	1246		0	1224					NO						Scheduled Follow-up Submission	2013-9-19	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	1040	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	10	0	false	M0	N3	T4b	Stage IIIC			0		0		0		0		100		0		0		0	TUMOR FREE							YES	No			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2007			TCGA-E9-A1RC-11A-33R-A156-13	TCGA-E9-A1RC-11A-33R-A156-13						81769714-1765-4b76-8a3a-18f79e314852			81769714-1765-4b76-8a3a-18f79e314852	TCGA-E9-A1RC-11A-33D-A161-05			81769714-1765-4b76-8a3a-18f79e314852	81769714-1765-4b76-8a3a-18f79e314852						
TCGA-E9-A1RD-01	Stage IIA	67	2	Stage IIA	20			FEMALE	Negative				Negative	M0	Negative	N0	20	0	LumA						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1RD-01	34	0	Iq	C3-BRCA/Luminal	cluster 3	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13		mutation cluster 4	TCGA-E9-A1RD	34	0	34	Breast	TCGA Breast Cancer	breast invasive carcinoma					67	Right Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RD-F48702								Modified Radical Mastectomy		NO			-24719	38		0	34					NO						Scheduled Follow-up Submission	2013-9-19	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	340	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	0		true	M0	N0	T2	Stage IIA	TCGA-E9-A1RD.EDDEB48B-B712-40B0-9DE5-9F5B5791AF4D.pdf		3		1		1		1		0		19		80		80	TUMOR FREE							YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A1RD-01A-11D-A159-09		TCGA-E9-A1RD-01A-11R-A156-13	TCGA-E9-A1RD-01A-11R-A156-13	TCGA-E9-A1RD-01A-11D-A159-09		TCGA-E9-A1RD-01A-11D-A159-09	TCGA-E9-A1RD-01A-21-A17J-20	TCGA-E9-A1RD-01A-11D-A159-09	eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16	709852ad-ac59-48af-ba05-2d7a80326afa	TCGA-E9-A1RD-01A-11D-A160-01	eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16	TCGA-E9-A1RD-01A-11D-A161-05	TCGA-E9-A1RD-01		eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16	eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16	TCGA-E9-A1RD-01A-11D-A160-01		TCGA-E9-A1RD-01		709852ad-ac59-48af-ba05-2d7a80326afa	
TCGA-E9-A1RD-11		67			20			FEMALE									20	0	Normal						enrollment			LIVING	0	TCGA-E9-A1RD-11	34	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-E9-A1RD	34	0	34	Breast	TCGA Breast Cancer	breast invasive carcinoma					67	Right Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RD-F48702								Modified Radical Mastectomy		NO			-24719	38		0	34					NO						Scheduled Follow-up Submission	2013-9-19	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	640	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T2	Stage IIA			1		1		0		0		0		100		0		0	TUMOR FREE							YES	No			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011			TCGA-E9-A1RD-11A-33R-A156-13	TCGA-E9-A1RD-11A-33R-A156-13						000d877f-8d03-44bc-8607-27b5ba84b5fe			000d877f-8d03-44bc-8607-27b5ba84b5fe	TCGA-E9-A1RD-11A-33D-A161-05			000d877f-8d03-44bc-8607-27b5ba84b5fe	000d877f-8d03-44bc-8607-27b5ba84b5fe						
TCGA-E9-A1RE-01	Stage IIIA	74	4	Stage IIIA	47			FEMALE	Negative				Negative	M0	Positive	N2	47	0	LumB						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1RE-01	1054	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 9		mutation cluster 4	TCGA-E9-A1RE	1054	0	1054	Breast	TCGA Breast Cancer	breast invasive carcinoma					74	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RE-F39532								Modified Radical Mastectomy		NO			-27392	65		0	1054					NO						Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	730	NO			NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	9		true	M0	N2	T2	Stage IIIA	TCGA-E9-A1RE.80831A1A-95BD-4ECD-B7D9-6DDCD5313B25.pdf		2		1		0		1		0		10		90		90	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A1RE-01A-11D-A159-09		TCGA-E9-A1RE-01A-11R-A156-13	TCGA-E9-A1RE-01A-11R-A156-13	TCGA-E9-A1RE-01A-11D-A159-09		TCGA-E9-A1RE-01A-11D-A159-09	TCGA-E9-A1RE-01A-21-A17J-20	TCGA-E9-A1RE-01A-11D-A159-09	dce9e705-2d4f-4786-ad68-fb47615c7f3f	09a7d8d3-0973-405b-96e0-01b579b331b4	TCGA-E9-A1RE-01A-11D-A160-01	dce9e705-2d4f-4786-ad68-fb47615c7f3f	TCGA-E9-A1RE-01A-11D-A161-05	TCGA-E9-A1RE-01		dce9e705-2d4f-4786-ad68-fb47615c7f3f	dce9e705-2d4f-4786-ad68-fb47615c7f3f	TCGA-E9-A1RE-01A-11D-A160-01		TCGA-E9-A1RE-01		09a7d8d3-0973-405b-96e0-01b579b331b4	
TCGA-E9-A1RF-01	Stage IIIA	68	5	Stage IIIA	38			FEMALE	Negative				Negative	M0	Positive	N2	38	0	LumA						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1RF-01	200	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4		mutation c1uster 9	TCGA-E9-A1RF	200	0	200	Breast	TCGA Breast Cancer	breast invasive carcinoma					68	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RF-F48703								Modified Radical Mastectomy		NO			-25119	56		0	200					NO						Scheduled Follow-up Submission	2013-9-19	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	330	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	5		true	M0	N2	T2	Stage IIIA	TCGA-E9-A1RF.50F3690C-2082-4590-A923-656C5F226FAE.pdf		3		2		1		1		0		24		75		75	TUMOR FREE							YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A1RF-01A-11D-A159-09		TCGA-E9-A1RF-01A-11R-A156-13	TCGA-E9-A1RF-01A-11R-A156-13	TCGA-E9-A1RF-01A-11D-A159-09		TCGA-E9-A1RF-01A-11D-A159-09	TCGA-E9-A1RF-01A-21-A17J-20	TCGA-E9-A1RF-01A-11D-A159-09	502939cc-3381-4bc2-9ae6-332846cf836b	cec10976-a9f7-47cf-b7b4-a9e04ef7d6c9	TCGA-E9-A1RF-01A-11D-A160-01	502939cc-3381-4bc2-9ae6-332846cf836b	TCGA-E9-A1RF-01A-11D-A161-05	TCGA-E9-A1RF-01		502939cc-3381-4bc2-9ae6-332846cf836b	502939cc-3381-4bc2-9ae6-332846cf836b	TCGA-E9-A1RF-01A-11D-A160-01		TCGA-E9-A1RF-01		cec10976-a9f7-47cf-b7b4-a9e04ef7d6c9	
TCGA-E9-A1RF-11		68			38			FEMALE									38	0	LumA						enrollment			LIVING	0	TCGA-E9-A1RF-11	200	0		C3-BRCA/Luminal							mutation c1uster 9	TCGA-E9-A1RF	200	0	200	Breast	TCGA Breast Cancer	breast invasive carcinoma					68	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RF-F48703								Modified Radical Mastectomy		NO			-25119	56		0	200					NO						Scheduled Follow-up Submission	2013-9-19	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	1050	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	5		false	M0	N2	T2	Stage IIIA			2		1		0		0		0		100		0		0	TUMOR FREE							YES	No			YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011			TCGA-E9-A1RF-11A-32R-A156-13	TCGA-E9-A1RF-11A-32R-A156-13						da13db3f-cde6-4e25-9596-009147aa3fa9			da13db3f-cde6-4e25-9596-009147aa3fa9	TCGA-E9-A1RF-11A-32D-A161-05			da13db3f-cde6-4e25-9596-009147aa3fa9	da13db3f-cde6-4e25-9596-009147aa3fa9						
TCGA-E9-A1RG-01	Stage IIIA	62	2	Stage IIIA	35			FEMALE	Negative				Negative	M0	Positive	N2	35	0							enrollment	T1	T1	LIVING	0	TCGA-E9-A1RG-01	647	0	High	C1-LUAD-enriched	cluster 2	Cluster 5	BRCA nonbasal-like c8		miRNA cluster 2	cluster 5	mutation c1uster 9	TCGA-E9-A1RG	647	0	647	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RG-F39534								Lumpectomy		NO			-22788	53		0	647					NO						Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	540	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	5								NO	4		true	M0	N2	T1c	Stage IIIA	TCGA-E9-A1RG.59D84893-8946-4C5C-A338-3E33A1F7DE00.pdf		2		0		4		0		0		31		65		85	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A1RG-01A-11D-A14G-09		TCGA-E9-A1RG-01A-11R-A14C-13	TCGA-E9-A1RG-01A-11R-A14C-13			TCGA-E9-A1RG-01A-11D-A14G-09	TCGA-E9-A1RG-01A-21-A17J-20	TCGA-E9-A1RG-01A-11D-A14G-09	dbf09347-4e3e-490e-977f-97d826143634	5cc785cc-8845-4b90-95eb-097896412250	TCGA-E9-A1RG-01A-11D-A14F-01	dbf09347-4e3e-490e-977f-97d826143634	TCGA-E9-A1RG-01A-11D-A14H-05	TCGA-E9-A1RG-01		dbf09347-4e3e-490e-977f-97d826143634	dbf09347-4e3e-490e-977f-97d826143634	TCGA-E9-A1RG-01A-11D-A14F-01		TCGA-E9-A1RG-01		5cc785cc-8845-4b90-95eb-097896412250	
TCGA-E9-A1RH-01	Stage IIA	63	4	Stage IIA	14			FEMALE	Negative				Negative	M0	Negative	N0	14	0	Her2						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1RH-01	1052	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E9-A1RH	1052	0	1052	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RH-F39538								Lumpectomy		NO			-23224	32		0	1052					NO						Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	410	NO			NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	0		true	M0	N0	T2	Stage IIA	TCGA-E9-A1RH.FA93BDAA-B56E-4217-9022-4EBE6009FCF7.pdf		5		0		4		0		0		26		70		85	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A1RH-01A-21D-A167-09		TCGA-E9-A1RH-01A-21R-A168-13	TCGA-E9-A1RH-01A-21R-A168-13	TCGA-E9-A1RH-01A-21D-A167-09		TCGA-E9-A1RH-01A-21D-A167-09	TCGA-E9-A1RH-01A-11-A17J-20	TCGA-E9-A1RH-01A-21D-A167-09	422a4277-12f1-42ae-9f94-88d37517b9b0	f1b4f790-083e-44f0-b924-06dc7c167a20	TCGA-E9-A1RH-01A-21D-A166-01	422a4277-12f1-42ae-9f94-88d37517b9b0	TCGA-E9-A1RH-01A-21D-A16A-05	TCGA-E9-A1RH-01		422a4277-12f1-42ae-9f94-88d37517b9b0	422a4277-12f1-42ae-9f94-88d37517b9b0	TCGA-E9-A1RH-01A-21D-A166-01		TCGA-E9-A1RH-01		f1b4f790-083e-44f0-b924-06dc7c167a20	
TCGA-E9-A1RH-11		63			14			FEMALE									14	0	Normal						enrollment			LIVING	0	TCGA-E9-A1RH-11	1052	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-E9-A1RH	1052	0	1052	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RH-F39538								Lumpectomy		NO			-23224	32		0	1052					NO						Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	720	NO			NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T2	Stage IIA			0		0		0		0		1		99		0		0	TUMOR FREE						YES	YES	No			YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011			TCGA-E9-A1RH-11A-34R-A168-13	TCGA-E9-A1RH-11A-34R-A168-13						6574e15e-7e1f-4dca-899e-56e911f27848			6574e15e-7e1f-4dca-899e-56e911f27848	TCGA-E9-A1RH-11A-34D-A16A-05			6574e15e-7e1f-4dca-899e-56e911f27848	6574e15e-7e1f-4dca-899e-56e911f27848						
TCGA-E9-A1RI-01	Stage IIIA	43	2	Stage IIIA	48			FEMALE					Negative	M0	Positive	N2	48	0	LumA						enrollment	T1	T1	LIVING	0	TCGA-E9-A1RI-01	1084	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E9-A1RI	1084	0	1084	Breast	TCGA Breast Cancer	breast invasive carcinoma					43	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RI-F39443								Modified Radical Mastectomy		NO			-15942	64		0	1084					NO						Scheduled Follow-up Submission	2013-1-23	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	290	NO			NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4								NO	5		true	M0	N2	T1c	Stage IIIA	TCGA-E9-A1RI.91303D10-CC36-47CF-BF14-E1DCE0157D1C.pdf		1		0		2		0		0		18		80		90	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A1RI-01A-11D-A167-09		TCGA-E9-A1RI-01A-11R-A168-13	TCGA-E9-A1RI-01A-11R-A168-13	TCGA-E9-A1RI-01A-11D-A167-09		TCGA-E9-A1RI-01A-11D-A167-09	TCGA-E9-A1RI-01A-21-A17J-20	TCGA-E9-A1RI-01A-11D-A167-09	1c77a00e-8cea-48ae-b9b5-193cdecf3604	815c2a7a-a33b-4899-a2aa-df187eccf1bd	TCGA-E9-A1RI-01A-11D-A166-01	1c77a00e-8cea-48ae-b9b5-193cdecf3604	TCGA-E9-A1RI-01A-11D-A16A-05	TCGA-E9-A1RI-01		1c77a00e-8cea-48ae-b9b5-193cdecf3604	1c77a00e-8cea-48ae-b9b5-193cdecf3604	TCGA-E9-A1RI-01A-11D-A166-01		TCGA-E9-A1RI-01		815c2a7a-a33b-4899-a2aa-df187eccf1bd	
TCGA-E9-A1RI-11		43			48			FEMALE									48	0	LumA						enrollment			LIVING	0	TCGA-E9-A1RI-11	1084	0		C3-BRCA/Luminal							mutation cluster 4	TCGA-E9-A1RI	1084	0	1084	Breast	TCGA Breast Cancer	breast invasive carcinoma					43	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RI-F39443								Modified Radical Mastectomy		NO			-15942	64		0	1084					NO						Scheduled Follow-up Submission	2013-1-23	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	800	NO			NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	5		false	M0	N2	T1c	Stage IIIA			0		0		0		0		0		100		0		0	TUMOR FREE						YES	YES	No			YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011			TCGA-E9-A1RI-11A-41R-A168-13	TCGA-E9-A1RI-11A-41R-A168-13						7391b882-0be5-45b0-aa01-43c3381a476d			7391b882-0be5-45b0-aa01-43c3381a476d	TCGA-E9-A1RI-11A-41D-A16A-05			7391b882-0be5-45b0-aa01-43c3381a476d	7391b882-0be5-45b0-aa01-43c3381a476d						
TCGA-E9-A226-01	Stage IIIA	45	2	Stage IIIA	16			FEMALE	Negative				Negative	M0	Positive	N2	16	0	LumB						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A226-01	1038	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4		mutation cluster 3	TCGA-E9-A226	790	1	1038	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO			45	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A226-F39536								Modified Radical Mastectomy		NO			-16511	48		0	1038			790		NO						Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	510	NO			NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		3					Bone	Distant Metastasis		NO	YES	6		true	M0	N2	T2	Stage IIIA	TCGA-E9-A226.7C8F01DC-9CD9-4D61-9032-BC9F28A687EE.pdf		0		0		0		0		0		0		100		65	WITH TUMOR						YES	YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A226-01A-21D-A159-09		TCGA-E9-A226-01A-21R-A156-13	TCGA-E9-A226-01A-21R-A156-13	TCGA-E9-A226-01A-21D-A159-09		TCGA-E9-A226-01A-21D-A159-09	TCGA-E9-A226-01A-11-A17K-20	TCGA-E9-A226-01A-21D-A159-09	2f11f003-9c39-46ba-990f-10d326953f1b	dbfe507d-f859-4ca8-9da1-18bfe3e89a68	TCGA-E9-A226-01A-21D-A160-01	2f11f003-9c39-46ba-990f-10d326953f1b	TCGA-E9-A226-01A-21D-A161-05	TCGA-E9-A226-01		2f11f003-9c39-46ba-990f-10d326953f1b	2f11f003-9c39-46ba-990f-10d326953f1b	TCGA-E9-A226-01A-21D-A160-01		TCGA-E9-A226-01		dbfe507d-f859-4ca8-9da1-18bfe3e89a68	
TCGA-E9-A227-01	Stage IIB	42	2	Stage IIB	24		Positive	FEMALE	Negative				Negative	M0	Positive	N1	24	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A227-01	24	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14		mutation cluster 1	TCGA-E9-A227			24	Breast	TCGA Breast Cancer	breast invasive carcinoma					42	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			Negative	Positive		4+		Other	Positive	Lumpectomy	Re-excision of original lumpectomy site	NO			-15602	66		0	24					NO		90-99%					2011-7-28	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	180	NO	Negative			17	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1										1		true	M0	N1	T2	Stage IIB	TCGA-E9-A227.13CA22BB-5EA5-46C9-82D3-77867122D1B4.pdf		0		0		0		0		0		35		65		80					Two-tier	Two-tier		YES	No	80-89%			Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A227-01A-11D-A159-09		TCGA-E9-A227-01A-11R-A156-13	TCGA-E9-A227-01A-11R-A156-13	TCGA-E9-A227-01A-11D-A159-09		TCGA-E9-A227-01A-11D-A159-09	TCGA-E9-A227-01A-21-A17K-20	TCGA-E9-A227-01A-11D-A159-09	2f315234-dee1-4f36-b7dc-72280c219a1c	3e648342-a21d-4c25-8e1f-1c1dda9b543f	TCGA-E9-A227-01A-11D-A160-01	2f315234-dee1-4f36-b7dc-72280c219a1c	TCGA-E9-A227-01A-11D-A161-05	TCGA-E9-A227-01		2f315234-dee1-4f36-b7dc-72280c219a1c	2f315234-dee1-4f36-b7dc-72280c219a1c	TCGA-E9-A227-01A-11D-A160-01		TCGA-E9-A227-01		3e648342-a21d-4c25-8e1f-1c1dda9b543f	
TCGA-E9-A228-01	Stage IIB	58	5	Stage IIB	0			FEMALE	Positive				Negative	M0	Positive	N1	0	0	LumB						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A228-01	381	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14		mutation c1uster 9	TCGA-E9-A228	381	0	381	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Right Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A228-F29761													-21294	42		0	381					NO						Scheduled Follow-up Submission	2012-3-28	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	740	NO				12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	2		true	M0	N1	T2	Stage IIB	TCGA-E9-A228.B0E8F3C1-E996-4E70-9630-AC95AF6E4EDC.pdf		2		1		0		1		0		15		85		85	TUMOR FREE							YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A228-01A-31D-A159-09		TCGA-E9-A228-01A-31R-A156-13	TCGA-E9-A228-01A-31R-A156-13	TCGA-E9-A228-01A-31D-A159-09		TCGA-E9-A228-01A-31D-A159-09	TCGA-E9-A228-01A-41-A17K-20	TCGA-E9-A228-01A-31D-A159-09	5903d969-2fd6-4952-b475-a79e6c241efd	6e3c544e-9a1d-431d-8775-cbbd41de89c2	TCGA-E9-A228-01A-31D-A160-01	5903d969-2fd6-4952-b475-a79e6c241efd	TCGA-E9-A228-01A-31D-A161-05	TCGA-E9-A228-01		5903d969-2fd6-4952-b475-a79e6c241efd	5903d969-2fd6-4952-b475-a79e6c241efd	TCGA-E9-A228-01A-31D-A160-01		TCGA-E9-A228-01		6e3c544e-9a1d-431d-8775-cbbd41de89c2	
TCGA-E9-A229-01	Stage IA	37	5	Stage I	0			FEMALE	Negative				Negative	M0	Negative	N0	0	0	LumA						enrollment	T1	T1	LIVING	0	TCGA-E9-A229-01	405	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4		mutation cluster 4	TCGA-E9-A229	405	0	405	Breast	TCGA Breast Cancer	breast invasive carcinoma					37	Right Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A229-F29798													-13817			0	405					NO						Scheduled Follow-up Submission	2012-3-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection						14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1									NO	0			M0	N0	T1c	Stage IA																		TUMOR FREE							YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast		LIVING	2011	TCGA-E9-A229-01A-31D-A17G-09		TCGA-E9-A229-01A-31R-A156-13	TCGA-E9-A229-01A-31R-A156-13	TCGA-E9-A229-01A-31D-A17G-09		TCGA-E9-A229-01A-31D-A17G-09	TCGA-E9-A229-01A-21-A17K-20	TCGA-E9-A229-01A-31D-A17G-09	b956a823-b7d5-4a9e-a9d1-c66f0faf544a	b56e8eb4-5efb-4f29-bee6-da6e61aa44a2	TCGA-E9-A229-01A-31D-A160-01	b956a823-b7d5-4a9e-a9d1-c66f0faf544a	TCGA-E9-A229-01A-31D-A161-05	TCGA-E9-A229-01		b956a823-b7d5-4a9e-a9d1-c66f0faf544a	b956a823-b7d5-4a9e-a9d1-c66f0faf544a	TCGA-E9-A229-01A-31D-A160-01		TCGA-E9-A229-01		b56e8eb4-5efb-4f29-bee6-da6e61aa44a2	
TCGA-E9-A22A-01	Stage IIA	74	1	Stage IIA	0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	0	0	LumB		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A22A-01	1189	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 9		mutation c1uster 9	TCGA-E9-A22A	1189	0	1189	Breast	TCGA Breast Cancer	breast invasive carcinoma					74	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A22A-F39785		Positive					Negative			YES			-27288	59		0	1189					NO		10-19%				Scheduled Follow-up Submission	2013-2-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	340	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	0	0	true	M0	N0	T2	Stage IIA	TCGA-E9-A22A.BC3061B7-9C99-4270-84EE-B1306FA01AE2.pdf		0		0		0		0		0		0		100		60	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A22A-01A-11D-A159-09		TCGA-E9-A22A-01A-11R-A156-13	TCGA-E9-A22A-01A-11R-A156-13	TCGA-E9-A22A-01A-11D-A159-09		TCGA-E9-A22A-01A-11D-A159-09	TCGA-E9-A22A-01A-21-A17K-20	TCGA-E9-A22A-01A-11D-A159-09	2513da31-4ee0-49cd-85de-d2bc8e71e2e5	3b807901-2667-4023-8210-20c0ebb5d189	TCGA-E9-A22A-01A-11D-A160-01	2513da31-4ee0-49cd-85de-d2bc8e71e2e5	TCGA-E9-A22A-01A-11D-A161-05	TCGA-E9-A22A-01		2513da31-4ee0-49cd-85de-d2bc8e71e2e5	2513da31-4ee0-49cd-85de-d2bc8e71e2e5	TCGA-E9-A22A-01A-11D-A160-01		TCGA-E9-A22A-01		3b807901-2667-4023-8210-20c0ebb5d189	
TCGA-E9-A22B-01	Stage IA	71	5	Stage I	0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	0	0	LumA		Negative				enrollment	T1	T1	LIVING	0	TCGA-E9-A22B-01	692	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 9		mutation c1uster 9	TCGA-E9-A22B	692	0	692	Breast	TCGA Breast Cancer	breast invasive carcinoma					71	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A22B-F39786		Positive					Negative			YES			-26278	59		0	692					NO		10-19%				Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	250	NO	Negative		NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	0	0	true	M0	N0	T1c	Stage IA	TCGA-E9-A22B.FC896EB8-1CEC-46A0-82E1-E3FBFAAB69F1.pdf		0		0		0		0		0		5		95		75	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A22B-01A-11D-A159-09		TCGA-E9-A22B-01A-11R-A156-13	TCGA-E9-A22B-01A-11R-A156-13	TCGA-E9-A22B-01A-11D-A159-09		TCGA-E9-A22B-01A-11D-A159-09	TCGA-E9-A22B-01A-21-A17K-20	TCGA-E9-A22B-01A-11D-A159-09	f563bc24-00d1-4637-a073-87744ed7311a	260ee6fb-7c05-41d7-93c4-8c5c5e40f5ff	TCGA-E9-A22B-01A-11D-A160-01	f563bc24-00d1-4637-a073-87744ed7311a	TCGA-E9-A22B-01A-11D-A161-05	TCGA-E9-A22B-01		f563bc24-00d1-4637-a073-87744ed7311a	f563bc24-00d1-4637-a073-87744ed7311a	TCGA-E9-A22B-01A-11D-A160-01		TCGA-E9-A22B-01		260ee6fb-7c05-41d7-93c4-8c5c5e40f5ff	
TCGA-E9-A22D-01	Stage IIA	38	5	Stage IIA	0		Positive	FEMALE	Positive				Negative	M0	Negative	N0	0	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A22D-01	1248	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4		mutation c1uster 9	TCGA-E9-A22D	1248	0	1248	Breast	TCGA Breast Cancer	breast invasive carcinoma					38	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A22D-F39787		Positive					Positive	Modified Radical Mastectomy		YES			-14115	52		0	1248							10-19%				Scheduled Follow-up Submission	2013-2-1	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	620	NO	Positive		NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		3									NO	0	0	true	M0	N0	T2	Stage IIA	TCGA-E9-A22D.ED60F792-A71B-4BAE-A536-5FF6D8C3DEAA.pdf		0		0		0		0		0		5		95		85	TUMOR FREE						YES	YES	No	<10%		NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A22D-01A-11D-A159-09		TCGA-E9-A22D-01A-11R-A156-13	TCGA-E9-A22D-01A-11R-A156-13	TCGA-E9-A22D-01A-11D-A159-09		TCGA-E9-A22D-01A-11D-A159-09	TCGA-E9-A22D-01A-21-A17K-20	TCGA-E9-A22D-01A-11D-A159-09	1fdac226-ed6b-41a8-9575-67117b4cf035	1b0a7689-323d-487b-8e4f-9e5742f24438	TCGA-E9-A22D-01A-11D-A160-01	1fdac226-ed6b-41a8-9575-67117b4cf035	TCGA-E9-A22D-01A-11D-A161-05	TCGA-E9-A22D-01		1fdac226-ed6b-41a8-9575-67117b4cf035	1fdac226-ed6b-41a8-9575-67117b4cf035	TCGA-E9-A22D-01A-11D-A160-01		TCGA-E9-A22D-01		1b0a7689-323d-487b-8e4f-9e5742f24438	
TCGA-E9-A22E-01	Stage IIIA	56	1	Stage IIIA	0		Positive	FEMALE	Negative				Negative	M0	Positive	N2	0	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A22E-01	392	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 9		mutation c1uster 9	TCGA-E9-A22E	392	0	392	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Right Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A22E-F29931		Positive					Positive			YES			-20574	52		0	392					NO		10-19%				Scheduled Follow-up Submission	2012-3-30	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	620	NO	Positive			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4									NO	4	0	true	M0	N2	T2	Stage IIIA	TCGA-E9-A22E.7788E7FD-B5A3-4B22-83CA-EA3FB5E826FC.pdf		0		0		0		0		0		0		100		75	TUMOR FREE							YES	No	<10%		YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A22E-01A-11D-A159-09		TCGA-E9-A22E-01A-11R-A156-13	TCGA-E9-A22E-01A-11R-A156-13	TCGA-E9-A22E-01A-11D-A159-09		TCGA-E9-A22E-01A-11D-A159-09	TCGA-E9-A22E-01A-21-A17K-20	TCGA-E9-A22E-01A-11D-A159-09	e4d09b12-f1b4-4d66-bc6c-ccd32ad8185b	2ea69f1e-ccd7-4691-a0c1-f6cb6f5f343c	TCGA-E9-A22E-01A-11D-A160-01	e4d09b12-f1b4-4d66-bc6c-ccd32ad8185b	TCGA-E9-A22E-01A-11D-A161-05	TCGA-E9-A22E-01		e4d09b12-f1b4-4d66-bc6c-ccd32ad8185b	e4d09b12-f1b4-4d66-bc6c-ccd32ad8185b	TCGA-E9-A22E-01A-11D-A160-01		TCGA-E9-A22E-01		2ea69f1e-ccd7-4691-a0c1-f6cb6f5f343c	
TCGA-E9-A22G-01	Stage IIIA	47	1	Stage IIA	0		Negative	FEMALE	Negative				Negative	M0	Negative	N0	0	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A22G-01	715	0	Squamous	C4-BRCA/Basal	cluster 3	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 1		mutation cluster 5	TCGA-E9-A22G	715	0	715	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A22G-F29939		Negative					Negative			YES			-17300	45		0	715					NO						Scheduled Follow-up Submission	2014-4-30	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	650	NO	Positive			6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	0	0	true	M0	N0	T2	Stage IIA	TCGA-E9-A22G.E34F4BF0-A0C3-4C72-8E3A-F319D4CDDD5D.pdf		0		0		0		0		0		0		100		85	TUMOR FREE							YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A22G-01A-11D-A159-09		TCGA-E9-A22G-01A-11R-A156-13	TCGA-E9-A22G-01A-11R-A156-13	TCGA-E9-A22G-01A-11D-A159-09		TCGA-E9-A22G-01A-11D-A159-09	TCGA-E9-A22G-01A-21-A17K-20	TCGA-E9-A22G-01A-11D-A159-09	88d93dca-ffae-4d57-9a60-346aec436543	3c37bf85-6a5c-4fe9-9c42-5ebd7b27d23f	TCGA-E9-A22G-01A-11D-A160-01	88d93dca-ffae-4d57-9a60-346aec436543	TCGA-E9-A22G-01A-11D-A161-05	TCGA-E9-A22G-01		88d93dca-ffae-4d57-9a60-346aec436543	88d93dca-ffae-4d57-9a60-346aec436543	TCGA-E9-A22G-01A-11D-A160-01		TCGA-E9-A22G-01		3c37bf85-6a5c-4fe9-9c42-5ebd7b27d23f	
TCGA-E9-A22H-01	Stage IIB	42	2	Stage IIB	0		Positive	FEMALE	Negative				Negative	M0	Positive	N1	0	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A22H-01	630	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6		mutation cluster 4	TCGA-E9-A22H	630	0	630	Breast	TCGA Breast Cancer	breast invasive carcinoma					42	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A22H-F40642		Positive					Positive	Modified Radical Mastectomy		YES			-15504	38		0	630					NO		<10%				Scheduled Follow-up Submission	2013-2-26	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	500	NO	Positive		NO	8	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1									NO	1	0	true	M0	N1	T2	Stage IIB	TCGA-E9-A22H.672E4D81-DA47-495C-A58B-BD2B4FEA2380.pdf		0		0		0		0		0		15		85		70	TUMOR FREE						YES	YES	No	10-19%		YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A22H-01A-11D-A159-09		TCGA-E9-A22H-01A-11R-A156-13	TCGA-E9-A22H-01A-11R-A156-13	TCGA-E9-A22H-01A-11D-A159-09		TCGA-E9-A22H-01A-11D-A159-09	TCGA-E9-A22H-01A-21-A17K-20	TCGA-E9-A22H-01A-11D-A159-09	c388d3be-37d9-4377-8c85-f6124b2ad436	80737d22-494c-491b-82de-4e3ab2f693ef	TCGA-E9-A22H-01A-11D-A160-01	c388d3be-37d9-4377-8c85-f6124b2ad436	TCGA-E9-A22H-01A-11D-A161-05	TCGA-E9-A22H-01		c388d3be-37d9-4377-8c85-f6124b2ad436	c388d3be-37d9-4377-8c85-f6124b2ad436	TCGA-E9-A22H-01A-11D-A160-01		TCGA-E9-A22H-01		80737d22-494c-491b-82de-4e3ab2f693ef	
TCGA-E9-A243-01	Stage IIA	52	3	Stage IIA	43			FEMALE	Negative				Negative	M0	Negative	N0	43	0	Basal						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A243-01	519	0	High	C4-BRCA/Basal	cluster 5	OV-like c1	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-E9-A243	305	1	519	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO	NO		52	Right Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A243-F39521								Lumpectomy		NO			-19035	94		0	519			305		NO						Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	270	NO			NO	10	Negative	Peri (6-12 months since last menstrual period)		Negative			Negative												Negative	5	3				Bone	Distant Metastasis		NO	YES	0		true	M0	N0 (i-)	T2	Stage IIA	TCGA-E9-A243.742A4812-9EB1-4348-996E-3F1AD7FA3E5D.pdf		0		0		0		0		0		0		100		80	WITH TUMOR						YES	YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A243-01A-21D-A167-09		TCGA-E9-A243-01A-21R-A168-13	TCGA-E9-A243-01A-21R-A168-13	TCGA-E9-A243-01A-21D-A167-09		TCGA-E9-A243-01A-21D-A167-09	TCGA-E9-A243-01A-11-A17K-20	TCGA-E9-A243-01A-21D-A167-09	619ffb2b-a591-4f3b-aa48-b0c44f4ee36a	2a67b3a1-4ab0-43ee-9630-8532d0f56b5d	TCGA-E9-A243-01A-21D-A166-01	619ffb2b-a591-4f3b-aa48-b0c44f4ee36a	TCGA-E9-A243-01A-21D-A16A-05	TCGA-E9-A243-01		619ffb2b-a591-4f3b-aa48-b0c44f4ee36a	619ffb2b-a591-4f3b-aa48-b0c44f4ee36a	TCGA-E9-A243-01A-21D-A166-01		TCGA-E9-A243-01		2a67b3a1-4ab0-43ee-9630-8532d0f56b5d	
TCGA-E9-A244-01	Stage IIA	54	1	Stage IIA	20			FEMALE	Negative				Negative	M0	Negative	N0	20	0	Basal						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A244-01	21	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA c1uster 9		mutation cluster 5	TCGA-E9-A244	21	0	21	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A244-F31164								Lumpectomy		NO			-19778	58		0	21					NO						Scheduled Follow-up Submission	2012-4-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	310	NO				10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5									NO	0		true	M0	N0 (i-)	T2	Stage IIA	TCGA-E9-A244.4158FEAB-066B-4500-8FD2-3F197438DFB5.pdf		0		0		0		0		5		5		90		60	TUMOR FREE							YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A244-01A-11D-A167-09		TCGA-E9-A244-01A-11R-A168-13	TCGA-E9-A244-01A-11R-A168-13	TCGA-E9-A244-01A-11D-A167-09		TCGA-E9-A244-01A-11D-A167-09	TCGA-E9-A244-01A-21-A17K-20	TCGA-E9-A244-01A-11D-A167-09	147d6ebb-7359-449a-9e6a-6c8443ebaa2e	4695c0f4-4d30-4604-84b3-81407bf980e8	TCGA-E9-A244-01A-11D-A166-01	147d6ebb-7359-449a-9e6a-6c8443ebaa2e	TCGA-E9-A244-01A-11D-A16A-05	TCGA-E9-A244-01		147d6ebb-7359-449a-9e6a-6c8443ebaa2e	147d6ebb-7359-449a-9e6a-6c8443ebaa2e	TCGA-E9-A244-01A-11D-A166-01		TCGA-E9-A244-01		4695c0f4-4d30-4604-84b3-81407bf980e8	
TCGA-E9-A245-01	Stage IIB	47	3	Stage IIB	25			FEMALE	Negative				Negative	M0	Positive	N1	25	0	LumA						enrollment	T_Other	T2	LIVING		TCGA-E9-A245-01			Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6		mutation c1uster 9	TCGA-E9-A245				Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A245-F31169								Lumpectomy		NO			-17363	62		0	26					NO						Scheduled Follow-up Submission	2012-4-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	490	NO				10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2									NO	3		true	M0	N1	T2	Stage IIB	TCGA-E9-A245.5F2A52E5-2844-4242-8CE4-A87DF9D9C97B.pdf		0		0		0		0		10		55		35		75	TUMOR FREE							YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	DECEASED	2011	TCGA-E9-A245-01A-22D-A16D-09		TCGA-E9-A245-01A-22R-A16E-13	TCGA-E9-A245-01A-22R-A16E-13	TCGA-E9-A245-01A-22D-A16D-09		TCGA-E9-A245-01A-22D-A16D-09	TCGA-E9-A245-01A-11-A17K-20	TCGA-E9-A245-01A-22D-A16D-09	538ab6dc-6dff-49e2-ae6a-b91ee6619bce	c45b38c4-d7ce-4f8d-ba2f-c42ff0794ecc	TCGA-E9-A245-01A-22D-A16C-01	538ab6dc-6dff-49e2-ae6a-b91ee6619bce	TCGA-E9-A245-01A-22D-A16G-05	TCGA-E9-A245-01		538ab6dc-6dff-49e2-ae6a-b91ee6619bce	538ab6dc-6dff-49e2-ae6a-b91ee6619bce	TCGA-E9-A245-01A-22D-A16C-01		TCGA-E9-A245-01		c45b38c4-d7ce-4f8d-ba2f-c42ff0794ecc	
TCGA-E9-A247-01	Stage IB	59	4	Stage I	12			FEMALE	Negative				Negative	M0	Negative	N0	12	0	LumA						enrollment	T1	T1	LIVING	0	TCGA-E9-A247-01	828	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6		mutation c1uster 9	TCGA-E9-A247	828	0	828	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A247-F40240													-21562	49		0	828					NO						Scheduled Follow-up Submission	2013-2-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Lumpectomy	Other method, specify:	370	NO			NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	0		true	M0	N0 (i-)	T1c	Stage IA	TCGA-E9-A247.61E73960-32B0-413E-AF1D-2EF4582293B3.pdf		0		0		0		0		15		0		85		90	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A247-01A-11D-A167-09		TCGA-E9-A247-01A-11R-A168-13	TCGA-E9-A247-01A-11R-A168-13	TCGA-E9-A247-01A-11D-A167-09		TCGA-E9-A247-01A-11D-A167-09	TCGA-E9-A247-01A-21-A17K-20	TCGA-E9-A247-01A-11D-A167-09	3c38c1fe-9f57-4523-9654-c4bc6b02e84f	37240e3a-9340-4509-a5e9-c7877ed93f52	TCGA-E9-A247-01A-11D-A166-01	3c38c1fe-9f57-4523-9654-c4bc6b02e84f	TCGA-E9-A247-01A-11D-A16A-05	TCGA-E9-A247-01		3c38c1fe-9f57-4523-9654-c4bc6b02e84f	3c38c1fe-9f57-4523-9654-c4bc6b02e84f	TCGA-E9-A247-01A-11D-A166-01		TCGA-E9-A247-01		37240e3a-9340-4509-a5e9-c7877ed93f52	
TCGA-E9-A248-01	Stage IIA	51	4	Stage IIA	21			FEMALE	Negative				Negative	M0	Negative	N0	21	0	Her2						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A248-01	59	0	Squamous	C3-BRCA/Luminal	cluster 1	OV-like c1	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-E9-A248	59	0	59	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A248-F31211								Lumpectomy		NO			-18684	52		0	59					NO						Scheduled Follow-up Submission	2012-4-25	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	540	NO				10	Negative	Peri (6-12 months since last menstrual period)																		1	3								NO	0		true	M0	N0 (i-)	T2	Stage IIA	TCGA-E9-A248.8950E632-451D-4436-9AA2-740CB08237E8.pdf		0		0		0		0		0		0		100		80	TUMOR FREE							YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A248-01A-11D-A167-09		TCGA-E9-A248-01A-11R-A168-13	TCGA-E9-A248-01A-11R-A168-13	TCGA-E9-A248-01A-11D-A167-09		TCGA-E9-A248-01A-11D-A167-09	TCGA-E9-A248-01A-21-A17K-20	TCGA-E9-A248-01A-11D-A167-09	0a9215ea-d5d2-41ad-a00d-bd7722f41229	091f70c0-586a-49e8-a0e5-0b60caa72c1b	TCGA-E9-A248-01A-11D-A166-01	0a9215ea-d5d2-41ad-a00d-bd7722f41229	TCGA-E9-A248-01A-11D-A16A-05	TCGA-E9-A248-01		0a9215ea-d5d2-41ad-a00d-bd7722f41229	0a9215ea-d5d2-41ad-a00d-bd7722f41229	TCGA-E9-A248-01A-11D-A166-01		TCGA-E9-A248-01		091f70c0-586a-49e8-a0e5-0b60caa72c1b	
TCGA-E9-A249-01	Stage IIA	45	2	Stage IIA	28			FEMALE	Negative				Negative	M0	Negative	N0	28	0	LumB						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A249-01	217	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-E9-A249	217	0	217	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A249-F49108								Lumpectomy		NO			-16689	59		0	217					NO						Scheduled Follow-up Submission	2013-9-25	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	470	NO			YES	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	3								NO	0		true	M0	N0 (i-)	T2	Stage IIA	TCGA-E9-A249.6272ED78-501A-4055-8C87-430F46F518AA.pdf		0		0		0		0		0		0		100		90	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A249-01A-11D-A167-09		TCGA-E9-A249-01A-11R-A168-13	TCGA-E9-A249-01A-11R-A168-13	TCGA-E9-A249-01A-11D-A167-09		TCGA-E9-A249-01A-11D-A167-09	TCGA-E9-A249-01A-21-A17K-20	TCGA-E9-A249-01A-11D-A167-09	5285c747-0cb2-4f6a-83d8-40e45f8e4f6e	2e3fb75f-065e-4db0-bddf-8bcc6c7ace38	TCGA-E9-A249-01A-11D-A166-01	5285c747-0cb2-4f6a-83d8-40e45f8e4f6e	TCGA-E9-A249-01A-11D-A16A-05	TCGA-E9-A249-01		5285c747-0cb2-4f6a-83d8-40e45f8e4f6e	5285c747-0cb2-4f6a-83d8-40e45f8e4f6e	TCGA-E9-A249-01A-11D-A166-01		TCGA-E9-A249-01		2e3fb75f-065e-4db0-bddf-8bcc6c7ace38	
TCGA-E9-A24A-01	Stage IIA	69	2	Stage IIA	10			FEMALE	Negative				Negative	M0	Positive	N1	10	0	LumA						enrollment	T1	T1	LIVING	0	TCGA-E9-A24A-01	747	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-E9-A24A	747	0	747	Breast	TCGA Breast Cancer	breast invasive carcinoma					69	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A24A-F39541										NO			-25370	41		0	747					NO						Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Lumpectomy	Other method, specify:	390	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	1		true	M0	N1	T1c	Stage IIA	TCGA-E9-A24A.392524F7-B570-4047-A439-71FC15642DC8.pdf		0		0		0		0		0		20		80		88	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A24A-01A-11D-A167-09		TCGA-E9-A24A-01A-11R-A168-13	TCGA-E9-A24A-01A-11R-A168-13	TCGA-E9-A24A-01A-11D-A167-09		TCGA-E9-A24A-01A-11D-A167-09	TCGA-E9-A24A-01A-21-A17K-20	TCGA-E9-A24A-01A-11D-A167-09	a2bec98a-d946-40d2-b4d9-6495d815de9a	646a5d15-e48b-4183-b437-98280a5821c3	TCGA-E9-A24A-01A-11D-A166-01	a2bec98a-d946-40d2-b4d9-6495d815de9a	TCGA-E9-A24A-01A-11D-A16A-05	TCGA-E9-A24A-01		a2bec98a-d946-40d2-b4d9-6495d815de9a	a2bec98a-d946-40d2-b4d9-6495d815de9a	TCGA-E9-A24A-01A-11D-A166-01		TCGA-E9-A24A-01		646a5d15-e48b-4183-b437-98280a5821c3	
TCGA-E9-A295-01			3																LumA										0	TCGA-E9-A295-01	22	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6		mutation cluster 4	TCGA-E9-A295			22	Breast	TCGA Breast Cancer	breast invasive carcinoma					71	Right Lower Outer Quadrant	Axillary lymph node dissection alone				Positive					Positive	Modified Radical Mastectomy		YES			-25957	63		0	22							80-89%					2011-9-12	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	670	NO	Positive			7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4										0	0	false	M0	N0 (i-)	T2	Stage IIA	TCGA-E9-A295.A23D86FF-CCA9-42B2-B6AE-9E365AAC03C8.pdf		1		0		2		0		5		63		30		60	TUMOR FREE				7	7		YES	No	80-89%			Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2011	TCGA-E9-A295-01A-11D-A16D-09		TCGA-E9-A295-01A-11R-A16E-13	TCGA-E9-A295-01A-11R-A16E-13	TCGA-E9-A295-01A-11D-A16D-09		TCGA-E9-A295-01A-11D-A16D-09	TCGA-E9-A295-01A-21-A17K-20	TCGA-E9-A295-01A-11D-A16D-09	28ad8481-78a8-4103-b501-5cfd23ae3e81	17b870b5-a1e1-4cd3-8120-da9c6e95747f	TCGA-E9-A295-01A-11D-A16C-01	28ad8481-78a8-4103-b501-5cfd23ae3e81	TCGA-E9-A295-01A-11D-A16G-05	TCGA-E9-A295-01		28ad8481-78a8-4103-b501-5cfd23ae3e81	28ad8481-78a8-4103-b501-5cfd23ae3e81	TCGA-E9-A295-01A-11D-A16C-01		TCGA-E9-A295-01		17b870b5-a1e1-4cd3-8120-da9c6e95747f	
TCGA-E9-A2JS-01																			LumB										1	TCGA-E9-A2JS-01	904	1	High	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-E9-A2JS	524	1	904	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO	NO		72	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A2JS-F40293								Lumpectomy		NO			-26407	79	904	0	540			524								Scheduled Follow-up Submission	2013-2-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	420	NO			NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																							Bone	Distant Metastasis	Liver	NO	YES	1		true	M0	N1	T2	Stage IIB	TCGA-E9-A2JS.1DFFCBD1-962D-4E9B-BEE1-726CABE3AA95.pdf		0		0		0		0		0		30		70		80	WITH TUMOR						YES	YES	No			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	DECEASED	2011			TCGA-E9-A2JS-01A-11R-A17X-13	TCGA-E9-A2JS-01A-11R-A17X-13			TCGA-E9-A2JS-01A-11D-A17W-09	TCGA-E9-A2JS-01A-21-A24B-20		4fe55069-e1b6-4d85-a51a-03a10c6116e2	93e94458-a4e5-4de6-b4f0-13eb5e558d74	TCGA-E9-A2JS-01A-11D-A17U-01	4fe55069-e1b6-4d85-a51a-03a10c6116e2	TCGA-E9-A2JS-01A-11D-A17Z-05	TCGA-E9-A2JS-01		4fe55069-e1b6-4d85-a51a-03a10c6116e2	4fe55069-e1b6-4d85-a51a-03a10c6116e2	TCGA-E9-A2JS-01A-11D-A17U-01		TCGA-E9-A2JS-01		93e94458-a4e5-4de6-b4f0-13eb5e558d74	
TCGA-E9-A2JT-01																			LumA										0	TCGA-E9-A2JT-01	23	0	Kirc+	C3-BRCA/Luminal		Low purity c2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-E9-A2JT			23	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Left Upper Outer Quadrant	Axillary lymph node dissection alone										Lumpectomy		NO			-23318	94		0	23												2011-12-20	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	260	NO				10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N0 (i-)	T2	Stage IIA	TCGA-E9-A2JT.C70325C1-54EB-41BF-B77C-D92FADA8D23E.pdf		0		0		0		0		0		60		40		60	TUMOR FREE							YES	No				Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2011			TCGA-E9-A2JT-01A-22R-A18L-13	TCGA-E9-A2JT-01A-22R-A18L-13			TCGA-E9-A2JT-01A-22D-A18P-09	TCGA-E9-A2JT-01A-11-A24A-20		95b5e301-f942-43bb-8211-d992948e8136	27145418-15bb-49d6-bc77-80194079b46d	TCGA-E9-A2JT-01A-22D-A18N-01	95b5e301-f942-43bb-8211-d992948e8136	TCGA-E9-A2JT-01A-22D-A18O-05	TCGA-E9-A2JT-01		95b5e301-f942-43bb-8211-d992948e8136	95b5e301-f942-43bb-8211-d992948e8136	TCGA-E9-A2JT-01A-22D-A18N-01		TCGA-E9-A2JT-01		27145418-15bb-49d6-bc77-80194079b46d	
TCGA-E9-A3HO-01																			LumB										0	TCGA-E9-A3HO-01	793	0	Iq	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7				TCGA-E9-A3HO	793	0	793	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A3HO-F40289								Modified Radical Mastectomy		NO			-18046			0	793					NO						Scheduled Follow-up Submission	2013-2-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)					NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0			M0	N0 (i-)	T2	Stage IIA																		TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast		LIVING	2011							TCGA-E9-A3HO-01A-11D-A20S-09	TCGA-E9-A3HO-01A-21-A24A-20		d151b46a-1e20-455a-bab3-9c698cee312d	ce888acf-cb20-43f6-936b-be22ed0f817e	TCGA-E9-A3HO-01A-11D-A20R-01	d151b46a-1e20-455a-bab3-9c698cee312d	TCGA-E9-A3HO-01A-11D-A212-05	TCGA-E9-A3HO-01		d151b46a-1e20-455a-bab3-9c698cee312d	d151b46a-1e20-455a-bab3-9c698cee312d	TCGA-E9-A3HO-01A-11D-A20R-01		TCGA-E9-A3HO-01		ce888acf-cb20-43f6-936b-be22ed0f817e	
TCGA-E9-A3Q9-01																			LumA										0	TCGA-E9-A3Q9-01	560	0	Iq	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6			TCGA-E9-A3Q9	560	0	560	Breast	TCGA Breast Cancer	breast invasive carcinoma					78	Right Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A3Q9-F40589		Positive					Positive			YES			-28715	198		0	560					NO		40-49%					2013-2-25	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	580	NO	Indeterminate		NO	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	22	0	true	M0	N3	T3	Stage IIIC	TCGA-E9-A3Q9.FE3E1376-1527-42C0-8F5F-8849D0F2743B.pdf		2		1		0		0		0		25		75		75	TUMOR FREE				8	8	YES	YES	No	40-49%		NO	Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2011			TCGA-E9-A3Q9-01A-11R-A21U-13	TCGA-E9-A3Q9-01A-11R-A21U-13			TCGA-E9-A3Q9-01A-11D-A21Q-09	TCGA-E9-A3Q9-01A-21-A24A-20		941748e8-5690-4e98-a5f4-d79b0e033ba1	31afcf05-454e-40db-99db-c2ad7828d87f	TCGA-E9-A3Q9-01A-11D-A21P-01	941748e8-5690-4e98-a5f4-d79b0e033ba1	TCGA-E9-A3Q9-01A-11D-A21R-05	TCGA-E9-A3Q9-01		941748e8-5690-4e98-a5f4-d79b0e033ba1	941748e8-5690-4e98-a5f4-d79b0e033ba1	TCGA-E9-A3Q9-01A-11D-A21P-01		TCGA-E9-A3Q9-01		31afcf05-454e-40db-99db-c2ad7828d87f	
TCGA-E9-A3QA-01																													0	TCGA-E9-A3QA-01	918	0	High			Low purity c2	BRCA basal-like c6		miRNA cluster 4			TCGA-E9-A3QA	918	0	918	Breast	TCGA Breast Cancer	breast invasive carcinoma					33	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A3QA-F66100													-12142	282		0	918					NO							2014-10-2	FEMALE										Medullary Carcinoma		No		C50.9	8510/3	C50.9		YES		Tumor resection	750	NO			NO	14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0		true	M0	N0 (i-)	T2	Stage IIA	TCGA-E9-A3QA.1F02AA5F-67B1-4BAF-A3A9-CA20BCD7FBAF.pdf		0		0		0		0		0		20		80		90	TUMOR FREE						NO	YES	No			NO	Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2011			TCGA-E9-A3QA-01A-61R-A22I-13	TCGA-E9-A3QA-01A-61R-A22I-13			TCGA-E9-A3QA-01A-61D-A228-09	TCGA-E9-A3QA-01A-71-A24A-20		8a7e272c-39f2-42e6-b1d5-7225cf12fceb	d8a0163f-045f-415c-a456-4ae0cf0e307e	TCGA-E9-A3QA-01A-61D-A227-01	8a7e272c-39f2-42e6-b1d5-7225cf12fceb	TCGA-E9-A3QA-01A-61D-A22B-05	TCGA-E9-A3QA-01		8a7e272c-39f2-42e6-b1d5-7225cf12fceb	8a7e272c-39f2-42e6-b1d5-7225cf12fceb	TCGA-E9-A3QA-01A-61D-A227-01		TCGA-E9-A3QA-01		d8a0163f-045f-415c-a456-4ae0cf0e307e	
TCGA-E9-A3X8-01																													0	TCGA-E9-A3X8-01	478	0					BRCA nonbasal-like c8					TCGA-E9-A3X8	478	0	478	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A3X8-F41704		Positive					Positive	Modified Radical Mastectomy		YES			-17588			0	478					NO		20-29%					2013-3-26	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection			Positive		NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	4	0		M0	N1	T2	Stage IIB																		TUMOR FREE				8	8	YES	YES	No	20-29%		YES	Primary Tumor	01		7th		YES	NO	E9	Breast		LIVING	2011			TCGA-E9-A3X8-01A-31R-A22V-13	TCGA-E9-A3X8-01A-31R-A22V-13			TCGA-E9-A3X8-01A-31D-A22X-09	TCGA-E9-A3X8-01A-21-A24A-20		b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9	e753e2a7-4812-4ba1-8e21-7b4dff099d40	TCGA-E9-A3X8-01A-31D-A22W-01	b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9	TCGA-E9-A3X8-01A-31D-A230-05	TCGA-E9-A3X8-01		b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9	b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9	TCGA-E9-A3X8-01A-31D-A22W-01		TCGA-E9-A3X8-01		e753e2a7-4812-4ba1-8e21-7b4dff099d40	
TCGA-E9-A54X-01																													0	TCGA-E9-A54X-01	375	0										TCGA-E9-A54X	375	0	375	Breast	TCGA Breast Cancer	breast invasive carcinoma					85	Left|Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A54X-F51390		Positive		3+			Positive	Lumpectomy		NO			-31173	78		0	375							90-99%					2013-11-18	FEMALE										Mucinous Carcinoma		No		C50.9	8480/3	C50.9	3+	YES		Tumor resection	220	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		true	M0	N0 (i-)	T1b	Stage IA	TCGA-E9-A54X.BCDA7E7B-396B-4809-A0B3-2BC2C22DC908.pdf		0		0		0		0		0		95		5		90	TUMOR FREE						NO	YES	No	90-99%		NO	Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2012			TCGA-E9-A54X-01A-11R-A25Z-13	TCGA-E9-A54X-01A-11R-A25Z-13			TCGA-E9-A54X-01A-11D-A25Q-09			fc36b662-fabd-4caa-81f7-00fe0a3164a6	65112812-773c-4bcc-b32d-fcef869d0e4f	TCGA-E9-A54X-01A-11D-A25N-01	fc36b662-fabd-4caa-81f7-00fe0a3164a6	TCGA-E9-A54X-01A-11D-A268-05	TCGA-E9-A54X-01		fc36b662-fabd-4caa-81f7-00fe0a3164a6	fc36b662-fabd-4caa-81f7-00fe0a3164a6	TCGA-E9-A54X-01A-11D-A25N-01		TCGA-E9-A54X-01		65112812-773c-4bcc-b32d-fcef869d0e4f	
TCGA-E9-A54Y-01																													0	TCGA-E9-A54Y-01	384	0										TCGA-E9-A54Y	384	0	384	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Right	Axillary lymph node dissection alone		TCGA-E9-A54Y-F51391		Positive		3+			Positive	Modified Radical Mastectomy		NO			-23057	76		0	384							90-99%					2014-1-23	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Fine needle aspiration biopsy	370	NO	Negative		NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	8		true	M0	N2	T2	Stage IIIA	TCGA-E9-A54Y.3F43AE57-0EB8-4F40-980F-6E2C8C2B3A74.pdf		0		0		0		0		0		60		40		70	TUMOR FREE						NO	YES	No	50-59%		NO	Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2012			TCGA-E9-A54Y-01A-11R-A25Z-13	TCGA-E9-A54Y-01A-11R-A25Z-13			TCGA-E9-A54Y-01A-11D-A25Q-09				fc728459-51da-4bed-8f19-89c724e2139f	TCGA-E9-A54Y-01A-11D-A25N-01		TCGA-E9-A54Y-01A-11D-A268-05					TCGA-E9-A54Y-01A-11D-A25N-01				fc728459-51da-4bed-8f19-89c724e2139f	
TCGA-E9-A5FK-01																													0	TCGA-E9-A5FK-01	447	0										TCGA-E9-A5FK	447	0	447	Breast	TCGA Breast Cancer	breast invasive carcinoma					60	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A5FK-F56473		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-22199	77		0	447							80-89%					2014-2-10	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Cytology (e.g. Peritoneal or pleural fluid)	490	NO	Negative		NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	10		true	M0	N3	T2	Stage IIIC	TCGA-E9-A5FK.D346F4E5-4E4A-4161-96FB-7B8ABBB17128.pdf		1		0		0		0		5		0		95		70	TUMOR FREE						YES	YES	No	70-79%		YES	Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2012			TCGA-E9-A5FK-01A-11R-A27U-13	TCGA-E9-A5FK-01A-11R-A27U-13			TCGA-E9-A5FK-01A-11D-A27P-09			6cdd2900-2b84-44d4-a9b3-bf75b12946b9	daaa223b-f768-4c89-8426-1c4f00bf9d0c	TCGA-E9-A5FK-01A-11D-A27O-01	6cdd2900-2b84-44d4-a9b3-bf75b12946b9		TCGA-E9-A5FK-01		6cdd2900-2b84-44d4-a9b3-bf75b12946b9	6cdd2900-2b84-44d4-a9b3-bf75b12946b9	TCGA-E9-A5FK-01A-11D-A27O-01		TCGA-E9-A5FK-01		daaa223b-f768-4c89-8426-1c4f00bf9d0c	
TCGA-E9-A5FL-01																													0	TCGA-E9-A5FL-01	24	0										TCGA-E9-A5FL	24	0	24	Breast	TCGA Breast Cancer	breast invasive carcinoma					65	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A5FL-F56061		Negative					Negative	Modified Radical Mastectomy		NO			-24053	73		0	24												2014-1-24	FEMALE										Metaplastic Carcinoma		No		C50.9	8575/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	590	NO	Negative		YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		true	M0	N0	T3	Stage IIB	TCGA-E9-A5FL.72186F5B-9F97-428C-8E06-9240E17E88DD.pdf		2		0		0		0		15		0		85		70	TUMOR FREE						NO	YES	No			NO	Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2012			TCGA-E9-A5FL-01A-11R-A27U-13	TCGA-E9-A5FL-01A-11R-A27U-13			TCGA-E9-A5FL-01A-11D-A27P-09			7810122d-fa8b-483d-9398-aa26fc7fedc5	82a8cdff-ba8d-4eb6-ae65-4881a10abc7a	TCGA-E9-A5FL-01A-11D-A27O-01	7810122d-fa8b-483d-9398-aa26fc7fedc5		TCGA-E9-A5FL-01		7810122d-fa8b-483d-9398-aa26fc7fedc5	7810122d-fa8b-483d-9398-aa26fc7fedc5	TCGA-E9-A5FL-01A-11D-A27O-01		TCGA-E9-A5FL-01		82a8cdff-ba8d-4eb6-ae65-4881a10abc7a	
TCGA-E9-A5UO-01																													0	TCGA-E9-A5UO-01	420	0										TCGA-E9-A5UO	420	0	420	Breast	TCGA Breast Cancer	breast invasive carcinoma					41	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A5UO-F56481								Other		NO			-15050	98		0	420												2014-2-10	FEMALE										Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Fine needle aspiration biopsy	400	NO			NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0		true	M0	N0	T2	Stage IIA	TCGA-E9-A5UO.6C698240-6557-4F96-BF56-60792693920F.pdf		40		20		0		20		0		5		95		95	TUMOR FREE						NO	YES	No			NO	Primary Tumor	01	Partial mastectomy	7th		YES	NO	E9	Breast	A	LIVING	2012			TCGA-E9-A5UO-01A-11R-A28I-13	TCGA-E9-A5UO-01A-11R-A28I-13			TCGA-E9-A5UO-01A-11D-A28B-09			4d601c2f-824f-461e-9270-42db0ab9138e	c70418fa-6b66-401e-b1c4-330100fe60a0	TCGA-E9-A5UO-01A-11D-A28A-01	4d601c2f-824f-461e-9270-42db0ab9138e	TCGA-E9-A5UO-01A-11D-A28C-05	TCGA-E9-A5UO-01		4d601c2f-824f-461e-9270-42db0ab9138e	4d601c2f-824f-461e-9270-42db0ab9138e	TCGA-E9-A5UO-01A-11D-A28A-01		TCGA-E9-A5UO-01		c70418fa-6b66-401e-b1c4-330100fe60a0	
TCGA-E9-A5UP-01																													0	TCGA-E9-A5UP-01	438	0										TCGA-E9-A5UP	438	0	438	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A5UP-F57716										NO			-23371	85		0	438												2014-3-21	FEMALE										Other  specify	Infiltrating papillary adenocarcinoma	No		C50.9	8503/3	C50.9		YES		Tumor resection	140	NO			NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		true	M0	N0	T2	Stage IIA	TCGA-E9-A5UP.B50AB6D5-3010-450E-9CCE-E9BFA0202736.pdf		40		20		0		20		0		10		90		90	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2012			TCGA-E9-A5UP-01A-11R-A28I-13	TCGA-E9-A5UP-01A-11R-A28I-13			TCGA-E9-A5UP-01A-11D-A28B-09			0a9af348-b2a7-4fad-b939-7eda53e4f5a0	4bc204b6-5ec6-4786-9504-209305c82371	TCGA-E9-A5UP-01A-11D-A28A-01	0a9af348-b2a7-4fad-b939-7eda53e4f5a0	TCGA-E9-A5UP-01A-11D-A28C-05	TCGA-E9-A5UP-01		0a9af348-b2a7-4fad-b939-7eda53e4f5a0	0a9af348-b2a7-4fad-b939-7eda53e4f5a0	TCGA-E9-A5UP-01A-11D-A28A-01		TCGA-E9-A5UP-01		4bc204b6-5ec6-4786-9504-209305c82371	
TCGA-E9-A6HE-01																													0	TCGA-E9-A6HE-01	468	0										TCGA-E9-A6HE	468	0	468	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-E9-A6HE-F56813		Positive					Positive	Simple Mastectomy		NO			-16697	203		0	468							90-99%			1.7		2014-2-24	FEMALE			<10%		1+	30	1.8	1.08		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	580	NO	Negative	Negative	NO	12	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	12		true	MX	N3	T3	Stage IIIC	TCGA-E9-A6HE.649E6215-36F9-4BEB-9EE9-683E4FC75C42.pdf		5		5		0		0		5		15		80		80	TUMOR FREE						YES	YES	No	90-99%		YES	Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2012			TCGA-E9-A6HE-01A-11R-A31S-13	TCGA-E9-A6HE-01A-11R-A31S-13						ce48b228-7e2a-46e9-beca-ab990b5c2b3e	4d7aae97-ae34-43e0-97a4-bfb15e3543b4	TCGA-E9-A6HE-01A-11D-A31T-01	ce48b228-7e2a-46e9-beca-ab990b5c2b3e	TCGA-E9-A6HE-01A-11D-A31V-05	TCGA-E9-A6HE-01		ce48b228-7e2a-46e9-beca-ab990b5c2b3e	ce48b228-7e2a-46e9-beca-ab990b5c2b3e	TCGA-E9-A6HE-01A-11D-A31T-01		TCGA-E9-A6HE-01		4d7aae97-ae34-43e0-97a4-bfb15e3543b4	
TCGA-EW-A1IW-01	Stage IIB	80	2	Stage IIB	252		Positive	FEMALE	Positive				Negative	M0	Positive	N1	252	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1IW-01	371	0	Iq	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-EW-A1IW	371	0	371	Breast	TCGA Breast Cancer	breast invasive carcinoma					80	Right Lower Inner Quadrant|Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A1IW-F21380		Positive	3 Point Scale	3+	3 Point Scale		Positive	Other		YES			-29529	213		0	371					NO		90-99%				Scheduled Follow-up Submission	2012-2-6	FEMALE		+ or -	90-99%		3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	90	NO	Positive			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4								NO	2	0	true	MX	N1a	T2	Stage IIB	TCGA-EW-A1IW.D4194F52-3E15-4105-9A1A-1326CF128BF8.pdf		0		0		0		0		0		10		90		70	TUMOR FREE		CISH					YES	No	90-99%		NO	Primary Tumor	01	total mastectomy	7th	YES	NO	YES	EW	Breast	A	LIVING	2010	TCGA-EW-A1IW-01A-11D-A13L-09		TCGA-EW-A1IW-01A-11R-A13P-13	TCGA-EW-A1IW-01A-11R-A13P-13	TCGA-EW-A1IW-01A-11D-A13L-09		TCGA-EW-A1IW-01A-11D-A13L-09		TCGA-EW-A1IW-01A-11D-A13L-09	7ddad1e7-783e-4095-87e0-48dbf5c5aa39	11707654-03d2-4f5b-988d-7d5f5b17386b	TCGA-EW-A1IW-01A-11D-A13J-01	7ddad1e7-783e-4095-87e0-48dbf5c5aa39	TCGA-EW-A1IW-01A-11D-A13K-05	TCGA-EW-A1IW-01		7ddad1e7-783e-4095-87e0-48dbf5c5aa39	7ddad1e7-783e-4095-87e0-48dbf5c5aa39	TCGA-EW-A1IW-01A-11D-A13J-01		TCGA-EW-A1IW-01		11707654-03d2-4f5b-988d-7d5f5b17386b	
TCGA-EW-A1IX-01	Stage IIA	48	4	Stage IIA	1082		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1082	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-EW-A1IX-01	1208	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-EW-A1IX	1208	0	1208	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	sentinal node bx first, axillary dissection after initial pathology report	TCGA-EW-A1IX-F21542		Positive	3 Point Scale	3+	3 Point Scale		Positive	Other		YES			-17597	1030		0	1208					NO		90-99%				Scheduled Follow-up Submission	2012-2-6	FEMALE			<10%							Other  specify	Invasive tubulolobular carcinoma	No		C50.9	8524/3	C50.2	3+	YES		Core needle biopsy	130	NO	Negative			27	Negative	Peri (6-12 months since last menstrual period)																		1	4								NO	1	1	true	MX	N1a	T1b	Stage IIA	TCGA-EW-A1IX.3CF4FC36-70EF-4EA3-874C-4A514FCDB717.pdf		0		0		0		0		0		0		100		85	TUMOR FREE							YES	No	90-99%		NO	Primary Tumor	01	total mastectomy	6th	YES	NO	YES	EW	Breast	A	LIVING	2008	TCGA-EW-A1IX-01A-12D-A142-09		TCGA-EW-A1IX-01A-12R-A143-13	TCGA-EW-A1IX-01A-12R-A143-13	TCGA-EW-A1IX-01A-12D-A142-09		TCGA-EW-A1IX-01A-12D-A142-09	TCGA-EW-A1IX-01A-21-A17J-20	TCGA-EW-A1IX-01A-12D-A142-09	b908cd1b-b274-4b23-9cd5-b59d93a7a6c2	1f0fc4e8-c27e-40dd-b531-4315a15be5af	TCGA-EW-A1IX-01A-12D-A141-01	b908cd1b-b274-4b23-9cd5-b59d93a7a6c2	TCGA-EW-A1IX-01A-12D-A145-05	TCGA-EW-A1IX-01		b908cd1b-b274-4b23-9cd5-b59d93a7a6c2	b908cd1b-b274-4b23-9cd5-b59d93a7a6c2	TCGA-EW-A1IX-01A-12D-A141-01		TCGA-EW-A1IX-01		1f0fc4e8-c27e-40dd-b531-4315a15be5af	
TCGA-EW-A1IY-01	Stage I	38	2	Stage I	258		Positive	FEMALE	Negative				Negative	M0	Negative	N0	258	0	LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-EW-A1IY-01	258	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 12	cluster 7	mutation cluster 4	TCGA-EW-A1IY	258	0	258	Breast	TCGA Breast Cancer	breast invasive carcinoma					38	Right Upper Inner Quadrant	Other (specify)	sentinel LN and one non sentinel LN	TCGA-EW-A1IY-F29084		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		YES			-14122	590		0	258					NO		90-99%				Scheduled Follow-up Submission	2012-3-5	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	50	NO	Negative			6	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	7								NO	0	0	true	MX	N0	T1c	Stage I	TCGA-EW-A1IY.7C003A4F-DC30-43D0-AC61-ACE6BA118BEE.pdf		0		0		0		0		10		40		50		70	TUMOR FREE							YES	No	90-99%		NO	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2009	TCGA-EW-A1IY-01A-11D-A188-09		TCGA-EW-A1IY-01A-11R-A13P-13	TCGA-EW-A1IY-01A-11R-A13P-13	TCGA-EW-A1IY-01A-11D-A188-09		TCGA-EW-A1IY-01A-11D-A188-09		TCGA-EW-A1IY-01A-11D-A188-09	9b605e4f-fb75-4b02-a827-a6acfeb3c1b2	8bdd50df-ff86-4ba2-ba6c-0b1ee39ceb25	TCGA-EW-A1IY-01A-11D-A13J-01	9b605e4f-fb75-4b02-a827-a6acfeb3c1b2	TCGA-EW-A1IY-01A-11D-A13K-05	TCGA-EW-A1IY-01		9b605e4f-fb75-4b02-a827-a6acfeb3c1b2	9b605e4f-fb75-4b02-a827-a6acfeb3c1b2	TCGA-EW-A1IY-01A-11D-A13J-01		TCGA-EW-A1IY-01		8bdd50df-ff86-4ba2-ba6c-0b1ee39ceb25	
TCGA-EW-A1IZ-01	Stage IIIA	53	1	Stage IIIA	260		Positive	FEMALE	Negative				Negative	M0	Positive	N2	260	0			Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1IZ-01	554	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-EW-A1IZ	554	0	554	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-EW-A1IZ-F21543		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-19706	194		0	554					NO		90-99%				Scheduled Follow-up Submission	2012-2-6	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES	stereotactic biopsy	Other method, specify:	130	NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	3								NO	5		true	MX	N2a	T2	Stage IIIA	TCGA-EW-A1IZ.F5EF4698-364C-4A5B-A8EC-1CF231BEEF31.pdf		0		0		0		0		0		10		90		85	TUMOR FREE							YES	No	90-99%		YES	Primary Tumor	01		7th	YES	NO	YES	EW	Breast	A	LIVING	2010	TCGA-EW-A1IZ-01A-11D-A188-09		TCGA-EW-A1IZ-01A-11R-A13P-13	TCGA-EW-A1IZ-01A-11R-A13P-13			TCGA-EW-A1IZ-01A-11D-A188-09	TCGA-EW-A1IZ-01A-21-A17J-20	TCGA-EW-A1IZ-01A-11D-A188-09	f5c72291-4c3f-456f-97a3-d93878744b54	8e008f46-3426-4b3f-b9bd-57f4b0ae24c6	TCGA-EW-A1IZ-01A-11D-A13J-01	f5c72291-4c3f-456f-97a3-d93878744b54	TCGA-EW-A1IZ-01A-11D-A13K-05	TCGA-EW-A1IZ-01		f5c72291-4c3f-456f-97a3-d93878744b54	f5c72291-4c3f-456f-97a3-d93878744b54	TCGA-EW-A1IZ-01A-11D-A13J-01		TCGA-EW-A1IZ-01		8e008f46-3426-4b3f-b9bd-57f4b0ae24c6	
TCGA-EW-A1J1-01	Stage IIB	38	2	Stage IIB	282		Positive	FEMALE	Negative				Negative	M0	Positive	N1	282	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1J1-01	575	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 4	TCGA-EW-A1J1	575	0	575	Breast	TCGA Breast Cancer	breast invasive carcinoma					38	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A1J1-F21181		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		YES			-14122	214		0	575					NO		90-99%				Scheduled Follow-up Submission	2012-2-3	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	170	NO	Negative			17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	5								NO	1	0	true	M0	N1a	T2	Stage IIB	TCGA-EW-A1J1.E8B860F6-F3FD-4FDF-B467-8988646C2F00.pdf		0		0		0		0		0		30		70		80	TUMOR FREE							YES	No	90-99%		YES	Primary Tumor	01		7th	YES	NO	YES	EW	Breast	A	LIVING	2010	TCGA-EW-A1J1-01A-11D-A188-09		TCGA-EW-A1J1-01A-11R-A13P-13	TCGA-EW-A1J1-01A-11R-A13P-13	TCGA-EW-A1J1-01A-11D-A188-09		TCGA-EW-A1J1-01A-11D-A188-09	TCGA-EW-A1J1-01A-21-A17J-20	TCGA-EW-A1J1-01A-11D-A188-09	9d64aa0c-84a6-4e48-b28b-12aaf04813b6	a9358498-02cf-4073-89bd-7c6add6e4120	TCGA-EW-A1J1-01A-11D-A13J-01	9d64aa0c-84a6-4e48-b28b-12aaf04813b6	TCGA-EW-A1J1-01A-11D-A13K-05	TCGA-EW-A1J1-01		9d64aa0c-84a6-4e48-b28b-12aaf04813b6	9d64aa0c-84a6-4e48-b28b-12aaf04813b6	TCGA-EW-A1J1-01A-11D-A13J-01		TCGA-EW-A1J1-01		a9358498-02cf-4073-89bd-7c6add6e4120	
TCGA-EW-A1J2-01	Stage IIB	50	2	Stage IIA	139		Positive	FEMALE	Negative				Negative	M0	Positive	N1	139	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-EW-A1J2-01	403	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-EW-A1J2	403	0	403	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A1J2-F21544		Positive	3 Point Scale	3+	3 Point Scale		Positive	Other		YES			-18558	51		0	403					NO		90-99%				Scheduled Follow-up Submission	2012-2-6	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.5	3+	YES		Core needle biopsy	110	NO	Negative			21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6								NO	1	1	true	MX	N1mi	T1c	Stage IIB	TCGA-EW-A1J2.0046FACA-9E90-4BA9-B216-258A2A7A2EC6.pdf		0		0		0		0		0		30		70		80	TUMOR FREE							YES	No	90-99%		NO	Primary Tumor	01	total mastectomy	7th	YES	NO	YES	EW	Breast	A	LIVING	2010	TCGA-EW-A1J2-01A-21D-A13L-09		TCGA-EW-A1J2-01A-21R-A13P-13	TCGA-EW-A1J2-01A-21R-A13P-13	TCGA-EW-A1J2-01A-21D-A13L-09		TCGA-EW-A1J2-01A-21D-A13L-09	TCGA-EW-A1J2-01A-11-A17J-20	TCGA-EW-A1J2-01A-21D-A13L-09	5a6b6013-11d0-498d-a014-3ea8e14c61d5	92172c25-66d6-497f-b9cf-03945ba27acd	TCGA-EW-A1J2-01A-21D-A13J-01	5a6b6013-11d0-498d-a014-3ea8e14c61d5	TCGA-EW-A1J2-01A-21D-A13K-05	TCGA-EW-A1J2-01		5a6b6013-11d0-498d-a014-3ea8e14c61d5	5a6b6013-11d0-498d-a014-3ea8e14c61d5	TCGA-EW-A1J2-01A-21D-A13J-01		TCGA-EW-A1J2-01		92172c25-66d6-497f-b9cf-03945ba27acd	
TCGA-EW-A1J3-01	Stage IA	61	2	Stage I	252		Positive	FEMALE	Positive				Negative	M0	Negative	N0	252	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-EW-A1J3-01	504	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-EW-A1J3	504	0	504	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-EW-A1J3-F21351		Positive	3 Point Scale	3+	3 Point Scale		Positive	Other		YES			-22332	155		0	504					NO		90-99%				Scheduled Follow-up Submission	2012-2-6	FEMALE			90-99%		3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.5	3+	YES		Core needle biopsy	80	NO	Positive			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO	0	0	true	M0	N0	T1c	Stage IA	TCGA-EW-A1J3.79C0D757-50BE-4375-AF69-E577629EE0CA.pdf		0		0		0		0		0		20		80		90	TUMOR FREE							YES	No	90-99%		NO	Primary Tumor	01	TOTAL MASTECTOMY	7th	YES	NO	YES	EW	Breast	A	LIVING	2010	TCGA-EW-A1J3-01A-11D-A13L-09		TCGA-EW-A1J3-01A-11R-A13P-13	TCGA-EW-A1J3-01A-11R-A13P-13	TCGA-EW-A1J3-01A-11D-A13L-09		TCGA-EW-A1J3-01A-11D-A13L-09	TCGA-EW-A1J3-01A-21-A17J-20	TCGA-EW-A1J3-01A-11D-A13L-09	6e757a91-de03-4c2d-9088-22235e4b745a	f2f5bfd3-c9a3-4f3a-a7c9-ea412c46c589	TCGA-EW-A1J3-01A-11D-A13J-01	6e757a91-de03-4c2d-9088-22235e4b745a	TCGA-EW-A1J3-01A-11D-A13K-05	TCGA-EW-A1J3-01		6e757a91-de03-4c2d-9088-22235e4b745a	6e757a91-de03-4c2d-9088-22235e4b745a	TCGA-EW-A1J3-01A-11D-A13J-01		TCGA-EW-A1J3-01		f2f5bfd3-c9a3-4f3a-a7c9-ea412c46c589	
TCGA-EW-A1J5-01	Stage IIB	59	5	Stage IIB	227		Positive	FEMALE	Negative				Negative	M0	Negative	N0	227	0	LumA		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-EW-A1J5-01	477	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-EW-A1J5	477	0	477	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Left	Sentinel node biopsy alone		TCGA-EW-A1J5-F21353		Positive	3 Point Scale	3+	3 Point Scale		Positive	Other		YES			-21559	123		0	477					NO		90-99%				Scheduled Follow-up Submission	2012-2-6	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	180	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	7								NO	0	0	true	M0	N0 (i-)	T3	Stage IIB	TCGA-EW-A1J5.D92CABBE-8D7E-41E5-B702-9ED07E94E5C4.pdf		0		0		0		0		0		20		80		90	TUMOR FREE							YES	No	90-99%		NO	Primary Tumor	01	total mastectomy	7th	YES	NO	YES	EW	Breast	A	LIVING	2010	TCGA-EW-A1J5-01A-11D-A13L-09		TCGA-EW-A1J5-01A-11R-A13P-13	TCGA-EW-A1J5-01A-11R-A13P-13	TCGA-EW-A1J5-01A-11D-A13L-09		TCGA-EW-A1J5-01A-11D-A13L-09	TCGA-EW-A1J5-01A-21-A17J-20	TCGA-EW-A1J5-01A-11D-A13L-09	b1c4af00-f395-47ac-93c7-b32a293ca060	8069f916-9d52-4a2c-b30d-3f10e520e1e1	TCGA-EW-A1J5-01A-11D-A13J-01	b1c4af00-f395-47ac-93c7-b32a293ca060	TCGA-EW-A1J5-01A-11D-A13K-05	TCGA-EW-A1J5-01		b1c4af00-f395-47ac-93c7-b32a293ca060	b1c4af00-f395-47ac-93c7-b32a293ca060	TCGA-EW-A1J5-01A-11D-A13J-01		TCGA-EW-A1J5-01		8069f916-9d52-4a2c-b30d-3f10e520e1e1	
TCGA-EW-A1J6-01	Stage I	70	4	Stage I	595		Positive	FEMALE	Negative				Negative	M0	Negative	N0	595	0	LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-EW-A1J6-01	875	0	High	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-EW-A1J6	875	0	875	Breast	TCGA Breast Cancer	breast invasive carcinoma					70	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-EW-A1J6-F21347		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		YES			-25830	528		0	875					NO		90-99%				Scheduled Follow-up Submission	2012-2-6	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	80	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	2								NO	0	0	true	M0	N0 (i-)	T1c	Stage I	TCGA-EW-A1J6.F282122D-C129-4A8B-9A49-78D5267C37CA.pdf		0		0		0		0		0		20		80		90	TUMOR FREE							YES	No	90-99%		NO	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2009	TCGA-EW-A1J6-01A-11D-A188-09		TCGA-EW-A1J6-01A-11R-A13P-13	TCGA-EW-A1J6-01A-11R-A13P-13	TCGA-EW-A1J6-01A-11D-A188-09		TCGA-EW-A1J6-01A-11D-A188-09		TCGA-EW-A1J6-01A-11D-A188-09	7051836f-e1d4-49dd-8118-4541c0bdde57	64cc469d-eaf1-4a4e-853e-612c931c28b6	TCGA-EW-A1J6-01A-11D-A13J-01	7051836f-e1d4-49dd-8118-4541c0bdde57	TCGA-EW-A1J6-01A-11D-A13K-05	TCGA-EW-A1J6-01		7051836f-e1d4-49dd-8118-4541c0bdde57	7051836f-e1d4-49dd-8118-4541c0bdde57	TCGA-EW-A1J6-01A-11D-A13J-01		TCGA-EW-A1J6-01		64cc469d-eaf1-4a4e-853e-612c931c28b6	
TCGA-EW-A1OV-01	Stage IIB	56	1	Stage IIB	522		Negative	FEMALE	Negative				Negative	M0	Positive	N1	522	0	Her2		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1OV-01	789	0	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 4	TCGA-EW-A1OV	789	0	789	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-EW-A1OV-F29119	Negative	Negative	3 Point Scale		3 Point Scale	Modified radical mastectomy	Negative	Lumpectomy		YES			-20764	469		0	789					NO		<10%				Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%					1.8		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO	Negative	Negative		6	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5								NO	0	1	true	MX	N1mi	T2	Stage IIB	TCGA-EW-A1OV.88E39E13-8ADC-481A-992E-610B3BEBCBD4.pdf		18		0		5		0		2		10		83		80	TUMOR FREE							YES	No	<10%		NO	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2009	TCGA-EW-A1OV-01A-11D-A142-09		TCGA-EW-A1OV-01A-11R-A143-13	TCGA-EW-A1OV-01A-11R-A143-13	TCGA-EW-A1OV-01A-11D-A142-09		TCGA-EW-A1OV-01A-11D-A142-09	TCGA-EW-A1OV-01A-21-A17J-20	TCGA-EW-A1OV-01A-11D-A142-09	b21367b5-91a3-4546-ba89-e33c462cb75b	5ffeb466-cd09-441c-a635-9feea1d71ff4	TCGA-EW-A1OV-01A-11D-A141-01	b21367b5-91a3-4546-ba89-e33c462cb75b	TCGA-EW-A1OV-01A-11D-A145-05	TCGA-EW-A1OV-01		b21367b5-91a3-4546-ba89-e33c462cb75b	b21367b5-91a3-4546-ba89-e33c462cb75b	TCGA-EW-A1OV-01A-11D-A141-01		TCGA-EW-A1OV-01		5ffeb466-cd09-441c-a635-9feea1d71ff4	
TCGA-EW-A1OW-01	Stage IIA	58	1	Stage IIA	463		Negative	FEMALE	Negative				Negative	M0	Negative	N0	463	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1OW-01	694	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8				TCGA-EW-A1OW	694	0	694	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-EW-A1OW-F29117		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		YES			-21465	444		0	694					NO		<10%				Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8090/3	C50.9		YES		Core needle biopsy	100	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5									NO	0	0	true	MX	N0	T2	Stage IIA	TCGA-EW-A1OW.2153CBCE-6DA9-4E0F-9F41-B9F08FD50647.pdf		8		0		1		0		1		8		90		85	TUMOR FREE							YES	No	<10%		YES	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2009			TCGA-EW-A1OW-01A-21R-A143-13	TCGA-EW-A1OW-01A-21R-A143-13				TCGA-EW-A1OW-01A-11-A17J-20		21cc5775-0987-4088-b19c-86bf43f09bb2	0941a978-c8aa-467b-8464-9f979d1f0418	TCGA-EW-A1OW-01A-21D-A141-01	21cc5775-0987-4088-b19c-86bf43f09bb2	TCGA-EW-A1OW-01A-21D-A145-05	TCGA-EW-A1OW-01		21cc5775-0987-4088-b19c-86bf43f09bb2	21cc5775-0987-4088-b19c-86bf43f09bb2	TCGA-EW-A1OW-01A-21D-A141-01		TCGA-EW-A1OW-01		0941a978-c8aa-467b-8464-9f979d1f0418	
TCGA-EW-A1OX-01	Stage IIA	43	3	Stage IIA	562		Positive	FEMALE	Negative				Negative	M0	Negative	N0	562	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1OX-01	911	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-EW-A1OX	911	0	911	Breast	TCGA Breast Cancer	breast invasive carcinoma					43	Right Upper Inner Quadrant	Other (specify)	sentinel + non sentinel	TCGA-EW-A1OX-F29099		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		YES			-15837	550		0	911					NO		90-99%				Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%							Mucinous Carcinoma		No		C50.9	8523/3	C50.9	3+	YES		Core needle biopsy	140	NO	Negative			4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		3	1								NO	0	0	true	MX	N0	T2	Stage IIA	TCGA-EW-A1OX.4C40B309-3178-4E7E-A987-47698E5E364B.pdf		2		0		0		0		0		80		20		85	TUMOR FREE							YES	No	90-99%		YES	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2009	TCGA-EW-A1OX-01A-11D-A142-09		TCGA-EW-A1OX-01A-11R-A143-13	TCGA-EW-A1OX-01A-11R-A143-13	TCGA-EW-A1OX-01A-11D-A142-09		TCGA-EW-A1OX-01A-11D-A142-09	TCGA-EW-A1OX-01A-21-A17J-20	TCGA-EW-A1OX-01A-11D-A142-09	9b5d680e-5662-442c-a8ab-5fd16551b23e	d6e0a8bc-62cf-476a-8528-9a6e7b98871f	TCGA-EW-A1OX-01A-11D-A141-01	9b5d680e-5662-442c-a8ab-5fd16551b23e	TCGA-EW-A1OX-01A-11D-A145-05	TCGA-EW-A1OX-01		9b5d680e-5662-442c-a8ab-5fd16551b23e	9b5d680e-5662-442c-a8ab-5fd16551b23e	TCGA-EW-A1OX-01A-11D-A141-01		TCGA-EW-A1OX-01		d6e0a8bc-62cf-476a-8528-9a6e7b98871f	
TCGA-EW-A1OY-01	Stage IIA	63	5	Stage IIA	593		Positive	FEMALE	Negative				Negative	M0	Negative	N0	593	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1OY-01	908	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-EW-A1OY	908	0	908	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Left	Sentinel node biopsy alone		TCGA-EW-A1OY-F30950		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		YES			-23266	526		0	908					NO		90-99%				Scheduled Follow-up Submission	2012-3-23	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	100	NO	Negative	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4								NO	0	0	true	MX	N0	T2	Stage IIA	TCGA-EW-A1OY.76358109-41A0-4D5C-8894-F6A63A925961.pdf		9		0		0		0		0		36		64		80	TUMOR FREE							YES	No	90-99%		YES	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2009	TCGA-EW-A1OY-01A-11D-A142-09		TCGA-EW-A1OY-01A-11R-A143-13	TCGA-EW-A1OY-01A-11R-A143-13	TCGA-EW-A1OY-01A-11D-A142-09		TCGA-EW-A1OY-01A-11D-A142-09	TCGA-EW-A1OY-01A-21-A17J-20	TCGA-EW-A1OY-01A-11D-A142-09	0c3f0857-32d7-4ef6-b303-6e452ee04516	5c54e392-615a-4904-b3a4-d50ed00a8f73	TCGA-EW-A1OY-01A-11D-A141-01	0c3f0857-32d7-4ef6-b303-6e452ee04516	TCGA-EW-A1OY-01A-11D-A145-05	TCGA-EW-A1OY-01		0c3f0857-32d7-4ef6-b303-6e452ee04516	0c3f0857-32d7-4ef6-b303-6e452ee04516	TCGA-EW-A1OY-01A-11D-A141-01		TCGA-EW-A1OY-01		5c54e392-615a-4904-b3a4-d50ed00a8f73	
TCGA-EW-A1OZ-01	Stage IIA	56	5	Stage IIA	941		Positive	FEMALE	Positive				Negative	M0	Negative	N0	941	0	LumB		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1OZ-01	1229	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 8	TCGA-EW-A1OZ	1229	0	1229	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-EW-A1OZ-F29098		Positive	3 Point Scale		3 Point Scale		Negative	Other		YES			-20664	928		0	1229					NO		90-99%			2	Scheduled Follow-up Submission	2012-3-8	FEMALE			20-29%		2+	40		2.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	210	NO	Equivocal	Positive		4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-EW-A1OZ.42DE8E2C-395D-4E9B-B7BC-6A0B2F9BD7CE.pdf		10		0		0		0		10		26		64		75	TUMOR FREE							YES	No	<10%		NO	Primary Tumor	01	total mastectomy	6th	YES	NO	YES	EW	Breast	A	LIVING	2008	TCGA-EW-A1OZ-01A-11D-A142-09		TCGA-EW-A1OZ-01A-11R-A143-13	TCGA-EW-A1OZ-01A-11R-A143-13	TCGA-EW-A1OZ-01A-11D-A142-09		TCGA-EW-A1OZ-01A-11D-A142-09	TCGA-EW-A1OZ-01A-21-A17J-20	TCGA-EW-A1OZ-01A-11D-A142-09	73f6a579-eab4-4fbf-bb17-41f1a6614ace	d71a4ddd-13bd-4c7d-86c4-dd64b25450ac	TCGA-EW-A1OZ-01A-11D-A141-01	73f6a579-eab4-4fbf-bb17-41f1a6614ace	TCGA-EW-A1OZ-01A-11D-A145-05	TCGA-EW-A1OZ-01		73f6a579-eab4-4fbf-bb17-41f1a6614ace	73f6a579-eab4-4fbf-bb17-41f1a6614ace	TCGA-EW-A1OZ-01A-11D-A141-01		TCGA-EW-A1OZ-01		d71a4ddd-13bd-4c7d-86c4-dd64b25450ac	
TCGA-EW-A1P0-01	Stage IIB	55	4	Stage IIB	1121		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1121	0	LumB		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1P0-01	1251	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-EW-A1P0	1094	1	1251	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO	YES		55	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-EW-A1P0-F29105		Positive	3 Point Scale		3 Point Scale		Negative	Modified Radical Mastectomy		NO		1105	-20107	1142		0	1251			1094		YES		90-99%				Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%							Mixed Histology (please specify)	IDC+ mucinous carcinoma	No		C50.9	8523/3	C50.9	3+	YES		Core needle biopsy	190	NO	Negative			21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative	1+		Positive	90-99%		<10%			3+	1+			<10%		Negative	5	7				Other, specify	Distant Metastasis	mediastinal lymph node		YES	1		true	MX	N1b	T2	Stage IIB	TCGA-EW-A1P0.F9FB00C3-9F86-40AC-A5E8-08712CD5002B.pdf		15		0		0		0		0		35		65		75	TUMOR FREE							YES	No	<10%		YES	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2008	TCGA-EW-A1P0-01A-11D-A142-09		TCGA-EW-A1P0-01A-11R-A143-13	TCGA-EW-A1P0-01A-11R-A143-13	TCGA-EW-A1P0-01A-11D-A142-09		TCGA-EW-A1P0-01A-11D-A142-09	TCGA-EW-A1P0-01A-21-A17J-20	TCGA-EW-A1P0-01A-11D-A142-09	16fcbaec-f629-4d04-ab61-3f9b782e710d	c5e3d0a9-e703-4c1c-92eb-3dcc093d14e2	TCGA-EW-A1P0-01A-11D-A141-01	16fcbaec-f629-4d04-ab61-3f9b782e710d	TCGA-EW-A1P0-01A-11D-A145-05	TCGA-EW-A1P0-01		16fcbaec-f629-4d04-ab61-3f9b782e710d	16fcbaec-f629-4d04-ab61-3f9b782e710d	TCGA-EW-A1P0-01A-11D-A141-01		TCGA-EW-A1P0-01		c5e3d0a9-e703-4c1c-92eb-3dcc093d14e2	
TCGA-EW-A1P1-01	Stage IIIC	68	1	Stage IIIC	919		Negative	FEMALE	Negative				Negative	M0	Positive	N3	919	0			Negative				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1P1-01	1210	0	Kirc+	C5-KIRC	cluster 1	Low purity c2	KIRC-like c1		miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-EW-A1P1	1014	1	1210	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO	YES		68	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A1P1-F29115		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		NO		1200	-24923	850		0	1210			1014		YES		<10%	Lung			Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%		2+			1.8		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Equivocal	Negative		32	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Equivocal	1+		Negative	<10%		<10%							<10%		Negative	1	6				Lung	Distant Metastasis			YES	11		true	MX	N3b	T2	Stage IIIC	TCGA-EW-A1P1.AE0C51EF-017E-4F53-968C-804110F9A7E6.pdf		0		0		0		0		5		55		40		65	TUMOR FREE							YES	No	<10%		YES	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2008	TCGA-EW-A1P1-01A-31D-A14G-09		TCGA-EW-A1P1-01A-31R-A14C-13	TCGA-EW-A1P1-01A-31R-A14C-13			TCGA-EW-A1P1-01A-31D-A14G-09	TCGA-EW-A1P1-01A-21-A17J-20	TCGA-EW-A1P1-01A-31D-A14G-09	8a430d45-6511-4900-954e-fd01106d0f22	cceccfe3-7764-4959-89ee-978af184c489	TCGA-EW-A1P1-01A-31D-A14F-01	8a430d45-6511-4900-954e-fd01106d0f22	TCGA-EW-A1P1-01A-31D-A14H-05	TCGA-EW-A1P1-01		8a430d45-6511-4900-954e-fd01106d0f22	8a430d45-6511-4900-954e-fd01106d0f22	TCGA-EW-A1P1-01A-31D-A14F-01		TCGA-EW-A1P1-01		cceccfe3-7764-4959-89ee-978af184c489	
TCGA-EW-A1P3-01	Stage IIA	48	2	Stage IIA	987		Positive	FEMALE	Negative				Negative	M0	Negative	N0	987	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1P3-01	1611	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-EW-A1P3	1611	0	1611	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Right Lower Outer Quadrant	Other (specify)	SN+1 non sentinel node	TCGA-EW-A1P3-F41142		Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		YES			-17637	919		0	1611					NO		90-99%				Scheduled Follow-up Submission	2013-3-12	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	150	NO	Negative		NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4								NO	0	0	true	MX	N0	T2	Stage IIA	TCGA-EW-A1P3.042304AE-706A-4033-A97F-3765A6AEC649.pdf		3		1		2		1		1		17		80		80	TUMOR FREE						YES	YES	Yes	90-99%		NO	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2008	TCGA-EW-A1P3-01A-11D-A142-09		TCGA-EW-A1P3-01A-11R-A143-13	TCGA-EW-A1P3-01A-11R-A143-13	TCGA-EW-A1P3-01A-11D-A142-09		TCGA-EW-A1P3-01A-11D-A142-09	TCGA-EW-A1P3-01A-21-A17J-20	TCGA-EW-A1P3-01A-11D-A142-09	43c8eaea-f686-4e28-ba9c-360fea61b3ca	85ca025c-dd6b-413d-8994-e2d3e91d040f	TCGA-EW-A1P3-01A-11D-A141-01	43c8eaea-f686-4e28-ba9c-360fea61b3ca	TCGA-EW-A1P3-01A-11D-A145-05	TCGA-EW-A1P3-01		43c8eaea-f686-4e28-ba9c-360fea61b3ca	43c8eaea-f686-4e28-ba9c-360fea61b3ca	TCGA-EW-A1P3-01A-11D-A141-01		TCGA-EW-A1P3-01		85ca025c-dd6b-413d-8994-e2d3e91d040f	
TCGA-EW-A1P4-01	Stage IIA	43	1	Stage IIA	501		Negative	FEMALE	Negative				Negative	M0	Negative	N0	501	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1P4-01	907	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-EW-A1P4	907	0	907	Breast	TCGA Breast Cancer	breast invasive carcinoma					43	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-EW-A1P4-F29684		Negative	3 Point Scale		3 Point Scale		Negative	Simple Mastectomy		YES			-15989	525		0	907					NO		<10%				Scheduled Follow-up Submission	2012-3-26	FEMALE			<10%							Medullary Carcinoma		No		C50.9	8510/3	C50.9		YES		Core needle biopsy	290	NO	Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	5								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	TCGA-EW-A1P4.70C8D54A-9698-4275-BD96-A6EF2E26474B.pdf		3		1		5		1		0		15		80		80	TUMOR FREE							YES	No	<10%		YES	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2009	TCGA-EW-A1P4-01A-21D-A142-09		TCGA-EW-A1P4-01A-21R-A143-13	TCGA-EW-A1P4-01A-21R-A143-13	TCGA-EW-A1P4-01A-21D-A142-09		TCGA-EW-A1P4-01A-21D-A142-09	TCGA-EW-A1P4-01A-11-A17J-20	TCGA-EW-A1P4-01A-21D-A142-09	91a5b906-6a04-4f0d-8710-172311e84789	260e860c-9034-4c71-bc77-db7f25ae2baf	TCGA-EW-A1P4-01A-21D-A141-01	91a5b906-6a04-4f0d-8710-172311e84789	TCGA-EW-A1P4-01A-21D-A145-05	TCGA-EW-A1P4-01		91a5b906-6a04-4f0d-8710-172311e84789	91a5b906-6a04-4f0d-8710-172311e84789	TCGA-EW-A1P4-01A-21D-A141-01		TCGA-EW-A1P4-01		260e860c-9034-4c71-bc77-db7f25ae2baf	
TCGA-EW-A1P5-01	Stage IIB	77	3	Stage IIB	365		Positive	FEMALE	Negative				Negative	M0	Positive	N1	365	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1P5-01	703	0	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 3	mutation cluster 4	TCGA-EW-A1P5	703	0	703	Breast	TCGA Breast Cancer	breast invasive carcinoma					77	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A1P5-F32249		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		YES			-28177	325		0	703					NO		90-99%				Scheduled Follow-up Submission	2012-5-15	FEMALE			<10%					1.12		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	110	NO	Negative	Negative		40	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	3								NO	3	0	true	M0	N1a	T2	Stage IIB	TCGA-EW-A1P5.82771A56-81CA-4414-949F-EFBCAE1C98D4.pdf		3		1		0		1		0		15		85		85	TUMOR FREE							YES	No	90-99%		YES	Primary Tumor	01		7th	YES	NO	YES	EW	Breast	A	LIVING	2010	TCGA-EW-A1P5-01A-11D-A142-09		TCGA-EW-A1P5-01A-11R-A143-13	TCGA-EW-A1P5-01A-11R-A143-13	TCGA-EW-A1P5-01A-11D-A142-09		TCGA-EW-A1P5-01A-11D-A142-09	TCGA-EW-A1P5-01A-21-A17J-20	TCGA-EW-A1P5-01A-11D-A142-09	e9d4f9c8-7355-44c4-9b18-923db7bae832	9e80cde3-cb84-4a55-a77d-15eb2d799d10	TCGA-EW-A1P5-01A-11D-A141-01	e9d4f9c8-7355-44c4-9b18-923db7bae832	TCGA-EW-A1P5-01A-11D-A145-05	TCGA-EW-A1P5-01		e9d4f9c8-7355-44c4-9b18-923db7bae832	e9d4f9c8-7355-44c4-9b18-923db7bae832	TCGA-EW-A1P5-01A-11D-A141-01		TCGA-EW-A1P5-01		9e80cde3-cb84-4a55-a77d-15eb2d799d10	
TCGA-EW-A1P6-01	Stage IIB	64	4	Stage IIB	312		Positive	FEMALE	Negative				Negative	M0	Positive	N1	312	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1P6-01	562	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-EW-A1P6	562	0	562	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A1P6-F29114		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		YES			-23485	249		0	562					NO		90-99%				Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	50	NO	Negative			25	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	2	0	true	M0	N1a	T2	Stage IIB	TCGA-EW-A1P6.6FEAD496-58BA-42DC-A3F2-2F380EEB1588.pdf		2		1		1		1		0		14		85		85	TUMOR FREE							YES	No	90-99%		YES	Primary Tumor	01		7th	YES	NO	YES	EW	Breast	A	LIVING	2010	TCGA-EW-A1P6-01A-11D-A142-09		TCGA-EW-A1P6-01A-11R-A143-13	TCGA-EW-A1P6-01A-11R-A143-13	TCGA-EW-A1P6-01A-11D-A142-09		TCGA-EW-A1P6-01A-11D-A142-09		TCGA-EW-A1P6-01A-11D-A142-09	9dddaf60-64ed-4d41-a546-79e86db1101e	b6a2cace-5fb3-440b-8647-08548b388755	TCGA-EW-A1P6-01A-11D-A141-01	9dddaf60-64ed-4d41-a546-79e86db1101e	TCGA-EW-A1P6-01A-11D-A145-05	TCGA-EW-A1P6-01		9dddaf60-64ed-4d41-a546-79e86db1101e	9dddaf60-64ed-4d41-a546-79e86db1101e	TCGA-EW-A1P6-01A-11D-A141-01		TCGA-EW-A1P6-01		b6a2cace-5fb3-440b-8647-08548b388755	
TCGA-EW-A1P7-01	Stage IIA	59	1	Stage IIA	635		Negative	FEMALE	Negative				Negative	M0	Negative	N0	635	0	Normal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1P7-01	915	0	Kirc+	C4-BRCA/Basal	cluster 5	Low purity c2		BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-EW-A1P7	729	1	915	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	NO	YES		59	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-EW-A1P7-F29118		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		YES		793	-21750			0	915			729		NO		<10%				Scheduled Follow-up Submission	2012-3-8	FEMALE			10-19%		2+			1.8		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3				Other, specify	Distant Metastasis	mediastinal lymph nodes		YES	0	0		M0	N0 (i-)	T2	Stage IIA																		WITH TUMOR							YES	No	<10%		NO	Primary Tumor	01		6th	YES	NO	YES	EW	Breast		LIVING	2009	TCGA-EW-A1P7-01A-21D-A142-09		TCGA-EW-A1P7-01A-21R-A143-13	TCGA-EW-A1P7-01A-21R-A143-13	TCGA-EW-A1P7-01A-21D-A142-09		TCGA-EW-A1P7-01A-21D-A142-09		TCGA-EW-A1P7-01A-21D-A142-09	e11a1fd3-d409-4e09-a8ab-5d0afb455263	f179bb91-8b60-4eaf-aea1-5161b0c96719	TCGA-EW-A1P7-01A-21D-A141-01	e11a1fd3-d409-4e09-a8ab-5d0afb455263	TCGA-EW-A1P7-01A-21D-A145-05	TCGA-EW-A1P7-01		e11a1fd3-d409-4e09-a8ab-5d0afb455263	e11a1fd3-d409-4e09-a8ab-5d0afb455263	TCGA-EW-A1P7-01A-21D-A141-01		TCGA-EW-A1P7-01		f179bb91-8b60-4eaf-aea1-5161b0c96719	
TCGA-EW-A1P8-01	Stage IIIC	58	3	Stage IIIC	239	239	Negative	FEMALE	Negative				Negative	M0	Positive	N3	239	1	Basal		Negative				enrollment	T_Other	T2	DECEASED	1	TCGA-EW-A1P8-01	239	1	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 12	TCGA-EW-A1P8	207	1	239	Breast	TCGA Breast Cancer	breast invasive carcinoma			NO		58	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A1P8-F29121		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		NO			-21501	224	239	0				207		YES		<10%	Lung|Bone|Liver|Other, specify	skin		Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	160	NO	Negative			15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative			Negative	<10%		<10%							<10%		Negative	5	5				Lung	Distant Metastasis			YES	14		true	M0	N3b	T2	Stage IIIC	TCGA-EW-A1P8.6CB5A0ED-5569-4FDC-B651-758BFC6B59D8.pdf		2		1		0		1		0		10		90		90	WITH TUMOR							YES	No	<10%		NO	Primary Tumor	01		7th	YES	NO	YES	EW	Breast	A	DECEASED	2010	TCGA-EW-A1P8-01A-11D-A142-09		TCGA-EW-A1P8-01A-11R-A143-13	TCGA-EW-A1P8-01A-11R-A143-13	TCGA-EW-A1P8-01A-11D-A142-09		TCGA-EW-A1P8-01A-11D-A142-09	TCGA-EW-A1P8-01A-21-A17J-20	TCGA-EW-A1P8-01A-11D-A142-09	d763ccd4-4a11-4e84-b0a6-1b42da020ce4	1dce5c12-1c51-4544-b148-7d313826a491	TCGA-EW-A1P8-01A-11D-A141-01	d763ccd4-4a11-4e84-b0a6-1b42da020ce4	TCGA-EW-A1P8-01A-11D-A145-05	TCGA-EW-A1P8-01		d763ccd4-4a11-4e84-b0a6-1b42da020ce4	d763ccd4-4a11-4e84-b0a6-1b42da020ce4	TCGA-EW-A1P8-01A-11D-A141-01		TCGA-EW-A1P8-01		1dce5c12-1c51-4544-b148-7d313826a491	
TCGA-EW-A1PA-01	Stage IIB	59	1	Stage IIB	267		Positive	FEMALE	Negative				Negative	M0	Positive	N1	267	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1PA-01	575	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7			mutation cluster 5	TCGA-EW-A1PA	575	0	575	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-EW-A1PA-F30937		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		NO			-21837	220		0	575					NO		90-99%				Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	60	NO	Negative			13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4									NO	1		true	M0	N1a	T2	Stage IIB	TCGA-EW-A1PA.A68B2364-89DA-4DC7-9AA7-A08BBCC85025.pdf		4		1		1		1		0		29		70		70	TUMOR FREE							YES	No	90-99%		YES	Primary Tumor	01		7th	YES	NO	YES	EW	Breast	A	LIVING	2010	TCGA-EW-A1PA-01A-11D-A142-09		TCGA-EW-A1PA-01A-11R-A143-13	TCGA-EW-A1PA-01A-11R-A143-13	TCGA-EW-A1PA-01A-11D-A142-09		TCGA-EW-A1PA-01A-11D-A142-09	TCGA-EW-A1PA-01A-21-A17K-20	TCGA-EW-A1PA-01A-11D-A142-09	8c0b7027-f371-4a72-9152-2d00fc54e086	80450b0c-0c95-4b4a-9575-4d5a07de3821	TCGA-EW-A1PA-01A-11D-A141-01	8c0b7027-f371-4a72-9152-2d00fc54e086	TCGA-EW-A1PA-01A-11D-A145-05	TCGA-EW-A1PA-01		8c0b7027-f371-4a72-9152-2d00fc54e086	8c0b7027-f371-4a72-9152-2d00fc54e086	TCGA-EW-A1PA-01A-11D-A141-01		TCGA-EW-A1PA-01		80450b0c-0c95-4b4a-9575-4d5a07de3821	
TCGA-EW-A1PB-01	Stage IIIA	70	3	Stage IIIA	608		Negative	FEMALE	Negative				Negative	M0	Positive	N1	608	0	Basal		Negative				enrollment	T_Other	T3	LIVING	0	TCGA-EW-A1PB-01	608	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-EW-A1PB	608	0	608	Breast	TCGA Breast Cancer	breast invasive carcinoma					70	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-EW-A1PB-F29107		Negative	3 Point Scale		3 Point Scale		Negative	Simple Mastectomy		NO			-25770	569		0	608							<10%				Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	320	NO	Negative			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	2								NO	2		true	MX	N1a	T3	Stage IIIA	TCGA-EW-A1PB.B3B6DE56-F40C-40BF-B6B3-2BC10F695F16.pdf		2		1		0		1		0		10		90		90	TUMOR FREE							YES	No	<10%		NO	Primary Tumor	01		6th	NO	NO	YES	EW	Breast	A	LIVING	2009	TCGA-EW-A1PB-01A-11D-A142-09		TCGA-EW-A1PB-01A-11R-A143-13	TCGA-EW-A1PB-01A-11R-A143-13	TCGA-EW-A1PB-01A-11D-A142-09		TCGA-EW-A1PB-01A-11D-A142-09	TCGA-EW-A1PB-01A-21-A17J-20	TCGA-EW-A1PB-01A-11D-A142-09	50674dde-30c1-4530-a164-381d5326e29c	e50f848e-a469-41c1-b44b-4dbc283fd0a6	TCGA-EW-A1PB-01A-11D-A141-01	50674dde-30c1-4530-a164-381d5326e29c	TCGA-EW-A1PB-01A-11D-A145-05	TCGA-EW-A1PB-01		50674dde-30c1-4530-a164-381d5326e29c	50674dde-30c1-4530-a164-381d5326e29c	TCGA-EW-A1PB-01A-11D-A141-01		TCGA-EW-A1PB-01		e50f848e-a469-41c1-b44b-4dbc283fd0a6	
TCGA-EW-A1PC-01																			LumB										0	TCGA-EW-A1PC-01	187	0	High	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-EW-A1PC	187	0	187	Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Left	Sentinel node biopsy alone		TCGA-EW-A1PC-F29681		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		YES			-24434	146		0	187					NO		90-99%				Scheduled Follow-up Submission	2012-3-26	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	150	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	true	MX	N0 (i-)	T3	Stage IIB			3		0		7		0		0		23		70		85	TUMOR FREE							YES	No	50-59%		NO	Primary Tumor	01		7th	YES	NO	YES	EW	Breast	B	LIVING	2011			TCGA-EW-A1PC-01B-11R-A21U-13	TCGA-EW-A1PC-01B-11R-A21U-13			TCGA-EW-A1PC-01B-11D-A21Q-09	TCGA-EW-A1PC-01B-21-A24A-20		3960601b-c341-45fb-8a8c-ec244ee719ac	21b60917-e609-4abf-ae06-cb5da81971a2	TCGA-EW-A1PC-01B-11D-A21P-01	3960601b-c341-45fb-8a8c-ec244ee719ac	TCGA-EW-A1PC-01B-11D-A21R-05	TCGA-EW-A1PC-01		3960601b-c341-45fb-8a8c-ec244ee719ac	3960601b-c341-45fb-8a8c-ec244ee719ac	TCGA-EW-A1PC-01B-11D-A21P-01		TCGA-EW-A1PC-01		21b60917-e609-4abf-ae06-cb5da81971a2	
TCGA-EW-A1PD-01	Stage IIA	61	5	Stage IIA	174		Positive	MALE	Positive				Negative	M0	Positive	N1	174	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-EW-A1PD-01	424	0	High	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 14	cluster 4	mutation c1uster 9	TCGA-EW-A1PD	424	0	424	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A1PD-F29106		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-22536	112		0	424					NO		90-99%				Scheduled Follow-up Submission	2012-3-8	MALE			20-29%		2+		>6.0	2.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	120	NO	Equivocal	Positive		7	Negative																			2	4								NO	2		true	M0	N1a	T1c	Stage IIA	TCGA-EW-A1PD.B6D80CA9-F4DA-4DFB-80BF-08BEE17142BD.pdf		3		1		0		1		5		25		70		70	TUMOR FREE							YES	No	90-99%		NO	Primary Tumor	01		7th	YES	NO	YES	EW	Breast	A	LIVING	2010	TCGA-EW-A1PD-01A-11D-A142-09		TCGA-EW-A1PD-01A-11R-A143-13	TCGA-EW-A1PD-01A-11R-A143-13	TCGA-EW-A1PD-01A-11D-A142-09		TCGA-EW-A1PD-01A-11D-A142-09	TCGA-EW-A1PD-01A-21-A17J-20	TCGA-EW-A1PD-01A-11D-A142-09	69971d5c-5be4-4886-bf7c-753de9593a1e	954517bf-4fed-4279-9e69-f036b0a48858	TCGA-EW-A1PD-01A-11D-A141-01	69971d5c-5be4-4886-bf7c-753de9593a1e	TCGA-EW-A1PD-01A-11D-A145-05	TCGA-EW-A1PD-01		69971d5c-5be4-4886-bf7c-753de9593a1e	69971d5c-5be4-4886-bf7c-753de9593a1e	TCGA-EW-A1PD-01A-11D-A141-01		TCGA-EW-A1PD-01		954517bf-4fed-4279-9e69-f036b0a48858	
TCGA-EW-A1PE-01	Stage IIA	56	2	Stage IIA	139		Positive	FEMALE	Negative				Negative	M0	Positive	N1	139	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-EW-A1PE-01	320	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-EW-A1PE	320	0	320	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-EW-A1PE-F29108		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		NO			-20694	44		0	320					NO		90-99%				Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8507/3	C50.9	3+	YES		Core needle biopsy	150	NO	Negative			23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	3								NO	1		true	M0	N1a	T1c	Stage IIA	TCGA-EW-A1PE.F59530A5-7370-4E77-9099-9F38B25A38EB.pdf		2		1		0		1		0		25		75		75	TUMOR FREE							YES	No	90-99%		YES	Primary Tumor	01		7th	YES	NO	YES	EW	Breast	A	LIVING	2011	TCGA-EW-A1PE-01A-11D-A142-09		TCGA-EW-A1PE-01A-11R-A143-13	TCGA-EW-A1PE-01A-11R-A143-13	TCGA-EW-A1PE-01A-11D-A142-09		TCGA-EW-A1PE-01A-11D-A142-09	TCGA-EW-A1PE-01A-21-A17J-20	TCGA-EW-A1PE-01A-11D-A142-09	4a21d42c-b231-4ffc-8c15-4bd73bf610b4	edb71760-a163-45eb-9e5a-671cdebc2539	TCGA-EW-A1PE-01A-11D-A141-01	4a21d42c-b231-4ffc-8c15-4bd73bf610b4	TCGA-EW-A1PE-01A-11D-A145-05	TCGA-EW-A1PE-01		4a21d42c-b231-4ffc-8c15-4bd73bf610b4	4a21d42c-b231-4ffc-8c15-4bd73bf610b4	TCGA-EW-A1PE-01A-11D-A141-01		TCGA-EW-A1PE-01		edb71760-a163-45eb-9e5a-671cdebc2539	
TCGA-EW-A1PF-01	Stage IA	50	5	Stage I	139		Positive	FEMALE	Negative				Negative	M0	Negative	N0	139	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-EW-A1PF-01	439	0	Kirc+		cluster 1	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4		TCGA-EW-A1PF	439	0	439	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Right Upper Outer Quadrant	Other (specify)	sentinel + 2 non-sentinel LN	TCGA-EW-A1PF-F29109		Positive	3 Point Scale	3+	3 Point Scale		Positive	Other		YES			-18384			0	439					NO		90-99%				Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy			Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	0	0		M0	N0	T1c	Stage IA																		TUMOR FREE							YES	No	90-99%		NO	Primary Tumor	01	total mastectomy	7th	YES	NO	YES	EW	Breast		LIVING	2010			TCGA-EW-A1PF-01A-11R-A143-13	TCGA-EW-A1PF-01A-11R-A143-13						faa3383f-6f9f-43d8-b61d-4a1522a71444	c8b29059-d76b-4b62-9a59-31f7dc9bc3a1	TCGA-EW-A1PF-01A-11D-A141-01	faa3383f-6f9f-43d8-b61d-4a1522a71444	TCGA-EW-A1PF-01A-11D-A145-05	TCGA-EW-A1PF-01		faa3383f-6f9f-43d8-b61d-4a1522a71444	faa3383f-6f9f-43d8-b61d-4a1522a71444	TCGA-EW-A1PF-01A-11D-A141-01		TCGA-EW-A1PF-01		c8b29059-d76b-4b62-9a59-31f7dc9bc3a1	
TCGA-EW-A1PG-01	Stage IIB	53	1	Stage IIB	875		Positive	FEMALE	Negative				Negative	M0	Positive	N1	875	0	Normal		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1PG-01	1051	0	Quiet	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation c1uster 9	TCGA-EW-A1PG	1051	0	1051	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Left Lower Inner Quadrant|Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A1PG-F29103		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		YES			-19464	829		0	1051					NO		90-99%				Scheduled Follow-up Submission	2012-3-8	FEMALE			10-19%		2+		<4.0	1.8		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	210	NO	Equivocal	Negative		25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6								NO	1	1	true	MX	N1a	T2	Stage IIB	TCGA-EW-A1PG.6197798C-6F04-470E-BA91-922548E2DFAF.pdf		3		1		0		1		5		25		70		70	TUMOR FREE							YES	No	90-99%		NO	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2008	TCGA-EW-A1PG-01A-11D-A142-09		TCGA-EW-A1PG-01A-11R-A143-13	TCGA-EW-A1PG-01A-11R-A143-13	TCGA-EW-A1PG-01A-11D-A142-09		TCGA-EW-A1PG-01A-11D-A142-09	TCGA-EW-A1PG-01A-21-A17J-20	TCGA-EW-A1PG-01A-11D-A142-09	1205dc3c-e766-4a25-b485-c66e301e3b6d	ae1d6f65-aca6-4e15-86e3-f9a6db8a726b	TCGA-EW-A1PG-01A-11D-A141-01	1205dc3c-e766-4a25-b485-c66e301e3b6d	TCGA-EW-A1PG-01A-11D-A145-05	TCGA-EW-A1PG-01		1205dc3c-e766-4a25-b485-c66e301e3b6d	1205dc3c-e766-4a25-b485-c66e301e3b6d	TCGA-EW-A1PG-01A-11D-A141-01		TCGA-EW-A1PG-01		ae1d6f65-aca6-4e15-86e3-f9a6db8a726b	
TCGA-EW-A1PH-01	Stage IIA	52	1	Stage IIA	139		Negative	FEMALE					Negative	M0	Positive	N1	139	0	Basal		Negative				enrollment	T1	T1	LIVING	0	TCGA-EW-A1PH-01	607	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-EW-A1PH	607	0	607	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A1PH-F41145		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		YES			-19073	77		0	607					NO		<10%				Scheduled Follow-up Submission	2013-3-12	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	70	NO	Negative		NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5								NO	1	0	true	M0	N1a	T1c	Stage IIA	TCGA-EW-A1PH.2E77693B-FAAD-4CCC-BD4F-3D2470C25143.pdf		2		1		2		1		0		13		85		85	TUMOR FREE						YES	YES	No	<10%		YES	Primary Tumor	01		7th	YES	NO	YES	EW	Breast	A	LIVING	2010	TCGA-EW-A1PH-01A-11D-A14K-09		TCGA-EW-A1PH-01A-11R-A14L-13	TCGA-EW-A1PH-01A-11R-A14L-13	TCGA-EW-A1PH-01A-11D-A14K-09		TCGA-EW-A1PH-01A-11D-A14K-09		TCGA-EW-A1PH-01A-11D-A14K-09	39413018-090f-46ca-b6df-244124f098c3	9bbe17d3-db31-4ab5-8fea-9c222bc1bbba	TCGA-EW-A1PH-01A-11D-A14J-01	39413018-090f-46ca-b6df-244124f098c3	TCGA-EW-A1PH-01A-11D-A14N-05	TCGA-EW-A1PH-01		39413018-090f-46ca-b6df-244124f098c3	39413018-090f-46ca-b6df-244124f098c3	TCGA-EW-A1PH-01A-11D-A14J-01		TCGA-EW-A1PH-01		9bbe17d3-db31-4ab5-8fea-9c222bc1bbba	
TCGA-EW-A2FR-01																			Her2										0	TCGA-EW-A2FR-01	1673	0	BRCA-LUAD+	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-EW-A2FR	1673	0	1673	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-EW-A2FR-F42056		Negative	3 Point Scale	1+	3 Point Scale		Negative	Lumpectomy		NO			-21628	1015		0	1673					NO		<10%			2	Scheduled Follow-up Submission	2013-4-10	FEMALE			10-19%	ratio > 2.2 is positive	2+	40	>6	3.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Core needle biopsy	100	NO	Equivocal	Positive	NO	21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	19		true	MX	N3a	T1b	Stage IIIC	TCGA-EW-A2FR.792A24F5-065E-4001-97F6-3F9BA121C65D.pdf		10		0		2		0		0		38		60		75	TUMOR FREE						YES	YES	No	<10%		YES	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2008			TCGA-EW-A2FR-01A-11R-A21U-13	TCGA-EW-A2FR-01A-11R-A21U-13			TCGA-EW-A2FR-01A-11D-A21Q-09	TCGA-EW-A2FR-01A-21-A24A-20		2bd1673c-b5c0-425b-9e62-c501bf29616b	e7f50845-3225-4f28-88ce-4a11cdd598b3	TCGA-EW-A2FR-01A-11D-A21P-01	2bd1673c-b5c0-425b-9e62-c501bf29616b	TCGA-EW-A2FR-01A-11D-A21R-05	TCGA-EW-A2FR-01		2bd1673c-b5c0-425b-9e62-c501bf29616b	2bd1673c-b5c0-425b-9e62-c501bf29616b	TCGA-EW-A2FR-01A-11D-A21P-01		TCGA-EW-A2FR-01		e7f50845-3225-4f28-88ce-4a11cdd598b3	
TCGA-EW-A2FS-01		41	5		1173		Positive	FEMALE									1173	0	LumA		Negative				enrollment			LIVING	0	TCGA-EW-A2FS-01	1604	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-EW-A2FS	1604	0	1604	Breast	TCGA Breast Cancer	breast invasive carcinoma					41	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-EW-A2FS-F42061		Positive	3 Point Scale	1+	3 Point Scale		Negative	Lumpectomy		YES			-15302	1074		0	1604					NO		90-99%				Scheduled Follow-up Submission	2013-4-10	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	110	NO	Negative		NO	8	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4									NO	1		true	MX	N1mi	T2	Stage IIB	TCGA-EW-A2FS.F273B11F-D3CE-4619-BEC2-15C110567503.pdf		1		1		5		0		0		55		40		70	TUMOR FREE						YES	YES	No	<10%		YES	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2008			TCGA-EW-A2FS-01A-11R-A17A-13	TCGA-EW-A2FS-01A-11R-A17A-13			TCGA-EW-A2FS-01A-11D-A17D-09	TCGA-EW-A2FS-01A-21-A24A-20		c0f29396-d239-4f0d-a95a-0838770eb24a	21baef37-e289-498a-b523-a283df5485af	TCGA-EW-A2FS-01A-11D-A17C-01	c0f29396-d239-4f0d-a95a-0838770eb24a	TCGA-EW-A2FS-01A-11D-A17F-05	TCGA-EW-A2FS-01		c0f29396-d239-4f0d-a95a-0838770eb24a	c0f29396-d239-4f0d-a95a-0838770eb24a	TCGA-EW-A2FS-01A-11D-A17C-01		TCGA-EW-A2FS-01		21baef37-e289-498a-b523-a283df5485af	
TCGA-EW-A2FV-01		39	3		238		Positive	FEMALE									238	0	LumA		Positive				enrollment			LIVING	0	TCGA-EW-A2FV-01	788	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-EW-A2FV	788	0	788	Breast	TCGA Breast Cancer	breast invasive carcinoma					39	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-EW-A2FV-F42065	Negative	Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-14316	133		0	788					NO		90-99%				Scheduled Follow-up Submission	2013-4-10	FEMALE			<10%		1+					Other  specify	invasive micropapillary ductal carcinoma	No		C50.9	8507/3	C50.9	3+	YES		Excisional Biopsy	80	NO	Negative		NO	32	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4									NO	29		true	MX	N3a	T3	Stage IIIC	TCGA-EW-A2FV.335BFEB5-6356-43A3-896D-50BF3830B59E.pdf		5		0		0		0		3		67		30		60	TUMOR FREE						YES	NO	No	90-99%		YES	Primary Tumor	01		7th	YES	NO	YES	EW	Breast	A	LIVING	2011			TCGA-EW-A2FV-01A-11R-A17A-13	TCGA-EW-A2FV-01A-11R-A17A-13			TCGA-EW-A2FV-01A-11D-A17D-09	TCGA-EW-A2FV-01A-21-A24A-20		d60bfd82-87f0-4f13-8e90-6766beb84e9a	6c8f4fa1-9a13-4038-9ec1-a6b75b369488	TCGA-EW-A2FV-01A-11D-A17C-01	d60bfd82-87f0-4f13-8e90-6766beb84e9a	TCGA-EW-A2FV-01A-11D-A17F-05	TCGA-EW-A2FV-01		d60bfd82-87f0-4f13-8e90-6766beb84e9a	d60bfd82-87f0-4f13-8e90-6766beb84e9a	TCGA-EW-A2FV-01A-11D-A17C-01		TCGA-EW-A2FV-01		6c8f4fa1-9a13-4038-9ec1-a6b75b369488	
TCGA-EW-A2FW-01		52	3		190		Positive	FEMALE									190	0	LumB		Positive				enrollment			LIVING	0	TCGA-EW-A2FW-01	672	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6			TCGA-EW-A2FW	672	0	672	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-EW-A2FW-F42062		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		YES			-19085	99		0	672					NO		90-99%				Scheduled Follow-up Submission	2013-4-10	FEMALE			<10%		1+					Other  specify	invasive papillary carcinoma	No		C50.9	8503/3	C50.9	3+	YES		Core needle biopsy	150	NO	Negative		NO	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2									NO	0	0	true	MX	N0 (i-)	T2	Stage IIA	TCGA-EW-A2FW.0487E2B3-C03F-43A0-ABCB-B2BDBE0FF47E.pdf		1		0		2		0		0		13		85		95	TUMOR FREE						YES	YES	No	90-99%		YES	Primary Tumor	01		7th	YES	NO	YES	EW	Breast	A	LIVING	2011			TCGA-EW-A2FW-01A-11R-A17A-13	TCGA-EW-A2FW-01A-11R-A17A-13			TCGA-EW-A2FW-01A-11D-A17D-09	TCGA-EW-A2FW-01A-21-A24A-20		743f2962-126c-4b28-92fa-250b1170b825	0a9860d2-bf4a-4951-8bec-e9106594a1e8	TCGA-EW-A2FW-01A-11D-A17C-01	743f2962-126c-4b28-92fa-250b1170b825	TCGA-EW-A2FW-01A-11D-A17F-05	TCGA-EW-A2FW-01		743f2962-126c-4b28-92fa-250b1170b825	743f2962-126c-4b28-92fa-250b1170b825	TCGA-EW-A2FW-01A-11D-A17C-01		TCGA-EW-A2FW-01		0a9860d2-bf4a-4951-8bec-e9106594a1e8	
TCGA-EW-A3E8-01																													0	TCGA-EW-A3E8-01	1035	0										TCGA-EW-A3E8	1035	0	1035	Breast	TCGA Breast Cancer	breast invasive carcinoma					60	Left|Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A3E8-F57617		Positive					Negative	Simple Mastectomy					-21922	505		0	1035												2014-3-18	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	50	NO	Negative		NO	2	Negative																												NO	0		true	MX	N0	T3	Stage IIB			1		0		0		0		0		0		100		80	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th		YES	NO	EW	Breast	B	LIVING	2011			TCGA-EW-A3E8-01B-11R-A24J-13	TCGA-EW-A3E8-01B-11R-A24J-13			TCGA-EW-A3E8-01B-11D-A243-09			37cb523b-c33a-4980-9b06-6e91389ce70e	6102c7a1-159c-4b8a-8725-6f0cd54959f7	TCGA-EW-A3E8-01B-11D-A242-01	37cb523b-c33a-4980-9b06-6e91389ce70e	TCGA-EW-A3E8-01B-11D-A244-05	TCGA-EW-A3E8-01		37cb523b-c33a-4980-9b06-6e91389ce70e	37cb523b-c33a-4980-9b06-6e91389ce70e	TCGA-EW-A3E8-01B-11D-A242-01		TCGA-EW-A3E8-01		6102c7a1-159c-4b8a-8725-6f0cd54959f7	
TCGA-EW-A3U0-01																													0	TCGA-EW-A3U0-01	532	0	High			Low purity c2	BRCA basal-like c6		miRNA cluster 4			TCGA-EW-A3U0	532	0	532	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A3U0-F42032		Negative					Negative	Other		NO			-22520	182		0	532					NO							2013-4-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Negative		NO	25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1		true	M0	N1a	T3	Stage IIIA	TCGA-EW-A3U0.8652E026-9C4D-4AB6-AADE-29DA3345892E.pdf		0		0		0		0		0		45		55		80	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01	partial left mastectomy	7th		YES	NO	EW	Breast	A	LIVING	2011			TCGA-EW-A3U0-01A-11R-A22I-13	TCGA-EW-A3U0-01A-11R-A22I-13			TCGA-EW-A3U0-01A-11D-A228-09	TCGA-EW-A3U0-01A-21-A24A-20		4763b4dd-1eef-4503-9381-4baa57cc690f	f24585b7-37a2-47c7-91fd-e427fb1ff7d9	TCGA-EW-A3U0-01A-11D-A227-01	4763b4dd-1eef-4503-9381-4baa57cc690f	TCGA-EW-A3U0-01A-11D-A22B-05	TCGA-EW-A3U0-01		4763b4dd-1eef-4503-9381-4baa57cc690f	4763b4dd-1eef-4503-9381-4baa57cc690f	TCGA-EW-A3U0-01A-11D-A227-01		TCGA-EW-A3U0-01		f24585b7-37a2-47c7-91fd-e427fb1ff7d9	
TCGA-EW-A423-01																													0	TCGA-EW-A423-01	309	0										TCGA-EW-A423	309	0	309	Breast	TCGA Breast Cancer	breast invasive carcinoma					75	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-EW-A423-F38895		Positive					Positive	Lumpectomy		NO			-27627	161		0	309							50-59%					2013-3-26	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	80	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	true	MX	N0	T2	Stage IIA	TCGA-EW-A423.0BB6CAC8-CE26-461F-A9FE-46E28E96A368.pdf		0		0		0		0		0		5		95		95	TUMOR FREE						YES	YES	No	<10%		YES	Primary Tumor	01		7th		YES	NO	EW	Breast	A	LIVING	2012			TCGA-EW-A423-01A-11R-A24J-13	TCGA-EW-A423-01A-11R-A24J-13			TCGA-EW-A423-01A-11D-A243-09			994c8287-b6e2-4743-80bb-fe8d0076ae44	c338d9aa-93a4-48d4-9774-e9c5b1a5b589	TCGA-EW-A423-01A-11D-A242-01	994c8287-b6e2-4743-80bb-fe8d0076ae44	TCGA-EW-A423-01A-11D-A244-05	TCGA-EW-A423-01		994c8287-b6e2-4743-80bb-fe8d0076ae44	994c8287-b6e2-4743-80bb-fe8d0076ae44	TCGA-EW-A423-01A-11D-A242-01		TCGA-EW-A423-01		c338d9aa-93a4-48d4-9774-e9c5b1a5b589	
TCGA-EW-A424-01																													0	TCGA-EW-A424-01	715	0										TCGA-EW-A424	715	0	715	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Right	Sentinel node biopsy alone		TCGA-EW-A424-F57612		Positive					Positive	Simple Mastectomy		YES			-18850	141		0	715							50-59%					2014-3-18	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	140	NO	Positive		NO	1	Negative																												NO	0	1	true	MX	N1	T3	Stage IIIA	TCGA-EW-A424.EE644ADF-639E-450A-92E6-2A6F1BAD561F.pdf		0		0		0		0		2		58		40		70	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th		YES	NO	EW	Breast	A	LIVING	2012			TCGA-EW-A424-01A-11R-A24J-13	TCGA-EW-A424-01A-11R-A24J-13						1a571942-1f4c-4f93-8ad3-ea84dad7edaa	0ef9295c-2b43-455b-9cba-68eb70dd27d3	TCGA-EW-A424-01A-11D-A242-01	1a571942-1f4c-4f93-8ad3-ea84dad7edaa	TCGA-EW-A424-01A-11D-A244-05	TCGA-EW-A424-01		1a571942-1f4c-4f93-8ad3-ea84dad7edaa	1a571942-1f4c-4f93-8ad3-ea84dad7edaa	TCGA-EW-A424-01A-11D-A242-01		TCGA-EW-A424-01		0ef9295c-2b43-455b-9cba-68eb70dd27d3	
TCGA-EW-A6S9-01																														TCGA-EW-A6S9-01												TCGA-EW-A6S9				Breast	TCGA Breast Cancer	breast invasive carcinoma																																																												190	NO																																				true					TCGA-EW-A6S9.4FC32F17-7A4D-4FF6-A710-FFFBC610CB56.pdf		0		0		0		0		20		10		70		80													Primary Tumor	01								A					TCGA-EW-A6S9-01A-22R-A33A-13	TCGA-EW-A6S9-01A-22R-A33A-13						692abecd-9c2a-48ec-8794-7e84a5317c46	0a049359-6f7d-44c2-8a8a-3867fb4d87e1	TCGA-EW-A6S9-01A-22D-A33D-01	692abecd-9c2a-48ec-8794-7e84a5317c46	TCGA-EW-A6S9-01A-22D-A33F-05	TCGA-EW-A6S9-01		692abecd-9c2a-48ec-8794-7e84a5317c46	692abecd-9c2a-48ec-8794-7e84a5317c46	TCGA-EW-A6S9-01A-22D-A33D-01		TCGA-EW-A6S9-01		0a049359-6f7d-44c2-8a8a-3867fb4d87e1	
TCGA-EW-A6SA-01																														TCGA-EW-A6SA-01												TCGA-EW-A6SA				Breast	TCGA Breast Cancer	breast invasive carcinoma																																																												80	NO																																				true					TCGA-EW-A6SA.9C971870-BA92-4E0C-9861-31C56B7E7D64.pdf		0		0		0		0		10		20		70		80													Primary Tumor	01								A					TCGA-EW-A6SA-01A-21R-A32K-13	TCGA-EW-A6SA-01A-21R-A32K-13						2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168	6631aa60-6bc2-4604-98ab-0c7d5187fc7f	TCGA-EW-A6SA-01A-21D-A32H-01	2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168	TCGA-EW-A6SA-01A-21D-A32T-05	TCGA-EW-A6SA-01		2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168	2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168	TCGA-EW-A6SA-01A-21D-A32H-01		TCGA-EW-A6SA-01		6631aa60-6bc2-4604-98ab-0c7d5187fc7f	
TCGA-EW-A6SB-01																														TCGA-EW-A6SB-01												TCGA-EW-A6SB				Breast	TCGA Breast Cancer	breast invasive carcinoma																																																												200	NO																																				true					TCGA-EW-A6SB.6EEF1F11-603E-4196-91AB-724BBEE20CE7.pdf		0		0		0		0		0		10		90		95													Primary Tumor	01								A					TCGA-EW-A6SB-01A-12R-A32K-13	TCGA-EW-A6SB-01A-12R-A32K-13						5cb6b038-fe0b-48db-af0b-2a25beb8d79b	d9b9b065-fec4-4abf-b818-6f832d64ead4	TCGA-EW-A6SB-01A-12D-A32H-01	5cb6b038-fe0b-48db-af0b-2a25beb8d79b	TCGA-EW-A6SB-01A-12D-A32T-05	TCGA-EW-A6SB-01		5cb6b038-fe0b-48db-af0b-2a25beb8d79b	5cb6b038-fe0b-48db-af0b-2a25beb8d79b	TCGA-EW-A6SB-01A-12D-A32H-01		TCGA-EW-A6SB-01		d9b9b065-fec4-4abf-b818-6f832d64ead4	
TCGA-EW-A6SC-01																														TCGA-EW-A6SC-01												TCGA-EW-A6SC				Breast	TCGA Breast Cancer	breast invasive carcinoma																																																												160	NO																																				true					TCGA-EW-A6SC.315A77B4-1A2E-468D-9E44-FF0B07697943.pdf		1		0		0		0		2		8		90		90													Primary Tumor	01								A					TCGA-EW-A6SC-01A-12R-A32K-13	TCGA-EW-A6SC-01A-12R-A32K-13						3b7ae466-954f-42aa-8e01-9908ef1c8123	71796d70-39a8-4fa4-894e-2e19953dd94d	TCGA-EW-A6SC-01A-12D-A32H-01	3b7ae466-954f-42aa-8e01-9908ef1c8123	TCGA-EW-A6SC-01A-12D-A32T-05	TCGA-EW-A6SC-01		3b7ae466-954f-42aa-8e01-9908ef1c8123	3b7ae466-954f-42aa-8e01-9908ef1c8123	TCGA-EW-A6SC-01A-12D-A32H-01		TCGA-EW-A6SC-01		71796d70-39a8-4fa4-894e-2e19953dd94d	
TCGA-EW-A6SD-01																														TCGA-EW-A6SD-01												TCGA-EW-A6SD				Breast	TCGA Breast Cancer	breast invasive carcinoma																																																												210	NO																																				true					TCGA-EW-A6SD.9FB40DC5-BED9-420E-B334-4D0BE8B8BCF5.pdf		3		0		0		0		5		10		85		85													Primary Tumor	01								A					TCGA-EW-A6SD-01A-12R-A33A-13	TCGA-EW-A6SD-01A-12R-A33A-13						54d166b6-fb32-4003-b944-8d0f23cfa125	58cceccb-40f5-4907-9e65-2e6b51f62a0a	TCGA-EW-A6SD-01A-12D-A33D-01	54d166b6-fb32-4003-b944-8d0f23cfa125	TCGA-EW-A6SD-01A-12D-A33F-05	TCGA-EW-A6SD-01		54d166b6-fb32-4003-b944-8d0f23cfa125	54d166b6-fb32-4003-b944-8d0f23cfa125	TCGA-EW-A6SD-01A-12D-A33D-01		TCGA-EW-A6SD-01		58cceccb-40f5-4907-9e65-2e6b51f62a0a	
TCGA-GI-A2C8-01			3																LumA										0	TCGA-GI-A2C8-01	225	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4		mutation c1uster 9	TCGA-GI-A2C8	225	0	225	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Right	Sentinel node biopsy alone		TCGA-GI-A2C8-F21661		Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-23103	2429		0	225					NO		90-99%				Scheduled Follow-up Submission	2012-5-8	FEMALE										Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9	3+	YES			100	NO	Negative	Negative		10	Negative																			3									NO	0		false	MX	N0	T4b	Stage IIIB	TCGA-GI-A2C8.4AABCBD1-DF12-45E1-9307-21D6CB0894A9.pdf		1		0		20		0		0		25		55		85								YES	No	<10%		YES	Primary Tumor	01		6th	YES	NO	YES	GI	Breast	A	LIVING	2004	TCGA-GI-A2C8-01A-11D-A16D-09		TCGA-GI-A2C8-01A-11R-A16E-13	TCGA-GI-A2C8-01A-11R-A16E-13	TCGA-GI-A2C8-01A-11D-A16D-09		TCGA-GI-A2C8-01A-11D-A16D-09	TCGA-GI-A2C8-01A-21-A17K-20	TCGA-GI-A2C8-01A-11D-A16D-09	21531069-76ec-4e0f-b915-51c00b2c42f1	d986386e-b0cc-46f5-a9dc-8e0c58178f4a	TCGA-GI-A2C8-01A-11D-A16C-01	21531069-76ec-4e0f-b915-51c00b2c42f1	TCGA-GI-A2C8-01A-11D-A16G-05	TCGA-GI-A2C8-01		21531069-76ec-4e0f-b915-51c00b2c42f1	21531069-76ec-4e0f-b915-51c00b2c42f1	TCGA-GI-A2C8-01A-11D-A16C-01		TCGA-GI-A2C8-01		d986386e-b0cc-46f5-a9dc-8e0c58178f4a	
TCGA-GI-A2C8-11																			LumA										0	TCGA-GI-A2C8-11	225	0		C3-BRCA/Luminal							mutation c1uster 9	TCGA-GI-A2C8	225	0	225	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Right	Sentinel node biopsy alone		TCGA-GI-A2C8-F21661		Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-23103	2429		0	225					NO		90-99%				Scheduled Follow-up Submission	2012-5-8	FEMALE										Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9	3+	YES			100	NO	Negative	Negative		10	Negative																												NO	0		false	MX	N0	T4b	Stage IIIB			0		0		0		0		0		100		0		0								YES	No	<10%		YES	Solid Tissue Normal	11		6th	YES	NO	YES	GI	Breast	A	LIVING	2004			TCGA-GI-A2C8-11A-22R-A16E-13	TCGA-GI-A2C8-11A-22R-A16E-13						6eaf6c1c-13d6-4293-aaa5-7d9aecf61db7			6eaf6c1c-13d6-4293-aaa5-7d9aecf61db7				6eaf6c1c-13d6-4293-aaa5-7d9aecf61db7	6eaf6c1c-13d6-4293-aaa5-7d9aecf61db7						
TCGA-GI-A2C9-01																			Basal										0	TCGA-GI-A2C9-01	3342	0	High	C4-BRCA/Basal		BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4			TCGA-GI-A2C9	3342	0	3342	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-GI-A2C9-F21663		Negative					Negative	Lumpectomy		YES			-21534	2979		0	3342					NO						Scheduled Follow-up Submission	2012-5-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0	T3	Stage IIB	TCGA-GI-A2C9.ADDE6090-5278-42D5-8E89-E0AB630A4C06.pdf		1		0		3		0		0		42		55		80	TUMOR FREE							YES	No			YES	Primary Tumor	01		6th	YES	NO	YES	GI	Breast	A	LIVING	2003			TCGA-GI-A2C9-01A-11R-A21U-13	TCGA-GI-A2C9-01A-11R-A21U-13			TCGA-GI-A2C9-01A-11D-A21Q-09	TCGA-GI-A2C9-01A-21-A24A-20		b5b8fdd8-c4df-4f79-aed5-23ac41f75f18	49f9eae1-6d7c-45a8-bcf1-b321f980a581	TCGA-GI-A2C9-01A-11D-A21P-01	b5b8fdd8-c4df-4f79-aed5-23ac41f75f18	TCGA-GI-A2C9-01A-11D-A21R-05	TCGA-GI-A2C9-01		b5b8fdd8-c4df-4f79-aed5-23ac41f75f18	b5b8fdd8-c4df-4f79-aed5-23ac41f75f18	TCGA-GI-A2C9-01A-11D-A21P-01		TCGA-GI-A2C9-01		49f9eae1-6d7c-45a8-bcf1-b321f980a581	
TCGA-GI-A2C9-11																			Normal										0	TCGA-GI-A2C9-11	3342	0		C4-BRCA/Basal								TCGA-GI-A2C9	3342	0	3342	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-GI-A2C9-F21663		Negative					Negative	Lumpectomy		YES			-21534	2979		0	3342					NO						Scheduled Follow-up Submission	2012-5-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0	T3	Stage IIB			1		0		0		0		15		85		0		0	TUMOR FREE							YES	No			YES	Solid Tissue Normal	11		6th	YES	NO	YES	GI	Breast	A	LIVING	2003			TCGA-GI-A2C9-11A-22R-A21U-13	TCGA-GI-A2C9-11A-22R-A21U-13						69a8b5fd-7ca6-49d7-b16a-2beba16e40b1			69a8b5fd-7ca6-49d7-b16a-2beba16e40b1				69a8b5fd-7ca6-49d7-b16a-2beba16e40b1	69a8b5fd-7ca6-49d7-b16a-2beba16e40b1						
TCGA-GM-A2D9-01		69				1812	Positive	FEMALE									1812	1	LumA		Positive				enrollment			DECEASED	1	TCGA-GM-A2D9-01	1812	1	BRCA-LUAD+	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3			TCGA-GM-A2D9	536	1	1812	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	YES			69	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-GM-A2D9-F47033		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		YES			-25490	1910	1812	0			536	536		YES		90-99%	Bone		1.93		2013-8-21	FEMALE						60	2.23	1.16		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	130	NO		Negative	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)					Positive	90-99%																	Bone	Distant Metastasis		YES	YES	0	0	false	M0	N0 (i-)	T1c	Stage I	TCGA-GM-A2D9.C690925E-38A2-48BC-8E2B-4EA383E27FE2.pdf		0		0		0		0		0		5		95		85	WITH TUMOR						YES	YES	No	40-49%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast	A	DECEASED	2006			TCGA-GM-A2D9-01A-11R-A18L-13	TCGA-GM-A2D9-01A-11R-A18L-13			TCGA-GM-A2D9-01A-11D-A18P-09	TCGA-GM-A2D9-01A-21-A24A-20		4ffff9ea-3386-47d5-8974-722037f31849	1fcd4cc6-e594-415c-956a-a65c309fa105	TCGA-GM-A2D9-01A-11D-A18N-01	4ffff9ea-3386-47d5-8974-722037f31849	TCGA-GM-A2D9-01A-11D-A18O-05	TCGA-GM-A2D9-01		4ffff9ea-3386-47d5-8974-722037f31849	4ffff9ea-3386-47d5-8974-722037f31849	TCGA-GM-A2D9-01A-11D-A18N-01		TCGA-GM-A2D9-01		1fcd4cc6-e594-415c-956a-a65c309fa105	
TCGA-GM-A2DA-01		46			5909		Positive	FEMALE									5909	0	LumA		Positive				enrollment			LIVING	1	TCGA-GM-A2DA-01	6593	1	Iq			BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 5			TCGA-GM-A2DA	3014	1	6593	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	YES			46	Right Upper Inner Quadrant|Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-GM-A2DA-F47040		Positive					Positive	Modified Radical Mastectomy		NO			-16854	6583	6593	0	5909			3014		YES		90-99%	Bone		3.70		2013-8-21	FEMALE			90-99%		2+	60	15	4.05		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	50	NO	Equivocal	Positive	NO	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																							Bone	Distant Metastasis		NO	YES	2	0	false	M0	N1b	T2	Stage IIB	TCGA-GM-A2DA.F3CD8E6E-B02F-4D5D-B895-6DF063F61603.pdf		0		0		0		0		0		15		85		85	WITH TUMOR						YES	YES	No	50-59%		YES	Primary Tumor	01		4th		NO	YES	GM	Breast	A	DECEASED	1993			TCGA-GM-A2DA-01A-11R-A18L-13	TCGA-GM-A2DA-01A-11R-A18L-13			TCGA-GM-A2DA-01A-11D-A18P-09			df5061ca-929b-4e23-89fb-6d05c1a9ffa4	9bd1f34e-2bf1-45d9-8553-9abc40c3c175	TCGA-GM-A2DA-01A-11D-A18N-01	df5061ca-929b-4e23-89fb-6d05c1a9ffa4	TCGA-GM-A2DA-01A-11D-A18O-05	TCGA-GM-A2DA-01		df5061ca-929b-4e23-89fb-6d05c1a9ffa4	df5061ca-929b-4e23-89fb-6d05c1a9ffa4	TCGA-GM-A2DA-01A-11D-A18N-01		TCGA-GM-A2DA-01		9bd1f34e-2bf1-45d9-8553-9abc40c3c175	
TCGA-GM-A2DB-01		62			1615		Negative	FEMALE									1615	0	Her2		Negative				enrollment			LIVING	0	TCGA-GM-A2DB-01	2406	0	Squamous	C3-BRCA/Luminal		BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-GM-A2DB	2406	0	2406	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-GM-A2DB-F47156		Negative					Negative	Lumpectomy		YES			-22883	1644		0	2406					NO		<10%			1.50		2013-8-22	FEMALE					1+	60	1.67	1.11		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO	Negative	Negative	NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	M0	N0 (i-)	T2	Stage IIA	TCGA-GM-A2DB.5A315635-886B-459E-AF5D-079F66E859F0.pdf		0		0		15		0		0		5		80		75	TUMOR FREE						YES	YES	No	<10%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2006			TCGA-GM-A2DB-01A-31R-A18L-13	TCGA-GM-A2DB-01A-31R-A18L-13			TCGA-GM-A2DB-01A-31D-A19Y-09	TCGA-GM-A2DB-01A-21-A24A-20		e5aeb7a3-1454-4605-a924-d4b1ed082e87	49a7d88b-449d-4070-82b3-d81ee76c7757	TCGA-GM-A2DB-01A-31D-A18N-01	e5aeb7a3-1454-4605-a924-d4b1ed082e87	TCGA-GM-A2DB-01A-31D-A18O-05	TCGA-GM-A2DB-01		e5aeb7a3-1454-4605-a924-d4b1ed082e87	e5aeb7a3-1454-4605-a924-d4b1ed082e87	TCGA-GM-A2DB-01A-31D-A18N-01		TCGA-GM-A2DB-01		49a7d88b-449d-4070-82b3-d81ee76c7757	
TCGA-GM-A2DC-01		57			1628		Positive	FEMALE									1628	0	LumA		Positive				enrollment			LIVING	0	TCGA-GM-A2DC-01	2535	0	BRCA-LUAD+	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-GM-A2DC	2535	0	2535	Breast	TCGA Breast Cancer	breast invasive carcinoma					57	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-GM-A2DC-F47061		Positive					Positive	Lumpectomy		NO			-21122			0	2535					NO		90-99%			4.43		2013-8-22	FEMALE						60	4.70	1.06		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy				Negative	NO	21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1	0		M0	N1a	T1c	Stage IIA																		TUMOR FREE						YES	YES	No	90-99%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast		LIVING	2006			TCGA-GM-A2DC-01A-11R-A18L-13	TCGA-GM-A2DC-01A-11R-A18L-13			TCGA-GM-A2DC-01A-11D-A18P-09	TCGA-GM-A2DC-01A-21-A24A-20		beb2f2cc-8893-4db2-a527-50a7a40d6d4f	b567c843-1143-4bbf-842d-42ece6a80242	TCGA-GM-A2DC-01A-11D-A18N-01	beb2f2cc-8893-4db2-a527-50a7a40d6d4f	TCGA-GM-A2DC-01A-11D-A18O-05	TCGA-GM-A2DC-01		beb2f2cc-8893-4db2-a527-50a7a40d6d4f	beb2f2cc-8893-4db2-a527-50a7a40d6d4f	TCGA-GM-A2DC-01A-11D-A18N-01		TCGA-GM-A2DC-01		b567c843-1143-4bbf-842d-42ece6a80242	
TCGA-GM-A2DD-01		53			1309		Negative	FEMALE									1309	0	Normal		Negative				enrollment			LIVING	0	TCGA-GM-A2DD-01	1309	0	High	C3-BRCA/Luminal		BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-GM-A2DD			1309	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Right	Sentinel node biopsy alone				Negative					Negative	Simple Mastectomy		YES			-19415			0	1309					NO		<10%			1.45		2011-9-29	FEMALE			<10%		2+	60	1.62	1.11		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0	0		M0	N0 (i-)	T1c	Stage I																		TUMOR FREE							YES	No	<10%			Primary Tumor	01		6th		NO	YES	GM	Breast		LIVING	2007			TCGA-GM-A2DD-01A-11R-A17X-13	TCGA-GM-A2DD-01A-11R-A17X-13			TCGA-GM-A2DD-01A-11D-A17W-09	TCGA-GM-A2DD-01A-21-A24A-20		ddc6e148-34b7-4466-b692-3bb227004e2b	ebef101a-cc11-448a-b8a6-b5e0c6f0f998	TCGA-GM-A2DD-01A-11D-A17U-01	ddc6e148-34b7-4466-b692-3bb227004e2b	TCGA-GM-A2DD-01A-11D-A17Z-05	TCGA-GM-A2DD-01		ddc6e148-34b7-4466-b692-3bb227004e2b	ddc6e148-34b7-4466-b692-3bb227004e2b	TCGA-GM-A2DD-01A-11D-A17U-01		TCGA-GM-A2DD-01		ebef101a-cc11-448a-b8a6-b5e0c6f0f998	
TCGA-GM-A2DF-01		53			1299		Negative	FEMALE									1299	0	Basal		Negative				enrollment			LIVING	0	TCGA-GM-A2DF-01	2155	0	High	C4-BRCA/Basal		BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 5			TCGA-GM-A2DF	2155	0	2155	Breast	TCGA Breast Cancer	breast invasive carcinoma					53	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-GM-A2DF-F47074		Negative					Negative	Lumpectomy		NO			-19614	1372		0	2155					NO		<10%			1.40		2013-8-22	FEMALE					1+	60	1.57	1.12		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	100	NO	Negative	Negative	NO	32	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1	0	false	M0	N1a	T1c	Stage IIA	TCGA-GM-A2DF.CA6B733A-6030-422C-9DE9-B9718CBB2FDC.pdf		0		0		0		0		0		0		100		95	TUMOR FREE						YES	YES	No	<10%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2007			TCGA-GM-A2DF-01A-11R-A17X-13	TCGA-GM-A2DF-01A-11R-A17X-13			TCGA-GM-A2DF-01A-11D-A17W-09	TCGA-GM-A2DF-01A-21-A24A-20		83f8c292-5ae0-4c58-9f08-e58ce391f4f4	1fdda772-80cf-45f4-ae85-79ebf4000fb7	TCGA-GM-A2DF-01A-11D-A17U-01	83f8c292-5ae0-4c58-9f08-e58ce391f4f4	TCGA-GM-A2DF-01A-11D-A17Z-05	TCGA-GM-A2DF-01		83f8c292-5ae0-4c58-9f08-e58ce391f4f4	83f8c292-5ae0-4c58-9f08-e58ce391f4f4	TCGA-GM-A2DF-01A-11D-A17U-01		TCGA-GM-A2DF-01		1fdda772-80cf-45f4-ae85-79ebf4000fb7	
TCGA-GM-A2DH-01		58			1286		Negative	FEMALE									1286	0	Her2		Negative				enrollment			LIVING	0	TCGA-GM-A2DH-01	2193	0	High	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA c1uster 10			TCGA-GM-A2DH	2193	0	2193	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-GM-A2DH-F47081		Negative					Negative	Simple Mastectomy		YES			-21344	1464		0	2193					NO		<10%			2.80		2013-8-22	FEMALE					1+	60	2.80	1.00		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	110	NO	Negative	Negative	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	1	false	M0	N0 (i+)	T1c	Stage I	TCGA-GM-A2DH.C3243207-2190-4435-9AA9-39E3B913E316.pdf		0		0		0		0		0		5		95		80	TUMOR FREE						YES	YES	No	<10%		NO	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2007			TCGA-GM-A2DH-01A-11R-A17X-13	TCGA-GM-A2DH-01A-11R-A17X-13			TCGA-GM-A2DH-01A-11D-A17W-09	TCGA-GM-A2DH-01A-21-A24A-20		ec2ac902-f5ca-45a5-a72a-1b266360410a	9a25d4b1-36c8-47f9-9b9c-72a11a7388ba	TCGA-GM-A2DH-01A-11D-A17U-01	ec2ac902-f5ca-45a5-a72a-1b266360410a	TCGA-GM-A2DH-01A-11D-A17Z-05	TCGA-GM-A2DH-01		ec2ac902-f5ca-45a5-a72a-1b266360410a	ec2ac902-f5ca-45a5-a72a-1b266360410a	TCGA-GM-A2DH-01A-11D-A17U-01		TCGA-GM-A2DH-01		9a25d4b1-36c8-47f9-9b9c-72a11a7388ba	
TCGA-GM-A2DI-01		52			1883		Negative	FEMALE									1883	0	LumA		Negative				enrollment			LIVING	0	TCGA-GM-A2DI-01	2590	0	Squamous	C3-BRCA/Luminal		Low purity c2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3			TCGA-GM-A2DI	2590	0	2590	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-GM-A2DI-F47089		Negative					Negative	Simple Mastectomy		YES			-19030	2144		0	2590					NO		<10%			3.33		2013-8-22	FEMALE						60	3.53	1.06		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	150	NO		Negative	NO	9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0	1	false	M0	N0 (i+)	T1c	Stage I	TCGA-GM-A2DI.D437E9FF-5C09-4FD6-BB0B-0881CD4C50D7.pdf		0		0		0		0		0		5		95		80	TUMOR FREE						YES	YES	No	<10%		NO	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2005			TCGA-GM-A2DI-01A-31R-A18L-13	TCGA-GM-A2DI-01A-31R-A18L-13			TCGA-GM-A2DI-01A-31D-A18P-09	TCGA-GM-A2DI-01A-21-A24A-20		c50e1f9f-6059-4609-876d-938efb8a784e	82f1dfdc-1d68-4dd2-b933-80961316de23	TCGA-GM-A2DI-01A-31D-A18N-01	c50e1f9f-6059-4609-876d-938efb8a784e	TCGA-GM-A2DI-01A-31D-A18O-05	TCGA-GM-A2DI-01		c50e1f9f-6059-4609-876d-938efb8a784e	c50e1f9f-6059-4609-876d-938efb8a784e	TCGA-GM-A2DI-01A-31D-A18N-01		TCGA-GM-A2DI-01		82f1dfdc-1d68-4dd2-b933-80961316de23	
TCGA-GM-A2DK-01		58			1896		Positive	FEMALE									1896	0	LumA		Negative				enrollment			LIVING	0	TCGA-GM-A2DK-01	2645	0	COAD-READ	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-GM-A2DK	2645	0	2645	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-GM-A2DK-F47094		Positive					Negative	Lumpectomy		YES			-21198	2109		0	2645					NO		90-99%					2013-8-22	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	M0	N0 (i-)	T1c	Stage I	TCGA-GM-A2DK.FBD7BD94-2870-431D-A519-DAF72A97845F.pdf		1		0		4		0		0		56		40		70	TUMOR FREE						YES	YES	No	<10%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2005			TCGA-GM-A2DK-01A-21R-A17X-13	TCGA-GM-A2DK-01A-21R-A17X-13			TCGA-GM-A2DK-01A-21D-A17W-09	TCGA-GM-A2DK-01A-11-A24A-20		52df7d5d-7236-464f-9394-7c20f8726280	d7061bf4-68ed-452b-93d0-46005a916bd6	TCGA-GM-A2DK-01A-21D-A17U-01	52df7d5d-7236-464f-9394-7c20f8726280	TCGA-GM-A2DK-01A-21D-A17Z-05	TCGA-GM-A2DK-01		52df7d5d-7236-464f-9394-7c20f8726280	52df7d5d-7236-464f-9394-7c20f8726280	TCGA-GM-A2DK-01A-21D-A17U-01		TCGA-GM-A2DK-01		d7061bf4-68ed-452b-93d0-46005a916bd6	
TCGA-GM-A2DL-01		50			2762		Positive	FEMALE									2762	0	LumA		Positive				enrollment			LIVING	0	TCGA-GM-A2DL-01	3519	0	BRCA-LUAD+	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-GM-A2DL	3519	0	3519	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-GM-A2DL-F47098		Positive					Positive	Lumpectomy		YES			-18475	2723		0	3519					NO		90-99%					2013-8-22	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO	Negative		NO	2	Negative	Peri (6-12 months since last menstrual period)																											NO	0	0	false	M0	N0 (i-)	T1c	Stage I	TCGA-GM-A2DL.8CF4E53E-924F-4DC6-8748-BC8A1F7D5662.pdf		1		0		3		0		0		35		62		80	TUMOR FREE						YES	YES	No	90-99%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2003			TCGA-GM-A2DL-01A-11R-A18L-13	TCGA-GM-A2DL-01A-11R-A18L-13			TCGA-GM-A2DL-01A-11D-A18P-09	TCGA-GM-A2DL-01A-21-A24A-20		8955404a-c756-4116-9613-dea06077a056	2cd3acc2-31e5-41b3-9db4-baad97c03990	TCGA-GM-A2DL-01A-11D-A18N-01	8955404a-c756-4116-9613-dea06077a056	TCGA-GM-A2DL-01A-11D-A18O-05	TCGA-GM-A2DL-01		8955404a-c756-4116-9613-dea06077a056	8955404a-c756-4116-9613-dea06077a056	TCGA-GM-A2DL-01A-11D-A18N-01		TCGA-GM-A2DL-01		2cd3acc2-31e5-41b3-9db4-baad97c03990	
TCGA-GM-A2DM-01		57			2331		Positive	FEMALE									2331	0	LumA		Positive				enrollment			LIVING	0	TCGA-GM-A2DM-01	3226	0	Quiet	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6			TCGA-GM-A2DM	3226	0	3226	Breast	TCGA Breast Cancer	breast invasive carcinoma					57	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-GM-A2DM-F47104		Positive					Positive	Lumpectomy		YES			-21160	2464		0	3226					NO		40-49%					2013-8-22	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	M0	N0 (i-)	T2	Stage IIA	TCGA-GM-A2DM.18D46E96-4E16-4736-AACF-C6BF8AEC9368.pdf		1		0		3		0		0		32		65		90	TUMOR FREE						YES	YES	No	30-39%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2004			TCGA-GM-A2DM-01A-11R-A17X-13	TCGA-GM-A2DM-01A-11R-A17X-13			TCGA-GM-A2DM-01A-11D-A17W-09	TCGA-GM-A2DM-01A-21-A24A-20		8d8fed5e-4b27-472a-93fa-2dba57098576	4b642fb4-cae4-42d6-99d4-f07470b4fe3f	TCGA-GM-A2DM-01A-11D-A17U-01	8d8fed5e-4b27-472a-93fa-2dba57098576	TCGA-GM-A2DM-01A-11D-A17Z-05	TCGA-GM-A2DM-01		8d8fed5e-4b27-472a-93fa-2dba57098576	8d8fed5e-4b27-472a-93fa-2dba57098576	TCGA-GM-A2DM-01A-11D-A17U-01		TCGA-GM-A2DM-01		4b642fb4-cae4-42d6-99d4-f07470b4fe3f	
TCGA-GM-A2DN-01		58			2352		Positive	FEMALE									2352	0	LumA		Positive				enrollment			LIVING	0	TCGA-GM-A2DN-01	3091	0	Iq	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-GM-A2DN	3091	0	3091	Breast	TCGA Breast Cancer	breast invasive carcinoma					58	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-GM-A2DN-F47124		Positive					Positive	Modified Radical Mastectomy		YES			-21288	2436		0	3091					NO		90-99%					2013-8-22	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Negative		NO	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	M0	N0 (i-)	T2	Stage IIA	TCGA-GM-A2DN.8829274B-EB82-4155-A458-CF9F0E60B36E.pdf		2		0		3		0		0		57		40		70	TUMOR FREE						YES	YES	No	90-99%		NO	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2004			TCGA-GM-A2DN-01A-11R-A17X-13	TCGA-GM-A2DN-01A-11R-A17X-13			TCGA-GM-A2DN-01A-11D-A17W-09	TCGA-GM-A2DN-01A-21-A24A-20		0872770d-ed18-47c4-8190-212b7250f7cf	8ca7be4e-bcbe-444f-a2d3-c4ffdcb8ca5e	TCGA-GM-A2DN-01A-11D-A17U-01	0872770d-ed18-47c4-8190-212b7250f7cf	TCGA-GM-A2DN-01A-11D-A17Z-05	TCGA-GM-A2DN-01		0872770d-ed18-47c4-8190-212b7250f7cf	0872770d-ed18-47c4-8190-212b7250f7cf	TCGA-GM-A2DN-01A-11D-A17U-01		TCGA-GM-A2DN-01		8ca7be4e-bcbe-444f-a2d3-c4ffdcb8ca5e	
TCGA-GM-A2DO-01		54			1622		Positive	FEMALE									1622	0	LumB		Positive				enrollment			LIVING	0	TCGA-GM-A2DO-01	2596	0	Kirc+	C3-BRCA/Luminal		Cluster 5	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-GM-A2DO	2596	0	2596	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-GM-A2DO-F47151		Positive					Positive	Lumpectomy		YES			-19842	1932		0	2596					NO		90-99%					2013-8-22	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	110	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	M0	N0 (i-)	T1c	Stage I	TCGA-GM-A2DO.100E842E-0ADD-4E58-B31B-0C67DC175787.pdf		2		0		3		0		0		20		77		90	TUMOR FREE						YES	YES	No	90-99%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2006			TCGA-GM-A2DO-01A-11R-A18L-13	TCGA-GM-A2DO-01A-11R-A18L-13			TCGA-GM-A2DO-01A-11D-A19Y-09	TCGA-GM-A2DO-01A-21-A24A-20		9827d98e-4e2e-44cb-b0a5-f51b74ec0675	5ac03fe2-dfd1-4fad-aad6-bd1b04be6298	TCGA-GM-A2DO-01A-11D-A18N-01	9827d98e-4e2e-44cb-b0a5-f51b74ec0675	TCGA-GM-A2DO-01A-11D-A18O-05	TCGA-GM-A2DO-01		9827d98e-4e2e-44cb-b0a5-f51b74ec0675	9827d98e-4e2e-44cb-b0a5-f51b74ec0675	TCGA-GM-A2DO-01A-11D-A18N-01		TCGA-GM-A2DO-01		5ac03fe2-dfd1-4fad-aad6-bd1b04be6298	
TCGA-GM-A3NW-01																													0	TCGA-GM-A3NW-01	3361	0	BRCA-LUAD+			BRCA CIMP c7			miRNA cluster 14			TCGA-GM-A3NW	3361	0	3361	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-GM-A3NW-F40398		Negative					Positive	Simple Mastectomy		YES			-23041	3110		0	3361					NO					1.57		2013-2-18	FEMALE			30-39%		1+	60	1.80	1.15		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	150	NO	Equivocal	Negative	NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	M0	N0 (i-)	T2	Stage IIA	TCGA-GM-A3NW.00C6FB2B-A1C9-4310-B178-740313565A32.pdf		1		0		0		0		10		60		30		75	TUMOR FREE						YES	YES	No	20-29%		NO	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2003			TCGA-GM-A3NW-01A-21R-A22I-13	TCGA-GM-A3NW-01A-21R-A22I-13			TCGA-GM-A3NW-01A-21D-A228-09			e996b750-d0d3-43c8-860a-17da2f607b15	35b6fe5d-68fc-4d0d-916c-f66d18eae97e	TCGA-GM-A3NW-01A-21D-A227-01	e996b750-d0d3-43c8-860a-17da2f607b15	TCGA-GM-A3NW-01A-21D-A22B-05	TCGA-GM-A3NW-01		e996b750-d0d3-43c8-860a-17da2f607b15	e996b750-d0d3-43c8-860a-17da2f607b15	TCGA-GM-A3NW-01A-21D-A227-01		TCGA-GM-A3NW-01		35b6fe5d-68fc-4d0d-916c-f66d18eae97e	
TCGA-GM-A3NY-01																			LumA										0	TCGA-GM-A3NY-01	1162	0	Iq	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6			TCGA-GM-A3NY	1162	0	1162	Breast	TCGA Breast Cancer	breast invasive carcinoma					72	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-GM-A3NY-F40403		Positive					Positive	Lumpectomy		NO			-26642	778		0	1162					NO		90-99%					2013-2-19	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	140	NO	Negative		NO	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1	0	false	M0	N1a	T2	Stage IIB	TCGA-GM-A3NY.1659798C-9B6A-4DF9-A5B6-79AD2194DF11.pdf		0		0		0		0		3		7		90		85	TUMOR FREE						YES	YES	No	20-29%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2009			TCGA-GM-A3NY-01A-11R-A21U-13	TCGA-GM-A3NY-01A-11R-A21U-13			TCGA-GM-A3NY-01A-11D-A21Q-09	TCGA-GM-A3NY-01A-21-A24A-20		85c4a097-4567-4bdf-879c-96c9a4f48052	5c02b684-a187-4b98-8e99-3b8234ac9161	TCGA-GM-A3NY-01A-11D-A21P-01	85c4a097-4567-4bdf-879c-96c9a4f48052	TCGA-GM-A3NY-01A-11D-A21R-05	TCGA-GM-A3NY-01		85c4a097-4567-4bdf-879c-96c9a4f48052	85c4a097-4567-4bdf-879c-96c9a4f48052	TCGA-GM-A3NY-01A-11D-A21P-01		TCGA-GM-A3NY-01		5c02b684-a187-4b98-8e99-3b8234ac9161	
TCGA-GM-A3XG-01																													0	TCGA-GM-A3XG-01	1330	0										TCGA-GM-A3XG	1330	0	1330	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Right|Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-GM-A3XG-F46963		Positive					Positive	Modified Radical Mastectomy		YES			-16948	899		0	1330							90-99%			1.67		2013-8-20	FEMALE					1+	60	1.73	1.04		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	270	NO	Negative	Negative	NO	26	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	3	0	false	M0	N1a	T3	Stage IIIA	TCGA-GM-A3XG.E76B5204-99E5-42D0-AE7E-ED5525796CCB.pdf		1		0		0		0		20		30		50		60	TUMOR FREE						YES	YES	No	90-99%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2009			TCGA-GM-A3XG-01A-31R-A24J-13	TCGA-GM-A3XG-01A-31R-A24J-13			TCGA-GM-A3XG-01A-31D-A243-09			718c3d2a-517e-4e32-a96b-ef17848d56d8	b02fe819-aeca-4af8-9057-856dbebce2fc	TCGA-GM-A3XG-01A-31D-A242-01	718c3d2a-517e-4e32-a96b-ef17848d56d8	TCGA-GM-A3XG-01A-31D-A244-05	TCGA-GM-A3XG-01		718c3d2a-517e-4e32-a96b-ef17848d56d8	718c3d2a-517e-4e32-a96b-ef17848d56d8	TCGA-GM-A3XG-01A-31D-A242-01		TCGA-GM-A3XG-01		b02fe819-aeca-4af8-9057-856dbebce2fc	
TCGA-GM-A3XL-01																													0	TCGA-GM-A3XL-01	2108	0					BRCA basal-like c6		miRNA cluster 4			TCGA-GM-A3XL	2108	0	2108	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Right|Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-GM-A3XL-F41970		Negative					Negative	Lumpectomy		YES			-18171	1779		0	2108							<10%					2013-4-8	FEMALE								0.99		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO		Negative	NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	M0	N0 (i-)	T2	Stage IIA	TCGA-GM-A3XL.E8583D11-D6F7-41AC-8CD5-53437CBD8820.pdf		0		0		15		0		5		15		65		90	TUMOR FREE						YES	YES	No	<10%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2007			TCGA-GM-A3XL-01A-11R-A22V-13	TCGA-GM-A3XL-01A-11R-A22V-13			TCGA-GM-A3XL-01A-11D-A22X-09	TCGA-GM-A3XL-01A-21-A24A-20		29c98197-249e-45c9-96dc-34dfb4ac1430	bb56f0b4-2c20-4ca7-bc85-8f7cc13d5458	TCGA-GM-A3XL-01A-11D-A22W-01	29c98197-249e-45c9-96dc-34dfb4ac1430	TCGA-GM-A3XL-01A-11D-A230-05	TCGA-GM-A3XL-01		29c98197-249e-45c9-96dc-34dfb4ac1430	29c98197-249e-45c9-96dc-34dfb4ac1430	TCGA-GM-A3XL-01A-11D-A22W-01		TCGA-GM-A3XL-01		bb56f0b4-2c20-4ca7-bc85-8f7cc13d5458	
TCGA-GM-A3XN-01																													0	TCGA-GM-A3XN-01	2019	0					BRCA nonbasal-like c8		miRNA cluster 4			TCGA-GM-A3XN	2019	0	2019	Breast	TCGA Breast Cancer	breast invasive carcinoma					44	Left|Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-GM-A3XN-F46967		Positive					Positive	Lumpectomy		NO			-16109	1627		0	2019							80-89%			1.73		2013-8-20	FEMALE					1+	60	1.85	1.07		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Incisional Biopsy	100	NO	Negative	Negative	NO	34	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	5	0	false	M0	N2a	T1c	Stage IIIA	TCGA-GM-A3XN.E9A88E5B-4F50-4683-9C65-56CFCB15405E.pdf		0		0		0		0		0		0		100		82	TUMOR FREE						YES	YES	No	90-99%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2007			TCGA-GM-A3XN-01A-12R-A22V-13	TCGA-GM-A3XN-01A-12R-A22V-13			TCGA-GM-A3XN-01A-12D-A22X-09	TCGA-GM-A3XN-01A-21-A24A-20		740c53d0-b037-4475-82b3-044b2f879aac	de3f72da-05ed-4aeb-a82e-ca2263907159	TCGA-GM-A3XN-01A-12D-A22W-01	740c53d0-b037-4475-82b3-044b2f879aac	TCGA-GM-A3XN-01A-12D-A230-05	TCGA-GM-A3XN-01		740c53d0-b037-4475-82b3-044b2f879aac	740c53d0-b037-4475-82b3-044b2f879aac	TCGA-GM-A3XN-01A-12D-A22W-01		TCGA-GM-A3XN-01		de3f72da-05ed-4aeb-a82e-ca2263907159	
TCGA-GM-A4E0-01																													0	TCGA-GM-A4E0-01	2191	0										TCGA-GM-A4E0	2191	0	2191	Breast	TCGA Breast Cancer	breast invasive carcinoma					67	Left|Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-GM-A4E0-F47030		Positive					Positive	Modified Radical Mastectomy		YES			-24788	1871		0	2191							90-99%					2013-8-21	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	210	NO		Negative	NO	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	10	1	false	M0	N3a	T3	Stage IIIC	TCGA-GM-A4E0.DB0291E6-E371-40F8-BDB3-0F85F015B3DE.pdf		0		0		0		0		0		40		60		80	TUMOR FREE						YES	YES	No	90-99%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2007			TCGA-GM-A4E0-01A-12R-A25Z-13	TCGA-GM-A4E0-01A-12R-A25Z-13			TCGA-GM-A4E0-01A-12D-A25Q-09			da8c1ab5-7b67-4ebc-b854-cc45eaec8ee0	323df895-a6a9-4fd1-9aab-6ae770381071	TCGA-GM-A4E0-01A-12D-A25N-01	da8c1ab5-7b67-4ebc-b854-cc45eaec8ee0	TCGA-GM-A4E0-01A-12D-A268-05	TCGA-GM-A4E0-01		da8c1ab5-7b67-4ebc-b854-cc45eaec8ee0	da8c1ab5-7b67-4ebc-b854-cc45eaec8ee0	TCGA-GM-A4E0-01A-12D-A25N-01		TCGA-GM-A4E0-01		323df895-a6a9-4fd1-9aab-6ae770381071	
TCGA-GM-A5PV-01																													0	TCGA-GM-A5PV-01	412	0										TCGA-GM-A5PV	412	0	412	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Right	Sentinel lymph node biopsy plus axillary dissection				Positive					Positive	Modified Radical Mastectomy		NO			-23215	499		0	412							90-99%			2.70		2013-4-12	FEMALE						40	3.65	1.35		Infiltrating Lobular Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO		Negative		24	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1		false	M0	N1a	T2	Stage IIB	TCGA-GM-A5PV.A616A83A-8D19-4085-B430-1AF80D4F9642.pdf		0		0		0		0		75		10		15		65	TUMOR FREE						YES	YES	No	30-39%		NO	Primary Tumor	01		7th		NO	YES	GM	Breast	A	LIVING	2011			TCGA-GM-A5PV-01A-11R-A28I-13	TCGA-GM-A5PV-01A-11R-A28I-13			TCGA-GM-A5PV-01A-11D-A28B-09			96c1cfef-0507-46f5-a007-d0f7369cced5	0e4a3b1c-9795-4261-8a01-3e604d04422e	TCGA-GM-A5PV-01A-11D-A28A-01	96c1cfef-0507-46f5-a007-d0f7369cced5	TCGA-GM-A5PV-01A-11D-A28C-05	TCGA-GM-A5PV-01		96c1cfef-0507-46f5-a007-d0f7369cced5	96c1cfef-0507-46f5-a007-d0f7369cced5	TCGA-GM-A5PV-01A-11D-A28A-01		TCGA-GM-A5PV-01		0e4a3b1c-9795-4261-8a01-3e604d04422e	
TCGA-GM-A5PX-01																													0	TCGA-GM-A5PX-01	551	0										TCGA-GM-A5PX	551	0	551	Breast	TCGA Breast Cancer	breast invasive carcinoma					65	Left	Sentinel lymph node biopsy plus axillary dissection				Positive					Positive	Simple Mastectomy		YES			-23753	616		0	551							90-99%			1.78		2013-4-12	FEMALE			30-39%		1+	60	1.98			Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	110	NO	Negative	Negative		13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1	2	false	M0	N1mi	T2	Stage IIB	TCGA-GM-A5PX.E49FAC55-434A-429B-8E61-C5E0FBD7C15C.pdf		0		0		0		0		0		0		100		70	TUMOR FREE						YES	YES	No	90-99%		NO	Primary Tumor	01		7th		NO	YES	GM	Breast	A	LIVING	2011			TCGA-GM-A5PX-01A-12R-A28I-13	TCGA-GM-A5PX-01A-12R-A28I-13			TCGA-GM-A5PX-01A-12D-A28B-09			76f171dd-1980-4504-8dc2-d8c8264458c9	10c8c344-12f5-4c1d-860c-10ba59d82ce3	TCGA-GM-A5PX-01A-12D-A28A-01	76f171dd-1980-4504-8dc2-d8c8264458c9	TCGA-GM-A5PX-01A-12D-A28C-05	TCGA-GM-A5PX-01		76f171dd-1980-4504-8dc2-d8c8264458c9	76f171dd-1980-4504-8dc2-d8c8264458c9	TCGA-GM-A5PX-01A-12D-A28A-01		TCGA-GM-A5PX-01		10c8c344-12f5-4c1d-860c-10ba59d82ce3	
TCGA-HN-A2NL-01																			Basal										0	TCGA-HN-A2NL-01	79	0	Squamous	C4-BRCA/Basal		BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 1			TCGA-HN-A2NL	79	0	79	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-HN-A2NL-F60149		Negative					Negative	Simple Mastectomy		YES			-20483			0	79												2014-5-30	FEMALE										Other  specify	Infiltrating mammary carcinoma of no special type, with lobular features	No		C50.9	8500/3	C50.9		YES		Tumor resection	170	NO	Negative		YES	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	M0	N0	T2	Stage IIA	TCGA-HN-A2NL.CC1EE9E0-BC1A-46ED-A262-7A2B9CC8BBB1.pdf		3		1		1		1		0		19		80		80	TUMOR FREE						YES	YES	No				Primary Tumor	01		6th		NO	YES	HN	Breast	A	LIVING				TCGA-HN-A2NL-01A-11R-A18L-13	TCGA-HN-A2NL-01A-11R-A18L-13			TCGA-HN-A2NL-01A-11D-A18P-09	TCGA-HN-A2NL-01A-21-A24A-20		6593576c-a4a8-4284-8591-321f980f2e58	a5327c43-f90e-42b7-b76e-13602f606844	TCGA-HN-A2NL-01A-11D-A18N-01	6593576c-a4a8-4284-8591-321f980f2e58	TCGA-HN-A2NL-01A-11D-A18O-05	TCGA-HN-A2NL-01		6593576c-a4a8-4284-8591-321f980f2e58	6593576c-a4a8-4284-8591-321f980f2e58	TCGA-HN-A2NL-01A-11D-A18N-01		TCGA-HN-A2NL-01		a5327c43-f90e-42b7-b76e-13602f606844	
TCGA-HN-A2OB-01																													0	TCGA-HN-A2OB-01	1883	0										TCGA-HN-A2OB	1883	0	1883	Breast	TCGA Breast Cancer	breast invasive carcinoma					45	Right|Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-HN-A2OB-F65011		Positive					Positive	Simple Mastectomy		NO			-16672		1899	0	1883										1.7		2014-9-17	FEMALE						60	2.0	1.2		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Negative	Negative	NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	2			M0	N1	T2	Stage IIB																		WITH TUMOR						YES	YES	No			YES	Primary Tumor	01		6th		NO	YES	HN	Breast		LIVING				TCGA-HN-A2OB-01A-21R-A27U-13	TCGA-HN-A2OB-01A-21R-A27U-13			TCGA-HN-A2OB-01A-21D-A27P-09			f6aa5164-4438-4df2-9e5d-9dd8f5cdfd5e	b6a8307b-66fe-4aa1-aa5c-9cd0822c6d3f	TCGA-HN-A2OB-01A-21D-A27O-01	f6aa5164-4438-4df2-9e5d-9dd8f5cdfd5e		TCGA-HN-A2OB-01		f6aa5164-4438-4df2-9e5d-9dd8f5cdfd5e	f6aa5164-4438-4df2-9e5d-9dd8f5cdfd5e	TCGA-HN-A2OB-01A-21D-A27O-01		TCGA-HN-A2OB-01		b6a8307b-66fe-4aa1-aa5c-9cd0822c6d3f	
TCGA-JL-A3YW-01																													0	TCGA-JL-A3YW-01	360	0					BRCA basal-like c6					TCGA-JL-A3YW	360	0	360	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Left	Axillary lymph node dissection alone				Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy						312		0	360							30-39%					2012-11-8	FEMALE			30-39%		1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Tumor resection	400	NO	Positive			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	3	0	false	M0	N1	T2	Stage IIB	TCGA-JL-A3YW.476488A9-3708-4B11-854A-C91B583C7804.pdf		2		0		18		0		0		42		40		80							NO	YES	No	30-39%		NO	Primary Tumor	01		7th		YES	NO	JL	Breast	A	LIVING	2011			TCGA-JL-A3YW-01A-12R-A23A-13	TCGA-JL-A3YW-01A-12R-A23A-13			TCGA-JL-A3YW-01A-12D-A23C-09	TCGA-JL-A3YW-01A-21-A24B-20		a550da17-2d06-49ac-96dc-a2204298ddfb	0d134d64-ce0b-4b15-a56a-550830ab02e6	TCGA-JL-A3YW-01A-12D-A238-01	a550da17-2d06-49ac-96dc-a2204298ddfb	TCGA-JL-A3YW-01A-12D-A23D-05	TCGA-JL-A3YW-01		a550da17-2d06-49ac-96dc-a2204298ddfb	a550da17-2d06-49ac-96dc-a2204298ddfb	TCGA-JL-A3YW-01A-12D-A238-01		TCGA-JL-A3YW-01		0d134d64-ce0b-4b15-a56a-550830ab02e6	
TCGA-JL-A3YX-01																													0	TCGA-JL-A3YX-01	352	0					KIRC-like c1		miRNA cluster 4			TCGA-JL-A3YX	352	0	352	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Left	Axillary lymph node dissection alone				Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy								0	352							30-39%					2012-11-8	FEMALE			30-39%		3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Tumor resection			Positive			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0		M0	N0	T2	Stage IIA																								NO	YES	No	30-39%		NO	Primary Tumor	01		7th		YES	NO	JL	Breast		LIVING	2011			TCGA-JL-A3YX-01A-11R-A22V-13	TCGA-JL-A3YX-01A-11R-A22V-13			TCGA-JL-A3YX-01A-11D-A22X-09	TCGA-JL-A3YX-01A-21-A24B-20		b2b92b23-3f2a-4305-8c6c-27c91c67c072	bd5865c1-e787-42c6-94d7-456b97b866e8	TCGA-JL-A3YX-01A-11D-A22W-01	b2b92b23-3f2a-4305-8c6c-27c91c67c072	TCGA-JL-A3YX-01A-11D-A230-05	TCGA-JL-A3YX-01		b2b92b23-3f2a-4305-8c6c-27c91c67c072	b2b92b23-3f2a-4305-8c6c-27c91c67c072	TCGA-JL-A3YX-01A-11D-A22W-01		TCGA-JL-A3YX-01		bd5865c1-e787-42c6-94d7-456b97b866e8	
TCGA-LD-A66U-01																													0	TCGA-LD-A66U-01	422	0										TCGA-LD-A66U	422	0	422	Breast	TCGA Breast Cancer	breast invasive carcinoma					44	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-LD-A66U-F58445		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-16101			0	422							90-99%					2014-4-10	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy			Negative		NO	15	Negative																												NO	2			MX	N1mi	T2	Stage IIB																		TUMOR FREE						YES	YES	No	90-99%		YES	Primary Tumor	01		7th		YES	NO	LD	Breast		LIVING	2012			TCGA-LD-A66U-01A-11R-A31S-13	TCGA-LD-A66U-01A-11R-A31S-13						d37ab528-22b6-4b9e-b838-4d90f6d8bc14	f0f7b361-1498-4cff-8929-cf600a350ce8	TCGA-LD-A66U-01A-11D-A31T-01	d37ab528-22b6-4b9e-b838-4d90f6d8bc14	TCGA-LD-A66U-01A-11D-A31V-05	TCGA-LD-A66U-01		d37ab528-22b6-4b9e-b838-4d90f6d8bc14	d37ab528-22b6-4b9e-b838-4d90f6d8bc14	TCGA-LD-A66U-01A-11D-A31T-01		TCGA-LD-A66U-01		f0f7b361-1498-4cff-8929-cf600a350ce8	
TCGA-LD-A74U-01																													0	TCGA-LD-A74U-01	402	0										TCGA-LD-A74U	402	0	402	Breast	TCGA Breast Cancer	breast invasive carcinoma					79	Right	Axillary lymph node dissection alone		TCGA-LD-A74U-F69186		Positive	3 Point Scale		3 Point Scale		Negative	Lumpectomy					-28981	59		0	402							<10%					2014-12-30	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8524/3	C50.8	3+	YES		Core needle biopsy	210	NO	Negative		NO	12	Negative																												NO	11		true	M0	N3a	T3	Stage IIIC	TCGA-LD-A74U.CA6A13D4-DD80-4424-B5F3-654EE31263AE.pdf		40		20		0		20		0		40		60		60	WITH TUMOR						YES	YES	Yes	<10%		NO	Primary Tumor	01		7th		YES	NO	LD	Breast	A	LIVING	2013			TCGA-LD-A74U-01A-13R-A33A-13	TCGA-LD-A74U-01A-13R-A33A-13						11782f87-4d58-4897-9a61-7a4605c05eca	a7e1a7ba-762d-45b0-b084-118c6ed9690b	TCGA-LD-A74U-01A-13D-A33D-01	11782f87-4d58-4897-9a61-7a4605c05eca	TCGA-LD-A74U-01A-13D-A33F-05	TCGA-LD-A74U-01		11782f87-4d58-4897-9a61-7a4605c05eca	11782f87-4d58-4897-9a61-7a4605c05eca	TCGA-LD-A74U-01A-13D-A33D-01		TCGA-LD-A74U-01		a7e1a7ba-762d-45b0-b084-118c6ed9690b	
TCGA-LD-A7W5-01																													0	TCGA-LD-A7W5-01	216	0										TCGA-LD-A7W5	216	0	216	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-LD-A7W5-F69184		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		NO			-19169			0	216							90-99%					2014-12-30	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy			Negative		NO	23	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	23			M0	N3a	T2	Stage IIIC																		WITH TUMOR						YES	YES	No			NO	Primary Tumor	01		7th		YES	NO	LD	Breast		LIVING	2013			TCGA-LD-A7W5-01A-22R-A358-13	TCGA-LD-A7W5-01A-22R-A358-13						c83d9436-3f08-4197-9392-ff33fe4c632e	ac9fab7a-b830-4ebe-bd2c-939c812d7826	TCGA-LD-A7W5-01A-22D-A350-01	c83d9436-3f08-4197-9392-ff33fe4c632e	TCGA-LD-A7W5-01A-22D-A357-05	TCGA-LD-A7W5-01		c83d9436-3f08-4197-9392-ff33fe4c632e	c83d9436-3f08-4197-9392-ff33fe4c632e	TCGA-LD-A7W5-01A-22D-A350-01		TCGA-LD-A7W5-01		ac9fab7a-b830-4ebe-bd2c-939c812d7826	
TCGA-LD-A7W6-01																													0	TCGA-LD-A7W6-01	404	0										TCGA-LD-A7W6	404	0	404	Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Right|Right Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-LD-A7W6-F69193		Positive	3 Point Scale		3 Point Scale		Positive	Modified Radical Mastectomy		NO			-20077			0	404							90-99%					2014-12-30	FEMALE										Infiltrating Lobular Carcinoma		No			8524/3	C50.2	3+	YES		Core needle biopsy			Negative		NO	18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	2			M0	N1a	T2	Stage IIB																		TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		7th		YES	NO	LD	Breast		LIVING	2013			TCGA-LD-A7W6-01A-81R-A358-13	TCGA-LD-A7W6-01A-81R-A358-13						da8e08c7-6006-4e66-ae0f-7047177ca02a	b52a570c-9511-40f3-911e-de079cdbb1ec	TCGA-LD-A7W6-01A-81D-A350-01	da8e08c7-6006-4e66-ae0f-7047177ca02a	TCGA-LD-A7W6-01A-81D-A357-05	TCGA-LD-A7W6-01		da8e08c7-6006-4e66-ae0f-7047177ca02a	da8e08c7-6006-4e66-ae0f-7047177ca02a	TCGA-LD-A7W6-01A-81D-A350-01		TCGA-LD-A7W6-01		b52a570c-9511-40f3-911e-de079cdbb1ec	
TCGA-LD-A9QF-01																													0	TCGA-LD-A9QF-01	323	0										TCGA-LD-A9QF	323	0	323	Breast	TCGA Breast Cancer	breast invasive carcinoma					73	Left	Sentinel node biopsy alone		TCGA-LD-A9QF-F69216		Negative					Negative	Simple Mastectomy		YES			-26869			0	323												2014-12-30	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Positive		NO	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0			M0	N0	T1c	Stage IA																		TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		7th		YES	NO	LD	Breast		LIVING	2013			TCGA-LD-A9QF-01A-32R-A41G-13	TCGA-LD-A9QF-01A-32R-A41G-13						c2df60f6-40d5-4fe0-88f8-d168feb0d921	fccb2cd3-cb95-47ec-a684-91e3ba16faa9	TCGA-LD-A9QF-01A-32D-A41E-01	c2df60f6-40d5-4fe0-88f8-d168feb0d921	TCGA-LD-A9QF-01A-32D-A41Q-05	TCGA-LD-A9QF-01		c2df60f6-40d5-4fe0-88f8-d168feb0d921	c2df60f6-40d5-4fe0-88f8-d168feb0d921	TCGA-LD-A9QF-01A-32D-A41E-01		TCGA-LD-A9QF-01		fccb2cd3-cb95-47ec-a684-91e3ba16faa9	
TCGA-LL-A440-01																													0	TCGA-LL-A440-01	759	0										TCGA-LL-A440	759	0	759	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-LL-A440-F46387		Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		YES			-22497			0	759							90-99%			46		2013-8-7	FEMALE					2+	20	79	1.7		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy			Equivocal	Negative	NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0		MX	N0 (i-)	T1c	Stage IA																		TUMOR FREE						YES	YES	Yes	90-99%		NO	Primary Tumor	01		7th		YES	NO	LL	Breast		LIVING	2012			TCGA-LL-A440-01A-11R-A24J-13	TCGA-LL-A440-01A-11R-A24J-13			TCGA-LL-A440-01A-11D-A243-09			f34965fe-e7d5-48bd-b0a0-575cbd895c5a	c8bb9247-4dc5-487a-beba-19d8fa955c47	TCGA-LL-A440-01A-11D-A242-01	f34965fe-e7d5-48bd-b0a0-575cbd895c5a	TCGA-LL-A440-01A-11D-A244-05	TCGA-LL-A440-01		f34965fe-e7d5-48bd-b0a0-575cbd895c5a	f34965fe-e7d5-48bd-b0a0-575cbd895c5a	TCGA-LL-A440-01A-11D-A242-01		TCGA-LL-A440-01		c8bb9247-4dc5-487a-beba-19d8fa955c47	
TCGA-LL-A441-01																													0	TCGA-LL-A441-01	348	0										TCGA-LL-A441	348	0	348	Breast	TCGA Breast Cancer	breast invasive carcinoma					62	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-LL-A441-F46386		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		YES			-22772	37		0	348												2013-8-7	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	300	NO	Negative		NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0	T1c	Stage IA	TCGA-LL-A441.1FFDD2E3-02D5-4C38-B6E9-1261EB57835A.pdf		5		0		0		0		5		10		85		75	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2012			TCGA-LL-A441-01A-11R-A24J-13	TCGA-LL-A441-01A-11R-A24J-13			TCGA-LL-A441-01A-11D-A243-09			8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662	4588244d-e5f9-4cad-9915-1c6f4c0f887c	TCGA-LL-A441-01A-11D-A242-01	8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662	TCGA-LL-A441-01A-11D-A244-05	TCGA-LL-A441-01		8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662	8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662	TCGA-LL-A441-01A-11D-A242-01		TCGA-LL-A441-01		4588244d-e5f9-4cad-9915-1c6f4c0f887c	
TCGA-LL-A442-01																													0	TCGA-LL-A442-01	333	0										TCGA-LL-A442	333	0	333	Breast	TCGA Breast Cancer	breast invasive carcinoma					56	Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-LL-A442-F46384		Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		YES			-20495	60		0	333							90-99%			35		2013-8-7	FEMALE					2+	20	60	1.7		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	140	NO	Equivocal	Negative	NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0 (i-)	T2	Stage IIA	TCGA-LL-A442.389044F0-9D90-4639-8C42-C1A6EA816442.pdf		0		0		0		0		0		20		80		90	TUMOR FREE						YES	YES	Yes	90-99%		NO	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2012			TCGA-LL-A442-01A-11R-A24J-13	TCGA-LL-A442-01A-11R-A24J-13						7c355987-c70f-43f1-94cc-f4d12afe0132	765cb9f5-7c66-49fb-840b-7a85c9b7c64e	TCGA-LL-A442-01A-11D-A242-01	7c355987-c70f-43f1-94cc-f4d12afe0132	TCGA-LL-A442-01A-11D-A244-05	TCGA-LL-A442-01		7c355987-c70f-43f1-94cc-f4d12afe0132	7c355987-c70f-43f1-94cc-f4d12afe0132	TCGA-LL-A442-01A-11D-A242-01		TCGA-LL-A442-01		765cb9f5-7c66-49fb-840b-7a85c9b7c64e	
TCGA-LL-A50Y-01																													0	TCGA-LL-A50Y-01	762	0										TCGA-LL-A50Y	762	0	762	Breast	TCGA Breast Cancer	breast invasive carcinoma					84	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-LL-A50Y-F50406		Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		YES			-30934	91		0	762							90-99%			2.5		2013-10-23	FEMALE					2+	167	2.6	1.0		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	130	NO	Equivocal	Negative	NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0	T2	Stage IIA	TCGA-LL-A50Y.C3BD4B5F-0FB9-4B22-B8FE-9D689660B5E9.pdf		100		0		0		0		2		40		58		80	TUMOR FREE						YES	YES	Yes	90-99%		NO	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2012			TCGA-LL-A50Y-01A-11R-A25Z-13	TCGA-LL-A50Y-01A-11R-A25Z-13			TCGA-LL-A50Y-01A-11D-A25Q-09			02a65cb0-158c-478b-b72e-d6bae04429c7	1cfb1bb1-082b-4fda-a30a-ad5189c7602b	TCGA-LL-A50Y-01A-11D-A25N-01	02a65cb0-158c-478b-b72e-d6bae04429c7	TCGA-LL-A50Y-01A-11D-A268-05	TCGA-LL-A50Y-01		02a65cb0-158c-478b-b72e-d6bae04429c7	02a65cb0-158c-478b-b72e-d6bae04429c7	TCGA-LL-A50Y-01A-11D-A25N-01		TCGA-LL-A50Y-01		1cfb1bb1-082b-4fda-a30a-ad5189c7602b	
TCGA-LL-A5YL-01																													0	TCGA-LL-A5YL-01	519	0										TCGA-LL-A5YL	519	0	519	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Right|Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-LL-A5YL-F59650		Positive	3 Point Scale		3 Point Scale		Negative	Simple Mastectomy					-23395	84		0	519							90-99%			2.9		2014-5-19	FEMALE					3+	65	2.6	0.9		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4	3+	YES		Core needle biopsy	570	NO	Positive	Negative	NO	23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	3	0	false	MX	N1a	T2	Stage IIB	TCGA-LL-A5YL.17B51CA5-E325-4EA0-AFED-C6D0FD5A40EF.pdf		0		0		0		0		30		0		70		60							YES	YES	No	<10%		YES	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2012			TCGA-LL-A5YL-01A-12R-A29V-13	TCGA-LL-A5YL-01A-12R-A29V-13			TCGA-LL-A5YL-01A-12D-A29N-09			979d9841-337c-47a3-acaf-77d45e276589	59f1a99c-e061-4ef5-97be-6edaa58239d9	TCGA-LL-A5YL-01A-12D-A29M-01	979d9841-337c-47a3-acaf-77d45e276589	TCGA-LL-A5YL-01A-12D-A29O-05	TCGA-LL-A5YL-01		979d9841-337c-47a3-acaf-77d45e276589	979d9841-337c-47a3-acaf-77d45e276589	TCGA-LL-A5YL-01A-12D-A29M-01		TCGA-LL-A5YL-01		59f1a99c-e061-4ef5-97be-6edaa58239d9	
TCGA-LL-A5YM-01																													0	TCGA-LL-A5YM-01	466	0										TCGA-LL-A5YM	258	1	466	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	YES			88	Left|Left Upper Inner Quadrant	No axillary staging		TCGA-LL-A5YM-F57541	Negative	Positive	3 Point Scale	3+	3 Point Scale	Mastectomy NOS	Positive	Other					-32478	131		0	466		258	258				90-99%			54		2014-3-14	FEMALE					2+	20	172	3.2		Infiltrating Ductal Carcinoma		No		C50.9	8541/3	C50.1	3+	YES		Core needle biopsy	280	NO	Equivocal	Positive	NO		Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																							Other, specify	Locoregional Recurrence	Skin left chest wall	YES	YES			false	M0	NX	T4b	Stage IIIB	TCGA-LL-A5YM.B169A5B5-27CD-48A6-A8D7-C14D3824A20A.pdf		0		0		0		0		0		10		90		90	WITH TUMOR						NO	NO	No	90-99%		NO	Primary Tumor	01	partial mastectomy	7th		YES	NO	LL	Breast	A	LIVING	2012			TCGA-LL-A5YM-01A-11R-A28I-13	TCGA-LL-A5YM-01A-11R-A28I-13			TCGA-LL-A5YM-01A-11D-A28B-09			02a7b2f2-7ae3-426c-9ec5-cdb5ffcaaaa6	7de0d9d1-8ff8-4bc3-a4b0-a10092804380	TCGA-LL-A5YM-01A-11D-A28A-01	02a7b2f2-7ae3-426c-9ec5-cdb5ffcaaaa6	TCGA-LL-A5YM-01A-11D-A28C-05	TCGA-LL-A5YM-01		02a7b2f2-7ae3-426c-9ec5-cdb5ffcaaaa6	02a7b2f2-7ae3-426c-9ec5-cdb5ffcaaaa6	TCGA-LL-A5YM-01A-11D-A28A-01		TCGA-LL-A5YM-01		7de0d9d1-8ff8-4bc3-a4b0-a10092804380	
TCGA-LL-A5YN-01																													0	TCGA-LL-A5YN-01	447	0										TCGA-LL-A5YN	447	0	447	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Right|Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-LL-A5YN-F59362		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		NO			-16884	41		0	447							90-99%			54		2014-5-9	FEMALE					2+	20	172	3.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	230	NO	Equivocal	Positive	NO	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	M0	N0 (i-)	T2	Stage IIA	TCGA-LL-A5YN.4D4811FB-5BF1-4574-975B-1740602E43D8.pdf		0		0		0		0		20		0		80		70	TUMOR FREE						YES	YES	No	90-99%		YES	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2013			TCGA-LL-A5YN-01A-11R-A28I-13	TCGA-LL-A5YN-01A-11R-A28I-13			TCGA-LL-A5YN-01A-11D-A28B-09			844d9d2c-4467-415f-b66d-a4c35c818310	75bea157-67fe-4ded-a3a5-d8c1b05aee78	TCGA-LL-A5YN-01A-11D-A28A-01	844d9d2c-4467-415f-b66d-a4c35c818310	TCGA-LL-A5YN-01A-11D-A28C-05	TCGA-LL-A5YN-01		844d9d2c-4467-415f-b66d-a4c35c818310	844d9d2c-4467-415f-b66d-a4c35c818310	TCGA-LL-A5YN-01A-11D-A28A-01		TCGA-LL-A5YN-01		75bea157-67fe-4ded-a3a5-d8c1b05aee78	
TCGA-LL-A5YO-01																													0	TCGA-LL-A5YO-01	440	0										TCGA-LL-A5YO	440	0	440	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-LL-A5YO-F58638		Negative					Negative	Lumpectomy		YES			-18354	47		0	440												2014-4-17	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	260	NO	Negative		NO	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0	0	false	MX	N0	T1b	Stage IA	TCGA-LL-A5YO.C5C5D704-2558-4D4B-937B-33BD91132882.pdf		0		0		0		0		0		0		100		65	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2013			TCGA-LL-A5YO-01A-21R-A28I-13	TCGA-LL-A5YO-01A-21R-A28I-13			TCGA-LL-A5YO-01A-21D-A28B-09			4b5b44ea-8589-4aea-a69f-b5d5041b1acd	51c263b0-32eb-49fe-b7ed-7de6b0a94c33	TCGA-LL-A5YO-01A-21D-A28A-01	4b5b44ea-8589-4aea-a69f-b5d5041b1acd	TCGA-LL-A5YO-01A-21D-A28C-05	TCGA-LL-A5YO-01		4b5b44ea-8589-4aea-a69f-b5d5041b1acd	4b5b44ea-8589-4aea-a69f-b5d5041b1acd	TCGA-LL-A5YO-01A-21D-A28A-01		TCGA-LL-A5YO-01		51c263b0-32eb-49fe-b7ed-7de6b0a94c33	
TCGA-LL-A5YP-01																													0	TCGA-LL-A5YP-01	450	0										TCGA-LL-A5YP	450	0	450	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Right|Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-LL-A5YP-F59323		Positive	3 Point Scale		3 Point Scale		Negative	Modified Radical Mastectomy		NO			-18041	29		0	450							<10%			35		2014-5-8	FEMALE			<10%		1+	20	118	3.4		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	490	NO	Negative	Positive	NO	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	2		false	M0	N1a	T2	Stage IIB	TCGA-LL-A5YP.B6B4DCFE-F044-44D6-BB90-EF71E6981E82.pdf		0		0		5		0		0		0		95		75							YES	YES	Yes	<10%		YES	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2013			TCGA-LL-A5YP-01A-21R-A28I-13	TCGA-LL-A5YP-01A-21R-A28I-13			TCGA-LL-A5YP-01A-21D-A28B-09			5cc1fd95-8c43-4d40-9e50-fe9f65ee9f1c	de637c67-c60e-4b6f-99cf-0bcef33204cc	TCGA-LL-A5YP-01A-21D-A28A-01	5cc1fd95-8c43-4d40-9e50-fe9f65ee9f1c	TCGA-LL-A5YP-01A-21D-A28C-05	TCGA-LL-A5YP-01		5cc1fd95-8c43-4d40-9e50-fe9f65ee9f1c	5cc1fd95-8c43-4d40-9e50-fe9f65ee9f1c	TCGA-LL-A5YP-01A-21D-A28A-01		TCGA-LL-A5YP-01		de637c67-c60e-4b6f-99cf-0bcef33204cc	
TCGA-LL-A6FP-01																													0	TCGA-LL-A6FP-01	677	0										TCGA-LL-A6FP	677	0	677	Breast	TCGA Breast Cancer	breast invasive carcinoma					90	Right Upper Outer Quadrant	No axillary staging		TCGA-LL-A6FP-F64050		Positive	3 Point Scale	1+	3 Point Scale		Positive	Simple Mastectomy		NO			-32873	259		0	677							90-99%			3.1		2014-8-25	FEMALE					2+	549	2.6	0.9		Infiltrating Lobular Carcinoma		Yes		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	500	NO	Equivocal	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO			false	MX	NX	T2	Stage IIA	TCGA-LL-A6FP.D318A0F0-38B2-4DFA-8326-E362603AAC5E.pdf		3		1		0		1		0		20		80		80	TUMOR FREE						YES	NO	No	20-29%		NO	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2012			TCGA-LL-A6FP-01A-11R-A31S-13	TCGA-LL-A6FP-01A-11R-A31S-13						b7cbb41f-b7ba-4bc7-8b6a-ce93317495b1	23353deb-8af1-474e-8654-70d444529e5e	TCGA-LL-A6FP-01A-11D-A31T-01	b7cbb41f-b7ba-4bc7-8b6a-ce93317495b1	TCGA-LL-A6FP-01A-11D-A31V-05	TCGA-LL-A6FP-01		b7cbb41f-b7ba-4bc7-8b6a-ce93317495b1	b7cbb41f-b7ba-4bc7-8b6a-ce93317495b1	TCGA-LL-A6FP-01A-11D-A31T-01		TCGA-LL-A6FP-01		23353deb-8af1-474e-8654-70d444529e5e	
TCGA-LL-A6FQ-01																													0	TCGA-LL-A6FQ-01	80	0										TCGA-LL-A6FQ			80	Breast	TCGA Breast Cancer	breast invasive carcinoma					77	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-LL-A6FQ-F58204		Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		YES			-28375			0	80							90-99%					2014-4-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4	3+	YES		Core needle biopsy			Negative		YES	18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												7	0		MX	N2a	T2	Stage IIIA																								NO	YES	No	80-89%		NO	Primary Tumor	01		7th		YES	NO	LL	Breast		LIVING	2013			TCGA-LL-A6FQ-01A-11R-A31S-13	TCGA-LL-A6FQ-01A-11R-A31S-13						d490ceb7-e3b2-44ee-8c46-923cbd4374dd	ae249200-498e-4044-9aa2-fa9b8c3daa7e	TCGA-LL-A6FQ-01A-11D-A31T-01	d490ceb7-e3b2-44ee-8c46-923cbd4374dd	TCGA-LL-A6FQ-01A-11D-A31V-05	TCGA-LL-A6FQ-01		d490ceb7-e3b2-44ee-8c46-923cbd4374dd	d490ceb7-e3b2-44ee-8c46-923cbd4374dd	TCGA-LL-A6FQ-01A-11D-A31T-01		TCGA-LL-A6FQ-01		ae249200-498e-4044-9aa2-fa9b8c3daa7e	
TCGA-LL-A6FR-01																													0	TCGA-LL-A6FR-01	489	0										TCGA-LL-A6FR	489	0	489	Breast	TCGA Breast Cancer	breast invasive carcinoma					50	Right|Right Lower Inner Quadrant	Sentinel node biopsy alone		TCGA-LL-A6FR-F64045		Negative		1+	3 Point Scale		Positive	Lumpectomy		YES			-18520	30		0	489												2014-8-25	FEMALE					2+	20		2.7		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	250	NO	Equivocal	Positive	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0 (i-)	T2	Stage IIA	TCGA-LL-A6FR.B18B184D-B7F1-4C4D-8DA2-D5ECF49749F6.pdf		2		1		0		4		0		25		75		75	TUMOR FREE						YES	YES	No	<10%		YES	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2013			TCGA-LL-A6FR-01A-12R-A31S-13	TCGA-LL-A6FR-01A-12R-A31S-13						1cefed42-1e09-4bff-b323-55faeaee18e1	380ab3e1-4711-4b6b-9914-8e826c2d58c0	TCGA-LL-A6FR-01A-12D-A31T-01	1cefed42-1e09-4bff-b323-55faeaee18e1	TCGA-LL-A6FR-01A-12D-A31V-05	TCGA-LL-A6FR-01		1cefed42-1e09-4bff-b323-55faeaee18e1	1cefed42-1e09-4bff-b323-55faeaee18e1	TCGA-LL-A6FR-01A-12D-A31T-01		TCGA-LL-A6FR-01		380ab3e1-4711-4b6b-9914-8e826c2d58c0	
TCGA-LL-A73Y-01																													0	TCGA-LL-A73Y-01	477	0										TCGA-LL-A73Y	477	0	477	Breast	TCGA Breast Cancer	breast invasive carcinoma					67	Right|Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-LL-A73Y-F67099		Negative	3 Point Scale	3+	3 Point Scale		Negative	Simple Mastectomy		NO			-24647	55		0	477												2014-10-30	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	60	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0	T1c	Stage IA	TCGA-LL-A73Y.9A8F7726-D97C-44DE-B72F-6BF0FC2078F8.pdf		40		20		0		20		0		20		80		80	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2013			TCGA-LL-A73Y-01A-11R-A33A-13	TCGA-LL-A73Y-01A-11R-A33A-13						535ab8cf-47a9-4541-b3ef-223bba76a13e	8e13bd29-de53-4cb0-991f-7ae7460cb548	TCGA-LL-A73Y-01A-11D-A33D-01	535ab8cf-47a9-4541-b3ef-223bba76a13e	TCGA-LL-A73Y-01A-11D-A33F-05	TCGA-LL-A73Y-01		535ab8cf-47a9-4541-b3ef-223bba76a13e	535ab8cf-47a9-4541-b3ef-223bba76a13e	TCGA-LL-A73Y-01A-11D-A33D-01		TCGA-LL-A73Y-01		8e13bd29-de53-4cb0-991f-7ae7460cb548	
TCGA-LL-A73Z-01																													1	TCGA-LL-A73Z-01	227	1										TCGA-LL-A73Z	192	1	227	Breast	TCGA Breast Cancer	breast invasive carcinoma	NO	NO			55	Left|Left Lower Inner Quadrant	No axillary staging		TCGA-LL-A73Z-F64983		Positive	3 Point Scale	1+	3 Point Scale		Positive	Lumpectomy		NO			-20118	40	227	0	137			192				10-19%	Other, specify	skin	2.2		2014-9-16	FEMALE					2+	243	2.5	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Excisional Biopsy	240	NO	Equivocal	Negative	NO		Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																							Brain	Distant Metastasis		NO	YES			false	M1	NX	T1c	Stage IV	TCGA-LL-A73Z.D9FE314C-61F4-4E4D-BB29-4B681C2A8A10.pdf		40		20		10		20		0		20		70		70	WITH TUMOR						YES	NO	No	<10%		YES	Primary Tumor	01		7th		YES	NO	LL	Breast	A	DECEASED	2013			TCGA-LL-A73Z-01A-11R-A32K-13	TCGA-LL-A73Z-01A-11R-A32K-13						9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126	5e1d2320-02a9-4d5b-89b6-d5a95eb774b8	TCGA-LL-A73Z-01A-11D-A32H-01	9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126	TCGA-LL-A73Z-01A-11D-A32T-05	TCGA-LL-A73Z-01		9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126	9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126	TCGA-LL-A73Z-01A-11D-A32H-01		TCGA-LL-A73Z-01		5e1d2320-02a9-4d5b-89b6-d5a95eb774b8	
TCGA-LL-A740-01																													0	TCGA-LL-A740-01	441	0										TCGA-LL-A740	441	0	441	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-LL-A740-F65059		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		YES			-22416	37		0	441										2.9		2014-9-18	FEMALE					2+	113	3.3	1.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	410	NO	Equivocal	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0 (i-)	T1c	Stage IA	TCGA-LL-A740.3AD4AA3C-5F68-43D1-B578-07AB574D4DE3.pdf		40		20		0		20		0		40		60		60	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2013			TCGA-LL-A740-01A-21R-A32K-13	TCGA-LL-A740-01A-21R-A32K-13						9014d9c4-ab6b-4318-9b07-c00266d9f5a9	02600c52-6742-4d06-b417-16694f0c026b	TCGA-LL-A740-01A-21D-A32H-01	9014d9c4-ab6b-4318-9b07-c00266d9f5a9	TCGA-LL-A740-01A-21D-A32T-05	TCGA-LL-A740-01		9014d9c4-ab6b-4318-9b07-c00266d9f5a9	9014d9c4-ab6b-4318-9b07-c00266d9f5a9	TCGA-LL-A740-01A-21D-A32H-01		TCGA-LL-A740-01		02600c52-6742-4d06-b417-16694f0c026b	
TCGA-LL-A7SZ-01																													0	TCGA-LL-A7SZ-01	447	0										TCGA-LL-A7SZ	447	0	447	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-LL-A7SZ-F66973		Positive	3 Point Scale	2+	3 Point Scale		Positive	Other		YES			-18161	63		0	447							90-99%					2014-10-29	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4	2+	YES		Core needle biopsy	240	NO	Negative		NO	11	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	2	0	false	MX	N1a	T2	Stage IIB	TCGA-LL-A7SZ.3FA5FACA-8A6B-4F42-A557-3B69866859E7.pdf		0		0		0		0		50		0		50		70	TUMOR FREE						YES	YES	No	90-99%		YES	Primary Tumor	01	SKIN SPARING RADICAL MASTECTOMY	7th		YES	NO	LL	Breast	A	LIVING	2013			TCGA-LL-A7SZ-01A-32R-A358-13	TCGA-LL-A7SZ-01A-32R-A358-13						e256282c-da2c-4272-a94b-14cf44da6178	9dca3383-62e0-4375-a816-2e4f257f714e	TCGA-LL-A7SZ-01A-32D-A350-01	e256282c-da2c-4272-a94b-14cf44da6178	TCGA-LL-A7SZ-01A-32D-A357-05	TCGA-LL-A7SZ-01		e256282c-da2c-4272-a94b-14cf44da6178	e256282c-da2c-4272-a94b-14cf44da6178	TCGA-LL-A7SZ-01A-32D-A350-01		TCGA-LL-A7SZ-01		9dca3383-62e0-4375-a816-2e4f257f714e	
TCGA-LL-A7T0-01																													0	TCGA-LL-A7T0-01	376	0										TCGA-LL-A7T0	376	0	376	Breast	TCGA Breast Cancer	breast invasive carcinoma					70	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-LL-A7T0-F64970		Positive	3 Point Scale	1+	3 Point Scale		Positive	Simple Mastectomy		NO			-25867	70		0	376							90-99%					2014-9-16	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1	3+	YES		Tumor resection	380	NO	Positive		NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1		false	M0	N1a	T2	Stage IIB	TCGA-LL-A7T0.5540DD9C-FA3F-48B6-8243-414616816A76.pdf		0		0		0		0		25		10		65		60	TUMOR FREE						NO	YES	No	<10%		NO	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2013			TCGA-LL-A7T0-01A-31R-A358-13	TCGA-LL-A7T0-01A-31R-A358-13						67e967d6-be17-4fe1-a1fb-197655fad18d	9432254f-7c2d-4b93-adc6-8c360c0e2e20	TCGA-LL-A7T0-01A-31D-A350-01	67e967d6-be17-4fe1-a1fb-197655fad18d	TCGA-LL-A7T0-01A-31D-A357-05	TCGA-LL-A7T0-01		67e967d6-be17-4fe1-a1fb-197655fad18d	67e967d6-be17-4fe1-a1fb-197655fad18d	TCGA-LL-A7T0-01A-31D-A350-01		TCGA-LL-A7T0-01		9432254f-7c2d-4b93-adc6-8c360c0e2e20	
TCGA-LL-A8F5-01																													0	TCGA-LL-A8F5-01	448	0										TCGA-LL-A8F5	448	0	448	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Right|Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-LL-A8F5-F66965		Positive	3 Point Scale		3 Point Scale		Negative	Lumpectomy		YES			-22544	78		0	448							20-29%					2014-10-29	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Core needle biopsy	230	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0 (i-)	T2	Stage IIA	TCGA-LL-A8F5.79A10C4B-1B5F-47BB-99EA-E694FB341696.pdf		40		20		0		20		0		20		80		80	TUMOR FREE						YES	YES	No	<10%		YES	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2013			TCGA-LL-A8F5-01A-11R-A36A-13	TCGA-LL-A8F5-01A-11R-A36A-13						3cc7e12e-2bc8-494c-b74a-de071d711410	b9fdf03c-d0d2-4b11-bbe6-f6996d403e90	TCGA-LL-A8F5-01A-11D-A36I-01	3cc7e12e-2bc8-494c-b74a-de071d711410	TCGA-LL-A8F5-01A-11D-A36K-05	TCGA-LL-A8F5-01		3cc7e12e-2bc8-494c-b74a-de071d711410	3cc7e12e-2bc8-494c-b74a-de071d711410	TCGA-LL-A8F5-01A-11D-A36I-01		TCGA-LL-A8F5-01		b9fdf03c-d0d2-4b11-bbe6-f6996d403e90	
TCGA-LL-A9Q3-01																													0	TCGA-LL-A9Q3-01	428	0										TCGA-LL-A9Q3	428	0	428	Breast	TCGA Breast Cancer	breast invasive carcinoma					69	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-LL-A9Q3-F67103		Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		YES			-25477	80		0	428							90-99%					2014-10-30	FEMALE					3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	610	NO	Positive		NO	28	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	28	0	false	MX	N3a	T3	Stage IIIC	TCGA-LL-A9Q3.2697F2B6-725C-438F-B4D3-3E32DEF86FD6.pdf		70		10		0		10		0		20		80		80	TUMOR FREE						YES	YES	No	<10%		YES	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2013			TCGA-LL-A9Q3-01A-11R-A41G-13	TCGA-LL-A9Q3-01A-11R-A41G-13						0aad6d2a-1699-4403-8d45-f0b315ec89c7	56fb1d49-78c7-4965-9a17-a90a2c1a9b95	TCGA-LL-A9Q3-01A-11D-A41E-01	0aad6d2a-1699-4403-8d45-f0b315ec89c7	TCGA-LL-A9Q3-01A-11D-A41Q-05	TCGA-LL-A9Q3-01		0aad6d2a-1699-4403-8d45-f0b315ec89c7	0aad6d2a-1699-4403-8d45-f0b315ec89c7	TCGA-LL-A9Q3-01A-11D-A41E-01		TCGA-LL-A9Q3-01		56fb1d49-78c7-4965-9a17-a90a2c1a9b95	
TCGA-LQ-A4E4-01																													0	TCGA-LQ-A4E4-01	849	0										TCGA-LQ-A4E4	681	1	849	Breast	TCGA Breast Cancer	breast invasive carcinoma	YES	YES			73	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-LQ-A4E4-F52290		Positive	3 Point Scale	1+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-26883	414		0	849			681				90-99%			1.1		2013-12-2	FEMALE						60	1.1	1.05		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	1+	YES		Core needle biopsy	200	NO		Negative	NO	26	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)					Positive												Negative						Bone	Distant Metastasis		NO	YES	3	0	true	MX	N1a	T3	Stage IIIA	TCGA-LQ-A4E4.C13D16C9-BAC7-4CA4-B062-D925466F9E2B.pdf		1		0		0		0		0		0		100		85	WITH TUMOR						YES	YES	No	90-99%		YES	Primary Tumor	01		7th		NO	YES	LQ	Breast	A	LIVING	2011			TCGA-LQ-A4E4-01A-11R-A25Z-13	TCGA-LQ-A4E4-01A-11R-A25Z-13			TCGA-LQ-A4E4-01A-11D-A25Q-09			5965fc49-0ee5-41d8-b673-9ade5c70db71	77cf9295-680b-433c-98b6-022747c28474	TCGA-LQ-A4E4-01A-11D-A25N-01	5965fc49-0ee5-41d8-b673-9ade5c70db71	TCGA-LQ-A4E4-01A-11D-A268-05	TCGA-LQ-A4E4-01		5965fc49-0ee5-41d8-b673-9ade5c70db71	5965fc49-0ee5-41d8-b673-9ade5c70db71	TCGA-LQ-A4E4-01A-11D-A25N-01		TCGA-LQ-A4E4-01		77cf9295-680b-433c-98b6-022747c28474	
TCGA-MS-A51U-01																													0	TCGA-MS-A51U-01	85	0										TCGA-MS-A51U			85	Breast	TCGA Breast Cancer	breast invasive carcinoma					44	Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left					Positive					Positive	Modified Radical Mastectomy					-16213			0	85					NO		90-99%					2012-9-12	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES					Negative	Negative		18	Negative																													2			M0	N1	T2	Stage IIB																		WITH TUMOR							YES	No	20-29%			Primary Tumor	01		7th		YES	NO	MS	Breast		LIVING	2012			TCGA-MS-A51U-01A-31R-A25Z-13	TCGA-MS-A51U-01A-31R-A25Z-13			TCGA-MS-A51U-01A-31D-A25Q-09			b41dfa6b-a221-4e03-95d7-428781787067	d220df14-d382-4b98-9c10-1df8c28808e1	TCGA-MS-A51U-01A-31D-A25N-01	b41dfa6b-a221-4e03-95d7-428781787067	TCGA-MS-A51U-01A-31D-A268-05	TCGA-MS-A51U-01		b41dfa6b-a221-4e03-95d7-428781787067	b41dfa6b-a221-4e03-95d7-428781787067	TCGA-MS-A51U-01A-31D-A25N-01		TCGA-MS-A51U-01		d220df14-d382-4b98-9c10-1df8c28808e1	
TCGA-OK-A5Q2-01																													0	TCGA-OK-A5Q2-01	64	0										TCGA-OK-A5Q2	64	0	64	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Right	Axillary lymph node dissection alone				Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		YES			-21555	149		0	64							90-99%					2013-1-22	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4	3+	YES			20	NO	Negative			13	Negative																												NO	2	2	false	MX	N1a	T2	Stage II	TCGA-OK-A5Q2.8F2F2141-EC62-4321-B799-054D32FEBA87.pdf		2		0		0		0		0		0		100		60								YES	No	20-29%			Primary Tumor	01		7th		YES	NO	OK	Breast	A	LIVING	2012			TCGA-OK-A5Q2-01A-11R-A27U-13	TCGA-OK-A5Q2-01A-11R-A27U-13			TCGA-OK-A5Q2-01A-11D-A27P-09			b835c127-4f06-4870-a0a4-7f95be0260a4	8141d561-b148-446e-b500-566f1a2cd075	TCGA-OK-A5Q2-01A-11D-A27O-01	b835c127-4f06-4870-a0a4-7f95be0260a4		TCGA-OK-A5Q2-01		b835c127-4f06-4870-a0a4-7f95be0260a4	b835c127-4f06-4870-a0a4-7f95be0260a4	TCGA-OK-A5Q2-01A-11D-A27O-01		TCGA-OK-A5Q2-01		8141d561-b148-446e-b500-566f1a2cd075	
TCGA-OL-A5D6-01																													1	TCGA-OL-A5D6-01	1104	1										TCGA-OL-A5D6	1104	0	1104	Breast	TCGA Breast Cancer	breast invasive carcinoma					71	Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-OL-A5D6-F55437		Negative					Negative	Simple Mastectomy					-26052	1378	1104	0	385												2014-1-10	FEMALE								1.13		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	200	NO		Negative	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO		0	true	MX	N0	T2	Stage IIA	TCGA-OL-A5D6.AD80BBA3-DA8E-4DFB-BDA1-FFDC131E9740.pdf		0		0		0		0		0		0		100		80	TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		6th		NO	YES	OL	Breast	A	DECEASED	2009			TCGA-OL-A5D6-01A-21R-A27U-13	TCGA-OL-A5D6-01A-21R-A27U-13			TCGA-OL-A5D6-01A-21D-A27P-09			5657c6b6-ba04-4dd8-8623-2a3834820f7d	5e5b667c-4179-45ba-882c-21d35684ae1a	TCGA-OL-A5D6-01A-21D-A27O-01	5657c6b6-ba04-4dd8-8623-2a3834820f7d		TCGA-OL-A5D6-01		5657c6b6-ba04-4dd8-8623-2a3834820f7d	5657c6b6-ba04-4dd8-8623-2a3834820f7d	TCGA-OL-A5D6-01A-21D-A27O-01		TCGA-OL-A5D6-01		5e5b667c-4179-45ba-882c-21d35684ae1a	
TCGA-OL-A5D7-01																													0	TCGA-OL-A5D7-01	1780	0										TCGA-OL-A5D7	1780	0	1780	Breast	TCGA Breast Cancer	breast invasive carcinoma					70	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-OL-A5D7-F55439		Negative					Negative	Lumpectomy					-25643	1415		0	1780												2014-1-10	FEMALE								1.36		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	370	NO		Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO		0	true	MX	N0	T2	Stage IIA	TCGA-OL-A5D7.A8980EE8-52DE-4DA5-84DD-F8E86EBF6A9B.pdf		0		0		10		0		0		0		90		85	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		6th		NO	YES	OL	Breast	A	LIVING	2009			TCGA-OL-A5D7-01A-11R-A27U-13	TCGA-OL-A5D7-01A-11R-A27U-13			TCGA-OL-A5D7-01A-11D-A27P-09			a9f404db-e7fa-49bf-acca-fccd676f2e7c	589febe7-e680-4541-b582-d8eeade0625d	TCGA-OL-A5D7-01A-11D-A27O-01	a9f404db-e7fa-49bf-acca-fccd676f2e7c		TCGA-OL-A5D7-01		a9f404db-e7fa-49bf-acca-fccd676f2e7c	a9f404db-e7fa-49bf-acca-fccd676f2e7c	TCGA-OL-A5D7-01A-11D-A27O-01		TCGA-OL-A5D7-01		589febe7-e680-4541-b582-d8eeade0625d	
TCGA-OL-A5D8-01																													0	TCGA-OL-A5D8-01	973	0										TCGA-OL-A5D8	973	0	973	Breast	TCGA Breast Cancer	breast invasive carcinoma					40	Left Lower Outer Quadrant	Other (specify)	axillary ultrasound	TCGA-OL-A5D8-F55438		Positive					Positive	Simple Mastectomy		NO			-14853	1357		0	973							90-99%			2.25		2014-1-10	FEMALE						20	2	0.8		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.8		YES		Core needle biopsy	370	NO		Negative	NO	2		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO			true	MX	N0	T3	Stage IIB	TCGA-OL-A5D8.FD496AFB-43EF-41D8-850F-E57DD53C185C.pdf		0		0		0		0		0		0		100		90	TUMOR FREE						YES	YES	No	90-99%		YES	Primary Tumor	01		6th		NO	YES	OL	Breast	A	LIVING	2009			TCGA-OL-A5D8-01A-11R-A27U-13	TCGA-OL-A5D8-01A-11R-A27U-13			TCGA-OL-A5D8-01A-11D-A27P-09			8c435d42-a76a-4078-a593-6a41a2bb6f5e	666c158e-0a58-493a-8f2d-39f81778957f	TCGA-OL-A5D8-01A-11D-A27O-01	8c435d42-a76a-4078-a593-6a41a2bb6f5e		TCGA-OL-A5D8-01		8c435d42-a76a-4078-a593-6a41a2bb6f5e	8c435d42-a76a-4078-a593-6a41a2bb6f5e	TCGA-OL-A5D8-01A-11D-A27O-01		TCGA-OL-A5D8-01		666c158e-0a58-493a-8f2d-39f81778957f	
TCGA-OL-A5DA-01																													0	TCGA-OL-A5DA-01	1783	0										TCGA-OL-A5DA	1783	0	1783	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-OL-A5DA-F55440		Positive					Positive	Other					-22411			0	1783							60-69%					2014-1-10	FEMALE	1									Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES	Ultrasound-guided mammotome biopsy	Other method, specify:				Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO		0		MX	N0	T2	Stage IIA																		TUMOR FREE						NO	YES	No	60-69%		NO	Primary Tumor	01	partial mastectomy	6th		NO	YES	OL	Breast		LIVING	2009			TCGA-OL-A5DA-01A-11R-A27U-13	TCGA-OL-A5DA-01A-11R-A27U-13			TCGA-OL-A5DA-01A-11D-A27P-09			b881706f-5ee8-43da-a691-53c036d94494	f1dacc81-2040-4772-94d3-0bc349ab567c	TCGA-OL-A5DA-01A-11D-A27O-01	b881706f-5ee8-43da-a691-53c036d94494		TCGA-OL-A5DA-01		b881706f-5ee8-43da-a691-53c036d94494	b881706f-5ee8-43da-a691-53c036d94494	TCGA-OL-A5DA-01A-11D-A27O-01		TCGA-OL-A5DA-01		f1dacc81-2040-4772-94d3-0bc349ab567c	
TCGA-OL-A5RU-01																													0	TCGA-OL-A5RU-01	1219	0										TCGA-OL-A5RU	1219	0	1219	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-OL-A5RU-F56569		Positive					Positive	Modified Radical Mastectomy					-23108	826		0	1219							90-99%					2014-2-14	FEMALE								1.02		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	430	NO		Negative	NO	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1		true	MX	N1	T1c	Stage IIA	TCGA-OL-A5RU.7507AC79-4C8E-4393-92B9-BFA6BEB492D0.pdf		10		2		3		0		2		65		30		65	TUMOR FREE						YES	YES	No	80-89%		YES	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2010			TCGA-OL-A5RU-01A-11R-A28I-13	TCGA-OL-A5RU-01A-11R-A28I-13			TCGA-OL-A5RU-01A-11D-A28B-09			02873204-1097-45ea-b143-a97f3e047537	fbdb3e72-fa98-48f6-be78-a112b93de1d4	TCGA-OL-A5RU-01A-11D-A28A-01	02873204-1097-45ea-b143-a97f3e047537	TCGA-OL-A5RU-01A-11D-A28C-05	TCGA-OL-A5RU-01		02873204-1097-45ea-b143-a97f3e047537	02873204-1097-45ea-b143-a97f3e047537	TCGA-OL-A5RU-01A-11D-A28A-01		TCGA-OL-A5RU-01		fbdb3e72-fa98-48f6-be78-a112b93de1d4	
TCGA-OL-A5RV-01																													0	TCGA-OL-A5RV-01	1062	0										TCGA-OL-A5RV	1062	0	1062	Breast	TCGA Breast Cancer	breast invasive carcinoma					43	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-OL-A5RV-F56564		Positive					Positive	Modified Radical Mastectomy		NO			-15820	755		0	1062							90-99%					2014-2-14	FEMALE								1.00		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	370	NO		Negative	NO	29	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	20		true	MX	N3	T2	Stage IIIC	TCGA-OL-A5RV.0CA74400-1596-4C14-AF02-4F5169D61942.pdf		5		0		0		0		4		71		25		70	TUMOR FREE						YES	YES	No	90-99%		YES	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2011			TCGA-OL-A5RV-01A-12R-A28I-13	TCGA-OL-A5RV-01A-12R-A28I-13			TCGA-OL-A5RV-01A-12D-A28B-09			2dca31d2-af60-4529-afac-e8838a7ee67c	974a292a-7fcd-424c-8cf3-28991184425b	TCGA-OL-A5RV-01A-12D-A28A-01	2dca31d2-af60-4529-afac-e8838a7ee67c	TCGA-OL-A5RV-01A-12D-A28C-05	TCGA-OL-A5RV-01		2dca31d2-af60-4529-afac-e8838a7ee67c	2dca31d2-af60-4529-afac-e8838a7ee67c	TCGA-OL-A5RV-01A-12D-A28A-01		TCGA-OL-A5RV-01		974a292a-7fcd-424c-8cf3-28991184425b	
TCGA-OL-A5RW-01																													0	TCGA-OL-A5RW-01	1106	0										TCGA-OL-A5RW	1106	0	1106	Breast	TCGA Breast Cancer	breast invasive carcinoma					40	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-OL-A5RW-F56568		Negative					Negative	Lumpectomy					-14638			0	1106												2014-2-14	FEMALE								1.91		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy				Negative	NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	1			MX	N1	T1c	Stage IIA																		TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th		NO	YES	OL	Breast		LIVING	2010			TCGA-OL-A5RW-01A-11R-A28I-13	TCGA-OL-A5RW-01A-11R-A28I-13			TCGA-OL-A5RW-01A-11D-A28B-09			c5a7673a-c45e-4789-a2c8-32889f39c102	b3f1bdd3-a76f-4ab7-9c8c-c02c36f1ecee	TCGA-OL-A5RW-01A-11D-A28A-01	c5a7673a-c45e-4789-a2c8-32889f39c102	TCGA-OL-A5RW-01A-11D-A28C-05	TCGA-OL-A5RW-01		c5a7673a-c45e-4789-a2c8-32889f39c102	c5a7673a-c45e-4789-a2c8-32889f39c102	TCGA-OL-A5RW-01A-11D-A28A-01		TCGA-OL-A5RW-01		b3f1bdd3-a76f-4ab7-9c8c-c02c36f1ecee	
TCGA-OL-A5RX-01																													0	TCGA-OL-A5RX-01	878	0										TCGA-OL-A5RX	878	0	878	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-OL-A5RX-F56570		Positive					Positive	Simple Mastectomy					-18942	561		0	878							90-99%					2014-2-14	FEMALE								1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	260	NO		Negative	NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO			true	MX	N0	T1c	Stage IA	TCGA-OL-A5RX.9536A134-A44C-4698-A525-DEEE7FACD144.pdf		5		0		0		0		0		0		100		65	TUMOR FREE						NO	YES	No	90-99%		NO	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2011			TCGA-OL-A5RX-01A-11R-A28I-13	TCGA-OL-A5RX-01A-11R-A28I-13			TCGA-OL-A5RX-01A-11D-A28B-09			650c0c98-4432-4e9a-9e83-4ad8a7a0d628	0b486cb1-bb48-4a49-b96f-ed9468831195	TCGA-OL-A5RX-01A-11D-A28A-01	650c0c98-4432-4e9a-9e83-4ad8a7a0d628	TCGA-OL-A5RX-01A-11D-A28C-05	TCGA-OL-A5RX-01		650c0c98-4432-4e9a-9e83-4ad8a7a0d628	650c0c98-4432-4e9a-9e83-4ad8a7a0d628	TCGA-OL-A5RX-01A-11D-A28A-01		TCGA-OL-A5RX-01		0b486cb1-bb48-4a49-b96f-ed9468831195	
TCGA-OL-A5RY-01																													0	TCGA-OL-A5RY-01	752	0										TCGA-OL-A5RY	752	0	752	Breast	TCGA Breast Cancer	breast invasive carcinoma					52	Right	Sentinel node biopsy alone		TCGA-OL-A5RY-F56565	Negative	Positive				Mastectomy NOS	Negative	Lumpectomy					-19216	421		0	752							10-19%					2014-2-14	FEMALE								7.6		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Ultrasound-guided biopsy	Other method, specify:	300	NO		Positive	NO	25	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1		true	MX	N1	T1c	Stage IIA	TCGA-OL-A5RY.C8297152-7551-49A1-8C9D-6B411391AC77.pdf		8		2		0		0		0		0		100		70	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2011			TCGA-OL-A5RY-01A-21R-A28I-13	TCGA-OL-A5RY-01A-21R-A28I-13			TCGA-OL-A5RY-01A-21D-A28B-09			2407816a-86e7-4094-a028-e81c0cda5448	3fd01fad-79d8-461d-9aec-a2bf42474827	TCGA-OL-A5RY-01A-21D-A28A-01	2407816a-86e7-4094-a028-e81c0cda5448	TCGA-OL-A5RY-01A-21D-A28C-05	TCGA-OL-A5RY-01		2407816a-86e7-4094-a028-e81c0cda5448	2407816a-86e7-4094-a028-e81c0cda5448	TCGA-OL-A5RY-01A-21D-A28A-01		TCGA-OL-A5RY-01		3fd01fad-79d8-461d-9aec-a2bf42474827	
TCGA-OL-A5RZ-01																													0	TCGA-OL-A5RZ-01	679	0										TCGA-OL-A5RZ	679	0	679	Breast	TCGA Breast Cancer	breast invasive carcinoma					57	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-OL-A5RZ-F56571		Positive					Negative	Simple Mastectomy					-21038			0	679							30-39%			2.0		2014-2-14	FEMALE							21.0	10.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy				Positive	NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO				MX	N0	T1b	Stage IA																		TUMOR FREE						YES	YES	No	<10%		NO	Primary Tumor	01		7th		NO	YES	OL	Breast		LIVING	2012			TCGA-OL-A5RZ-01A-11R-A28I-13	TCGA-OL-A5RZ-01A-11R-A28I-13			TCGA-OL-A5RZ-01A-11D-A28B-09			fc8c0c74-cd1b-4bc7-ab1d-568d302c5719	a7893e2d-7629-4815-9913-712291d8f693	TCGA-OL-A5RZ-01A-11D-A28A-01	fc8c0c74-cd1b-4bc7-ab1d-568d302c5719	TCGA-OL-A5RZ-01A-11D-A28C-05	TCGA-OL-A5RZ-01		fc8c0c74-cd1b-4bc7-ab1d-568d302c5719	fc8c0c74-cd1b-4bc7-ab1d-568d302c5719	TCGA-OL-A5RZ-01A-11D-A28A-01		TCGA-OL-A5RZ-01		a7893e2d-7629-4815-9913-712291d8f693	
TCGA-OL-A5S0-01																													0	TCGA-OL-A5S0-01	620	0										TCGA-OL-A5S0	620	0	620	Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Right	Axillary lymph node dissection alone		TCGA-OL-A5S0-F56567		Positive					Negative	Modified Radical Mastectomy					-24139			0	620							30-39%					2014-2-14	FEMALE								3.8		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy				Positive	NO	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	2			MX	N1a	T2	Stage IIB																		TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th		NO	YES	OL	Breast		LIVING	2012			TCGA-OL-A5S0-01A-11R-A28I-13	TCGA-OL-A5S0-01A-11R-A28I-13			TCGA-OL-A5S0-01A-11D-A28B-09			f6e02767-7522-4895-bc70-c7de6b1796ab	a03329fe-b674-48be-9ef6-0c4d4f439830	TCGA-OL-A5S0-01A-11D-A28A-01	f6e02767-7522-4895-bc70-c7de6b1796ab	TCGA-OL-A5S0-01A-11D-A28C-05	TCGA-OL-A5S0-01		f6e02767-7522-4895-bc70-c7de6b1796ab	f6e02767-7522-4895-bc70-c7de6b1796ab	TCGA-OL-A5S0-01A-11D-A28A-01		TCGA-OL-A5S0-01		a03329fe-b674-48be-9ef6-0c4d4f439830	
TCGA-OL-A66H-01																													0	TCGA-OL-A66H-01	812	0										TCGA-OL-A66H	812	0	812	Breast	TCGA Breast Cancer	breast invasive carcinoma					74	Right			TCGA-OL-A66H-F58492		Positive					Positive	Lumpectomy					-27280	441		0	812							90-99%			1.7		2014-4-11	FEMALE							1.8	1.03		Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Fine needle aspiration biopsy	80	NO		Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO			true	MX	N1mi	T1c	Stage IB	TCGA-OL-A66H.3D84D02A-42B1-42E1-84FB-E9AE9381ABB4.pdf		2		0		0		0		30		0		70		70	TUMOR FREE						NO	YES	No	80-89%		YES	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2012			TCGA-OL-A66H-01A-11R-A29V-13	TCGA-OL-A66H-01A-11R-A29V-13			TCGA-OL-A66H-01A-11D-A29N-09			428ca7a1-6f08-4426-8f2d-28939166df70	ce6abca6-47d8-4404-82d3-2209e450c709	TCGA-OL-A66H-01A-11D-A29M-01	428ca7a1-6f08-4426-8f2d-28939166df70	TCGA-OL-A66H-01A-11D-A29O-05	TCGA-OL-A66H-01		428ca7a1-6f08-4426-8f2d-28939166df70	428ca7a1-6f08-4426-8f2d-28939166df70	TCGA-OL-A66H-01A-11D-A29M-01		TCGA-OL-A66H-01		ce6abca6-47d8-4404-82d3-2209e450c709	
TCGA-OL-A66I-01																													0	TCGA-OL-A66I-01	714	0										TCGA-OL-A66I	714	0	714	Breast	TCGA Breast Cancer	breast invasive carcinoma					36	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-OL-A66I-F58496		Negative					Negative	Lumpectomy					-13458			0	714												2014-4-11	FEMALE								1.04		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy				Negative	YES	13	Negative																												NO	0			MX	N1mi	T1c	Stage IIA																		TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		6th		NO	YES	OL	Breast		LIVING	2008			TCGA-OL-A66I-01A-21R-A29V-13	TCGA-OL-A66I-01A-21R-A29V-13			TCGA-OL-A66I-01A-21D-A29N-09			d92ddf45-68b6-42da-9497-8faabcc50be0	a9914a13-282b-42c9-ae86-ad7241f462a9	TCGA-OL-A66I-01A-21D-A29M-01	d92ddf45-68b6-42da-9497-8faabcc50be0	TCGA-OL-A66I-01A-21D-A29O-05	TCGA-OL-A66I-01		d92ddf45-68b6-42da-9497-8faabcc50be0	d92ddf45-68b6-42da-9497-8faabcc50be0	TCGA-OL-A66I-01A-21D-A29M-01		TCGA-OL-A66I-01		a9914a13-282b-42c9-ae86-ad7241f462a9	
TCGA-OL-A66J-01																													0	TCGA-OL-A66J-01	1996	0										TCGA-OL-A66J	1996	0	1996	Breast	TCGA Breast Cancer	breast invasive carcinoma					80	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-OL-A66J-F58495		Positive					Positive	Lumpectomy					-29345	1645		0	1996							90-99%					2014-4-11	FEMALE								1.50		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	210	NO		Negative	NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		true	MX	N0	T1c	Stage I	TCGA-OL-A66J.D5DE4BB3-81AC-44CB-9336-060F324C7A2F.pdf		2		0		0		0		0		0		100		80	TUMOR FREE						NO	YES	No	50-59%		YES	Primary Tumor	01		6th		NO	YES	OL	Breast	A	LIVING	2008			TCGA-OL-A66J-01A-11R-A29V-13	TCGA-OL-A66J-01A-11R-A29V-13			TCGA-OL-A66J-01A-11D-A29N-09			fc8cb6a7-c7ed-4037-8fb9-7530cdebc705	415eb849-be66-47d3-a813-100c1eed8345	TCGA-OL-A66J-01A-11D-A29M-01	fc8cb6a7-c7ed-4037-8fb9-7530cdebc705	TCGA-OL-A66J-01A-11D-A29O-05	TCGA-OL-A66J-01		fc8cb6a7-c7ed-4037-8fb9-7530cdebc705	fc8cb6a7-c7ed-4037-8fb9-7530cdebc705	TCGA-OL-A66J-01A-11D-A29M-01		TCGA-OL-A66J-01		415eb849-be66-47d3-a813-100c1eed8345	
TCGA-OL-A66K-01																													1	TCGA-OL-A66K-01	1275	1										TCGA-OL-A66K	1275	0	1275	Breast	TCGA Breast Cancer	breast invasive carcinoma					72	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-OL-A66K-F58498		Positive					Positive	Simple Mastectomy					-26299	981	1275	0	1021							70-79%					2014-4-11	FEMALE					2+			1.23		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	230	NO	Equivocal	Negative	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO			true	MX	N0	T2	Stage IIA	TCGA-OL-A66K.8A19AA55-9B1F-4325-B730-068F928F1C13.pdf		2		0		0		0		0		50		50		70	TUMOR FREE						NO	YES	No	90-99%		NO	Primary Tumor	01		7th		NO	YES	OL	Breast	A	DECEASED	2010			TCGA-OL-A66K-01A-11R-A29V-13	TCGA-OL-A66K-01A-11R-A29V-13			TCGA-OL-A66K-01A-11D-A29N-09			7cd7e1cf-4390-4b0e-884c-fc0a26c7e1bf	04ca65ff-5024-4c58-9c7e-5f03691f3c6d	TCGA-OL-A66K-01A-11D-A29M-01	7cd7e1cf-4390-4b0e-884c-fc0a26c7e1bf	TCGA-OL-A66K-01A-11D-A29O-05	TCGA-OL-A66K-01		7cd7e1cf-4390-4b0e-884c-fc0a26c7e1bf	7cd7e1cf-4390-4b0e-884c-fc0a26c7e1bf	TCGA-OL-A66K-01A-11D-A29M-01		TCGA-OL-A66K-01		04ca65ff-5024-4c58-9c7e-5f03691f3c6d	
TCGA-OL-A66L-01																													0	TCGA-OL-A66L-01	1301	0										TCGA-OL-A66L	1301	0	1301	Breast	TCGA Breast Cancer	breast invasive carcinoma					71	Right Lower Inner Quadrant			TCGA-OL-A66L-F58493		Positive					Positive	Lumpectomy					-26186	952		0	1301							90-99%					2014-4-11	FEMALE								1.10		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO		Negative	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO			true	MX	N0	T1c	Stage IA	TCGA-OL-A66L.B8C192A7-E530-4301-B4D3-FF528A230260.pdf		2		0		0		0		0		0		100		75	TUMOR FREE						NO	YES	No	90-99%		YES	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2010			TCGA-OL-A66L-01A-12R-A31S-13	TCGA-OL-A66L-01A-12R-A31S-13						0df01f96-a14b-4bd9-bddb-1dab47491d2d	83411c5a-3bb9-45dd-9ed2-f0e27eb3e7c5	TCGA-OL-A66L-01A-12D-A31T-01	0df01f96-a14b-4bd9-bddb-1dab47491d2d	TCGA-OL-A66L-01A-12D-A31V-05	TCGA-OL-A66L-01		0df01f96-a14b-4bd9-bddb-1dab47491d2d	0df01f96-a14b-4bd9-bddb-1dab47491d2d	TCGA-OL-A66L-01A-12D-A31T-01		TCGA-OL-A66L-01		83411c5a-3bb9-45dd-9ed2-f0e27eb3e7c5	
TCGA-OL-A66N-01																													0	TCGA-OL-A66N-01	792	0										TCGA-OL-A66N	792	0	792	Breast	TCGA Breast Cancer	breast invasive carcinoma					59	Left	Sentinel node biopsy alone		TCGA-OL-A66N-F58500		Positive					Negative	Modified Radical Mastectomy					-21608	505		0	792							80-89%					2014-4-11	FEMALE								1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	310	NO		Negative	NO	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	13		true	MX	N3	T3	Stage IIIC	TCGA-OL-A66N.CDB6A529-DE8B-48F6-A569-D07251D139C3.pdf		0		0		0		0		0		60		40		70	TUMOR FREE						NO	YES	No			YES	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2011			TCGA-OL-A66N-01A-12R-A31S-13	TCGA-OL-A66N-01A-12R-A31S-13						43cde130-82ef-43ca-ba81-8ab14588069c	dfedbd6d-63f7-4b3f-8ba2-5f56ba2712ce	TCGA-OL-A66N-01A-12D-A31T-01	43cde130-82ef-43ca-ba81-8ab14588069c	TCGA-OL-A66N-01A-12D-A31V-05	TCGA-OL-A66N-01		43cde130-82ef-43ca-ba81-8ab14588069c	43cde130-82ef-43ca-ba81-8ab14588069c	TCGA-OL-A66N-01A-12D-A31T-01		TCGA-OL-A66N-01		dfedbd6d-63f7-4b3f-8ba2-5f56ba2712ce	
TCGA-OL-A66O-01																													0	TCGA-OL-A66O-01	528	0										TCGA-OL-A66O	528	0	528	Breast	TCGA Breast Cancer	breast invasive carcinoma					39	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-OL-A66O-F58497		Positive					Positive	Modified Radical Mastectomy					-14272	170		0	528							90-99%					2014-4-11	FEMALE								1.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	260	NO		Negative	NO	17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	3		true	MX	N1a	T2	Stage IIB	TCGA-OL-A66O.60ACE33B-BEE2-4A49-85F0-1364D245FCA9.pdf		0		0		0		0		0		30		70		80	TUMOR FREE						YES	YES	No	90-99%		YES	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2012			TCGA-OL-A66O-01A-11R-A31S-13	TCGA-OL-A66O-01A-11R-A31S-13						c7f57147-b774-4209-8b7f-2666f59543d8	67db47cd-e3f4-48f3-bf1e-e0c9e5b862b0	TCGA-OL-A66O-01A-11D-A31T-01	c7f57147-b774-4209-8b7f-2666f59543d8	TCGA-OL-A66O-01A-11D-A31V-05	TCGA-OL-A66O-01		c7f57147-b774-4209-8b7f-2666f59543d8	c7f57147-b774-4209-8b7f-2666f59543d8	TCGA-OL-A66O-01A-11D-A31T-01		TCGA-OL-A66O-01		67db47cd-e3f4-48f3-bf1e-e0c9e5b862b0	
TCGA-OL-A66P-01																													0	TCGA-OL-A66P-01	428	0										TCGA-OL-A66P	428	0	428	Breast	TCGA Breast Cancer	breast invasive carcinoma					75	Right	Sentinel node biopsy alone		TCGA-OL-A66P-F58494		Negative					Negative	Simple Mastectomy					-27489			0	428												2014-4-11	FEMALE								1.13		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy				Negative	NO	2	Negative																												NO				MX	N0	T2	Stage IIA																		TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		7th		NO	YES	OL	Breast		LIVING	2013			TCGA-OL-A66P-01A-11R-A31S-13	TCGA-OL-A66P-01A-11R-A31S-13						bbd01868-6fc1-42e7-b375-f0ac1a54a43c	da0238e7-c2e7-4a86-a3ef-3e49d1dfc228	TCGA-OL-A66P-01A-11D-A31T-01	bbd01868-6fc1-42e7-b375-f0ac1a54a43c	TCGA-OL-A66P-01A-11D-A31V-05	TCGA-OL-A66P-01		bbd01868-6fc1-42e7-b375-f0ac1a54a43c	bbd01868-6fc1-42e7-b375-f0ac1a54a43c	TCGA-OL-A66P-01A-11D-A31T-01		TCGA-OL-A66P-01		da0238e7-c2e7-4a86-a3ef-3e49d1dfc228	
TCGA-OL-A6VO-01																													0	TCGA-OL-A6VO-01	858	0										TCGA-OL-A6VO	858	0	858	Breast	TCGA Breast Cancer	breast invasive carcinoma					43	Right|Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-OL-A6VO-F59365		Negative					Negative	Lumpectomy					-15780	507		0	858												2014-5-10	FEMALE								1.23		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative	Negative	NO	7	Negative																												NO	0		true	MX	N0	T1c	Stage IA	TCGA-OL-A6VO.961547D2-F235-47E9-9A6D-D286758E332E.pdf		2		0		0		0		5		5		90		90	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2012			TCGA-OL-A6VO-01A-12R-A33A-13	TCGA-OL-A6VO-01A-12R-A33A-13						5cb12edf-25a1-40f6-831a-5fb1f56676e1	98c2fa71-63aa-4bfe-b49e-41aa4abdb391	TCGA-OL-A6VO-01A-12D-A33D-01	5cb12edf-25a1-40f6-831a-5fb1f56676e1	TCGA-OL-A6VO-01A-12D-A33F-05	TCGA-OL-A6VO-01		5cb12edf-25a1-40f6-831a-5fb1f56676e1	5cb12edf-25a1-40f6-831a-5fb1f56676e1	TCGA-OL-A6VO-01A-12D-A33D-01		TCGA-OL-A6VO-01		98c2fa71-63aa-4bfe-b49e-41aa4abdb391	
TCGA-OL-A6VQ-01																													0	TCGA-OL-A6VQ-01	600	0										TCGA-OL-A6VQ	600	0	600	Breast	TCGA Breast Cancer	breast invasive carcinoma					49	Right			TCGA-OL-A6VQ-F59366	Negative	Positive				Mastectomy NOS	Positive	Lumpectomy					-18151	278		0	600							90-99%					2014-5-10	FEMALE								1.05		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			110	NO		Negative	NO	1	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0		true	MX	N0	T2	Stage IIA	TCGA-OL-A6VQ.17C74789-D7B0-4291-A2AC-7A72C5DC58EE.pdf		2		0		0		0		10		10		80		80	TUMOR FREE						NO	YES	No	10-19%		NO	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2012			TCGA-OL-A6VQ-01A-12R-A41G-13	TCGA-OL-A6VQ-01A-12R-A41G-13							95aa9717-87dc-42e6-8149-251e9b743de8	TCGA-OL-A6VQ-01A-12D-A41E-01		TCGA-OL-A6VQ-01A-12D-A41Q-05					TCGA-OL-A6VQ-01A-12D-A41E-01				95aa9717-87dc-42e6-8149-251e9b743de8	
TCGA-OL-A6VR-01																													0	TCGA-OL-A6VR-01	1220	0										TCGA-OL-A6VR	1220	0	1220	Breast	TCGA Breast Cancer	breast invasive carcinoma					48	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-OL-A6VR-F59367		Positive					Positive	Simple Mastectomy					-17702	869		0	1220							30-39%					2014-5-10	FEMALE								1.23		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	380	NO	Negative	Negative	NO	2	Negative																												NO	0		true	MX	N0	T1b	Stage IA	TCGA-OL-A6VR.217745AA-6C5A-46C5-AC04-1C6581A96A04.pdf		3		0		2		0		3		75		20		75	TUMOR FREE						NO	YES	No	90-99%		NO	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2011			TCGA-OL-A6VR-01A-32R-A33A-13	TCGA-OL-A6VR-01A-32R-A33A-13						19cbf7e8-ab1f-495c-a09e-ff3fe7c172e4	15e01f89-f689-4b8f-92dd-1037cc87626b	TCGA-OL-A6VR-01A-32D-A33D-01	19cbf7e8-ab1f-495c-a09e-ff3fe7c172e4	TCGA-OL-A6VR-01A-32D-A33F-05	TCGA-OL-A6VR-01		19cbf7e8-ab1f-495c-a09e-ff3fe7c172e4	19cbf7e8-ab1f-495c-a09e-ff3fe7c172e4	TCGA-OL-A6VR-01A-32D-A33D-01		TCGA-OL-A6VR-01		15e01f89-f689-4b8f-92dd-1037cc87626b	
TCGA-OL-A97C-01																													0	TCGA-OL-A97C-01	271	0										TCGA-OL-A97C	271	0	271	Breast	TCGA Breast Cancer	breast invasive carcinoma					67	Left			TCGA-OL-A97C-F66330		Negative					Negative	Simple Mastectomy					-24735	216		0	271												2014-10-31	FEMALE										Other  specify	malignant phyllodes	No		C50.9	9020/3	C50.9		YES		Fine needle aspiration biopsy	410	NO		Negative	NO	6		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		true	M0	N0	T3	Stage IIB	TCGA-OL-A97C.1582865E-9294-4D78-8B16-92FB70381D15.pdf		4		0		5		0		5		25		65		65	TUMOR FREE							YES	No			NO	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2013			TCGA-OL-A97C-01A-32R-A41G-13	TCGA-OL-A97C-01A-32R-A41G-13						590ae2bc-c076-4547-97dc-e2c8a0d396a6	9eb5ef11-18df-40b8-8c58-0236102b90e0	TCGA-OL-A97C-01A-32D-A41E-01	590ae2bc-c076-4547-97dc-e2c8a0d396a6	TCGA-OL-A97C-01A-32D-A41Q-05	TCGA-OL-A97C-01		590ae2bc-c076-4547-97dc-e2c8a0d396a6	590ae2bc-c076-4547-97dc-e2c8a0d396a6	TCGA-OL-A97C-01A-32D-A41E-01		TCGA-OL-A97C-01		9eb5ef11-18df-40b8-8c58-0236102b90e0	
TCGA-PE-A5DC-01																													1	TCGA-PE-A5DC-01	1430	1										TCGA-PE-A5DC	1430	0	1430	Breast	TCGA Breast Cancer	breast invasive carcinoma					72	Right Upper Inner Quadrant					Positive					Positive						-26514	2858	1430	0													2013-4-30	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			350	NO	Positive			31		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	5		true	M0	N2a	T2	Stage IIIA	TCGA-PE-A5DC.8693580D-FCB3-4943-9C2F-5F3DABFB5AF0.pdf		0		0		0		0		0		25		75		85	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01		6th		NO	YES	PE	Breast	A	DECEASED	2005			TCGA-PE-A5DC-01A-12R-A27U-13	TCGA-PE-A5DC-01A-12R-A27U-13			TCGA-PE-A5DC-01A-12D-A27P-09			05a8e240-5384-4a03-abeb-7ef3697c946d	c5b1d103-453a-4fe5-aef2-63683a56d262	TCGA-PE-A5DC-01A-12D-A27O-01	05a8e240-5384-4a03-abeb-7ef3697c946d		TCGA-PE-A5DC-01		05a8e240-5384-4a03-abeb-7ef3697c946d	05a8e240-5384-4a03-abeb-7ef3697c946d	TCGA-PE-A5DC-01A-12D-A27O-01		TCGA-PE-A5DC-01		c5b1d103-453a-4fe5-aef2-63683a56d262	
TCGA-PE-A5DD-01																													0	TCGA-PE-A5DD-01	1953	0										TCGA-PE-A5DD	1953	0	1953	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Right Lower Inner Quadrant			TCGA-PE-A5DD-F66361		Positive					Negative	Other					-23686	2411		0	1953												2014-10-13	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Incisional Biopsy	270	NO	Positive	Positive	YES	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		true	M0	N0	T2	Stage IIA	TCGA-PE-A5DD.7A2719FC-1CA2-4D58-9EF7-594926D1FF66.pdf		0		0		0		0		0		35		65		80	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01	Reexc of biopsy site for gross/micro residual disease	6th		NO	YES	PE	Breast	A	LIVING	2006			TCGA-PE-A5DD-01A-12R-A27U-13	TCGA-PE-A5DD-01A-12R-A27U-13			TCGA-PE-A5DD-01A-12D-A27P-09			38adc5a4-bf82-4a06-a179-e84dd42593da	51c041dc-88a3-4619-82f3-29995e05c5db	TCGA-PE-A5DD-01A-12D-A27O-01	38adc5a4-bf82-4a06-a179-e84dd42593da		TCGA-PE-A5DD-01		38adc5a4-bf82-4a06-a179-e84dd42593da	38adc5a4-bf82-4a06-a179-e84dd42593da	TCGA-PE-A5DD-01A-12D-A27O-01		TCGA-PE-A5DD-01		51c041dc-88a3-4619-82f3-29995e05c5db	
TCGA-PE-A5DE-01																													0	TCGA-PE-A5DE-01	2645	0										TCGA-PE-A5DE	2645	0	2645	Breast	TCGA Breast Cancer	breast invasive carcinoma					41	Left			TCGA-PE-A5DE-F66373		Positive					Positive	Other					-15216	2066		0	2645												2014-10-13	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	190	NO	Negative		NO	1		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0		true	M0	N0	T2	Stage IIA	TCGA-PE-A5DE.6D2FA4DD-285F-4815-9494-76B297FA04AF.pdf		0		0		0		0		0		15		85		90	TUMOR FREE						YES	YES	No			YES	Primary Tumor	01	Partial Mastectomy	6th		NO	YES	PE	Breast	A	LIVING	2007			TCGA-PE-A5DE-01A-11R-A27U-13	TCGA-PE-A5DE-01A-11R-A27U-13			TCGA-PE-A5DE-01A-11D-A27P-09			041c71a0-06d5-44a5-8930-7f1dd2a638d1	303dc766-ae5f-4f9d-b840-8609cc453153	TCGA-PE-A5DE-01A-11D-A27O-01	041c71a0-06d5-44a5-8930-7f1dd2a638d1		TCGA-PE-A5DE-01		041c71a0-06d5-44a5-8930-7f1dd2a638d1	041c71a0-06d5-44a5-8930-7f1dd2a638d1	TCGA-PE-A5DE-01A-11D-A27O-01		TCGA-PE-A5DE-01		303dc766-ae5f-4f9d-b840-8609cc453153	
TCGA-PL-A8LV-01																														TCGA-PL-A8LV-01												TCGA-PL-A8LV				Breast	TCGA Breast Cancer	breast invasive carcinoma					54	Right|Right Upper Outer Quadrant	No axillary staging		TCGA-PL-A8LV-F64849													-19746	240		0	-7												2014-10-17	FEMALE										Medullary Carcinoma		No		C50.9	8510/3	C50.9		YES		Excisional Biopsy	840	NO			YES																																	false	M0	N0	T4	Stage IIIB	TCGA-PL-A8LV.D35DBECD-5241-4562-85CC-2822BB338279.pdf		40		20		0		20		0		20		80		80	WITH TUMOR							NO	No			NO	Primary Tumor	01		7th		YES	NO	PL	Breast	A	LIVING	2013			TCGA-PL-A8LV-01A-21R-A41G-13	TCGA-PL-A8LV-01A-21R-A41G-13						34f3d207-0bfe-4699-b01b-d145942ba488	22f1be3b-bde1-4466-9f54-316c0924a835	TCGA-PL-A8LV-01A-21D-A41E-01	34f3d207-0bfe-4699-b01b-d145942ba488	TCGA-PL-A8LV-01A-21D-A41Q-05	TCGA-PL-A8LV-01		34f3d207-0bfe-4699-b01b-d145942ba488	34f3d207-0bfe-4699-b01b-d145942ba488	TCGA-PL-A8LV-01A-21D-A41E-01		TCGA-PL-A8LV-01		22f1be3b-bde1-4466-9f54-316c0924a835	
TCGA-PL-A8LX-01																													0	TCGA-PL-A8LX-01	5	0										TCGA-PL-A8LX			5	Breast	TCGA Breast Cancer	breast invasive carcinoma					35	Left|Left Upper Outer Quadrant			TCGA-PL-A8LX-F64852													-12840	74		0	5								Bone|Liver				2014-10-17	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	540	NO			YES			Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																														false	M1	N1a	T4	Stage IV	TCGA-PL-A8LX.E6DD0840-4D71-4EEC-B559-F6BFC9E7E68B.pdf		40		20		0		20		0		20		80		80	WITH TUMOR						NO	YES	No			NO	Primary Tumor	01		7th		YES	NO	PL	Breast	A	LIVING	2013			TCGA-PL-A8LX-01A-11R-A41G-13	TCGA-PL-A8LX-01A-11R-A41G-13						19cadb60-b213-4fd3-b5ad-d2b49000b6a3	e28bac01-5bd3-4b66-83f7-2c778be9a0d5	TCGA-PL-A8LX-01A-11D-A41E-01	19cadb60-b213-4fd3-b5ad-d2b49000b6a3	TCGA-PL-A8LX-01A-11D-A41Q-05	TCGA-PL-A8LX-01		19cadb60-b213-4fd3-b5ad-d2b49000b6a3	19cadb60-b213-4fd3-b5ad-d2b49000b6a3	TCGA-PL-A8LX-01A-11D-A41E-01		TCGA-PL-A8LX-01		e28bac01-5bd3-4b66-83f7-2c778be9a0d5	
TCGA-PL-A8LY-01																													0	TCGA-PL-A8LY-01	8	0										TCGA-PL-A8LY	8	0	8	Breast	TCGA Breast Cancer	breast invasive carcinoma					30	Right|Right Upper Outer Quadrant			TCGA-PL-A8LY-F64851													-11199	129		0	8												2014-10-17	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	350	NO			YES			Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO			false	M0	N0	T3	Stage IIB	TCGA-PL-A8LY.8C97B391-96B4-468D-AAA3-24E196DE03CA.pdf		40		20		0		20		0		20		80		80	WITH TUMOR						NO	NO	No			NO	Primary Tumor	01		7th		YES	NO	PL	Breast	A	LIVING	2013			TCGA-PL-A8LY-01A-11R-A41G-13	TCGA-PL-A8LY-01A-11R-A41G-13						2ca5942e-dcbf-46f1-8427-1ea7216dc559	9a1bfc69-79f4-442d-b7f5-b451e22cf143	TCGA-PL-A8LY-01A-11D-A41E-01	2ca5942e-dcbf-46f1-8427-1ea7216dc559	TCGA-PL-A8LY-01A-11D-A41Q-05	TCGA-PL-A8LY-01		2ca5942e-dcbf-46f1-8427-1ea7216dc559	2ca5942e-dcbf-46f1-8427-1ea7216dc559	TCGA-PL-A8LY-01A-11D-A41E-01		TCGA-PL-A8LY-01		9a1bfc69-79f4-442d-b7f5-b451e22cf143	
TCGA-PL-A8LZ-01																													0	TCGA-PL-A8LZ-01	302	0										TCGA-PL-A8LZ	302	0	302	Breast	TCGA Breast Cancer	breast invasive carcinoma					29	Left|Left Upper Outer Quadrant			TCGA-PL-A8LZ-F64850													-10869	157		0	302												2014-9-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	830	NO			NO			Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO			false	M0	N2	T4b	Stage IIIB	TCGA-PL-A8LZ.436F3280-98C7-4FA9-BD6F-1B02CAF1D262.pdf		14		2		5		2		2		30		63		80	TUMOR FREE						YES		No			NO	Primary Tumor	01		7th		YES	NO	PL	Breast	A	LIVING	2013			TCGA-PL-A8LZ-01A-31R-A36A-13	TCGA-PL-A8LZ-01A-31R-A36A-13						de01d9b6-e29d-495e-815a-c7d2a7c15af3	0e185d4c-d0cd-4098-a9ce-0a0ead6ab508	TCGA-PL-A8LZ-01A-31D-A36I-01	de01d9b6-e29d-495e-815a-c7d2a7c15af3	TCGA-PL-A8LZ-01A-31D-A36K-05	TCGA-PL-A8LZ-01		de01d9b6-e29d-495e-815a-c7d2a7c15af3	de01d9b6-e29d-495e-815a-c7d2a7c15af3	TCGA-PL-A8LZ-01A-31D-A36I-01		TCGA-PL-A8LZ-01		0e185d4c-d0cd-4098-a9ce-0a0ead6ab508	
TCGA-S3-A6ZF-01																													0	TCGA-S3-A6ZF-01	502	0										TCGA-S3-A6ZF	502	0	502	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Right|Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-S3-A6ZF-F59305		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		YES			-23650	107		0	502						CAP scoring guideline 2010	90-99%			39		2014-8-27	FEMALE		CAP scoring guideline 2010	50-59%		2+	20	60	1.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Fine needle aspiration biopsy	1350	NO	Equivocal	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	M0	N0	T2	Stage IIA	TCGA-S3-A6ZF.7B53A0D4-E13E-4573-B0A2-BB55AE54BD62.pdf		5		1		0		1		20		20		60		60	TUMOR FREE	CAP scoring guideline 2010			moderate	Moderate	YES	YES	No	40-49%		NO	Primary Tumor	01		7th		YES	NO	S3	Breast	A	LIVING	2013			TCGA-S3-A6ZF-01A-32R-A32K-13	TCGA-S3-A6ZF-01A-32R-A32K-13						4d464cde-4885-4b17-9e02-23be26be0540	48198b9b-450c-40fd-a50b-fb804e663cb0	TCGA-S3-A6ZF-01A-32D-A32H-01	4d464cde-4885-4b17-9e02-23be26be0540	TCGA-S3-A6ZF-01A-32D-A32T-05	TCGA-S3-A6ZF-01		4d464cde-4885-4b17-9e02-23be26be0540	4d464cde-4885-4b17-9e02-23be26be0540	TCGA-S3-A6ZF-01A-32D-A32H-01		TCGA-S3-A6ZF-01		48198b9b-450c-40fd-a50b-fb804e663cb0	
TCGA-S3-A6ZG-01																													0	TCGA-S3-A6ZG-01	399	0										TCGA-S3-A6ZG	399	0	399	Breast	TCGA Breast Cancer	breast invasive carcinoma					71	Left|Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-S3-A6ZG-F63645		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		YES			-26141	102		0	399						CAP scoring guideline 2010	90-99%					2014-8-27	FEMALE		CAP scoring guidelines 2010	<10%							Mixed Histology (please specify)	Invasive mixed ductal and lobular carcinoma	No		C50.9	8520/3	C50.9		YES		Excisional Biopsy	980	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1	0	false	M0	N1	T2	Stage IIB	TCGA-S3-A6ZG.47D02B80-47DA-4135-A288-21077C5947A9.pdf		10		3		0		2		20		20		60		60	TUMOR FREE	CAP scoring guideline 2010			Moderate	Moderate	YES	YES	No	80-89%		YES	Primary Tumor	01		7th		YES	NO	S3	Breast	A	LIVING	2013			TCGA-S3-A6ZG-01A-22R-A32K-13	TCGA-S3-A6ZG-01A-22R-A32K-13						0967df37-66ae-4ab3-a1fd-e196d4bc9995	e18e9c74-60c6-4687-93e5-6d216c131587	TCGA-S3-A6ZG-01A-22D-A32H-01	0967df37-66ae-4ab3-a1fd-e196d4bc9995	TCGA-S3-A6ZG-01A-22D-A32T-05	TCGA-S3-A6ZG-01		0967df37-66ae-4ab3-a1fd-e196d4bc9995	0967df37-66ae-4ab3-a1fd-e196d4bc9995	TCGA-S3-A6ZG-01A-22D-A32H-01		TCGA-S3-A6ZG-01		e18e9c74-60c6-4687-93e5-6d216c131587	
TCGA-S3-A6ZH-01																													0	TCGA-S3-A6ZH-01	515	0										TCGA-S3-A6ZH	515	0	515	Breast	TCGA Breast Cancer	breast invasive carcinoma					29	Left|Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-S3-A6ZH-F63625		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		NO			-10832	158		0	515							90-99%			69		2014-8-27	FEMALE		CAP scoring guideline 2010		CAP scoring guideline 2010	2+	20	79	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Core needle biopsy	580	NO	Equivocal	Negative	NO	21	Negative																												NO	14	0	false	MX	N3a	T3	Stage IIIC	TCGA-S3-A6ZH.030860D0-66DF-46FF-95A3-2AE4852D5C19.pdf		4		1		0		1		7		8		85		85	TUMOR FREE	CAP scoring guideline 2010			Strong	Strong	YES	YES	No	80-89%		YES	Primary Tumor	01		7th		YES	NO	S3	Breast	A	LIVING	2013			TCGA-S3-A6ZH-01A-22R-A32K-13	TCGA-S3-A6ZH-01A-22R-A32K-13						4cb51871-a26f-467e-8742-bb7c09b26ed2	889e93b1-b471-4cd4-ad09-398ddc375719	TCGA-S3-A6ZH-01A-22D-A32H-01	4cb51871-a26f-467e-8742-bb7c09b26ed2	TCGA-S3-A6ZH-01A-22D-A32T-05	TCGA-S3-A6ZH-01		4cb51871-a26f-467e-8742-bb7c09b26ed2	4cb51871-a26f-467e-8742-bb7c09b26ed2	TCGA-S3-A6ZH-01A-22D-A32H-01		TCGA-S3-A6ZH-01		889e93b1-b471-4cd4-ad09-398ddc375719	
TCGA-S3-AA0Z-01																													0	TCGA-S3-AA0Z-01	511	0										TCGA-S3-AA0Z	511	0	511	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Left|Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-S3-AA0Z-F67525		Positive	3 Point Scale	1+	3 Point Scale		Positive	Modified Radical Mastectomy		YES			-23314	204		0	511						CAP scoring guideline 2010	90-99%			33		2014-11-6	FEMALE		CAP scoring guideline 2010	10-19%	CAP scoring guideline 2010	1+	20	42	1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.8		YES		Core needle biopsy	330	NO	Equivocal	Negative	NO	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	2	0	true	M0	N1a	T2	Stage IIB	TCGA-S3-AA0Z.6EC48BF8-C9AE-4B53-9DF4-850A5BAC6A6E.pdf		2		0		0		0		2		8		90		90	TUMOR FREE	CAP scoring guideline 2010				moderate	YES	YES	No	<10%		NO	Primary Tumor	01		7th		YES	NO	S3	Breast	A	LIVING	2013			TCGA-S3-AA0Z-01A-11R-A41G-13	TCGA-S3-AA0Z-01A-11R-A41G-13						cfe44709-9e63-4dd4-9778-80176be7fbd9	406831ad-971a-438b-843b-b2e2912e8b29	TCGA-S3-AA0Z-01A-11D-A41E-01	cfe44709-9e63-4dd4-9778-80176be7fbd9	TCGA-S3-AA0Z-01A-11D-A41Q-05	TCGA-S3-AA0Z-01		cfe44709-9e63-4dd4-9778-80176be7fbd9	cfe44709-9e63-4dd4-9778-80176be7fbd9	TCGA-S3-AA0Z-01A-11D-A41E-01		TCGA-S3-AA0Z-01		406831ad-971a-438b-843b-b2e2912e8b29	
TCGA-S3-AA10-01																													0	TCGA-S3-AA10-01	468	0										TCGA-S3-AA10	468	0	468	Breast	TCGA Breast Cancer	breast invasive carcinoma					65	Right|Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-S3-AA10-F67528		Negative	3 Point Scale		3 Point Scale		Negative	Simple Mastectomy		NO			-24075	168		0	468						CAP scoring guideline 2010						2014-11-11	FEMALE		CAP scoring guideline 2010			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Fine needle aspiration biopsy	410	NO	Negative		NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		true	M0	N0	T2	Stage IIA	TCGA-S3-AA10.6A981CB0-F551-48B1-AB91-5D5585A7F282.pdf		8		0		20		2		10		10		60		60	TUMOR FREE	CAP scoring guideline 2010					YES	YES	No			NO	Primary Tumor	01		7th		YES	NO	S3	Breast	A	LIVING	2013			TCGA-S3-AA10-01A-21R-A41G-13	TCGA-S3-AA10-01A-21R-A41G-13						4c80c4a1-7e99-4f9e-b32c-898ae20206c5	7779cc82-d022-43c2-83be-e23303797ce0	TCGA-S3-AA10-01A-21D-A41E-01	4c80c4a1-7e99-4f9e-b32c-898ae20206c5	TCGA-S3-AA10-01A-21D-A41Q-05	TCGA-S3-AA10-01		4c80c4a1-7e99-4f9e-b32c-898ae20206c5	4c80c4a1-7e99-4f9e-b32c-898ae20206c5	TCGA-S3-AA10-01A-21D-A41E-01		TCGA-S3-AA10-01		7779cc82-d022-43c2-83be-e23303797ce0	
TCGA-S3-AA11-01																													0	TCGA-S3-AA11-01	421	0										TCGA-S3-AA11	421	0	421	Breast	TCGA Breast Cancer	breast invasive carcinoma					67	Right	Sentinel node biopsy alone		TCGA-S3-AA11-F67563		Positive	4 Point Scale	2+	3 Point Scale		Positive	Lumpectomy		YES			-24813	148		0	421						CAP scoring guideline 2010	90-99%			40		2014-11-7	FEMALE		CAP scoring guideline 2010	<10%	CAP scoring guideline 2010	2+	20	59	1.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	280	NO	Equivocal	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	true	M0	N0	T2	Stage IIA	TCGA-S3-AA11.B6605B1A-264D-46EF-BB6F-AD5EBE1B34DB.pdf		4		0		0		2		10		30		60		60	TUMOR FREE	CAP scoring guideline 2010					YES	YES	No	60-69%		YES	Primary Tumor	01		7th		YES	NO	S3	Breast	A	LIVING	2013			TCGA-S3-AA11-01A-31R-A41G-13	TCGA-S3-AA11-01A-31R-A41G-13						11785b0e-04c6-4cf5-80c6-2c4ffcb206f6	0a50d096-f517-485c-9b61-5ab097ce7d8d	TCGA-S3-AA11-01A-31D-A41E-01	11785b0e-04c6-4cf5-80c6-2c4ffcb206f6	TCGA-S3-AA11-01A-31D-A41Q-05	TCGA-S3-AA11-01		11785b0e-04c6-4cf5-80c6-2c4ffcb206f6	11785b0e-04c6-4cf5-80c6-2c4ffcb206f6	TCGA-S3-AA11-01A-31D-A41E-01		TCGA-S3-AA11-01		0a50d096-f517-485c-9b61-5ab097ce7d8d	
TCGA-S3-AA12-01																													0	TCGA-S3-AA12-01	467	0										TCGA-S3-AA12	467	0	467	Breast	TCGA Breast Cancer	breast invasive carcinoma					82	Left|Left Upper Inner Quadrant|Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-S3-AA12-F67620		Positive	3 Point Scale	2+	3 Point Scale		Negative	Simple Mastectomy		NO			-30101	156		0	467						CAP SCORING GUIDELINE 2010	90-99%	Lung|Other, specify	left adrenal gland			2014-11-7	FEMALE		CAP SCORING GUIDELINE 2010		CAP SCORING GUIDELINE 2007	1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	2190	NO	Negative	Negative	NO	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	2	0	true	MX	N1a	T3	Stage IIIA	TCGA-S3-AA12.9F96B0B1-2B88-49AE-8D3C-9FED70F1D950.pdf		5		0		5		0		5		10		80		80	TUMOR FREE	CAP SCORING GUIDELINE 2010			MODERATE	MODERATE	YES	YES	Yes			NO	Primary Tumor	01		7th		YES	NO	S3	Breast	A	LIVING	2013			TCGA-S3-AA12-01A-11R-A41G-13	TCGA-S3-AA12-01A-11R-A41G-13						a18a4d65-5383-4c29-ac03-959f8b9cb37d	2113ca5c-95af-4433-a3d9-e589b4a04a57	TCGA-S3-AA12-01A-11D-A41E-01	a18a4d65-5383-4c29-ac03-959f8b9cb37d	TCGA-S3-AA12-01A-11D-A41Q-05	TCGA-S3-AA12-01		a18a4d65-5383-4c29-ac03-959f8b9cb37d	a18a4d65-5383-4c29-ac03-959f8b9cb37d	TCGA-S3-AA12-01A-11D-A41E-01		TCGA-S3-AA12-01		2113ca5c-95af-4433-a3d9-e589b4a04a57	
TCGA-S3-AA14-01																													0	TCGA-S3-AA14-01	455	0										TCGA-S3-AA14	455	0	455	Breast	TCGA Breast Cancer	breast invasive carcinoma					47	Right	Sentinel node biopsy alone		TCGA-S3-AA14-F67622		Positive	3 Point Scale	3+	3 Point Scale		Positive	Other		YES			-17352	127		0	455						CAP SCORING GUIDELINE 2010	70-79%					2014-11-7	FEMALE		CAP SCORING GUIDELINE 2010	70-79%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	290	NO	Positive		NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	3	true	cM0 (i+)	N0 (i+)	T1	Stage I	TCGA-S3-AA14.F4B87B89-A066-4BE9-88C9-60C7FB5BF373.pdf		40		20		0		20		0		20		80		80	TUMOR FREE	CAP SCORING GUIDELINE 2010					YES	YES	No	70-79%		YES	Primary Tumor	01	EXCISION WITH NEEDLE WIRE LOCALIZATION	7th		YES	NO	S3	Breast	A	LIVING	2013			TCGA-S3-AA14-01A-11R-A41G-13	TCGA-S3-AA14-01A-11R-A41G-13						eb8b259a-b2b3-4fb1-b9d3-b41480642da7	54351c40-70e3-4afb-aa2a-6349a0b843ec	TCGA-S3-AA14-01A-11D-A41E-01	eb8b259a-b2b3-4fb1-b9d3-b41480642da7	TCGA-S3-AA14-01A-11D-A41Q-05	TCGA-S3-AA14-01		eb8b259a-b2b3-4fb1-b9d3-b41480642da7	eb8b259a-b2b3-4fb1-b9d3-b41480642da7	TCGA-S3-AA14-01A-11D-A41E-01		TCGA-S3-AA14-01		54351c40-70e3-4afb-aa2a-6349a0b843ec	
TCGA-S3-AA15-01																													0	TCGA-S3-AA15-01	421	0										TCGA-S3-AA15	421	0	421	Breast	TCGA Breast Cancer	breast invasive carcinoma					51	Right|Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-S3-AA15-F67625		Negative			3 Point Scale		Negative	Simple Mastectomy		YES			-18659	93		0	421						CAP SCORING GUIDELINE 2010						2014-11-7	FEMALE		CAP SCORING GUIDELINE 2010								Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES		Core needle biopsy	990	NO	Negative		NO	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	2	0	true	cM0 (i+)	N1a	T2	Stage IIB	TCGA-S3-AA15.DD2B9E47-8C67-4599-B0B6-0D30DE727B55.pdf		40		20		0		20		5		35		60		60	TUMOR FREE	CAP SCORING GUIDELINE 2010					YES	YES	No			YES	Primary Tumor	01		7th		YES	NO	S3	Breast	A	LIVING	2013			TCGA-S3-AA15-01A-11R-A41G-13	TCGA-S3-AA15-01A-11R-A41G-13						181e9c9f-7dbd-4f3a-8298-12797c717e1f	51ab9b17-4565-4792-826e-4ea1e86ddaba	TCGA-S3-AA15-01A-11D-A41E-01	181e9c9f-7dbd-4f3a-8298-12797c717e1f	TCGA-S3-AA15-01A-11D-A41Q-05	TCGA-S3-AA15-01		181e9c9f-7dbd-4f3a-8298-12797c717e1f	181e9c9f-7dbd-4f3a-8298-12797c717e1f	TCGA-S3-AA15-01A-11D-A41E-01		TCGA-S3-AA15-01		51ab9b17-4565-4792-826e-4ea1e86ddaba	
TCGA-S3-AA17-01																													0	TCGA-S3-AA17-01	424	0										TCGA-S3-AA17	424	0	424	Breast	TCGA Breast Cancer	breast invasive carcinoma					64	Right|Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-S3-AA17-F67708		Positive	3 Point Scale	2+	3 Point Scale		Positive	Simple Mastectomy		YES			-23642	92		0	424						CAP SCORING GUIDELINE 2010	90-99%			35		2014-11-11	FEMALE		CAP SCORING GUIDELINE 2010		CAP SCORING GUIDELINE 2010	2+	20	61	1.7		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.5	3+	YES		Core needle biopsy	520	NO	Equivocal	Negative	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	1	true	cM0 (i+)	N1mi	T2	Stage IIB	TCGA-S3-AA17.D7E24E6B-797F-4FC9-B0FB-794C4D379091.pdf		40		20		0		20		0		20		80		80	TUMOR FREE	CAP SCORING GUIDELINE 2010			MODERATE	STRONG	YES	YES	Yes	70-79%		YES	Primary Tumor	01		7th		YES	NO	S3	Breast	A	LIVING	2013			TCGA-S3-AA17-01A-11R-A41G-13	TCGA-S3-AA17-01A-11R-A41G-13						5e032694-2d7f-4e11-8800-0451ff71e5fe	41e8549a-9aed-42bb-9955-cf8b7aff0203	TCGA-S3-AA17-01A-11D-A41E-01	5e032694-2d7f-4e11-8800-0451ff71e5fe	TCGA-S3-AA17-01A-11D-A41Q-05	TCGA-S3-AA17-01		5e032694-2d7f-4e11-8800-0451ff71e5fe	5e032694-2d7f-4e11-8800-0451ff71e5fe	TCGA-S3-AA17-01A-11D-A41E-01		TCGA-S3-AA17-01		41e8549a-9aed-42bb-9955-cf8b7aff0203	
TCGA-UL-AAZ6-01																													0	TCGA-UL-AAZ6-01	518	0										TCGA-UL-AAZ6	518	0	518	Breast	TCGA Breast Cancer	breast invasive carcinoma					73	Right			TCGA-UL-AAZ6-F69329		Positive	3 Point Scale				Positive						-26999	187		0	518							90-99%					2015-1-5	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.8	3+	YES			170	NO	Positive		NO			Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Positive	3+		Positive	90-99%		50-59%		3 Point Scale	3+	1+			<10%		Negative					3 Point Scale					NO			true	MX	N0	T2	Stage IIA	TCGA-UL-AAZ6.1AD1E3C4-0D7C-447B-B330-0245F9159FCC.pdf		5		0		0		0		5		25		70		70	TUMOR FREE						YES		No	<10%		NO	Primary Tumor	01		7th		YES	NO	UL	Breast	A	LIVING	2013			TCGA-UL-AAZ6-01A-11R-A41G-13	TCGA-UL-AAZ6-01A-11R-A41G-13						5a6b1292-431d-4057-912f-6c8b8f12aed8	d1990a4b-9db1-4f6f-9564-eed89ccc47f0	TCGA-UL-AAZ6-01A-11D-A41E-01	5a6b1292-431d-4057-912f-6c8b8f12aed8	TCGA-UL-AAZ6-01A-11D-A41Q-05	TCGA-UL-AAZ6-01		5a6b1292-431d-4057-912f-6c8b8f12aed8	5a6b1292-431d-4057-912f-6c8b8f12aed8	TCGA-UL-AAZ6-01A-11D-A41E-01		TCGA-UL-AAZ6-01		d1990a4b-9db1-4f6f-9564-eed89ccc47f0	
TCGA-UU-A93S-01																													1	TCGA-UU-A93S-01	116	1										TCGA-UU-A93S	116	0	116	Breast	TCGA Breast Cancer	breast invasive carcinoma					63	Right|Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant	No axillary staging				Negative					Negative	Modified Radical Mastectomy		YES			-23278	22	116	0									Bone|Liver				2014-11-11	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	980	NO	Positive				Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO			true	M1	N3b	T4d	Stage IV	TCGA-UU-A93S.821ED144-DF12-4E49-ADC7-27FA5E422B83.pdf		0		0		0		0		10		20		70		80	WITH TUMOR						NO	NO	No			NO	Primary Tumor	01		7th		YES	NO	UU	Breast	A	DECEASED	2013			TCGA-UU-A93S-01A-21R-A41G-13	TCGA-UU-A93S-01A-21R-A41G-13						24ef9702-a1e5-4276-abb2-87088861d471	8f2c56aa-6e4e-4b56-90bf-e70cfc9206f3	TCGA-UU-A93S-01A-21D-A41E-01	24ef9702-a1e5-4276-abb2-87088861d471	TCGA-UU-A93S-01A-21D-A41Q-05	TCGA-UU-A93S-01		24ef9702-a1e5-4276-abb2-87088861d471	24ef9702-a1e5-4276-abb2-87088861d471	TCGA-UU-A93S-01A-21D-A41E-01		TCGA-UU-A93S-01		8f2c56aa-6e4e-4b56-90bf-e70cfc9206f3	
TCGA-V7-A7HQ-01																														TCGA-V7-A7HQ-01												TCGA-V7-A7HQ				Breast	TCGA Breast Cancer	breast invasive carcinoma																							1493																																					50	NO																																				false					TCGA-V7-A7HQ.82B46073-10CE-4D05-9421-6308E3FAD1AD.pdf		4		0		2		0		8		20		70		70													Primary Tumor	01								A					TCGA-V7-A7HQ-01A-11R-A33A-13	TCGA-V7-A7HQ-01A-11R-A33A-13						d42c079f-31a6-42cd-b02a-ea951b8d15a9	00d8d966-3b07-4ecc-aa3e-3adf967de41c	TCGA-V7-A7HQ-01A-11D-A33D-01	d42c079f-31a6-42cd-b02a-ea951b8d15a9	TCGA-V7-A7HQ-01A-11D-A33F-05	TCGA-V7-A7HQ-01		d42c079f-31a6-42cd-b02a-ea951b8d15a9	d42c079f-31a6-42cd-b02a-ea951b8d15a9	TCGA-V7-A7HQ-01A-11D-A33D-01		TCGA-V7-A7HQ-01		00d8d966-3b07-4ecc-aa3e-3adf967de41c	
TCGA-W8-A86G-01																													0	TCGA-W8-A86G-01	347	0										TCGA-W8-A86G	347	0	347	Breast	TCGA Breast Cancer	breast invasive carcinoma					66	Left|Left Lower Inner Quadrant	Sentinel node biopsy alone		TCGA-W8-A86G-F65574	Negative	Positive	3 Point Scale	1+	3 Point Scale	Other	Positive	Lumpectomy	Mastectomy	YES			-24125	126		0	347							90-99%					2014-9-25	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.1	1+	YES		Core needle biopsy	210	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0 (i-)	T2a	Stage IIA	TCGA-W8-A86G.A5433CA5-1DCC-4711-9B3B-6478AE7B5FAA.pdf		40		20		0		20		0		20		80		80	TUMOR FREE						YES	YES	Yes	70-79%		NO	Primary Tumor	01		7th		YES	NO	W8	Breast	A	LIVING	2013			TCGA-W8-A86G-01A-21R-A36A-13	TCGA-W8-A86G-01A-21R-A36A-13						37106eb9-90ee-4468-aded-0709fa4bba47	b88956ed-4bc5-44f9-9995-2cef9c30391f	TCGA-W8-A86G-01A-21D-A36I-01	37106eb9-90ee-4468-aded-0709fa4bba47	TCGA-W8-A86G-01A-21D-A36K-05	TCGA-W8-A86G-01		37106eb9-90ee-4468-aded-0709fa4bba47	37106eb9-90ee-4468-aded-0709fa4bba47	TCGA-W8-A86G-01A-21D-A36I-01		TCGA-W8-A86G-01		b88956ed-4bc5-44f9-9995-2cef9c30391f	
TCGA-WT-AB41-01																													0	TCGA-WT-AB41-01	1611	0										TCGA-WT-AB41	1611	0	1611	Breast	TCGA Breast Cancer	breast invasive carcinoma					55	Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant	No axillary staging		TCGA-WT-AB41-F66639		Positive	3 Point Scale	1+	3 Point Scale		Positive	Modified Radical Mastectomy						1415		0	1611							90-99%					2014-10-21	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	110	NO			NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1		false	MX	N1mi	T2	Stage IIB	TCGA-WT-AB41.FDB00212-9782-4ACE-AD59-019384297A2F.pdf		0		0		0		0		0		0		100		75	TUMOR FREE						YES	YES	Yes	<10%		NO	Primary Tumor	01		7th		NO	YES	WT	Breast	A	LIVING	2010			TCGA-WT-AB41-01A-11R-A41G-13	TCGA-WT-AB41-01A-11R-A41G-13						a8358182-9a5c-4272-b0e3-1cfc5b4cb2aa	64a77049-5d0c-4cc6-ba17-014e39eb7711	TCGA-WT-AB41-01A-11D-A41E-01	a8358182-9a5c-4272-b0e3-1cfc5b4cb2aa	TCGA-WT-AB41-01A-11D-A41Q-05	TCGA-WT-AB41-01		a8358182-9a5c-4272-b0e3-1cfc5b4cb2aa	a8358182-9a5c-4272-b0e3-1cfc5b4cb2aa	TCGA-WT-AB41-01A-11D-A41E-01		TCGA-WT-AB41-01		64a77049-5d0c-4cc6-ba17-014e39eb7711	
TCGA-WT-AB44-01																													0	TCGA-WT-AB44-01	883	0										TCGA-WT-AB44	883	0	883	Breast	TCGA Breast Cancer	breast invasive carcinoma					77	Left	No axillary staging		TCGA-WT-AB44-F66640		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy						656		0	883							90-99%					2014-10-21	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4	3+	YES		Core needle biopsy	20	NO	Negative		NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	MX	N0 (i-)	T1c	Stage IA	TCGA-WT-AB44.B7EB0E0B-46C5-43C0-A78D-FB094290765A.pdf		2		0		0		0		0		0		100		65	TUMOR FREE						YES	YES	No	90-99%		YES	Primary Tumor	01		7th		NO	YES	WT	Breast	A	LIVING	2012			TCGA-WT-AB44-01A-11R-A41G-13	TCGA-WT-AB44-01A-11R-A41G-13						77ea5b95-f8df-4fae-b271-182680c4a62a	5b7aacc0-7bc9-4318-b439-e5b15e61cdfc	TCGA-WT-AB44-01A-11D-A41E-01	77ea5b95-f8df-4fae-b271-182680c4a62a	TCGA-WT-AB44-01A-11D-A41Q-05	TCGA-WT-AB44-01		77ea5b95-f8df-4fae-b271-182680c4a62a	77ea5b95-f8df-4fae-b271-182680c4a62a	TCGA-WT-AB44-01A-11D-A41E-01		TCGA-WT-AB44-01		5b7aacc0-7bc9-4318-b439-e5b15e61cdfc	
TCGA-XX-A899-01																													0	TCGA-XX-A899-01	467	0										TCGA-XX-A899	467	0	467	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-XX-A899-F67626		Positive					Positive	Modified Radical Mastectomy		NO			-17022	181		0	467							90-99%					2014-11-11	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.8		YES		Core needle biopsy	260	NO	Negative		NO	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	5	0	false	MX	N2a	T1c	Stage IIIA	TCGA-XX-A899.EA8A0A91-7A83-4EC9-B7A0-0C3300D1FD14.pdf		4		0		0		0		0		0		100		65	TUMOR FREE				strong	strong	YES	YES	No	70-79%		YES	Primary Tumor	01		7th		NO	YES	XX	Breast	A	LIVING	2013			TCGA-XX-A899-01A-11R-A36A-13	TCGA-XX-A899-01A-11R-A36A-13						8e339298-3e3c-4b31-96a9-a842e973e583	31fad9a6-80ba-4ed8-862a-d8e17816c645	TCGA-XX-A899-01A-11D-A36I-01	8e339298-3e3c-4b31-96a9-a842e973e583	TCGA-XX-A899-01A-11D-A36K-05	TCGA-XX-A899-01		8e339298-3e3c-4b31-96a9-a842e973e583	8e339298-3e3c-4b31-96a9-a842e973e583	TCGA-XX-A899-01A-11D-A36I-01		TCGA-XX-A899-01		31fad9a6-80ba-4ed8-862a-d8e17816c645	
TCGA-XX-A89A-01																													0	TCGA-XX-A89A-01	488	0										TCGA-XX-A89A	488	0	488	Breast	TCGA Breast Cancer	breast invasive carcinoma					68	Left Upper Outer Quadrant			TCGA-XX-A89A-F67425		Positive					Positive	Simple Mastectomy					-25000	174		0	488							70-79%					2014-11-11	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES		Core needle biopsy	250	NO	Negative		NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	MX	N0	T3	Stage IIB	TCGA-XX-A89A.5D85E578-64B4-4238-922E-802B8ED87800.pdf		3		0		0		0		0		0		100		65	TUMOR FREE				moderately to strongly	moderately to strongly	NO	YES	No	70-79%		YES	Primary Tumor	01		7th		NO	YES	XX	Breast	A	LIVING	2013			TCGA-XX-A89A-01A-11R-A36A-13	TCGA-XX-A89A-01A-11R-A36A-13						501a70d8-3932-49c0-aa13-774756fb89e3	e6031cb7-3b18-4a8e-a40a-c1c86066b9a1	TCGA-XX-A89A-01A-11D-A36I-01	501a70d8-3932-49c0-aa13-774756fb89e3	TCGA-XX-A89A-01A-11D-A36K-05	TCGA-XX-A89A-01		501a70d8-3932-49c0-aa13-774756fb89e3	501a70d8-3932-49c0-aa13-774756fb89e3	TCGA-XX-A89A-01A-11D-A36I-01		TCGA-XX-A89A-01		e6031cb7-3b18-4a8e-a40a-c1c86066b9a1	
TCGA-Z7-A8R5-01																													0	TCGA-Z7-A8R5-01	3287	0										TCGA-Z7-A8R5	3287	1	3287	Breast	TCGA Breast Cancer	breast invasive carcinoma					61	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-Z7-A8R5-F58763		Positive	4 Point Scale	1+	4 Point Scale		Positive	Other		YES			-22280	2928		0	3287			3287									2014-7-9	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Core needle biopsy	450	NO	Negative		NO	5	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																							Bone	Locoregional Recurrence			YES	3	3	true	MX	N1a	T3	Stage IIIA	TCGA-Z7-A8R5.7726F7AA-88A8-4DD6-B322-6FC68893E0D2.pdf		40		20		5		20		0		25		70		70	WITH TUMOR						YES	YES	Yes			NO	Primary Tumor	01	Segmental Mastectomy	6th		NO	YES	Z7	Breast	A	LIVING	2005			TCGA-Z7-A8R5-01A-42R-A41G-13	TCGA-Z7-A8R5-01A-42R-A41G-13						43c6d23b-2fcd-499e-82ef-10f15d8ede90	54a35393-ebdf-4d7c-a8fe-a89b9a0f6cb6	TCGA-Z7-A8R5-01A-42D-A41E-01	43c6d23b-2fcd-499e-82ef-10f15d8ede90	TCGA-Z7-A8R5-01A-42D-A41Q-05	TCGA-Z7-A8R5-01		43c6d23b-2fcd-499e-82ef-10f15d8ede90	43c6d23b-2fcd-499e-82ef-10f15d8ede90	TCGA-Z7-A8R5-01A-42D-A41E-01		TCGA-Z7-A8R5-01		54a35393-ebdf-4d7c-a8fe-a89b9a0f6cb6	
TCGA-Z7-A8R6-01																													0	TCGA-Z7-A8R6-01	3256	0										TCGA-Z7-A8R6	3256	0	3256	Breast	TCGA Breast Cancer	breast invasive carcinoma					46	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-Z7-A8R6-F58752		Positive	4 Point Scale	2+	4 Point Scale		Positive	Lumpectomy		YES			-16955			0	3256												2014-7-9	FEMALE					1+					Infiltrating Lobular Carcinoma		No			8022/3	C50.8	2+	YES		Tumor resection			Negative		NO	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0	0		M0	N0	T1c	Stage I																		TUMOR FREE						YES	YES	No			NO	Primary Tumor	01		6th		NO	YES	Z7	Breast		LIVING	2005			TCGA-Z7-A8R6-01A-11R-A41G-13	TCGA-Z7-A8R6-01A-11R-A41G-13						d8a45ca6-8f09-4949-8d55-13259b4826d2	bb3b3be9-0e57-4a9f-b80f-2d9240999803	TCGA-Z7-A8R6-01A-11D-A41E-01	d8a45ca6-8f09-4949-8d55-13259b4826d2	TCGA-Z7-A8R6-01A-11D-A41Q-05	TCGA-Z7-A8R6-01		d8a45ca6-8f09-4949-8d55-13259b4826d2	d8a45ca6-8f09-4949-8d55-13259b4826d2	TCGA-Z7-A8R6-01A-11D-A41E-01		TCGA-Z7-A8R6-01		bb3b3be9-0e57-4a9f-b80f-2d9240999803	
